data_2avg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2avg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 119.985 -0.055 . . . . 1.6499999999999999 111.003 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.28 69.98 2.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.916 2.411 . . . . 1.24 112.374 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.593 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -92.88 -54.61 7.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.013 -0.994 . . . . 1.2 109.323 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.23 6.24 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.798 -2.121 . . . . 0.44 107.798 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.917 HD23 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -53.34 -36.57 61.46 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 112.78 -1.71 . . . . 1.1100000000000001 110.575 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.545 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -94.82 85.29 4.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.367 -0.833 . . . . 0.97999999999999998 109.642 172.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.88 -49.02 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.6 -1.182 . . . . 1.1100000000000001 109.719 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.0 tpt -143.74 133.73 24.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 3.3100000000000001 108.912 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 20.7 ptt180 -103.86 132.84 20.65 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.107 -0.497 . . . . 4.1699999999999999 111.405 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.1 Cg_endo -64.34 151.63 84.69 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.683 2.255 . . . . 0.81999999999999995 111.328 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.8 mm-40 -121.13 176.54 5.54 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.042 -0.527 . . . . 1.6299999999999999 110.452 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.23 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.524 1.154 . . . . 2.0600000000000001 111.586 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.27 135.61 2.0 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.11 -1.405 . . . . 0.34999999999999998 111.953 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.842 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 44.8 mt-10 -114.01 115.05 27.0 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.332 -0.934 . . . . 1.53 108.943 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -136.07 163.23 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 N-CA-C 107.645 -1.242 . . . . 1.0800000000000001 107.645 -173.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.44 152.36 19.14 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.866 -1.061 . . . . 1.22 108.925 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.691 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -73.3 106.6 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 123.897 1.808 . . . . 1.3799999999999999 109.419 172.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.59 -3.93 5.44 Favored Glycine 0 C--N 1.274 -2.873 0 CA-C-N 110.331 -3.122 . . . . 0.52000000000000002 111.196 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.13 -127.5 5.94 Favored Glycine 0 N--CA 1.411 -2.988 0 C-N-CA 119.24 -1.457 . . . . 0.44 110.217 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 9.5 p -150.85 170.08 20.14 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.0 -1.6 . . . . 1.23 110.76 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 104' ' ' LEU . 8.7 tp -147.16 149.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 113.592 -1.64 . . . . 1.0900000000000001 108.065 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 m -138.87 128.51 24.71 Favored 'General case' 0 C--N 1.268 -2.973 0 CA-C-N 113.503 -1.681 . . . . 1.05 110.73 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.454 ' HB2' ' CG ' ' A' ' 74' ' ' LEU . 45.2 m-85 -125.19 152.69 44.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.182 -1.372 . . . . 0.71999999999999997 108.44 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.51 125.98 18.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.214 -0.662 . . . . 0.87 109.214 175.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.612 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.11 121.03 36.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.161 -0.927 . . . . 1.1000000000000001 110.367 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 56.3 mtp180 -108.02 117.08 33.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.353 -0.385 . . . . 2.9300000000000002 110.021 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 23.6 t -120.87 130.53 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.286 1.041 . . . . 1.0700000000000001 110.436 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.896 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -60.96 109.12 0.98 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.286 -1.779 . . . . 1.1200000000000001 113.696 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.56 3.04 Favored Glycine 0 N--CA 1.462 0.401 0 CA-C-N 114.728 -1.123 . . . . 0.76000000000000001 113.091 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.593 ' HB3' ' CE ' ' A' ' 68' ' ' LYS . . . -50.68 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 114.669 1.359 . . . . 1.0 114.669 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -81.58 127.59 33.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.481 -1.236 . . . . 2.1699999999999999 108.361 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.817 HD12 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -157.12 177.79 11.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.168 -0.469 . . . . 2.6299999999999999 111.179 -172.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.83 -51.09 71.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.45 0.643 . . . . 1.99 109.287 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.47 149.41 26.29 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.785 -1.098 . . . . 1.8799999999999999 108.718 171.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HB3' ' HH ' ' A' ' 70' ' ' TYR . 79.2 Cg_exo -43.01 143.9 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.524 2.816 . . . . 1.1200000000000001 112.651 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.817 ' HD3' HD12 ' A' ' 33' ' ' LEU . 2.0 Cg_endo -48.7 133.03 26.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.715 1.61 . . . . 0.81999999999999995 113.25 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.1 105.99 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 106.54 -1.652 . . . . 1.4299999999999999 106.54 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.27 114.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 CA-C-N 113.655 -1.611 . . . . 1.0900000000000001 107.962 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.5 127.3 49.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 123.456 1.598 . . . . 2.1299999999999999 110.096 173.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.026 ' HB3' HD12 ' A' ' 49' ' ' LEU . 86.0 m95 -87.04 155.47 20.14 Favored 'General case' 0 C--N 1.273 -2.724 0 CA-C-N 111.178 -2.737 . . . . 0.40999999999999998 112.05 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.5 t80 -134.26 135.94 43.25 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 104.173 -2.528 . . . . 0.80000000000000004 104.173 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 50.8 tttm -98.43 171.85 7.9 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.023 -1.843 . . . . 2.6800000000000002 106.023 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.988 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -15.43 -172.48 0.0 OUTLIER Glycine 0 C--O 1.178 -3.358 0 N-CA-C 119.117 2.407 . . . . 1.6000000000000001 119.117 172.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.62 -8.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.169 2.285 . . . . 4.2999999999999998 117.169 -162.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ3' HG11 ' A' ' 47' ' ' VAL . 11.1 p-90 -162.09 -6.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.012 1.115 . . . . 2.5099999999999998 114.012 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.894 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.5 163.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.769 0 CA-C-O 123.712 1.72 . . . . 1.78 112.565 -161.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.679 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.6 p-10 -109.94 157.65 19.04 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.987 -2.824 . . . . 2.73 105.925 170.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.026 HD12 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -99.34 -30.11 12.4 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.294 -0.562 . . . . 1.1299999999999999 112.185 168.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.2 t -56.9 -21.63 31.21 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.038 0.535 . . . . 1.71 109.733 -164.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -99.9 -36.12 9.51 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.86 0.838 . . . . 1.76 111.503 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.679 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -87.68 -31.85 19.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.406 -1.27 . . . . 1.9099999999999999 111.319 -167.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 49' ' ' LEU . 52.4 t -36.43 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 125.391 1.476 . . . . 1.1499999999999999 111.215 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.59 -93.71 0.1 OUTLIER Glycine 0 C--N 1.298 -1.536 0 CA-C-N 112.701 -2.045 . . . . 0.69999999999999996 113.812 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -94.15 -44.84 7.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.578 0.584 . . . . 3.3599999999999999 112.578 -168.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 19.6 p80 -95.76 -36.21 11.25 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.339 0.59 . . . . 1.78 110.731 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.992 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -115.55 106.38 13.87 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.1 -1.815 . . . . 1.72 106.1 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.76 115.19 29.71 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 106.75 -1.574 . . . . 0.96999999999999997 106.75 166.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.659 HD13 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -100.42 92.26 5.08 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.742 -2.318 . . . . 1.0600000000000001 104.742 172.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.666 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 44.0 m170 -86.09 163.82 17.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.096 -1.411 . . . . 2.5899999999999999 110.916 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.17 115.74 16.76 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.847 -1.979 . . . . 0.92000000000000004 109.649 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -98.11 149.3 22.65 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 112.759 -2.019 . . . . 0.76000000000000001 107.839 170.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.86 99.04 3.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.48 1.133 . . . . 1.8 110.961 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.7 m-20 -110.26 107.19 16.87 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 112.904 -1.953 . . . . 2.4199999999999999 108.954 176.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -45.94 61.35 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.604 -0.725 . . . . 3.0800000000000001 110.333 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.34 -30.33 71.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.745 -1.116 . . . . 1.6899999999999999 110.984 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 19.5 m -89.49 -19.35 25.18 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.977 -0.749 . . . . 1.96 108.977 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.896 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 2.2 ttpm? 61.92 41.05 11.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.078 -0.965 . . . . 3.7799999999999998 108.399 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.491 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 21.9 t -133.27 124.92 50.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.875 -1.057 . . . . 1.1299999999999999 111.139 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.3 m-30 -97.81 106.06 18.3 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.992 -1.855 . . . . 1.95 105.992 163.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 7.9 tp -95.07 105.27 17.18 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 122.622 1.201 . . . . 1.1799999999999999 108.984 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.9 m-85 -85.66 114.7 22.84 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.469 -1.696 . . . . 0.40000000000000002 108.289 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 30.5 mt-10 -96.48 134.54 39.53 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.461 -1.7 . . . . 1.3200000000000001 108.628 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.871 HD23 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -106.75 111.36 23.85 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.564 -1.273 . . . . 1.5900000000000001 107.564 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -108.7 94.24 4.95 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 103.403 -2.814 . . . . 2.0099999999999998 103.403 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 57' ' ' LEU . 57.5 mt -120.77 100.89 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.698 1.237 . . . . 1.1899999999999999 109.214 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 60.1 p -100.58 165.9 11.18 Favored 'General case' 0 N--CA 1.391 -3.425 0 CA-C-N 114.355 -1.293 . . . . 1.05 109.364 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 50.68 73.5 0.28 Allowed 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 110.848 -2.887 . . . . 2.1200000000000001 111.722 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB1' HD23 ' A' ' 104' ' ' LEU . . . -73.71 112.32 9.7 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 113.004 -1.907 . . . . 1.0900000000000001 110.017 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.808 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.38 146.62 52.44 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 1.77 110.029 171.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.691 ' HD3' HG21 ' A' ' 18' ' ' VAL . 19.9 Cg_endo -61.15 -13.89 30.58 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.554 2.17 . . . . 1.3300000000000001 112.742 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.808 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -104.4 17.24 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.031 -0.531 . . . . 1.6599999999999999 110.45 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.6 OUTLIER -95.31 -11.29 28.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.393 -0.813 . . . . 1.24 111.005 -177.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m -17.97 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 125.668 1.855 . . . . 1.6799999999999999 111.74 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.988 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -56.9 120.51 20.97 Favored Glycine 0 N--CA 1.404 -3.441 0 CA-C-N 110.633 -2.985 . . . . 2.0 114.876 -167.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.67 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -115.5 72.31 0.25 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 112.359 -1.92 . . . . 0.81000000000000005 108.556 152.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.699 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 56.0 m-85 -77.04 118.38 19.54 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.728 -0.842 . . . . 1.0800000000000001 108.728 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 29.4 mtp180 -114.38 125.08 53.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.212 -0.662 . . . . 3.6899999999999999 109.212 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 2.9 t -112.6 117.52 32.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.899 -0.778 . . . . 1.22 108.899 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 36.0 mt-10 -132.4 104.02 6.5 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.179 -0.919 . . . . 1.8100000000000001 110.115 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.629 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -94.04 142.53 13.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.418 0.628 . . . . 1.24 110.267 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.7 t -134.83 108.18 7.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.914 -1.039 . . . . 1.6399999999999999 108.337 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -132.35 153.18 51.0 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.958 -1.02 . . . . 1.26 108.649 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.718 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 23.2 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.691 1.87 . . . . 0.93999999999999995 113.999 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.718 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 16.6 t70 -144.17 -3.78 0.84 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.829 -1.078 . . . . 1.05 109.802 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.917 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.32 135.04 33.92 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.148 -1.056 . . . . 1.78 108.148 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.498 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 31.0 t80 -132.71 131.29 41.09 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.898 -1.501 . . . . 1.0 110.503 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.78 149.98 31.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.635 -1.166 . . . . 1.6000000000000001 108.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 7.4 p -152.77 154.37 35.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.243 0.544 . . . . 1.98 112.216 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.577 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 11.6 p -129.86 150.6 51.09 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.773 0.797 . . . . 1.02 112.06 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.531 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.0 OUTLIER -131.31 109.42 10.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.038 -1.437 . . . . 1.5800000000000001 109.38 177.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.838 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.8 p90 -142.72 129.71 20.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.374 0.607 . . . . 1.1000000000000001 109.667 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.5 p30 -101.93 157.96 16.48 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.899 1.333 . . . . 2.1099999999999999 111.954 -172.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -121.71 109.65 14.99 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.18 -1.827 . . . . 1.0900000000000001 109.745 171.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 28.9 m -91.23 97.69 11.28 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.187 -0.671 . . . . 1.0700000000000001 109.187 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 80' ' ' GLN . 4.6 p -81.3 116.2 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 123.204 1.478 . . . . 1.1399999999999999 109.292 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.842 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 94.9 m-70 -88.81 100.26 13.02 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.571 -2.104 . . . . 1.8200000000000001 109.002 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.49 ' HA ' ' CG1' ' A' ' 18' ' ' VAL . 31.4 tt0 . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.704 -1.135 . . . . 1.6699999999999999 109.82 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.572 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 23.8 m-20 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 110.246 -0.279 . . . . 1.6499999999999999 110.246 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.84 86.91 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.478 2.118 . . . . 1.24 112.349 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.795 HD12 ' HZ3' ' A' ' 94' ' ' LYS . 1.8 mp -116.45 -60.29 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 1.2 109.513 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.69 5.59 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 108.473 -1.851 . . . . 0.44 108.473 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.708 HD13 ' HB3' ' A' ' 37' ' ' PRO . 12.1 tp -53.67 -45.43 70.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.403 -1.899 . . . . 1.1100000000000001 111.87 -168.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.694 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.82 84.78 3.95 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.562 0.696 . . . . 0.97999999999999998 109.818 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.48 -40.55 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.152 -1.385 . . . . 1.1100000000000001 110.686 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.5 ttm -157.57 132.1 8.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.916 -0.584 . . . . 3.3100000000000001 110.18 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.539 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 13.2 ptp180 -103.67 139.25 19.93 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.046 -0.979 . . . . 4.1699999999999999 109.865 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -75.19 165.28 31.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.382 1.388 . . . . 0.81999999999999995 111.135 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -122.91 -177.63 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.043 -0.526 . . . . 1.6299999999999999 110.343 -172.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 5.1 p-10 -67.94 -150.48 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-O 123.076 1.417 . . . . 2.0600000000000001 111.704 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.456 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 152.97 131.44 1.64 Allowed Glycine 0 C--N 1.291 -1.945 0 CA-C-N 112.762 -2.017 . . . . 0.34999999999999998 112.063 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -110.54 110.93 21.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.422 -0.955 . . . . 1.53 108.422 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 m -130.58 141.82 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 107.598 -1.26 . . . . 1.0800000000000001 107.598 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.763 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -77.52 156.88 30.69 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.871 -1.059 . . . . 1.22 109.387 -177.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 79' ' ' ALA . 3.9 t -66.38 105.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 CA-C-O 122.767 1.27 . . . . 1.3799999999999999 107.886 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.0 10.01 Favored Glycine 0 C--N 1.266 -3.318 0 CA-C-N 112.36 -2.2 . . . . 0.52000000000000002 112.688 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.84 4.94 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 118.668 -1.729 . . . . 0.44 108.92 172.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.9 p -151.43 163.57 38.68 Favored 'General case' 0 N--CA 1.397 -3.124 0 CA-C-N 112.882 -1.659 . . . . 1.23 110.527 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 76' ' ' ILE . 9.4 tp -136.67 146.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.141 -1.845 . . . . 1.0900000000000001 107.106 171.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -137.91 125.07 21.57 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 113.088 -1.869 . . . . 1.05 110.743 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.501 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 75.5 m-85 -123.36 143.24 50.23 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.266 -1.334 . . . . 0.71999999999999997 109.239 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -131.99 118.73 20.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.277 -0.874 . . . . 0.87 109.79 177.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -117.11 116.15 26.76 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.514 -1.221 . . . . 1.1000000000000001 110.145 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.27 124.2 49.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.362 -0.211 . . . . 2.9300000000000002 110.886 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.56 130.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 122.093 0.949 . . . . 1.0700000000000001 110.589 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.841 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -63.66 111.54 2.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.25 -1.795 . . . . 1.1200000000000001 111.589 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.837 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.49 -53.04 17.69 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 114.761 -1.108 . . . . 0.76000000000000001 111.976 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.704 ' CA ' ' HE3' ' A' ' 68' ' ' LYS . . . 59.96 -174.22 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.666 0.987 . . . . 1.0 113.666 169.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -111.61 128.87 56.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.69 -1.141 . . . . 2.1699999999999999 108.975 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.35 -179.47 7.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.155 0.503 . . . . 2.6299999999999999 111.992 -170.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.08 -44.31 80.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.82 -1.082 . . . . 1.99 108.962 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.59 148.26 23.29 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.909 -1.041 . . . . 1.8799999999999999 109.547 175.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HB3' ' HH ' ' A' ' 70' ' ' TYR . 88.8 Cg_exo -47.64 142.38 13.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.231 2.62 . . . . 1.1200000000000001 111.507 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HB3' HD13 ' A' ' 6' ' ' LEU . 1.8 Cg_endo -49.11 131.9 26.89 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.897 1.731 . . . . 0.81999999999999995 113.002 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.74 104.97 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 106.922 -1.51 . . . . 1.4299999999999999 106.922 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -108.33 114.08 45.63 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 112.81 -1.996 . . . . 1.0900000000000001 107.306 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.61 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.91 125.37 48.58 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-O 123.266 1.508 . . . . 2.1299999999999999 110.132 174.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.913 ' HB3' HD12 ' A' ' 49' ' ' LEU . 55.2 m95 -83.49 157.06 22.54 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 111.39 -2.641 . . . . 0.40999999999999998 111.555 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 20.3 t80 -135.66 139.55 43.82 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 104.794 -2.299 . . . . 0.80000000000000004 104.794 168.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.956 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttm -100.63 167.24 10.46 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.424 -2.435 . . . . 2.6800000000000002 104.424 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.26 -165.51 0.0 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 118.982 2.353 . . . . 1.6000000000000001 118.982 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.525 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 15.0 mtpt -45.23 -11.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.095 0 O-C-N 118.592 -2.71 . . . . 4.2999999999999998 116.417 -168.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -164.18 -2.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.83 1.418 . . . . 2.5099999999999998 114.83 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.956 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.73 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-O 122.942 1.353 . . . . 1.78 112.173 -163.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 1.5 p-10 -109.66 101.71 10.6 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 112.29 -2.232 . . . . 2.73 112.191 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.981 HD23 HD23 ' A' ' 57' ' ' LEU . 5.1 mp -54.34 -34.89 62.02 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.041 0.756 . . . . 1.1299999999999999 113.041 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 m -57.28 -21.9 37.82 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.548 0.69 . . . . 1.71 109.668 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.444 ' HB2' ' CD ' ' A' ' 52' ' ' LYS . 22.7 m -98.19 -34.91 10.55 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.982 -1.008 . . . . 1.76 111.707 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.557 ' HB2' HD12 ' A' ' 57' ' ' LEU . 3.0 mmmt -90.92 -36.06 14.36 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.941 -1.027 . . . . 1.9099999999999999 111.67 -168.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.629 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 44.3 t -37.54 96.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 125.888 1.675 . . . . 1.1499999999999999 111.869 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.705 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -153.41 -111.84 0.46 Allowed Glycine 0 C--N 1.298 -1.541 0 CA-C-N 111.546 -2.57 . . . . 0.69999999999999996 112.742 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.873 HE21 ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -95.73 -27.44 15.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.348 0.87 . . . . 3.3599999999999999 113.348 -169.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -95.36 -36.45 11.37 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.574 0.702 . . . . 1.78 110.439 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.981 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.69 105.49 11.22 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.14 -1.8 . . . . 1.72 106.14 172.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -98.56 115.86 29.53 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.658 -1.608 . . . . 0.96999999999999997 106.658 165.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.564 ' HA ' HD23 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -92.05 92.09 8.11 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 103.495 -2.78 . . . . 1.0600000000000001 103.495 167.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.683 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -92.33 164.22 13.59 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 113.896 -1.502 . . . . 2.5899999999999999 109.502 -173.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -137.26 117.98 14.04 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 111.341 -2.663 . . . . 0.92000000000000004 109.998 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -101.28 142.52 32.58 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.622 -2.081 . . . . 0.76000000000000001 106.895 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -137.91 98.58 3.68 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.757 1.265 . . . . 1.8 110.792 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.27 105.72 13.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 113.132 -1.849 . . . . 2.4199999999999999 109.695 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.561 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -74.83 -29.83 61.18 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.845 -1.071 . . . . 3.0800000000000001 110.796 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -35.27 80.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.34 -0.845 . . . . 1.6899999999999999 110.93 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -98.85 -12.38 20.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.641 -0.708 . . . . 1.96 109.839 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.841 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 18.4 tttt 67.22 33.7 5.34 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.745 0.783 . . . . 3.7799999999999998 109.564 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.24 128.33 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.969 -0.559 . . . . 1.1299999999999999 109.685 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.837 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 22.5 m-85 -95.71 116.2 28.53 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.586 -2.005 . . . . 1.95 105.586 162.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 25' ' ' SER . 38.0 tp -94.08 104.13 16.17 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.517 -1.29 . . . . 1.1799999999999999 107.517 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.9 m-85 -83.04 110.66 18.18 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.117 -1.809 . . . . 0.40000000000000002 106.117 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.683 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.2 pt-20 -114.75 122.7 47.21 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.666 -1.606 . . . . 1.3200000000000001 110.278 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.4 mt -91.46 131.07 37.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.201 -1.363 . . . . 1.5900000000000001 108.374 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -117.85 95.47 4.94 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 103.077 -2.934 . . . . 2.0099999999999998 103.077 167.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.726 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.4 mt -121.24 100.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.979 0 CA-C-O 122.902 1.334 . . . . 1.1899999999999999 108.619 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.1 p -104.43 165.16 11.24 Favored 'General case' 0 N--CA 1.389 -3.519 0 CA-C-N 114.116 -1.402 . . . . 1.05 109.941 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 38.45 75.73 0.07 Allowed 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 110.563 -3.017 . . . . 2.1200000000000001 111.84 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.516 ' O ' HG11 ' A' ' 18' ' ' VAL . . . -68.74 117.77 10.87 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.789 -2.914 . . . . 1.0900000000000001 111.074 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.806 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -51.27 135.03 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.848 -0.797 . . . . 1.77 108.848 165.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.596 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 19.3 Cg_endo -60.0 -13.49 23.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.932 2.421 . . . . 1.3300000000000001 112.685 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.806 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -96.6 15.48 21.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.974 -0.557 . . . . 1.6599999999999999 110.797 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.1 m-30 -95.09 -10.59 30.26 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.972 -0.381 . . . . 1.24 109.972 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.6 m -46.28 98.51 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.829 0 O-C-N 124.606 1.191 . . . . 1.6799999999999999 108.732 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -169.35 -130.1 1.17 Allowed Glycine 0 C--N 1.266 -3.353 0 CA-C-N 112.698 -2.046 . . . . 2.0 113.145 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.0 118.74 0.9 Allowed Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 119.962 -1.113 . . . . 0.81000000000000005 112.695 -170.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.874 ' HH ' ' HZ1' ' A' ' 43' ' ' LYS . 1.3 m-85 -85.13 134.95 34.16 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.04 -1.58 . . . . 1.0800000000000001 107.577 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 63.7 mtt180 -118.99 155.07 32.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.204 0.526 . . . . 3.6899999999999999 110.6 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.643 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 75.0 m -131.31 132.26 44.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.825 -1.176 . . . . 1.22 107.825 163.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.61 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 35.0 tt0 -134.95 103.33 5.54 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.723 -1.214 . . . . 1.8100000000000001 107.723 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.528 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.6 p -99.6 134.91 37.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.983 0.897 . . . . 1.24 110.835 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -133.46 108.5 8.69 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.794 -1.548 . . . . 1.6399999999999999 108.864 -176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.68 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -132.09 155.13 48.66 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.376 -0.972 . . . . 1.26 108.376 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.795 ' HZ3' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 18.61 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 125.601 1.813 . . . . 0.93999999999999995 114.882 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.778 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 5.0 t70 -151.81 1.23 0.36 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.748 -1.115 . . . . 1.05 109.668 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.714 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmtp -98.17 130.05 44.93 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.961 -1.126 . . . . 1.78 107.961 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -131.26 147.17 52.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.991 -1.004 . . . . 1.0 111.189 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -172.13 166.24 6.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.933 -0.765 . . . . 1.6000000000000001 108.933 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.4 p -155.67 156.76 35.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 1.98 110.461 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.694 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 30.8 p -135.39 147.63 49.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.715 -0.675 . . . . 1.02 111.086 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.456 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -127.19 121.92 32.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 1.5800000000000001 110.066 177.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.711 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -141.98 116.66 9.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.121 0.486 . . . . 1.1000000000000001 109.796 -175.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.549 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.3 p30 -100.3 146.26 27.14 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 122.418 1.104 . . . . 2.1099999999999999 111.88 -169.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -116.76 122.91 45.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.219 -1.355 . . . . 1.0900000000000001 109.349 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -101.58 96.69 7.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.508 -0.923 . . . . 1.0700000000000001 108.508 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 3.8 p -79.19 114.58 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-O 123.203 1.477 . . . . 1.1399999999999999 109.711 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.763 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 9.3 m-70 -79.97 99.33 7.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.098 -2.319 . . . . 1.8200000000000001 109.816 -175.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.479 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 35.5 tt0 . . . . . 0 C--N 1.295 -1.784 0 CA-C-N 114.039 -1.437 . . . . 1.6699999999999999 109.348 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.461 ' HB2' ' CE ' ' A' ' 94' ' ' LYS . 8.4 m-20 . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 109.624 -0.51 . . . . 1.6499999999999999 109.624 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 84.41 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.24 1.96 . . . . 1.24 113.132 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.819 HD11 ' HE2' ' A' ' 94' ' ' LYS . 1.8 mp -110.71 -66.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.11 -0.95 . . . . 1.2 109.187 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.85 37.47 6.06 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 108.573 -1.811 . . . . 0.44 108.573 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.2 tp -38.57 -51.34 1.62 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.767 -1.716 . . . . 1.1100000000000001 110.858 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.699 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -85.93 85.57 7.37 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 121.635 0.731 . . . . 0.97999999999999998 110.537 175.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.92 -33.8 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.09 -1.414 . . . . 1.1100000000000001 109.553 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.431 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 18.5 ttt -163.69 136.98 5.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.361 -0.836 . . . . 3.3100000000000001 110.226 174.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.617 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 6.1 ptt180 -116.11 137.57 23.52 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.031 -0.531 . . . . 4.1699999999999999 110.761 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.685 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -71.58 176.66 7.8 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.986 2.457 . . . . 0.81999999999999995 112.585 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -126.91 177.08 6.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.647 -0.706 . . . . 1.6299999999999999 110.671 -175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.5 p-10 -71.42 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.602 1.191 . . . . 2.0600000000000001 111.641 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.06 137.44 2.59 Favored Glycine 0 N--CA 1.426 -2.003 0 CA-C-N 113.821 -1.536 . . . . 0.34999999999999998 111.807 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.482 ' HG3' ' CD2' ' A' ' 107' ' ' HIS . 27.9 tt0 -113.33 115.14 27.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.094 -1.053 . . . . 1.53 109.497 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -139.46 163.16 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 N-CA-C 107.308 -1.367 . . . . 1.0800000000000001 107.308 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -93.92 162.02 14.07 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.548 -0.751 . . . . 1.22 109.617 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.771 HG22 ' HB3' ' A' ' 81' ' ' PRO . 3.5 t -72.74 105.64 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.458 0 N-CA-C 107.205 -1.405 . . . . 1.3799999999999999 107.205 172.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.41 3.05 6.23 Favored Glycine 0 C--N 1.263 -3.506 0 CA-C-N 112.685 -2.052 . . . . 0.52000000000000002 111.472 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.9 -131.92 7.48 Favored Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 118.78 -1.676 . . . . 0.44 109.094 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.2 p -152.22 168.26 25.93 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 113.016 -1.592 . . . . 1.23 110.872 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.576 HG22 HD11 ' A' ' 104' ' ' LEU . 10.7 tp -147.74 149.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 CA-C-N 113.274 -1.784 . . . . 1.0900000000000001 107.536 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 m -139.22 127.08 22.13 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-N 113.513 -1.676 . . . . 1.05 111.098 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' HB2' HD21 ' A' ' 74' ' ' LEU . 33.0 m-85 -122.65 148.24 45.5 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.952 -1.476 . . . . 0.71999999999999997 108.392 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -135.01 122.48 21.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.575 -0.898 . . . . 0.87 108.575 175.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.727 ' HB1' ' HH2' ' A' ' 41' ' ' TRP . . . -126.09 126.64 44.53 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.943 -1.026 . . . . 1.1000000000000001 111.086 -174.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HB3' HG11 ' A' ' 69' ' ' VAL . 52.0 mtt180 -113.68 123.65 50.42 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.416 -0.356 . . . . 2.9300000000000002 111.135 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.0 t -122.33 125.13 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.946 0.879 . . . . 1.0700000000000001 109.837 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.91 111.11 0.76 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.505 -1.679 . . . . 1.1200000000000001 111.094 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.769 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -52.87 -43.06 60.68 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.177 -1.374 . . . . 0.76000000000000001 111.162 171.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.716 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 49.23 -167.06 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.252 1.204 . . . . 1.0 114.252 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -119.77 123.13 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.062 -1.426 . . . . 2.1699999999999999 107.527 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.79 HD12 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -149.78 178.58 8.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.838 0.681 . . . . 2.6299999999999999 112.838 -168.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.05 -57.23 4.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.989 -1.005 . . . . 1.99 109.234 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.646 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -129.58 145.54 57.36 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.468 -0.787 . . . . 1.8799999999999999 109.726 171.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.46 138.89 10.15 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 122.78 2.32 . . . . 1.1200000000000001 110.961 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.79 ' HD3' HD12 ' A' ' 33' ' ' LEU . 27.0 Cg_exo -58.82 136.98 77.28 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.443 1.429 . . . . 0.81999999999999995 111.961 -172.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.04 104.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.369 -1.715 . . . . 1.4299999999999999 106.369 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.516 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -107.25 114.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 113.44 -1.709 . . . . 1.0900000000000001 107.21 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.78 129.39 53.05 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 123.222 1.487 . . . . 2.1299999999999999 110.078 175.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.044 ' HB3' HD11 ' A' ' 49' ' ' LEU . 87.6 m95 -90.84 141.84 28.39 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.794 -2.457 . . . . 0.40999999999999998 111.268 171.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.7 t80 -125.82 125.79 43.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.785 -1.931 . . . . 0.80000000000000004 105.785 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 29.6 ttpt -103.65 108.59 19.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.8 -1.555 . . . . 2.6800000000000002 106.8 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.564 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -79.77 92.02 1.32 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 115.997 -3.001 . . . . 1.6000000000000001 113.968 -165.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.717 ' HG3' ' HA ' ' A' ' 83' ' ' PHE . 32.9 tttt -106.58 -32.77 7.9 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 104.24 -2.504 . . . . 4.2999999999999998 104.24 138.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.752 ' HD1' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER 157.85 -13.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 110.921 -2.854 . . . . 2.5099999999999998 111.447 -165.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.752 HG21 ' HD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -94.76 173.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 CA-C-O 122.994 1.378 . . . . 1.78 111.909 -168.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 5.4 m-20 -104.38 155.91 18.38 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.927 -2.397 . . . . 2.73 106.228 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.044 HD11 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -84.79 -32.33 23.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 118.325 0.512 . . . . 1.1299999999999999 111.464 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -20.35 37.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.711 0.767 . . . . 1.71 110.244 -167.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.742 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 26.4 t -92.22 -30.42 15.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.72 -1.127 . . . . 1.76 111.132 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.742 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 3.7 mmmt -98.81 -42.08 7.35 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.631 -1.168 . . . . 1.9099999999999999 112.122 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.9 t -22.57 95.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.208 1.803 . . . . 1.1499999999999999 112.987 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.71 -126.61 1.36 Allowed Glycine 0 C--N 1.303 -1.275 0 CA-C-N 112.138 -2.301 . . . . 0.69999999999999996 113.157 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.91 -20.08 31.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.881 0.697 . . . . 3.3599999999999999 112.881 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.7 p80 -100.72 -37.56 8.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.347 0.594 . . . . 1.78 110.427 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.938 HD22 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.89 103.7 10.21 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.03 -1.841 . . . . 1.72 106.03 172.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -95.43 115.22 27.13 Favored 'General case' 0 N--CA 1.409 -2.521 0 N-CA-C 105.809 -1.922 . . . . 0.96999999999999997 105.809 167.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.757 HD13 ' CD1' ' A' ' 41' ' ' TRP . 0.6 OUTLIER -98.94 91.58 5.11 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 103.496 -2.779 . . . . 1.0600000000000001 103.496 167.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 5.8 t-80 -99.75 164.65 11.95 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.21 -1.814 . . . . 2.5899999999999999 108.728 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.51 126.37 27.53 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 113.191 -1.822 . . . . 0.92000000000000004 111.933 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.543 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -103.24 148.04 26.3 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 110.996 -2.82 . . . . 0.76000000000000001 108.24 169.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.0 101.31 3.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.976 0.893 . . . . 1.8 110.987 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.53 109.17 17.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.322 -1.308 . . . . 2.4199999999999999 111.006 169.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -72.64 -31.44 65.13 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.445 -0.798 . . . . 3.0800000000000001 111.013 177.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -14.93 63.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.759 -0.655 . . . . 1.6899999999999999 110.431 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -106.8 -20.18 13.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.808 -1.182 . . . . 1.96 107.808 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER 60.54 40.2 17.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.652 -1.158 . . . . 3.7799999999999998 109.292 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 27' ' ' ARG . 13.8 t -133.39 143.06 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.242 -0.89 . . . . 1.1299999999999999 109.776 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.769 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 27.9 m-85 -105.62 113.05 26.38 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.622 -1.622 . . . . 1.95 106.622 163.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 10.1 tp -94.91 105.61 17.54 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 122.261 1.029 . . . . 1.1799999999999999 108.762 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.1 m-85 -87.88 115.32 25.26 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.001 -1.454 . . . . 0.40000000000000002 108.275 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -98.55 132.86 43.64 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.045 -1.889 . . . . 1.3200000000000001 108.353 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.808 HD23 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -103.64 115.7 30.97 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.488 -1.301 . . . . 1.5900000000000001 107.488 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -113.65 95.21 5.22 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.583 -2.377 . . . . 2.0099999999999998 104.583 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.618 HG12 HD23 ' A' ' 57' ' ' LEU . 63.7 mt -119.55 100.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.928 1.347 . . . . 1.1899999999999999 110.36 -174.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 82.5 p -106.45 135.78 47.36 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.435 -1.711 . . . . 1.05 108.262 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.65 101.47 0.05 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 111.714 -2.493 . . . . 2.1200000000000001 110.174 -174.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.585 ' O ' HG11 ' A' ' 18' ' ' VAL . . . -94.87 124.68 39.06 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 109.72 -3.4 . . . . 1.0900000000000001 109.402 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.729 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.64 130.94 77.65 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.295 -0.631 . . . . 1.77 109.295 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.771 ' HB3' HG22 ' A' ' 18' ' ' VAL . 19.1 Cg_endo -60.74 -10.65 14.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.129 2.553 . . . . 1.3300000000000001 112.855 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.729 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -113.5 15.4 19.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.046 -0.525 . . . . 1.6599999999999999 111.41 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.717 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -73.5 -57.55 3.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.417 -0.957 . . . . 1.24 108.417 177.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 26.0 m 42.67 62.07 1.86 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.665 -1.606 . . . . 1.6799999999999999 106.665 -158.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -56.53 86.16 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 112.084 -2.326 . . . . 2.0 114.17 -163.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -90.79 83.38 1.3 Allowed Glycine 0 C--N 1.279 -2.62 0 N-CA-C 108.862 -1.695 . . . . 0.81000000000000005 108.862 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.694 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.2 m-85 -78.07 110.93 13.45 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.997 -1.101 . . . . 1.0800000000000001 108.751 -176.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -99.91 109.24 21.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.419 -0.956 . . . . 3.6899999999999999 108.419 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.4 t -97.84 129.58 44.8 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.075 -0.65 . . . . 1.22 109.247 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 53.8 mt-10 -132.15 119.18 20.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.856 -0.611 . . . . 1.8100000000000001 109.664 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.516 ' HB ' HG11 ' A' ' 39' ' ' VAL . 2.6 p -106.42 137.31 37.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.738 0.78 . . . . 1.24 110.794 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.1 t -129.93 109.38 10.85 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.351 -1.295 . . . . 1.6399999999999999 108.313 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 33' ' ' LEU . 1.3 m -127.45 174.98 8.57 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.35 -0.841 . . . . 1.26 109.941 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 1.097 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -3.5 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.431 1.707 . . . . 0.93999999999999995 115.016 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 1.097 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 17.4 t70 -163.93 5.19 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.511 -1.222 . . . . 1.05 109.63 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.856 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -101.83 143.06 32.2 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.733 0.778 . . . . 1.78 109.088 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -131.54 136.47 47.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.165 -1.834 . . . . 1.0 110.815 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 7' ' ' PHE . 4.0 m-20 -155.43 151.73 28.16 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.903 -1.044 . . . . 1.6000000000000001 109.443 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.5 p -152.32 152.62 32.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.98 111.028 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.825 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 96.0 p -130.03 147.23 51.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.227 0.537 . . . . 1.02 111.941 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -126.43 113.44 16.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.406 -0.815 . . . . 1.5800000000000001 110.844 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.845 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 3.8 p90 -143.99 129.99 19.52 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.852 -0.53 . . . . 1.1000000000000001 111.123 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -112.45 127.21 55.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 122.192 0.996 . . . . 2.1099999999999999 113.106 -173.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.576 HD11 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.33 107.6 20.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.848 -1.523 . . . . 1.0900000000000001 109.924 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m -88.85 97.09 10.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.99 -0.745 . . . . 1.0700000000000001 108.99 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 80' ' ' GLN . 7.7 p -86.95 116.97 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.631 1.205 . . . . 1.1399999999999999 110.222 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 15' ' ' GLU . 95.7 m-70 -111.57 93.79 4.64 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.739 -1.573 . . . . 1.8200000000000001 112.138 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' CA ' HG23 ' A' ' 18' ' ' VAL . 31.0 tt0 . . . . . 0 C--N 1.3 -1.557 0 CA-C-N 115.937 -0.574 . . . . 1.6699999999999999 109.898 164.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.563 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 4.5 m-20 . . . . . 0 N--CA 1.443 -0.816 0 CA-C-O 119.102 -0.475 . . . . 1.6499999999999999 110.988 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.95 83.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.357 2.038 . . . . 1.24 113.734 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 1.077 ' HB ' ' HD3' ' A' ' 96' ' ' LYS . 1.8 mp -110.78 -69.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.026 -0.988 . . . . 1.2 109.22 173.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 92.22 50.15 2.67 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 108.199 -1.96 . . . . 0.44 108.199 -173.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.585 ' N ' HG22 ' A' ' 4' ' ' ILE . 10.1 tp -53.38 -50.29 65.41 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.984 -1.608 . . . . 1.1100000000000001 110.829 -167.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.663 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -86.7 84.46 7.38 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.585 -0.734 . . . . 0.97999999999999998 109.507 174.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -66.03 -39.96 85.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.342 -1.299 . . . . 1.1100000000000001 109.664 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.568 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 21.7 ttt -141.49 133.95 28.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.165 -0.925 . . . . 3.3100000000000001 108.651 169.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.663 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 31.7 mtt180 -99.14 127.27 35.32 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.062 -0.517 . . . . 4.1699999999999999 109.64 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.456 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 10.4 Cg_endo -57.79 151.28 57.24 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.735 2.29 . . . . 0.81999999999999995 111.72 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.445 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 19.3 mm-40 -126.46 169.66 12.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 1.6299999999999999 111.467 -169.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.8 m-20 -65.62 -147.19 0.01 OUTLIER 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.952 1.358 . . . . 2.0600000000000001 111.781 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.84 133.6 2.56 Favored Glycine 0 C--N 1.297 -1.6 0 CA-C-N 113.628 -1.623 . . . . 0.34999999999999998 111.678 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.81 114.86 24.53 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.308 -0.946 . . . . 1.53 108.755 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.607 HG22 HD11 ' A' ' 104' ' ' LEU . 3.0 m -136.63 165.0 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 107.755 -1.202 . . . . 1.0800000000000001 107.755 -172.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.546 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -88.48 155.52 19.62 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.934 -1.03 . . . . 1.22 110.273 -176.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.563 HG22 HG23 ' A' ' 106' ' ' VAL . 60.0 t -70.41 105.69 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 122.901 1.334 . . . . 1.3799999999999999 108.253 173.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.01 12.16 Favored Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.412 -2.176 . . . . 0.52000000000000002 112.367 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.86 -123.05 2.99 Favored Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.113 -1.595 . . . . 0.44 109.113 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.6 p -151.99 169.55 22.06 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 112.84 -1.68 . . . . 1.23 110.553 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -145.31 147.19 18.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 113.763 -1.562 . . . . 1.0900000000000001 107.256 167.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -137.96 130.26 29.1 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.851 -1.522 . . . . 1.05 110.916 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 62.9 m-85 -126.43 147.63 49.76 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.203 -1.362 . . . . 0.71999999999999997 110.128 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -136.61 123.72 21.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.953 -1.021 . . . . 0.87 109.248 175.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -119.74 116.31 25.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.745 -1.116 . . . . 1.1000000000000001 110.185 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 39.3 mtt180 -101.21 122.15 43.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.308 -0.406 . . . . 2.9300000000000002 110.77 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 17.2 t -123.82 128.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 122.168 0.985 . . . . 1.0700000000000001 110.248 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.99 114.21 2.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.318 -1.765 . . . . 1.1200000000000001 111.016 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.538 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -55.21 -32.69 57.31 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.343 -1.298 . . . . 0.76000000000000001 111.187 170.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.557 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 56.1 -172.26 0.07 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.791 1.034 . . . . 1.0 113.791 168.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 t -110.0 117.06 32.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 2.1699999999999999 107.061 164.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.777 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -150.98 166.59 30.22 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.891 0.7 . . . . 2.6299999999999999 112.891 -162.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -64.23 -64.56 0.85 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.063 -0.971 . . . . 1.99 109.956 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.56 158.33 74.94 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.266 -1.013 . . . . 1.8799999999999999 108.266 172.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 4.5 Cg_endo -45.79 146.8 3.6 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.246 2.631 . . . . 1.1200000000000001 112.356 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.777 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -62.64 135.65 53.91 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.655 1.57 . . . . 0.81999999999999995 111.248 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.79 104.56 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.614 0 N-CA-C 106.541 -1.651 . . . . 1.4299999999999999 106.541 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -108.75 114.55 47.08 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-N 113.335 -1.757 . . . . 1.0900000000000001 107.814 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.878 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.89 125.39 50.94 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 123.384 1.564 . . . . 2.1299999999999999 110.412 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.019 ' HB3' HD13 ' A' ' 49' ' ' LEU . 82.5 m95 -88.78 157.23 18.56 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 111.664 -2.516 . . . . 0.40999999999999998 112.564 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.9 t80 -136.79 136.09 38.56 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 104.948 -2.241 . . . . 0.80000000000000004 104.948 166.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.701 ' HE2' HD13 ' A' ' 76' ' ' ILE . 21.1 tttm -112.4 162.12 15.93 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.617 -1.623 . . . . 2.6800000000000002 106.617 -173.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 1.081 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -4.35 -167.78 0.0 OUTLIER Glycine 0 C--O 1.191 -2.594 0 N-CA-C 118.692 2.237 . . . . 1.6000000000000001 118.692 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -44.37 -9.07 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.201 1.926 . . . . 4.2999999999999998 116.201 -166.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CZ3' HG12 ' A' ' 47' ' ' VAL . 30.0 p-90 -167.67 -3.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.012 1.486 . . . . 2.5099999999999998 115.012 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.567 HG12 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -91.13 135.4 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-O 123.496 1.617 . . . . 1.78 112.817 -163.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -104.36 99.33 9.04 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 112.048 -2.342 . . . . 2.73 111.84 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.029 HD21 HD21 ' A' ' 57' ' ' LEU . 4.4 mp -51.93 -38.49 56.6 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.223 1.194 . . . . 1.1299999999999999 114.223 -169.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 t -57.5 -22.22 42.67 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.345 0.593 . . . . 1.71 109.407 -166.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 m -100.38 -28.81 12.75 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.313 -0.858 . . . . 1.76 113.052 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 6.0 mmmt -90.33 -39.8 12.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.085 -0.507 . . . . 1.9099999999999999 111.516 -171.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 59' ' ' LEU . 55.1 t -32.34 95.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 126.449 1.899 . . . . 1.1499999999999999 112.3 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.641 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.82 -103.29 0.21 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 111.707 -2.497 . . . . 0.69999999999999996 113.898 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -95.22 -33.15 12.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.007 0.743 . . . . 3.3599999999999999 113.007 -168.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.598 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 27.6 p80 -97.88 -36.29 10.22 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.653 0.739 . . . . 1.78 110.822 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 1.029 HD21 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.29 106.14 12.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.39 -1.707 . . . . 1.72 106.39 174.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.641 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.87 115.86 30.6 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.517 -1.66 . . . . 0.96999999999999997 106.517 165.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.661 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -103.04 93.64 5.12 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.307 -2.109 . . . . 1.0600000000000001 105.307 172.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 53.2 m-70 -92.86 160.38 14.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-O 122.902 1.334 . . . . 2.5899999999999999 109.499 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -129.29 110.79 12.24 Favored 'General case' 0 C--N 1.265 -3.102 0 CA-C-N 111.458 -2.61 . . . . 0.92000000000000004 108.936 175.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.9 m -92.28 145.38 24.53 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.582 -2.099 . . . . 0.76000000000000001 107.776 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.0 t80 -141.26 99.77 3.65 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.07 0.938 . . . . 1.8 111.57 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -116.46 121.73 42.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.125 -1.398 . . . . 2.4199999999999999 108.811 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -85.36 -39.07 18.04 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 113.721 -1.581 . . . . 3.0800000000000001 112.117 -172.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.23 60.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.604 -0.725 . . . . 1.6899999999999999 111.417 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -95.58 -16.76 21.89 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.283 -1.377 . . . . 1.96 107.283 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 67.59 31.47 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.864 -1.516 . . . . 3.7799999999999998 109.789 173.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.45 128.49 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.764 0.793 . . . . 1.1299999999999999 110.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 62' ' ' SER . 45.8 m-85 -98.47 112.22 24.31 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.143 -1.799 . . . . 1.95 106.143 162.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.4 tp -98.92 106.2 18.44 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.017 0.913 . . . . 1.1799999999999999 108.61 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 51.4 m-85 -84.46 115.65 22.67 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.303 -1.317 . . . . 0.40000000000000002 108.001 172.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.2 123.62 47.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.055 -1.43 . . . . 1.3200000000000001 109.269 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.697 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -94.74 118.9 32.49 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.144 -1.428 . . . . 1.5900000000000001 107.144 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -110.71 95.76 5.76 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 103.556 -2.757 . . . . 2.0099999999999998 103.556 169.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.701 HD13 ' HE2' ' A' ' 43' ' ' LYS . 13.9 mt -123.55 99.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 123.229 1.49 . . . . 1.1899999999999999 108.66 -175.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.8 p -107.53 170.07 8.2 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 113.441 -1.709 . . . . 1.05 108.007 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.9 t70 65.52 33.56 8.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.722 -2.036 . . . . 2.1200000000000001 110.003 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -49.94 112.05 0.61 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.994 -1.912 . . . . 1.0900000000000001 111.7 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.536 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -70.85 153.7 94.65 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.198 -0.91 . . . . 1.77 109.179 173.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.573 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 40.9 Cg_endo -66.9 -3.39 9.46 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.245 1.963 . . . . 1.3300000000000001 113.189 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.536 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.82 17.0 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.265 -0.425 . . . . 1.6599999999999999 110.331 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.3 m-30 -99.56 0.74 42.87 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.658 -0.497 . . . . 1.24 109.658 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 14.9 m -28.97 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 125.779 1.924 . . . . 1.6799999999999999 110.579 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.808 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -34.37 106.84 0.03 OUTLIER Glycine 0 N--CA 1.411 -3.015 0 CA-C-N 109.662 -3.426 . . . . 2.0 114.798 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 1.081 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -122.66 65.39 0.51 Allowed Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.33 -1.908 . . . . 0.81000000000000005 108.33 159.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.695 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 79.0 m-85 -81.48 128.81 34.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.862 -1.169 . . . . 1.0800000000000001 109.562 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -135.04 104.26 5.88 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.772 -0.825 . . . . 3.6899999999999999 108.772 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.462 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -102.11 129.58 48.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.474 -0.491 . . . . 1.22 110.154 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.878 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 22.0 tt0 -131.64 116.37 17.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.472 -0.785 . . . . 1.8100000000000001 110.007 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HB ' HG12 ' A' ' 39' ' ' VAL . 3.3 p -106.39 140.53 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.428 0.632 . . . . 1.24 109.957 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.1 t -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.11 -0.95 . . . . 1.6399999999999999 108.745 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.535 HG22 HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.09 157.46 44.15 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 118.145 -0.931 . . . . 1.26 109.341 -178.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 1.079 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 17.92 -73.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.536 1.772 . . . . 0.93999999999999995 114.662 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 1.079 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.6 t0 -150.74 1.97 0.44 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.058 -0.974 . . . . 1.05 109.697 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.077 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 14.7 mtpp -103.75 146.21 28.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 122.459 1.123 . . . . 1.78 109.541 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -136.14 140.26 43.53 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.279 -2.237 . . . . 1.0 110.6 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.48 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 2.4 m-20 -156.91 149.74 23.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.044 -0.98 . . . . 1.6000000000000001 109.596 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 p -152.69 149.03 27.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.13 0.49 . . . . 1.98 110.975 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 89' ' ' CYS . 3.9 p -127.97 149.6 50.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.6 -0.727 . . . . 1.02 112.268 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.522 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.0 OUTLIER -132.65 109.55 9.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.409 -1.269 . . . . 1.5800000000000001 109.23 178.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.79 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 4.6 p90 -141.37 129.36 21.94 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.823 0.82 . . . . 1.1000000000000001 110.078 -172.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 15.9 m-80 -105.31 146.22 29.67 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.607 -1.178 . . . . 2.1099999999999999 111.107 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.808 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -112.83 118.16 34.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.042 -1.435 . . . . 1.0900000000000001 109.145 173.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 m -95.25 97.51 9.93 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.842 -0.743 . . . . 1.0700000000000001 109.237 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.563 HG23 HG22 ' A' ' 18' ' ' VAL . 7.2 p -86.59 113.31 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 123.331 1.539 . . . . 1.1399999999999999 109.397 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 82.2 m-70 -86.15 99.8 11.77 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.295 -2.229 . . . . 1.8200000000000001 109.354 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 52.7 tt0 . . . . . 0 C--N 1.303 -1.449 0 CA-C-N 115.321 -0.854 . . . . 1.6699999999999999 111.114 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 110.057 -0.349 . . . . 1.6499999999999999 110.057 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.03 45.95 0.39 Allowed 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.296 2.664 . . . . 1.24 113.915 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.649 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.7 mp -63.15 -58.68 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.643 -0.708 . . . . 1.2 110.096 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.85 53.97 3.2 Favored Glycine 0 CA--C 1.492 -1.376 0 N-CA-C 107.625 -2.19 . . . . 0.44 107.625 -173.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.762 HD23 ' HB3' ' A' ' 96' ' ' LYS . 9.2 tp -60.75 -33.62 73.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.978 -1.611 . . . . 1.1100000000000001 110.201 -165.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.793 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.87 84.61 3.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.05 -0.977 . . . . 0.97999999999999998 109.572 172.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.54 -50.7 64.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.545 -1.207 . . . . 1.1100000000000001 109.91 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.634 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 16.5 tpt -147.84 131.18 16.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.2 -0.909 . . . . 3.3100000000000001 108.66 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 34.4 ptt180 -98.65 138.15 20.7 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 116.133 -0.485 . . . . 4.1699999999999999 111.436 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.635 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 28.1 Cg_endo -68.36 153.99 72.98 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.545 2.163 . . . . 0.81999999999999995 111.155 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.0 mm-40 -123.17 173.17 8.06 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.119 -0.491 . . . . 1.6299999999999999 110.514 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.6 p-10 -68.33 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.67 1.224 . . . . 2.0600000000000001 111.537 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 155.76 138.97 2.66 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 113.736 -1.575 . . . . 0.34999999999999998 111.156 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 43.0 mt-10 -117.96 116.93 27.91 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.398 -0.964 . . . . 1.53 108.398 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.08 163.73 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.326 -1.361 . . . . 1.0800000000000001 107.326 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 156.02 16.5 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.962 -1.017 . . . . 1.22 109.304 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG11 ' HD3' ' A' ' 81' ' ' PRO . 47.5 t -57.93 107.45 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 122.81 1.29 . . . . 1.3799999999999999 109.825 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.56 12.25 19.57 Favored Glycine 0 C--N 1.274 -2.862 0 CA-C-N 112.029 -2.351 . . . . 0.52000000000000002 114.07 170.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.8 -122.46 3.46 Favored Glycine 0 CA--C 1.478 -2.256 0 C-N-CA 118.818 -1.658 . . . . 0.44 111.103 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.2 p -151.71 167.91 26.71 Favored 'General case' 0 N--CA 1.403 -2.822 0 CA-C-N 112.474 -1.863 . . . . 1.23 110.408 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 104' ' ' LEU . 10.6 tp -146.29 150.58 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 CA-C-N 112.938 -1.937 . . . . 1.0900000000000001 107.919 169.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 m -137.5 126.19 23.82 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 113.048 -1.887 . . . . 1.05 110.757 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.65 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 37.3 m-85 -122.11 140.99 51.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.033 -1.439 . . . . 0.71999999999999997 109.408 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.78 119.52 22.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.645 -0.707 . . . . 0.87 109.601 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.749 ' HB1' ' CH2' ' A' ' 41' ' ' TRP . . . -121.33 116.75 25.41 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.507 -1.224 . . . . 1.1000000000000001 110.691 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.634 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 28.5 mtp180 -105.05 120.04 40.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.072 -0.513 . . . . 2.9300000000000002 111.142 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 t -122.14 132.72 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.707 0.765 . . . . 1.0700000000000001 109.303 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.87 111.24 1.81 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.71 -1.586 . . . . 1.1200000000000001 110.7 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -50.89 -35.12 31.27 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 114.675 -1.148 . . . . 0.76000000000000001 110.295 169.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 4' ' ' ILE . . . 47.09 -143.98 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.38 -0.91 . . . . 1.0 113.383 166.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.528 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -119.58 154.8 33.37 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.327 -1.36 . . . . 2.1699999999999999 107.327 170.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' A' ' 93' ' ' THR . 3.7 tp 171.0 147.53 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.475 -1.306 . . . . 2.6299999999999999 107.475 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.771 ' N ' HD11 ' A' ' 33' ' ' LEU . 24.3 tp -44.91 -42.27 7.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.031 0.92 . . . . 1.99 111.169 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.738 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.47 -179.67 0.79 Allowed Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.197 -1.365 . . . . 1.8799999999999999 108.116 175.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 8.1 Cg_exo -67.9 153.69 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.533 1.489 . . . . 1.1200000000000001 108.888 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 26.4 Cg_exo -60.38 137.23 73.06 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.013 1.809 . . . . 0.81999999999999995 111.548 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.27 102.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 106.94 -1.504 . . . . 1.4299999999999999 106.94 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.667 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -107.59 114.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 CA-C-N 112.839 -1.982 . . . . 1.0900000000000001 106.947 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.688 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.01 127.95 53.09 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 123.313 1.53 . . . . 2.1299999999999999 109.22 173.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.031 ' HB3' HD12 ' A' ' 49' ' ' LEU . 69.4 m95 -85.4 154.25 21.97 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 111.448 -2.615 . . . . 0.40999999999999998 111.111 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.814 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 29.9 t80 -126.22 138.2 53.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.80000000000000004 105.186 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.714 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 71.2 tttt -104.76 165.05 11.33 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.719 -1.956 . . . . 2.6800000000000002 105.719 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.78 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -9.65 -168.79 0.0 OUTLIER Glycine 0 C--O 1.188 -2.747 0 N-CA-C 119.522 2.569 . . . . 1.6000000000000001 119.522 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 84' ' ' THR . 19.5 mtpt -45.47 -1.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 O-C-N 119.463 -2.198 . . . . 4.2999999999999998 116.826 -166.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.689 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 13.8 p-90 -166.03 -10.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.403 1.26 . . . . 2.5099999999999998 114.403 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.689 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.2 170.06 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-O 123.482 1.611 . . . . 1.78 112.492 -162.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.694 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 7.0 p-10 -112.88 158.13 20.57 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 111.825 -2.443 . . . . 2.73 107.528 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.031 HD12 ' HB3' ' A' ' 41' ' ' TRP . 6.0 mp -98.57 -36.94 9.73 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.142 0.423 . . . . 1.1299999999999999 112.142 168.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 t -57.69 -20.76 36.23 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.719 0.637 . . . . 1.71 109.661 -162.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.694 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 17.0 m -100.47 -21.24 15.42 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.619 -0.832 . . . . 1.76 112.855 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.582 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 1.9 mmmt -94.11 -67.93 0.83 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.425 -0.807 . . . . 1.9099999999999999 111.132 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 49' ' ' LEU . 78.5 t 12.8 93.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 126.358 1.863 . . . . 1.1499999999999999 113.593 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.43 -154.49 7.28 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.052 -1.431 . . . . 0.69999999999999996 110.281 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' C ' HE22 ' A' ' 58' ' ' GLN . 55.5 mt-30 -63.98 -5.21 4.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.971 1.1 . . . . 3.3599999999999999 113.971 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -101.83 -41.26 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.768 0.794 . . . . 1.78 110.831 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.897 HD21 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.72 104.73 7.36 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.25 -1.759 . . . . 1.72 106.25 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.844 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -95.1 113.75 25.48 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.259 -2.126 . . . . 0.96999999999999997 105.259 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.611 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -101.74 91.42 4.4 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.065 -2.568 . . . . 1.0600000000000001 104.065 170.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.501 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 45.7 t60 -106.37 162.69 13.47 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.365 -1.289 . . . . 2.5899999999999999 109.279 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -128.65 125.56 38.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 112.331 -2.213 . . . . 0.92000000000000004 110.966 -176.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.649 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -98.78 147.54 24.8 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 110.996 -2.82 . . . . 0.76000000000000001 107.043 169.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.569 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 6.6 t80 -144.25 101.11 3.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.058 0.932 . . . . 1.8 112.312 -168.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 7.7 t70 -117.4 127.63 54.22 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.98 -1.464 . . . . 2.4199999999999999 109.321 168.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -86.75 -41.12 14.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.813 -1.54 . . . . 3.0800000000000001 112.018 -174.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.69 57.93 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.988 -1.005 . . . . 1.6899999999999999 111.102 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 29.6 t -91.19 -19.4 23.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.542 -1.651 . . . . 1.96 106.542 173.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.4 tpmt? 70.69 29.32 3.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.841 -1.527 . . . . 3.7799999999999998 109.722 173.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.04 127.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.83 0.824 . . . . 1.1299999999999999 111.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.525 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 61.2 m-85 -96.89 113.33 24.86 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.182 -1.784 . . . . 1.95 106.182 162.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 36.0 tp -92.4 103.82 16.22 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.345 -0.983 . . . . 1.1799999999999999 108.345 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.3 m-85 -85.26 112.73 21.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.386 -1.709 . . . . 0.40000000000000002 106.386 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 119.92 39.03 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.098 -1.864 . . . . 1.3200000000000001 109.798 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.721 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.6 mt -89.41 130.83 35.71 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 114.116 -1.402 . . . . 1.5900000000000001 107.984 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.844 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 81.7 m-70 -120.69 95.81 4.87 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 104.114 -2.551 . . . . 2.0099999999999998 104.114 168.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.721 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.8 mt -119.77 101.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 113.937 -1.483 . . . . 1.1899999999999999 108.318 -171.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 78.5 p -101.68 166.19 10.82 Favored 'General case' 0 N--CA 1.382 -3.861 0 CA-C-N 113.987 -1.461 . . . . 1.05 109.145 -175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 39.38 78.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 111.362 -2.654 . . . . 2.1200000000000001 112.579 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 104' ' ' LEU . . . -70.77 121.04 17.26 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 111.089 -2.778 . . . . 1.0900000000000001 110.181 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.921 HE21 ' HD2' ' A' ' 81' ' ' PRO . 2.1 tp60 -63.07 137.91 97.19 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.49 -0.777 . . . . 1.77 109.874 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.921 ' HD2' HE21 ' A' ' 80' ' ' GLN . 16.5 Cg_endo -57.73 -12.86 12.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.283 2.655 . . . . 1.3300000000000001 113.545 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.03 21.78 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.339 . . . . 1.6599999999999999 111.245 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -46.89 8.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.536 -0.466 . . . . 1.24 111.984 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 83.2 m 22.67 79.77 0.01 OUTLIER 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.902 1.334 . . . . 1.6799999999999999 110.609 -165.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.78 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.1 99.39 0.5 Allowed Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 112.711 -2.041 . . . . 2.0 114.495 -159.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.715 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -86.59 69.49 3.1 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 109.208 -1.557 . . . . 0.81000000000000005 109.208 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.714 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 77.8 m-85 -78.42 128.11 33.14 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.871 -1.165 . . . . 1.0800000000000001 108.758 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.814 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -122.56 156.72 33.62 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.082 0.468 . . . . 3.6899999999999999 110.618 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 72.6 m -130.55 115.8 17.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.197 -0.668 . . . . 1.22 109.197 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.688 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 39.2 mt-10 -125.34 105.24 8.95 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.627 -0.429 . . . . 1.8100000000000001 109.908 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.667 ' HB ' HG12 ' A' ' 39' ' ' VAL . 2.8 p -103.62 144.1 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 1.24 111.009 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.8 t -135.2 109.09 8.11 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.894 -1.048 . . . . 1.6399999999999999 108.428 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.068 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -131.58 146.78 52.38 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-O 117.55 -1.214 . . . . 1.26 109.353 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.86 -71.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 125.49 1.744 . . . . 0.93999999999999995 113.56 -167.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.766 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -152.18 3.66 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.159 -1.382 . . . . 1.05 110.443 -172.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.762 ' HB3' HD23 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -94.23 142.73 27.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.027 -1.101 . . . . 1.78 108.027 177.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.476 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 31.3 t80 -133.64 132.84 41.23 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.79 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.6 m-20 -151.35 153.05 34.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.063 -0.972 . . . . 1.6000000000000001 110.4 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 33.4 m -148.54 148.84 30.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.117 0.484 . . . . 1.98 111.737 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.793 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 28.9 t -133.4 150.76 51.79 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.804 0.812 . . . . 1.02 111.947 174.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.45 120.86 18.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.752 -1.567 . . . . 1.5800000000000001 109.916 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.739 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 10.1 p90 -143.48 130.57 20.68 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.939 -0.393 . . . . 1.1000000000000001 109.939 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -107.86 128.31 54.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.318 1.056 . . . . 2.1099999999999999 113.359 -170.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -95.08 109.28 21.36 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.842 -1.526 . . . . 1.0900000000000001 109.196 176.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.436 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.0 m -90.43 96.79 10.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.405 -0.591 . . . . 1.0700000000000001 109.405 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 80' ' ' GLN . 3.2 p -77.68 113.36 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 122.765 1.269 . . . . 1.1399999999999999 108.626 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 85.4 m-70 -84.35 97.97 9.77 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.186 -1.825 . . . . 1.8200000000000001 109.664 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.469 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.2 tm-20 . . . . . 0 C--N 1.301 -1.512 0 CA-C-N 113.491 -1.686 . . . . 1.6699999999999999 109.339 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 m-20 . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 109.277 -0.638 . . . . 1.6499999999999999 109.277 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.83 91.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.38 2.054 . . . . 1.24 112.454 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.788 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -117.8 -64.94 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.335 -0.848 . . . . 1.2 109.174 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 94.11 42.88 3.93 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.208 -1.957 . . . . 0.44 108.208 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.948 HD21 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -52.64 -39.75 62.1 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 112.87 -1.665 . . . . 1.1100000000000001 110.293 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.85 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.9 84.39 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.281 -0.872 . . . . 0.97999999999999998 109.6 177.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.42 -49.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.343 -1.299 . . . . 1.1100000000000001 109.388 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.426 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 24.1 ttt -141.6 136.68 31.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.394 -0.821 . . . . 3.3100000000000001 109.317 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.72 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -110.76 137.99 20.95 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.193 -0.458 . . . . 4.1699999999999999 110.987 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.677 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 4.0 Cg_endo -71.49 155.47 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.223 1.949 . . . . 0.81999999999999995 110.718 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.427 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.2 mm-40 -120.25 177.25 5.09 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.687 -0.486 . . . . 1.6299999999999999 109.687 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.0 p-10 -66.67 -141.59 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 122.884 1.326 . . . . 2.0600000000000001 111.828 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 148.97 133.33 2.22 Favored Glycine 0 C--N 1.291 -1.938 0 CA-C-N 113.586 -1.643 . . . . 0.34999999999999998 111.716 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.447 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 28.6 mt-10 -113.62 111.86 22.56 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.357 -0.979 . . . . 1.53 108.357 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.451 ' CG1' HD12 ' A' ' 22' ' ' ILE . 3.0 m -127.74 163.64 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.862 0 N-CA-C 107.252 -1.388 . . . . 1.0800000000000001 107.252 -170.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.55 152.89 18.03 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.83 -1.077 . . . . 1.22 109.13 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.747 HG22 ' HB3' ' A' ' 81' ' ' PRO . 3.7 t -66.67 105.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 122.923 1.344 . . . . 1.3799999999999999 108.123 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.55 5.9 Favored Glycine 0 C--N 1.263 -3.494 0 CA-C-N 111.921 -2.4 . . . . 0.52000000000000002 111.678 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.83 -127.83 6.16 Favored Glycine 0 N--CA 1.409 -3.16 0 C-N-CA 118.932 -1.604 . . . . 0.44 109.188 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.9 p -152.15 174.35 13.83 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.04 -1.58 . . . . 1.23 110.075 177.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.2 tp -147.58 150.47 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-N 113.703 -1.589 . . . . 1.0900000000000001 107.505 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.5 m -138.53 124.01 19.51 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 113.222 -1.808 . . . . 1.05 109.943 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.747 ' HD2' HD12 ' A' ' 74' ' ' LEU . 33.1 m-85 -119.96 146.04 46.19 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.404 -1.271 . . . . 0.71999999999999997 109.015 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.36 120.42 15.59 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.141 -0.936 . . . . 0.87 110.192 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -120.18 116.22 25.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.478 -1.237 . . . . 1.1000000000000001 110.613 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.5 mtt180 -103.6 121.93 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.557 -0.292 . . . . 2.9300000000000002 110.548 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 23.5 t -123.34 129.42 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.032 0.92 . . . . 1.0700000000000001 110.524 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.78 110.81 2.96 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.36 -1.745 . . . . 1.1200000000000001 111.529 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -51.05 -39.26 40.84 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.856 -1.066 . . . . 0.76000000000000001 112.633 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . . . 58.03 -170.64 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.517 0.727 . . . . 1.0 112.406 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.2 m -73.59 -71.54 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.49 -0.93 . . . . 2.1699999999999999 108.49 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 69.2 158.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 O-C-N 123.782 0.676 . . . . 2.6299999999999999 112.378 166.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.919 ' N ' HD21 ' A' ' 33' ' ' LEU . 19.2 tp -80.71 -66.24 0.91 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.906 -0.588 . . . . 1.99 110.879 168.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.796 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -122.91 130.12 24.73 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 114.281 1.215 . . . . 1.8799999999999999 114.281 172.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' N ' HD12 ' A' ' 33' ' ' LEU . 18.4 Cg_exo -34.36 131.66 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.305 3.337 . . . . 1.1200000000000001 113.171 -171.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.882 ' HG3' HG23 ' A' ' 93' ' ' THR . 34.0 Cg_exo -49.02 133.47 28.65 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 122.484 2.122 . . . . 0.81999999999999995 112.671 -170.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.38 103.6 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.784 -1.562 . . . . 1.4299999999999999 106.784 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.633 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -105.34 113.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.959 -1.928 . . . . 1.0900000000000001 107.504 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HB2' ' HZ2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -102.04 128.7 48.37 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-O 123.331 1.539 . . . . 2.1299999999999999 109.006 174.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.115 ' HB3' HD12 ' A' ' 49' ' ' LEU . 57.2 m95 -84.91 153.27 22.96 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 111.829 -2.441 . . . . 0.40999999999999998 110.867 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 17.8 t80 -122.31 135.81 54.79 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.932 -2.247 . . . . 0.80000000000000004 104.932 172.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.645 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 76.9 tttt -103.31 166.52 10.38 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.674 -1.602 . . . . 2.6800000000000002 106.674 -175.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.643 ' HA2' ' CA ' ' A' ' 85' ' ' GLY . . . -8.7 -162.09 0.0 OUTLIER Glycine 0 C--O 1.196 -2.227 0 N-CA-C 118.903 2.321 . . . . 1.6000000000000001 118.903 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.755 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 39.6 pttt -38.68 -20.42 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.18 1.918 . . . . 4.2999999999999998 116.18 -163.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.755 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 15.2 p-90 -167.27 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 120.073 1.306 . . . . 2.5099999999999998 113.395 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.55 170.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 123.19 1.471 . . . . 1.78 112.072 -162.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 27.8 t70 -113.35 154.1 27.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 112.345 -2.207 . . . . 2.73 106.797 175.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.115 HD12 ' HB3' ' A' ' 41' ' ' TRP . 6.1 mp -91.29 -39.92 11.79 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 119.008 -0.52 . . . . 1.1299999999999999 112.057 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.6 t -59.99 -20.14 56.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.813 -0.81 . . . . 1.71 108.813 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -86.67 -28.6 23.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.983 -1.008 . . . . 1.76 111.456 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 11.4 mmmt -100.11 -62.73 1.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.446 -0.797 . . . . 1.9099999999999999 111.395 -172.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 49' ' ' LEU . 48.3 t 4.48 93.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 O-C-N 125.88 1.987 . . . . 1.1499999999999999 113.804 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -164.99 -123.99 0.68 Allowed Glycine 0 C--N 1.31 -0.914 0 CA-C-N 113.001 -1.909 . . . . 0.69999999999999996 113.048 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.36 -38.49 78.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.763 0.425 . . . . 3.3599999999999999 111.839 -170.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.457 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 6.8 t-80 -88.16 -38.64 15.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.75 0.786 . . . . 1.78 111.463 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.14 105.29 7.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.824 -1.547 . . . . 1.72 106.824 -177.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.8 114.78 27.12 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.063 -1.458 . . . . 0.96999999999999997 107.063 168.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.54 HD13 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.7 92.61 5.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.011 -2.589 . . . . 1.0600000000000001 104.011 169.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.717 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 8.5 t-160 -100.13 161.38 13.64 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.924 -1.489 . . . . 2.5899999999999999 109.268 -173.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.02 119.83 26.25 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 111.982 -2.372 . . . . 0.92000000000000004 110.839 -173.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.773 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.4 m -97.48 146.39 25.29 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 111.826 -2.443 . . . . 0.76000000000000001 106.75 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' HD1' ' CD1' ' A' ' 70' ' ' TYR . 28.5 t80 -145.43 96.63 2.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.385 1.088 . . . . 1.8 111.389 -168.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 10.8 m-20 -115.67 101.11 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.235 -1.802 . . . . 2.4199999999999999 109.084 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -44.78 60.93 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.24 -0.891 . . . . 3.0800000000000001 111.278 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -19.52 60.68 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.112 -0.949 . . . . 1.6899999999999999 111.118 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.493 ' HB2' ' CB ' ' A' ' 64' ' ' ASP . 49.4 m -92.8 -13.12 29.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.376 -1.342 . . . . 1.96 107.376 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 tpmt? 69.6 27.45 4.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.806 -1.543 . . . . 3.7799999999999998 110.52 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 t -131.54 126.72 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.815 0.817 . . . . 1.1299999999999999 110.549 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.852 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 10.6 m-85 -101.35 109.27 21.09 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.944 -1.502 . . . . 1.95 106.944 165.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.1 tp -92.5 104.49 16.8 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.113 0.959 . . . . 1.1799999999999999 108.989 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -83.9 113.82 21.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.909 -1.515 . . . . 0.40000000000000002 106.909 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.5 pt-20 -117.5 122.94 45.1 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.513 -1.676 . . . . 1.3200000000000001 110.086 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.747 HD12 ' HD2' ' A' ' 24' ' ' PHE . 2.4 mt -94.23 133.15 38.05 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.108 -1.405 . . . . 1.5900000000000001 108.935 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 5.6 m170 -115.38 96.66 5.76 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.357 -2.831 . . . . 2.0099999999999998 103.357 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.696 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.5 mt -124.59 100.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.976 1.37 . . . . 1.1899999999999999 108.545 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.3 p -105.46 169.3 8.54 Favored 'General case' 0 N--CA 1.394 -3.238 0 CA-C-N 114.323 -1.308 . . . . 1.05 110.102 -172.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 36.71 69.05 0.22 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 111.206 -2.725 . . . . 2.1200000000000001 111.392 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.19 126.26 26.42 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 112.196 -2.274 . . . . 1.0900000000000001 111.397 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.693 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -56.05 131.42 74.17 Favored Pre-proline 0 C--O 1.223 -0.34 0 CA-C-N 115.76 -0.655 . . . . 1.77 109.634 172.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.747 ' HB3' HG22 ' A' ' 18' ' ' VAL . 21.9 Cg_endo -61.32 -15.9 43.43 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.982 2.455 . . . . 1.3300000000000001 113.148 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.613 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -108.25 26.63 10.2 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.807 -0.633 . . . . 1.6599999999999999 110.365 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -81.34 -52.91 6.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.47 -0.492 . . . . 1.24 111.188 -178.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.4 m 21.71 75.48 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 123.427 1.584 . . . . 1.6799999999999999 109.276 -159.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.643 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.95 114.96 4.56 Favored Glycine 0 N--CA 1.407 -3.254 0 CA-C-N 112.152 -2.294 . . . . 2.0 112.397 -156.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.558 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -98.74 87.81 0.82 Allowed Glycine 0 C--N 1.273 -2.957 0 N-CA-C 109.544 -1.423 . . . . 0.81000000000000005 109.544 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.714 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 m-85 -85.46 139.62 31.36 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.194 -1.503 . . . . 1.0800000000000001 107.629 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.674 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 49.0 mtm180 -137.24 155.73 49.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.629 0.252 . . . . 3.6899999999999999 110.378 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 3.4 m -122.82 120.95 35.05 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.147 -0.686 . . . . 1.22 109.147 173.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -123.41 105.12 9.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.002 -0.74 . . . . 1.8100000000000001 109.002 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.633 ' HB ' HG12 ' A' ' 39' ' ' VAL . 3.8 p -101.55 142.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.465 0.65 . . . . 1.24 111.501 -175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 t -132.13 108.11 9.07 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.346 -1.297 . . . . 1.6399999999999999 108.681 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.882 HG23 ' HG3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -133.36 154.01 51.1 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 117.853 -1.07 . . . . 1.26 108.718 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.788 ' HZ3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 21.72 -75.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 125.895 1.997 . . . . 0.93999999999999995 114.391 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.701 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t70 -151.44 3.17 0.42 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.979 -1.01 . . . . 1.05 109.31 -175.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.948 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -96.39 128.47 43.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.378 -0.971 . . . . 1.78 108.378 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -130.57 132.15 45.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.879 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -154.04 153.9 32.75 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.418 -1.265 . . . . 1.6000000000000001 110.379 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 59.6 m -145.02 152.44 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 1.98 110.749 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.85 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 56.3 p -131.22 148.26 52.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.641 -0.709 . . . . 1.02 109.371 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.674 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -133.84 124.36 26.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.72 0.295 . . . . 1.5800000000000001 110.329 177.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.714 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 9.6 p90 -143.85 126.4 15.94 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.144 0.497 . . . . 1.1000000000000001 110.5 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 59.6 m-20 -103.46 136.86 42.42 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.273 1.035 . . . . 2.1099999999999999 111.047 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -105.64 110.52 22.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.085 -1.416 . . . . 1.0900000000000001 109.157 177.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.447 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.0 m -94.61 97.22 9.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.006 -0.738 . . . . 1.0700000000000001 109.006 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 80' ' ' GLN . 4.3 p -81.48 119.11 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-O 122.851 1.31 . . . . 1.1399999999999999 108.883 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -91.4 99.16 12.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.034 -1.894 . . . . 1.8200000000000001 108.763 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 44.1 tt0 . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 114.122 -1.399 . . . . 1.6699999999999999 110.094 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.894 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.74 -0.837 . . . . 1.6499999999999999 108.74 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.409 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -40.7 96.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 125.015 3.81 . . . . 1.24 115.162 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.621 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.4 mp -128.85 -60.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.036 -0.983 . . . . 1.2 109.225 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.445 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 87.12 54.96 2.46 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.635 -1.786 . . . . 0.44 108.635 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -62.97 -32.49 73.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.466 -1.367 . . . . 1.1100000000000001 111.051 -165.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.12 84.96 3.36 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.746 -0.661 . . . . 0.97999999999999998 109.813 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.65 -46.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.825 -1.08 . . . . 1.1100000000000001 109.766 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.568 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 25.1 ttt -140.4 130.51 24.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.408 -0.814 . . . . 3.3100000000000001 108.943 174.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -102.69 128.6 27.63 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.141 -0.481 . . . . 4.1699999999999999 110.195 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.63 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 10.8 Cg_endo -62.16 150.98 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.291 1.994 . . . . 0.81999999999999995 110.675 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.475 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.5 mm-40 -121.96 173.91 7.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.884 -0.598 . . . . 1.6299999999999999 110.327 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 8.0 p-10 -70.7 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.937 1.351 . . . . 2.0600000000000001 111.896 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 158.42 130.14 1.15 Allowed Glycine 0 C--N 1.294 -1.755 0 CA-C-N 113.099 -1.864 . . . . 0.34999999999999998 112.689 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -112.94 107.78 16.47 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.044 -1.078 . . . . 1.53 109.071 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.24 163.52 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 N-CA-C 107.255 -1.387 . . . . 1.0800000000000001 107.255 -167.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.92 156.74 16.2 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.303 -0.862 . . . . 1.22 109.638 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 106' ' ' VAL . 18.1 t -68.51 104.53 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 CA-C-O 122.876 1.322 . . . . 1.3799999999999999 108.326 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.72 4.85 7.9 Favored Glycine 0 C--N 1.27 -3.087 0 CA-C-N 112.36 -2.2 . . . . 0.52000000000000002 112.837 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.67 -125.33 5.13 Favored Glycine 0 N--CA 1.415 -2.706 0 N-CA-C 109.674 -1.37 . . . . 0.44 109.674 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 14.5 p -150.36 172.59 15.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 112.847 -1.676 . . . . 1.23 110.38 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.604 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.7 tp -148.86 145.66 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 112.896 -1.957 . . . . 1.0900000000000001 106.988 172.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 m -139.08 129.13 25.18 Favored 'General case' 0 C--N 1.261 -3.278 0 CA-C-N 114.003 -1.453 . . . . 1.05 110.711 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.634 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 38.7 m-85 -127.15 145.2 50.83 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.199 -1.364 . . . . 0.71999999999999997 110.012 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.11 121.61 22.88 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.432 -0.804 . . . . 0.87 109.251 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.622 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -124.42 117.78 25.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.92 -1.037 . . . . 1.1000000000000001 110.541 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.7 mtt180 -107.71 118.59 37.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.209 -0.45 . . . . 2.9300000000000002 110.498 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.5 t -117.92 127.15 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 122.044 0.926 . . . . 1.0700000000000001 109.695 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.1 0.65 Allowed 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.339 -1.755 . . . . 1.1200000000000001 111.076 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.688 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -51.32 -50.63 39.96 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.263 -1.335 . . . . 0.76000000000000001 112.025 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.661 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 48.1 -161.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.558 0.743 . . . . 1.0 112.319 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -127.33 86.07 2.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.633 -0.877 . . . . 2.1699999999999999 108.633 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -110.32 -175.83 2.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.206 -0.452 . . . . 2.6299999999999999 109.914 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.24 -24.51 42.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.337 0.589 . . . . 1.99 111.471 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.751 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -151.83 -179.39 1.01 Allowed Pre-proline 0 C--O 1.212 -0.905 0 CA-C-N 115.133 -0.94 . . . . 1.8799999999999999 109.148 -173.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 2.9 Cg_exo -73.19 141.98 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 N-CA-C 107.965 -1.59 . . . . 1.1200000000000001 107.965 165.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' HG23 ' A' ' 93' ' ' THR . 21.8 Cg_exo -52.34 135.31 53.67 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.087 1.191 . . . . 0.81999999999999995 111.592 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.58 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.68 0 N-CA-C 106.586 -1.635 . . . . 1.4299999999999999 106.586 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.597 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -111.23 114.56 47.44 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.084 0 CA-C-N 113.127 -1.852 . . . . 1.0900000000000001 107.517 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.816 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.02 129.85 51.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 123.086 1.422 . . . . 2.1299999999999999 109.816 173.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.98 ' HB3' HD12 ' A' ' 49' ' ' LEU . 83.3 m95 -87.87 154.99 20.09 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 111.689 -2.505 . . . . 0.40999999999999998 111.875 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.8 t80 -135.1 138.06 43.42 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 104.578 -2.379 . . . . 0.80000000000000004 104.578 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.776 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 60.5 tttp -103.98 166.22 10.55 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.983 -2.229 . . . . 2.6800000000000002 104.983 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.02 -165.31 0.0 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 119.215 2.446 . . . . 1.6000000000000001 119.215 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.606 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 7.0 mtpp -43.37 -10.44 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 O-C-N 119.489 -2.183 . . . . 4.2999999999999998 116.574 -166.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CZ3' HG12 ' A' ' 47' ' ' VAL . 15.2 p-90 -163.21 -9.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.751 1.389 . . . . 2.5099999999999998 114.751 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.62 151.5 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 CA-C-O 123.112 1.434 . . . . 1.78 112.336 -160.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.8 t70 -110.48 127.31 55.09 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 111.87 -2.423 . . . . 2.73 108.721 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.98 HD12 ' HB3' ' A' ' 41' ' ' TRP . 3.1 mp -68.23 -34.97 77.22 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.04 -0.527 . . . . 1.1299999999999999 112.268 -175.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -58.76 -21.76 56.43 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.45 0.643 . . . . 1.71 109.36 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.45 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -92.72 -29.57 15.99 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.782 -1.099 . . . . 1.76 111.365 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.7 ' HB2' HD13 ' A' ' 57' ' ' LEU . 11.1 mmmt -98.05 -30.59 12.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.526 -0.761 . . . . 1.9099999999999999 111.569 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 42.7 t -45.01 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 125.704 1.602 . . . . 1.1499999999999999 111.264 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.92 -98.23 0.13 Allowed Glycine 0 C--N 1.298 -1.545 0 CA-C-N 112.374 -2.194 . . . . 0.69999999999999996 113.749 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -91.62 -42.32 10.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.497 . . . . 3.3599999999999999 112.341 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.672 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.5 p80 -95.86 -38.12 10.42 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.073 0.463 . . . . 1.78 110.897 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.905 HD21 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.82 105.82 13.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.261 -1.755 . . . . 1.72 106.261 173.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.16 115.96 31.06 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 106.757 -1.571 . . . . 0.96999999999999997 106.757 165.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.577 HD12 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -97.02 92.27 5.99 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 104.146 -2.538 . . . . 1.0600000000000001 104.146 170.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.718 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 29.3 m-70 -91.87 162.86 14.25 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 114.361 -1.291 . . . . 2.5899999999999999 110.106 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.95 115.75 14.75 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.132 -2.304 . . . . 0.92000000000000004 109.835 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.579 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -92.29 147.87 22.58 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.24 -1.8 . . . . 0.76000000000000001 107.463 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -142.25 98.19 3.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.244 1.021 . . . . 1.8 110.799 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.597 ' OD1' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -114.46 114.6 26.03 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.37 -1.741 . . . . 2.4199999999999999 111.014 174.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.735 ' HD3' ' HE2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.526 -0.761 . . . . 3.0800000000000001 110.756 175.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.83 -28.88 70.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.292 -0.867 . . . . 1.6899999999999999 111.304 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.597 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 15.0 m -100.66 -18.49 16.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.175 -1.046 . . . . 1.96 108.175 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.735 ' HE2' ' HD3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER 64.05 37.33 9.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.277 -1.328 . . . . 3.7799999999999998 109.736 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.65 139.18 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 115.373 -0.83 . . . . 1.1299999999999999 109.758 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.688 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 70.0 m-85 -102.82 109.08 20.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.383 -1.71 . . . . 1.95 106.383 162.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.3 tp -94.53 104.07 16.02 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.404 1.097 . . . . 1.1799999999999999 108.806 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.66 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.6 m-85 -88.35 113.95 24.47 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.713 -1.585 . . . . 0.40000000000000002 107.624 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 8.2 pt-20 -115.0 124.46 51.7 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.877 -1.51 . . . . 1.3200000000000001 109.877 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.774 HD22 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -90.23 120.8 31.69 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.416 -1.72 . . . . 1.5900000000000001 108.33 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -112.12 95.65 5.59 Favored 'General case' 0 C--N 1.268 -2.947 0 N-CA-C 103.976 -2.602 . . . . 2.0099999999999998 103.976 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 64.6 mt -120.84 98.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-O 123.26 1.505 . . . . 1.1899999999999999 109.54 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 21.3 p -112.29 136.31 51.9 Favored 'General case' 0 N--CA 1.393 -3.321 0 CA-C-N 113.213 -1.812 . . . . 1.05 106.96 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER 72.83 100.13 0.07 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 111.684 -2.507 . . . . 2.1200000000000001 109.017 -171.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.98 113.24 26.66 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 110.431 -3.077 . . . . 1.0900000000000001 109.538 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.608 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -54.32 140.19 55.39 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.438 -0.801 . . . . 1.77 110.252 171.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.552 ' HD2' HE21 ' A' ' 80' ' ' GLN . 21.6 Cg_endo -61.03 -11.59 19.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.142 2.561 . . . . 1.3300000000000001 112.875 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.608 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -97.64 11.14 38.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.124 -0.489 . . . . 1.6599999999999999 110.687 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 2.6 m-30 -97.32 -8.86 28.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 119.449 -0.31 . . . . 1.24 110.636 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 20.5 m -47.95 97.71 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.116 -1.068 . . . . 1.6799999999999999 108.116 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.606 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -168.53 -129.07 1.05 Allowed Glycine 0 C--N 1.263 -3.508 0 CA-C-N 113.365 -1.743 . . . . 2.0 112.563 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -152.86 119.25 0.94 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 119.95 -1.119 . . . . 0.81000000000000005 112.369 -171.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.776 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -84.97 114.7 22.35 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 113.496 -1.352 . . . . 1.0800000000000001 107.541 174.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.446 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 45.2 mtm180 -105.49 127.41 52.99 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.909 0.385 . . . . 3.6899999999999999 110.497 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 t -111.83 123.61 50.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.433 -0.58 . . . . 1.22 109.433 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.816 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 47.5 mt-10 -133.02 115.87 15.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.649 -0.705 . . . . 1.8100000000000001 110.347 -175.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 39' ' ' VAL . 2.5 p -107.7 141.46 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.266 0.555 . . . . 1.24 110.977 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 t -134.68 111.52 10.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.069 -0.968 . . . . 1.6399999999999999 110.215 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 37' ' ' PRO . 11.1 p -117.27 -177.45 3.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.168 -0.924 . . . . 1.26 111.213 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.923 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -18.04 -48.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 125.682 1.864 . . . . 0.93999999999999995 113.678 175.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.923 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -167.54 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.837 -1.529 . . . . 1.05 110.723 -173.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.621 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -95.76 132.71 40.69 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.079 -1.082 . . . . 1.78 108.079 -177.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -130.99 133.97 46.27 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.269 -1.332 . . . . 1.0 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -152.15 147.32 26.3 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.458 -1.247 . . . . 1.6000000000000001 109.259 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.7 p -149.64 149.22 30.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.151 0.5 . . . . 1.98 111.578 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.6 p -124.57 148.14 48.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.496 -0.775 . . . . 1.02 111.739 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.483 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -128.04 112.8 15.01 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.604 -1.18 . . . . 1.5800000000000001 109.106 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.762 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 12.9 p90 -141.47 128.11 20.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.41 0.624 . . . . 1.1000000000000001 109.664 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 7.7 p30 -104.71 140.26 38.32 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.233 1.016 . . . . 2.1099999999999999 112.59 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -109.37 114.31 27.87 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.423 -1.262 . . . . 1.0900000000000001 108.329 175.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 m -97.35 96.11 8.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.959 -0.756 . . . . 1.0700000000000001 108.959 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 18' ' ' VAL . 5.1 p -80.08 113.06 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 123.193 1.473 . . . . 1.1399999999999999 109.252 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 41.1 m170 -82.78 99.04 9.43 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 112.447 -2.161 . . . . 1.8200000000000001 110.229 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 41.8 tt0 . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 114.441 -1.254 . . . . 1.6699999999999999 108.624 167.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.875 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 6.2 t70 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.909 -0.774 . . . . 1.6499999999999999 108.909 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 87.3 Cg_exo -47.52 92.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 124.156 3.237 . . . . 1.24 114.959 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.5 mp -119.18 -51.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.924 -1.035 . . . . 1.2 109.264 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.09 41.14 8.2 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.548 -1.821 . . . . 0.44 108.548 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.713 HD23 ' HB3' ' A' ' 96' ' ' LYS . 12.4 tp -51.5 -48.18 63.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.757 -1.721 . . . . 1.1100000000000001 110.927 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.735 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -92.25 84.12 5.16 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.674 0.749 . . . . 0.97999999999999998 109.643 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.64 -46.49 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.33 -1.305 . . . . 1.1100000000000001 110.138 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.529 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 18.1 mmt -140.96 130.7 24.22 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.044 -0.526 . . . . 3.3100000000000001 111.077 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.581 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.9 ptp180 -101.24 132.65 21.65 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.123 -0.944 . . . . 4.1699999999999999 108.877 173.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.751 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 68.6 Cg_endo -78.9 158.01 27.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.244 1.963 . . . . 0.81999999999999995 110.172 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -118.72 -178.41 3.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 120.348 -0.541 . . . . 1.6299999999999999 112.003 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.1 p-10 -69.98 -147.97 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 122.684 1.23 . . . . 2.0600000000000001 111.421 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 155.41 133.38 1.7 Allowed Glycine 0 C--N 1.291 -1.952 0 CA-C-N 113.549 -1.66 . . . . 0.34999999999999998 112.227 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 36.0 mt-10 -109.96 107.47 17.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.718 -1.241 . . . . 1.53 108.153 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 22' ' ' ILE . 2.8 m -125.79 163.32 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.158 0 N-CA-C 106.779 -1.563 . . . . 1.0800000000000001 106.779 -171.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.54 155.84 17.08 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.064 -0.971 . . . . 1.22 108.888 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 81' ' ' PRO . 2.9 t -66.64 106.7 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 122.362 1.077 . . . . 1.3799999999999999 108.56 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 6.64 8.17 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.54 -2.118 . . . . 0.52000000000000002 111.663 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.86 -124.71 5.19 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.52 -1.432 . . . . 0.44 109.52 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.1 p -151.64 174.62 13.25 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 112.983 -1.609 . . . . 1.23 109.852 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.8 tp -146.14 147.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.481 -1.69 . . . . 1.0900000000000001 107.119 166.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 m -140.76 130.9 24.81 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.45 -1.704 . . . . 1.05 110.17 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' HB2' HD22 ' A' ' 74' ' ' LEU . 23.7 m-85 -125.56 144.47 50.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.268 -1.333 . . . . 0.71999999999999997 108.855 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.12 117.9 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.15 -0.932 . . . . 0.87 110.313 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB1' ' HH2' ' A' ' 41' ' ' TRP . . . -125.9 116.99 22.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 113.947 -1.479 . . . . 1.1000000000000001 111.428 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.598 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 79.3 mtt-85 -104.88 127.68 52.8 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.09 -0.244 . . . . 2.9300000000000002 110.775 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.3 t -126.66 126.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.084 0.945 . . . . 1.0700000000000001 110.223 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . . . -58.54 112.2 1.52 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.607 -1.633 . . . . 1.1200000000000001 112.596 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.81 -57.37 12.69 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-N 114.441 -1.254 . . . . 0.76000000000000001 112.086 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' LEU . . . 67.29 177.29 0.24 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -103.36 22.07 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.535 -1.211 . . . . 2.1699999999999999 109.842 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.922 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -52.18 171.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.617 -1.174 . . . . 2.6299999999999999 112.666 175.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.31 -51.42 54.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.275 0.56 . . . . 1.99 110.12 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.554 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -150.39 157.49 36.78 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.207 -1.035 . . . . 1.8799999999999999 108.207 168.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.12 143.99 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.337 2.692 . . . . 1.1200000000000001 112.798 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.922 ' HD3' HD13 ' A' ' 33' ' ' LEU . 15.0 Cg_exo -50.1 143.13 25.95 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.81999999999999995 113.021 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.22 104.54 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.108 -2.182 . . . . 1.4299999999999999 105.108 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -113.09 114.88 48.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.995 -1.457 . . . . 1.0900000000000001 107.799 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.896 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.11 131.6 51.22 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.161 -1.382 . . . . 2.1299999999999999 109.418 173.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.067 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.8 m95 -91.92 149.32 21.62 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.221 -2.263 . . . . 0.40999999999999998 112.099 172.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.718 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 28.0 t80 -130.59 138.33 50.08 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.671 -2.344 . . . . 0.80000000000000004 104.671 170.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.87 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 83.1 tttt -98.41 174.07 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.375 -1.713 . . . . 2.6800000000000002 106.375 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -18.84 -169.64 0.0 OUTLIER Glycine 0 C--O 1.179 -3.299 0 C-N-CA 125.991 1.758 . . . . 1.6000000000000001 117.282 166.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.538 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 6.7 mtpp -41.34 -14.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.846 2.536 . . . . 4.2999999999999998 117.846 -160.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' GLY . 26.5 p-90 -162.46 -6.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.639 1.563 . . . . 2.5099999999999998 114.891 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.87 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.97 143.74 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-O 122.827 1.299 . . . . 1.78 111.791 -163.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -105.89 107.1 17.92 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 112.181 -2.281 . . . . 2.73 109.9 175.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.067 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.0 mp -54.65 -42.87 71.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 112.628 0.603 . . . . 1.1299999999999999 112.628 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -61.48 -19.07 61.63 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.649 -0.871 . . . . 1.71 108.649 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -86.88 -27.25 23.53 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.023 -0.989 . . . . 1.76 110.956 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 12.1 mmmt -102.9 -64.32 1.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.948 . . . . 1.9099999999999999 111.847 -171.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.724 HG21 ' O ' ' A' ' 49' ' ' LEU . 49.3 t 3.72 92.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.743 2.017 . . . . 1.1499999999999999 113.802 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -157.42 -130.17 1.19 Allowed Glycine 0 CA--C 1.525 0.676 0 CA-C-N 112.803 -1.999 . . . . 0.69999999999999996 112.597 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.26 -38.11 89.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.549 0.944 . . . . 3.3599999999999999 113.549 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 28.2 p80 -91.21 -31.52 16.13 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.776 0.798 . . . . 1.78 111.669 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.99 HD21 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.89 105.39 7.09 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.955 -1.498 . . . . 1.72 106.955 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -97.2 114.75 26.5 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 106.364 -1.717 . . . . 0.96999999999999997 106.364 166.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.64 92.54 4.68 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.259 -2.497 . . . . 1.0600000000000001 104.259 170.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 88.7 m-70 -97.35 160.54 14.27 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 115.009 -0.996 . . . . 2.5899999999999999 109.348 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.88 112.13 12.18 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.768 -2.015 . . . . 0.92000000000000004 109.537 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -106.51 151.1 25.42 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 112.47 -2.15 . . . . 0.76000000000000001 107.156 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -144.32 115.64 8.02 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-O 122.01 0.909 . . . . 1.8 111.196 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -94.95 96.23 9.16 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.285 -1.325 . . . . 2.4199999999999999 107.957 169.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.513 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -71.78 -30.5 65.63 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.699 -1.591 . . . . 3.0800000000000001 111.674 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.22 73.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.487 -0.779 . . . . 1.6899999999999999 110.234 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 m -89.62 -12.13 40.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.337 -0.847 . . . . 1.96 109.057 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.792 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 1.7 ttpm? 66.03 35.28 6.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.519 -1.219 . . . . 3.7799999999999998 109.743 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.598 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.7 t -125.81 136.85 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.455 0.645 . . . . 1.1299999999999999 110.899 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.39 123.19 43.45 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.904 -1.517 . . . . 1.95 106.904 158.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 tp -105.95 104.63 14.38 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.793 -1.094 . . . . 1.1799999999999999 108.114 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.2 m-85 -85.71 115.59 23.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.806 -1.543 . . . . 0.40000000000000002 107.663 173.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.11 121.8 45.21 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.96 -1.473 . . . . 1.3200000000000001 109.503 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.822 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.104 -1.407 . . . . 1.5900000000000001 108.356 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 70.8 m80 -110.01 95.05 5.34 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 104.811 -2.292 . . . . 2.0099999999999998 104.811 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.757 HD12 ' HE2' ' A' ' 87' ' ' TYR . 63.9 mt -121.51 99.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 122.825 1.297 . . . . 1.1899999999999999 109.353 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.4 p -104.11 168.73 8.92 Favored 'General case' 0 N--CA 1.394 -3.266 0 CA-C-N 114.359 -1.292 . . . . 1.05 110.569 -173.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 39.33 67.89 0.41 Allowed 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 110.473 -3.058 . . . . 2.1200000000000001 111.461 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB2' HD21 ' A' ' 104' ' ' LEU . . . -58.51 116.43 3.65 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 112.445 -2.162 . . . . 1.0900000000000001 110.547 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.762 HE21 ' HD2' ' A' ' 81' ' ' PRO . 1.3 tp60 -54.94 139.4 63.09 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.31 -0.859 . . . . 1.77 109.778 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.762 ' HD2' HE21 ' A' ' 80' ' ' GLN . 24.0 Cg_exo -61.23 -12.49 23.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.56 2.173 . . . . 1.3300000000000001 112.863 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -103.15 14.34 31.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 1.6599999999999999 110.795 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -89.73 -15.28 32.86 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.762 -0.637 . . . . 1.24 111.182 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.1 m -41.07 87.97 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 124.947 1.405 . . . . 1.6799999999999999 111.211 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.538 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -157.51 -137.98 2.4 Favored Glycine 0 C--N 1.28 -2.544 0 CA-C-N 113.098 -1.864 . . . . 2.0 112.835 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.11 119.22 0.91 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.974 -1.584 . . . . 0.81000000000000005 113.418 -167.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.818 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.8 m-85 -82.66 114.42 21.01 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 112.952 -1.624 . . . . 1.0800000000000001 108.47 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.718 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 11.0 mmm180 -103.98 104.52 14.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.455 -0.339 . . . . 3.6899999999999999 110.181 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.65 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 3.8 t -94.94 123.62 38.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.14 -0.689 . . . . 1.22 109.14 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.896 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 66.1 mt-10 -136.67 107.79 6.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.135 -0.939 . . . . 1.8100000000000001 110.271 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.568 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -99.78 141.6 16.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.533 0.682 . . . . 1.24 110.388 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -141.24 109.29 5.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.821 -1.081 . . . . 1.6399999999999999 108.623 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.598 HG23 ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -134.5 150.65 50.81 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 117.885 -1.055 . . . . 1.26 109.477 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.875 ' HZ2' ' HB3' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 29.54 -73.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.673 1.858 . . . . 0.93999999999999995 114.693 177.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.857 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 11.1 t0 -152.13 -4.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.492 -1.231 . . . . 1.05 110.056 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.713 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -92.27 125.72 37.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.765 -1.198 . . . . 1.78 107.765 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -129.56 140.92 51.09 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.109 -0.95 . . . . 1.0 110.974 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -168.46 156.92 8.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.354 -0.839 . . . . 1.6000000000000001 109.769 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 m -150.32 145.23 26.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.276 0.56 . . . . 1.98 110.098 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.735 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 26.8 p -125.2 134.71 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.616 -0.72 . . . . 1.02 110.668 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.2 117.46 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.484 0.659 . . . . 1.5800000000000001 110.97 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.751 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -141.0 124.83 17.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.643 -0.708 . . . . 1.1000000000000001 109.658 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.547 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 78.8 m-20 -100.16 153.22 19.42 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 122.31 1.052 . . . . 2.1099999999999999 111.553 -170.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -117.02 115.37 25.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.531 -1.213 . . . . 1.0900000000000001 107.943 173.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.49 ' HA ' HG22 ' A' ' 84' ' ' THR . 7.5 m -100.64 95.9 6.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.399 -0.963 . . . . 1.0700000000000001 108.399 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.711 HG12 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.61 117.18 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.254 1.502 . . . . 1.1399999999999999 108.942 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.445 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 33.4 m170 -87.72 100.17 12.63 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.47 -2.15 . . . . 1.8200000000000001 108.442 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 49.0 tt0 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.852 -1.067 . . . . 1.6699999999999999 110.275 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.626 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.435 -1.214 0 CA-C-O 119.555 -0.259 . . . . 1.6499999999999999 110.371 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 60.2 Cg_endo -73.29 36.32 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.649 2.233 . . . . 1.24 113.791 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.759 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -57.6 -60.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.091 -0.959 . . . . 1.2 109.904 170.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 88.7 45.86 4.75 Favored Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 109.248 -1.541 . . . . 0.44 109.248 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.966 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.1 tp -46.59 -43.86 17.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.288 -1.456 . . . . 1.1100000000000001 110.502 -173.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.736 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.34 84.85 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.998 0.904 . . . . 0.97999999999999998 110.483 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.51 -47.3 52.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.03 -1.441 . . . . 1.1100000000000001 109.612 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.511 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 16.6 tpt -152.7 133.21 13.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.372 -0.831 . . . . 3.3100000000000001 109.087 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.599 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -101.09 136.51 19.7 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.771 -0.649 . . . . 4.1699999999999999 110.637 -177.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.754 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.6 Cg_endo -63.41 155.29 63.17 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.2 1.934 . . . . 0.81999999999999995 111.057 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -119.96 174.31 6.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.124 -0.489 . . . . 1.6299999999999999 110.735 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.4 p-10 -68.49 -142.66 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 122.738 1.256 . . . . 2.0600000000000001 111.807 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 146.55 137.4 3.02 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.317 -1.765 . . . . 0.34999999999999998 111.811 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 40.9 mt-10 -109.71 116.08 31.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.337 -0.932 . . . . 1.53 108.529 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -138.29 153.78 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.727 -1.212 . . . . 1.0800000000000001 107.727 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -84.14 156.4 22.13 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.687 -1.142 . . . . 1.22 109.474 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.669 HG11 ' HD3' ' A' ' 81' ' ' PRO . 9.1 t -68.9 105.63 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 123.313 1.53 . . . . 1.3799999999999999 107.629 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.39 15.2 7.16 Favored Glycine 0 C--N 1.264 -3.437 0 CA-C-N 111.926 -2.397 . . . . 0.52000000000000002 112.342 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.58 -123.18 4.59 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.179 -1.486 . . . . 0.44 109.477 167.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 58.6 m -154.47 173.23 16.55 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 113.087 -1.556 . . . . 1.23 108.646 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.617 HG22 HD11 ' A' ' 104' ' ' LEU . 10.3 tp -149.11 150.58 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 N-CA-C 107.127 -1.434 . . . . 1.0900000000000001 107.127 167.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 22' ' ' ILE . 8.6 m -137.7 123.86 20.42 Favored 'General case' 0 C--N 1.262 -3.238 0 CA-C-N 113.636 -1.62 . . . . 1.05 110.336 -177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 36.7 m-85 -117.84 147.83 42.69 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.906 -1.497 . . . . 0.71999999999999997 108.38 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -140.23 122.24 15.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.272 -0.876 . . . . 0.87 109.574 176.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.679 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -116.35 115.84 26.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.873 -1.058 . . . . 1.1000000000000001 109.903 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -102.74 111.6 24.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.247 -0.433 . . . . 2.9300000000000002 110.283 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 19.0 t -115.53 126.62 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-O 121.988 0.899 . . . . 1.0700000000000001 110.185 -178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 104.33 1.04 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.564 -1.653 . . . . 1.1200000000000001 110.378 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.785 ' HA3' ' NZ ' ' A' ' 68' ' ' LYS . . . -51.94 -66.95 2.27 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.163 -1.38 . . . . 0.76000000000000001 112.031 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.766 ' H ' ' HB3' ' A' ' 68' ' ' LYS . . . 60.34 -167.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.762 0.825 . . . . 1.0 111.96 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -106.57 144.12 33.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 2.1699999999999999 109.833 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.39 -172.14 3.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.44 0.638 . . . . 2.6299999999999999 112.465 -169.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.41 -44.36 17.64 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 1.99 108.895 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.562 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 1.3 pptp? -142.36 142.39 23.66 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.321 -0.854 . . . . 1.8799999999999999 108.855 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.91 146.46 4.08 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.183 2.588 . . . . 1.1200000000000001 112.43 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.739 ' HB3' ' HG1' ' A' ' 93' ' ' THR . 3.1 Cg_endo -54.9 128.4 30.33 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 120.952 1.101 . . . . 0.81999999999999995 111.877 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.84 103.96 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 106.774 -1.565 . . . . 1.4299999999999999 106.774 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.8 t -105.83 114.51 45.4 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 113.56 -1.654 . . . . 1.0900000000000001 107.436 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.926 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.59 128.87 54.91 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-O 123.221 1.486 . . . . 2.1299999999999999 109.81 176.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.044 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -90.31 152.53 20.99 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 112.138 -2.301 . . . . 0.40999999999999998 111.96 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 32.8 t80 -128.02 130.75 48.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.556 -2.016 . . . . 0.80000000000000004 105.556 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 3.4 tttm -107.85 102.31 11.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.878 -1.156 . . . . 2.6800000000000002 107.878 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.585 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -90.9 100.11 2.65 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 116.632 -2.699 . . . . 1.6000000000000001 116.88 -161.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 1.4 pttm -102.6 -41.18 6.34 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 103.925 -2.621 . . . . 4.2999999999999998 103.925 123.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.62 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.8 p-90 -171.09 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 112.667 -2.06 . . . . 2.5099999999999998 112.48 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.624 HG21 ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.92 173.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-O 123.28 1.514 . . . . 1.78 112.614 -163.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.605 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.1 p-10 -96.57 161.29 13.96 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.413 -2.63 . . . . 2.73 106.887 170.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.044 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -97.43 -31.36 12.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 119.02 -0.514 . . . . 1.1299999999999999 112.0 167.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -56.89 -21.8 32.36 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 123.585 0.553 . . . . 1.71 109.733 -161.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -100.79 -26.43 13.78 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.384 -0.926 . . . . 1.76 112.116 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.76 -27.12 14.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.496 -1.229 . . . . 1.9099999999999999 111.537 -167.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 49' ' ' LEU . 74.6 t -37.18 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.53 1.532 . . . . 1.1499999999999999 110.953 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.526 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.05 -105.14 0.23 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 112.803 -1.999 . . . . 0.69999999999999996 114.015 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -83.95 -45.01 13.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.206 0.447 . . . . 3.3599999999999999 112.206 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.571 ' HE1' ' HE3' ' A' ' 43' ' ' LYS . 19.9 p80 -91.44 -36.83 13.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.653 . . . . 1.78 111.14 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.928 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.58 106.71 12.03 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.051 -1.463 . . . . 1.72 107.051 176.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.55 ' HB3' ' HD2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -96.98 114.41 26.02 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 106.811 -1.551 . . . . 0.96999999999999997 106.811 164.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.804 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.9 92.3 4.52 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 104.687 -2.338 . . . . 1.0600000000000001 104.687 170.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.614 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 22.9 m-70 -100.34 163.83 12.21 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.463 1.125 . . . . 2.5899999999999999 109.473 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.84 112.92 12.89 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 112.113 -2.312 . . . . 0.92000000000000004 109.817 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 4.7 m -94.95 150.03 20.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.729 -2.032 . . . . 0.76000000000000001 108.289 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -144.38 107.76 4.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.354 1.073 . . . . 1.8 111.323 -170.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.11 122.54 47.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.887 -1.96 . . . . 2.4199999999999999 108.913 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.664 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -79.35 -29.59 42.28 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.349 -1.296 . . . . 3.0800000000000001 111.66 -177.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.31 33.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.072 -0.513 . . . . 1.6899999999999999 110.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 m -124.48 4.15 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.75 -0.659 . . . . 1.96 111.245 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.785 ' NZ ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.81 7.8 3.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.611 0.764 . . . . 3.7799999999999998 112.318 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 46.0 t -76.18 117.67 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 CA-C-O 122.407 1.099 . . . . 1.1299999999999999 110.223 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 62' ' ' SER . 81.4 m-85 -90.07 100.51 13.32 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.663 -2.062 . . . . 1.95 106.312 165.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.9 tp -93.25 103.56 15.8 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.523 1.154 . . . . 1.1799999999999999 108.026 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.0 m-85 -81.78 113.91 20.06 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 113.321 -1.763 . . . . 0.40000000000000002 107.716 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.439 ' CG ' ' HG ' ' A' ' 71' ' ' LEU . 51.7 mt-10 -107.32 121.21 44.12 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.328 -1.76 . . . . 1.3200000000000001 109.037 -175.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.708 HD22 ' CH2' ' A' ' 41' ' ' TRP . 1.4 mm? -98.45 117.02 31.94 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 112.936 -1.938 . . . . 1.5900000000000001 108.079 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -110.96 95.23 5.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 105.175 -2.157 . . . . 2.0099999999999998 105.175 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.598 HG12 HD21 ' A' ' 57' ' ' LEU . 54.5 mt -121.53 99.5 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 113.842 -1.526 . . . . 1.1899999999999999 106.923 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 35.8 p -106.19 167.08 10.05 Favored 'General case' 0 N--CA 1.394 -3.271 0 CA-C-N 114.197 -1.365 . . . . 1.05 109.778 -171.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 40.51 59.35 2.13 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 111.544 -2.571 . . . . 2.1200000000000001 111.34 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -51.0 123.35 9.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.405 -1.725 . . . . 1.0900000000000001 109.509 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.612 ' HA ' HG12 ' A' ' 18' ' ' VAL . 1.7 pt20 -78.54 156.13 78.34 Favored Pre-proline 0 C--N 1.311 -1.076 0 N-CA-C 108.033 -1.099 . . . . 1.77 108.033 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.669 ' HD3' HG11 ' A' ' 18' ' ' VAL . 50.8 Cg_endo -68.75 162.72 40.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.005 1.137 . . . . 1.3300000000000001 109.975 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . 70.74 14.43 7.09 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.616 0.572 . . . . 1.6599999999999999 111.705 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.461 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -80.45 -54.92 5.25 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.303 -0.999 . . . . 1.24 108.303 168.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.2 m 36.6 57.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.429 -1.323 . . . . 1.6799999999999999 107.429 -160.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.622 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -48.73 85.17 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.004 0 CA-C-N 111.56 -2.563 . . . . 2.0 114.788 -161.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -90.79 78.29 1.44 Allowed Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 108.957 -1.657 . . . . 0.81000000000000005 108.957 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.663 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 49.0 m-85 -80.71 122.76 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.769 -1.567 . . . . 1.0800000000000001 106.769 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -115.53 107.64 15.42 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.472 -0.491 . . . . 3.6899999999999999 109.677 -171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -92.06 131.37 37.39 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.766 -0.652 . . . . 1.22 109.7 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.926 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 44.4 tt0 -139.77 110.63 6.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.407 -0.815 . . . . 1.8100000000000001 109.5 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 p -102.0 137.82 28.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.656 0.741 . . . . 1.24 110.534 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.7 t -132.1 108.76 9.51 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.636 -1.165 . . . . 1.6399999999999999 108.732 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.739 ' HG1' ' HB3' ' A' ' 37' ' ' PRO . 1.2 m -123.47 167.34 14.0 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.031 -1.1 . . . . 1.26 108.031 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -4.6 -61.26 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 125.316 1.635 . . . . 0.93999999999999995 114.926 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.916 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -147.76 -10.75 0.4 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.035 -0.984 . . . . 1.05 111.211 -174.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.966 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.2 tttp -94.31 134.89 36.33 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 119.133 -1.027 . . . . 1.78 108.23 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.16 135.47 46.39 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 1.0 110.846 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -155.6 147.84 23.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.141 -0.936 . . . . 1.6000000000000001 109.925 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 33.2 m -141.94 150.68 41.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.535 0.207 . . . . 1.98 110.674 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.736 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 78.4 p -134.86 132.62 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.427 . . . . 1.02 111.279 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 122.56 47.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.646 -0.707 . . . . 1.5800000000000001 110.676 176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.776 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 5.0 p90 -142.63 129.48 20.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 1.1000000000000001 109.416 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 71.7 m-20 -108.7 135.27 50.21 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.417 1.103 . . . . 2.1099999999999999 111.783 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.622 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.49 105.51 15.78 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.102 -1.408 . . . . 1.0900000000000001 110.448 178.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.445 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 10.4 m -84.12 97.34 9.29 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.732 -0.84 . . . . 1.0700000000000001 108.732 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.6 p -84.94 115.53 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 123.236 1.494 . . . . 1.1399999999999999 110.087 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 78.1 m-70 -88.79 100.68 13.34 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.368 -2.196 . . . . 1.8200000000000001 109.394 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.551 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 34.7 tt0 . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 114.208 -1.36 . . . . 1.6699999999999999 110.594 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.811 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 108.435 -0.95 . . . . 1.6499999999999999 108.435 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -41.34 94.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 124.656 3.571 . . . . 1.24 114.809 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.633 ' CD1' ' HZ3' ' A' ' 94' ' ' LYS . 1.3 mp -126.25 -61.1 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.031 -0.986 . . . . 1.2 109.58 172.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.567 ' N ' HG23 ' A' ' 4' ' ' ILE . . . 91.11 52.81 2.31 Favored Glycine 0 CA--C 1.496 -1.142 0 N-CA-C 108.685 -1.766 . . . . 0.44 108.685 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.032 HD23 ' HB3' ' A' ' 96' ' ' LYS . 8.3 tp -59.77 -40.71 89.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.225 -1.487 . . . . 1.1100000000000001 110.191 -169.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.51 5.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.99 -1.005 . . . . 0.97999999999999998 109.881 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.82 -47.25 33.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.419 -1.264 . . . . 1.1100000000000001 109.641 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 17.2 tpt -147.48 129.96 15.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.199 -0.909 . . . . 3.3100000000000001 109.398 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -106.78 132.46 20.89 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.549 -0.75 . . . . 4.1699999999999999 110.398 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 17.4 Cg_endo -66.53 153.59 77.42 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.369 2.046 . . . . 0.81999999999999995 111.372 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.5 mm-40 -121.14 176.93 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.228 -0.442 . . . . 1.6299999999999999 110.327 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.5 p30 -68.03 -148.56 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.384 0 CA-C-O 122.776 1.275 . . . . 2.0600000000000001 111.237 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 153.4 138.74 2.73 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 113.44 -1.709 . . . . 0.34999999999999998 111.745 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 29.2 mt-10 -117.47 113.09 21.53 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.297 -0.951 . . . . 1.53 109.029 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.402 HG21 HD13 ' A' ' 104' ' ' LEU . 2.5 m -132.82 163.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.929 -1.508 . . . . 1.0800000000000001 106.929 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -94.32 157.74 15.9 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.538 -0.755 . . . . 1.22 109.836 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.608 HG11 ' HD3' ' A' ' 81' ' ' PRO . 2.9 t -67.89 106.35 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 107.679 -1.23 . . . . 1.3799999999999999 107.679 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.46 7.57 8.95 Favored Glycine 0 C--N 1.263 -3.507 0 CA-C-N 112.657 -2.065 . . . . 0.52000000000000002 112.194 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.51 -125.04 5.02 Favored Glycine 0 N--CA 1.409 -3.154 0 C-N-CA 119.181 -1.485 . . . . 0.44 109.714 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.2 p -152.74 167.87 27.54 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.127 -1.537 . . . . 1.23 110.372 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 104' ' ' LEU . 10.4 tp -147.62 149.67 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-N 113.637 -1.619 . . . . 1.0900000000000001 107.652 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -139.3 127.24 22.24 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 113.711 -1.586 . . . . 1.05 110.344 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 76' ' ' ILE . 42.0 m-85 -123.71 147.18 47.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.516 -1.22 . . . . 0.71999999999999997 108.812 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.19 122.59 19.49 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.179 -0.919 . . . . 0.87 109.671 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -119.03 115.64 24.74 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.593 -1.185 . . . . 1.1000000000000001 110.226 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -106.71 117.62 34.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.043 -0.526 . . . . 2.9300000000000002 110.394 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 t -122.27 128.93 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.208 1.004 . . . . 1.0700000000000001 110.739 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -60.0 110.04 1.1 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.128 -1.851 . . . . 1.1200000000000001 112.352 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.18 81.43 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 114.897 -1.047 . . . . 0.76000000000000001 112.463 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.812 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 58.3 -179.07 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.522 1.304 . . . . 1.0 114.522 168.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -101.11 23.81 10.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.525 -1.216 . . . . 2.1699999999999999 109.809 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.037 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -57.05 175.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.52 -1.218 . . . . 2.6299999999999999 113.855 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.2 tp -64.73 -56.83 11.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.315 -0.857 . . . . 1.99 109.773 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.711 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.76 143.26 48.63 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.93 -1.032 . . . . 1.8799999999999999 108.642 176.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.18 140.25 11.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.606 2.204 . . . . 1.1200000000000001 110.638 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.037 ' HD3' HD13 ' A' ' 33' ' ' LEU . 1.6 Cg_endo -58.94 135.29 65.73 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.325 0.683 . . . . 0.81999999999999995 112.121 -171.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 92' ' ' SER . 14.1 p -99.71 104.81 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-O 123.724 1.726 . . . . 1.4299999999999999 107.97 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -105.67 114.82 46.07 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 111.892 -2.413 . . . . 1.0900000000000001 107.592 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.771 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.03 126.1 47.69 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 122.939 1.352 . . . . 2.1299999999999999 109.051 174.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.837 ' HB3' HD12 ' A' ' 49' ' ' LEU . 76.0 m95 -84.46 152.54 23.92 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 112.308 -2.224 . . . . 0.40999999999999998 112.112 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -129.31 139.61 51.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.378 -2.452 . . . . 0.80000000000000004 104.378 172.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 38.3 tttt -107.13 165.03 11.66 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.399 -1.334 . . . . 2.6800000000000002 107.399 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.953 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -7.63 -165.43 0.0 OUTLIER Glycine 0 C--O 1.197 -2.184 0 N-CA-C 118.963 2.345 . . . . 1.6000000000000001 118.963 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HG3' ' HB ' ' A' ' 84' ' ' THR . 10.5 mtpp -43.06 -3.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.249 1.944 . . . . 4.2999999999999998 116.249 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.57 ' CZ3' HG12 ' A' ' 47' ' ' VAL . 20.6 p-90 -172.12 -13.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.287 1.588 . . . . 2.5099999999999998 115.287 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.02 169.09 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 123.297 1.522 . . . . 1.78 112.344 -160.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.51 154.7 23.3 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.1 -2.318 . . . . 2.73 107.942 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 57' ' ' LEU . 1.8 mp -94.4 -32.61 13.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.936 0.717 . . . . 1.1299999999999999 112.936 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -58.05 -25.58 61.38 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.301 0.572 . . . . 1.71 109.5 -164.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -104.13 -41.57 5.78 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.299 -0.864 . . . . 1.76 113.069 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 5.9 mptt -67.02 -52.39 43.07 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.011 -0.995 . . . . 1.9099999999999999 111.864 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 ' H ' ' A' ' 59' ' ' LEU . 11.9 t -23.85 100.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 111.38 -2.645 . . . . 1.1499999999999999 113.512 175.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -166.11 -129.72 1.08 Allowed Glycine 0 C--N 1.299 -1.504 0 CA-C-N 110.561 -3.018 . . . . 0.69999999999999996 112.154 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -56.47 -37.01 69.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.465 0.913 . . . . 3.3599999999999999 113.465 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.658 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.5 p80 -95.07 -38.88 10.42 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.267 0.469 . . . . 1.78 112.267 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.888 ' HB2' HG12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.97 107.76 8.9 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.015 -0.735 . . . . 1.72 109.015 173.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.41 116.25 28.8 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.14 -1.43 . . . . 0.96999999999999997 107.14 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.848 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -90.51 93.32 9.24 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.044 -2.206 . . . . 1.0600000000000001 105.044 171.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -86.02 163.03 18.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-O 122.96 1.362 . . . . 2.5899999999999999 109.382 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -141.38 118.91 11.58 Favored 'General case' 0 C--N 1.259 -3.339 0 CA-C-N 111.332 -2.667 . . . . 0.92000000000000004 109.585 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.7 m -103.39 148.95 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.777 -2.011 . . . . 0.76000000000000001 107.99 172.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.448 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 13.2 t80 -142.33 97.29 3.1 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.439 1.114 . . . . 1.8 110.821 -176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -117.6 118.22 31.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.786 -1.552 . . . . 2.4199999999999999 109.911 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -36.33 25.02 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.557 -1.656 . . . . 3.0800000000000001 111.554 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.23 67.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.432 -0.803 . . . . 1.6899999999999999 110.912 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -96.55 -19.42 19.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.391 -0.966 . . . . 1.96 108.391 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.812 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 11.4 ttpt 67.08 32.54 6.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.961 -1.472 . . . . 3.7799999999999998 110.427 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -128.07 126.63 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.761 0.791 . . . . 1.1299999999999999 110.311 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.3 m-30 -99.17 108.81 21.5 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.119 -1.808 . . . . 1.95 106.119 166.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HG ' ' HG2' ' A' ' 73' ' ' GLU . 14.3 tp -98.25 105.74 17.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.522 1.153 . . . . 1.1799999999999999 109.142 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.0 m-85 -85.45 113.52 21.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 113.322 -1.763 . . . . 0.40000000000000002 107.905 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 9.6 mt-10 -107.56 121.2 44.16 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.465 -1.698 . . . . 1.3200000000000001 110.044 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.816 HD22 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -91.08 126.66 36.23 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.462 -1.244 . . . . 1.5900000000000001 107.849 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.635 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 78.7 m80 -117.06 95.32 4.94 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 104.569 -2.382 . . . . 2.0099999999999998 104.569 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.888 HG12 ' HB2' ' A' ' 57' ' ' LEU . 25.4 mt -121.85 100.47 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-O 122.74 1.257 . . . . 1.1899999999999999 109.066 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.3 p -111.86 161.13 16.7 Favored 'General case' 0 N--CA 1.395 -3.224 0 CA-C-N 114.569 -1.196 . . . . 1.05 109.572 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 48.35 57.75 5.88 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 111.271 -2.695 . . . . 2.1200000000000001 110.611 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' O ' HG12 ' A' ' 18' ' ' VAL . . . -52.62 119.81 4.96 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.824 -1.989 . . . . 1.0900000000000001 110.608 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.747 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -60.15 143.84 88.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.461 -0.791 . . . . 1.77 109.306 173.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.747 ' HD2' HE21 ' A' ' 80' ' ' GLN . 31.7 Cg_endo -63.54 -3.32 5.22 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.286 1.99 . . . . 1.3300000000000001 112.564 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.492 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -115.17 15.73 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.566 . . . . 1.6599999999999999 110.131 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.8 m-30 -94.53 -8.7 37.54 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 118.838 -0.601 . . . . 1.24 110.181 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 15.6 m -19.1 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 125.788 1.93 . . . . 1.6799999999999999 111.529 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.755 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -37.12 110.83 0.1 Allowed Glycine 0 CA--C 1.473 -2.579 0 CA-C-N 110.062 -3.245 . . . . 2.0 114.584 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.953 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -127.45 60.08 0.67 Allowed Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 108.277 -1.929 . . . . 0.81000000000000005 108.277 157.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.599 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 80.7 m-85 -80.2 126.78 31.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.07 -1.065 . . . . 1.0800000000000001 108.555 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -130.83 121.11 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.951 -0.468 . . . . 3.6899999999999999 110.274 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.543 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -98.53 120.61 39.25 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.587 -0.523 . . . . 1.22 109.587 176.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.771 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.8 mt-10 -121.56 105.44 10.45 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.189 -0.671 . . . . 1.8100000000000001 109.189 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.4 p -96.07 137.17 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.356 0.598 . . . . 1.24 110.384 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.682 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.0 t -130.09 110.65 11.78 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.875 -1.057 . . . . 1.6399999999999999 109.146 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -129.06 173.63 10.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.877 -0.602 . . . . 1.26 110.17 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.859 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.96 -62.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.243 1.59 . . . . 0.93999999999999995 114.474 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.859 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.9 t70 -154.24 -0.57 0.2 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.384 -1.28 . . . . 1.05 109.289 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.032 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -93.36 128.25 39.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.001 -1.111 . . . . 1.78 108.001 -177.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -130.73 130.71 44.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.756 -1.111 . . . . 1.0 110.831 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.96 151.22 35.44 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.402 -1.272 . . . . 1.6000000000000001 109.02 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 9.5 p -151.13 146.59 26.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.133 0.492 . . . . 1.98 111.294 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.48 146.45 50.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.479 -0.782 . . . . 1.02 111.593 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.24 119.0 22.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.69 -1.141 . . . . 1.5800000000000001 109.477 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.835 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 6.7 p90 -143.1 128.73 19.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.344 0.592 . . . . 1.1000000000000001 110.153 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.689 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 41.8 m-20 -102.45 135.48 44.0 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.22 1.009 . . . . 2.1099999999999999 110.999 -172.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.755 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -105.46 107.34 18.27 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.046 -1.434 . . . . 1.0900000000000001 108.856 174.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 9.0 m -87.94 95.08 9.98 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.163 -1.015 . . . . 1.0700000000000001 108.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 80' ' ' GLN . 3.3 p -76.69 112.51 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 122.948 1.356 . . . . 1.1399999999999999 107.768 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 66.4 m170 -82.03 97.66 8.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.902 -1.954 . . . . 1.8200000000000001 108.623 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HA ' HG21 ' A' ' 18' ' ' VAL . 39.2 tt0 . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.376 -1.342 . . . . 1.6699999999999999 107.376 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 8.0 m-20 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 111.625 0.232 . . . . 1.6499999999999999 111.625 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -70.51 69.04 2.09 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.579 2.186 . . . . 1.24 112.534 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 1.031 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -88.12 -63.82 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.8 -1.091 . . . . 1.2 108.729 171.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.85 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 91.72 43.2 4.57 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.588 -1.805 . . . . 0.44 108.588 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.0 tp -52.77 -39.59 62.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.827 -1.687 . . . . 1.1100000000000001 110.389 -171.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.749 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.95 83.41 5.65 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.162 -0.926 . . . . 0.97999999999999998 109.816 177.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.31 -43.03 74.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.565 -1.198 . . . . 1.1100000000000001 108.835 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.36 135.67 15.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.123 -0.944 . . . . 3.3100000000000001 109.571 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -113.92 136.43 22.12 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.0 -0.741 . . . . 4.1699999999999999 109.0 176.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.676 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -71.58 160.08 49.34 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.437 1.425 . . . . 0.81999999999999995 110.646 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.38 -177.78 3.53 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.75 -0.659 . . . . 1.6299999999999999 109.498 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.9 p-10 -69.67 -151.08 0.02 OUTLIER 'General case' 0 N--CA 1.405 -2.721 0 CA-C-O 123.166 1.46 . . . . 2.0600000000000001 111.939 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.04 134.86 2.01 Favored Glycine 0 C--N 1.293 -1.811 0 CA-C-N 112.824 -1.989 . . . . 0.34999999999999998 112.036 -174.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 32.4 mt-10 -112.49 112.35 23.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.154 -1.023 . . . . 1.53 108.48 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.0 m -130.76 163.99 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 108.005 -1.109 . . . . 1.0800000000000001 108.005 -171.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -90.97 152.84 20.54 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.279 -1.328 . . . . 1.22 109.256 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 81' ' ' PRO . 21.8 t -69.4 106.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 CA-C-O 122.796 1.284 . . . . 1.3799999999999999 107.663 172.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.8 11.57 7.02 Favored Glycine 0 C--N 1.263 -3.52 0 CA-C-N 111.9 -2.409 . . . . 0.52000000000000002 112.717 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.38 -121.84 4.96 Favored Glycine 0 CA--C 1.472 -2.614 0 C-N-CA 118.893 -1.622 . . . . 0.44 110.419 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.9 p -152.49 172.03 17.17 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 112.614 -1.793 . . . . 1.23 110.322 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.61 HG22 HD13 ' A' ' 104' ' ' LEU . 9.3 tp -148.37 149.61 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 113.022 -1.899 . . . . 1.0900000000000001 106.185 169.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m -137.89 124.99 21.49 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 114.411 -1.268 . . . . 1.05 111.235 -173.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.895 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.9 m-85 -119.55 139.85 51.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.921 -1.49 . . . . 0.71999999999999997 109.525 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.126 -0.943 . . . . 0.87 108.75 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.748 ' HB1' ' HH2' ' A' ' 41' ' ' TRP . . . -122.14 115.98 23.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.374 -1.284 . . . . 1.1000000000000001 110.261 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HG2' HD11 ' A' ' 71' ' ' LEU . 66.1 mtp180 -111.41 122.5 48.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.649 -0.251 . . . . 2.9300000000000002 110.46 -174.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.7 t -121.18 128.11 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.012 0.91 . . . . 1.0700000000000001 110.394 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.38 109.39 1.34 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.285 -1.779 . . . . 1.1200000000000001 110.486 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.65 -42.19 35.68 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.106 -0.952 . . . . 0.76000000000000001 111.68 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.614 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 57.41 -166.55 0.14 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.039 0.755 . . . . 1.0 113.039 172.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 p -113.23 110.72 20.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.08 -0.964 . . . . 2.1699999999999999 108.648 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.003 HD13 ' H ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -148.34 158.36 44.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.145 -0.479 . . . . 2.6299999999999999 110.289 -171.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.722 ' N ' HD11 ' A' ' 33' ' ' LEU . 4.9 mt -47.13 -37.93 10.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.053 1.406 . . . . 1.99 111.501 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.778 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.99 -178.83 0.86 Allowed Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 111.933 -2.394 . . . . 1.8799999999999999 107.809 -170.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.65 145.61 20.63 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.198 -1.886 . . . . 1.1200000000000001 107.198 162.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.671 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 16.6 Cg_exo -58.18 129.56 33.56 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 CA-C-N 119.49 0.854 . . . . 0.81999999999999995 110.606 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.23 102.3 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 122.781 1.277 . . . . 1.4299999999999999 107.657 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -104.88 115.8 47.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 112.427 -2.17 . . . . 1.0900000000000001 108.023 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.92 130.83 54.52 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.108 1.432 . . . . 2.1299999999999999 109.757 173.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.066 ' HB3' HD11 ' A' ' 49' ' ' LEU . 86.7 m95 -86.59 152.47 22.58 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.103 -2.317 . . . . 0.40999999999999998 112.746 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.9 t80 -131.18 136.71 48.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.239 -2.134 . . . . 0.80000000000000004 105.239 170.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.741 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 80.3 tttt -102.84 166.53 10.42 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.712 -1.588 . . . . 2.6800000000000002 106.712 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.72 -168.22 0.0 OUTLIER Glycine 0 C--O 1.187 -2.8 0 N-CA-C 119.549 2.58 . . . . 1.6000000000000001 119.549 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 84' ' ' THR . 16.6 mtpt -44.97 -1.31 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.549 -2.147 . . . . 4.2999999999999998 116.384 -167.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.622 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.6 p-90 -167.7 -11.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.765 1.395 . . . . 2.5099999999999998 114.765 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.741 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.23 168.04 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 CA-C-O 123.459 1.6 . . . . 1.78 112.816 -159.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.499 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.5 t70 -112.28 155.43 24.08 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 111.549 -2.569 . . . . 2.73 105.937 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.066 HD11 ' HB3' ' A' ' 41' ' ' TRP . 5.4 mp -94.08 -36.34 12.14 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.579 0.955 . . . . 1.1299999999999999 113.579 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 t -58.72 -21.23 54.55 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.2 -0.667 . . . . 1.71 109.2 -165.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -96.13 -27.57 14.99 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.022 -0.99 . . . . 1.76 113.419 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 16.7 mmmt -100.75 -32.6 10.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.033 0.444 . . . . 1.9099999999999999 111.566 -170.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 27.0 t -35.11 97.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 125.817 1.647 . . . . 1.1499999999999999 111.94 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.48 -146.2 4.43 Favored Glycine 0 C--O 1.213 -1.212 0 CA-C-N 111.604 -2.544 . . . . 0.69999999999999996 110.309 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' C ' HE22 ' A' ' 58' ' ' GLN . 41.7 tt0 -71.37 -2.0 14.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.943 0.872 . . . . 3.3599999999999999 112.916 -170.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 21.8 p80 -114.29 -33.38 5.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.87 0.843 . . . . 1.78 111.064 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.952 HD11 HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -133.3 105.18 6.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.706 -1.961 . . . . 1.72 105.706 171.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.81 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -99.28 114.49 27.35 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.073 -1.825 . . . . 0.96999999999999997 106.073 171.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.528 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -97.2 92.81 6.2 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.901 -2.259 . . . . 1.0600000000000001 104.901 172.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.5 m-70 -93.53 163.07 13.71 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.013 1.387 . . . . 2.5899999999999999 110.378 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.02 119.15 24.85 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 111.399 -2.637 . . . . 0.92000000000000004 108.88 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -102.59 138.93 38.85 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.574 -2.103 . . . . 0.76000000000000001 106.538 167.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -145.64 99.13 3.24 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.991 0.9 . . . . 1.8 112.156 -166.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 5.0 t70 -119.68 120.69 37.34 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.349 -1.296 . . . . 2.4199999999999999 109.866 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -81.62 -38.8 25.44 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.684 -1.598 . . . . 3.0800000000000001 111.289 -176.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.9 -28.01 60.45 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.69 -1.141 . . . . 1.6899999999999999 111.248 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 27.5 m -89.0 -13.31 39.1 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.635 -1.246 . . . . 1.96 107.635 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 72.98 25.85 2.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.597 -1.638 . . . . 3.7799999999999998 110.484 171.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.59 120.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.912 0.863 . . . . 1.1299999999999999 110.709 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.671 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -103.43 105.94 16.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.322 -1.733 . . . . 1.95 106.322 166.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 8.0 tp -96.7 104.38 16.37 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 1.1799999999999999 108.806 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -85.01 115.14 22.66 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.105 -1.407 . . . . 0.40000000000000002 107.515 174.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -102.65 126.2 49.66 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 113.727 -1.579 . . . . 1.3200000000000001 109.435 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.895 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 3.7 mm? -95.74 125.48 40.34 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.877 -1.511 . . . . 1.5900000000000001 107.749 172.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.81 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 30.9 m170 -120.39 95.98 4.96 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 103.85 -2.648 . . . . 2.0099999999999998 103.85 172.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.607 ' CD1' HD22 ' A' ' 57' ' ' LEU . 58.5 mt -120.3 102.22 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 113.894 -1.503 . . . . 1.1899999999999999 108.874 -170.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 80.6 p -114.05 141.66 47.16 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 113.219 -1.81 . . . . 1.05 109.845 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 61.21 70.71 0.59 Allowed 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 111.28 -2.691 . . . . 2.1200000000000001 110.222 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.45 126.9 28.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.435 -2.166 . . . . 1.0900000000000001 110.524 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.779 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -55.67 139.33 68.82 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.386 -0.824 . . . . 1.77 109.378 173.154 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HB3' HG22 ' A' ' 18' ' ' VAL . 34.6 Cg_endo -67.74 145.04 67.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.357 1.371 . . . . 1.3300000000000001 110.888 176.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.88 17.22 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.659 0.599 . . . . 1.6599999999999999 110.758 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.779 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -71.01 -30.27 66.45 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.002 -0.544 . . . . 1.24 109.712 177.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 40.6 m 14.46 79.59 0.01 OUTLIER 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.566 1.791 . . . . 1.6799999999999999 110.712 -168.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -64.06 94.82 0.15 Allowed Glycine 0 N--CA 1.423 -2.216 0 CA-C-N 112.35 -2.205 . . . . 2.0 113.764 -161.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.71 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -88.19 70.48 2.66 Favored Glycine 0 C--N 1.288 -2.133 0 N-CA-C 109.324 -1.51 . . . . 0.81000000000000005 109.324 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.571 ' HE2' ' CD2' ' A' ' 57' ' ' LEU . 54.3 m-85 -74.58 120.77 20.59 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.676 -1.262 . . . . 1.0800000000000001 108.788 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 90.3 mtt180 -120.09 110.93 17.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.788 -0.449 . . . . 3.6899999999999999 109.788 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 t -94.93 122.65 37.79 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.54 -0.541 . . . . 1.22 109.54 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.496 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 24.1 mt-10 -126.77 110.83 13.53 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.081 -0.963 . . . . 1.8100000000000001 109.937 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HB ' HG11 ' A' ' 39' ' ' VAL . 3.0 p -107.99 139.82 28.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.443 0.639 . . . . 1.24 110.655 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -133.36 110.87 10.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.758 -1.11 . . . . 1.6399999999999999 110.279 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 37' ' ' PRO . 31.9 p -120.33 -176.33 3.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.185 -0.916 . . . . 1.26 111.123 176.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 1.003 ' H ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -25.92 -45.07 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 125.724 1.89 . . . . 0.93999999999999995 112.367 -178.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.753 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -172.72 7.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.77 -1.559 . . . . 1.05 110.84 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.031 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 tmtm? -92.91 123.69 36.35 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 106.571 -1.64 . . . . 1.78 106.571 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.52 123.24 29.18 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.974 -1.012 . . . . 1.0 111.124 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -145.58 144.27 30.39 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.1 -1.409 . . . . 1.6000000000000001 109.873 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.4 p -142.83 145.04 32.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.947 -0.569 . . . . 1.98 109.543 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.749 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 60.9 p -130.41 133.55 46.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.935 -0.575 . . . . 1.02 111.57 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.528 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -109.13 123.72 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.82 -0.627 . . . . 1.5800000000000001 110.389 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.676 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.16 115.76 9.57 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.685 -0.487 . . . . 1.1000000000000001 109.685 -177.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.782 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 50.4 m-20 -100.63 141.24 33.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.051 0.929 . . . . 2.1099999999999999 111.191 -168.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -111.38 111.3 22.24 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.249 -1.341 . . . . 1.0900000000000001 110.061 176.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.446 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m -93.6 97.73 10.68 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.956 -0.757 . . . . 1.0700000000000001 108.956 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 80' ' ' GLN . 7.4 p -84.77 121.34 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 123.138 1.447 . . . . 1.1399999999999999 110.32 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 17' ' ' THR . 98.7 m-70 -106.58 102.0 11.42 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.45 -2.159 . . . . 1.8200000000000001 109.722 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.49 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.7 tt0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 115.054 -0.975 . . . . 1.6699999999999999 111.302 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 1.087 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 14.3 t70 . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.083 -0.71 . . . . 1.6499999999999999 109.083 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.42 ' C ' HD11 ' A' ' 4' ' ' ILE . 77.3 Cg_exo -52.2 99.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.588 2.859 . . . . 1.24 114.656 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.687 HD12 ' HZ3' ' A' ' 94' ' ' LYS . 1.5 mp -125.04 -60.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 1.2 110.091 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.81 49.44 3.83 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.645 -1.782 . . . . 0.44 108.645 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 96' ' ' LYS . 12.7 tp -59.89 -41.95 92.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.839 -1.681 . . . . 1.1100000000000001 110.475 -168.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.73 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -90.32 84.7 6.06 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.433 -0.803 . . . . 0.97999999999999998 109.65 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -71.97 -48.02 52.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.901 -1.045 . . . . 1.1100000000000001 110.313 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.534 ' CG ' ' HD3' ' A' ' 27' ' ' ARG . 20.7 mmt -136.6 130.9 33.01 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.061 -0.518 . . . . 3.3100000000000001 110.828 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.73 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 26.1 mtm180 -93.78 128.14 42.86 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.565 -0.902 . . . . 4.1699999999999999 108.565 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.62 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 79.1 Cg_endo -77.5 148.5 26.36 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.656 1.571 . . . . 0.81999999999999995 108.807 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.575 ' O ' ' HD2' ' A' ' 24' ' ' PHE . 17.3 mm-40 -112.93 179.46 3.96 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 111.629 0.233 . . . . 1.6299999999999999 111.629 -168.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.72 -144.48 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 123.005 1.383 . . . . 2.0600000000000001 111.325 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.44 127.82 1.59 Allowed Glycine 0 C--N 1.296 -1.69 0 CA-C-N 113.279 -1.782 . . . . 0.34999999999999998 111.543 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.455 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 1.9 mp0 -112.69 113.45 25.57 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.583 -0.895 . . . . 1.53 108.583 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.54 165.09 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 107.583 -1.265 . . . . 1.0800000000000001 107.583 -167.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.67 156.9 16.2 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.939 -1.028 . . . . 1.22 108.958 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.638 HG22 HG23 ' A' ' 106' ' ' VAL . 20.6 t -67.71 107.73 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 CA-C-O 122.83 1.3 . . . . 1.3799999999999999 108.604 175.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA2' ' OD1' ' A' ' 78' ' ' ASP . . . 120.98 3.58 10.72 Favored Glycine 0 C--N 1.267 -3.285 0 CA-C-N 111.788 -2.46 . . . . 0.52000000000000002 113.551 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -124.48 4.59 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.077 -1.535 . . . . 0.44 110.797 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.631 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.8 p -152.13 166.37 31.87 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 112.897 -1.651 . . . . 1.23 111.279 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.666 HG22 HD11 ' A' ' 104' ' ' LEU . 10.6 tp -147.84 148.71 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 113.423 -1.717 . . . . 1.0900000000000001 108.02 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 m -142.1 126.98 18.22 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 113.524 -1.671 . . . . 1.05 110.827 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.679 ' HD1' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -136.13 146.75 47.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.0 -1.0 . . . . 0.71999999999999997 109.429 173.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.76 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.9 126.1 33.33 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.517 -0.765 . . . . 0.87 109.727 -177.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -116.46 116.28 27.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.645 -1.161 . . . . 1.1000000000000001 110.718 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.611 ' HE ' HG12 ' A' ' 69' ' ' VAL . 43.3 mtp85 -102.25 130.36 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.835 -0.346 . . . . 2.9300000000000002 110.477 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.7 t -127.93 127.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.755 0.788 . . . . 1.0700000000000001 109.874 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.37 114.81 2.6 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.711 -1.586 . . . . 1.1200000000000001 111.531 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.86 -37.87 58.61 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 114.49 -1.232 . . . . 0.76000000000000001 110.375 168.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.656 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 58.66 -174.68 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 115.193 1.553 . . . . 1.0 115.193 164.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -103.16 113.78 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.13 -1.396 . . . . 2.1699999999999999 107.912 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -151.18 165.8 32.82 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.117 -0.492 . . . . 2.6299999999999999 111.807 -166.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.8 -69.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.415 -0.587 . . . . 1.99 109.415 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 151.21 41.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.029 -0.73 . . . . 1.8799999999999999 109.029 170.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.24 152.35 5.49 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.854 2.37 . . . . 1.1200000000000001 111.873 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.734 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -65.55 134.27 37.68 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.771 1.647 . . . . 0.81999999999999995 111.52 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.16 104.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 106.447 -1.686 . . . . 1.4299999999999999 106.447 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.568 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.44 114.74 47.78 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 113.194 -1.821 . . . . 1.0900000000000001 107.135 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.893 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.23 122.24 45.52 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 123.153 1.454 . . . . 2.1299999999999999 110.265 176.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.035 ' HB3' HD11 ' A' ' 49' ' ' LEU . 76.3 m95 -86.69 152.08 22.86 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 111.978 -2.374 . . . . 0.40999999999999998 110.921 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 38.4 t80 -136.97 135.15 37.42 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 104.243 -2.502 . . . . 0.80000000000000004 104.243 173.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.981 ' HB3' HG23 ' A' ' 47' ' ' VAL . 81.4 tttt -101.7 173.12 6.56 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 105.619 -1.993 . . . . 2.6800000000000002 105.619 -172.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 1.019 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -8.15 -168.03 0.0 OUTLIER Glycine 0 C--O 1.192 -2.487 0 N-CA-C 119.525 2.57 . . . . 1.6000000000000001 119.525 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 84' ' ' THR . 20.4 mtpp -39.22 -22.08 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 115.834 1.791 . . . . 4.2999999999999998 115.834 -163.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.405 ' HD1' ' CB ' ' A' ' 45' ' ' LYS . 2.6 p-90 -161.06 -6.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.937 1.088 . . . . 2.5099999999999998 113.937 -178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.981 HG23 ' HB3' ' A' ' 43' ' ' LYS . 31.5 m -94.4 171.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.778 0 CA-C-O 124.116 1.912 . . . . 1.78 113.539 -160.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.895 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -100.57 161.24 13.74 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 110.449 -3.069 . . . . 2.73 108.756 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.035 HD11 ' HB3' ' A' ' 41' ' ' TRP . 3.7 mp -99.42 -32.32 11.21 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 116.055 -0.52 . . . . 1.1299999999999999 111.612 160.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 t -58.13 -23.78 56.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.255 0.55 . . . . 1.71 109.884 -164.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.734 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 58.5 m -102.08 -27.62 12.81 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.037 0.922 . . . . 1.76 112.907 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.895 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 28.9 mttp -90.92 -27.35 18.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.658 -1.61 . . . . 1.9099999999999999 112.806 -168.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.694 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 35.9 t -50.32 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 111.529 -2.578 . . . . 1.1499999999999999 111.267 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.535 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.42 -99.23 0.15 Allowed Glycine 0 C--N 1.304 -1.246 0 CA-C-N 112.421 -2.172 . . . . 0.69999999999999996 113.299 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -86.05 -53.2 5.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.278 0.473 . . . . 3.3599999999999999 112.278 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.1 p80 -87.54 -36.19 17.72 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.394 0.616 . . . . 1.78 111.207 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.926 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.91 106.89 13.43 Favored 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 106.35 -1.722 . . . . 1.72 106.35 176.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -102.42 116.42 32.58 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.277 -1.379 . . . . 0.96999999999999997 107.277 166.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HB2' HG21 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -95.03 92.99 7.11 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.499 -2.408 . . . . 1.0600000000000001 104.499 170.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.61 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 46.5 m170 -87.66 162.56 17.04 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.645 1.212 . . . . 2.5899999999999999 109.968 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.93 118.91 19.47 Favored 'General case' 0 C--N 1.268 -2.963 0 CA-C-N 111.959 -2.382 . . . . 0.92000000000000004 108.933 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -101.05 149.46 23.92 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.58 -2.1 . . . . 0.76000000000000001 108.202 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -141.61 97.05 3.08 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.224 1.012 . . . . 1.8 110.762 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.5 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.4 OUTLIER -113.8 101.67 9.51 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.81 -1.541 . . . . 2.4199999999999999 110.393 173.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.04 -29.71 43.71 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.263 -1.335 . . . . 3.0800000000000001 110.937 -176.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.6 -21.26 65.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.196 -0.911 . . . . 1.6899999999999999 109.862 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 19.4 m -110.94 -11.98 14.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.18 -0.918 . . . . 1.96 109.076 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.656 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 67.1 32.48 6.18 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.323 -0.853 . . . . 3.7799999999999998 109.547 175.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.611 HG12 ' HE ' ' A' ' 27' ' ' ARG . 3.3 t -127.32 135.64 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.944 0.878 . . . . 1.1299999999999999 110.425 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.7 m-30 -107.44 112.82 25.8 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.244 -1.391 . . . . 1.95 107.244 165.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.76 HD12 ' HB3' ' A' ' 25' ' ' SER . 23.9 tp -95.32 107.65 19.78 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.041 0.924 . . . . 1.1799999999999999 109.537 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.61 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.2 m-85 -87.72 112.68 22.64 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.587 -1.264 . . . . 0.40000000000000002 107.587 170.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.433 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.69 120.16 41.1 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.952 -1.476 . . . . 1.3200000000000001 110.381 -175.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.6 mt -81.74 129.42 34.72 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.958 -1.127 . . . . 1.5900000000000001 107.958 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -115.88 96.57 5.65 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 103.351 -2.833 . . . . 2.0099999999999998 103.351 165.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.711 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -120.83 99.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 123.047 1.403 . . . . 1.1899999999999999 109.922 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.5 p -106.51 146.76 30.2 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 113.445 -1.707 . . . . 1.05 108.651 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' HA2' ' A' ' 19' ' ' GLY . 27.2 t70 64.8 82.7 0.18 Allowed 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 111.613 -2.54 . . . . 2.1200000000000001 109.926 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' A' ' 104' ' ' LEU . . . -81.27 109.92 16.24 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 111.375 -2.648 . . . . 1.0900000000000001 110.688 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.847 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -52.74 139.13 41.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.587 -0.733 . . . . 1.77 109.862 167.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.589 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 37.7 Cg_endo -63.57 -3.39 5.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.29 2.66 . . . . 1.3300000000000001 112.768 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.847 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -110.97 14.74 22.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.053 -0.521 . . . . 1.6599999999999999 110.894 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -90.14 -29.66 18.14 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 117.721 -1.133 . . . . 1.24 110.756 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 75.0 m 2.34 80.34 0.0 OUTLIER 'General case' 0 C--N 1.354 0.785 0 O-C-N 125.688 1.867 . . . . 1.6799999999999999 111.226 -174.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 1.019 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.19 121.7 5.61 Favored Glycine 0 N--CA 1.408 -3.213 0 CA-C-N 111.458 -2.61 . . . . 2.0 114.776 -163.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.919 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -120.94 70.23 0.39 Allowed Glycine 0 C--N 1.268 -3.24 0 CA-C-N 111.366 -2.417 . . . . 0.81000000000000005 107.97 159.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.768 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 54.5 m-85 -74.49 127.61 33.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.094 -1.053 . . . . 1.0800000000000001 109.013 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 48.0 mtp180 -121.38 104.68 9.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.643 -0.502 . . . . 3.6899999999999999 109.643 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.402 ' H ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -91.77 121.3 33.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.09 -1.078 . . . . 1.22 108.09 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.893 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 25.7 tt0 -137.48 106.67 6.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.229 -0.896 . . . . 1.8100000000000001 109.228 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.568 ' HB ' HG12 ' A' ' 39' ' ' VAL . 5.7 p -103.44 141.48 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.677 0.751 . . . . 1.24 111.305 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 t -138.71 109.88 6.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.435 -1.257 . . . . 1.6399999999999999 108.563 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.566 ' HG1' HD22 ' A' ' 6' ' ' LEU . 1.6 m -129.44 174.21 9.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.142 -1.058 . . . . 1.26 108.142 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 1.087 ' HZ2' ' HB3' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -5.88 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 125.199 1.562 . . . . 0.93999999999999995 114.756 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.951 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -156.98 -0.81 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.555 -1.202 . . . . 1.05 110.042 -174.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -96.36 131.43 42.91 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.244 -1.021 . . . . 1.78 108.244 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -132.65 145.6 51.2 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.173 -1.376 . . . . 1.0 111.516 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 10.6 t70 -176.08 164.96 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.797 -0.638 . . . . 1.6000000000000001 110.037 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.686 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 6.0 p -153.62 146.47 24.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.116 0.484 . . . . 1.98 110.576 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 88.8 p -124.34 131.94 53.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.805 -0.634 . . . . 1.02 110.55 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.79 121.12 42.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.972 0.415 . . . . 1.5800000000000001 110.461 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.62 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -142.83 126.31 16.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.466 0.651 . . . . 1.1000000000000001 109.789 -177.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 19.5 m-80 -105.09 152.88 22.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.182 0.991 . . . . 2.1099999999999999 111.563 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.682 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -123.03 104.27 9.11 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.818 -1.083 . . . . 1.0900000000000001 110.475 173.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -85.88 96.41 9.77 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.7 -0.8 . . . . 1.0700000000000001 109.251 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.638 HG23 HG22 ' A' ' 18' ' ' VAL . 7.5 p -81.87 113.22 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-O 123.387 1.565 . . . . 1.1399999999999999 109.221 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 99.9 m-70 -94.91 100.95 12.72 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.362 -2.199 . . . . 1.8200000000000001 109.872 -174.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 18' ' ' VAL . 36.1 tt0 . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 115.383 -0.826 . . . . 1.6699999999999999 110.134 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.571 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.0 m-20 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 112.134 0.42 . . . . 1.6499999999999999 112.134 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.497 ' C ' HD13 ' A' ' 4' ' ' ILE . 42.4 Cg_endo -68.45 87.16 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.814 2.343 . . . . 1.24 112.269 176.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.761 HD12 ' HE2' ' A' ' 94' ' ' LYS . 1.6 mp -126.4 -58.91 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.96 -1.018 . . . . 1.2 109.444 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.63 37.08 7.08 Favored Glycine 0 CA--C 1.496 -1.135 0 N-CA-C 108.991 -1.644 . . . . 0.44 108.991 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.142 HD21 ' HB3' ' A' ' 96' ' ' LYS . 8.9 tp -46.52 -47.5 19.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.104 -1.548 . . . . 1.1100000000000001 110.383 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.758 ' CZ ' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -89.57 83.45 6.31 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.741 0.781 . . . . 0.97999999999999998 109.02 175.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.2 t -68.26 -48.28 74.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.448 -1.251 . . . . 1.1100000000000001 109.598 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 ttp -148.47 129.58 14.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.651 -1.159 . . . . 3.3100000000000001 108.828 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -95.84 148.64 34.87 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.662 -0.699 . . . . 4.1699999999999999 109.615 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.919 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 1.9 Cg_endo -79.35 162.59 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.557 2.171 . . . . 0.81999999999999995 111.074 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.4 mm-40 -125.8 169.65 12.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.099 -0.501 . . . . 1.6299999999999999 110.329 -171.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HB3' ' H ' ' A' ' 103' ' ' ASN . 7.3 p-10 -74.78 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-O 122.695 1.236 . . . . 2.0600000000000001 111.922 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 159.83 137.34 2.21 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.206 -1.815 . . . . 0.34999999999999998 112.175 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.481 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 31.2 mt-10 -115.76 113.85 24.0 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.054 -1.073 . . . . 1.53 108.87 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.526 HG21 HD11 ' A' ' 104' ' ' LEU . 3.1 m -134.52 163.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.715 0 N-CA-C 107.13 -1.433 . . . . 1.0800000000000001 107.13 -173.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -93.13 157.21 16.4 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.541 -0.754 . . . . 1.22 110.035 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 81' ' ' PRO . 9.0 t -62.58 106.76 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 CA-C-O 122.956 1.36 . . . . 1.3799999999999999 109.488 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.34 11.42 17.88 Favored Glycine 0 C--N 1.269 -3.18 0 CA-C-N 112.08 -2.327 . . . . 0.52000000000000002 113.712 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.3 -122.33 4.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 109.867 -1.293 . . . . 0.44 109.867 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.3 p -151.66 164.24 37.36 Favored 'General case' 0 N--CA 1.401 -2.89 0 CA-C-N 113.088 -1.556 . . . . 1.23 110.971 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.617 HG21 ' HB ' ' A' ' 76' ' ' ILE . 6.8 tp -148.1 142.92 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 112.801 -1.999 . . . . 1.0900000000000001 107.904 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -138.64 129.39 26.41 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-N 114.237 -1.347 . . . . 1.05 111.054 -171.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.488 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 31.8 m-85 -126.98 143.03 51.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.129 -1.396 . . . . 0.71999999999999997 110.369 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.523 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -130.25 123.42 30.08 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.009 -0.996 . . . . 0.87 109.438 174.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.919 ' HB3' ' HG3' ' A' ' 11' ' ' PRO . . . -120.89 118.16 29.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.13 -1.396 . . . . 1.1000000000000001 110.324 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -105.28 122.41 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.225 -0.297 . . . . 2.9300000000000002 111.008 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.2 t -124.89 127.39 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.849 0.833 . . . . 1.0700000000000001 109.83 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 6' ' ' LEU . . . -57.64 113.31 1.76 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.665 -1.607 . . . . 1.1200000000000001 111.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.746 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -54.22 -42.16 72.28 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.537 -1.21 . . . . 0.76000000000000001 110.651 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.667 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.32 -151.01 0.1 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 115.193 1.553 . . . . 1.0 115.193 167.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -128.34 130.54 47.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.264 -1.334 . . . . 2.1699999999999999 108.717 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.62 ' HB3' ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -156.78 179.02 9.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.298 0.571 . . . . 2.6299999999999999 111.775 -173.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.41 -42.09 59.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.712 -1.131 . . . . 1.99 108.921 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -149.48 149.9 29.89 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 1.8799999999999999 109.558 175.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.54 140.24 12.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.86 2.373 . . . . 1.1200000000000001 112.248 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 93' ' ' THR . 33.3 Cg_exo -53.59 137.51 66.23 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 C-N-CA 122.095 1.863 . . . . 0.81999999999999995 112.377 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.86 104.4 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 106.787 -1.56 . . . . 1.4299999999999999 106.787 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.53 HG23 HG21 ' A' ' 91' ' ' VAL . 2.4 t -113.09 115.22 49.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.022 0 CA-C-N 113.782 -1.554 . . . . 1.0900000000000001 107.595 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.627 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -106.55 131.67 53.45 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.896 1.331 . . . . 2.1299999999999999 108.978 172.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.888 ' HB3' HD13 ' A' ' 49' ' ' LEU . 50.1 m95 -90.73 157.24 17.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.394 -2.185 . . . . 0.40999999999999998 110.622 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.5 t80 -139.62 124.58 18.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.431 -2.063 . . . . 0.80000000000000004 105.431 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 1.047 ' HE3' ' HH ' ' A' ' 87' ' ' TYR . 60.5 tttt -104.26 112.47 25.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.3 -1.36 . . . . 2.6800000000000002 108.145 -172.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 85' ' ' GLY . . . -84.81 92.31 1.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 115.572 -3.204 . . . . 1.6000000000000001 114.39 -166.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.783 ' HE3' ' HE1' ' A' ' 46' ' ' TRP . 21.9 ttpt -102.85 -31.53 10.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 103.173 -2.899 . . . . 4.2999999999999998 103.173 137.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.878 ' HD1' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER 158.78 -11.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 111.243 -2.708 . . . . 2.5099999999999998 111.369 -167.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.917 ' HB ' ' HE2' ' A' ' 52' ' ' LYS . 0.7 OUTLIER -88.08 168.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.03 1.395 . . . . 1.78 113.53 -165.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.681 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 16.5 t70 -113.09 132.57 55.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 111.666 -2.515 . . . . 2.73 108.886 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.888 HD13 ' HB3' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -76.31 -30.91 57.89 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 113.714 1.005 . . . . 1.1299999999999999 113.714 -174.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -61.47 -21.94 64.63 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.26 0.482 . . . . 1.71 109.894 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 t -101.09 -20.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.825 0.822 . . . . 1.76 112.215 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.917 ' HE2' ' HB ' ' A' ' 47' ' ' VAL . 45.2 mttp -96.81 -78.21 0.47 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.219 -1.355 . . . . 1.9099999999999999 113.687 -164.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.794 HG13 ' H ' ' A' ' 59' ' ' LEU . 37.8 t 22.98 98.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 125.293 1.621 . . . . 1.1499999999999999 114.273 161.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -145.14 -150.87 5.3 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.251 -1.34 . . . . 0.69999999999999996 113.983 -173.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.54 -27.13 68.95 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.83 0.452 . . . . 3.3599999999999999 112.149 -170.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.665 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.3 p80 -92.52 -39.08 11.57 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.668 -0.413 . . . . 1.78 111.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.909 HD22 ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -130.82 106.07 8.2 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.09 -0.707 . . . . 1.72 109.09 170.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.34 116.67 29.08 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.741 -1.577 . . . . 0.96999999999999997 106.741 170.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.794 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -91.87 93.67 8.94 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 105.222 -2.14 . . . . 1.0600000000000001 105.222 171.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.629 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 42.2 m170 -94.03 162.03 14.05 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-O 122.758 1.266 . . . . 2.5899999999999999 109.933 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -132.62 111.93 11.62 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 111.775 -2.466 . . . . 0.92000000000000004 108.768 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.0 m -87.67 148.75 24.65 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 112.71 -2.041 . . . . 0.76000000000000001 108.518 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.574 ' HH ' ' HG3' ' A' ' 65' ' ' ARG . 72.0 t80 -126.65 97.14 4.9 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.303 1.049 . . . . 1.8 110.121 -168.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.678 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -114.34 95.05 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.327 -1.761 . . . . 2.4199999999999999 108.554 177.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.574 ' HG3' ' HH ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -84.01 -27.22 28.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.173 -0.921 . . . . 3.0800000000000001 110.457 -176.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.44 -17.63 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.57 -1.196 . . . . 1.6899999999999999 109.847 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.678 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 24.2 m -108.79 -15.25 14.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.925 . . . . 1.96 108.774 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.667 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 64.93 35.47 8.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.097 -0.956 . . . . 3.7799999999999998 109.402 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.07 136.83 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 1.1299999999999999 109.667 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.746 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 13.9 m-85 -101.68 116.78 33.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.685 -1.598 . . . . 1.95 106.685 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 25' ' ' SER . 24.3 tp -95.55 104.54 16.45 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.441 -0.948 . . . . 1.1799999999999999 108.441 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.629 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.9 m-85 -81.92 112.03 18.65 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.539 -1.652 . . . . 0.40000000000000002 106.539 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -119.68 120.88 37.92 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.97 -1.468 . . . . 1.3200000000000001 110.385 -173.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.653 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -88.21 125.15 34.48 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.763 -1.562 . . . . 1.5900000000000001 107.584 177.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.651 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 12.8 m170 -110.75 96.01 5.91 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.148 -2.538 . . . . 2.0099999999999998 104.148 170.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.825 HG12 ' HB2' ' A' ' 57' ' ' LEU . 27.8 mt -119.57 99.98 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 122.89 1.328 . . . . 1.1899999999999999 110.279 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 31.4 p -116.05 139.97 49.74 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 114.301 -1.318 . . . . 1.05 107.77 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' A' ' 77' ' ' THR . 22.0 t70 74.85 64.98 0.07 Allowed 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.309 -2.223 . . . . 2.1200000000000001 108.312 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.17 9.18 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.098 -2.319 . . . . 1.0900000000000001 109.259 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.634 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -62.6 151.7 83.08 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.25 -0.648 . . . . 1.77 109.25 176.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.716 ' HB3' HG22 ' A' ' 18' ' ' VAL . 72.3 Cg_endo -72.95 11.06 0.94 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.795 2.33 . . . . 1.3300000000000001 113.958 -169.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -118.17 -3.97 11.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.595 -0.275 . . . . 1.6599999999999999 110.626 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' HD1' ' HB2' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -80.63 0.51 33.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.182 -0.673 . . . . 1.24 109.182 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 94.9 m -52.24 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 CA-C-O 122.609 1.195 . . . . 1.6799999999999999 109.657 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 44' ' ' GLY . . . -164.98 -119.42 0.48 Allowed Glycine 0 C--N 1.27 -3.093 0 CA-C-N 113.15 -1.841 . . . . 2.0 113.559 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -164.99 121.97 1.05 Allowed Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 113.501 -1.35 . . . . 0.81000000000000005 111.195 -171.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 1.047 ' HH ' ' HE3' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -87.01 125.48 34.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.413 -0.958 . . . . 1.0800000000000001 108.413 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -105.0 132.71 50.9 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.239 -0.652 . . . . 3.6899999999999999 109.239 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 3.9 m -111.76 121.7 45.79 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.837 -0.801 . . . . 1.22 108.837 169.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 41.9 mt-10 -120.01 105.2 10.81 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.78 -0.646 . . . . 1.8100000000000001 109.608 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 HG23 ' A' ' 39' ' ' VAL . 7.1 p -99.74 134.05 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.187 0.994 . . . . 1.24 110.717 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -135.58 108.03 7.37 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.591 -1.64 . . . . 1.6399999999999999 108.389 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.716 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -133.22 163.23 29.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.308 -0.853 . . . . 1.26 109.09 -178.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.761 ' HE2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 22.28 -79.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 125.52 1.762 . . . . 0.93999999999999995 113.536 168.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.532 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 16.3 t70 -153.43 6.3 0.35 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.898 -1.047 . . . . 1.05 109.156 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.142 ' HB3' HD21 ' A' ' 6' ' ' LEU . 44.7 tptt -92.01 132.1 36.8 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.782 -1.562 . . . . 1.78 106.782 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -131.7 146.17 52.03 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.847 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.57 163.18 2.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.98 . . . . 1.6000000000000001 110.104 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.4 p -152.22 138.44 18.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.981 -0.554 . . . . 1.98 110.038 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.758 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 57.9 p -107.45 147.25 30.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.631 -0.713 . . . . 1.02 110.325 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.448 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -132.98 114.91 14.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.431 0.634 . . . . 1.5800000000000001 110.354 176.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.778 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 33.7 p90 -143.24 140.23 30.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.082 -0.508 . . . . 1.1000000000000001 109.796 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.555 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.3 m-20 -96.98 155.97 16.55 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.207 1.003 . . . . 2.1099999999999999 111.974 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.709 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -125.7 114.44 18.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.726 -1.213 . . . . 1.0900000000000001 107.726 164.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.1 m -98.83 95.86 7.48 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.654 -0.869 . . . . 1.0700000000000001 108.654 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 80' ' ' GLN . 4.1 p -78.39 111.74 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 123.065 1.412 . . . . 1.1399999999999999 108.834 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 65.2 m170 -78.57 98.11 6.01 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.664 -2.062 . . . . 1.8200000000000001 109.788 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 113.542 -1.663 . . . . 1.6699999999999999 108.866 171.341 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.601 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 19.6 t70 . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 109.846 -0.427 . . . . 1.6499999999999999 109.846 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 18.2 Cg_endo -61.04 77.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.737 2.292 . . . . 1.24 114.066 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.688 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -99.59 -60.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.773 -1.103 . . . . 1.2 109.574 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.7 43.69 6.01 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 108.321 -1.912 . . . . 0.44 108.321 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.599 ' N ' HG21 ' A' ' 4' ' ' ILE . 9.8 tp -50.11 -43.83 51.87 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.652 -1.774 . . . . 1.1100000000000001 111.031 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.744 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -88.52 84.73 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.646 -0.706 . . . . 0.97999999999999998 110.301 176.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.46 -40.95 72.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.447 -1.251 . . . . 1.1100000000000001 109.167 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.497 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 18.2 ttt -151.06 137.45 18.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.617 -1.174 . . . . 3.3100000000000001 108.655 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 7.8 ptp180 -102.47 139.23 20.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.229 -0.441 . . . . 4.1699999999999999 110.201 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.791 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 14.1 Cg_endo -69.73 154.1 68.28 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.741 2.294 . . . . 0.81999999999999995 112.375 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.444 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -112.93 170.75 7.98 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.099 0.778 . . . . 1.6299999999999999 113.099 -168.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 1.6 m-20 -69.88 -147.35 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.701 1.239 . . . . 2.0600000000000001 110.741 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 22' ' ' ILE . . . 153.32 133.31 1.84 Allowed Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 113.611 -1.631 . . . . 0.34999999999999998 112.242 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 23.1 mt-10 -110.68 119.01 37.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.256 -0.972 . . . . 1.53 108.527 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.2 m -137.77 162.06 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.21 0 N-CA-C 107.047 -1.464 . . . . 1.0800000000000001 107.047 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -96.4 155.33 16.81 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.41 -0.959 . . . . 1.22 108.41 176.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.671 HG11 ' HD3' ' A' ' 81' ' ' PRO . 6.2 t -67.28 105.85 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.862 -1.162 . . . . 1.3799999999999999 107.862 173.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.34 -6.74 3.97 Favored Glycine 0 C--N 1.273 -2.953 0 CA-C-N 112.926 -1.943 . . . . 0.52000000000000002 113.368 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.37 -123.93 5.29 Favored Glycine 0 CA--C 1.471 -2.704 0 C-N-CA 119.089 -1.529 . . . . 0.44 110.6 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.8 p -148.98 174.45 12.26 Favored 'General case' 0 N--CA 1.396 -3.149 0 CA-C-N 112.555 -1.822 . . . . 1.23 110.2 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.617 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.1 tp -146.09 140.39 21.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 112.651 -2.068 . . . . 1.0900000000000001 107.21 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.9 m -139.24 127.59 22.79 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 113.398 -1.728 . . . . 1.05 111.492 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.733 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 3.4 m-85 -128.19 154.71 45.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.057 -1.429 . . . . 0.71999999999999997 108.877 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -134.42 122.05 21.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.461 -0.79 . . . . 0.87 109.382 173.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.791 ' HB3' ' HG3' ' A' ' 11' ' ' PRO . . . -113.51 116.38 29.47 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.878 -1.056 . . . . 1.1000000000000001 110.184 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.1 mtt180 -105.61 115.66 30.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.469 -0.332 . . . . 2.9300000000000002 110.412 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 t -118.23 126.3 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.065 0.936 . . . . 1.0700000000000001 110.121 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.788 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . . . -56.36 108.97 0.53 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.147 -1.842 . . . . 1.1200000000000001 112.188 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.62 80.78 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.764 -1.107 . . . . 0.76000000000000001 112.423 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.679 ' HB1' HD13 ' A' ' 33' ' ' LEU . . . 61.05 -178.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.137 1.162 . . . . 1.0 114.137 168.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -105.39 29.53 6.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.292 -1.322 . . . . 2.1699999999999999 109.083 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.107 HD12 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -58.57 175.71 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.645 -1.161 . . . . 2.6299999999999999 113.133 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.44 -40.52 64.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.874 0.845 . . . . 1.99 109.927 -176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.93 134.88 11.14 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.442 -1.253 . . . . 1.8799999999999999 108.532 176.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -43.58 141.62 3.62 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.333 2.689 . . . . 1.1200000000000001 112.18 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.107 ' HD3' HD12 ' A' ' 33' ' ' LEU . 4.0 Cg_exo -52.93 136.63 60.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.813 1.675 . . . . 0.81999999999999995 113.068 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.31 104.99 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.175 -1.787 . . . . 1.4299999999999999 106.175 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.667 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.65 114.37 46.78 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 113.535 -1.666 . . . . 1.0900000000000001 108.037 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.995 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.57 122.24 43.47 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-O 123.344 1.545 . . . . 2.1299999999999999 110.238 174.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.056 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.8 m95 -86.91 149.01 25.11 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.871 -2.422 . . . . 0.40999999999999998 112.021 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.665 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 43.7 t80 -128.89 140.09 51.84 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.096 -2.557 . . . . 0.80000000000000004 104.096 172.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.792 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 58.2 tttp -106.23 166.25 10.65 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 116.627 -1.654 . . . . 2.6800000000000002 106.708 -173.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -11.97 -166.17 0.0 OUTLIER Glycine 0 C--O 1.186 -2.875 0 N-CA-C 119.136 2.414 . . . . 1.6000000000000001 119.136 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.909 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 13.4 ptmt -44.14 -6.34 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.495 2.406 . . . . 4.2999999999999998 117.495 -161.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.909 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 2.8 p-90 -167.95 -1.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.931 1.242 . . . . 2.5099999999999998 113.266 174.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.27 167.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 CA-C-O 123.659 1.695 . . . . 1.78 112.405 -159.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 3.3 p-10 -111.35 156.99 20.73 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.137 -2.756 . . . . 2.73 106.506 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.056 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -97.9 -31.27 12.28 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.509 0.559 . . . . 1.1299999999999999 112.509 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -58.52 -19.67 39.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.013 0.435 . . . . 1.71 109.88 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 73.9 m -98.25 -26.74 14.43 Favored 'General case' 0 N--CA 1.415 -2.198 0 C-N-CA 119.865 -0.734 . . . . 1.76 112.432 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.3 -32.16 10.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.623 -1.172 . . . . 1.9099999999999999 111.794 -167.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 49' ' ' LEU . 70.3 t -35.39 92.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 O-C-N 125.076 1.485 . . . . 1.1499999999999999 111.532 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.25 -114.79 0.7 Allowed Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 112.338 -2.21 . . . . 0.69999999999999996 111.952 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -95.74 -25.4 16.09 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.364 0.876 . . . . 3.3599999999999999 113.364 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.665 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.6 p80 -93.32 -37.82 11.82 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-O 121.622 0.725 . . . . 1.78 110.079 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.976 HD22 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.66 106.97 10.51 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 105.657 -1.979 . . . . 1.72 105.657 171.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.902 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -106.39 114.59 28.81 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.445 -1.687 . . . . 0.96999999999999997 106.445 166.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.568 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -92.72 92.42 7.96 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 103.957 -2.608 . . . . 1.0600000000000001 103.957 175.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 80.4 t60 -95.0 159.66 14.93 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 113.944 -1.48 . . . . 2.5899999999999999 110.22 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.58 121.57 39.64 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.929 -2.85 . . . . 0.92000000000000004 109.153 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 25.9 m -110.23 143.47 40.34 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-N 111.773 -2.467 . . . . 0.76000000000000001 106.34 167.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.88 99.51 3.35 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.748 0.785 . . . . 1.8 109.275 -164.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -115.01 132.07 56.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.489 -1.232 . . . . 2.4199999999999999 109.122 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.807 HH11 ' HH ' ' A' ' 70' ' ' TYR . 6.1 mmm180 -119.01 18.23 13.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.06 -1.427 . . . . 3.0800000000000001 111.25 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.24 -31.88 4.55 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.736 -1.574 . . . . 1.6899999999999999 108.488 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t -93.18 -14.75 26.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.479 -1.237 . . . . 1.96 108.8 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.788 ' HE2' ' HB2' ' A' ' 29' ' ' ALA . 15.2 tttt 68.88 31.61 4.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.85 0.833 . . . . 3.7799999999999998 109.23 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 7.9 t -128.35 125.77 64.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.603 0.716 . . . . 1.1299999999999999 110.453 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.807 ' HH ' HH11 ' A' ' 65' ' ' ARG . 2.4 m-30 -101.18 107.44 18.85 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.031 -1.841 . . . . 1.95 106.031 167.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.0 tp -94.92 104.21 16.1 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.706 -1.134 . . . . 1.1799999999999999 108.013 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.5 m-85 -86.94 113.65 22.89 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.68 -1.6 . . . . 0.40000000000000002 106.68 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.65 125.24 49.3 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.917 -1.492 . . . . 1.3200000000000001 110.585 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.922 HD22 ' CH2' ' A' ' 41' ' ' TRP . 2.2 mm? -89.59 124.51 34.62 Favored 'General case' 0 CA--C 1.471 -2.064 0 CA-C-N 112.889 -1.96 . . . . 1.5900000000000001 107.698 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.902 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 26.1 m170 -114.45 94.29 4.72 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 103.15 -2.908 . . . . 2.0099999999999998 103.15 167.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 60.4 mt -115.14 97.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 123.603 1.668 . . . . 1.1899999999999999 108.983 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.636 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 29.9 p -116.31 138.75 51.07 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 112.302 -2.226 . . . . 1.05 107.076 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 77' ' ' THR . 13.5 t70 77.76 63.77 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 O-C-N 125.855 1.972 . . . . 2.1200000000000001 107.351 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -76.92 94.44 3.93 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 111.605 -2.543 . . . . 1.0900000000000001 107.893 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.66 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -53.71 151.32 11.55 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-N 115.127 -0.942 . . . . 1.77 108.708 176.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.671 ' HD3' HG11 ' A' ' 18' ' ' VAL . 60.0 Cg_endo -68.83 155.32 69.02 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.039 1.159 . . . . 1.3300000000000001 110.032 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 45' ' ' LYS . . . 63.38 21.69 12.91 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.381 0.426 . . . . 1.6599999999999999 110.728 -175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.66 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -86.6 -13.21 46.37 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.195 -1.409 . . . . 1.24 107.195 173.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 1.098 HG23 HG13 ' A' ' 106' ' ' VAL . 4.3 p -90.11 150.26 22.12 Favored 'General case' 1 N--CA 1.363 -4.808 0 CA-C-O 126.041 2.829 . . . . 1.6799999999999999 116.17 -163.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.414 ' HA3' ' CA ' ' A' ' 45' ' ' LYS . . . 159.4 -109.61 0.41 Allowed Glycine 1 C--N 1.239 -4.833 1 CA-C-N 105.381 -5.372 . . . . 2.0 112.527 -155.532 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -167.91 124.78 1.23 Allowed Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.338 -1.41 . . . . 0.81000000000000005 114.172 -170.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.3 m-85 -87.95 124.54 33.81 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.227 -1.487 . . . . 1.0800000000000001 108.56 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.665 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 mtp180 -105.51 105.21 15.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.538 -0.726 . . . . 3.6899999999999999 109.728 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.3 t -89.92 125.39 35.34 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.372 -0.973 . . . . 1.22 108.372 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.995 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 21.7 tt0 -145.47 106.77 4.19 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.419 -0.81 . . . . 1.8100000000000001 109.961 -169.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.667 ' HB ' HG11 ' A' ' 39' ' ' VAL . 2.7 p -102.66 144.36 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.362 0.601 . . . . 1.24 110.504 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.4 m -139.12 109.47 6.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.277 -0.874 . . . . 1.6399999999999999 108.898 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.554 HG22 ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.39 153.78 50.45 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.401 -0.809 . . . . 1.26 109.886 -177.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.734 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.7 -75.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 125.654 1.846 . . . . 0.93999999999999995 114.572 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 12.2 t70 -149.7 -1.07 0.45 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.087 -1.415 . . . . 1.05 109.379 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -104.76 140.09 38.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.111 0.958 . . . . 1.78 109.627 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -132.61 139.06 47.61 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.142 -1.844 . . . . 1.0 110.577 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 6.8 m-20 -152.85 147.88 26.53 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.25 -0.886 . . . . 1.6000000000000001 109.083 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 13.4 p -151.43 153.88 35.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.504 . . . . 1.98 110.905 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.744 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 85.7 p -137.31 130.26 30.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.774 -0.648 . . . . 1.02 110.766 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.81 116.85 33.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.615 -0.721 . . . . 1.5800000000000001 110.305 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.79 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 22.5 p90 -143.12 135.8 27.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.458 0.647 . . . . 1.1000000000000001 109.903 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.535 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 86.9 m-20 -97.26 156.15 16.55 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.538 -1.21 . . . . 2.1099999999999999 110.387 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.838 ' HG ' ' CG2' ' A' ' 84' ' ' THR . 1.2 tp -120.67 132.91 55.34 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 102.336 -3.209 . . . . 1.0900000000000001 102.336 166.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.507 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 23.4 m -124.16 113.57 18.51 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.318 -1.353 . . . . 1.0700000000000001 109.727 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 1.098 HG13 HG23 ' A' ' 84' ' ' THR . 5.6 p -102.87 114.14 41.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 113.779 -1.555 . . . . 1.1399999999999999 110.046 -172.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 35.5 m-70 -79.78 98.55 7.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.798 -2.455 . . . . 1.8200000000000001 109.354 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 18' ' ' VAL . 70.1 tt0 . . . . . 0 C--N 1.295 -1.762 0 CA-C-N 113.099 -1.864 . . . . 1.6699999999999999 109.736 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.504 ' HB2' HD13 ' A' ' 4' ' ' ILE . 5.8 m-20 . . . . . 0 N--CA 1.433 -1.285 0 N-CA-C 110.514 -0.18 . . . . 1.6499999999999999 110.514 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.76 42.26 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.393 2.729 . . . . 1.24 113.357 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.936 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -58.22 -51.27 73.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.74 -0.664 . . . . 1.2 110.163 172.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.522 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 86.72 40.28 7.26 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.602 -1.799 . . . . 0.44 108.602 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.105 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.8 tp -53.2 -50.07 65.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.544 -1.828 . . . . 1.1100000000000001 110.252 -172.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.646 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -84.23 84.48 7.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.97999999999999998 110.176 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.2 t -73.2 -42.88 58.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.43 -1.259 . . . . 1.1100000000000001 109.416 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.7 ttm -152.19 135.87 16.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.225 -0.898 . . . . 3.3100000000000001 108.715 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -91.1 139.76 25.77 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.862 -0.422 . . . . 4.1699999999999999 109.862 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.663 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 33.6 Cg_endo -67.49 141.57 56.22 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.091 1.86 . . . . 0.81999999999999995 109.164 171.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.619 ' O ' ' HD1' ' A' ' 24' ' ' PHE . 6.3 tp60 -118.2 163.83 16.08 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.932 0.715 . . . . 1.6299999999999999 112.932 -168.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.1 m-20 -57.67 -139.94 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 125.674 1.589 . . . . 2.0600000000000001 112.928 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 143.13 136.19 3.13 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 113.291 -1.777 . . . . 0.34999999999999998 111.975 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 35.8 mt-10 -108.51 114.93 29.16 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.349 -0.926 . . . . 1.53 108.527 175.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.4 m -135.25 163.6 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.867 0 N-CA-C 107.932 -1.136 . . . . 1.0800000000000001 107.932 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 154.29 17.33 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.636 -1.166 . . . . 1.22 109.193 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.653 HG11 ' HD3' ' A' ' 81' ' ' PRO . 4.0 t -65.78 107.58 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 CA-C-O 122.845 1.307 . . . . 1.3799999999999999 108.9 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.3 10.38 10.74 Favored Glycine 0 C--N 1.269 -3.162 0 CA-C-N 112.107 -2.315 . . . . 0.52000000000000002 112.734 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.82 -123.43 4.89 Favored Glycine 0 N--CA 1.42 -2.409 0 C-N-CA 119.331 -1.414 . . . . 0.44 110.269 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.6 p -151.35 168.44 24.8 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.079 -1.561 . . . . 1.23 110.201 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 104' ' ' LEU . 9.0 tp -147.79 149.44 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 CA-C-N 113.693 -1.594 . . . . 1.0900000000000001 108.04 169.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 m -138.11 128.64 26.44 Favored 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 114.066 -1.425 . . . . 1.05 111.163 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.619 ' HD1' ' O ' ' A' ' 12' ' ' GLN . 3.4 m-85 -126.01 147.54 49.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 113.879 -1.51 . . . . 0.71999999999999997 107.817 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -140.89 127.73 20.46 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.57 0.7 . . . . 0.87 109.78 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.64 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.19 115.5 23.16 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.922 -1.035 . . . . 1.1000000000000001 110.383 -176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -104.31 121.11 42.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.312 -0.255 . . . . 2.9300000000000002 110.312 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.1 t -122.31 126.03 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.129 0.966 . . . . 1.0700000000000001 110.319 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.545 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -57.83 109.01 0.65 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.151 -1.84 . . . . 1.1200000000000001 111.432 176.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.602 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -50.1 -58.58 8.52 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.946 -1.025 . . . . 0.76000000000000001 111.418 172.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.764 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 59.8 -171.15 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.137 1.162 . . . . 1.0 114.137 168.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -109.09 130.42 55.48 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.916 -1.038 . . . . 2.1699999999999999 109.846 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.602 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -160.93 -176.2 5.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.396 0.617 . . . . 2.6299999999999999 112.038 -172.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.8 tp -70.77 -44.86 65.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.966 -1.015 . . . . 1.99 108.741 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.46 150.27 28.41 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 114.79 -1.096 . . . . 1.8799999999999999 109.634 174.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.77 148.79 5.76 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.484 2.789 . . . . 1.1200000000000001 112.426 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HA ' HG21 ' A' ' 93' ' ' THR . 4.1 Cg_exo -50.11 132.51 33.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.709 1.606 . . . . 0.81999999999999995 113.207 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.3 105.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.404 -1.702 . . . . 1.4299999999999999 106.404 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.617 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.56 114.5 47.11 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.784 -1.553 . . . . 1.0900000000000001 107.195 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.93 124.82 50.16 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 123.287 1.518 . . . . 2.1299999999999999 109.16 174.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.01 ' HB3' HD11 ' A' ' 49' ' ' LEU . 79.8 m95 -83.93 151.09 25.26 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 111.646 -2.525 . . . . 0.40999999999999998 111.231 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 36.9 t80 -128.61 138.75 52.36 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 104.58 -2.378 . . . . 0.80000000000000004 104.58 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.877 ' NZ ' ' HH ' ' A' ' 87' ' ' TYR . 31.6 tptt -104.64 165.28 11.17 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.41 -2.07 . . . . 2.6800000000000002 105.41 -172.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.804 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.62 -168.95 0.0 OUTLIER Glycine 0 C--O 1.188 -2.741 0 N-CA-C 119.321 2.488 . . . . 1.6000000000000001 119.321 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -44.82 -1.47 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.95 2.204 . . . . 4.2999999999999998 116.95 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.654 ' CZ3' HG11 ' A' ' 47' ' ' VAL . 11.8 p-90 -167.16 -11.5 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.858 1.429 . . . . 2.5099999999999998 114.858 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.654 HG11 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.37 169.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 CA-C-O 123.452 1.596 . . . . 1.78 112.889 -161.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.473 ' OD1' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -111.05 156.19 21.67 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 111.613 -2.54 . . . . 2.73 107.511 172.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.01 HD11 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -96.77 -36.88 10.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 119.292 -0.385 . . . . 1.1299999999999999 111.896 169.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 t -58.15 -20.49 41.16 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.31 0.576 . . . . 1.71 109.47 -165.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -98.02 -17.64 19.04 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.302 -0.863 . . . . 1.76 113.014 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 6.2 mmmt -102.87 -54.59 2.6 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.773 -0.649 . . . . 1.9099999999999999 111.174 -173.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 49' ' ' LEU . 70.3 t -6.25 90.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 O-C-N 125.93 2.019 . . . . 1.1499999999999999 113.139 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.87 -129.61 1.16 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 112.579 -2.101 . . . . 0.69999999999999996 112.191 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -72.65 -28.71 62.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.764 0.653 . . . . 3.3599999999999999 112.764 -168.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 30.0 p80 -96.06 -37.17 10.74 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.699 0.762 . . . . 1.78 111.181 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.956 HD22 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -125.62 105.22 8.85 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.313 -1.736 . . . . 1.72 106.313 175.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.626 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.45 113.93 25.55 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 106.325 -1.732 . . . . 0.96999999999999997 106.325 166.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.593 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.48 92.47 5.4 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 104.47 -2.419 . . . . 1.0600000000000001 104.47 171.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 33.0 m170 -87.61 159.86 18.4 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.831 1.3 . . . . 2.5899999999999999 110.306 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -135.03 110.27 8.96 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 111.548 -2.569 . . . . 0.92000000000000004 109.866 175.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -91.77 148.78 21.98 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 112.302 -2.226 . . . . 0.76000000000000001 107.576 174.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.8 98.31 3.31 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.45 1.119 . . . . 1.8 110.843 -173.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -118.01 124.82 49.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.554 -1.657 . . . . 2.4199999999999999 109.931 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -35.41 19.12 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.148 -1.842 . . . . 3.0800000000000001 110.62 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.995 -1.002 . . . . 1.6899999999999999 110.789 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -90.22 -18.78 25.08 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.771 -0.826 . . . . 1.96 108.771 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.764 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 7.4 ttpt 66.0 33.18 7.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.871 -1.059 . . . . 3.7799999999999998 109.367 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.48 122.91 56.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.721 0.772 . . . . 1.1299999999999999 109.826 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' SER . 2.9 m-30 -96.67 108.39 21.0 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.548 -1.649 . . . . 1.95 106.548 167.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 28.1 tp -93.42 105.9 17.91 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.966 -1.015 . . . . 1.1799999999999999 109.336 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.623 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 71.0 m-85 -91.1 111.19 22.56 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.333 -1.728 . . . . 0.40000000000000002 106.333 170.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -121.61 132.29 54.59 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.722 -1.126 . . . . 1.3200000000000001 110.107 -174.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.699 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.3 mt -98.27 131.71 44.37 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.199 -1.819 . . . . 1.5900000000000001 108.936 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -116.8 97.64 6.08 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 104.041 -2.577 . . . . 2.0099999999999998 104.041 165.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.699 HG13 ' HB3' ' A' ' 74' ' ' LEU . 10.8 mt -123.0 101.56 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.395 1.093 . . . . 1.1899999999999999 108.281 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.7 p -104.76 171.56 7.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 CA-C-N 114.874 -1.057 . . . . 1.05 110.105 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 39.89 67.41 0.48 Allowed 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.838 -2.892 . . . . 2.1200000000000001 111.562 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.493 ' HB1' HD23 ' A' ' 104' ' ' LEU . . . -65.49 116.32 6.65 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.625 -2.08 . . . . 1.0900000000000001 109.878 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.778 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -67.77 152.04 96.67 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.034 -0.728 . . . . 1.77 109.034 175.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.653 ' HD3' HG11 ' A' ' 18' ' ' VAL . 38.2 Cg_endo -66.16 -8.3 19.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.45 2.1 . . . . 1.3300000000000001 112.605 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.778 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -105.59 15.29 27.22 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.096 -0.502 . . . . 1.6599999999999999 110.278 176.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.7 m-30 -97.37 -6.4 34.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 118.849 -0.596 . . . . 1.24 110.983 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 22.9 m -23.59 95.07 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 125.497 1.748 . . . . 1.6799999999999999 111.393 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.804 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -55.49 115.52 5.93 Favored Glycine 0 N--CA 1.406 -3.341 0 CA-C-N 110.431 -3.077 . . . . 2.0 114.863 -169.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.619 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -119.18 68.7 0.35 Allowed Glycine 0 C--N 1.269 -3.188 0 CA-C-N 111.815 -2.192 . . . . 0.81000000000000005 108.433 149.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.877 ' HH ' ' NZ ' ' A' ' 43' ' ' LYS . 32.5 m-85 -73.98 115.75 13.8 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.179 -1.045 . . . . 1.0800000000000001 108.179 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.616 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 37.6 mtp180 -109.09 113.39 26.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.671 -0.492 . . . . 3.6899999999999999 109.671 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.1 t -101.8 110.7 22.73 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.624 0.726 . . . . 1.22 109.355 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.668 ' HG3' ' HG ' ' A' ' 99' ' ' CYS . 0.8 OUTLIER -121.1 110.91 16.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.5 -1.227 . . . . 1.8100000000000001 110.07 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.617 ' HB ' HG11 ' A' ' 39' ' ' VAL . 7.0 p -100.12 140.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.299 0.571 . . . . 1.24 110.27 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -135.74 108.59 7.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.409 -0.96 . . . . 1.6399999999999999 108.409 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -132.2 144.85 50.94 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-O 117.374 -1.298 . . . . 1.26 108.242 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.699 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.25 -72.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 O-C-N 125.629 1.831 . . . . 0.93999999999999995 113.699 -173.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.699 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 24.8 t70 -153.33 -1.18 0.23 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.681 -1.145 . . . . 1.05 110.707 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.105 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.8 tttp -88.25 126.45 35.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.447 -0.945 . . . . 1.78 108.447 176.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.405 ' HD1' ' O ' ' A' ' 91' ' ' VAL . 15.1 t80 -130.42 117.7 20.09 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 1.0 110.063 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -134.61 141.67 46.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.498 -1.683 . . . . 1.6000000000000001 108.639 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.668 ' HG ' ' HG3' ' A' ' 90' ' ' GLU . 5.0 m -136.21 144.22 44.79 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.473 . . . . 1.98 110.688 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.646 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 82.1 p -130.74 118.66 21.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.732 -0.667 . . . . 1.02 110.507 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.452 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -101.41 123.57 45.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.621 -0.718 . . . . 1.5800000000000001 109.516 176.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.677 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.9 p90 -142.88 135.56 27.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.005 0.907 . . . . 1.1000000000000001 110.581 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.796 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.6 m-80 -105.19 132.38 51.48 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.068 -1.424 . . . . 2.1099999999999999 111.449 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.721 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.41 106.58 17.74 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.554 -1.203 . . . . 1.0900000000000001 108.651 172.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.41 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 8.1 m -89.28 96.45 10.72 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.592 -0.892 . . . . 1.0700000000000001 108.592 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.557 HG22 HG21 ' A' ' 18' ' ' VAL . 4.7 p -85.2 113.69 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 123.031 1.396 . . . . 1.1399999999999999 109.104 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.93 99.21 11.7 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.648 -2.069 . . . . 1.8200000000000001 109.666 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 40.1 tt0 . . . . . 0 C--N 1.302 -1.465 0 CA-C-N 113.004 -1.907 . . . . 1.6699999999999999 110.16 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.613 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 23.1 t70 . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 108.31 -0.996 . . . . 1.6499999999999999 108.31 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.59 58.25 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.445 2.763 . . . . 1.24 114.421 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.974 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -67.86 -52.31 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 1.2 109.463 168.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.36 46.0 5.39 Favored Glycine 0 CA--C 1.494 -1.232 0 N-CA-C 108.252 -1.939 . . . . 0.44 108.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 96' ' ' LYS . 10.9 tp -55.04 -38.05 67.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.69 -1.755 . . . . 1.1100000000000001 110.643 -169.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.74 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -96.07 85.13 3.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.209 -0.905 . . . . 0.97999999999999998 109.823 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.03 -37.55 41.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.553 -1.203 . . . . 1.1100000000000001 110.01 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 tpp -151.28 134.39 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.513 -0.767 . . . . 3.3100000000000001 109.636 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 17.0 ptm180 -108.57 136.86 19.89 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.786 -0.643 . . . . 4.1699999999999999 109.916 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.72 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 2.0 Cg_endo -76.35 138.36 19.79 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.672 2.248 . . . . 0.81999999999999995 111.531 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.657 HE21 ' C ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -89.31 -177.98 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.696 -0.684 . . . . 1.6299999999999999 110.527 176.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -74.61 -142.87 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.291 1.043 . . . . 2.0600000000000001 110.7 178.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.77 140.02 2.86 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.355 -1.293 . . . . 0.34999999999999998 112.512 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 27.4 mt-10 -116.87 119.18 34.57 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.277 -0.961 . . . . 1.53 108.52 172.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.2 m -136.43 162.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 N-CA-C 107.068 -1.456 . . . . 1.0800000000000001 107.068 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.704 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -91.03 156.53 17.86 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.039 -0.982 . . . . 1.22 110.22 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 81' ' ' PRO . 11.6 t -66.47 107.12 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-O 123.023 1.392 . . . . 1.3799999999999999 108.202 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.69 14.31 12.78 Favored Glycine 0 C--N 1.266 -3.327 0 CA-C-N 111.925 -2.398 . . . . 0.52000000000000002 112.438 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.89 -125.24 5.32 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.366 -1.493 . . . . 0.44 109.366 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.682 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 24.4 p -152.73 165.51 35.08 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.236 -1.482 . . . . 1.23 110.685 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.643 HG22 HD11 ' A' ' 104' ' ' LEU . 10.3 tp -147.72 150.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.187 -1.824 . . . . 1.0900000000000001 107.252 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -138.95 125.94 21.13 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 113.442 -1.708 . . . . 1.05 110.043 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.76 150.06 44.86 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.375 -1.284 . . . . 0.71999999999999997 108.446 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.629 ' HB3' HD13 ' A' ' 71' ' ' LEU . 9.9 m -142.04 131.37 23.59 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.881 -0.785 . . . . 0.87 108.881 175.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.871 ' HB1' ' CH2' ' A' ' 41' ' ' TRP . . . -127.42 115.54 19.08 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.205 -1.361 . . . . 1.1000000000000001 109.772 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HB3' HG11 ' A' ' 69' ' ' VAL . 48.9 mtp180 -104.98 123.4 47.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.123 -0.49 . . . . 2.9300000000000002 110.329 -173.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 14.1 t -123.76 127.58 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.463 1.125 . . . . 1.0700000000000001 110.752 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.31 113.86 2.86 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.086 -1.87 . . . . 1.1200000000000001 112.931 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 1.032 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -49.78 -64.75 3.26 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 114.313 -1.312 . . . . 0.76000000000000001 111.085 166.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.696 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 60.52 -175.69 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 115.196 1.554 . . . . 1.0 115.196 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -96.55 106.88 19.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.867 -1.515 . . . . 2.1699999999999999 109.759 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.769 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -151.83 171.03 18.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.975 -0.557 . . . . 2.6299999999999999 110.674 -171.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.73 -49.06 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.42 0.629 . . . . 1.99 110.244 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.654 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -149.92 158.14 37.29 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.611 -0.885 . . . . 1.8799999999999999 108.611 174.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.75 139.62 3.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.159 2.573 . . . . 1.1200000000000001 112.296 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.769 ' HD3' HD13 ' A' ' 33' ' ' LEU . 8.9 Cg_exo -55.27 141.96 79.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.012 1.142 . . . . 0.81999999999999995 112.916 -175.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.84 106.38 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.332 -1.729 . . . . 1.4299999999999999 106.332 174.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.8 t -109.22 115.22 49.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.918 0 CA-C-N 113.384 -1.735 . . . . 1.0900000000000001 108.083 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.949 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.66 130.53 52.67 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 123.126 1.441 . . . . 2.1299999999999999 110.029 175.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.005 ' HB3' HD12 ' A' ' 49' ' ' LEU . 90.8 m95 -94.32 145.28 24.86 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 112.158 -2.292 . . . . 0.40999999999999998 111.917 173.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.5 t80 -126.88 130.86 50.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.641 -1.985 . . . . 0.80000000000000004 105.641 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 35.3 ttpt -104.76 111.58 24.36 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.523 -1.288 . . . . 2.6800000000000002 107.523 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.646 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -81.24 92.63 1.49 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 116.146 -2.93 . . . . 1.6000000000000001 114.274 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 tttp -106.67 -53.98 2.54 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 102.765 -3.05 . . . . 4.2999999999999998 102.765 134.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.769 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 9.0 p-90 -168.0 0.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 110.171 -3.195 . . . . 2.5099999999999998 110.933 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.87 173.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.574 1.654 . . . . 1.78 113.357 -159.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.5 t70 -110.27 145.23 37.74 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.097 -2.774 . . . . 2.73 105.775 174.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.005 HD12 ' HB3' ' A' ' 41' ' ' TRP . 5.9 mp -80.47 -38.26 30.31 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.22 -0.592 . . . . 1.1299999999999999 111.705 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -62.35 -18.78 62.35 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.809 -0.812 . . . . 1.71 108.809 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.448 ' C ' ' HD2' ' A' ' 52' ' ' LYS . 33.5 m -84.48 -22.63 30.21 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 114.681 -1.145 . . . . 1.76 111.532 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 8.0 mmmt -109.16 -67.52 0.98 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.181 -0.918 . . . . 1.9099999999999999 111.623 -174.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 49' ' ' LEU . 53.3 t 8.02 92.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 126.696 1.998 . . . . 1.1499999999999999 113.912 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.99 -135.97 2.43 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.215 -1.812 . . . . 0.69999999999999996 113.291 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.69 -36.58 79.14 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.967 1.099 . . . . 3.3599999999999999 113.967 -168.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.698 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -98.19 -36.52 10.02 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 119.741 -0.784 . . . . 1.78 111.393 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.801 HD23 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.39 103.68 10.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.347 -1.353 . . . . 1.72 107.347 173.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.45 115.7 29.88 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 106.448 -1.686 . . . . 0.96999999999999997 106.448 166.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.6 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.02 93.29 5.92 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 104.782 -2.303 . . . . 1.0600000000000001 104.782 172.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 4.3 m-70 -94.41 162.7 13.72 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.43 -1.259 . . . . 2.5899999999999999 109.533 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.0 p-10 -137.09 112.1 8.99 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 111.961 -2.381 . . . . 0.92000000000000004 110.103 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 8.4 m -95.66 150.8 19.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 112.455 -2.157 . . . . 0.76000000000000001 108.525 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 65' ' ' ARG . 6.7 t80 -143.67 98.53 3.26 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 122.643 1.211 . . . . 1.8 110.983 -173.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' OD2' ' HB3' ' A' ' 67' ' ' SER . 0.1 OUTLIER -110.0 105.47 14.62 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 112.759 -2.019 . . . . 2.4199999999999999 110.045 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -75.65 -30.78 59.56 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 3.0800000000000001 111.038 -175.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.66 -24.49 64.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.208 -0.905 . . . . 1.6899999999999999 110.461 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.526 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 6.5 t -100.94 -12.48 18.9 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.018 -0.734 . . . . 1.96 109.018 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.696 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 8.7 ttpt 67.18 31.25 6.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.101 -0.954 . . . . 3.7799999999999998 110.5 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 27' ' ' ARG . 5.0 t -125.23 133.54 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.954 0.883 . . . . 1.1299999999999999 110.631 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 1.032 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.9 m-85 -98.8 111.56 23.9 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.518 -2.03 . . . . 1.95 105.518 162.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 25' ' ' SER . 9.2 tp -100.87 104.0 15.2 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.113 0.959 . . . . 1.1799999999999999 108.539 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 58.6 m-85 -84.64 113.39 21.24 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.929 -1.508 . . . . 0.40000000000000002 106.929 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 5.2 pt-20 -117.99 123.85 46.73 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.376 -1.738 . . . . 1.3200000000000001 110.216 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.814 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.1 mm? -91.88 126.87 37.13 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 112.653 -2.067 . . . . 1.5900000000000001 108.127 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -116.19 96.42 5.54 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 104.368 -2.456 . . . . 2.0099999999999998 104.368 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.698 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 55.5 mt -122.09 100.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 123.012 1.387 . . . . 1.1899999999999999 109.875 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 45.5 p -104.18 154.38 19.82 Favored 'General case' 0 N--CA 1.394 -3.227 0 CA-C-N 113.964 -1.471 . . . . 1.05 108.492 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 44.21 85.7 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.322 -2.672 . . . . 2.1200000000000001 112.429 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.85 136.81 47.13 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 110.926 -2.852 . . . . 1.0900000000000001 111.191 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.795 HE21 ' HD2' ' A' ' 81' ' ' PRO . 1.1 tp60 -63.44 130.12 94.08 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.259 -0.645 . . . . 1.77 109.259 173.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.795 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.6 Cg_endo -58.71 -13.04 16.27 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.561 2.841 . . . . 1.3300000000000001 114.285 -171.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HB1' ' HZ2' ' A' ' 45' ' ' LYS . . . -120.45 28.8 7.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.887 -0.325 . . . . 1.6599999999999999 111.622 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.573 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.21 -57.27 4.0 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.252 -0.648 . . . . 1.24 109.252 172.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 7.3 m 43.86 58.56 3.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.97 -1.492 . . . . 1.6799999999999999 106.97 -157.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.702 ' HA3' HD22 ' A' ' 104' ' ' LEU . . . -51.26 85.48 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.498 0 CA-C-N 112.545 -2.116 . . . . 2.0 114.705 -164.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -92.08 80.71 1.2 Allowed Glycine 0 C--N 1.282 -2.429 0 N-CA-C 108.938 -1.665 . . . . 0.81000000000000005 108.938 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.569 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 13.2 m-85 -78.64 109.8 13.18 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.812 -1.194 . . . . 1.0800000000000001 108.807 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -94.36 105.03 17.0 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.694 -0.854 . . . . 3.6899999999999999 108.694 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.555 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 8.4 t -95.52 126.23 40.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.571 -0.851 . . . . 1.22 109.176 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.949 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 92.3 mt-10 -133.96 118.68 18.14 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.65 -0.705 . . . . 1.8100000000000001 110.367 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.4 p -107.52 143.67 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.485 0.659 . . . . 1.24 110.133 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 m -140.44 112.59 7.75 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.171 -0.922 . . . . 1.6399999999999999 110.012 -176.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.522 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -130.21 174.95 9.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 118.621 -0.704 . . . . 1.26 110.048 177.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.858 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -8.61 -60.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.196 1.56 . . . . 0.93999999999999995 114.732 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.858 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.0 t70 -151.11 -8.05 0.25 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.293 -1.321 . . . . 1.05 109.669 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.974 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -91.13 124.88 35.69 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.679 -1.23 . . . . 1.78 107.679 -177.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -131.54 133.64 45.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.293 -0.867 . . . . 1.0 111.513 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -154.24 150.53 28.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.701 -1.136 . . . . 1.6000000000000001 109.99 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 90' ' ' GLU . 72.1 m -142.5 150.33 40.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.025 -0.361 . . . . 1.98 110.025 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.74 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 47.6 p -128.62 135.63 49.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 1.02 111.764 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.47 138.58 33.39 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.297 -0.865 . . . . 1.5800000000000001 109.394 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.932 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -150.1 128.93 12.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.725 -0.79 . . . . 1.1000000000000001 111.879 151.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.74 125.85 54.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.959 0.885 . . . . 2.1099999999999999 111.279 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.702 HD22 ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.94 104.17 14.12 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.133 -1.394 . . . . 1.0900000000000001 109.575 -178.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.0 m -84.81 96.28 9.24 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.568 -0.901 . . . . 1.0700000000000001 108.568 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.6 113.95 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 123.061 1.41 . . . . 1.1399999999999999 109.18 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.0 m170 -78.55 97.24 5.69 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 112.852 -1.976 . . . . 1.8200000000000001 109.653 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 34.7 tt0 . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.228 -1.351 . . . . 1.6699999999999999 109.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 119.897 -0.096 . . . . 1.6499999999999999 111.153 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.68 84.43 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.63 2.22 . . . . 1.24 111.948 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.832 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.0 -59.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.088 -0.96 . . . . 1.2 109.488 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.23 41.4 5.53 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 108.842 -1.703 . . . . 0.44 108.842 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.583 ' N ' HG21 ' A' ' 4' ' ' ILE . 9.3 tp -49.74 -38.97 35.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.738 -1.731 . . . . 1.1100000000000001 111.048 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.635 ' HE2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -92.61 84.52 5.07 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.97999999999999998 109.672 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.8 -48.03 35.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.851 -1.068 . . . . 1.1100000000000001 109.998 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.495 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 16.5 tpt -151.19 129.03 11.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.048 -0.978 . . . . 3.3100000000000001 108.842 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.635 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 16.3 ptm180 -88.2 144.32 34.09 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.733 -0.667 . . . . 4.1699999999999999 110.162 -176.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.634 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 59.8 Cg_endo -65.8 145.8 81.73 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.557 2.171 . . . . 0.81999999999999995 110.161 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.536 HE21 ' H ' ' A' ' 13' ' ' ASP . 12.6 tp60 -115.67 159.03 21.89 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 119.331 -0.366 . . . . 1.6299999999999999 111.747 -173.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.3 m-20 -57.89 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 123.418 1.58 . . . . 2.0600000000000001 113.044 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.18 137.0 2.73 Favored Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 112.963 -1.926 . . . . 0.34999999999999998 111.551 -174.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.7 mt-10 -116.06 114.45 24.57 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.714 -0.847 . . . . 1.53 108.714 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.504 HG12 ' HB ' ' A' ' 22' ' ' ILE . 4.9 m -134.2 164.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.712 -1.218 . . . . 1.0800000000000001 107.712 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -95.21 156.73 16.2 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.886 -1.052 . . . . 1.22 109.534 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.607 HG11 ' HD3' ' A' ' 81' ' ' PRO . 42.4 t -62.56 107.02 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-O 122.754 1.264 . . . . 1.3799999999999999 109.294 175.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.09 11.09 Favored Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.912 -2.404 . . . . 0.52000000000000002 113.333 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.7 -122.58 4.84 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 119.616 -1.278 . . . . 0.44 110.009 171.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 11.9 p -150.36 165.04 34.28 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 113.087 -1.557 . . . . 1.23 110.645 175.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.673 HG22 HD13 ' A' ' 104' ' ' LEU . 8.8 tp -148.08 147.48 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.078 -1.874 . . . . 1.0900000000000001 107.18 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m -139.5 125.97 20.36 Favored 'General case' 0 C--N 1.259 -3.354 0 CA-C-N 113.74 -1.573 . . . . 1.05 110.396 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.543 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 10.2 m-85 -123.54 146.67 47.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.618 -1.173 . . . . 0.71999999999999997 109.458 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.475 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -126.51 129.93 49.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.038 -1.097 . . . . 0.87 108.038 173.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB1' ' HH2' ' A' ' 41' ' ' TRP . . . -130.66 125.16 33.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.57 -1.195 . . . . 1.1000000000000001 110.812 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.5 mtt180 -115.36 123.12 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.842 0.312 . . . . 2.9300000000000002 111.842 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 t -121.69 128.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.775 0.798 . . . . 1.0700000000000001 109.593 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -57.63 107.38 0.44 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.881 -1.508 . . . . 1.1200000000000001 110.527 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.722 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -55.79 -39.1 75.93 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.731 -1.122 . . . . 0.76000000000000001 110.925 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.62 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.67 -163.93 0.03 OUTLIER 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.695 1.368 . . . . 1.0 114.695 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -111.64 123.02 49.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.443 -1.253 . . . . 2.1699999999999999 108.153 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.899 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -155.1 174.65 14.89 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.673 0.249 . . . . 2.6299999999999999 111.673 -172.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.6 tp -62.07 -47.99 82.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 1.99 109.539 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -151.15 154.59 34.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.059 -0.973 . . . . 1.8799999999999999 108.963 170.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -44.14 134.37 8.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.627 2.885 . . . . 1.1200000000000001 112.049 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.899 ' HD3' HD13 ' A' ' 33' ' ' LEU . 8.7 Cg_exo -42.89 142.87 1.98 Allowed 'Trans proline' 0 CA--C 1.499 -1.232 0 C-N-CA 123.849 3.033 . . . . 0.81999999999999995 115.189 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.1 99.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 105.875 -1.898 . . . . 1.4299999999999999 105.875 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.6 t -103.42 114.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-N 113.504 -1.68 . . . . 1.0900000000000001 107.415 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.857 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.76 128.59 52.94 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.057 -1.429 . . . . 2.1299999999999999 109.743 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.908 ' HB3' HD13 ' A' ' 49' ' ' LEU . 74.0 m95 -91.51 157.86 16.79 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 112.063 -2.335 . . . . 0.40999999999999998 111.104 172.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.733 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.9 t80 -139.06 125.51 20.44 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.934 -2.247 . . . . 0.80000000000000004 104.934 178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.835 ' HD3' HD22 ' A' ' 57' ' ' LEU . 33.8 ttpt -103.02 100.34 10.27 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.715 -1.587 . . . . 2.6800000000000002 106.715 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.443 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -90.38 97.46 2.33 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 115.993 -3.004 . . . . 1.6000000000000001 117.293 -157.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.873 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 3.8 ptmt -99.14 -47.39 5.23 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.449 -2.797 . . . . 4.2999999999999998 103.449 137.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.873 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 9.4 p-90 -170.38 3.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 112.468 -2.151 . . . . 2.5099999999999998 111.102 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.626 HG11 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -98.82 169.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 C-N-CA 125.04 1.336 . . . . 1.78 112.981 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.626 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -105.43 154.15 20.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.455 -2.157 . . . . 2.73 107.001 175.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.908 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.4 mp -89.24 -30.46 18.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 1.1299999999999999 112.605 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -57.2 -21.0 30.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.349 0.595 . . . . 1.71 109.854 -167.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.554 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 8.0 t -96.38 -22.55 17.1 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.178 -0.919 . . . . 1.76 111.992 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 1.7 mmmt -106.55 -15.19 14.85 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.778 -1.101 . . . . 1.9099999999999999 111.671 -171.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 49' ' ' LEU . 55.7 t -59.17 89.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 114.013 -1.449 . . . . 1.1499999999999999 110.213 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.49 -142.1 3.58 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 112.438 -2.165 . . . . 0.69999999999999996 112.988 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -67.4 -22.63 65.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.007 0.744 . . . . 3.3599999999999999 113.007 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.594 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.1 p-80 -101.21 -38.02 8.29 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 120.23 -0.588 . . . . 1.78 111.247 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.835 HD22 ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -120.69 102.25 8.28 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.144 -1.799 . . . . 1.72 106.144 172.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -94.41 115.02 27.15 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.724 -1.584 . . . . 0.96999999999999997 106.724 167.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.709 HD12 ' CD1' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -97.95 91.49 5.35 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.114 -2.55 . . . . 1.0600000000000001 104.114 167.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 34.4 m170 -90.18 162.43 15.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.228 -1.351 . . . . 2.5899999999999999 110.039 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -133.57 110.48 9.94 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 112.323 -2.217 . . . . 0.92000000000000004 109.866 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 14.2 m -93.95 112.36 24.19 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.89 -1.959 . . . . 0.76000000000000001 109.322 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.433 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.0 t80 -102.23 98.08 8.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.96 -1.018 . . . . 1.8 110.212 -176.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.91 107.08 15.21 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.585 -1.643 . . . . 2.4199999999999999 109.141 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.579 ' HD3' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -81.45 -32.72 32.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.382 -0.827 . . . . 3.0800000000000001 110.968 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.58 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.229 -0.896 . . . . 1.6899999999999999 110.527 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 m -108.66 -18.63 13.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.72 -0.844 . . . . 1.96 108.72 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.722 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 62.99 35.65 13.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 3.7799999999999998 109.979 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -129.62 130.69 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.002 -0.999 . . . . 1.1299999999999999 108.392 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.63 ' HH ' ' HZ3' ' A' ' 68' ' ' LYS . 3.9 m-30 -101.26 106.72 17.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.599 -1.63 . . . . 1.95 106.599 171.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 22.7 tp -96.12 104.42 16.37 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.189 -1.368 . . . . 1.1799999999999999 108.316 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.684 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.7 m-85 -83.53 113.47 20.83 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 113.819 -1.537 . . . . 0.40000000000000002 107.533 174.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 6.6 mt-10 -106.84 119.02 38.22 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 113.113 -1.858 . . . . 1.3200000000000001 108.935 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 76' ' ' ILE . 3.1 mm? -88.36 122.76 32.23 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.454 -1.313 . . . . 1.5900000000000001 107.454 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 36.8 m80 -118.31 95.67 4.98 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 104.327 -2.472 . . . . 2.0099999999999998 104.327 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 74' ' ' LEU . 39.4 mt -122.11 101.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 123.041 1.4 . . . . 1.1899999999999999 110.2 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.2 p -110.53 134.79 52.05 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-N 113.621 -1.627 . . . . 1.05 107.692 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 77' ' ' THR . 3.5 t70 73.14 97.31 0.07 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 111.642 -2.526 . . . . 2.1200000000000001 110.024 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.74 122.77 45.14 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 110.552 -3.022 . . . . 1.0900000000000001 109.943 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.536 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -64.24 138.26 97.37 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.153 -0.93 . . . . 1.77 109.577 173.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.607 ' HD3' HG11 ' A' ' 18' ' ' VAL . 26.2 Cg_endo -61.44 -9.06 12.04 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.23 2.62 . . . . 1.3300000000000001 112.421 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.63 17.67 22.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.835 -0.621 . . . . 1.6599999999999999 111.441 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.733 ' HD1' ' HD2' ' A' ' 45' ' ' LYS . 1.4 m-30 -85.43 -55.33 4.06 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.91 -0.774 . . . . 1.24 108.91 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 88.7 m 28.51 63.84 0.11 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 123.183 1.468 . . . . 1.6799999999999999 108.68 -161.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.587 ' O ' ' HD1' ' A' ' 87' ' ' TYR . . . -66.55 91.61 0.17 Allowed Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 111.975 -2.375 . . . . 2.0 114.05 -159.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -83.61 83.74 1.6 Allowed Glycine 0 C--N 1.276 -2.768 0 N-CA-C 108.185 -1.966 . . . . 0.81000000000000005 108.185 169.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.733 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 3.7 m-85 -74.6 113.65 12.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.685 -1.257 . . . . 1.0800000000000001 108.812 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.409 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 99.8 mtt180 -87.89 109.76 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.391 -0.966 . . . . 3.6899999999999999 108.391 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.6 t -95.97 122.67 39.04 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.601 -0.888 . . . . 1.22 108.601 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.857 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 38.5 tt0 -137.82 107.64 6.29 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.244 -0.889 . . . . 1.8100000000000001 110.289 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.6 p -102.59 141.57 18.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.676 0.75 . . . . 1.24 110.699 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -139.86 108.33 5.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.342 -1.299 . . . . 1.6399999999999999 108.561 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.557 HG23 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.47 145.33 51.1 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-O 117.936 -1.03 . . . . 1.26 108.894 -179.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.679 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 32.95 -74.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 126.148 2.155 . . . . 0.93999999999999995 113.578 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.679 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -148.16 -8.07 0.4 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.035 -0.984 . . . . 1.05 110.563 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.832 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.9 mmtm -86.05 129.53 34.81 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.432 -1.321 . . . . 1.78 107.432 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 21.3 t80 -132.33 148.39 52.43 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.85 -1.523 . . . . 1.0 111.773 -173.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 t70 -179.0 165.39 1.52 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.207 0.942 . . . . 1.6000000000000001 110.33 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.496 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.3 m -145.22 151.73 38.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.267 -0.271 . . . . 1.98 110.267 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 58.5 p -132.6 130.31 40.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.041 0.448 . . . . 1.02 112.149 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -94.56 127.32 40.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.368 -0.833 . . . . 1.5800000000000001 109.393 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 87' ' ' TYR . 28.4 p90 -149.38 143.75 25.96 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.119 -0.632 . . . . 1.1000000000000001 109.872 165.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.54 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.9 m-80 -115.8 140.23 49.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.255 1.026 . . . . 2.1099999999999999 112.471 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.673 HD13 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -103.82 107.99 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.336 -1.302 . . . . 1.0900000000000001 108.463 172.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.435 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 3.8 m -87.81 96.38 10.44 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.253 -0.647 . . . . 1.0700000000000001 109.253 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.536 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.4 p -79.41 112.78 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.25 1.5 . . . . 1.1399999999999999 108.672 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 44.0 m170 -85.65 100.34 11.91 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.527 -2.124 . . . . 1.8200000000000001 109.421 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 37.1 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 114.805 -1.089 . . . . 1.6699999999999999 109.836 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 110.067 -0.345 . . . . 1.6499999999999999 110.067 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.38 88.18 0.33 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.311 2.007 . . . . 1.24 111.889 172.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.89 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.13 -65.16 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.378 -0.828 . . . . 1.2 109.537 177.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 4' ' ' ILE . . . 93.8 49.06 2.57 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 108.595 -1.802 . . . . 0.44 108.595 -174.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 96' ' ' LYS . 9.8 tp -61.41 -33.39 73.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.083 -1.558 . . . . 1.1100000000000001 110.22 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.656 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -91.68 84.66 5.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.931 -1.031 . . . . 0.97999999999999998 110.088 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.57 -46.6 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.899 -1.046 . . . . 1.1100000000000001 110.405 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.11 131.03 11.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 3.3100000000000001 109.708 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 21.2 ptt180 -108.12 142.89 26.27 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.575 -0.739 . . . . 4.1699999999999999 109.843 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.762 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 11.0 Cg_endo -73.4 158.09 48.64 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.538 1.492 . . . . 0.81999999999999995 110.82 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -116.3 -180.0 3.83 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.363 -0.606 . . . . 1.6299999999999999 109.363 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 2.0 p-10 -71.55 -148.92 0.02 OUTLIER 'General case' 0 N--CA 1.407 -2.578 0 CA-C-O 122.932 1.348 . . . . 2.0600000000000001 111.635 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.69 133.82 1.69 Allowed Glycine 0 C--N 1.293 -1.819 0 CA-C-N 113.356 -1.747 . . . . 0.34999999999999998 112.045 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.2 mt-10 -113.82 111.12 21.22 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.006 -1.097 . . . . 1.53 108.082 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.422 HG11 ' HB ' ' A' ' 22' ' ' ILE . 3.0 m -126.74 163.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 106.666 -1.605 . . . . 1.0800000000000001 106.666 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.74 154.61 17.48 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 115.404 -0.816 . . . . 1.22 109.27 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.664 HG22 ' HG3' ' A' ' 81' ' ' PRO . 3.1 t -64.33 106.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 CA-C-O 122.719 1.247 . . . . 1.3799999999999999 108.365 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.13 8.64 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.378 -2.192 . . . . 0.52000000000000002 112.145 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.96 -122.28 4.82 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 108.73 -1.748 . . . . 0.44 108.73 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.2 p -151.94 171.1 18.31 Favored 'General case' 0 N--CA 1.399 -3.015 0 CA-C-N 113.344 -1.428 . . . . 1.23 109.894 172.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.49 HG22 HD12 ' A' ' 104' ' ' LEU . 10.5 tp -146.34 147.53 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 113.276 -1.783 . . . . 1.0900000000000001 107.316 166.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -139.03 123.96 18.8 Favored 'General case' 0 C--N 1.262 -3.214 0 CA-C-N 113.333 -1.758 . . . . 1.05 110.241 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.68 ' CD2' HD12 ' A' ' 74' ' ' LEU . 73.1 m-85 -123.44 145.66 48.63 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.129 -1.396 . . . . 0.71999999999999997 107.769 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.765 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.3 m -138.18 124.91 20.99 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.745 0.783 . . . . 0.87 109.439 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 41' ' ' TRP . . . -116.7 115.73 26.2 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.285 -1.325 . . . . 1.1000000000000001 110.48 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -106.41 115.57 30.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.654 -0.248 . . . . 2.9300000000000002 110.549 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.92 126.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.958 0.885 . . . . 1.0700000000000001 110.523 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.14 112.06 1.76 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.337 -1.756 . . . . 1.1200000000000001 110.724 173.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.567 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -45.2 -51.53 8.91 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 114.794 -1.094 . . . . 0.76000000000000001 111.269 171.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' H ' ' CG ' ' A' ' 68' ' ' LYS . . . 55.49 -155.77 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.408 0.892 . . . . 1.0 113.408 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 p -115.68 135.92 53.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.861 -0.608 . . . . 2.1699999999999999 109.953 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.562 ' HB3' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -155.08 -174.61 5.05 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.826 0.822 . . . . 2.6299999999999999 112.8 -175.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.3 tp -98.06 -45.17 6.35 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.27 -1.332 . . . . 1.99 108.128 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.39 139.05 29.02 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.723 -1.126 . . . . 1.8799999999999999 108.982 172.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.11 156.57 24.09 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.956 2.437 . . . . 1.1200000000000001 111.103 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 93' ' ' THR . 3.3 Cg_endo -57.1 125.15 18.04 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.544 0.829 . . . . 0.81999999999999995 112.716 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 104.54 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.054 -1.462 . . . . 1.4299999999999999 107.054 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.5 t -102.73 114.42 42.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.832 -1.531 . . . . 1.0900000000000001 108.397 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.666 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.02 127.85 53.05 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.743 -1.571 . . . . 2.1299999999999999 109.817 175.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.958 ' HB3' HD11 ' A' ' 49' ' ' LEU . 77.0 m95 -91.63 155.03 18.63 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 111.969 -2.378 . . . . 0.40999999999999998 111.677 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 39.7 t80 -133.36 139.9 47.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.316 -2.476 . . . . 0.80000000000000004 104.316 170.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.846 ' HZ3' ' HH ' ' A' ' 87' ' ' TYR . 62.9 tttp -102.51 166.61 10.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 105.721 -1.955 . . . . 2.6800000000000002 105.721 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -14.03 -167.31 0.0 OUTLIER Glycine 0 C--O 1.183 -3.088 0 N-CA-C 119.248 2.459 . . . . 1.6000000000000001 119.248 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.689 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 8.4 mtpt -44.41 -8.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 O-C-N 119.125 -2.397 . . . . 4.2999999999999998 116.786 -164.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ3' HG11 ' A' ' 47' ' ' VAL . 9.9 p-90 -160.8 -9.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 114.101 1.148 . . . . 2.5099999999999998 114.101 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.791 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.92 164.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 CA-C-O 123.218 1.485 . . . . 1.78 112.481 -160.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.569 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 9.9 p-10 -111.1 158.54 18.75 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 111.815 -2.448 . . . . 2.73 106.508 172.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.066 HD21 HD23 ' A' ' 57' ' ' LEU . 5.7 mp -98.88 -28.74 13.32 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.476 -0.49 . . . . 1.1299999999999999 111.792 167.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -57.3 -21.37 34.37 Favored 'General case' 0 C--N 1.315 -0.891 0 O-C-N 123.706 0.629 . . . . 1.71 109.864 -163.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 33.2 m -100.03 -35.38 9.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 122.033 0.921 . . . . 1.76 112.224 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.569 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -88.61 -31.29 18.66 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.159 -1.382 . . . . 1.9099999999999999 111.685 -165.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 49' ' ' LEU . 79.2 t -35.46 94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.392 1.477 . . . . 1.1499999999999999 111.753 172.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.44 -95.91 0.11 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 112.501 -2.136 . . . . 0.69999999999999996 113.837 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -95.3 -45.37 7.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.944 0.72 . . . . 3.3599999999999999 112.944 -172.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 31.5 p80 -88.45 -37.11 16.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.736 0.779 . . . . 1.78 110.609 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 1.066 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.55 106.92 12.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.428 -1.693 . . . . 1.72 106.428 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.81 116.13 31.98 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 106.63 -1.619 . . . . 0.96999999999999997 106.63 164.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.661 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -95.19 93.8 7.53 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 104.829 -2.285 . . . . 1.0600000000000001 104.829 173.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 90.3 m-70 -84.33 162.49 20.04 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.338 -1.301 . . . . 2.5899999999999999 109.887 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -140.13 114.76 9.41 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 111.986 -2.37 . . . . 0.92000000000000004 109.42 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 2.0 m -101.52 149.35 24.18 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.796 -2.002 . . . . 0.76000000000000001 108.628 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -141.29 98.62 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.569 1.175 . . . . 1.8 111.251 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.46 101.71 9.39 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.315 -1.766 . . . . 2.4199999999999999 109.319 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -73.85 -29.58 62.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.508 -0.769 . . . . 3.0800000000000001 110.228 177.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.98 70.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.106 -0.952 . . . . 1.6899999999999999 110.668 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -103.36 -13.81 16.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.209 -0.905 . . . . 1.96 109.455 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER 63.36 36.88 11.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.872 0.844 . . . . 3.7799999999999998 109.898 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.41 128.1 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.673 0.749 . . . . 1.1299999999999999 109.726 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.567 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.7 m-85 -98.19 113.36 25.25 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.922 -1.881 . . . . 1.95 105.922 164.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 25' ' ' SER . 21.7 tp -99.06 106.4 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 122.217 1.008 . . . . 1.1799999999999999 109.374 174.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 55.3 m-85 -84.47 113.33 21.13 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 113.726 -1.579 . . . . 0.40000000000000002 107.953 168.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.9 116.84 32.37 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.67 -1.604 . . . . 1.3200000000000001 110.7 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.827 ' HB3' HG13 ' A' ' 76' ' ' ILE . 18.0 mt -81.97 123.65 29.07 Favored 'General case' 0 CA--C 1.475 -1.926 0 CA-C-N 115.081 -0.963 . . . . 1.5900000000000001 108.927 170.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -111.73 93.65 4.56 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 103.108 -2.923 . . . . 2.0099999999999998 103.108 163.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.827 HG13 ' HB3' ' A' ' 74' ' ' LEU . 18.1 mt -118.39 99.96 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 122.83 1.3 . . . . 1.1899999999999999 109.255 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.0 p -102.85 166.51 10.43 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 114.078 -1.419 . . . . 1.05 110.439 -176.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 41.03 67.38 0.53 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 110.658 -2.974 . . . . 2.1200000000000001 111.551 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -62.18 120.01 10.1 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.894 -1.957 . . . . 1.0900000000000001 111.252 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.833 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -54.91 140.21 61.22 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.349 -0.841 . . . . 1.77 109.728 169.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.664 ' HG3' HG22 ' A' ' 18' ' ' VAL . 23.2 Cg_exo -62.9 -10.25 19.58 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.692 2.261 . . . . 1.3300000000000001 112.465 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.833 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -98.64 10.76 40.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.962 -0.563 . . . . 1.6599999999999999 110.773 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -95.54 -10.84 28.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.722 -0.391 . . . . 1.24 110.898 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 21.8 m -46.11 101.31 0.02 OUTLIER 'General case' 0 CA--C 1.475 -1.92 0 CA-C-O 122.358 1.075 . . . . 1.6799999999999999 108.802 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.689 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -172.69 -128.79 1.08 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.701 -2.045 . . . . 2.0 113.383 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.95 119.03 0.88 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.174 -1.013 . . . . 0.81000000000000005 112.712 -170.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.846 ' HH ' ' HZ3' ' A' ' 43' ' ' LYS . 2.0 m-85 -82.81 120.94 26.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.348 -1.426 . . . . 1.0800000000000001 108.212 175.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 57.7 ttt180 -110.91 104.49 13.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.976 0.417 . . . . 3.6899999999999999 110.193 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.861 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.7 t -92.19 129.86 38.04 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.05 -0.722 . . . . 1.22 109.05 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.697 ' HG3' ' HB3' ' A' ' 99' ' ' CYS . 30.6 tt0 -140.22 106.69 5.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.477 -0.783 . . . . 1.8100000000000001 109.458 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 5.5 p -95.05 138.01 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 121.858 0.837 . . . . 1.24 110.73 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.2 t -133.29 108.88 9.01 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.146 -1.388 . . . . 1.6399999999999999 107.94 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 94' ' ' LYS . 2.4 m -127.27 170.06 12.86 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.888 -1.153 . . . . 1.26 107.888 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.71 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 0.82 -65.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 125.513 1.758 . . . . 0.93999999999999995 114.555 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.71 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 1.2 t0 -148.82 -8.96 0.35 Allowed 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.837 -1.074 . . . . 1.05 109.967 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.89 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.2 mmtm -87.5 124.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.79 -1.189 . . . . 1.78 107.79 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -130.65 137.41 49.58 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.735 -1.12 . . . . 1.0 111.153 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -163.07 161.85 25.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.79 -1.096 . . . . 1.6000000000000001 108.892 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.697 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 3.9 p -153.46 145.33 23.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.152 0.501 . . . . 1.98 111.183 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.742 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 42.5 p -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 1.02 111.253 -175.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.94 125.27 50.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.226 0.536 . . . . 1.5800000000000001 110.868 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.861 ' HZ ' ' HB2' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -140.1 116.18 10.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.431 -0.581 . . . . 1.1000000000000001 109.431 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.526 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 51.1 m-20 -95.16 151.65 19.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.292 -0.867 . . . . 2.1099999999999999 110.846 -168.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.634 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -123.95 121.28 34.87 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.256 -0.884 . . . . 1.0900000000000001 108.806 174.235 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -103.35 96.05 6.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.416 -0.586 . . . . 1.0700000000000001 109.416 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 80' ' ' GLN . 3.5 p -77.63 116.19 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 123.077 1.418 . . . . 1.1399999999999999 109.05 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -87.56 102.02 14.19 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.395 -2.184 . . . . 1.8200000000000001 108.275 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.597 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 33.0 tt0 . . . . . 0 C--N 1.299 -1.595 0 CA-C-N 114.133 -1.394 . . . . 1.6699999999999999 111.277 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.92 ' HB2' ' HZ2' ' A' ' 94' ' ' LYS . 2.3 m-20 . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 109.4 -0.593 . . . . 1.6499999999999999 109.4 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.01 77.07 4.07 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.848 1.699 . . . . 1.24 113.19 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.82 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -93.87 -62.6 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.315 -0.994 . . . . 1.2 108.315 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.7 4.64 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 109.368 -1.493 . . . . 0.44 109.368 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.691 HD23 ' HB3' ' A' ' 96' ' ' LYS . 3.7 tp -41.04 -44.37 2.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 112.897 -1.652 . . . . 1.1100000000000001 111.421 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.697 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -93.0 84.43 4.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.246 -0.888 . . . . 0.97999999999999998 109.793 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' A' ' 27' ' ' ARG . 15.8 t -76.16 -33.06 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.018 -1.446 . . . . 1.1100000000000001 109.187 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp -167.95 137.41 2.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.095 -0.957 . . . . 3.3100000000000001 109.639 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 27.7 ptt180 -105.66 148.79 37.02 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.933 -0.576 . . . . 4.1699999999999999 110.079 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.759 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 13.5 Cg_endo -79.48 164.52 23.73 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.646 1.564 . . . . 0.81999999999999995 110.728 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -123.7 179.3 4.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.326 -0.397 . . . . 1.6299999999999999 110.337 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.2 -144.59 0.01 OUTLIER 'General case' 0 N--CA 1.41 -2.433 0 CA-C-O 122.809 1.29 . . . . 2.0600000000000001 110.98 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.34 132.26 1.79 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.606 -1.634 . . . . 0.34999999999999998 111.726 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.0 mt-10 -110.49 114.16 27.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.981 -1.109 . . . . 1.53 108.213 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.9 m -134.48 162.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 N-CA-C 107.821 -1.177 . . . . 1.0800000000000001 107.821 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 153.15 17.95 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.487 -1.233 . . . . 1.22 108.738 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.669 HG13 ' HD3' ' A' ' 81' ' ' PRO . 5.8 t -69.0 105.01 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.826 1.298 . . . . 1.3799999999999999 107.956 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.22 12.54 5.22 Favored Glycine 0 C--N 1.267 -3.304 0 CA-C-N 112.445 -2.162 . . . . 0.52000000000000002 112.642 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.03 -122.66 5.14 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.264 -1.446 . . . . 0.44 110.366 170.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.1 p -151.51 169.41 22.14 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 113.054 -1.573 . . . . 1.23 110.329 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.473 HG21 HD12 ' A' ' 104' ' ' LEU . 9.6 tp -148.19 149.98 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.539 -1.664 . . . . 1.0900000000000001 107.285 168.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 m -140.15 131.49 26.75 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.022 -1.445 . . . . 1.05 110.947 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 50.0 m-85 -129.55 148.05 51.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.148 -1.387 . . . . 0.71999999999999997 108.764 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.538 ' HB3' HD12 ' A' ' 71' ' ' LEU . 3.5 m -140.08 127.33 21.17 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.879 0.847 . . . . 0.87 109.188 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.12 117.23 24.92 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.125 -1.398 . . . . 1.1000000000000001 110.718 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 75.2 mtt180 -102.07 121.78 42.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.3 -0.409 . . . . 2.9300000000000002 110.505 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.1 t -126.06 128.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 122.082 0.944 . . . . 1.0700000000000001 110.531 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.685 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -61.36 105.39 0.5 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.444 -1.707 . . . . 1.1200000000000001 112.398 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.743 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -59.7 -36.26 89.08 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 115.061 -0.972 . . . . 0.76000000000000001 111.745 172.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.912 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . . . 57.54 -163.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.783 1.031 . . . . 1.0 113.783 162.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -118.89 31.13 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 2.1699999999999999 109.529 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.743 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -56.1 -175.76 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.639 1.348 . . . . 2.6299999999999999 114.639 176.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 tp -68.98 -53.95 17.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.04 -0.982 . . . . 1.99 109.593 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.88 146.49 47.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 114.846 -1.07 . . . . 1.8799999999999999 108.688 172.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -42.98 140.37 3.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.464 2.776 . . . . 1.1200000000000001 111.934 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.737 ' HA ' HG22 ' A' ' 93' ' ' THR . 3.7 Cg_endo -53.16 136.59 62.17 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.563 1.509 . . . . 0.81999999999999995 112.761 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.01 104.31 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.638 0 N-CA-C 106.157 -1.794 . . . . 1.4299999999999999 106.157 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.609 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -106.88 114.75 46.79 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 113.136 -1.847 . . . . 1.0900000000000001 107.785 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.953 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.69 125.33 50.11 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.825 -1.534 . . . . 2.1299999999999999 109.58 174.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.035 ' HB3' HD12 ' A' ' 49' ' ' LEU . 68.0 m95 -86.45 149.1 25.23 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.816 -2.447 . . . . 0.40999999999999998 111.482 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 25.8 t80 -125.37 138.55 54.04 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 104.66 -2.348 . . . . 0.80000000000000004 104.66 169.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.699 ' HD2' HD11 ' A' ' 57' ' ' LEU . 67.5 tttt -99.35 171.13 8.17 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.612 -1.996 . . . . 2.6800000000000002 105.612 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.912 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -19.56 -173.59 0.0 OUTLIER Glycine 0 C--O 1.179 -3.308 0 C-N-CA 126.749 2.118 . . . . 1.6000000000000001 117.878 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.658 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 7.8 ttpp -40.98 -9.56 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 117.577 2.436 . . . . 4.2999999999999998 117.577 -157.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.658 ' HD1' ' HB3' ' A' ' 45' ' ' LYS . 4.8 p-90 -161.58 -7.05 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.287 0.949 . . . . 2.5099999999999998 113.342 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -95.39 165.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-O 123.014 1.388 . . . . 1.78 112.601 -158.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.686 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 6.5 p-10 -114.05 154.3 27.95 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 112.022 -2.353 . . . . 2.73 109.284 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.035 HD12 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -98.44 -32.24 11.59 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.774 -0.648 . . . . 1.1299999999999999 111.637 169.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -59.47 -23.38 62.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.369 -0.604 . . . . 1.71 109.369 -166.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.686 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 6.2 m -102.95 -27.69 12.47 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.621 -0.832 . . . . 1.76 113.023 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 11.4 mptt -80.78 -84.61 0.1 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.716 -0.674 . . . . 1.9099999999999999 111.584 -173.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 49' ' ' LEU . 24.7 t 21.68 95.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 126.068 2.105 . . . . 1.1499999999999999 113.966 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.93 -99.54 0.14 Allowed Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.132 -1.395 . . . . 0.69999999999999996 113.264 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -83.2 -53.57 5.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.321 0.489 . . . . 3.3599999999999999 112.321 -170.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.9 p80 -92.02 -33.83 14.67 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.235 -0.586 . . . . 1.78 111.432 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 1.004 HD22 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.39 106.24 14.35 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.112 -1.81 . . . . 1.72 106.112 174.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -101.35 116.72 33.43 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.949 -1.5 . . . . 0.96999999999999997 106.949 165.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.541 HD11 ' CB ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -97.88 92.96 6.08 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.216 -2.142 . . . . 1.0600000000000001 105.216 170.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.915 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.8 m170 -87.99 162.1 17.03 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.673 -1.149 . . . . 2.5899999999999999 109.912 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -142.13 115.71 9.09 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.214 -2.267 . . . . 0.92000000000000004 109.784 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.2 m -95.82 150.33 20.53 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.393 -2.185 . . . . 0.76000000000000001 109.038 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.74 100.61 5.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.517 1.151 . . . . 1.8 111.422 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.5 t70 -114.42 114.25 25.59 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.292 -1.776 . . . . 2.4199999999999999 108.819 174.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.63 -37.13 17.05 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.054 -0.975 . . . . 3.0800000000000001 112.133 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.07 68.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.43 0.633 . . . . 1.6899999999999999 110.113 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -104.12 -11.86 17.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.056 -0.974 . . . . 1.96 109.898 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.912 ' HE3' ' HA ' ' A' ' 31' ' ' ALA 0.295 0.2 OUTLIER 38.84 57.8 1.82 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 124.49 2.091 . . . . 3.7799999999999998 111.568 -166.528 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 t -122.91 115.31 45.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 112.373 -2.194 . . . . 1.1299999999999999 109.355 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 62' ' ' SER . 34.1 m-85 -91.25 105.96 18.16 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.898 -1.519 . . . . 1.95 106.898 167.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 25' ' ' SER . 32.7 tp -86.51 104.5 16.03 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.681 -1.145 . . . . 1.1799999999999999 108.522 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 80.5 m-85 -87.25 110.81 20.45 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.795 -1.557 . . . . 0.40000000000000002 106.795 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.915 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -114.3 125.59 54.06 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.148 -1.387 . . . . 1.3200000000000001 110.136 -176.585 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.69 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.6 mt -92.41 131.9 37.2 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 113.571 -1.65 . . . . 1.5900000000000001 108.437 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -119.88 97.43 5.62 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 104.491 -2.411 . . . . 2.0099999999999998 104.491 165.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.69 HG13 ' HB3' ' A' ' 74' ' ' LEU . 14.3 mt -123.47 99.85 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.624 1.202 . . . . 1.1899999999999999 108.871 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 25.0 p -99.04 166.69 11.15 Favored 'General case' 0 N--CA 1.395 -3.22 0 CA-C-O 122.891 1.329 . . . . 1.05 110.444 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 40.58 74.17 0.11 Allowed 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 110.361 -3.108 . . . . 2.1200000000000001 111.468 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.476 ' HB1' HD23 ' A' ' 104' ' ' LEU . . . -64.34 115.11 4.75 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.765 -2.016 . . . . 1.0900000000000001 108.701 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.773 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -67.42 159.62 76.7 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.708 -0.849 . . . . 1.77 108.708 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.669 ' HD3' HG13 ' A' ' 18' ' ' VAL . 68.5 Cg_endo -73.68 156.34 49.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 120.984 1.123 . . . . 1.3300000000000001 111.394 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.4 15.5 9.56 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.747 0.655 . . . . 1.6599999999999999 110.523 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.773 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -85.29 -8.28 58.59 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.791 -0.623 . . . . 1.24 109.621 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 23.2 m -10.98 84.9 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 126.042 2.089 . . . . 1.6799999999999999 111.974 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.912 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.76 118.34 3.59 Favored Glycine 0 N--CA 1.406 -3.333 0 CA-C-N 110.816 -2.902 . . . . 2.0 113.478 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.518 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -116.34 63.38 0.36 Allowed Glycine 0 C--N 1.266 -3.328 0 CA-C-N 112.545 -1.827 . . . . 0.81000000000000005 108.716 158.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 75.8 m-85 -73.02 106.78 5.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.204 -1.406 . . . . 1.0800000000000001 107.204 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 55.3 mtt-85 -118.3 105.36 11.67 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.242 -0.583 . . . . 3.6899999999999999 109.967 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.661 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -89.36 124.48 34.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.861 -0.608 . . . . 1.22 109.642 -177.06 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 36.9 tt0 -129.2 110.81 12.29 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.77 -1.104 . . . . 1.8100000000000001 109.244 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.2 p -99.97 139.95 20.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.429 0.633 . . . . 1.24 110.151 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -137.02 110.05 7.71 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.788 -1.097 . . . . 1.6399999999999999 108.329 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.737 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.1 m -129.86 167.41 18.18 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.925 -0.769 . . . . 1.26 108.925 -176.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.92 ' HZ2' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 6.75 -69.16 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.668 1.855 . . . . 0.93999999999999995 114.028 172.148 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 93' ' ' THR . 7.5 t70 -154.23 1.98 0.23 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.672 -0.695 . . . . 1.05 109.134 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.82 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -91.68 136.19 33.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 122.073 0.94 . . . . 1.78 108.812 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -132.52 134.02 44.48 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 112.683 -2.053 . . . . 1.0 111.592 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -157.0 148.07 21.89 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.813 -1.085 . . . . 1.6000000000000001 110.47 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.2 149.35 34.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.836 -0.62 . . . . 1.98 109.838 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.737 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 80.4 p -141.41 136.12 31.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.959 0.409 . . . . 1.02 110.386 176.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.476 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -107.53 130.09 54.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.799 -0.637 . . . . 1.5800000000000001 109.395 175.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.759 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -141.1 112.83 7.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.649 0.737 . . . . 1.1000000000000001 109.496 -177.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.785 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 61.5 m-20 -95.37 148.76 22.1 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.51 1.148 . . . . 2.1099999999999999 111.359 -167.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.777 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -119.31 108.78 15.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.052 -1.431 . . . . 1.0900000000000001 110.796 177.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.2 m -91.54 96.92 10.74 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.687 -0.856 . . . . 1.0700000000000001 108.687 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 8.0 p -86.88 120.76 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.096 1.427 . . . . 1.1399999999999999 109.782 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 96.7 m-70 -95.41 100.97 12.66 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 112.145 -2.298 . . . . 1.8200000000000001 108.987 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 18' ' ' VAL . 48.7 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 114.255 -1.339 . . . . 1.6699999999999999 110.743 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.516 ' HB2' HD11 ' A' ' 4' ' ' ILE . 15.2 m-20 . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 119.645 -0.216 . . . . 1.6499999999999999 110.623 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 41.77 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.076 2.517 . . . . 1.24 113.386 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.776 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -61.59 -50.01 82.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.696 0.76 . . . . 1.2 109.537 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.21 30.55 22.23 Favored Glycine 0 CA--C 1.497 -1.064 0 N-CA-C 109.176 -1.57 . . . . 0.44 109.176 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.974 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 10.6 tp -41.8 -54.41 3.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.981 -1.609 . . . . 1.1100000000000001 111.426 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.751 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -84.57 83.89 7.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.54 0.686 . . . . 0.97999999999999998 109.801 176.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.69 -45.37 66.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.66 -1.155 . . . . 1.1100000000000001 109.767 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.743 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 22.8 mmt -136.68 132.63 35.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.688 -0.687 . . . . 3.3100000000000001 110.027 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.736 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 88.0 mtt180 -90.98 121.82 67.47 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.052 -0.721 . . . . 4.1699999999999999 109.052 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.668 ' HG2' ' HE1' ' A' ' 102' ' ' PHE . 18.6 Cg_endo -62.21 156.75 48.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.858 2.372 . . . . 0.81999999999999995 110.856 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 11.1 tp60 -120.0 160.07 23.49 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 119.075 -0.488 . . . . 1.6299999999999999 112.185 -167.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.592 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -58.41 -144.77 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 123.053 1.406 . . . . 2.0600000000000001 112.611 176.126 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 151.38 135.31 2.29 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 113.404 -1.726 . . . . 0.34999999999999998 111.951 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 26.2 mt-10 -111.03 118.74 36.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.476 -0.935 . . . . 1.53 108.476 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.449 ' CG1' HD12 ' A' ' 22' ' ' ILE . 2.3 m -139.23 162.97 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.706 -1.22 . . . . 1.0800000000000001 107.706 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.745 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.19 158.11 15.75 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.142 -0.936 . . . . 1.22 109.489 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 107' ' ' HIS . 10.1 t -66.18 107.68 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 122.993 1.378 . . . . 1.3799999999999999 108.365 172.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 12.2 10.71 Favored Glycine 0 C--N 1.269 -3.159 0 CA-C-N 112.097 -2.32 . . . . 0.52000000000000002 112.833 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.35 -124.7 5.09 Favored Glycine 0 N--CA 1.418 -2.507 0 C-N-CA 119.314 -1.422 . . . . 0.44 110.09 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 71.2 m -154.49 171.0 20.09 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 113.271 -1.465 . . . . 1.23 109.19 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 104' ' ' LEU . 9.9 tp -149.11 149.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.337 0 CA-C-O 122.719 1.247 . . . . 1.0900000000000001 107.78 170.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -140.42 125.42 18.43 Favored 'General case' 0 C--N 1.261 -3.241 0 CA-C-N 113.669 -1.605 . . . . 1.05 110.454 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.502 ' HB2' HD22 ' A' ' 74' ' ' LEU . 22.1 m-85 -120.03 152.25 37.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.325 -1.307 . . . . 0.71999999999999997 108.049 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -139.54 129.6 25.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.787 -0.82 . . . . 0.87 108.787 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.668 ' HB1' ' CH2' ' A' ' 41' ' ' TRP . . . -133.2 122.18 23.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.803 -1.089 . . . . 1.1000000000000001 110.695 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.743 ' HD2' ' CG ' ' A' ' 9' ' ' MET . 60.4 mtt180 -107.93 122.64 47.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.665 -0.243 . . . . 2.9300000000000002 111.015 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 6.6 t -121.23 125.79 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.997 0.903 . . . . 1.0700000000000001 110.132 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -56.35 113.14 1.45 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.594 -1.639 . . . . 1.1200000000000001 112.575 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.76 -58.07 12.47 Favored Glycine 0 C--O 1.225 -0.422 0 CA-C-N 114.589 -1.187 . . . . 0.76000000000000001 111.334 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.705 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.48 -174.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.303 1.223 . . . . 1.0 114.303 167.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.6 t -110.09 25.68 11.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.001 -1.0 . . . . 2.1699999999999999 109.185 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.979 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -55.05 171.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.701 -1.136 . . . . 2.6299999999999999 112.889 177.154 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.1 tp -50.95 -54.91 20.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.669 -0.696 . . . . 1.99 110.415 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -147.87 155.5 44.35 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 108.212 -1.033 . . . . 1.8799999999999999 108.212 172.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -39.67 138.31 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.459 2.773 . . . . 1.1200000000000001 112.681 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.979 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.9 Cg_exo -55.54 139.28 82.38 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.939 1.759 . . . . 0.81999999999999995 112.312 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 2.2 t -98.47 104.76 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 105.904 -1.888 . . . . 1.4299999999999999 105.904 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -112.26 113.57 44.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.195 -1.82 . . . . 1.0900000000000001 107.445 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.571 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.73 126.71 51.04 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 123.182 1.467 . . . . 2.1299999999999999 109.346 174.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.119 ' HB3' HD12 ' A' ' 49' ' ' LEU . 76.2 m95 -84.17 152.01 24.53 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.03 -2.35 . . . . 0.40999999999999998 110.957 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.6 t80 -130.04 136.46 49.41 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.747 -2.316 . . . . 0.80000000000000004 104.747 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 59.0 tttp -102.77 168.18 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.013 -2.218 . . . . 2.6800000000000002 105.013 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.991 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -9.5 -172.59 0.0 OUTLIER Glycine 0 C--O 1.183 -3.074 0 N-CA-C 119.808 2.683 . . . . 1.6000000000000001 119.808 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.7 mtpp -45.82 -3.86 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 116.375 1.991 . . . . 4.2999999999999998 116.375 -165.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.481 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 7.5 p-90 -163.76 -6.77 0.03 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.323 1.231 . . . . 2.5099999999999998 114.323 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.34 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-O 123.41 1.576 . . . . 1.78 112.499 -162.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.1 t70 -113.84 154.12 28.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 111.585 -2.552 . . . . 2.73 105.548 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.119 HD12 ' HB3' ' A' ' 41' ' ' TRP . 2.2 mp -93.75 -37.91 11.56 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 118.362 0.528 . . . . 1.1299999999999999 112.095 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 t -58.94 -21.05 57.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.754 0.788 . . . . 1.71 108.88 -169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -84.34 -32.74 24.1 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.356 -1.293 . . . . 1.76 112.811 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.691 ' HB2' HD13 ' A' ' 57' ' ' LEU . 15.4 mmmt -104.5 -25.43 12.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.245 -0.889 . . . . 1.9099999999999999 111.323 -167.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.747 HG21 ' O ' ' A' ' 49' ' ' LEU . 43.4 t -43.12 89.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 113.365 -1.743 . . . . 1.1499999999999999 111.479 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.697 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.44 -113.84 0.5 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.209 -2.269 . . . . 0.69999999999999996 112.602 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.4 -30.85 18.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.195 0.497 . . . . 3.3599999999999999 112.022 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.548 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.8 p80 -90.23 -37.2 14.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.672 0.749 . . . . 1.78 111.017 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.897 HD21 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.36 106.35 9.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.317 -1.734 . . . . 1.72 106.317 174.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -95.81 115.46 27.46 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.606 -1.628 . . . . 0.96999999999999997 106.606 165.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -99.74 92.44 5.32 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 104.411 -2.441 . . . . 1.0600000000000001 104.411 170.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.597 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 63.7 m170 -81.74 161.9 23.14 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.627 -1.17 . . . . 2.5899999999999999 110.114 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -133.04 112.93 12.22 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 112.592 -2.094 . . . . 0.92000000000000004 108.711 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -93.9 148.82 21.78 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 112.982 -1.917 . . . . 0.76000000000000001 107.408 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -139.46 97.78 3.35 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.575 1.179 . . . . 1.8 110.926 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.65 120.54 39.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 112.846 -1.979 . . . . 2.4199999999999999 109.338 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.57 -34.94 27.58 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.573 -1.648 . . . . 3.0800000000000001 111.38 -176.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 1.6899999999999999 110.35 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.453 ' O ' HG22 ' A' ' 69' ' ' VAL . 18.9 t -94.52 -17.55 22.29 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.423 -0.808 . . . . 1.96 108.904 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 13.7 ttpt 62.05 37.25 14.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.024 -0.989 . . . . 3.7799999999999998 108.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 67' ' ' SER . 38.0 t -128.83 131.39 68.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.369 1.081 . . . . 1.1299999999999999 111.053 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -94.96 105.19 17.09 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 105.888 -1.893 . . . . 1.95 105.888 162.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.3 tp -96.55 105.24 17.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.479 1.133 . . . . 1.1799999999999999 108.855 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.7 m-85 -85.22 114.58 22.43 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.40000000000000002 107.846 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -107.06 119.86 40.52 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.587 -1.642 . . . . 1.3200000000000001 108.998 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.827 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.7 mm? -92.81 120.9 33.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.629 -1.169 . . . . 1.5900000000000001 107.919 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.67 95.61 5.33 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 104.593 -2.373 . . . . 2.0099999999999998 104.593 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.614 HG12 HD22 ' A' ' 57' ' ' LEU . 66.4 mt -120.63 100.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 114.491 -1.231 . . . . 1.1899999999999999 109.152 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 28.9 p -104.84 159.81 15.5 Favored 'General case' 0 N--CA 1.393 -3.32 0 CA-C-N 114.526 -1.216 . . . . 1.05 109.183 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.55 74.03 0.22 Allowed 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 111.611 -2.54 . . . . 2.1200000000000001 111.158 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.37 123.54 19.87 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.228 -1.805 . . . . 1.0900000000000001 111.327 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.845 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.8 OUTLIER -60.59 137.0 92.64 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.477 -0.783 . . . . 1.77 109.739 170.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.845 ' HD2' HE21 ' A' ' 80' ' ' GLN . 35.4 Cg_endo -65.0 -3.36 6.96 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.32 2.68 . . . . 1.3300000000000001 113.197 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -111.01 13.01 22.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.171 -0.468 . . . . 1.6599999999999999 111.102 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' THR . 2.3 m-30 -86.93 -37.32 17.72 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 118.502 -0.761 . . . . 1.24 111.002 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.652 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 88.8 m 12.04 73.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.497 0 O-C-N 125.195 1.559 . . . . 1.6799999999999999 110.647 -168.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.825 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -36.55 124.53 0.91 Allowed Glycine 0 N--CA 1.412 -2.926 0 CA-C-N 111.979 -2.373 . . . . 2.0 115.211 -163.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.991 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -123.59 68.56 0.47 Allowed Glycine 0 C--N 1.262 -3.54 0 CA-C-N 111.648 -2.276 . . . . 0.81000000000000005 108.23 158.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.723 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 74.1 m-85 -75.07 108.53 7.87 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.094 -1.053 . . . . 1.0800000000000001 108.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.545 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 25.0 mtp180 -109.33 106.88 16.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.724 -0.472 . . . . 3.6899999999999999 109.724 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -91.04 116.1 28.53 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.627 -0.509 . . . . 1.22 109.627 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 34.4 mt-10 -122.61 103.03 8.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.52 -0.764 . . . . 1.8100000000000001 109.144 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.664 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -95.01 143.64 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.077 0.465 . . . . 1.24 109.751 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 t -140.35 108.37 5.73 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.755 -0.832 . . . . 1.6399999999999999 108.755 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.565 HG21 ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.83 152.23 51.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 117.798 -1.096 . . . . 1.26 108.639 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.66 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.32 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 O-C-N 125.599 1.812 . . . . 0.93999999999999995 114.572 178.065 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.66 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 25.2 t70 -145.55 -11.67 0.52 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.432 -1.258 . . . . 1.05 110.009 -174.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.974 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.4 mttp -90.77 124.64 35.29 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.462 -0.94 . . . . 1.78 108.462 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -131.31 127.94 38.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.251 -1.34 . . . . 1.0 109.793 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.454 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 16.1 m-20 -143.12 139.5 30.43 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.098 -1.41 . . . . 1.6000000000000001 108.808 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.0 p -135.08 145.3 47.8 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.168 0.508 . . . . 1.98 109.791 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.751 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 91.5 p -131.9 126.5 34.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.49 -0.777 . . . . 1.02 110.462 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.09 119.05 36.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 1.5800000000000001 111.122 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.668 ' HE1' ' HG2' ' A' ' 11' ' ' PRO . 30.0 p90 -143.61 147.05 33.78 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.52 -0.548 . . . . 1.1000000000000001 109.52 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.79 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 11.4 p30 -104.04 151.81 22.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.635 1.207 . . . . 2.1099999999999999 112.022 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.624 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -116.06 99.35 7.19 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.472 -1.695 . . . . 1.0900000000000001 108.86 167.152 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.423 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 29.8 m -81.41 96.94 7.52 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.211 -1.033 . . . . 1.0700000000000001 108.211 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 80' ' ' GLN . 3.9 p -81.27 112.54 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 123.099 1.428 . . . . 1.1399999999999999 108.751 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 14.1 m-70 -77.49 97.9 5.15 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.441 -2.163 . . . . 1.8200000000000001 109.222 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.3 -1.544 0 CA-C-N 113.821 -1.536 . . . . 1.6699999999999999 110.296 173.287 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.5 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 16.7 m-20 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 108.651 -0.87 . . . . 1.6499999999999999 108.651 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 39.2 Cg_endo -69.74 81.28 0.82 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 121.652 1.568 . . . . 1.24 113.077 176.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.99 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.9 mp -109.18 -70.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.313 -0.858 . . . . 1.2 109.82 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.443 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 89.76 51.01 2.96 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.816 -1.714 . . . . 0.44 108.816 -172.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 6.0 tp -51.73 -40.26 59.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.209 -1.495 . . . . 1.1100000000000001 110.312 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.757 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.6 OUTLIER -86.2 85.17 7.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.307 -0.86 . . . . 0.97999999999999998 110.461 174.473 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.26 -42.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 1.1100000000000001 109.207 175.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.407 ' CB ' ' HD2' ' A' ' 27' ' ' ARG . 25.3 ttt -148.68 130.2 14.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.035 -0.984 . . . . 3.3100000000000001 108.35 173.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -105.25 129.31 24.97 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 116.007 -0.542 . . . . 4.1699999999999999 111.137 -174.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.628 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 13.7 Cg_endo -60.98 158.18 35.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.656 2.237 . . . . 0.81999999999999995 112.122 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.491 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.4 mm-40 -126.68 174.61 8.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 1.6299999999999999 111.37 -171.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 3.3 p-10 -69.72 -149.63 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.66 1.219 . . . . 2.0600000000000001 111.87 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 154.62 134.35 1.9 Allowed Glycine 0 C--N 1.298 -1.583 0 CA-C-N 113.703 -1.589 . . . . 0.34999999999999998 112.719 -174.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 6.1 mp0 -109.75 112.62 24.78 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.577 -1.312 . . . . 1.53 107.632 175.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.01 164.92 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 108.141 -1.059 . . . . 1.0800000000000001 108.141 -172.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 154.72 17.07 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.778 -1.101 . . . . 1.22 109.69 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 88.4 t -69.71 104.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 122.939 1.352 . . . . 1.3799999999999999 108.517 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.21 4.1 9.37 Favored Glycine 0 C--N 1.275 -2.836 0 CA-C-N 112.217 -2.265 . . . . 0.52000000000000002 112.816 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -120.17 3.12 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 108.901 -1.68 . . . . 0.44 108.901 171.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.2 p -151.59 174.05 13.91 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.102 -1.549 . . . . 1.23 110.368 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.441 HG22 ' HB ' ' A' ' 76' ' ' ILE . 9.0 tp -146.64 146.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 CA-C-N 113.213 -1.812 . . . . 1.0900000000000001 106.336 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.5 m -139.21 128.0 23.42 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 114.105 -1.407 . . . . 1.05 111.157 -172.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.745 ' HD2' HD13 ' A' ' 74' ' ' LEU . 34.3 m-85 -126.14 141.46 51.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.885 -1.507 . . . . 0.71999999999999997 109.726 177.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.469 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.91 118.81 20.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.805 0.812 . . . . 0.87 109.715 175.426 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.786 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -113.71 113.17 24.62 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.414 -1.266 . . . . 1.1000000000000001 109.203 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 99.3 mtt180 -102.66 117.8 35.45 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.952 -0.388 . . . . 2.9300000000000002 109.952 -176.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.9 t -115.33 125.39 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 122.348 1.07 . . . . 1.0700000000000001 110.307 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.75 107.69 0.55 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.92 -1.945 . . . . 1.1200000000000001 110.384 176.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.541 ' C ' ' HE3' ' A' ' 68' ' ' LYS . . . -51.53 -40.59 47.53 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.668 -1.151 . . . . 0.76000000000000001 111.775 173.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.584 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 42.77 -140.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.15 1.167 . . . . 1.0 114.15 172.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -134.54 132.31 38.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.398 -0.819 . . . . 2.1699999999999999 109.555 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.89 -174.31 4.87 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.142 -0.481 . . . . 2.6299999999999999 111.795 -173.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 tp -74.87 -51.98 12.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.029 -0.987 . . . . 1.99 108.838 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.7 151.16 59.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.311 -0.858 . . . . 1.8799999999999999 109.475 176.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.47 138.92 7.29 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.593 2.862 . . . . 1.1200000000000001 112.914 -176.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 2.3 Cg_endo -45.68 133.13 13.45 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 123.311 2.674 . . . . 0.81999999999999995 113.351 -177.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.35 105.29 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.697 -1.594 . . . . 1.4299999999999999 106.697 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.764 HG11 ' HB ' ' A' ' 91' ' ' VAL . 1.9 t -105.42 114.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 113.566 -1.652 . . . . 1.0900000000000001 107.344 178.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.81 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -97.58 122.41 40.62 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-O 123.248 1.499 . . . . 2.1299999999999999 109.294 173.846 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.995 ' HB3' HD11 ' A' ' 49' ' ' LEU . 63.4 m95 -88.32 153.15 21.43 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 111.769 -2.469 . . . . 0.40999999999999998 110.97 173.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 39.0 t80 -131.39 134.46 46.28 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 104.432 -2.432 . . . . 0.80000000000000004 104.432 173.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.79 ' HZ1' ' HB ' ' A' ' 47' ' ' VAL . 1.8 ttpm? -100.76 163.3 12.38 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.969 -1.863 . . . . 2.6800000000000002 105.969 -175.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -9.77 -165.02 0.0 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.938 2.335 . . . . 1.6000000000000001 118.938 -177.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.652 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 5.6 mtpp -44.28 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 O-C-N 119.541 -2.152 . . . . 4.2999999999999998 116.68 -166.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.616 ' CZ3' HG11 ' A' ' 47' ' ' VAL . 17.4 p-90 -165.58 -9.13 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.955 1.465 . . . . 2.5099999999999998 114.955 -177.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.79 ' HB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.0 167.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 CA-C-O 123.814 1.769 . . . . 1.78 113.215 -162.754 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.672 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 2.6 p-10 -109.67 155.9 20.91 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 110.994 -2.821 . . . . 2.73 107.164 174.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.995 HD11 ' HB3' ' A' ' 41' ' ' TRP . 4.9 mp -99.15 -36.81 9.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.014 0.746 . . . . 1.1299999999999999 113.014 168.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.7 t -57.84 -21.21 41.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.255 0.55 . . . . 1.71 109.811 -162.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.548 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 52.3 m -99.1 -21.48 16.15 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 115.476 -0.784 . . . . 1.76 112.842 -176.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.672 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 6.7 mmmt -100.34 -36.38 9.27 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.306 -0.861 . . . . 1.9099999999999999 111.184 -170.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.794 HG21 ' O ' ' A' ' 49' ' ' LEU . 74.0 t -31.63 94.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 113.373 -1.74 . . . . 1.1499999999999999 111.993 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -162.74 -122.85 0.63 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 111.864 -2.425 . . . . 0.69999999999999996 112.197 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.77 -47.1 79.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.748 1.018 . . . . 3.3599999999999999 113.748 -169.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.597 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.7 p80 -92.27 -35.33 13.83 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.256 0.55 . . . . 1.78 111.415 -174.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.56 105.27 11.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.564 -1.643 . . . . 1.72 106.564 175.358 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.23 115.57 27.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 106.844 -1.539 . . . . 0.96999999999999997 106.844 164.227 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.64 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -98.97 90.71 4.72 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 103.45 -2.796 . . . . 1.0600000000000001 103.45 167.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.611 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 29.9 t-80 -103.01 160.29 14.76 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.171 -1.377 . . . . 2.5899999999999999 108.972 -173.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -130.48 113.93 14.89 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 112.295 -2.229 . . . . 0.92000000000000004 110.393 -176.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -90.84 143.58 26.58 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 111.737 -2.483 . . . . 0.76000000000000001 107.136 171.3 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.539 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 2.0 t80 -140.84 98.88 3.48 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.082 0.944 . . . . 1.8 111.687 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -118.11 129.87 55.79 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.169 -1.378 . . . . 2.4199999999999999 109.887 170.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.492 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -88.93 -38.92 14.13 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.037 -1.438 . . . . 3.0800000000000001 112.616 -177.414 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.73 81.56 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.658 0.599 . . . . 1.6899999999999999 111.351 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.2 p -92.05 -17.38 25.11 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.28 -1.378 . . . . 1.96 107.28 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.661 ' HZ3' ' HH ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER 69.19 30.99 4.14 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.526 -1.67 . . . . 3.7799999999999998 109.712 171.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.9 t -122.93 123.9 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 122.159 0.98 . . . . 1.1299999999999999 109.991 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.661 ' HH ' ' HZ3' ' A' ' 68' ' ' LYS . 3.9 m-30 -104.13 105.81 16.09 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.926 -1.488 . . . . 1.95 107.035 170.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 25' ' ' SER . 29.5 tp -90.31 106.79 18.73 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.474 -1.239 . . . . 1.1799999999999999 109.525 -176.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.6 m-85 -87.77 112.04 22.0 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.342 -1.725 . . . . 0.40000000000000002 106.342 169.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 6.9 pt-20 -118.1 125.16 49.73 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.621 -1.627 . . . . 1.3200000000000001 110.131 -171.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.745 HD13 ' HD2' ' A' ' 24' ' ' PHE . 1.3 mt -89.98 124.99 35.21 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.485 -1.234 . . . . 1.5900000000000001 108.562 174.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -112.49 96.36 5.95 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 104.081 -2.563 . . . . 2.0099999999999998 104.081 166.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.719 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.1 mt -122.4 100.67 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 123.285 1.517 . . . . 1.1899999999999999 108.743 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 51.1 p -112.54 157.1 21.56 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-N 113.456 -1.702 . . . . 1.05 109.29 -172.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.12 39.71 5.42 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.89 -2.414 . . . . 2.1200000000000001 108.798 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -44.28 120.86 2.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 111.997 -2.365 . . . . 1.0900000000000001 110.388 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -87.59 156.66 53.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.33 -0.989 . . . . 1.77 108.33 -177.867 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.805 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 50.4 Cg_endo -69.27 -3.48 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 121.296 1.331 . . . . 1.3300000000000001 113.139 -170.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.54 7.57 44.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.112 -0.494 . . . . 1.6599999999999999 110.212 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.702 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -92.78 -20.55 20.63 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.173 -0.467 . . . . 1.24 111.002 -176.357 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 45.2 m -49.03 103.22 0.04 OUTLIER 'General case' 0 CA--C 1.473 -2.014 0 CA-C-O 122.509 1.147 . . . . 1.6799999999999999 108.552 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.652 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -174.64 -130.71 1.32 Allowed Glycine 0 C--N 1.265 -3.371 0 CA-C-N 112.364 -2.198 . . . . 2.0 112.964 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.52 118.23 0.86 Allowed Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.244 -0.979 . . . . 0.81000000000000005 112.157 -172.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.761 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.4 m-85 -87.12 124.34 33.15 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.078 -1.453 . . . . 1.0800000000000001 107.078 175.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 44.1 mtp180 -122.42 124.43 43.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.422 0.555 . . . . 3.6899999999999999 111.698 -175.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.493 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 4.0 m -97.0 131.09 44.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 1.22 109.856 176.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.81 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.0 mt-10 -132.14 103.34 6.2 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.685 -0.857 . . . . 1.8100000000000001 108.685 170.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.764 ' HB ' HG11 ' A' ' 39' ' ' VAL . 4.3 p -93.17 138.24 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.561 0.696 . . . . 1.24 110.089 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.1 m -132.59 107.81 8.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.701 -1.136 . . . . 1.6399999999999999 108.903 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.601 ' OG1' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -132.08 157.97 42.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 117.669 -1.158 . . . . 1.26 108.51 -179.648 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.691 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 20.13 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 125.574 1.797 . . . . 0.93999999999999995 114.276 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.691 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -146.92 -3.52 0.58 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.989 -1.005 . . . . 1.05 110.001 -177.479 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.99 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 4.9 mmmt -96.29 133.65 40.38 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.88 0.848 . . . . 1.78 109.56 -175.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.69 131.27 44.74 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.497 -1.683 . . . . 1.0 110.892 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB3' ' CG ' ' A' ' 7' ' ' PHE . 28.8 m-20 -144.85 140.83 28.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.428 -1.26 . . . . 1.6000000000000001 108.702 176.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.7 p -138.3 154.06 49.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.254 0.55 . . . . 1.98 111.118 -176.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.757 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 36.2 t -136.12 149.35 48.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.205 1.002 . . . . 1.02 111.246 177.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.42 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -134.31 109.72 9.01 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.322 -1.763 . . . . 1.5800000000000001 109.466 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.699 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 29.4 p90 -140.81 132.55 27.35 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.217 -0.66 . . . . 1.1000000000000001 109.217 -174.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.521 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 2.1 p-10 -102.42 153.15 20.31 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 122.39 1.091 . . . . 2.1099999999999999 111.317 -171.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.666 ' CD2' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -121.33 120.78 36.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.427 -1.261 . . . . 1.0900000000000001 108.526 172.716 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.476 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 5.9 m -100.16 96.11 7.27 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.749 -0.834 . . . . 1.0700000000000001 108.749 174.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 80' ' ' GLN . 9.5 p -84.27 116.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 123.485 1.612 . . . . 1.1399999999999999 109.339 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -91.39 100.29 13.1 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 112.504 -2.134 . . . . 1.8200000000000001 109.976 -175.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.805 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 9.9 tt0 . . . . . 0 C--N 1.303 -1.428 0 CA-C-N 114.923 -1.035 . . . . 1.6699999999999999 109.556 170.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.511 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-20 . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 109.822 -0.436 . . . . 1.6499999999999999 109.822 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 73.5 Cg_endo -77.21 59.48 6.61 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 121.852 1.701 . . . . 1.24 112.862 177.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.921 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -75.15 -63.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.228 -0.896 . . . . 1.2 109.457 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.61 41.29 5.75 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 107.812 -2.115 . . . . 0.44 107.812 -175.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.647 ' N ' HG21 ' A' ' 4' ' ' ILE . 8.4 tp -49.25 -46.37 46.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.573 -1.814 . . . . 1.1100000000000001 110.643 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.678 ' HD2' ' HE ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -88.65 84.91 6.72 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.827 0.822 . . . . 0.97999999999999998 109.863 171.806 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.37 -37.82 79.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.24 -1.345 . . . . 1.1100000000000001 109.285 178.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 tpp -148.65 132.92 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.837 -1.074 . . . . 3.3100000000000001 108.307 171.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.678 ' HE ' ' HD2' ' A' ' 7' ' ' PHE . 38.1 mtt180 -96.24 130.81 30.03 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.886 0.374 . . . . 4.1699999999999999 110.873 -174.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.457 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 13.9 Cg_endo -60.22 153.26 60.38 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.093 2.528 . . . . 0.81999999999999995 111.794 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.473 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.1 mm-40 -124.67 170.19 11.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.01 -0.541 . . . . 1.6299999999999999 111.999 -172.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.1 p-10 -70.83 -145.75 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.321 0 C-N-CA 124.673 1.189 . . . . 2.0600000000000001 113.076 -175.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.76 133.1 1.58 Allowed Glycine 0 C--N 1.307 -1.06 0 CA-C-N 113.708 -1.587 . . . . 0.34999999999999998 114.015 -176.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 1.7 mp0 -106.47 111.36 23.9 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.689 -1.256 . . . . 1.53 109.083 175.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.438 HG12 ' HB ' ' A' ' 22' ' ' ILE . 1.9 m -137.43 163.04 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.155 -1.054 . . . . 1.0800000000000001 108.155 -174.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.13 156.26 16.39 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.78 -1.1 . . . . 1.22 109.677 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.845 HG23 ' HB3' ' A' ' 81' ' ' PRO . 24.9 t -69.93 107.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-O 123.056 1.407 . . . . 1.3799999999999999 109.171 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.65 -0.6 15.67 Favored Glycine 0 C--N 1.266 -3.359 0 CA-C-N 111.957 -2.383 . . . . 0.52000000000000002 112.221 176.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 -126.14 3.76 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 109.101 -1.6 . . . . 0.44 109.101 172.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 9.3 p -151.68 167.9 26.7 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-N 112.985 -1.608 . . . . 1.23 111.042 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD11 ' A' ' 104' ' ' LEU . 7.8 tp -146.11 147.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 113.291 -1.777 . . . . 1.0900000000000001 108.42 170.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 m -139.88 130.6 25.87 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 113.239 -1.8 . . . . 1.05 110.399 -175.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.601 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -128.58 160.49 32.23 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.921 -1.036 . . . . 0.71999999999999997 108.753 169.8 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.73 129.27 22.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.968 -1.015 . . . . 0.87 108.866 178.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.656 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -125.61 127.59 46.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.736 -0.666 . . . . 1.1000000000000001 111.138 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -108.64 121.32 44.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.06 -0.518 . . . . 2.9300000000000002 110.557 -177.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 14.6 t -123.44 127.94 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.258 1.028 . . . . 1.0700000000000001 110.508 -176.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.509 ' HB3' ' CE ' ' A' ' 68' ' ' LYS . . . -61.18 110.21 1.33 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.113 -1.858 . . . . 1.1200000000000001 113.212 -177.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' HD22 ' A' ' 33' ' ' LEU . . . -54.36 -48.57 63.86 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 114.587 -1.188 . . . . 0.76000000000000001 112.184 171.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.74 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 56.74 -170.23 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.734 0.814 . . . . 1.0 112.87 173.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -114.11 35.7 4.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.243 1.021 . . . . 2.1699999999999999 108.459 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.009 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.18 172.97 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.015 -1.448 . . . . 2.6299999999999999 113.358 177.394 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.75 -49.62 76.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.343 0.592 . . . . 1.99 110.307 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.662 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -144.8 150.09 45.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.041 -1.096 . . . . 1.8799999999999999 108.041 174.057 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.91 142.14 5.49 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.416 2.744 . . . . 1.1200000000000001 111.588 -177.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.009 ' HD3' HD11 ' A' ' 33' ' ' LEU . 6.4 Cg_exo -54.54 137.45 73.0 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.138 1.225 . . . . 0.81999999999999995 112.836 -174.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 35' ' ' LYS . 3.6 t -99.13 104.68 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 105.708 -1.96 . . . . 1.4299999999999999 105.708 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.671 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -111.54 113.57 44.61 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.596 -1.638 . . . . 1.0900000000000001 107.594 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.548 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -103.95 130.99 51.62 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 123.389 1.566 . . . . 2.1299999999999999 109.751 173.173 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.031 ' HB3' HD11 ' A' ' 49' ' ' LEU . 81.9 m95 -91.23 157.25 17.27 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.859 -2.428 . . . . 0.40999999999999998 111.259 173.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 27.1 t80 -131.47 130.71 42.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.564 -2.013 . . . . 0.80000000000000004 105.564 175.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.669 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 31.7 ttpt -109.05 104.83 14.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.25 -1.759 . . . . 2.6800000000000002 106.25 -176.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.26 91.65 1.67 Allowed Glycine 0 CA--C 1.481 -2.044 0 C-N-CA 115.906 -3.045 . . . . 1.6000000000000001 114.112 -164.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 1.003 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -105.04 -27.44 11.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 104.104 -2.554 . . . . 4.2999999999999998 104.104 139.549 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 1.003 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 27.5 p-90 160.2 -20.19 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.078 -2.328 . . . . 2.5099999999999998 111.529 -165.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.53 169.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 123.046 1.403 . . . . 1.78 112.539 -163.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.3 t70 -113.11 133.89 54.8 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 111.617 -2.538 . . . . 2.73 107.04 175.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.031 HD11 ' HB3' ' A' ' 41' ' ' TRP . 4.8 mp -69.85 -35.3 74.62 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 119.169 -0.443 . . . . 1.1299999999999999 111.869 -175.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 m -58.27 -20.01 39.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.543 0.687 . . . . 1.71 109.817 -167.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 m -98.4 -18.86 18.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.973 -1.012 . . . . 1.76 112.424 -176.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.42 -70.27 0.74 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.876 -0.602 . . . . 1.9099999999999999 111.118 -176.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 49' ' ' LEU . 70.5 t 16.6 91.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.23 1.812 . . . . 1.1499999999999999 113.965 175.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -151.4 -138.5 2.82 Favored Glycine 0 C--N 1.319 -0.397 0 CA-C-N 114.174 -1.375 . . . . 0.69999999999999996 113.488 -174.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -64.18 -42.83 96.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.382 0.882 . . . . 3.3599999999999999 113.382 -169.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.485 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 4.8 p80 -86.97 -37.97 17.06 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 119.64 -0.824 . . . . 1.78 111.702 -175.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.918 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.39 108.76 13.07 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.289 -1.004 . . . . 1.72 108.289 170.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -96.34 115.69 27.84 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 105.834 -1.913 . . . . 0.96999999999999997 105.834 168.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.693 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -95.09 92.28 6.74 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 104.353 -2.462 . . . . 1.0600000000000001 104.353 170.357 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.624 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 4.0 m170 -88.24 164.2 15.74 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 113.748 -1.569 . . . . 2.5899999999999999 111.003 -178.187 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -134.29 113.38 11.89 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 111.716 -2.493 . . . . 0.92000000000000004 109.937 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.8 m -99.14 149.34 23.16 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.597 -2.092 . . . . 0.76000000000000001 107.891 174.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -145.58 99.38 3.28 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.097 0.951 . . . . 1.8 112.362 -171.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.88 106.43 14.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.837 -1.528 . . . . 2.4199999999999999 110.374 169.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.04 -27.68 65.87 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.556 -1.202 . . . . 3.0800000000000001 110.504 179.065 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.18 73.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.216 -0.902 . . . . 1.6899999999999999 110.746 175.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -91.65 -18.24 24.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.6 -0.727 . . . . 1.96 109.287 175.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.74 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 10.3 ttpt 66.62 33.82 6.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.665 -1.152 . . . . 3.7799999999999998 109.699 -177.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.84 133.52 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.166 0.984 . . . . 1.1299999999999999 110.766 -176.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 62' ' ' SER . 36.7 m-85 -97.65 108.07 20.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.532 -1.655 . . . . 1.95 106.532 161.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 15.0 tp -95.18 104.7 16.59 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.508 1.147 . . . . 1.1799999999999999 109.011 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.624 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.7 m-85 -86.2 114.47 23.06 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.331 -1.759 . . . . 0.40000000000000002 108.606 175.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.47 127.71 46.74 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.374 -1.739 . . . . 1.3200000000000001 109.007 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.837 HD23 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -99.38 116.65 32.03 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.206 -1.405 . . . . 1.5900000000000001 107.206 171.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.754 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 14.5 m80 -114.63 94.41 4.76 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 104.953 -2.24 . . . . 2.0099999999999998 104.953 167.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.807 HG12 ' HB2' ' A' ' 57' ' ' LEU . 47.5 mt -118.13 99.15 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 123.18 1.466 . . . . 1.1899999999999999 110.055 -173.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.7 p -106.71 163.89 12.54 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.022 -1.444 . . . . 1.05 108.121 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 68.86 38.91 1.99 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.804 -1.998 . . . . 2.1200000000000001 110.215 170.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.09 118.06 2.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.207 -1.815 . . . . 1.0900000000000001 112.024 -178.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.648 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -57.82 140.97 80.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.818 -1.083 . . . . 1.77 109.758 172.014 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.845 ' HB3' HG23 ' A' ' 18' ' ' VAL . 36.4 Cg_endo -67.89 5.02 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.707 2.271 . . . . 1.3300000000000001 113.42 -177.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.477 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.99 -3.83 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.473 -0.33 . . . . 1.6599999999999999 110.324 173.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.896 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -75.66 4.45 7.75 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.798 -0.62 . . . . 1.24 109.368 -172.046 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 29.5 m -23.02 90.07 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 125.696 1.873 . . . . 1.6799999999999999 111.325 177.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.76 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -39.79 110.2 0.16 Allowed Glycine 0 CA--C 1.466 -3.029 0 CA-C-N 109.703 -3.408 . . . . 2.0 113.902 -169.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.88 62.78 0.55 Allowed Glycine 0 C--N 1.262 -3.567 0 CA-C-N 111.718 -2.241 . . . . 0.81000000000000005 107.895 160.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.669 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 73.9 m-85 -81.43 109.79 16.24 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.251 -1.388 . . . . 1.0800000000000001 107.251 -177.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.468 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 24.4 ttm180 -109.91 110.03 20.86 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.069 -0.715 . . . . 3.6899999999999999 109.069 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.537 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.3 t -91.33 125.1 35.98 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.658 -0.867 . . . . 1.22 108.658 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 38.8 tt0 -134.03 103.88 6.0 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.309 -0.86 . . . . 1.8100000000000001 109.755 -172.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.671 ' HB ' HG12 ' A' ' 39' ' ' VAL . 2.7 p -100.58 143.63 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 1.24 110.343 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -139.87 108.84 6.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.341 -0.845 . . . . 1.6399999999999999 108.812 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.56 HG22 ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.96 146.85 52.15 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-O 117.775 -1.107 . . . . 1.26 109.851 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.796 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.41 -73.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.679 1.862 . . . . 0.93999999999999995 114.28 -177.275 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.796 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 10.7 t70 -151.78 -2.03 0.3 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.904 -1.044 . . . . 1.05 110.28 -175.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.921 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmmt -93.45 133.84 36.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.117 0.961 . . . . 1.78 108.849 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -130.35 129.94 43.79 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.467 -1.697 . . . . 1.0 110.16 -176.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 4.4 m-20 -146.97 142.17 27.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.166 -1.379 . . . . 1.6000000000000001 109.099 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.464 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 58.3 m -144.94 148.28 33.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.604 -0.726 . . . . 1.98 110.154 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 89' ' ' CYS . 2.9 p -128.23 148.07 50.61 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.532 -0.758 . . . . 1.02 111.567 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.79 112.37 14.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.557 -1.201 . . . . 1.5800000000000001 109.58 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.761 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 7.0 p90 -141.7 131.4 24.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.6 0.714 . . . . 1.1000000000000001 109.568 -175.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.74 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 5.7 p30 -105.64 138.49 41.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.532 1.158 . . . . 2.1099999999999999 112.976 -168.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.76 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.22 103.94 13.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.667 -1.606 . . . . 1.0900000000000001 109.501 173.367 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.479 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 11.9 m -86.23 95.41 9.59 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.175 -1.01 . . . . 1.0700000000000001 108.333 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 18' ' ' VAL . 8.3 p -82.74 112.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.27 1.509 . . . . 1.1399999999999999 108.706 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 97.5 m-70 -85.76 99.15 11.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.276 -2.238 . . . . 1.8200000000000001 109.724 -173.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 114.129 -1.396 . . . . 1.6699999999999999 110.131 172.792 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.629 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 14.2 m-20 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 119.859 -0.115 . . . . 1.6499999999999999 110.844 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 55.8 Cg_endo -70.2 68.07 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.933 2.422 . . . . 1.24 112.56 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.955 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -91.59 -55.39 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 114.797 -1.092 . . . . 1.2 108.927 173.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.546 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 84.27 48.9 4.9 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.53 -2.228 . . . . 0.44 107.53 -176.492 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.919 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.0 tp -51.24 -44.9 61.83 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 112.553 -1.823 . . . . 1.1100000000000001 109.241 -173.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.507 ' CE2' ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -82.62 83.31 7.66 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.663 -1.153 . . . . 0.97999999999999998 109.544 170.874 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.98 -27.61 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.756 -1.111 . . . . 1.1100000000000001 108.978 176.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.8 tpt -163.51 148.8 11.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.09 -1.414 . . . . 3.3100000000000001 107.246 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -115.36 144.08 31.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.192 -0.603 . . . . 4.1699999999999999 111.059 177.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.755 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -76.44 170.46 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.132 2.554 . . . . 0.81999999999999995 112.451 -178.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -131.0 166.19 21.56 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.682 -0.69 . . . . 1.6299999999999999 110.977 -171.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.61 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -65.5 -141.13 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.566 1.174 . . . . 2.0600000000000001 111.982 -179.308 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.19 139.8 3.17 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.125 -1.398 . . . . 0.34999999999999998 111.934 -175.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.9 mt-10 -116.66 118.08 31.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.813 -0.693 . . . . 1.53 109.263 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -139.29 164.77 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 107.825 -1.176 . . . . 1.0800000000000001 107.825 -173.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.79 157.45 17.39 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.237 -0.892 . . . . 1.22 109.753 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 106' ' ' VAL . 16.7 t -68.66 106.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 CA-C-O 122.677 1.227 . . . . 1.3799999999999999 108.116 172.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.16 3.85 10.42 Favored Glycine 0 C--N 1.27 -3.11 0 CA-C-N 112.276 -2.238 . . . . 0.52000000000000002 113.554 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.85 -123.83 4.32 Favored Glycine 0 N--CA 1.422 -2.252 0 C-N-CA 119.235 -1.46 . . . . 0.44 111.252 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.1 p -150.88 166.99 28.88 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 112.826 -1.687 . . . . 1.23 110.934 178.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.554 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -149.41 150.74 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.023 -1.899 . . . . 1.0900000000000001 107.638 171.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.0 m -138.22 129.51 27.48 Favored 'General case' 0 C--N 1.265 -3.096 0 CA-C-N 113.721 -1.581 . . . . 1.05 110.876 -176.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.7 m-85 -128.11 155.43 44.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.278 -1.328 . . . . 0.71999999999999997 109.88 176.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.604 ' HB3' HD12 ' A' ' 71' ' ' LEU . 1.2 m -140.93 131.81 25.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.287 -0.869 . . . . 0.87 109.287 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.853 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -129.32 115.22 17.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 1.1000000000000001 110.943 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.653 ' HE ' HG11 ' A' ' 69' ' ' VAL . 18.9 mtp180 -100.6 126.32 47.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.535 -0.302 . . . . 2.9300000000000002 110.851 -177.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.5 t -127.9 129.44 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 122.057 0.932 . . . . 1.0700000000000001 110.687 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.79 108.27 2.07 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.344 -1.753 . . . . 1.1200000000000001 111.113 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -50.88 22.84 Favored Glycine 0 C--O 1.226 -0.391 0 CA-C-N 115.287 -0.87 . . . . 0.76000000000000001 111.105 172.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.952 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . . . 61.64 -100.52 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.772 1.027 . . . . 1.0 113.772 167.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.421 ' H ' ' HB1' ' A' ' 31' ' ' ALA . 4.4 p -146.39 -109.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 2.1699999999999999 110.205 -174.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.06 HD22 ' HA ' ' A' ' 93' ' ' THR . 4.4 tp 63.74 156.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.576 -0.528 . . . . 2.6299999999999999 109.576 -175.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.878 ' H ' HD13 ' A' ' 33' ' ' LEU . 21.4 tp -53.39 -27.32 23.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.129 0.966 . . . . 1.99 110.546 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.766 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.83 177.15 2.08 Favored Pre-proline 0 C--O 1.211 -0.973 0 CA-C-N 113.549 -1.66 . . . . 1.8799999999999999 106.803 178.143 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.5 Cg_exo -65.24 154.37 73.88 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.495 1.464 . . . . 1.1200000000000001 109.521 174.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.581 ' HG3' ' CG2' ' A' ' 93' ' ' THR . 67.2 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 121.569 1.513 . . . . 0.81999999999999995 113.401 -175.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.58 HG22 ' HE2' ' A' ' 35' ' ' LYS . 2.0 t -100.01 103.89 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 106.489 -1.671 . . . . 1.4299999999999999 106.489 175.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.8 t -106.71 115.25 47.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.013 -1.449 . . . . 1.0900000000000001 107.683 176.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.07 131.5 55.01 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 122.874 1.321 . . . . 2.1299999999999999 109.615 175.989 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.053 ' HB3' HD13 ' A' ' 49' ' ' LEU . 72.0 m95 -92.48 156.83 16.91 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.425 -2.171 . . . . 0.40999999999999998 112.326 174.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.704 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 37.3 t80 -129.28 133.14 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.303 -2.11 . . . . 0.80000000000000004 105.303 173.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.79 ' HZ1' ' HB3' ' A' ' 43' ' ' LYS . 3.6 ttpm? -109.66 107.51 17.58 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.336 -1.357 . . . . 2.6800000000000002 107.336 -177.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.32 91.91 1.63 Allowed Glycine 0 CA--C 1.487 -1.688 0 C-N-CA 115.982 -3.009 . . . . 1.6000000000000001 114.562 -165.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.915 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 71.2 tttt -108.86 -24.79 11.1 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.034 -2.21 . . . . 4.2999999999999998 105.034 135.216 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.915 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 25.7 p-90 159.97 -20.14 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 CA-C-N 112.677 -2.056 . . . . 2.5099999999999998 111.763 -164.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.489 ' HB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.34 174.11 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.461 1.6 . . . . 1.78 113.331 -163.264 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.3 t70 -109.49 155.04 21.83 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 111.208 -2.724 . . . . 2.73 105.763 173.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.053 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -89.77 -38.67 13.64 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.905 0.706 . . . . 1.1299999999999999 112.905 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 t -59.58 -19.76 50.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.894 0.854 . . . . 1.71 108.936 -166.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 p -87.58 -33.11 19.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.536 -1.211 . . . . 1.76 111.317 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.704 ' HG3' ' HZ3' ' A' ' 43' ' ' LYS . 5.5 mmmt -93.79 -70.37 0.71 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.266 -1.333 . . . . 1.9099999999999999 111.616 -175.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 49' ' ' LEU . 53.4 t 11.1 92.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.566 1.946 . . . . 1.1499999999999999 113.489 177.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.596 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -146.67 -118.04 1.07 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.841 -1.527 . . . . 0.69999999999999996 113.357 -177.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -86.12 -32.67 21.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.082 0.771 . . . . 3.3599999999999999 113.082 -167.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -93.54 -36.69 12.29 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.026 -0.669 . . . . 1.78 110.257 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.879 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.95 105.28 11.31 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.809 -1.552 . . . . 1.72 106.809 175.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -98.77 115.53 28.98 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 105.763 -1.94 . . . . 0.96999999999999997 105.763 165.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.636 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -98.51 92.03 5.44 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 103.547 -2.76 . . . . 1.0600000000000001 103.547 169.171 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.647 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 83.0 t60 -99.66 162.43 13.01 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 113.943 -1.48 . . . . 2.5899999999999999 108.694 -173.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.47 124.25 29.79 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 112.464 -2.153 . . . . 0.92000000000000004 110.949 -177.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.669 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.2 m -93.62 148.52 22.03 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 111.08 -2.782 . . . . 0.76000000000000001 106.685 169.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -138.16 98.09 3.54 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.705 1.241 . . . . 1.8 111.365 -168.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 8.4 m-20 -113.98 100.32 8.32 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 112.856 -1.975 . . . . 2.4199999999999999 108.743 172.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -37.41 36.27 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.644 -0.707 . . . . 3.0800000000000001 110.337 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.68 -22.2 60.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.004 -0.998 . . . . 1.6899999999999999 110.448 179.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 47.5 m -101.69 -9.84 20.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.494 -0.776 . . . . 1.96 109.592 175.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.952 ' HE3' ' HA ' ' A' ' 31' ' ' ALA . 74.5 tttt 67.18 29.84 7.55 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.114 -0.948 . . . . 3.7799999999999998 110.53 173.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.653 HG11 ' HE ' ' A' ' 27' ' ' ARG . 2.7 t -127.98 121.95 57.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.014 0.911 . . . . 1.1299999999999999 110.588 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -100.53 107.02 18.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.396 -1.705 . . . . 1.95 106.396 167.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.5 tp -95.15 104.73 16.62 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.3 1.048 . . . . 1.1799999999999999 109.049 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.647 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.8 m-85 -85.36 113.96 22.06 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.939 -1.482 . . . . 0.40000000000000002 108.277 174.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 19.4 mt-10 -106.8 124.41 49.58 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 113.3 -1.773 . . . . 1.3200000000000001 108.976 -176.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.824 HD23 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -90.69 118.18 29.92 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.995 -1.113 . . . . 1.5900000000000001 107.995 173.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -112.14 94.33 4.88 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 103.587 -2.746 . . . . 2.0099999999999998 103.587 169.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 52.3 mt -123.54 101.07 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.22 1.486 . . . . 1.1899999999999999 110.263 -175.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 74.8 p -106.02 144.88 32.12 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 113.002 -1.908 . . . . 1.05 107.917 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 70.96 77.61 0.18 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.914 -2.403 . . . . 2.1200000000000001 109.766 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -78.24 110.87 13.63 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.779 -2.464 . . . . 1.0900000000000001 108.24 174.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.594 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -69.58 165.07 44.41 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.418 -0.956 . . . . 1.77 108.418 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HG3' HG23 ' A' ' 18' ' ' VAL . 3.8 Cg_exo -72.41 152.28 54.69 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 120.819 1.013 . . . . 1.3300000000000001 111.124 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . 66.98 5.26 3.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.855 -0.612 . . . . 1.6599999999999999 111.358 -177.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -84.42 1.49 45.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.69 -0.856 . . . . 1.24 108.69 -178.773 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 49.2 m -10.02 82.14 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.981 0 O-C-N 126.292 2.245 . . . . 1.6799999999999999 111.316 171.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.886 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -65.71 73.94 0.11 Allowed Glycine 0 CA--C 1.473 -2.576 0 CA-C-N 111.555 -2.566 . . . . 2.0 114.002 -160.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -84.54 74.1 2.55 Favored Glycine 0 C--N 1.276 -2.787 0 N-CA-C 108.477 -1.849 . . . . 0.81000000000000005 108.477 172.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.782 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 49.2 m-85 -80.86 121.9 26.54 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.57 -1.315 . . . . 1.0800000000000001 107.694 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.79 109.82 19.54 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.645 -0.502 . . . . 3.6899999999999999 109.645 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.643 ' SG ' ' HE2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -91.6 108.35 19.84 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.537 -0.542 . . . . 1.22 109.537 -179.623 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.669 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 37.3 mt-10 -118.71 103.79 9.99 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.756 -0.656 . . . . 1.8100000000000001 109.486 -176.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -99.24 143.01 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.308 0.575 . . . . 1.24 110.868 -177.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -133.19 109.26 9.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.017 -1.105 . . . . 1.6399999999999999 108.017 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.06 ' HA ' HD22 ' A' ' 33' ' ' LEU . 1.3 m -130.28 164.21 25.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 118.331 -0.842 . . . . 1.26 109.067 -177.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.824 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 7.94 -71.23 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.567 1.792 . . . . 0.93999999999999995 113.392 173.516 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.689 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 28.6 t70 -147.8 -1.68 0.58 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.739 -1.119 . . . . 1.05 110.136 177.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.955 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.9 OUTLIER -92.84 129.25 38.82 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.478 -1.305 . . . . 1.78 107.478 -177.543 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.46 130.58 40.71 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.023 -0.989 . . . . 1.0 110.14 175.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -142.48 147.9 36.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.448 -1.251 . . . . 1.6000000000000001 109.031 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 6.8 p -144.48 141.88 29.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.343 0.592 . . . . 1.98 111.025 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.525 ' HB3' ' SG ' ' A' ' 89' ' ' CYS . 24.2 t -118.26 148.94 41.92 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.24 -0.891 . . . . 1.02 111.093 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 112.82 11.28 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.803 -1.544 . . . . 1.5800000000000001 110.053 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.782 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 40.0 p90 -142.21 140.91 32.47 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 1.1000000000000001 108.762 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.61 ' O ' ' HB3' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -117.39 134.44 54.82 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.497 1.141 . . . . 2.1099999999999999 113.555 -174.355 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.886 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -95.6 109.45 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.365 -1.743 . . . . 1.0900000000000001 109.6 177.422 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -86.85 96.54 10.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.272 -0.64 . . . . 1.0700000000000001 109.272 -178.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 18' ' ' VAL . 6.8 p -83.03 113.78 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.932 1.348 . . . . 1.1399999999999999 109.522 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -90.98 100.5 13.35 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 112.747 -2.024 . . . . 1.8200000000000001 109.549 -176.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.024 -0.989 . . . . 1.6699999999999999 110.566 172.295 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.621 ' HB2' ' HZ2' ' A' ' 94' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 109.871 -0.418 . . . . 1.6499999999999999 109.871 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.4 81.9 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.607 2.205 . . . . 1.24 112.365 172.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.952 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -108.11 -69.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 1.2 109.214 174.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.531 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 94.72 45.5 3.15 Favored Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 108.301 -1.92 . . . . 0.44 108.301 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 96' ' ' LYS . 13.3 tp -53.1 -46.13 68.55 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 112.175 -2.012 . . . . 1.1100000000000001 111.623 -169.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.762 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -89.4 84.3 6.43 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.073 -0.967 . . . . 0.97999999999999998 109.893 -176.195 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.4 t -72.42 -48.48 47.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.662 -1.153 . . . . 1.1100000000000001 110.029 -178.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.758 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 88.9 mmm -132.87 134.58 44.79 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 115.263 -0.881 . . . . 3.3100000000000001 109.766 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.762 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 22.1 mtt-85 -99.28 124.23 45.69 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 109.301 -0.629 . . . . 4.1699999999999999 109.301 174.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 17.6 Cg_endo -60.68 145.83 98.24 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.393 2.062 . . . . 0.81999999999999995 109.606 174.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.501 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 17.9 mm-40 -121.43 170.79 9.29 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 112.286 0.476 . . . . 1.6299999999999999 112.286 -168.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.0 m-20 -69.18 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.911 0 CA-C-O 122.825 1.298 . . . . 2.0600000000000001 110.627 -173.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 150.08 139.26 3.03 Favored Glycine 0 N--CA 1.423 -2.184 0 CA-C-N 114.094 -1.412 . . . . 0.34999999999999998 111.811 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 32.8 mt-10 -117.71 109.85 17.13 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.251 -0.974 . . . . 1.53 108.888 176.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.53 163.19 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.02 -1.474 . . . . 1.0800000000000001 107.02 -175.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.738 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.41 154.7 17.32 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 115.479 -0.782 . . . . 1.22 109.874 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 HG22 ' A' ' 106' ' ' VAL . 16.5 t -63.68 107.12 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 123.193 1.473 . . . . 1.3799999999999999 108.917 173.03 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.25 -10.87 5.59 Favored Glycine 0 C--N 1.268 -3.207 0 CA-C-N 111.711 -2.495 . . . . 0.52000000000000002 112.503 176.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.0 -163.69 20.36 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 119.879 -1.153 . . . . 0.44 111.316 177.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 2.5 p -122.75 169.81 10.7 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-O 122.582 1.182 . . . . 1.23 111.456 -170.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.632 HG23 HD13 ' A' ' 104' ' ' LEU . 10.4 tp -145.16 151.83 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-N 112.335 -2.211 . . . . 1.0900000000000001 107.229 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.7 m -139.67 127.46 21.97 Favored 'General case' 0 C--N 1.256 -3.486 0 CA-C-N 113.815 -1.539 . . . . 1.05 110.814 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.598 ' HD2' HD12 ' A' ' 74' ' ' LEU . 27.7 m-85 -123.48 142.49 50.95 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.788 -1.551 . . . . 0.71999999999999997 109.51 -178.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.99 120.17 17.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.94 0.876 . . . . 0.87 110.399 173.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HB3' ' HG3' ' A' ' 11' ' ' PRO . . . -117.52 114.41 23.41 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.075 -1.421 . . . . 1.1000000000000001 109.805 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.758 ' HD2' ' HG3' ' A' ' 9' ' ' MET . 88.0 mtt180 -106.71 121.76 45.0 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 121.226 -0.19 . . . . 2.9300000000000002 110.564 -176.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.2 125.65 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.027 0.917 . . . . 1.0700000000000001 109.925 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 108.39 0.59 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.309 -1.768 . . . . 1.1200000000000001 110.959 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.722 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.11 -44.3 63.19 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.817 -1.083 . . . . 0.76000000000000001 111.406 172.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.62 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 54.06 -164.2 0.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.572 0.749 . . . . 1.0 112.996 177.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -78.47 -71.58 0.42 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.81 -0.811 . . . . 2.1699999999999999 108.81 173.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.915 HD22 ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 69.58 159.75 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.675 -0.693 . . . . 2.6299999999999999 112.102 168.496 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.915 ' N ' HD22 ' A' ' 33' ' ' LEU . 17.0 tp -75.6 -71.56 0.36 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.525 -0.761 . . . . 1.99 111.149 168.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.856 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -123.31 129.55 24.87 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 113.643 0.979 . . . . 1.8799999999999999 113.643 171.555 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' N ' HD11 ' A' ' 33' ' ' LEU . 17.2 Cg_exo -32.96 129.16 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 124.735 3.623 . . . . 1.1200000000000001 113.234 -170.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 1.5 Cg_endo -46.9 132.67 17.54 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.493 2.129 . . . . 0.81999999999999995 112.898 -171.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.66 104.64 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 106.769 -1.567 . . . . 1.4299999999999999 106.769 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.661 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.25 115.02 48.51 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.997 0 CA-C-N 113.159 -1.837 . . . . 1.0900000000000001 107.262 177.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.709 ' HB2' ' HZ3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -105.22 128.76 53.57 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 122.972 1.368 . . . . 2.1299999999999999 109.294 172.52 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.032 ' HB3' HD12 ' A' ' 49' ' ' LEU . 60.0 m95 -82.92 152.44 25.53 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 112.395 -2.184 . . . . 0.40999999999999998 110.786 175.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 32.3 t80 -128.03 138.88 52.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.725 -2.324 . . . . 0.80000000000000004 104.725 169.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 1.039 ' HE2' ' HG ' ' A' ' 49' ' ' LEU . 13.7 ttmt -100.4 171.53 7.7 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.927 -1.138 . . . . 2.6800000000000002 107.927 -173.03 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 1.001 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -13.44 -169.27 0.0 OUTLIER Glycine 0 C--O 1.185 -2.931 0 O-C-N 126.673 2.483 . . . . 1.6000000000000001 118.3 166.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.3 mtpp -42.4 -2.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 117.556 2.428 . . . . 4.2999999999999998 117.556 -166.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.645 ' CZ3' HG12 ' A' ' 47' ' ' VAL . 8.6 p-90 -169.47 -17.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.901 1.445 . . . . 2.5099999999999998 114.901 -177.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.757 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.95 167.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 CA-C-O 123.464 1.602 . . . . 1.78 112.44 -161.368 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.636 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 14.4 t70 -113.89 154.27 27.81 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.537 -2.574 . . . . 2.73 104.976 169.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.039 ' HG ' ' HE2' ' A' ' 43' ' ' LYS . 6.3 mp -90.39 -36.35 14.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.901 1.074 . . . . 1.1299999999999999 113.901 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 t -59.05 -20.73 55.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.585 0.707 . . . . 1.71 109.432 -164.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -98.88 -28.42 13.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.074 -0.966 . . . . 1.76 113.531 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.842 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.25 -40.31 7.6 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.254 0.464 . . . . 1.9099999999999999 112.254 -169.402 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.712 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 23.0 t -18.11 97.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 125.935 1.694 . . . . 1.1499999999999999 113.063 173.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -152.83 -147.9 4.73 Favored Glycine 0 C--N 1.306 -1.125 0 CA-C-N 111.575 -2.557 . . . . 0.69999999999999996 112.823 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -64.13 -16.34 61.64 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.003 0.742 . . . . 3.3599999999999999 113.003 -170.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.7 p80 -102.49 -36.34 8.43 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.379 0.609 . . . . 1.78 110.899 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.787 HD21 ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -129.22 103.43 6.95 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.961 -1.496 . . . . 1.72 106.961 172.348 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.27 116.04 28.38 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 106.976 -1.49 . . . . 0.96999999999999997 106.976 168.503 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.658 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -98.4 93.8 6.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 105.137 -2.171 . . . . 1.0600000000000001 105.137 174.632 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.616 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 46.2 m-70 -84.81 159.4 20.43 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-O 122.843 1.306 . . . . 2.5899999999999999 109.618 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.97 18.75 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 111.85 -2.432 . . . . 0.92000000000000004 109.645 177.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -103.52 145.45 30.0 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 111.094 -2.775 . . . . 0.76000000000000001 108.709 176.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.432 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 38.0 t80 -139.34 97.01 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.215 1.007 . . . . 1.8 110.143 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -114.06 105.22 12.95 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.278 -1.783 . . . . 2.4199999999999999 108.766 176.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.671 ' HD3' ' HZ3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -77.21 -36.63 54.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.588 -0.733 . . . . 3.0800000000000001 110.864 -178.834 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.87 61.18 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.616 -0.72 . . . . 1.6899999999999999 110.796 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.0 t -102.96 -19.82 14.46 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.351 -1.352 . . . . 1.96 107.351 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.722 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.86 35.47 11.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.321 -1.309 . . . . 3.7799999999999998 110.056 177.699 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 27' ' ' ARG . 10.9 t -134.19 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.201 -0.909 . . . . 1.1299999999999999 109.475 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 8.0 m-85 -102.64 111.06 23.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.068 -1.456 . . . . 1.95 107.068 166.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.7 tp -95.51 106.64 18.73 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.196 0.998 . . . . 1.1799999999999999 108.86 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.2 m-85 -89.26 112.18 23.17 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.168 -1.79 . . . . 0.40000000000000002 106.168 169.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.616 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -120.44 125.53 48.15 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.562 -1.199 . . . . 1.3200000000000001 110.093 -173.955 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.673 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.1 mt -90.95 136.43 33.08 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.774 -1.557 . . . . 1.5900000000000001 108.666 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 63.3 m170 -117.69 97.99 6.14 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.164 -2.532 . . . . 2.0099999999999998 104.164 166.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.741 ' CD1' HD22 ' A' ' 57' ' ' LEU . 66.1 mt -120.31 101.62 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-O 122.718 1.247 . . . . 1.1899999999999999 109.643 -174.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 12.7 p -118.4 145.49 45.15 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 114.05 -1.432 . . . . 1.05 109.872 -176.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 77' ' ' THR . 1.5 m-20 73.47 70.55 0.12 Allowed 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 111.258 -2.701 . . . . 2.1200000000000001 109.924 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.53 109.33 3.19 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 111.717 -2.492 . . . . 1.0900000000000001 110.947 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.685 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -60.41 142.54 90.55 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.166 -0.924 . . . . 1.77 109.286 171.249 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.485 ' HG3' HG21 ' A' ' 18' ' ' VAL . 26.4 Cg_exo -60.27 -18.8 54.38 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.409 2.073 . . . . 1.3300000000000001 112.22 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.685 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -100.1 16.25 24.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.08 -0.509 . . . . 1.6599999999999999 110.728 178.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -83.66 -36.76 23.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.831 -0.604 . . . . 1.24 110.085 -178.823 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.8 m 1.41 82.38 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 0 O-C-N 125.585 1.803 . . . . 1.6799999999999999 112.179 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 1.001 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -47.13 117.89 3.48 Favored Glycine 0 N--CA 1.408 -3.177 0 CA-C-N 111.988 -2.369 . . . . 2.0 114.353 -171.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.661 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -117.51 67.57 0.32 Allowed Glycine 0 C--N 1.273 -2.927 0 N-CA-C 108.001 -2.04 . . . . 0.81000000000000005 108.001 155.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 63.7 m-85 -78.13 118.99 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.765 -0.828 . . . . 1.0800000000000001 108.765 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.516 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 28.4 ttm180 -114.38 126.52 55.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.45 . . . . 3.6899999999999999 110.878 178.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.622 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 91.6 m -97.35 108.52 21.26 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.092 -0.707 . . . . 1.22 109.092 173.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.627 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 33.5 tt0 -114.84 103.26 10.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.525 -0.917 . . . . 1.8100000000000001 108.525 -176.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.661 ' HB ' HG11 ' A' ' 39' ' ' VAL . 6.4 p -105.0 141.9 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.655 0.741 . . . . 1.24 111.601 -173.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -134.99 108.99 8.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.338 -1.301 . . . . 1.6399999999999999 109.08 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 37' ' ' PRO . 1.4 m -120.8 168.25 11.64 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.071 -1.455 . . . . 1.26 107.071 177.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -10.66 -61.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.945 1.403 . . . . 0.93999999999999995 114.138 -175.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.635 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -149.22 -3.14 0.43 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.993 -1.003 . . . . 1.05 109.994 177.776 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.952 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 3.9 mmtm -89.74 116.69 28.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.055 -1.831 . . . . 1.78 106.055 -176.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -134.06 139.69 46.15 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.892 -1.049 . . . . 1.0 111.274 -173.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 4.8 t0 -167.27 170.47 11.6 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.947 -1.024 . . . . 1.6000000000000001 108.858 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 17.0 p -148.81 151.06 34.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 1.98 110.28 179.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.744 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 54.7 p -122.31 137.2 54.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.945 -0.702 . . . . 1.02 111.335 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -110.79 123.93 51.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.449 -0.796 . . . . 1.5800000000000001 109.601 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.767 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.3 p90 -145.05 131.05 19.26 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.185 -0.606 . . . . 1.1000000000000001 110.493 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.1 p30 -106.21 139.62 40.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.502 1.144 . . . . 2.1099999999999999 112.294 -175.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.632 HD13 HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -107.84 105.52 15.37 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.775 -1.557 . . . . 1.0900000000000001 108.778 173.015 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.457 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.3 m -87.24 96.56 10.37 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.316 -0.994 . . . . 1.0700000000000001 108.316 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 18' ' ' VAL . 3.1 p -75.39 112.2 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-O 122.842 1.306 . . . . 1.1399999999999999 107.989 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.738 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.2 m170 -74.43 95.95 2.81 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.688 -2.051 . . . . 1.8200000000000001 108.178 -178.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.448 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.7 tm-20 . . . . . 0 C--N 1.301 -1.52 0 CA-C-N 113.448 -1.706 . . . . 1.6699999999999999 108.191 173.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 1.003 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 6.9 t70 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 108.898 -0.778 . . . . 1.6499999999999999 108.898 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.447 ' C ' HD13 ' A' ' 4' ' ' ILE . 2.0 Cg_endo -45.44 90.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.224 3.283 . . . . 1.24 115.223 -177.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.673 HG23 ' N ' ' A' ' 6' ' ' LEU . 1.7 mp -125.07 -60.52 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 114.628 -1.169 . . . . 1.2 108.042 173.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.55 33.98 6.86 Favored Glycine 0 CA--C 1.492 -1.357 0 N-CA-C 108.805 -1.718 . . . . 0.44 108.805 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 1.002 HD23 ' HB3' ' A' ' 96' ' ' LYS . 5.5 tp -37.92 -51.39 1.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.38 -1.91 . . . . 1.1100000000000001 110.635 178.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.74 84.28 5.58 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.333 -0.849 . . . . 0.97999999999999998 110.157 172.243 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.27 -41.3 57.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.634 -1.166 . . . . 1.1100000000000001 108.812 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 15.6 tpt -153.92 134.77 13.76 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.747 -1.115 . . . . 3.3100000000000001 109.289 173.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -104.39 140.73 21.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.26 -0.882 . . . . 4.1699999999999999 109.73 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.683 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 34.7 Cg_endo -73.7 156.34 48.95 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.842 1.695 . . . . 0.81999999999999995 110.46 178.187 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -118.04 -179.85 3.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.225 -0.443 . . . . 1.6299999999999999 110.593 -173.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 5.4 p-10 -72.61 -145.62 0.02 OUTLIER 'General case' 0 N--CA 1.41 -2.462 0 CA-C-O 122.746 1.26 . . . . 2.0600000000000001 111.704 -176.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.13 133.33 1.78 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.306 -1.77 . . . . 0.34999999999999998 112.525 -176.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.632 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 37.3 mt-10 -110.36 111.16 22.27 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.682 -1.259 . . . . 1.53 108.435 176.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.0 m -133.63 163.36 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.884 -1.154 . . . . 1.0800000000000001 107.884 -172.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.45 147.37 23.32 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.566 -1.197 . . . . 1.22 109.193 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.904 HG22 ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.79 107.42 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 CA-C-O 123.786 1.755 . . . . 1.3799999999999999 109.993 174.62 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.06 -1.66 6.74 Favored Glycine 0 C--N 1.273 -2.959 0 CA-C-N 110.517 -3.038 . . . . 0.52000000000000002 112.168 178.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.87 -119.66 2.48 Favored Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 119.223 -1.465 . . . . 0.44 110.383 176.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.682 ' OG ' HG22 ' A' ' 77' ' ' THR . 48.1 t -154.09 173.63 15.79 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.611 -1.794 . . . . 1.23 108.859 173.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 76' ' ' ILE . 11.1 tp -149.32 147.36 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.039 0 CA-C-N 113.237 -1.801 . . . . 1.0900000000000001 106.845 167.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.3 m -140.9 126.84 19.33 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.632 -1.622 . . . . 1.05 111.338 -173.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.501 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 56.7 m-85 -124.45 147.02 48.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.65 -1.613 . . . . 0.71999999999999997 109.07 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.41 120.82 16.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.132 -0.94 . . . . 0.87 110.082 176.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -113.73 116.89 30.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.467 -1.242 . . . . 1.1000000000000001 110.145 -178.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 97.5 mtt180 -101.8 119.82 39.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.704 -0.225 . . . . 2.9300000000000002 110.879 -177.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.9 t -118.77 125.28 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 122.067 0.937 . . . . 1.0700000000000001 110.419 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.05 109.21 0.91 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.126 -1.852 . . . . 1.1200000000000001 110.829 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.619 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -54.74 -33.22 55.3 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.222 -0.899 . . . . 0.76000000000000001 111.947 172.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 53.97 -162.42 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.494 1.294 . . . . 1.0 114.494 169.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.0 p -118.44 38.81 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.939 -1.028 . . . . 2.1699999999999999 109.2 173.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.07 HD12 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -64.44 177.32 0.89 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.678 -1.146 . . . . 2.6299999999999999 113.521 -179.055 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 tp -69.21 -55.08 11.65 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.61 -0.723 . . . . 1.99 109.819 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.62 152.74 71.48 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.345 -0.843 . . . . 1.8799999999999999 109.182 176.527 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -43.0 135.87 5.16 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.19 2.593 . . . . 1.1200000000000001 112.987 -178.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.07 ' HD3' HD12 ' A' ' 33' ' ' LEU . 3.0 Cg_endo -55.52 135.93 71.56 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 122.726 2.284 . . . . 0.81999999999999995 112.383 -176.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.2 104.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.507 -1.664 . . . . 1.4299999999999999 106.507 177.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 91' ' ' VAL . 42.9 t -103.84 115.22 45.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.91 0 CA-C-N 112.805 -1.998 . . . . 1.0900000000000001 108.558 -179.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 1.03 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.33 123.38 46.69 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 113.591 -1.64 . . . . 2.1299999999999999 109.444 170.465 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.978 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.9 m95 -89.34 157.37 18.21 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.702 -2.499 . . . . 0.40999999999999998 111.256 173.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 21.1 t80 -136.55 125.8 24.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.876 -2.268 . . . . 0.80000000000000004 104.876 167.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.787 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 20.4 tttm -102.57 162.35 12.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.494 -2.039 . . . . 2.6800000000000002 105.494 -175.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.956 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -4.62 -165.94 0.0 OUTLIER Glycine 0 C--O 1.199 -2.043 0 N-CA-C 118.86 2.304 . . . . 1.6000000000000001 118.86 -174.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 84' ' ' THR . 10.4 mtpp -41.67 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.026 -1.867 . . . . 4.2999999999999998 115.716 -165.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -166.02 2.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 114.416 1.265 . . . . 2.5099999999999998 114.416 -177.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.412 HG13 ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.39 117.11 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.993 1.378 . . . . 1.78 112.254 -163.229 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -84.85 98.42 10.3 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 112.437 -2.165 . . . . 2.73 111.32 175.211 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.978 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.1 mp -49.64 -36.08 23.38 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.781 -0.645 . . . . 1.1299999999999999 112.719 -174.365 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 t -58.68 -22.2 56.48 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.427 -0.582 . . . . 1.71 109.427 -169.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.2 m -101.51 -28.18 12.69 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 112.919 0.711 . . . . 1.76 112.919 178.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 7.8 mmmt -90.1 -45.84 8.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.092 -0.504 . . . . 1.9099999999999999 111.288 -171.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.2 t -22.67 93.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 126.504 1.922 . . . . 1.1499999999999999 112.737 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -168.66 -124.73 0.74 Allowed Glycine 0 C--N 1.308 -1.025 0 CA-C-N 111.844 -2.435 . . . . 0.69999999999999996 113.227 -177.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -56.8 -52.72 63.95 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.16 0.8 . . . . 3.3599999999999999 113.16 -169.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.578 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.1 p80 -88.48 -38.6 14.86 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 112.208 0.447 . . . . 1.78 112.208 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.959 HD22 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.18 109.16 13.09 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.413 -0.958 . . . . 1.72 108.413 174.628 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -94.46 115.84 28.08 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.445 -1.687 . . . . 0.96999999999999997 106.445 167.768 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 HD21 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -95.32 92.68 6.85 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 104.476 -2.416 . . . . 1.0600000000000001 104.476 170.393 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 2.1 m170 -101.41 166.75 10.58 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.048 -1.433 . . . . 2.5899999999999999 110.454 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 125.09 22.72 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 111.98 -2.373 . . . . 0.92000000000000004 110.124 -177.458 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.3 m -94.48 148.4 22.28 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 111.506 -2.588 . . . . 0.76000000000000001 107.366 172.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 2.4 t80 -135.81 97.78 3.74 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.251 1.024 . . . . 1.8 110.978 -173.286 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 5.4 m-20 -113.8 105.17 12.96 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 113.115 -1.857 . . . . 2.4199999999999999 108.564 173.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HG3' HH11 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -84.41 -41.38 16.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.08 -0.964 . . . . 3.0800000000000001 110.45 -178.728 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.28 -22.16 62.89 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.443 -1.253 . . . . 1.6899999999999999 111.028 176.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.78 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.4 t -97.7 -16.42 19.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.285 -1.376 . . . . 1.96 107.285 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 68.04 29.18 6.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.044 -1.435 . . . . 3.7799999999999998 110.903 173.699 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.48 126.87 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 121.682 0.753 . . . . 1.1299999999999999 109.426 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.1 m-30 -105.0 109.11 20.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.796 -1.557 . . . . 1.95 106.796 170.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.6 tp -94.74 104.73 16.64 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 122.175 0.988 . . . . 1.1799999999999999 109.516 -177.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.6 m-85 -84.16 113.33 21.0 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.134 -1.432 . . . . 0.40000000000000002 107.134 171.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.51 125.61 52.16 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.789 -1.551 . . . . 1.3200000000000001 110.51 -172.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.675 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -92.15 132.5 36.57 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.838 -1.528 . . . . 1.5900000000000001 107.509 176.28 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 73.4 m-70 -119.95 96.72 5.29 Favored 'General case' 0 C--N 1.265 -3.066 0 N-CA-C 104.532 -2.396 . . . . 2.0099999999999998 104.532 167.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 57' ' ' LEU . 14.2 mt -122.03 99.32 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 122.382 1.087 . . . . 1.1899999999999999 108.856 -174.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.682 HG22 ' OG ' ' A' ' 21' ' ' SER . 75.8 p -100.41 165.0 11.66 Favored 'General case' 0 N--CA 1.388 -3.556 0 CA-C-N 114.546 -1.206 . . . . 1.05 110.374 -175.131 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 34.9 75.55 0.05 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 110.317 -3.129 . . . . 2.1200000000000001 112.43 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -65.5 105.84 1.28 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 110.786 -2.916 . . . . 1.0900000000000001 110.022 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.765 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.98 145.46 79.89 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.951 -0.759 . . . . 1.77 108.951 174.456 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.904 ' HD3' HG22 ' A' ' 18' ' ' VAL . 30.4 Cg_endo -62.49 150.28 88.03 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.439 1.426 . . . . 1.3300000000000001 111.254 -175.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.53 15.48 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.725 0.64 . . . . 1.6599999999999999 111.02 -175.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.765 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.58 -7.34 59.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.865 -1.161 . . . . 1.24 107.865 172.057 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.0 m -13.15 90.96 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 126.066 2.104 . . . . 1.6799999999999999 112.176 -177.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.956 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -49.8 112.76 1.54 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 110.946 -2.843 . . . . 2.0 114.034 -173.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.623 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -111.25 75.73 0.22 Allowed Glycine 0 C--N 1.27 -3.103 0 N-CA-C 108.295 -1.922 . . . . 0.81000000000000005 108.295 154.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.787 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 52.6 m-85 -80.08 119.15 22.5 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.298 -0.951 . . . . 1.0800000000000001 109.065 175.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.5 104.21 8.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.295 -1.002 . . . . 3.6899999999999999 108.295 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.6 t -90.58 127.73 36.36 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.852 -0.795 . . . . 1.22 108.852 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 1.03 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 34.1 tt0 -136.7 107.48 6.62 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.526 -0.761 . . . . 1.8100000000000001 109.699 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 39' ' ' VAL . 21.6 t -98.81 141.46 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.644 -0.422 . . . . 1.24 109.899 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 m -131.95 107.75 8.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.876 -0.787 . . . . 1.6399999999999999 108.876 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.6 HG21 HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.9 157.05 46.07 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 118.6 -0.714 . . . . 1.26 109.082 178.021 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 1.003 ' HZ2' ' HB3' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 24.46 -79.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 125.61 1.819 . . . . 0.93999999999999995 113.793 168.781 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.615 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 t70 -142.81 -4.17 0.96 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.894 -1.048 . . . . 1.05 109.944 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.002 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -91.65 122.74 34.49 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.536 0.684 . . . . 1.78 109.348 -177.424 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -129.81 114.29 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.388 -1.278 . . . . 1.0 110.044 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -130.44 145.26 51.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.777 -1.556 . . . . 1.6000000000000001 109.531 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.5 m -142.86 147.33 35.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.374 0.607 . . . . 1.98 110.959 -178.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 p -127.6 148.41 50.36 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.398 -0.819 . . . . 1.02 111.987 178.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.94 114.92 22.78 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.739 -1.119 . . . . 1.5800000000000001 109.807 173.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.683 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.29 119.98 12.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.434 0.635 . . . . 1.1000000000000001 109.441 -176.593 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.683 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.7 p30 -103.7 155.1 18.84 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.254 1.026 . . . . 2.1099999999999999 111.59 -168.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.682 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -121.81 111.72 17.48 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.26 -1.336 . . . . 1.0900000000000001 109.611 175.387 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 m -94.13 96.8 9.86 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.127 -0.694 . . . . 1.0700000000000001 109.127 177.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 4.0 p -82.87 113.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 122.955 1.36 . . . . 1.1399999999999999 109.234 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.632 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 99.7 m-70 -87.5 101.21 13.39 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 112.201 -2.272 . . . . 1.8200000000000001 109.044 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.533 ' HA ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-N 114.6 -1.182 . . . . 1.6699999999999999 108.647 170.762 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.437 ' CG ' ' HZ2' ' A' ' 94' ' ' LYS . 3.0 m-20 . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 119.783 -0.151 . . . . 1.6499999999999999 111.281 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.99 84.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.317 2.011 . . . . 1.24 111.711 171.078 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.97 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -110.01 -64.87 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.16 -0.927 . . . . 1.2 109.329 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.447 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 95.6 46.55 2.71 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 108.284 -1.926 . . . . 0.44 108.284 -175.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.578 ' N ' HG21 ' A' ' 4' ' ' ILE . 11.6 tp -56.72 -47.57 79.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.156 -1.522 . . . . 1.1100000000000001 111.203 -166.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.477 ' HD1' ' HA ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -93.98 84.76 4.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.933 0.873 . . . . 0.97999999999999998 109.665 178.367 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.48 -35.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.983 -1.462 . . . . 1.1100000000000001 109.693 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -158.57 130.9 6.88 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 114.948 -1.024 . . . . 3.3100000000000001 109.016 172.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -109.28 133.32 20.83 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 4.1699999999999999 110.206 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.687 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.5 Cg_endo -63.76 157.54 51.47 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.725 2.283 . . . . 0.81999999999999995 111.966 -176.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.0 mm-40 -121.26 174.17 6.87 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.858 -0.61 . . . . 1.6299999999999999 110.472 -173.137 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 5.5 p-10 -68.48 -142.85 0.01 OUTLIER 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 122.942 1.354 . . . . 2.0600000000000001 111.968 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.85 137.16 2.7 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 113.433 -1.712 . . . . 0.34999999999999998 112.112 -175.435 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.469 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 34.0 mt-10 -110.49 115.81 30.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.413 -0.958 . . . . 1.53 108.413 174.171 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -134.86 155.7 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.02 0 N-CA-C 106.982 -1.488 . . . . 1.0800000000000001 106.982 -173.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.451 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.36 157.28 18.23 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.041 -0.981 . . . . 1.22 108.908 -179.562 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.476 ' CG1' ' HD3' ' A' ' 81' ' ' PRO . 21.5 t -67.69 105.98 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.847 1.308 . . . . 1.3799999999999999 108.117 173.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.76 11.41 6.49 Favored Glycine 0 C--N 1.265 -3.395 0 CA-C-N 112.132 -2.304 . . . . 0.52000000000000002 113.055 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.14 -126.81 5.89 Favored Glycine 0 N--CA 1.416 -2.66 0 C-N-CA 119.278 -1.439 . . . . 0.44 110.529 171.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.7 p -151.21 170.46 19.41 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 112.697 -1.752 . . . . 1.23 110.613 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.61 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.8 tp -148.7 150.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-N 112.835 -1.984 . . . . 1.0900000000000001 106.952 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -138.71 130.11 27.27 Favored 'General case' 0 C--N 1.258 -3.383 0 CA-C-N 114.32 -1.309 . . . . 1.05 110.639 -175.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' HD2' HD13 ' A' ' 74' ' ' LEU . 26.9 m-85 -124.96 142.52 51.42 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.417 -1.265 . . . . 0.71999999999999997 109.85 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.83 121.28 20.42 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.078 0.942 . . . . 0.87 110.43 176.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.77 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -118.83 115.94 25.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.119 -1.401 . . . . 1.1000000000000001 110.459 -178.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -105.06 122.81 46.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.439 -0.346 . . . . 2.9300000000000002 110.76 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 8.4 t -125.74 127.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 122.085 0.945 . . . . 1.0700000000000001 110.126 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -58.27 114.09 2.25 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.254 -1.794 . . . . 1.1200000000000001 111.397 177.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.03 -29.05 61.79 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.293 -1.321 . . . . 0.76000000000000001 110.757 168.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.652 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 52.86 -166.58 0.06 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.83 1.418 . . . . 1.0 114.83 165.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 t -120.9 107.77 13.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.066 -1.457 . . . . 2.1699999999999999 107.066 169.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.803 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -143.05 176.32 9.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.061 0.763 . . . . 2.6299999999999999 113.061 -165.311 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.0 tp -70.56 -71.44 0.25 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.386 -0.825 . . . . 1.99 108.824 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -116.63 148.4 41.82 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.609 -0.723 . . . . 1.8799999999999999 109.302 171.318 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.67 142.92 9.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.877 2.385 . . . . 1.1200000000000001 111.809 178.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.803 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.9 Cg_exo -62.37 139.63 78.07 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 121.938 1.759 . . . . 0.81999999999999995 111.924 -173.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.3 104.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.813 -1.551 . . . . 1.4299999999999999 106.813 178.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.538 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -105.98 115.1 46.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 113.323 -1.762 . . . . 1.0900000000000001 107.528 176.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.579 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.09 127.91 55.14 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-O 122.944 1.354 . . . . 2.1299999999999999 110.132 175.371 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.948 ' HB3' HD11 ' A' ' 49' ' ' LEU . 64.3 m95 -84.21 155.77 22.36 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 112.148 -2.297 . . . . 0.40999999999999998 111.923 175.358 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.9 t80 -131.16 141.48 50.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 104.703 -2.332 . . . . 0.80000000000000004 104.703 170.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.785 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 62.5 tttt -108.81 163.53 13.19 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.349 -1.723 . . . . 2.6800000000000002 106.349 -172.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -7.81 -165.81 0.0 OUTLIER Glycine 0 C--O 1.196 -2.252 0 O-C-N 126.4 2.312 . . . . 1.6000000000000001 118.845 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 84' ' ' THR . 15.6 mtpp -44.24 -3.7 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 O-C-N 119.449 -2.207 . . . . 4.2999999999999998 116.271 -169.003 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.638 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.9 p-90 -171.2 -8.99 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 N-CA-C 115.295 1.591 . . . . 2.5099999999999998 115.295 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.785 ' HB ' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.83 159.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 123.222 1.487 . . . . 1.78 113.795 -159.277 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -112.48 106.11 14.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 111.817 -2.447 . . . . 2.73 113.084 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.948 HD11 ' HB3' ' A' ' 41' ' ' TRP . 4.6 mp -55.08 -36.32 65.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.086 0.773 . . . . 1.1299999999999999 113.086 -175.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -59.02 -20.85 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.763 -0.829 . . . . 1.71 108.763 -169.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.527 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 12.6 m -98.79 -41.9 7.44 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.058 -0.974 . . . . 1.76 112.088 178.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 10.7 mmmt -85.09 -37.39 20.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.952 -1.022 . . . . 1.9099999999999999 112.389 -166.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 59' ' ' LEU . 17.5 t -35.2 96.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 125.967 1.707 . . . . 1.1499999999999999 112.542 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.63 -138.98 3.08 Favored Glycine 0 C--N 1.3 -1.457 0 CA-C-N 111.316 -2.675 . . . . 0.69999999999999996 112.809 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -74.07 -8.37 55.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.973 0.731 . . . . 3.3599999999999999 112.973 -167.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.719 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 29.3 p80 -111.79 -37.52 5.12 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 120.618 -0.433 . . . . 1.78 110.985 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.907 HD12 HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -121.38 102.55 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.531 -1.655 . . . . 1.72 106.531 171.86 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -95.89 116.16 28.5 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.288 -1.375 . . . . 0.96999999999999997 107.288 168.119 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.702 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.24 93.28 7.21 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.965 -2.235 . . . . 1.0600000000000001 104.965 170.372 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 56.8 t60 -94.19 158.98 15.34 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 122.954 1.359 . . . . 2.5899999999999999 109.042 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.95 112.87 10.29 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 111.753 -2.476 . . . . 0.92000000000000004 110.605 -176.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.4 m -97.44 149.27 22.34 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 112.308 -2.224 . . . . 0.76000000000000001 108.577 174.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -141.98 97.63 3.17 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.08 0.943 . . . . 1.8 110.632 -170.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 6.0 t70 -116.76 128.0 54.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.766 -1.561 . . . . 2.4199999999999999 108.596 174.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.428 HH11 ' HH ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -99.86 -31.38 11.53 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.858 -1.519 . . . . 3.0800000000000001 111.021 -173.465 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.47 -19.88 60.22 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.385 -1.279 . . . . 1.6899999999999999 110.549 174.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 50.7 m -98.53 -20.47 17.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 107.821 -1.177 . . . . 1.96 107.821 174.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.652 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 69.15 32.24 3.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.13 -1.395 . . . . 3.7799999999999998 109.383 175.415 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.86 129.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.615 -0.72 . . . . 1.1299999999999999 109.776 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.665 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 4.9 m-85 -100.25 112.33 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.495 -1.668 . . . . 1.95 106.495 164.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 27.5 tp -95.27 106.32 18.35 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 122.09 0.948 . . . . 1.1799999999999999 109.075 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -86.95 112.34 21.71 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.511 -1.663 . . . . 0.40000000000000002 106.511 169.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.64 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 4.0 pt-20 -121.54 122.35 39.49 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.29 -1.323 . . . . 1.3200000000000001 110.557 -173.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.684 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -89.08 132.08 34.95 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.033 -1.44 . . . . 1.5900000000000001 108.45 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 19.8 m170 -115.03 97.01 5.97 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 103.798 -2.668 . . . . 2.0099999999999998 103.798 169.005 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 62.9 mt -121.55 101.3 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-O 122.985 1.374 . . . . 1.1899999999999999 109.775 -174.336 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.7 p -112.69 143.78 43.32 Favored 'General case' 0 N--CA 1.398 -3.045 0 CA-C-N 114.126 -1.397 . . . . 1.05 109.257 -178.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.77 86.05 0.12 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 111.183 -2.735 . . . . 2.1200000000000001 110.49 -177.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.91 125.17 28.59 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 112.713 -2.04 . . . . 1.0900000000000001 109.52 179.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.869 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 1.2 tp60 -61.84 134.33 94.05 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.281 -0.872 . . . . 1.77 108.978 175.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.658 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.1 Cg_endo -60.79 145.78 98.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.704 0.936 . . . . 1.3300000000000001 110.37 176.249 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.18 17.2 10.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.441 0.463 . . . . 1.6599999999999999 111.288 -173.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.869 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -73.1 -32.67 65.11 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.546 -0.539 . . . . 1.24 109.546 175.745 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m 13.12 78.35 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 125.379 1.675 . . . . 1.6799999999999999 111.137 -168.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -65.74 99.0 0.37 Allowed Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 112.112 -2.313 . . . . 2.0 113.877 -161.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.658 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.13 74.04 1.87 Allowed Glycine 0 C--N 1.289 -2.078 0 N-CA-C 109.181 -1.568 . . . . 0.81000000000000005 109.181 171.288 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.624 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 45.3 m-85 -81.01 120.1 24.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.071 -1.065 . . . . 1.0800000000000001 108.165 176.355 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 72.7 mtt180 -127.61 115.36 18.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.935 -0.478 . . . . 3.6899999999999999 111.034 -173.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.1 m -92.64 129.12 38.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.067 -0.515 . . . . 1.22 110.03 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.579 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 41.7 tt0 -126.8 113.22 16.33 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.606 -0.887 . . . . 1.8100000000000001 108.606 174.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.538 ' HB ' HG11 ' A' ' 39' ' ' VAL . 3.0 p -105.26 135.51 43.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.853 0.835 . . . . 1.24 110.655 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -129.45 109.2 10.87 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.856 -1.52 . . . . 1.6399999999999999 108.688 -176.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.605 HG21 ' HG3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -125.11 167.11 15.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 118.249 -0.882 . . . . 1.26 108.835 178.938 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.692 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -2.94 -62.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.618 1.824 . . . . 0.93999999999999995 114.571 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.692 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 12.9 t0 -150.63 -7.05 0.28 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.773 -1.103 . . . . 1.05 110.239 -176.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.97 ' HD2' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mttp -95.35 135.63 36.72 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.14 -1.024 . . . . 1.78 108.681 -177.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -132.9 142.2 48.78 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.403 -1.726 . . . . 1.0 110.735 -177.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -164.02 163.84 23.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.317 -0.856 . . . . 1.6000000000000001 108.972 173.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 p -153.31 148.67 27.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.244 0.545 . . . . 1.98 111.198 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.5 t -125.45 148.97 48.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.913 0.863 . . . . 1.02 111.71 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.24 114.28 11.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.671 -1.604 . . . . 1.5800000000000001 110.092 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.697 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 18.6 p90 -142.47 131.67 23.36 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.562 -0.533 . . . . 1.1000000000000001 109.562 -176.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.722 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 52.7 m-20 -109.04 135.24 50.52 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.154 0.978 . . . . 2.1099999999999999 111.324 -171.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -102.74 110.11 21.93 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.145 -1.389 . . . . 1.0900000000000001 109.434 176.811 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 13.3 m -90.85 97.87 11.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.381 0.61 . . . . 1.0700000000000001 109.391 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.5 p -82.13 115.67 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.987 1.375 . . . . 1.1399999999999999 109.288 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.469 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 94.6 m-70 -87.24 99.57 12.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.552 -2.113 . . . . 1.8200000000000001 109.538 -177.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 41.3 tt0 . . . . . 0 C--N 1.301 -1.541 0 CA-C-N 113.845 -1.525 . . . . 1.6699999999999999 109.803 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.743 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-20 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.45 0.537 . . . . 1.6499999999999999 112.45 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.5 ' C ' HD13 ' A' ' 4' ' ' ILE . 24.8 Cg_exo -64.01 86.55 0.15 Allowed 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.195 2.597 . . . . 1.24 112.406 173.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.917 HG12 ' HD3' ' A' ' 94' ' ' LYS . 1.7 mp -119.59 -56.54 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.71 -1.132 . . . . 1.2 109.573 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.001 -1.64 . . . . 0.44 109.001 -175.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.879 HD21 ' HB3' ' A' ' 96' ' ' LYS . 7.7 tp -52.27 -37.78 56.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.309 -1.446 . . . . 1.1100000000000001 109.811 -176.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.777 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.06 84.11 5.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.04 -0.982 . . . . 0.97999999999999998 109.911 176.235 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.3 t -72.57 -43.2 63.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.264 -1.335 . . . . 1.1100000000000001 109.826 178.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.409 ' HB3' ' HG3' ' A' ' 27' ' ' ARG . 16.0 tpt -156.95 130.25 7.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.372 -0.831 . . . . 3.3100000000000001 109.56 174.199 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -102.8 136.42 19.29 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 115.185 -0.916 . . . . 4.1699999999999999 109.107 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.685 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.1 Cg_endo -74.14 160.53 42.46 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.323 1.349 . . . . 0.81999999999999995 110.897 176.644 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -117.13 -179.77 3.8 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.297 -0.631 . . . . 1.6299999999999999 109.297 -176.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 4.6 m-20 -69.99 -146.73 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 122.979 1.371 . . . . 2.0600000000000001 111.264 -175.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.65 133.53 1.65 Allowed Glycine 0 C--N 1.294 -1.799 0 CA-C-N 113.438 -1.71 . . . . 0.34999999999999998 111.5 -173.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 32.2 mt-10 -113.2 116.71 30.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.393 -0.904 . . . . 1.53 108.663 177.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -135.77 156.4 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.643 -1.244 . . . . 1.0800000000000001 107.643 -171.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 156.19 18.64 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.638 -1.165 . . . . 1.22 108.916 176.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' HB3' ' A' ' 81' ' ' PRO . 13.5 t -66.89 107.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 123.151 1.453 . . . . 1.3799999999999999 108.477 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.17 3.71 11.65 Favored Glycine 0 C--N 1.266 -3.323 0 CA-C-N 111.612 -2.54 . . . . 0.52000000000000002 112.463 178.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.86 -127.88 5.2 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 118.988 -1.577 . . . . 0.44 110.023 176.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 18.8 p -153.06 164.9 37.16 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 113.437 -1.381 . . . . 1.23 110.718 177.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.602 HG21 HD13 ' A' ' 104' ' ' LEU . 10.8 tp -147.05 149.67 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.401 -1.727 . . . . 1.0900000000000001 107.924 171.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -139.81 127.33 21.58 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 113.016 -1.902 . . . . 1.05 110.385 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.616 ' HB2' HD23 ' A' ' 74' ' ' LEU . 54.5 m-85 -121.92 147.31 46.18 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.607 -1.179 . . . . 0.71999999999999997 108.883 174.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -132.44 119.73 21.03 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.208 -0.905 . . . . 0.87 109.183 178.199 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.604 ' HB1' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.39 119.96 29.76 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.456 -1.247 . . . . 1.1000000000000001 110.805 -173.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' HD13 ' A' ' 71' ' ' LEU . 72.0 mtp180 -114.21 127.09 55.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.266 -0.425 . . . . 2.9300000000000002 110.774 -176.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 22.4 t -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-O 122.005 0.907 . . . . 1.0700000000000001 110.558 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.96 111.38 2.13 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.197 -1.819 . . . . 1.1200000000000001 110.566 174.172 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.81 -40.07 9.02 Favored Glycine 0 C--N 1.32 -0.336 0 CA-C-N 114.543 -1.208 . . . . 0.76000000000000001 111.548 170.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . 50.69 -156.01 0.12 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.869 0.868 . . . . 1.0 113.282 171.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.6 m -120.01 84.33 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.216 0.532 . . . . 2.1699999999999999 110.852 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' A' ' 93' ' ' THR . 1.8 tp -114.28 150.38 34.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.323 -0.992 . . . . 2.6299999999999999 108.323 173.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 33' ' ' LEU . 21.0 tp -44.24 -37.41 3.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.948 0.88 . . . . 1.99 111.292 178.107 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.788 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.36 178.41 1.7 Allowed Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.41 -1.268 . . . . 1.8799999999999999 108.121 177.193 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.0 Cg_exo -65.59 146.23 83.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.662 1.575 . . . . 1.1200000000000001 109.997 173.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HG3' HG23 ' A' ' 93' ' ' THR . 49.4 Cg_exo -45.57 140.76 8.63 Favored 'Trans proline' 0 CA--C 1.498 -1.297 0 C-N-CA 123.211 2.607 . . . . 0.81999999999999995 113.286 178.536 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 92' ' ' SER . 7.3 p -100.09 96.84 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.075 1.417 . . . . 1.4299999999999999 107.664 168.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.609 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -99.26 114.47 37.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 112.703 -2.044 . . . . 1.0900000000000001 106.923 170.308 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.924 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.6 127.27 53.5 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 114.027 -1.442 . . . . 2.1299999999999999 109.6 177.729 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 1.034 ' HB3' HD13 ' A' ' 49' ' ' LEU . 89.2 m95 -89.6 147.48 23.9 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.078 -2.328 . . . . 0.40999999999999998 111.792 173.149 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.658 ' HD2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 t80 -131.35 125.48 32.78 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.71 -1.589 . . . . 0.80000000000000004 106.71 172.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.717 ' HZ2' ' HG3' ' A' ' 52' ' ' LYS . 5.1 ttpm? -98.93 109.91 22.6 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.214 -1.402 . . . . 2.6800000000000002 107.214 -173.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.673 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -83.3 92.49 1.66 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 116.012 -2.994 . . . . 1.6000000000000001 114.797 -167.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.843 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -106.15 -53.52 2.62 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.61 -3.107 . . . . 4.2999999999999998 102.61 132.16 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.843 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 6.5 p-90 -167.38 -1.56 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 110.459 -3.064 . . . . 2.5099999999999998 111.476 178.416 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.5 HG12 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -94.67 170.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-O 123.144 1.45 . . . . 1.78 112.496 -159.7 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 7.3 t70 -106.22 150.0 26.31 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.675 -2.511 . . . . 2.73 106.07 173.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -88.17 -36.84 16.6 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.402 -0.519 . . . . 1.1299999999999999 110.902 176.106 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -59.97 -19.54 52.76 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.866 0.841 . . . . 1.71 109.011 -169.585 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -86.14 -28.78 23.76 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.571 -1.195 . . . . 1.76 111.094 -176.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.717 ' HG3' ' HZ2' ' A' ' 43' ' ' LYS . 2.4 mmmt -104.65 -71.4 0.74 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.03 -0.986 . . . . 1.9099999999999999 111.125 -172.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.808 HG22 ' O ' ' A' ' 49' ' ' LEU . 56.2 t 19.01 85.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 O-C-N 125.366 1.667 . . . . 1.1499999999999999 113.181 -177.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.74 -131.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 114.659 -1.155 . . . . 0.69999999999999996 113.639 -173.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -48.78 -53.87 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.909 1.077 . . . . 3.3599999999999999 113.909 -168.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.2 p80 -91.17 -38.09 12.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.837 -0.745 . . . . 1.78 111.498 -173.142 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.877 ' HB2' HG12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -124.0 108.81 12.78 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.809 -0.811 . . . . 1.72 108.809 175.443 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.43 115.61 27.72 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 106.343 -1.725 . . . . 0.96999999999999997 106.343 168.218 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.744 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.05 92.7 6.97 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.961 -2.237 . . . . 1.0600000000000001 104.961 172.099 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.582 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 36.1 m170 -81.9 163.3 22.33 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.046 -1.434 . . . . 2.5899999999999999 109.994 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -139.21 114.8 9.9 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 112.328 -2.214 . . . . 0.92000000000000004 109.604 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 3.2 m -92.26 148.22 22.31 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.153 -1.84 . . . . 0.76000000000000001 106.516 169.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.46 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.2 t80 -144.75 98.96 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.211 1.005 . . . . 1.8 111.011 -170.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' A' ' 67' ' ' SER . 2.5 p30 -113.69 128.23 56.34 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.697 -1.592 . . . . 2.4199999999999999 110.342 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 5.1 mmm180 -105.95 29.03 7.03 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.705 -1.589 . . . . 3.0800000000000001 109.295 172.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.04 -30.17 6.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.195 -1.82 . . . . 1.6899999999999999 109.27 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 5.7 t -111.91 -8.47 14.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.89 -1.05 . . . . 1.96 108.939 178.016 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 72.48 31.68 1.72 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.547 -0.909 . . . . 3.7799999999999998 108.547 173.654 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.43 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 3.3 t -127.33 133.8 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 122.506 1.146 . . . . 1.1299999999999999 111.473 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' SER . 5.0 m-85 -101.96 113.39 26.57 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.26 -1.755 . . . . 1.95 106.26 162.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 14.7 tp -97.36 104.82 16.88 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 122.302 1.049 . . . . 1.1799999999999999 109.391 177.623 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.4 m-85 -88.64 114.58 25.4 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.833 -1.53 . . . . 0.40000000000000002 108.534 174.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.52 125.66 50.21 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 113.708 -1.587 . . . . 1.3200000000000001 109.566 -176.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.865 HD22 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -94.08 122.23 36.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.862 -1.162 . . . . 1.5900000000000001 107.862 171.701 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.646 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 11.4 m170 -115.79 93.83 4.43 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.967 -2.605 . . . . 2.0099999999999998 103.967 169.593 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.877 HG12 ' HB2' ' A' ' 57' ' ' LEU . 38.0 mt -121.78 100.79 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 122.883 1.325 . . . . 1.1899999999999999 110.026 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 72.4 p -103.02 154.61 19.07 Favored 'General case' 0 N--CA 1.391 -3.395 0 CA-C-N 114.057 -1.429 . . . . 1.05 109.051 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.89 84.26 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.115 -2.766 . . . . 2.1200000000000001 112.064 178.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.84 132.28 43.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 110.731 -2.94 . . . . 1.0900000000000001 112.252 -175.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.722 HE21 ' HD2' ' A' ' 81' ' ' PRO . 3.2 tp60 -54.01 125.62 49.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.402 -0.817 . . . . 1.77 109.323 170.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.722 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.4 Cg_endo -59.23 -7.19 4.67 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.738 2.959 . . . . 1.3300000000000001 114.03 -175.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.597 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.6 0.41 19.08 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.974 -0.29 . . . . 1.6599999999999999 111.569 -178.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.63 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.48 -58.09 9.57 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.642 0.258 . . . . 1.24 110.889 -172.601 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 34.2 m 38.64 66.2 0.55 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.592 -1.633 . . . . 1.6799999999999999 106.592 -155.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -62.72 84.77 0.04 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 CA-C-N 112.445 -2.162 . . . . 2.0 114.139 -161.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -86.72 82.78 1.62 Allowed Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.916 -1.673 . . . . 0.81000000000000005 108.916 175.307 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 18.1 m-85 -78.75 113.99 17.3 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.779 -1.211 . . . . 1.0800000000000001 107.998 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.658 ' HB2' ' HD2' ' A' ' 42' ' ' PHE . 7.4 mtp180 -104.02 105.95 16.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.267 0.556 . . . . 3.6899999999999999 109.854 -176.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.451 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.8 t -87.71 126.96 35.28 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.568 -0.742 . . . . 1.22 109.076 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.924 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 37.6 tt0 -136.03 110.37 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.222 -0.899 . . . . 1.8100000000000001 109.606 -175.572 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 39' ' ' VAL . 1.7 p -106.27 142.3 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.957 0.408 . . . . 1.24 111.046 -179.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.549 ' O ' HG12 ' A' ' 38' ' ' VAL . 20.7 t -132.13 108.28 9.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.919 -1.141 . . . . 1.6399999999999999 107.919 177.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.068 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -131.44 146.62 52.34 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 117.912 -1.042 . . . . 1.26 108.501 -178.639 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.917 ' HD3' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 32.74 -74.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.642 1.839 . . . . 0.93999999999999995 112.976 -177.558 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.784 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 22.2 t70 -147.69 -7.56 0.44 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.569 -1.196 . . . . 1.05 110.429 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.889 ' HD2' ' HB ' ' A' ' 4' ' ' ILE . 2.7 tttp -86.38 131.65 34.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.998 -1.112 . . . . 1.78 107.998 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -133.2 120.45 21.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.485 -1.689 . . . . 1.0 110.233 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -139.69 148.27 42.11 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.502 -1.226 . . . . 1.6000000000000001 109.338 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 43.8 m -140.0 149.17 42.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.371 -0.377 . . . . 1.98 110.303 -179.032 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.777 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 40.7 p -131.9 134.43 45.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 1.02 111.273 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.526 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -107.78 119.43 39.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 1.5800000000000001 110.096 177.356 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.757 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -142.27 118.56 10.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.137 -0.69 . . . . 1.1000000000000001 109.137 -179.105 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.525 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 3.7 p30 -106.43 154.6 20.58 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 123.034 1.397 . . . . 2.1099999999999999 111.876 -170.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -116.57 106.42 13.54 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.924 -1.944 . . . . 1.0900000000000001 110.456 178.517 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -87.43 95.86 10.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.334 -0.987 . . . . 1.0700000000000001 108.334 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 80' ' ' GLN . 7.2 p -83.37 120.23 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 122.876 1.322 . . . . 1.1399999999999999 108.54 -177.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 98.8 m-70 -93.81 98.31 10.99 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 112.892 -1.958 . . . . 1.8200000000000001 109.322 -176.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 . . . . . 0 C--N 1.302 -1.48 0 CA-C-N 114.258 -1.337 . . . . 1.6699999999999999 109.665 171.218 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 8.2 m-20 . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 109.311 -0.626 . . . . 1.6499999999999999 109.311 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.22 81.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.464 2.109 . . . . 1.24 111.596 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.558 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -102.0 -62.51 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 115.457 -0.792 . . . . 1.2 109.608 178.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.12 40.71 3.68 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.987 -1.645 . . . . 0.44 108.987 -176.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' A' ' 96' ' ' LYS . 9.7 tp -55.07 -33.62 62.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.42 -1.39 . . . . 1.1100000000000001 110.131 -172.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CZ ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -97.81 84.58 3.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.391 -1.277 . . . . 0.97999999999999998 109.608 176.847 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.65 -46.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.664 -1.153 . . . . 1.1100000000000001 110.374 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ttt -159.74 134.46 7.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.851 -1.068 . . . . 3.3100000000000001 108.567 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.817 ' HD2' ' CZ ' ' A' ' 7' ' ' PHE . 5.5 mmp_? -125.25 145.66 51.45 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 116.173 -0.467 . . . . 4.1699999999999999 111.077 -172.023 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.792 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -70.73 159.4 52.82 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.773 1.649 . . . . 0.81999999999999995 110.573 179.145 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -124.79 -176.81 3.64 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.04 -0.527 . . . . 1.6299999999999999 110.142 -173.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 3.7 p-10 -68.27 -152.34 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.732 0 CA-C-O 122.869 1.318 . . . . 2.0600000000000001 111.211 -177.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 153.17 139.1 2.81 Favored Glycine 0 C--N 1.287 -2.171 0 CA-C-N 113.044 -1.889 . . . . 0.34999999999999998 111.744 -173.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 21.2 mt-10 -115.07 114.96 26.05 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.297 -0.952 . . . . 1.53 109.055 175.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -136.4 158.32 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 N-CA-C 107.104 -1.443 . . . . 1.0800000000000001 107.104 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.04 157.74 18.24 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.83 -1.077 . . . . 1.22 109.548 -178.873 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 22.6 t -64.99 107.06 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 123.088 1.423 . . . . 1.3799999999999999 108.554 173.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 10.12 16.34 Favored Glycine 0 C--N 1.267 -3.284 0 CA-C-N 111.882 -2.417 . . . . 0.52000000000000002 113.041 175.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 -123.14 3.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 119.703 -1.237 . . . . 0.44 110.198 175.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.9 p -152.43 164.24 37.93 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 112.989 -1.605 . . . . 1.23 110.817 176.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 tp -148.29 150.96 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 113.609 -1.632 . . . . 1.0900000000000001 107.774 170.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.8 m -138.54 129.28 26.47 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 113.941 -1.481 . . . . 1.05 110.996 -176.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.682 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 87.7 m-85 -125.21 145.19 50.09 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.955 -1.475 . . . . 0.71999999999999997 109.089 178.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -137.43 124.86 21.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.943 -0.762 . . . . 0.87 108.943 174.352 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.663 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.85 114.4 19.81 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.741 -1.118 . . . . 1.1000000000000001 110.208 -176.252 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HG2' HD11 ' A' ' 71' ' ' LEU . 67.7 mtp180 -104.86 128.98 53.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.504 -0.316 . . . . 2.9300000000000002 110.267 -176.024 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.1 t -125.5 127.48 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.902 0.858 . . . . 1.0700000000000001 109.964 -177.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.11 108.82 1.33 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.961 -1.472 . . . . 1.1200000000000001 110.939 175.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.665 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.62 -54.92 11.95 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.76000000000000001 112.35 173.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 57.57 -166.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.275 0.843 . . . . 1.0 113.275 177.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -107.73 127.65 53.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.37 -0.832 . . . . 2.1699999999999999 109.037 172.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -123.41 -178.86 4.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.088 0.947 . . . . 2.6299999999999999 112.319 -168.665 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' H ' ' HB3' ' A' ' 94' ' ' LYS . 17.4 tp -88.29 -37.36 16.07 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.586 -1.643 . . . . 1.99 106.846 154.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.35 145.8 19.07 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.595 -1.184 . . . . 1.8799999999999999 110.895 171.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.82 148.48 12.42 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.348 2.699 . . . . 1.1200000000000001 112.27 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.595 ' HA ' HG22 ' A' ' 93' ' ' THR . 6.3 Cg_endo -55.21 132.26 51.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.091 1.861 . . . . 0.81999999999999995 113.572 -175.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.13 106.28 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.277 -1.749 . . . . 1.4299999999999999 106.277 174.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -115.08 114.31 46.1 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 113.703 -1.589 . . . . 1.0900000000000001 108.03 179.082 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.774 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.84 128.72 45.91 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 123.066 1.413 . . . . 2.1299999999999999 109.19 172.906 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.981 ' HB3' HD12 ' A' ' 49' ' ' LEU . 60.0 m95 -87.89 153.54 21.23 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 112.061 -2.336 . . . . 0.40999999999999998 110.709 172.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -135.01 125.23 26.15 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.202 -2.147 . . . . 0.80000000000000004 105.202 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HB3' HG11 ' A' ' 47' ' ' VAL . 27.1 tttt -104.09 99.57 9.31 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.38 -1.711 . . . . 2.6800000000000002 106.38 -175.481 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.676 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -86.45 95.14 2.01 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 115.882 -3.056 . . . . 1.6000000000000001 117.078 -154.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.926 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -101.69 -48.17 4.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.007 -2.59 . . . . 4.2999999999999998 104.007 135.322 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.926 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 11.6 p-90 -170.41 1.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 112.676 -2.056 . . . . 2.5099999999999998 111.915 175.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -97.35 169.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 C-N-CA 125.275 1.43 . . . . 1.78 113.171 -159.427 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.532 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 m-20 -100.95 147.45 26.15 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 112.456 -2.156 . . . . 2.73 107.527 173.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.981 HD12 ' HB3' ' A' ' 41' ' ' TRP . 5.3 mp -79.21 -29.25 42.72 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.678 -0.409 . . . . 1.1299999999999999 110.639 173.383 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -57.36 -20.93 32.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 1.71 109.608 -167.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.475 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -97.59 -27.85 14.21 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 119.78 -0.768 . . . . 1.76 111.79 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 57' ' ' LEU . 5.9 mmmt -95.68 -33.37 12.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.392 -0.822 . . . . 1.9099999999999999 111.319 -171.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 49' ' ' LEU . 53.8 t -40.79 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 126.02 1.728 . . . . 1.1499999999999999 111.908 175.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.89 -103.2 0.19 Allowed Glycine 0 C--N 1.302 -1.353 0 CA-C-N 112.427 -2.17 . . . . 0.69999999999999996 113.42 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.11 -54.68 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.118 0.784 . . . . 3.3599999999999999 113.118 -169.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -96.05 -29.37 14.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.487 0.661 . . . . 1.78 111.189 -174.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.918 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.12 106.05 13.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.541 -1.651 . . . . 1.72 106.541 173.494 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -104.68 118.28 36.18 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.074 -1.454 . . . . 0.96999999999999997 107.074 167.119 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.641 ' H ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -98.96 92.83 5.7 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.211 -2.144 . . . . 1.0600000000000001 105.211 172.073 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.674 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.2 m170 -91.31 162.91 14.41 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.161 -1.381 . . . . 2.5899999999999999 110.21 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.45 122.95 20.83 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 112.348 -2.205 . . . . 0.92000000000000004 110.145 176.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -97.0 148.54 22.87 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 111.367 -2.651 . . . . 0.76000000000000001 108.559 176.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 37.3 t80 -127.78 99.83 5.7 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.352 1.072 . . . . 1.8 111.563 -170.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.822 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 3.2 m-20 -113.44 103.96 11.8 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.036 -1.893 . . . . 2.4199999999999999 109.285 172.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.46 ' HD3' ' HZ3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -85.9 -42.1 14.38 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.054 -0.521 . . . . 3.0800000000000001 110.26 174.495 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.38 61.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.295 -0.866 . . . . 1.6899999999999999 110.637 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.822 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 9.4 m -99.67 -16.3 18.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.8 -1.185 . . . . 1.96 107.8 175.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.577 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 68.24 31.62 5.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.362 -1.29 . . . . 3.7799999999999998 110.001 172.523 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 2.6 t -129.97 122.54 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-N 115.48 -0.782 . . . . 1.1299999999999999 110.175 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.665 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 46.2 m-85 -95.92 113.22 24.83 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.026 -1.472 . . . . 1.95 107.026 164.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 25' ' ' SER . 22.6 tp -97.47 105.02 17.1 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.106 0.955 . . . . 1.1799999999999999 108.78 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.0 m-85 -86.19 111.65 20.59 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.262 -1.755 . . . . 0.40000000000000002 106.262 170.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.674 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -116.57 129.52 56.22 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 114.348 -1.296 . . . . 1.3200000000000001 110.344 -174.833 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.742 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.5 mt -92.29 135.92 33.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 113.789 -1.551 . . . . 1.5900000000000001 108.635 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -120.09 97.32 5.54 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 103.915 -2.624 . . . . 2.0099999999999998 103.915 165.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.742 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -125.48 100.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 122.982 1.372 . . . . 1.1899999999999999 109.153 -175.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 40.7 p -97.6 165.12 12.13 Favored 'General case' 0 N--CA 1.381 -3.886 0 CA-C-N 114.004 -1.453 . . . . 1.05 107.866 178.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.4 84.27 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 111.404 -2.635 . . . . 2.1200000000000001 112.755 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -76.66 132.69 39.53 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 111.574 -2.557 . . . . 1.0900000000000001 108.383 176.084 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.553 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 1.1 pt20 -93.63 152.02 40.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.616 -0.883 . . . . 1.77 108.616 -178.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.478 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 36.8 Cg_endo -63.92 -16.84 57.15 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.75 2.3 . . . . 1.3300000000000001 113.403 -167.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.616 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -92.04 13.06 19.87 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.961 -0.563 . . . . 1.6599999999999999 111.68 -176.576 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.577 ' CD1' ' HD2' ' A' ' 45' ' ' LYS . 15.9 m-30 -89.09 -61.17 1.76 Allowed 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.258 -0.577 . . . . 1.24 110.52 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.3 m 36.7 63.16 0.69 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.027 -1.471 . . . . 1.6799999999999999 107.027 -158.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.676 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -67.21 90.94 0.19 Allowed Glycine 0 CA--C 1.481 -2.055 0 CA-C-N 111.978 -2.374 . . . . 2.0 113.782 -160.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.504 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -84.72 82.04 1.71 Allowed Glycine 0 C--N 1.277 -2.715 0 N-CA-C 107.933 -2.067 . . . . 0.81000000000000005 107.933 168.302 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 8.3 m-85 -74.71 134.33 41.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.653 -1.274 . . . . 1.0800000000000001 108.088 179.283 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -126.44 138.12 53.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.92 -0.4 . . . . 3.6899999999999999 109.92 -178.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.674 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 4.3 m -112.09 116.42 30.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.415 -0.957 . . . . 1.22 108.415 168.065 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.774 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 64.5 mt-10 -110.19 102.07 10.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.544 -1.28 . . . . 1.8100000000000001 107.544 176.302 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.7 p -99.19 135.92 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.752 0.787 . . . . 1.24 111.36 -173.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.6 t -130.07 108.89 10.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.891 -1.504 . . . . 1.6399999999999999 107.862 -179.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.5 m -130.3 158.47 39.7 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.8 -1.095 . . . . 1.26 108.054 179.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.685 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 10.96 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 125.819 1.949 . . . . 0.93999999999999995 114.342 -177.489 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.685 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -146.18 -3.16 0.67 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.923 -1.035 . . . . 1.05 110.193 -176.694 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.6 ' HB3' HD23 ' A' ' 6' ' ' LEU . 4.5 mmtp -95.39 129.63 42.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.612 -0.884 . . . . 1.78 108.612 -177.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -131.7 128.63 39.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.81 -1.087 . . . . 1.0 112.341 -178.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.7 160.47 43.82 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.46 -1.245 . . . . 1.6000000000000001 109.95 175.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -140.95 145.86 36.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.624 0.25 . . . . 1.98 110.487 176.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.849 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 89.2 p -126.8 135.53 51.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.542 -0.299 . . . . 1.02 110.915 -175.645 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.33 128.49 51.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.378 0.609 . . . . 1.5800000000000001 111.05 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.849 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 0.1 OUTLIER -143.08 119.0 10.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.6 -0.727 . . . . 1.1000000000000001 109.694 -177.143 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -104.32 129.58 52.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.423 1.106 . . . . 2.1099999999999999 113.114 -170.007 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -102.75 111.98 24.55 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.526 -1.67 . . . . 1.0900000000000001 109.733 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.5 m -90.62 98.38 11.74 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.977 -0.749 . . . . 1.0700000000000001 108.977 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 80' ' ' GLN . 5.6 p -81.9 115.02 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-O 122.967 1.365 . . . . 1.1399999999999999 109.399 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.7 m170 -83.14 99.79 10.13 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.71 -2.041 . . . . 1.8200000000000001 110.05 -176.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 3.0 tm-20 . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.307 -1.315 . . . . 1.6699999999999999 109.101 170.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.831 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 4.5 t70 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 108.625 -0.88 . . . . 1.6499999999999999 108.625 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 3.0 Cg_endo -46.59 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.385 3.39 . . . . 1.24 113.954 179.013 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.665 HD13 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -123.29 -65.18 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.97 -1.014 . . . . 1.2 109.124 175.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.503 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 90.05 47.74 3.79 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 108.131 -1.987 . . . . 0.44 108.131 -174.167 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 4' ' ' ILE . 8.7 tp -58.12 -41.49 83.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.783 -1.709 . . . . 1.1100000000000001 110.346 -167.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.814 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.02 85.67 6.01 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.887 0.851 . . . . 0.97999999999999998 109.772 174.796 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.08 -40.02 85.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.774 -1.557 . . . . 1.1100000000000001 110.078 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.459 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 57.3 ttm -153.42 134.58 14.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 3.3100000000000001 110.19 176.37 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.658 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 6.8 mtm180 -91.91 139.35 24.58 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 107.905 -1.146 . . . . 4.1699999999999999 107.905 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 40.2 Cg_endo -78.64 -163.85 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.981 2.454 . . . . 0.81999999999999995 113.509 -175.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -127.26 131.29 50.58 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.745 -0.661 . . . . 1.6299999999999999 111.405 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.577 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 8.4 m-20 -43.91 -98.99 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.668 1.587 . . . . 2.0600000000000001 113.162 -176.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.3 145.93 4.36 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-O 121.769 0.649 . . . . 0.34999999999999998 111.758 169.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.5 112.1 10.0 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.966 -0.617 . . . . 1.53 109.707 170.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 22' ' ' ILE . 10.4 m -138.87 165.87 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.093 -1.077 . . . . 1.0800000000000001 108.093 -172.174 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.94 157.38 15.92 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.932 -1.031 . . . . 1.22 109.288 178.074 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.515 ' CG1' ' HD3' ' A' ' 81' ' ' PRO . 59.5 t -64.77 106.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 122.96 1.362 . . . . 1.3799999999999999 109.583 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.7 10.68 14.14 Favored Glycine 0 C--N 1.272 -2.995 0 CA-C-N 112.105 -2.316 . . . . 0.52000000000000002 113.561 171.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.35 -122.15 3.56 Favored Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 118.615 -1.755 . . . . 0.44 110.457 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 5.7 p -151.03 165.05 34.97 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 112.716 -1.742 . . . . 1.23 110.302 177.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.627 HG22 HD11 ' A' ' 104' ' ' LEU . 8.3 tp -147.98 150.2 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 113.665 -1.607 . . . . 1.0900000000000001 106.837 172.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -138.55 132.8 31.68 Favored 'General case' 0 C--N 1.263 -3.184 0 CA-C-N 114.672 -1.149 . . . . 1.05 110.623 -174.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.779 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 18.6 m-85 -128.38 137.71 52.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.228 -1.351 . . . . 0.71999999999999997 109.98 -175.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.408 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.79 124.3 16.85 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.985 0.898 . . . . 0.87 111.262 172.694 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -122.94 129.26 51.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.011 -1.449 . . . . 1.1000000000000001 110.328 -178.321 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.459 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 54.2 mtt180 -107.31 126.39 52.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.404 -0.362 . . . . 2.9300000000000002 111.688 -174.849 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 20.1 t -128.37 131.87 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.93 0.871 . . . . 1.0700000000000001 110.137 -177.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.96 118.1 9.27 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.614 -1.63 . . . . 1.1200000000000001 111.439 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.78 -33.66 56.04 Favored Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.579 -1.192 . . . . 0.76000000000000001 110.868 168.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 59.58 -164.19 0.22 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.735 1.383 . . . . 1.0 114.735 162.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -113.48 118.4 34.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.01 -1.45 . . . . 2.1699999999999999 107.446 170.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.72 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.61 166.03 33.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.436 0.532 . . . . 2.6299999999999999 112.436 -165.564 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 35' ' ' LYS . 1.8 mt -81.86 -30.36 32.08 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.576 1.179 . . . . 1.99 109.528 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -150.6 139.36 12.95 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 112.673 -2.058 . . . . 1.8799999999999999 108.661 -166.81 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -47.4 141.87 13.61 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.571 2.181 . . . . 1.1200000000000001 111.397 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.72 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_exo -63.0 130.16 28.22 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.297 1.331 . . . . 0.81999999999999995 111.536 -175.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.13 104.11 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.052 -1.462 . . . . 1.4299999999999999 107.052 179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.1 t -107.69 113.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 113.444 -1.707 . . . . 1.0900000000000001 107.387 176.236 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.753 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -98.42 119.0 36.36 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 122.95 1.357 . . . . 2.1299999999999999 110.062 176.029 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.672 ' HB3' HD23 ' A' ' 49' ' ' LEU . 46.5 m95 -86.61 139.26 30.98 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 112.079 -2.328 . . . . 0.40999999999999998 110.662 175.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 58.1 t80 -117.55 153.75 32.68 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.166 -1.42 . . . . 0.80000000000000004 107.166 170.775 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.98 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 22.9 tptt -106.6 165.57 11.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.601 -0.888 . . . . 2.6800000000000002 108.601 -172.176 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 1.039 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -25.14 168.47 0.0 OUTLIER Glycine 0 C--O 1.204 -1.76 0 O-C-N 124.348 1.03 . . . . 1.6000000000000001 114.749 169.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.921 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 ptmt -39.86 0.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 119.763 3.245 . . . . 4.2999999999999998 119.763 -140.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.921 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -162.6 -15.54 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.96 1.255 . . . . 2.5099999999999998 113.594 -179.413 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.698 HG12 ' CZ3' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -94.62 166.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.812 0 CA-C-O 122.816 1.293 . . . . 1.78 110.114 -164.687 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.699 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 3.0 p-10 -113.65 154.81 26.61 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 112.489 -2.141 . . . . 2.73 108.867 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.98 ' CD1' ' HB2' ' A' ' 43' ' ' LYS . 5.3 mp -92.35 -23.73 19.14 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.163 0.431 . . . . 1.1299999999999999 112.163 169.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 t -61.06 -21.58 63.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.883 -0.784 . . . . 1.71 108.883 -168.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.587 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 22.1 m -101.35 -41.59 6.62 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.315 1.055 . . . . 1.76 110.457 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.699 ' HD3' ' O ' ' A' ' 48' ' ' ASP . 3.7 mptp? -73.74 -75.58 0.15 Allowed 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 113.398 -1.728 . . . . 1.9099999999999999 111.821 -168.201 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.755 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 25.2 t 7.66 87.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 126.189 2.181 . . . . 1.1499999999999999 113.908 175.117 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.64 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -155.5 -131.54 1.45 Allowed Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.824 -1.989 . . . . 0.69999999999999996 111.693 179.068 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -42.35 93.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.246 0.832 . . . . 3.3599999999999999 113.246 -169.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.9 p80 -92.98 -38.11 11.84 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.548 -0.461 . . . . 1.78 112.075 -175.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.12 105.73 10.88 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.353 -1.351 . . . . 1.72 107.353 175.526 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -99.43 113.14 25.32 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.831 -1.544 . . . . 0.96999999999999997 106.831 164.656 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.943 ' HB2' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -93.0 94.45 8.9 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 103.538 -2.764 . . . . 1.0600000000000001 103.538 168.515 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.518 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 41.4 m-70 -96.38 164.67 12.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 123.259 1.504 . . . . 2.5899999999999999 111.344 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.43 120.93 17.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 110.847 -2.888 . . . . 0.92000000000000004 108.498 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.28 116.06 25.47 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.41 -1.723 . . . . 0.76000000000000001 109.933 172.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -121.23 106.91 11.94 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.935 -1.03 . . . . 1.8 110.843 -169.843 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -106.14 102.16 11.6 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.67 -1.15 . . . . 2.4199999999999999 109.252 172.318 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.79 -30.26 70.42 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.197 -1.365 . . . . 3.0800000000000001 111.352 -174.051 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.14 -12.32 60.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.763 -0.653 . . . . 1.6899999999999999 110.659 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.429 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 14.7 m -101.33 -15.85 17.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.935 -1.135 . . . . 1.96 107.935 173.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER 68.62 31.17 4.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.565 -1.198 . . . . 3.7799999999999998 109.822 179.192 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -132.91 134.3 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.661 0.743 . . . . 1.1299999999999999 110.329 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.482 ' CD2' ' HB2' ' A' ' 63' ' ' TYR . 3.0 m-85 -104.24 111.52 24.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.311 -1.737 . . . . 1.95 106.311 162.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 25' ' ' SER . 29.2 tp -94.41 104.98 16.95 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.668 -1.234 . . . . 1.1799999999999999 107.668 175.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 83.0 m-85 -86.81 113.81 22.94 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 106.642 -1.614 . . . . 0.40000000000000002 106.642 171.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.95 121.94 36.63 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 113.724 -1.58 . . . . 1.3200000000000001 110.172 -173.568 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.909 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -92.11 132.97 36.19 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.758 -1.564 . . . . 1.5900000000000001 108.399 179.114 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.37 98.62 7.03 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 103.603 -2.74 . . . . 2.0099999999999998 103.603 167.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.721 HG13 ' HB3' ' A' ' 74' ' ' LEU . 8.5 mt -124.55 100.24 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-O 122.97 1.367 . . . . 1.1899999999999999 109.282 -174.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 77.3 p -102.25 166.07 10.78 Favored 'General case' 0 N--CA 1.384 -3.736 0 CA-C-N 114.101 -1.409 . . . . 1.05 108.5 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.44 76.17 0.18 Allowed 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 111.454 -2.612 . . . . 2.1200000000000001 111.318 176.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.79 108.11 9.58 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.9 -1.955 . . . . 1.0900000000000001 110.694 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.447 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -54.23 143.43 44.8 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 1.77 109.948 167.612 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.515 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 23.4 Cg_endo -61.12 -8.39 9.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.105 2.536 . . . . 1.3300000000000001 113.25 -179.125 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.43 12.05 30.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.33 -0.395 . . . . 1.6599999999999999 110.992 178.262 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -97.56 -3.81 38.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 118.102 -0.952 . . . . 1.24 111.08 -178.296 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.1 m -18.17 93.99 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.453 1.721 . . . . 1.6799999999999999 111.291 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.84 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -40.51 114.51 0.53 Allowed Glycine 0 CA--C 1.465 -3.093 0 CA-C-N 109.626 -3.443 . . . . 2.0 114.24 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 1.039 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -131.68 60.69 0.67 Allowed Glycine 0 N--CA 1.405 -3.411 0 CA-C-N 111.394 -2.403 . . . . 0.81000000000000005 108.941 159.544 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.799 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 31.2 m-85 -77.79 108.0 10.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.863 -1.162 . . . . 1.0800000000000001 107.863 178.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.413 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 16.0 tpt180 -106.21 112.49 25.54 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.258 0.552 . . . . 3.6899999999999999 110.616 -175.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 38.0 m -99.7 118.23 35.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.66 -0.7 . . . . 1.22 110.241 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.753 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 76.0 mt-10 -129.18 116.56 19.39 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.711 -0.477 . . . . 1.8100000000000001 109.711 175.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 p -95.41 139.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.517 0.675 . . . . 1.24 110.141 177.084 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.8 m -134.41 108.5 8.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.862 -1.063 . . . . 1.6399999999999999 108.271 -176.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.7 HG21 ' H ' ' A' ' 94' ' ' LYS . 1.1 m -131.26 -176.75 4.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.412 -0.813 . . . . 1.26 109.92 -176.056 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.933 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -10.41 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 125.04 1.462 . . . . 0.93999999999999995 114.688 -177.343 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.933 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.8 t70 -159.33 0.74 0.08 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.522 -1.217 . . . . 1.05 109.338 -175.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.588 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -100.95 145.21 28.95 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.223 1.011 . . . . 1.78 109.718 -177.769 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -134.77 136.8 42.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.653 -2.067 . . . . 1.0 110.315 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.579 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 m-20 -155.09 154.66 32.75 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.048 -0.978 . . . . 1.6000000000000001 108.623 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 9.2 p -155.8 154.45 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.296 0.48 . . . . 1.98 112.296 -175.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.814 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 79.9 p -132.01 147.79 52.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.86 -0.609 . . . . 1.02 112.367 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.16 144.76 26.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.326 -0.852 . . . . 1.5800000000000001 110.606 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.779 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 7.6 m-85 -137.73 103.51 5.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.558 -0.746 . . . . 1.1000000000000001 110.318 172.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.77 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -105.67 110.55 22.9 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 118.743 -1.183 . . . . 2.1099999999999999 112.363 170.414 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.84 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -98.02 106.98 19.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.146 -1.388 . . . . 1.0900000000000001 109.755 -179.265 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -83.77 96.65 8.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.512 -0.551 . . . . 1.0700000000000001 109.512 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 18' ' ' VAL . 3.4 p -80.65 112.45 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.875 1.321 . . . . 1.1399999999999999 109.118 177.34 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.642 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.0 m170 -80.44 99.74 8.14 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.027 -1.897 . . . . 1.8200000000000001 110.656 -176.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.489 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 32.3 tt0 . . . . . 0 C--N 1.303 -1.414 0 CA-C-N 114.452 -1.249 . . . . 1.6699999999999999 110.244 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.819 ' HB3' ' HA ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.158 1.54 . . . . 1.9299999999999999 115.158 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.13 170.57 12.16 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 114.858 -1.065 . . . . 1.6499999999999999 111.003 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.28 69.98 2.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.916 2.411 . . . . 1.24 112.374 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.593 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -92.88 -54.61 7.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.013 -0.994 . . . . 1.2 109.323 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.23 6.24 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.798 -2.121 . . . . 0.44 107.798 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.917 HD23 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -53.34 -36.57 61.46 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 112.78 -1.71 . . . . 1.1100000000000001 110.575 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.545 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -94.82 85.29 4.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.367 -0.833 . . . . 0.97999999999999998 109.642 172.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.88 -49.02 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.6 -1.182 . . . . 1.1100000000000001 109.719 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.0 tpt -143.74 133.73 24.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 3.3100000000000001 108.912 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 20.7 ptt180 -103.86 132.84 20.65 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.107 -0.497 . . . . 4.1699999999999999 111.405 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.1 Cg_endo -64.34 151.63 84.69 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.683 2.255 . . . . 0.81999999999999995 111.328 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.8 mm-40 -121.13 176.54 5.54 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.042 -0.527 . . . . 1.6299999999999999 110.452 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.23 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.524 1.154 . . . . 2.0600000000000001 111.586 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.27 135.61 2.0 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.11 -1.405 . . . . 0.34999999999999998 111.953 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.842 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 44.8 mt-10 -114.01 115.05 27.0 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.332 -0.934 . . . . 1.53 108.943 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -136.07 163.23 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 N-CA-C 107.645 -1.242 . . . . 1.0800000000000001 107.645 -173.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.44 152.36 19.14 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.866 -1.061 . . . . 1.22 108.925 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.691 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -73.3 106.6 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 123.897 1.808 . . . . 1.3799999999999999 109.419 172.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.59 -3.93 5.44 Favored Glycine 0 C--N 1.274 -2.873 0 CA-C-N 110.331 -3.122 . . . . 0.52000000000000002 111.196 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.13 -127.5 5.94 Favored Glycine 0 N--CA 1.411 -2.988 0 C-N-CA 119.24 -1.457 . . . . 0.44 110.217 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 9.5 p -150.85 170.08 20.14 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.0 -1.6 . . . . 1.23 110.76 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 104' ' ' LEU . 8.7 tp -147.16 149.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 113.592 -1.64 . . . . 1.0900000000000001 108.065 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 m -138.87 128.51 24.71 Favored 'General case' 0 C--N 1.268 -2.973 0 CA-C-N 113.503 -1.681 . . . . 1.05 110.73 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.454 ' HB2' ' CG ' ' A' ' 74' ' ' LEU . 45.2 m-85 -125.19 152.69 44.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.182 -1.372 . . . . 0.71999999999999997 108.44 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.51 125.98 18.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.214 -0.662 . . . . 0.87 109.214 175.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.612 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.11 121.03 36.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.161 -0.927 . . . . 1.1000000000000001 110.367 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 56.3 mtp180 -108.02 117.08 33.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.353 -0.385 . . . . 2.9300000000000002 110.021 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 23.6 t -120.87 130.53 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.286 1.041 . . . . 1.0700000000000001 110.436 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.896 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -60.96 109.12 0.98 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.286 -1.779 . . . . 1.1200000000000001 113.696 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.56 3.04 Favored Glycine 0 N--CA 1.462 0.401 0 CA-C-N 114.728 -1.123 . . . . 0.76000000000000001 113.091 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.593 ' HB3' ' CE ' ' A' ' 68' ' ' LYS . . . -50.68 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 114.669 1.359 . . . . 1.0 114.669 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -81.58 127.59 33.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.481 -1.236 . . . . 2.1699999999999999 108.361 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.817 HD12 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -157.12 177.79 11.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.168 -0.469 . . . . 2.6299999999999999 111.179 -172.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.83 -51.09 71.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.45 0.643 . . . . 1.99 109.287 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.47 149.41 26.29 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.785 -1.098 . . . . 1.8799999999999999 108.718 171.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HB3' ' HH ' ' A' ' 70' ' ' TYR . 79.2 Cg_exo -43.01 143.9 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.524 2.816 . . . . 1.1200000000000001 112.651 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.817 ' HD3' HD12 ' A' ' 33' ' ' LEU . 2.0 Cg_endo -48.7 133.03 26.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.715 1.61 . . . . 0.81999999999999995 113.25 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.1 105.99 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 106.54 -1.652 . . . . 1.4299999999999999 106.54 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.629 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.27 114.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 CA-C-N 113.655 -1.611 . . . . 1.0900000000000001 107.962 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.5 127.3 49.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 123.456 1.598 . . . . 2.1299999999999999 110.096 173.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.026 ' HB3' HD12 ' A' ' 49' ' ' LEU . 86.0 m95 -87.04 155.47 20.14 Favored 'General case' 0 C--N 1.273 -2.724 0 CA-C-N 111.178 -2.737 . . . . 0.40999999999999998 112.05 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.5 t80 -134.26 135.94 43.25 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 104.173 -2.528 . . . . 0.80000000000000004 104.173 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 50.8 tttm -98.43 171.85 7.9 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.023 -1.843 . . . . 2.6800000000000002 106.023 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.988 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -15.43 -172.48 0.0 OUTLIER Glycine 0 C--O 1.178 -3.358 0 N-CA-C 119.117 2.407 . . . . 1.6000000000000001 119.117 172.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.62 -8.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.169 2.285 . . . . 4.2999999999999998 117.169 -162.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ3' HG11 ' A' ' 47' ' ' VAL . 11.1 p-90 -162.09 -6.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.012 1.115 . . . . 2.5099999999999998 114.012 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.894 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.5 163.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.769 0 CA-C-O 123.712 1.72 . . . . 1.78 112.565 -161.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.679 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.6 p-10 -109.94 157.65 19.04 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.987 -2.824 . . . . 2.73 105.925 170.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.026 HD12 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -99.34 -30.11 12.4 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.294 -0.562 . . . . 1.1299999999999999 112.185 168.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.2 t -56.9 -21.63 31.21 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.038 0.535 . . . . 1.71 109.733 -164.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -99.9 -36.12 9.51 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.86 0.838 . . . . 1.76 111.503 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.679 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -87.68 -31.85 19.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.406 -1.27 . . . . 1.9099999999999999 111.319 -167.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 49' ' ' LEU . 52.4 t -36.43 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 125.391 1.476 . . . . 1.1499999999999999 111.215 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.59 -93.71 0.1 OUTLIER Glycine 0 C--N 1.298 -1.536 0 CA-C-N 112.701 -2.045 . . . . 0.69999999999999996 113.812 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -94.15 -44.84 7.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.578 0.584 . . . . 3.3599999999999999 112.578 -168.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 19.6 p80 -95.76 -36.21 11.25 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.339 0.59 . . . . 1.78 110.731 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.992 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -115.55 106.38 13.87 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.1 -1.815 . . . . 1.72 106.1 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.76 115.19 29.71 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 106.75 -1.574 . . . . 0.96999999999999997 106.75 166.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.659 HD13 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -100.42 92.26 5.08 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.742 -2.318 . . . . 1.0600000000000001 104.742 172.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.666 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 44.0 m170 -86.09 163.82 17.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.096 -1.411 . . . . 2.5899999999999999 110.916 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.17 115.74 16.76 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.847 -1.979 . . . . 0.92000000000000004 109.649 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -98.11 149.3 22.65 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 112.759 -2.019 . . . . 0.76000000000000001 107.839 170.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.86 99.04 3.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.48 1.133 . . . . 1.8 110.961 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.7 m-20 -110.26 107.19 16.87 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 112.904 -1.953 . . . . 2.4199999999999999 108.954 176.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -45.94 61.35 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.604 -0.725 . . . . 3.0800000000000001 110.333 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.34 -30.33 71.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.745 -1.116 . . . . 1.6899999999999999 110.984 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 19.5 m -89.49 -19.35 25.18 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.977 -0.749 . . . . 1.96 108.977 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.896 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 2.2 ttpm? 61.92 41.05 11.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.078 -0.965 . . . . 3.7799999999999998 108.399 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.491 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 21.9 t -133.27 124.92 50.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.875 -1.057 . . . . 1.1299999999999999 111.139 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.3 m-30 -97.81 106.06 18.3 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.992 -1.855 . . . . 1.95 105.992 163.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 7.9 tp -95.07 105.27 17.18 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 122.622 1.201 . . . . 1.1799999999999999 108.984 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.9 m-85 -85.66 114.7 22.84 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.469 -1.696 . . . . 0.40000000000000002 108.289 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 30.5 mt-10 -96.48 134.54 39.53 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.461 -1.7 . . . . 1.3200000000000001 108.628 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.871 HD23 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -106.75 111.36 23.85 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.564 -1.273 . . . . 1.5900000000000001 107.564 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -108.7 94.24 4.95 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 103.403 -2.814 . . . . 2.0099999999999998 103.403 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 57' ' ' LEU . 57.5 mt -120.77 100.89 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.698 1.237 . . . . 1.1899999999999999 109.214 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 60.1 p -100.58 165.9 11.18 Favored 'General case' 0 N--CA 1.391 -3.425 0 CA-C-N 114.355 -1.293 . . . . 1.05 109.364 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 50.68 73.5 0.28 Allowed 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 110.848 -2.887 . . . . 2.1200000000000001 111.722 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB1' HD23 ' A' ' 104' ' ' LEU . . . -73.71 112.32 9.7 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 113.004 -1.907 . . . . 1.0900000000000001 110.017 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.808 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.38 146.62 52.44 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 1.77 110.029 171.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.691 ' HD3' HG21 ' A' ' 18' ' ' VAL . 19.9 Cg_endo -61.15 -13.89 30.58 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.554 2.17 . . . . 1.3300000000000001 112.742 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.808 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -104.4 17.24 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.031 -0.531 . . . . 1.6599999999999999 110.45 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.6 OUTLIER -95.31 -11.29 28.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.393 -0.813 . . . . 1.24 111.005 -177.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m -17.97 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 125.668 1.855 . . . . 1.6799999999999999 111.74 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.988 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -56.9 120.51 20.97 Favored Glycine 0 N--CA 1.404 -3.441 0 CA-C-N 110.633 -2.985 . . . . 2.0 114.876 -167.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.67 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -115.5 72.31 0.25 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 112.359 -1.92 . . . . 0.81000000000000005 108.556 152.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.699 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 56.0 m-85 -77.04 118.38 19.54 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.728 -0.842 . . . . 1.0800000000000001 108.728 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 29.4 mtp180 -114.38 125.08 53.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.212 -0.662 . . . . 3.6899999999999999 109.212 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 2.9 t -112.6 117.52 32.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.899 -0.778 . . . . 1.22 108.899 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 36.0 mt-10 -132.4 104.02 6.5 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.179 -0.919 . . . . 1.8100000000000001 110.115 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.629 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -94.04 142.53 13.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.418 0.628 . . . . 1.24 110.267 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.7 t -134.83 108.18 7.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.914 -1.039 . . . . 1.6399999999999999 108.337 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -132.35 153.18 51.0 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.958 -1.02 . . . . 1.26 108.649 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.718 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 23.2 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.691 1.87 . . . . 0.93999999999999995 113.999 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.718 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 16.6 t70 -144.17 -3.78 0.84 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.829 -1.078 . . . . 1.05 109.802 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.917 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.32 135.04 33.92 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.148 -1.056 . . . . 1.78 108.148 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.498 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 31.0 t80 -132.71 131.29 41.09 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.898 -1.501 . . . . 1.0 110.503 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.78 149.98 31.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.635 -1.166 . . . . 1.6000000000000001 108.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 7.4 p -152.77 154.37 35.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.243 0.544 . . . . 1.98 112.216 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.577 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 11.6 p -129.86 150.6 51.09 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.773 0.797 . . . . 1.02 112.06 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.531 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.0 OUTLIER -131.31 109.42 10.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.038 -1.437 . . . . 1.5800000000000001 109.38 177.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.838 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.8 p90 -142.72 129.71 20.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.374 0.607 . . . . 1.1000000000000001 109.667 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.5 p30 -101.93 157.96 16.48 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.899 1.333 . . . . 2.1099999999999999 111.954 -172.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -121.71 109.65 14.99 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.18 -1.827 . . . . 1.0900000000000001 109.745 171.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 28.9 m -91.23 97.69 11.28 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.187 -0.671 . . . . 1.0700000000000001 109.187 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 80' ' ' GLN . 4.6 p -81.3 116.2 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 123.204 1.478 . . . . 1.1399999999999999 109.292 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.842 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 94.9 m-70 -88.81 100.26 13.02 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.571 -2.104 . . . . 1.8200000000000001 109.002 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.49 ' HA ' ' CG1' ' A' ' 18' ' ' VAL . 31.4 tt0 -62.02 -64.42 0.94 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.704 -1.135 . . . . 1.6699999999999999 109.82 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.43 -51.84 2.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 2.98 110.031 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 C--O 1.244 0.778 0 CA-C-N 115.845 -0.616 . . . . 7.3399999999999999 109.642 178.385 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.806 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.192 0.52 . . . . 1.9299999999999999 112.251 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.572 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 23.8 m-20 -82.52 174.14 6.51 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-N 115.458 -0.792 . . . . 1.6499999999999999 110.246 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.84 86.91 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.478 2.118 . . . . 1.24 112.349 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.795 HD12 ' HZ3' ' A' ' 94' ' ' LYS . 1.8 mp -116.45 -60.29 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 1.2 109.513 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.69 5.59 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 108.473 -1.851 . . . . 0.44 108.473 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.708 HD13 ' HB3' ' A' ' 37' ' ' PRO . 12.1 tp -53.67 -45.43 70.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.403 -1.899 . . . . 1.1100000000000001 111.87 -168.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.694 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.82 84.78 3.95 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.562 0.696 . . . . 0.97999999999999998 109.818 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.48 -40.55 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.152 -1.385 . . . . 1.1100000000000001 110.686 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.5 ttm -157.57 132.1 8.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.916 -0.584 . . . . 3.3100000000000001 110.18 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.539 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 13.2 ptp180 -103.67 139.25 19.93 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.046 -0.979 . . . . 4.1699999999999999 109.865 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -75.19 165.28 31.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.382 1.388 . . . . 0.81999999999999995 111.135 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -122.91 -177.63 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.043 -0.526 . . . . 1.6299999999999999 110.343 -172.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 5.1 p-10 -67.94 -150.48 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-O 123.076 1.417 . . . . 2.0600000000000001 111.704 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.456 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 152.97 131.44 1.64 Allowed Glycine 0 C--N 1.291 -1.945 0 CA-C-N 112.762 -2.017 . . . . 0.34999999999999998 112.063 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -110.54 110.93 21.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.422 -0.955 . . . . 1.53 108.422 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 m -130.58 141.82 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 107.598 -1.26 . . . . 1.0800000000000001 107.598 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.763 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -77.52 156.88 30.69 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.871 -1.059 . . . . 1.22 109.387 -177.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 79' ' ' ALA . 3.9 t -66.38 105.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 CA-C-O 122.767 1.27 . . . . 1.3799999999999999 107.886 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.0 10.01 Favored Glycine 0 C--N 1.266 -3.318 0 CA-C-N 112.36 -2.2 . . . . 0.52000000000000002 112.688 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.84 4.94 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 118.668 -1.729 . . . . 0.44 108.92 172.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.9 p -151.43 163.57 38.68 Favored 'General case' 0 N--CA 1.397 -3.124 0 CA-C-N 112.882 -1.659 . . . . 1.23 110.527 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 76' ' ' ILE . 9.4 tp -136.67 146.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.141 -1.845 . . . . 1.0900000000000001 107.106 171.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -137.91 125.07 21.57 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 113.088 -1.869 . . . . 1.05 110.743 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.501 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 75.5 m-85 -123.36 143.24 50.23 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.266 -1.334 . . . . 0.71999999999999997 109.239 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -131.99 118.73 20.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.277 -0.874 . . . . 0.87 109.79 177.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -117.11 116.15 26.76 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.514 -1.221 . . . . 1.1000000000000001 110.145 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.27 124.2 49.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.362 -0.211 . . . . 2.9300000000000002 110.886 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.56 130.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 122.093 0.949 . . . . 1.0700000000000001 110.589 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.841 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -63.66 111.54 2.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.25 -1.795 . . . . 1.1200000000000001 111.589 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.837 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.49 -53.04 17.69 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 114.761 -1.108 . . . . 0.76000000000000001 111.976 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.704 ' CA ' ' HE3' ' A' ' 68' ' ' LYS . . . 59.96 -174.22 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.666 0.987 . . . . 1.0 113.666 169.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -111.61 128.87 56.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.69 -1.141 . . . . 2.1699999999999999 108.975 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.35 -179.47 7.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.155 0.503 . . . . 2.6299999999999999 111.992 -170.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.08 -44.31 80.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.82 -1.082 . . . . 1.99 108.962 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.59 148.26 23.29 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.909 -1.041 . . . . 1.8799999999999999 109.547 175.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HB3' ' HH ' ' A' ' 70' ' ' TYR . 88.8 Cg_exo -47.64 142.38 13.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.231 2.62 . . . . 1.1200000000000001 111.507 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HB3' HD13 ' A' ' 6' ' ' LEU . 1.8 Cg_endo -49.11 131.9 26.89 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.897 1.731 . . . . 0.81999999999999995 113.002 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.74 104.97 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 106.922 -1.51 . . . . 1.4299999999999999 106.922 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -108.33 114.08 45.63 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 112.81 -1.996 . . . . 1.0900000000000001 107.306 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.61 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.91 125.37 48.58 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-O 123.266 1.508 . . . . 2.1299999999999999 110.132 174.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.913 ' HB3' HD12 ' A' ' 49' ' ' LEU . 55.2 m95 -83.49 157.06 22.54 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 111.39 -2.641 . . . . 0.40999999999999998 111.555 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 20.3 t80 -135.66 139.55 43.82 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 104.794 -2.299 . . . . 0.80000000000000004 104.794 168.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.956 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttm -100.63 167.24 10.46 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.424 -2.435 . . . . 2.6800000000000002 104.424 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.26 -165.51 0.0 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 118.982 2.353 . . . . 1.6000000000000001 118.982 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.525 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 15.0 mtpt -45.23 -11.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.095 0 O-C-N 118.592 -2.71 . . . . 4.2999999999999998 116.417 -168.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -164.18 -2.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.83 1.418 . . . . 2.5099999999999998 114.83 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.956 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.73 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-O 122.942 1.353 . . . . 1.78 112.173 -163.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 1.5 p-10 -109.66 101.71 10.6 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 112.29 -2.232 . . . . 2.73 112.191 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.981 HD23 HD23 ' A' ' 57' ' ' LEU . 5.1 mp -54.34 -34.89 62.02 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.041 0.756 . . . . 1.1299999999999999 113.041 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 m -57.28 -21.9 37.82 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.548 0.69 . . . . 1.71 109.668 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.444 ' HB2' ' CD ' ' A' ' 52' ' ' LYS . 22.7 m -98.19 -34.91 10.55 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.982 -1.008 . . . . 1.76 111.707 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.557 ' HB2' HD12 ' A' ' 57' ' ' LEU . 3.0 mmmt -90.92 -36.06 14.36 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.941 -1.027 . . . . 1.9099999999999999 111.67 -168.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.629 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 44.3 t -37.54 96.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 125.888 1.675 . . . . 1.1499999999999999 111.869 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.705 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -153.41 -111.84 0.46 Allowed Glycine 0 C--N 1.298 -1.541 0 CA-C-N 111.546 -2.57 . . . . 0.69999999999999996 112.742 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.873 HE21 ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -95.73 -27.44 15.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.348 0.87 . . . . 3.3599999999999999 113.348 -169.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -95.36 -36.45 11.37 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.574 0.702 . . . . 1.78 110.439 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.981 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.69 105.49 11.22 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.14 -1.8 . . . . 1.72 106.14 172.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -98.56 115.86 29.53 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.658 -1.608 . . . . 0.96999999999999997 106.658 165.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.564 ' HA ' HD23 ' A' ' 74' ' ' LEU . 0.8 OUTLIER -92.05 92.09 8.11 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 103.495 -2.78 . . . . 1.0600000000000001 103.495 167.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.683 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -92.33 164.22 13.59 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 113.896 -1.502 . . . . 2.5899999999999999 109.502 -173.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -137.26 117.98 14.04 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 111.341 -2.663 . . . . 0.92000000000000004 109.998 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -101.28 142.52 32.58 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.622 -2.081 . . . . 0.76000000000000001 106.895 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -137.91 98.58 3.68 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.757 1.265 . . . . 1.8 110.792 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.27 105.72 13.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 113.132 -1.849 . . . . 2.4199999999999999 109.695 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.561 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -74.83 -29.83 61.18 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.845 -1.071 . . . . 3.0800000000000001 110.796 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -35.27 80.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.34 -0.845 . . . . 1.6899999999999999 110.93 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -98.85 -12.38 20.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.641 -0.708 . . . . 1.96 109.839 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.841 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 18.4 tttt 67.22 33.7 5.34 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.745 0.783 . . . . 3.7799999999999998 109.564 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.24 128.33 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.969 -0.559 . . . . 1.1299999999999999 109.685 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.837 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 22.5 m-85 -95.71 116.2 28.53 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.586 -2.005 . . . . 1.95 105.586 162.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 25' ' ' SER . 38.0 tp -94.08 104.13 16.17 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.517 -1.29 . . . . 1.1799999999999999 107.517 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.9 m-85 -83.04 110.66 18.18 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.117 -1.809 . . . . 0.40000000000000002 106.117 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.683 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.2 pt-20 -114.75 122.7 47.21 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.666 -1.606 . . . . 1.3200000000000001 110.278 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.4 mt -91.46 131.07 37.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.201 -1.363 . . . . 1.5900000000000001 108.374 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -117.85 95.47 4.94 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 103.077 -2.934 . . . . 2.0099999999999998 103.077 167.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.726 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.4 mt -121.24 100.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.979 0 CA-C-O 122.902 1.334 . . . . 1.1899999999999999 108.619 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.1 p -104.43 165.16 11.24 Favored 'General case' 0 N--CA 1.389 -3.519 0 CA-C-N 114.116 -1.402 . . . . 1.05 109.941 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 38.45 75.73 0.07 Allowed 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 110.563 -3.017 . . . . 2.1200000000000001 111.84 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.516 ' O ' HG11 ' A' ' 18' ' ' VAL . . . -68.74 117.77 10.87 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.789 -2.914 . . . . 1.0900000000000001 111.074 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.806 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -51.27 135.03 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.848 -0.797 . . . . 1.77 108.848 165.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.596 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 19.3 Cg_endo -60.0 -13.49 23.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.932 2.421 . . . . 1.3300000000000001 112.685 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.806 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -96.6 15.48 21.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.974 -0.557 . . . . 1.6599999999999999 110.797 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.1 m-30 -95.09 -10.59 30.26 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.972 -0.381 . . . . 1.24 109.972 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.6 m -46.28 98.51 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.829 0 O-C-N 124.606 1.191 . . . . 1.6799999999999999 108.732 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -169.35 -130.1 1.17 Allowed Glycine 0 C--N 1.266 -3.353 0 CA-C-N 112.698 -2.046 . . . . 2.0 113.145 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.0 118.74 0.9 Allowed Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 119.962 -1.113 . . . . 0.81000000000000005 112.695 -170.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.874 ' HH ' ' HZ1' ' A' ' 43' ' ' LYS . 1.3 m-85 -85.13 134.95 34.16 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.04 -1.58 . . . . 1.0800000000000001 107.577 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 63.7 mtt180 -118.99 155.07 32.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.204 0.526 . . . . 3.6899999999999999 110.6 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.643 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 75.0 m -131.31 132.26 44.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.825 -1.176 . . . . 1.22 107.825 163.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.61 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 35.0 tt0 -134.95 103.33 5.54 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.723 -1.214 . . . . 1.8100000000000001 107.723 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.528 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.6 p -99.6 134.91 37.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.983 0.897 . . . . 1.24 110.835 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -133.46 108.5 8.69 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.794 -1.548 . . . . 1.6399999999999999 108.864 -176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.68 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -132.09 155.13 48.66 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.376 -0.972 . . . . 1.26 108.376 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.795 ' HZ3' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 18.61 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 125.601 1.813 . . . . 0.93999999999999995 114.882 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.778 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 5.0 t70 -151.81 1.23 0.36 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.748 -1.115 . . . . 1.05 109.668 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.806 ' HE3' ' HB3' ' A' ' 1' ' ' ASP . 2.2 mmtp -98.17 130.05 44.93 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.961 -1.126 . . . . 1.78 107.961 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -131.26 147.17 52.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.991 -1.004 . . . . 1.0 111.189 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -172.13 166.24 6.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.933 -0.765 . . . . 1.6000000000000001 108.933 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.4 p -155.67 156.76 35.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 1.98 110.461 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.694 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 30.8 p -135.39 147.63 49.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.715 -0.675 . . . . 1.02 111.086 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.456 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -127.19 121.92 32.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 1.5800000000000001 110.066 177.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.711 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -141.98 116.66 9.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.121 0.486 . . . . 1.1000000000000001 109.796 -175.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.549 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.3 p30 -100.3 146.26 27.14 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 122.418 1.104 . . . . 2.1099999999999999 111.88 -169.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -116.76 122.91 45.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.219 -1.355 . . . . 1.0900000000000001 109.349 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -101.58 96.69 7.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.508 -0.923 . . . . 1.0700000000000001 108.508 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 3.8 p -79.19 114.58 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-O 123.203 1.477 . . . . 1.1399999999999999 109.711 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.763 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 9.3 m-70 -79.97 99.33 7.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.098 -2.319 . . . . 1.8200000000000001 109.816 -175.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.479 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 35.5 tt0 -68.34 -69.42 0.33 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.039 -1.437 . . . . 1.6699999999999999 109.348 172.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.51 18.1 1.31 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.817 -0.629 . . . . 2.98 112.131 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.497 -0.763 . . . . 7.3399999999999999 109.858 -179.742 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 121.853 0.835 . . . . 1.9299999999999999 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.461 ' HB2' ' CE ' ' A' ' 94' ' ' LYS . 8.4 m-20 -92.09 168.79 12.19 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.303 -1.317 . . . . 1.6499999999999999 109.624 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 84.41 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.24 1.96 . . . . 1.24 113.132 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.819 HD11 ' HE2' ' A' ' 94' ' ' LYS . 1.8 mp -110.71 -66.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.11 -0.95 . . . . 1.2 109.187 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.85 37.47 6.06 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 108.573 -1.811 . . . . 0.44 108.573 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.2 tp -38.57 -51.34 1.62 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.767 -1.716 . . . . 1.1100000000000001 110.858 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.699 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -85.93 85.57 7.37 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 121.635 0.731 . . . . 0.97999999999999998 110.537 175.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.92 -33.8 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.09 -1.414 . . . . 1.1100000000000001 109.553 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.431 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 18.5 ttt -163.69 136.98 5.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.361 -0.836 . . . . 3.3100000000000001 110.226 174.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.617 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 6.1 ptt180 -116.11 137.57 23.52 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.031 -0.531 . . . . 4.1699999999999999 110.761 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.685 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -71.58 176.66 7.8 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.986 2.457 . . . . 0.81999999999999995 112.585 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -126.91 177.08 6.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.647 -0.706 . . . . 1.6299999999999999 110.671 -175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.5 p-10 -71.42 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.602 1.191 . . . . 2.0600000000000001 111.641 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.06 137.44 2.59 Favored Glycine 0 N--CA 1.426 -2.003 0 CA-C-N 113.821 -1.536 . . . . 0.34999999999999998 111.807 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.482 ' HG3' ' CD2' ' A' ' 107' ' ' HIS . 27.9 tt0 -113.33 115.14 27.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.094 -1.053 . . . . 1.53 109.497 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -139.46 163.16 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 N-CA-C 107.308 -1.367 . . . . 1.0800000000000001 107.308 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -93.92 162.02 14.07 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.548 -0.751 . . . . 1.22 109.617 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG22 ' HB3' ' A' ' 81' ' ' PRO . 3.5 t -72.74 105.64 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.458 0 N-CA-C 107.205 -1.405 . . . . 1.3799999999999999 107.205 172.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.41 3.05 6.23 Favored Glycine 0 C--N 1.263 -3.506 0 CA-C-N 112.685 -2.052 . . . . 0.52000000000000002 111.472 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.9 -131.92 7.48 Favored Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 118.78 -1.676 . . . . 0.44 109.094 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.2 p -152.22 168.26 25.93 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 113.016 -1.592 . . . . 1.23 110.872 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.576 HG22 HD11 ' A' ' 104' ' ' LEU . 10.7 tp -147.74 149.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 CA-C-N 113.274 -1.784 . . . . 1.0900000000000001 107.536 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 m -139.22 127.08 22.13 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-N 113.513 -1.676 . . . . 1.05 111.098 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' HB2' HD21 ' A' ' 74' ' ' LEU . 33.0 m-85 -122.65 148.24 45.5 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.952 -1.476 . . . . 0.71999999999999997 108.392 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -135.01 122.48 21.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.575 -0.898 . . . . 0.87 108.575 175.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.727 ' HB1' ' HH2' ' A' ' 41' ' ' TRP . . . -126.09 126.64 44.53 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.943 -1.026 . . . . 1.1000000000000001 111.086 -174.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HB3' HG11 ' A' ' 69' ' ' VAL . 52.0 mtt180 -113.68 123.65 50.42 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.416 -0.356 . . . . 2.9300000000000002 111.135 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.0 t -122.33 125.13 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.946 0.879 . . . . 1.0700000000000001 109.837 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.91 111.11 0.76 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.505 -1.679 . . . . 1.1200000000000001 111.094 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.769 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -52.87 -43.06 60.68 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.177 -1.374 . . . . 0.76000000000000001 111.162 171.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.716 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 49.23 -167.06 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.252 1.204 . . . . 1.0 114.252 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -119.77 123.13 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.062 -1.426 . . . . 2.1699999999999999 107.527 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.79 HD12 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -149.78 178.58 8.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.838 0.681 . . . . 2.6299999999999999 112.838 -168.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.05 -57.23 4.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.989 -1.005 . . . . 1.99 109.234 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.646 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -129.58 145.54 57.36 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.468 -0.787 . . . . 1.8799999999999999 109.726 171.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.46 138.89 10.15 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 122.78 2.32 . . . . 1.1200000000000001 110.961 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.79 ' HD3' HD12 ' A' ' 33' ' ' LEU . 27.0 Cg_exo -58.82 136.98 77.28 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.443 1.429 . . . . 0.81999999999999995 111.961 -172.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.04 104.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.369 -1.715 . . . . 1.4299999999999999 106.369 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.516 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -107.25 114.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 113.44 -1.709 . . . . 1.0900000000000001 107.21 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.78 129.39 53.05 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 123.222 1.487 . . . . 2.1299999999999999 110.078 175.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.044 ' HB3' HD11 ' A' ' 49' ' ' LEU . 87.6 m95 -90.84 141.84 28.39 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.794 -2.457 . . . . 0.40999999999999998 111.268 171.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.7 t80 -125.82 125.79 43.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.785 -1.931 . . . . 0.80000000000000004 105.785 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 29.6 ttpt -103.65 108.59 19.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.8 -1.555 . . . . 2.6800000000000002 106.8 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.564 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -79.77 92.02 1.32 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 115.997 -3.001 . . . . 1.6000000000000001 113.968 -165.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.717 ' HG3' ' HA ' ' A' ' 83' ' ' PHE . 32.9 tttt -106.58 -32.77 7.9 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 104.24 -2.504 . . . . 4.2999999999999998 104.24 138.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.752 ' HD1' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER 157.85 -13.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 110.921 -2.854 . . . . 2.5099999999999998 111.447 -165.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.752 HG21 ' HD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -94.76 173.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 CA-C-O 122.994 1.378 . . . . 1.78 111.909 -168.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 5.4 m-20 -104.38 155.91 18.38 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.927 -2.397 . . . . 2.73 106.228 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.044 HD11 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -84.79 -32.33 23.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 118.325 0.512 . . . . 1.1299999999999999 111.464 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -20.35 37.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.711 0.767 . . . . 1.71 110.244 -167.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.742 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 26.4 t -92.22 -30.42 15.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.72 -1.127 . . . . 1.76 111.132 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.742 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 3.7 mmmt -98.81 -42.08 7.35 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.631 -1.168 . . . . 1.9099999999999999 112.122 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.9 t -22.57 95.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.208 1.803 . . . . 1.1499999999999999 112.987 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.71 -126.61 1.36 Allowed Glycine 0 C--N 1.303 -1.275 0 CA-C-N 112.138 -2.301 . . . . 0.69999999999999996 113.157 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.91 -20.08 31.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.881 0.697 . . . . 3.3599999999999999 112.881 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.7 p80 -100.72 -37.56 8.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.347 0.594 . . . . 1.78 110.427 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.938 HD22 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.89 103.7 10.21 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.03 -1.841 . . . . 1.72 106.03 172.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -95.43 115.22 27.13 Favored 'General case' 0 N--CA 1.409 -2.521 0 N-CA-C 105.809 -1.922 . . . . 0.96999999999999997 105.809 167.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.757 HD13 ' CD1' ' A' ' 41' ' ' TRP . 0.6 OUTLIER -98.94 91.58 5.11 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 103.496 -2.779 . . . . 1.0600000000000001 103.496 167.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 5.8 t-80 -99.75 164.65 11.95 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.21 -1.814 . . . . 2.5899999999999999 108.728 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.51 126.37 27.53 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 113.191 -1.822 . . . . 0.92000000000000004 111.933 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.543 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -103.24 148.04 26.3 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 110.996 -2.82 . . . . 0.76000000000000001 108.24 169.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.0 101.31 3.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.976 0.893 . . . . 1.8 110.987 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.53 109.17 17.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.322 -1.308 . . . . 2.4199999999999999 111.006 169.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -72.64 -31.44 65.13 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.445 -0.798 . . . . 3.0800000000000001 111.013 177.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -14.93 63.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.759 -0.655 . . . . 1.6899999999999999 110.431 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -106.8 -20.18 13.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.808 -1.182 . . . . 1.96 107.808 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER 60.54 40.2 17.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.652 -1.158 . . . . 3.7799999999999998 109.292 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 27' ' ' ARG . 13.8 t -133.39 143.06 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.242 -0.89 . . . . 1.1299999999999999 109.776 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.769 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 27.9 m-85 -105.62 113.05 26.38 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.622 -1.622 . . . . 1.95 106.622 163.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 10.1 tp -94.91 105.61 17.54 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 122.261 1.029 . . . . 1.1799999999999999 108.762 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.1 m-85 -87.88 115.32 25.26 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.001 -1.454 . . . . 0.40000000000000002 108.275 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -98.55 132.86 43.64 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.045 -1.889 . . . . 1.3200000000000001 108.353 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.808 HD23 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -103.64 115.7 30.97 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.488 -1.301 . . . . 1.5900000000000001 107.488 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -113.65 95.21 5.22 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.583 -2.377 . . . . 2.0099999999999998 104.583 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.618 HG12 HD23 ' A' ' 57' ' ' LEU . 63.7 mt -119.55 100.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.928 1.347 . . . . 1.1899999999999999 110.36 -174.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 82.5 p -106.45 135.78 47.36 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.435 -1.711 . . . . 1.05 108.262 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.65 101.47 0.05 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 111.714 -2.493 . . . . 2.1200000000000001 110.174 -174.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.585 ' O ' HG11 ' A' ' 18' ' ' VAL . . . -94.87 124.68 39.06 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 109.72 -3.4 . . . . 1.0900000000000001 109.402 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.729 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.64 130.94 77.65 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.295 -0.631 . . . . 1.77 109.295 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.771 ' HB3' HG22 ' A' ' 18' ' ' VAL . 19.1 Cg_endo -60.74 -10.65 14.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.129 2.553 . . . . 1.3300000000000001 112.855 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.729 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -113.5 15.4 19.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.046 -0.525 . . . . 1.6599999999999999 111.41 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.717 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -73.5 -57.55 3.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.417 -0.957 . . . . 1.24 108.417 177.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 26.0 m 42.67 62.07 1.86 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.665 -1.606 . . . . 1.6799999999999999 106.665 -158.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -56.53 86.16 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 112.084 -2.326 . . . . 2.0 114.17 -163.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -90.79 83.38 1.3 Allowed Glycine 0 C--N 1.279 -2.62 0 N-CA-C 108.862 -1.695 . . . . 0.81000000000000005 108.862 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.694 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.2 m-85 -78.07 110.93 13.45 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.997 -1.101 . . . . 1.0800000000000001 108.751 -176.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -99.91 109.24 21.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.419 -0.956 . . . . 3.6899999999999999 108.419 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.4 t -97.84 129.58 44.8 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.075 -0.65 . . . . 1.22 109.247 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 53.8 mt-10 -132.15 119.18 20.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.856 -0.611 . . . . 1.8100000000000001 109.664 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.516 ' HB ' HG11 ' A' ' 39' ' ' VAL . 2.6 p -106.42 137.31 37.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.738 0.78 . . . . 1.24 110.794 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.1 t -129.93 109.38 10.85 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.351 -1.295 . . . . 1.6399999999999999 108.313 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 33' ' ' LEU . 1.3 m -127.45 174.98 8.57 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.35 -0.841 . . . . 1.26 109.941 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 1.097 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -3.5 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.431 1.707 . . . . 0.93999999999999995 115.016 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 1.097 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 17.4 t70 -163.93 5.19 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.511 -1.222 . . . . 1.05 109.63 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.856 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -101.83 143.06 32.2 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.733 0.778 . . . . 1.78 109.088 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -131.54 136.47 47.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.165 -1.834 . . . . 1.0 110.815 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 7' ' ' PHE . 4.0 m-20 -155.43 151.73 28.16 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.903 -1.044 . . . . 1.6000000000000001 109.443 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.5 p -152.32 152.62 32.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.98 111.028 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.825 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 96.0 p -130.03 147.23 51.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.227 0.537 . . . . 1.02 111.941 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -126.43 113.44 16.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.406 -0.815 . . . . 1.5800000000000001 110.844 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.845 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 3.8 p90 -143.99 129.99 19.52 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.852 -0.53 . . . . 1.1000000000000001 111.123 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -112.45 127.21 55.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 122.192 0.996 . . . . 2.1099999999999999 113.106 -173.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.576 HD11 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.33 107.6 20.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.848 -1.523 . . . . 1.0900000000000001 109.924 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m -88.85 97.09 10.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.99 -0.745 . . . . 1.0700000000000001 108.99 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 80' ' ' GLN . 7.7 p -86.95 116.97 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.631 1.205 . . . . 1.1399999999999999 110.222 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 15' ' ' GLU . 95.7 m-70 -111.57 93.79 4.64 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.739 -1.573 . . . . 1.8200000000000001 112.138 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' CA ' HG23 ' A' ' 18' ' ' VAL . 31.0 tt0 -61.82 107.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.937 -0.574 . . . . 1.6699999999999999 109.898 164.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.26 -78.23 0.33 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.38 -0.6 . . . . 2.98 109.38 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.241 -0.885 . . . . 7.3399999999999999 109.148 179.038 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.561 ' OD1' ' HG2' ' A' ' 96' ' ' LYS . 9.6 t70 . . . . . 0 CA--C 1.487 -1.458 0 CA-C-O 124.602 2.144 . . . . 1.9299999999999999 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.563 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 4.5 m-20 -106.62 158.62 32.29 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 109.09 -3.686 . . . . 1.6499999999999999 110.988 -166.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.95 83.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.357 2.038 . . . . 1.24 113.734 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 1.077 ' HB ' ' HD3' ' A' ' 96' ' ' LYS . 1.8 mp -110.78 -69.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.026 -0.988 . . . . 1.2 109.22 173.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 92.22 50.15 2.67 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 108.199 -1.96 . . . . 0.44 108.199 -173.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.585 ' N ' HG22 ' A' ' 4' ' ' ILE . 10.1 tp -53.38 -50.29 65.41 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.984 -1.608 . . . . 1.1100000000000001 110.829 -167.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.663 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -86.7 84.46 7.38 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.585 -0.734 . . . . 0.97999999999999998 109.507 174.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -66.03 -39.96 85.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.342 -1.299 . . . . 1.1100000000000001 109.664 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.568 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 21.7 ttt -141.49 133.95 28.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.165 -0.925 . . . . 3.3100000000000001 108.651 169.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.663 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 31.7 mtt180 -99.14 127.27 35.32 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.062 -0.517 . . . . 4.1699999999999999 109.64 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.456 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 10.4 Cg_endo -57.79 151.28 57.24 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.735 2.29 . . . . 0.81999999999999995 111.72 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 19.3 mm-40 -126.46 169.66 12.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 1.6299999999999999 111.467 -169.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.8 m-20 -65.62 -147.19 0.01 OUTLIER 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.952 1.358 . . . . 2.0600000000000001 111.781 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.84 133.6 2.56 Favored Glycine 0 C--N 1.297 -1.6 0 CA-C-N 113.628 -1.623 . . . . 0.34999999999999998 111.678 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.81 114.86 24.53 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.308 -0.946 . . . . 1.53 108.755 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.607 HG22 HD11 ' A' ' 104' ' ' LEU . 3.0 m -136.63 165.0 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 107.755 -1.202 . . . . 1.0800000000000001 107.755 -172.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.546 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -88.48 155.52 19.62 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.934 -1.03 . . . . 1.22 110.273 -176.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.563 HG22 HG23 ' A' ' 106' ' ' VAL . 60.0 t -70.41 105.69 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 122.901 1.334 . . . . 1.3799999999999999 108.253 173.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.01 12.16 Favored Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.412 -2.176 . . . . 0.52000000000000002 112.367 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.86 -123.05 2.99 Favored Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.113 -1.595 . . . . 0.44 109.113 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.6 p -151.99 169.55 22.06 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 112.84 -1.68 . . . . 1.23 110.553 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -145.31 147.19 18.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 113.763 -1.562 . . . . 1.0900000000000001 107.256 167.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -137.96 130.26 29.1 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.851 -1.522 . . . . 1.05 110.916 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 62.9 m-85 -126.43 147.63 49.76 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.203 -1.362 . . . . 0.71999999999999997 110.128 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -136.61 123.72 21.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.953 -1.021 . . . . 0.87 109.248 175.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -119.74 116.31 25.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.745 -1.116 . . . . 1.1000000000000001 110.185 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 39.3 mtt180 -101.21 122.15 43.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.308 -0.406 . . . . 2.9300000000000002 110.77 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 17.2 t -123.82 128.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 122.168 0.985 . . . . 1.0700000000000001 110.248 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.99 114.21 2.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.318 -1.765 . . . . 1.1200000000000001 111.016 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.538 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -55.21 -32.69 57.31 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.343 -1.298 . . . . 0.76000000000000001 111.187 170.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.557 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 56.1 -172.26 0.07 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.791 1.034 . . . . 1.0 113.791 168.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 t -110.0 117.06 32.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 2.1699999999999999 107.061 164.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.777 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -150.98 166.59 30.22 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.891 0.7 . . . . 2.6299999999999999 112.891 -162.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -64.23 -64.56 0.85 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.063 -0.971 . . . . 1.99 109.956 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.56 158.33 74.94 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.266 -1.013 . . . . 1.8799999999999999 108.266 172.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 4.5 Cg_endo -45.79 146.8 3.6 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.246 2.631 . . . . 1.1200000000000001 112.356 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.777 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -62.64 135.65 53.91 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.655 1.57 . . . . 0.81999999999999995 111.248 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.79 104.56 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.614 0 N-CA-C 106.541 -1.651 . . . . 1.4299999999999999 106.541 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.626 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -108.75 114.55 47.08 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-N 113.335 -1.757 . . . . 1.0900000000000001 107.814 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.878 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.89 125.39 50.94 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 123.384 1.564 . . . . 2.1299999999999999 110.412 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.019 ' HB3' HD13 ' A' ' 49' ' ' LEU . 82.5 m95 -88.78 157.23 18.56 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 111.664 -2.516 . . . . 0.40999999999999998 112.564 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.9 t80 -136.79 136.09 38.56 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 104.948 -2.241 . . . . 0.80000000000000004 104.948 166.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.701 ' HE2' HD13 ' A' ' 76' ' ' ILE . 21.1 tttm -112.4 162.12 15.93 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.617 -1.623 . . . . 2.6800000000000002 106.617 -173.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 1.081 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -4.35 -167.78 0.0 OUTLIER Glycine 0 C--O 1.191 -2.594 0 N-CA-C 118.692 2.237 . . . . 1.6000000000000001 118.692 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -44.37 -9.07 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.201 1.926 . . . . 4.2999999999999998 116.201 -166.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CZ3' HG12 ' A' ' 47' ' ' VAL . 30.0 p-90 -167.67 -3.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.012 1.486 . . . . 2.5099999999999998 115.012 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.567 HG12 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -91.13 135.4 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-O 123.496 1.617 . . . . 1.78 112.817 -163.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -104.36 99.33 9.04 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 112.048 -2.342 . . . . 2.73 111.84 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.029 HD21 HD21 ' A' ' 57' ' ' LEU . 4.4 mp -51.93 -38.49 56.6 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.223 1.194 . . . . 1.1299999999999999 114.223 -169.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 t -57.5 -22.22 42.67 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.345 0.593 . . . . 1.71 109.407 -166.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 m -100.38 -28.81 12.75 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.313 -0.858 . . . . 1.76 113.052 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 6.0 mmmt -90.33 -39.8 12.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.085 -0.507 . . . . 1.9099999999999999 111.516 -171.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 59' ' ' LEU . 55.1 t -32.34 95.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 126.449 1.899 . . . . 1.1499999999999999 112.3 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.641 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.82 -103.29 0.21 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 111.707 -2.497 . . . . 0.69999999999999996 113.898 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -95.22 -33.15 12.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.007 0.743 . . . . 3.3599999999999999 113.007 -168.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.598 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 27.6 p80 -97.88 -36.29 10.22 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.653 0.739 . . . . 1.78 110.822 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 1.029 HD21 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.29 106.14 12.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.39 -1.707 . . . . 1.72 106.39 174.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.641 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.87 115.86 30.6 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.517 -1.66 . . . . 0.96999999999999997 106.517 165.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.661 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -103.04 93.64 5.12 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.307 -2.109 . . . . 1.0600000000000001 105.307 172.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 53.2 m-70 -92.86 160.38 14.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-O 122.902 1.334 . . . . 2.5899999999999999 109.499 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -129.29 110.79 12.24 Favored 'General case' 0 C--N 1.265 -3.102 0 CA-C-N 111.458 -2.61 . . . . 0.92000000000000004 108.936 175.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.9 m -92.28 145.38 24.53 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.582 -2.099 . . . . 0.76000000000000001 107.776 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.0 t80 -141.26 99.77 3.65 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.07 0.938 . . . . 1.8 111.57 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -116.46 121.73 42.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.125 -1.398 . . . . 2.4199999999999999 108.811 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -85.36 -39.07 18.04 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 113.721 -1.581 . . . . 3.0800000000000001 112.117 -172.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.23 60.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.604 -0.725 . . . . 1.6899999999999999 111.417 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -95.58 -16.76 21.89 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.283 -1.377 . . . . 1.96 107.283 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 67.59 31.47 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.864 -1.516 . . . . 3.7799999999999998 109.789 173.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.45 128.49 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.764 0.793 . . . . 1.1299999999999999 110.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 62' ' ' SER . 45.8 m-85 -98.47 112.22 24.31 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.143 -1.799 . . . . 1.95 106.143 162.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.4 tp -98.92 106.2 18.44 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.017 0.913 . . . . 1.1799999999999999 108.61 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 51.4 m-85 -84.46 115.65 22.67 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.303 -1.317 . . . . 0.40000000000000002 108.001 172.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.2 123.62 47.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.055 -1.43 . . . . 1.3200000000000001 109.269 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.697 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -94.74 118.9 32.49 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.144 -1.428 . . . . 1.5900000000000001 107.144 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -110.71 95.76 5.76 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 103.556 -2.757 . . . . 2.0099999999999998 103.556 169.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.701 HD13 ' HE2' ' A' ' 43' ' ' LYS . 13.9 mt -123.55 99.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 123.229 1.49 . . . . 1.1899999999999999 108.66 -175.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.8 p -107.53 170.07 8.2 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 113.441 -1.709 . . . . 1.05 108.007 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.9 t70 65.52 33.56 8.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.722 -2.036 . . . . 2.1200000000000001 110.003 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -49.94 112.05 0.61 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.994 -1.912 . . . . 1.0900000000000001 111.7 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.536 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -70.85 153.7 94.65 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.198 -0.91 . . . . 1.77 109.179 173.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.573 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 40.9 Cg_endo -66.9 -3.39 9.46 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.245 1.963 . . . . 1.3300000000000001 113.189 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.536 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.82 17.0 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.265 -0.425 . . . . 1.6599999999999999 110.331 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.3 m-30 -99.56 0.74 42.87 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.658 -0.497 . . . . 1.24 109.658 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 14.9 m -28.97 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 125.779 1.924 . . . . 1.6799999999999999 110.579 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.808 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -34.37 106.84 0.03 OUTLIER Glycine 0 N--CA 1.411 -3.015 0 CA-C-N 109.662 -3.426 . . . . 2.0 114.798 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 1.081 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -122.66 65.39 0.51 Allowed Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.33 -1.908 . . . . 0.81000000000000005 108.33 159.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.695 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 79.0 m-85 -81.48 128.81 34.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.862 -1.169 . . . . 1.0800000000000001 109.562 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -135.04 104.26 5.88 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.772 -0.825 . . . . 3.6899999999999999 108.772 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.462 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -102.11 129.58 48.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.474 -0.491 . . . . 1.22 110.154 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.878 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 22.0 tt0 -131.64 116.37 17.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.472 -0.785 . . . . 1.8100000000000001 110.007 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HB ' HG12 ' A' ' 39' ' ' VAL . 3.3 p -106.39 140.53 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.428 0.632 . . . . 1.24 109.957 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.1 t -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.11 -0.95 . . . . 1.6399999999999999 108.745 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.535 HG22 HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.09 157.46 44.15 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 118.145 -0.931 . . . . 1.26 109.341 -178.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 1.079 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 17.92 -73.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.536 1.772 . . . . 0.93999999999999995 114.662 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 1.079 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.6 t0 -150.74 1.97 0.44 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.058 -0.974 . . . . 1.05 109.697 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.077 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 14.7 mtpp -103.75 146.21 28.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 122.459 1.123 . . . . 1.78 109.541 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -136.14 140.26 43.53 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.279 -2.237 . . . . 1.0 110.6 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.48 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 2.4 m-20 -156.91 149.74 23.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.044 -0.98 . . . . 1.6000000000000001 109.596 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 p -152.69 149.03 27.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.13 0.49 . . . . 1.98 110.975 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 89' ' ' CYS . 3.9 p -127.97 149.6 50.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.6 -0.727 . . . . 1.02 112.268 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.522 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.0 OUTLIER -132.65 109.55 9.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.409 -1.269 . . . . 1.5800000000000001 109.23 178.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.79 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 4.6 p90 -141.37 129.36 21.94 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.823 0.82 . . . . 1.1000000000000001 110.078 -172.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 15.9 m-80 -105.31 146.22 29.67 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.607 -1.178 . . . . 2.1099999999999999 111.107 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.808 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -112.83 118.16 34.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.042 -1.435 . . . . 1.0900000000000001 109.145 173.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 m -95.25 97.51 9.93 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.842 -0.743 . . . . 1.0700000000000001 109.237 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.563 HG23 HG22 ' A' ' 18' ' ' VAL . 7.2 p -86.59 113.31 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 123.331 1.539 . . . . 1.1399999999999999 109.397 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 82.2 m-70 -86.15 99.8 11.77 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.295 -2.229 . . . . 1.8200000000000001 109.354 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 52.7 tt0 -63.45 -74.3 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.321 -0.854 . . . . 1.6699999999999999 111.114 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.54 129.73 52.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.48 -0.327 . . . . 2.98 110.381 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.434 -0.793 . . . . 7.3399999999999999 110.305 179.608 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.477 0.656 . . . . 1.9299999999999999 110.646 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.3 m-20 -101.65 166.71 11.76 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 114.746 -1.116 . . . . 1.6499999999999999 110.057 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.03 45.95 0.39 Allowed 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.296 2.664 . . . . 1.24 113.915 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.649 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.7 mp -63.15 -58.68 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.643 -0.708 . . . . 1.2 110.096 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.85 53.97 3.2 Favored Glycine 0 CA--C 1.492 -1.376 0 N-CA-C 107.625 -2.19 . . . . 0.44 107.625 -173.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.762 HD23 ' HB3' ' A' ' 96' ' ' LYS . 9.2 tp -60.75 -33.62 73.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.978 -1.611 . . . . 1.1100000000000001 110.201 -165.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.793 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.87 84.61 3.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.05 -0.977 . . . . 0.97999999999999998 109.572 172.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.54 -50.7 64.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.545 -1.207 . . . . 1.1100000000000001 109.91 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.634 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 16.5 tpt -147.84 131.18 16.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.2 -0.909 . . . . 3.3100000000000001 108.66 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 34.4 ptt180 -98.65 138.15 20.7 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 116.133 -0.485 . . . . 4.1699999999999999 111.436 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.635 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 28.1 Cg_endo -68.36 153.99 72.98 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.545 2.163 . . . . 0.81999999999999995 111.155 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.0 mm-40 -123.17 173.17 8.06 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.119 -0.491 . . . . 1.6299999999999999 110.514 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.6 p-10 -68.33 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.67 1.224 . . . . 2.0600000000000001 111.537 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 155.76 138.97 2.66 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 113.736 -1.575 . . . . 0.34999999999999998 111.156 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 43.0 mt-10 -117.96 116.93 27.91 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.398 -0.964 . . . . 1.53 108.398 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.08 163.73 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.326 -1.361 . . . . 1.0800000000000001 107.326 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 156.02 16.5 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.962 -1.017 . . . . 1.22 109.304 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG11 ' HD3' ' A' ' 81' ' ' PRO . 47.5 t -57.93 107.45 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 122.81 1.29 . . . . 1.3799999999999999 109.825 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.56 12.25 19.57 Favored Glycine 0 C--N 1.274 -2.862 0 CA-C-N 112.029 -2.351 . . . . 0.52000000000000002 114.07 170.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.8 -122.46 3.46 Favored Glycine 0 CA--C 1.478 -2.256 0 C-N-CA 118.818 -1.658 . . . . 0.44 111.103 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.2 p -151.71 167.91 26.71 Favored 'General case' 0 N--CA 1.403 -2.822 0 CA-C-N 112.474 -1.863 . . . . 1.23 110.408 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 104' ' ' LEU . 10.6 tp -146.29 150.58 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 CA-C-N 112.938 -1.937 . . . . 1.0900000000000001 107.919 169.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 m -137.5 126.19 23.82 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 113.048 -1.887 . . . . 1.05 110.757 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.65 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 37.3 m-85 -122.11 140.99 51.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.033 -1.439 . . . . 0.71999999999999997 109.408 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.78 119.52 22.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.645 -0.707 . . . . 0.87 109.601 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.749 ' HB1' ' CH2' ' A' ' 41' ' ' TRP . . . -121.33 116.75 25.41 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.507 -1.224 . . . . 1.1000000000000001 110.691 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.634 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 28.5 mtp180 -105.05 120.04 40.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.072 -0.513 . . . . 2.9300000000000002 111.142 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.9 t -122.14 132.72 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.707 0.765 . . . . 1.0700000000000001 109.303 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.87 111.24 1.81 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.71 -1.586 . . . . 1.1200000000000001 110.7 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -50.89 -35.12 31.27 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 114.675 -1.148 . . . . 0.76000000000000001 110.295 169.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 4' ' ' ILE . . . 47.09 -143.98 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.38 -0.91 . . . . 1.0 113.383 166.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.528 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -119.58 154.8 33.37 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.327 -1.36 . . . . 2.1699999999999999 107.327 170.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' A' ' 93' ' ' THR . 3.7 tp 171.0 147.53 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.475 -1.306 . . . . 2.6299999999999999 107.475 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.771 ' N ' HD11 ' A' ' 33' ' ' LEU . 24.3 tp -44.91 -42.27 7.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.031 0.92 . . . . 1.99 111.169 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.738 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.47 -179.67 0.79 Allowed Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.197 -1.365 . . . . 1.8799999999999999 108.116 175.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 8.1 Cg_exo -67.9 153.69 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.533 1.489 . . . . 1.1200000000000001 108.888 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 26.4 Cg_exo -60.38 137.23 73.06 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.013 1.809 . . . . 0.81999999999999995 111.548 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.27 102.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 106.94 -1.504 . . . . 1.4299999999999999 106.94 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.667 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -107.59 114.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 CA-C-N 112.839 -1.982 . . . . 1.0900000000000001 106.947 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.688 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.01 127.95 53.09 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 123.313 1.53 . . . . 2.1299999999999999 109.22 173.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.031 ' HB3' HD12 ' A' ' 49' ' ' LEU . 69.4 m95 -85.4 154.25 21.97 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 111.448 -2.615 . . . . 0.40999999999999998 111.111 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.814 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 29.9 t80 -126.22 138.2 53.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.80000000000000004 105.186 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.714 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 71.2 tttt -104.76 165.05 11.33 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.719 -1.956 . . . . 2.6800000000000002 105.719 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.78 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -9.65 -168.79 0.0 OUTLIER Glycine 0 C--O 1.188 -2.747 0 N-CA-C 119.522 2.569 . . . . 1.6000000000000001 119.522 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 84' ' ' THR . 19.5 mtpt -45.47 -1.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 O-C-N 119.463 -2.198 . . . . 4.2999999999999998 116.826 -166.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.689 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 13.8 p-90 -166.03 -10.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.403 1.26 . . . . 2.5099999999999998 114.403 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.689 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.2 170.06 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-O 123.482 1.611 . . . . 1.78 112.492 -162.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.694 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 7.0 p-10 -112.88 158.13 20.57 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 111.825 -2.443 . . . . 2.73 107.528 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.031 HD12 ' HB3' ' A' ' 41' ' ' TRP . 6.0 mp -98.57 -36.94 9.73 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.142 0.423 . . . . 1.1299999999999999 112.142 168.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 t -57.69 -20.76 36.23 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.719 0.637 . . . . 1.71 109.661 -162.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.694 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 17.0 m -100.47 -21.24 15.42 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.619 -0.832 . . . . 1.76 112.855 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.582 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 1.9 mmmt -94.11 -67.93 0.83 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.425 -0.807 . . . . 1.9099999999999999 111.132 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 49' ' ' LEU . 78.5 t 12.8 93.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 126.358 1.863 . . . . 1.1499999999999999 113.593 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.43 -154.49 7.28 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.052 -1.431 . . . . 0.69999999999999996 110.281 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' C ' HE22 ' A' ' 58' ' ' GLN . 55.5 mt-30 -63.98 -5.21 4.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.971 1.1 . . . . 3.3599999999999999 113.971 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -101.83 -41.26 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.768 0.794 . . . . 1.78 110.831 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.897 HD21 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.72 104.73 7.36 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.25 -1.759 . . . . 1.72 106.25 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.844 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -95.1 113.75 25.48 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.259 -2.126 . . . . 0.96999999999999997 105.259 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.611 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -101.74 91.42 4.4 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.065 -2.568 . . . . 1.0600000000000001 104.065 170.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.501 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 45.7 t60 -106.37 162.69 13.47 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.365 -1.289 . . . . 2.5899999999999999 109.279 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -128.65 125.56 38.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 112.331 -2.213 . . . . 0.92000000000000004 110.966 -176.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.649 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -98.78 147.54 24.8 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 110.996 -2.82 . . . . 0.76000000000000001 107.043 169.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.569 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 6.6 t80 -144.25 101.11 3.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.058 0.932 . . . . 1.8 112.312 -168.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 7.7 t70 -117.4 127.63 54.22 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.98 -1.464 . . . . 2.4199999999999999 109.321 168.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -86.75 -41.12 14.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.813 -1.54 . . . . 3.0800000000000001 112.018 -174.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.69 57.93 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.988 -1.005 . . . . 1.6899999999999999 111.102 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 29.6 t -91.19 -19.4 23.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.542 -1.651 . . . . 1.96 106.542 173.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.4 tpmt? 70.69 29.32 3.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.841 -1.527 . . . . 3.7799999999999998 109.722 173.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.04 127.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.83 0.824 . . . . 1.1299999999999999 111.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.525 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 61.2 m-85 -96.89 113.33 24.86 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.182 -1.784 . . . . 1.95 106.182 162.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 36.0 tp -92.4 103.82 16.22 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.345 -0.983 . . . . 1.1799999999999999 108.345 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.3 m-85 -85.26 112.73 21.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.386 -1.709 . . . . 0.40000000000000002 106.386 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 119.92 39.03 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.098 -1.864 . . . . 1.3200000000000001 109.798 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.721 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.6 mt -89.41 130.83 35.71 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 114.116 -1.402 . . . . 1.5900000000000001 107.984 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.844 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 81.7 m-70 -120.69 95.81 4.87 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 104.114 -2.551 . . . . 2.0099999999999998 104.114 168.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.721 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.8 mt -119.77 101.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 113.937 -1.483 . . . . 1.1899999999999999 108.318 -171.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 78.5 p -101.68 166.19 10.82 Favored 'General case' 0 N--CA 1.382 -3.861 0 CA-C-N 113.987 -1.461 . . . . 1.05 109.145 -175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 39.38 78.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 111.362 -2.654 . . . . 2.1200000000000001 112.579 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 104' ' ' LEU . . . -70.77 121.04 17.26 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 111.089 -2.778 . . . . 1.0900000000000001 110.181 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.921 HE21 ' HD2' ' A' ' 81' ' ' PRO . 2.1 tp60 -63.07 137.91 97.19 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.49 -0.777 . . . . 1.77 109.874 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.921 ' HD2' HE21 ' A' ' 80' ' ' GLN . 16.5 Cg_endo -57.73 -12.86 12.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.283 2.655 . . . . 1.3300000000000001 113.545 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.03 21.78 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.339 . . . . 1.6599999999999999 111.245 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -46.89 8.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.536 -0.466 . . . . 1.24 111.984 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 83.2 m 22.67 79.77 0.01 OUTLIER 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.902 1.334 . . . . 1.6799999999999999 110.609 -165.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.78 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.1 99.39 0.5 Allowed Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 112.711 -2.041 . . . . 2.0 114.495 -159.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.715 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -86.59 69.49 3.1 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 109.208 -1.557 . . . . 0.81000000000000005 109.208 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.714 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 77.8 m-85 -78.42 128.11 33.14 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.871 -1.165 . . . . 1.0800000000000001 108.758 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.814 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -122.56 156.72 33.62 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.082 0.468 . . . . 3.6899999999999999 110.618 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 72.6 m -130.55 115.8 17.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.197 -0.668 . . . . 1.22 109.197 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.688 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 39.2 mt-10 -125.34 105.24 8.95 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.627 -0.429 . . . . 1.8100000000000001 109.908 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.667 ' HB ' HG12 ' A' ' 39' ' ' VAL . 2.8 p -103.62 144.1 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 1.24 111.009 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.8 t -135.2 109.09 8.11 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.894 -1.048 . . . . 1.6399999999999999 108.428 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.068 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -131.58 146.78 52.38 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-O 117.55 -1.214 . . . . 1.26 109.353 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.86 -71.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 125.49 1.744 . . . . 0.93999999999999995 113.56 -167.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.766 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -152.18 3.66 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.159 -1.382 . . . . 1.05 110.443 -172.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.762 ' HB3' HD23 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -94.23 142.73 27.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.027 -1.101 . . . . 1.78 108.027 177.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.476 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 31.3 t80 -133.64 132.84 41.23 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.79 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.6 m-20 -151.35 153.05 34.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.063 -0.972 . . . . 1.6000000000000001 110.4 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 33.4 m -148.54 148.84 30.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.117 0.484 . . . . 1.98 111.737 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.793 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 28.9 t -133.4 150.76 51.79 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.804 0.812 . . . . 1.02 111.947 174.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.45 120.86 18.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.752 -1.567 . . . . 1.5800000000000001 109.916 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.739 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 10.1 p90 -143.48 130.57 20.68 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.939 -0.393 . . . . 1.1000000000000001 109.939 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -107.86 128.31 54.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.318 1.056 . . . . 2.1099999999999999 113.359 -170.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -95.08 109.28 21.36 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.842 -1.526 . . . . 1.0900000000000001 109.196 176.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.436 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.0 m -90.43 96.79 10.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.405 -0.591 . . . . 1.0700000000000001 109.405 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 80' ' ' GLN . 3.2 p -77.68 113.36 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 122.765 1.269 . . . . 1.1399999999999999 108.626 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 85.4 m-70 -84.35 97.97 9.77 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.186 -1.825 . . . . 1.8200000000000001 109.664 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.469 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.2 tm-20 -72.79 124.46 25.4 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.491 -1.686 . . . . 1.6699999999999999 109.339 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.58 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.746 0.654 . . . . 2.98 110.259 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.256 -0.878 . . . . 7.3399999999999999 109.93 179.032 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.565 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m-20 . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.88 0.848 . . . . 1.9299999999999999 110.994 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.438 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 m-20 -94.35 161.47 29.19 Favored Pre-proline 0 N--CA 1.429 -1.508 0 CA-C-N 113.79 -1.55 . . . . 1.6499999999999999 109.277 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.83 91.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.38 2.054 . . . . 1.24 112.454 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.788 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -117.8 -64.94 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.335 -0.848 . . . . 1.2 109.174 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 94.11 42.88 3.93 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.208 -1.957 . . . . 0.44 108.208 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.948 HD21 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -52.64 -39.75 62.1 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 112.87 -1.665 . . . . 1.1100000000000001 110.293 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.85 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.9 84.39 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.281 -0.872 . . . . 0.97999999999999998 109.6 177.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.42 -49.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.343 -1.299 . . . . 1.1100000000000001 109.388 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.426 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 24.1 ttt -141.6 136.68 31.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.394 -0.821 . . . . 3.3100000000000001 109.317 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.72 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -110.76 137.99 20.95 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.193 -0.458 . . . . 4.1699999999999999 110.987 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.677 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 4.0 Cg_endo -71.49 155.47 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.223 1.949 . . . . 0.81999999999999995 110.718 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.427 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.2 mm-40 -120.25 177.25 5.09 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.687 -0.486 . . . . 1.6299999999999999 109.687 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.0 p-10 -66.67 -141.59 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 122.884 1.326 . . . . 2.0600000000000001 111.828 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 148.97 133.33 2.22 Favored Glycine 0 C--N 1.291 -1.938 0 CA-C-N 113.586 -1.643 . . . . 0.34999999999999998 111.716 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 28.6 mt-10 -113.62 111.86 22.56 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.357 -0.979 . . . . 1.53 108.357 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.451 ' CG1' HD12 ' A' ' 22' ' ' ILE . 3.0 m -127.74 163.64 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.862 0 N-CA-C 107.252 -1.388 . . . . 1.0800000000000001 107.252 -170.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.55 152.89 18.03 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.83 -1.077 . . . . 1.22 109.13 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.747 HG22 ' HB3' ' A' ' 81' ' ' PRO . 3.7 t -66.67 105.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 122.923 1.344 . . . . 1.3799999999999999 108.123 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.55 5.9 Favored Glycine 0 C--N 1.263 -3.494 0 CA-C-N 111.921 -2.4 . . . . 0.52000000000000002 111.678 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.83 -127.83 6.16 Favored Glycine 0 N--CA 1.409 -3.16 0 C-N-CA 118.932 -1.604 . . . . 0.44 109.188 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.9 p -152.15 174.35 13.83 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.04 -1.58 . . . . 1.23 110.075 177.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.2 tp -147.58 150.47 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-N 113.703 -1.589 . . . . 1.0900000000000001 107.505 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.5 m -138.53 124.01 19.51 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 113.222 -1.808 . . . . 1.05 109.943 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.747 ' HD2' HD12 ' A' ' 74' ' ' LEU . 33.1 m-85 -119.96 146.04 46.19 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.404 -1.271 . . . . 0.71999999999999997 109.015 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.36 120.42 15.59 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.141 -0.936 . . . . 0.87 110.192 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.569 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -120.18 116.22 25.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.478 -1.237 . . . . 1.1000000000000001 110.613 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.5 mtt180 -103.6 121.93 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.557 -0.292 . . . . 2.9300000000000002 110.548 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 23.5 t -123.34 129.42 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.032 0.92 . . . . 1.0700000000000001 110.524 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.78 110.81 2.96 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.36 -1.745 . . . . 1.1200000000000001 111.529 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -51.05 -39.26 40.84 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.856 -1.066 . . . . 0.76000000000000001 112.633 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . . . 58.03 -170.64 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.517 0.727 . . . . 1.0 112.406 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.2 m -73.59 -71.54 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.49 -0.93 . . . . 2.1699999999999999 108.49 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 69.2 158.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 O-C-N 123.782 0.676 . . . . 2.6299999999999999 112.378 166.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.919 ' N ' HD21 ' A' ' 33' ' ' LEU . 19.2 tp -80.71 -66.24 0.91 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.906 -0.588 . . . . 1.99 110.879 168.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.796 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -122.91 130.12 24.73 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 114.281 1.215 . . . . 1.8799999999999999 114.281 172.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' N ' HD12 ' A' ' 33' ' ' LEU . 18.4 Cg_exo -34.36 131.66 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.305 3.337 . . . . 1.1200000000000001 113.171 -171.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.882 ' HG3' HG23 ' A' ' 93' ' ' THR . 34.0 Cg_exo -49.02 133.47 28.65 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 122.484 2.122 . . . . 0.81999999999999995 112.671 -170.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.38 103.6 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.784 -1.562 . . . . 1.4299999999999999 106.784 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.633 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -105.34 113.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.959 -1.928 . . . . 1.0900000000000001 107.504 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HB2' ' HZ2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -102.04 128.7 48.37 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-O 123.331 1.539 . . . . 2.1299999999999999 109.006 174.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.115 ' HB3' HD12 ' A' ' 49' ' ' LEU . 57.2 m95 -84.91 153.27 22.96 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 111.829 -2.441 . . . . 0.40999999999999998 110.867 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 17.8 t80 -122.31 135.81 54.79 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.932 -2.247 . . . . 0.80000000000000004 104.932 172.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.645 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 76.9 tttt -103.31 166.52 10.38 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.674 -1.602 . . . . 2.6800000000000002 106.674 -175.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.643 ' HA2' ' CA ' ' A' ' 85' ' ' GLY . . . -8.7 -162.09 0.0 OUTLIER Glycine 0 C--O 1.196 -2.227 0 N-CA-C 118.903 2.321 . . . . 1.6000000000000001 118.903 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.755 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 39.6 pttt -38.68 -20.42 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.18 1.918 . . . . 4.2999999999999998 116.18 -163.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.755 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 15.2 p-90 -167.27 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 120.073 1.306 . . . . 2.5099999999999998 113.395 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.55 170.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 123.19 1.471 . . . . 1.78 112.072 -162.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 27.8 t70 -113.35 154.1 27.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 112.345 -2.207 . . . . 2.73 106.797 175.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.115 HD12 ' HB3' ' A' ' 41' ' ' TRP . 6.1 mp -91.29 -39.92 11.79 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 119.008 -0.52 . . . . 1.1299999999999999 112.057 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.6 t -59.99 -20.14 56.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.813 -0.81 . . . . 1.71 108.813 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -86.67 -28.6 23.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.983 -1.008 . . . . 1.76 111.456 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 11.4 mmmt -100.11 -62.73 1.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.446 -0.797 . . . . 1.9099999999999999 111.395 -172.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 49' ' ' LEU . 48.3 t 4.48 93.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 O-C-N 125.88 1.987 . . . . 1.1499999999999999 113.804 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -164.99 -123.99 0.68 Allowed Glycine 0 C--N 1.31 -0.914 0 CA-C-N 113.001 -1.909 . . . . 0.69999999999999996 113.048 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.36 -38.49 78.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.763 0.425 . . . . 3.3599999999999999 111.839 -170.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.457 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 6.8 t-80 -88.16 -38.64 15.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.75 0.786 . . . . 1.78 111.463 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.14 105.29 7.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.824 -1.547 . . . . 1.72 106.824 -177.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.8 114.78 27.12 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.063 -1.458 . . . . 0.96999999999999997 107.063 168.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.54 HD13 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.7 92.61 5.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.011 -2.589 . . . . 1.0600000000000001 104.011 169.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.717 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 8.5 t-160 -100.13 161.38 13.64 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.924 -1.489 . . . . 2.5899999999999999 109.268 -173.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.02 119.83 26.25 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 111.982 -2.372 . . . . 0.92000000000000004 110.839 -173.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.773 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.4 m -97.48 146.39 25.29 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 111.826 -2.443 . . . . 0.76000000000000001 106.75 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' HD1' ' CD1' ' A' ' 70' ' ' TYR . 28.5 t80 -145.43 96.63 2.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.385 1.088 . . . . 1.8 111.389 -168.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' CB ' ' HB2' ' A' ' 67' ' ' SER . 10.8 m-20 -115.67 101.11 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.235 -1.802 . . . . 2.4199999999999999 109.084 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -44.78 60.93 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.24 -0.891 . . . . 3.0800000000000001 111.278 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -19.52 60.68 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.112 -0.949 . . . . 1.6899999999999999 111.118 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.493 ' HB2' ' CB ' ' A' ' 64' ' ' ASP . 49.4 m -92.8 -13.12 29.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.376 -1.342 . . . . 1.96 107.376 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 tpmt? 69.6 27.45 4.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.806 -1.543 . . . . 3.7799999999999998 110.52 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 t -131.54 126.72 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.815 0.817 . . . . 1.1299999999999999 110.549 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.852 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 10.6 m-85 -101.35 109.27 21.09 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.944 -1.502 . . . . 1.95 106.944 165.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.1 tp -92.5 104.49 16.8 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.113 0.959 . . . . 1.1799999999999999 108.989 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -83.9 113.82 21.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.909 -1.515 . . . . 0.40000000000000002 106.909 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.5 pt-20 -117.5 122.94 45.1 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.513 -1.676 . . . . 1.3200000000000001 110.086 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.747 HD12 ' HD2' ' A' ' 24' ' ' PHE . 2.4 mt -94.23 133.15 38.05 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.108 -1.405 . . . . 1.5900000000000001 108.935 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 5.6 m170 -115.38 96.66 5.76 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.357 -2.831 . . . . 2.0099999999999998 103.357 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.696 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.5 mt -124.59 100.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.976 1.37 . . . . 1.1899999999999999 108.545 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.3 p -105.46 169.3 8.54 Favored 'General case' 0 N--CA 1.394 -3.238 0 CA-C-N 114.323 -1.308 . . . . 1.05 110.102 -172.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 36.71 69.05 0.22 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 111.206 -2.725 . . . . 2.1200000000000001 111.392 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.19 126.26 26.42 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 112.196 -2.274 . . . . 1.0900000000000001 111.397 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.693 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -56.05 131.42 74.17 Favored Pre-proline 0 C--O 1.223 -0.34 0 CA-C-N 115.76 -0.655 . . . . 1.77 109.634 172.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.747 ' HB3' HG22 ' A' ' 18' ' ' VAL . 21.9 Cg_endo -61.32 -15.9 43.43 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.982 2.455 . . . . 1.3300000000000001 113.148 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.613 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -108.25 26.63 10.2 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.807 -0.633 . . . . 1.6599999999999999 110.365 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -81.34 -52.91 6.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.47 -0.492 . . . . 1.24 111.188 -178.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.4 m 21.71 75.48 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 123.427 1.584 . . . . 1.6799999999999999 109.276 -159.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.643 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.95 114.96 4.56 Favored Glycine 0 N--CA 1.407 -3.254 0 CA-C-N 112.152 -2.294 . . . . 2.0 112.397 -156.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.558 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -98.74 87.81 0.82 Allowed Glycine 0 C--N 1.273 -2.957 0 N-CA-C 109.544 -1.423 . . . . 0.81000000000000005 109.544 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.714 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 m-85 -85.46 139.62 31.36 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.194 -1.503 . . . . 1.0800000000000001 107.629 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.674 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 49.0 mtm180 -137.24 155.73 49.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.629 0.252 . . . . 3.6899999999999999 110.378 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 3.4 m -122.82 120.95 35.05 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.147 -0.686 . . . . 1.22 109.147 173.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -123.41 105.12 9.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.002 -0.74 . . . . 1.8100000000000001 109.002 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.633 ' HB ' HG12 ' A' ' 39' ' ' VAL . 3.8 p -101.55 142.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.465 0.65 . . . . 1.24 111.501 -175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 t -132.13 108.11 9.07 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.346 -1.297 . . . . 1.6399999999999999 108.681 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.882 HG23 ' HG3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -133.36 154.01 51.1 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 117.853 -1.07 . . . . 1.26 108.718 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.788 ' HZ3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 21.72 -75.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 125.895 1.997 . . . . 0.93999999999999995 114.391 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.701 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t70 -151.44 3.17 0.42 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.979 -1.01 . . . . 1.05 109.31 -175.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.948 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -96.39 128.47 43.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.378 -0.971 . . . . 1.78 108.378 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -130.57 132.15 45.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.879 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -154.04 153.9 32.75 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.418 -1.265 . . . . 1.6000000000000001 110.379 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 59.6 m -145.02 152.44 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 1.98 110.749 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.85 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 56.3 p -131.22 148.26 52.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.641 -0.709 . . . . 1.02 109.371 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.674 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -133.84 124.36 26.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.72 0.295 . . . . 1.5800000000000001 110.329 177.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.714 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 9.6 p90 -143.85 126.4 15.94 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.144 0.497 . . . . 1.1000000000000001 110.5 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 59.6 m-20 -103.46 136.86 42.42 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.273 1.035 . . . . 2.1099999999999999 111.047 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -105.64 110.52 22.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.085 -1.416 . . . . 1.0900000000000001 109.157 177.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.447 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.0 m -94.61 97.22 9.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.006 -0.738 . . . . 1.0700000000000001 109.006 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 80' ' ' GLN . 4.3 p -81.48 119.11 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-O 122.851 1.31 . . . . 1.1399999999999999 108.883 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -91.4 99.16 12.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.034 -1.894 . . . . 1.8200000000000001 108.763 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 44.1 tt0 -70.01 113.54 7.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.122 -1.399 . . . . 1.6699999999999999 110.094 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.79 126.78 54.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.754 -0.657 . . . . 2.98 110.087 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.533 -0.746 . . . . 7.3399999999999999 109.607 -179.672 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.937 0.875 . . . . 1.9299999999999999 112.569 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.894 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -117.77 147.89 42.02 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.008 -0.996 . . . . 1.6499999999999999 108.74 179.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.409 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -40.7 96.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 125.015 3.81 . . . . 1.24 115.162 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.621 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.4 mp -128.85 -60.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.036 -0.983 . . . . 1.2 109.225 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.445 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 87.12 54.96 2.46 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.635 -1.786 . . . . 0.44 108.635 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -62.97 -32.49 73.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.466 -1.367 . . . . 1.1100000000000001 111.051 -165.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.12 84.96 3.36 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.746 -0.661 . . . . 0.97999999999999998 109.813 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.65 -46.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.825 -1.08 . . . . 1.1100000000000001 109.766 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.568 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 25.1 ttt -140.4 130.51 24.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.408 -0.814 . . . . 3.3100000000000001 108.943 174.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -102.69 128.6 27.63 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.141 -0.481 . . . . 4.1699999999999999 110.195 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.63 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 10.8 Cg_endo -62.16 150.98 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.291 1.994 . . . . 0.81999999999999995 110.675 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.475 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.5 mm-40 -121.96 173.91 7.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.884 -0.598 . . . . 1.6299999999999999 110.327 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 8.0 p-10 -70.7 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.937 1.351 . . . . 2.0600000000000001 111.896 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 158.42 130.14 1.15 Allowed Glycine 0 C--N 1.294 -1.755 0 CA-C-N 113.099 -1.864 . . . . 0.34999999999999998 112.689 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -112.94 107.78 16.47 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.044 -1.078 . . . . 1.53 109.071 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.24 163.52 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 N-CA-C 107.255 -1.387 . . . . 1.0800000000000001 107.255 -167.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.92 156.74 16.2 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.303 -0.862 . . . . 1.22 109.638 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 106' ' ' VAL . 18.1 t -68.51 104.53 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 CA-C-O 122.876 1.322 . . . . 1.3799999999999999 108.326 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.72 4.85 7.9 Favored Glycine 0 C--N 1.27 -3.087 0 CA-C-N 112.36 -2.2 . . . . 0.52000000000000002 112.837 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.67 -125.33 5.13 Favored Glycine 0 N--CA 1.415 -2.706 0 N-CA-C 109.674 -1.37 . . . . 0.44 109.674 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 14.5 p -150.36 172.59 15.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 112.847 -1.676 . . . . 1.23 110.38 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.604 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.7 tp -148.86 145.66 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 112.896 -1.957 . . . . 1.0900000000000001 106.988 172.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 m -139.08 129.13 25.18 Favored 'General case' 0 C--N 1.261 -3.278 0 CA-C-N 114.003 -1.453 . . . . 1.05 110.711 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.634 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 38.7 m-85 -127.15 145.2 50.83 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.199 -1.364 . . . . 0.71999999999999997 110.012 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.11 121.61 22.88 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.432 -0.804 . . . . 0.87 109.251 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.622 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -124.42 117.78 25.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.92 -1.037 . . . . 1.1000000000000001 110.541 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.7 mtt180 -107.71 118.59 37.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.209 -0.45 . . . . 2.9300000000000002 110.498 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.5 t -117.92 127.15 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 122.044 0.926 . . . . 1.0700000000000001 109.695 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.1 0.65 Allowed 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.339 -1.755 . . . . 1.1200000000000001 111.076 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.688 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -51.32 -50.63 39.96 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.263 -1.335 . . . . 0.76000000000000001 112.025 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.661 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 48.1 -161.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.558 0.743 . . . . 1.0 112.319 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -127.33 86.07 2.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.633 -0.877 . . . . 2.1699999999999999 108.633 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -110.32 -175.83 2.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.206 -0.452 . . . . 2.6299999999999999 109.914 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.24 -24.51 42.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.337 0.589 . . . . 1.99 111.471 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.751 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -151.83 -179.39 1.01 Allowed Pre-proline 0 C--O 1.212 -0.905 0 CA-C-N 115.133 -0.94 . . . . 1.8799999999999999 109.148 -173.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 2.9 Cg_exo -73.19 141.98 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 N-CA-C 107.965 -1.59 . . . . 1.1200000000000001 107.965 165.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' HG23 ' A' ' 93' ' ' THR . 21.8 Cg_exo -52.34 135.31 53.67 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.087 1.191 . . . . 0.81999999999999995 111.592 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.58 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.68 0 N-CA-C 106.586 -1.635 . . . . 1.4299999999999999 106.586 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.597 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -111.23 114.56 47.44 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.084 0 CA-C-N 113.127 -1.852 . . . . 1.0900000000000001 107.517 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.816 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.02 129.85 51.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 123.086 1.422 . . . . 2.1299999999999999 109.816 173.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.98 ' HB3' HD12 ' A' ' 49' ' ' LEU . 83.3 m95 -87.87 154.99 20.09 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 111.689 -2.505 . . . . 0.40999999999999998 111.875 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.8 t80 -135.1 138.06 43.42 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 104.578 -2.379 . . . . 0.80000000000000004 104.578 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.776 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 60.5 tttp -103.98 166.22 10.55 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.983 -2.229 . . . . 2.6800000000000002 104.983 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.02 -165.31 0.0 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 119.215 2.446 . . . . 1.6000000000000001 119.215 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.606 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 7.0 mtpp -43.37 -10.44 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 O-C-N 119.489 -2.183 . . . . 4.2999999999999998 116.574 -166.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CZ3' HG12 ' A' ' 47' ' ' VAL . 15.2 p-90 -163.21 -9.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.751 1.389 . . . . 2.5099999999999998 114.751 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.62 151.5 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 CA-C-O 123.112 1.434 . . . . 1.78 112.336 -160.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.8 t70 -110.48 127.31 55.09 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 111.87 -2.423 . . . . 2.73 108.721 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.98 HD12 ' HB3' ' A' ' 41' ' ' TRP . 3.1 mp -68.23 -34.97 77.22 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.04 -0.527 . . . . 1.1299999999999999 112.268 -175.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -58.76 -21.76 56.43 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.45 0.643 . . . . 1.71 109.36 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.45 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -92.72 -29.57 15.99 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.782 -1.099 . . . . 1.76 111.365 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.7 ' HB2' HD13 ' A' ' 57' ' ' LEU . 11.1 mmmt -98.05 -30.59 12.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.526 -0.761 . . . . 1.9099999999999999 111.569 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 42.7 t -45.01 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 125.704 1.602 . . . . 1.1499999999999999 111.264 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.92 -98.23 0.13 Allowed Glycine 0 C--N 1.298 -1.545 0 CA-C-N 112.374 -2.194 . . . . 0.69999999999999996 113.749 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -91.62 -42.32 10.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.497 . . . . 3.3599999999999999 112.341 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.672 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.5 p80 -95.86 -38.12 10.42 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.073 0.463 . . . . 1.78 110.897 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.905 HD21 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.82 105.82 13.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.261 -1.755 . . . . 1.72 106.261 173.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.16 115.96 31.06 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 106.757 -1.571 . . . . 0.96999999999999997 106.757 165.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.577 HD12 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -97.02 92.27 5.99 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 104.146 -2.538 . . . . 1.0600000000000001 104.146 170.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.718 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 29.3 m-70 -91.87 162.86 14.25 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 114.361 -1.291 . . . . 2.5899999999999999 110.106 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.95 115.75 14.75 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.132 -2.304 . . . . 0.92000000000000004 109.835 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.579 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -92.29 147.87 22.58 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.24 -1.8 . . . . 0.76000000000000001 107.463 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -142.25 98.19 3.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.244 1.021 . . . . 1.8 110.799 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.597 ' OD1' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -114.46 114.6 26.03 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.37 -1.741 . . . . 2.4199999999999999 111.014 174.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.735 ' HD3' ' HE2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.526 -0.761 . . . . 3.0800000000000001 110.756 175.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.83 -28.88 70.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.292 -0.867 . . . . 1.6899999999999999 111.304 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.597 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 15.0 m -100.66 -18.49 16.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.175 -1.046 . . . . 1.96 108.175 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.735 ' HE2' ' HD3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER 64.05 37.33 9.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.277 -1.328 . . . . 3.7799999999999998 109.736 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.65 139.18 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 115.373 -0.83 . . . . 1.1299999999999999 109.758 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.688 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 70.0 m-85 -102.82 109.08 20.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.383 -1.71 . . . . 1.95 106.383 162.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.3 tp -94.53 104.07 16.02 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.404 1.097 . . . . 1.1799999999999999 108.806 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.66 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.6 m-85 -88.35 113.95 24.47 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.713 -1.585 . . . . 0.40000000000000002 107.624 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 8.2 pt-20 -115.0 124.46 51.7 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.877 -1.51 . . . . 1.3200000000000001 109.877 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.774 HD22 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -90.23 120.8 31.69 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.416 -1.72 . . . . 1.5900000000000001 108.33 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -112.12 95.65 5.59 Favored 'General case' 0 C--N 1.268 -2.947 0 N-CA-C 103.976 -2.602 . . . . 2.0099999999999998 103.976 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 64.6 mt -120.84 98.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-O 123.26 1.505 . . . . 1.1899999999999999 109.54 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 21.3 p -112.29 136.31 51.9 Favored 'General case' 0 N--CA 1.393 -3.321 0 CA-C-N 113.213 -1.812 . . . . 1.05 106.96 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER 72.83 100.13 0.07 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 111.684 -2.507 . . . . 2.1200000000000001 109.017 -171.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.98 113.24 26.66 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 110.431 -3.077 . . . . 1.0900000000000001 109.538 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.608 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -54.32 140.19 55.39 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.438 -0.801 . . . . 1.77 110.252 171.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.552 ' HD2' HE21 ' A' ' 80' ' ' GLN . 21.6 Cg_endo -61.03 -11.59 19.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.142 2.561 . . . . 1.3300000000000001 112.875 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.608 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -97.64 11.14 38.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.124 -0.489 . . . . 1.6599999999999999 110.687 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 2.6 m-30 -97.32 -8.86 28.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 119.449 -0.31 . . . . 1.24 110.636 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 20.5 m -47.95 97.71 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.116 -1.068 . . . . 1.6799999999999999 108.116 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.606 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -168.53 -129.07 1.05 Allowed Glycine 0 C--N 1.263 -3.508 0 CA-C-N 113.365 -1.743 . . . . 2.0 112.563 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -152.86 119.25 0.94 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 119.95 -1.119 . . . . 0.81000000000000005 112.369 -171.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.776 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -84.97 114.7 22.35 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 113.496 -1.352 . . . . 1.0800000000000001 107.541 174.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 45.2 mtm180 -105.49 127.41 52.99 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.909 0.385 . . . . 3.6899999999999999 110.497 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 t -111.83 123.61 50.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.433 -0.58 . . . . 1.22 109.433 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.816 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 47.5 mt-10 -133.02 115.87 15.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.649 -0.705 . . . . 1.8100000000000001 110.347 -175.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.597 ' HB ' HG12 ' A' ' 39' ' ' VAL . 2.5 p -107.7 141.46 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.266 0.555 . . . . 1.24 110.977 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 t -134.68 111.52 10.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.069 -0.968 . . . . 1.6399999999999999 110.215 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 37' ' ' PRO . 11.1 p -117.27 -177.45 3.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.168 -0.924 . . . . 1.26 111.213 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.923 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -18.04 -48.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 125.682 1.864 . . . . 0.93999999999999995 113.678 175.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.923 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -167.54 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.837 -1.529 . . . . 1.05 110.723 -173.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.621 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -95.76 132.71 40.69 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.079 -1.082 . . . . 1.78 108.079 -177.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -130.99 133.97 46.27 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.269 -1.332 . . . . 1.0 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -152.15 147.32 26.3 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.458 -1.247 . . . . 1.6000000000000001 109.259 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.7 p -149.64 149.22 30.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.151 0.5 . . . . 1.98 111.578 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.6 p -124.57 148.14 48.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.496 -0.775 . . . . 1.02 111.739 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.483 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -128.04 112.8 15.01 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.604 -1.18 . . . . 1.5800000000000001 109.106 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.762 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 12.9 p90 -141.47 128.11 20.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.41 0.624 . . . . 1.1000000000000001 109.664 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 7.7 p30 -104.71 140.26 38.32 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.233 1.016 . . . . 2.1099999999999999 112.59 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -109.37 114.31 27.87 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.423 -1.262 . . . . 1.0900000000000001 108.329 175.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 m -97.35 96.11 8.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.959 -0.756 . . . . 1.0700000000000001 108.959 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 18' ' ' VAL . 5.1 p -80.08 113.06 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 123.193 1.473 . . . . 1.1399999999999999 109.252 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 41.1 m170 -82.78 99.04 9.43 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 112.447 -2.161 . . . . 1.8200000000000001 110.229 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 41.8 tt0 -86.15 -81.54 0.21 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.441 -1.254 . . . . 1.6699999999999999 108.624 167.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 46.26 71.52 0.29 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.336 0.865 . . . . 2.98 113.336 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.711 -0.662 . . . . 7.3399999999999999 109.713 177.139 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 m-20 . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 122.063 0.935 . . . . 1.9299999999999999 110.409 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.875 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 6.2 t70 -102.98 142.97 25.66 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.093 -1.412 . . . . 1.6499999999999999 108.909 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 87.3 Cg_exo -47.52 92.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 124.156 3.237 . . . . 1.24 114.959 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.5 mp -119.18 -51.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.924 -1.035 . . . . 1.2 109.264 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.09 41.14 8.2 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.548 -1.821 . . . . 0.44 108.548 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.713 HD23 ' HB3' ' A' ' 96' ' ' LYS . 12.4 tp -51.5 -48.18 63.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.757 -1.721 . . . . 1.1100000000000001 110.927 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.735 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -92.25 84.12 5.16 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.674 0.749 . . . . 0.97999999999999998 109.643 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.64 -46.49 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.33 -1.305 . . . . 1.1100000000000001 110.138 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.529 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 18.1 mmt -140.96 130.7 24.22 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.044 -0.526 . . . . 3.3100000000000001 111.077 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.581 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.9 ptp180 -101.24 132.65 21.65 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.123 -0.944 . . . . 4.1699999999999999 108.877 173.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.751 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 68.6 Cg_endo -78.9 158.01 27.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.244 1.963 . . . . 0.81999999999999995 110.172 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -118.72 -178.41 3.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 120.348 -0.541 . . . . 1.6299999999999999 112.003 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.1 p-10 -69.98 -147.97 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 122.684 1.23 . . . . 2.0600000000000001 111.421 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 155.41 133.38 1.7 Allowed Glycine 0 C--N 1.291 -1.952 0 CA-C-N 113.549 -1.66 . . . . 0.34999999999999998 112.227 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 36.0 mt-10 -109.96 107.47 17.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.718 -1.241 . . . . 1.53 108.153 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 22' ' ' ILE . 2.8 m -125.79 163.32 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.158 0 N-CA-C 106.779 -1.563 . . . . 1.0800000000000001 106.779 -171.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.54 155.84 17.08 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.064 -0.971 . . . . 1.22 108.888 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 81' ' ' PRO . 2.9 t -66.64 106.7 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 122.362 1.077 . . . . 1.3799999999999999 108.56 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 6.64 8.17 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.54 -2.118 . . . . 0.52000000000000002 111.663 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.86 -124.71 5.19 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.52 -1.432 . . . . 0.44 109.52 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.1 p -151.64 174.62 13.25 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 112.983 -1.609 . . . . 1.23 109.852 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.8 tp -146.14 147.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.481 -1.69 . . . . 1.0900000000000001 107.119 166.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 m -140.76 130.9 24.81 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.45 -1.704 . . . . 1.05 110.17 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' HB2' HD22 ' A' ' 74' ' ' LEU . 23.7 m-85 -125.56 144.47 50.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.268 -1.333 . . . . 0.71999999999999997 108.855 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.12 117.9 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.15 -0.932 . . . . 0.87 110.313 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB1' ' HH2' ' A' ' 41' ' ' TRP . . . -125.9 116.99 22.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 113.947 -1.479 . . . . 1.1000000000000001 111.428 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.598 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 79.3 mtt-85 -104.88 127.68 52.8 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.09 -0.244 . . . . 2.9300000000000002 110.775 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.3 t -126.66 126.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.084 0.945 . . . . 1.0700000000000001 110.223 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . . . -58.54 112.2 1.52 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.607 -1.633 . . . . 1.1200000000000001 112.596 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.81 -57.37 12.69 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-N 114.441 -1.254 . . . . 0.76000000000000001 112.086 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' LEU . . . 67.29 177.29 0.24 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -103.36 22.07 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.535 -1.211 . . . . 2.1699999999999999 109.842 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.922 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -52.18 171.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.617 -1.174 . . . . 2.6299999999999999 112.666 175.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.31 -51.42 54.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.275 0.56 . . . . 1.99 110.12 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.554 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -150.39 157.49 36.78 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.207 -1.035 . . . . 1.8799999999999999 108.207 168.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.12 143.99 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.337 2.692 . . . . 1.1200000000000001 112.798 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.922 ' HD3' HD13 ' A' ' 33' ' ' LEU . 15.0 Cg_exo -50.1 143.13 25.95 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.81999999999999995 113.021 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.22 104.54 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.108 -2.182 . . . . 1.4299999999999999 105.108 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -113.09 114.88 48.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.995 -1.457 . . . . 1.0900000000000001 107.799 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.896 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.11 131.6 51.22 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.161 -1.382 . . . . 2.1299999999999999 109.418 173.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.067 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.8 m95 -91.92 149.32 21.62 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.221 -2.263 . . . . 0.40999999999999998 112.099 172.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.718 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 28.0 t80 -130.59 138.33 50.08 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.671 -2.344 . . . . 0.80000000000000004 104.671 170.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.87 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 83.1 tttt -98.41 174.07 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.375 -1.713 . . . . 2.6800000000000002 106.375 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -18.84 -169.64 0.0 OUTLIER Glycine 0 C--O 1.179 -3.299 0 C-N-CA 125.991 1.758 . . . . 1.6000000000000001 117.282 166.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.538 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 6.7 mtpp -41.34 -14.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.846 2.536 . . . . 4.2999999999999998 117.846 -160.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' GLY . 26.5 p-90 -162.46 -6.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.639 1.563 . . . . 2.5099999999999998 114.891 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.87 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.97 143.74 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-O 122.827 1.299 . . . . 1.78 111.791 -163.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -105.89 107.1 17.92 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 112.181 -2.281 . . . . 2.73 109.9 175.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.067 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.0 mp -54.65 -42.87 71.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 112.628 0.603 . . . . 1.1299999999999999 112.628 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -61.48 -19.07 61.63 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.649 -0.871 . . . . 1.71 108.649 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -86.88 -27.25 23.53 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.023 -0.989 . . . . 1.76 110.956 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 12.1 mmmt -102.9 -64.32 1.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.948 . . . . 1.9099999999999999 111.847 -171.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.724 HG21 ' O ' ' A' ' 49' ' ' LEU . 49.3 t 3.72 92.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.743 2.017 . . . . 1.1499999999999999 113.802 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -157.42 -130.17 1.19 Allowed Glycine 0 CA--C 1.525 0.676 0 CA-C-N 112.803 -1.999 . . . . 0.69999999999999996 112.597 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.26 -38.11 89.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.549 0.944 . . . . 3.3599999999999999 113.549 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 28.2 p80 -91.21 -31.52 16.13 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.776 0.798 . . . . 1.78 111.669 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.99 HD21 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.89 105.39 7.09 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.955 -1.498 . . . . 1.72 106.955 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -97.2 114.75 26.5 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 106.364 -1.717 . . . . 0.96999999999999997 106.364 166.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.64 92.54 4.68 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.259 -2.497 . . . . 1.0600000000000001 104.259 170.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 88.7 m-70 -97.35 160.54 14.27 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 115.009 -0.996 . . . . 2.5899999999999999 109.348 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.88 112.13 12.18 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.768 -2.015 . . . . 0.92000000000000004 109.537 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -106.51 151.1 25.42 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 112.47 -2.15 . . . . 0.76000000000000001 107.156 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -144.32 115.64 8.02 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-O 122.01 0.909 . . . . 1.8 111.196 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -94.95 96.23 9.16 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.285 -1.325 . . . . 2.4199999999999999 107.957 169.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.513 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -71.78 -30.5 65.63 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.699 -1.591 . . . . 3.0800000000000001 111.674 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.22 73.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.487 -0.779 . . . . 1.6899999999999999 110.234 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 m -89.62 -12.13 40.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.337 -0.847 . . . . 1.96 109.057 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.792 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 1.7 ttpm? 66.03 35.28 6.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.519 -1.219 . . . . 3.7799999999999998 109.743 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.598 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.7 t -125.81 136.85 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.455 0.645 . . . . 1.1299999999999999 110.899 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.39 123.19 43.45 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.904 -1.517 . . . . 1.95 106.904 158.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 tp -105.95 104.63 14.38 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.793 -1.094 . . . . 1.1799999999999999 108.114 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.2 m-85 -85.71 115.59 23.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.806 -1.543 . . . . 0.40000000000000002 107.663 173.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.11 121.8 45.21 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.96 -1.473 . . . . 1.3200000000000001 109.503 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.822 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.104 -1.407 . . . . 1.5900000000000001 108.356 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 70.8 m80 -110.01 95.05 5.34 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 104.811 -2.292 . . . . 2.0099999999999998 104.811 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.757 HD12 ' HE2' ' A' ' 87' ' ' TYR . 63.9 mt -121.51 99.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 122.825 1.297 . . . . 1.1899999999999999 109.353 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.4 p -104.11 168.73 8.92 Favored 'General case' 0 N--CA 1.394 -3.266 0 CA-C-N 114.359 -1.292 . . . . 1.05 110.569 -173.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 39.33 67.89 0.41 Allowed 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 110.473 -3.058 . . . . 2.1200000000000001 111.461 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB2' HD21 ' A' ' 104' ' ' LEU . . . -58.51 116.43 3.65 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 112.445 -2.162 . . . . 1.0900000000000001 110.547 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.762 HE21 ' HD2' ' A' ' 81' ' ' PRO . 1.3 tp60 -54.94 139.4 63.09 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.31 -0.859 . . . . 1.77 109.778 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.762 ' HD2' HE21 ' A' ' 80' ' ' GLN . 24.0 Cg_exo -61.23 -12.49 23.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.56 2.173 . . . . 1.3300000000000001 112.863 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -103.15 14.34 31.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 1.6599999999999999 110.795 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -89.73 -15.28 32.86 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.762 -0.637 . . . . 1.24 111.182 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.1 m -41.07 87.97 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 124.947 1.405 . . . . 1.6799999999999999 111.211 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.538 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -157.51 -137.98 2.4 Favored Glycine 0 C--N 1.28 -2.544 0 CA-C-N 113.098 -1.864 . . . . 2.0 112.835 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.11 119.22 0.91 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.974 -1.584 . . . . 0.81000000000000005 113.418 -167.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.818 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.8 m-85 -82.66 114.42 21.01 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 112.952 -1.624 . . . . 1.0800000000000001 108.47 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.718 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 11.0 mmm180 -103.98 104.52 14.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.455 -0.339 . . . . 3.6899999999999999 110.181 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.65 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 3.8 t -94.94 123.62 38.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.14 -0.689 . . . . 1.22 109.14 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.896 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 66.1 mt-10 -136.67 107.79 6.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.135 -0.939 . . . . 1.8100000000000001 110.271 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.568 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -99.78 141.6 16.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.533 0.682 . . . . 1.24 110.388 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -141.24 109.29 5.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.821 -1.081 . . . . 1.6399999999999999 108.623 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.598 HG23 ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -134.5 150.65 50.81 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 117.885 -1.055 . . . . 1.26 109.477 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.875 ' HZ2' ' HB3' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 29.54 -73.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.673 1.858 . . . . 0.93999999999999995 114.693 177.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.857 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 11.1 t0 -152.13 -4.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.492 -1.231 . . . . 1.05 110.056 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.713 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -92.27 125.72 37.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.765 -1.198 . . . . 1.78 107.765 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -129.56 140.92 51.09 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.109 -0.95 . . . . 1.0 110.974 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -168.46 156.92 8.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.354 -0.839 . . . . 1.6000000000000001 109.769 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 m -150.32 145.23 26.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.276 0.56 . . . . 1.98 110.098 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.735 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 26.8 p -125.2 134.71 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.616 -0.72 . . . . 1.02 110.668 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.2 117.46 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.484 0.659 . . . . 1.5800000000000001 110.97 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.751 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -141.0 124.83 17.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.643 -0.708 . . . . 1.1000000000000001 109.658 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.547 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 78.8 m-20 -100.16 153.22 19.42 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 122.31 1.052 . . . . 2.1099999999999999 111.553 -170.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -117.02 115.37 25.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.531 -1.213 . . . . 1.0900000000000001 107.943 173.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.49 ' HA ' HG22 ' A' ' 84' ' ' THR . 7.5 m -100.64 95.9 6.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.399 -0.963 . . . . 1.0700000000000001 108.399 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.711 HG12 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.61 117.18 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.254 1.502 . . . . 1.1399999999999999 108.942 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.445 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 33.4 m170 -87.72 100.17 12.63 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.47 -2.15 . . . . 1.8200000000000001 108.442 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 49.0 tt0 -69.44 113.84 7.12 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.852 -1.067 . . . . 1.6699999999999999 110.275 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.39 103.32 14.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 2.98 109.972 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 C--O 1.249 1.076 0 N-CA-C 109.266 -0.642 . . . . 7.3399999999999999 109.266 179.31 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.807 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.471 0.653 . . . . 1.9299999999999999 109.977 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.626 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 7.1 m-20 -102.05 174.14 3.08 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.153 -0.93 . . . . 1.6499999999999999 110.371 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 60.2 Cg_endo -73.29 36.32 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.649 2.233 . . . . 1.24 113.791 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.759 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -57.6 -60.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.091 -0.959 . . . . 1.2 109.904 170.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 88.7 45.86 4.75 Favored Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 109.248 -1.541 . . . . 0.44 109.248 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.966 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.1 tp -46.59 -43.86 17.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.288 -1.456 . . . . 1.1100000000000001 110.502 -173.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.736 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.34 84.85 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.998 0.904 . . . . 0.97999999999999998 110.483 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.51 -47.3 52.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.03 -1.441 . . . . 1.1100000000000001 109.612 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.511 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 16.6 tpt -152.7 133.21 13.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.372 -0.831 . . . . 3.3100000000000001 109.087 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.599 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -101.09 136.51 19.7 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.771 -0.649 . . . . 4.1699999999999999 110.637 -177.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.754 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.6 Cg_endo -63.41 155.29 63.17 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.2 1.934 . . . . 0.81999999999999995 111.057 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -119.96 174.31 6.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.124 -0.489 . . . . 1.6299999999999999 110.735 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.4 p-10 -68.49 -142.66 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 122.738 1.256 . . . . 2.0600000000000001 111.807 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 146.55 137.4 3.02 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.317 -1.765 . . . . 0.34999999999999998 111.811 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 40.9 mt-10 -109.71 116.08 31.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.337 -0.932 . . . . 1.53 108.529 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -138.29 153.78 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.727 -1.212 . . . . 1.0800000000000001 107.727 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -84.14 156.4 22.13 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.687 -1.142 . . . . 1.22 109.474 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.669 HG11 ' HD3' ' A' ' 81' ' ' PRO . 9.1 t -68.9 105.63 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 123.313 1.53 . . . . 1.3799999999999999 107.629 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.39 15.2 7.16 Favored Glycine 0 C--N 1.264 -3.437 0 CA-C-N 111.926 -2.397 . . . . 0.52000000000000002 112.342 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.58 -123.18 4.59 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.179 -1.486 . . . . 0.44 109.477 167.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 58.6 m -154.47 173.23 16.55 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 113.087 -1.556 . . . . 1.23 108.646 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.617 HG22 HD11 ' A' ' 104' ' ' LEU . 10.3 tp -149.11 150.58 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 N-CA-C 107.127 -1.434 . . . . 1.0900000000000001 107.127 167.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 22' ' ' ILE . 8.6 m -137.7 123.86 20.42 Favored 'General case' 0 C--N 1.262 -3.238 0 CA-C-N 113.636 -1.62 . . . . 1.05 110.336 -177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 36.7 m-85 -117.84 147.83 42.69 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.906 -1.497 . . . . 0.71999999999999997 108.38 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -140.23 122.24 15.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.272 -0.876 . . . . 0.87 109.574 176.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.679 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -116.35 115.84 26.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.873 -1.058 . . . . 1.1000000000000001 109.903 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -102.74 111.6 24.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.247 -0.433 . . . . 2.9300000000000002 110.283 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 19.0 t -115.53 126.62 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-O 121.988 0.899 . . . . 1.0700000000000001 110.185 -178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 104.33 1.04 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.564 -1.653 . . . . 1.1200000000000001 110.378 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.785 ' HA3' ' NZ ' ' A' ' 68' ' ' LYS . . . -51.94 -66.95 2.27 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.163 -1.38 . . . . 0.76000000000000001 112.031 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.766 ' H ' ' HB3' ' A' ' 68' ' ' LYS . . . 60.34 -167.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.762 0.825 . . . . 1.0 111.96 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -106.57 144.12 33.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 2.1699999999999999 109.833 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.39 -172.14 3.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.44 0.638 . . . . 2.6299999999999999 112.465 -169.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.41 -44.36 17.64 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 1.99 108.895 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.562 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 1.3 pptp? -142.36 142.39 23.66 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.321 -0.854 . . . . 1.8799999999999999 108.855 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.91 146.46 4.08 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.183 2.588 . . . . 1.1200000000000001 112.43 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.739 ' HB3' ' HG1' ' A' ' 93' ' ' THR . 3.1 Cg_endo -54.9 128.4 30.33 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 120.952 1.101 . . . . 0.81999999999999995 111.877 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.84 103.96 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 106.774 -1.565 . . . . 1.4299999999999999 106.774 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.8 t -105.83 114.51 45.4 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 113.56 -1.654 . . . . 1.0900000000000001 107.436 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.926 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.59 128.87 54.91 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-O 123.221 1.486 . . . . 2.1299999999999999 109.81 176.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.044 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -90.31 152.53 20.99 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 112.138 -2.301 . . . . 0.40999999999999998 111.96 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 32.8 t80 -128.02 130.75 48.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.556 -2.016 . . . . 0.80000000000000004 105.556 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HB2' ' HG ' ' A' ' 49' ' ' LEU . 3.4 tttm -107.85 102.31 11.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.878 -1.156 . . . . 2.6800000000000002 107.878 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.585 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -90.9 100.11 2.65 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 116.632 -2.699 . . . . 1.6000000000000001 116.88 -161.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 1.4 pttm -102.6 -41.18 6.34 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 103.925 -2.621 . . . . 4.2999999999999998 103.925 123.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.62 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.8 p-90 -171.09 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 112.667 -2.06 . . . . 2.5099999999999998 112.48 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.624 HG21 ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.92 173.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-O 123.28 1.514 . . . . 1.78 112.614 -163.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.605 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.1 p-10 -96.57 161.29 13.96 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.413 -2.63 . . . . 2.73 106.887 170.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.044 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -97.43 -31.36 12.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 119.02 -0.514 . . . . 1.1299999999999999 112.0 167.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -56.89 -21.8 32.36 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 123.585 0.553 . . . . 1.71 109.733 -161.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -100.79 -26.43 13.78 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.384 -0.926 . . . . 1.76 112.116 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.76 -27.12 14.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.496 -1.229 . . . . 1.9099999999999999 111.537 -167.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 49' ' ' LEU . 74.6 t -37.18 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.53 1.532 . . . . 1.1499999999999999 110.953 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.526 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.05 -105.14 0.23 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 112.803 -1.999 . . . . 0.69999999999999996 114.015 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -83.95 -45.01 13.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.206 0.447 . . . . 3.3599999999999999 112.206 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.571 ' HE1' ' HE3' ' A' ' 43' ' ' LYS . 19.9 p80 -91.44 -36.83 13.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.653 . . . . 1.78 111.14 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.928 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.58 106.71 12.03 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.051 -1.463 . . . . 1.72 107.051 176.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.55 ' HB3' ' HD2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -96.98 114.41 26.02 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 106.811 -1.551 . . . . 0.96999999999999997 106.811 164.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.804 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.9 92.3 4.52 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 104.687 -2.338 . . . . 1.0600000000000001 104.687 170.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.614 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 22.9 m-70 -100.34 163.83 12.21 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.463 1.125 . . . . 2.5899999999999999 109.473 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.84 112.92 12.89 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 112.113 -2.312 . . . . 0.92000000000000004 109.817 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 4.7 m -94.95 150.03 20.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.729 -2.032 . . . . 0.76000000000000001 108.289 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -144.38 107.76 4.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.354 1.073 . . . . 1.8 111.323 -170.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.11 122.54 47.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.887 -1.96 . . . . 2.4199999999999999 108.913 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.664 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -79.35 -29.59 42.28 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.349 -1.296 . . . . 3.0800000000000001 111.66 -177.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.31 33.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.072 -0.513 . . . . 1.6899999999999999 110.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 m -124.48 4.15 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.75 -0.659 . . . . 1.96 111.245 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.785 ' NZ ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.81 7.8 3.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.611 0.764 . . . . 3.7799999999999998 112.318 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 46.0 t -76.18 117.67 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 CA-C-O 122.407 1.099 . . . . 1.1299999999999999 110.223 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 62' ' ' SER . 81.4 m-85 -90.07 100.51 13.32 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.663 -2.062 . . . . 1.95 106.312 165.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.9 tp -93.25 103.56 15.8 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.523 1.154 . . . . 1.1799999999999999 108.026 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.0 m-85 -81.78 113.91 20.06 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 113.321 -1.763 . . . . 0.40000000000000002 107.716 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.439 ' CG ' ' HG ' ' A' ' 71' ' ' LEU . 51.7 mt-10 -107.32 121.21 44.12 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.328 -1.76 . . . . 1.3200000000000001 109.037 -175.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.708 HD22 ' CH2' ' A' ' 41' ' ' TRP . 1.4 mm? -98.45 117.02 31.94 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 112.936 -1.938 . . . . 1.5900000000000001 108.079 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -110.96 95.23 5.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 105.175 -2.157 . . . . 2.0099999999999998 105.175 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.598 HG12 HD21 ' A' ' 57' ' ' LEU . 54.5 mt -121.53 99.5 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 113.842 -1.526 . . . . 1.1899999999999999 106.923 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 35.8 p -106.19 167.08 10.05 Favored 'General case' 0 N--CA 1.394 -3.271 0 CA-C-N 114.197 -1.365 . . . . 1.05 109.778 -171.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 40.51 59.35 2.13 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 111.544 -2.571 . . . . 2.1200000000000001 111.34 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -51.0 123.35 9.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.405 -1.725 . . . . 1.0900000000000001 109.509 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.612 ' HA ' HG12 ' A' ' 18' ' ' VAL . 1.7 pt20 -78.54 156.13 78.34 Favored Pre-proline 0 C--N 1.311 -1.076 0 N-CA-C 108.033 -1.099 . . . . 1.77 108.033 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.669 ' HD3' HG11 ' A' ' 18' ' ' VAL . 50.8 Cg_endo -68.75 162.72 40.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.005 1.137 . . . . 1.3300000000000001 109.975 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . 70.74 14.43 7.09 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.616 0.572 . . . . 1.6599999999999999 111.705 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.461 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -80.45 -54.92 5.25 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.303 -0.999 . . . . 1.24 108.303 168.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.2 m 36.6 57.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.429 -1.323 . . . . 1.6799999999999999 107.429 -160.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.622 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -48.73 85.17 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.004 0 CA-C-N 111.56 -2.563 . . . . 2.0 114.788 -161.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -90.79 78.29 1.44 Allowed Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 108.957 -1.657 . . . . 0.81000000000000005 108.957 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.663 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 49.0 m-85 -80.71 122.76 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.769 -1.567 . . . . 1.0800000000000001 106.769 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -115.53 107.64 15.42 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.472 -0.491 . . . . 3.6899999999999999 109.677 -171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -92.06 131.37 37.39 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.766 -0.652 . . . . 1.22 109.7 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.926 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 44.4 tt0 -139.77 110.63 6.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.407 -0.815 . . . . 1.8100000000000001 109.5 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 p -102.0 137.82 28.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.656 0.741 . . . . 1.24 110.534 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.7 t -132.1 108.76 9.51 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.636 -1.165 . . . . 1.6399999999999999 108.732 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.739 ' HG1' ' HB3' ' A' ' 37' ' ' PRO . 1.2 m -123.47 167.34 14.0 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.031 -1.1 . . . . 1.26 108.031 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -4.6 -61.26 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 125.316 1.635 . . . . 0.93999999999999995 114.926 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.916 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -147.76 -10.75 0.4 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.035 -0.984 . . . . 1.05 111.211 -174.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.966 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.2 tttp -94.31 134.89 36.33 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 119.133 -1.027 . . . . 1.78 108.23 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.16 135.47 46.39 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 1.0 110.846 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -155.6 147.84 23.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.141 -0.936 . . . . 1.6000000000000001 109.925 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 33.2 m -141.94 150.68 41.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.535 0.207 . . . . 1.98 110.674 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.736 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 78.4 p -134.86 132.62 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.427 . . . . 1.02 111.279 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 122.56 47.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.646 -0.707 . . . . 1.5800000000000001 110.676 176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.776 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 5.0 p90 -142.63 129.48 20.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 1.1000000000000001 109.416 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 71.7 m-20 -108.7 135.27 50.21 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.417 1.103 . . . . 2.1099999999999999 111.783 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.622 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.49 105.51 15.78 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.102 -1.408 . . . . 1.0900000000000001 110.448 178.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.445 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 10.4 m -84.12 97.34 9.29 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.732 -0.84 . . . . 1.0700000000000001 108.732 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.6 p -84.94 115.53 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 123.236 1.494 . . . . 1.1399999999999999 110.087 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 78.1 m-70 -88.79 100.68 13.34 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.368 -2.196 . . . . 1.8200000000000001 109.394 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.551 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 34.7 tt0 -56.2 -52.29 64.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.208 -1.36 . . . . 1.6699999999999999 110.594 174.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.22 -30.22 0.18 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.788 -0.642 . . . . 2.98 110.056 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.315 -0.857 . . . . 7.3399999999999999 109.118 179.574 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.978 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.854 0.835 . . . . 1.9299999999999999 110.282 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.811 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -104.97 145.49 30.83 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.029 -1.441 . . . . 1.6499999999999999 108.435 -178.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -41.34 94.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 124.656 3.571 . . . . 1.24 114.809 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.633 ' CD1' ' HZ3' ' A' ' 94' ' ' LYS . 1.3 mp -126.25 -61.1 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.031 -0.986 . . . . 1.2 109.58 172.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.567 ' N ' HG23 ' A' ' 4' ' ' ILE . . . 91.11 52.81 2.31 Favored Glycine 0 CA--C 1.496 -1.142 0 N-CA-C 108.685 -1.766 . . . . 0.44 108.685 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.032 HD23 ' HB3' ' A' ' 96' ' ' LYS . 8.3 tp -59.77 -40.71 89.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.225 -1.487 . . . . 1.1100000000000001 110.191 -169.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.51 5.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.99 -1.005 . . . . 0.97999999999999998 109.881 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.82 -47.25 33.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.419 -1.264 . . . . 1.1100000000000001 109.641 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 17.2 tpt -147.48 129.96 15.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.199 -0.909 . . . . 3.3100000000000001 109.398 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -106.78 132.46 20.89 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.549 -0.75 . . . . 4.1699999999999999 110.398 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 17.4 Cg_endo -66.53 153.59 77.42 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.369 2.046 . . . . 0.81999999999999995 111.372 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.5 mm-40 -121.14 176.93 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.228 -0.442 . . . . 1.6299999999999999 110.327 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.5 p30 -68.03 -148.56 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.384 0 CA-C-O 122.776 1.275 . . . . 2.0600000000000001 111.237 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 153.4 138.74 2.73 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 113.44 -1.709 . . . . 0.34999999999999998 111.745 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 29.2 mt-10 -117.47 113.09 21.53 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.297 -0.951 . . . . 1.53 109.029 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.402 HG21 HD13 ' A' ' 104' ' ' LEU . 2.5 m -132.82 163.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.929 -1.508 . . . . 1.0800000000000001 106.929 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.517 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -94.32 157.74 15.9 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.538 -0.755 . . . . 1.22 109.836 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.608 HG11 ' HD3' ' A' ' 81' ' ' PRO . 2.9 t -67.89 106.35 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 107.679 -1.23 . . . . 1.3799999999999999 107.679 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.46 7.57 8.95 Favored Glycine 0 C--N 1.263 -3.507 0 CA-C-N 112.657 -2.065 . . . . 0.52000000000000002 112.194 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.51 -125.04 5.02 Favored Glycine 0 N--CA 1.409 -3.154 0 C-N-CA 119.181 -1.485 . . . . 0.44 109.714 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.2 p -152.74 167.87 27.54 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.127 -1.537 . . . . 1.23 110.372 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 104' ' ' LEU . 10.4 tp -147.62 149.67 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-N 113.637 -1.619 . . . . 1.0900000000000001 107.652 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -139.3 127.24 22.24 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 113.711 -1.586 . . . . 1.05 110.344 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 76' ' ' ILE . 42.0 m-85 -123.71 147.18 47.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.516 -1.22 . . . . 0.71999999999999997 108.812 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.19 122.59 19.49 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.179 -0.919 . . . . 0.87 109.671 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -119.03 115.64 24.74 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.593 -1.185 . . . . 1.1000000000000001 110.226 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -106.71 117.62 34.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.043 -0.526 . . . . 2.9300000000000002 110.394 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.3 t -122.27 128.93 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.208 1.004 . . . . 1.0700000000000001 110.739 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -60.0 110.04 1.1 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.128 -1.851 . . . . 1.1200000000000001 112.352 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.18 81.43 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 114.897 -1.047 . . . . 0.76000000000000001 112.463 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.812 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 58.3 -179.07 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.522 1.304 . . . . 1.0 114.522 168.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -101.11 23.81 10.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.525 -1.216 . . . . 2.1699999999999999 109.809 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.037 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -57.05 175.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.52 -1.218 . . . . 2.6299999999999999 113.855 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.2 tp -64.73 -56.83 11.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.315 -0.857 . . . . 1.99 109.773 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.711 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.76 143.26 48.63 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.93 -1.032 . . . . 1.8799999999999999 108.642 176.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.18 140.25 11.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.606 2.204 . . . . 1.1200000000000001 110.638 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.037 ' HD3' HD13 ' A' ' 33' ' ' LEU . 1.6 Cg_endo -58.94 135.29 65.73 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.325 0.683 . . . . 0.81999999999999995 112.121 -171.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 92' ' ' SER . 14.1 p -99.71 104.81 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-O 123.724 1.726 . . . . 1.4299999999999999 107.97 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -105.67 114.82 46.07 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 111.892 -2.413 . . . . 1.0900000000000001 107.592 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.771 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.03 126.1 47.69 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 122.939 1.352 . . . . 2.1299999999999999 109.051 174.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.837 ' HB3' HD12 ' A' ' 49' ' ' LEU . 76.0 m95 -84.46 152.54 23.92 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 112.308 -2.224 . . . . 0.40999999999999998 112.112 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -129.31 139.61 51.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.378 -2.452 . . . . 0.80000000000000004 104.378 172.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 38.3 tttt -107.13 165.03 11.66 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.399 -1.334 . . . . 2.6800000000000002 107.399 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.953 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -7.63 -165.43 0.0 OUTLIER Glycine 0 C--O 1.197 -2.184 0 N-CA-C 118.963 2.345 . . . . 1.6000000000000001 118.963 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HG3' ' HB ' ' A' ' 84' ' ' THR . 10.5 mtpp -43.06 -3.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.249 1.944 . . . . 4.2999999999999998 116.249 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.57 ' CZ3' HG12 ' A' ' 47' ' ' VAL . 20.6 p-90 -172.12 -13.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.287 1.588 . . . . 2.5099999999999998 115.287 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.02 169.09 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 123.297 1.522 . . . . 1.78 112.344 -160.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.51 154.7 23.3 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.1 -2.318 . . . . 2.73 107.942 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 57' ' ' LEU . 1.8 mp -94.4 -32.61 13.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.936 0.717 . . . . 1.1299999999999999 112.936 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -58.05 -25.58 61.38 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.301 0.572 . . . . 1.71 109.5 -164.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -104.13 -41.57 5.78 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.299 -0.864 . . . . 1.76 113.069 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 5.9 mptt -67.02 -52.39 43.07 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.011 -0.995 . . . . 1.9099999999999999 111.864 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 ' H ' ' A' ' 59' ' ' LEU . 11.9 t -23.85 100.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 111.38 -2.645 . . . . 1.1499999999999999 113.512 175.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -166.11 -129.72 1.08 Allowed Glycine 0 C--N 1.299 -1.504 0 CA-C-N 110.561 -3.018 . . . . 0.69999999999999996 112.154 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -56.47 -37.01 69.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.465 0.913 . . . . 3.3599999999999999 113.465 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.658 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.5 p80 -95.07 -38.88 10.42 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.267 0.469 . . . . 1.78 112.267 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.888 ' HB2' HG12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.97 107.76 8.9 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.015 -0.735 . . . . 1.72 109.015 173.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.41 116.25 28.8 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.14 -1.43 . . . . 0.96999999999999997 107.14 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.848 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -90.51 93.32 9.24 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.044 -2.206 . . . . 1.0600000000000001 105.044 171.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -86.02 163.03 18.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-O 122.96 1.362 . . . . 2.5899999999999999 109.382 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -141.38 118.91 11.58 Favored 'General case' 0 C--N 1.259 -3.339 0 CA-C-N 111.332 -2.667 . . . . 0.92000000000000004 109.585 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.7 m -103.39 148.95 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.777 -2.011 . . . . 0.76000000000000001 107.99 172.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.448 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 13.2 t80 -142.33 97.29 3.1 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.439 1.114 . . . . 1.8 110.821 -176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -117.6 118.22 31.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.786 -1.552 . . . . 2.4199999999999999 109.911 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -36.33 25.02 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.557 -1.656 . . . . 3.0800000000000001 111.554 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.23 67.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.432 -0.803 . . . . 1.6899999999999999 110.912 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -96.55 -19.42 19.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.391 -0.966 . . . . 1.96 108.391 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.812 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 11.4 ttpt 67.08 32.54 6.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.961 -1.472 . . . . 3.7799999999999998 110.427 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -128.07 126.63 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.761 0.791 . . . . 1.1299999999999999 110.311 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.3 m-30 -99.17 108.81 21.5 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.119 -1.808 . . . . 1.95 106.119 166.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HG ' ' HG2' ' A' ' 73' ' ' GLU . 14.3 tp -98.25 105.74 17.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.522 1.153 . . . . 1.1799999999999999 109.142 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.0 m-85 -85.45 113.52 21.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 113.322 -1.763 . . . . 0.40000000000000002 107.905 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 9.6 mt-10 -107.56 121.2 44.16 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.465 -1.698 . . . . 1.3200000000000001 110.044 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.816 HD22 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -91.08 126.66 36.23 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.462 -1.244 . . . . 1.5900000000000001 107.849 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.635 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 78.7 m80 -117.06 95.32 4.94 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 104.569 -2.382 . . . . 2.0099999999999998 104.569 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.888 HG12 ' HB2' ' A' ' 57' ' ' LEU . 25.4 mt -121.85 100.47 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-O 122.74 1.257 . . . . 1.1899999999999999 109.066 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.3 p -111.86 161.13 16.7 Favored 'General case' 0 N--CA 1.395 -3.224 0 CA-C-N 114.569 -1.196 . . . . 1.05 109.572 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 48.35 57.75 5.88 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 111.271 -2.695 . . . . 2.1200000000000001 110.611 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' O ' HG12 ' A' ' 18' ' ' VAL . . . -52.62 119.81 4.96 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.824 -1.989 . . . . 1.0900000000000001 110.608 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.747 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -60.15 143.84 88.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.461 -0.791 . . . . 1.77 109.306 173.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.747 ' HD2' HE21 ' A' ' 80' ' ' GLN . 31.7 Cg_endo -63.54 -3.32 5.22 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.286 1.99 . . . . 1.3300000000000001 112.564 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.492 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -115.17 15.73 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.566 . . . . 1.6599999999999999 110.131 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.8 m-30 -94.53 -8.7 37.54 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 118.838 -0.601 . . . . 1.24 110.181 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 15.6 m -19.1 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 125.788 1.93 . . . . 1.6799999999999999 111.529 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.755 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -37.12 110.83 0.1 Allowed Glycine 0 CA--C 1.473 -2.579 0 CA-C-N 110.062 -3.245 . . . . 2.0 114.584 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.953 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -127.45 60.08 0.67 Allowed Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 108.277 -1.929 . . . . 0.81000000000000005 108.277 157.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.599 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 80.7 m-85 -80.2 126.78 31.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.07 -1.065 . . . . 1.0800000000000001 108.555 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -130.83 121.11 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.951 -0.468 . . . . 3.6899999999999999 110.274 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.543 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -98.53 120.61 39.25 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.587 -0.523 . . . . 1.22 109.587 176.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.771 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.8 mt-10 -121.56 105.44 10.45 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.189 -0.671 . . . . 1.8100000000000001 109.189 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.4 p -96.07 137.17 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.356 0.598 . . . . 1.24 110.384 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.682 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.0 t -130.09 110.65 11.78 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.875 -1.057 . . . . 1.6399999999999999 109.146 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -129.06 173.63 10.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.877 -0.602 . . . . 1.26 110.17 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.859 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.96 -62.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.243 1.59 . . . . 0.93999999999999995 114.474 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.859 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.9 t70 -154.24 -0.57 0.2 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.384 -1.28 . . . . 1.05 109.289 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.032 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -93.36 128.25 39.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.001 -1.111 . . . . 1.78 108.001 -177.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -130.73 130.71 44.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.756 -1.111 . . . . 1.0 110.831 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.96 151.22 35.44 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.402 -1.272 . . . . 1.6000000000000001 109.02 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 9.5 p -151.13 146.59 26.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.133 0.492 . . . . 1.98 111.294 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.48 146.45 50.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.479 -0.782 . . . . 1.02 111.593 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.24 119.0 22.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.69 -1.141 . . . . 1.5800000000000001 109.477 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.835 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 6.7 p90 -143.1 128.73 19.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.344 0.592 . . . . 1.1000000000000001 110.153 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.689 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 41.8 m-20 -102.45 135.48 44.0 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.22 1.009 . . . . 2.1099999999999999 110.999 -172.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.755 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -105.46 107.34 18.27 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.046 -1.434 . . . . 1.0900000000000001 108.856 174.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 9.0 m -87.94 95.08 9.98 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.163 -1.015 . . . . 1.0700000000000001 108.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 80' ' ' GLN . 3.3 p -76.69 112.51 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 122.948 1.356 . . . . 1.1399999999999999 107.768 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 66.4 m170 -82.03 97.66 8.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.902 -1.954 . . . . 1.8200000000000001 108.623 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HA ' HG21 ' A' ' 18' ' ' VAL . 39.2 tt0 -67.77 -35.71 79.18 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.376 -1.342 . . . . 1.6699999999999999 107.376 166.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.6 68.8 0.71 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.152 -1.385 . . . . 2.98 112.564 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tmm? . . . . . 0 C--O 1.248 0.985 0 N-CA-C 108.747 -0.835 . . . . 7.3399999999999999 108.747 176.691 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.333 -0.988 . . . . 1.9299999999999999 108.333 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 8.0 m-20 -110.08 171.26 4.53 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.883 -0.599 . . . . 1.6499999999999999 111.625 -172.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -70.51 69.04 2.09 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.579 2.186 . . . . 1.24 112.534 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 1.031 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -88.12 -63.82 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.8 -1.091 . . . . 1.2 108.729 171.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.85 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 91.72 43.2 4.57 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.588 -1.805 . . . . 0.44 108.588 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.0 tp -52.77 -39.59 62.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.827 -1.687 . . . . 1.1100000000000001 110.389 -171.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.749 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.95 83.41 5.65 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.162 -0.926 . . . . 0.97999999999999998 109.816 177.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.31 -43.03 74.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.565 -1.198 . . . . 1.1100000000000001 108.835 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.36 135.67 15.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.123 -0.944 . . . . 3.3100000000000001 109.571 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -113.92 136.43 22.12 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.0 -0.741 . . . . 4.1699999999999999 109.0 176.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.676 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -71.58 160.08 49.34 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.437 1.425 . . . . 0.81999999999999995 110.646 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.38 -177.78 3.53 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.75 -0.659 . . . . 1.6299999999999999 109.498 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.9 p-10 -69.67 -151.08 0.02 OUTLIER 'General case' 0 N--CA 1.405 -2.721 0 CA-C-O 123.166 1.46 . . . . 2.0600000000000001 111.939 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.04 134.86 2.01 Favored Glycine 0 C--N 1.293 -1.811 0 CA-C-N 112.824 -1.989 . . . . 0.34999999999999998 112.036 -174.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 32.4 mt-10 -112.49 112.35 23.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.154 -1.023 . . . . 1.53 108.48 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.0 m -130.76 163.99 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 108.005 -1.109 . . . . 1.0800000000000001 108.005 -171.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -90.97 152.84 20.54 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.279 -1.328 . . . . 1.22 109.256 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 81' ' ' PRO . 21.8 t -69.4 106.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 CA-C-O 122.796 1.284 . . . . 1.3799999999999999 107.663 172.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.8 11.57 7.02 Favored Glycine 0 C--N 1.263 -3.52 0 CA-C-N 111.9 -2.409 . . . . 0.52000000000000002 112.717 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.38 -121.84 4.96 Favored Glycine 0 CA--C 1.472 -2.614 0 C-N-CA 118.893 -1.622 . . . . 0.44 110.419 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.9 p -152.49 172.03 17.17 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 112.614 -1.793 . . . . 1.23 110.322 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG22 HD13 ' A' ' 104' ' ' LEU . 9.3 tp -148.37 149.61 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 113.022 -1.899 . . . . 1.0900000000000001 106.185 169.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m -137.89 124.99 21.49 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 114.411 -1.268 . . . . 1.05 111.235 -173.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.895 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.9 m-85 -119.55 139.85 51.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.921 -1.49 . . . . 0.71999999999999997 109.525 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.126 -0.943 . . . . 0.87 108.75 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.748 ' HB1' ' HH2' ' A' ' 41' ' ' TRP . . . -122.14 115.98 23.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.374 -1.284 . . . . 1.1000000000000001 110.261 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HG2' HD11 ' A' ' 71' ' ' LEU . 66.1 mtp180 -111.41 122.5 48.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.649 -0.251 . . . . 2.9300000000000002 110.46 -174.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.7 t -121.18 128.11 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.012 0.91 . . . . 1.0700000000000001 110.394 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.38 109.39 1.34 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.285 -1.779 . . . . 1.1200000000000001 110.486 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.65 -42.19 35.68 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.106 -0.952 . . . . 0.76000000000000001 111.68 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.614 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 57.41 -166.55 0.14 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.039 0.755 . . . . 1.0 113.039 172.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 p -113.23 110.72 20.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.08 -0.964 . . . . 2.1699999999999999 108.648 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.003 HD13 ' H ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -148.34 158.36 44.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.145 -0.479 . . . . 2.6299999999999999 110.289 -171.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.722 ' N ' HD11 ' A' ' 33' ' ' LEU . 4.9 mt -47.13 -37.93 10.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.053 1.406 . . . . 1.99 111.501 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.778 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.99 -178.83 0.86 Allowed Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 111.933 -2.394 . . . . 1.8799999999999999 107.809 -170.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.65 145.61 20.63 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.198 -1.886 . . . . 1.1200000000000001 107.198 162.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.671 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 16.6 Cg_exo -58.18 129.56 33.56 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 CA-C-N 119.49 0.854 . . . . 0.81999999999999995 110.606 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.23 102.3 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 122.781 1.277 . . . . 1.4299999999999999 107.657 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.586 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -104.88 115.8 47.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 112.427 -2.17 . . . . 1.0900000000000001 108.023 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.92 130.83 54.52 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.108 1.432 . . . . 2.1299999999999999 109.757 173.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.066 ' HB3' HD11 ' A' ' 49' ' ' LEU . 86.7 m95 -86.59 152.47 22.58 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.103 -2.317 . . . . 0.40999999999999998 112.746 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.9 t80 -131.18 136.71 48.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.239 -2.134 . . . . 0.80000000000000004 105.239 170.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.741 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 80.3 tttt -102.84 166.53 10.42 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.712 -1.588 . . . . 2.6800000000000002 106.712 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.72 -168.22 0.0 OUTLIER Glycine 0 C--O 1.187 -2.8 0 N-CA-C 119.549 2.58 . . . . 1.6000000000000001 119.549 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 84' ' ' THR . 16.6 mtpt -44.97 -1.31 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.549 -2.147 . . . . 4.2999999999999998 116.384 -167.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.622 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.6 p-90 -167.7 -11.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.765 1.395 . . . . 2.5099999999999998 114.765 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.741 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.23 168.04 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 CA-C-O 123.459 1.6 . . . . 1.78 112.816 -159.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.499 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.5 t70 -112.28 155.43 24.08 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 111.549 -2.569 . . . . 2.73 105.937 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.066 HD11 ' HB3' ' A' ' 41' ' ' TRP . 5.4 mp -94.08 -36.34 12.14 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.579 0.955 . . . . 1.1299999999999999 113.579 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 t -58.72 -21.23 54.55 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.2 -0.667 . . . . 1.71 109.2 -165.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -96.13 -27.57 14.99 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.022 -0.99 . . . . 1.76 113.419 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 16.7 mmmt -100.75 -32.6 10.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.033 0.444 . . . . 1.9099999999999999 111.566 -170.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 27.0 t -35.11 97.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 125.817 1.647 . . . . 1.1499999999999999 111.94 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.48 -146.2 4.43 Favored Glycine 0 C--O 1.213 -1.212 0 CA-C-N 111.604 -2.544 . . . . 0.69999999999999996 110.309 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' C ' HE22 ' A' ' 58' ' ' GLN . 41.7 tt0 -71.37 -2.0 14.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.943 0.872 . . . . 3.3599999999999999 112.916 -170.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 21.8 p80 -114.29 -33.38 5.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.87 0.843 . . . . 1.78 111.064 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.952 HD11 HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -133.3 105.18 6.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.706 -1.961 . . . . 1.72 105.706 171.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.81 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -99.28 114.49 27.35 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.073 -1.825 . . . . 0.96999999999999997 106.073 171.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.528 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -97.2 92.81 6.2 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.901 -2.259 . . . . 1.0600000000000001 104.901 172.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.5 m-70 -93.53 163.07 13.71 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.013 1.387 . . . . 2.5899999999999999 110.378 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.02 119.15 24.85 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 111.399 -2.637 . . . . 0.92000000000000004 108.88 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -102.59 138.93 38.85 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.574 -2.103 . . . . 0.76000000000000001 106.538 167.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -145.64 99.13 3.24 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.991 0.9 . . . . 1.8 112.156 -166.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 5.0 t70 -119.68 120.69 37.34 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.349 -1.296 . . . . 2.4199999999999999 109.866 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -81.62 -38.8 25.44 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.684 -1.598 . . . . 3.0800000000000001 111.289 -176.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.9 -28.01 60.45 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.69 -1.141 . . . . 1.6899999999999999 111.248 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 27.5 m -89.0 -13.31 39.1 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.635 -1.246 . . . . 1.96 107.635 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 72.98 25.85 2.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.597 -1.638 . . . . 3.7799999999999998 110.484 171.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.59 120.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.912 0.863 . . . . 1.1299999999999999 110.709 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.671 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -103.43 105.94 16.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.322 -1.733 . . . . 1.95 106.322 166.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 8.0 tp -96.7 104.38 16.37 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 1.1799999999999999 108.806 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -85.01 115.14 22.66 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.105 -1.407 . . . . 0.40000000000000002 107.515 174.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -102.65 126.2 49.66 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 113.727 -1.579 . . . . 1.3200000000000001 109.435 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.895 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 3.7 mm? -95.74 125.48 40.34 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.877 -1.511 . . . . 1.5900000000000001 107.749 172.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.81 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 30.9 m170 -120.39 95.98 4.96 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 103.85 -2.648 . . . . 2.0099999999999998 103.85 172.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.607 ' CD1' HD22 ' A' ' 57' ' ' LEU . 58.5 mt -120.3 102.22 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 113.894 -1.503 . . . . 1.1899999999999999 108.874 -170.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 80.6 p -114.05 141.66 47.16 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 113.219 -1.81 . . . . 1.05 109.845 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 61.21 70.71 0.59 Allowed 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 111.28 -2.691 . . . . 2.1200000000000001 110.222 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.45 126.9 28.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.435 -2.166 . . . . 1.0900000000000001 110.524 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.779 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -55.67 139.33 68.82 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.386 -0.824 . . . . 1.77 109.378 173.154 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HB3' HG22 ' A' ' 18' ' ' VAL . 34.6 Cg_endo -67.74 145.04 67.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.357 1.371 . . . . 1.3300000000000001 110.888 176.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.88 17.22 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.659 0.599 . . . . 1.6599999999999999 110.758 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.779 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -71.01 -30.27 66.45 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.002 -0.544 . . . . 1.24 109.712 177.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 40.6 m 14.46 79.59 0.01 OUTLIER 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.566 1.791 . . . . 1.6799999999999999 110.712 -168.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -64.06 94.82 0.15 Allowed Glycine 0 N--CA 1.423 -2.216 0 CA-C-N 112.35 -2.205 . . . . 2.0 113.764 -161.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.71 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -88.19 70.48 2.66 Favored Glycine 0 C--N 1.288 -2.133 0 N-CA-C 109.324 -1.51 . . . . 0.81000000000000005 109.324 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.571 ' HE2' ' CD2' ' A' ' 57' ' ' LEU . 54.3 m-85 -74.58 120.77 20.59 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.676 -1.262 . . . . 1.0800000000000001 108.788 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 90.3 mtt180 -120.09 110.93 17.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.788 -0.449 . . . . 3.6899999999999999 109.788 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 t -94.93 122.65 37.79 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.54 -0.541 . . . . 1.22 109.54 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.496 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 24.1 mt-10 -126.77 110.83 13.53 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.081 -0.963 . . . . 1.8100000000000001 109.937 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HB ' HG11 ' A' ' 39' ' ' VAL . 3.0 p -107.99 139.82 28.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.443 0.639 . . . . 1.24 110.655 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -133.36 110.87 10.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.758 -1.11 . . . . 1.6399999999999999 110.279 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 37' ' ' PRO . 31.9 p -120.33 -176.33 3.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.185 -0.916 . . . . 1.26 111.123 176.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 1.003 ' H ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -25.92 -45.07 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 125.724 1.89 . . . . 0.93999999999999995 112.367 -178.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.753 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -172.72 7.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.77 -1.559 . . . . 1.05 110.84 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.031 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 tmtm? -92.91 123.69 36.35 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 106.571 -1.64 . . . . 1.78 106.571 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.52 123.24 29.18 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.974 -1.012 . . . . 1.0 111.124 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -145.58 144.27 30.39 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.1 -1.409 . . . . 1.6000000000000001 109.873 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.4 p -142.83 145.04 32.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.947 -0.569 . . . . 1.98 109.543 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.749 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 60.9 p -130.41 133.55 46.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.935 -0.575 . . . . 1.02 111.57 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.528 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -109.13 123.72 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.82 -0.627 . . . . 1.5800000000000001 110.389 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.676 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.16 115.76 9.57 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.685 -0.487 . . . . 1.1000000000000001 109.685 -177.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.782 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 50.4 m-20 -100.63 141.24 33.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.051 0.929 . . . . 2.1099999999999999 111.191 -168.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -111.38 111.3 22.24 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.249 -1.341 . . . . 1.0900000000000001 110.061 176.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.446 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m -93.6 97.73 10.68 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.956 -0.757 . . . . 1.0700000000000001 108.956 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 80' ' ' GLN . 7.4 p -84.77 121.34 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 123.138 1.447 . . . . 1.1399999999999999 110.32 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 17' ' ' THR . 98.7 m-70 -106.58 102.0 11.42 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.45 -2.159 . . . . 1.8200000000000001 109.722 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.49 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.7 tt0 -67.55 -78.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.054 -0.975 . . . . 1.6699999999999999 111.302 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -179.59 -173.89 0.27 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.698 -0.683 . . . . 2.98 109.617 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 57.7 ttp . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.654 -0.689 . . . . 7.3399999999999999 109.641 176.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.607 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.534 0.683 . . . . 1.9299999999999999 112.801 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 1.087 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 14.3 t70 -139.57 148.65 56.98 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 115.137 -0.938 . . . . 1.6499999999999999 109.083 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' C ' HD11 ' A' ' 4' ' ' ILE . 77.3 Cg_exo -52.2 99.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.588 2.859 . . . . 1.24 114.656 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.687 HD12 ' HZ3' ' A' ' 94' ' ' LYS . 1.5 mp -125.04 -60.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 1.2 110.091 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.81 49.44 3.83 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.645 -1.782 . . . . 0.44 108.645 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 96' ' ' LYS . 12.7 tp -59.89 -41.95 92.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.839 -1.681 . . . . 1.1100000000000001 110.475 -168.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.73 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -90.32 84.7 6.06 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.433 -0.803 . . . . 0.97999999999999998 109.65 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -71.97 -48.02 52.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.901 -1.045 . . . . 1.1100000000000001 110.313 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.534 ' CG ' ' HD3' ' A' ' 27' ' ' ARG . 20.7 mmt -136.6 130.9 33.01 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.061 -0.518 . . . . 3.3100000000000001 110.828 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.73 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 26.1 mtm180 -93.78 128.14 42.86 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.565 -0.902 . . . . 4.1699999999999999 108.565 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.62 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 79.1 Cg_endo -77.5 148.5 26.36 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.656 1.571 . . . . 0.81999999999999995 108.807 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.575 ' O ' ' HD2' ' A' ' 24' ' ' PHE . 17.3 mm-40 -112.93 179.46 3.96 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 111.629 0.233 . . . . 1.6299999999999999 111.629 -168.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.72 -144.48 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 123.005 1.383 . . . . 2.0600000000000001 111.325 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.44 127.82 1.59 Allowed Glycine 0 C--N 1.296 -1.69 0 CA-C-N 113.279 -1.782 . . . . 0.34999999999999998 111.543 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 1.9 mp0 -112.69 113.45 25.57 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.583 -0.895 . . . . 1.53 108.583 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.54 165.09 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 107.583 -1.265 . . . . 1.0800000000000001 107.583 -167.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.67 156.9 16.2 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.939 -1.028 . . . . 1.22 108.958 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.638 HG22 HG23 ' A' ' 106' ' ' VAL . 20.6 t -67.71 107.73 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 CA-C-O 122.83 1.3 . . . . 1.3799999999999999 108.604 175.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA2' ' OD1' ' A' ' 78' ' ' ASP . . . 120.98 3.58 10.72 Favored Glycine 0 C--N 1.267 -3.285 0 CA-C-N 111.788 -2.46 . . . . 0.52000000000000002 113.551 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -124.48 4.59 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.077 -1.535 . . . . 0.44 110.797 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.631 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.8 p -152.13 166.37 31.87 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 112.897 -1.651 . . . . 1.23 111.279 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.666 HG22 HD11 ' A' ' 104' ' ' LEU . 10.6 tp -147.84 148.71 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 113.423 -1.717 . . . . 1.0900000000000001 108.02 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 m -142.1 126.98 18.22 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 113.524 -1.671 . . . . 1.05 110.827 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.679 ' HD1' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -136.13 146.75 47.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.0 -1.0 . . . . 0.71999999999999997 109.429 173.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.76 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.9 126.1 33.33 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.517 -0.765 . . . . 0.87 109.727 -177.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -116.46 116.28 27.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.645 -1.161 . . . . 1.1000000000000001 110.718 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.611 ' HE ' HG12 ' A' ' 69' ' ' VAL . 43.3 mtp85 -102.25 130.36 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.835 -0.346 . . . . 2.9300000000000002 110.477 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.7 t -127.93 127.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.755 0.788 . . . . 1.0700000000000001 109.874 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.37 114.81 2.6 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.711 -1.586 . . . . 1.1200000000000001 111.531 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.86 -37.87 58.61 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 114.49 -1.232 . . . . 0.76000000000000001 110.375 168.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.656 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 58.66 -174.68 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 115.193 1.553 . . . . 1.0 115.193 164.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -103.16 113.78 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.13 -1.396 . . . . 2.1699999999999999 107.912 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -151.18 165.8 32.82 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.117 -0.492 . . . . 2.6299999999999999 111.807 -166.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.8 -69.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.415 -0.587 . . . . 1.99 109.415 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 151.21 41.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.029 -0.73 . . . . 1.8799999999999999 109.029 170.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.24 152.35 5.49 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.854 2.37 . . . . 1.1200000000000001 111.873 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.734 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -65.55 134.27 37.68 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.771 1.647 . . . . 0.81999999999999995 111.52 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.16 104.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 106.447 -1.686 . . . . 1.4299999999999999 106.447 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.568 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.44 114.74 47.78 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 113.194 -1.821 . . . . 1.0900000000000001 107.135 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.893 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.23 122.24 45.52 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 123.153 1.454 . . . . 2.1299999999999999 110.265 176.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.035 ' HB3' HD11 ' A' ' 49' ' ' LEU . 76.3 m95 -86.69 152.08 22.86 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 111.978 -2.374 . . . . 0.40999999999999998 110.921 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 38.4 t80 -136.97 135.15 37.42 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 104.243 -2.502 . . . . 0.80000000000000004 104.243 173.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.981 ' HB3' HG23 ' A' ' 47' ' ' VAL . 81.4 tttt -101.7 173.12 6.56 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 105.619 -1.993 . . . . 2.6800000000000002 105.619 -172.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 1.019 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -8.15 -168.03 0.0 OUTLIER Glycine 0 C--O 1.192 -2.487 0 N-CA-C 119.525 2.57 . . . . 1.6000000000000001 119.525 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 84' ' ' THR . 20.4 mtpp -39.22 -22.08 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 115.834 1.791 . . . . 4.2999999999999998 115.834 -163.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.405 ' HD1' ' CB ' ' A' ' 45' ' ' LYS . 2.6 p-90 -161.06 -6.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.937 1.088 . . . . 2.5099999999999998 113.937 -178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.981 HG23 ' HB3' ' A' ' 43' ' ' LYS . 31.5 m -94.4 171.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.778 0 CA-C-O 124.116 1.912 . . . . 1.78 113.539 -160.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.895 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -100.57 161.24 13.74 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 110.449 -3.069 . . . . 2.73 108.756 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.035 HD11 ' HB3' ' A' ' 41' ' ' TRP . 3.7 mp -99.42 -32.32 11.21 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 116.055 -0.52 . . . . 1.1299999999999999 111.612 160.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 t -58.13 -23.78 56.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.255 0.55 . . . . 1.71 109.884 -164.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.734 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 58.5 m -102.08 -27.62 12.81 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.037 0.922 . . . . 1.76 112.907 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.895 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 28.9 mttp -90.92 -27.35 18.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.658 -1.61 . . . . 1.9099999999999999 112.806 -168.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.694 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 35.9 t -50.32 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 111.529 -2.578 . . . . 1.1499999999999999 111.267 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.535 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.42 -99.23 0.15 Allowed Glycine 0 C--N 1.304 -1.246 0 CA-C-N 112.421 -2.172 . . . . 0.69999999999999996 113.299 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -86.05 -53.2 5.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.278 0.473 . . . . 3.3599999999999999 112.278 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.539 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.1 p80 -87.54 -36.19 17.72 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.394 0.616 . . . . 1.78 111.207 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.926 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.91 106.89 13.43 Favored 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 106.35 -1.722 . . . . 1.72 106.35 176.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -102.42 116.42 32.58 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.277 -1.379 . . . . 0.96999999999999997 107.277 166.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HB2' HG21 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -95.03 92.99 7.11 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.499 -2.408 . . . . 1.0600000000000001 104.499 170.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.61 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 46.5 m170 -87.66 162.56 17.04 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.645 1.212 . . . . 2.5899999999999999 109.968 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.93 118.91 19.47 Favored 'General case' 0 C--N 1.268 -2.963 0 CA-C-N 111.959 -2.382 . . . . 0.92000000000000004 108.933 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -101.05 149.46 23.92 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.58 -2.1 . . . . 0.76000000000000001 108.202 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -141.61 97.05 3.08 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.224 1.012 . . . . 1.8 110.762 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.5 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.4 OUTLIER -113.8 101.67 9.51 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.81 -1.541 . . . . 2.4199999999999999 110.393 173.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.04 -29.71 43.71 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.263 -1.335 . . . . 3.0800000000000001 110.937 -176.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.6 -21.26 65.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.196 -0.911 . . . . 1.6899999999999999 109.862 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 19.4 m -110.94 -11.98 14.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.18 -0.918 . . . . 1.96 109.076 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.656 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 67.1 32.48 6.18 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.323 -0.853 . . . . 3.7799999999999998 109.547 175.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.611 HG12 ' HE ' ' A' ' 27' ' ' ARG . 3.3 t -127.32 135.64 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.944 0.878 . . . . 1.1299999999999999 110.425 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.7 m-30 -107.44 112.82 25.8 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.244 -1.391 . . . . 1.95 107.244 165.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.76 HD12 ' HB3' ' A' ' 25' ' ' SER . 23.9 tp -95.32 107.65 19.78 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.041 0.924 . . . . 1.1799999999999999 109.537 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.61 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.2 m-85 -87.72 112.68 22.64 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.587 -1.264 . . . . 0.40000000000000002 107.587 170.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.433 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.69 120.16 41.1 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.952 -1.476 . . . . 1.3200000000000001 110.381 -175.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.6 mt -81.74 129.42 34.72 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.958 -1.127 . . . . 1.5900000000000001 107.958 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -115.88 96.57 5.65 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 103.351 -2.833 . . . . 2.0099999999999998 103.351 165.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.711 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -120.83 99.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 123.047 1.403 . . . . 1.1899999999999999 109.922 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.5 p -106.51 146.76 30.2 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 113.445 -1.707 . . . . 1.05 108.651 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' HA2' ' A' ' 19' ' ' GLY . 27.2 t70 64.8 82.7 0.18 Allowed 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 111.613 -2.54 . . . . 2.1200000000000001 109.926 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' A' ' 104' ' ' LEU . . . -81.27 109.92 16.24 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 111.375 -2.648 . . . . 1.0900000000000001 110.688 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.847 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -52.74 139.13 41.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.587 -0.733 . . . . 1.77 109.862 167.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.589 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 37.7 Cg_endo -63.57 -3.39 5.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.29 2.66 . . . . 1.3300000000000001 112.768 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.847 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -110.97 14.74 22.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.053 -0.521 . . . . 1.6599999999999999 110.894 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -90.14 -29.66 18.14 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 117.721 -1.133 . . . . 1.24 110.756 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 75.0 m 2.34 80.34 0.0 OUTLIER 'General case' 0 C--N 1.354 0.785 0 O-C-N 125.688 1.867 . . . . 1.6799999999999999 111.226 -174.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 1.019 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.19 121.7 5.61 Favored Glycine 0 N--CA 1.408 -3.213 0 CA-C-N 111.458 -2.61 . . . . 2.0 114.776 -163.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.919 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -120.94 70.23 0.39 Allowed Glycine 0 C--N 1.268 -3.24 0 CA-C-N 111.366 -2.417 . . . . 0.81000000000000005 107.97 159.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.768 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 54.5 m-85 -74.49 127.61 33.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.094 -1.053 . . . . 1.0800000000000001 109.013 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 48.0 mtp180 -121.38 104.68 9.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.643 -0.502 . . . . 3.6899999999999999 109.643 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.402 ' H ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -91.77 121.3 33.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.09 -1.078 . . . . 1.22 108.09 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.893 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 25.7 tt0 -137.48 106.67 6.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.229 -0.896 . . . . 1.8100000000000001 109.228 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.568 ' HB ' HG12 ' A' ' 39' ' ' VAL . 5.7 p -103.44 141.48 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.677 0.751 . . . . 1.24 111.305 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 t -138.71 109.88 6.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.435 -1.257 . . . . 1.6399999999999999 108.563 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.566 ' HG1' HD22 ' A' ' 6' ' ' LEU . 1.6 m -129.44 174.21 9.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.142 -1.058 . . . . 1.26 108.142 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 1.087 ' HZ2' ' HB3' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -5.88 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 125.199 1.562 . . . . 0.93999999999999995 114.756 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.951 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -156.98 -0.81 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.555 -1.202 . . . . 1.05 110.042 -174.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.674 ' HB3' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -96.36 131.43 42.91 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.244 -1.021 . . . . 1.78 108.244 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -132.65 145.6 51.2 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.173 -1.376 . . . . 1.0 111.516 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 10.6 t70 -176.08 164.96 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.797 -0.638 . . . . 1.6000000000000001 110.037 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.686 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 6.0 p -153.62 146.47 24.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.116 0.484 . . . . 1.98 110.576 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 88.8 p -124.34 131.94 53.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.805 -0.634 . . . . 1.02 110.55 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.79 121.12 42.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.972 0.415 . . . . 1.5800000000000001 110.461 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.62 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -142.83 126.31 16.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.466 0.651 . . . . 1.1000000000000001 109.789 -177.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 19.5 m-80 -105.09 152.88 22.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.182 0.991 . . . . 2.1099999999999999 111.563 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.682 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -123.03 104.27 9.11 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.818 -1.083 . . . . 1.0900000000000001 110.475 173.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -85.88 96.41 9.77 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.7 -0.8 . . . . 1.0700000000000001 109.251 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.638 HG23 HG22 ' A' ' 18' ' ' VAL . 7.5 p -81.87 113.22 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-O 123.387 1.565 . . . . 1.1399999999999999 109.221 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 99.9 m-70 -94.91 100.95 12.72 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.362 -2.199 . . . . 1.8200000000000001 109.872 -174.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 18' ' ' VAL . 36.1 tt0 -75.78 -63.58 1.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.383 -0.826 . . . . 1.6699999999999999 110.134 171.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.62 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.256 -0.429 . . . . 2.98 110.646 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.6 ptm . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.62 -0.705 . . . . 7.3399999999999999 109.955 -177.787 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.909 0.385 . . . . 1.9299999999999999 110.599 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.571 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.0 m-20 -111.78 167.52 8.99 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.109 -0.496 . . . . 1.6499999999999999 112.134 -172.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' C ' HD13 ' A' ' 4' ' ' ILE . 42.4 Cg_endo -68.45 87.16 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.814 2.343 . . . . 1.24 112.269 176.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.761 HD12 ' HE2' ' A' ' 94' ' ' LYS . 1.6 mp -126.4 -58.91 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.96 -1.018 . . . . 1.2 109.444 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.63 37.08 7.08 Favored Glycine 0 CA--C 1.496 -1.135 0 N-CA-C 108.991 -1.644 . . . . 0.44 108.991 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.142 HD21 ' HB3' ' A' ' 96' ' ' LYS . 8.9 tp -46.52 -47.5 19.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.104 -1.548 . . . . 1.1100000000000001 110.383 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.758 ' CZ ' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -89.57 83.45 6.31 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.741 0.781 . . . . 0.97999999999999998 109.02 175.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.2 t -68.26 -48.28 74.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.448 -1.251 . . . . 1.1100000000000001 109.598 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 ttp -148.47 129.58 14.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.651 -1.159 . . . . 3.3100000000000001 108.828 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -95.84 148.64 34.87 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.662 -0.699 . . . . 4.1699999999999999 109.615 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.919 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 1.9 Cg_endo -79.35 162.59 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.557 2.171 . . . . 0.81999999999999995 111.074 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.4 mm-40 -125.8 169.65 12.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.099 -0.501 . . . . 1.6299999999999999 110.329 -171.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.555 ' HB3' ' H ' ' A' ' 103' ' ' ASN . 7.3 p-10 -74.78 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-O 122.695 1.236 . . . . 2.0600000000000001 111.922 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 159.83 137.34 2.21 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.206 -1.815 . . . . 0.34999999999999998 112.175 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.481 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 31.2 mt-10 -115.76 113.85 24.0 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.054 -1.073 . . . . 1.53 108.87 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.526 HG21 HD11 ' A' ' 104' ' ' LEU . 3.1 m -134.52 163.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.715 0 N-CA-C 107.13 -1.433 . . . . 1.0800000000000001 107.13 -173.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.509 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -93.13 157.21 16.4 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.541 -0.754 . . . . 1.22 110.035 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 81' ' ' PRO . 9.0 t -62.58 106.76 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 CA-C-O 122.956 1.36 . . . . 1.3799999999999999 109.488 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.34 11.42 17.88 Favored Glycine 0 C--N 1.269 -3.18 0 CA-C-N 112.08 -2.327 . . . . 0.52000000000000002 113.712 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.3 -122.33 4.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 109.867 -1.293 . . . . 0.44 109.867 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.3 p -151.66 164.24 37.36 Favored 'General case' 0 N--CA 1.401 -2.89 0 CA-C-N 113.088 -1.556 . . . . 1.23 110.971 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.617 HG21 ' HB ' ' A' ' 76' ' ' ILE . 6.8 tp -148.1 142.92 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 112.801 -1.999 . . . . 1.0900000000000001 107.904 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -138.64 129.39 26.41 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-N 114.237 -1.347 . . . . 1.05 111.054 -171.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.488 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 31.8 m-85 -126.98 143.03 51.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.129 -1.396 . . . . 0.71999999999999997 110.369 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.523 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -130.25 123.42 30.08 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.009 -0.996 . . . . 0.87 109.438 174.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.919 ' HB3' ' HG3' ' A' ' 11' ' ' PRO . . . -120.89 118.16 29.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.13 -1.396 . . . . 1.1000000000000001 110.324 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -105.28 122.41 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.225 -0.297 . . . . 2.9300000000000002 111.008 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.2 t -124.89 127.39 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.849 0.833 . . . . 1.0700000000000001 109.83 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 6' ' ' LEU . . . -57.64 113.31 1.76 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.665 -1.607 . . . . 1.1200000000000001 111.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.746 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -54.22 -42.16 72.28 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.537 -1.21 . . . . 0.76000000000000001 110.651 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.667 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.32 -151.01 0.1 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 115.193 1.553 . . . . 1.0 115.193 167.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -128.34 130.54 47.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.264 -1.334 . . . . 2.1699999999999999 108.717 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.62 ' HB3' ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -156.78 179.02 9.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.298 0.571 . . . . 2.6299999999999999 111.775 -173.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.41 -42.09 59.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.712 -1.131 . . . . 1.99 108.921 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -149.48 149.9 29.89 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 1.8799999999999999 109.558 175.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.54 140.24 12.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.86 2.373 . . . . 1.1200000000000001 112.248 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 93' ' ' THR . 33.3 Cg_exo -53.59 137.51 66.23 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 C-N-CA 122.095 1.863 . . . . 0.81999999999999995 112.377 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.86 104.4 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 106.787 -1.56 . . . . 1.4299999999999999 106.787 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.53 HG23 HG21 ' A' ' 91' ' ' VAL . 2.4 t -113.09 115.22 49.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.022 0 CA-C-N 113.782 -1.554 . . . . 1.0900000000000001 107.595 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.627 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -106.55 131.67 53.45 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.896 1.331 . . . . 2.1299999999999999 108.978 172.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.888 ' HB3' HD13 ' A' ' 49' ' ' LEU . 50.1 m95 -90.73 157.24 17.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.394 -2.185 . . . . 0.40999999999999998 110.622 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.5 t80 -139.62 124.58 18.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.431 -2.063 . . . . 0.80000000000000004 105.431 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 1.047 ' HE3' ' HH ' ' A' ' 87' ' ' TYR . 60.5 tttt -104.26 112.47 25.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.3 -1.36 . . . . 2.6800000000000002 108.145 -172.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 85' ' ' GLY . . . -84.81 92.31 1.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 115.572 -3.204 . . . . 1.6000000000000001 114.39 -166.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.783 ' HE3' ' HE1' ' A' ' 46' ' ' TRP . 21.9 ttpt -102.85 -31.53 10.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 103.173 -2.899 . . . . 4.2999999999999998 103.173 137.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.878 ' HD1' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER 158.78 -11.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 111.243 -2.708 . . . . 2.5099999999999998 111.369 -167.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.917 ' HB ' ' HE2' ' A' ' 52' ' ' LYS . 0.7 OUTLIER -88.08 168.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.03 1.395 . . . . 1.78 113.53 -165.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.681 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 16.5 t70 -113.09 132.57 55.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 111.666 -2.515 . . . . 2.73 108.886 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.888 HD13 ' HB3' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -76.31 -30.91 57.89 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 113.714 1.005 . . . . 1.1299999999999999 113.714 -174.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -61.47 -21.94 64.63 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.26 0.482 . . . . 1.71 109.894 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 t -101.09 -20.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.825 0.822 . . . . 1.76 112.215 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.917 ' HE2' ' HB ' ' A' ' 47' ' ' VAL . 45.2 mttp -96.81 -78.21 0.47 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.219 -1.355 . . . . 1.9099999999999999 113.687 -164.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.794 HG13 ' H ' ' A' ' 59' ' ' LEU . 37.8 t 22.98 98.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 125.293 1.621 . . . . 1.1499999999999999 114.273 161.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -145.14 -150.87 5.3 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.251 -1.34 . . . . 0.69999999999999996 113.983 -173.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.54 -27.13 68.95 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.83 0.452 . . . . 3.3599999999999999 112.149 -170.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.665 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.3 p80 -92.52 -39.08 11.57 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.668 -0.413 . . . . 1.78 111.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.909 HD22 ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -130.82 106.07 8.2 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.09 -0.707 . . . . 1.72 109.09 170.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.34 116.67 29.08 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.741 -1.577 . . . . 0.96999999999999997 106.741 170.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.794 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -91.87 93.67 8.94 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 105.222 -2.14 . . . . 1.0600000000000001 105.222 171.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.629 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 42.2 m170 -94.03 162.03 14.05 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-O 122.758 1.266 . . . . 2.5899999999999999 109.933 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -132.62 111.93 11.62 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 111.775 -2.466 . . . . 0.92000000000000004 108.768 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.0 m -87.67 148.75 24.65 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 112.71 -2.041 . . . . 0.76000000000000001 108.518 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.574 ' HH ' ' HG3' ' A' ' 65' ' ' ARG . 72.0 t80 -126.65 97.14 4.9 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.303 1.049 . . . . 1.8 110.121 -168.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.678 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -114.34 95.05 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.327 -1.761 . . . . 2.4199999999999999 108.554 177.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.574 ' HG3' ' HH ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -84.01 -27.22 28.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.173 -0.921 . . . . 3.0800000000000001 110.457 -176.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.44 -17.63 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.57 -1.196 . . . . 1.6899999999999999 109.847 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.678 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 24.2 m -108.79 -15.25 14.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.925 . . . . 1.96 108.774 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.667 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 64.93 35.47 8.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.097 -0.956 . . . . 3.7799999999999998 109.402 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.07 136.83 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 1.1299999999999999 109.667 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.746 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 13.9 m-85 -101.68 116.78 33.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.685 -1.598 . . . . 1.95 106.685 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 25' ' ' SER . 24.3 tp -95.55 104.54 16.45 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.441 -0.948 . . . . 1.1799999999999999 108.441 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.629 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.9 m-85 -81.92 112.03 18.65 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.539 -1.652 . . . . 0.40000000000000002 106.539 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -119.68 120.88 37.92 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.97 -1.468 . . . . 1.3200000000000001 110.385 -173.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.653 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -88.21 125.15 34.48 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.763 -1.562 . . . . 1.5900000000000001 107.584 177.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.651 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 12.8 m170 -110.75 96.01 5.91 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.148 -2.538 . . . . 2.0099999999999998 104.148 170.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.825 HG12 ' HB2' ' A' ' 57' ' ' LEU . 27.8 mt -119.57 99.98 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 122.89 1.328 . . . . 1.1899999999999999 110.279 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 31.4 p -116.05 139.97 49.74 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 114.301 -1.318 . . . . 1.05 107.77 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' A' ' 77' ' ' THR . 22.0 t70 74.85 64.98 0.07 Allowed 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.309 -2.223 . . . . 2.1200000000000001 108.312 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.17 9.18 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.098 -2.319 . . . . 1.0900000000000001 109.259 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.634 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -62.6 151.7 83.08 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.25 -0.648 . . . . 1.77 109.25 176.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.716 ' HB3' HG22 ' A' ' 18' ' ' VAL . 72.3 Cg_endo -72.95 11.06 0.94 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.795 2.33 . . . . 1.3300000000000001 113.958 -169.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.705 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -118.17 -3.97 11.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.595 -0.275 . . . . 1.6599999999999999 110.626 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' HD1' ' HB2' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -80.63 0.51 33.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.182 -0.673 . . . . 1.24 109.182 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 94.9 m -52.24 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 CA-C-O 122.609 1.195 . . . . 1.6799999999999999 109.657 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 44' ' ' GLY . . . -164.98 -119.42 0.48 Allowed Glycine 0 C--N 1.27 -3.093 0 CA-C-N 113.15 -1.841 . . . . 2.0 113.559 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -164.99 121.97 1.05 Allowed Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 113.501 -1.35 . . . . 0.81000000000000005 111.195 -171.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 1.047 ' HH ' ' HE3' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -87.01 125.48 34.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.413 -0.958 . . . . 1.0800000000000001 108.413 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -105.0 132.71 50.9 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.239 -0.652 . . . . 3.6899999999999999 109.239 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 3.9 m -111.76 121.7 45.79 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.837 -0.801 . . . . 1.22 108.837 169.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 41.9 mt-10 -120.01 105.2 10.81 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.78 -0.646 . . . . 1.8100000000000001 109.608 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 HG23 ' A' ' 39' ' ' VAL . 7.1 p -99.74 134.05 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.187 0.994 . . . . 1.24 110.717 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -135.58 108.03 7.37 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.591 -1.64 . . . . 1.6399999999999999 108.389 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.716 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -133.22 163.23 29.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.308 -0.853 . . . . 1.26 109.09 -178.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.761 ' HE2' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 22.28 -79.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 125.52 1.762 . . . . 0.93999999999999995 113.536 168.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 1' ' ' ASP . 16.3 t70 -153.43 6.3 0.35 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.898 -1.047 . . . . 1.05 109.156 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.142 ' HB3' HD21 ' A' ' 6' ' ' LEU . 44.7 tptt -92.01 132.1 36.8 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.782 -1.562 . . . . 1.78 106.782 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -131.7 146.17 52.03 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.847 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.57 163.18 2.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.98 . . . . 1.6000000000000001 110.104 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.4 p -152.22 138.44 18.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.981 -0.554 . . . . 1.98 110.038 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.758 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 57.9 p -107.45 147.25 30.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.631 -0.713 . . . . 1.02 110.325 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.448 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -132.98 114.91 14.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.431 0.634 . . . . 1.5800000000000001 110.354 176.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.778 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 33.7 p90 -143.24 140.23 30.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.082 -0.508 . . . . 1.1000000000000001 109.796 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.3 m-20 -96.98 155.97 16.55 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.207 1.003 . . . . 2.1099999999999999 111.974 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.709 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -125.7 114.44 18.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.726 -1.213 . . . . 1.0900000000000001 107.726 164.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.1 m -98.83 95.86 7.48 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.654 -0.869 . . . . 1.0700000000000001 108.654 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 80' ' ' GLN . 4.1 p -78.39 111.74 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 123.065 1.412 . . . . 1.1399999999999999 108.834 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 65.2 m170 -78.57 98.11 6.01 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.664 -2.062 . . . . 1.8200000000000001 109.788 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.69 -34.76 58.18 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.542 -1.663 . . . . 1.6699999999999999 108.866 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.78 31.72 16.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.258 -0.883 . . . . 2.98 111.801 175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.17 -0.678 . . . . 7.3399999999999999 109.17 177.726 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.729 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 122.044 0.926 . . . . 1.9299999999999999 110.739 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.601 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 19.6 t70 -74.53 157.81 85.77 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.614 -1.175 . . . . 1.6499999999999999 109.846 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 18.2 Cg_endo -61.04 77.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.737 2.292 . . . . 1.24 114.066 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.688 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -99.59 -60.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.773 -1.103 . . . . 1.2 109.574 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.7 43.69 6.01 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 108.321 -1.912 . . . . 0.44 108.321 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.599 ' N ' HG21 ' A' ' 4' ' ' ILE . 9.8 tp -50.11 -43.83 51.87 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.652 -1.774 . . . . 1.1100000000000001 111.031 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.744 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -88.52 84.73 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.646 -0.706 . . . . 0.97999999999999998 110.301 176.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.46 -40.95 72.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.447 -1.251 . . . . 1.1100000000000001 109.167 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.497 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 18.2 ttt -151.06 137.45 18.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.617 -1.174 . . . . 3.3100000000000001 108.655 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 7.8 ptp180 -102.47 139.23 20.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.229 -0.441 . . . . 4.1699999999999999 110.201 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.791 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 14.1 Cg_endo -69.73 154.1 68.28 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.741 2.294 . . . . 0.81999999999999995 112.375 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.444 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -112.93 170.75 7.98 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.099 0.778 . . . . 1.6299999999999999 113.099 -168.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 1.6 m-20 -69.88 -147.35 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.701 1.239 . . . . 2.0600000000000001 110.741 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 22' ' ' ILE . . . 153.32 133.31 1.84 Allowed Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 113.611 -1.631 . . . . 0.34999999999999998 112.242 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 23.1 mt-10 -110.68 119.01 37.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.256 -0.972 . . . . 1.53 108.527 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.2 m -137.77 162.06 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.21 0 N-CA-C 107.047 -1.464 . . . . 1.0800000000000001 107.047 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -96.4 155.33 16.81 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.41 -0.959 . . . . 1.22 108.41 176.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.671 HG11 ' HD3' ' A' ' 81' ' ' PRO . 6.2 t -67.28 105.85 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.862 -1.162 . . . . 1.3799999999999999 107.862 173.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.34 -6.74 3.97 Favored Glycine 0 C--N 1.273 -2.953 0 CA-C-N 112.926 -1.943 . . . . 0.52000000000000002 113.368 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.37 -123.93 5.29 Favored Glycine 0 CA--C 1.471 -2.704 0 C-N-CA 119.089 -1.529 . . . . 0.44 110.6 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.8 p -148.98 174.45 12.26 Favored 'General case' 0 N--CA 1.396 -3.149 0 CA-C-N 112.555 -1.822 . . . . 1.23 110.2 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.617 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.1 tp -146.09 140.39 21.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 112.651 -2.068 . . . . 1.0900000000000001 107.21 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.9 m -139.24 127.59 22.79 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 113.398 -1.728 . . . . 1.05 111.492 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.733 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 3.4 m-85 -128.19 154.71 45.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.057 -1.429 . . . . 0.71999999999999997 108.877 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -134.42 122.05 21.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.461 -0.79 . . . . 0.87 109.382 173.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.791 ' HB3' ' HG3' ' A' ' 11' ' ' PRO . . . -113.51 116.38 29.47 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.878 -1.056 . . . . 1.1000000000000001 110.184 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.1 mtt180 -105.61 115.66 30.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.469 -0.332 . . . . 2.9300000000000002 110.412 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 t -118.23 126.3 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.065 0.936 . . . . 1.0700000000000001 110.121 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.788 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . . . -56.36 108.97 0.53 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.147 -1.842 . . . . 1.1200000000000001 112.188 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.62 80.78 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.764 -1.107 . . . . 0.76000000000000001 112.423 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.679 ' HB1' HD13 ' A' ' 33' ' ' LEU . . . 61.05 -178.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.137 1.162 . . . . 1.0 114.137 168.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -105.39 29.53 6.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.292 -1.322 . . . . 2.1699999999999999 109.083 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.107 HD12 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -58.57 175.71 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.645 -1.161 . . . . 2.6299999999999999 113.133 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.44 -40.52 64.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.874 0.845 . . . . 1.99 109.927 -176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.93 134.88 11.14 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.442 -1.253 . . . . 1.8799999999999999 108.532 176.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -43.58 141.62 3.62 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.333 2.689 . . . . 1.1200000000000001 112.18 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.107 ' HD3' HD12 ' A' ' 33' ' ' LEU . 4.0 Cg_exo -52.93 136.63 60.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.813 1.675 . . . . 0.81999999999999995 113.068 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.31 104.99 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.175 -1.787 . . . . 1.4299999999999999 106.175 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.667 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.65 114.37 46.78 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 113.535 -1.666 . . . . 1.0900000000000001 108.037 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.995 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.57 122.24 43.47 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-O 123.344 1.545 . . . . 2.1299999999999999 110.238 174.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.056 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.8 m95 -86.91 149.01 25.11 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.871 -2.422 . . . . 0.40999999999999998 112.021 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.665 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 43.7 t80 -128.89 140.09 51.84 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.096 -2.557 . . . . 0.80000000000000004 104.096 172.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.792 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 58.2 tttp -106.23 166.25 10.65 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 116.627 -1.654 . . . . 2.6800000000000002 106.708 -173.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -11.97 -166.17 0.0 OUTLIER Glycine 0 C--O 1.186 -2.875 0 N-CA-C 119.136 2.414 . . . . 1.6000000000000001 119.136 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.909 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 13.4 ptmt -44.14 -6.34 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.495 2.406 . . . . 4.2999999999999998 117.495 -161.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.909 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 2.8 p-90 -167.95 -1.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.931 1.242 . . . . 2.5099999999999998 113.266 174.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.27 167.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 CA-C-O 123.659 1.695 . . . . 1.78 112.405 -159.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 3.3 p-10 -111.35 156.99 20.73 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.137 -2.756 . . . . 2.73 106.506 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.056 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -97.9 -31.27 12.28 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.509 0.559 . . . . 1.1299999999999999 112.509 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -58.52 -19.67 39.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.013 0.435 . . . . 1.71 109.88 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 73.9 m -98.25 -26.74 14.43 Favored 'General case' 0 N--CA 1.415 -2.198 0 C-N-CA 119.865 -0.734 . . . . 1.76 112.432 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.3 -32.16 10.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.623 -1.172 . . . . 1.9099999999999999 111.794 -167.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 49' ' ' LEU . 70.3 t -35.39 92.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 O-C-N 125.076 1.485 . . . . 1.1499999999999999 111.532 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.25 -114.79 0.7 Allowed Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 112.338 -2.21 . . . . 0.69999999999999996 111.952 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -95.74 -25.4 16.09 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.364 0.876 . . . . 3.3599999999999999 113.364 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.665 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.6 p80 -93.32 -37.82 11.82 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-O 121.622 0.725 . . . . 1.78 110.079 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.976 HD22 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.66 106.97 10.51 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 105.657 -1.979 . . . . 1.72 105.657 171.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.902 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -106.39 114.59 28.81 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.445 -1.687 . . . . 0.96999999999999997 106.445 166.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.568 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -92.72 92.42 7.96 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 103.957 -2.608 . . . . 1.0600000000000001 103.957 175.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 80.4 t60 -95.0 159.66 14.93 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 113.944 -1.48 . . . . 2.5899999999999999 110.22 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.58 121.57 39.64 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.929 -2.85 . . . . 0.92000000000000004 109.153 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 25.9 m -110.23 143.47 40.34 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-N 111.773 -2.467 . . . . 0.76000000000000001 106.34 167.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.88 99.51 3.35 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.748 0.785 . . . . 1.8 109.275 -164.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -115.01 132.07 56.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.489 -1.232 . . . . 2.4199999999999999 109.122 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.807 HH11 ' HH ' ' A' ' 70' ' ' TYR . 6.1 mmm180 -119.01 18.23 13.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.06 -1.427 . . . . 3.0800000000000001 111.25 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.24 -31.88 4.55 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.736 -1.574 . . . . 1.6899999999999999 108.488 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t -93.18 -14.75 26.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.479 -1.237 . . . . 1.96 108.8 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.788 ' HE2' ' HB2' ' A' ' 29' ' ' ALA . 15.2 tttt 68.88 31.61 4.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.85 0.833 . . . . 3.7799999999999998 109.23 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 7.9 t -128.35 125.77 64.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.603 0.716 . . . . 1.1299999999999999 110.453 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.807 ' HH ' HH11 ' A' ' 65' ' ' ARG . 2.4 m-30 -101.18 107.44 18.85 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.031 -1.841 . . . . 1.95 106.031 167.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.0 tp -94.92 104.21 16.1 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.706 -1.134 . . . . 1.1799999999999999 108.013 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.5 m-85 -86.94 113.65 22.89 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.68 -1.6 . . . . 0.40000000000000002 106.68 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.65 125.24 49.3 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.917 -1.492 . . . . 1.3200000000000001 110.585 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.922 HD22 ' CH2' ' A' ' 41' ' ' TRP . 2.2 mm? -89.59 124.51 34.62 Favored 'General case' 0 CA--C 1.471 -2.064 0 CA-C-N 112.889 -1.96 . . . . 1.5900000000000001 107.698 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.902 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 26.1 m170 -114.45 94.29 4.72 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 103.15 -2.908 . . . . 2.0099999999999998 103.15 167.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 60.4 mt -115.14 97.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 123.603 1.668 . . . . 1.1899999999999999 108.983 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.636 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 29.9 p -116.31 138.75 51.07 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 112.302 -2.226 . . . . 1.05 107.076 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 77' ' ' THR . 13.5 t70 77.76 63.77 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 O-C-N 125.855 1.972 . . . . 2.1200000000000001 107.351 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -76.92 94.44 3.93 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 111.605 -2.543 . . . . 1.0900000000000001 107.893 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.66 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -53.71 151.32 11.55 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-N 115.127 -0.942 . . . . 1.77 108.708 176.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.671 ' HD3' HG11 ' A' ' 18' ' ' VAL . 60.0 Cg_endo -68.83 155.32 69.02 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.039 1.159 . . . . 1.3300000000000001 110.032 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 45' ' ' LYS . . . 63.38 21.69 12.91 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.381 0.426 . . . . 1.6599999999999999 110.728 -175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.66 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -86.6 -13.21 46.37 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.195 -1.409 . . . . 1.24 107.195 173.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 1.098 HG23 HG13 ' A' ' 106' ' ' VAL . 4.3 p -90.11 150.26 22.12 Favored 'General case' 1 N--CA 1.363 -4.808 0 CA-C-O 126.041 2.829 . . . . 1.6799999999999999 116.17 -163.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.414 ' HA3' ' CA ' ' A' ' 45' ' ' LYS . . . 159.4 -109.61 0.41 Allowed Glycine 1 C--N 1.239 -4.833 1 CA-C-N 105.381 -5.372 . . . . 2.0 112.527 -155.532 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -167.91 124.78 1.23 Allowed Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.338 -1.41 . . . . 0.81000000000000005 114.172 -170.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.3 m-85 -87.95 124.54 33.81 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.227 -1.487 . . . . 1.0800000000000001 108.56 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.665 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 mtp180 -105.51 105.21 15.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.538 -0.726 . . . . 3.6899999999999999 109.728 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.3 t -89.92 125.39 35.34 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.372 -0.973 . . . . 1.22 108.372 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.995 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 21.7 tt0 -145.47 106.77 4.19 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.419 -0.81 . . . . 1.8100000000000001 109.961 -169.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.667 ' HB ' HG11 ' A' ' 39' ' ' VAL . 2.7 p -102.66 144.36 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.362 0.601 . . . . 1.24 110.504 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.4 m -139.12 109.47 6.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.277 -0.874 . . . . 1.6399999999999999 108.898 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.554 HG22 ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.39 153.78 50.45 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.401 -0.809 . . . . 1.26 109.886 -177.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.734 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.7 -75.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 125.654 1.846 . . . . 0.93999999999999995 114.572 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.734 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 12.2 t70 -149.7 -1.07 0.45 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.087 -1.415 . . . . 1.05 109.379 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.729 ' HG2' ' HB3' ' A' ' 1' ' ' ASP . 0.6 OUTLIER -104.76 140.09 38.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.111 0.958 . . . . 1.78 109.627 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -132.61 139.06 47.61 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.142 -1.844 . . . . 1.0 110.577 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 6.8 m-20 -152.85 147.88 26.53 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.25 -0.886 . . . . 1.6000000000000001 109.083 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 13.4 p -151.43 153.88 35.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.504 . . . . 1.98 110.905 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.744 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 85.7 p -137.31 130.26 30.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.774 -0.648 . . . . 1.02 110.766 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.81 116.85 33.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.615 -0.721 . . . . 1.5800000000000001 110.305 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.79 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 22.5 p90 -143.12 135.8 27.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.458 0.647 . . . . 1.1000000000000001 109.903 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.535 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 86.9 m-20 -97.26 156.15 16.55 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.538 -1.21 . . . . 2.1099999999999999 110.387 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.838 ' HG ' ' CG2' ' A' ' 84' ' ' THR . 1.2 tp -120.67 132.91 55.34 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 102.336 -3.209 . . . . 1.0900000000000001 102.336 166.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.507 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 23.4 m -124.16 113.57 18.51 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.318 -1.353 . . . . 1.0700000000000001 109.727 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 1.098 HG13 HG23 ' A' ' 84' ' ' THR . 5.6 p -102.87 114.14 41.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 113.779 -1.555 . . . . 1.1399999999999999 110.046 -172.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 35.5 m-70 -79.78 98.55 7.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.798 -2.455 . . . . 1.8200000000000001 109.354 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 18' ' ' VAL . 70.1 tt0 -82.4 -64.11 1.24 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.099 -1.864 . . . . 1.6699999999999999 109.736 175.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.59 87.68 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.897 -0.592 . . . . 2.98 110.271 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.23 -0.89 . . . . 7.3399999999999999 110.974 177.138 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.207 0.527 . . . . 1.9299999999999999 110.251 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' HB2' HD13 ' A' ' 4' ' ' ILE . 5.8 m-20 -90.56 168.75 13.41 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.295 -0.866 . . . . 1.6499999999999999 110.514 175.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.76 42.26 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.393 2.729 . . . . 1.24 113.357 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.936 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -58.22 -51.27 73.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.74 -0.664 . . . . 1.2 110.163 172.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.522 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 86.72 40.28 7.26 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.602 -1.799 . . . . 0.44 108.602 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.105 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.8 tp -53.2 -50.07 65.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.544 -1.828 . . . . 1.1100000000000001 110.252 -172.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.646 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -84.23 84.48 7.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.97999999999999998 110.176 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.2 t -73.2 -42.88 58.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.43 -1.259 . . . . 1.1100000000000001 109.416 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.7 ttm -152.19 135.87 16.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.225 -0.898 . . . . 3.3100000000000001 108.715 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -91.1 139.76 25.77 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.862 -0.422 . . . . 4.1699999999999999 109.862 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.663 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 33.6 Cg_endo -67.49 141.57 56.22 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.091 1.86 . . . . 0.81999999999999995 109.164 171.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.619 ' O ' ' HD1' ' A' ' 24' ' ' PHE . 6.3 tp60 -118.2 163.83 16.08 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.932 0.715 . . . . 1.6299999999999999 112.932 -168.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.1 m-20 -57.67 -139.94 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 125.674 1.589 . . . . 2.0600000000000001 112.928 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 143.13 136.19 3.13 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 113.291 -1.777 . . . . 0.34999999999999998 111.975 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 35.8 mt-10 -108.51 114.93 29.16 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.349 -0.926 . . . . 1.53 108.527 175.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.4 m -135.25 163.6 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.867 0 N-CA-C 107.932 -1.136 . . . . 1.0800000000000001 107.932 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 154.29 17.33 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.636 -1.166 . . . . 1.22 109.193 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.653 HG11 ' HD3' ' A' ' 81' ' ' PRO . 4.0 t -65.78 107.58 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 CA-C-O 122.845 1.307 . . . . 1.3799999999999999 108.9 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.3 10.38 10.74 Favored Glycine 0 C--N 1.269 -3.162 0 CA-C-N 112.107 -2.315 . . . . 0.52000000000000002 112.734 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.82 -123.43 4.89 Favored Glycine 0 N--CA 1.42 -2.409 0 C-N-CA 119.331 -1.414 . . . . 0.44 110.269 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.6 p -151.35 168.44 24.8 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.079 -1.561 . . . . 1.23 110.201 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 104' ' ' LEU . 9.0 tp -147.79 149.44 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 CA-C-N 113.693 -1.594 . . . . 1.0900000000000001 108.04 169.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 m -138.11 128.64 26.44 Favored 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 114.066 -1.425 . . . . 1.05 111.163 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.619 ' HD1' ' O ' ' A' ' 12' ' ' GLN . 3.4 m-85 -126.01 147.54 49.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 113.879 -1.51 . . . . 0.71999999999999997 107.817 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -140.89 127.73 20.46 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.57 0.7 . . . . 0.87 109.78 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.64 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.19 115.5 23.16 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.922 -1.035 . . . . 1.1000000000000001 110.383 -176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -104.31 121.11 42.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.312 -0.255 . . . . 2.9300000000000002 110.312 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.1 t -122.31 126.03 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.129 0.966 . . . . 1.0700000000000001 110.319 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.545 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -57.83 109.01 0.65 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.151 -1.84 . . . . 1.1200000000000001 111.432 176.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.602 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -50.1 -58.58 8.52 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.946 -1.025 . . . . 0.76000000000000001 111.418 172.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.764 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 59.8 -171.15 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.137 1.162 . . . . 1.0 114.137 168.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -109.09 130.42 55.48 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.916 -1.038 . . . . 2.1699999999999999 109.846 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.602 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -160.93 -176.2 5.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.396 0.617 . . . . 2.6299999999999999 112.038 -172.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.8 tp -70.77 -44.86 65.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.966 -1.015 . . . . 1.99 108.741 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.46 150.27 28.41 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 114.79 -1.096 . . . . 1.8799999999999999 109.634 174.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.77 148.79 5.76 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.484 2.789 . . . . 1.1200000000000001 112.426 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HA ' HG21 ' A' ' 93' ' ' THR . 4.1 Cg_exo -50.11 132.51 33.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.709 1.606 . . . . 0.81999999999999995 113.207 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.3 105.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.404 -1.702 . . . . 1.4299999999999999 106.404 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.617 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.56 114.5 47.11 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.784 -1.553 . . . . 1.0900000000000001 107.195 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.93 124.82 50.16 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 123.287 1.518 . . . . 2.1299999999999999 109.16 174.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.01 ' HB3' HD11 ' A' ' 49' ' ' LEU . 79.8 m95 -83.93 151.09 25.26 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 111.646 -2.525 . . . . 0.40999999999999998 111.231 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 36.9 t80 -128.61 138.75 52.36 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 104.58 -2.378 . . . . 0.80000000000000004 104.58 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.877 ' NZ ' ' HH ' ' A' ' 87' ' ' TYR . 31.6 tptt -104.64 165.28 11.17 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.41 -2.07 . . . . 2.6800000000000002 105.41 -172.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.804 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.62 -168.95 0.0 OUTLIER Glycine 0 C--O 1.188 -2.741 0 N-CA-C 119.321 2.488 . . . . 1.6000000000000001 119.321 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -44.82 -1.47 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.95 2.204 . . . . 4.2999999999999998 116.95 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.654 ' CZ3' HG11 ' A' ' 47' ' ' VAL . 11.8 p-90 -167.16 -11.5 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.858 1.429 . . . . 2.5099999999999998 114.858 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.654 HG11 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.37 169.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 CA-C-O 123.452 1.596 . . . . 1.78 112.889 -161.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.473 ' OD1' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -111.05 156.19 21.67 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 111.613 -2.54 . . . . 2.73 107.511 172.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.01 HD11 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -96.77 -36.88 10.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 119.292 -0.385 . . . . 1.1299999999999999 111.896 169.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 t -58.15 -20.49 41.16 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.31 0.576 . . . . 1.71 109.47 -165.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -98.02 -17.64 19.04 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.302 -0.863 . . . . 1.76 113.014 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 6.2 mmmt -102.87 -54.59 2.6 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.773 -0.649 . . . . 1.9099999999999999 111.174 -173.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 49' ' ' LEU . 70.3 t -6.25 90.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 O-C-N 125.93 2.019 . . . . 1.1499999999999999 113.139 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.87 -129.61 1.16 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 112.579 -2.101 . . . . 0.69999999999999996 112.191 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -72.65 -28.71 62.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.764 0.653 . . . . 3.3599999999999999 112.764 -168.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 30.0 p80 -96.06 -37.17 10.74 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.699 0.762 . . . . 1.78 111.181 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.956 HD22 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -125.62 105.22 8.85 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.313 -1.736 . . . . 1.72 106.313 175.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.626 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.45 113.93 25.55 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 106.325 -1.732 . . . . 0.96999999999999997 106.325 166.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.593 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.48 92.47 5.4 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 104.47 -2.419 . . . . 1.0600000000000001 104.47 171.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 33.0 m170 -87.61 159.86 18.4 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.831 1.3 . . . . 2.5899999999999999 110.306 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -135.03 110.27 8.96 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 111.548 -2.569 . . . . 0.92000000000000004 109.866 175.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -91.77 148.78 21.98 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 112.302 -2.226 . . . . 0.76000000000000001 107.576 174.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.8 98.31 3.31 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.45 1.119 . . . . 1.8 110.843 -173.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -118.01 124.82 49.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.554 -1.657 . . . . 2.4199999999999999 109.931 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -35.41 19.12 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.148 -1.842 . . . . 3.0800000000000001 110.62 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.995 -1.002 . . . . 1.6899999999999999 110.789 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -90.22 -18.78 25.08 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.771 -0.826 . . . . 1.96 108.771 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.764 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 7.4 ttpt 66.0 33.18 7.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.871 -1.059 . . . . 3.7799999999999998 109.367 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.48 122.91 56.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.721 0.772 . . . . 1.1299999999999999 109.826 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 62' ' ' SER . 2.9 m-30 -96.67 108.39 21.0 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.548 -1.649 . . . . 1.95 106.548 167.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 28.1 tp -93.42 105.9 17.91 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.966 -1.015 . . . . 1.1799999999999999 109.336 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.623 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 71.0 m-85 -91.1 111.19 22.56 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.333 -1.728 . . . . 0.40000000000000002 106.333 170.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -121.61 132.29 54.59 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.722 -1.126 . . . . 1.3200000000000001 110.107 -174.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.699 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.3 mt -98.27 131.71 44.37 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.199 -1.819 . . . . 1.5900000000000001 108.936 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -116.8 97.64 6.08 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 104.041 -2.577 . . . . 2.0099999999999998 104.041 165.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.699 HG13 ' HB3' ' A' ' 74' ' ' LEU . 10.8 mt -123.0 101.56 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.395 1.093 . . . . 1.1899999999999999 108.281 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.7 p -104.76 171.56 7.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 CA-C-N 114.874 -1.057 . . . . 1.05 110.105 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 39.89 67.41 0.48 Allowed 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.838 -2.892 . . . . 2.1200000000000001 111.562 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.493 ' HB1' HD23 ' A' ' 104' ' ' LEU . . . -65.49 116.32 6.65 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.625 -2.08 . . . . 1.0900000000000001 109.878 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.778 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -67.77 152.04 96.67 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.034 -0.728 . . . . 1.77 109.034 175.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.653 ' HD3' HG11 ' A' ' 18' ' ' VAL . 38.2 Cg_endo -66.16 -8.3 19.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.45 2.1 . . . . 1.3300000000000001 112.605 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.778 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -105.59 15.29 27.22 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.096 -0.502 . . . . 1.6599999999999999 110.278 176.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.7 m-30 -97.37 -6.4 34.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 118.849 -0.596 . . . . 1.24 110.983 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 22.9 m -23.59 95.07 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 125.497 1.748 . . . . 1.6799999999999999 111.393 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.804 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -55.49 115.52 5.93 Favored Glycine 0 N--CA 1.406 -3.341 0 CA-C-N 110.431 -3.077 . . . . 2.0 114.863 -169.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.619 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -119.18 68.7 0.35 Allowed Glycine 0 C--N 1.269 -3.188 0 CA-C-N 111.815 -2.192 . . . . 0.81000000000000005 108.433 149.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.877 ' HH ' ' NZ ' ' A' ' 43' ' ' LYS . 32.5 m-85 -73.98 115.75 13.8 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.179 -1.045 . . . . 1.0800000000000001 108.179 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.616 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 37.6 mtp180 -109.09 113.39 26.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.671 -0.492 . . . . 3.6899999999999999 109.671 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.1 t -101.8 110.7 22.73 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.624 0.726 . . . . 1.22 109.355 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.668 ' HG3' ' HG ' ' A' ' 99' ' ' CYS . 0.8 OUTLIER -121.1 110.91 16.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.5 -1.227 . . . . 1.8100000000000001 110.07 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.617 ' HB ' HG11 ' A' ' 39' ' ' VAL . 7.0 p -100.12 140.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.299 0.571 . . . . 1.24 110.27 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -135.74 108.59 7.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.409 -0.96 . . . . 1.6399999999999999 108.409 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -132.2 144.85 50.94 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-O 117.374 -1.298 . . . . 1.26 108.242 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.699 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.25 -72.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 O-C-N 125.629 1.831 . . . . 0.93999999999999995 113.699 -173.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.699 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 24.8 t70 -153.33 -1.18 0.23 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.681 -1.145 . . . . 1.05 110.707 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.105 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.8 tttp -88.25 126.45 35.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.447 -0.945 . . . . 1.78 108.447 176.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.405 ' HD1' ' O ' ' A' ' 91' ' ' VAL . 15.1 t80 -130.42 117.7 20.09 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 1.0 110.063 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -134.61 141.67 46.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.498 -1.683 . . . . 1.6000000000000001 108.639 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.668 ' HG ' ' HG3' ' A' ' 90' ' ' GLU . 5.0 m -136.21 144.22 44.79 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.473 . . . . 1.98 110.688 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.646 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 82.1 p -130.74 118.66 21.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.732 -0.667 . . . . 1.02 110.507 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.452 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -101.41 123.57 45.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.621 -0.718 . . . . 1.5800000000000001 109.516 176.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.677 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.9 p90 -142.88 135.56 27.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.005 0.907 . . . . 1.1000000000000001 110.581 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.796 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.6 m-80 -105.19 132.38 51.48 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.068 -1.424 . . . . 2.1099999999999999 111.449 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.721 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.41 106.58 17.74 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.554 -1.203 . . . . 1.0900000000000001 108.651 172.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.41 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 8.1 m -89.28 96.45 10.72 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.592 -0.892 . . . . 1.0700000000000001 108.592 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.557 HG22 HG21 ' A' ' 18' ' ' VAL . 4.7 p -85.2 113.69 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 123.031 1.396 . . . . 1.1399999999999999 109.104 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.93 99.21 11.7 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.648 -2.069 . . . . 1.8200000000000001 109.666 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 40.1 tt0 -69.21 -46.84 66.41 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.004 -1.907 . . . . 1.6699999999999999 110.16 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.03 37.13 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.541 -0.754 . . . . 2.98 111.329 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.526 -0.749 . . . . 7.3399999999999999 110.325 178.925 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.825 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 7.4 p-10 . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 122.451 1.119 . . . . 1.9299999999999999 111.035 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.613 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 23.1 t70 -76.59 150.84 82.43 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 113.712 -1.585 . . . . 1.6499999999999999 108.31 169.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.59 58.25 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.445 2.763 . . . . 1.24 114.421 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.974 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -67.86 -52.31 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 1.2 109.463 168.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.36 46.0 5.39 Favored Glycine 0 CA--C 1.494 -1.232 0 N-CA-C 108.252 -1.939 . . . . 0.44 108.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 96' ' ' LYS . 10.9 tp -55.04 -38.05 67.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.69 -1.755 . . . . 1.1100000000000001 110.643 -169.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.74 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -96.07 85.13 3.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.209 -0.905 . . . . 0.97999999999999998 109.823 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.03 -37.55 41.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.553 -1.203 . . . . 1.1100000000000001 110.01 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 tpp -151.28 134.39 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.513 -0.767 . . . . 3.3100000000000001 109.636 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 17.0 ptm180 -108.57 136.86 19.89 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.786 -0.643 . . . . 4.1699999999999999 109.916 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.72 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 2.0 Cg_endo -76.35 138.36 19.79 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.672 2.248 . . . . 0.81999999999999995 111.531 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.657 HE21 ' C ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -89.31 -177.98 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.696 -0.684 . . . . 1.6299999999999999 110.527 176.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -74.61 -142.87 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.291 1.043 . . . . 2.0600000000000001 110.7 178.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.77 140.02 2.86 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.355 -1.293 . . . . 0.34999999999999998 112.512 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 27.4 mt-10 -116.87 119.18 34.57 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.277 -0.961 . . . . 1.53 108.52 172.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.2 m -136.43 162.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 N-CA-C 107.068 -1.456 . . . . 1.0800000000000001 107.068 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.704 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -91.03 156.53 17.86 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.039 -0.982 . . . . 1.22 110.22 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 81' ' ' PRO . 11.6 t -66.47 107.12 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-O 123.023 1.392 . . . . 1.3799999999999999 108.202 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.69 14.31 12.78 Favored Glycine 0 C--N 1.266 -3.327 0 CA-C-N 111.925 -2.398 . . . . 0.52000000000000002 112.438 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.89 -125.24 5.32 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.366 -1.493 . . . . 0.44 109.366 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.682 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 24.4 p -152.73 165.51 35.08 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.236 -1.482 . . . . 1.23 110.685 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.643 HG22 HD11 ' A' ' 104' ' ' LEU . 10.3 tp -147.72 150.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.187 -1.824 . . . . 1.0900000000000001 107.252 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -138.95 125.94 21.13 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 113.442 -1.708 . . . . 1.05 110.043 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.76 150.06 44.86 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.375 -1.284 . . . . 0.71999999999999997 108.446 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.629 ' HB3' HD13 ' A' ' 71' ' ' LEU . 9.9 m -142.04 131.37 23.59 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.881 -0.785 . . . . 0.87 108.881 175.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.871 ' HB1' ' CH2' ' A' ' 41' ' ' TRP . . . -127.42 115.54 19.08 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.205 -1.361 . . . . 1.1000000000000001 109.772 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HB3' HG11 ' A' ' 69' ' ' VAL . 48.9 mtp180 -104.98 123.4 47.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.123 -0.49 . . . . 2.9300000000000002 110.329 -173.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 14.1 t -123.76 127.58 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.463 1.125 . . . . 1.0700000000000001 110.752 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.564 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.31 113.86 2.86 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.086 -1.87 . . . . 1.1200000000000001 112.931 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 1.032 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -49.78 -64.75 3.26 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 114.313 -1.312 . . . . 0.76000000000000001 111.085 166.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.696 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 60.52 -175.69 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 115.196 1.554 . . . . 1.0 115.196 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -96.55 106.88 19.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.867 -1.515 . . . . 2.1699999999999999 109.759 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.769 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -151.83 171.03 18.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.975 -0.557 . . . . 2.6299999999999999 110.674 -171.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.73 -49.06 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.42 0.629 . . . . 1.99 110.244 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.654 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -149.92 158.14 37.29 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.611 -0.885 . . . . 1.8799999999999999 108.611 174.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.75 139.62 3.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.159 2.573 . . . . 1.1200000000000001 112.296 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.769 ' HD3' HD13 ' A' ' 33' ' ' LEU . 8.9 Cg_exo -55.27 141.96 79.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.012 1.142 . . . . 0.81999999999999995 112.916 -175.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.84 106.38 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.332 -1.729 . . . . 1.4299999999999999 106.332 174.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.8 t -109.22 115.22 49.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.918 0 CA-C-N 113.384 -1.735 . . . . 1.0900000000000001 108.083 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.949 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.66 130.53 52.67 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 123.126 1.441 . . . . 2.1299999999999999 110.029 175.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.005 ' HB3' HD12 ' A' ' 49' ' ' LEU . 90.8 m95 -94.32 145.28 24.86 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 112.158 -2.292 . . . . 0.40999999999999998 111.917 173.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.5 t80 -126.88 130.86 50.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.641 -1.985 . . . . 0.80000000000000004 105.641 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 35.3 ttpt -104.76 111.58 24.36 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.523 -1.288 . . . . 2.6800000000000002 107.523 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.646 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -81.24 92.63 1.49 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 116.146 -2.93 . . . . 1.6000000000000001 114.274 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.769 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 tttp -106.67 -53.98 2.54 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 102.765 -3.05 . . . . 4.2999999999999998 102.765 134.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.769 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 9.0 p-90 -168.0 0.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 110.171 -3.195 . . . . 2.5099999999999998 110.933 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.87 173.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.574 1.654 . . . . 1.78 113.357 -159.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.5 t70 -110.27 145.23 37.74 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.097 -2.774 . . . . 2.73 105.775 174.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.005 HD12 ' HB3' ' A' ' 41' ' ' TRP . 5.9 mp -80.47 -38.26 30.31 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.22 -0.592 . . . . 1.1299999999999999 111.705 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -62.35 -18.78 62.35 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.809 -0.812 . . . . 1.71 108.809 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.448 ' C ' ' HD2' ' A' ' 52' ' ' LYS . 33.5 m -84.48 -22.63 30.21 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 114.681 -1.145 . . . . 1.76 111.532 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 8.0 mmmt -109.16 -67.52 0.98 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.181 -0.918 . . . . 1.9099999999999999 111.623 -174.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 49' ' ' LEU . 53.3 t 8.02 92.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 126.696 1.998 . . . . 1.1499999999999999 113.912 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.99 -135.97 2.43 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.215 -1.812 . . . . 0.69999999999999996 113.291 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.69 -36.58 79.14 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.967 1.099 . . . . 3.3599999999999999 113.967 -168.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.698 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -98.19 -36.52 10.02 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 119.741 -0.784 . . . . 1.78 111.393 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.801 HD23 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.39 103.68 10.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.347 -1.353 . . . . 1.72 107.347 173.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.45 115.7 29.88 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 106.448 -1.686 . . . . 0.96999999999999997 106.448 166.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.6 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.02 93.29 5.92 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 104.782 -2.303 . . . . 1.0600000000000001 104.782 172.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.59 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 4.3 m-70 -94.41 162.7 13.72 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.43 -1.259 . . . . 2.5899999999999999 109.533 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.0 p-10 -137.09 112.1 8.99 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 111.961 -2.381 . . . . 0.92000000000000004 110.103 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 8.4 m -95.66 150.8 19.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 112.455 -2.157 . . . . 0.76000000000000001 108.525 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 65' ' ' ARG . 6.7 t80 -143.67 98.53 3.26 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 122.643 1.211 . . . . 1.8 110.983 -173.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' OD2' ' HB3' ' A' ' 67' ' ' SER . 0.1 OUTLIER -110.0 105.47 14.62 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 112.759 -2.019 . . . . 2.4199999999999999 110.045 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -75.65 -30.78 59.56 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 3.0800000000000001 111.038 -175.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.66 -24.49 64.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.208 -0.905 . . . . 1.6899999999999999 110.461 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.526 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 6.5 t -100.94 -12.48 18.9 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.018 -0.734 . . . . 1.96 109.018 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.696 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 8.7 ttpt 67.18 31.25 6.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.101 -0.954 . . . . 3.7799999999999998 110.5 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 27' ' ' ARG . 5.0 t -125.23 133.54 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.954 0.883 . . . . 1.1299999999999999 110.631 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 1.032 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.9 m-85 -98.8 111.56 23.9 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.518 -2.03 . . . . 1.95 105.518 162.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.629 HD13 ' HB3' ' A' ' 25' ' ' SER . 9.2 tp -100.87 104.0 15.2 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.113 0.959 . . . . 1.1799999999999999 108.539 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 58.6 m-85 -84.64 113.39 21.24 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.929 -1.508 . . . . 0.40000000000000002 106.929 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 5.2 pt-20 -117.99 123.85 46.73 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.376 -1.738 . . . . 1.3200000000000001 110.216 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.1 mm? -91.88 126.87 37.13 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 112.653 -2.067 . . . . 1.5900000000000001 108.127 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -116.19 96.42 5.54 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 104.368 -2.456 . . . . 2.0099999999999998 104.368 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.698 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 55.5 mt -122.09 100.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 123.012 1.387 . . . . 1.1899999999999999 109.875 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 45.5 p -104.18 154.38 19.82 Favored 'General case' 0 N--CA 1.394 -3.227 0 CA-C-N 113.964 -1.471 . . . . 1.05 108.492 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 44.21 85.7 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.322 -2.672 . . . . 2.1200000000000001 112.429 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.85 136.81 47.13 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 110.926 -2.852 . . . . 1.0900000000000001 111.191 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.795 HE21 ' HD2' ' A' ' 81' ' ' PRO . 1.1 tp60 -63.44 130.12 94.08 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.259 -0.645 . . . . 1.77 109.259 173.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.795 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.6 Cg_endo -58.71 -13.04 16.27 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.561 2.841 . . . . 1.3300000000000001 114.285 -171.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HB1' ' HZ2' ' A' ' 45' ' ' LYS . . . -120.45 28.8 7.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.887 -0.325 . . . . 1.6599999999999999 111.622 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.573 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.21 -57.27 4.0 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.252 -0.648 . . . . 1.24 109.252 172.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 7.3 m 43.86 58.56 3.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.97 -1.492 . . . . 1.6799999999999999 106.97 -157.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.702 ' HA3' HD22 ' A' ' 104' ' ' LEU . . . -51.26 85.48 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.498 0 CA-C-N 112.545 -2.116 . . . . 2.0 114.705 -164.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -92.08 80.71 1.2 Allowed Glycine 0 C--N 1.282 -2.429 0 N-CA-C 108.938 -1.665 . . . . 0.81000000000000005 108.938 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.569 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 13.2 m-85 -78.64 109.8 13.18 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.812 -1.194 . . . . 1.0800000000000001 108.807 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -94.36 105.03 17.0 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.694 -0.854 . . . . 3.6899999999999999 108.694 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.555 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 8.4 t -95.52 126.23 40.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.571 -0.851 . . . . 1.22 109.176 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.949 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 92.3 mt-10 -133.96 118.68 18.14 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.65 -0.705 . . . . 1.8100000000000001 110.367 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.4 p -107.52 143.67 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.485 0.659 . . . . 1.24 110.133 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 m -140.44 112.59 7.75 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.171 -0.922 . . . . 1.6399999999999999 110.012 -176.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.522 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -130.21 174.95 9.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 118.621 -0.704 . . . . 1.26 110.048 177.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.858 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -8.61 -60.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.196 1.56 . . . . 0.93999999999999995 114.732 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.858 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.0 t70 -151.11 -8.05 0.25 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.293 -1.321 . . . . 1.05 109.669 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.974 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -91.13 124.88 35.69 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.679 -1.23 . . . . 1.78 107.679 -177.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -131.54 133.64 45.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.293 -0.867 . . . . 1.0 111.513 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -154.24 150.53 28.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.701 -1.136 . . . . 1.6000000000000001 109.99 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 90' ' ' GLU . 72.1 m -142.5 150.33 40.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.025 -0.361 . . . . 1.98 110.025 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.74 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 47.6 p -128.62 135.63 49.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 1.02 111.764 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.47 138.58 33.39 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.297 -0.865 . . . . 1.5800000000000001 109.394 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.932 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -150.1 128.93 12.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.725 -0.79 . . . . 1.1000000000000001 111.879 151.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.74 125.85 54.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.959 0.885 . . . . 2.1099999999999999 111.279 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.702 HD22 ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.94 104.17 14.12 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.133 -1.394 . . . . 1.0900000000000001 109.575 -178.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.0 m -84.81 96.28 9.24 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.568 -0.901 . . . . 1.0700000000000001 108.568 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.6 113.95 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 123.061 1.41 . . . . 1.1399999999999999 109.18 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.0 m170 -78.55 97.24 5.69 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 112.852 -1.976 . . . . 1.8200000000000001 109.653 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 34.7 tt0 -75.84 -34.57 60.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.228 -1.351 . . . . 1.6699999999999999 109.699 172.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.48 14.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 2.98 110.84 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.495 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 26.4 mmt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.681 -0.69 . . . . 7.3399999999999999 110.841 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.808 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 6.9 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.468 0.652 . . . . 1.9299999999999999 109.68 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -94.14 166.07 16.35 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.014 -0.994 . . . . 1.6499999999999999 111.153 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.68 84.43 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.63 2.22 . . . . 1.24 111.948 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.832 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.0 -59.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.088 -0.96 . . . . 1.2 109.488 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.23 41.4 5.53 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 108.842 -1.703 . . . . 0.44 108.842 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.583 ' N ' HG21 ' A' ' 4' ' ' ILE . 9.3 tp -49.74 -38.97 35.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.738 -1.731 . . . . 1.1100000000000001 111.048 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.635 ' HE2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -92.61 84.52 5.07 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.97999999999999998 109.672 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.8 -48.03 35.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.851 -1.068 . . . . 1.1100000000000001 109.998 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.495 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 16.5 tpt -151.19 129.03 11.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.048 -0.978 . . . . 3.3100000000000001 108.842 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.635 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 16.3 ptm180 -88.2 144.32 34.09 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.733 -0.667 . . . . 4.1699999999999999 110.162 -176.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.634 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 59.8 Cg_endo -65.8 145.8 81.73 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.557 2.171 . . . . 0.81999999999999995 110.161 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.536 HE21 ' H ' ' A' ' 13' ' ' ASP . 12.6 tp60 -115.67 159.03 21.89 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 119.331 -0.366 . . . . 1.6299999999999999 111.747 -173.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.3 m-20 -57.89 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 123.418 1.58 . . . . 2.0600000000000001 113.044 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.18 137.0 2.73 Favored Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 112.963 -1.926 . . . . 0.34999999999999998 111.551 -174.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.7 mt-10 -116.06 114.45 24.57 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.714 -0.847 . . . . 1.53 108.714 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.504 HG12 ' HB ' ' A' ' 22' ' ' ILE . 4.9 m -134.2 164.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.712 -1.218 . . . . 1.0800000000000001 107.712 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -95.21 156.73 16.2 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.886 -1.052 . . . . 1.22 109.534 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.607 HG11 ' HD3' ' A' ' 81' ' ' PRO . 42.4 t -62.56 107.02 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-O 122.754 1.264 . . . . 1.3799999999999999 109.294 175.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.09 11.09 Favored Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.912 -2.404 . . . . 0.52000000000000002 113.333 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.7 -122.58 4.84 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 119.616 -1.278 . . . . 0.44 110.009 171.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 11.9 p -150.36 165.04 34.28 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 113.087 -1.557 . . . . 1.23 110.645 175.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.673 HG22 HD13 ' A' ' 104' ' ' LEU . 8.8 tp -148.08 147.48 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.078 -1.874 . . . . 1.0900000000000001 107.18 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m -139.5 125.97 20.36 Favored 'General case' 0 C--N 1.259 -3.354 0 CA-C-N 113.74 -1.573 . . . . 1.05 110.396 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.543 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 10.2 m-85 -123.54 146.67 47.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.618 -1.173 . . . . 0.71999999999999997 109.458 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.475 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -126.51 129.93 49.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.038 -1.097 . . . . 0.87 108.038 173.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB1' ' HH2' ' A' ' 41' ' ' TRP . . . -130.66 125.16 33.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.57 -1.195 . . . . 1.1000000000000001 110.812 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.5 mtt180 -115.36 123.12 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.842 0.312 . . . . 2.9300000000000002 111.842 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 t -121.69 128.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.775 0.798 . . . . 1.0700000000000001 109.593 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -57.63 107.38 0.44 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.881 -1.508 . . . . 1.1200000000000001 110.527 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.722 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -55.79 -39.1 75.93 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.731 -1.122 . . . . 0.76000000000000001 110.925 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.62 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.67 -163.93 0.03 OUTLIER 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.695 1.368 . . . . 1.0 114.695 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -111.64 123.02 49.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.443 -1.253 . . . . 2.1699999999999999 108.153 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.899 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -155.1 174.65 14.89 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.673 0.249 . . . . 2.6299999999999999 111.673 -172.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.6 tp -62.07 -47.99 82.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 1.99 109.539 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -151.15 154.59 34.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.059 -0.973 . . . . 1.8799999999999999 108.963 170.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -44.14 134.37 8.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.627 2.885 . . . . 1.1200000000000001 112.049 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.899 ' HD3' HD13 ' A' ' 33' ' ' LEU . 8.7 Cg_exo -42.89 142.87 1.98 Allowed 'Trans proline' 0 CA--C 1.499 -1.232 0 C-N-CA 123.849 3.033 . . . . 0.81999999999999995 115.189 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.1 99.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 105.875 -1.898 . . . . 1.4299999999999999 105.875 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.6 t -103.42 114.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-N 113.504 -1.68 . . . . 1.0900000000000001 107.415 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.857 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.76 128.59 52.94 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.057 -1.429 . . . . 2.1299999999999999 109.743 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.908 ' HB3' HD13 ' A' ' 49' ' ' LEU . 74.0 m95 -91.51 157.86 16.79 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 112.063 -2.335 . . . . 0.40999999999999998 111.104 172.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.733 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.9 t80 -139.06 125.51 20.44 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.934 -2.247 . . . . 0.80000000000000004 104.934 178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.835 ' HD3' HD22 ' A' ' 57' ' ' LEU . 33.8 ttpt -103.02 100.34 10.27 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.715 -1.587 . . . . 2.6800000000000002 106.715 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -90.38 97.46 2.33 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 115.993 -3.004 . . . . 1.6000000000000001 117.293 -157.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.873 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 3.8 ptmt -99.14 -47.39 5.23 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.449 -2.797 . . . . 4.2999999999999998 103.449 137.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.873 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 9.4 p-90 -170.38 3.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 112.468 -2.151 . . . . 2.5099999999999998 111.102 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.626 HG11 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -98.82 169.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 C-N-CA 125.04 1.336 . . . . 1.78 112.981 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.626 ' O ' HG11 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -105.43 154.15 20.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.455 -2.157 . . . . 2.73 107.001 175.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.908 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.4 mp -89.24 -30.46 18.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 1.1299999999999999 112.605 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -57.2 -21.0 30.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.349 0.595 . . . . 1.71 109.854 -167.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.554 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 8.0 t -96.38 -22.55 17.1 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.178 -0.919 . . . . 1.76 111.992 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 1.7 mmmt -106.55 -15.19 14.85 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.778 -1.101 . . . . 1.9099999999999999 111.671 -171.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 49' ' ' LEU . 55.7 t -59.17 89.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 114.013 -1.449 . . . . 1.1499999999999999 110.213 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.49 -142.1 3.58 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 112.438 -2.165 . . . . 0.69999999999999996 112.988 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -67.4 -22.63 65.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.007 0.744 . . . . 3.3599999999999999 113.007 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.594 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.1 p-80 -101.21 -38.02 8.29 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 120.23 -0.588 . . . . 1.78 111.247 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.835 HD22 ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -120.69 102.25 8.28 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.144 -1.799 . . . . 1.72 106.144 172.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -94.41 115.02 27.15 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.724 -1.584 . . . . 0.96999999999999997 106.724 167.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.709 HD12 ' CD1' ' A' ' 41' ' ' TRP . 0.4 OUTLIER -97.95 91.49 5.35 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.114 -2.55 . . . . 1.0600000000000001 104.114 167.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 34.4 m170 -90.18 162.43 15.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.228 -1.351 . . . . 2.5899999999999999 110.039 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -133.57 110.48 9.94 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 112.323 -2.217 . . . . 0.92000000000000004 109.866 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 14.2 m -93.95 112.36 24.19 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.89 -1.959 . . . . 0.76000000000000001 109.322 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.433 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.0 t80 -102.23 98.08 8.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.96 -1.018 . . . . 1.8 110.212 -176.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.91 107.08 15.21 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.585 -1.643 . . . . 2.4199999999999999 109.141 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.579 ' HD3' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -81.45 -32.72 32.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.382 -0.827 . . . . 3.0800000000000001 110.968 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.58 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.229 -0.896 . . . . 1.6899999999999999 110.527 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 m -108.66 -18.63 13.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.72 -0.844 . . . . 1.96 108.72 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.722 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 62.99 35.65 13.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 3.7799999999999998 109.979 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -129.62 130.69 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.002 -0.999 . . . . 1.1299999999999999 108.392 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.63 ' HH ' ' HZ3' ' A' ' 68' ' ' LYS . 3.9 m-30 -101.26 106.72 17.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.599 -1.63 . . . . 1.95 106.599 171.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 22.7 tp -96.12 104.42 16.37 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.189 -1.368 . . . . 1.1799999999999999 108.316 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.684 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.7 m-85 -83.53 113.47 20.83 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 113.819 -1.537 . . . . 0.40000000000000002 107.533 174.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 6.6 mt-10 -106.84 119.02 38.22 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 113.113 -1.858 . . . . 1.3200000000000001 108.935 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 76' ' ' ILE . 3.1 mm? -88.36 122.76 32.23 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.454 -1.313 . . . . 1.5900000000000001 107.454 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 36.8 m80 -118.31 95.67 4.98 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 104.327 -2.472 . . . . 2.0099999999999998 104.327 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 74' ' ' LEU . 39.4 mt -122.11 101.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 123.041 1.4 . . . . 1.1899999999999999 110.2 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.2 p -110.53 134.79 52.05 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-N 113.621 -1.627 . . . . 1.05 107.692 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 77' ' ' THR . 3.5 t70 73.14 97.31 0.07 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 111.642 -2.526 . . . . 2.1200000000000001 110.024 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.74 122.77 45.14 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 110.552 -3.022 . . . . 1.0900000000000001 109.943 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.536 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -64.24 138.26 97.37 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.153 -0.93 . . . . 1.77 109.577 173.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.607 ' HD3' HG11 ' A' ' 18' ' ' VAL . 26.2 Cg_endo -61.44 -9.06 12.04 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.23 2.62 . . . . 1.3300000000000001 112.421 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.63 17.67 22.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.835 -0.621 . . . . 1.6599999999999999 111.441 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.733 ' HD1' ' HD2' ' A' ' 45' ' ' LYS . 1.4 m-30 -85.43 -55.33 4.06 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.91 -0.774 . . . . 1.24 108.91 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 88.7 m 28.51 63.84 0.11 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 123.183 1.468 . . . . 1.6799999999999999 108.68 -161.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.587 ' O ' ' HD1' ' A' ' 87' ' ' TYR . . . -66.55 91.61 0.17 Allowed Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 111.975 -2.375 . . . . 2.0 114.05 -159.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -83.61 83.74 1.6 Allowed Glycine 0 C--N 1.276 -2.768 0 N-CA-C 108.185 -1.966 . . . . 0.81000000000000005 108.185 169.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.733 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 3.7 m-85 -74.6 113.65 12.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.685 -1.257 . . . . 1.0800000000000001 108.812 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 99.8 mtt180 -87.89 109.76 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.391 -0.966 . . . . 3.6899999999999999 108.391 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.6 t -95.97 122.67 39.04 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.601 -0.888 . . . . 1.22 108.601 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.857 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 38.5 tt0 -137.82 107.64 6.29 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.244 -0.889 . . . . 1.8100000000000001 110.289 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.6 p -102.59 141.57 18.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.676 0.75 . . . . 1.24 110.699 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -139.86 108.33 5.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.342 -1.299 . . . . 1.6399999999999999 108.561 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.557 HG23 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.47 145.33 51.1 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-O 117.936 -1.03 . . . . 1.26 108.894 -179.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.679 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 32.95 -74.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 126.148 2.155 . . . . 0.93999999999999995 113.578 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.808 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 0.5 OUTLIER -148.16 -8.07 0.4 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.035 -0.984 . . . . 1.05 110.563 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.832 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.9 mmtm -86.05 129.53 34.81 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.432 -1.321 . . . . 1.78 107.432 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 21.3 t80 -132.33 148.39 52.43 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.85 -1.523 . . . . 1.0 111.773 -173.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 t70 -179.0 165.39 1.52 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.207 0.942 . . . . 1.6000000000000001 110.33 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.496 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.3 m -145.22 151.73 38.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.267 -0.271 . . . . 1.98 110.267 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 58.5 p -132.6 130.31 40.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.041 0.448 . . . . 1.02 112.149 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -94.56 127.32 40.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.368 -0.833 . . . . 1.5800000000000001 109.393 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 87' ' ' TYR . 28.4 p90 -149.38 143.75 25.96 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.119 -0.632 . . . . 1.1000000000000001 109.872 165.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.54 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.9 m-80 -115.8 140.23 49.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.255 1.026 . . . . 2.1099999999999999 112.471 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.673 HD13 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -103.82 107.99 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.336 -1.302 . . . . 1.0900000000000001 108.463 172.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.435 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 3.8 m -87.81 96.38 10.44 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.253 -0.647 . . . . 1.0700000000000001 109.253 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.536 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.4 p -79.41 112.78 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.25 1.5 . . . . 1.1399999999999999 108.672 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 44.0 m170 -85.65 100.34 11.91 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.527 -2.124 . . . . 1.8200000000000001 109.421 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 37.1 tt0 -68.45 98.52 0.86 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.805 -1.089 . . . . 1.6699999999999999 109.836 170.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.28 120.04 40.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.402 -0.817 . . . . 2.98 110.18 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.699 -0.667 . . . . 7.3399999999999999 109.951 179.614 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.733 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 7.7 p-10 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.944 0.878 . . . . 1.9299999999999999 110.464 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -84.57 167.2 28.31 Favored Pre-proline 0 N--CA 1.428 -1.574 0 CA-C-N 114.527 -1.215 . . . . 1.6499999999999999 110.067 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.38 88.18 0.33 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.311 2.007 . . . . 1.24 111.889 172.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.89 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.13 -65.16 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.378 -0.828 . . . . 1.2 109.537 177.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 4' ' ' ILE . . . 93.8 49.06 2.57 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 108.595 -1.802 . . . . 0.44 108.595 -174.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 96' ' ' LYS . 9.8 tp -61.41 -33.39 73.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.083 -1.558 . . . . 1.1100000000000001 110.22 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.656 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -91.68 84.66 5.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.931 -1.031 . . . . 0.97999999999999998 110.088 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.57 -46.6 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.899 -1.046 . . . . 1.1100000000000001 110.405 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.11 131.03 11.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 3.3100000000000001 109.708 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 21.2 ptt180 -108.12 142.89 26.27 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.575 -0.739 . . . . 4.1699999999999999 109.843 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.762 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 11.0 Cg_endo -73.4 158.09 48.64 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.538 1.492 . . . . 0.81999999999999995 110.82 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -116.3 -180.0 3.83 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.363 -0.606 . . . . 1.6299999999999999 109.363 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 2.0 p-10 -71.55 -148.92 0.02 OUTLIER 'General case' 0 N--CA 1.407 -2.578 0 CA-C-O 122.932 1.348 . . . . 2.0600000000000001 111.635 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.69 133.82 1.69 Allowed Glycine 0 C--N 1.293 -1.819 0 CA-C-N 113.356 -1.747 . . . . 0.34999999999999998 112.045 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.2 mt-10 -113.82 111.12 21.22 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.006 -1.097 . . . . 1.53 108.082 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.422 HG11 ' HB ' ' A' ' 22' ' ' ILE . 3.0 m -126.74 163.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 106.666 -1.605 . . . . 1.0800000000000001 106.666 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.74 154.61 17.48 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 115.404 -0.816 . . . . 1.22 109.27 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.664 HG22 ' HG3' ' A' ' 81' ' ' PRO . 3.1 t -64.33 106.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 CA-C-O 122.719 1.247 . . . . 1.3799999999999999 108.365 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.13 8.64 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.378 -2.192 . . . . 0.52000000000000002 112.145 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.96 -122.28 4.82 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 108.73 -1.748 . . . . 0.44 108.73 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.2 p -151.94 171.1 18.31 Favored 'General case' 0 N--CA 1.399 -3.015 0 CA-C-N 113.344 -1.428 . . . . 1.23 109.894 172.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.49 HG22 HD12 ' A' ' 104' ' ' LEU . 10.5 tp -146.34 147.53 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 113.276 -1.783 . . . . 1.0900000000000001 107.316 166.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -139.03 123.96 18.8 Favored 'General case' 0 C--N 1.262 -3.214 0 CA-C-N 113.333 -1.758 . . . . 1.05 110.241 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.68 ' CD2' HD12 ' A' ' 74' ' ' LEU . 73.1 m-85 -123.44 145.66 48.63 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.129 -1.396 . . . . 0.71999999999999997 107.769 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.765 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.3 m -138.18 124.91 20.99 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.745 0.783 . . . . 0.87 109.439 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.574 ' HB2' ' CZ2' ' A' ' 41' ' ' TRP . . . -116.7 115.73 26.2 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.285 -1.325 . . . . 1.1000000000000001 110.48 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -106.41 115.57 30.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.654 -0.248 . . . . 2.9300000000000002 110.549 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.92 126.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.958 0.885 . . . . 1.0700000000000001 110.523 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.14 112.06 1.76 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.337 -1.756 . . . . 1.1200000000000001 110.724 173.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.567 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -45.2 -51.53 8.91 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 114.794 -1.094 . . . . 0.76000000000000001 111.269 171.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' H ' ' CG ' ' A' ' 68' ' ' LYS . . . 55.49 -155.77 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.408 0.892 . . . . 1.0 113.408 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 p -115.68 135.92 53.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.861 -0.608 . . . . 2.1699999999999999 109.953 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.562 ' HB3' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -155.08 -174.61 5.05 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.826 0.822 . . . . 2.6299999999999999 112.8 -175.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.3 tp -98.06 -45.17 6.35 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.27 -1.332 . . . . 1.99 108.128 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.39 139.05 29.02 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.723 -1.126 . . . . 1.8799999999999999 108.982 172.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.11 156.57 24.09 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.956 2.437 . . . . 1.1200000000000001 111.103 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 93' ' ' THR . 3.3 Cg_endo -57.1 125.15 18.04 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.544 0.829 . . . . 0.81999999999999995 112.716 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 104.54 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.054 -1.462 . . . . 1.4299999999999999 107.054 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.5 t -102.73 114.42 42.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.832 -1.531 . . . . 1.0900000000000001 108.397 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.666 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.02 127.85 53.05 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.743 -1.571 . . . . 2.1299999999999999 109.817 175.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.958 ' HB3' HD11 ' A' ' 49' ' ' LEU . 77.0 m95 -91.63 155.03 18.63 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 111.969 -2.378 . . . . 0.40999999999999998 111.677 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 39.7 t80 -133.36 139.9 47.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.316 -2.476 . . . . 0.80000000000000004 104.316 170.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.846 ' HZ3' ' HH ' ' A' ' 87' ' ' TYR . 62.9 tttp -102.51 166.61 10.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 105.721 -1.955 . . . . 2.6800000000000002 105.721 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -14.03 -167.31 0.0 OUTLIER Glycine 0 C--O 1.183 -3.088 0 N-CA-C 119.248 2.459 . . . . 1.6000000000000001 119.248 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.689 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 8.4 mtpt -44.41 -8.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 O-C-N 119.125 -2.397 . . . . 4.2999999999999998 116.786 -164.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ3' HG11 ' A' ' 47' ' ' VAL . 9.9 p-90 -160.8 -9.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 114.101 1.148 . . . . 2.5099999999999998 114.101 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.791 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.92 164.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 CA-C-O 123.218 1.485 . . . . 1.78 112.481 -160.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.569 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 9.9 p-10 -111.1 158.54 18.75 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 111.815 -2.448 . . . . 2.73 106.508 172.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.066 HD21 HD23 ' A' ' 57' ' ' LEU . 5.7 mp -98.88 -28.74 13.32 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.476 -0.49 . . . . 1.1299999999999999 111.792 167.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -57.3 -21.37 34.37 Favored 'General case' 0 C--N 1.315 -0.891 0 O-C-N 123.706 0.629 . . . . 1.71 109.864 -163.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 33.2 m -100.03 -35.38 9.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 122.033 0.921 . . . . 1.76 112.224 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.569 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -88.61 -31.29 18.66 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.159 -1.382 . . . . 1.9099999999999999 111.685 -165.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 49' ' ' LEU . 79.2 t -35.46 94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.392 1.477 . . . . 1.1499999999999999 111.753 172.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.44 -95.91 0.11 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 112.501 -2.136 . . . . 0.69999999999999996 113.837 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -95.3 -45.37 7.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.944 0.72 . . . . 3.3599999999999999 112.944 -172.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 31.5 p80 -88.45 -37.11 16.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.736 0.779 . . . . 1.78 110.609 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 1.066 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.55 106.92 12.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.428 -1.693 . . . . 1.72 106.428 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.81 116.13 31.98 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 106.63 -1.619 . . . . 0.96999999999999997 106.63 164.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.661 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -95.19 93.8 7.53 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 104.829 -2.285 . . . . 1.0600000000000001 104.829 173.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.571 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 90.3 m-70 -84.33 162.49 20.04 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.338 -1.301 . . . . 2.5899999999999999 109.887 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -140.13 114.76 9.41 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 111.986 -2.37 . . . . 0.92000000000000004 109.42 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 2.0 m -101.52 149.35 24.18 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.796 -2.002 . . . . 0.76000000000000001 108.628 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -141.29 98.62 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.569 1.175 . . . . 1.8 111.251 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.46 101.71 9.39 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.315 -1.766 . . . . 2.4199999999999999 109.319 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -73.85 -29.58 62.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.508 -0.769 . . . . 3.0800000000000001 110.228 177.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.98 70.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.106 -0.952 . . . . 1.6899999999999999 110.668 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -103.36 -13.81 16.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.209 -0.905 . . . . 1.96 109.455 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER 63.36 36.88 11.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.872 0.844 . . . . 3.7799999999999998 109.898 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.41 128.1 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.673 0.749 . . . . 1.1299999999999999 109.726 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.567 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.7 m-85 -98.19 113.36 25.25 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.922 -1.881 . . . . 1.95 105.922 164.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 25' ' ' SER . 21.7 tp -99.06 106.4 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 122.217 1.008 . . . . 1.1799999999999999 109.374 174.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 55.3 m-85 -84.47 113.33 21.13 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 113.726 -1.579 . . . . 0.40000000000000002 107.953 168.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.9 116.84 32.37 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.67 -1.604 . . . . 1.3200000000000001 110.7 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.827 ' HB3' HG13 ' A' ' 76' ' ' ILE . 18.0 mt -81.97 123.65 29.07 Favored 'General case' 0 CA--C 1.475 -1.926 0 CA-C-N 115.081 -0.963 . . . . 1.5900000000000001 108.927 170.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -111.73 93.65 4.56 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 103.108 -2.923 . . . . 2.0099999999999998 103.108 163.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.827 HG13 ' HB3' ' A' ' 74' ' ' LEU . 18.1 mt -118.39 99.96 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 122.83 1.3 . . . . 1.1899999999999999 109.255 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.0 p -102.85 166.51 10.43 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 114.078 -1.419 . . . . 1.05 110.439 -176.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 41.03 67.38 0.53 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 110.658 -2.974 . . . . 2.1200000000000001 111.551 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -62.18 120.01 10.1 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.894 -1.957 . . . . 1.0900000000000001 111.252 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.833 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -54.91 140.21 61.22 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.349 -0.841 . . . . 1.77 109.728 169.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.664 ' HG3' HG22 ' A' ' 18' ' ' VAL . 23.2 Cg_exo -62.9 -10.25 19.58 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.692 2.261 . . . . 1.3300000000000001 112.465 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.833 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -98.64 10.76 40.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.962 -0.563 . . . . 1.6599999999999999 110.773 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -95.54 -10.84 28.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.722 -0.391 . . . . 1.24 110.898 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 21.8 m -46.11 101.31 0.02 OUTLIER 'General case' 0 CA--C 1.475 -1.92 0 CA-C-O 122.358 1.075 . . . . 1.6799999999999999 108.802 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.689 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -172.69 -128.79 1.08 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.701 -2.045 . . . . 2.0 113.383 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.95 119.03 0.88 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.174 -1.013 . . . . 0.81000000000000005 112.712 -170.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.846 ' HH ' ' HZ3' ' A' ' 43' ' ' LYS . 2.0 m-85 -82.81 120.94 26.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.348 -1.426 . . . . 1.0800000000000001 108.212 175.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 57.7 ttt180 -110.91 104.49 13.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.976 0.417 . . . . 3.6899999999999999 110.193 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.861 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.7 t -92.19 129.86 38.04 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.05 -0.722 . . . . 1.22 109.05 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.697 ' HG3' ' HB3' ' A' ' 99' ' ' CYS . 30.6 tt0 -140.22 106.69 5.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.477 -0.783 . . . . 1.8100000000000001 109.458 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 5.5 p -95.05 138.01 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 121.858 0.837 . . . . 1.24 110.73 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.2 t -133.29 108.88 9.01 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.146 -1.388 . . . . 1.6399999999999999 107.94 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 94' ' ' LYS . 2.4 m -127.27 170.06 12.86 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.888 -1.153 . . . . 1.26 107.888 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.71 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 0.82 -65.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 125.513 1.758 . . . . 0.93999999999999995 114.555 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.733 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 1.2 t0 -148.82 -8.96 0.35 Allowed 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.837 -1.074 . . . . 1.05 109.967 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.89 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.2 mmtm -87.5 124.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.79 -1.189 . . . . 1.78 107.79 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -130.65 137.41 49.58 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.735 -1.12 . . . . 1.0 111.153 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -163.07 161.85 25.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.79 -1.096 . . . . 1.6000000000000001 108.892 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.697 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 3.9 p -153.46 145.33 23.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.152 0.501 . . . . 1.98 111.183 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.742 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 42.5 p -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 1.02 111.253 -175.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.94 125.27 50.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.226 0.536 . . . . 1.5800000000000001 110.868 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.861 ' HZ ' ' HB2' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -140.1 116.18 10.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.431 -0.581 . . . . 1.1000000000000001 109.431 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.526 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 51.1 m-20 -95.16 151.65 19.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.292 -0.867 . . . . 2.1099999999999999 110.846 -168.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.634 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -123.95 121.28 34.87 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.256 -0.884 . . . . 1.0900000000000001 108.806 174.235 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -103.35 96.05 6.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.416 -0.586 . . . . 1.0700000000000001 109.416 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 80' ' ' GLN . 3.5 p -77.63 116.19 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 123.077 1.418 . . . . 1.1399999999999999 109.05 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -87.56 102.02 14.19 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.395 -2.184 . . . . 1.8200000000000001 108.275 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.597 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 33.0 tt0 -51.94 -58.59 6.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.133 -1.394 . . . . 1.6699999999999999 111.277 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.8 135.24 7.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 2.98 110.571 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.704 -0.665 . . . . 7.3399999999999999 109.42 178.518 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.591 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 10.6 t70 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.798 0.332 . . . . 1.9299999999999999 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.92 ' HB2' ' HZ2' ' A' ' 94' ' ' LYS . 2.3 m-20 -131.36 173.96 5.25 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 123.969 0.908 . . . . 1.6499999999999999 109.4 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.01 77.07 4.07 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.848 1.699 . . . . 1.24 113.19 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.82 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -93.87 -62.6 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.315 -0.994 . . . . 1.2 108.315 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.7 4.64 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 109.368 -1.493 . . . . 0.44 109.368 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.691 HD23 ' HB3' ' A' ' 96' ' ' LYS . 3.7 tp -41.04 -44.37 2.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 112.897 -1.652 . . . . 1.1100000000000001 111.421 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.697 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -93.0 84.43 4.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.246 -0.888 . . . . 0.97999999999999998 109.793 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' A' ' 27' ' ' ARG . 15.8 t -76.16 -33.06 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.018 -1.446 . . . . 1.1100000000000001 109.187 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp -167.95 137.41 2.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.095 -0.957 . . . . 3.3100000000000001 109.639 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 27.7 ptt180 -105.66 148.79 37.02 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.933 -0.576 . . . . 4.1699999999999999 110.079 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.759 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 13.5 Cg_endo -79.48 164.52 23.73 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.646 1.564 . . . . 0.81999999999999995 110.728 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -123.7 179.3 4.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.326 -0.397 . . . . 1.6299999999999999 110.337 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.2 -144.59 0.01 OUTLIER 'General case' 0 N--CA 1.41 -2.433 0 CA-C-O 122.809 1.29 . . . . 2.0600000000000001 110.98 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.34 132.26 1.79 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.606 -1.634 . . . . 0.34999999999999998 111.726 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.0 mt-10 -110.49 114.16 27.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.981 -1.109 . . . . 1.53 108.213 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.9 m -134.48 162.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 N-CA-C 107.821 -1.177 . . . . 1.0800000000000001 107.821 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 153.15 17.95 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.487 -1.233 . . . . 1.22 108.738 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.669 HG13 ' HD3' ' A' ' 81' ' ' PRO . 5.8 t -69.0 105.01 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.826 1.298 . . . . 1.3799999999999999 107.956 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.22 12.54 5.22 Favored Glycine 0 C--N 1.267 -3.304 0 CA-C-N 112.445 -2.162 . . . . 0.52000000000000002 112.642 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.03 -122.66 5.14 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.264 -1.446 . . . . 0.44 110.366 170.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.1 p -151.51 169.41 22.14 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 113.054 -1.573 . . . . 1.23 110.329 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.473 HG21 HD12 ' A' ' 104' ' ' LEU . 9.6 tp -148.19 149.98 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.539 -1.664 . . . . 1.0900000000000001 107.285 168.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 m -140.15 131.49 26.75 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.022 -1.445 . . . . 1.05 110.947 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 50.0 m-85 -129.55 148.05 51.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.148 -1.387 . . . . 0.71999999999999997 108.764 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.538 ' HB3' HD12 ' A' ' 71' ' ' LEU . 3.5 m -140.08 127.33 21.17 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.879 0.847 . . . . 0.87 109.188 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.12 117.23 24.92 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.125 -1.398 . . . . 1.1000000000000001 110.718 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 75.2 mtt180 -102.07 121.78 42.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.3 -0.409 . . . . 2.9300000000000002 110.505 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.1 t -126.06 128.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 122.082 0.944 . . . . 1.0700000000000001 110.531 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.685 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -61.36 105.39 0.5 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.444 -1.707 . . . . 1.1200000000000001 112.398 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.743 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -59.7 -36.26 89.08 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 115.061 -0.972 . . . . 0.76000000000000001 111.745 172.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.912 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . . . 57.54 -163.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.783 1.031 . . . . 1.0 113.783 162.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -118.89 31.13 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 2.1699999999999999 109.529 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.743 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -56.1 -175.76 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.639 1.348 . . . . 2.6299999999999999 114.639 176.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 tp -68.98 -53.95 17.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.04 -0.982 . . . . 1.99 109.593 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.88 146.49 47.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 114.846 -1.07 . . . . 1.8799999999999999 108.688 172.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -42.98 140.37 3.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.464 2.776 . . . . 1.1200000000000001 111.934 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.737 ' HA ' HG22 ' A' ' 93' ' ' THR . 3.7 Cg_endo -53.16 136.59 62.17 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.563 1.509 . . . . 0.81999999999999995 112.761 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.01 104.31 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.638 0 N-CA-C 106.157 -1.794 . . . . 1.4299999999999999 106.157 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.609 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -106.88 114.75 46.79 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 113.136 -1.847 . . . . 1.0900000000000001 107.785 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.953 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.69 125.33 50.11 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.825 -1.534 . . . . 2.1299999999999999 109.58 174.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.035 ' HB3' HD12 ' A' ' 49' ' ' LEU . 68.0 m95 -86.45 149.1 25.23 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.816 -2.447 . . . . 0.40999999999999998 111.482 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 25.8 t80 -125.37 138.55 54.04 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 104.66 -2.348 . . . . 0.80000000000000004 104.66 169.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.699 ' HD2' HD11 ' A' ' 57' ' ' LEU . 67.5 tttt -99.35 171.13 8.17 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.612 -1.996 . . . . 2.6800000000000002 105.612 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.912 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -19.56 -173.59 0.0 OUTLIER Glycine 0 C--O 1.179 -3.308 0 C-N-CA 126.749 2.118 . . . . 1.6000000000000001 117.878 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.658 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 7.8 ttpp -40.98 -9.56 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 117.577 2.436 . . . . 4.2999999999999998 117.577 -157.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.658 ' HD1' ' HB3' ' A' ' 45' ' ' LYS . 4.8 p-90 -161.58 -7.05 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.287 0.949 . . . . 2.5099999999999998 113.342 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -95.39 165.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-O 123.014 1.388 . . . . 1.78 112.601 -158.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.686 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 6.5 p-10 -114.05 154.3 27.95 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 112.022 -2.353 . . . . 2.73 109.284 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.035 HD12 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -98.44 -32.24 11.59 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.774 -0.648 . . . . 1.1299999999999999 111.637 169.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -59.47 -23.38 62.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.369 -0.604 . . . . 1.71 109.369 -166.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.686 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 6.2 m -102.95 -27.69 12.47 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.621 -0.832 . . . . 1.76 113.023 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 11.4 mptt -80.78 -84.61 0.1 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.716 -0.674 . . . . 1.9099999999999999 111.584 -173.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 49' ' ' LEU . 24.7 t 21.68 95.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 126.068 2.105 . . . . 1.1499999999999999 113.966 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.93 -99.54 0.14 Allowed Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.132 -1.395 . . . . 0.69999999999999996 113.264 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -83.2 -53.57 5.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.321 0.489 . . . . 3.3599999999999999 112.321 -170.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.9 p80 -92.02 -33.83 14.67 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.235 -0.586 . . . . 1.78 111.432 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 1.004 HD22 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.39 106.24 14.35 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.112 -1.81 . . . . 1.72 106.112 174.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -101.35 116.72 33.43 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.949 -1.5 . . . . 0.96999999999999997 106.949 165.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.541 HD11 ' CB ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -97.88 92.96 6.08 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.216 -2.142 . . . . 1.0600000000000001 105.216 170.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.915 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.8 m170 -87.99 162.1 17.03 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.673 -1.149 . . . . 2.5899999999999999 109.912 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -142.13 115.71 9.09 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.214 -2.267 . . . . 0.92000000000000004 109.784 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.2 m -95.82 150.33 20.53 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.393 -2.185 . . . . 0.76000000000000001 109.038 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.74 100.61 5.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.517 1.151 . . . . 1.8 111.422 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.5 t70 -114.42 114.25 25.59 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.292 -1.776 . . . . 2.4199999999999999 108.819 174.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.63 -37.13 17.05 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.054 -0.975 . . . . 3.0800000000000001 112.133 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.07 68.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.43 0.633 . . . . 1.6899999999999999 110.113 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -104.12 -11.86 17.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.056 -0.974 . . . . 1.96 109.898 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.912 ' HE3' ' HA ' ' A' ' 31' ' ' ALA 0.295 0.2 OUTLIER 38.84 57.8 1.82 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 124.49 2.091 . . . . 3.7799999999999998 111.568 -166.528 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 t -122.91 115.31 45.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 112.373 -2.194 . . . . 1.1299999999999999 109.355 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 62' ' ' SER . 34.1 m-85 -91.25 105.96 18.16 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.898 -1.519 . . . . 1.95 106.898 167.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 25' ' ' SER . 32.7 tp -86.51 104.5 16.03 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.681 -1.145 . . . . 1.1799999999999999 108.522 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.617 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 80.5 m-85 -87.25 110.81 20.45 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.795 -1.557 . . . . 0.40000000000000002 106.795 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.915 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -114.3 125.59 54.06 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.148 -1.387 . . . . 1.3200000000000001 110.136 -176.585 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.69 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.6 mt -92.41 131.9 37.2 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 113.571 -1.65 . . . . 1.5900000000000001 108.437 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -119.88 97.43 5.62 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 104.491 -2.411 . . . . 2.0099999999999998 104.491 165.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.69 HG13 ' HB3' ' A' ' 74' ' ' LEU . 14.3 mt -123.47 99.85 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.624 1.202 . . . . 1.1899999999999999 108.871 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 25.0 p -99.04 166.69 11.15 Favored 'General case' 0 N--CA 1.395 -3.22 0 CA-C-O 122.891 1.329 . . . . 1.05 110.444 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 40.58 74.17 0.11 Allowed 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 110.361 -3.108 . . . . 2.1200000000000001 111.468 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.476 ' HB1' HD23 ' A' ' 104' ' ' LEU . . . -64.34 115.11 4.75 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.765 -2.016 . . . . 1.0900000000000001 108.701 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.773 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -67.42 159.62 76.7 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.708 -0.849 . . . . 1.77 108.708 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.669 ' HD3' HG13 ' A' ' 18' ' ' VAL . 68.5 Cg_endo -73.68 156.34 49.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 120.984 1.123 . . . . 1.3300000000000001 111.394 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.4 15.5 9.56 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.747 0.655 . . . . 1.6599999999999999 110.523 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.773 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -85.29 -8.28 58.59 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.791 -0.623 . . . . 1.24 109.621 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 23.2 m -10.98 84.9 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 126.042 2.089 . . . . 1.6799999999999999 111.974 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.912 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.76 118.34 3.59 Favored Glycine 0 N--CA 1.406 -3.333 0 CA-C-N 110.816 -2.902 . . . . 2.0 113.478 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.518 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -116.34 63.38 0.36 Allowed Glycine 0 C--N 1.266 -3.328 0 CA-C-N 112.545 -1.827 . . . . 0.81000000000000005 108.716 158.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 75.8 m-85 -73.02 106.78 5.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.204 -1.406 . . . . 1.0800000000000001 107.204 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 55.3 mtt-85 -118.3 105.36 11.67 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.242 -0.583 . . . . 3.6899999999999999 109.967 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.661 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -89.36 124.48 34.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.861 -0.608 . . . . 1.22 109.642 -177.06 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 36.9 tt0 -129.2 110.81 12.29 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.77 -1.104 . . . . 1.8100000000000001 109.244 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.2 p -99.97 139.95 20.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.429 0.633 . . . . 1.24 110.151 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -137.02 110.05 7.71 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.788 -1.097 . . . . 1.6399999999999999 108.329 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.737 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.1 m -129.86 167.41 18.18 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.925 -0.769 . . . . 1.26 108.925 -176.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.92 ' HZ2' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 6.75 -69.16 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.668 1.855 . . . . 0.93999999999999995 114.028 172.148 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 1' ' ' ASP . 7.5 t70 -154.23 1.98 0.23 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.672 -0.695 . . . . 1.05 109.134 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.82 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -91.68 136.19 33.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 122.073 0.94 . . . . 1.78 108.812 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -132.52 134.02 44.48 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 112.683 -2.053 . . . . 1.0 111.592 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -157.0 148.07 21.89 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.813 -1.085 . . . . 1.6000000000000001 110.47 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.2 149.35 34.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.836 -0.62 . . . . 1.98 109.838 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.737 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 80.4 p -141.41 136.12 31.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.959 0.409 . . . . 1.02 110.386 176.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.476 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -107.53 130.09 54.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.799 -0.637 . . . . 1.5800000000000001 109.395 175.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.759 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -141.1 112.83 7.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.649 0.737 . . . . 1.1000000000000001 109.496 -177.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.785 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 61.5 m-20 -95.37 148.76 22.1 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.51 1.148 . . . . 2.1099999999999999 111.359 -167.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.777 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -119.31 108.78 15.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.052 -1.431 . . . . 1.0900000000000001 110.796 177.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.2 m -91.54 96.92 10.74 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.687 -0.856 . . . . 1.0700000000000001 108.687 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 8.0 p -86.88 120.76 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.096 1.427 . . . . 1.1399999999999999 109.782 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 96.7 m-70 -95.41 100.97 12.66 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 112.145 -2.298 . . . . 1.8200000000000001 108.987 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 18' ' ' VAL . 48.7 tt0 -64.5 -54.53 30.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.255 -1.339 . . . . 1.6699999999999999 110.743 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.47 14.83 0.87 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.38 -0.373 . . . . 2.98 111.041 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.389 -0.815 . . . . 7.3399999999999999 109.848 -179.17 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 1.001 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 3.3 p-10 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.661 0.743 . . . . 1.9299999999999999 110.128 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.516 ' HB2' HD11 ' A' ' 4' ' ' ILE . 15.2 m-20 -82.58 171.18 12.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 115.434 -0.803 . . . . 1.6499999999999999 110.623 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 41.77 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.076 2.517 . . . . 1.24 113.386 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.776 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -61.59 -50.01 82.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.696 0.76 . . . . 1.2 109.537 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.21 30.55 22.23 Favored Glycine 0 CA--C 1.497 -1.064 0 N-CA-C 109.176 -1.57 . . . . 0.44 109.176 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.974 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 10.6 tp -41.8 -54.41 3.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.981 -1.609 . . . . 1.1100000000000001 111.426 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.751 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -84.57 83.89 7.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.54 0.686 . . . . 0.97999999999999998 109.801 176.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.69 -45.37 66.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.66 -1.155 . . . . 1.1100000000000001 109.767 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.743 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 22.8 mmt -136.68 132.63 35.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.688 -0.687 . . . . 3.3100000000000001 110.027 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.736 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 88.0 mtt180 -90.98 121.82 67.47 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.052 -0.721 . . . . 4.1699999999999999 109.052 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.668 ' HG2' ' HE1' ' A' ' 102' ' ' PHE . 18.6 Cg_endo -62.21 156.75 48.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.858 2.372 . . . . 0.81999999999999995 110.856 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 11.1 tp60 -120.0 160.07 23.49 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 119.075 -0.488 . . . . 1.6299999999999999 112.185 -167.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.592 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -58.41 -144.77 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 123.053 1.406 . . . . 2.0600000000000001 112.611 176.126 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 151.38 135.31 2.29 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 113.404 -1.726 . . . . 0.34999999999999998 111.951 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 26.2 mt-10 -111.03 118.74 36.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.476 -0.935 . . . . 1.53 108.476 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.449 ' CG1' HD12 ' A' ' 22' ' ' ILE . 2.3 m -139.23 162.97 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.706 -1.22 . . . . 1.0800000000000001 107.706 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.745 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.19 158.11 15.75 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.142 -0.936 . . . . 1.22 109.489 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 107' ' ' HIS . 10.1 t -66.18 107.68 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 122.993 1.378 . . . . 1.3799999999999999 108.365 172.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 12.2 10.71 Favored Glycine 0 C--N 1.269 -3.159 0 CA-C-N 112.097 -2.32 . . . . 0.52000000000000002 112.833 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.35 -124.7 5.09 Favored Glycine 0 N--CA 1.418 -2.507 0 C-N-CA 119.314 -1.422 . . . . 0.44 110.09 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 71.2 m -154.49 171.0 20.09 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 113.271 -1.465 . . . . 1.23 109.19 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 104' ' ' LEU . 9.9 tp -149.11 149.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.337 0 CA-C-O 122.719 1.247 . . . . 1.0900000000000001 107.78 170.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -140.42 125.42 18.43 Favored 'General case' 0 C--N 1.261 -3.241 0 CA-C-N 113.669 -1.605 . . . . 1.05 110.454 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.502 ' HB2' HD22 ' A' ' 74' ' ' LEU . 22.1 m-85 -120.03 152.25 37.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.325 -1.307 . . . . 0.71999999999999997 108.049 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -139.54 129.6 25.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.787 -0.82 . . . . 0.87 108.787 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.668 ' HB1' ' CH2' ' A' ' 41' ' ' TRP . . . -133.2 122.18 23.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.803 -1.089 . . . . 1.1000000000000001 110.695 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.743 ' HD2' ' CG ' ' A' ' 9' ' ' MET . 60.4 mtt180 -107.93 122.64 47.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.665 -0.243 . . . . 2.9300000000000002 111.015 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 6.6 t -121.23 125.79 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.997 0.903 . . . . 1.0700000000000001 110.132 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -56.35 113.14 1.45 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.594 -1.639 . . . . 1.1200000000000001 112.575 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.76 -58.07 12.47 Favored Glycine 0 C--O 1.225 -0.422 0 CA-C-N 114.589 -1.187 . . . . 0.76000000000000001 111.334 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.705 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.48 -174.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.303 1.223 . . . . 1.0 114.303 167.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.6 t -110.09 25.68 11.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.001 -1.0 . . . . 2.1699999999999999 109.185 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.979 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -55.05 171.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.701 -1.136 . . . . 2.6299999999999999 112.889 177.154 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.1 tp -50.95 -54.91 20.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.669 -0.696 . . . . 1.99 110.415 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -147.87 155.5 44.35 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 108.212 -1.033 . . . . 1.8799999999999999 108.212 172.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -39.67 138.31 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.459 2.773 . . . . 1.1200000000000001 112.681 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.979 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.9 Cg_exo -55.54 139.28 82.38 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.939 1.759 . . . . 0.81999999999999995 112.312 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 2.2 t -98.47 104.76 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 105.904 -1.888 . . . . 1.4299999999999999 105.904 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -112.26 113.57 44.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.195 -1.82 . . . . 1.0900000000000001 107.445 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.571 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.73 126.71 51.04 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 123.182 1.467 . . . . 2.1299999999999999 109.346 174.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.119 ' HB3' HD12 ' A' ' 49' ' ' LEU . 76.2 m95 -84.17 152.01 24.53 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.03 -2.35 . . . . 0.40999999999999998 110.957 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.6 t80 -130.04 136.46 49.41 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.747 -2.316 . . . . 0.80000000000000004 104.747 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 59.0 tttp -102.77 168.18 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.013 -2.218 . . . . 2.6800000000000002 105.013 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.991 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -9.5 -172.59 0.0 OUTLIER Glycine 0 C--O 1.183 -3.074 0 N-CA-C 119.808 2.683 . . . . 1.6000000000000001 119.808 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.7 mtpp -45.82 -3.86 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 116.375 1.991 . . . . 4.2999999999999998 116.375 -165.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.481 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 7.5 p-90 -163.76 -6.77 0.03 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.323 1.231 . . . . 2.5099999999999998 114.323 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.34 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-O 123.41 1.576 . . . . 1.78 112.499 -162.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.1 t70 -113.84 154.12 28.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 111.585 -2.552 . . . . 2.73 105.548 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.119 HD12 ' HB3' ' A' ' 41' ' ' TRP . 2.2 mp -93.75 -37.91 11.56 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 118.362 0.528 . . . . 1.1299999999999999 112.095 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 t -58.94 -21.05 57.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.754 0.788 . . . . 1.71 108.88 -169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -84.34 -32.74 24.1 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.356 -1.293 . . . . 1.76 112.811 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.691 ' HB2' HD13 ' A' ' 57' ' ' LEU . 15.4 mmmt -104.5 -25.43 12.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.245 -0.889 . . . . 1.9099999999999999 111.323 -167.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.747 HG21 ' O ' ' A' ' 49' ' ' LEU . 43.4 t -43.12 89.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 113.365 -1.743 . . . . 1.1499999999999999 111.479 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.697 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.44 -113.84 0.5 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.209 -2.269 . . . . 0.69999999999999996 112.602 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.4 -30.85 18.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.195 0.497 . . . . 3.3599999999999999 112.022 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.548 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.8 p80 -90.23 -37.2 14.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.672 0.749 . . . . 1.78 111.017 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.897 HD21 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.36 106.35 9.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.317 -1.734 . . . . 1.72 106.317 174.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -95.81 115.46 27.46 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.606 -1.628 . . . . 0.96999999999999997 106.606 165.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -99.74 92.44 5.32 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 104.411 -2.441 . . . . 1.0600000000000001 104.411 170.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.597 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 63.7 m170 -81.74 161.9 23.14 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.627 -1.17 . . . . 2.5899999999999999 110.114 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -133.04 112.93 12.22 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 112.592 -2.094 . . . . 0.92000000000000004 108.711 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -93.9 148.82 21.78 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 112.982 -1.917 . . . . 0.76000000000000001 107.408 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -139.46 97.78 3.35 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.575 1.179 . . . . 1.8 110.926 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.65 120.54 39.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 112.846 -1.979 . . . . 2.4199999999999999 109.338 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.442 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.57 -34.94 27.58 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.573 -1.648 . . . . 3.0800000000000001 111.38 -176.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 1.6899999999999999 110.35 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.453 ' O ' HG22 ' A' ' 69' ' ' VAL . 18.9 t -94.52 -17.55 22.29 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.423 -0.808 . . . . 1.96 108.904 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 13.7 ttpt 62.05 37.25 14.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.024 -0.989 . . . . 3.7799999999999998 108.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 67' ' ' SER . 38.0 t -128.83 131.39 68.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.369 1.081 . . . . 1.1299999999999999 111.053 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -94.96 105.19 17.09 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 105.888 -1.893 . . . . 1.95 105.888 162.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.3 tp -96.55 105.24 17.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.479 1.133 . . . . 1.1799999999999999 108.855 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.7 m-85 -85.22 114.58 22.43 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.40000000000000002 107.846 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -107.06 119.86 40.52 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.587 -1.642 . . . . 1.3200000000000001 108.998 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.827 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.7 mm? -92.81 120.9 33.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.629 -1.169 . . . . 1.5900000000000001 107.919 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.67 95.61 5.33 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 104.593 -2.373 . . . . 2.0099999999999998 104.593 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.614 HG12 HD22 ' A' ' 57' ' ' LEU . 66.4 mt -120.63 100.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 114.491 -1.231 . . . . 1.1899999999999999 109.152 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 28.9 p -104.84 159.81 15.5 Favored 'General case' 0 N--CA 1.393 -3.32 0 CA-C-N 114.526 -1.216 . . . . 1.05 109.183 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.55 74.03 0.22 Allowed 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 111.611 -2.54 . . . . 2.1200000000000001 111.158 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.37 123.54 19.87 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.228 -1.805 . . . . 1.0900000000000001 111.327 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.845 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.8 OUTLIER -60.59 137.0 92.64 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.477 -0.783 . . . . 1.77 109.739 170.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.845 ' HD2' HE21 ' A' ' 80' ' ' GLN . 35.4 Cg_endo -65.0 -3.36 6.96 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.32 2.68 . . . . 1.3300000000000001 113.197 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -111.01 13.01 22.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.171 -0.468 . . . . 1.6599999999999999 111.102 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' THR . 2.3 m-30 -86.93 -37.32 17.72 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 118.502 -0.761 . . . . 1.24 111.002 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.652 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 88.8 m 12.04 73.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.497 0 O-C-N 125.195 1.559 . . . . 1.6799999999999999 110.647 -168.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.825 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -36.55 124.53 0.91 Allowed Glycine 0 N--CA 1.412 -2.926 0 CA-C-N 111.979 -2.373 . . . . 2.0 115.211 -163.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.991 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -123.59 68.56 0.47 Allowed Glycine 0 C--N 1.262 -3.54 0 CA-C-N 111.648 -2.276 . . . . 0.81000000000000005 108.23 158.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.723 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 74.1 m-85 -75.07 108.53 7.87 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.094 -1.053 . . . . 1.0800000000000001 108.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.545 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 25.0 mtp180 -109.33 106.88 16.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.724 -0.472 . . . . 3.6899999999999999 109.724 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -91.04 116.1 28.53 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.627 -0.509 . . . . 1.22 109.627 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 34.4 mt-10 -122.61 103.03 8.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.52 -0.764 . . . . 1.8100000000000001 109.144 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.664 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -95.01 143.64 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.077 0.465 . . . . 1.24 109.751 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 t -140.35 108.37 5.73 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.755 -0.832 . . . . 1.6399999999999999 108.755 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.565 HG21 ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.83 152.23 51.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 117.798 -1.096 . . . . 1.26 108.639 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.66 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.32 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 O-C-N 125.599 1.812 . . . . 0.93999999999999995 114.572 178.065 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.66 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 25.2 t70 -145.55 -11.67 0.52 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.432 -1.258 . . . . 1.05 110.009 -174.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.001 ' HG2' ' HB2' ' A' ' 1' ' ' ASP . 2.4 mttp -90.77 124.64 35.29 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.462 -0.94 . . . . 1.78 108.462 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -131.31 127.94 38.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.251 -1.34 . . . . 1.0 109.793 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.454 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 16.1 m-20 -143.12 139.5 30.43 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.098 -1.41 . . . . 1.6000000000000001 108.808 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.0 p -135.08 145.3 47.8 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.168 0.508 . . . . 1.98 109.791 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.751 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 91.5 p -131.9 126.5 34.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.49 -0.777 . . . . 1.02 110.462 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.09 119.05 36.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 1.5800000000000001 111.122 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.668 ' HE1' ' HG2' ' A' ' 11' ' ' PRO . 30.0 p90 -143.61 147.05 33.78 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.52 -0.548 . . . . 1.1000000000000001 109.52 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.79 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 11.4 p30 -104.04 151.81 22.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.635 1.207 . . . . 2.1099999999999999 112.022 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.624 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -116.06 99.35 7.19 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.472 -1.695 . . . . 1.0900000000000001 108.86 167.152 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.423 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 29.8 m -81.41 96.94 7.52 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.211 -1.033 . . . . 1.0700000000000001 108.211 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 80' ' ' GLN . 3.9 p -81.27 112.54 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 123.099 1.428 . . . . 1.1399999999999999 108.751 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 14.1 m-70 -77.49 97.9 5.15 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.441 -2.163 . . . . 1.8200000000000001 109.222 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.47 -76.21 0.4 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.821 -1.536 . . . . 1.6699999999999999 110.296 173.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.69 177.44 4.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.064 -0.516 . . . . 2.98 110.684 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.42 -0.8 . . . . 7.3399999999999999 109.847 177.482 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.946 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 2.1 m-20 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.246 0.546 . . . . 1.9299999999999999 110.65 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.5 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 16.7 m-20 -83.22 172.97 8.21 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 115.266 -0.879 . . . . 1.6499999999999999 108.651 168.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 39.2 Cg_endo -69.74 81.28 0.82 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 121.652 1.568 . . . . 1.24 113.077 176.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.99 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.9 mp -109.18 -70.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.313 -0.858 . . . . 1.2 109.82 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 89.76 51.01 2.96 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.816 -1.714 . . . . 0.44 108.816 -172.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 6.0 tp -51.73 -40.26 59.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.209 -1.495 . . . . 1.1100000000000001 110.312 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.757 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.6 OUTLIER -86.2 85.17 7.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.307 -0.86 . . . . 0.97999999999999998 110.461 174.473 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.26 -42.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 1.1100000000000001 109.207 175.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.407 ' CB ' ' HD2' ' A' ' 27' ' ' ARG . 25.3 ttt -148.68 130.2 14.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.035 -0.984 . . . . 3.3100000000000001 108.35 173.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -105.25 129.31 24.97 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 116.007 -0.542 . . . . 4.1699999999999999 111.137 -174.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.628 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 13.7 Cg_endo -60.98 158.18 35.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.656 2.237 . . . . 0.81999999999999995 112.122 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.491 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.4 mm-40 -126.68 174.61 8.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 1.6299999999999999 111.37 -171.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 3.3 p-10 -69.72 -149.63 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.66 1.219 . . . . 2.0600000000000001 111.87 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 154.62 134.35 1.9 Allowed Glycine 0 C--N 1.298 -1.583 0 CA-C-N 113.703 -1.589 . . . . 0.34999999999999998 112.719 -174.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 6.1 mp0 -109.75 112.62 24.78 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.577 -1.312 . . . . 1.53 107.632 175.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.01 164.92 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 108.141 -1.059 . . . . 1.0800000000000001 108.141 -172.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 154.72 17.07 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.778 -1.101 . . . . 1.22 109.69 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 88.4 t -69.71 104.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 122.939 1.352 . . . . 1.3799999999999999 108.517 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.21 4.1 9.37 Favored Glycine 0 C--N 1.275 -2.836 0 CA-C-N 112.217 -2.265 . . . . 0.52000000000000002 112.816 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -120.17 3.12 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 108.901 -1.68 . . . . 0.44 108.901 171.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.2 p -151.59 174.05 13.91 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.102 -1.549 . . . . 1.23 110.368 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG22 ' HB ' ' A' ' 76' ' ' ILE . 9.0 tp -146.64 146.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 CA-C-N 113.213 -1.812 . . . . 1.0900000000000001 106.336 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.5 m -139.21 128.0 23.42 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 114.105 -1.407 . . . . 1.05 111.157 -172.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.745 ' HD2' HD13 ' A' ' 74' ' ' LEU . 34.3 m-85 -126.14 141.46 51.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.885 -1.507 . . . . 0.71999999999999997 109.726 177.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.469 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.91 118.81 20.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.805 0.812 . . . . 0.87 109.715 175.426 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.786 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -113.71 113.17 24.62 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.414 -1.266 . . . . 1.1000000000000001 109.203 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 99.3 mtt180 -102.66 117.8 35.45 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.952 -0.388 . . . . 2.9300000000000002 109.952 -176.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.9 t -115.33 125.39 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 122.348 1.07 . . . . 1.0700000000000001 110.307 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.75 107.69 0.55 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.92 -1.945 . . . . 1.1200000000000001 110.384 176.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.541 ' C ' ' HE3' ' A' ' 68' ' ' LYS . . . -51.53 -40.59 47.53 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.668 -1.151 . . . . 0.76000000000000001 111.775 173.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 42.77 -140.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.15 1.167 . . . . 1.0 114.15 172.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -134.54 132.31 38.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.398 -0.819 . . . . 2.1699999999999999 109.555 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.89 -174.31 4.87 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.142 -0.481 . . . . 2.6299999999999999 111.795 -173.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 tp -74.87 -51.98 12.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.029 -0.987 . . . . 1.99 108.838 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.7 151.16 59.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.311 -0.858 . . . . 1.8799999999999999 109.475 176.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.47 138.92 7.29 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.593 2.862 . . . . 1.1200000000000001 112.914 -176.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 2.3 Cg_endo -45.68 133.13 13.45 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 123.311 2.674 . . . . 0.81999999999999995 113.351 -177.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.35 105.29 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.697 -1.594 . . . . 1.4299999999999999 106.697 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.764 HG11 ' HB ' ' A' ' 91' ' ' VAL . 1.9 t -105.42 114.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 113.566 -1.652 . . . . 1.0900000000000001 107.344 178.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.81 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -97.58 122.41 40.62 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-O 123.248 1.499 . . . . 2.1299999999999999 109.294 173.846 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.995 ' HB3' HD11 ' A' ' 49' ' ' LEU . 63.4 m95 -88.32 153.15 21.43 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 111.769 -2.469 . . . . 0.40999999999999998 110.97 173.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 39.0 t80 -131.39 134.46 46.28 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 104.432 -2.432 . . . . 0.80000000000000004 104.432 173.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.79 ' HZ1' ' HB ' ' A' ' 47' ' ' VAL . 1.8 ttpm? -100.76 163.3 12.38 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.969 -1.863 . . . . 2.6800000000000002 105.969 -175.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -9.77 -165.02 0.0 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.938 2.335 . . . . 1.6000000000000001 118.938 -177.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.652 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 5.6 mtpp -44.28 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 O-C-N 119.541 -2.152 . . . . 4.2999999999999998 116.68 -166.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.616 ' CZ3' HG11 ' A' ' 47' ' ' VAL . 17.4 p-90 -165.58 -9.13 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.955 1.465 . . . . 2.5099999999999998 114.955 -177.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.79 ' HB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.0 167.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 CA-C-O 123.814 1.769 . . . . 1.78 113.215 -162.754 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.672 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 2.6 p-10 -109.67 155.9 20.91 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 110.994 -2.821 . . . . 2.73 107.164 174.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.995 HD11 ' HB3' ' A' ' 41' ' ' TRP . 4.9 mp -99.15 -36.81 9.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.014 0.746 . . . . 1.1299999999999999 113.014 168.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.7 t -57.84 -21.21 41.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.255 0.55 . . . . 1.71 109.811 -162.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.548 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 52.3 m -99.1 -21.48 16.15 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 115.476 -0.784 . . . . 1.76 112.842 -176.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.672 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 6.7 mmmt -100.34 -36.38 9.27 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.306 -0.861 . . . . 1.9099999999999999 111.184 -170.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.794 HG21 ' O ' ' A' ' 49' ' ' LEU . 74.0 t -31.63 94.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 113.373 -1.74 . . . . 1.1499999999999999 111.993 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -162.74 -122.85 0.63 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 111.864 -2.425 . . . . 0.69999999999999996 112.197 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.77 -47.1 79.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.748 1.018 . . . . 3.3599999999999999 113.748 -169.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.597 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.7 p80 -92.27 -35.33 13.83 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.256 0.55 . . . . 1.78 111.415 -174.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.56 105.27 11.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.564 -1.643 . . . . 1.72 106.564 175.358 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.23 115.57 27.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 106.844 -1.539 . . . . 0.96999999999999997 106.844 164.227 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.64 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -98.97 90.71 4.72 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 103.45 -2.796 . . . . 1.0600000000000001 103.45 167.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.611 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 29.9 t-80 -103.01 160.29 14.76 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.171 -1.377 . . . . 2.5899999999999999 108.972 -173.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -130.48 113.93 14.89 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 112.295 -2.229 . . . . 0.92000000000000004 110.393 -176.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -90.84 143.58 26.58 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 111.737 -2.483 . . . . 0.76000000000000001 107.136 171.3 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.539 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 2.0 t80 -140.84 98.88 3.48 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.082 0.944 . . . . 1.8 111.687 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -118.11 129.87 55.79 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.169 -1.378 . . . . 2.4199999999999999 109.887 170.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.492 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -88.93 -38.92 14.13 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.037 -1.438 . . . . 3.0800000000000001 112.616 -177.414 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.73 81.56 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.658 0.599 . . . . 1.6899999999999999 111.351 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.2 p -92.05 -17.38 25.11 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.28 -1.378 . . . . 1.96 107.28 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.661 ' HZ3' ' HH ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER 69.19 30.99 4.14 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.526 -1.67 . . . . 3.7799999999999998 109.712 171.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.9 t -122.93 123.9 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 122.159 0.98 . . . . 1.1299999999999999 109.991 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.661 ' HH ' ' HZ3' ' A' ' 68' ' ' LYS . 3.9 m-30 -104.13 105.81 16.09 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.926 -1.488 . . . . 1.95 107.035 170.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 25' ' ' SER . 29.5 tp -90.31 106.79 18.73 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.474 -1.239 . . . . 1.1799999999999999 109.525 -176.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.6 m-85 -87.77 112.04 22.0 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.342 -1.725 . . . . 0.40000000000000002 106.342 169.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 6.9 pt-20 -118.1 125.16 49.73 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.621 -1.627 . . . . 1.3200000000000001 110.131 -171.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.745 HD13 ' HD2' ' A' ' 24' ' ' PHE . 1.3 mt -89.98 124.99 35.21 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.485 -1.234 . . . . 1.5900000000000001 108.562 174.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -112.49 96.36 5.95 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 104.081 -2.563 . . . . 2.0099999999999998 104.081 166.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.719 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.1 mt -122.4 100.67 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 123.285 1.517 . . . . 1.1899999999999999 108.743 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 51.1 p -112.54 157.1 21.56 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-N 113.456 -1.702 . . . . 1.05 109.29 -172.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.12 39.71 5.42 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.89 -2.414 . . . . 2.1200000000000001 108.798 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -44.28 120.86 2.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 111.997 -2.365 . . . . 1.0900000000000001 110.388 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -87.59 156.66 53.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.33 -0.989 . . . . 1.77 108.33 -177.867 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.805 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 50.4 Cg_endo -69.27 -3.48 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 121.296 1.331 . . . . 1.3300000000000001 113.139 -170.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.54 7.57 44.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.112 -0.494 . . . . 1.6599999999999999 110.212 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.702 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -92.78 -20.55 20.63 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.173 -0.467 . . . . 1.24 111.002 -176.357 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 45.2 m -49.03 103.22 0.04 OUTLIER 'General case' 0 CA--C 1.473 -2.014 0 CA-C-O 122.509 1.147 . . . . 1.6799999999999999 108.552 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.652 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -174.64 -130.71 1.32 Allowed Glycine 0 C--N 1.265 -3.371 0 CA-C-N 112.364 -2.198 . . . . 2.0 112.964 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.52 118.23 0.86 Allowed Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.244 -0.979 . . . . 0.81000000000000005 112.157 -172.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.761 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.4 m-85 -87.12 124.34 33.15 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.078 -1.453 . . . . 1.0800000000000001 107.078 175.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 44.1 mtp180 -122.42 124.43 43.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.422 0.555 . . . . 3.6899999999999999 111.698 -175.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.493 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 4.0 m -97.0 131.09 44.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 1.22 109.856 176.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.81 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.0 mt-10 -132.14 103.34 6.2 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.685 -0.857 . . . . 1.8100000000000001 108.685 170.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.764 ' HB ' HG11 ' A' ' 39' ' ' VAL . 4.3 p -93.17 138.24 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.561 0.696 . . . . 1.24 110.089 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.1 m -132.59 107.81 8.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.701 -1.136 . . . . 1.6399999999999999 108.903 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.601 ' OG1' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -132.08 157.97 42.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 117.669 -1.158 . . . . 1.26 108.51 -179.648 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.691 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 20.13 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 125.574 1.797 . . . . 0.93999999999999995 114.276 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.691 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -146.92 -3.52 0.58 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.989 -1.005 . . . . 1.05 110.001 -177.479 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.99 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 4.9 mmmt -96.29 133.65 40.38 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.88 0.848 . . . . 1.78 109.56 -175.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.69 131.27 44.74 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.497 -1.683 . . . . 1.0 110.892 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB3' ' CG ' ' A' ' 7' ' ' PHE . 28.8 m-20 -144.85 140.83 28.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.428 -1.26 . . . . 1.6000000000000001 108.702 176.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.7 p -138.3 154.06 49.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.254 0.55 . . . . 1.98 111.118 -176.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.757 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 36.2 t -136.12 149.35 48.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.205 1.002 . . . . 1.02 111.246 177.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.42 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -134.31 109.72 9.01 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.322 -1.763 . . . . 1.5800000000000001 109.466 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.699 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 29.4 p90 -140.81 132.55 27.35 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.217 -0.66 . . . . 1.1000000000000001 109.217 -174.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.521 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 2.1 p-10 -102.42 153.15 20.31 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 122.39 1.091 . . . . 2.1099999999999999 111.317 -171.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.666 ' CD2' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -121.33 120.78 36.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.427 -1.261 . . . . 1.0900000000000001 108.526 172.716 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.476 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 5.9 m -100.16 96.11 7.27 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.749 -0.834 . . . . 1.0700000000000001 108.749 174.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 80' ' ' GLN . 9.5 p -84.27 116.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 123.485 1.612 . . . . 1.1399999999999999 109.339 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -91.39 100.29 13.1 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 112.504 -2.134 . . . . 1.8200000000000001 109.976 -175.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.805 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 9.9 tt0 -73.57 -67.22 0.61 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.923 -1.035 . . . . 1.6699999999999999 109.556 170.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.85 -175.03 3.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 2.98 109.504 178.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.753 -0.641 . . . . 7.3399999999999999 109.738 178.545 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.734 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 1.6 m-20 . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 120.844 0.354 . . . . 1.9299999999999999 110.96 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.511 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-20 -87.81 175.76 3.96 Favored Pre-proline 0 N--CA 1.438 -1.051 0 CA-C-N 116.004 -0.544 . . . . 1.6499999999999999 109.822 170.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 73.5 Cg_endo -77.21 59.48 6.61 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 121.852 1.701 . . . . 1.24 112.862 177.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.921 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -75.15 -63.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.228 -0.896 . . . . 1.2 109.457 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.61 41.29 5.75 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 107.812 -2.115 . . . . 0.44 107.812 -175.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.647 ' N ' HG21 ' A' ' 4' ' ' ILE . 8.4 tp -49.25 -46.37 46.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.573 -1.814 . . . . 1.1100000000000001 110.643 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.678 ' HD2' ' HE ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -88.65 84.91 6.72 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.827 0.822 . . . . 0.97999999999999998 109.863 171.806 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.37 -37.82 79.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.24 -1.345 . . . . 1.1100000000000001 109.285 178.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 tpp -148.65 132.92 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.837 -1.074 . . . . 3.3100000000000001 108.307 171.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.678 ' HE ' ' HD2' ' A' ' 7' ' ' PHE . 38.1 mtt180 -96.24 130.81 30.03 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.886 0.374 . . . . 4.1699999999999999 110.873 -174.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.457 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 13.9 Cg_endo -60.22 153.26 60.38 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.093 2.528 . . . . 0.81999999999999995 111.794 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.1 mm-40 -124.67 170.19 11.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.01 -0.541 . . . . 1.6299999999999999 111.999 -172.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.1 p-10 -70.83 -145.75 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.321 0 C-N-CA 124.673 1.189 . . . . 2.0600000000000001 113.076 -175.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.76 133.1 1.58 Allowed Glycine 0 C--N 1.307 -1.06 0 CA-C-N 113.708 -1.587 . . . . 0.34999999999999998 114.015 -176.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 1.7 mp0 -106.47 111.36 23.9 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.689 -1.256 . . . . 1.53 109.083 175.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 HG12 ' HB ' ' A' ' 22' ' ' ILE . 1.9 m -137.43 163.04 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.155 -1.054 . . . . 1.0800000000000001 108.155 -174.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.13 156.26 16.39 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.78 -1.1 . . . . 1.22 109.677 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.845 HG23 ' HB3' ' A' ' 81' ' ' PRO . 24.9 t -69.93 107.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-O 123.056 1.407 . . . . 1.3799999999999999 109.171 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.65 -0.6 15.67 Favored Glycine 0 C--N 1.266 -3.359 0 CA-C-N 111.957 -2.383 . . . . 0.52000000000000002 112.221 176.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 -126.14 3.76 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 109.101 -1.6 . . . . 0.44 109.101 172.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 9.3 p -151.68 167.9 26.7 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-N 112.985 -1.608 . . . . 1.23 111.042 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD11 ' A' ' 104' ' ' LEU . 7.8 tp -146.11 147.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 113.291 -1.777 . . . . 1.0900000000000001 108.42 170.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 m -139.88 130.6 25.87 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 113.239 -1.8 . . . . 1.05 110.399 -175.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.601 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -128.58 160.49 32.23 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.921 -1.036 . . . . 0.71999999999999997 108.753 169.8 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.73 129.27 22.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.968 -1.015 . . . . 0.87 108.866 178.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.656 ' HB3' ' CH2' ' A' ' 41' ' ' TRP . . . -125.61 127.59 46.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.736 -0.666 . . . . 1.1000000000000001 111.138 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -108.64 121.32 44.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.06 -0.518 . . . . 2.9300000000000002 110.557 -177.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 14.6 t -123.44 127.94 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.258 1.028 . . . . 1.0700000000000001 110.508 -176.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.509 ' HB3' ' CE ' ' A' ' 68' ' ' LYS . . . -61.18 110.21 1.33 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.113 -1.858 . . . . 1.1200000000000001 113.212 -177.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' HD22 ' A' ' 33' ' ' LEU . . . -54.36 -48.57 63.86 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 114.587 -1.188 . . . . 0.76000000000000001 112.184 171.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.74 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 56.74 -170.23 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.734 0.814 . . . . 1.0 112.87 173.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -114.11 35.7 4.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.243 1.021 . . . . 2.1699999999999999 108.459 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.009 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.18 172.97 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.015 -1.448 . . . . 2.6299999999999999 113.358 177.394 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.75 -49.62 76.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.343 0.592 . . . . 1.99 110.307 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.662 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -144.8 150.09 45.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.041 -1.096 . . . . 1.8799999999999999 108.041 174.057 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.91 142.14 5.49 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.416 2.744 . . . . 1.1200000000000001 111.588 -177.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.009 ' HD3' HD11 ' A' ' 33' ' ' LEU . 6.4 Cg_exo -54.54 137.45 73.0 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.138 1.225 . . . . 0.81999999999999995 112.836 -174.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 35' ' ' LYS . 3.6 t -99.13 104.68 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 105.708 -1.96 . . . . 1.4299999999999999 105.708 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.671 HG12 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -111.54 113.57 44.61 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.596 -1.638 . . . . 1.0900000000000001 107.594 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.548 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -103.95 130.99 51.62 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 123.389 1.566 . . . . 2.1299999999999999 109.751 173.173 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.031 ' HB3' HD11 ' A' ' 49' ' ' LEU . 81.9 m95 -91.23 157.25 17.27 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.859 -2.428 . . . . 0.40999999999999998 111.259 173.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 27.1 t80 -131.47 130.71 42.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.564 -2.013 . . . . 0.80000000000000004 105.564 175.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.669 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 31.7 ttpt -109.05 104.83 14.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.25 -1.759 . . . . 2.6800000000000002 106.25 -176.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.26 91.65 1.67 Allowed Glycine 0 CA--C 1.481 -2.044 0 C-N-CA 115.906 -3.045 . . . . 1.6000000000000001 114.112 -164.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.003 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -105.04 -27.44 11.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 104.104 -2.554 . . . . 4.2999999999999998 104.104 139.549 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 1.003 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 27.5 p-90 160.2 -20.19 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.078 -2.328 . . . . 2.5099999999999998 111.529 -165.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.53 169.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 123.046 1.403 . . . . 1.78 112.539 -163.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.3 t70 -113.11 133.89 54.8 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 111.617 -2.538 . . . . 2.73 107.04 175.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.031 HD11 ' HB3' ' A' ' 41' ' ' TRP . 4.8 mp -69.85 -35.3 74.62 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 119.169 -0.443 . . . . 1.1299999999999999 111.869 -175.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 m -58.27 -20.01 39.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.543 0.687 . . . . 1.71 109.817 -167.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 m -98.4 -18.86 18.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.973 -1.012 . . . . 1.76 112.424 -176.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.42 -70.27 0.74 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.876 -0.602 . . . . 1.9099999999999999 111.118 -176.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.804 HG22 ' O ' ' A' ' 49' ' ' LEU . 70.5 t 16.6 91.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.23 1.812 . . . . 1.1499999999999999 113.965 175.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -151.4 -138.5 2.82 Favored Glycine 0 C--N 1.319 -0.397 0 CA-C-N 114.174 -1.375 . . . . 0.69999999999999996 113.488 -174.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -64.18 -42.83 96.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.382 0.882 . . . . 3.3599999999999999 113.382 -169.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.485 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 4.8 p80 -86.97 -37.97 17.06 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 119.64 -0.824 . . . . 1.78 111.702 -175.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.918 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.39 108.76 13.07 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.289 -1.004 . . . . 1.72 108.289 170.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -96.34 115.69 27.84 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 105.834 -1.913 . . . . 0.96999999999999997 105.834 168.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.693 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -95.09 92.28 6.74 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 104.353 -2.462 . . . . 1.0600000000000001 104.353 170.357 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.624 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 4.0 m170 -88.24 164.2 15.74 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 113.748 -1.569 . . . . 2.5899999999999999 111.003 -178.187 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -134.29 113.38 11.89 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 111.716 -2.493 . . . . 0.92000000000000004 109.937 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.8 m -99.14 149.34 23.16 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.597 -2.092 . . . . 0.76000000000000001 107.891 174.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -145.58 99.38 3.28 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.097 0.951 . . . . 1.8 112.362 -171.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.88 106.43 14.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.837 -1.528 . . . . 2.4199999999999999 110.374 169.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.04 -27.68 65.87 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.556 -1.202 . . . . 3.0800000000000001 110.504 179.065 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.18 73.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.216 -0.902 . . . . 1.6899999999999999 110.746 175.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -91.65 -18.24 24.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.6 -0.727 . . . . 1.96 109.287 175.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.74 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 10.3 ttpt 66.62 33.82 6.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.665 -1.152 . . . . 3.7799999999999998 109.699 -177.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.84 133.52 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.166 0.984 . . . . 1.1299999999999999 110.766 -176.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 62' ' ' SER . 36.7 m-85 -97.65 108.07 20.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.532 -1.655 . . . . 1.95 106.532 161.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 15.0 tp -95.18 104.7 16.59 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.508 1.147 . . . . 1.1799999999999999 109.011 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.624 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.7 m-85 -86.2 114.47 23.06 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.331 -1.759 . . . . 0.40000000000000002 108.606 175.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.47 127.71 46.74 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.374 -1.739 . . . . 1.3200000000000001 109.007 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.837 HD23 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -99.38 116.65 32.03 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.206 -1.405 . . . . 1.5900000000000001 107.206 171.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.754 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 14.5 m80 -114.63 94.41 4.76 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 104.953 -2.24 . . . . 2.0099999999999998 104.953 167.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.807 HG12 ' HB2' ' A' ' 57' ' ' LEU . 47.5 mt -118.13 99.15 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 123.18 1.466 . . . . 1.1899999999999999 110.055 -173.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.7 p -106.71 163.89 12.54 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.022 -1.444 . . . . 1.05 108.121 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 68.86 38.91 1.99 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.804 -1.998 . . . . 2.1200000000000001 110.215 170.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.09 118.06 2.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.207 -1.815 . . . . 1.0900000000000001 112.024 -178.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.648 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -57.82 140.97 80.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.818 -1.083 . . . . 1.77 109.758 172.014 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.845 ' HB3' HG23 ' A' ' 18' ' ' VAL . 36.4 Cg_endo -67.89 5.02 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.707 2.271 . . . . 1.3300000000000001 113.42 -177.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.99 -3.83 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.473 -0.33 . . . . 1.6599999999999999 110.324 173.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.896 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -75.66 4.45 7.75 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.798 -0.62 . . . . 1.24 109.368 -172.046 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 29.5 m -23.02 90.07 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 125.696 1.873 . . . . 1.6799999999999999 111.325 177.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.76 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -39.79 110.2 0.16 Allowed Glycine 0 CA--C 1.466 -3.029 0 CA-C-N 109.703 -3.408 . . . . 2.0 113.902 -169.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.88 62.78 0.55 Allowed Glycine 0 C--N 1.262 -3.567 0 CA-C-N 111.718 -2.241 . . . . 0.81000000000000005 107.895 160.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.669 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 73.9 m-85 -81.43 109.79 16.24 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.251 -1.388 . . . . 1.0800000000000001 107.251 -177.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.468 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 24.4 ttm180 -109.91 110.03 20.86 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.069 -0.715 . . . . 3.6899999999999999 109.069 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.537 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.3 t -91.33 125.1 35.98 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.658 -0.867 . . . . 1.22 108.658 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 38.8 tt0 -134.03 103.88 6.0 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.309 -0.86 . . . . 1.8100000000000001 109.755 -172.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.671 ' HB ' HG12 ' A' ' 39' ' ' VAL . 2.7 p -100.58 143.63 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 1.24 110.343 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -139.87 108.84 6.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.341 -0.845 . . . . 1.6399999999999999 108.812 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.56 HG22 ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.96 146.85 52.15 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-O 117.775 -1.107 . . . . 1.26 109.851 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.796 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.41 -73.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.679 1.862 . . . . 0.93999999999999995 114.28 -177.275 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.796 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 10.7 t70 -151.78 -2.03 0.3 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.904 -1.044 . . . . 1.05 110.28 -175.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.921 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmmt -93.45 133.84 36.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.117 0.961 . . . . 1.78 108.849 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -130.35 129.94 43.79 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.467 -1.697 . . . . 1.0 110.16 -176.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 4.4 m-20 -146.97 142.17 27.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.166 -1.379 . . . . 1.6000000000000001 109.099 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.464 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 58.3 m -144.94 148.28 33.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.604 -0.726 . . . . 1.98 110.154 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 89' ' ' CYS . 2.9 p -128.23 148.07 50.61 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.532 -0.758 . . . . 1.02 111.567 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.79 112.37 14.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.557 -1.201 . . . . 1.5800000000000001 109.58 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.761 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 7.0 p90 -141.7 131.4 24.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.6 0.714 . . . . 1.1000000000000001 109.568 -175.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.74 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 5.7 p30 -105.64 138.49 41.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.532 1.158 . . . . 2.1099999999999999 112.976 -168.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.76 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.22 103.94 13.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.667 -1.606 . . . . 1.0900000000000001 109.501 173.367 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.479 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 11.9 m -86.23 95.41 9.59 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.175 -1.01 . . . . 1.0700000000000001 108.333 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 18' ' ' VAL . 8.3 p -82.74 112.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.27 1.509 . . . . 1.1399999999999999 108.706 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 97.5 m-70 -85.76 99.15 11.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.276 -2.238 . . . . 1.8200000000000001 109.724 -173.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -77.38 -72.82 0.33 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.129 -1.396 . . . . 1.6699999999999999 110.131 172.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.55 13.0 6.47 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.68 -0.691 . . . . 2.98 109.76 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.403 ' C ' ' HD1' ' A' ' 107' ' ' HIS . 52.9 ttp . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.831 -0.622 . . . . 7.3399999999999999 109.498 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 9.8 p-10 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 121.911 0.863 . . . . 1.9299999999999999 110.756 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.629 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 14.2 m-20 -70.86 167.29 29.61 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.75 -1.114 . . . . 1.6499999999999999 110.844 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 55.8 Cg_endo -70.2 68.07 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.933 2.422 . . . . 1.24 112.56 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.955 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -91.59 -55.39 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 114.797 -1.092 . . . . 1.2 108.927 173.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.546 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 84.27 48.9 4.9 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.53 -2.228 . . . . 0.44 107.53 -176.492 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.919 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.0 tp -51.24 -44.9 61.83 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 112.553 -1.823 . . . . 1.1100000000000001 109.241 -173.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.507 ' CE2' ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -82.62 83.31 7.66 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.663 -1.153 . . . . 0.97999999999999998 109.544 170.874 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.98 -27.61 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.756 -1.111 . . . . 1.1100000000000001 108.978 176.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.8 tpt -163.51 148.8 11.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.09 -1.414 . . . . 3.3100000000000001 107.246 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -115.36 144.08 31.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.192 -0.603 . . . . 4.1699999999999999 111.059 177.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.755 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -76.44 170.46 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.132 2.554 . . . . 0.81999999999999995 112.451 -178.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -131.0 166.19 21.56 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.682 -0.69 . . . . 1.6299999999999999 110.977 -171.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.61 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -65.5 -141.13 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.566 1.174 . . . . 2.0600000000000001 111.982 -179.308 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.19 139.8 3.17 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.125 -1.398 . . . . 0.34999999999999998 111.934 -175.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.9 mt-10 -116.66 118.08 31.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.813 -0.693 . . . . 1.53 109.263 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -139.29 164.77 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 107.825 -1.176 . . . . 1.0800000000000001 107.825 -173.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.79 157.45 17.39 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.237 -0.892 . . . . 1.22 109.753 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 106' ' ' VAL . 16.7 t -68.66 106.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 CA-C-O 122.677 1.227 . . . . 1.3799999999999999 108.116 172.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.16 3.85 10.42 Favored Glycine 0 C--N 1.27 -3.11 0 CA-C-N 112.276 -2.238 . . . . 0.52000000000000002 113.554 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.85 -123.83 4.32 Favored Glycine 0 N--CA 1.422 -2.252 0 C-N-CA 119.235 -1.46 . . . . 0.44 111.252 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.1 p -150.88 166.99 28.88 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 112.826 -1.687 . . . . 1.23 110.934 178.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.554 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -149.41 150.74 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.023 -1.899 . . . . 1.0900000000000001 107.638 171.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.0 m -138.22 129.51 27.48 Favored 'General case' 0 C--N 1.265 -3.096 0 CA-C-N 113.721 -1.581 . . . . 1.05 110.876 -176.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.7 m-85 -128.11 155.43 44.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.278 -1.328 . . . . 0.71999999999999997 109.88 176.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.604 ' HB3' HD12 ' A' ' 71' ' ' LEU . 1.2 m -140.93 131.81 25.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.287 -0.869 . . . . 0.87 109.287 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.853 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -129.32 115.22 17.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 1.1000000000000001 110.943 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.653 ' HE ' HG11 ' A' ' 69' ' ' VAL . 18.9 mtp180 -100.6 126.32 47.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.535 -0.302 . . . . 2.9300000000000002 110.851 -177.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.5 t -127.9 129.44 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 122.057 0.932 . . . . 1.0700000000000001 110.687 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.79 108.27 2.07 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.344 -1.753 . . . . 1.1200000000000001 111.113 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -50.88 22.84 Favored Glycine 0 C--O 1.226 -0.391 0 CA-C-N 115.287 -0.87 . . . . 0.76000000000000001 111.105 172.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.952 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . . . 61.64 -100.52 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.772 1.027 . . . . 1.0 113.772 167.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.421 ' H ' ' HB1' ' A' ' 31' ' ' ALA . 4.4 p -146.39 -109.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 2.1699999999999999 110.205 -174.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.06 HD22 ' HA ' ' A' ' 93' ' ' THR . 4.4 tp 63.74 156.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.576 -0.528 . . . . 2.6299999999999999 109.576 -175.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.878 ' H ' HD13 ' A' ' 33' ' ' LEU . 21.4 tp -53.39 -27.32 23.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.129 0.966 . . . . 1.99 110.546 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.766 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.83 177.15 2.08 Favored Pre-proline 0 C--O 1.211 -0.973 0 CA-C-N 113.549 -1.66 . . . . 1.8799999999999999 106.803 178.143 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.5 Cg_exo -65.24 154.37 73.88 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.495 1.464 . . . . 1.1200000000000001 109.521 174.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.581 ' HG3' ' CG2' ' A' ' 93' ' ' THR . 67.2 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 121.569 1.513 . . . . 0.81999999999999995 113.401 -175.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.58 HG22 ' HE2' ' A' ' 35' ' ' LYS . 2.0 t -100.01 103.89 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 106.489 -1.671 . . . . 1.4299999999999999 106.489 175.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.8 t -106.71 115.25 47.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.013 -1.449 . . . . 1.0900000000000001 107.683 176.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.07 131.5 55.01 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 122.874 1.321 . . . . 2.1299999999999999 109.615 175.989 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.053 ' HB3' HD13 ' A' ' 49' ' ' LEU . 72.0 m95 -92.48 156.83 16.91 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.425 -2.171 . . . . 0.40999999999999998 112.326 174.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.704 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 37.3 t80 -129.28 133.14 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.303 -2.11 . . . . 0.80000000000000004 105.303 173.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.79 ' HZ1' ' HB3' ' A' ' 43' ' ' LYS . 3.6 ttpm? -109.66 107.51 17.58 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.336 -1.357 . . . . 2.6800000000000002 107.336 -177.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.32 91.91 1.63 Allowed Glycine 0 CA--C 1.487 -1.688 0 C-N-CA 115.982 -3.009 . . . . 1.6000000000000001 114.562 -165.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.915 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 71.2 tttt -108.86 -24.79 11.1 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.034 -2.21 . . . . 4.2999999999999998 105.034 135.216 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.915 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 25.7 p-90 159.97 -20.14 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 CA-C-N 112.677 -2.056 . . . . 2.5099999999999998 111.763 -164.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' HB ' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.34 174.11 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.461 1.6 . . . . 1.78 113.331 -163.264 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.3 t70 -109.49 155.04 21.83 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 111.208 -2.724 . . . . 2.73 105.763 173.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.053 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -89.77 -38.67 13.64 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.905 0.706 . . . . 1.1299999999999999 112.905 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 t -59.58 -19.76 50.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.894 0.854 . . . . 1.71 108.936 -166.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 p -87.58 -33.11 19.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.536 -1.211 . . . . 1.76 111.317 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.704 ' HG3' ' HZ3' ' A' ' 43' ' ' LYS . 5.5 mmmt -93.79 -70.37 0.71 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.266 -1.333 . . . . 1.9099999999999999 111.616 -175.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 49' ' ' LEU . 53.4 t 11.1 92.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.566 1.946 . . . . 1.1499999999999999 113.489 177.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.596 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -146.67 -118.04 1.07 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.841 -1.527 . . . . 0.69999999999999996 113.357 -177.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -86.12 -32.67 21.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.082 0.771 . . . . 3.3599999999999999 113.082 -167.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -93.54 -36.69 12.29 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.026 -0.669 . . . . 1.78 110.257 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.879 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.95 105.28 11.31 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.809 -1.552 . . . . 1.72 106.809 175.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -98.77 115.53 28.98 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 105.763 -1.94 . . . . 0.96999999999999997 105.763 165.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.636 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -98.51 92.03 5.44 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 103.547 -2.76 . . . . 1.0600000000000001 103.547 169.171 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.647 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 83.0 t60 -99.66 162.43 13.01 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 113.943 -1.48 . . . . 2.5899999999999999 108.694 -173.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.47 124.25 29.79 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 112.464 -2.153 . . . . 0.92000000000000004 110.949 -177.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.669 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.2 m -93.62 148.52 22.03 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 111.08 -2.782 . . . . 0.76000000000000001 106.685 169.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -138.16 98.09 3.54 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.705 1.241 . . . . 1.8 111.365 -168.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 8.4 m-20 -113.98 100.32 8.32 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 112.856 -1.975 . . . . 2.4199999999999999 108.743 172.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -37.41 36.27 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.644 -0.707 . . . . 3.0800000000000001 110.337 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.68 -22.2 60.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.004 -0.998 . . . . 1.6899999999999999 110.448 179.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 47.5 m -101.69 -9.84 20.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.494 -0.776 . . . . 1.96 109.592 175.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.952 ' HE3' ' HA ' ' A' ' 31' ' ' ALA . 74.5 tttt 67.18 29.84 7.55 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.114 -0.948 . . . . 3.7799999999999998 110.53 173.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.653 HG11 ' HE ' ' A' ' 27' ' ' ARG . 2.7 t -127.98 121.95 57.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.014 0.911 . . . . 1.1299999999999999 110.588 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -100.53 107.02 18.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.396 -1.705 . . . . 1.95 106.396 167.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.5 tp -95.15 104.73 16.62 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.3 1.048 . . . . 1.1799999999999999 109.049 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.647 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.8 m-85 -85.36 113.96 22.06 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.939 -1.482 . . . . 0.40000000000000002 108.277 174.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 19.4 mt-10 -106.8 124.41 49.58 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 113.3 -1.773 . . . . 1.3200000000000001 108.976 -176.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.824 HD23 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -90.69 118.18 29.92 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.995 -1.113 . . . . 1.5900000000000001 107.995 173.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -112.14 94.33 4.88 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 103.587 -2.746 . . . . 2.0099999999999998 103.587 169.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 52.3 mt -123.54 101.07 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.22 1.486 . . . . 1.1899999999999999 110.263 -175.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 74.8 p -106.02 144.88 32.12 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 113.002 -1.908 . . . . 1.05 107.917 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 70.96 77.61 0.18 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.914 -2.403 . . . . 2.1200000000000001 109.766 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -78.24 110.87 13.63 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.779 -2.464 . . . . 1.0900000000000001 108.24 174.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.594 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -69.58 165.07 44.41 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.418 -0.956 . . . . 1.77 108.418 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HG3' HG23 ' A' ' 18' ' ' VAL . 3.8 Cg_exo -72.41 152.28 54.69 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 120.819 1.013 . . . . 1.3300000000000001 111.124 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.696 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . 66.98 5.26 3.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.855 -0.612 . . . . 1.6599999999999999 111.358 -177.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -84.42 1.49 45.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.69 -0.856 . . . . 1.24 108.69 -178.773 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 49.2 m -10.02 82.14 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.981 0 O-C-N 126.292 2.245 . . . . 1.6799999999999999 111.316 171.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.886 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -65.71 73.94 0.11 Allowed Glycine 0 CA--C 1.473 -2.576 0 CA-C-N 111.555 -2.566 . . . . 2.0 114.002 -160.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -84.54 74.1 2.55 Favored Glycine 0 C--N 1.276 -2.787 0 N-CA-C 108.477 -1.849 . . . . 0.81000000000000005 108.477 172.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.782 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 49.2 m-85 -80.86 121.9 26.54 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.57 -1.315 . . . . 1.0800000000000001 107.694 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.79 109.82 19.54 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.645 -0.502 . . . . 3.6899999999999999 109.645 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.643 ' SG ' ' HE2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -91.6 108.35 19.84 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.537 -0.542 . . . . 1.22 109.537 -179.623 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.669 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 37.3 mt-10 -118.71 103.79 9.99 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.756 -0.656 . . . . 1.8100000000000001 109.486 -176.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -99.24 143.01 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.308 0.575 . . . . 1.24 110.868 -177.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -133.19 109.26 9.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.017 -1.105 . . . . 1.6399999999999999 108.017 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.06 ' HA ' HD22 ' A' ' 33' ' ' LEU . 1.3 m -130.28 164.21 25.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 118.331 -0.842 . . . . 1.26 109.067 -177.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.824 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 7.94 -71.23 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.567 1.792 . . . . 0.93999999999999995 113.392 173.516 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.689 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 28.6 t70 -147.8 -1.68 0.58 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.739 -1.119 . . . . 1.05 110.136 177.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.955 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.9 OUTLIER -92.84 129.25 38.82 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.478 -1.305 . . . . 1.78 107.478 -177.543 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.46 130.58 40.71 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.023 -0.989 . . . . 1.0 110.14 175.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -142.48 147.9 36.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.448 -1.251 . . . . 1.6000000000000001 109.031 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 6.8 p -144.48 141.88 29.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.343 0.592 . . . . 1.98 111.025 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.525 ' HB3' ' SG ' ' A' ' 89' ' ' CYS . 24.2 t -118.26 148.94 41.92 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.24 -0.891 . . . . 1.02 111.093 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 112.82 11.28 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.803 -1.544 . . . . 1.5800000000000001 110.053 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.782 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 40.0 p90 -142.21 140.91 32.47 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 1.1000000000000001 108.762 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.61 ' O ' ' HB3' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -117.39 134.44 54.82 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.497 1.141 . . . . 2.1099999999999999 113.555 -174.355 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.886 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -95.6 109.45 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.365 -1.743 . . . . 1.0900000000000001 109.6 177.422 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -86.85 96.54 10.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.272 -0.64 . . . . 1.0700000000000001 109.272 -178.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 18' ' ' VAL . 6.8 p -83.03 113.78 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.932 1.348 . . . . 1.1399999999999999 109.522 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -90.98 100.5 13.35 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 112.747 -2.024 . . . . 1.8200000000000001 109.549 -176.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -80.74 -79.96 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.024 -0.989 . . . . 1.6699999999999999 110.566 172.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.83 -48.61 8.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.954 -0.566 . . . . 2.98 110.232 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.237 -0.887 . . . . 7.3399999999999999 109.818 178.97 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 1.025 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.611 -0.514 . . . . 1.9299999999999999 109.611 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.621 ' HB2' ' HZ2' ' A' ' 94' ' ' LYS . 1.1 m-20 -122.53 173.22 4.41 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 1.6499999999999999 109.871 174.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.4 81.9 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.607 2.205 . . . . 1.24 112.365 172.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.952 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -108.11 -69.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 1.2 109.214 174.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.531 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 94.72 45.5 3.15 Favored Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 108.301 -1.92 . . . . 0.44 108.301 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 96' ' ' LYS . 13.3 tp -53.1 -46.13 68.55 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 112.175 -2.012 . . . . 1.1100000000000001 111.623 -169.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.762 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -89.4 84.3 6.43 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.073 -0.967 . . . . 0.97999999999999998 109.893 -176.195 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.4 t -72.42 -48.48 47.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.662 -1.153 . . . . 1.1100000000000001 110.029 -178.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.758 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 88.9 mmm -132.87 134.58 44.79 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 115.263 -0.881 . . . . 3.3100000000000001 109.766 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.762 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 22.1 mtt-85 -99.28 124.23 45.69 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 109.301 -0.629 . . . . 4.1699999999999999 109.301 174.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 17.6 Cg_endo -60.68 145.83 98.24 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.393 2.062 . . . . 0.81999999999999995 109.606 174.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.501 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 17.9 mm-40 -121.43 170.79 9.29 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 112.286 0.476 . . . . 1.6299999999999999 112.286 -168.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.0 m-20 -69.18 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.911 0 CA-C-O 122.825 1.298 . . . . 2.0600000000000001 110.627 -173.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 150.08 139.26 3.03 Favored Glycine 0 N--CA 1.423 -2.184 0 CA-C-N 114.094 -1.412 . . . . 0.34999999999999998 111.811 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 32.8 mt-10 -117.71 109.85 17.13 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.251 -0.974 . . . . 1.53 108.888 176.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.53 163.19 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.02 -1.474 . . . . 1.0800000000000001 107.02 -175.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.738 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.41 154.7 17.32 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 115.479 -0.782 . . . . 1.22 109.874 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 HG22 ' A' ' 106' ' ' VAL . 16.5 t -63.68 107.12 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 123.193 1.473 . . . . 1.3799999999999999 108.917 173.03 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.25 -10.87 5.59 Favored Glycine 0 C--N 1.268 -3.207 0 CA-C-N 111.711 -2.495 . . . . 0.52000000000000002 112.503 176.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.0 -163.69 20.36 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 119.879 -1.153 . . . . 0.44 111.316 177.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 2.5 p -122.75 169.81 10.7 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-O 122.582 1.182 . . . . 1.23 111.456 -170.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.632 HG23 HD13 ' A' ' 104' ' ' LEU . 10.4 tp -145.16 151.83 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-N 112.335 -2.211 . . . . 1.0900000000000001 107.229 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.7 m -139.67 127.46 21.97 Favored 'General case' 0 C--N 1.256 -3.486 0 CA-C-N 113.815 -1.539 . . . . 1.05 110.814 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.598 ' HD2' HD12 ' A' ' 74' ' ' LEU . 27.7 m-85 -123.48 142.49 50.95 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.788 -1.551 . . . . 0.71999999999999997 109.51 -178.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.99 120.17 17.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.94 0.876 . . . . 0.87 110.399 173.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HB3' ' HG3' ' A' ' 11' ' ' PRO . . . -117.52 114.41 23.41 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.075 -1.421 . . . . 1.1000000000000001 109.805 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.758 ' HD2' ' HG3' ' A' ' 9' ' ' MET . 88.0 mtt180 -106.71 121.76 45.0 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 121.226 -0.19 . . . . 2.9300000000000002 110.564 -176.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.2 125.65 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.027 0.917 . . . . 1.0700000000000001 109.925 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 108.39 0.59 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.309 -1.768 . . . . 1.1200000000000001 110.959 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.722 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.11 -44.3 63.19 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.817 -1.083 . . . . 0.76000000000000001 111.406 172.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.62 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 54.06 -164.2 0.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.572 0.749 . . . . 1.0 112.996 177.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -78.47 -71.58 0.42 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.81 -0.811 . . . . 2.1699999999999999 108.81 173.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.915 HD22 ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER 69.58 159.75 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.675 -0.693 . . . . 2.6299999999999999 112.102 168.496 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.915 ' N ' HD22 ' A' ' 33' ' ' LEU . 17.0 tp -75.6 -71.56 0.36 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.525 -0.761 . . . . 1.99 111.149 168.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.856 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -123.31 129.55 24.87 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 113.643 0.979 . . . . 1.8799999999999999 113.643 171.555 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' N ' HD11 ' A' ' 33' ' ' LEU . 17.2 Cg_exo -32.96 129.16 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 124.735 3.623 . . . . 1.1200000000000001 113.234 -170.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 1.5 Cg_endo -46.9 132.67 17.54 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.493 2.129 . . . . 0.81999999999999995 112.898 -171.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.66 104.64 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 106.769 -1.567 . . . . 1.4299999999999999 106.769 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.661 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.25 115.02 48.51 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.997 0 CA-C-N 113.159 -1.837 . . . . 1.0900000000000001 107.262 177.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.709 ' HB2' ' HZ3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -105.22 128.76 53.57 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 122.972 1.368 . . . . 2.1299999999999999 109.294 172.52 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.032 ' HB3' HD12 ' A' ' 49' ' ' LEU . 60.0 m95 -82.92 152.44 25.53 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 112.395 -2.184 . . . . 0.40999999999999998 110.786 175.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 32.3 t80 -128.03 138.88 52.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.725 -2.324 . . . . 0.80000000000000004 104.725 169.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 1.039 ' HE2' ' HG ' ' A' ' 49' ' ' LEU . 13.7 ttmt -100.4 171.53 7.7 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.927 -1.138 . . . . 2.6800000000000002 107.927 -173.03 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 1.001 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -13.44 -169.27 0.0 OUTLIER Glycine 0 C--O 1.185 -2.931 0 O-C-N 126.673 2.483 . . . . 1.6000000000000001 118.3 166.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.3 mtpp -42.4 -2.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 117.556 2.428 . . . . 4.2999999999999998 117.556 -166.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.645 ' CZ3' HG12 ' A' ' 47' ' ' VAL . 8.6 p-90 -169.47 -17.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.901 1.445 . . . . 2.5099999999999998 114.901 -177.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.757 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.95 167.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 CA-C-O 123.464 1.602 . . . . 1.78 112.44 -161.368 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.636 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 14.4 t70 -113.89 154.27 27.81 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.537 -2.574 . . . . 2.73 104.976 169.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.039 ' HG ' ' HE2' ' A' ' 43' ' ' LYS . 6.3 mp -90.39 -36.35 14.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.901 1.074 . . . . 1.1299999999999999 113.901 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 t -59.05 -20.73 55.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.585 0.707 . . . . 1.71 109.432 -164.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -98.88 -28.42 13.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.074 -0.966 . . . . 1.76 113.531 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.842 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.25 -40.31 7.6 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.254 0.464 . . . . 1.9099999999999999 112.254 -169.402 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.712 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 23.0 t -18.11 97.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 125.935 1.694 . . . . 1.1499999999999999 113.063 173.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -152.83 -147.9 4.73 Favored Glycine 0 C--N 1.306 -1.125 0 CA-C-N 111.575 -2.557 . . . . 0.69999999999999996 112.823 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -64.13 -16.34 61.64 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.003 0.742 . . . . 3.3599999999999999 113.003 -170.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.7 p80 -102.49 -36.34 8.43 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.379 0.609 . . . . 1.78 110.899 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.787 HD21 ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -129.22 103.43 6.95 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.961 -1.496 . . . . 1.72 106.961 172.348 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.27 116.04 28.38 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 106.976 -1.49 . . . . 0.96999999999999997 106.976 168.503 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.658 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -98.4 93.8 6.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 105.137 -2.171 . . . . 1.0600000000000001 105.137 174.632 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.616 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 46.2 m-70 -84.81 159.4 20.43 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-O 122.843 1.306 . . . . 2.5899999999999999 109.618 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.97 18.75 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 111.85 -2.432 . . . . 0.92000000000000004 109.645 177.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -103.52 145.45 30.0 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 111.094 -2.775 . . . . 0.76000000000000001 108.709 176.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.432 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 38.0 t80 -139.34 97.01 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.215 1.007 . . . . 1.8 110.143 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -114.06 105.22 12.95 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.278 -1.783 . . . . 2.4199999999999999 108.766 176.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.671 ' HD3' ' HZ3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -77.21 -36.63 54.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.588 -0.733 . . . . 3.0800000000000001 110.864 -178.834 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.87 61.18 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.616 -0.72 . . . . 1.6899999999999999 110.796 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.0 t -102.96 -19.82 14.46 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.351 -1.352 . . . . 1.96 107.351 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.722 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.86 35.47 11.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.321 -1.309 . . . . 3.7799999999999998 110.056 177.699 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 27' ' ' ARG . 10.9 t -134.19 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.201 -0.909 . . . . 1.1299999999999999 109.475 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 8.0 m-85 -102.64 111.06 23.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.068 -1.456 . . . . 1.95 107.068 166.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.7 tp -95.51 106.64 18.73 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.196 0.998 . . . . 1.1799999999999999 108.86 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.2 m-85 -89.26 112.18 23.17 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.168 -1.79 . . . . 0.40000000000000002 106.168 169.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.616 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -120.44 125.53 48.15 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.562 -1.199 . . . . 1.3200000000000001 110.093 -173.955 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.673 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.1 mt -90.95 136.43 33.08 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.774 -1.557 . . . . 1.5900000000000001 108.666 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 63.3 m170 -117.69 97.99 6.14 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.164 -2.532 . . . . 2.0099999999999998 104.164 166.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.741 ' CD1' HD22 ' A' ' 57' ' ' LEU . 66.1 mt -120.31 101.62 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-O 122.718 1.247 . . . . 1.1899999999999999 109.643 -174.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 12.7 p -118.4 145.49 45.15 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 114.05 -1.432 . . . . 1.05 109.872 -176.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 77' ' ' THR . 1.5 m-20 73.47 70.55 0.12 Allowed 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 111.258 -2.701 . . . . 2.1200000000000001 109.924 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.53 109.33 3.19 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 111.717 -2.492 . . . . 1.0900000000000001 110.947 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.685 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -60.41 142.54 90.55 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.166 -0.924 . . . . 1.77 109.286 171.249 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.485 ' HG3' HG21 ' A' ' 18' ' ' VAL . 26.4 Cg_exo -60.27 -18.8 54.38 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.409 2.073 . . . . 1.3300000000000001 112.22 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.685 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -100.1 16.25 24.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.08 -0.509 . . . . 1.6599999999999999 110.728 178.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -83.66 -36.76 23.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.831 -0.604 . . . . 1.24 110.085 -178.823 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.8 m 1.41 82.38 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 0 O-C-N 125.585 1.803 . . . . 1.6799999999999999 112.179 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 1.001 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -47.13 117.89 3.48 Favored Glycine 0 N--CA 1.408 -3.177 0 CA-C-N 111.988 -2.369 . . . . 2.0 114.353 -171.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.661 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -117.51 67.57 0.32 Allowed Glycine 0 C--N 1.273 -2.927 0 N-CA-C 108.001 -2.04 . . . . 0.81000000000000005 108.001 155.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 63.7 m-85 -78.13 118.99 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.765 -0.828 . . . . 1.0800000000000001 108.765 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.516 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 28.4 ttm180 -114.38 126.52 55.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.45 . . . . 3.6899999999999999 110.878 178.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.622 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 91.6 m -97.35 108.52 21.26 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.092 -0.707 . . . . 1.22 109.092 173.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 33.5 tt0 -114.84 103.26 10.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.525 -0.917 . . . . 1.8100000000000001 108.525 -176.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.661 ' HB ' HG11 ' A' ' 39' ' ' VAL . 6.4 p -105.0 141.9 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.655 0.741 . . . . 1.24 111.601 -173.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -134.99 108.99 8.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.338 -1.301 . . . . 1.6399999999999999 109.08 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 37' ' ' PRO . 1.4 m -120.8 168.25 11.64 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.071 -1.455 . . . . 1.26 107.071 177.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -10.66 -61.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.945 1.403 . . . . 0.93999999999999995 114.138 -175.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 1.025 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 0.4 OUTLIER -149.22 -3.14 0.43 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.993 -1.003 . . . . 1.05 109.994 177.776 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.952 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 3.9 mmtm -89.74 116.69 28.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.055 -1.831 . . . . 1.78 106.055 -176.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -134.06 139.69 46.15 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.892 -1.049 . . . . 1.0 111.274 -173.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 4.8 t0 -167.27 170.47 11.6 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.947 -1.024 . . . . 1.6000000000000001 108.858 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 17.0 p -148.81 151.06 34.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 1.98 110.28 179.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.744 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 54.7 p -122.31 137.2 54.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.945 -0.702 . . . . 1.02 111.335 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -110.79 123.93 51.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.449 -0.796 . . . . 1.5800000000000001 109.601 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.767 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.3 p90 -145.05 131.05 19.26 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.185 -0.606 . . . . 1.1000000000000001 110.493 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.1 p30 -106.21 139.62 40.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.502 1.144 . . . . 2.1099999999999999 112.294 -175.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.632 HD13 HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -107.84 105.52 15.37 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.775 -1.557 . . . . 1.0900000000000001 108.778 173.015 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.457 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.3 m -87.24 96.56 10.37 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.316 -0.994 . . . . 1.0700000000000001 108.316 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.52 HG22 HG23 ' A' ' 18' ' ' VAL . 3.1 p -75.39 112.2 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-O 122.842 1.306 . . . . 1.1399999999999999 107.989 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.738 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.2 m170 -74.43 95.95 2.81 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.688 -2.051 . . . . 1.8200000000000001 108.178 -178.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.448 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.7 tm-20 -76.15 92.86 3.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.448 -1.706 . . . . 1.6699999999999999 108.191 173.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.41 151.01 35.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.277 -0.874 . . . . 2.98 111.243 -174.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.315 1.009 . . . . 7.3399999999999999 111.488 176.672 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.5 m-20 . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.009 -0.737 . . . . 1.9299999999999999 109.009 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 1.003 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 6.9 t70 -115.05 148.6 40.93 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 114.671 -1.149 . . . . 1.6499999999999999 108.898 -175.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.447 ' C ' HD13 ' A' ' 4' ' ' ILE . 2.0 Cg_endo -45.44 90.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.224 3.283 . . . . 1.24 115.223 -177.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.673 HG23 ' N ' ' A' ' 6' ' ' LEU . 1.7 mp -125.07 -60.52 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 114.628 -1.169 . . . . 1.2 108.042 173.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.55 33.98 6.86 Favored Glycine 0 CA--C 1.492 -1.357 0 N-CA-C 108.805 -1.718 . . . . 0.44 108.805 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 1.002 HD23 ' HB3' ' A' ' 96' ' ' LYS . 5.5 tp -37.92 -51.39 1.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.38 -1.91 . . . . 1.1100000000000001 110.635 178.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.74 84.28 5.58 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.333 -0.849 . . . . 0.97999999999999998 110.157 172.243 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.27 -41.3 57.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.634 -1.166 . . . . 1.1100000000000001 108.812 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 15.6 tpt -153.92 134.77 13.76 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.747 -1.115 . . . . 3.3100000000000001 109.289 173.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -104.39 140.73 21.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.26 -0.882 . . . . 4.1699999999999999 109.73 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.683 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 34.7 Cg_endo -73.7 156.34 48.95 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.842 1.695 . . . . 0.81999999999999995 110.46 178.187 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -118.04 -179.85 3.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.225 -0.443 . . . . 1.6299999999999999 110.593 -173.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 5.4 p-10 -72.61 -145.62 0.02 OUTLIER 'General case' 0 N--CA 1.41 -2.462 0 CA-C-O 122.746 1.26 . . . . 2.0600000000000001 111.704 -176.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.13 133.33 1.78 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.306 -1.77 . . . . 0.34999999999999998 112.525 -176.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.632 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 37.3 mt-10 -110.36 111.16 22.27 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.682 -1.259 . . . . 1.53 108.435 176.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.0 m -133.63 163.36 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.884 -1.154 . . . . 1.0800000000000001 107.884 -172.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.45 147.37 23.32 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.566 -1.197 . . . . 1.22 109.193 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.904 HG22 ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.79 107.42 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 CA-C-O 123.786 1.755 . . . . 1.3799999999999999 109.993 174.62 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.06 -1.66 6.74 Favored Glycine 0 C--N 1.273 -2.959 0 CA-C-N 110.517 -3.038 . . . . 0.52000000000000002 112.168 178.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.87 -119.66 2.48 Favored Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 119.223 -1.465 . . . . 0.44 110.383 176.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.682 ' OG ' HG22 ' A' ' 77' ' ' THR . 48.1 t -154.09 173.63 15.79 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.611 -1.794 . . . . 1.23 108.859 173.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 76' ' ' ILE . 11.1 tp -149.32 147.36 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.039 0 CA-C-N 113.237 -1.801 . . . . 1.0900000000000001 106.845 167.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.3 m -140.9 126.84 19.33 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.632 -1.622 . . . . 1.05 111.338 -173.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.501 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 56.7 m-85 -124.45 147.02 48.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.65 -1.613 . . . . 0.71999999999999997 109.07 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.41 120.82 16.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.132 -0.94 . . . . 0.87 110.082 176.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -113.73 116.89 30.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.467 -1.242 . . . . 1.1000000000000001 110.145 -178.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 97.5 mtt180 -101.8 119.82 39.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.704 -0.225 . . . . 2.9300000000000002 110.879 -177.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.9 t -118.77 125.28 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 122.067 0.937 . . . . 1.0700000000000001 110.419 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.05 109.21 0.91 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.126 -1.852 . . . . 1.1200000000000001 110.829 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.619 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -54.74 -33.22 55.3 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.222 -0.899 . . . . 0.76000000000000001 111.947 172.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 53.97 -162.42 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.494 1.294 . . . . 1.0 114.494 169.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.0 p -118.44 38.81 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.939 -1.028 . . . . 2.1699999999999999 109.2 173.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.07 HD12 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -64.44 177.32 0.89 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.678 -1.146 . . . . 2.6299999999999999 113.521 -179.055 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 tp -69.21 -55.08 11.65 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.61 -0.723 . . . . 1.99 109.819 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.62 152.74 71.48 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.345 -0.843 . . . . 1.8799999999999999 109.182 176.527 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -43.0 135.87 5.16 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.19 2.593 . . . . 1.1200000000000001 112.987 -178.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.07 ' HD3' HD12 ' A' ' 33' ' ' LEU . 3.0 Cg_endo -55.52 135.93 71.56 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 122.726 2.284 . . . . 0.81999999999999995 112.383 -176.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.2 104.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.507 -1.664 . . . . 1.4299999999999999 106.507 177.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 91' ' ' VAL . 42.9 t -103.84 115.22 45.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.91 0 CA-C-N 112.805 -1.998 . . . . 1.0900000000000001 108.558 -179.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 1.03 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.33 123.38 46.69 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 113.591 -1.64 . . . . 2.1299999999999999 109.444 170.465 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.978 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.9 m95 -89.34 157.37 18.21 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.702 -2.499 . . . . 0.40999999999999998 111.256 173.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 21.1 t80 -136.55 125.8 24.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.876 -2.268 . . . . 0.80000000000000004 104.876 167.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.787 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 20.4 tttm -102.57 162.35 12.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.494 -2.039 . . . . 2.6800000000000002 105.494 -175.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.956 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -4.62 -165.94 0.0 OUTLIER Glycine 0 C--O 1.199 -2.043 0 N-CA-C 118.86 2.304 . . . . 1.6000000000000001 118.86 -174.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 84' ' ' THR . 10.4 mtpp -41.67 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.026 -1.867 . . . . 4.2999999999999998 115.716 -165.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -166.02 2.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 114.416 1.265 . . . . 2.5099999999999998 114.416 -177.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.412 HG13 ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.39 117.11 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.993 1.378 . . . . 1.78 112.254 -163.229 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -84.85 98.42 10.3 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 112.437 -2.165 . . . . 2.73 111.32 175.211 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.978 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.1 mp -49.64 -36.08 23.38 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.781 -0.645 . . . . 1.1299999999999999 112.719 -174.365 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 t -58.68 -22.2 56.48 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.427 -0.582 . . . . 1.71 109.427 -169.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.2 m -101.51 -28.18 12.69 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 112.919 0.711 . . . . 1.76 112.919 178.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 7.8 mmmt -90.1 -45.84 8.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.092 -0.504 . . . . 1.9099999999999999 111.288 -171.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.2 t -22.67 93.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 126.504 1.922 . . . . 1.1499999999999999 112.737 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -168.66 -124.73 0.74 Allowed Glycine 0 C--N 1.308 -1.025 0 CA-C-N 111.844 -2.435 . . . . 0.69999999999999996 113.227 -177.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -56.8 -52.72 63.95 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.16 0.8 . . . . 3.3599999999999999 113.16 -169.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.578 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.1 p80 -88.48 -38.6 14.86 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 112.208 0.447 . . . . 1.78 112.208 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.959 HD22 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.18 109.16 13.09 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.413 -0.958 . . . . 1.72 108.413 174.628 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -94.46 115.84 28.08 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.445 -1.687 . . . . 0.96999999999999997 106.445 167.768 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 HD21 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -95.32 92.68 6.85 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 104.476 -2.416 . . . . 1.0600000000000001 104.476 170.393 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 2.1 m170 -101.41 166.75 10.58 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.048 -1.433 . . . . 2.5899999999999999 110.454 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 125.09 22.72 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 111.98 -2.373 . . . . 0.92000000000000004 110.124 -177.458 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.3 m -94.48 148.4 22.28 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 111.506 -2.588 . . . . 0.76000000000000001 107.366 172.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 2.4 t80 -135.81 97.78 3.74 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.251 1.024 . . . . 1.8 110.978 -173.286 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 5.4 m-20 -113.8 105.17 12.96 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 113.115 -1.857 . . . . 2.4199999999999999 108.564 173.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HG3' HH11 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -84.41 -41.38 16.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.08 -0.964 . . . . 3.0800000000000001 110.45 -178.728 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.28 -22.16 62.89 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.443 -1.253 . . . . 1.6899999999999999 111.028 176.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.78 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.4 t -97.7 -16.42 19.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.285 -1.376 . . . . 1.96 107.285 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 68.04 29.18 6.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.044 -1.435 . . . . 3.7799999999999998 110.903 173.699 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.48 126.87 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 121.682 0.753 . . . . 1.1299999999999999 109.426 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.1 m-30 -105.0 109.11 20.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.796 -1.557 . . . . 1.95 106.796 170.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.6 tp -94.74 104.73 16.64 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 122.175 0.988 . . . . 1.1799999999999999 109.516 -177.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.6 m-85 -84.16 113.33 21.0 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.134 -1.432 . . . . 0.40000000000000002 107.134 171.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.51 125.61 52.16 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.789 -1.551 . . . . 1.3200000000000001 110.51 -172.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.675 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -92.15 132.5 36.57 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.838 -1.528 . . . . 1.5900000000000001 107.509 176.28 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 73.4 m-70 -119.95 96.72 5.29 Favored 'General case' 0 C--N 1.265 -3.066 0 N-CA-C 104.532 -2.396 . . . . 2.0099999999999998 104.532 167.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 57' ' ' LEU . 14.2 mt -122.03 99.32 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 122.382 1.087 . . . . 1.1899999999999999 108.856 -174.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.682 HG22 ' OG ' ' A' ' 21' ' ' SER . 75.8 p -100.41 165.0 11.66 Favored 'General case' 0 N--CA 1.388 -3.556 0 CA-C-N 114.546 -1.206 . . . . 1.05 110.374 -175.131 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 34.9 75.55 0.05 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 110.317 -3.129 . . . . 2.1200000000000001 112.43 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -65.5 105.84 1.28 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 110.786 -2.916 . . . . 1.0900000000000001 110.022 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.765 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.98 145.46 79.89 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.951 -0.759 . . . . 1.77 108.951 174.456 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.904 ' HD3' HG22 ' A' ' 18' ' ' VAL . 30.4 Cg_endo -62.49 150.28 88.03 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.439 1.426 . . . . 1.3300000000000001 111.254 -175.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.53 15.48 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.725 0.64 . . . . 1.6599999999999999 111.02 -175.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.765 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.58 -7.34 59.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.865 -1.161 . . . . 1.24 107.865 172.057 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.0 m -13.15 90.96 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 126.066 2.104 . . . . 1.6799999999999999 112.176 -177.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.956 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -49.8 112.76 1.54 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 110.946 -2.843 . . . . 2.0 114.034 -173.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.623 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -111.25 75.73 0.22 Allowed Glycine 0 C--N 1.27 -3.103 0 N-CA-C 108.295 -1.922 . . . . 0.81000000000000005 108.295 154.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.787 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 52.6 m-85 -80.08 119.15 22.5 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.298 -0.951 . . . . 1.0800000000000001 109.065 175.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.5 104.21 8.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.295 -1.002 . . . . 3.6899999999999999 108.295 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.6 t -90.58 127.73 36.36 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.852 -0.795 . . . . 1.22 108.852 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 1.03 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 34.1 tt0 -136.7 107.48 6.62 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.526 -0.761 . . . . 1.8100000000000001 109.699 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 39' ' ' VAL . 21.6 t -98.81 141.46 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.644 -0.422 . . . . 1.24 109.899 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 m -131.95 107.75 8.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.876 -0.787 . . . . 1.6399999999999999 108.876 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.6 HG21 HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.9 157.05 46.07 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 118.6 -0.714 . . . . 1.26 109.082 178.021 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 1.003 ' HZ2' ' HB3' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 24.46 -79.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 125.61 1.819 . . . . 0.93999999999999995 113.793 168.781 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.615 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 t70 -142.81 -4.17 0.96 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.894 -1.048 . . . . 1.05 109.944 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.002 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -91.65 122.74 34.49 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.536 0.684 . . . . 1.78 109.348 -177.424 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -129.81 114.29 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.388 -1.278 . . . . 1.0 110.044 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -130.44 145.26 51.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.777 -1.556 . . . . 1.6000000000000001 109.531 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.5 m -142.86 147.33 35.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.374 0.607 . . . . 1.98 110.959 -178.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 p -127.6 148.41 50.36 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.398 -0.819 . . . . 1.02 111.987 178.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.94 114.92 22.78 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.739 -1.119 . . . . 1.5800000000000001 109.807 173.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.683 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.29 119.98 12.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.434 0.635 . . . . 1.1000000000000001 109.441 -176.593 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.683 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.7 p30 -103.7 155.1 18.84 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.254 1.026 . . . . 2.1099999999999999 111.59 -168.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.682 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -121.81 111.72 17.48 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.26 -1.336 . . . . 1.0900000000000001 109.611 175.387 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 m -94.13 96.8 9.86 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.127 -0.694 . . . . 1.0700000000000001 109.127 177.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 4.0 p -82.87 113.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 122.955 1.36 . . . . 1.1399999999999999 109.234 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.632 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 99.7 m-70 -87.5 101.21 13.39 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 112.201 -2.272 . . . . 1.8200000000000001 109.044 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.533 ' HA ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -64.21 95.15 0.12 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.6 -1.182 . . . . 1.6699999999999999 108.647 170.762 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.18 52.82 1.83 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.068 -0.969 . . . . 2.98 109.167 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 C--O 1.245 0.843 0 CA-C-N 115.49 -0.777 . . . . 7.3399999999999999 110.078 179.677 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.794 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 4.6 p-10 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.119 0.485 . . . . 1.9299999999999999 109.982 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.437 ' CG ' ' HZ2' ' A' ' 94' ' ' LYS . 3.0 m-20 -97.95 172.8 4.49 Favored Pre-proline 0 N--CA 1.444 -0.742 0 C-N-CA 123.174 0.59 . . . . 1.6499999999999999 111.281 -178.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.99 84.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.317 2.011 . . . . 1.24 111.711 171.078 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.97 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -110.01 -64.87 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.16 -0.927 . . . . 1.2 109.329 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.447 ' N ' HG21 ' A' ' 4' ' ' ILE . . . 95.6 46.55 2.71 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 108.284 -1.926 . . . . 0.44 108.284 -175.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.578 ' N ' HG21 ' A' ' 4' ' ' ILE . 11.6 tp -56.72 -47.57 79.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.156 -1.522 . . . . 1.1100000000000001 111.203 -166.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.477 ' HD1' ' HA ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -93.98 84.76 4.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.933 0.873 . . . . 0.97999999999999998 109.665 178.367 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.48 -35.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.983 -1.462 . . . . 1.1100000000000001 109.693 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -158.57 130.9 6.88 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 114.948 -1.024 . . . . 3.3100000000000001 109.016 172.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -109.28 133.32 20.83 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 4.1699999999999999 110.206 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.687 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.5 Cg_endo -63.76 157.54 51.47 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.725 2.283 . . . . 0.81999999999999995 111.966 -176.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.0 mm-40 -121.26 174.17 6.87 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.858 -0.61 . . . . 1.6299999999999999 110.472 -173.137 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 5.5 p-10 -68.48 -142.85 0.01 OUTLIER 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 122.942 1.354 . . . . 2.0600000000000001 111.968 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.85 137.16 2.7 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 113.433 -1.712 . . . . 0.34999999999999998 112.112 -175.435 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.469 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 34.0 mt-10 -110.49 115.81 30.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.413 -0.958 . . . . 1.53 108.413 174.171 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -134.86 155.7 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.02 0 N-CA-C 106.982 -1.488 . . . . 1.0800000000000001 106.982 -173.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.451 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.36 157.28 18.23 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.041 -0.981 . . . . 1.22 108.908 -179.562 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.476 ' CG1' ' HD3' ' A' ' 81' ' ' PRO . 21.5 t -67.69 105.98 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.847 1.308 . . . . 1.3799999999999999 108.117 173.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.76 11.41 6.49 Favored Glycine 0 C--N 1.265 -3.395 0 CA-C-N 112.132 -2.304 . . . . 0.52000000000000002 113.055 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.14 -126.81 5.89 Favored Glycine 0 N--CA 1.416 -2.66 0 C-N-CA 119.278 -1.439 . . . . 0.44 110.529 171.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.7 p -151.21 170.46 19.41 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 112.697 -1.752 . . . . 1.23 110.613 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.8 tp -148.7 150.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-N 112.835 -1.984 . . . . 1.0900000000000001 106.952 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -138.71 130.11 27.27 Favored 'General case' 0 C--N 1.258 -3.383 0 CA-C-N 114.32 -1.309 . . . . 1.05 110.639 -175.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' HD2' HD13 ' A' ' 74' ' ' LEU . 26.9 m-85 -124.96 142.52 51.42 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.417 -1.265 . . . . 0.71999999999999997 109.85 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.83 121.28 20.42 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.078 0.942 . . . . 0.87 110.43 176.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.77 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -118.83 115.94 25.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.119 -1.401 . . . . 1.1000000000000001 110.459 -178.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -105.06 122.81 46.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.439 -0.346 . . . . 2.9300000000000002 110.76 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 8.4 t -125.74 127.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 122.085 0.945 . . . . 1.0700000000000001 110.126 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -58.27 114.09 2.25 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.254 -1.794 . . . . 1.1200000000000001 111.397 177.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.03 -29.05 61.79 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.293 -1.321 . . . . 0.76000000000000001 110.757 168.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.652 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 52.86 -166.58 0.06 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.83 1.418 . . . . 1.0 114.83 165.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 t -120.9 107.77 13.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.066 -1.457 . . . . 2.1699999999999999 107.066 169.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.803 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -143.05 176.32 9.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.061 0.763 . . . . 2.6299999999999999 113.061 -165.311 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.0 tp -70.56 -71.44 0.25 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.386 -0.825 . . . . 1.99 108.824 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -116.63 148.4 41.82 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.609 -0.723 . . . . 1.8799999999999999 109.302 171.318 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.67 142.92 9.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.877 2.385 . . . . 1.1200000000000001 111.809 178.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.803 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.9 Cg_exo -62.37 139.63 78.07 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 121.938 1.759 . . . . 0.81999999999999995 111.924 -173.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.3 104.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.813 -1.551 . . . . 1.4299999999999999 106.813 178.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.538 HG11 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -105.98 115.1 46.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 113.323 -1.762 . . . . 1.0900000000000001 107.528 176.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.579 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.09 127.91 55.14 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-O 122.944 1.354 . . . . 2.1299999999999999 110.132 175.371 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.948 ' HB3' HD11 ' A' ' 49' ' ' LEU . 64.3 m95 -84.21 155.77 22.36 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 112.148 -2.297 . . . . 0.40999999999999998 111.923 175.358 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.9 t80 -131.16 141.48 50.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 104.703 -2.332 . . . . 0.80000000000000004 104.703 170.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.785 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 62.5 tttt -108.81 163.53 13.19 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.349 -1.723 . . . . 2.6800000000000002 106.349 -172.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -7.81 -165.81 0.0 OUTLIER Glycine 0 C--O 1.196 -2.252 0 O-C-N 126.4 2.312 . . . . 1.6000000000000001 118.845 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 84' ' ' THR . 15.6 mtpp -44.24 -3.7 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 O-C-N 119.449 -2.207 . . . . 4.2999999999999998 116.271 -169.003 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.638 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.9 p-90 -171.2 -8.99 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 N-CA-C 115.295 1.591 . . . . 2.5099999999999998 115.295 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.785 ' HB ' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.83 159.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 123.222 1.487 . . . . 1.78 113.795 -159.277 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -112.48 106.11 14.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 111.817 -2.447 . . . . 2.73 113.084 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.948 HD11 ' HB3' ' A' ' 41' ' ' TRP . 4.6 mp -55.08 -36.32 65.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.086 0.773 . . . . 1.1299999999999999 113.086 -175.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -59.02 -20.85 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.763 -0.829 . . . . 1.71 108.763 -169.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.527 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 12.6 m -98.79 -41.9 7.44 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.058 -0.974 . . . . 1.76 112.088 178.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 10.7 mmmt -85.09 -37.39 20.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.952 -1.022 . . . . 1.9099999999999999 112.389 -166.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 59' ' ' LEU . 17.5 t -35.2 96.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 125.967 1.707 . . . . 1.1499999999999999 112.542 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.63 -138.98 3.08 Favored Glycine 0 C--N 1.3 -1.457 0 CA-C-N 111.316 -2.675 . . . . 0.69999999999999996 112.809 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -74.07 -8.37 55.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.973 0.731 . . . . 3.3599999999999999 112.973 -167.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.719 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 29.3 p80 -111.79 -37.52 5.12 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 120.618 -0.433 . . . . 1.78 110.985 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.907 HD12 HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -121.38 102.55 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.531 -1.655 . . . . 1.72 106.531 171.86 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -95.89 116.16 28.5 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.288 -1.375 . . . . 0.96999999999999997 107.288 168.119 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.702 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.24 93.28 7.21 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.965 -2.235 . . . . 1.0600000000000001 104.965 170.372 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 56.8 t60 -94.19 158.98 15.34 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 122.954 1.359 . . . . 2.5899999999999999 109.042 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.95 112.87 10.29 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 111.753 -2.476 . . . . 0.92000000000000004 110.605 -176.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.4 m -97.44 149.27 22.34 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 112.308 -2.224 . . . . 0.76000000000000001 108.577 174.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -141.98 97.63 3.17 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.08 0.943 . . . . 1.8 110.632 -170.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 6.0 t70 -116.76 128.0 54.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.766 -1.561 . . . . 2.4199999999999999 108.596 174.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.428 HH11 ' HH ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -99.86 -31.38 11.53 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.858 -1.519 . . . . 3.0800000000000001 111.021 -173.465 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.47 -19.88 60.22 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.385 -1.279 . . . . 1.6899999999999999 110.549 174.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 50.7 m -98.53 -20.47 17.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 107.821 -1.177 . . . . 1.96 107.821 174.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.652 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 69.15 32.24 3.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.13 -1.395 . . . . 3.7799999999999998 109.383 175.415 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.86 129.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.615 -0.72 . . . . 1.1299999999999999 109.776 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.665 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 4.9 m-85 -100.25 112.33 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.495 -1.668 . . . . 1.95 106.495 164.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 27.5 tp -95.27 106.32 18.35 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 122.09 0.948 . . . . 1.1799999999999999 109.075 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -86.95 112.34 21.71 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.511 -1.663 . . . . 0.40000000000000002 106.511 169.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.64 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 4.0 pt-20 -121.54 122.35 39.49 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.29 -1.323 . . . . 1.3200000000000001 110.557 -173.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.684 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -89.08 132.08 34.95 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.033 -1.44 . . . . 1.5900000000000001 108.45 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 19.8 m170 -115.03 97.01 5.97 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 103.798 -2.668 . . . . 2.0099999999999998 103.798 169.005 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 62.9 mt -121.55 101.3 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-O 122.985 1.374 . . . . 1.1899999999999999 109.775 -174.336 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.7 p -112.69 143.78 43.32 Favored 'General case' 0 N--CA 1.398 -3.045 0 CA-C-N 114.126 -1.397 . . . . 1.05 109.257 -178.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.77 86.05 0.12 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 111.183 -2.735 . . . . 2.1200000000000001 110.49 -177.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.91 125.17 28.59 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 112.713 -2.04 . . . . 1.0900000000000001 109.52 179.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.869 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 1.2 tp60 -61.84 134.33 94.05 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.281 -0.872 . . . . 1.77 108.978 175.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.658 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.1 Cg_endo -60.79 145.78 98.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.704 0.936 . . . . 1.3300000000000001 110.37 176.249 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.18 17.2 10.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.441 0.463 . . . . 1.6599999999999999 111.288 -173.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.869 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -73.1 -32.67 65.11 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.546 -0.539 . . . . 1.24 109.546 175.745 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m 13.12 78.35 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 125.379 1.675 . . . . 1.6799999999999999 111.137 -168.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -65.74 99.0 0.37 Allowed Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 112.112 -2.313 . . . . 2.0 113.877 -161.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.658 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.13 74.04 1.87 Allowed Glycine 0 C--N 1.289 -2.078 0 N-CA-C 109.181 -1.568 . . . . 0.81000000000000005 109.181 171.288 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.624 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 45.3 m-85 -81.01 120.1 24.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.071 -1.065 . . . . 1.0800000000000001 108.165 176.355 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 72.7 mtt180 -127.61 115.36 18.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.935 -0.478 . . . . 3.6899999999999999 111.034 -173.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.1 m -92.64 129.12 38.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.067 -0.515 . . . . 1.22 110.03 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.579 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 41.7 tt0 -126.8 113.22 16.33 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.606 -0.887 . . . . 1.8100000000000001 108.606 174.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.538 ' HB ' HG11 ' A' ' 39' ' ' VAL . 3.0 p -105.26 135.51 43.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.853 0.835 . . . . 1.24 110.655 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -129.45 109.2 10.87 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.856 -1.52 . . . . 1.6399999999999999 108.688 -176.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.605 HG21 ' HG3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -125.11 167.11 15.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 118.249 -0.882 . . . . 1.26 108.835 178.938 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.692 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -2.94 -62.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.618 1.824 . . . . 0.93999999999999995 114.571 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.692 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 12.9 t0 -150.63 -7.05 0.28 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.773 -1.103 . . . . 1.05 110.239 -176.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.97 ' HD2' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mttp -95.35 135.63 36.72 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.14 -1.024 . . . . 1.78 108.681 -177.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -132.9 142.2 48.78 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.403 -1.726 . . . . 1.0 110.735 -177.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -164.02 163.84 23.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.317 -0.856 . . . . 1.6000000000000001 108.972 173.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 p -153.31 148.67 27.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.244 0.545 . . . . 1.98 111.198 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.5 t -125.45 148.97 48.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.913 0.863 . . . . 1.02 111.71 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.24 114.28 11.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.671 -1.604 . . . . 1.5800000000000001 110.092 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.697 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 18.6 p90 -142.47 131.67 23.36 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.562 -0.533 . . . . 1.1000000000000001 109.562 -176.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.722 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 52.7 m-20 -109.04 135.24 50.52 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.154 0.978 . . . . 2.1099999999999999 111.324 -171.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -102.74 110.11 21.93 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.145 -1.389 . . . . 1.0900000000000001 109.434 176.811 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 13.3 m -90.85 97.87 11.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.381 0.61 . . . . 1.0700000000000001 109.391 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.5 p -82.13 115.67 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.987 1.375 . . . . 1.1399999999999999 109.288 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.469 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 94.6 m-70 -87.24 99.57 12.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.552 -2.113 . . . . 1.8200000000000001 109.538 -177.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 41.3 tt0 -75.12 -59.71 2.62 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.845 -1.525 . . . . 1.6699999999999999 109.803 173.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.33 17.42 0.48 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.343 -0.844 . . . . 2.98 109.46 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.172 -0.922 . . . . 7.3399999999999999 109.349 -175.274 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.638 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 6.0 p-10 . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 121.036 0.446 . . . . 1.9299999999999999 110.142 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.743 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-20 -94.81 166.13 15.71 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 123.16 0.584 . . . . 1.6499999999999999 112.45 -175.06 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' C ' HD13 ' A' ' 4' ' ' ILE . 24.8 Cg_exo -64.01 86.55 0.15 Allowed 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.195 2.597 . . . . 1.24 112.406 173.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.917 HG12 ' HD3' ' A' ' 94' ' ' LYS . 1.7 mp -119.59 -56.54 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.71 -1.132 . . . . 1.2 109.573 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.001 -1.64 . . . . 0.44 109.001 -175.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.879 HD21 ' HB3' ' A' ' 96' ' ' LYS . 7.7 tp -52.27 -37.78 56.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.309 -1.446 . . . . 1.1100000000000001 109.811 -176.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.777 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.06 84.11 5.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.04 -0.982 . . . . 0.97999999999999998 109.911 176.235 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.3 t -72.57 -43.2 63.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.264 -1.335 . . . . 1.1100000000000001 109.826 178.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.409 ' HB3' ' HG3' ' A' ' 27' ' ' ARG . 16.0 tpt -156.95 130.25 7.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.372 -0.831 . . . . 3.3100000000000001 109.56 174.199 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -102.8 136.42 19.29 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 115.185 -0.916 . . . . 4.1699999999999999 109.107 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.685 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.1 Cg_endo -74.14 160.53 42.46 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.323 1.349 . . . . 0.81999999999999995 110.897 176.644 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -117.13 -179.77 3.8 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.297 -0.631 . . . . 1.6299999999999999 109.297 -176.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 4.6 m-20 -69.99 -146.73 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 122.979 1.371 . . . . 2.0600000000000001 111.264 -175.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.65 133.53 1.65 Allowed Glycine 0 C--N 1.294 -1.799 0 CA-C-N 113.438 -1.71 . . . . 0.34999999999999998 111.5 -173.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' A' ' 107' ' ' HIS . 32.2 mt-10 -113.2 116.71 30.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.393 -0.904 . . . . 1.53 108.663 177.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -135.77 156.4 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.643 -1.244 . . . . 1.0800000000000001 107.643 -171.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 156.19 18.64 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.638 -1.165 . . . . 1.22 108.916 176.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' HB3' ' A' ' 81' ' ' PRO . 13.5 t -66.89 107.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 123.151 1.453 . . . . 1.3799999999999999 108.477 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.17 3.71 11.65 Favored Glycine 0 C--N 1.266 -3.323 0 CA-C-N 111.612 -2.54 . . . . 0.52000000000000002 112.463 178.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.86 -127.88 5.2 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 118.988 -1.577 . . . . 0.44 110.023 176.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 18.8 p -153.06 164.9 37.16 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 113.437 -1.381 . . . . 1.23 110.718 177.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.602 HG21 HD13 ' A' ' 104' ' ' LEU . 10.8 tp -147.05 149.67 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.401 -1.727 . . . . 1.0900000000000001 107.924 171.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -139.81 127.33 21.58 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 113.016 -1.902 . . . . 1.05 110.385 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.616 ' HB2' HD23 ' A' ' 74' ' ' LEU . 54.5 m-85 -121.92 147.31 46.18 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.607 -1.179 . . . . 0.71999999999999997 108.883 174.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -132.44 119.73 21.03 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.208 -0.905 . . . . 0.87 109.183 178.199 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.604 ' HB1' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.39 119.96 29.76 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.456 -1.247 . . . . 1.1000000000000001 110.805 -173.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' HD13 ' A' ' 71' ' ' LEU . 72.0 mtp180 -114.21 127.09 55.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.266 -0.425 . . . . 2.9300000000000002 110.774 -176.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 22.4 t -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-O 122.005 0.907 . . . . 1.0700000000000001 110.558 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.96 111.38 2.13 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.197 -1.819 . . . . 1.1200000000000001 110.566 174.172 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.81 -40.07 9.02 Favored Glycine 0 C--N 1.32 -0.336 0 CA-C-N 114.543 -1.208 . . . . 0.76000000000000001 111.548 170.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . 50.69 -156.01 0.12 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.869 0.868 . . . . 1.0 113.282 171.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.6 m -120.01 84.33 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.216 0.532 . . . . 2.1699999999999999 110.852 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' A' ' 93' ' ' THR . 1.8 tp -114.28 150.38 34.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.323 -0.992 . . . . 2.6299999999999999 108.323 173.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 33' ' ' LEU . 21.0 tp -44.24 -37.41 3.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.948 0.88 . . . . 1.99 111.292 178.107 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.788 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.36 178.41 1.7 Allowed Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.41 -1.268 . . . . 1.8799999999999999 108.121 177.193 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.0 Cg_exo -65.59 146.23 83.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.662 1.575 . . . . 1.1200000000000001 109.997 173.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HG3' HG23 ' A' ' 93' ' ' THR . 49.4 Cg_exo -45.57 140.76 8.63 Favored 'Trans proline' 0 CA--C 1.498 -1.297 0 C-N-CA 123.211 2.607 . . . . 0.81999999999999995 113.286 178.536 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 92' ' ' SER . 7.3 p -100.09 96.84 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.075 1.417 . . . . 1.4299999999999999 107.664 168.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.609 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -99.26 114.47 37.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 112.703 -2.044 . . . . 1.0900000000000001 106.923 170.308 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.924 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.6 127.27 53.5 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 114.027 -1.442 . . . . 2.1299999999999999 109.6 177.729 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 1.034 ' HB3' HD13 ' A' ' 49' ' ' LEU . 89.2 m95 -89.6 147.48 23.9 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.078 -2.328 . . . . 0.40999999999999998 111.792 173.149 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.658 ' HD2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 t80 -131.35 125.48 32.78 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.71 -1.589 . . . . 0.80000000000000004 106.71 172.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.717 ' HZ2' ' HG3' ' A' ' 52' ' ' LYS . 5.1 ttpm? -98.93 109.91 22.6 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.214 -1.402 . . . . 2.6800000000000002 107.214 -173.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.673 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -83.3 92.49 1.66 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 116.012 -2.994 . . . . 1.6000000000000001 114.797 -167.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.843 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -106.15 -53.52 2.62 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.61 -3.107 . . . . 4.2999999999999998 102.61 132.16 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.843 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 6.5 p-90 -167.38 -1.56 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 110.459 -3.064 . . . . 2.5099999999999998 111.476 178.416 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.5 HG12 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -94.67 170.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-O 123.144 1.45 . . . . 1.78 112.496 -159.7 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 7.3 t70 -106.22 150.0 26.31 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.675 -2.511 . . . . 2.73 106.07 173.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -88.17 -36.84 16.6 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.402 -0.519 . . . . 1.1299999999999999 110.902 176.106 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -59.97 -19.54 52.76 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.866 0.841 . . . . 1.71 109.011 -169.585 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -86.14 -28.78 23.76 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.571 -1.195 . . . . 1.76 111.094 -176.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.717 ' HG3' ' HZ2' ' A' ' 43' ' ' LYS . 2.4 mmmt -104.65 -71.4 0.74 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.03 -0.986 . . . . 1.9099999999999999 111.125 -172.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.808 HG22 ' O ' ' A' ' 49' ' ' LEU . 56.2 t 19.01 85.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 O-C-N 125.366 1.667 . . . . 1.1499999999999999 113.181 -177.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.74 -131.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 114.659 -1.155 . . . . 0.69999999999999996 113.639 -173.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -48.78 -53.87 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.909 1.077 . . . . 3.3599999999999999 113.909 -168.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.2 p80 -91.17 -38.09 12.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.837 -0.745 . . . . 1.78 111.498 -173.142 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.877 ' HB2' HG12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -124.0 108.81 12.78 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.809 -0.811 . . . . 1.72 108.809 175.443 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.43 115.61 27.72 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 106.343 -1.725 . . . . 0.96999999999999997 106.343 168.218 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.744 ' H ' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.05 92.7 6.97 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.961 -2.237 . . . . 1.0600000000000001 104.961 172.099 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.582 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 36.1 m170 -81.9 163.3 22.33 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.046 -1.434 . . . . 2.5899999999999999 109.994 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -139.21 114.8 9.9 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 112.328 -2.214 . . . . 0.92000000000000004 109.604 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 3.2 m -92.26 148.22 22.31 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.153 -1.84 . . . . 0.76000000000000001 106.516 169.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.46 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.2 t80 -144.75 98.96 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.211 1.005 . . . . 1.8 111.011 -170.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' A' ' 67' ' ' SER . 2.5 p30 -113.69 128.23 56.34 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.697 -1.592 . . . . 2.4199999999999999 110.342 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 5.1 mmm180 -105.95 29.03 7.03 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.705 -1.589 . . . . 3.0800000000000001 109.295 172.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.04 -30.17 6.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.195 -1.82 . . . . 1.6899999999999999 109.27 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 5.7 t -111.91 -8.47 14.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.89 -1.05 . . . . 1.96 108.939 178.016 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 72.48 31.68 1.72 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.547 -0.909 . . . . 3.7799999999999998 108.547 173.654 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.43 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 3.3 t -127.33 133.8 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 122.506 1.146 . . . . 1.1299999999999999 111.473 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' SER . 5.0 m-85 -101.96 113.39 26.57 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.26 -1.755 . . . . 1.95 106.26 162.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 14.7 tp -97.36 104.82 16.88 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 122.302 1.049 . . . . 1.1799999999999999 109.391 177.623 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.4 m-85 -88.64 114.58 25.4 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.833 -1.53 . . . . 0.40000000000000002 108.534 174.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.52 125.66 50.21 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 113.708 -1.587 . . . . 1.3200000000000001 109.566 -176.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.865 HD22 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -94.08 122.23 36.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.862 -1.162 . . . . 1.5900000000000001 107.862 171.701 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.646 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 11.4 m170 -115.79 93.83 4.43 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.967 -2.605 . . . . 2.0099999999999998 103.967 169.593 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.877 HG12 ' HB2' ' A' ' 57' ' ' LEU . 38.0 mt -121.78 100.79 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 122.883 1.325 . . . . 1.1899999999999999 110.026 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 72.4 p -103.02 154.61 19.07 Favored 'General case' 0 N--CA 1.391 -3.395 0 CA-C-N 114.057 -1.429 . . . . 1.05 109.051 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.89 84.26 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.115 -2.766 . . . . 2.1200000000000001 112.064 178.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.84 132.28 43.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 110.731 -2.94 . . . . 1.0900000000000001 112.252 -175.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.722 HE21 ' HD2' ' A' ' 81' ' ' PRO . 3.2 tp60 -54.01 125.62 49.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.402 -0.817 . . . . 1.77 109.323 170.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.722 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.4 Cg_endo -59.23 -7.19 4.67 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.738 2.959 . . . . 1.3300000000000001 114.03 -175.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.597 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.6 0.41 19.08 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.974 -0.29 . . . . 1.6599999999999999 111.569 -178.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.63 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.48 -58.09 9.57 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.642 0.258 . . . . 1.24 110.889 -172.601 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 34.2 m 38.64 66.2 0.55 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.592 -1.633 . . . . 1.6799999999999999 106.592 -155.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -62.72 84.77 0.04 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 CA-C-N 112.445 -2.162 . . . . 2.0 114.139 -161.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -86.72 82.78 1.62 Allowed Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.916 -1.673 . . . . 0.81000000000000005 108.916 175.307 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 18.1 m-85 -78.75 113.99 17.3 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.779 -1.211 . . . . 1.0800000000000001 107.998 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.658 ' HB2' ' HD2' ' A' ' 42' ' ' PHE . 7.4 mtp180 -104.02 105.95 16.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.267 0.556 . . . . 3.6899999999999999 109.854 -176.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.451 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.8 t -87.71 126.96 35.28 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.568 -0.742 . . . . 1.22 109.076 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.924 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 37.6 tt0 -136.03 110.37 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.222 -0.899 . . . . 1.8100000000000001 109.606 -175.572 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 39' ' ' VAL . 1.7 p -106.27 142.3 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.957 0.408 . . . . 1.24 111.046 -179.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.549 ' O ' HG12 ' A' ' 38' ' ' VAL . 20.7 t -132.13 108.28 9.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.919 -1.141 . . . . 1.6399999999999999 107.919 177.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.068 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -131.44 146.62 52.34 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 117.912 -1.042 . . . . 1.26 108.501 -178.639 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.917 ' HD3' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 32.74 -74.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.642 1.839 . . . . 0.93999999999999995 112.976 -177.558 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.784 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 22.2 t70 -147.69 -7.56 0.44 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.569 -1.196 . . . . 1.05 110.429 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.889 ' HD2' ' HB ' ' A' ' 4' ' ' ILE . 2.7 tttp -86.38 131.65 34.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.998 -1.112 . . . . 1.78 107.998 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -133.2 120.45 21.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.485 -1.689 . . . . 1.0 110.233 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -139.69 148.27 42.11 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.502 -1.226 . . . . 1.6000000000000001 109.338 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 43.8 m -140.0 149.17 42.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.371 -0.377 . . . . 1.98 110.303 -179.032 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.777 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 40.7 p -131.9 134.43 45.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 1.02 111.273 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.526 ' H ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -107.78 119.43 39.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 1.5800000000000001 110.096 177.356 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.757 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -142.27 118.56 10.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.137 -0.69 . . . . 1.1000000000000001 109.137 -179.105 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.525 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 3.7 p30 -106.43 154.6 20.58 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 123.034 1.397 . . . . 2.1099999999999999 111.876 -170.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -116.57 106.42 13.54 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.924 -1.944 . . . . 1.0900000000000001 110.456 178.517 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -87.43 95.86 10.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.334 -0.987 . . . . 1.0700000000000001 108.334 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 80' ' ' GLN . 7.2 p -83.37 120.23 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 122.876 1.322 . . . . 1.1399999999999999 108.54 -177.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 98.8 m-70 -93.81 98.31 10.99 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 112.892 -1.958 . . . . 1.8200000000000001 109.322 -176.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -75.54 -63.86 1.2 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.258 -1.337 . . . . 1.6699999999999999 109.665 171.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.7 126.3 35.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 2.98 110.384 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.604 -0.712 . . . . 7.3399999999999999 110.002 177.686 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.671 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.227 0.537 . . . . 1.9299999999999999 109.8 . . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 8.2 m-20 -91.47 169.74 10.82 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.318 -0.856 . . . . 1.6499999999999999 109.311 173.023 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.22 81.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.464 2.109 . . . . 1.24 111.596 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.558 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -102.0 -62.51 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 115.457 -0.792 . . . . 1.2 109.608 178.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.12 40.71 3.68 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.987 -1.645 . . . . 0.44 108.987 -176.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' A' ' 96' ' ' LYS . 9.7 tp -55.07 -33.62 62.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.42 -1.39 . . . . 1.1100000000000001 110.131 -172.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CZ ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -97.81 84.58 3.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.391 -1.277 . . . . 0.97999999999999998 109.608 176.847 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.65 -46.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.664 -1.153 . . . . 1.1100000000000001 110.374 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ttt -159.74 134.46 7.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.851 -1.068 . . . . 3.3100000000000001 108.567 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.817 ' HD2' ' CZ ' ' A' ' 7' ' ' PHE . 5.5 mmp_? -125.25 145.66 51.45 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 116.173 -0.467 . . . . 4.1699999999999999 111.077 -172.023 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.792 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -70.73 159.4 52.82 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.773 1.649 . . . . 0.81999999999999995 110.573 179.145 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -124.79 -176.81 3.64 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.04 -0.527 . . . . 1.6299999999999999 110.142 -173.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 3.7 p-10 -68.27 -152.34 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.732 0 CA-C-O 122.869 1.318 . . . . 2.0600000000000001 111.211 -177.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 153.17 139.1 2.81 Favored Glycine 0 C--N 1.287 -2.171 0 CA-C-N 113.044 -1.889 . . . . 0.34999999999999998 111.744 -173.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 21.2 mt-10 -115.07 114.96 26.05 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.297 -0.952 . . . . 1.53 109.055 175.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -136.4 158.32 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 N-CA-C 107.104 -1.443 . . . . 1.0800000000000001 107.104 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.04 157.74 18.24 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.83 -1.077 . . . . 1.22 109.548 -178.873 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 22.6 t -64.99 107.06 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 123.088 1.423 . . . . 1.3799999999999999 108.554 173.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 10.12 16.34 Favored Glycine 0 C--N 1.267 -3.284 0 CA-C-N 111.882 -2.417 . . . . 0.52000000000000002 113.041 175.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 -123.14 3.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 119.703 -1.237 . . . . 0.44 110.198 175.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.9 p -152.43 164.24 37.93 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 112.989 -1.605 . . . . 1.23 110.817 176.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 tp -148.29 150.96 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 113.609 -1.632 . . . . 1.0900000000000001 107.774 170.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.8 m -138.54 129.28 26.47 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 113.941 -1.481 . . . . 1.05 110.996 -176.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.682 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 87.7 m-85 -125.21 145.19 50.09 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.955 -1.475 . . . . 0.71999999999999997 109.089 178.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB3' HD13 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -137.43 124.86 21.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.943 -0.762 . . . . 0.87 108.943 174.352 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.663 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.85 114.4 19.81 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.741 -1.118 . . . . 1.1000000000000001 110.208 -176.252 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HG2' HD11 ' A' ' 71' ' ' LEU . 67.7 mtp180 -104.86 128.98 53.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.504 -0.316 . . . . 2.9300000000000002 110.267 -176.024 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.1 t -125.5 127.48 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.902 0.858 . . . . 1.0700000000000001 109.964 -177.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.11 108.82 1.33 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.961 -1.472 . . . . 1.1200000000000001 110.939 175.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.665 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.62 -54.92 11.95 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.76000000000000001 112.35 173.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 57.57 -166.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.275 0.843 . . . . 1.0 113.275 177.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -107.73 127.65 53.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.37 -0.832 . . . . 2.1699999999999999 109.037 172.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -123.41 -178.86 4.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.088 0.947 . . . . 2.6299999999999999 112.319 -168.665 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' H ' ' HB3' ' A' ' 94' ' ' LYS . 17.4 tp -88.29 -37.36 16.07 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.586 -1.643 . . . . 1.99 106.846 154.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.35 145.8 19.07 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.595 -1.184 . . . . 1.8799999999999999 110.895 171.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.82 148.48 12.42 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.348 2.699 . . . . 1.1200000000000001 112.27 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.595 ' HA ' HG22 ' A' ' 93' ' ' THR . 6.3 Cg_endo -55.21 132.26 51.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.091 1.861 . . . . 0.81999999999999995 113.572 -175.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.13 106.28 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.277 -1.749 . . . . 1.4299999999999999 106.277 174.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -115.08 114.31 46.1 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 113.703 -1.589 . . . . 1.0900000000000001 108.03 179.082 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.774 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.84 128.72 45.91 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 123.066 1.413 . . . . 2.1299999999999999 109.19 172.906 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.981 ' HB3' HD12 ' A' ' 49' ' ' LEU . 60.0 m95 -87.89 153.54 21.23 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 112.061 -2.336 . . . . 0.40999999999999998 110.709 172.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -135.01 125.23 26.15 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.202 -2.147 . . . . 0.80000000000000004 105.202 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HB3' HG11 ' A' ' 47' ' ' VAL . 27.1 tttt -104.09 99.57 9.31 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.38 -1.711 . . . . 2.6800000000000002 106.38 -175.481 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.676 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -86.45 95.14 2.01 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 115.882 -3.056 . . . . 1.6000000000000001 117.078 -154.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.926 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -101.69 -48.17 4.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.007 -2.59 . . . . 4.2999999999999998 104.007 135.322 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.926 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 11.6 p-90 -170.41 1.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 112.676 -2.056 . . . . 2.5099999999999998 111.915 175.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -97.35 169.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 C-N-CA 125.275 1.43 . . . . 1.78 113.171 -159.427 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.532 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 m-20 -100.95 147.45 26.15 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 112.456 -2.156 . . . . 2.73 107.527 173.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.981 HD12 ' HB3' ' A' ' 41' ' ' TRP . 5.3 mp -79.21 -29.25 42.72 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.678 -0.409 . . . . 1.1299999999999999 110.639 173.383 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -57.36 -20.93 32.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 1.71 109.608 -167.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.475 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -97.59 -27.85 14.21 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 119.78 -0.768 . . . . 1.76 111.79 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 57' ' ' LEU . 5.9 mmmt -95.68 -33.37 12.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.392 -0.822 . . . . 1.9099999999999999 111.319 -171.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 49' ' ' LEU . 53.8 t -40.79 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 126.02 1.728 . . . . 1.1499999999999999 111.908 175.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.89 -103.2 0.19 Allowed Glycine 0 C--N 1.302 -1.353 0 CA-C-N 112.427 -2.17 . . . . 0.69999999999999996 113.42 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.11 -54.68 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.118 0.784 . . . . 3.3599999999999999 113.118 -169.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -96.05 -29.37 14.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.487 0.661 . . . . 1.78 111.189 -174.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.918 HD23 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.12 106.05 13.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.541 -1.651 . . . . 1.72 106.541 173.494 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -104.68 118.28 36.18 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.074 -1.454 . . . . 0.96999999999999997 107.074 167.119 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.641 ' H ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -98.96 92.83 5.7 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.211 -2.144 . . . . 1.0600000000000001 105.211 172.073 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.674 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.2 m170 -91.31 162.91 14.41 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.161 -1.381 . . . . 2.5899999999999999 110.21 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.45 122.95 20.83 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 112.348 -2.205 . . . . 0.92000000000000004 110.145 176.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -97.0 148.54 22.87 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 111.367 -2.651 . . . . 0.76000000000000001 108.559 176.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 37.3 t80 -127.78 99.83 5.7 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.352 1.072 . . . . 1.8 111.563 -170.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.822 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 3.2 m-20 -113.44 103.96 11.8 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.036 -1.893 . . . . 2.4199999999999999 109.285 172.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.46 ' HD3' ' HZ3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -85.9 -42.1 14.38 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.054 -0.521 . . . . 3.0800000000000001 110.26 174.495 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.38 61.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.295 -0.866 . . . . 1.6899999999999999 110.637 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.822 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 9.4 m -99.67 -16.3 18.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.8 -1.185 . . . . 1.96 107.8 175.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.577 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 68.24 31.62 5.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.362 -1.29 . . . . 3.7799999999999998 110.001 172.523 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 2.6 t -129.97 122.54 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-N 115.48 -0.782 . . . . 1.1299999999999999 110.175 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.665 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 46.2 m-85 -95.92 113.22 24.83 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.026 -1.472 . . . . 1.95 107.026 164.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 25' ' ' SER . 22.6 tp -97.47 105.02 17.1 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.106 0.955 . . . . 1.1799999999999999 108.78 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.0 m-85 -86.19 111.65 20.59 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.262 -1.755 . . . . 0.40000000000000002 106.262 170.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.674 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -116.57 129.52 56.22 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 114.348 -1.296 . . . . 1.3200000000000001 110.344 -174.833 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.742 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.5 mt -92.29 135.92 33.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 113.789 -1.551 . . . . 1.5900000000000001 108.635 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -120.09 97.32 5.54 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 103.915 -2.624 . . . . 2.0099999999999998 103.915 165.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.742 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -125.48 100.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 122.982 1.372 . . . . 1.1899999999999999 109.153 -175.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 40.7 p -97.6 165.12 12.13 Favored 'General case' 0 N--CA 1.381 -3.886 0 CA-C-N 114.004 -1.453 . . . . 1.05 107.866 178.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.4 84.27 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 111.404 -2.635 . . . . 2.1200000000000001 112.755 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -76.66 132.69 39.53 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 111.574 -2.557 . . . . 1.0900000000000001 108.383 176.084 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.553 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 1.1 pt20 -93.63 152.02 40.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.616 -0.883 . . . . 1.77 108.616 -178.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.478 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 36.8 Cg_endo -63.92 -16.84 57.15 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.75 2.3 . . . . 1.3300000000000001 113.403 -167.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.616 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -92.04 13.06 19.87 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.961 -0.563 . . . . 1.6599999999999999 111.68 -176.576 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.577 ' CD1' ' HD2' ' A' ' 45' ' ' LYS . 15.9 m-30 -89.09 -61.17 1.76 Allowed 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.258 -0.577 . . . . 1.24 110.52 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.3 m 36.7 63.16 0.69 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.027 -1.471 . . . . 1.6799999999999999 107.027 -158.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.676 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -67.21 90.94 0.19 Allowed Glycine 0 CA--C 1.481 -2.055 0 CA-C-N 111.978 -2.374 . . . . 2.0 113.782 -160.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -84.72 82.04 1.71 Allowed Glycine 0 C--N 1.277 -2.715 0 N-CA-C 107.933 -2.067 . . . . 0.81000000000000005 107.933 168.302 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 8.3 m-85 -74.71 134.33 41.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.653 -1.274 . . . . 1.0800000000000001 108.088 179.283 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -126.44 138.12 53.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.92 -0.4 . . . . 3.6899999999999999 109.92 -178.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.674 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 4.3 m -112.09 116.42 30.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.415 -0.957 . . . . 1.22 108.415 168.065 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.774 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 64.5 mt-10 -110.19 102.07 10.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.544 -1.28 . . . . 1.8100000000000001 107.544 176.302 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.7 p -99.19 135.92 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.752 0.787 . . . . 1.24 111.36 -173.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.6 t -130.07 108.89 10.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.891 -1.504 . . . . 1.6399999999999999 107.862 -179.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.5 m -130.3 158.47 39.7 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.8 -1.095 . . . . 1.26 108.054 179.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.685 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 10.96 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 125.819 1.949 . . . . 0.93999999999999995 114.342 -177.489 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.685 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -146.18 -3.16 0.67 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.923 -1.035 . . . . 1.05 110.193 -176.694 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.671 ' HE3' ' HB3' ' A' ' 1' ' ' ASP . 4.5 mmtp -95.39 129.63 42.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.612 -0.884 . . . . 1.78 108.612 -177.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -131.7 128.63 39.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.81 -1.087 . . . . 1.0 112.341 -178.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.7 160.47 43.82 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.46 -1.245 . . . . 1.6000000000000001 109.95 175.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -140.95 145.86 36.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.624 0.25 . . . . 1.98 110.487 176.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.849 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 89.2 p -126.8 135.53 51.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.542 -0.299 . . . . 1.02 110.915 -175.645 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.33 128.49 51.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.378 0.609 . . . . 1.5800000000000001 111.05 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.849 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 0.1 OUTLIER -143.08 119.0 10.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.6 -0.727 . . . . 1.1000000000000001 109.694 -177.143 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -104.32 129.58 52.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.423 1.106 . . . . 2.1099999999999999 113.114 -170.007 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -102.75 111.98 24.55 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.526 -1.67 . . . . 1.0900000000000001 109.733 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.5 m -90.62 98.38 11.74 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.977 -0.749 . . . . 1.0700000000000001 108.977 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 80' ' ' GLN . 5.6 p -81.9 115.02 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-O 122.967 1.365 . . . . 1.1399999999999999 109.399 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.7 m170 -83.14 99.79 10.13 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.71 -2.041 . . . . 1.8200000000000001 110.05 -176.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 3.0 tm-20 -78.48 -56.53 4.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.307 -1.315 . . . . 1.6699999999999999 109.101 170.115 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 139.87 39.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.134 -0.939 . . . . 2.98 110.772 -178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.664 -0.698 . . . . 7.3399999999999999 109.848 178.908 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 6.6 p-10 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.98 0.895 . . . . 1.9299999999999999 110.217 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.831 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 4.5 t70 -111.84 152.31 44.1 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.293 -1.321 . . . . 1.6499999999999999 108.625 -178.746 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 3.0 Cg_endo -46.59 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.385 3.39 . . . . 1.24 113.954 179.013 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.665 HD13 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -123.29 -65.18 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.97 -1.014 . . . . 1.2 109.124 175.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.503 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 90.05 47.74 3.79 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 108.131 -1.987 . . . . 0.44 108.131 -174.167 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 4' ' ' ILE . 8.7 tp -58.12 -41.49 83.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.783 -1.709 . . . . 1.1100000000000001 110.346 -167.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.814 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.02 85.67 6.01 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.887 0.851 . . . . 0.97999999999999998 109.772 174.796 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.08 -40.02 85.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.774 -1.557 . . . . 1.1100000000000001 110.078 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.459 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 57.3 ttm -153.42 134.58 14.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 3.3100000000000001 110.19 176.37 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.658 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 6.8 mtm180 -91.91 139.35 24.58 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 107.905 -1.146 . . . . 4.1699999999999999 107.905 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 40.2 Cg_endo -78.64 -163.85 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.981 2.454 . . . . 0.81999999999999995 113.509 -175.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -127.26 131.29 50.58 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.745 -0.661 . . . . 1.6299999999999999 111.405 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.577 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 8.4 m-20 -43.91 -98.99 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.668 1.587 . . . . 2.0600000000000001 113.162 -176.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.3 145.93 4.36 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-O 121.769 0.649 . . . . 0.34999999999999998 111.758 169.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.5 112.1 10.0 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.966 -0.617 . . . . 1.53 109.707 170.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 22' ' ' ILE . 10.4 m -138.87 165.87 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.093 -1.077 . . . . 1.0800000000000001 108.093 -172.174 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.94 157.38 15.92 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.932 -1.031 . . . . 1.22 109.288 178.074 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.515 ' CG1' ' HD3' ' A' ' 81' ' ' PRO . 59.5 t -64.77 106.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 122.96 1.362 . . . . 1.3799999999999999 109.583 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.7 10.68 14.14 Favored Glycine 0 C--N 1.272 -2.995 0 CA-C-N 112.105 -2.316 . . . . 0.52000000000000002 113.561 171.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.35 -122.15 3.56 Favored Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 118.615 -1.755 . . . . 0.44 110.457 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 5.7 p -151.03 165.05 34.97 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 112.716 -1.742 . . . . 1.23 110.302 177.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.627 HG22 HD11 ' A' ' 104' ' ' LEU . 8.3 tp -147.98 150.2 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 113.665 -1.607 . . . . 1.0900000000000001 106.837 172.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -138.55 132.8 31.68 Favored 'General case' 0 C--N 1.263 -3.184 0 CA-C-N 114.672 -1.149 . . . . 1.05 110.623 -174.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.779 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 18.6 m-85 -128.38 137.71 52.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.228 -1.351 . . . . 0.71999999999999997 109.98 -175.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.408 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.79 124.3 16.85 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.985 0.898 . . . . 0.87 111.262 172.694 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' HB2' ' HZ2' ' A' ' 41' ' ' TRP . . . -122.94 129.26 51.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.011 -1.449 . . . . 1.1000000000000001 110.328 -178.321 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.459 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 54.2 mtt180 -107.31 126.39 52.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.404 -0.362 . . . . 2.9300000000000002 111.688 -174.849 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 20.1 t -128.37 131.87 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.93 0.871 . . . . 1.0700000000000001 110.137 -177.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.96 118.1 9.27 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.614 -1.63 . . . . 1.1200000000000001 111.439 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.78 -33.66 56.04 Favored Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.579 -1.192 . . . . 0.76000000000000001 110.868 168.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 59.58 -164.19 0.22 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.735 1.383 . . . . 1.0 114.735 162.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -113.48 118.4 34.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.01 -1.45 . . . . 2.1699999999999999 107.446 170.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.72 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.61 166.03 33.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.436 0.532 . . . . 2.6299999999999999 112.436 -165.564 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 35' ' ' LYS . 1.8 mt -81.86 -30.36 32.08 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.576 1.179 . . . . 1.99 109.528 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -150.6 139.36 12.95 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 112.673 -2.058 . . . . 1.8799999999999999 108.661 -166.81 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -47.4 141.87 13.61 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.571 2.181 . . . . 1.1200000000000001 111.397 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.72 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_exo -63.0 130.16 28.22 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.297 1.331 . . . . 0.81999999999999995 111.536 -175.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.13 104.11 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.052 -1.462 . . . . 1.4299999999999999 107.052 179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.1 t -107.69 113.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 113.444 -1.707 . . . . 1.0900000000000001 107.387 176.236 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.753 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -98.42 119.0 36.36 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 122.95 1.357 . . . . 2.1299999999999999 110.062 176.029 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.672 ' HB3' HD23 ' A' ' 49' ' ' LEU . 46.5 m95 -86.61 139.26 30.98 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 112.079 -2.328 . . . . 0.40999999999999998 110.662 175.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 58.1 t80 -117.55 153.75 32.68 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.166 -1.42 . . . . 0.80000000000000004 107.166 170.775 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.98 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 22.9 tptt -106.6 165.57 11.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.601 -0.888 . . . . 2.6800000000000002 108.601 -172.176 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 1.039 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -25.14 168.47 0.0 OUTLIER Glycine 0 C--O 1.204 -1.76 0 O-C-N 124.348 1.03 . . . . 1.6000000000000001 114.749 169.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.921 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 ptmt -39.86 0.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 119.763 3.245 . . . . 4.2999999999999998 119.763 -140.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.921 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -162.6 -15.54 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.96 1.255 . . . . 2.5099999999999998 113.594 -179.413 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.698 HG12 ' CZ3' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -94.62 166.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.812 0 CA-C-O 122.816 1.293 . . . . 1.78 110.114 -164.687 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.699 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 3.0 p-10 -113.65 154.81 26.61 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 112.489 -2.141 . . . . 2.73 108.867 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.98 ' CD1' ' HB2' ' A' ' 43' ' ' LYS . 5.3 mp -92.35 -23.73 19.14 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.163 0.431 . . . . 1.1299999999999999 112.163 169.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 t -61.06 -21.58 63.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.883 -0.784 . . . . 1.71 108.883 -168.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.587 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 22.1 m -101.35 -41.59 6.62 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.315 1.055 . . . . 1.76 110.457 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.699 ' HD3' ' O ' ' A' ' 48' ' ' ASP . 3.7 mptp? -73.74 -75.58 0.15 Allowed 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 113.398 -1.728 . . . . 1.9099999999999999 111.821 -168.201 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.755 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 25.2 t 7.66 87.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 126.189 2.181 . . . . 1.1499999999999999 113.908 175.117 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.64 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -155.5 -131.54 1.45 Allowed Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.824 -1.989 . . . . 0.69999999999999996 111.693 179.068 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -42.35 93.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.246 0.832 . . . . 3.3599999999999999 113.246 -169.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.9 p80 -92.98 -38.11 11.84 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.548 -0.461 . . . . 1.78 112.075 -175.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.12 105.73 10.88 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.353 -1.351 . . . . 1.72 107.353 175.526 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -99.43 113.14 25.32 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.831 -1.544 . . . . 0.96999999999999997 106.831 164.656 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.943 ' HB2' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -93.0 94.45 8.9 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 103.538 -2.764 . . . . 1.0600000000000001 103.538 168.515 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.518 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 41.4 m-70 -96.38 164.67 12.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 123.259 1.504 . . . . 2.5899999999999999 111.344 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.43 120.93 17.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 110.847 -2.888 . . . . 0.92000000000000004 108.498 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.28 116.06 25.47 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.41 -1.723 . . . . 0.76000000000000001 109.933 172.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -121.23 106.91 11.94 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.935 -1.03 . . . . 1.8 110.843 -169.843 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -106.14 102.16 11.6 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.67 -1.15 . . . . 2.4199999999999999 109.252 172.318 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.79 -30.26 70.42 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.197 -1.365 . . . . 3.0800000000000001 111.352 -174.051 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.14 -12.32 60.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.763 -0.653 . . . . 1.6899999999999999 110.659 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.429 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 14.7 m -101.33 -15.85 17.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.935 -1.135 . . . . 1.96 107.935 173.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER 68.62 31.17 4.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.565 -1.198 . . . . 3.7799999999999998 109.822 179.192 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -132.91 134.3 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.661 0.743 . . . . 1.1299999999999999 110.329 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.482 ' CD2' ' HB2' ' A' ' 63' ' ' TYR . 3.0 m-85 -104.24 111.52 24.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.311 -1.737 . . . . 1.95 106.311 162.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 25' ' ' SER . 29.2 tp -94.41 104.98 16.95 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.668 -1.234 . . . . 1.1799999999999999 107.668 175.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 83.0 m-85 -86.81 113.81 22.94 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 106.642 -1.614 . . . . 0.40000000000000002 106.642 171.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.95 121.94 36.63 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 113.724 -1.58 . . . . 1.3200000000000001 110.172 -173.568 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.909 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -92.11 132.97 36.19 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.758 -1.564 . . . . 1.5900000000000001 108.399 179.114 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.37 98.62 7.03 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 103.603 -2.74 . . . . 2.0099999999999998 103.603 167.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.721 HG13 ' HB3' ' A' ' 74' ' ' LEU . 8.5 mt -124.55 100.24 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-O 122.97 1.367 . . . . 1.1899999999999999 109.282 -174.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 77.3 p -102.25 166.07 10.78 Favored 'General case' 0 N--CA 1.384 -3.736 0 CA-C-N 114.101 -1.409 . . . . 1.05 108.5 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.44 76.17 0.18 Allowed 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 111.454 -2.612 . . . . 2.1200000000000001 111.318 176.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.79 108.11 9.58 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.9 -1.955 . . . . 1.0900000000000001 110.694 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.447 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -54.23 143.43 44.8 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 1.77 109.948 167.612 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.515 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 23.4 Cg_endo -61.12 -8.39 9.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.105 2.536 . . . . 1.3300000000000001 113.25 -179.125 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.43 12.05 30.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.33 -0.395 . . . . 1.6599999999999999 110.992 178.262 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -97.56 -3.81 38.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 118.102 -0.952 . . . . 1.24 111.08 -178.296 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.1 m -18.17 93.99 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.453 1.721 . . . . 1.6799999999999999 111.291 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.84 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -40.51 114.51 0.53 Allowed Glycine 0 CA--C 1.465 -3.093 0 CA-C-N 109.626 -3.443 . . . . 2.0 114.24 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 1.039 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -131.68 60.69 0.67 Allowed Glycine 0 N--CA 1.405 -3.411 0 CA-C-N 111.394 -2.403 . . . . 0.81000000000000005 108.941 159.544 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.799 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 31.2 m-85 -77.79 108.0 10.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.863 -1.162 . . . . 1.0800000000000001 107.863 178.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.413 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 16.0 tpt180 -106.21 112.49 25.54 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.258 0.552 . . . . 3.6899999999999999 110.616 -175.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 38.0 m -99.7 118.23 35.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.66 -0.7 . . . . 1.22 110.241 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.753 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 76.0 mt-10 -129.18 116.56 19.39 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.711 -0.477 . . . . 1.8100000000000001 109.711 175.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 p -95.41 139.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.517 0.675 . . . . 1.24 110.141 177.084 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.8 m -134.41 108.5 8.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.862 -1.063 . . . . 1.6399999999999999 108.271 -176.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.7 HG21 ' H ' ' A' ' 94' ' ' LYS . 1.1 m -131.26 -176.75 4.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.412 -0.813 . . . . 1.26 109.92 -176.056 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.933 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -10.41 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 125.04 1.462 . . . . 0.93999999999999995 114.688 -177.343 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.933 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.8 t70 -159.33 0.74 0.08 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.522 -1.217 . . . . 1.05 109.338 -175.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.588 ' HB3' HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -100.95 145.21 28.95 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.223 1.011 . . . . 1.78 109.718 -177.769 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -134.77 136.8 42.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.653 -2.067 . . . . 1.0 110.315 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.579 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 m-20 -155.09 154.66 32.75 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.048 -0.978 . . . . 1.6000000000000001 108.623 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 9.2 p -155.8 154.45 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.296 0.48 . . . . 1.98 112.296 -175.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.814 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 79.9 p -132.01 147.79 52.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.86 -0.609 . . . . 1.02 112.367 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.16 144.76 26.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.326 -0.852 . . . . 1.5800000000000001 110.606 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.779 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 7.6 m-85 -137.73 103.51 5.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.558 -0.746 . . . . 1.1000000000000001 110.318 172.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.77 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -105.67 110.55 22.9 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 118.743 -1.183 . . . . 2.1099999999999999 112.363 170.414 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.84 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -98.02 106.98 19.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.146 -1.388 . . . . 1.0900000000000001 109.755 -179.265 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -83.77 96.65 8.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.512 -0.551 . . . . 1.0700000000000001 109.512 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 18' ' ' VAL . 3.4 p -80.65 112.45 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.875 1.321 . . . . 1.1399999999999999 109.118 177.34 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.642 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.0 m170 -80.44 99.74 8.14 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.027 -1.897 . . . . 1.8200000000000001 110.656 -176.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.489 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 32.3 tt0 -74.34 125.33 28.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.452 -1.249 . . . . 1.6699999999999999 110.244 172.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.19 -61.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.185 -0.461 . . . . 2.98 110.56 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.664 -0.684 . . . . 7.3399999999999999 110.865 179.761 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 119.985 -0.055 . . . . 1.65 111.003 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.28 69.98 2.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.916 2.411 . . . . 0.97 112.374 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.652 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -92.88 -54.61 7.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.013 -0.994 . . . . 0.5 109.323 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.23 6.24 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.798 -2.121 . . . . 0.39 107.798 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.957 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -53.34 -36.57 61.46 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 112.78 -1.71 . . . . 0.33 110.575 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.565 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -94.82 85.29 4.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.367 -0.833 . . . . 0.72 109.642 172.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.88 -49.02 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.6 -1.182 . . . . 0.63 109.719 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.0 tpt -143.74 133.73 24.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 2.88 108.912 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 20.7 ptt180 -103.86 132.84 20.65 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.107 -0.497 . . . . 3.67 111.405 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.1 Cg_endo -64.34 151.63 84.69 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.683 2.255 . . . . 0.64 111.328 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.8 mm-40 -121.13 176.54 5.54 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.042 -0.527 . . . . 1.43 110.452 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.23 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.524 1.154 . . . . 2.06 111.586 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.27 135.61 2.0 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.11 -1.405 . . . . 0.3 111.953 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 44.8 mt-10 -114.01 115.05 27.0 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.332 -0.934 . . . . 1.53 108.943 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -136.07 163.23 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 N-CA-C 107.645 -1.242 . . . . 0.27 107.645 -173.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.44 152.36 19.14 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.866 -1.061 . . . . 0.77 108.925 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.727 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -73.3 106.6 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 123.897 1.808 . . . . 0.78 109.419 172.387 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.59 -3.93 5.44 Favored Glycine 0 C--N 1.274 -2.873 0 CA-C-N 110.331 -3.122 . . . . 0.48 111.196 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.13 -127.5 5.94 Favored Glycine 0 N--CA 1.411 -2.988 0 C-N-CA 119.24 -1.457 . . . . 0.44 110.217 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.5 p -150.85 170.08 20.14 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.0 -1.6 . . . . 0.82 110.76 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 HD13 ' A' ' 104' ' ' LEU . 8.7 tp -147.16 149.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 113.592 -1.64 . . . . 0.32 108.065 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 m -138.87 128.51 24.71 Favored 'General case' 0 C--N 1.268 -2.973 0 CA-C-N 113.503 -1.681 . . . . 0.31 110.73 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' HB2' ' CG ' ' A' ' 74' ' ' LEU . 45.2 m-85 -125.19 152.69 44.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.182 -1.372 . . . . 0.53 108.44 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.51 125.98 18.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.214 -0.662 . . . . 0.58 109.214 175.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.11 121.03 36.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.161 -0.927 . . . . 0.32 110.367 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 56.3 mtp180 -108.02 117.08 33.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.353 -0.385 . . . . 2.43 110.021 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.564 HG21 HG21 ' A' ' 39' ' ' VAL . 23.6 t -120.87 130.53 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.286 1.041 . . . . 0.26 110.436 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.879 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -60.96 109.12 0.98 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.286 -1.779 . . . . 0.4 113.696 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.56 3.04 Favored Glycine 0 N--CA 1.462 0.401 0 CA-C-N 114.728 -1.123 . . . . 0.76 113.091 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HB2' ' CE ' ' A' ' 68' ' ' LYS . . . -50.68 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 114.669 1.359 . . . . 0.71 114.669 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -81.58 127.59 33.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.481 -1.236 . . . . 1.74 108.361 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.835 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -157.12 177.79 11.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.168 -0.469 . . . . 2.16 111.179 -172.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.83 -51.09 71.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.45 0.643 . . . . 1.47 109.287 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.47 149.41 26.29 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.785 -1.098 . . . . 1.4 108.718 171.09 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -43.01 143.9 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.524 2.816 . . . . 0.88 112.651 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.835 ' HD3' HD11 ' A' ' 33' ' ' LEU . 2.0 Cg_endo -48.7 133.03 26.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.715 1.61 . . . . 0.53 113.25 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.1 105.99 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 106.54 -1.652 . . . . 0.77 106.54 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.659 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.27 114.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 CA-C-N 113.655 -1.611 . . . . 0.28 107.962 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.5 127.3 49.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 123.456 1.598 . . . . 1.54 110.096 173.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.997 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -87.04 155.47 20.14 Favored 'General case' 0 C--N 1.273 -2.724 0 CA-C-N 111.178 -2.737 . . . . 0.34 112.05 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.521 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 35.5 t80 -134.26 135.94 43.25 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 104.173 -2.528 . . . . 0.62 104.173 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.929 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 50.8 tttm -98.43 171.85 7.9 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.023 -1.843 . . . . 2.17 106.023 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.984 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -15.43 -172.48 0.0 OUTLIER Glycine 0 C--O 1.178 -3.358 0 N-CA-C 119.117 2.407 . . . . 1.23 119.117 172.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -42.62 -8.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.169 2.285 . . . . 3.87 117.169 -162.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.538 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.1 p-90 -162.09 -6.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.012 1.115 . . . . 2.11 114.012 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.929 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.5 163.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.769 0 CA-C-O 123.712 1.72 . . . . 1.29 112.565 -161.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.682 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.6 p-10 -109.94 157.65 19.04 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.987 -2.824 . . . . 2.73 105.925 170.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.044 HD23 HD21 ' A' ' 57' ' ' LEU . 5.6 mp -99.34 -30.11 12.4 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.294 -0.562 . . . . 0.44 112.185 168.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.2 t -56.9 -21.63 31.21 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.038 0.535 . . . . 1.23 109.733 -164.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -99.9 -36.12 9.51 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.86 0.838 . . . . 1.34 111.503 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.682 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -87.68 -31.85 19.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.406 -1.27 . . . . 1.4 111.319 -167.112 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.751 HG13 ' H ' ' A' ' 59' ' ' LEU . 52.4 t -36.43 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.37 111.215 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.59 -93.71 0.1 OUTLIER Glycine 0 C--N 1.298 -1.536 0 CA-C-N 112.701 -2.045 . . . . 0.7 113.812 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -94.15 -44.84 7.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.578 0.584 . . . . 2.75 112.578 -168.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.585 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 19.6 p80 -95.76 -36.21 11.25 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.339 0.59 . . . . 1.33 110.731 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.044 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -115.55 106.38 13.87 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.1 -1.815 . . . . 1.11 106.1 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -100.76 115.19 29.71 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 106.75 -1.574 . . . . 0.76 106.75 166.275 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.751 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -100.42 92.26 5.08 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.742 -2.318 . . . . 0.26 104.742 172.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.701 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 44.0 m170 -86.09 163.82 17.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.096 -1.411 . . . . 2.03 110.916 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.17 115.74 16.76 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.847 -1.979 . . . . 0.92 109.649 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -98.11 149.3 22.65 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 112.759 -2.019 . . . . 0.47 107.839 170.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.86 99.04 3.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.48 1.133 . . . . 1.39 110.961 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.7 m-20 -110.26 107.19 16.87 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 112.904 -1.953 . . . . 2.42 108.954 176.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -45.94 61.35 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.604 -0.725 . . . . 2.46 110.333 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.34 -30.33 71.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.745 -1.116 . . . . 1.15 110.984 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 19.5 m -89.49 -19.35 25.18 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.977 -0.749 . . . . 1.41 108.977 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.879 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 2.2 ttpm? 61.92 41.05 11.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.078 -0.965 . . . . 3.31 108.399 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 21.9 t -133.27 124.92 50.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.875 -1.057 . . . . 0.43 111.139 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.3 m-30 -97.81 106.06 18.3 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.992 -1.855 . . . . 1.24 105.992 163.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 7.9 tp -95.07 105.27 17.18 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 122.622 1.201 . . . . 0.52 108.984 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.701 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.9 m-85 -85.66 114.7 22.84 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.469 -1.696 . . . . 0.33 108.289 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 30.5 mt-10 -96.48 134.54 39.53 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.461 -1.7 . . . . 1.32 108.628 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.891 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -106.75 111.36 23.85 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.564 -1.273 . . . . 0.96 107.564 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -108.7 94.24 4.95 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 103.403 -2.814 . . . . 1.15 103.403 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.603 HG12 HD23 ' A' ' 57' ' ' LEU . 57.5 mt -120.77 100.89 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.698 1.237 . . . . 0.52 109.214 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 21' ' ' SER . 60.1 p -100.58 165.9 11.18 Favored 'General case' 0 N--CA 1.391 -3.425 0 CA-C-N 114.355 -1.293 . . . . 0.58 109.364 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 50.68 73.5 0.28 Allowed 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 110.848 -2.887 . . . . 2.12 111.722 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -73.71 112.32 9.7 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 113.004 -1.907 . . . . 0.4 110.017 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.863 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 3.4 tp60 -56.38 146.62 52.44 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 1.43 110.029 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.727 ' HD3' HG21 ' A' ' 18' ' ' VAL . 19.9 Cg_endo -61.15 -13.89 30.58 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.554 2.17 . . . . 1.33 112.742 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.863 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -104.4 17.24 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.031 -0.531 . . . . 1.12 110.45 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.6 OUTLIER -95.31 -11.29 28.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.393 -0.813 . . . . 1.24 111.005 -177.237 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m -17.97 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 125.668 1.855 . . . . 1.22 111.74 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.984 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -56.9 120.51 20.97 Favored Glycine 0 N--CA 1.404 -3.441 0 CA-C-N 110.633 -2.985 . . . . 1.43 114.876 -167.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.691 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -115.5 72.31 0.25 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 112.359 -1.92 . . . . 0.52 108.556 152.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.72 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 56.0 m-85 -77.04 118.38 19.54 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.728 -0.842 . . . . 0.63 108.728 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 29.4 mtp180 -114.38 125.08 53.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.212 -0.662 . . . . 3.15 109.212 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 2.9 t -112.6 117.52 32.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.899 -0.778 . . . . 1.08 108.899 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 36.0 mt-10 -132.4 104.02 6.5 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.179 -0.919 . . . . 1.81 110.115 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.659 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -94.04 142.53 13.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.418 0.628 . . . . 0.54 110.267 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.7 t -134.83 108.18 7.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.914 -1.039 . . . . 1.18 108.337 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -132.35 153.18 51.0 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.958 -1.02 . . . . 0.74 108.649 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.758 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 23.2 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.691 1.87 . . . . 0.65 113.999 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.758 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 16.6 t70 -144.17 -3.78 0.84 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.829 -1.078 . . . . 1.05 109.802 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.957 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.32 135.04 33.92 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.148 -1.056 . . . . 1.29 108.148 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.504 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 31.0 t80 -132.71 131.29 41.09 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.898 -1.501 . . . . 0.77 110.503 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.78 149.98 31.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.635 -1.166 . . . . 1.6 108.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 7.4 p -152.77 154.37 35.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.243 0.544 . . . . 1.19 112.216 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 11.6 p -129.86 150.6 51.09 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.773 0.797 . . . . 0.84 112.06 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -131.31 109.42 10.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.038 -1.437 . . . . 1.58 109.38 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.841 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.8 p90 -142.72 129.71 20.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.374 0.607 . . . . 0.86 109.667 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.5 p30 -101.93 157.96 16.48 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.899 1.333 . . . . 2.11 111.954 -172.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -121.71 109.65 14.99 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.18 -1.827 . . . . 0.37 109.745 171.334 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 28.9 m -91.23 97.69 11.28 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.187 -0.671 . . . . 0.33 109.187 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.6 p -81.3 116.2 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 123.204 1.478 . . . . 0.33 109.292 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.546 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 94.9 m-70 -88.81 100.26 13.02 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.571 -2.104 . . . . 1.19 109.002 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' A' ' 18' ' ' VAL . 31.4 tt0 . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.704 -1.135 . . . . 1.67 109.82 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.582 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 23.8 m-20 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 110.246 -0.279 . . . . 1.65 110.246 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.84 86.91 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.478 2.118 . . . . 0.97 112.349 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.724 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -116.45 -60.29 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 0.5 109.513 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.69 5.59 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 108.473 -1.851 . . . . 0.39 108.473 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.69 HD11 ' HB3' ' A' ' 37' ' ' PRO . 12.1 tp -53.67 -45.43 70.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.403 -1.899 . . . . 0.33 111.87 -168.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.692 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.82 84.78 3.95 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.562 0.696 . . . . 0.72 109.818 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.48 -40.55 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.152 -1.385 . . . . 0.63 110.686 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.5 ttm -157.57 132.1 8.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.916 -0.584 . . . . 2.88 110.18 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.556 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 13.2 ptp180 -103.67 139.25 19.93 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.046 -0.979 . . . . 3.67 109.865 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.735 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -75.19 165.28 31.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.382 1.388 . . . . 0.64 111.135 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -122.91 -177.63 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.043 -0.526 . . . . 1.43 110.343 -172.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.94 -150.48 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-O 123.076 1.417 . . . . 2.06 111.704 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.97 131.44 1.64 Allowed Glycine 0 C--N 1.291 -1.945 0 CA-C-N 112.762 -2.017 . . . . 0.3 112.063 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -110.54 110.93 21.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.422 -0.955 . . . . 1.53 108.422 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 m -130.58 141.82 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 107.598 -1.26 . . . . 0.27 107.598 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.772 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -77.52 156.88 30.69 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.871 -1.059 . . . . 0.77 109.387 -177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 79' ' ' ALA . 3.9 t -66.38 105.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 CA-C-O 122.767 1.27 . . . . 0.78 107.886 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.0 10.01 Favored Glycine 0 C--N 1.266 -3.318 0 CA-C-N 112.36 -2.2 . . . . 0.48 112.688 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.84 4.94 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 118.668 -1.729 . . . . 0.44 108.92 172.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.9 p -151.43 163.57 38.68 Favored 'General case' 0 N--CA 1.397 -3.124 0 CA-C-N 112.882 -1.659 . . . . 0.82 110.527 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.5 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.4 tp -136.67 146.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.141 -1.845 . . . . 0.32 107.106 171.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -137.91 125.07 21.57 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 113.088 -1.869 . . . . 0.31 110.743 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 75.5 m-85 -123.36 143.24 50.23 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.266 -1.334 . . . . 0.53 109.239 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -131.99 118.73 20.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.277 -0.874 . . . . 0.58 109.79 177.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -117.11 116.15 26.76 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.514 -1.221 . . . . 0.32 110.145 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.27 124.2 49.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.362 -0.211 . . . . 2.43 110.886 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 39' ' ' VAL . 12.1 t -129.56 130.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 122.093 0.949 . . . . 0.26 110.589 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.86 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -63.66 111.54 2.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.25 -1.795 . . . . 0.4 111.589 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.853 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.49 -53.04 17.69 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 114.761 -1.108 . . . . 0.76 111.976 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.701 ' CA ' ' HE3' ' A' ' 68' ' ' LYS . . . 59.96 -174.22 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.666 0.987 . . . . 0.71 113.666 169.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -111.61 128.87 56.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.69 -1.141 . . . . 1.74 108.975 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.35 -179.47 7.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.155 0.503 . . . . 2.16 111.992 -170.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.08 -44.31 80.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.82 -1.082 . . . . 1.47 108.962 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.657 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.59 148.26 23.29 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.909 -1.041 . . . . 1.4 109.547 175.02 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.64 142.38 13.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.231 2.62 . . . . 0.88 111.507 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.69 ' HB3' HD11 ' A' ' 6' ' ' LEU . 1.8 Cg_endo -49.11 131.9 26.89 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.897 1.731 . . . . 0.53 113.002 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.74 104.97 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 106.922 -1.51 . . . . 0.77 106.922 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 28' ' ' VAL . 2.3 t -108.33 114.08 45.63 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 112.81 -1.996 . . . . 0.28 107.306 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.628 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.91 125.37 48.58 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-O 123.266 1.508 . . . . 1.54 110.132 174.1 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.902 ' HB3' HD13 ' A' ' 49' ' ' LEU . 55.2 m95 -83.49 157.06 22.54 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 111.39 -2.641 . . . . 0.34 111.555 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 20.3 t80 -135.66 139.55 43.82 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 104.794 -2.299 . . . . 0.62 104.794 168.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.996 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttm -100.63 167.24 10.46 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.424 -2.435 . . . . 2.17 104.424 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.26 -165.51 0.0 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 118.982 2.353 . . . . 1.23 118.982 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.528 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 15.0 mtpt -45.23 -11.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.095 0 O-C-N 118.592 -2.71 . . . . 3.87 116.417 -168.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.412 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 22.7 p-90 -164.18 -2.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.83 1.418 . . . . 2.11 114.83 -175.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.996 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.73 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-O 122.942 1.353 . . . . 1.29 112.173 -163.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 1.5 p-10 -109.66 101.71 10.6 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 112.29 -2.232 . . . . 2.73 112.191 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.034 HD23 HD21 ' A' ' 57' ' ' LEU . 5.1 mp -54.34 -34.89 62.02 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.041 0.756 . . . . 0.44 113.041 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 m -57.28 -21.9 37.82 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.548 0.69 . . . . 1.23 109.668 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.46 ' HB2' ' CD ' ' A' ' 52' ' ' LYS . 22.7 m -98.19 -34.91 10.55 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.982 -1.008 . . . . 1.34 111.707 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.581 ' HB2' HD12 ' A' ' 57' ' ' LEU . 3.0 mmmt -90.92 -36.06 14.36 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.941 -1.027 . . . . 1.4 111.67 -168.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.66 HG13 ' H ' ' A' ' 59' ' ' LEU . 44.3 t -37.54 96.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 125.888 1.675 . . . . 0.37 111.869 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.719 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -153.41 -111.84 0.46 Allowed Glycine 0 C--N 1.298 -1.541 0 CA-C-N 111.546 -2.57 . . . . 0.7 112.742 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -95.73 -27.44 15.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.348 0.87 . . . . 2.75 113.348 -169.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -95.36 -36.45 11.37 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.574 0.702 . . . . 1.33 110.439 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.034 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.69 105.49 11.22 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.14 -1.8 . . . . 1.11 106.14 172.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.719 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -98.56 115.86 29.53 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.658 -1.608 . . . . 0.76 106.658 165.341 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.66 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -92.05 92.09 8.11 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 103.495 -2.78 . . . . 0.26 103.495 167.019 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.717 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -92.33 164.22 13.59 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 113.896 -1.502 . . . . 2.03 109.502 -173.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -137.26 117.98 14.04 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 111.341 -2.663 . . . . 0.92 109.998 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -101.28 142.52 32.58 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.622 -2.081 . . . . 0.47 106.895 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -137.91 98.58 3.68 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.757 1.265 . . . . 1.39 110.792 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.27 105.72 13.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 113.132 -1.849 . . . . 2.42 109.695 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.56 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -74.83 -29.83 61.18 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.845 -1.071 . . . . 2.46 110.796 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -35.27 80.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.34 -0.845 . . . . 1.15 110.93 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -98.85 -12.38 20.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.641 -0.708 . . . . 1.41 109.839 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.86 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 18.4 tttt 67.22 33.7 5.34 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.745 0.783 . . . . 3.31 109.564 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.24 128.33 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.969 -0.559 . . . . 0.43 109.685 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.853 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 22.5 m-85 -95.71 116.2 28.53 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.586 -2.005 . . . . 1.24 105.586 162.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 25' ' ' SER . 38.0 tp -94.08 104.13 16.17 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.517 -1.29 . . . . 0.52 107.517 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.9 m-85 -83.04 110.66 18.18 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.117 -1.809 . . . . 0.33 106.117 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.2 pt-20 -114.75 122.7 47.21 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.666 -1.606 . . . . 1.32 110.278 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.716 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.4 mt -91.46 131.07 37.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.201 -1.363 . . . . 0.96 108.374 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -117.85 95.47 4.94 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 103.077 -2.934 . . . . 1.15 103.077 167.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.4 mt -121.24 100.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.979 0 CA-C-O 122.902 1.334 . . . . 0.52 108.619 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.1 p -104.43 165.16 11.24 Favored 'General case' 0 N--CA 1.389 -3.519 0 CA-C-N 114.116 -1.402 . . . . 0.58 109.941 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 38.45 75.73 0.07 Allowed 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 110.563 -3.017 . . . . 2.12 111.84 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.542 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -68.74 117.77 10.87 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.789 -2.914 . . . . 0.4 111.074 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.858 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 2.2 tp60 -51.27 135.03 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.848 -0.797 . . . . 1.43 108.848 165.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.452 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 19.3 Cg_endo -60.0 -13.49 23.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.932 2.421 . . . . 1.33 112.685 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.858 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -96.6 15.48 21.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.974 -0.557 . . . . 1.12 110.797 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.1 m-30 -95.09 -10.59 30.26 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.972 -0.381 . . . . 1.24 109.972 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.6 m -46.28 98.51 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.829 0 O-C-N 124.606 1.191 . . . . 1.22 108.732 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -169.35 -130.1 1.17 Allowed Glycine 0 C--N 1.266 -3.353 0 CA-C-N 112.698 -2.046 . . . . 1.43 113.145 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.0 118.74 0.9 Allowed Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 119.962 -1.113 . . . . 0.52 112.695 -170.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.703 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.3 m-85 -85.13 134.95 34.16 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.04 -1.58 . . . . 0.63 107.577 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.472 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 63.7 mtt180 -118.99 155.07 32.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.204 0.526 . . . . 3.15 110.6 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.634 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 75.0 m -131.31 132.26 44.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.825 -1.176 . . . . 1.08 107.825 163.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.628 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 35.0 tt0 -134.95 103.33 5.54 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.723 -1.214 . . . . 1.81 107.723 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.6 p -99.6 134.91 37.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.983 0.897 . . . . 0.54 110.835 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -133.46 108.5 8.69 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.794 -1.548 . . . . 1.18 108.864 -176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.642 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -132.09 155.13 48.66 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.376 -0.972 . . . . 0.74 108.376 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.813 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 18.61 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 125.601 1.813 . . . . 0.65 114.882 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.813 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 5.0 t70 -151.81 1.23 0.36 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.748 -1.115 . . . . 1.05 109.668 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.724 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmtp -98.17 130.05 44.93 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.961 -1.126 . . . . 1.29 107.961 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -131.26 147.17 52.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.991 -1.004 . . . . 0.77 111.189 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -172.13 166.24 6.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.933 -0.765 . . . . 1.6 108.933 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.4 p -155.67 156.76 35.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 1.19 110.461 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.692 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 30.8 p -135.39 147.63 49.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.715 -0.675 . . . . 0.84 111.086 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -127.19 121.92 32.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 1.58 110.066 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.735 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -141.98 116.66 9.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.121 0.486 . . . . 0.86 109.796 -175.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.3 p30 -100.3 146.26 27.14 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 122.418 1.104 . . . . 2.11 111.88 -169.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -116.76 122.91 45.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.219 -1.355 . . . . 0.37 109.349 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -101.58 96.69 7.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.508 -0.923 . . . . 0.33 108.508 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 3.8 p -79.19 114.58 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-O 123.203 1.477 . . . . 0.33 109.711 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.772 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 9.3 m-70 -79.97 99.33 7.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.098 -2.319 . . . . 1.19 109.816 -175.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 18' ' ' VAL . 35.5 tt0 . . . . . 0 C--N 1.295 -1.784 0 CA-C-N 114.039 -1.437 . . . . 1.67 109.348 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.463 ' HB2' ' CE ' ' A' ' 94' ' ' LYS . 8.4 m-20 . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 109.624 -0.51 . . . . 1.65 109.624 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 84.41 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.24 1.96 . . . . 0.97 113.132 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.84 HD11 ' HE2' ' A' ' 94' ' ' LYS . 1.8 mp -110.71 -66.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.11 -0.95 . . . . 0.5 109.187 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.85 37.47 6.06 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 108.573 -1.811 . . . . 0.39 108.573 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.92 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.2 tp -38.57 -51.34 1.62 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.767 -1.716 . . . . 0.33 110.858 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.71 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -85.93 85.57 7.37 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 121.635 0.731 . . . . 0.72 110.537 175.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.92 -33.8 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.09 -1.414 . . . . 0.63 109.553 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.421 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 18.5 ttt -163.69 136.98 5.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.361 -0.836 . . . . 2.88 110.226 174.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.628 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 6.1 ptt180 -116.11 137.57 23.52 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.031 -0.531 . . . . 3.67 110.761 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -71.58 176.66 7.8 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.986 2.457 . . . . 0.64 112.585 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -126.91 177.08 6.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.647 -0.706 . . . . 1.43 110.671 -175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.5 p-10 -71.42 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.602 1.191 . . . . 2.06 111.641 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.06 137.44 2.59 Favored Glycine 0 N--CA 1.426 -2.003 0 CA-C-N 113.821 -1.536 . . . . 0.3 111.807 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.497 ' HG3' ' CD2' ' A' ' 107' ' ' HIS . 27.9 tt0 -113.33 115.14 27.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.094 -1.053 . . . . 1.53 109.497 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -139.46 163.16 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 N-CA-C 107.308 -1.367 . . . . 0.27 107.308 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -93.92 162.02 14.07 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.548 -0.751 . . . . 0.77 109.617 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 81' ' ' PRO . 3.5 t -72.74 105.64 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.458 0 N-CA-C 107.205 -1.405 . . . . 0.78 107.205 172.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.41 3.05 6.23 Favored Glycine 0 C--N 1.263 -3.506 0 CA-C-N 112.685 -2.052 . . . . 0.48 111.472 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.9 -131.92 7.48 Favored Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 118.78 -1.676 . . . . 0.44 109.094 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.747 ' HB3' HG22 ' A' ' 77' ' ' THR . 8.2 p -152.22 168.26 25.93 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 113.016 -1.592 . . . . 0.82 110.872 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.602 HG21 HD13 ' A' ' 104' ' ' LEU . 10.7 tp -147.74 149.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 CA-C-N 113.274 -1.784 . . . . 0.32 107.536 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 m -139.22 127.08 22.13 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-N 113.513 -1.676 . . . . 0.31 111.098 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' HB2' HD23 ' A' ' 74' ' ' LEU . 33.0 m-85 -122.65 148.24 45.5 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.952 -1.476 . . . . 0.53 108.392 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -135.01 122.48 21.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.575 -0.898 . . . . 0.58 108.575 175.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -126.09 126.64 44.53 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.943 -1.026 . . . . 0.32 111.086 -174.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' HB3' HG11 ' A' ' 69' ' ' VAL . 52.0 mtt180 -113.68 123.65 50.42 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.416 -0.356 . . . . 2.43 111.135 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.0 t -122.33 125.13 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.946 0.879 . . . . 0.26 109.837 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -54.91 111.11 0.76 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.505 -1.679 . . . . 0.4 111.094 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.784 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -52.87 -43.06 60.68 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.177 -1.374 . . . . 0.76 111.162 171.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.79 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 49.23 -167.06 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.252 1.204 . . . . 0.71 114.252 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -119.77 123.13 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.062 -1.426 . . . . 1.74 107.527 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.779 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -149.78 178.58 8.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.838 0.681 . . . . 2.16 112.838 -168.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.05 -57.23 4.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.989 -1.005 . . . . 1.47 109.234 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.671 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -129.58 145.54 57.36 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.468 -0.787 . . . . 1.4 109.726 171.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.4 Cg_exo -45.46 138.89 10.15 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 122.78 2.32 . . . . 0.88 110.961 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.779 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.0 Cg_exo -58.82 136.98 77.28 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.443 1.429 . . . . 0.53 111.961 -172.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.04 104.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.369 -1.715 . . . . 0.77 106.369 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -107.25 114.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 113.44 -1.709 . . . . 0.28 107.21 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.609 ' O ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.78 129.39 53.05 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 123.222 1.487 . . . . 1.54 110.078 175.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.07 ' HB3' HD13 ' A' ' 49' ' ' LEU . 87.6 m95 -90.84 141.84 28.39 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.794 -2.457 . . . . 0.34 111.268 171.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.7 t80 -125.82 125.79 43.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.785 -1.931 . . . . 0.62 105.785 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 29.6 ttpt -103.65 108.59 19.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.8 -1.555 . . . . 2.17 106.8 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.562 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -79.77 92.02 1.32 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 115.997 -3.001 . . . . 1.23 113.968 -165.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.719 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 32.9 tttt -106.58 -32.77 7.9 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 104.24 -2.504 . . . . 3.87 104.24 138.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.741 ' HD1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER 157.85 -13.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 110.921 -2.854 . . . . 2.11 111.447 -165.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.741 HG22 ' HD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -94.76 173.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 CA-C-O 122.994 1.378 . . . . 1.29 111.909 -168.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 5.4 m-20 -104.38 155.91 18.38 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.927 -2.397 . . . . 2.73 106.228 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.07 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -84.79 -32.33 23.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 118.325 0.512 . . . . 0.44 111.464 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -20.35 37.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.711 0.767 . . . . 1.23 110.244 -167.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.757 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 26.4 t -92.22 -30.42 15.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.72 -1.127 . . . . 1.34 111.132 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 3.7 mmmt -98.81 -42.08 7.35 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.631 -1.168 . . . . 1.4 112.122 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.788 HG13 ' H ' ' A' ' 59' ' ' LEU . 54.9 t -22.57 95.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.208 1.803 . . . . 0.37 112.987 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.71 -126.61 1.36 Allowed Glycine 0 C--N 1.303 -1.275 0 CA-C-N 112.138 -2.301 . . . . 0.7 113.157 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -84.91 -20.08 31.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.881 0.697 . . . . 2.75 112.881 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.7 p80 -100.72 -37.56 8.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.347 0.594 . . . . 1.33 110.427 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.952 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.89 103.7 10.21 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.03 -1.841 . . . . 1.11 106.03 172.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -95.43 115.22 27.13 Favored 'General case' 0 N--CA 1.409 -2.521 0 N-CA-C 105.809 -1.922 . . . . 0.76 105.809 167.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.809 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.6 OUTLIER -98.94 91.58 5.11 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 103.496 -2.779 . . . . 0.26 103.496 167.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 5.8 t-80 -99.75 164.65 11.95 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.21 -1.814 . . . . 2.03 108.728 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.51 126.37 27.53 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 113.191 -1.822 . . . . 0.92 111.933 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -103.24 148.04 26.3 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 110.996 -2.82 . . . . 0.47 108.24 169.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.0 101.31 3.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.976 0.893 . . . . 1.39 110.987 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.53 109.17 17.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.322 -1.308 . . . . 2.42 111.006 169.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.562 HH11 ' HD2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.64 -31.44 65.13 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.445 -0.798 . . . . 2.46 111.013 177.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -14.93 63.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.759 -0.655 . . . . 1.15 110.431 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -106.8 -20.18 13.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.808 -1.182 . . . . 1.41 107.808 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.79 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER 60.54 40.2 17.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.652 -1.158 . . . . 3.31 109.292 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 27' ' ' ARG . 13.8 t -133.39 143.06 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.242 -0.89 . . . . 0.43 109.776 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.784 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 27.9 m-85 -105.62 113.05 26.38 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.622 -1.622 . . . . 1.24 106.622 163.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 10.1 tp -94.91 105.61 17.54 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 122.261 1.029 . . . . 0.52 108.762 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.1 m-85 -87.88 115.32 25.26 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.001 -1.454 . . . . 0.33 108.275 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -98.55 132.86 43.64 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.045 -1.889 . . . . 1.32 108.353 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.84 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -103.64 115.7 30.97 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.488 -1.301 . . . . 0.96 107.488 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -113.65 95.21 5.22 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.583 -2.377 . . . . 1.15 104.583 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.622 HG12 HD23 ' A' ' 57' ' ' LEU . 63.7 mt -119.55 100.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.928 1.347 . . . . 0.52 110.36 -174.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.747 HG22 ' HB3' ' A' ' 21' ' ' SER . 82.5 p -106.45 135.78 47.36 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.435 -1.711 . . . . 0.58 108.262 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.65 101.47 0.05 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 111.714 -2.493 . . . . 2.12 110.174 -174.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -94.87 124.68 39.06 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 109.72 -3.4 . . . . 0.4 109.402 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.797 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.64 130.94 77.65 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.295 -0.631 . . . . 1.43 109.295 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.752 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.1 Cg_endo -60.74 -10.65 14.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.129 2.553 . . . . 1.33 112.855 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.797 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -113.5 15.4 19.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.046 -0.525 . . . . 1.12 111.41 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.684 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -73.5 -57.55 3.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.417 -0.957 . . . . 1.24 108.417 177.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 26.0 m 42.67 62.07 1.86 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.665 -1.606 . . . . 1.22 106.665 -158.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.683 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -56.53 86.16 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 112.084 -2.326 . . . . 1.43 114.17 -163.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -90.79 83.38 1.3 Allowed Glycine 0 C--N 1.279 -2.62 0 N-CA-C 108.862 -1.695 . . . . 0.52 108.862 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.714 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.2 m-85 -78.07 110.93 13.45 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.997 -1.101 . . . . 0.63 108.751 -176.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -99.91 109.24 21.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.419 -0.956 . . . . 3.15 108.419 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.417 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -97.84 129.58 44.8 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.075 -0.65 . . . . 1.08 109.247 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 53.8 mt-10 -132.15 119.18 20.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.856 -0.611 . . . . 1.81 109.664 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.6 p -106.42 137.31 37.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.738 0.78 . . . . 0.54 110.794 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.1 t -129.93 109.38 10.85 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.351 -1.295 . . . . 1.18 108.313 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.589 HG21 HD12 ' A' ' 33' ' ' LEU . 1.3 m -127.45 174.98 8.57 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.35 -0.841 . . . . 0.74 109.941 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 1.018 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -3.5 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.431 1.707 . . . . 0.65 115.016 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 1.018 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 17.4 t70 -163.93 5.19 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.511 -1.222 . . . . 1.05 109.63 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.92 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -101.83 143.06 32.2 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.733 0.778 . . . . 1.29 109.088 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -131.54 136.47 47.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.165 -1.834 . . . . 0.77 110.815 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 7' ' ' PHE . 4.0 m-20 -155.43 151.73 28.16 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.903 -1.044 . . . . 1.6 109.443 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.5 p -152.32 152.62 32.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.19 111.028 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.71 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 96.0 p -130.03 147.23 51.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.227 0.537 . . . . 0.84 111.941 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -126.43 113.44 16.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.406 -0.815 . . . . 1.58 110.844 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.855 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 3.8 p90 -143.99 129.99 19.52 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.852 -0.53 . . . . 0.86 111.123 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.647 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -112.45 127.21 55.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 122.192 0.996 . . . . 2.11 113.106 -173.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -97.33 107.6 20.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.848 -1.523 . . . . 0.37 109.924 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m -88.85 97.09 10.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.99 -0.745 . . . . 0.33 108.99 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.684 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.7 p -86.95 116.97 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.631 1.205 . . . . 0.33 110.222 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.497 ' CD2' ' HG3' ' A' ' 15' ' ' GLU . 95.7 m-70 -111.57 93.79 4.64 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.739 -1.573 . . . . 1.19 112.138 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.526 ' HB2' HG21 ' A' ' 18' ' ' VAL . 31.0 tt0 . . . . . 0 C--N 1.3 -1.557 0 CA-C-N 115.937 -0.574 . . . . 1.67 109.898 164.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 4.5 m-20 . . . . . 0 N--CA 1.443 -0.816 0 CA-C-O 119.102 -0.475 . . . . 1.65 110.988 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.95 83.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.357 2.038 . . . . 0.97 113.734 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.06 ' HB ' ' HD3' ' A' ' 96' ' ' LYS . 1.8 mp -110.78 -69.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.026 -0.988 . . . . 0.5 109.22 173.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.447 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 92.22 50.15 2.67 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 108.199 -1.96 . . . . 0.39 108.199 -173.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.603 ' N ' HG22 ' A' ' 4' ' ' ILE . 10.1 tp -53.38 -50.29 65.41 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.984 -1.608 . . . . 0.33 110.829 -167.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -86.7 84.46 7.38 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.585 -0.734 . . . . 0.72 109.507 174.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -66.03 -39.96 85.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.342 -1.299 . . . . 0.63 109.664 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 21.7 ttt -141.49 133.95 28.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.165 -0.925 . . . . 2.88 108.651 169.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.658 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 31.7 mtt180 -99.14 127.27 35.32 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.062 -0.517 . . . . 3.67 109.64 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 10.4 Cg_endo -57.79 151.28 57.24 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.735 2.29 . . . . 0.64 111.72 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 19.3 mm-40 -126.46 169.66 12.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 1.43 111.467 -169.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.8 m-20 -65.62 -147.19 0.01 OUTLIER 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.952 1.358 . . . . 2.06 111.781 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.84 133.6 2.56 Favored Glycine 0 C--N 1.297 -1.6 0 CA-C-N 113.628 -1.623 . . . . 0.3 111.678 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.81 114.86 24.53 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.308 -0.946 . . . . 1.53 108.755 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.711 HG22 HD11 ' A' ' 104' ' ' LEU . 3.0 m -136.63 165.0 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 107.755 -1.202 . . . . 0.27 107.755 -172.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.557 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -88.48 155.52 19.62 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.934 -1.03 . . . . 0.77 110.273 -176.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.664 HG22 HG22 ' A' ' 106' ' ' VAL . 60.0 t -70.41 105.69 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 122.901 1.334 . . . . 0.78 108.253 173.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.01 12.16 Favored Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.412 -2.176 . . . . 0.48 112.367 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.86 -123.05 2.99 Favored Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.113 -1.595 . . . . 0.44 109.113 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.6 p -151.99 169.55 22.06 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 112.84 -1.68 . . . . 0.82 110.553 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -145.31 147.19 18.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 113.763 -1.562 . . . . 0.32 107.256 167.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -137.96 130.26 29.1 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.851 -1.522 . . . . 0.31 110.916 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 62.9 m-85 -126.43 147.63 49.76 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.203 -1.362 . . . . 0.53 110.128 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -136.61 123.72 21.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.953 -1.021 . . . . 0.58 109.248 175.072 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.614 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -119.74 116.31 25.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.745 -1.116 . . . . 0.32 110.185 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 39.3 mtt180 -101.21 122.15 43.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.308 -0.406 . . . . 2.43 110.77 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 39' ' ' VAL . 17.2 t -123.82 128.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 122.168 0.985 . . . . 0.26 110.248 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.99 114.21 2.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.318 -1.765 . . . . 0.4 111.016 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -55.21 -32.69 57.31 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.343 -1.298 . . . . 0.76 111.187 170.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.599 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 56.1 -172.26 0.07 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.791 1.034 . . . . 0.71 113.791 168.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 t -110.0 117.06 32.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 1.74 107.061 164.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.803 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -150.98 166.59 30.22 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.891 0.7 . . . . 2.16 112.891 -162.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -64.23 -64.56 0.85 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.063 -0.971 . . . . 1.47 109.956 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.56 158.33 74.94 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.266 -1.013 . . . . 1.4 108.266 172.132 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 4.5 Cg_endo -45.79 146.8 3.6 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.246 2.631 . . . . 0.88 112.356 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.803 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -62.64 135.65 53.91 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.655 1.57 . . . . 0.53 111.248 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.79 104.56 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.614 0 N-CA-C 106.541 -1.651 . . . . 0.77 106.541 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.643 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -108.75 114.55 47.08 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-N 113.335 -1.757 . . . . 0.28 107.814 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.898 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.89 125.39 50.94 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 123.384 1.564 . . . . 1.54 110.412 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.959 ' HB3' HD13 ' A' ' 49' ' ' LEU . 82.5 m95 -88.78 157.23 18.56 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 111.664 -2.516 . . . . 0.34 112.564 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.9 t80 -136.79 136.09 38.56 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 104.948 -2.241 . . . . 0.62 104.948 166.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.709 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 21.1 tttm -112.4 162.12 15.93 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.617 -1.623 . . . . 2.17 106.617 -173.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 1.029 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -4.35 -167.78 0.0 OUTLIER Glycine 0 C--O 1.191 -2.594 0 N-CA-C 118.692 2.237 . . . . 1.23 118.692 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -44.37 -9.07 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.201 1.926 . . . . 3.87 116.201 -166.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.606 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 30.0 p-90 -167.67 -3.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.012 1.486 . . . . 2.11 115.012 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.606 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -91.13 135.4 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-O 123.496 1.617 . . . . 1.29 112.817 -163.14 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -104.36 99.33 9.04 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 112.048 -2.342 . . . . 2.73 111.84 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.114 HD23 HD21 ' A' ' 57' ' ' LEU . 4.4 mp -51.93 -38.49 56.6 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.223 1.194 . . . . 0.44 114.223 -169.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 t -57.5 -22.22 42.67 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.345 0.593 . . . . 1.23 109.407 -166.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 m -100.38 -28.81 12.75 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.313 -0.858 . . . . 1.34 113.052 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.536 ' HG3' HG12 ' A' ' 47' ' ' VAL . 6.0 mmmt -90.33 -39.8 12.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.085 -0.507 . . . . 1.4 111.516 -171.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.91 HG13 ' H ' ' A' ' 59' ' ' LEU . 55.1 t -32.34 95.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 126.449 1.899 . . . . 0.37 112.3 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.651 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.82 -103.29 0.21 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 111.707 -2.497 . . . . 0.7 113.898 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -95.22 -33.15 12.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.007 0.743 . . . . 2.75 113.007 -168.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 27.6 p80 -97.88 -36.29 10.22 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.653 0.739 . . . . 1.33 110.822 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.114 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.29 106.14 12.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.39 -1.707 . . . . 1.11 106.39 174.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.87 115.86 30.6 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.517 -1.66 . . . . 0.76 106.517 165.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.91 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -103.04 93.64 5.12 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.307 -2.109 . . . . 0.26 105.307 172.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 43.7 m80 -92.86 160.38 14.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-O 122.902 1.334 . . . . 2.03 109.499 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -129.29 110.79 12.24 Favored 'General case' 0 C--N 1.265 -3.102 0 CA-C-N 111.458 -2.61 . . . . 0.92 108.936 175.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.9 m -92.28 145.38 24.53 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.582 -2.099 . . . . 0.47 107.776 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.441 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.0 t80 -141.26 99.77 3.65 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.07 0.938 . . . . 1.39 111.57 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -116.46 121.73 42.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.125 -1.398 . . . . 2.42 108.811 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.441 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -85.36 -39.07 18.04 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 113.721 -1.581 . . . . 2.46 112.117 -172.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.23 60.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.604 -0.725 . . . . 1.15 111.417 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -95.58 -16.76 21.89 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.283 -1.377 . . . . 1.41 107.283 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.599 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 67.59 31.47 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.864 -1.516 . . . . 3.31 109.789 173.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.45 128.49 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.764 0.793 . . . . 0.43 110.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.558 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 45.8 m-85 -98.47 112.22 24.31 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.143 -1.799 . . . . 1.24 106.143 162.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.4 tp -98.92 106.2 18.44 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.017 0.913 . . . . 0.52 108.61 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 51.4 m-85 -84.46 115.65 22.67 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.303 -1.317 . . . . 0.33 108.001 172.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.2 123.62 47.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.055 -1.43 . . . . 1.32 109.269 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -94.74 118.9 32.49 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.144 -1.428 . . . . 0.96 107.144 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -110.71 95.76 5.76 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 103.556 -2.757 . . . . 1.15 103.556 169.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.699 HD13 ' HE2' ' A' ' 43' ' ' LYS . 13.9 mt -123.55 99.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 123.229 1.49 . . . . 0.52 108.66 -175.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.8 p -107.53 170.07 8.2 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 113.441 -1.709 . . . . 0.58 108.007 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.9 t70 65.52 33.56 8.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.722 -2.036 . . . . 2.12 110.003 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -49.94 112.05 0.61 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.994 -1.912 . . . . 0.4 111.7 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.603 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -70.85 153.7 94.65 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.198 -0.91 . . . . 1.43 109.179 173.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 40.9 Cg_endo -66.9 -3.39 9.46 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.245 1.963 . . . . 1.33 113.189 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.603 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.82 17.0 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.265 -0.425 . . . . 1.12 110.331 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.3 m-30 -99.56 0.74 42.87 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.658 -0.497 . . . . 1.24 109.658 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 14.9 m -28.97 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 125.779 1.924 . . . . 1.22 110.579 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.871 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -34.37 106.84 0.03 OUTLIER Glycine 0 N--CA 1.411 -3.015 0 CA-C-N 109.662 -3.426 . . . . 1.43 114.798 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 1.029 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -122.66 65.39 0.51 Allowed Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.33 -1.908 . . . . 0.52 108.33 159.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.709 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 79.0 m-85 -81.48 128.81 34.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.862 -1.169 . . . . 0.63 109.562 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -135.04 104.26 5.88 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.772 -0.825 . . . . 3.15 108.772 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -102.11 129.58 48.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.474 -0.491 . . . . 1.08 110.154 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.898 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 22.0 tt0 -131.64 116.37 17.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.472 -0.785 . . . . 1.81 110.007 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.643 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -106.39 140.53 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.428 0.632 . . . . 0.54 109.957 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.1 t -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.11 -0.95 . . . . 1.18 108.745 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.667 HG21 HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.09 157.46 44.15 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 118.145 -0.931 . . . . 0.74 109.341 -178.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 1.058 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 17.92 -73.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.536 1.772 . . . . 0.65 114.662 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 1.058 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.6 t0 -150.74 1.97 0.44 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.058 -0.974 . . . . 1.05 109.697 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.06 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 14.7 mtpp -103.75 146.21 28.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 122.459 1.123 . . . . 1.29 109.541 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -136.14 140.26 43.53 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.279 -2.237 . . . . 0.77 110.6 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 2.4 m-20 -156.91 149.74 23.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.044 -0.98 . . . . 1.6 109.596 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 p -152.69 149.03 27.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.13 0.49 . . . . 1.19 110.975 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.491 ' HG ' ' HZ ' ' A' ' 7' ' ' PHE . 3.9 p -127.97 149.6 50.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.6 -0.727 . . . . 0.84 112.268 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -132.65 109.55 9.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.409 -1.269 . . . . 1.58 109.23 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.788 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 4.6 p90 -141.37 129.36 21.94 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.823 0.82 . . . . 0.86 110.078 -172.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 15.9 m-80 -105.31 146.22 29.67 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.607 -1.178 . . . . 2.11 111.107 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.871 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -112.83 118.16 34.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.042 -1.435 . . . . 0.37 109.145 173.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 m -95.25 97.51 9.93 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.842 -0.743 . . . . 0.33 109.237 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.664 HG22 HG22 ' A' ' 18' ' ' VAL . 7.2 p -86.59 113.31 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 123.331 1.539 . . . . 0.33 109.397 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 82.2 m-70 -86.15 99.8 11.77 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.295 -2.229 . . . . 1.19 109.354 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 52.7 tt0 . . . . . 0 C--N 1.303 -1.449 0 CA-C-N 115.321 -0.854 . . . . 1.67 111.114 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 110.057 -0.349 . . . . 1.65 110.057 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.03 45.95 0.39 Allowed 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.296 2.664 . . . . 0.97 113.915 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.631 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -63.15 -58.68 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.643 -0.708 . . . . 0.5 110.096 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.85 53.97 3.2 Favored Glycine 0 CA--C 1.492 -1.376 0 N-CA-C 107.625 -2.19 . . . . 0.39 107.625 -173.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.82 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.2 tp -60.75 -33.62 73.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.978 -1.611 . . . . 0.33 110.201 -165.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.821 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.87 84.61 3.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.05 -0.977 . . . . 0.72 109.572 172.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.54 -50.7 64.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.545 -1.207 . . . . 0.63 109.91 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.658 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 16.5 tpt -147.84 131.18 16.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.2 -0.909 . . . . 2.88 108.66 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 34.4 ptt180 -98.65 138.15 20.7 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 116.133 -0.485 . . . . 3.67 111.436 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.774 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 28.1 Cg_endo -68.36 153.99 72.98 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.545 2.163 . . . . 0.64 111.155 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.0 mm-40 -123.17 173.17 8.06 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.119 -0.491 . . . . 1.43 110.514 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.6 p-10 -68.33 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.67 1.224 . . . . 2.06 111.537 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 155.76 138.97 2.66 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 113.736 -1.575 . . . . 0.3 111.156 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 43.0 mt-10 -117.96 116.93 27.91 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.398 -0.964 . . . . 1.53 108.398 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.08 163.73 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.326 -1.361 . . . . 0.27 107.326 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 156.02 16.5 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.962 -1.017 . . . . 0.77 109.304 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.757 HG13 ' HD3' ' A' ' 81' ' ' PRO . 47.5 t -57.93 107.45 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 122.81 1.29 . . . . 0.78 109.825 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.56 12.25 19.57 Favored Glycine 0 C--N 1.274 -2.862 0 CA-C-N 112.029 -2.351 . . . . 0.48 114.07 170.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.8 -122.46 3.46 Favored Glycine 0 CA--C 1.478 -2.256 0 C-N-CA 118.818 -1.658 . . . . 0.44 111.103 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.2 p -151.71 167.91 26.71 Favored 'General case' 0 N--CA 1.403 -2.822 0 CA-C-N 112.474 -1.863 . . . . 0.82 110.408 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 104' ' ' LEU . 10.6 tp -146.29 150.58 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 CA-C-N 112.938 -1.937 . . . . 0.32 107.919 169.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 m -137.5 126.19 23.82 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 113.048 -1.887 . . . . 0.31 110.757 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.675 ' HD2' HD12 ' A' ' 74' ' ' LEU . 37.3 m-85 -122.11 140.99 51.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.033 -1.439 . . . . 0.53 109.408 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.78 119.52 22.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.645 -0.707 . . . . 0.58 109.601 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.774 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -121.33 116.75 25.41 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.507 -1.224 . . . . 0.32 110.691 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.658 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 28.5 mtp180 -105.05 120.04 40.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.072 -0.513 . . . . 2.43 111.142 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.524 HG21 HG21 ' A' ' 39' ' ' VAL . 12.9 t -122.14 132.72 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.707 0.765 . . . . 0.26 109.303 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.87 111.24 1.81 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.71 -1.586 . . . . 0.4 110.7 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -50.89 -35.12 31.27 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 114.675 -1.148 . . . . 0.76 110.295 169.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.63 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.09 -143.98 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.38 -0.91 . . . . 0.71 113.383 166.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.542 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -119.58 154.8 33.37 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.327 -1.36 . . . . 1.74 107.327 170.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.065 HD22 ' HA ' ' A' ' 93' ' ' THR . 3.7 tp 171.0 147.53 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.475 -1.306 . . . . 2.16 107.475 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.803 ' H ' HD12 ' A' ' 33' ' ' LEU . 24.3 tp -44.91 -42.27 7.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.031 0.92 . . . . 1.47 111.169 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.772 ' HD2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.47 -179.67 0.79 Allowed Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.197 -1.365 . . . . 1.4 108.116 175.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 8.1 Cg_exo -67.9 153.69 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.533 1.489 . . . . 0.88 108.888 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.692 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 26.4 Cg_exo -60.38 137.23 73.06 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.013 1.809 . . . . 0.53 111.548 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.27 102.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 106.94 -1.504 . . . . 0.77 106.94 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.677 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -107.59 114.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 CA-C-N 112.839 -1.982 . . . . 0.28 106.947 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.706 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.01 127.95 53.09 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 123.313 1.53 . . . . 1.54 109.22 173.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.039 ' HB3' HD13 ' A' ' 49' ' ' LEU . 69.4 m95 -85.4 154.25 21.97 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 111.448 -2.615 . . . . 0.34 111.111 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.838 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 29.9 t80 -126.22 138.2 53.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.62 105.186 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 71.2 tttt -104.76 165.05 11.33 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.719 -1.956 . . . . 2.17 105.719 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.807 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -9.65 -168.79 0.0 OUTLIER Glycine 0 C--O 1.188 -2.747 0 N-CA-C 119.522 2.569 . . . . 1.23 119.522 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 84' ' ' THR . 19.5 mtpt -45.47 -1.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 O-C-N 119.463 -2.198 . . . . 3.87 116.826 -166.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.695 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 13.8 p-90 -166.03 -10.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.403 1.26 . . . . 2.11 114.403 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.695 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.2 170.06 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-O 123.482 1.611 . . . . 1.29 112.492 -162.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.694 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 7.0 p-10 -112.88 158.13 20.57 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 111.825 -2.443 . . . . 2.73 107.528 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.039 HD13 ' HB3' ' A' ' 41' ' ' TRP . 6.0 mp -98.57 -36.94 9.73 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.142 0.423 . . . . 0.44 112.142 168.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 t -57.69 -20.76 36.23 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.719 0.637 . . . . 1.23 109.661 -162.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.694 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 17.0 m -100.47 -21.24 15.42 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.619 -0.832 . . . . 1.34 112.855 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 1.9 mmmt -94.11 -67.93 0.83 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.425 -0.807 . . . . 1.4 111.132 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.833 HG13 ' H ' ' A' ' 59' ' ' LEU . 78.5 t 12.8 93.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 126.358 1.863 . . . . 0.37 113.593 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.43 -154.49 7.28 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.052 -1.431 . . . . 0.7 110.281 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.45 ' C ' HE22 ' A' ' 58' ' ' GLN . 55.5 mt-30 -63.98 -5.21 4.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.971 1.1 . . . . 2.75 113.971 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -101.83 -41.26 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.768 0.794 . . . . 1.33 110.831 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.019 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.72 104.73 7.36 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.25 -1.759 . . . . 1.11 106.25 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.887 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -95.1 113.75 25.48 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.259 -2.126 . . . . 0.76 105.259 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.833 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -101.74 91.42 4.4 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.065 -2.568 . . . . 0.26 104.065 170.501 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 45.7 t60 -106.37 162.69 13.47 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.365 -1.289 . . . . 2.03 109.279 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.65 125.56 38.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 112.331 -2.213 . . . . 0.92 110.966 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -98.78 147.54 24.8 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 110.996 -2.82 . . . . 0.47 107.043 169.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.585 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 6.6 t80 -144.25 101.11 3.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.058 0.932 . . . . 1.39 112.312 -168.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 7.7 t70 -117.4 127.63 54.22 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.98 -1.464 . . . . 2.42 109.321 168.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.585 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -86.75 -41.12 14.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.813 -1.54 . . . . 2.46 112.018 -174.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.69 57.93 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.988 -1.005 . . . . 1.15 111.102 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 29.6 t -91.19 -19.4 23.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.542 -1.651 . . . . 1.41 106.542 173.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 1.4 tpmt? 70.69 29.32 3.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.841 -1.527 . . . . 3.31 109.722 173.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.04 127.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.43 111.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.544 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 61.2 m-85 -96.89 113.33 24.86 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.182 -1.784 . . . . 1.24 106.182 162.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 36.0 tp -92.4 103.82 16.22 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.345 -0.983 . . . . 0.52 108.345 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.3 m-85 -85.26 112.73 21.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.386 -1.709 . . . . 0.33 106.386 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 119.92 39.03 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.098 -1.864 . . . . 1.32 109.798 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.703 HD13 HD11 ' A' ' 76' ' ' ILE . 1.6 mt -89.41 130.83 35.71 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 114.116 -1.402 . . . . 0.96 107.984 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.887 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 81.7 m-70 -120.69 95.81 4.87 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 104.114 -2.551 . . . . 1.15 104.114 168.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 74' ' ' LEU . 12.8 mt -119.77 101.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 113.937 -1.483 . . . . 0.52 108.318 -171.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 78.5 p -101.68 166.19 10.82 Favored 'General case' 0 N--CA 1.382 -3.861 0 CA-C-N 113.987 -1.461 . . . . 0.58 109.145 -175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 39.38 78.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 111.362 -2.654 . . . . 2.12 112.579 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -70.77 121.04 17.26 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 111.089 -2.778 . . . . 0.4 110.181 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.613 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -63.07 137.91 97.19 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.49 -0.777 . . . . 1.43 109.874 174.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.757 ' HD3' HG13 ' A' ' 18' ' ' VAL . 16.5 Cg_endo -57.73 -12.86 12.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.283 2.655 . . . . 1.33 113.545 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.512 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.03 21.78 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.339 . . . . 1.12 111.245 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -46.89 8.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.536 -0.466 . . . . 1.24 111.984 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 83.2 m 22.67 79.77 0.01 OUTLIER 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.902 1.334 . . . . 1.22 110.609 -165.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.807 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.1 99.39 0.5 Allowed Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 112.711 -2.041 . . . . 1.43 114.495 -159.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.727 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -86.59 69.49 3.1 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 109.208 -1.557 . . . . 0.52 109.208 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.723 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 77.8 m-85 -78.42 128.11 33.14 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.871 -1.165 . . . . 0.63 108.758 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.838 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -122.56 156.72 33.62 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.082 0.468 . . . . 3.15 110.618 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 72.6 m -130.55 115.8 17.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.197 -0.668 . . . . 1.08 109.197 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.706 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 39.2 mt-10 -125.34 105.24 8.95 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.627 -0.429 . . . . 1.81 109.908 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.8 p -103.62 144.1 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.54 111.009 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.8 t -135.2 109.09 8.11 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.894 -1.048 . . . . 1.18 108.428 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.065 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -131.58 146.78 52.38 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-O 117.55 -1.214 . . . . 0.74 109.353 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.795 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.86 -71.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 125.49 1.744 . . . . 0.65 113.56 -167.202 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.795 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -152.18 3.66 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.159 -1.382 . . . . 1.05 110.443 -172.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.82 ' HB3' HD22 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -94.23 142.73 27.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.027 -1.101 . . . . 1.29 108.027 177.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.48 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 31.3 t80 -133.64 132.84 41.23 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 113.64 -1.618 . . . . 0.77 111.79 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.6 m-20 -151.35 153.05 34.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.063 -0.972 . . . . 1.6 110.4 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 33.4 m -148.54 148.84 30.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.117 0.484 . . . . 1.19 111.737 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.821 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 28.9 t -133.4 150.76 51.79 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.804 0.812 . . . . 0.84 111.947 174.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.45 120.86 18.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.752 -1.567 . . . . 1.58 109.916 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 10.1 p90 -143.48 130.57 20.68 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.939 -0.393 . . . . 0.86 109.939 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.795 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -107.86 128.31 54.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.318 1.056 . . . . 2.11 113.359 -170.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -95.08 109.28 21.36 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.842 -1.526 . . . . 0.37 109.196 176.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.0 m -90.43 96.79 10.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.405 -0.591 . . . . 0.33 109.405 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.613 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.2 p -77.68 113.36 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 122.765 1.269 . . . . 0.33 108.626 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -84.35 97.97 9.77 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.186 -1.825 . . . . 1.19 109.664 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.2 tm-20 . . . . . 0 C--N 1.301 -1.512 0 CA-C-N 113.491 -1.686 . . . . 1.67 109.339 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.457 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 m-20 . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 109.277 -0.638 . . . . 1.65 109.277 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.83 91.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.38 2.054 . . . . 0.97 112.454 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.722 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -117.8 -64.94 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.335 -0.848 . . . . 0.5 109.174 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 94.11 42.88 3.93 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.208 -1.957 . . . . 0.39 108.208 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.01 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -52.64 -39.75 62.1 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 112.87 -1.665 . . . . 0.33 110.293 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.866 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.9 84.39 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.281 -0.872 . . . . 0.72 109.6 177.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.42 -49.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.343 -1.299 . . . . 0.63 109.388 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.44 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 24.1 ttt -141.6 136.68 31.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.394 -0.821 . . . . 2.88 109.317 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.732 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -110.76 137.99 20.95 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.193 -0.458 . . . . 3.67 110.987 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.67 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 4.0 Cg_endo -71.49 155.47 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.223 1.949 . . . . 0.64 110.718 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.2 mm-40 -120.25 177.25 5.09 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.687 -0.486 . . . . 1.43 109.687 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.0 p-10 -66.67 -141.59 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 122.884 1.326 . . . . 2.06 111.828 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 148.97 133.33 2.22 Favored Glycine 0 C--N 1.291 -1.938 0 CA-C-N 113.586 -1.643 . . . . 0.3 111.716 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 28.6 mt-10 -113.62 111.86 22.56 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.357 -0.979 . . . . 1.53 108.357 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.462 ' CG1' HD13 ' A' ' 22' ' ' ILE . 3.0 m -127.74 163.64 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.862 0 N-CA-C 107.252 -1.388 . . . . 0.27 107.252 -170.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.55 152.89 18.03 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.83 -1.077 . . . . 0.77 109.13 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.866 HG21 ' HB3' ' A' ' 81' ' ' PRO . 3.7 t -66.67 105.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 122.923 1.344 . . . . 0.78 108.123 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.55 5.9 Favored Glycine 0 C--N 1.263 -3.494 0 CA-C-N 111.921 -2.4 . . . . 0.48 111.678 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.83 -127.83 6.16 Favored Glycine 0 N--CA 1.409 -3.16 0 C-N-CA 118.932 -1.604 . . . . 0.44 109.188 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.9 p -152.15 174.35 13.83 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.04 -1.58 . . . . 0.82 110.075 177.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.2 tp -147.58 150.47 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-N 113.703 -1.589 . . . . 0.32 107.505 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.5 m -138.53 124.01 19.51 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 113.222 -1.808 . . . . 0.31 109.943 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.776 ' HD2' HD12 ' A' ' 74' ' ' LEU . 33.1 m-85 -119.96 146.04 46.19 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.404 -1.271 . . . . 0.53 109.015 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.36 120.42 15.59 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.141 -0.936 . . . . 0.58 110.192 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.579 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -120.18 116.22 25.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.478 -1.237 . . . . 0.32 110.613 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.5 mtt180 -103.6 121.93 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.557 -0.292 . . . . 2.43 110.548 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG21 HG21 ' A' ' 39' ' ' VAL . 23.5 t -123.34 129.42 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.032 0.92 . . . . 0.26 110.524 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.78 110.81 2.96 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.36 -1.745 . . . . 0.4 111.529 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.634 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -51.05 -39.26 40.84 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.856 -1.066 . . . . 0.76 112.633 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 58.03 -170.64 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.517 0.727 . . . . 0.71 112.406 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.2 m -73.59 -71.54 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.49 -0.93 . . . . 1.74 108.49 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.938 HD23 HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 69.2 158.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 O-C-N 123.782 0.676 . . . . 2.16 112.378 166.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.903 ' N ' HD22 ' A' ' 33' ' ' LEU . 19.2 tp -80.71 -66.24 0.91 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.906 -0.588 . . . . 1.47 110.879 168.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.766 ' O ' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -122.91 130.12 24.73 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 114.281 1.215 . . . . 1.4 114.281 172.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' N ' HD11 ' A' ' 33' ' ' LEU . 18.4 Cg_exo -34.36 131.66 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.305 3.337 . . . . 0.88 113.171 -171.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.851 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 34.0 Cg_exo -49.02 133.47 28.65 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 122.484 2.122 . . . . 0.53 112.671 -170.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.38 103.6 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.784 -1.562 . . . . 0.77 106.784 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -105.34 113.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.959 -1.928 . . . . 0.28 107.504 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HB2' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -102.04 128.7 48.37 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-O 123.331 1.539 . . . . 1.54 109.006 174.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.054 ' HB3' HD13 ' A' ' 49' ' ' LEU . 57.2 m95 -84.91 153.27 22.96 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 111.829 -2.441 . . . . 0.34 110.867 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 17.8 t80 -122.31 135.81 54.79 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.932 -2.247 . . . . 0.62 104.932 172.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.661 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 76.9 tttt -103.31 166.52 10.38 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.674 -1.602 . . . . 2.17 106.674 -175.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA2' ' CA ' ' A' ' 85' ' ' GLY . . . -8.7 -162.09 0.0 OUTLIER Glycine 0 C--O 1.196 -2.227 0 N-CA-C 118.903 2.321 . . . . 1.23 118.903 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.746 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 39.6 pttt -38.68 -20.42 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.18 1.918 . . . . 3.87 116.18 -163.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.746 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 15.2 p-90 -167.27 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 120.073 1.306 . . . . 2.11 113.395 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -92.55 170.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 123.19 1.471 . . . . 1.29 112.072 -162.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 27.8 t70 -113.35 154.1 27.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 112.345 -2.207 . . . . 2.73 106.797 175.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.054 HD13 ' HB3' ' A' ' 41' ' ' TRP . 6.1 mp -91.29 -39.92 11.79 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 119.008 -0.52 . . . . 0.44 112.057 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.6 t -59.99 -20.14 56.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.813 -0.81 . . . . 1.23 108.813 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -86.67 -28.6 23.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.983 -1.008 . . . . 1.34 111.456 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 11.4 mmmt -100.11 -62.73 1.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.446 -0.797 . . . . 1.4 111.395 -172.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 49' ' ' LEU . 48.3 t 4.48 93.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 O-C-N 125.88 1.987 . . . . 0.37 113.804 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -164.99 -123.99 0.68 Allowed Glycine 0 C--N 1.31 -0.914 0 CA-C-N 113.001 -1.909 . . . . 0.7 113.048 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.36 -38.49 78.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.763 0.425 . . . . 2.75 111.839 -170.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 6.8 t-80 -88.16 -38.64 15.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.75 0.786 . . . . 1.33 111.463 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.0 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.14 105.29 7.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.824 -1.547 . . . . 1.11 106.824 -177.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.8 114.78 27.12 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.063 -1.458 . . . . 0.76 107.063 168.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.661 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.7 92.61 5.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.011 -2.589 . . . . 0.26 104.011 169.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.733 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 8.5 t-160 -100.13 161.38 13.64 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.924 -1.489 . . . . 2.03 109.268 -173.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.02 119.83 26.25 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 111.982 -2.372 . . . . 0.92 110.839 -173.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.794 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.4 m -97.48 146.39 25.29 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 111.826 -2.443 . . . . 0.47 106.75 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.449 ' HD1' ' CD1' ' A' ' 70' ' ' TYR . 28.5 t80 -145.43 96.63 2.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.385 1.088 . . . . 1.39 111.389 -168.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 10.8 m-20 -115.67 101.11 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.235 -1.802 . . . . 2.42 109.084 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -44.78 60.93 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.24 -0.891 . . . . 2.46 111.278 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -19.52 60.68 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.112 -0.949 . . . . 1.15 111.118 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 49.4 m -92.8 -13.12 29.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.376 -1.342 . . . . 1.41 107.376 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 tpmt? 69.6 27.45 4.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.806 -1.543 . . . . 3.31 110.52 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 67' ' ' SER . 5.4 t -131.54 126.72 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.815 0.817 . . . . 0.43 110.549 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.851 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 10.6 m-85 -101.35 109.27 21.09 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.944 -1.502 . . . . 1.24 106.944 165.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.1 tp -92.5 104.49 16.8 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.113 0.959 . . . . 0.52 108.989 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -83.9 113.82 21.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.909 -1.515 . . . . 0.33 106.909 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.733 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.5 pt-20 -117.5 122.94 45.1 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.513 -1.676 . . . . 1.32 110.086 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.776 HD12 ' HD2' ' A' ' 24' ' ' PHE . 2.4 mt -94.23 133.15 38.05 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.108 -1.405 . . . . 0.96 108.935 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 5.6 m170 -115.38 96.66 5.76 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.357 -2.831 . . . . 1.15 103.357 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.675 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.5 mt -124.59 100.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.976 1.37 . . . . 0.52 108.545 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.3 p -105.46 169.3 8.54 Favored 'General case' 0 N--CA 1.394 -3.238 0 CA-C-N 114.323 -1.308 . . . . 0.58 110.102 -172.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 36.71 69.05 0.22 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 111.206 -2.725 . . . . 2.12 111.392 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -57.19 126.26 26.42 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 112.196 -2.274 . . . . 0.4 111.397 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.716 ' O ' HG11 ' A' ' 106' ' ' VAL . 3.3 tp60 -56.05 131.42 74.17 Favored Pre-proline 0 C--O 1.223 -0.34 0 CA-C-N 115.76 -0.655 . . . . 1.43 109.634 172.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.866 ' HB3' HG21 ' A' ' 18' ' ' VAL . 21.9 Cg_endo -61.32 -15.9 43.43 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.982 2.455 . . . . 1.33 113.148 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -108.25 26.63 10.2 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.807 -0.633 . . . . 1.12 110.365 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -81.34 -52.91 6.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.47 -0.492 . . . . 1.24 111.188 -178.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.4 m 21.71 75.48 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 123.427 1.584 . . . . 1.22 109.276 -159.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.659 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.95 114.96 4.56 Favored Glycine 0 N--CA 1.407 -3.254 0 CA-C-N 112.152 -2.294 . . . . 1.43 112.397 -156.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.563 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -98.74 87.81 0.82 Allowed Glycine 0 C--N 1.273 -2.957 0 N-CA-C 109.544 -1.423 . . . . 0.52 109.544 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.737 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 m-85 -85.46 139.62 31.36 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.194 -1.503 . . . . 0.63 107.629 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.704 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 49.0 mtm180 -137.24 155.73 49.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.629 0.252 . . . . 3.15 110.378 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 3.4 m -122.82 120.95 35.05 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.147 -0.686 . . . . 1.08 109.147 173.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -123.41 105.12 9.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.002 -0.74 . . . . 1.81 109.002 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.8 p -101.55 142.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.465 0.65 . . . . 0.54 111.501 -175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 t -132.13 108.11 9.07 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.346 -1.297 . . . . 1.18 108.681 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.938 HG22 HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.36 154.01 51.1 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 117.853 -1.07 . . . . 0.74 108.718 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.735 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.72 -75.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 125.895 1.997 . . . . 0.65 114.391 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.735 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t70 -151.44 3.17 0.42 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.979 -1.01 . . . . 1.05 109.31 -175.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.01 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -96.39 128.47 43.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.378 -0.971 . . . . 1.29 108.378 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -130.57 132.15 45.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.708 -1.133 . . . . 0.77 110.879 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -154.04 153.9 32.75 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.418 -1.265 . . . . 1.6 110.379 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 59.6 m -145.02 152.44 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 1.19 110.749 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.866 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 56.3 p -131.22 148.26 52.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.641 -0.709 . . . . 0.84 109.371 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.704 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 27.9 p-10 -133.84 124.36 26.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.72 0.295 . . . . 1.58 110.329 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 9.6 p90 -143.85 126.4 15.94 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.144 0.497 . . . . 0.86 110.5 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 59.6 m-20 -103.46 136.86 42.42 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.273 1.035 . . . . 2.11 111.047 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -105.64 110.52 22.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.085 -1.416 . . . . 0.37 109.157 177.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.442 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.0 m -94.61 97.22 9.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.006 -0.738 . . . . 0.33 109.006 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.3 p -81.48 119.11 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-O 122.851 1.31 . . . . 0.33 108.883 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -91.4 99.16 12.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.034 -1.894 . . . . 1.19 108.763 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 18' ' ' VAL . 44.1 tt0 . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 114.122 -1.399 . . . . 1.67 110.094 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.616 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.74 -0.837 . . . . 1.65 108.74 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.417 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -40.7 96.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 125.015 3.81 . . . . 0.97 115.162 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 6' ' ' LEU . 1.4 mp -128.85 -60.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.036 -0.983 . . . . 0.5 109.225 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.12 54.96 2.46 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.635 -1.786 . . . . 0.39 108.635 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -62.97 -32.49 73.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.466 -1.367 . . . . 0.33 111.051 -165.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.12 84.96 3.36 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.746 -0.661 . . . . 0.72 109.813 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.65 -46.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.825 -1.08 . . . . 0.63 109.766 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.59 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 25.1 ttt -140.4 130.51 24.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.408 -0.814 . . . . 2.88 108.943 174.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -102.69 128.6 27.63 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.141 -0.481 . . . . 3.67 110.195 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.683 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 10.8 Cg_endo -62.16 150.98 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.291 1.994 . . . . 0.64 110.675 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.496 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.5 mm-40 -121.96 173.91 7.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.884 -0.598 . . . . 1.43 110.327 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 8.0 p-10 -70.7 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.937 1.351 . . . . 2.06 111.896 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 158.42 130.14 1.15 Allowed Glycine 0 C--N 1.294 -1.755 0 CA-C-N 113.099 -1.864 . . . . 0.3 112.689 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -112.94 107.78 16.47 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.044 -1.078 . . . . 1.53 109.071 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.24 163.52 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 N-CA-C 107.255 -1.387 . . . . 0.27 107.255 -167.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.92 156.74 16.2 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.303 -0.862 . . . . 0.77 109.638 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.662 HG22 HG22 ' A' ' 106' ' ' VAL . 18.1 t -68.51 104.53 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 CA-C-O 122.876 1.322 . . . . 0.78 108.326 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.72 4.85 7.9 Favored Glycine 0 C--N 1.27 -3.087 0 CA-C-N 112.36 -2.2 . . . . 0.48 112.837 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.67 -125.33 5.13 Favored Glycine 0 N--CA 1.415 -2.706 0 N-CA-C 109.674 -1.37 . . . . 0.44 109.674 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 14.5 p -150.36 172.59 15.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 112.847 -1.676 . . . . 0.82 110.38 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.7 tp -148.86 145.66 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 112.896 -1.957 . . . . 0.32 106.988 172.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 m -139.08 129.13 25.18 Favored 'General case' 0 C--N 1.261 -3.278 0 CA-C-N 114.003 -1.453 . . . . 0.31 110.711 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.643 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 38.7 m-85 -127.15 145.2 50.83 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.199 -1.364 . . . . 0.53 110.012 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.11 121.61 22.88 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.432 -0.804 . . . . 0.58 109.251 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.683 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -124.42 117.78 25.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.92 -1.037 . . . . 0.32 110.541 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.7 mtt180 -107.71 118.59 37.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.209 -0.45 . . . . 2.43 110.498 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.54 HG21 HG21 ' A' ' 39' ' ' VAL . 18.5 t -117.92 127.15 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 122.044 0.926 . . . . 0.26 109.695 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.1 0.65 Allowed 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.339 -1.755 . . . . 0.4 111.076 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.697 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -51.32 -50.63 39.96 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.263 -1.335 . . . . 0.76 112.025 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.736 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 48.1 -161.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.558 0.743 . . . . 0.71 112.319 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -127.33 86.07 2.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.633 -0.877 . . . . 1.74 108.633 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.852 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -110.32 -175.83 2.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.206 -0.452 . . . . 2.16 109.914 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.24 -24.51 42.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.337 0.589 . . . . 1.47 111.471 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.852 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -151.83 -179.39 1.01 Allowed Pre-proline 0 C--O 1.212 -0.905 0 CA-C-N 115.133 -0.94 . . . . 1.4 109.148 -173.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 2.9 Cg_exo -73.19 141.98 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 N-CA-C 107.965 -1.59 . . . . 0.88 107.965 165.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 93' ' ' THR . 21.8 Cg_exo -52.34 135.31 53.67 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.087 1.191 . . . . 0.53 111.592 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 35' ' ' LYS . 2.6 t -97.58 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.68 0 N-CA-C 106.586 -1.635 . . . . 0.77 106.586 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.64 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -111.23 114.56 47.44 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.084 0 CA-C-N 113.127 -1.852 . . . . 0.28 107.517 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.836 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.02 129.85 51.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 123.086 1.422 . . . . 1.54 109.816 173.25 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.052 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.3 m95 -87.87 154.99 20.09 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 111.689 -2.505 . . . . 0.34 111.875 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 30.8 t80 -135.1 138.06 43.42 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 104.578 -2.379 . . . . 0.62 104.578 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.794 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 60.5 tttp -103.98 166.22 10.55 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.983 -2.229 . . . . 2.17 104.983 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.02 -165.31 0.0 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 119.215 2.446 . . . . 1.23 119.215 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.612 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 7.0 mtpp -43.37 -10.44 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 O-C-N 119.489 -2.183 . . . . 3.87 116.574 -166.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.429 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 15.2 p-90 -163.21 -9.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.751 1.389 . . . . 2.11 114.751 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.62 151.5 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 CA-C-O 123.112 1.434 . . . . 1.29 112.336 -160.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.8 t70 -110.48 127.31 55.09 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 111.87 -2.423 . . . . 2.73 108.721 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.052 HD13 ' HB3' ' A' ' 41' ' ' TRP . 3.1 mp -68.23 -34.97 77.22 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.04 -0.527 . . . . 0.44 112.268 -175.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -58.76 -21.76 56.43 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.45 0.643 . . . . 1.23 109.36 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -92.72 -29.57 15.99 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.782 -1.099 . . . . 1.34 111.365 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.76 ' HB2' HD12 ' A' ' 57' ' ' LEU . 11.1 mmmt -98.05 -30.59 12.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.526 -0.761 . . . . 1.4 111.569 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 42.7 t -45.01 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 125.704 1.602 . . . . 0.37 111.264 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.92 -98.23 0.13 Allowed Glycine 0 C--N 1.298 -1.545 0 CA-C-N 112.374 -2.194 . . . . 0.7 113.749 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -91.62 -42.32 10.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.497 . . . . 2.75 112.341 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.5 p80 -95.86 -38.12 10.42 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.073 0.463 . . . . 1.33 110.897 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.935 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.82 105.82 13.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.261 -1.755 . . . . 1.11 106.261 173.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -100.16 115.96 31.06 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 106.757 -1.571 . . . . 0.76 106.757 165.317 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -97.02 92.27 5.99 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 104.146 -2.538 . . . . 0.26 104.146 170.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.756 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 29.3 m-70 -91.87 162.86 14.25 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 114.361 -1.291 . . . . 2.03 110.106 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.95 115.75 14.75 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.132 -2.304 . . . . 0.92 109.835 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -92.29 147.87 22.58 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.24 -1.8 . . . . 0.47 107.463 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -142.25 98.19 3.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.244 1.021 . . . . 1.39 110.799 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.608 ' OD1' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -114.46 114.6 26.03 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.37 -1.741 . . . . 2.42 111.014 174.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.734 ' HD3' ' HE2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.526 -0.761 . . . . 2.46 110.756 175.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.83 -28.88 70.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.292 -0.867 . . . . 1.15 111.304 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.608 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 15.0 m -100.66 -18.49 16.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.175 -1.046 . . . . 1.41 108.175 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.736 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 64.05 37.33 9.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.277 -1.328 . . . . 3.31 109.736 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.65 139.18 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 115.373 -0.83 . . . . 0.43 109.758 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 70.0 m-85 -102.82 109.08 20.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.383 -1.71 . . . . 1.24 106.383 162.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.3 tp -94.53 104.07 16.02 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.404 1.097 . . . . 0.52 108.806 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.6 m-85 -88.35 113.95 24.47 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.713 -1.585 . . . . 0.33 107.624 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.756 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 8.2 pt-20 -115.0 124.46 51.7 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.877 -1.51 . . . . 1.32 109.877 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.779 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -90.23 120.8 31.69 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.416 -1.72 . . . . 0.96 108.33 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -112.12 95.65 5.59 Favored 'General case' 0 C--N 1.268 -2.947 0 N-CA-C 103.976 -2.602 . . . . 1.15 103.976 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.723 ' HB ' HG23 ' A' ' 22' ' ' ILE . 64.6 mt -120.84 98.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-O 123.26 1.505 . . . . 0.52 109.54 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 21.3 p -112.29 136.31 51.9 Favored 'General case' 0 N--CA 1.393 -3.321 0 CA-C-N 113.213 -1.812 . . . . 0.58 106.96 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER 72.83 100.13 0.07 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 111.684 -2.507 . . . . 2.12 109.017 -171.165 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.98 113.24 26.66 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 110.431 -3.077 . . . . 0.4 109.538 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.676 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -54.32 140.19 55.39 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.438 -0.801 . . . . 1.43 110.252 171.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 21.6 Cg_endo -61.03 -11.59 19.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.142 2.561 . . . . 1.33 112.875 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -97.64 11.14 38.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.124 -0.489 . . . . 1.12 110.687 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.439 ' O ' HD23 ' A' ' 104' ' ' LEU . 2.6 m-30 -97.32 -8.86 28.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 119.449 -0.31 . . . . 1.24 110.636 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 20.5 m -47.95 97.71 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.116 -1.068 . . . . 1.22 108.116 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.612 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -168.53 -129.07 1.05 Allowed Glycine 0 C--N 1.263 -3.508 0 CA-C-N 113.365 -1.743 . . . . 1.43 112.563 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -152.86 119.25 0.94 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 119.95 -1.119 . . . . 0.52 112.369 -171.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.788 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -84.97 114.7 22.35 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 113.496 -1.352 . . . . 0.63 107.541 174.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 45.2 mtm180 -105.49 127.41 52.99 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.909 0.385 . . . . 3.15 110.497 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 t -111.83 123.61 50.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.433 -0.58 . . . . 1.08 109.433 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.836 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 47.5 mt-10 -133.02 115.87 15.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.649 -0.705 . . . . 1.81 110.347 -175.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -107.7 141.46 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.266 0.555 . . . . 0.54 110.977 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 t -134.68 111.52 10.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.069 -0.968 . . . . 1.18 110.215 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.463 ' CG2' HD22 ' A' ' 33' ' ' LEU . 11.1 p -117.27 -177.45 3.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.168 -0.924 . . . . 0.74 111.213 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.986 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -18.04 -48.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 125.682 1.864 . . . . 0.65 113.678 175.276 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.986 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -167.54 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.837 -1.529 . . . . 1.05 110.723 -173.194 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.646 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -95.76 132.71 40.69 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.079 -1.082 . . . . 1.29 108.079 -177.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -130.99 133.97 46.27 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.269 -1.332 . . . . 0.77 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -152.15 147.32 26.3 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.458 -1.247 . . . . 1.6 109.259 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.7 p -149.64 149.22 30.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.151 0.5 . . . . 1.19 111.578 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.6 p -124.57 148.14 48.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.496 -0.775 . . . . 0.84 111.739 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -128.04 112.8 15.01 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.604 -1.18 . . . . 1.58 109.106 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.767 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 12.9 p90 -141.47 128.11 20.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.41 0.624 . . . . 0.86 109.664 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 7.7 p30 -104.71 140.26 38.32 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.233 1.016 . . . . 2.11 112.59 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -109.37 114.31 27.87 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.423 -1.262 . . . . 0.37 108.329 175.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 m -97.35 96.11 8.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.959 -0.756 . . . . 0.33 108.959 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.662 HG22 HG22 ' A' ' 18' ' ' VAL . 5.1 p -80.08 113.06 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 123.193 1.473 . . . . 0.33 109.252 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 41.1 m170 -82.78 99.04 9.43 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 112.447 -2.161 . . . . 1.19 110.229 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 41.8 tt0 . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 114.441 -1.254 . . . . 1.67 108.624 167.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.635 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 6.2 t70 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.909 -0.774 . . . . 1.65 108.909 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.443 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 87.3 Cg_exo -47.52 92.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 124.156 3.237 . . . . 0.97 114.959 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.5 mp -119.18 -51.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.924 -1.035 . . . . 0.5 109.264 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.09 41.14 8.2 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.548 -1.821 . . . . 0.39 108.548 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 96' ' ' LYS . 12.4 tp -51.5 -48.18 63.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.757 -1.721 . . . . 0.33 110.927 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.737 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -92.25 84.12 5.16 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.674 0.749 . . . . 0.72 109.643 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.64 -46.49 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.33 -1.305 . . . . 0.63 110.138 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.508 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 18.1 mmt -140.96 130.7 24.22 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.044 -0.526 . . . . 2.88 111.077 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.9 ptp180 -101.24 132.65 21.65 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.123 -0.944 . . . . 3.67 108.877 173.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.784 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 68.6 Cg_endo -78.9 158.01 27.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.244 1.963 . . . . 0.64 110.172 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 12.6 mm100 -118.72 -178.41 3.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 120.348 -0.541 . . . . 1.43 112.003 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.1 p-10 -69.98 -147.97 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 122.684 1.23 . . . . 2.06 111.421 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 155.41 133.38 1.7 Allowed Glycine 0 C--N 1.291 -1.952 0 CA-C-N 113.549 -1.66 . . . . 0.3 112.227 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 36.0 mt-10 -109.96 107.47 17.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.718 -1.241 . . . . 1.53 108.153 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' CG1' HD13 ' A' ' 22' ' ' ILE . 2.8 m -125.79 163.32 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.158 0 N-CA-C 106.779 -1.563 . . . . 0.27 106.779 -171.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.54 155.84 17.08 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.064 -0.971 . . . . 0.77 108.888 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 81' ' ' PRO . 2.9 t -66.64 106.7 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 122.362 1.077 . . . . 0.78 108.56 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 6.64 8.17 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.54 -2.118 . . . . 0.48 111.663 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.86 -124.71 5.19 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.52 -1.432 . . . . 0.44 109.52 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.1 p -151.64 174.62 13.25 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 112.983 -1.609 . . . . 0.82 109.852 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.8 tp -146.14 147.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.481 -1.69 . . . . 0.32 107.119 166.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 m -140.76 130.9 24.81 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.45 -1.704 . . . . 0.31 110.17 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.602 ' HB2' HD23 ' A' ' 74' ' ' LEU . 23.7 m-85 -125.56 144.47 50.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.268 -1.333 . . . . 0.53 108.855 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.12 117.9 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.15 -0.932 . . . . 0.58 110.313 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.9 116.99 22.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 113.947 -1.479 . . . . 0.32 111.428 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 79.3 mtt-85 -104.88 127.68 52.8 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.09 -0.244 . . . . 2.43 110.775 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.3 t -126.66 126.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.084 0.945 . . . . 0.26 110.223 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -58.54 112.2 1.52 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.607 -1.633 . . . . 0.4 112.596 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.81 -57.37 12.69 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-N 114.441 -1.254 . . . . 0.76 112.086 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.848 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.29 177.29 0.24 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.37 1.248 . . . . 0.71 114.37 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -103.36 22.07 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.535 -1.211 . . . . 1.74 109.842 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.957 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -52.18 171.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.617 -1.174 . . . . 2.16 112.666 175.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.31 -51.42 54.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.275 0.56 . . . . 1.47 110.12 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -150.39 157.49 36.78 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.207 -1.035 . . . . 1.4 108.207 168.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.12 143.99 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.337 2.692 . . . . 0.88 112.798 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.957 ' HD3' HD11 ' A' ' 33' ' ' LEU . 15.0 Cg_exo -50.1 143.13 25.95 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.53 113.021 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.22 104.54 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.108 -2.182 . . . . 0.77 105.108 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.609 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -113.09 114.88 48.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.995 -1.457 . . . . 0.28 107.799 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.914 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.11 131.6 51.22 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.161 -1.382 . . . . 1.54 109.418 173.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.067 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.8 m95 -91.92 149.32 21.62 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.221 -2.263 . . . . 0.34 112.099 172.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.728 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 28.0 t80 -130.59 138.33 50.08 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.671 -2.344 . . . . 0.62 104.671 170.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.904 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 83.1 tttt -98.41 174.07 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.375 -1.713 . . . . 2.17 106.375 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -18.84 -169.64 0.0 OUTLIER Glycine 0 C--O 1.179 -3.299 0 C-N-CA 125.991 1.758 . . . . 1.23 117.282 166.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 6.7 mtpp -41.34 -14.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.846 2.536 . . . . 3.87 117.846 -160.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' GLY . 26.5 p-90 -162.46 -6.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.639 1.563 . . . . 2.11 114.891 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.904 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.97 143.74 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-O 122.827 1.299 . . . . 1.29 111.791 -163.031 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -105.89 107.1 17.92 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 112.181 -2.281 . . . . 2.73 109.9 175.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.067 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.0 mp -54.65 -42.87 71.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 112.628 0.603 . . . . 0.44 112.628 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -61.48 -19.07 61.63 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.649 -0.871 . . . . 1.23 108.649 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -86.88 -27.25 23.53 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.023 -0.989 . . . . 1.34 110.956 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 12.1 mmmt -102.9 -64.32 1.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.948 . . . . 1.4 111.847 -171.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 49' ' ' LEU . 49.3 t 3.72 92.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.743 2.017 . . . . 0.37 113.802 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -157.42 -130.17 1.19 Allowed Glycine 0 CA--C 1.525 0.676 0 CA-C-N 112.803 -1.999 . . . . 0.7 112.597 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.26 -38.11 89.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.549 0.944 . . . . 2.75 113.549 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 28.2 p80 -91.21 -31.52 16.13 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.776 0.798 . . . . 1.33 111.669 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.009 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.89 105.39 7.09 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.955 -1.498 . . . . 1.11 106.955 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -97.2 114.75 26.5 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 106.364 -1.717 . . . . 0.76 106.364 166.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.63 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.64 92.54 4.68 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.259 -2.497 . . . . 0.26 104.259 170.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 88.7 m-70 -97.35 160.54 14.27 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 115.009 -0.996 . . . . 2.03 109.348 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.88 112.13 12.18 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.768 -2.015 . . . . 0.92 109.537 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 71' ' ' LEU . 1.3 m -106.51 151.1 25.42 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 112.47 -2.15 . . . . 0.47 107.156 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 17.2 p90 -144.32 115.64 8.02 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-O 122.01 0.909 . . . . 1.39 111.196 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -94.95 96.23 9.16 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.285 -1.325 . . . . 2.42 107.957 169.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -71.78 -30.5 65.63 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.699 -1.591 . . . . 2.46 111.674 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.22 73.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.487 -0.779 . . . . 1.15 110.234 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.441 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 m -89.62 -12.13 40.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.337 -0.847 . . . . 1.41 109.057 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.848 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 1.7 ttpm? 66.03 35.28 6.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.519 -1.219 . . . . 3.31 109.743 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.604 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.7 t -125.81 136.85 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.455 0.645 . . . . 0.43 110.899 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.39 123.19 43.45 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.904 -1.517 . . . . 1.24 106.904 158.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 62' ' ' SER . 18.0 tp -105.95 104.63 14.38 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.793 -1.094 . . . . 0.52 108.114 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.2 m-85 -85.71 115.59 23.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.806 -1.543 . . . . 0.33 107.663 173.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.11 121.8 45.21 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.96 -1.473 . . . . 1.32 109.503 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.832 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.104 -1.407 . . . . 0.96 108.356 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 70.8 m80 -110.01 95.05 5.34 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 104.811 -2.292 . . . . 1.15 104.811 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.74 HD13 ' HE2' ' A' ' 87' ' ' TYR . 63.9 mt -121.51 99.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 122.825 1.297 . . . . 0.52 109.353 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.4 p -104.11 168.73 8.92 Favored 'General case' 0 N--CA 1.394 -3.266 0 CA-C-N 114.359 -1.292 . . . . 0.58 110.569 -173.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 39.33 67.89 0.41 Allowed 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 110.473 -3.058 . . . . 2.12 111.461 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.447 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -58.51 116.43 3.65 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 112.445 -2.162 . . . . 0.4 110.547 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.722 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -54.94 139.4 63.09 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.31 -0.859 . . . . 1.43 109.778 171.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.741 ' HG3' HG21 ' A' ' 18' ' ' VAL . 24.0 Cg_exo -61.23 -12.49 23.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.56 2.173 . . . . 1.33 112.863 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.525 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -103.15 14.34 31.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 1.12 110.795 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -89.73 -15.28 32.86 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.762 -0.637 . . . . 1.24 111.182 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.1 m -41.07 87.97 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 124.947 1.405 . . . . 1.22 111.211 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -157.51 -137.98 2.4 Favored Glycine 0 C--N 1.28 -2.544 0 CA-C-N 113.098 -1.864 . . . . 1.43 112.835 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.11 119.22 0.91 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.974 -1.584 . . . . 0.52 113.418 -167.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.83 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.8 m-85 -82.66 114.42 21.01 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 112.952 -1.624 . . . . 0.63 108.47 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 11.0 mmm180 -103.98 104.52 14.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.455 -0.339 . . . . 3.15 110.181 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.678 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 3.8 t -94.94 123.62 38.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.14 -0.689 . . . . 1.08 109.14 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.914 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 66.1 mt-10 -136.67 107.79 6.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.135 -0.939 . . . . 1.81 110.271 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -99.78 141.6 16.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.533 0.682 . . . . 0.54 110.388 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -141.24 109.29 5.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.821 -1.081 . . . . 1.18 108.623 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.706 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -134.5 150.65 50.81 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 117.885 -1.055 . . . . 0.74 109.477 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.886 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 29.54 -73.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.673 1.858 . . . . 0.65 114.693 177.06 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.886 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 11.1 t0 -152.13 -4.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.492 -1.231 . . . . 1.05 110.056 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.761 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -92.27 125.72 37.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.765 -1.198 . . . . 1.29 107.765 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -129.56 140.92 51.09 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.109 -0.95 . . . . 0.77 110.974 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -168.46 156.92 8.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.354 -0.839 . . . . 1.6 109.769 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 m -150.32 145.23 26.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.276 0.56 . . . . 1.19 110.098 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.845 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 26.8 p -125.2 134.71 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.616 -0.72 . . . . 0.84 110.668 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.2 117.46 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.484 0.659 . . . . 1.58 110.97 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.845 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -141.0 124.83 17.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.643 -0.708 . . . . 0.86 109.658 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.599 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 78.8 m-20 -100.16 153.22 19.42 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 122.31 1.052 . . . . 2.11 111.553 -170.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -117.02 115.37 25.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.531 -1.213 . . . . 0.37 107.943 173.465 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.514 ' HA ' HG23 ' A' ' 84' ' ' THR . 7.5 m -100.64 95.9 6.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.399 -0.963 . . . . 0.33 108.399 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.722 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.61 117.18 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.254 1.502 . . . . 0.33 108.942 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.447 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 33.4 m170 -87.72 100.17 12.63 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.47 -2.15 . . . . 1.19 108.442 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 49.0 tt0 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.852 -1.067 . . . . 1.67 110.275 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.646 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.435 -1.214 0 CA-C-O 119.555 -0.259 . . . . 1.65 110.371 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 60.2 Cg_endo -73.29 36.32 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.649 2.233 . . . . 0.97 113.791 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.79 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -57.6 -60.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.091 -0.959 . . . . 0.5 109.904 170.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 88.7 45.86 4.75 Favored Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 109.248 -1.541 . . . . 0.39 109.248 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.985 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.1 tp -46.59 -43.86 17.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.288 -1.456 . . . . 0.33 110.502 -173.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.74 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.34 84.85 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.998 0.904 . . . . 0.72 110.483 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.51 -47.3 52.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.03 -1.441 . . . . 0.63 109.612 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.539 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 16.6 tpt -152.7 133.21 13.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.372 -0.831 . . . . 2.88 109.087 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.611 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -101.09 136.51 19.7 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.771 -0.649 . . . . 3.67 110.637 -177.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.761 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.6 Cg_endo -63.41 155.29 63.17 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.2 1.934 . . . . 0.64 111.057 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.406 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.8 mm-40 -119.96 174.31 6.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.124 -0.489 . . . . 1.43 110.735 -174.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.4 p-10 -68.49 -142.66 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 122.738 1.256 . . . . 2.06 111.807 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 146.55 137.4 3.02 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.317 -1.765 . . . . 0.3 111.811 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 40.9 mt-10 -109.71 116.08 31.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.337 -0.932 . . . . 1.53 108.529 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -138.29 153.78 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.727 -1.212 . . . . 0.27 107.727 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -84.14 156.4 22.13 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.687 -1.142 . . . . 0.77 109.474 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.753 HG11 ' HD3' ' A' ' 81' ' ' PRO . 9.1 t -68.9 105.63 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 123.313 1.53 . . . . 0.78 107.629 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.39 15.2 7.16 Favored Glycine 0 C--N 1.264 -3.437 0 CA-C-N 111.926 -2.397 . . . . 0.48 112.342 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.58 -123.18 4.59 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.179 -1.486 . . . . 0.44 109.477 167.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 58.6 m -154.47 173.23 16.55 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 113.087 -1.556 . . . . 0.82 108.646 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.64 HG21 HD13 ' A' ' 104' ' ' LEU . 10.3 tp -149.11 150.58 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 N-CA-C 107.127 -1.434 . . . . 0.32 107.127 167.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.431 ' N ' HG13 ' A' ' 22' ' ' ILE . 8.6 m -137.7 123.86 20.42 Favored 'General case' 0 C--N 1.262 -3.238 0 CA-C-N 113.636 -1.62 . . . . 0.31 110.336 -177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 36.7 m-85 -117.84 147.83 42.69 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.906 -1.497 . . . . 0.53 108.38 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -140.23 122.24 15.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.272 -0.876 . . . . 0.58 109.574 176.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -116.35 115.84 26.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.873 -1.058 . . . . 0.32 109.903 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -102.74 111.6 24.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.247 -0.433 . . . . 2.43 110.283 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 91' ' ' VAL . 19.0 t -115.53 126.62 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-O 121.988 0.899 . . . . 0.26 110.185 -178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 104.33 1.04 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.564 -1.653 . . . . 0.4 110.378 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.783 ' HA3' ' NZ ' ' A' ' 68' ' ' LYS . . . -51.94 -66.95 2.27 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.163 -1.38 . . . . 0.76 112.031 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.758 ' H ' ' HB3' ' A' ' 68' ' ' LYS . . . 60.34 -167.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.762 0.825 . . . . 0.71 111.96 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -106.57 144.12 33.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 1.74 109.833 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.39 -172.14 3.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.44 0.638 . . . . 2.16 112.465 -169.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.41 -44.36 17.64 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 1.47 108.895 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.592 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 1.3 pptp? -142.36 142.39 23.66 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.321 -0.854 . . . . 1.4 108.855 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.91 146.46 4.08 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.183 2.588 . . . . 0.88 112.43 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_endo -54.9 128.4 30.33 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 120.952 1.101 . . . . 0.53 111.877 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.84 103.96 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 106.774 -1.565 . . . . 0.77 106.774 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.8 t -105.83 114.51 45.4 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 113.56 -1.654 . . . . 0.28 107.436 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.59 128.87 54.91 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-O 123.221 1.486 . . . . 1.54 109.81 176.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.023 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -90.31 152.53 20.99 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 112.138 -2.301 . . . . 0.34 111.96 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 32.8 t80 -128.02 130.75 48.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.556 -2.016 . . . . 0.62 105.556 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 tttm -107.85 102.31 11.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.878 -1.156 . . . . 2.17 107.878 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -90.9 100.11 2.65 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 116.632 -2.699 . . . . 1.23 116.88 -161.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.4 pttm -102.6 -41.18 6.34 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 103.925 -2.621 . . . . 3.87 103.925 123.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.639 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.8 p-90 -171.09 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 112.667 -2.06 . . . . 2.11 112.48 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.92 173.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-O 123.28 1.514 . . . . 1.29 112.614 -163.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.613 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.1 p-10 -96.57 161.29 13.96 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.413 -2.63 . . . . 2.73 106.887 170.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.023 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -97.43 -31.36 12.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 119.02 -0.514 . . . . 0.44 112.0 167.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -56.89 -21.8 32.36 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 123.585 0.553 . . . . 1.23 109.733 -161.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.604 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -100.79 -26.43 13.78 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.384 -0.926 . . . . 1.34 112.116 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.615 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.76 -27.12 14.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.496 -1.229 . . . . 1.4 111.537 -167.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.974 HG13 ' H ' ' A' ' 59' ' ' LEU . 74.6 t -37.18 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.53 1.532 . . . . 0.37 110.953 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.05 -105.14 0.23 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 112.803 -1.999 . . . . 0.7 114.015 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -83.95 -45.01 13.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.206 0.447 . . . . 2.75 112.206 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.566 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 57.3 p-80 -91.44 -36.83 13.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.653 . . . . 1.33 111.14 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.977 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.58 106.71 12.03 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.051 -1.463 . . . . 1.11 107.051 176.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -96.98 114.41 26.02 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 106.811 -1.551 . . . . 0.76 106.811 164.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.974 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.9 92.3 4.52 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 104.687 -2.338 . . . . 0.26 104.687 170.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.64 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 17.9 m80 -100.34 163.83 12.21 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.463 1.125 . . . . 2.03 109.473 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.84 112.92 12.89 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 112.113 -2.312 . . . . 0.92 109.817 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 4.7 m -94.95 150.03 20.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.729 -2.032 . . . . 0.47 108.289 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -144.38 107.76 4.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.354 1.073 . . . . 1.39 111.323 -170.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.11 122.54 47.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.887 -1.96 . . . . 2.42 108.913 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.65 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -79.35 -29.59 42.28 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.349 -1.296 . . . . 2.46 111.66 -177.159 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.31 33.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.072 -0.513 . . . . 1.15 110.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 69' ' ' VAL . 25.7 m -124.48 4.15 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.75 -0.659 . . . . 1.41 111.245 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.783 ' NZ ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.81 7.8 3.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.611 0.764 . . . . 3.31 112.318 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 67' ' ' SER . 46.0 t -76.18 117.67 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 CA-C-O 122.407 1.099 . . . . 0.43 110.223 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' A' ' 37' ' ' PRO . 81.4 m-85 -90.07 100.51 13.32 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.663 -2.062 . . . . 1.24 106.312 165.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.9 tp -93.25 103.56 15.8 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.523 1.154 . . . . 0.52 108.026 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.0 m-85 -81.78 113.91 20.06 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 113.321 -1.763 . . . . 0.33 107.716 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.434 ' CG ' ' HG ' ' A' ' 71' ' ' LEU . 51.7 mt-10 -107.32 121.21 44.12 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.328 -1.76 . . . . 1.32 109.037 -175.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.724 HD21 ' CH2' ' A' ' 41' ' ' TRP . 1.4 mm? -98.45 117.02 31.94 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 112.936 -1.938 . . . . 0.96 108.079 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -110.96 95.23 5.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 105.175 -2.157 . . . . 1.15 105.175 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.644 HG12 HD23 ' A' ' 57' ' ' LEU . 54.5 mt -121.53 99.5 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 113.842 -1.526 . . . . 0.52 106.923 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 35.8 p -106.19 167.08 10.05 Favored 'General case' 0 N--CA 1.394 -3.271 0 CA-C-N 114.197 -1.365 . . . . 0.58 109.778 -171.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 40.51 59.35 2.13 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 111.544 -2.571 . . . . 2.12 111.34 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -51.0 123.35 9.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.405 -1.725 . . . . 0.4 109.509 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.564 ' HA ' HG13 ' A' ' 18' ' ' VAL . 1.7 pt20 -78.54 156.13 78.34 Favored Pre-proline 0 C--N 1.311 -1.076 0 N-CA-C 108.033 -1.099 . . . . 1.43 108.033 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.753 ' HD3' HG11 ' A' ' 18' ' ' VAL . 50.8 Cg_endo -68.75 162.72 40.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.005 1.137 . . . . 1.33 109.975 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . 70.74 14.43 7.09 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.616 0.572 . . . . 1.12 111.705 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -80.45 -54.92 5.25 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.303 -0.999 . . . . 1.24 108.303 168.341 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.2 m 36.6 57.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.429 -1.323 . . . . 1.22 107.429 -160.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.672 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -48.73 85.17 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.004 0 CA-C-N 111.56 -2.563 . . . . 1.43 114.788 -161.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.487 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -90.79 78.29 1.44 Allowed Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 108.957 -1.657 . . . . 0.52 108.957 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.687 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 49.0 m-85 -80.71 122.76 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.769 -1.567 . . . . 0.63 106.769 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -115.53 107.64 15.42 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.472 -0.491 . . . . 3.15 109.677 -171.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -92.06 131.37 37.39 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.766 -0.652 . . . . 1.08 109.7 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.947 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 44.4 tt0 -139.77 110.63 6.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.407 -0.815 . . . . 1.81 109.5 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 p -102.0 137.82 28.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.656 0.741 . . . . 0.54 110.534 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.7 t -132.1 108.76 9.51 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.636 -1.165 . . . . 1.18 108.732 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.523 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.2 m -123.47 167.34 14.0 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.031 -1.1 . . . . 0.74 108.031 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.938 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -4.6 -61.26 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 125.316 1.635 . . . . 0.65 114.926 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.938 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -147.76 -10.75 0.4 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.035 -0.984 . . . . 1.05 111.211 -174.261 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.985 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.2 tttp -94.31 134.89 36.33 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 119.133 -1.027 . . . . 1.29 108.23 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.16 135.47 46.39 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 0.77 110.846 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -155.6 147.84 23.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.141 -0.936 . . . . 1.6 109.925 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.461 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 33.2 m -141.94 150.68 41.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.535 0.207 . . . . 1.19 110.674 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.74 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 78.4 p -134.86 132.62 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.427 . . . . 0.84 111.279 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 122.56 47.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.646 -0.707 . . . . 1.58 110.676 176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.779 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 5.0 p90 -142.63 129.48 20.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 0.86 109.416 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 71.7 m-20 -108.7 135.27 50.21 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.417 1.103 . . . . 2.11 111.783 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.49 105.51 15.78 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.102 -1.408 . . . . 0.37 110.448 178.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.446 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 10.4 m -84.12 97.34 9.29 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.732 -0.84 . . . . 0.33 108.732 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 18' ' ' VAL . 7.6 p -84.94 115.53 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 123.236 1.494 . . . . 0.33 110.087 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 78.1 m-70 -88.79 100.68 13.34 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.368 -2.196 . . . . 1.19 109.394 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.616 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.7 tt0 . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 114.208 -1.36 . . . . 1.67 110.594 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.566 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 108.435 -0.95 . . . . 1.65 108.435 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -41.34 94.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 124.656 3.571 . . . . 0.97 114.809 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 6' ' ' LEU . 1.3 mp -126.25 -61.1 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.031 -0.986 . . . . 0.5 109.58 172.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 91.11 52.81 2.31 Favored Glycine 0 CA--C 1.496 -1.142 0 N-CA-C 108.685 -1.766 . . . . 0.39 108.685 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.041 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.3 tp -59.77 -40.71 89.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.225 -1.487 . . . . 0.33 110.191 -169.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.51 5.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.99 -1.005 . . . . 0.72 109.881 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.82 -47.25 33.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.419 -1.264 . . . . 0.63 109.641 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.551 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 17.2 tpt -147.48 129.96 15.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.199 -0.909 . . . . 2.88 109.398 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -106.78 132.46 20.89 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.549 -0.75 . . . . 3.67 110.398 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.682 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 17.4 Cg_endo -66.53 153.59 77.42 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.369 2.046 . . . . 0.64 111.372 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.433 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.5 mm-40 -121.14 176.93 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.228 -0.442 . . . . 1.43 110.327 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.5 p30 -68.03 -148.56 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.384 0 CA-C-O 122.776 1.275 . . . . 2.06 111.237 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 153.4 138.74 2.73 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 113.44 -1.709 . . . . 0.3 111.745 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 29.2 mt-10 -117.47 113.09 21.53 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.297 -0.951 . . . . 1.53 109.029 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 104' ' ' LEU . 2.5 m -132.82 163.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.929 -1.508 . . . . 0.27 106.929 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -94.32 157.74 15.9 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.538 -0.755 . . . . 0.77 109.836 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 106' ' ' VAL . 2.9 t -67.89 106.35 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 107.679 -1.23 . . . . 0.78 107.679 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.46 7.57 8.95 Favored Glycine 0 C--N 1.263 -3.507 0 CA-C-N 112.657 -2.065 . . . . 0.48 112.194 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.51 -125.04 5.02 Favored Glycine 0 N--CA 1.409 -3.154 0 C-N-CA 119.181 -1.485 . . . . 0.44 109.714 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.2 p -152.74 167.87 27.54 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.127 -1.537 . . . . 0.82 110.372 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 76' ' ' ILE . 10.4 tp -147.62 149.67 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-N 113.637 -1.619 . . . . 0.32 107.652 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -139.3 127.24 22.24 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 113.711 -1.586 . . . . 0.31 110.344 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 76' ' ' ILE . 42.0 m-85 -123.71 147.18 47.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.516 -1.22 . . . . 0.53 108.812 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.19 122.59 19.49 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.179 -0.919 . . . . 0.58 109.671 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.676 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -119.03 115.64 24.74 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.593 -1.185 . . . . 0.32 110.226 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -106.71 117.62 34.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.043 -0.526 . . . . 2.43 110.394 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 39' ' ' VAL . 6.3 t -122.27 128.93 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.208 1.004 . . . . 0.26 110.739 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -60.0 110.04 1.1 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.128 -1.851 . . . . 0.4 112.352 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.18 81.43 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 114.897 -1.047 . . . . 0.76 112.463 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.863 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 58.3 -179.07 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.522 1.304 . . . . 0.71 114.522 168.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -101.11 23.81 10.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.525 -1.216 . . . . 1.74 109.809 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.034 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -57.05 175.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.52 -1.218 . . . . 2.16 113.855 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.2 tp -64.73 -56.83 11.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.315 -0.857 . . . . 1.47 109.773 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.709 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.76 143.26 48.63 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.93 -1.032 . . . . 1.4 108.642 176.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.18 140.25 11.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.606 2.204 . . . . 0.88 110.638 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.034 ' HD3' HD11 ' A' ' 33' ' ' LEU . 1.6 Cg_endo -58.94 135.29 65.73 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.325 0.683 . . . . 0.53 112.121 -171.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 92' ' ' SER . 14.1 p -99.71 104.81 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-O 123.724 1.726 . . . . 0.77 107.97 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 28' ' ' VAL . 2.1 t -105.67 114.82 46.07 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 111.892 -2.413 . . . . 0.28 107.592 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.798 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.03 126.1 47.69 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 122.939 1.352 . . . . 1.54 109.051 174.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.952 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.0 m95 -84.46 152.54 23.92 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 112.308 -2.224 . . . . 0.34 112.112 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -129.31 139.61 51.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.378 -2.452 . . . . 0.62 104.378 172.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 38.3 tttt -107.13 165.03 11.66 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.399 -1.334 . . . . 2.17 107.399 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 1.032 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -7.63 -165.43 0.0 OUTLIER Glycine 0 C--O 1.197 -2.184 0 N-CA-C 118.963 2.345 . . . . 1.23 118.963 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG3' ' HB ' ' A' ' 84' ' ' THR . 10.5 mtpp -43.06 -3.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.249 1.944 . . . . 3.87 116.249 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.585 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 20.6 p-90 -172.12 -13.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.287 1.588 . . . . 2.11 115.287 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.02 169.09 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 123.297 1.522 . . . . 1.29 112.344 -160.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.51 154.7 23.3 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.1 -2.318 . . . . 2.73 107.942 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.8 mp -94.4 -32.61 13.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.936 0.717 . . . . 0.44 112.936 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -58.05 -25.58 61.38 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.301 0.572 . . . . 1.23 109.5 -164.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -104.13 -41.57 5.78 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.299 -0.864 . . . . 1.34 113.069 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 5.9 mptt -67.02 -52.39 43.07 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.011 -0.995 . . . . 1.4 111.864 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.961 HG13 ' H ' ' A' ' 59' ' ' LEU . 11.9 t -23.85 100.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 111.38 -2.645 . . . . 0.37 113.512 175.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -166.11 -129.72 1.08 Allowed Glycine 0 C--N 1.299 -1.504 0 CA-C-N 110.561 -3.018 . . . . 0.7 112.154 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -56.47 -37.01 69.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.465 0.913 . . . . 2.75 113.465 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.667 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.5 p80 -95.07 -38.88 10.42 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.267 0.469 . . . . 1.33 112.267 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.875 ' HB2' HG12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.97 107.76 8.9 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.015 -0.735 . . . . 1.11 109.015 173.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.41 116.25 28.8 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.14 -1.43 . . . . 0.76 107.14 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.961 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -90.51 93.32 9.24 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.044 -2.206 . . . . 0.26 105.044 171.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.57 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -86.02 163.03 18.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-O 122.96 1.362 . . . . 2.03 109.382 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -141.38 118.91 11.58 Favored 'General case' 0 C--N 1.259 -3.339 0 CA-C-N 111.332 -2.667 . . . . 0.92 109.585 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.7 m -103.39 148.95 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.777 -2.011 . . . . 0.47 107.99 172.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.452 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 13.2 t80 -142.33 97.29 3.1 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.439 1.114 . . . . 1.39 110.821 -176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -117.6 118.22 31.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.786 -1.552 . . . . 2.42 109.911 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -36.33 25.02 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.557 -1.656 . . . . 2.46 111.554 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.23 67.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.432 -0.803 . . . . 1.15 110.912 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -96.55 -19.42 19.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.391 -0.966 . . . . 1.41 108.391 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.837 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 11.4 ttpt 67.08 32.54 6.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.961 -1.472 . . . . 3.31 110.427 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -128.07 126.63 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.761 0.791 . . . . 0.43 110.311 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.578 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.3 m-30 -99.17 108.81 21.5 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.119 -1.808 . . . . 1.24 106.119 166.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HG ' ' HG2' ' A' ' 73' ' ' GLU . 14.3 tp -98.25 105.74 17.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.522 1.153 . . . . 0.52 109.142 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.0 m-85 -85.45 113.52 21.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 113.322 -1.763 . . . . 0.33 107.905 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 9.6 mt-10 -107.56 121.2 44.16 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.465 -1.698 . . . . 1.32 110.044 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.844 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -91.08 126.66 36.23 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.462 -1.244 . . . . 0.96 107.849 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 78.7 m80 -117.06 95.32 4.94 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 104.569 -2.382 . . . . 1.15 104.569 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.875 HG12 ' HB2' ' A' ' 57' ' ' LEU . 25.4 mt -121.85 100.47 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-O 122.74 1.257 . . . . 0.52 109.066 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.3 p -111.86 161.13 16.7 Favored 'General case' 0 N--CA 1.395 -3.224 0 CA-C-N 114.569 -1.196 . . . . 0.58 109.572 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 48.35 57.75 5.88 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 111.271 -2.695 . . . . 2.12 110.611 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -52.62 119.81 4.96 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.824 -1.989 . . . . 0.4 110.608 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.605 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -60.15 143.84 88.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.461 -0.791 . . . . 1.43 109.306 173.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.607 ' HD3' HG11 ' A' ' 18' ' ' VAL . 31.7 Cg_endo -63.54 -3.32 5.22 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.286 1.99 . . . . 1.33 112.564 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -115.17 15.73 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.566 . . . . 1.12 110.131 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.8 m-30 -94.53 -8.7 37.54 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 118.838 -0.601 . . . . 1.24 110.181 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 15.6 m -19.1 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 125.788 1.93 . . . . 1.22 111.529 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.87 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -37.12 110.83 0.1 Allowed Glycine 0 CA--C 1.473 -2.579 0 CA-C-N 110.062 -3.245 . . . . 1.43 114.584 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 1.032 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -127.45 60.08 0.67 Allowed Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 108.277 -1.929 . . . . 0.52 108.277 157.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 80.7 m-85 -80.2 126.78 31.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.07 -1.065 . . . . 0.63 108.555 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 22.4 ttm180 -130.83 121.11 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.951 -0.468 . . . . 3.15 110.274 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.54 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -98.53 120.61 39.25 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.587 -0.523 . . . . 1.08 109.587 176.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.798 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.8 mt-10 -121.56 105.44 10.45 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.189 -0.671 . . . . 1.81 109.189 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.4 p -96.07 137.17 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.356 0.598 . . . . 0.54 110.384 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.69 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.0 t -130.09 110.65 11.78 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.875 -1.057 . . . . 1.18 109.146 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.89 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -129.06 173.63 10.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.877 -0.602 . . . . 0.74 110.17 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.9 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.96 -62.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.243 1.59 . . . . 0.65 114.474 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.9 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.9 t70 -154.24 -0.57 0.2 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.384 -1.28 . . . . 1.05 109.289 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.041 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -93.36 128.25 39.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.001 -1.111 . . . . 1.29 108.001 -177.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -130.73 130.71 44.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.756 -1.111 . . . . 0.77 110.831 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.96 151.22 35.44 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.402 -1.272 . . . . 1.6 109.02 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 9.5 p -151.13 146.59 26.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.133 0.492 . . . . 1.19 111.294 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.48 146.45 50.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.479 -0.782 . . . . 0.84 111.593 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.24 119.0 22.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.69 -1.141 . . . . 1.58 109.477 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.815 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 6.7 p90 -143.1 128.73 19.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.344 0.592 . . . . 0.86 110.153 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 41.8 m-20 -102.45 135.48 44.0 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.22 1.009 . . . . 2.11 110.999 -172.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.87 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -105.46 107.34 18.27 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.046 -1.434 . . . . 0.37 108.856 174.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 9.0 m -87.94 95.08 9.98 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.163 -1.015 . . . . 0.33 108.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 18' ' ' VAL . 3.3 p -76.69 112.51 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 122.948 1.356 . . . . 0.33 107.768 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 66.4 m170 -82.03 97.66 8.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.902 -1.954 . . . . 1.19 108.623 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HA ' HG23 ' A' ' 18' ' ' VAL . 39.2 tt0 . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.376 -1.342 . . . . 1.67 107.376 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.479 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 8.0 m-20 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 111.625 0.232 . . . . 1.65 111.625 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -70.51 69.04 2.09 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.579 2.186 . . . . 0.97 112.534 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.054 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -88.12 -63.82 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.8 -1.091 . . . . 0.5 108.729 171.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.917 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 91.72 43.2 4.57 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.588 -1.805 . . . . 0.39 108.588 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.854 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.0 tp -52.77 -39.59 62.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.827 -1.687 . . . . 0.33 110.389 -171.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.745 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.95 83.41 5.65 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.162 -0.926 . . . . 0.72 109.816 177.342 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.31 -43.03 74.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.565 -1.198 . . . . 0.63 108.835 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.36 135.67 15.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.123 -0.944 . . . . 2.88 109.571 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -113.92 136.43 22.12 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.0 -0.741 . . . . 3.67 109.0 176.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -71.58 160.08 49.34 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.437 1.425 . . . . 0.64 110.646 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.38 -177.78 3.53 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.75 -0.659 . . . . 1.43 109.498 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.9 p-10 -69.67 -151.08 0.02 OUTLIER 'General case' 0 N--CA 1.405 -2.721 0 CA-C-O 123.166 1.46 . . . . 2.06 111.939 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.453 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.04 134.86 2.01 Favored Glycine 0 C--N 1.293 -1.811 0 CA-C-N 112.824 -1.989 . . . . 0.3 112.036 -174.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 32.4 mt-10 -112.49 112.35 23.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.154 -1.023 . . . . 1.53 108.48 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.0 m -130.76 163.99 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 108.005 -1.109 . . . . 0.27 108.005 -171.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -90.97 152.84 20.54 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.279 -1.328 . . . . 0.77 109.256 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.603 HG23 ' HA ' ' A' ' 108' ' ' GLU . 21.8 t -69.4 106.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 CA-C-O 122.796 1.284 . . . . 0.78 107.663 172.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.8 11.57 7.02 Favored Glycine 0 C--N 1.263 -3.52 0 CA-C-N 111.9 -2.409 . . . . 0.48 112.717 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.38 -121.84 4.96 Favored Glycine 0 CA--C 1.472 -2.614 0 C-N-CA 118.893 -1.622 . . . . 0.44 110.419 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.9 p -152.49 172.03 17.17 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 112.614 -1.793 . . . . 0.82 110.322 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.612 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.3 tp -148.37 149.61 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 113.022 -1.899 . . . . 0.32 106.185 169.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m -137.89 124.99 21.49 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 114.411 -1.268 . . . . 0.31 111.235 -173.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.94 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.9 m-85 -119.55 139.85 51.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.921 -1.49 . . . . 0.53 109.525 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.126 -0.943 . . . . 0.58 108.75 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -122.14 115.98 23.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.374 -1.284 . . . . 0.32 110.261 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HG2' HD13 ' A' ' 71' ' ' LEU . 66.1 mtp180 -111.41 122.5 48.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.649 -0.251 . . . . 2.43 110.46 -174.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 91' ' ' VAL . 15.7 t -121.18 128.11 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.012 0.91 . . . . 0.26 110.394 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.745 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.38 109.39 1.34 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.285 -1.779 . . . . 0.4 110.486 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.65 -42.19 35.68 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.106 -0.952 . . . . 0.76 111.68 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 57.41 -166.55 0.14 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.039 0.755 . . . . 0.71 113.039 172.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 p -113.23 110.72 20.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.08 -0.964 . . . . 1.74 108.648 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.064 HD13 ' H ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -148.34 158.36 44.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.145 -0.479 . . . . 2.16 110.289 -171.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.721 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.9 mt -47.13 -37.93 10.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.053 1.406 . . . . 1.47 111.501 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.777 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.99 -178.83 0.86 Allowed Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 111.933 -2.394 . . . . 1.4 107.809 -170.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.65 145.61 20.63 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.198 -1.886 . . . . 0.88 107.198 162.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.711 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 16.6 Cg_exo -58.18 129.56 33.56 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 CA-C-N 119.49 0.854 . . . . 0.53 110.606 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.23 102.3 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 122.781 1.277 . . . . 0.77 107.657 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -104.88 115.8 47.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 112.427 -2.17 . . . . 0.28 108.023 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.92 130.83 54.52 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.108 1.432 . . . . 1.54 109.757 173.432 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.039 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.7 m95 -86.59 152.47 22.58 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.103 -2.317 . . . . 0.34 112.746 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.9 t80 -131.18 136.71 48.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.239 -2.134 . . . . 0.62 105.239 170.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.756 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 80.3 tttt -102.84 166.53 10.42 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.712 -1.588 . . . . 2.17 106.712 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.737 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.72 -168.22 0.0 OUTLIER Glycine 0 C--O 1.187 -2.8 0 N-CA-C 119.549 2.58 . . . . 1.23 119.549 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.495 ' CD ' ' HB ' ' A' ' 84' ' ' THR . 16.6 mtpt -44.97 -1.31 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.549 -2.147 . . . . 3.87 116.384 -167.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.64 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.6 p-90 -167.7 -11.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.765 1.395 . . . . 2.11 114.765 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.23 168.04 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 CA-C-O 123.459 1.6 . . . . 1.29 112.816 -159.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.5 t70 -112.28 155.43 24.08 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 111.549 -2.569 . . . . 2.73 105.937 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.039 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.4 mp -94.08 -36.34 12.14 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.579 0.955 . . . . 0.44 113.579 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 t -58.72 -21.23 54.55 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.2 -0.667 . . . . 1.23 109.2 -165.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -96.13 -27.57 14.99 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.022 -0.99 . . . . 1.34 113.419 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 16.7 mmmt -100.75 -32.6 10.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.033 0.444 . . . . 1.4 111.566 -170.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.743 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 27.0 t -35.11 97.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 125.817 1.647 . . . . 0.37 111.94 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.48 -146.2 4.43 Favored Glycine 0 C--O 1.213 -1.212 0 CA-C-N 111.604 -2.544 . . . . 0.7 110.309 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.523 ' C ' HE22 ' A' ' 58' ' ' GLN . 41.7 tt0 -71.37 -2.0 14.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.943 0.872 . . . . 2.75 112.916 -170.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 21.8 p80 -114.29 -33.38 5.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.87 0.843 . . . . 1.33 111.064 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.008 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -133.3 105.18 6.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.706 -1.961 . . . . 1.11 105.706 171.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.86 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -99.28 114.49 27.35 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.073 -1.825 . . . . 0.76 106.073 171.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.726 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -97.2 92.81 6.2 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.901 -2.259 . . . . 0.26 104.901 172.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.5 m-70 -93.53 163.07 13.71 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.013 1.387 . . . . 2.03 110.378 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.02 119.15 24.85 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 111.399 -2.637 . . . . 0.92 108.88 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -102.59 138.93 38.85 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.574 -2.103 . . . . 0.47 106.538 167.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -145.64 99.13 3.24 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.991 0.9 . . . . 1.39 112.156 -166.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 5.0 t70 -119.68 120.69 37.34 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.349 -1.296 . . . . 2.42 109.866 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -81.62 -38.8 25.44 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.684 -1.598 . . . . 2.46 111.289 -176.23 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.9 -28.01 60.45 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.69 -1.141 . . . . 1.15 111.248 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 27.5 m -89.0 -13.31 39.1 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.635 -1.246 . . . . 1.41 107.635 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.745 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 72.98 25.85 2.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.597 -1.638 . . . . 3.31 110.484 171.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.59 120.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.912 0.863 . . . . 0.43 110.709 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.711 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -103.43 105.94 16.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.322 -1.733 . . . . 1.24 106.322 166.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 8.0 tp -96.7 104.38 16.37 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 0.52 108.806 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -85.01 115.14 22.66 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.105 -1.407 . . . . 0.33 107.515 174.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -102.65 126.2 49.66 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 113.727 -1.579 . . . . 1.32 109.435 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 3.7 mm? -95.74 125.48 40.34 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.877 -1.511 . . . . 0.96 107.749 172.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.86 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 30.9 m170 -120.39 95.98 4.96 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 103.85 -2.648 . . . . 1.15 103.85 172.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.615 ' CD1' HD22 ' A' ' 57' ' ' LEU . 58.5 mt -120.3 102.22 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 113.894 -1.503 . . . . 0.52 108.874 -170.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 80.6 p -114.05 141.66 47.16 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 113.219 -1.81 . . . . 0.58 109.845 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 61.21 70.71 0.59 Allowed 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 111.28 -2.691 . . . . 2.12 110.222 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -62.45 126.9 28.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.435 -2.166 . . . . 0.4 110.524 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.78 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 3.5 tp60 -55.67 139.33 68.82 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.386 -0.824 . . . . 1.43 109.378 173.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HB3' HG21 ' A' ' 18' ' ' VAL . 34.6 Cg_endo -67.74 145.04 67.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.357 1.371 . . . . 1.33 110.888 176.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.88 17.22 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.659 0.599 . . . . 1.12 110.758 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.78 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -71.01 -30.27 66.45 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.002 -0.544 . . . . 1.24 109.712 177.4 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 40.6 m 14.46 79.59 0.01 OUTLIER 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.566 1.791 . . . . 1.22 110.712 -168.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.797 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -64.06 94.82 0.15 Allowed Glycine 0 N--CA 1.423 -2.216 0 CA-C-N 112.35 -2.205 . . . . 1.43 113.764 -161.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.72 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -88.19 70.48 2.66 Favored Glycine 0 C--N 1.288 -2.133 0 N-CA-C 109.324 -1.51 . . . . 0.52 109.324 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.575 ' HE2' ' CD2' ' A' ' 57' ' ' LEU . 54.3 m-85 -74.58 120.77 20.59 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.676 -1.262 . . . . 0.63 108.788 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 90.3 mtt180 -120.09 110.93 17.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.788 -0.449 . . . . 3.15 109.788 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 t -94.93 122.65 37.79 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.54 -0.541 . . . . 1.08 109.54 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.525 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 24.1 mt-10 -126.77 110.83 13.53 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.081 -0.963 . . . . 1.81 109.937 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 28' ' ' VAL . 3.0 p -107.99 139.82 28.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.443 0.639 . . . . 0.54 110.655 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -133.36 110.87 10.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.758 -1.11 . . . . 1.18 110.279 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.798 HG22 HD22 ' A' ' 33' ' ' LEU . 31.9 p -120.33 -176.33 3.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.185 -0.916 . . . . 0.74 111.123 176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 1.064 ' H ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -25.92 -45.07 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 125.724 1.89 . . . . 0.65 112.367 -178.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.756 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -172.72 7.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.77 -1.559 . . . . 1.05 110.84 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.054 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 tmtm? -92.91 123.69 36.35 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 106.571 -1.64 . . . . 1.29 106.571 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.52 123.24 29.18 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.974 -1.012 . . . . 0.77 111.124 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -145.58 144.27 30.39 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.1 -1.409 . . . . 1.6 109.873 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.4 p -142.83 145.04 32.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.947 -0.569 . . . . 1.19 109.543 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.745 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 60.9 p -130.41 133.55 46.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.935 -0.575 . . . . 0.84 111.57 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -109.13 123.72 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.82 -0.627 . . . . 1.58 110.389 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.703 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.16 115.76 9.57 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.685 -0.487 . . . . 0.86 109.685 -177.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.797 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 50.4 m-20 -100.63 141.24 33.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.051 0.929 . . . . 2.11 111.191 -168.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -111.38 111.3 22.24 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.249 -1.341 . . . . 0.37 110.061 176.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m -93.6 97.73 10.68 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.956 -0.757 . . . . 0.33 108.956 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.4 p -84.77 121.34 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 123.138 1.447 . . . . 0.33 110.32 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' THR . 98.7 m-70 -106.58 102.0 11.42 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.45 -2.159 . . . . 1.19 109.722 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.7 tt0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 115.054 -0.975 . . . . 1.67 111.302 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.76 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 14.3 t70 . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.083 -0.71 . . . . 1.65 109.083 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 77.3 Cg_exo -52.2 99.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.588 2.859 . . . . 0.97 114.656 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.617 HG13 ' HB1' ' A' ' 31' ' ' ALA . 1.5 mp -125.04 -60.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 0.5 110.091 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.81 49.44 3.83 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.645 -1.782 . . . . 0.39 108.645 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 96' ' ' LYS . 12.7 tp -59.89 -41.95 92.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.839 -1.681 . . . . 0.33 110.475 -168.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.731 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -90.32 84.7 6.06 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.433 -0.803 . . . . 0.72 109.65 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -71.97 -48.02 52.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.901 -1.045 . . . . 0.63 110.313 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.543 ' CG ' ' HD3' ' A' ' 27' ' ' ARG . 20.7 mmt -136.6 130.9 33.01 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.061 -0.518 . . . . 2.88 110.828 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.731 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 26.1 mtm180 -93.78 128.14 42.86 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.565 -0.902 . . . . 3.67 108.565 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 79.1 Cg_endo -77.5 148.5 26.36 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.656 1.571 . . . . 0.64 108.807 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.574 ' O ' ' HD2' ' A' ' 24' ' ' PHE . 13.7 mm100 -112.93 179.46 3.96 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 111.629 0.233 . . . . 1.43 111.629 -168.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.72 -144.48 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 123.005 1.383 . . . . 2.06 111.325 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.44 127.82 1.59 Allowed Glycine 0 C--N 1.296 -1.69 0 CA-C-N 113.279 -1.782 . . . . 0.3 111.543 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.69 113.45 25.57 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.583 -0.895 . . . . 1.53 108.583 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.54 165.09 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 107.583 -1.265 . . . . 0.27 107.583 -167.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.67 156.9 16.2 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.939 -1.028 . . . . 0.77 108.958 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 106' ' ' VAL . 20.6 t -67.71 107.73 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 CA-C-O 122.83 1.3 . . . . 0.78 108.604 175.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 78' ' ' ASP . . . 120.98 3.58 10.72 Favored Glycine 0 C--N 1.267 -3.285 0 CA-C-N 111.788 -2.46 . . . . 0.48 113.551 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -124.48 4.59 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.077 -1.535 . . . . 0.44 110.797 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.8 p -152.13 166.37 31.87 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 112.897 -1.651 . . . . 0.82 111.279 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 104' ' ' LEU . 10.6 tp -147.84 148.71 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 113.423 -1.717 . . . . 0.32 108.02 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 m -142.1 126.98 18.22 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 113.524 -1.671 . . . . 0.31 110.827 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.704 ' HD1' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -136.13 146.75 47.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.0 -1.0 . . . . 0.53 109.429 173.226 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.861 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.9 126.1 33.33 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.517 -0.765 . . . . 0.58 109.727 -177.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -116.46 116.28 27.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.645 -1.161 . . . . 0.32 110.718 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HE ' HG11 ' A' ' 69' ' ' VAL . 43.3 mtp85 -102.25 130.36 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.835 -0.346 . . . . 2.43 110.477 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 39' ' ' VAL . 11.7 t -127.93 127.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.755 0.788 . . . . 0.26 109.874 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.37 114.81 2.6 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.711 -1.586 . . . . 0.4 111.531 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.86 -37.87 58.61 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 114.49 -1.232 . . . . 0.76 110.375 168.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.708 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 58.66 -174.68 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 115.193 1.553 . . . . 0.71 115.193 164.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -103.16 113.78 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.13 -1.396 . . . . 1.74 107.912 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.747 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -151.18 165.8 32.82 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.117 -0.492 . . . . 2.16 111.807 -166.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.8 -69.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.415 -0.587 . . . . 1.47 109.415 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 151.21 41.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.029 -0.73 . . . . 1.4 109.029 170.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HA ' HD11 ' A' ' 33' ' ' LEU . 88.1 Cg_exo -49.24 152.35 5.49 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.854 2.37 . . . . 0.88 111.873 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.747 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -65.55 134.27 37.68 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.771 1.647 . . . . 0.53 111.52 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.16 104.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 106.447 -1.686 . . . . 0.77 106.447 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.633 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.44 114.74 47.78 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 113.194 -1.821 . . . . 0.28 107.135 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.927 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.23 122.24 45.52 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 123.153 1.454 . . . . 1.54 110.265 176.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.087 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.3 m95 -86.69 152.08 22.86 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 111.978 -2.374 . . . . 0.34 110.921 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 38.4 t80 -136.97 135.15 37.42 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 104.243 -2.502 . . . . 0.62 104.243 173.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 1.021 ' HB3' HG23 ' A' ' 47' ' ' VAL . 81.4 tttt -101.7 173.12 6.56 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 105.619 -1.993 . . . . 2.17 105.619 -172.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 1.018 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -8.15 -168.03 0.0 OUTLIER Glycine 0 C--O 1.192 -2.487 0 N-CA-C 119.525 2.57 . . . . 1.23 119.525 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 84' ' ' THR . 20.4 mtpp -39.22 -22.08 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 115.834 1.791 . . . . 3.87 115.834 -163.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -161.06 -6.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.937 1.088 . . . . 2.11 113.937 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.021 HG23 ' HB3' ' A' ' 43' ' ' LYS . 31.5 m -94.4 171.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.778 0 CA-C-O 124.116 1.912 . . . . 1.29 113.539 -160.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.895 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -100.57 161.24 13.74 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 110.449 -3.069 . . . . 2.73 108.756 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.087 HD13 ' HB3' ' A' ' 41' ' ' TRP . 3.7 mp -99.42 -32.32 11.21 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 116.055 -0.52 . . . . 0.44 111.612 160.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 t -58.13 -23.78 56.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.255 0.55 . . . . 1.23 109.884 -164.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.736 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 58.5 m -102.08 -27.62 12.81 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.037 0.922 . . . . 1.34 112.907 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.895 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 28.9 mttp -90.92 -27.35 18.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.658 -1.61 . . . . 1.4 112.806 -168.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.727 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 35.9 t -50.32 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 111.529 -2.578 . . . . 0.37 111.267 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.42 -99.23 0.15 Allowed Glycine 0 C--N 1.304 -1.246 0 CA-C-N 112.421 -2.172 . . . . 0.7 113.299 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -86.05 -53.2 5.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.278 0.473 . . . . 2.75 112.278 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.1 p80 -87.54 -36.19 17.72 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.394 0.616 . . . . 1.33 111.207 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.976 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.91 106.89 13.43 Favored 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 106.35 -1.722 . . . . 1.11 106.35 176.054 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -102.42 116.42 32.58 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.277 -1.379 . . . . 0.76 107.277 166.12 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.693 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -95.03 92.99 7.11 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.499 -2.408 . . . . 0.26 104.499 170.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 46.5 m170 -87.66 162.56 17.04 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.645 1.212 . . . . 2.03 109.968 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.93 118.91 19.47 Favored 'General case' 0 C--N 1.268 -2.963 0 CA-C-N 111.959 -2.382 . . . . 0.92 108.933 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.532 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -101.05 149.46 23.92 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.58 -2.1 . . . . 0.47 108.202 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.4 t80 -141.61 97.05 3.08 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.224 1.012 . . . . 1.39 110.762 -174.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.4 OUTLIER -113.8 101.67 9.51 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.81 -1.541 . . . . 2.42 110.393 173.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.04 -29.71 43.71 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.263 -1.335 . . . . 2.46 110.937 -176.333 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.6 -21.26 65.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.196 -0.911 . . . . 1.15 109.862 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 19.4 m -110.94 -11.98 14.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.18 -0.918 . . . . 1.41 109.076 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.708 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 67.1 32.48 6.18 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.323 -0.853 . . . . 3.31 109.547 175.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.636 HG11 ' HE ' ' A' ' 27' ' ' ARG . 3.3 t -127.32 135.64 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.944 0.878 . . . . 0.43 110.425 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.7 m-30 -107.44 112.82 25.8 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.244 -1.391 . . . . 1.24 107.244 165.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 25' ' ' SER . 23.9 tp -95.32 107.65 19.78 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.041 0.924 . . . . 0.52 109.537 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.2 m-85 -87.72 112.68 22.64 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.587 -1.264 . . . . 0.33 107.587 170.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.69 120.16 41.1 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.952 -1.476 . . . . 1.32 110.381 -175.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.704 ' HB2' ' HD1' ' A' ' 24' ' ' PHE . 1.6 mt -81.74 129.42 34.72 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.958 -1.127 . . . . 0.96 107.958 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -115.88 96.57 5.65 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 103.351 -2.833 . . . . 1.15 103.351 165.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.691 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -120.83 99.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 123.047 1.403 . . . . 0.52 109.922 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.5 p -106.51 146.76 30.2 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 113.445 -1.707 . . . . 0.58 108.651 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' OD1' ' HA2' ' A' ' 19' ' ' GLY . 27.2 t70 64.8 82.7 0.18 Allowed 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 111.613 -2.54 . . . . 2.12 109.926 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.27 109.92 16.24 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 111.375 -2.648 . . . . 0.4 110.688 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.899 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 3.5 tp60 -52.74 139.13 41.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.587 -0.733 . . . . 1.43 109.862 167.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.494 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 37.7 Cg_endo -63.57 -3.39 5.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.29 2.66 . . . . 1.33 112.768 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.899 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -110.97 14.74 22.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.053 -0.521 . . . . 1.12 110.894 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -90.14 -29.66 18.14 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 117.721 -1.133 . . . . 1.24 110.756 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 75.0 m 2.34 80.34 0.0 OUTLIER 'General case' 0 C--N 1.354 0.785 0 O-C-N 125.688 1.867 . . . . 1.22 111.226 -174.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 1.018 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.19 121.7 5.61 Favored Glycine 0 N--CA 1.408 -3.213 0 CA-C-N 111.458 -2.61 . . . . 1.43 114.776 -163.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.952 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -120.94 70.23 0.39 Allowed Glycine 0 C--N 1.268 -3.24 0 CA-C-N 111.366 -2.417 . . . . 0.52 107.97 159.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.781 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 54.5 m-85 -74.49 127.61 33.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.094 -1.053 . . . . 0.63 109.013 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 48.0 mtp180 -121.38 104.68 9.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.643 -0.502 . . . . 3.15 109.643 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.476 ' H ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -91.77 121.3 33.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.09 -1.078 . . . . 1.08 108.09 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.927 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 25.7 tt0 -137.48 106.67 6.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.229 -0.896 . . . . 1.81 109.228 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.633 ' HB ' HG13 ' A' ' 39' ' ' VAL . 5.7 p -103.44 141.48 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.677 0.751 . . . . 0.54 111.305 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 t -138.71 109.88 6.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.435 -1.257 . . . . 1.18 108.563 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.566 HG21 HD12 ' A' ' 33' ' ' LEU . 1.6 m -129.44 174.21 9.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.142 -1.058 . . . . 0.74 108.142 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.979 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.88 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 125.199 1.562 . . . . 0.65 114.756 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.979 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -156.98 -0.81 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.555 -1.202 . . . . 1.05 110.042 -174.412 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.72 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -96.36 131.43 42.91 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.244 -1.021 . . . . 1.29 108.244 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -132.65 145.6 51.2 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.173 -1.376 . . . . 0.77 111.516 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 10.6 t70 -176.08 164.96 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.797 -0.638 . . . . 1.6 110.037 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.703 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 6.0 p -153.62 146.47 24.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.116 0.484 . . . . 1.19 110.576 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.57 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 88.8 p -124.34 131.94 53.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.805 -0.634 . . . . 0.84 110.55 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.79 121.12 42.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.972 0.415 . . . . 1.58 110.461 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.635 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -142.83 126.31 16.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.466 0.651 . . . . 0.86 109.789 -177.237 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 19.5 m-80 -105.09 152.88 22.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.182 0.991 . . . . 2.11 111.563 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.03 104.27 9.11 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.818 -1.083 . . . . 0.37 110.475 173.033 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -85.88 96.41 9.77 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.7 -0.8 . . . . 0.33 109.251 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 18' ' ' VAL . 7.5 p -81.87 113.22 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-O 123.387 1.565 . . . . 0.33 109.221 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -94.91 100.95 12.72 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.362 -2.199 . . . . 1.19 109.872 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 18' ' ' VAL . 36.1 tt0 . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 115.383 -0.826 . . . . 1.67 110.134 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.592 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.0 m-20 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 112.134 0.42 . . . . 1.65 112.134 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.494 ' C ' HD12 ' A' ' 4' ' ' ILE . 42.4 Cg_endo -68.45 87.16 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.814 2.343 . . . . 0.97 112.269 176.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.74 HD13 ' HE2' ' A' ' 94' ' ' LYS . 1.6 mp -126.4 -58.91 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.96 -1.018 . . . . 0.5 109.444 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.63 37.08 7.08 Favored Glycine 0 CA--C 1.496 -1.135 0 N-CA-C 108.991 -1.644 . . . . 0.39 108.991 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.147 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.9 tp -46.52 -47.5 19.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.104 -1.548 . . . . 0.33 110.383 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -89.57 83.45 6.31 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.741 0.781 . . . . 0.72 109.02 175.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.2 t -68.26 -48.28 74.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.448 -1.251 . . . . 0.63 109.598 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 ttp -148.47 129.58 14.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.651 -1.159 . . . . 2.88 108.828 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -95.84 148.64 34.87 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.662 -0.699 . . . . 3.67 109.615 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.842 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 1.9 Cg_endo -79.35 162.59 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.557 2.171 . . . . 0.64 111.074 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.511 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.4 mm-40 -125.8 169.65 12.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.099 -0.501 . . . . 1.43 110.329 -171.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' A' ' 103' ' ' ASN . 7.3 p-10 -74.78 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-O 122.695 1.236 . . . . 2.06 111.922 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 159.83 137.34 2.21 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.206 -1.815 . . . . 0.3 112.175 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 31.2 mt-10 -115.76 113.85 24.0 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.054 -1.073 . . . . 1.53 108.87 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.503 HG22 HD11 ' A' ' 104' ' ' LEU . 3.1 m -134.52 163.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.715 0 N-CA-C 107.13 -1.433 . . . . 0.27 107.13 -173.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -93.13 157.21 16.4 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.541 -0.754 . . . . 0.77 110.035 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' A' ' 81' ' ' PRO . 9.0 t -62.58 106.76 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 CA-C-O 122.956 1.36 . . . . 0.78 109.488 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.34 11.42 17.88 Favored Glycine 0 C--N 1.269 -3.18 0 CA-C-N 112.08 -2.327 . . . . 0.48 113.712 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.3 -122.33 4.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 109.867 -1.293 . . . . 0.44 109.867 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.3 p -151.66 164.24 37.36 Favored 'General case' 0 N--CA 1.401 -2.89 0 CA-C-N 113.088 -1.556 . . . . 0.82 110.971 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.825 HG23 ' HB ' ' A' ' 76' ' ' ILE . 6.8 tp -148.1 142.92 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 112.801 -1.999 . . . . 0.32 107.904 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -138.64 129.39 26.41 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-N 114.237 -1.347 . . . . 0.31 111.054 -171.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 31.8 m-85 -126.98 143.03 51.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.129 -1.396 . . . . 0.53 110.369 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -130.25 123.42 30.08 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.009 -0.996 . . . . 0.58 109.438 174.35 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.842 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -120.89 118.16 29.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.13 -1.396 . . . . 0.32 110.324 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -105.28 122.41 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.225 -0.297 . . . . 2.43 111.008 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.2 t -124.89 127.39 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.849 0.833 . . . . 0.26 109.83 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -57.64 113.31 1.76 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.665 -1.607 . . . . 0.4 111.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.76 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -54.22 -42.16 72.28 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.537 -1.21 . . . . 0.76 110.651 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.744 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.32 -151.01 0.1 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 115.193 1.553 . . . . 0.71 115.193 167.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -128.34 130.54 47.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.264 -1.334 . . . . 1.74 108.717 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -156.78 179.02 9.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.298 0.571 . . . . 2.16 111.775 -173.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.41 -42.09 59.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.712 -1.131 . . . . 1.47 108.921 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -149.48 149.9 29.89 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 1.4 109.558 175.442 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 85.4 Cg_exo -46.54 140.24 12.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.86 2.373 . . . . 0.88 112.248 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HA ' HG23 ' A' ' 93' ' ' THR . 33.3 Cg_exo -53.59 137.51 66.23 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 C-N-CA 122.095 1.863 . . . . 0.53 112.377 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.86 104.4 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 106.787 -1.56 . . . . 0.77 106.787 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.549 HG22 HG23 ' A' ' 91' ' ' VAL . 2.4 t -113.09 115.22 49.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.022 0 CA-C-N 113.782 -1.554 . . . . 0.28 107.595 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.642 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -106.55 131.67 53.45 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.896 1.331 . . . . 1.54 108.978 172.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.951 ' HB3' HD13 ' A' ' 49' ' ' LEU . 50.1 m95 -90.73 157.24 17.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.394 -2.185 . . . . 0.34 110.622 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.5 t80 -139.62 124.58 18.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.431 -2.063 . . . . 0.62 105.431 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.943 ' HD2' HD23 ' A' ' 57' ' ' LEU . 60.5 tttt -104.26 112.47 25.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.3 -1.36 . . . . 2.17 108.145 -172.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 85' ' ' GLY . . . -84.81 92.31 1.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 115.572 -3.204 . . . . 1.23 114.39 -166.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.835 ' HE3' ' HE1' ' A' ' 46' ' ' TRP . 21.9 ttpt -102.85 -31.53 10.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 103.173 -2.899 . . . . 3.87 103.173 137.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.835 ' HE1' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER 158.78 -11.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 111.243 -2.708 . . . . 2.11 111.369 -167.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.932 ' HB ' ' HE2' ' A' ' 52' ' ' LYS . 0.7 OUTLIER -88.08 168.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.03 1.395 . . . . 1.29 113.53 -165.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.662 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 16.5 t70 -113.09 132.57 55.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 111.666 -2.515 . . . . 2.73 108.886 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -76.31 -30.91 57.89 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 113.714 1.005 . . . . 0.44 113.714 -174.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -61.47 -21.94 64.63 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.26 0.482 . . . . 1.23 109.894 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 t -101.09 -20.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.825 0.822 . . . . 1.34 112.215 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.932 ' HE2' ' HB ' ' A' ' 47' ' ' VAL . 45.2 mttp -96.81 -78.21 0.47 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.219 -1.355 . . . . 1.4 113.687 -164.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.963 HG13 ' H ' ' A' ' 59' ' ' LEU . 37.8 t 22.98 98.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 125.293 1.621 . . . . 0.37 114.273 161.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -145.14 -150.87 5.3 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.251 -1.34 . . . . 0.7 113.983 -173.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -62.54 -27.13 68.95 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.83 0.452 . . . . 2.75 112.149 -170.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.668 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.3 p80 -92.52 -39.08 11.57 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.668 -0.413 . . . . 1.33 111.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -130.82 106.07 8.2 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.09 -0.707 . . . . 1.11 109.09 170.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.34 116.67 29.08 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.741 -1.577 . . . . 0.76 106.741 170.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.963 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -91.87 93.67 8.94 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 105.222 -2.14 . . . . 0.26 105.222 171.191 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 42.2 m170 -94.03 162.03 14.05 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-O 122.758 1.266 . . . . 2.03 109.933 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -132.62 111.93 11.62 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 111.775 -2.466 . . . . 0.92 108.768 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.0 m -87.67 148.75 24.65 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 112.71 -2.041 . . . . 0.47 108.518 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -126.65 97.14 4.9 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.303 1.049 . . . . 1.39 110.121 -168.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -114.34 95.05 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.327 -1.761 . . . . 2.42 108.554 177.255 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.01 -27.22 28.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.173 -0.921 . . . . 2.46 110.457 -176.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.44 -17.63 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.57 -1.196 . . . . 1.15 109.847 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.704 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 24.2 m -108.79 -15.25 14.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.925 . . . . 1.41 108.774 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.744 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 64.93 35.47 8.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.097 -0.956 . . . . 3.31 109.402 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.07 136.83 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.43 109.667 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 13.9 m-85 -101.68 116.78 33.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.685 -1.598 . . . . 1.24 106.685 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 25' ' ' SER . 24.3 tp -95.55 104.54 16.45 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.441 -0.948 . . . . 0.52 108.441 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.9 m-85 -81.92 112.03 18.65 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.539 -1.652 . . . . 0.33 106.539 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -119.68 120.88 37.92 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.97 -1.468 . . . . 1.32 110.385 -173.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.923 HD12 HD11 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -88.21 125.15 34.48 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.763 -1.562 . . . . 0.96 107.584 177.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 12.8 m170 -110.75 96.01 5.91 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.148 -2.538 . . . . 1.15 104.148 170.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.923 HD11 HD12 ' A' ' 74' ' ' LEU . 27.8 mt -119.57 99.98 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 122.89 1.328 . . . . 0.52 110.279 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 31.4 p -116.05 139.97 49.74 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 114.301 -1.318 . . . . 0.58 107.77 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 77' ' ' THR . 22.0 t70 74.85 64.98 0.07 Allowed 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.309 -2.223 . . . . 2.12 108.312 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.17 9.18 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.098 -2.319 . . . . 0.4 109.259 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -62.6 151.7 83.08 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.25 -0.648 . . . . 1.43 109.25 176.411 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.758 ' HB3' HG21 ' A' ' 18' ' ' VAL . 72.3 Cg_endo -72.95 11.06 0.94 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.795 2.33 . . . . 1.33 113.958 -169.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.708 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.17 -3.97 11.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.595 -0.275 . . . . 1.12 110.626 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD1' ' HE2' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -80.63 0.51 33.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.182 -0.673 . . . . 1.24 109.182 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 94.9 m -52.24 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 CA-C-O 122.609 1.195 . . . . 1.22 109.657 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 44' ' ' GLY . . . -164.98 -119.42 0.48 Allowed Glycine 0 C--N 1.27 -3.093 0 CA-C-N 113.15 -1.841 . . . . 1.43 113.559 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -164.99 121.97 1.05 Allowed Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 113.501 -1.35 . . . . 0.52 111.195 -171.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -87.01 125.48 34.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.413 -0.958 . . . . 0.63 108.413 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -105.0 132.71 50.9 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.239 -0.652 . . . . 3.15 109.239 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.47 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 3.9 m -111.76 121.7 45.79 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.837 -0.801 . . . . 1.08 108.837 169.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.642 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 41.9 mt-10 -120.01 105.2 10.81 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.78 -0.646 . . . . 1.81 109.608 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.549 HG23 HG22 ' A' ' 39' ' ' VAL . 7.1 p -99.74 134.05 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.187 0.994 . . . . 0.54 110.717 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -135.58 108.03 7.37 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.591 -1.64 . . . . 1.18 108.389 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.709 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -133.22 163.23 29.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.308 -0.853 . . . . 0.74 109.09 -178.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.74 ' HE2' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 22.28 -79.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 125.52 1.762 . . . . 0.65 113.536 168.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.616 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 16.3 t70 -153.43 6.3 0.35 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.898 -1.047 . . . . 1.05 109.156 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.147 ' HB3' HD22 ' A' ' 6' ' ' LEU . 44.7 tptt -92.01 132.1 36.8 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.782 -1.562 . . . . 1.29 106.782 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -131.7 146.17 52.03 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.941 -1.027 . . . . 0.77 111.847 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.57 163.18 2.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.98 . . . . 1.6 110.104 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.4 p -152.22 138.44 18.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.981 -0.554 . . . . 1.19 110.038 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.76 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 57.9 p -107.45 147.25 30.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.631 -0.713 . . . . 0.84 110.325 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -132.98 114.91 14.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.431 0.634 . . . . 1.58 110.354 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.792 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 33.7 p90 -143.24 140.23 30.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.082 -0.508 . . . . 0.86 109.796 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.643 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.3 m-20 -96.98 155.97 16.55 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.207 1.003 . . . . 2.11 111.974 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.666 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -125.7 114.44 18.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.726 -1.213 . . . . 0.37 107.726 164.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.433 ' HA ' HG23 ' A' ' 84' ' ' THR . 4.1 m -98.83 95.86 7.48 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.654 -0.869 . . . . 0.33 108.654 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.1 p -78.39 111.74 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 123.065 1.412 . . . . 0.33 108.834 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 65.2 m170 -78.57 98.11 6.01 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.664 -2.062 . . . . 1.19 109.788 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 113.542 -1.663 . . . . 1.67 108.866 171.341 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.601 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 19.6 t70 . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 109.846 -0.427 . . . . 1.65 109.846 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 18.2 Cg_endo -61.04 77.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.737 2.292 . . . . 0.97 114.066 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.703 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -99.59 -60.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.773 -1.103 . . . . 0.5 109.574 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.7 43.69 6.01 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 108.321 -1.912 . . . . 0.39 108.321 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 4' ' ' ILE . 9.8 tp -50.11 -43.83 51.87 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.652 -1.774 . . . . 0.33 111.031 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.744 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -88.52 84.73 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.646 -0.706 . . . . 0.72 110.301 176.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.46 -40.95 72.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.447 -1.251 . . . . 0.63 109.167 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.502 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 18.2 ttt -151.06 137.45 18.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.617 -1.174 . . . . 2.88 108.655 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 7.8 ptp180 -102.47 139.23 20.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.229 -0.441 . . . . 3.67 110.201 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.859 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 14.1 Cg_endo -69.73 154.1 68.28 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.741 2.294 . . . . 0.64 112.375 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 1.9 mp0 -112.93 170.75 7.98 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.099 0.778 . . . . 1.43 113.099 -168.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 1.6 m-20 -69.88 -147.35 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.701 1.239 . . . . 2.06 110.741 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.489 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 153.32 133.31 1.84 Allowed Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 113.611 -1.631 . . . . 0.3 112.242 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 23.1 mt-10 -110.68 119.01 37.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.256 -0.972 . . . . 1.53 108.527 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.77 162.06 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.21 0 N-CA-C 107.047 -1.464 . . . . 0.27 107.047 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -96.4 155.33 16.81 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.41 -0.959 . . . . 0.77 108.41 176.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.708 HG11 ' HD3' ' A' ' 81' ' ' PRO . 6.2 t -67.28 105.85 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.862 -1.162 . . . . 0.78 107.862 173.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.34 -6.74 3.97 Favored Glycine 0 C--N 1.273 -2.953 0 CA-C-N 112.926 -1.943 . . . . 0.48 113.368 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.37 -123.93 5.29 Favored Glycine 0 CA--C 1.471 -2.704 0 C-N-CA 119.089 -1.529 . . . . 0.44 110.6 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.638 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.8 p -148.98 174.45 12.26 Favored 'General case' 0 N--CA 1.396 -3.149 0 CA-C-N 112.555 -1.822 . . . . 0.82 110.2 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.682 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.1 tp -146.09 140.39 21.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 112.651 -2.068 . . . . 0.32 107.21 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.9 m -139.24 127.59 22.79 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 113.398 -1.728 . . . . 0.31 111.492 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.779 ' HB2' HD23 ' A' ' 74' ' ' LEU . 3.4 m-85 -128.19 154.71 45.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.057 -1.429 . . . . 0.53 108.877 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -134.42 122.05 21.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.461 -0.79 . . . . 0.58 109.382 173.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.859 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -113.51 116.38 29.47 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.878 -1.056 . . . . 0.32 110.184 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.1 mtt180 -105.61 115.66 30.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.469 -0.332 . . . . 2.43 110.412 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 39' ' ' VAL . 5.8 t -118.23 126.3 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.065 0.936 . . . . 0.26 110.121 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.775 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -56.36 108.97 0.53 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.147 -1.842 . . . . 0.4 112.188 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.62 80.78 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.764 -1.107 . . . . 0.76 112.423 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 61.05 -178.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.137 1.162 . . . . 0.71 114.137 168.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -105.39 29.53 6.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.292 -1.322 . . . . 1.74 109.083 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.046 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -58.57 175.71 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.645 -1.161 . . . . 2.16 113.133 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.44 -40.52 64.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.874 0.845 . . . . 1.47 109.927 -176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.93 134.88 11.14 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.442 -1.253 . . . . 1.4 108.532 176.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -43.58 141.62 3.62 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.333 2.689 . . . . 0.88 112.18 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.046 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.0 Cg_exo -52.93 136.63 60.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.813 1.675 . . . . 0.53 113.068 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.31 104.99 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.175 -1.787 . . . . 0.77 106.175 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.65 114.37 46.78 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 113.535 -1.666 . . . . 0.28 108.037 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 1.018 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.57 122.24 43.47 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-O 123.344 1.545 . . . . 1.54 110.238 174.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.034 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.8 m95 -86.91 149.01 25.11 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.871 -2.422 . . . . 0.34 112.021 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.734 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 43.7 t80 -128.89 140.09 51.84 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.096 -2.557 . . . . 0.62 104.096 172.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.798 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 58.2 tttp -106.23 166.25 10.65 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 116.627 -1.654 . . . . 2.17 106.708 -173.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -11.97 -166.17 0.0 OUTLIER Glycine 0 C--O 1.186 -2.875 0 N-CA-C 119.136 2.414 . . . . 1.23 119.136 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.914 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 13.4 ptmt -44.14 -6.34 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.495 2.406 . . . . 3.87 117.495 -161.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.914 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 2.8 p-90 -167.95 -1.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.931 1.242 . . . . 2.11 113.266 174.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.27 167.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 CA-C-O 123.659 1.695 . . . . 1.29 112.405 -159.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 3.3 p-10 -111.35 156.99 20.73 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.137 -2.756 . . . . 2.73 106.506 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -97.9 -31.27 12.28 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.509 0.559 . . . . 0.44 112.509 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -58.52 -19.67 39.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.013 0.435 . . . . 1.23 109.88 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.406 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 73.9 m -98.25 -26.74 14.43 Favored 'General case' 0 N--CA 1.415 -2.198 0 C-N-CA 119.865 -0.734 . . . . 1.34 112.432 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.3 -32.16 10.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.623 -1.172 . . . . 1.4 111.794 -167.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.82 HG13 ' H ' ' A' ' 59' ' ' LEU . 70.3 t -35.39 92.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 O-C-N 125.076 1.485 . . . . 0.37 111.532 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . -150.25 -114.79 0.7 Allowed Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 112.338 -2.21 . . . . 0.7 111.952 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -95.74 -25.4 16.09 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.364 0.876 . . . . 2.75 113.364 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.6 p80 -93.32 -37.82 11.82 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-O 121.622 0.725 . . . . 1.33 110.079 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.005 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.66 106.97 10.51 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 105.657 -1.979 . . . . 1.11 105.657 171.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -106.39 114.59 28.81 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.445 -1.687 . . . . 0.76 106.445 166.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.82 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -92.72 92.42 7.96 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 103.957 -2.608 . . . . 0.26 103.957 175.262 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 80.4 t60 -95.0 159.66 14.93 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 113.944 -1.48 . . . . 2.03 110.22 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.58 121.57 39.64 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.929 -2.85 . . . . 0.92 109.153 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 25.9 m -110.23 143.47 40.34 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-N 111.773 -2.467 . . . . 0.47 106.34 167.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.88 99.51 3.35 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.748 0.785 . . . . 1.39 109.275 -164.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -115.01 132.07 56.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.489 -1.232 . . . . 2.42 109.122 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.538 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 6.1 mmm180 -119.01 18.23 13.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.06 -1.427 . . . . 2.46 111.25 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.24 -31.88 4.55 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.736 -1.574 . . . . 1.15 108.488 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t -93.18 -14.75 26.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.479 -1.237 . . . . 1.41 108.8 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.775 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 15.2 tttt 68.88 31.61 4.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.85 0.833 . . . . 3.31 109.23 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 7.9 t -128.35 125.77 64.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.603 0.716 . . . . 0.43 110.453 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.447 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.4 m-30 -101.18 107.44 18.85 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.031 -1.841 . . . . 1.24 106.031 167.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.0 tp -94.92 104.21 16.1 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.706 -1.134 . . . . 0.52 108.013 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.5 m-85 -86.94 113.65 22.89 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.68 -1.6 . . . . 0.33 106.68 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.65 125.24 49.3 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.917 -1.492 . . . . 1.32 110.585 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.916 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.2 mm? -89.59 124.51 34.62 Favored 'General case' 0 CA--C 1.471 -2.064 0 CA-C-N 112.889 -1.96 . . . . 0.96 107.698 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.935 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 26.1 m170 -114.45 94.29 4.72 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 103.15 -2.908 . . . . 1.15 103.15 167.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 22' ' ' ILE . 60.4 mt -115.14 97.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 123.603 1.668 . . . . 0.52 108.983 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 29.9 p -116.31 138.75 51.07 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 112.302 -2.226 . . . . 0.58 107.076 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 77' ' ' THR . 13.5 t70 77.76 63.77 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 O-C-N 125.855 1.972 . . . . 2.12 107.351 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -76.92 94.44 3.93 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 111.605 -2.543 . . . . 0.4 107.893 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.673 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -53.71 151.32 11.55 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-N 115.127 -0.942 . . . . 1.43 108.708 176.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.708 ' HD3' HG11 ' A' ' 18' ' ' VAL . 60.0 Cg_endo -68.83 155.32 69.02 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.039 1.159 . . . . 1.33 110.032 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 45' ' ' LYS . . . 63.38 21.69 12.91 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.381 0.426 . . . . 1.12 110.728 -175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -86.6 -13.21 46.37 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.195 -1.409 . . . . 1.24 107.195 173.029 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 1.022 HG21 ' N ' ' A' ' 106' ' ' VAL . 4.3 p -90.11 150.26 22.12 Favored 'General case' 1 N--CA 1.363 -4.808 0 CA-C-O 126.041 2.829 . . . . 1.22 116.17 -163.599 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.417 ' HA3' ' CA ' ' A' ' 45' ' ' LYS . . . 159.4 -109.61 0.41 Allowed Glycine 1 C--N 1.239 -4.833 1 CA-C-N 105.381 -5.372 . . . . 1.43 112.527 -155.532 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -167.91 124.78 1.23 Allowed Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.338 -1.41 . . . . 0.52 114.172 -170.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.798 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.3 m-85 -87.95 124.54 33.81 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.227 -1.487 . . . . 0.63 108.56 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.734 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 mtp180 -105.51 105.21 15.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.538 -0.726 . . . . 3.15 109.728 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.424 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 4.3 t -89.92 125.39 35.34 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.372 -0.973 . . . . 1.08 108.372 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 1.018 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 21.7 tt0 -145.47 106.77 4.19 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.419 -0.81 . . . . 1.81 109.961 -169.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.7 p -102.66 144.36 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.362 0.601 . . . . 0.54 110.504 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.4 m -139.12 109.47 6.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.277 -0.874 . . . . 1.18 108.898 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.852 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.39 153.78 50.45 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.401 -0.809 . . . . 0.74 109.886 -177.413 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.784 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.7 -75.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 125.654 1.846 . . . . 0.65 114.572 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.784 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 12.2 t70 -149.7 -1.07 0.45 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.087 -1.415 . . . . 1.05 109.379 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.703 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -104.76 140.09 38.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.111 0.958 . . . . 1.29 109.627 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -132.61 139.06 47.61 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.142 -1.844 . . . . 0.77 110.577 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 6.8 m-20 -152.85 147.88 26.53 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.25 -0.886 . . . . 1.6 109.083 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 13.4 p -151.43 153.88 35.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.504 . . . . 1.19 110.905 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.744 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 85.7 p -137.31 130.26 30.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.774 -0.648 . . . . 0.84 110.766 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.81 116.85 33.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.615 -0.721 . . . . 1.58 110.305 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.791 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 22.5 p90 -143.12 135.8 27.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.458 0.647 . . . . 0.86 109.903 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.588 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 86.9 m-20 -97.26 156.15 16.55 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.538 -1.21 . . . . 2.11 110.387 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.959 ' HG ' HG22 ' A' ' 84' ' ' THR . 1.2 tp -120.67 132.91 55.34 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 102.336 -3.209 . . . . 0.37 102.336 166.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.544 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 23.4 m -124.16 113.57 18.51 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.318 -1.353 . . . . 0.33 109.727 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.022 ' N ' HG21 ' A' ' 84' ' ' THR . 5.6 p -102.87 114.14 41.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 113.779 -1.555 . . . . 0.33 110.046 -172.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 35.5 m-70 -79.78 98.55 7.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.798 -2.455 . . . . 1.19 109.354 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.43 ' HA ' HG23 ' A' ' 18' ' ' VAL . 70.1 tt0 . . . . . 0 C--N 1.295 -1.762 0 CA-C-N 113.099 -1.864 . . . . 1.67 109.736 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 4' ' ' ILE . 5.8 m-20 . . . . . 0 N--CA 1.433 -1.285 0 N-CA-C 110.514 -0.18 . . . . 1.65 110.514 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.76 42.26 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.393 2.729 . . . . 0.97 113.357 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.962 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -58.22 -51.27 73.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.74 -0.664 . . . . 0.5 110.163 172.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.591 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 86.72 40.28 7.26 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.602 -1.799 . . . . 0.39 108.602 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.137 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.8 tp -53.2 -50.07 65.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.544 -1.828 . . . . 0.33 110.252 -172.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -84.23 84.48 7.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.72 110.176 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.2 t -73.2 -42.88 58.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.43 -1.259 . . . . 0.63 109.416 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.7 ttm -152.19 135.87 16.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.225 -0.898 . . . . 2.88 108.715 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -91.1 139.76 25.77 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.862 -0.422 . . . . 3.67 109.862 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 33.6 Cg_endo -67.49 141.57 56.22 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.091 1.86 . . . . 0.64 109.164 171.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.619 ' O ' ' HD1' ' A' ' 24' ' ' PHE . 6.3 tp60 -118.2 163.83 16.08 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.932 0.715 . . . . 1.43 112.932 -168.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.1 m-20 -57.67 -139.94 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 125.674 1.589 . . . . 2.06 112.928 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 143.13 136.19 3.13 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 113.291 -1.777 . . . . 0.3 111.975 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 35.8 mt-10 -108.51 114.93 29.16 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.349 -0.926 . . . . 1.53 108.527 175.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.4 m -135.25 163.6 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.867 0 N-CA-C 107.932 -1.136 . . . . 0.27 107.932 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 154.29 17.33 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.636 -1.166 . . . . 0.77 109.193 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.69 HG11 ' HD3' ' A' ' 81' ' ' PRO . 4.0 t -65.78 107.58 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 CA-C-O 122.845 1.307 . . . . 0.78 108.9 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.3 10.38 10.74 Favored Glycine 0 C--N 1.269 -3.162 0 CA-C-N 112.107 -2.315 . . . . 0.48 112.734 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.82 -123.43 4.89 Favored Glycine 0 N--CA 1.42 -2.409 0 C-N-CA 119.331 -1.414 . . . . 0.44 110.269 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.6 p -151.35 168.44 24.8 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.079 -1.561 . . . . 0.82 110.201 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 104' ' ' LEU . 9.0 tp -147.79 149.44 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 CA-C-N 113.693 -1.594 . . . . 0.32 108.04 169.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 m -138.11 128.64 26.44 Favored 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 114.066 -1.425 . . . . 0.31 111.163 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.619 ' HD1' ' O ' ' A' ' 12' ' ' GLN . 3.4 m-85 -126.01 147.54 49.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 113.879 -1.51 . . . . 0.53 107.817 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -140.89 127.73 20.46 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.57 0.7 . . . . 0.58 109.78 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.19 115.5 23.16 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.922 -1.035 . . . . 0.32 110.383 -176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -104.31 121.11 42.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.312 -0.255 . . . . 2.43 110.312 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.606 HG21 HG21 ' A' ' 39' ' ' VAL . 15.1 t -122.31 126.03 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.129 0.966 . . . . 0.26 110.319 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -57.83 109.01 0.65 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.151 -1.84 . . . . 0.4 111.432 176.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.606 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -50.1 -58.58 8.52 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.946 -1.025 . . . . 0.76 111.418 172.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.823 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 59.8 -171.15 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.137 1.162 . . . . 0.71 114.137 168.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -109.09 130.42 55.48 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.916 -1.038 . . . . 1.74 109.846 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -160.93 -176.2 5.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.396 0.617 . . . . 2.16 112.038 -172.298 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.8 tp -70.77 -44.86 65.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.966 -1.015 . . . . 1.47 108.741 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.597 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.46 150.27 28.41 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 114.79 -1.096 . . . . 1.4 109.634 174.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.77 148.79 5.76 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.484 2.789 . . . . 0.88 112.426 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.639 ' HA ' HG23 ' A' ' 93' ' ' THR . 4.1 Cg_exo -50.11 132.51 33.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.709 1.606 . . . . 0.53 113.207 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.3 105.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.404 -1.702 . . . . 0.77 106.404 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.626 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.56 114.5 47.11 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.784 -1.553 . . . . 0.28 107.195 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.551 ' O ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.93 124.82 50.16 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 123.287 1.518 . . . . 1.54 109.16 174.072 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.068 ' HB3' HD13 ' A' ' 49' ' ' LEU . 79.8 m95 -83.93 151.09 25.26 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 111.646 -2.525 . . . . 0.34 111.231 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.699 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 36.9 t80 -128.61 138.75 52.36 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 104.58 -2.378 . . . . 0.62 104.58 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.816 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 31.6 tptt -104.64 165.28 11.17 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.41 -2.07 . . . . 2.17 105.41 -172.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.803 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.62 -168.95 0.0 OUTLIER Glycine 0 C--O 1.188 -2.741 0 N-CA-C 119.321 2.488 . . . . 1.23 119.321 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -44.82 -1.47 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.95 2.204 . . . . 3.87 116.95 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.8 p-90 -167.16 -11.5 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.858 1.429 . . . . 2.11 114.858 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.674 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.37 169.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 CA-C-O 123.452 1.596 . . . . 1.29 112.889 -161.257 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.482 ' OD1' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -111.05 156.19 21.67 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 111.613 -2.54 . . . . 2.73 107.511 172.196 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.068 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -96.77 -36.88 10.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 119.292 -0.385 . . . . 0.44 111.896 169.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 t -58.15 -20.49 41.16 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.31 0.576 . . . . 1.23 109.47 -165.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -98.02 -17.64 19.04 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.302 -0.863 . . . . 1.34 113.014 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 6.2 mmmt -102.87 -54.59 2.6 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.773 -0.649 . . . . 1.4 111.174 -173.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 49' ' ' LEU . 70.3 t -6.25 90.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 O-C-N 125.93 2.019 . . . . 0.37 113.139 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.633 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.87 -129.61 1.16 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 112.579 -2.101 . . . . 0.7 112.191 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -72.65 -28.71 62.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.764 0.653 . . . . 2.75 112.764 -168.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 30.0 p80 -96.06 -37.17 10.74 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.699 0.762 . . . . 1.33 111.181 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.988 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -125.62 105.22 8.85 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.313 -1.736 . . . . 1.11 106.313 175.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.45 113.93 25.55 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 106.325 -1.732 . . . . 0.76 106.325 166.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.79 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.48 92.47 5.4 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 104.47 -2.419 . . . . 0.26 104.47 171.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 33.0 m170 -87.61 159.86 18.4 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.831 1.3 . . . . 2.03 110.306 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -135.03 110.27 8.96 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 111.548 -2.569 . . . . 0.92 109.866 175.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -91.77 148.78 21.98 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 112.302 -2.226 . . . . 0.47 107.576 174.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.8 98.31 3.31 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.45 1.119 . . . . 1.39 110.843 -173.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -118.01 124.82 49.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.554 -1.657 . . . . 2.42 109.931 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -35.41 19.12 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.148 -1.842 . . . . 2.46 110.62 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.995 -1.002 . . . . 1.15 110.789 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -90.22 -18.78 25.08 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.771 -0.826 . . . . 1.41 108.771 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.823 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 7.4 ttpt 66.0 33.18 7.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.871 -1.059 . . . . 3.31 109.367 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.48 122.91 56.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.721 0.772 . . . . 0.43 109.826 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 62' ' ' SER . 2.9 m-30 -96.67 108.39 21.0 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.548 -1.649 . . . . 1.24 106.548 167.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 28.1 tp -93.42 105.9 17.91 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.966 -1.015 . . . . 0.52 109.336 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 71.0 m-85 -91.1 111.19 22.56 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.333 -1.728 . . . . 0.33 106.333 170.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -121.61 132.29 54.59 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.722 -1.126 . . . . 1.32 110.107 -174.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.68 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.3 mt -98.27 131.71 44.37 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.199 -1.819 . . . . 0.96 108.936 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -116.8 97.64 6.08 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 104.041 -2.577 . . . . 1.15 104.041 165.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.68 HG13 ' HB3' ' A' ' 74' ' ' LEU . 10.8 mt -123.0 101.56 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.395 1.093 . . . . 0.52 108.281 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.7 p -104.76 171.56 7.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 CA-C-N 114.874 -1.057 . . . . 0.58 110.105 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 39.89 67.41 0.48 Allowed 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.838 -2.892 . . . . 2.12 111.562 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.49 116.32 6.65 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.625 -2.08 . . . . 0.4 109.878 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.828 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -67.77 152.04 96.67 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.034 -0.728 . . . . 1.43 109.034 175.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.69 ' HD3' HG11 ' A' ' 18' ' ' VAL . 38.2 Cg_endo -66.16 -8.3 19.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.45 2.1 . . . . 1.33 112.605 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.828 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -105.59 15.29 27.22 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.096 -0.502 . . . . 1.12 110.278 176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.7 m-30 -97.37 -6.4 34.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 118.849 -0.596 . . . . 1.24 110.983 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 22.9 m -23.59 95.07 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 125.497 1.748 . . . . 1.22 111.393 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.803 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -55.49 115.52 5.93 Favored Glycine 0 N--CA 1.406 -3.341 0 CA-C-N 110.431 -3.077 . . . . 1.43 114.863 -169.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.681 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -119.18 68.7 0.35 Allowed Glycine 0 C--N 1.269 -3.188 0 CA-C-N 111.815 -2.192 . . . . 0.52 108.433 149.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.816 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 32.5 m-85 -73.98 115.75 13.8 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.179 -1.045 . . . . 0.63 108.179 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.699 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 37.6 mtp180 -109.09 113.39 26.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.671 -0.492 . . . . 3.15 109.671 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.1 t -101.8 110.7 22.73 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.624 0.726 . . . . 1.08 109.355 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 0.8 OUTLIER -121.1 110.91 16.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.5 -1.227 . . . . 1.81 110.07 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HB ' HG13 ' A' ' 39' ' ' VAL . 7.0 p -100.12 140.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.299 0.571 . . . . 0.54 110.27 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -135.74 108.59 7.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.409 -0.96 . . . . 1.18 108.409 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -132.2 144.85 50.94 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-O 117.374 -1.298 . . . . 0.74 108.242 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.25 -72.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 O-C-N 125.629 1.831 . . . . 0.65 113.699 -173.296 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.716 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 24.8 t70 -153.33 -1.18 0.23 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.681 -1.145 . . . . 1.05 110.707 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.137 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.8 tttp -88.25 126.45 35.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.447 -0.945 . . . . 1.29 108.447 176.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 91' ' ' VAL . 15.1 t80 -130.42 117.7 20.09 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 0.77 110.063 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -134.61 141.67 46.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.498 -1.683 . . . . 1.6 108.639 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 5.0 m -136.21 144.22 44.79 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.473 . . . . 1.19 110.688 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.651 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 82.1 p -130.74 118.66 21.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.732 -0.667 . . . . 0.84 110.507 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -101.41 123.57 45.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.621 -0.718 . . . . 1.58 109.516 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.67 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.9 p90 -142.88 135.56 27.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.005 0.907 . . . . 0.86 110.581 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.778 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.6 m-80 -105.19 132.38 51.48 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.068 -1.424 . . . . 2.11 111.449 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.705 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.41 106.58 17.74 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.554 -1.203 . . . . 0.37 108.651 172.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 8.1 m -89.28 96.45 10.72 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.592 -0.892 . . . . 0.33 108.592 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 18' ' ' VAL . 4.7 p -85.2 113.69 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 123.031 1.396 . . . . 0.33 109.104 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.93 99.21 11.7 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.648 -2.069 . . . . 1.19 109.666 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.1 tt0 . . . . . 0 C--N 1.302 -1.465 0 CA-C-N 113.004 -1.907 . . . . 1.67 110.16 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.738 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 23.1 t70 . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 108.31 -0.996 . . . . 1.65 108.31 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.59 58.25 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.445 2.763 . . . . 0.97 114.421 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.993 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -67.86 -52.31 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.5 109.463 168.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.36 46.0 5.39 Favored Glycine 0 CA--C 1.494 -1.232 0 N-CA-C 108.252 -1.939 . . . . 0.39 108.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.943 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.9 tp -55.04 -38.05 67.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.69 -1.755 . . . . 0.33 110.643 -169.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.743 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -96.07 85.13 3.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.209 -0.905 . . . . 0.72 109.823 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.03 -37.55 41.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.553 -1.203 . . . . 0.63 110.01 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 tpp -151.28 134.39 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.513 -0.767 . . . . 2.88 109.636 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 17.0 ptm180 -108.57 136.86 19.89 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.786 -0.643 . . . . 3.67 109.916 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 2.0 Cg_endo -76.35 138.36 19.79 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.672 2.248 . . . . 0.64 111.531 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -89.31 -177.98 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.696 -0.684 . . . . 1.43 110.527 176.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -74.61 -142.87 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.291 1.043 . . . . 2.06 110.7 178.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.77 140.02 2.86 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.355 -1.293 . . . . 0.3 112.512 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.464 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 27.4 mt-10 -116.87 119.18 34.57 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.277 -0.961 . . . . 1.53 108.52 172.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.2 m -136.43 162.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 N-CA-C 107.068 -1.456 . . . . 0.27 107.068 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.719 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -91.03 156.53 17.86 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.039 -0.982 . . . . 0.77 110.22 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 81' ' ' PRO . 11.6 t -66.47 107.12 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-O 123.023 1.392 . . . . 0.78 108.202 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.69 14.31 12.78 Favored Glycine 0 C--N 1.266 -3.327 0 CA-C-N 111.925 -2.398 . . . . 0.48 112.438 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.89 -125.24 5.32 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.366 -1.493 . . . . 0.44 109.366 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 24.4 p -152.73 165.51 35.08 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.236 -1.482 . . . . 0.82 110.685 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 104' ' ' LEU . 10.3 tp -147.72 150.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.187 -1.824 . . . . 0.32 107.252 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -138.95 125.94 21.13 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 113.442 -1.708 . . . . 0.31 110.043 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.76 150.06 44.86 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.375 -1.284 . . . . 0.53 108.446 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.667 ' HB3' HD11 ' A' ' 71' ' ' LEU . 9.9 m -142.04 131.37 23.59 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.881 -0.785 . . . . 0.58 108.881 175.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -127.42 115.54 19.08 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.205 -1.361 . . . . 0.32 109.772 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HG2' HD13 ' A' ' 71' ' ' LEU . 48.9 mtp180 -104.98 123.4 47.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.123 -0.49 . . . . 2.43 110.329 -173.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 39' ' ' VAL . 14.1 t -123.76 127.58 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.463 1.125 . . . . 0.26 110.752 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.31 113.86 2.86 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.086 -1.87 . . . . 0.4 112.931 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 1.048 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -49.78 -64.75 3.26 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 114.313 -1.312 . . . . 0.76 111.085 166.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.705 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 60.52 -175.69 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 115.196 1.554 . . . . 0.71 115.196 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -96.55 106.88 19.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.867 -1.515 . . . . 1.74 109.759 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.988 HD12 HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -151.83 171.03 18.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.975 -0.557 . . . . 2.16 110.674 -171.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.73 -49.06 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.42 0.629 . . . . 1.47 110.244 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.645 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -149.92 158.14 37.29 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.611 -0.885 . . . . 1.4 108.611 174.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.75 139.62 3.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.159 2.573 . . . . 0.88 112.296 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.8 ' HD3' HD11 ' A' ' 33' ' ' LEU . 8.9 Cg_exo -55.27 141.96 79.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.012 1.142 . . . . 0.53 112.916 -175.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.84 106.38 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.332 -1.729 . . . . 0.77 106.332 174.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 28' ' ' VAL . 2.8 t -109.22 115.22 49.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.918 0 CA-C-N 113.384 -1.735 . . . . 0.28 108.083 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.935 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.66 130.53 52.67 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 123.126 1.441 . . . . 1.54 110.029 175.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.058 ' HB3' HD13 ' A' ' 49' ' ' LEU . 90.8 m95 -94.32 145.28 24.86 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 112.158 -2.292 . . . . 0.34 111.917 173.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.5 t80 -126.88 130.86 50.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.641 -1.985 . . . . 0.62 105.641 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 35.3 ttpt -104.76 111.58 24.36 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.523 -1.288 . . . . 2.17 107.523 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.646 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -81.24 92.63 1.49 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 116.146 -2.93 . . . . 1.23 114.274 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.753 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 tttp -106.67 -53.98 2.54 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 102.765 -3.05 . . . . 3.87 102.765 134.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.753 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 9.0 p-90 -168.0 0.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 110.171 -3.195 . . . . 2.11 110.933 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG21 ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -96.87 173.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.574 1.654 . . . . 1.29 113.357 -159.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.5 t70 -110.27 145.23 37.74 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.097 -2.774 . . . . 2.73 105.775 174.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.058 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.9 mp -80.47 -38.26 30.31 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.22 -0.592 . . . . 0.44 111.705 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -62.35 -18.78 62.35 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.809 -0.812 . . . . 1.23 108.809 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.452 ' C ' ' HD2' ' A' ' 52' ' ' LYS . 33.5 m -84.48 -22.63 30.21 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 114.681 -1.145 . . . . 1.34 111.532 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 8.0 mmmt -109.16 -67.52 0.98 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.181 -0.918 . . . . 1.4 111.623 -174.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.844 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.3 t 8.02 92.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 126.696 1.998 . . . . 0.37 113.912 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.99 -135.97 2.43 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.215 -1.812 . . . . 0.7 113.291 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.69 -36.58 79.14 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.967 1.099 . . . . 2.75 113.967 -168.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.704 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -98.19 -36.52 10.02 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 119.741 -0.784 . . . . 1.33 111.393 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.837 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.39 103.68 10.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.347 -1.353 . . . . 1.11 107.347 173.692 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.45 115.7 29.88 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 106.448 -1.686 . . . . 0.76 106.448 166.585 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.844 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.02 93.29 5.92 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 104.782 -2.303 . . . . 0.26 104.782 172.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 2.1 m80 -94.41 162.7 13.72 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.43 -1.259 . . . . 2.03 109.533 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.0 p-10 -137.09 112.1 8.99 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 111.961 -2.381 . . . . 0.92 110.103 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -95.66 150.8 19.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 112.455 -2.157 . . . . 0.47 108.525 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CZ ' ' HG2' ' A' ' 65' ' ' ARG . 6.7 t80 -143.67 98.53 3.26 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 122.643 1.211 . . . . 1.39 110.983 -173.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' OD2' ' HB3' ' A' ' 67' ' ' SER . 0.1 OUTLIER -110.0 105.47 14.62 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 112.759 -2.019 . . . . 2.42 110.045 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HG2' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -75.65 -30.78 59.56 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 2.46 111.038 -175.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.66 -24.49 64.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.208 -0.905 . . . . 1.15 110.461 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.539 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 6.5 t -100.94 -12.48 18.9 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.018 -0.734 . . . . 1.41 109.018 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 8.7 ttpt 67.18 31.25 6.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.101 -0.954 . . . . 3.31 110.5 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 27' ' ' ARG . 5.0 t -125.23 133.54 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.954 0.883 . . . . 0.43 110.631 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 1.048 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.9 m-85 -98.8 111.56 23.9 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.518 -2.03 . . . . 1.24 105.518 162.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.2 tp -100.87 104.0 15.2 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.113 0.959 . . . . 0.52 108.539 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 58.6 m-85 -84.64 113.39 21.24 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.929 -1.508 . . . . 0.33 106.929 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 5.2 pt-20 -117.99 123.85 46.73 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.376 -1.738 . . . . 1.32 110.216 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.825 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.1 mm? -91.88 126.87 37.13 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 112.653 -2.067 . . . . 0.96 108.127 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -116.19 96.42 5.54 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 104.368 -2.456 . . . . 1.15 104.368 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 55.5 mt -122.09 100.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 123.012 1.387 . . . . 0.52 109.875 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 45.5 p -104.18 154.38 19.82 Favored 'General case' 0 N--CA 1.394 -3.227 0 CA-C-N 113.964 -1.471 . . . . 0.58 108.492 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 44.21 85.7 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.322 -2.672 . . . . 2.12 112.429 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -71.85 136.81 47.13 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 110.926 -2.852 . . . . 0.4 111.191 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.64 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -63.44 130.12 94.08 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.259 -0.645 . . . . 1.43 109.259 173.47 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.733 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.6 Cg_endo -58.71 -13.04 16.27 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.561 2.841 . . . . 1.33 114.285 -171.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -120.45 28.8 7.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.887 -0.325 . . . . 1.12 111.622 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.557 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.21 -57.27 4.0 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.252 -0.648 . . . . 1.24 109.252 172.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 7.3 m 43.86 58.56 3.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.97 -1.492 . . . . 1.22 106.97 -157.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.745 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -51.26 85.48 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.498 0 CA-C-N 112.545 -2.116 . . . . 1.43 114.705 -164.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -92.08 80.71 1.2 Allowed Glycine 0 C--N 1.282 -2.429 0 N-CA-C 108.938 -1.665 . . . . 0.52 108.938 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 13.2 m-85 -78.64 109.8 13.18 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.812 -1.194 . . . . 0.63 108.807 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -94.36 105.03 17.0 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.694 -0.854 . . . . 3.15 108.694 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.582 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 8.4 t -95.52 126.23 40.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.571 -0.851 . . . . 1.08 109.176 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.935 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 92.3 mt-10 -133.96 118.68 18.14 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.65 -0.705 . . . . 1.81 110.367 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.522 HG22 HD21 ' A' ' 6' ' ' LEU . 3.4 p -107.52 143.67 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.485 0.659 . . . . 0.54 110.133 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 m -140.44 112.59 7.75 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.171 -0.922 . . . . 1.18 110.012 -176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.988 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -130.21 174.95 9.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 118.621 -0.704 . . . . 0.74 110.048 177.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -8.61 -60.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.196 1.56 . . . . 0.65 114.732 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.916 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.0 t70 -151.11 -8.05 0.25 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.293 -1.321 . . . . 1.05 109.669 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.993 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -91.13 124.88 35.69 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.679 -1.23 . . . . 1.29 107.679 -177.128 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -131.54 133.64 45.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.293 -0.867 . . . . 0.77 111.513 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -154.24 150.53 28.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.701 -1.136 . . . . 1.6 109.99 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' SG ' ' HG2' ' A' ' 90' ' ' GLU . 72.1 m -142.5 150.33 40.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.025 -0.361 . . . . 1.19 110.025 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.743 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 47.6 p -128.62 135.63 49.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.84 111.764 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.47 138.58 33.39 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.297 -0.865 . . . . 1.58 109.394 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.925 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -150.1 128.93 12.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.725 -0.79 . . . . 0.86 111.879 151.304 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.74 125.85 54.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.959 0.885 . . . . 2.11 111.279 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.94 104.17 14.12 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.133 -1.394 . . . . 0.37 109.575 -178.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.464 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.0 m -84.81 96.28 9.24 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.568 -0.901 . . . . 0.33 108.568 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.64 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.6 113.95 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 123.061 1.41 . . . . 0.33 109.18 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.719 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.0 m170 -78.55 97.24 5.69 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 112.852 -1.976 . . . . 1.19 109.653 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.7 tt0 . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.228 -1.351 . . . . 1.67 109.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 119.897 -0.096 . . . . 1.65 111.153 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.68 84.43 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.63 2.22 . . . . 0.97 111.948 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.857 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.0 -59.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.088 -0.96 . . . . 0.5 109.488 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.23 41.4 5.53 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 108.842 -1.703 . . . . 0.39 108.842 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -49.74 -38.97 35.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.738 -1.731 . . . . 0.33 111.048 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.653 ' HE2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -92.61 84.52 5.07 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.72 109.672 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.8 -48.03 35.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.851 -1.068 . . . . 0.63 109.998 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.511 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 16.5 tpt -151.19 129.03 11.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.048 -0.978 . . . . 2.88 108.842 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.653 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 16.3 ptm180 -88.2 144.32 34.09 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.733 -0.667 . . . . 3.67 110.162 -176.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 59.8 Cg_endo -65.8 145.8 81.73 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.557 2.171 . . . . 0.64 110.161 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 4.6 tp-100 -115.67 159.03 21.89 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 119.331 -0.366 . . . . 1.43 111.747 -173.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.3 m-20 -57.89 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 123.418 1.58 . . . . 2.06 113.044 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.18 137.0 2.73 Favored Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 112.963 -1.926 . . . . 0.3 111.551 -174.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.434 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.7 mt-10 -116.06 114.45 24.57 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.714 -0.847 . . . . 1.53 108.714 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 22' ' ' ILE . 4.9 m -134.2 164.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.712 -1.218 . . . . 0.27 107.712 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -95.21 156.73 16.2 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.886 -1.052 . . . . 0.77 109.534 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.579 HG13 ' HD3' ' A' ' 81' ' ' PRO . 42.4 t -62.56 107.02 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-O 122.754 1.264 . . . . 0.78 109.294 175.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.09 11.09 Favored Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.912 -2.404 . . . . 0.48 113.333 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.7 -122.58 4.84 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 119.616 -1.278 . . . . 0.44 110.009 171.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 11.9 p -150.36 165.04 34.28 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 113.087 -1.557 . . . . 0.82 110.645 175.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.724 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.8 tp -148.08 147.48 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.078 -1.874 . . . . 0.32 107.18 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m -139.5 125.97 20.36 Favored 'General case' 0 C--N 1.259 -3.354 0 CA-C-N 113.74 -1.573 . . . . 0.31 110.396 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 10.2 m-85 -123.54 146.67 47.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.618 -1.173 . . . . 0.53 109.458 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.483 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -126.51 129.93 49.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.038 -1.097 . . . . 0.58 108.038 173.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.749 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . . . -130.66 125.16 33.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.57 -1.195 . . . . 0.32 110.812 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.5 mtt180 -115.36 123.12 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.842 0.312 . . . . 2.43 111.842 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 39' ' ' VAL . 13.2 t -121.69 128.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.775 0.798 . . . . 0.26 109.593 178.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -57.63 107.38 0.44 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.881 -1.508 . . . . 0.4 110.527 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.699 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -55.79 -39.1 75.93 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.731 -1.122 . . . . 0.76 110.925 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.67 -163.93 0.03 OUTLIER 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.695 1.368 . . . . 0.71 114.695 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -111.64 123.02 49.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.443 -1.253 . . . . 1.74 108.153 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.889 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -155.1 174.65 14.89 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.673 0.249 . . . . 2.16 111.673 -172.086 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.6 tp -62.07 -47.99 82.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 1.47 109.539 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -151.15 154.59 34.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.059 -0.973 . . . . 1.4 108.963 170.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -44.14 134.37 8.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.627 2.885 . . . . 0.88 112.049 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.889 ' HD3' HD11 ' A' ' 33' ' ' LEU . 8.7 Cg_exo -42.89 142.87 1.98 Allowed 'Trans proline' 0 CA--C 1.499 -1.232 0 C-N-CA 123.849 3.033 . . . . 0.53 115.189 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.1 99.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 105.875 -1.898 . . . . 0.77 105.875 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.6 t -103.42 114.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-N 113.504 -1.68 . . . . 0.28 107.415 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.882 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.76 128.59 52.94 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.057 -1.429 . . . . 1.54 109.743 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.964 ' HB3' HD13 ' A' ' 49' ' ' LEU . 74.0 m95 -91.51 157.86 16.79 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 112.063 -2.335 . . . . 0.34 111.104 172.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.744 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.9 t80 -139.06 125.51 20.44 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.934 -2.247 . . . . 0.62 104.934 178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.703 ' HD3' HD23 ' A' ' 57' ' ' LEU . 33.8 ttpt -103.02 100.34 10.27 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.715 -1.587 . . . . 2.17 106.715 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 86' ' ' GLY . . . -90.38 97.46 2.33 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 115.993 -3.004 . . . . 1.23 117.293 -157.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 3.8 ptmt -99.14 -47.39 5.23 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.449 -2.797 . . . . 3.87 103.449 137.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.927 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 9.4 p-90 -170.38 3.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 112.468 -2.151 . . . . 2.11 111.102 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -98.82 169.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 C-N-CA 125.04 1.336 . . . . 1.29 112.981 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.643 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -105.43 154.15 20.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.455 -2.157 . . . . 2.73 107.001 175.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.964 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.4 mp -89.24 -30.46 18.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 0.44 112.605 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -57.2 -21.0 30.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.349 0.595 . . . . 1.23 109.854 -167.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.567 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 8.0 t -96.38 -22.55 17.1 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.178 -0.919 . . . . 1.34 111.992 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 1.7 mmmt -106.55 -15.19 14.85 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.778 -1.101 . . . . 1.4 111.671 -171.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.922 HG13 ' H ' ' A' ' 59' ' ' LEU . 55.7 t -59.17 89.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 114.013 -1.449 . . . . 0.37 110.213 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.49 -142.1 3.58 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 112.438 -2.165 . . . . 0.7 112.988 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -67.4 -22.63 65.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.007 0.744 . . . . 2.75 113.007 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.607 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.1 p-80 -101.21 -38.02 8.29 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 120.23 -0.588 . . . . 1.33 111.247 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.826 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.69 102.25 8.28 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.144 -1.799 . . . . 1.11 106.144 172.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -94.41 115.02 27.15 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.724 -1.584 . . . . 0.76 106.724 167.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.922 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.95 91.49 5.35 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.114 -2.55 . . . . 0.26 104.114 167.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.727 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 34.4 m170 -90.18 162.43 15.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.228 -1.351 . . . . 2.03 110.039 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -133.57 110.48 9.94 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 112.323 -2.217 . . . . 0.92 109.866 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 14.2 m -93.95 112.36 24.19 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.89 -1.959 . . . . 0.47 109.322 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.0 t80 -102.23 98.08 8.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.96 -1.018 . . . . 1.39 110.212 -176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.91 107.08 15.21 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.585 -1.643 . . . . 2.42 109.141 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.549 ' HD3' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -81.45 -32.72 32.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.382 -0.827 . . . . 2.46 110.968 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.58 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.229 -0.896 . . . . 1.15 110.527 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 m -108.66 -18.63 13.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.72 -0.844 . . . . 1.41 108.72 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.699 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 62.99 35.65 13.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 3.31 109.979 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -129.62 130.69 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.002 -0.999 . . . . 0.43 108.392 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.55 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 3.9 m-30 -101.26 106.72 17.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.599 -1.63 . . . . 1.24 106.599 171.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 22.7 tp -96.12 104.42 16.37 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.189 -1.368 . . . . 0.52 108.316 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.727 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.7 m-85 -83.53 113.47 20.83 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 113.819 -1.537 . . . . 0.33 107.533 174.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 6.6 mt-10 -106.84 119.02 38.22 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 113.113 -1.858 . . . . 1.32 108.935 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 76' ' ' ILE . 3.1 mm? -88.36 122.76 32.23 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.454 -1.313 . . . . 0.96 107.454 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 36.8 m80 -118.31 95.67 4.98 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 104.327 -2.472 . . . . 1.15 104.327 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 74' ' ' LEU . 39.4 mt -122.11 101.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 123.041 1.4 . . . . 0.52 110.2 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.2 p -110.53 134.79 52.05 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-N 113.621 -1.627 . . . . 0.58 107.692 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 77' ' ' THR . 3.5 t70 73.14 97.31 0.07 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 111.642 -2.526 . . . . 2.12 110.024 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.74 122.77 45.14 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 110.552 -3.022 . . . . 0.4 109.943 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.546 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -64.24 138.26 97.37 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.153 -0.93 . . . . 1.43 109.577 173.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.579 ' HD3' HG13 ' A' ' 18' ' ' VAL . 26.2 Cg_endo -61.44 -9.06 12.04 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.23 2.62 . . . . 1.33 112.421 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.63 17.67 22.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.835 -0.621 . . . . 1.12 111.441 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.753 ' HD1' ' HD2' ' A' ' 45' ' ' LYS . 1.4 m-30 -85.43 -55.33 4.06 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.91 -0.774 . . . . 1.24 108.91 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 88.7 m 28.51 63.84 0.11 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 123.183 1.468 . . . . 1.22 108.68 -161.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.751 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -66.55 91.61 0.17 Allowed Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 111.975 -2.375 . . . . 1.43 114.05 -159.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -83.61 83.74 1.6 Allowed Glycine 0 C--N 1.276 -2.768 0 N-CA-C 108.185 -1.966 . . . . 0.52 108.185 169.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 3.7 m-85 -74.6 113.65 12.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.685 -1.257 . . . . 0.63 108.812 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 99.8 mtt180 -87.89 109.76 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.391 -0.966 . . . . 3.15 108.391 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.419 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 1.6 t -95.97 122.67 39.04 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.601 -0.888 . . . . 1.08 108.601 175.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.882 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 38.5 tt0 -137.82 107.64 6.29 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.244 -0.889 . . . . 1.81 110.289 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.6 p -102.59 141.57 18.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.676 0.75 . . . . 0.54 110.699 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -139.86 108.33 5.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.342 -1.299 . . . . 1.18 108.561 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.743 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.47 145.33 51.1 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-O 117.936 -1.03 . . . . 0.74 108.894 -179.045 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 32.95 -74.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 126.148 2.155 . . . . 0.65 113.578 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.68 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -148.16 -8.07 0.4 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.035 -0.984 . . . . 1.05 110.563 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.857 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.9 mmtm -86.05 129.53 34.81 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.432 -1.321 . . . . 1.29 107.432 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 21.3 t80 -132.33 148.39 52.43 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.85 -1.523 . . . . 0.77 111.773 -173.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 t70 -179.0 165.39 1.52 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.207 0.942 . . . . 1.6 110.33 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.3 m -145.22 151.73 38.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.267 -0.271 . . . . 1.19 110.267 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.595 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 58.5 p -132.6 130.31 40.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.041 0.448 . . . . 0.84 112.149 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -94.56 127.32 40.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.368 -0.833 . . . . 1.58 109.393 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 87' ' ' TYR . 28.4 p90 -149.38 143.75 25.96 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.119 -0.632 . . . . 0.86 109.872 165.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.9 m-80 -115.8 140.23 49.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.255 1.026 . . . . 2.11 112.471 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.82 107.99 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.336 -1.302 . . . . 0.37 108.463 172.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.434 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 3.8 m -87.81 96.38 10.44 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.253 -0.647 . . . . 0.33 109.253 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.4 p -79.41 112.78 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.25 1.5 . . . . 0.33 108.672 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 44.0 m170 -85.65 100.34 11.91 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.527 -2.124 . . . . 1.19 109.421 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.449 ' HA ' HG23 ' A' ' 18' ' ' VAL . 37.1 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 114.805 -1.089 . . . . 1.67 109.836 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 9.8 m-20 . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 110.067 -0.345 . . . . 1.65 110.067 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.38 88.18 0.33 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.311 2.007 . . . . 0.97 111.889 172.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.92 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.13 -65.16 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.378 -0.828 . . . . 0.5 109.537 177.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 93.8 49.06 2.57 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 108.595 -1.802 . . . . 0.39 108.595 -174.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.8 tp -61.41 -33.39 73.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.083 -1.558 . . . . 0.33 110.22 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.653 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -91.68 84.66 5.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.931 -1.031 . . . . 0.72 110.088 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.57 -46.6 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.899 -1.046 . . . . 0.63 110.405 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.11 131.03 11.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 2.88 109.708 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.542 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 21.2 ptt180 -108.12 142.89 26.27 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.575 -0.739 . . . . 3.67 109.843 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.781 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 11.0 Cg_endo -73.4 158.09 48.64 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.538 1.492 . . . . 0.64 110.82 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -116.3 -180.0 3.83 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.363 -0.606 . . . . 1.43 109.363 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 2.0 p-10 -71.55 -148.92 0.02 OUTLIER 'General case' 0 N--CA 1.407 -2.578 0 CA-C-O 122.932 1.348 . . . . 2.06 111.635 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.69 133.82 1.69 Allowed Glycine 0 C--N 1.293 -1.819 0 CA-C-N 113.356 -1.747 . . . . 0.3 112.045 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.2 mt-10 -113.82 111.12 21.22 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.006 -1.097 . . . . 1.53 108.082 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.424 HG11 ' HB ' ' A' ' 22' ' ' ILE . 3.0 m -126.74 163.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 106.666 -1.605 . . . . 0.27 106.666 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.74 154.61 17.48 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 115.404 -0.816 . . . . 0.77 109.27 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.719 HG21 ' HG3' ' A' ' 81' ' ' PRO . 3.1 t -64.33 106.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 CA-C-O 122.719 1.247 . . . . 0.78 108.365 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.13 8.64 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.378 -2.192 . . . . 0.48 112.145 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.96 -122.28 4.82 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 108.73 -1.748 . . . . 0.44 108.73 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.2 p -151.94 171.1 18.31 Favored 'General case' 0 N--CA 1.399 -3.015 0 CA-C-N 113.344 -1.428 . . . . 0.82 109.894 172.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 104' ' ' LEU . 10.5 tp -146.34 147.53 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 113.276 -1.783 . . . . 0.32 107.316 166.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -139.03 123.96 18.8 Favored 'General case' 0 C--N 1.262 -3.214 0 CA-C-N 113.333 -1.758 . . . . 0.31 110.241 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 74' ' ' LEU . 73.1 m-85 -123.44 145.66 48.63 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.129 -1.396 . . . . 0.53 107.769 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.795 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.3 m -138.18 124.91 20.99 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.745 0.783 . . . . 0.58 109.439 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -116.7 115.73 26.2 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.285 -1.325 . . . . 0.32 110.48 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HE ' HG11 ' A' ' 69' ' ' VAL . 77.1 mtp180 -106.41 115.57 30.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.654 -0.248 . . . . 2.43 110.549 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 91' ' ' VAL . 22.0 t -118.92 126.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.958 0.885 . . . . 0.26 110.523 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.14 112.06 1.76 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.337 -1.756 . . . . 0.4 110.724 173.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.53 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -45.2 -51.53 8.91 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 114.794 -1.094 . . . . 0.76 111.269 171.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.611 ' H ' ' CG ' ' A' ' 68' ' ' LYS . . . 55.49 -155.77 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.408 0.892 . . . . 0.71 113.408 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 p -115.68 135.92 53.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.861 -0.608 . . . . 1.74 109.953 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -155.08 -174.61 5.05 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.826 0.822 . . . . 2.16 112.8 -175.242 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.3 tp -98.06 -45.17 6.35 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.27 -1.332 . . . . 1.47 108.128 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.554 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.39 139.05 29.02 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.723 -1.126 . . . . 1.4 108.982 172.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.11 156.57 24.09 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.956 2.437 . . . . 0.88 111.103 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 93' ' ' THR . 3.3 Cg_endo -57.1 125.15 18.04 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.544 0.829 . . . . 0.53 112.716 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 104.54 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.054 -1.462 . . . . 0.77 107.054 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.5 t -102.73 114.42 42.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.832 -1.531 . . . . 0.28 108.397 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.02 127.85 53.05 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.743 -1.571 . . . . 1.54 109.817 175.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.99 ' HB3' HD13 ' A' ' 49' ' ' LEU . 77.0 m95 -91.63 155.03 18.63 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 111.969 -2.378 . . . . 0.34 111.677 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.642 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 39.7 t80 -133.36 139.9 47.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.316 -2.476 . . . . 0.62 104.316 170.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.817 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 62.9 tttp -102.51 166.61 10.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 105.721 -1.955 . . . . 2.17 105.721 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -14.03 -167.31 0.0 OUTLIER Glycine 0 C--O 1.183 -3.088 0 N-CA-C 119.248 2.459 . . . . 1.23 119.248 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.693 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 8.4 mtpt -44.41 -8.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 O-C-N 119.125 -2.397 . . . . 3.87 116.786 -164.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.517 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 9.9 p-90 -160.8 -9.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 114.101 1.148 . . . . 2.11 114.101 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.817 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.92 164.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 CA-C-O 123.218 1.485 . . . . 1.29 112.481 -160.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.575 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 9.9 p-10 -111.1 158.54 18.75 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 111.815 -2.448 . . . . 2.73 106.508 172.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.091 HD23 HD21 ' A' ' 57' ' ' LEU . 5.7 mp -98.88 -28.74 13.32 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.476 -0.49 . . . . 0.44 111.792 167.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -57.3 -21.37 34.37 Favored 'General case' 0 C--N 1.315 -0.891 0 O-C-N 123.706 0.629 . . . . 1.23 109.864 -163.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 33.2 m -100.03 -35.38 9.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 122.033 0.921 . . . . 1.34 112.224 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.575 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -88.61 -31.29 18.66 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.159 -1.382 . . . . 1.4 111.685 -165.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.846 HG13 ' H ' ' A' ' 59' ' ' LEU . 79.2 t -35.46 94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.392 1.477 . . . . 0.37 111.753 172.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.44 -95.91 0.11 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 112.501 -2.136 . . . . 0.7 113.837 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -95.3 -45.37 7.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.944 0.72 . . . . 2.75 112.944 -172.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 31.5 p80 -88.45 -37.11 16.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.736 0.779 . . . . 1.33 110.609 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.091 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.55 106.92 12.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.428 -1.693 . . . . 1.11 106.428 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -100.81 116.13 31.98 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 106.63 -1.619 . . . . 0.76 106.63 164.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.846 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -95.19 93.8 7.53 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 104.829 -2.285 . . . . 0.26 104.829 173.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 90.3 m-70 -84.33 162.49 20.04 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.338 -1.301 . . . . 2.03 109.887 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -140.13 114.76 9.41 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 111.986 -2.37 . . . . 0.92 109.42 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 2.0 m -101.52 149.35 24.18 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.796 -2.002 . . . . 0.47 108.628 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -141.29 98.62 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.569 1.175 . . . . 1.39 111.251 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.46 101.71 9.39 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.315 -1.766 . . . . 2.42 109.319 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -73.85 -29.58 62.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.508 -0.769 . . . . 2.46 110.228 177.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.98 70.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.106 -0.952 . . . . 1.15 110.668 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -103.36 -13.81 16.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.209 -0.905 . . . . 1.41 109.455 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER 63.36 36.88 11.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.872 0.844 . . . . 3.31 109.898 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.431 HG11 ' HE ' ' A' ' 27' ' ' ARG . 3.2 t -127.41 128.1 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.673 0.749 . . . . 0.43 109.726 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.53 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.7 m-85 -98.19 113.36 25.25 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.922 -1.881 . . . . 1.24 105.922 164.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' A' ' 25' ' ' SER . 21.7 tp -99.06 106.4 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 122.217 1.008 . . . . 0.52 109.374 174.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 55.3 m-85 -84.47 113.33 21.13 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 113.726 -1.579 . . . . 0.33 107.953 168.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.9 116.84 32.37 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.67 -1.604 . . . . 1.32 110.7 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.802 ' HB3' HG13 ' A' ' 76' ' ' ILE . 18.0 mt -81.97 123.65 29.07 Favored 'General case' 0 CA--C 1.475 -1.926 0 CA-C-N 115.081 -0.963 . . . . 0.96 108.927 170.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -111.73 93.65 4.56 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 103.108 -2.923 . . . . 1.15 103.108 163.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 74' ' ' LEU . 18.1 mt -118.39 99.96 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 122.83 1.3 . . . . 0.52 109.255 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.0 p -102.85 166.51 10.43 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 114.078 -1.419 . . . . 0.58 110.439 -176.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 41.03 67.38 0.53 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 110.658 -2.974 . . . . 2.12 111.551 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -62.18 120.01 10.1 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.894 -1.957 . . . . 0.4 111.252 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.879 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 3.1 tp60 -54.91 140.21 61.22 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.349 -0.841 . . . . 1.43 109.728 169.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.719 ' HG3' HG21 ' A' ' 18' ' ' VAL . 23.2 Cg_exo -62.9 -10.25 19.58 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.692 2.261 . . . . 1.33 112.465 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.879 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -98.64 10.76 40.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.962 -0.563 . . . . 1.12 110.773 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 83' ' ' PHE . 2.8 m-30 -95.54 -10.84 28.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.722 -0.391 . . . . 1.24 110.898 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 21.8 m -46.11 101.31 0.02 OUTLIER 'General case' 0 CA--C 1.475 -1.92 0 CA-C-O 122.358 1.075 . . . . 1.22 108.802 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.693 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -172.69 -128.79 1.08 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.701 -2.045 . . . . 1.43 113.383 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.95 119.03 0.88 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.174 -1.013 . . . . 0.52 112.712 -170.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.713 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.0 m-85 -82.81 120.94 26.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.348 -1.426 . . . . 0.63 108.212 175.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.642 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 57.7 ttt180 -110.91 104.49 13.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.976 0.417 . . . . 3.15 110.193 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.879 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.7 t -92.19 129.86 38.04 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.05 -0.722 . . . . 1.08 109.05 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.691 ' HG3' ' HB3' ' A' ' 99' ' ' CYS . 30.6 tt0 -140.22 106.69 5.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.477 -0.783 . . . . 1.81 109.458 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.634 HG21 HG11 ' A' ' 28' ' ' VAL . 5.5 p -95.05 138.01 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 121.858 0.837 . . . . 0.54 110.73 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.2 t -133.29 108.88 9.01 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.146 -1.388 . . . . 1.18 107.94 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.599 ' OG1' HD21 ' A' ' 6' ' ' LEU . 2.4 m -127.27 170.06 12.86 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.888 -1.153 . . . . 0.74 107.888 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.723 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 0.82 -65.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 125.513 1.758 . . . . 0.65 114.555 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.723 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 1.2 t0 -148.82 -8.96 0.35 Allowed 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.837 -1.074 . . . . 1.05 109.967 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.92 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.2 mmtm -87.5 124.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.79 -1.189 . . . . 1.29 107.79 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -130.65 137.41 49.58 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.735 -1.12 . . . . 0.77 111.153 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -163.07 161.85 25.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.79 -1.096 . . . . 1.6 108.892 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.691 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 3.9 p -153.46 145.33 23.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.152 0.501 . . . . 1.19 111.183 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.653 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 42.5 p -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.84 111.253 -175.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.94 125.27 50.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.226 0.536 . . . . 1.58 110.868 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.879 ' HZ ' ' HB2' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -140.1 116.18 10.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.431 -0.581 . . . . 0.86 109.431 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.574 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 51.1 m-20 -95.16 151.65 19.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.292 -0.867 . . . . 2.11 110.846 -168.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -123.95 121.28 34.87 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.256 -0.884 . . . . 0.37 108.806 174.235 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -103.35 96.05 6.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.416 -0.586 . . . . 0.33 109.416 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.5 p -77.63 116.19 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 123.077 1.418 . . . . 0.33 109.05 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 64.8 m170 -87.56 102.02 14.19 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.395 -2.184 . . . . 1.19 108.275 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.609 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 33.0 tt0 . . . . . 0 C--N 1.299 -1.595 0 CA-C-N 114.133 -1.394 . . . . 1.67 111.277 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.801 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 2.3 m-20 . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 109.4 -0.593 . . . . 1.65 109.4 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.01 77.07 4.07 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.848 1.699 . . . . 0.97 113.19 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.826 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -93.87 -62.6 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.315 -0.994 . . . . 0.5 108.315 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.7 4.64 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 109.368 -1.493 . . . . 0.39 109.368 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.737 HD22 ' HB3' ' A' ' 96' ' ' LYS . 3.7 tp -41.04 -44.37 2.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 112.897 -1.652 . . . . 0.33 111.421 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.691 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -93.0 84.43 4.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.246 -0.888 . . . . 0.72 109.793 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 27' ' ' ARG . 15.8 t -76.16 -33.06 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.018 -1.446 . . . . 0.63 109.187 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp -167.95 137.41 2.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.095 -0.957 . . . . 2.88 109.639 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 27.7 ptt180 -105.66 148.79 37.02 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.933 -0.576 . . . . 3.67 110.079 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 13.5 Cg_endo -79.48 164.52 23.73 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.646 1.564 . . . . 0.64 110.728 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -123.7 179.3 4.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.326 -0.397 . . . . 1.43 110.337 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.2 -144.59 0.01 OUTLIER 'General case' 0 N--CA 1.41 -2.433 0 CA-C-O 122.809 1.29 . . . . 2.06 110.98 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.34 132.26 1.79 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.606 -1.634 . . . . 0.3 111.726 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.0 mt-10 -110.49 114.16 27.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.981 -1.109 . . . . 1.53 108.213 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.9 m -134.48 162.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 N-CA-C 107.821 -1.177 . . . . 0.27 107.821 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 153.15 17.95 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.487 -1.233 . . . . 0.77 108.738 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.74 HG11 ' HD3' ' A' ' 81' ' ' PRO . 5.8 t -69.0 105.01 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.826 1.298 . . . . 0.78 107.956 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.22 12.54 5.22 Favored Glycine 0 C--N 1.267 -3.304 0 CA-C-N 112.445 -2.162 . . . . 0.48 112.642 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.03 -122.66 5.14 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.264 -1.446 . . . . 0.44 110.366 170.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.705 ' HB3' HG22 ' A' ' 77' ' ' THR . 8.1 p -151.51 169.41 22.14 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 113.054 -1.573 . . . . 0.82 110.329 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -148.19 149.98 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.539 -1.664 . . . . 0.32 107.285 168.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 m -140.15 131.49 26.75 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.022 -1.445 . . . . 0.31 110.947 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.547 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 50.0 m-85 -129.55 148.05 51.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.148 -1.387 . . . . 0.53 108.764 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.566 ' HB3' HD11 ' A' ' 71' ' ' LEU . 3.5 m -140.08 127.33 21.17 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.879 0.847 . . . . 0.58 109.188 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.12 117.23 24.92 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.125 -1.398 . . . . 0.32 110.718 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 75.2 mtt180 -102.07 121.78 42.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.3 -0.409 . . . . 2.43 110.505 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.1 t -126.06 128.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 122.082 0.944 . . . . 0.26 110.531 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.36 105.39 0.5 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.444 -1.707 . . . . 0.4 112.398 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.26 89.08 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 115.061 -0.972 . . . . 0.76 111.745 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.851 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 57.54 -163.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.783 1.031 . . . . 0.71 113.783 162.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -118.89 31.13 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 1.74 109.529 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.015 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -56.1 -175.76 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.639 1.348 . . . . 2.16 114.639 176.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 tp -68.98 -53.95 17.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.04 -0.982 . . . . 1.47 109.593 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.632 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.88 146.49 47.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 114.846 -1.07 . . . . 1.4 108.688 172.106 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -42.98 140.37 3.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.464 2.776 . . . . 0.88 111.934 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.7 Cg_endo -53.16 136.59 62.17 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.563 1.509 . . . . 0.53 112.761 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.01 104.31 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.638 0 N-CA-C 106.157 -1.794 . . . . 0.77 106.157 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -106.88 114.75 46.79 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 113.136 -1.847 . . . . 0.28 107.785 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.974 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.69 125.33 50.11 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.825 -1.534 . . . . 1.54 109.58 174.068 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.997 ' HB3' HD13 ' A' ' 49' ' ' LEU . 68.0 m95 -86.45 149.1 25.23 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.816 -2.447 . . . . 0.34 111.482 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.618 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 25.8 t80 -125.37 138.55 54.04 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 104.66 -2.348 . . . . 0.62 104.66 169.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 67.5 tttt -99.35 171.13 8.17 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.612 -1.996 . . . . 2.17 105.612 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.929 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -19.56 -173.59 0.0 OUTLIER Glycine 0 C--O 1.179 -3.308 0 C-N-CA 126.749 2.118 . . . . 1.23 117.878 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.649 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 7.8 ttpp -40.98 -9.56 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 117.577 2.436 . . . . 3.87 117.577 -157.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.649 ' HD1' ' HB3' ' A' ' 45' ' ' LYS . 4.8 p-90 -161.58 -7.05 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.287 0.949 . . . . 2.11 113.342 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -95.39 165.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-O 123.014 1.388 . . . . 1.29 112.601 -158.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.689 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 6.5 p-10 -114.05 154.3 27.95 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 112.022 -2.353 . . . . 2.73 109.284 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.054 HD23 HD21 ' A' ' 57' ' ' LEU . 5.6 mp -98.44 -32.24 11.59 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.774 -0.648 . . . . 0.44 111.637 169.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -59.47 -23.38 62.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.369 -0.604 . . . . 1.23 109.369 -166.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.689 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 6.2 m -102.95 -27.69 12.47 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.621 -0.832 . . . . 1.34 113.023 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 11.4 mptt -80.78 -84.61 0.1 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.716 -0.674 . . . . 1.4 111.584 -173.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 24.7 t 21.68 95.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 126.068 2.105 . . . . 0.37 113.966 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.93 -99.54 0.14 Allowed Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.132 -1.395 . . . . 0.7 113.264 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -83.2 -53.57 5.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.321 0.489 . . . . 2.75 112.321 -170.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.9 p80 -92.02 -33.83 14.67 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.235 -0.586 . . . . 1.33 111.432 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.054 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.39 106.24 14.35 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.112 -1.81 . . . . 1.11 106.112 174.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -101.35 116.72 33.43 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.949 -1.5 . . . . 0.76 106.949 165.283 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.88 92.96 6.08 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.216 -2.142 . . . . 0.26 105.216 170.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.942 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.8 m170 -87.99 162.1 17.03 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.673 -1.149 . . . . 2.03 109.912 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -142.13 115.71 9.09 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.214 -2.267 . . . . 0.92 109.784 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.2 m -95.82 150.33 20.53 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.393 -2.185 . . . . 0.47 109.038 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.74 100.61 5.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.517 1.151 . . . . 1.39 111.422 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.5 t70 -114.42 114.25 25.59 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.292 -1.776 . . . . 2.42 108.819 174.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' C ' ' H ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.63 -37.13 17.05 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.054 -0.975 . . . . 2.46 112.133 -177.333 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.07 68.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.43 0.633 . . . . 1.15 110.113 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -104.12 -11.86 17.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.056 -0.974 . . . . 1.41 109.898 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.833 ' HE3' ' HA ' ' A' ' 31' ' ' ALA 0.295 0.2 OUTLIER 38.84 57.8 1.82 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 124.49 2.091 . . . . 3.31 111.568 -166.528 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 t -122.91 115.31 45.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 112.373 -2.194 . . . . 0.43 109.355 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 62' ' ' SER . 34.1 m-85 -91.25 105.96 18.16 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.898 -1.519 . . . . 1.24 106.898 167.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.7 tp -86.51 104.5 16.03 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.681 -1.145 . . . . 0.52 108.522 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.653 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 80.5 m-85 -87.25 110.81 20.45 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.795 -1.557 . . . . 0.33 106.795 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.942 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -114.3 125.59 54.06 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.148 -1.387 . . . . 1.32 110.136 -176.585 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.694 HD13 HD11 ' A' ' 76' ' ' ILE . 2.6 mt -92.41 131.9 37.2 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 113.571 -1.65 . . . . 0.96 108.437 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -119.88 97.43 5.62 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 104.491 -2.411 . . . . 1.15 104.491 165.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.712 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 14.3 mt -123.47 99.85 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.624 1.202 . . . . 0.52 108.871 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' HB3' ' A' ' 21' ' ' SER . 25.0 p -99.04 166.69 11.15 Favored 'General case' 0 N--CA 1.395 -3.22 0 CA-C-O 122.891 1.329 . . . . 0.58 110.444 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 40.58 74.17 0.11 Allowed 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 110.361 -3.108 . . . . 2.12 111.468 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -64.34 115.11 4.75 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.765 -2.016 . . . . 0.4 108.701 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -67.42 159.62 76.7 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.708 -0.849 . . . . 1.43 108.708 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.74 ' HD3' HG11 ' A' ' 18' ' ' VAL . 68.5 Cg_endo -73.68 156.34 49.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 120.984 1.123 . . . . 1.33 111.394 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.4 15.5 9.56 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.747 0.655 . . . . 1.12 110.523 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.781 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -85.29 -8.28 58.59 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.791 -0.623 . . . . 1.24 109.621 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.755 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 23.2 m -10.98 84.9 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 126.042 2.089 . . . . 1.22 111.974 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.929 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.76 118.34 3.59 Favored Glycine 0 N--CA 1.406 -3.333 0 CA-C-N 110.816 -2.902 . . . . 1.43 113.478 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.53 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -116.34 63.38 0.36 Allowed Glycine 0 C--N 1.266 -3.328 0 CA-C-N 112.545 -1.827 . . . . 0.52 108.716 158.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 75.8 m-85 -73.02 106.78 5.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.204 -1.406 . . . . 0.63 107.204 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.618 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 55.3 mtt-85 -118.3 105.36 11.67 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.242 -0.583 . . . . 3.15 109.967 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.672 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -89.36 124.48 34.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.861 -0.608 . . . . 1.08 109.642 -177.06 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.974 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 36.9 tt0 -129.2 110.81 12.29 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.77 -1.104 . . . . 1.81 109.244 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.625 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.2 p -99.97 139.95 20.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.429 0.633 . . . . 0.54 110.151 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -137.02 110.05 7.71 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.788 -1.097 . . . . 1.18 108.329 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.746 HG21 HD12 ' A' ' 33' ' ' LEU . 1.1 m -129.86 167.41 18.18 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.925 -0.769 . . . . 0.74 108.925 -176.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.801 ' HZ3' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 6.75 -69.16 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.668 1.855 . . . . 0.65 114.028 172.148 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.411 ' H ' ' HE2' ' A' ' 94' ' ' LYS . 7.5 t70 -154.23 1.98 0.23 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.672 -0.695 . . . . 1.05 109.134 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.826 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -91.68 136.19 33.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 122.073 0.94 . . . . 1.29 108.812 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -132.52 134.02 44.48 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 112.683 -2.053 . . . . 0.77 111.592 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -157.0 148.07 21.89 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.813 -1.085 . . . . 1.6 110.47 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.2 149.35 34.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.836 -0.62 . . . . 1.19 109.838 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.691 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 80.4 p -141.41 136.12 31.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.959 0.409 . . . . 0.84 110.386 176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -107.53 130.09 54.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.799 -0.637 . . . . 1.58 109.395 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.78 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -141.1 112.83 7.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.649 0.737 . . . . 0.86 109.496 -177.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.769 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 61.5 m-20 -95.37 148.76 22.1 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.51 1.148 . . . . 2.11 111.359 -167.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.807 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -119.31 108.78 15.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.052 -1.431 . . . . 0.37 110.796 177.153 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.2 m -91.54 96.92 10.74 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.687 -0.856 . . . . 0.33 108.687 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 18' ' ' VAL . 8.0 p -86.88 120.76 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.096 1.427 . . . . 0.33 109.782 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -95.41 100.97 12.66 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 112.145 -2.298 . . . . 1.19 108.987 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.713 ' HA ' HG23 ' A' ' 18' ' ' VAL . 48.7 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 114.255 -1.339 . . . . 1.67 110.743 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.548 ' HB2' HD13 ' A' ' 4' ' ' ILE . 15.2 m-20 . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 119.645 -0.216 . . . . 1.65 110.623 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 41.77 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.076 2.517 . . . . 0.97 113.386 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.799 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -61.59 -50.01 82.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.696 0.76 . . . . 0.5 109.537 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.21 30.55 22.23 Favored Glycine 0 CA--C 1.497 -1.064 0 N-CA-C 109.176 -1.57 . . . . 0.39 109.176 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.001 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 10.6 tp -41.8 -54.41 3.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.981 -1.609 . . . . 0.33 111.426 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.752 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -84.57 83.89 7.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.54 0.686 . . . . 0.72 109.801 176.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.69 -45.37 66.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.66 -1.155 . . . . 0.63 109.767 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.742 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 22.8 mmt -136.68 132.63 35.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.688 -0.687 . . . . 2.88 110.027 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.745 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 88.0 mtt180 -90.98 121.82 67.47 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.052 -0.721 . . . . 3.67 109.052 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.68 ' HG2' ' HE1' ' A' ' 102' ' ' PHE . 18.6 Cg_endo -62.21 156.75 48.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.858 2.372 . . . . 0.64 110.856 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 4.1 tp-100 -120.0 160.07 23.49 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 119.075 -0.488 . . . . 1.43 112.185 -167.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.605 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -58.41 -144.77 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 123.053 1.406 . . . . 2.06 112.611 176.126 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 151.38 135.31 2.29 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 113.404 -1.726 . . . . 0.3 111.951 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 26.2 mt-10 -111.03 118.74 36.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.476 -0.935 . . . . 1.53 108.476 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 22' ' ' ILE . 2.3 m -139.23 162.97 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.706 -1.22 . . . . 0.27 107.706 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.768 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.19 158.11 15.75 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.142 -0.936 . . . . 0.77 109.489 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 106' ' ' VAL . 10.1 t -66.18 107.68 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 122.993 1.378 . . . . 0.78 108.365 172.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 12.2 10.71 Favored Glycine 0 C--N 1.269 -3.159 0 CA-C-N 112.097 -2.32 . . . . 0.48 112.833 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.35 -124.7 5.09 Favored Glycine 0 N--CA 1.418 -2.507 0 C-N-CA 119.314 -1.422 . . . . 0.44 110.09 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 71.2 m -154.49 171.0 20.09 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 113.271 -1.465 . . . . 0.82 109.19 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.598 HG21 HD13 ' A' ' 104' ' ' LEU . 9.9 tp -149.11 149.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.337 0 CA-C-O 122.719 1.247 . . . . 0.32 107.78 170.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -140.42 125.42 18.43 Favored 'General case' 0 C--N 1.261 -3.241 0 CA-C-N 113.669 -1.605 . . . . 0.31 110.454 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' HB2' HD23 ' A' ' 74' ' ' LEU . 22.1 m-85 -120.03 152.25 37.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.325 -1.307 . . . . 0.53 108.049 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -139.54 129.6 25.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.787 -0.82 . . . . 0.58 108.787 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -133.2 122.18 23.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.803 -1.089 . . . . 0.32 110.695 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.742 ' HD2' ' CG ' ' A' ' 9' ' ' MET . 60.4 mtt180 -107.93 122.64 47.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.665 -0.243 . . . . 2.43 111.015 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 39' ' ' VAL . 6.6 t -121.23 125.79 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.997 0.903 . . . . 0.26 110.132 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -56.35 113.14 1.45 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.594 -1.639 . . . . 0.4 112.575 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.76 -58.07 12.47 Favored Glycine 0 C--O 1.225 -0.422 0 CA-C-N 114.589 -1.187 . . . . 0.76 111.334 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.737 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.48 -174.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.303 1.223 . . . . 0.71 114.303 167.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.6 t -110.09 25.68 11.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.001 -1.0 . . . . 1.74 109.185 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.96 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -55.05 171.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.701 -1.136 . . . . 2.16 112.889 177.154 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.1 tp -50.95 -54.91 20.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.669 -0.696 . . . . 1.47 110.415 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.584 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -147.87 155.5 44.35 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 108.212 -1.033 . . . . 1.4 108.212 172.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -39.67 138.31 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.459 2.773 . . . . 0.88 112.681 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.96 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.9 Cg_exo -55.54 139.28 82.38 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.939 1.759 . . . . 0.53 112.312 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 2.2 t -98.47 104.76 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 105.904 -1.888 . . . . 0.77 105.904 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -112.26 113.57 44.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.195 -1.82 . . . . 0.28 107.445 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.591 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.73 126.71 51.04 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 123.182 1.467 . . . . 1.54 109.346 174.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.071 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.2 m95 -84.17 152.01 24.53 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.03 -2.35 . . . . 0.34 110.957 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.6 t80 -130.04 136.46 49.41 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.747 -2.316 . . . . 0.62 104.747 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.75 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttp -102.77 168.18 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.013 -2.218 . . . . 2.17 105.013 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.993 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -9.5 -172.59 0.0 OUTLIER Glycine 0 C--O 1.183 -3.074 0 N-CA-C 119.808 2.683 . . . . 1.23 119.808 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.7 mtpp -45.82 -3.86 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 116.375 1.991 . . . . 3.87 116.375 -165.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 7.5 p-90 -163.76 -6.77 0.03 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.323 1.231 . . . . 2.11 114.323 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.34 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-O 123.41 1.576 . . . . 1.29 112.499 -162.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.1 t70 -113.84 154.12 28.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 111.585 -2.552 . . . . 2.73 105.548 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.071 HD13 ' HB3' ' A' ' 41' ' ' TRP . 2.2 mp -93.75 -37.91 11.56 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 118.362 0.528 . . . . 0.44 112.095 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 t -58.94 -21.05 57.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.754 0.788 . . . . 1.23 108.88 -169.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -84.34 -32.74 24.1 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.356 -1.293 . . . . 1.34 112.811 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.751 ' HB2' HD12 ' A' ' 57' ' ' LEU . 15.4 mmmt -104.5 -25.43 12.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.245 -0.889 . . . . 1.4 111.323 -167.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 49' ' ' LEU . 43.4 t -43.12 89.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 113.365 -1.743 . . . . 0.37 111.479 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.44 -113.84 0.5 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.209 -2.269 . . . . 0.7 112.602 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.4 -30.85 18.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.195 0.497 . . . . 2.75 112.022 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.8 p80 -90.23 -37.2 14.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.672 0.749 . . . . 1.33 111.017 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.968 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.36 106.35 9.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.317 -1.734 . . . . 1.11 106.317 174.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -95.81 115.46 27.46 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.606 -1.628 . . . . 0.76 106.606 165.703 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -99.74 92.44 5.32 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 104.411 -2.441 . . . . 0.26 104.411 170.101 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.633 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 63.7 m170 -81.74 161.9 23.14 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.627 -1.17 . . . . 2.03 110.114 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -133.04 112.93 12.22 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 112.592 -2.094 . . . . 0.92 108.711 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -93.9 148.82 21.78 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 112.982 -1.917 . . . . 0.47 107.408 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -139.46 97.78 3.35 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.575 1.179 . . . . 1.39 110.926 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.65 120.54 39.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 112.846 -1.979 . . . . 2.42 109.338 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.57 -34.94 27.58 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.573 -1.648 . . . . 2.46 111.38 -176.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 1.15 110.35 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 69' ' ' VAL . 18.9 t -94.52 -17.55 22.29 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.423 -0.808 . . . . 1.41 108.904 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.737 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 13.7 ttpt 62.05 37.25 14.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.024 -0.989 . . . . 3.31 108.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 67' ' ' SER . 38.0 t -128.83 131.39 68.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.369 1.081 . . . . 0.43 111.053 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -94.96 105.19 17.09 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 105.888 -1.893 . . . . 1.24 105.888 162.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.3 tp -96.55 105.24 17.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.479 1.133 . . . . 0.52 108.855 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.7 m-85 -85.22 114.58 22.43 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.33 107.846 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -107.06 119.86 40.52 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.587 -1.642 . . . . 1.32 108.998 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.83 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.7 mm? -92.81 120.9 33.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.629 -1.169 . . . . 0.96 107.919 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.67 95.61 5.33 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 104.593 -2.373 . . . . 1.15 104.593 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.63 HG12 HD23 ' A' ' 57' ' ' LEU . 66.4 mt -120.63 100.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 114.491 -1.231 . . . . 0.52 109.152 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 28.9 p -104.84 159.81 15.5 Favored 'General case' 0 N--CA 1.393 -3.32 0 CA-C-N 114.526 -1.216 . . . . 0.58 109.183 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.55 74.03 0.22 Allowed 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 111.611 -2.54 . . . . 2.12 111.158 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.37 123.54 19.87 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.228 -1.805 . . . . 0.4 111.327 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.552 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -60.59 137.0 92.64 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.477 -0.783 . . . . 1.43 109.739 170.564 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.542 ' HB3' HG21 ' A' ' 18' ' ' VAL . 35.4 Cg_endo -65.0 -3.36 6.96 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.32 2.68 . . . . 1.33 113.197 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.552 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -111.01 13.01 22.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.171 -0.468 . . . . 1.12 111.102 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' THR . 2.3 m-30 -86.93 -37.32 17.72 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 118.502 -0.761 . . . . 1.24 111.002 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.653 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 88.8 m 12.04 73.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.497 0 O-C-N 125.195 1.559 . . . . 1.22 110.647 -168.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.824 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -36.55 124.53 0.91 Allowed Glycine 0 N--CA 1.412 -2.926 0 CA-C-N 111.979 -2.373 . . . . 1.43 115.211 -163.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.993 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -123.59 68.56 0.47 Allowed Glycine 0 C--N 1.262 -3.54 0 CA-C-N 111.648 -2.276 . . . . 0.52 108.23 158.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.736 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 74.1 m-85 -75.07 108.53 7.87 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.094 -1.053 . . . . 0.63 108.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.634 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 25.0 mtp180 -109.33 106.88 16.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.724 -0.472 . . . . 3.15 109.724 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -91.04 116.1 28.53 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.627 -0.509 . . . . 1.08 109.627 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 34.4 mt-10 -122.61 103.03 8.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.52 -0.764 . . . . 1.81 109.144 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -95.01 143.64 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.077 0.465 . . . . 0.54 109.751 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 t -140.35 108.37 5.73 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.755 -0.832 . . . . 1.18 108.755 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.746 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.83 152.23 51.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 117.798 -1.096 . . . . 0.74 108.639 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.32 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 O-C-N 125.599 1.812 . . . . 0.65 114.572 178.065 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.674 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 25.2 t70 -145.55 -11.67 0.52 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.432 -1.258 . . . . 1.05 110.009 -174.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.001 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.4 mttp -90.77 124.64 35.29 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.462 -0.94 . . . . 1.29 108.462 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -131.31 127.94 38.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.251 -1.34 . . . . 0.77 109.793 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 16.1 m-20 -143.12 139.5 30.43 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.098 -1.41 . . . . 1.6 108.808 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.0 p -135.08 145.3 47.8 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.168 0.508 . . . . 1.19 109.791 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.752 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 91.5 p -131.9 126.5 34.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.49 -0.777 . . . . 0.84 110.462 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.09 119.05 36.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 1.58 111.122 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.68 ' HE1' ' HG2' ' A' ' 11' ' ' PRO . 30.0 p90 -143.61 147.05 33.78 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.52 -0.548 . . . . 0.86 109.52 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.772 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 11.4 p30 -104.04 151.81 22.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.635 1.207 . . . . 2.11 112.022 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.616 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -116.06 99.35 7.19 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.472 -1.695 . . . . 0.37 108.86 167.152 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.432 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 29.8 m -81.41 96.94 7.52 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.211 -1.033 . . . . 0.33 108.211 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 18' ' ' VAL . 3.9 p -81.27 112.54 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 123.099 1.428 . . . . 0.33 108.751 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.768 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 14.1 m-70 -77.49 97.9 5.15 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.441 -2.163 . . . . 1.19 109.222 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.3 -1.544 0 CA-C-N 113.821 -1.536 . . . . 1.67 110.296 173.287 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.532 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 16.7 m-20 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 108.651 -0.87 . . . . 1.65 108.651 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 39.2 Cg_endo -69.74 81.28 0.82 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 121.652 1.568 . . . . 0.97 113.077 176.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.997 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.9 mp -109.18 -70.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.313 -0.858 . . . . 0.5 109.82 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 89.76 51.01 2.96 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.816 -1.714 . . . . 0.39 108.816 -172.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 4' ' ' ILE . 6.0 tp -51.73 -40.26 59.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.209 -1.495 . . . . 0.33 110.312 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.778 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.6 OUTLIER -86.2 85.17 7.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.307 -0.86 . . . . 0.72 110.461 174.473 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.26 -42.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 0.63 109.207 175.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.402 ' CB ' ' HD2' ' A' ' 27' ' ' ARG . 25.3 ttt -148.68 130.2 14.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.035 -0.984 . . . . 2.88 108.35 173.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 31.4 ptt180 -105.25 129.31 24.97 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 116.007 -0.542 . . . . 3.67 111.137 -174.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.635 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.7 Cg_endo -60.98 158.18 35.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.656 2.237 . . . . 0.64 112.122 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.503 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.4 mm-40 -126.68 174.61 8.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 1.43 111.37 -171.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 3.3 p-10 -69.72 -149.63 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.66 1.219 . . . . 2.06 111.87 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 154.62 134.35 1.9 Allowed Glycine 0 C--N 1.298 -1.583 0 CA-C-N 113.703 -1.589 . . . . 0.3 112.719 -174.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.502 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 6.1 mp0 -109.75 112.62 24.78 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.577 -1.312 . . . . 1.53 107.632 175.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.01 164.92 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 108.141 -1.059 . . . . 0.27 108.141 -172.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 154.72 17.07 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.778 -1.101 . . . . 0.77 109.69 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 106' ' ' VAL . 88.4 t -69.71 104.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 122.939 1.352 . . . . 0.78 108.517 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.21 4.1 9.37 Favored Glycine 0 C--N 1.275 -2.836 0 CA-C-N 112.217 -2.265 . . . . 0.48 112.816 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -120.17 3.12 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 108.901 -1.68 . . . . 0.44 108.901 171.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.651 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.2 p -151.59 174.05 13.91 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.102 -1.549 . . . . 0.82 110.368 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.452 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.0 tp -146.64 146.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 CA-C-N 113.213 -1.812 . . . . 0.32 106.336 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.5 m -139.21 128.0 23.42 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 114.105 -1.407 . . . . 0.31 111.157 -172.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.798 ' HD2' HD12 ' A' ' 74' ' ' LEU . 34.3 m-85 -126.14 141.46 51.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.885 -1.507 . . . . 0.53 109.726 177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.91 118.81 20.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.805 0.812 . . . . 0.58 109.715 175.426 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.635 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -113.71 113.17 24.62 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.414 -1.266 . . . . 0.32 109.203 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 99.3 mtt180 -102.66 117.8 35.45 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.952 -0.388 . . . . 2.43 109.952 -176.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.9 t -115.33 125.39 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 122.348 1.07 . . . . 0.26 110.307 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.75 107.69 0.55 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.92 -1.945 . . . . 0.4 110.384 176.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.541 ' C ' ' HE3' ' A' ' 68' ' ' LYS . . . -51.53 -40.59 47.53 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.668 -1.151 . . . . 0.76 111.775 173.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.646 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 42.77 -140.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.15 1.167 . . . . 0.71 114.15 172.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -134.54 132.31 38.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.398 -0.819 . . . . 1.74 109.555 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.89 -174.31 4.87 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.142 -0.481 . . . . 2.16 111.795 -173.525 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 tp -74.87 -51.98 12.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.029 -0.987 . . . . 1.47 108.838 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.7 151.16 59.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.311 -0.858 . . . . 1.4 109.475 176.853 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.47 138.92 7.29 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.593 2.862 . . . . 0.88 112.914 -176.263 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 93' ' ' THR . 2.3 Cg_endo -45.68 133.13 13.45 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 123.311 2.674 . . . . 0.53 113.351 -177.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.35 105.29 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.697 -1.594 . . . . 0.77 106.697 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.773 HG13 ' HB ' ' A' ' 91' ' ' VAL . 1.9 t -105.42 114.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 113.566 -1.652 . . . . 0.28 107.344 178.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.828 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -97.58 122.41 40.62 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-O 123.248 1.499 . . . . 1.54 109.294 173.846 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.993 ' HB3' HD13 ' A' ' 49' ' ' LEU . 63.4 m95 -88.32 153.15 21.43 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 111.769 -2.469 . . . . 0.34 110.97 173.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 39.0 t80 -131.39 134.46 46.28 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 104.432 -2.432 . . . . 0.62 104.432 173.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.796 ' HZ3' ' HB ' ' A' ' 47' ' ' VAL . 1.8 ttpm? -100.76 163.3 12.38 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.969 -1.863 . . . . 2.17 105.969 -175.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -9.77 -165.02 0.0 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.938 2.335 . . . . 1.23 118.938 -177.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.66 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 5.6 mtpp -44.28 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 O-C-N 119.541 -2.152 . . . . 3.87 116.68 -166.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.631 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.4 p-90 -165.58 -9.13 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.955 1.465 . . . . 2.11 114.955 -177.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.796 ' HB ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.0 167.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 CA-C-O 123.814 1.769 . . . . 1.29 113.215 -162.754 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.676 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 2.6 p-10 -109.67 155.9 20.91 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 110.994 -2.821 . . . . 2.73 107.164 174.252 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.9 mp -99.15 -36.81 9.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.014 0.746 . . . . 0.44 113.014 168.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.7 t -57.84 -21.21 41.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.255 0.55 . . . . 1.23 109.811 -162.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.55 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 52.3 m -99.1 -21.48 16.15 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 115.476 -0.784 . . . . 1.34 112.842 -176.268 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.676 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 6.7 mmmt -100.34 -36.38 9.27 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.306 -0.861 . . . . 1.4 111.184 -170.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.852 HG13 ' H ' ' A' ' 59' ' ' LEU . 74.0 t -31.63 94.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 113.373 -1.74 . . . . 0.37 111.993 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -162.74 -122.85 0.63 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 111.864 -2.425 . . . . 0.7 112.197 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.77 -47.1 79.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.748 1.018 . . . . 2.75 113.748 -169.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 38.7 p-80 -92.27 -35.33 13.83 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.256 0.55 . . . . 1.33 111.415 -174.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.975 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.56 105.27 11.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.564 -1.643 . . . . 1.11 106.564 175.358 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.23 115.57 27.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 106.844 -1.539 . . . . 0.76 106.844 164.227 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.852 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -98.97 90.71 4.72 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 103.45 -2.796 . . . . 0.26 103.45 167.604 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 29.9 t-80 -103.01 160.29 14.76 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.171 -1.377 . . . . 2.03 108.972 -173.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -130.48 113.93 14.89 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 112.295 -2.229 . . . . 0.92 110.393 -176.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -90.84 143.58 26.58 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 111.737 -2.483 . . . . 0.47 107.136 171.3 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.544 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 2.0 t80 -140.84 98.88 3.48 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.082 0.944 . . . . 1.39 111.687 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -118.11 129.87 55.79 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.169 -1.378 . . . . 2.42 109.887 170.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HA ' ' HZ3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -88.93 -38.92 14.13 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.037 -1.438 . . . . 2.46 112.616 -177.414 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.73 81.56 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.658 0.599 . . . . 1.15 111.351 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.2 p -92.05 -17.38 25.11 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.28 -1.378 . . . . 1.41 107.28 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.676 ' NZ ' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 69.19 30.99 4.14 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.526 -1.67 . . . . 3.31 109.712 171.959 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.9 t -122.93 123.9 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 122.159 0.98 . . . . 0.43 109.991 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.544 ' CE1' ' HD1' ' A' ' 63' ' ' TYR . 3.9 m-30 -104.13 105.81 16.09 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.926 -1.488 . . . . 1.24 107.035 170.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 25' ' ' SER . 29.5 tp -90.31 106.79 18.73 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.474 -1.239 . . . . 0.52 109.525 -176.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.613 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.6 m-85 -87.77 112.04 22.0 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.342 -1.725 . . . . 0.33 106.342 169.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 6.9 pt-20 -118.1 125.16 49.73 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.621 -1.627 . . . . 1.32 110.131 -171.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.798 HD12 ' HD2' ' A' ' 24' ' ' PHE . 1.3 mt -89.98 124.99 35.21 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.485 -1.234 . . . . 0.96 108.562 174.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -112.49 96.36 5.95 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 104.081 -2.563 . . . . 1.15 104.081 166.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.1 mt -122.4 100.67 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 123.285 1.517 . . . . 0.52 108.743 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 51.1 p -112.54 157.1 21.56 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-N 113.456 -1.702 . . . . 0.58 109.29 -172.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.12 39.71 5.42 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.89 -2.414 . . . . 2.12 108.798 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -44.28 120.86 2.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 111.997 -2.365 . . . . 0.4 110.388 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 13.0 pm0 -87.59 156.66 53.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.33 -0.989 . . . . 1.43 108.33 -177.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.812 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 50.4 Cg_endo -69.27 -3.48 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 121.296 1.331 . . . . 1.33 113.139 -170.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.54 7.57 44.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.112 -0.494 . . . . 1.12 110.212 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -92.78 -20.55 20.63 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.173 -0.467 . . . . 1.24 111.002 -176.357 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 45.2 m -49.03 103.22 0.04 OUTLIER 'General case' 0 CA--C 1.473 -2.014 0 CA-C-O 122.509 1.147 . . . . 1.22 108.552 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.66 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -174.64 -130.71 1.32 Allowed Glycine 0 C--N 1.265 -3.371 0 CA-C-N 112.364 -2.198 . . . . 1.43 112.964 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.52 118.23 0.86 Allowed Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.244 -0.979 . . . . 0.52 112.157 -172.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.763 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.4 m-85 -87.12 124.34 33.15 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.078 -1.453 . . . . 0.63 107.078 175.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 44.1 mtp180 -122.42 124.43 43.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.422 0.555 . . . . 3.15 111.698 -175.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.489 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 4.0 m -97.0 131.09 44.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 1.08 109.856 176.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.828 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.0 mt-10 -132.14 103.34 6.2 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.685 -0.857 . . . . 1.81 108.685 170.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.773 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -93.17 138.24 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.561 0.696 . . . . 0.54 110.089 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.1 m -132.59 107.81 8.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.701 -1.136 . . . . 1.18 108.903 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.608 ' OG1' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -132.08 157.97 42.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 117.669 -1.158 . . . . 0.74 108.51 -179.648 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.722 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 20.13 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 125.574 1.797 . . . . 0.65 114.276 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.722 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -146.92 -3.52 0.58 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.989 -1.005 . . . . 1.05 110.001 -177.479 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.997 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 4.9 mmmt -96.29 133.65 40.38 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.88 0.848 . . . . 1.29 109.56 -175.349 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.69 131.27 44.74 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.497 -1.683 . . . . 0.77 110.892 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.435 ' HB3' ' CG ' ' A' ' 7' ' ' PHE . 28.8 m-20 -144.85 140.83 28.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.428 -1.26 . . . . 1.6 108.702 176.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.7 p -138.3 154.06 49.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.254 0.55 . . . . 1.19 111.118 -176.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.778 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 36.2 t -136.12 149.35 48.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.205 1.002 . . . . 0.84 111.246 177.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -134.31 109.72 9.01 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.322 -1.763 . . . . 1.58 109.466 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 29.4 p90 -140.81 132.55 27.35 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.217 -0.66 . . . . 0.86 109.217 -174.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 2.1 p-10 -102.42 153.15 20.31 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 122.39 1.091 . . . . 2.11 111.317 -171.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -121.33 120.78 36.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.427 -1.261 . . . . 0.37 108.526 172.716 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 5.9 m -100.16 96.11 7.27 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.749 -0.834 . . . . 0.33 108.749 174.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 80' ' ' GLN . 9.5 p -84.27 116.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 123.485 1.612 . . . . 0.33 109.339 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -91.39 100.29 13.1 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 112.504 -2.134 . . . . 1.19 109.976 -175.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.812 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 9.9 tt0 . . . . . 0 C--N 1.303 -1.428 0 CA-C-N 114.923 -1.035 . . . . 1.67 109.556 170.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.54 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-20 . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 109.822 -0.436 . . . . 1.65 109.822 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 73.5 Cg_endo -77.21 59.48 6.61 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 121.852 1.701 . . . . 0.97 112.862 177.227 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.925 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -75.15 -63.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.228 -0.896 . . . . 0.5 109.457 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.61 41.29 5.75 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 107.812 -2.115 . . . . 0.39 107.812 -175.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.697 HD13 HG21 ' A' ' 4' ' ' ILE . 8.4 tp -49.25 -46.37 46.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.573 -1.814 . . . . 0.33 110.643 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.675 ' HD2' ' HE ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -88.65 84.91 6.72 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.827 0.822 . . . . 0.72 109.863 171.806 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.37 -37.82 79.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.24 -1.345 . . . . 0.63 109.285 178.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 tpp -148.65 132.92 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.837 -1.074 . . . . 2.88 108.307 171.527 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.675 ' HE ' ' HD2' ' A' ' 7' ' ' PHE . 38.1 mtt180 -96.24 130.81 30.03 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.886 0.374 . . . . 3.67 110.873 -174.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 13.9 Cg_endo -60.22 153.26 60.38 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.093 2.528 . . . . 0.64 111.794 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.482 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.1 mm-40 -124.67 170.19 11.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.01 -0.541 . . . . 1.43 111.999 -172.058 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.498 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.1 p-10 -70.83 -145.75 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.321 0 C-N-CA 124.673 1.189 . . . . 2.06 113.076 -175.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.76 133.1 1.58 Allowed Glycine 0 C--N 1.307 -1.06 0 CA-C-N 113.708 -1.587 . . . . 0.3 114.015 -176.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 1.7 mp0 -106.47 111.36 23.9 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.689 -1.256 . . . . 1.53 109.083 175.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.534 HG11 ' HB ' ' A' ' 22' ' ' ILE . 1.9 m -137.43 163.04 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.155 -1.054 . . . . 0.27 108.155 -174.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.448 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.13 156.26 16.39 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.78 -1.1 . . . . 0.77 109.677 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.883 HG21 ' HB3' ' A' ' 81' ' ' PRO . 24.9 t -69.93 107.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-O 123.056 1.407 . . . . 0.78 109.171 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.65 -0.6 15.67 Favored Glycine 0 C--N 1.266 -3.359 0 CA-C-N 111.957 -2.383 . . . . 0.48 112.221 176.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 -126.14 3.76 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 109.101 -1.6 . . . . 0.44 109.101 172.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 9.3 p -151.68 167.9 26.7 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-N 112.985 -1.608 . . . . 0.82 111.042 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.693 HG21 HD13 ' A' ' 104' ' ' LEU . 7.8 tp -146.11 147.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 113.291 -1.777 . . . . 0.32 108.42 170.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 m -139.88 130.6 25.87 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 113.239 -1.8 . . . . 0.31 110.399 -175.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -128.58 160.49 32.23 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.921 -1.036 . . . . 0.53 108.753 169.8 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.73 129.27 22.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.968 -1.015 . . . . 0.58 108.866 178.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.659 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.61 127.59 46.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.736 -0.666 . . . . 0.32 111.138 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -108.64 121.32 44.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.06 -0.518 . . . . 2.43 110.557 -177.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 14.6 t -123.44 127.94 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.258 1.028 . . . . 0.26 110.508 -176.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.502 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.18 110.21 1.33 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.113 -1.858 . . . . 0.4 113.212 -177.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -54.36 -48.57 63.86 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 114.587 -1.188 . . . . 0.76 112.184 171.089 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.786 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 56.74 -170.23 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.734 0.814 . . . . 0.71 112.87 173.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -114.11 35.7 4.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.243 1.021 . . . . 1.74 108.459 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.0 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.18 172.97 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.015 -1.448 . . . . 2.16 113.358 177.394 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.75 -49.62 76.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.343 0.592 . . . . 1.47 110.307 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.673 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -144.8 150.09 45.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.041 -1.096 . . . . 1.4 108.041 174.057 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.91 142.14 5.49 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.416 2.744 . . . . 0.88 111.588 -177.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.0 ' HD3' HD11 ' A' ' 33' ' ' LEU . 6.4 Cg_exo -54.54 137.45 73.0 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.138 1.225 . . . . 0.53 112.836 -174.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 35' ' ' LYS . 3.6 t -99.13 104.68 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 105.708 -1.96 . . . . 0.77 105.708 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.704 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -111.54 113.57 44.61 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.596 -1.638 . . . . 0.28 107.594 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.547 ' O ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -103.95 130.99 51.62 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 123.389 1.566 . . . . 1.54 109.751 173.173 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.05 ' HB3' HD13 ' A' ' 49' ' ' LEU . 81.9 m95 -91.23 157.25 17.27 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.859 -2.428 . . . . 0.34 111.259 173.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 27.1 t80 -131.47 130.71 42.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.564 -2.013 . . . . 0.62 105.564 175.051 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 31.7 ttpt -109.05 104.83 14.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.25 -1.759 . . . . 2.17 106.25 -176.293 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.26 91.65 1.67 Allowed Glycine 0 CA--C 1.481 -2.044 0 C-N-CA 115.906 -3.045 . . . . 1.23 114.112 -164.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 1.012 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -105.04 -27.44 11.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 104.104 -2.554 . . . . 3.87 104.104 139.549 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 1.012 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 27.5 p-90 160.2 -20.19 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.078 -2.328 . . . . 2.11 111.529 -165.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG21 ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.53 169.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 123.046 1.403 . . . . 1.29 112.539 -163.658 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.3 t70 -113.11 133.89 54.8 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 111.617 -2.538 . . . . 2.73 107.04 175.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.05 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.8 mp -69.85 -35.3 74.62 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 119.169 -0.443 . . . . 0.44 111.869 -175.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 m -58.27 -20.01 39.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.543 0.687 . . . . 1.23 109.817 -167.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 m -98.4 -18.86 18.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.973 -1.012 . . . . 1.34 112.424 -176.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.42 -70.27 0.74 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.876 -0.602 . . . . 1.4 111.118 -176.935 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.844 HG13 ' H ' ' A' ' 59' ' ' LEU . 70.5 t 16.6 91.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.23 1.812 . . . . 0.37 113.965 175.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -151.4 -138.5 2.82 Favored Glycine 0 C--N 1.319 -0.397 0 CA-C-N 114.174 -1.375 . . . . 0.7 113.488 -174.168 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -64.18 -42.83 96.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.382 0.882 . . . . 2.75 113.382 -169.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.485 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 4.8 p80 -86.97 -37.97 17.06 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 119.64 -0.824 . . . . 1.33 111.702 -175.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.915 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.39 108.76 13.07 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.289 -1.004 . . . . 1.11 108.289 170.891 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -96.34 115.69 27.84 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 105.834 -1.913 . . . . 0.76 105.834 168.614 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.844 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.09 92.28 6.74 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 104.353 -2.462 . . . . 0.26 104.353 170.357 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.651 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -88.24 164.2 15.74 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 113.748 -1.569 . . . . 2.03 111.003 -178.187 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -134.29 113.38 11.89 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 111.716 -2.493 . . . . 0.92 109.937 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.8 m -99.14 149.34 23.16 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.597 -2.092 . . . . 0.47 107.891 174.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -145.58 99.38 3.28 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.097 0.951 . . . . 1.39 112.362 -171.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.88 106.43 14.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.837 -1.528 . . . . 2.42 110.374 169.412 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.04 -27.68 65.87 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.556 -1.202 . . . . 2.46 110.504 179.065 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.18 73.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.216 -0.902 . . . . 1.15 110.746 175.61 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -91.65 -18.24 24.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.6 -0.727 . . . . 1.41 109.287 175.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.786 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 10.3 ttpt 66.62 33.82 6.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.665 -1.152 . . . . 3.31 109.699 -177.308 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.84 133.52 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.166 0.984 . . . . 0.43 110.766 -176.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' SER . 36.7 m-85 -97.65 108.07 20.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.532 -1.655 . . . . 1.24 106.532 161.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 15.0 tp -95.18 104.7 16.59 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.508 1.147 . . . . 0.52 109.011 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.651 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.7 m-85 -86.2 114.47 23.06 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.331 -1.759 . . . . 0.33 108.606 175.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.47 127.71 46.74 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.374 -1.739 . . . . 1.32 109.007 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.864 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -99.38 116.65 32.03 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.206 -1.405 . . . . 0.96 107.206 171.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.765 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 14.5 m80 -114.63 94.41 4.76 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 104.953 -2.24 . . . . 1.15 104.953 167.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.817 HG12 ' HB2' ' A' ' 57' ' ' LEU . 47.5 mt -118.13 99.15 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 123.18 1.466 . . . . 0.52 110.055 -173.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.7 p -106.71 163.89 12.54 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.022 -1.444 . . . . 0.58 108.121 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 68.86 38.91 1.99 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.804 -1.998 . . . . 2.12 110.215 170.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.09 118.06 2.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.207 -1.815 . . . . 0.4 112.024 -178.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.623 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -57.82 140.97 80.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.818 -1.083 . . . . 1.43 109.758 172.014 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.883 ' HB3' HG21 ' A' ' 18' ' ' VAL . 36.4 Cg_endo -67.89 5.02 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.707 2.271 . . . . 1.33 113.42 -177.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.99 -3.83 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.473 -0.33 . . . . 1.12 110.324 173.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.909 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -75.66 4.45 7.75 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.798 -0.62 . . . . 1.24 109.368 -172.046 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 29.5 m -23.02 90.07 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 125.696 1.873 . . . . 1.22 111.325 177.708 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.833 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -39.79 110.2 0.16 Allowed Glycine 0 CA--C 1.466 -3.029 0 CA-C-N 109.703 -3.408 . . . . 1.43 113.902 -169.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.88 62.78 0.55 Allowed Glycine 0 C--N 1.262 -3.567 0 CA-C-N 111.718 -2.241 . . . . 0.52 107.895 160.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.666 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 73.9 m-85 -81.43 109.79 16.24 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.251 -1.388 . . . . 0.63 107.251 -177.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 24.4 ttm180 -109.91 110.03 20.86 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.069 -0.715 . . . . 3.15 109.069 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.57 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.3 t -91.33 125.1 35.98 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.658 -0.867 . . . . 1.08 108.658 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 38.8 tt0 -134.03 103.88 6.0 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.309 -0.86 . . . . 1.81 109.755 -172.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.704 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.7 p -100.58 143.63 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.54 110.343 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -139.87 108.84 6.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.341 -0.845 . . . . 1.18 108.812 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.805 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.96 146.85 52.15 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-O 117.775 -1.107 . . . . 0.74 109.851 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.807 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.41 -73.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.679 1.862 . . . . 0.65 114.28 -177.275 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.807 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 10.7 t70 -151.78 -2.03 0.3 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.904 -1.044 . . . . 1.05 110.28 -175.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.925 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmmt -93.45 133.84 36.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.117 0.961 . . . . 1.29 108.849 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -130.35 129.94 43.79 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.467 -1.697 . . . . 0.77 110.16 -176.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 4.4 m-20 -146.97 142.17 27.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.166 -1.379 . . . . 1.6 109.099 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 58.3 m -144.94 148.28 33.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.604 -0.726 . . . . 1.19 110.154 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.57 ' OG ' ' HB3' ' A' ' 89' ' ' CYS . 2.9 p -128.23 148.07 50.61 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.532 -0.758 . . . . 0.84 111.567 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.79 112.37 14.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.557 -1.201 . . . . 1.58 109.58 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.76 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 7.0 p90 -141.7 131.4 24.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.6 0.714 . . . . 0.86 109.568 -175.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 5.7 p30 -105.64 138.49 41.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.532 1.158 . . . . 2.11 112.976 -168.114 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.833 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.22 103.94 13.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.667 -1.606 . . . . 0.37 109.501 173.367 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.499 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 11.9 m -86.23 95.41 9.59 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.175 -1.01 . . . . 0.33 108.333 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.784 HG22 HG22 ' A' ' 18' ' ' VAL . 8.3 p -82.74 112.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.27 1.509 . . . . 0.33 108.706 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 97.5 m-70 -85.76 99.15 11.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.276 -2.238 . . . . 1.19 109.724 -173.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 114.129 -1.396 . . . . 1.67 110.131 172.792 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.635 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 14.2 m-20 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 119.859 -0.115 . . . . 1.65 110.844 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 55.8 Cg_endo -70.2 68.07 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.933 2.422 . . . . 0.97 112.56 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.974 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -91.59 -55.39 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 114.797 -1.092 . . . . 0.5 108.927 173.141 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.614 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 84.27 48.9 4.9 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.53 -2.228 . . . . 0.39 107.53 -176.492 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.999 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.0 tp -51.24 -44.9 61.83 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 112.553 -1.823 . . . . 0.33 109.241 -173.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -82.62 83.31 7.66 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.663 -1.153 . . . . 0.72 109.544 170.874 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.98 -27.61 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.756 -1.111 . . . . 0.63 108.978 176.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.8 tpt -163.51 148.8 11.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.09 -1.414 . . . . 2.88 107.246 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 4.6 ptm180 -115.36 144.08 31.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.192 -0.603 . . . . 3.67 111.059 177.39 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.748 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -76.44 170.46 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.132 2.554 . . . . 0.64 112.451 -178.945 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -131.0 166.19 21.56 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.682 -0.69 . . . . 1.43 110.977 -171.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.625 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -65.5 -141.13 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.566 1.174 . . . . 2.06 111.982 -179.308 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.19 139.8 3.17 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.125 -1.398 . . . . 0.3 111.934 -175.189 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.9 mt-10 -116.66 118.08 31.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.813 -0.693 . . . . 1.53 109.263 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -139.29 164.77 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 107.825 -1.176 . . . . 0.27 107.825 -173.295 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.79 157.45 17.39 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.237 -0.892 . . . . 0.77 109.753 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 106' ' ' VAL . 16.7 t -68.66 106.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 CA-C-O 122.677 1.227 . . . . 0.78 108.116 172.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.16 3.85 10.42 Favored Glycine 0 C--N 1.27 -3.11 0 CA-C-N 112.276 -2.238 . . . . 0.48 113.554 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.85 -123.83 4.32 Favored Glycine 0 N--CA 1.422 -2.252 0 C-N-CA 119.235 -1.46 . . . . 0.44 111.252 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.1 p -150.88 166.99 28.88 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 112.826 -1.687 . . . . 0.82 110.934 178.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.569 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -149.41 150.74 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.023 -1.899 . . . . 0.32 107.638 171.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.0 m -138.22 129.51 27.48 Favored 'General case' 0 C--N 1.265 -3.096 0 CA-C-N 113.721 -1.581 . . . . 0.31 110.876 -176.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.718 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.7 m-85 -128.11 155.43 44.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.278 -1.328 . . . . 0.53 109.88 176.581 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.625 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.2 m -140.93 131.81 25.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.287 -0.869 . . . . 0.58 109.287 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.769 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -129.32 115.22 17.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 0.32 110.943 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.7 ' HE ' HG11 ' A' ' 69' ' ' VAL . 18.9 mtp180 -100.6 126.32 47.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.535 -0.302 . . . . 2.43 110.851 -177.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.5 t -127.9 129.44 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 122.057 0.932 . . . . 0.26 110.687 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.79 108.27 2.07 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.344 -1.753 . . . . 0.4 111.113 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -50.88 22.84 Favored Glycine 0 C--O 1.226 -0.391 0 CA-C-N 115.287 -0.87 . . . . 0.76 111.105 172.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.889 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . . . 61.64 -100.52 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.772 1.027 . . . . 0.71 113.772 167.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 p -146.39 -109.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 1.74 110.205 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.017 HD22 ' HA ' ' A' ' 93' ' ' THR . 4.4 tp 63.74 156.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.576 -0.528 . . . . 2.16 109.576 -175.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.952 ' H ' HD12 ' A' ' 33' ' ' LEU . 21.4 tp -53.39 -27.32 23.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.129 0.966 . . . . 1.47 110.546 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.769 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.83 177.15 2.08 Favored Pre-proline 0 C--O 1.211 -0.973 0 CA-C-N 113.549 -1.66 . . . . 1.4 106.803 178.143 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.5 Cg_exo -65.24 154.37 73.88 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.495 1.464 . . . . 0.88 109.521 174.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.64 ' HG3' HG21 ' A' ' 93' ' ' THR . 67.2 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 121.569 1.513 . . . . 0.53 113.401 -175.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.649 HG22 ' HE2' ' A' ' 35' ' ' LYS . 2.0 t -100.01 103.89 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 106.489 -1.671 . . . . 0.77 106.489 175.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.8 t -106.71 115.25 47.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.013 -1.449 . . . . 0.28 107.683 176.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.07 131.5 55.01 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 122.874 1.321 . . . . 1.54 109.615 175.989 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.022 ' HB3' HD13 ' A' ' 49' ' ' LEU . 72.0 m95 -92.48 156.83 16.91 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.425 -2.171 . . . . 0.34 112.326 174.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 37.3 t80 -129.28 133.14 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.303 -2.11 . . . . 0.62 105.303 173.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.865 ' HZ3' ' HB3' ' A' ' 43' ' ' LYS . 3.6 ttpm? -109.66 107.51 17.58 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.336 -1.357 . . . . 2.17 107.336 -177.579 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.32 91.91 1.63 Allowed Glycine 0 CA--C 1.487 -1.688 0 C-N-CA 115.982 -3.009 . . . . 1.23 114.562 -165.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.902 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 71.2 tttt -108.86 -24.79 11.1 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.034 -2.21 . . . . 3.87 105.034 135.216 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.902 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 25.7 p-90 159.97 -20.14 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 CA-C-N 112.677 -2.056 . . . . 2.11 111.763 -164.459 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.45 ' HB ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.34 174.11 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.461 1.6 . . . . 1.29 113.331 -163.264 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.3 t70 -109.49 155.04 21.83 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 111.208 -2.724 . . . . 2.73 105.763 173.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.022 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -89.77 -38.67 13.64 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.905 0.706 . . . . 0.44 112.905 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 t -59.58 -19.76 50.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.894 0.854 . . . . 1.23 108.936 -166.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 p -87.58 -33.11 19.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.536 -1.211 . . . . 1.34 111.317 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HG3' ' HZ1' ' A' ' 43' ' ' LYS . 5.5 mmmt -93.79 -70.37 0.71 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.266 -1.333 . . . . 1.4 111.616 -175.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.827 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.4 t 11.1 92.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.566 1.946 . . . . 0.37 113.489 177.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.605 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -146.67 -118.04 1.07 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.841 -1.527 . . . . 0.7 113.357 -177.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -86.12 -32.67 21.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.082 0.771 . . . . 2.75 113.082 -167.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -93.54 -36.69 12.29 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.026 -0.669 . . . . 1.33 110.257 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.908 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.95 105.28 11.31 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.809 -1.552 . . . . 1.11 106.809 175.899 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -98.77 115.53 28.98 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 105.763 -1.94 . . . . 0.76 105.763 165.781 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.827 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -98.51 92.03 5.44 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 103.547 -2.76 . . . . 0.26 103.547 169.171 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 83.0 t60 -99.66 162.43 13.01 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 113.943 -1.48 . . . . 2.03 108.694 -173.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.47 124.25 29.79 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 112.464 -2.153 . . . . 0.92 110.949 -177.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.688 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.2 m -93.62 148.52 22.03 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 111.08 -2.782 . . . . 0.47 106.685 169.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -138.16 98.09 3.54 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.705 1.241 . . . . 1.39 111.365 -168.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 8.4 m-20 -113.98 100.32 8.32 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 112.856 -1.975 . . . . 2.42 108.743 172.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -37.41 36.27 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.644 -0.707 . . . . 2.46 110.337 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.68 -22.2 60.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.004 -0.998 . . . . 1.15 110.448 179.232 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 47.5 m -101.69 -9.84 20.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.494 -0.776 . . . . 1.41 109.592 175.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.889 ' HE3' ' HA ' ' A' ' 31' ' ' ALA . 74.5 tttt 67.18 29.84 7.55 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.114 -0.948 . . . . 3.31 110.53 173.151 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.7 HG11 ' HE ' ' A' ' 27' ' ' ARG . 2.7 t -127.98 121.95 57.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.014 0.911 . . . . 0.43 110.588 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -100.53 107.02 18.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.396 -1.705 . . . . 1.24 106.396 167.001 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.5 tp -95.15 104.73 16.62 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.3 1.048 . . . . 0.52 109.049 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.661 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.8 m-85 -85.36 113.96 22.06 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.939 -1.482 . . . . 0.33 108.277 174.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 19.4 mt-10 -106.8 124.41 49.58 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 113.3 -1.773 . . . . 1.32 108.976 -176.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.829 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -90.69 118.18 29.92 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.995 -1.113 . . . . 0.96 107.995 173.055 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -112.14 94.33 4.88 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 103.587 -2.746 . . . . 1.15 103.587 169.422 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 52.3 mt -123.54 101.07 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.22 1.486 . . . . 0.52 110.263 -175.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 74.8 p -106.02 144.88 32.12 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 113.002 -1.908 . . . . 0.58 107.917 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 70.96 77.61 0.18 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.914 -2.403 . . . . 2.12 109.766 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.563 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -78.24 110.87 13.63 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.779 -2.464 . . . . 0.4 108.24 174.371 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.613 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -69.58 165.07 44.41 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.418 -0.956 . . . . 1.43 108.418 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HG3' HG21 ' A' ' 18' ' ' VAL . 3.8 Cg_exo -72.41 152.28 54.69 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 120.819 1.013 . . . . 1.33 111.124 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.711 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . 66.98 5.26 3.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.855 -0.612 . . . . 1.12 111.358 -177.117 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -84.42 1.49 45.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.69 -0.856 . . . . 1.24 108.69 -178.773 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.842 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 49.2 m -10.02 82.14 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.981 0 O-C-N 126.292 2.245 . . . . 1.22 111.316 171.22 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.917 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -65.71 73.94 0.11 Allowed Glycine 0 CA--C 1.473 -2.576 0 CA-C-N 111.555 -2.566 . . . . 1.43 114.002 -160.084 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -84.54 74.1 2.55 Favored Glycine 0 C--N 1.276 -2.787 0 N-CA-C 108.477 -1.849 . . . . 0.52 108.477 172.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.798 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 49.2 m-85 -80.86 121.9 26.54 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.57 -1.315 . . . . 0.63 107.694 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.79 109.82 19.54 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.645 -0.502 . . . . 3.15 109.645 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.646 ' SG ' ' HE2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -91.6 108.35 19.84 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.537 -0.542 . . . . 1.08 109.537 -179.623 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.705 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 37.3 mt-10 -118.71 103.79 9.99 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.756 -0.656 . . . . 1.81 109.486 -176.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -99.24 143.01 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.308 0.575 . . . . 0.54 110.868 -177.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -133.19 109.26 9.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.017 -1.105 . . . . 1.18 108.017 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.017 ' HA ' HD22 ' A' ' 33' ' ' LEU . 1.3 m -130.28 164.21 25.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 118.331 -0.842 . . . . 0.74 109.067 -177.169 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.872 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 7.94 -71.23 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.567 1.792 . . . . 0.65 113.392 173.516 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.758 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 28.6 t70 -147.8 -1.68 0.58 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.739 -1.119 . . . . 1.05 110.136 177.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.999 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -92.84 129.25 38.82 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.478 -1.305 . . . . 1.29 107.478 -177.543 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.46 130.58 40.71 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.023 -0.989 . . . . 0.77 110.14 175.032 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -142.48 147.9 36.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.448 -1.251 . . . . 1.6 109.031 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 6.8 p -144.48 141.88 29.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.343 0.592 . . . . 1.19 111.025 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.545 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 24.2 t -118.26 148.94 41.92 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.24 -0.891 . . . . 0.84 111.093 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 112.82 11.28 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.803 -1.544 . . . . 1.58 110.053 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.798 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 40.0 p90 -142.21 140.91 32.47 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.86 108.762 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 13' ' ' ASP . 4.3 p30 -117.39 134.44 54.82 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.497 1.141 . . . . 2.11 113.555 -174.355 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.917 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -95.6 109.45 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.365 -1.743 . . . . 0.37 109.6 177.422 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -86.85 96.54 10.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.272 -0.64 . . . . 0.33 109.272 -178.33 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 18' ' ' VAL . 6.8 p -83.03 113.78 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.932 1.348 . . . . 0.33 109.522 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -90.98 100.5 13.35 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 112.747 -2.024 . . . . 1.19 109.549 -176.153 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 18' ' ' VAL . 44.9 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.024 -0.989 . . . . 1.67 110.566 172.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.628 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 109.871 -0.418 . . . . 1.65 109.871 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.4 81.9 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.607 2.205 . . . . 0.97 112.365 172.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.962 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -108.11 -69.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.5 109.214 174.473 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.632 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 94.72 45.5 3.15 Favored Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 108.301 -1.92 . . . . 0.39 108.301 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 96' ' ' LYS . 13.3 tp -53.1 -46.13 68.55 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 112.175 -2.012 . . . . 0.33 111.623 -169.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.783 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -89.4 84.3 6.43 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.073 -0.967 . . . . 0.72 109.893 -176.195 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.4 t -72.42 -48.48 47.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.662 -1.153 . . . . 0.63 110.029 -178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.767 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 88.9 mmm -132.87 134.58 44.79 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 115.263 -0.881 . . . . 2.88 109.766 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.783 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 22.1 mtt-85 -99.28 124.23 45.69 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 109.301 -0.629 . . . . 3.67 109.301 174.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.653 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 17.6 Cg_endo -60.68 145.83 98.24 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.393 2.062 . . . . 0.64 109.606 174.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.514 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 17.9 mm-40 -121.43 170.79 9.29 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 112.286 0.476 . . . . 1.43 112.286 -168.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.0 m-20 -69.18 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.911 0 CA-C-O 122.825 1.298 . . . . 2.06 110.627 -173.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 150.08 139.26 3.03 Favored Glycine 0 N--CA 1.423 -2.184 0 CA-C-N 114.094 -1.412 . . . . 0.3 111.811 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 32.8 mt-10 -117.71 109.85 17.13 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.251 -0.974 . . . . 1.53 108.888 176.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.53 163.19 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.02 -1.474 . . . . 0.27 107.02 -175.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.751 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.41 154.7 17.32 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 115.479 -0.782 . . . . 0.77 109.874 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 106' ' ' VAL . 16.5 t -63.68 107.12 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 123.193 1.473 . . . . 0.78 108.917 173.03 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.25 -10.87 5.59 Favored Glycine 0 C--N 1.268 -3.207 0 CA-C-N 111.711 -2.495 . . . . 0.48 112.503 176.705 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.0 -163.69 20.36 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 119.879 -1.153 . . . . 0.44 111.316 177.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 2.5 p -122.75 169.81 10.7 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-O 122.582 1.182 . . . . 0.82 111.456 -170.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.651 HG21 HD13 ' A' ' 104' ' ' LEU . 10.4 tp -145.16 151.83 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-N 112.335 -2.211 . . . . 0.32 107.229 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.7 m -139.67 127.46 21.97 Favored 'General case' 0 C--N 1.256 -3.486 0 CA-C-N 113.815 -1.539 . . . . 0.31 110.814 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.612 ' HD2' HD12 ' A' ' 74' ' ' LEU . 27.7 m-85 -123.48 142.49 50.95 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.788 -1.551 . . . . 0.53 109.51 -178.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.99 120.17 17.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.94 0.876 . . . . 0.58 110.399 173.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -117.52 114.41 23.41 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.075 -1.421 . . . . 0.32 109.805 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.767 ' HD2' ' HG3' ' A' ' 9' ' ' MET . 88.0 mtt180 -106.71 121.76 45.0 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 121.226 -0.19 . . . . 2.43 110.564 -176.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG21 HG21 ' A' ' 39' ' ' VAL . 12.1 t -119.2 125.65 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.027 0.917 . . . . 0.26 109.925 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 108.39 0.59 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.309 -1.768 . . . . 0.4 110.959 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.711 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.11 -44.3 63.19 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.817 -1.083 . . . . 0.76 111.406 172.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.704 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 54.06 -164.2 0.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.572 0.749 . . . . 0.71 112.996 177.046 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -78.47 -71.58 0.42 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.81 -0.811 . . . . 1.74 108.81 173.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.945 HD23 HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 69.58 159.75 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.675 -0.693 . . . . 2.16 112.102 168.496 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.943 ' N ' HD22 ' A' ' 33' ' ' LEU . 17.0 tp -75.6 -71.56 0.36 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.525 -0.761 . . . . 1.47 111.149 168.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.795 ' O ' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -123.31 129.55 24.87 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 113.643 0.979 . . . . 1.4 113.643 171.555 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' N ' HD11 ' A' ' 33' ' ' LEU . 17.2 Cg_exo -32.96 129.16 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 124.735 3.623 . . . . 0.88 113.234 -170.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 1.5 Cg_endo -46.9 132.67 17.54 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.493 2.129 . . . . 0.53 112.898 -171.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.66 104.64 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 106.769 -1.567 . . . . 0.77 106.769 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.25 115.02 48.51 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.997 0 CA-C-N 113.159 -1.837 . . . . 0.28 107.262 177.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.22 128.76 53.57 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 122.972 1.368 . . . . 1.54 109.294 172.52 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.043 ' HB3' HD13 ' A' ' 49' ' ' LEU . 60.0 m95 -82.92 152.44 25.53 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 112.395 -2.184 . . . . 0.34 110.786 175.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.605 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 32.3 t80 -128.03 138.88 52.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.725 -2.324 . . . . 0.62 104.725 169.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 1.054 ' HE2' ' HG ' ' A' ' 49' ' ' LEU . 13.7 ttmt -100.4 171.53 7.7 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.927 -1.138 . . . . 2.17 107.927 -173.03 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.968 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -13.44 -169.27 0.0 OUTLIER Glycine 0 C--O 1.185 -2.931 0 O-C-N 126.673 2.483 . . . . 1.23 118.3 166.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.3 mtpp -42.4 -2.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 117.556 2.428 . . . . 3.87 117.556 -166.113 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.657 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.6 p-90 -169.47 -17.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.901 1.445 . . . . 2.11 114.901 -177.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.788 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.95 167.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 CA-C-O 123.464 1.602 . . . . 1.29 112.44 -161.368 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.667 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 14.4 t70 -113.89 154.27 27.81 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.537 -2.574 . . . . 2.73 104.976 169.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.054 ' HG ' ' HE2' ' A' ' 43' ' ' LYS . 6.3 mp -90.39 -36.35 14.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.901 1.074 . . . . 0.44 113.901 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 t -59.05 -20.73 55.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.585 0.707 . . . . 1.23 109.432 -164.249 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -98.88 -28.42 13.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.074 -0.966 . . . . 1.34 113.531 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.861 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.25 -40.31 7.6 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.254 0.464 . . . . 1.4 112.254 -169.402 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 ' H ' ' A' ' 59' ' ' LEU . 23.0 t -18.11 97.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 125.935 1.694 . . . . 0.37 113.063 173.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -152.83 -147.9 4.73 Favored Glycine 0 C--N 1.306 -1.125 0 CA-C-N 111.575 -2.557 . . . . 0.7 112.823 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -64.13 -16.34 61.64 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.003 0.742 . . . . 2.75 113.003 -170.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.7 p80 -102.49 -36.34 8.43 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.379 0.609 . . . . 1.33 110.899 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.83 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -129.22 103.43 6.95 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.961 -1.496 . . . . 1.11 106.961 172.348 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.27 116.04 28.38 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 106.976 -1.49 . . . . 0.76 106.976 168.503 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.813 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -98.4 93.8 6.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 105.137 -2.171 . . . . 0.26 105.137 174.632 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.628 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 46.2 m-70 -84.81 159.4 20.43 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-O 122.843 1.306 . . . . 2.03 109.618 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.97 18.75 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 111.85 -2.432 . . . . 0.92 109.645 177.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -103.52 145.45 30.0 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 111.094 -2.775 . . . . 0.47 108.709 176.623 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.436 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 38.0 t80 -139.34 97.01 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.215 1.007 . . . . 1.39 110.143 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -114.06 105.22 12.95 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.278 -1.783 . . . . 2.42 108.766 176.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.611 ' HD3' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -77.21 -36.63 54.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.588 -0.733 . . . . 2.46 110.864 -178.834 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.87 61.18 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.616 -0.72 . . . . 1.15 110.796 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.0 t -102.96 -19.82 14.46 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.351 -1.352 . . . . 1.41 107.351 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.711 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.86 35.47 11.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.321 -1.309 . . . . 3.31 110.056 177.699 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 27' ' ' ARG . 10.9 t -134.19 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.201 -0.909 . . . . 0.43 109.475 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.536 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 8.0 m-85 -102.64 111.06 23.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.068 -1.456 . . . . 1.24 107.068 166.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.7 tp -95.51 106.64 18.73 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.196 0.998 . . . . 0.52 108.86 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.2 m-85 -89.26 112.18 23.17 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.168 -1.79 . . . . 0.33 106.168 169.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.628 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -120.44 125.53 48.15 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.562 -1.199 . . . . 1.32 110.093 -173.955 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.686 ' CD1' HD11 ' A' ' 76' ' ' ILE . 1.1 mt -90.95 136.43 33.08 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.774 -1.557 . . . . 0.96 108.666 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 63.3 m170 -117.69 97.99 6.14 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.164 -2.532 . . . . 1.15 104.164 166.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.785 ' CD1' HD22 ' A' ' 57' ' ' LEU . 66.1 mt -120.31 101.62 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-O 122.718 1.247 . . . . 0.52 109.643 -174.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 12.7 p -118.4 145.49 45.15 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 114.05 -1.432 . . . . 0.58 109.872 -176.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 77' ' ' THR . 1.5 m-20 73.47 70.55 0.12 Allowed 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 111.258 -2.701 . . . . 2.12 109.924 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.53 109.33 3.19 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 111.717 -2.492 . . . . 0.4 110.947 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.742 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 3.9 tp60 -60.41 142.54 90.55 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.166 -0.924 . . . . 1.43 109.286 171.249 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 18' ' ' VAL . 26.4 Cg_exo -60.27 -18.8 54.38 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.409 2.073 . . . . 1.33 112.22 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.742 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -100.1 16.25 24.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.08 -0.509 . . . . 1.12 110.728 178.025 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -83.66 -36.76 23.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.831 -0.604 . . . . 1.24 110.085 -178.823 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.8 m 1.41 82.38 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 0 O-C-N 125.585 1.803 . . . . 1.22 112.179 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.968 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -47.13 117.89 3.48 Favored Glycine 0 N--CA 1.408 -3.177 0 CA-C-N 111.988 -2.369 . . . . 1.43 114.353 -171.215 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.696 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -117.51 67.57 0.32 Allowed Glycine 0 C--N 1.273 -2.927 0 N-CA-C 108.001 -2.04 . . . . 0.52 108.001 155.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.639 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 63.7 m-85 -78.13 118.99 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.765 -0.828 . . . . 0.63 108.765 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.605 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 28.4 ttm180 -114.38 126.52 55.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.45 . . . . 3.15 110.878 178.131 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.617 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 91.6 m -97.35 108.52 21.26 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.092 -0.707 . . . . 1.08 109.092 173.295 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 33.5 tt0 -114.84 103.26 10.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.525 -0.917 . . . . 1.81 108.525 -176.503 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.4 p -105.0 141.9 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.655 0.741 . . . . 0.54 111.601 -173.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -134.99 108.99 8.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.338 -1.301 . . . . 1.18 109.08 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.945 HG22 HD23 ' A' ' 33' ' ' LEU . 1.4 m -120.8 168.25 11.64 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.071 -1.455 . . . . 0.74 107.071 177.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.666 ' HZ3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -10.66 -61.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.945 1.403 . . . . 0.65 114.138 -175.576 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.634 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -149.22 -3.14 0.43 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.993 -1.003 . . . . 1.05 109.994 177.776 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.962 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 3.9 mmtm -89.74 116.69 28.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.055 -1.831 . . . . 1.29 106.055 -176.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -134.06 139.69 46.15 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.892 -1.049 . . . . 0.77 111.274 -173.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.468 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 4.8 t0 -167.27 170.47 11.6 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.947 -1.024 . . . . 1.6 108.858 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 17.0 p -148.81 151.06 34.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 1.19 110.28 179.139 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.735 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 54.7 p -122.31 137.2 54.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.945 -0.702 . . . . 0.84 111.335 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -110.79 123.93 51.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.449 -0.796 . . . . 1.58 109.601 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.757 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.3 p90 -145.05 131.05 19.26 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.86 110.493 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.1 p30 -106.21 139.62 40.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.502 1.144 . . . . 2.11 112.294 -175.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -107.84 105.52 15.37 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.775 -1.557 . . . . 0.37 108.778 173.015 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.3 m -87.24 96.56 10.37 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.316 -0.994 . . . . 0.33 108.316 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 18' ' ' VAL . 3.1 p -75.39 112.2 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-O 122.842 1.306 . . . . 0.33 107.989 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.2 m170 -74.43 95.95 2.81 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.688 -2.051 . . . . 1.19 108.178 -178.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.7 tm-20 . . . . . 0 C--N 1.301 -1.52 0 CA-C-N 113.448 -1.706 . . . . 1.67 108.191 173.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.553 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 6.9 t70 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 108.898 -0.778 . . . . 1.65 108.898 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.456 ' C ' HD12 ' A' ' 4' ' ' ILE . 2.0 Cg_endo -45.44 90.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.224 3.283 . . . . 0.97 115.223 -177.306 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.7 mp -125.07 -60.52 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 114.628 -1.169 . . . . 0.5 108.042 173.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.55 33.98 6.86 Favored Glycine 0 CA--C 1.492 -1.357 0 N-CA-C 108.805 -1.718 . . . . 0.39 108.805 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.04 HD22 ' HB3' ' A' ' 96' ' ' LYS . 5.5 tp -37.92 -51.39 1.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.38 -1.91 . . . . 0.33 110.635 178.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HZ ' ' HG ' ' A' ' 100' ' ' SER . 0.7 OUTLIER -79.74 84.28 5.58 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.333 -0.849 . . . . 0.72 110.157 172.243 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.27 -41.3 57.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.634 -1.166 . . . . 0.63 108.812 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 15.6 tpt -153.92 134.77 13.76 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.747 -1.115 . . . . 2.88 109.289 173.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -104.39 140.73 21.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.26 -0.882 . . . . 3.67 109.73 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 34.7 Cg_endo -73.7 156.34 48.95 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.842 1.695 . . . . 0.64 110.46 178.187 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -118.04 -179.85 3.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.225 -0.443 . . . . 1.43 110.593 -173.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 5.4 p-10 -72.61 -145.62 0.02 OUTLIER 'General case' 0 N--CA 1.41 -2.462 0 CA-C-O 122.746 1.26 . . . . 2.06 111.704 -176.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.13 133.33 1.78 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.306 -1.77 . . . . 0.3 112.525 -176.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.484 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 37.3 mt-10 -110.36 111.16 22.27 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.682 -1.259 . . . . 1.53 108.435 176.342 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 22' ' ' ILE . 3.0 m -133.63 163.36 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.884 -1.154 . . . . 0.27 107.884 -172.204 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.45 147.37 23.32 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.566 -1.197 . . . . 0.77 109.193 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.958 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.79 107.42 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 CA-C-O 123.786 1.755 . . . . 0.78 109.993 174.62 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.06 -1.66 6.74 Favored Glycine 0 C--N 1.273 -2.959 0 CA-C-N 110.517 -3.038 . . . . 0.48 112.168 178.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.87 -119.66 2.48 Favored Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 119.223 -1.465 . . . . 0.44 110.383 176.068 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 48.1 t -154.09 173.63 15.79 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.611 -1.794 . . . . 0.82 108.859 173.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.1 tp -149.32 147.36 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.039 0 CA-C-N 113.237 -1.801 . . . . 0.32 106.845 167.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.3 m -140.9 126.84 19.33 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.632 -1.622 . . . . 0.31 111.338 -173.122 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 56.7 m-85 -124.45 147.02 48.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.65 -1.613 . . . . 0.53 109.07 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.41 120.82 16.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.132 -0.94 . . . . 0.58 110.082 176.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -113.73 116.89 30.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.467 -1.242 . . . . 0.32 110.145 -178.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 97.5 mtt180 -101.8 119.82 39.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.704 -0.225 . . . . 2.43 110.879 -177.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.9 t -118.77 125.28 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 122.067 0.937 . . . . 0.26 110.419 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.05 109.21 0.91 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.126 -1.852 . . . . 0.4 110.829 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.618 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -54.74 -33.22 55.3 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.222 -0.899 . . . . 0.76 111.947 172.642 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 53.97 -162.42 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.494 1.294 . . . . 0.71 114.494 169.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.0 p -118.44 38.81 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.939 -1.028 . . . . 1.74 109.2 173.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.057 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -64.44 177.32 0.89 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.678 -1.146 . . . . 2.16 113.521 -179.055 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 tp -69.21 -55.08 11.65 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.61 -0.723 . . . . 1.47 109.819 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.62 152.74 71.48 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.345 -0.843 . . . . 1.4 109.182 176.527 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -43.0 135.87 5.16 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.19 2.593 . . . . 0.88 112.987 -178.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.057 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.0 Cg_endo -55.52 135.93 71.56 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 122.726 2.284 . . . . 0.53 112.383 -176.379 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.2 104.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.507 -1.664 . . . . 0.77 106.507 177.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.63 HG22 HG13 ' A' ' 91' ' ' VAL . 42.9 t -103.84 115.22 45.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.91 0 CA-C-N 112.805 -1.998 . . . . 0.28 108.558 -179.171 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 1.054 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.33 123.38 46.69 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 113.591 -1.64 . . . . 1.54 109.444 170.465 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.971 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.9 m95 -89.34 157.37 18.21 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.702 -2.499 . . . . 0.34 111.256 173.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 21.1 t80 -136.55 125.8 24.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.876 -2.268 . . . . 0.62 104.876 167.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.801 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 20.4 tttm -102.57 162.35 12.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.494 -2.039 . . . . 2.17 105.494 -175.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.95 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -4.62 -165.94 0.0 OUTLIER Glycine 0 C--O 1.199 -2.043 0 N-CA-C 118.86 2.304 . . . . 1.23 118.86 -174.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 84' ' ' THR . 10.4 mtpp -41.67 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.026 -1.867 . . . . 3.87 115.716 -165.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 38.2 p-90 -166.02 2.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 114.416 1.265 . . . . 2.11 114.416 -177.353 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.39 117.11 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.993 1.378 . . . . 1.29 112.254 -163.229 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -84.85 98.42 10.3 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 112.437 -2.165 . . . . 2.73 111.32 175.211 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.013 HD23 HD21 ' A' ' 57' ' ' LEU . 4.1 mp -49.64 -36.08 23.38 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.781 -0.645 . . . . 0.44 112.719 -174.365 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 t -58.68 -22.2 56.48 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.427 -0.582 . . . . 1.23 109.427 -169.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.2 m -101.51 -28.18 12.69 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 112.919 0.711 . . . . 1.34 112.919 178.202 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 7.8 mmmt -90.1 -45.84 8.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.092 -0.504 . . . . 1.4 111.288 -171.224 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.2 t -22.67 93.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 126.504 1.922 . . . . 0.37 112.737 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -168.66 -124.73 0.74 Allowed Glycine 0 C--N 1.308 -1.025 0 CA-C-N 111.844 -2.435 . . . . 0.7 113.227 -177.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -56.8 -52.72 63.95 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.16 0.8 . . . . 2.75 113.16 -169.183 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.1 p80 -88.48 -38.6 14.86 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 112.208 0.447 . . . . 1.33 112.208 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.013 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.18 109.16 13.09 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.413 -0.958 . . . . 1.11 108.413 174.628 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -94.46 115.84 28.08 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.445 -1.687 . . . . 0.76 106.445 167.768 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.699 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.32 92.68 6.85 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 104.476 -2.416 . . . . 0.26 104.476 170.393 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 2.1 m170 -101.41 166.75 10.58 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.048 -1.433 . . . . 2.03 110.454 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 125.09 22.72 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 111.98 -2.373 . . . . 0.92 110.124 -177.458 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.3 m -94.48 148.4 22.28 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 111.506 -2.588 . . . . 0.47 107.366 172.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 2.4 t80 -135.81 97.78 3.74 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.251 1.024 . . . . 1.39 110.978 -173.286 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 5.4 m-20 -113.8 105.17 12.96 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 113.115 -1.857 . . . . 2.42 108.564 173.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.679 HH11 ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -84.41 -41.38 16.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.08 -0.964 . . . . 2.46 110.45 -178.728 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.28 -22.16 62.89 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.443 -1.253 . . . . 1.15 111.028 176.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.822 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.4 t -97.7 -16.42 19.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.285 -1.376 . . . . 1.41 107.285 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.682 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 68.04 29.18 6.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.044 -1.435 . . . . 3.31 110.903 173.699 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.48 126.87 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 121.682 0.753 . . . . 0.43 109.426 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.469 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.1 m-30 -105.0 109.11 20.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.796 -1.557 . . . . 1.24 106.796 170.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.6 tp -94.74 104.73 16.64 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 122.175 0.988 . . . . 0.52 109.516 -177.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.6 m-85 -84.16 113.33 21.0 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.134 -1.432 . . . . 0.33 107.134 171.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.51 125.61 52.16 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.789 -1.551 . . . . 1.32 110.51 -172.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.652 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -92.15 132.5 36.57 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.838 -1.528 . . . . 0.96 107.509 176.28 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 73.4 m-70 -119.95 96.72 5.29 Favored 'General case' 0 C--N 1.265 -3.066 0 N-CA-C 104.532 -2.396 . . . . 1.15 104.532 167.282 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.812 HG12 ' HB2' ' A' ' 57' ' ' LEU . 14.2 mt -122.03 99.32 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 122.382 1.087 . . . . 0.52 108.856 -174.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 75.8 p -100.41 165.0 11.66 Favored 'General case' 0 N--CA 1.388 -3.556 0 CA-C-N 114.546 -1.206 . . . . 0.58 110.374 -175.131 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 34.9 75.55 0.05 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 110.317 -3.129 . . . . 2.12 112.43 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -65.5 105.84 1.28 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 110.786 -2.916 . . . . 0.4 110.022 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.774 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.98 145.46 79.89 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.951 -0.759 . . . . 1.43 108.951 174.456 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.958 ' HD3' HG21 ' A' ' 18' ' ' VAL . 30.4 Cg_endo -62.49 150.28 88.03 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.439 1.426 . . . . 1.33 111.254 -175.029 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.53 15.48 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.725 0.64 . . . . 1.12 111.02 -175.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.58 -7.34 59.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.865 -1.161 . . . . 1.24 107.865 172.057 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.0 m -13.15 90.96 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 126.066 2.104 . . . . 1.22 112.176 -177.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.95 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -49.8 112.76 1.54 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 110.946 -2.843 . . . . 1.43 114.034 -173.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.643 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -111.25 75.73 0.22 Allowed Glycine 0 C--N 1.27 -3.103 0 N-CA-C 108.295 -1.922 . . . . 0.52 108.295 154.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.801 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 52.6 m-85 -80.08 119.15 22.5 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.298 -0.951 . . . . 0.63 109.065 175.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.5 104.21 8.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.295 -1.002 . . . . 3.15 108.295 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.6 t -90.58 127.73 36.36 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.852 -0.795 . . . . 1.08 108.852 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 1.054 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 34.1 tt0 -136.7 107.48 6.62 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.526 -0.761 . . . . 1.81 109.699 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.63 HG13 HG22 ' A' ' 39' ' ' VAL . 21.6 t -98.81 141.46 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.644 -0.422 . . . . 0.54 109.899 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 m -131.95 107.75 8.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.876 -0.787 . . . . 1.18 108.876 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.763 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.9 157.05 46.07 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 118.6 -0.714 . . . . 0.74 109.082 178.021 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 24.46 -79.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 125.61 1.819 . . . . 0.65 113.793 168.781 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.63 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 t70 -142.81 -4.17 0.96 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.894 -1.048 . . . . 1.05 109.944 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.04 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -91.65 122.74 34.49 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.536 0.684 . . . . 1.29 109.348 -177.424 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -129.81 114.29 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.388 -1.278 . . . . 0.77 110.044 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -130.44 145.26 51.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.777 -1.556 . . . . 1.6 109.531 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.503 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.5 m -142.86 147.33 35.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.374 0.607 . . . . 1.19 110.959 -178.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.569 ' HG ' ' HZ ' ' A' ' 7' ' ' PHE . 1.5 p -127.6 148.41 50.36 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.398 -0.819 . . . . 0.84 111.987 178.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.94 114.92 22.78 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.739 -1.119 . . . . 1.58 109.807 173.007 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.711 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.29 119.98 12.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.434 0.635 . . . . 0.86 109.441 -176.593 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.7 p30 -103.7 155.1 18.84 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.254 1.026 . . . . 2.11 111.59 -168.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.715 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -121.81 111.72 17.48 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.26 -1.336 . . . . 0.37 109.611 175.387 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.7 m -94.13 96.8 9.86 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.127 -0.694 . . . . 0.33 109.127 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 79' ' ' ALA . 4.0 p -82.87 113.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 122.955 1.36 . . . . 0.33 109.234 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.484 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 99.7 m-70 -87.5 101.21 13.39 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 112.201 -2.272 . . . . 1.19 109.044 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HA ' HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-N 114.6 -1.182 . . . . 1.67 108.647 170.762 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 119.783 -0.151 . . . . 1.65 111.281 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.99 84.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.317 2.011 . . . . 0.97 111.711 171.078 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.007 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -110.01 -64.87 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.16 -0.927 . . . . 0.5 109.329 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 95.6 46.55 2.71 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 108.284 -1.926 . . . . 0.39 108.284 -175.285 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.6 tp -56.72 -47.57 79.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.156 -1.522 . . . . 0.33 111.203 -166.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.498 ' HD1' ' HA ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -93.98 84.76 4.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.933 0.873 . . . . 0.72 109.665 178.367 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.48 -35.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.983 -1.462 . . . . 0.63 109.693 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -158.57 130.9 6.88 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 114.948 -1.024 . . . . 2.88 109.016 172.41 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -109.28 133.32 20.83 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 3.67 110.206 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.69 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.5 Cg_endo -63.76 157.54 51.47 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.725 2.283 . . . . 0.64 111.966 -176.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.453 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.0 mm-40 -121.26 174.17 6.87 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.858 -0.61 . . . . 1.43 110.472 -173.137 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 5.5 p-10 -68.48 -142.85 0.01 OUTLIER 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 122.942 1.354 . . . . 2.06 111.968 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.85 137.16 2.7 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 113.433 -1.712 . . . . 0.3 112.112 -175.435 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.0 mt-10 -110.49 115.81 30.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.413 -0.958 . . . . 1.53 108.413 174.171 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -134.86 155.7 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.02 0 N-CA-C 106.982 -1.488 . . . . 0.27 106.982 -173.686 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.36 157.28 18.23 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.041 -0.981 . . . . 0.77 108.908 -179.562 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.549 HG22 ' CG2' ' A' ' 106' ' ' VAL . 21.5 t -67.69 105.98 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.847 1.308 . . . . 0.78 108.117 173.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.76 11.41 6.49 Favored Glycine 0 C--N 1.265 -3.395 0 CA-C-N 112.132 -2.304 . . . . 0.48 113.055 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.14 -126.81 5.89 Favored Glycine 0 N--CA 1.416 -2.66 0 C-N-CA 119.278 -1.439 . . . . 0.44 110.529 171.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.7 p -151.21 170.46 19.41 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 112.697 -1.752 . . . . 0.82 110.613 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.8 tp -148.7 150.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-N 112.835 -1.984 . . . . 0.32 106.952 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -138.71 130.11 27.27 Favored 'General case' 0 C--N 1.258 -3.383 0 CA-C-N 114.32 -1.309 . . . . 0.31 110.639 -175.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 74' ' ' LEU . 26.9 m-85 -124.96 142.52 51.42 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.417 -1.265 . . . . 0.53 109.85 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.83 121.28 20.42 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.078 0.942 . . . . 0.58 110.43 176.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.637 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -118.83 115.94 25.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.119 -1.401 . . . . 0.32 110.459 -178.132 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -105.06 122.81 46.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.439 -0.346 . . . . 2.43 110.76 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 39' ' ' VAL . 8.4 t -125.74 127.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 122.085 0.945 . . . . 0.26 110.126 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -58.27 114.09 2.25 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.254 -1.794 . . . . 0.4 111.397 177.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.03 -29.05 61.79 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.293 -1.321 . . . . 0.76 110.757 168.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.72 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 52.86 -166.58 0.06 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.83 1.418 . . . . 0.71 114.83 165.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 t -120.9 107.77 13.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.066 -1.457 . . . . 1.74 107.066 169.769 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.801 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -143.05 176.32 9.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.061 0.763 . . . . 2.16 113.061 -165.311 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.0 tp -70.56 -71.44 0.25 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.386 -0.825 . . . . 1.47 108.824 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -116.63 148.4 41.82 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.609 -0.723 . . . . 1.4 109.302 171.318 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 85.9 Cg_exo -46.67 142.92 9.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.877 2.385 . . . . 0.88 111.809 178.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.801 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.9 Cg_exo -62.37 139.63 78.07 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 121.938 1.759 . . . . 0.53 111.924 -173.367 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.3 104.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.813 -1.551 . . . . 0.77 106.813 178.084 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 28' ' ' VAL . 2.1 t -105.98 115.1 46.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 113.323 -1.762 . . . . 0.28 107.528 176.463 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.09 127.91 55.14 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-O 122.944 1.354 . . . . 1.54 110.132 175.371 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.932 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.3 m95 -84.21 155.77 22.36 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 112.148 -2.297 . . . . 0.34 111.923 175.358 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.9 t80 -131.16 141.48 50.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 104.703 -2.332 . . . . 0.62 104.703 170.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.768 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 62.5 tttt -108.81 163.53 13.19 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.349 -1.723 . . . . 2.17 106.349 -172.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.811 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -7.81 -165.81 0.0 OUTLIER Glycine 0 C--O 1.196 -2.252 0 O-C-N 126.4 2.312 . . . . 1.23 118.845 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 84' ' ' THR . 15.6 mtpp -44.24 -3.7 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 O-C-N 119.449 -2.207 . . . . 3.87 116.271 -169.003 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.652 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.9 p-90 -171.2 -8.99 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 N-CA-C 115.295 1.591 . . . . 2.11 115.295 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HB ' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.83 159.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 123.222 1.487 . . . . 1.29 113.795 -159.277 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.742 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -112.48 106.11 14.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 111.817 -2.447 . . . . 2.73 113.084 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.932 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.6 mp -55.08 -36.32 65.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.086 0.773 . . . . 0.44 113.086 -175.753 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -59.02 -20.85 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.763 -0.829 . . . . 1.23 108.763 -169.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 12.6 m -98.79 -41.9 7.44 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.058 -0.974 . . . . 1.34 112.088 178.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.742 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 10.7 mmmt -85.09 -37.39 20.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.952 -1.022 . . . . 1.4 112.389 -166.754 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.876 HG13 ' H ' ' A' ' 59' ' ' LEU . 17.5 t -35.2 96.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 125.967 1.707 . . . . 0.37 112.542 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.63 -138.98 3.08 Favored Glycine 0 C--N 1.3 -1.457 0 CA-C-N 111.316 -2.675 . . . . 0.7 112.809 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -74.07 -8.37 55.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.973 0.731 . . . . 2.75 112.973 -167.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.717 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 29.3 p80 -111.79 -37.52 5.12 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 120.618 -0.433 . . . . 1.33 110.985 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.803 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -121.38 102.55 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.531 -1.655 . . . . 1.11 106.531 171.86 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -95.89 116.16 28.5 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.288 -1.375 . . . . 0.76 107.288 168.119 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.876 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.24 93.28 7.21 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.965 -2.235 . . . . 0.26 104.965 170.372 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.669 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 56.8 t60 -94.19 158.98 15.34 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 122.954 1.359 . . . . 2.03 109.042 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.95 112.87 10.29 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 111.753 -2.476 . . . . 0.92 110.605 -176.183 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.4 m -97.44 149.27 22.34 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 112.308 -2.224 . . . . 0.47 108.577 174.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -141.98 97.63 3.17 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.08 0.943 . . . . 1.39 110.632 -170.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 6.0 t70 -116.76 128.0 54.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.766 -1.561 . . . . 2.42 108.596 174.046 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.86 -31.38 11.53 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.858 -1.519 . . . . 2.46 111.021 -173.465 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.47 -19.88 60.22 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.385 -1.279 . . . . 1.15 110.549 174.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 50.7 m -98.53 -20.47 17.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 107.821 -1.177 . . . . 1.41 107.821 174.734 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.72 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 69.15 32.24 3.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.13 -1.395 . . . . 3.31 109.383 175.415 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.86 129.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.615 -0.72 . . . . 0.43 109.776 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.686 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 4.9 m-85 -100.25 112.33 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.495 -1.668 . . . . 1.24 106.495 164.489 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 27.5 tp -95.27 106.32 18.35 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 122.09 0.948 . . . . 0.52 109.075 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -86.95 112.34 21.71 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.511 -1.663 . . . . 0.33 106.511 169.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.669 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 4.0 pt-20 -121.54 122.35 39.49 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.29 -1.323 . . . . 1.32 110.557 -173.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.716 ' CD1' HD11 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -89.08 132.08 34.95 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.033 -1.44 . . . . 0.96 108.45 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 19.8 m170 -115.03 97.01 5.97 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 103.798 -2.668 . . . . 1.15 103.798 169.005 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.727 ' CD1' HD22 ' A' ' 57' ' ' LEU . 62.9 mt -121.55 101.3 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-O 122.985 1.374 . . . . 0.52 109.775 -174.336 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.7 p -112.69 143.78 43.32 Favored 'General case' 0 N--CA 1.398 -3.045 0 CA-C-N 114.126 -1.397 . . . . 0.58 109.257 -178.218 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.77 86.05 0.12 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 111.183 -2.735 . . . . 2.12 110.49 -177.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.479 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -75.91 125.17 28.59 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 112.713 -2.04 . . . . 0.4 109.52 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.879 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -61.84 134.33 94.05 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.281 -0.872 . . . . 1.43 108.978 175.687 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.48 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 19.1 Cg_endo -60.79 145.78 98.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.704 0.936 . . . . 1.33 110.37 176.249 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.18 17.2 10.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.441 0.463 . . . . 1.12 111.288 -173.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.879 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -73.1 -32.67 65.11 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.546 -0.539 . . . . 1.24 109.546 175.745 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m 13.12 78.35 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 125.379 1.675 . . . . 1.22 111.137 -168.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.811 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -65.74 99.0 0.37 Allowed Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 112.112 -2.313 . . . . 1.43 113.877 -161.144 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.67 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.13 74.04 1.87 Allowed Glycine 0 C--N 1.289 -2.078 0 N-CA-C 109.181 -1.568 . . . . 0.52 109.181 171.288 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.644 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 45.3 m-85 -81.01 120.1 24.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.071 -1.065 . . . . 0.63 108.165 176.355 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.528 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 72.7 mtt180 -127.61 115.36 18.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.935 -0.478 . . . . 3.15 111.034 -173.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.1 m -92.64 129.12 38.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.067 -0.515 . . . . 1.08 110.03 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 41.7 tt0 -126.8 113.22 16.33 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.606 -0.887 . . . . 1.81 108.606 174.476 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.0 p -105.26 135.51 43.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.853 0.835 . . . . 0.54 110.655 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -129.45 109.2 10.87 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.856 -1.52 . . . . 1.18 108.688 -176.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.624 HG22 ' HG3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -125.11 167.11 15.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 118.249 -0.882 . . . . 0.74 108.835 178.938 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.689 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -2.94 -62.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.618 1.824 . . . . 0.65 114.571 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.689 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 12.9 t0 -150.63 -7.05 0.28 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.773 -1.103 . . . . 1.05 110.239 -176.471 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.007 ' HD2' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mttp -95.35 135.63 36.72 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.14 -1.024 . . . . 1.29 108.681 -177.533 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -132.9 142.2 48.78 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.403 -1.726 . . . . 0.77 110.735 -177.259 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -164.02 163.84 23.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.317 -0.856 . . . . 1.6 108.972 173.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 p -153.31 148.67 27.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.244 0.545 . . . . 1.19 111.198 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.5 t -125.45 148.97 48.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.913 0.863 . . . . 0.84 111.71 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.24 114.28 11.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.671 -1.604 . . . . 1.58 110.092 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.69 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 18.6 p90 -142.47 131.67 23.36 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.562 -0.533 . . . . 0.86 109.562 -176.327 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 52.7 m-20 -109.04 135.24 50.52 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.154 0.978 . . . . 2.11 111.324 -171.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -102.74 110.11 21.93 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.145 -1.389 . . . . 0.37 109.434 176.811 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 13.3 m -90.85 97.87 11.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.381 0.61 . . . . 0.33 109.391 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.5 p -82.13 115.67 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.987 1.375 . . . . 0.33 109.288 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 94.6 m-70 -87.24 99.57 12.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.552 -2.113 . . . . 1.19 109.538 -177.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.542 ' HA ' HG23 ' A' ' 18' ' ' VAL . 41.3 tt0 . . . . . 0 C--N 1.301 -1.541 0 CA-C-N 113.845 -1.525 . . . . 1.67 109.803 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.734 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-20 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.45 0.537 . . . . 1.65 112.45 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.474 ' C ' HD12 ' A' ' 4' ' ' ILE . 24.8 Cg_exo -64.01 86.55 0.15 Allowed 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.195 2.597 . . . . 0.97 112.406 173.187 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.947 HG12 ' HD3' ' A' ' 94' ' ' LYS . 1.7 mp -119.59 -56.54 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.71 -1.132 . . . . 0.5 109.573 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.001 -1.64 . . . . 0.39 109.001 -175.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.916 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.7 tp -52.27 -37.78 56.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.309 -1.446 . . . . 0.33 109.811 -176.024 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.771 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.06 84.11 5.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.04 -0.982 . . . . 0.72 109.911 176.235 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t -72.57 -43.2 63.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.264 -1.335 . . . . 0.63 109.826 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.412 ' HB3' ' HG3' ' A' ' 27' ' ' ARG . 16.0 tpt -156.95 130.25 7.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.372 -0.831 . . . . 2.88 109.56 174.199 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.2 ptp85 -102.8 136.42 19.29 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 115.185 -0.916 . . . . 3.67 109.107 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.1 Cg_endo -74.14 160.53 42.46 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.323 1.349 . . . . 0.64 110.897 176.644 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -117.13 -179.77 3.8 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.297 -0.631 . . . . 1.43 109.297 -176.365 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 4.6 m-20 -69.99 -146.73 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 122.979 1.371 . . . . 2.06 111.264 -175.168 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.65 133.53 1.65 Allowed Glycine 0 C--N 1.294 -1.799 0 CA-C-N 113.438 -1.71 . . . . 0.3 111.5 -173.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.2 116.71 30.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.393 -0.904 . . . . 1.53 108.663 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -135.77 156.4 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.643 -1.244 . . . . 0.27 107.643 -171.736 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 156.19 18.64 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.638 -1.165 . . . . 0.77 108.916 176.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 81' ' ' PRO . 13.5 t -66.89 107.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 123.151 1.453 . . . . 0.78 108.477 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.17 3.71 11.65 Favored Glycine 0 C--N 1.266 -3.323 0 CA-C-N 111.612 -2.54 . . . . 0.48 112.463 178.358 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.86 -127.88 5.2 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 118.988 -1.577 . . . . 0.44 110.023 176.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 18.8 p -153.06 164.9 37.16 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 113.437 -1.381 . . . . 0.82 110.718 177.145 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 104' ' ' LEU . 10.8 tp -147.05 149.67 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.401 -1.727 . . . . 0.32 107.924 171.009 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -139.81 127.33 21.58 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 113.016 -1.902 . . . . 0.31 110.385 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.633 ' HB2' HD23 ' A' ' 74' ' ' LEU . 54.5 m-85 -121.92 147.31 46.18 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.607 -1.179 . . . . 0.53 108.883 174.256 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -132.44 119.73 21.03 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.208 -0.905 . . . . 0.58 109.183 178.199 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.644 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.39 119.96 29.76 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.456 -1.247 . . . . 0.32 110.805 -173.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.514 ' HG2' HD13 ' A' ' 71' ' ' LEU . 72.0 mtp180 -114.21 127.09 55.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.266 -0.425 . . . . 2.43 110.774 -176.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 91' ' ' VAL . 22.4 t -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-O 122.005 0.907 . . . . 0.26 110.558 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.96 111.38 2.13 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.197 -1.819 . . . . 0.4 110.566 174.172 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.81 -40.07 9.02 Favored Glycine 0 C--N 1.32 -0.336 0 CA-C-N 114.543 -1.208 . . . . 0.76 111.548 170.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 50.69 -156.01 0.12 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.869 0.868 . . . . 0.71 113.282 171.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.6 m -120.01 84.33 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.216 0.532 . . . . 1.74 110.852 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.076 HD22 ' HA ' ' A' ' 93' ' ' THR . 1.8 tp -114.28 150.38 34.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.323 -0.992 . . . . 2.16 108.323 173.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 33' ' ' LEU . 21.0 tp -44.24 -37.41 3.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.948 0.88 . . . . 1.47 111.292 178.107 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.808 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.36 178.41 1.7 Allowed Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.41 -1.268 . . . . 1.4 108.121 177.193 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.0 Cg_exo -65.59 146.23 83.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.662 1.575 . . . . 0.88 109.997 173.264 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HG3' HG21 ' A' ' 93' ' ' THR . 49.4 Cg_exo -45.57 140.76 8.63 Favored 'Trans proline' 0 CA--C 1.498 -1.297 0 C-N-CA 123.211 2.607 . . . . 0.53 113.286 178.536 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 92' ' ' SER . 7.3 p -100.09 96.84 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.075 1.417 . . . . 0.77 107.664 168.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.639 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -99.26 114.47 37.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 112.703 -2.044 . . . . 0.28 106.923 170.308 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.6 127.27 53.5 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 114.027 -1.442 . . . . 1.54 109.6 177.729 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.046 ' HB3' HD13 ' A' ' 49' ' ' LEU . 89.2 m95 -89.6 147.48 23.9 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.078 -2.328 . . . . 0.34 111.792 173.149 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.655 ' HD2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 t80 -131.35 125.48 32.78 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.71 -1.589 . . . . 0.62 106.71 172.323 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 5.1 ttpm? -98.93 109.91 22.6 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.214 -1.402 . . . . 2.17 107.214 -173.561 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.671 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -83.3 92.49 1.66 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 116.012 -2.994 . . . . 1.23 114.797 -167.344 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.839 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -106.15 -53.52 2.62 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.61 -3.107 . . . . 3.87 102.61 132.16 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.839 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 6.5 p-90 -167.38 -1.56 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 110.459 -3.064 . . . . 2.11 111.476 178.416 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.526 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -94.67 170.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-O 123.144 1.45 . . . . 1.29 112.496 -159.7 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 7.3 t70 -106.22 150.0 26.31 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.675 -2.511 . . . . 2.73 106.07 173.687 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -88.17 -36.84 16.6 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.402 -0.519 . . . . 0.44 110.902 176.106 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -59.97 -19.54 52.76 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.866 0.841 . . . . 1.23 109.011 -169.585 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -86.14 -28.78 23.76 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.571 -1.195 . . . . 1.34 111.094 -176.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 43' ' ' LYS . 2.4 mmmt -104.65 -71.4 0.74 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.03 -0.986 . . . . 1.4 111.125 -172.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.93 HG13 ' H ' ' A' ' 59' ' ' LEU . 56.2 t 19.01 85.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 O-C-N 125.366 1.667 . . . . 0.37 113.181 -177.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.74 -131.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 114.659 -1.155 . . . . 0.7 113.639 -173.379 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -48.78 -53.87 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.909 1.077 . . . . 2.75 113.909 -168.605 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.2 p80 -91.17 -38.09 12.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.837 -0.745 . . . . 1.33 111.498 -173.142 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.886 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.0 108.81 12.78 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.809 -0.811 . . . . 1.11 108.809 175.443 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.43 115.61 27.72 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 106.343 -1.725 . . . . 0.76 106.343 168.218 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.93 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.05 92.7 6.97 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.961 -2.237 . . . . 0.26 104.961 172.099 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 36.1 m170 -81.9 163.3 22.33 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.046 -1.434 . . . . 2.03 109.994 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -139.21 114.8 9.9 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 112.328 -2.214 . . . . 0.92 109.604 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 3.2 m -92.26 148.22 22.31 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.153 -1.84 . . . . 0.47 106.516 169.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.486 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.2 t80 -144.75 98.96 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.211 1.005 . . . . 1.39 111.011 -170.206 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 67' ' ' SER . 2.5 p30 -113.69 128.23 56.34 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.697 -1.592 . . . . 2.42 110.342 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.1 mmm180 -105.95 29.03 7.03 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.705 -1.589 . . . . 2.46 109.295 172.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.04 -30.17 6.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.195 -1.82 . . . . 1.15 109.27 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 5.7 t -111.91 -8.47 14.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.89 -1.05 . . . . 1.41 108.939 178.016 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 72.48 31.68 1.72 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.547 -0.909 . . . . 3.31 108.547 173.654 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 3.3 t -127.33 133.8 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 122.506 1.146 . . . . 0.43 111.473 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' SER . 5.0 m-85 -101.96 113.39 26.57 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.26 -1.755 . . . . 1.24 106.26 162.633 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 14.7 tp -97.36 104.82 16.88 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 122.302 1.049 . . . . 0.52 109.391 177.623 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.4 m-85 -88.64 114.58 25.4 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.833 -1.53 . . . . 0.33 108.534 174.124 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 2.9 mt-10 -103.52 125.66 50.21 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 113.708 -1.587 . . . . 1.32 109.566 -176.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.876 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -94.08 122.23 36.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.862 -1.162 . . . . 0.96 107.862 171.701 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 11.4 m170 -115.79 93.83 4.43 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.967 -2.605 . . . . 1.15 103.967 169.593 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.885 HG12 ' HB2' ' A' ' 57' ' ' LEU . 38.0 mt -121.78 100.79 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 122.883 1.325 . . . . 0.52 110.026 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 72.4 p -103.02 154.61 19.07 Favored 'General case' 0 N--CA 1.391 -3.395 0 CA-C-N 114.057 -1.429 . . . . 0.58 109.051 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.89 84.26 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.115 -2.766 . . . . 2.12 112.064 178.983 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -72.84 132.28 43.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 110.731 -2.94 . . . . 0.4 112.252 -175.515 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.662 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -54.01 125.62 49.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.402 -0.817 . . . . 1.43 109.323 170.074 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.4 Cg_endo -59.23 -7.19 4.67 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.738 2.959 . . . . 1.33 114.03 -175.306 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.662 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.6 0.41 19.08 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.974 -0.29 . . . . 1.12 111.569 -178.435 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.639 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.48 -58.09 9.57 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.642 0.258 . . . . 1.24 110.889 -172.601 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 34.2 m 38.64 66.2 0.55 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.592 -1.633 . . . . 1.22 106.592 -155.512 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -62.72 84.77 0.04 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 CA-C-N 112.445 -2.162 . . . . 1.43 114.139 -161.823 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -86.72 82.78 1.62 Allowed Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.916 -1.673 . . . . 0.52 108.916 175.307 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 18.1 m-85 -78.75 113.99 17.3 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.779 -1.211 . . . . 0.63 107.998 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.655 ' HB2' ' HD2' ' A' ' 42' ' ' PHE . 7.4 mtp180 -104.02 105.95 16.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.267 0.556 . . . . 3.15 109.854 -176.704 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.8 t -87.71 126.96 35.28 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.568 -0.742 . . . . 1.08 109.076 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.947 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 37.6 tt0 -136.03 110.37 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.222 -0.899 . . . . 1.81 109.606 -175.572 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.639 ' HB ' HG13 ' A' ' 39' ' ' VAL . 1.7 p -106.27 142.3 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.957 0.408 . . . . 0.54 111.046 -179.036 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.557 ' O ' HG12 ' A' ' 38' ' ' VAL . 20.7 t -132.13 108.28 9.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.919 -1.141 . . . . 1.18 107.919 177.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.076 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -131.44 146.62 52.34 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 117.912 -1.042 . . . . 0.74 108.501 -178.639 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.947 ' HD3' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 32.74 -74.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.642 1.839 . . . . 0.65 112.976 -177.558 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 22.2 t70 -147.69 -7.56 0.44 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.569 -1.196 . . . . 1.05 110.429 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.916 ' HB3' HD22 ' A' ' 6' ' ' LEU . 2.7 tttp -86.38 131.65 34.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.998 -1.112 . . . . 1.29 107.998 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -133.2 120.45 21.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.485 -1.689 . . . . 0.77 110.233 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -139.69 148.27 42.11 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.502 -1.226 . . . . 1.6 109.338 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 43.8 m -140.0 149.17 42.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.371 -0.377 . . . . 1.19 110.303 -179.032 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.771 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 40.7 p -131.9 134.43 45.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 0.84 111.273 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -107.78 119.43 39.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 1.58 110.096 177.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.738 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -142.27 118.56 10.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.137 -0.69 . . . . 0.86 109.137 -179.105 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 3.7 p30 -106.43 154.6 20.58 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 123.034 1.397 . . . . 2.11 111.876 -170.792 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.644 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -116.57 106.42 13.54 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.924 -1.944 . . . . 0.37 110.456 178.517 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -87.43 95.86 10.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.334 -0.987 . . . . 0.33 108.334 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.2 p -83.37 120.23 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 122.876 1.322 . . . . 0.33 108.54 -177.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -93.81 98.31 10.99 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 112.892 -1.958 . . . . 1.19 109.322 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 18' ' ' VAL . 27.8 tt0 . . . . . 0 C--N 1.302 -1.48 0 CA-C-N 114.258 -1.337 . . . . 1.67 109.665 171.218 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 8.2 m-20 . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 109.311 -0.626 . . . . 1.65 109.311 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.22 81.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.464 2.109 . . . . 0.97 111.596 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.644 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -102.0 -62.51 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 115.457 -0.792 . . . . 0.5 109.608 178.685 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.12 40.71 3.68 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.987 -1.645 . . . . 0.39 108.987 -176.046 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.7 tp -55.07 -33.62 62.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.42 -1.39 . . . . 0.33 110.131 -172.592 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.833 ' CZ ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -97.81 84.58 3.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.391 -1.277 . . . . 0.72 109.608 176.847 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.65 -46.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.664 -1.153 . . . . 0.63 110.374 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ttt -159.74 134.46 7.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.851 -1.068 . . . . 2.88 108.567 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.833 ' HD2' ' CZ ' ' A' ' 7' ' ' PHE . 5.5 mmp_? -125.25 145.66 51.45 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 116.173 -0.467 . . . . 3.67 111.077 -172.023 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.812 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -70.73 159.4 52.82 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.773 1.649 . . . . 0.64 110.573 179.145 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -124.79 -176.81 3.64 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.04 -0.527 . . . . 1.43 110.142 -173.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 3.7 p-10 -68.27 -152.34 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.732 0 CA-C-O 122.869 1.318 . . . . 2.06 111.211 -177.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 153.17 139.1 2.81 Favored Glycine 0 C--N 1.287 -2.171 0 CA-C-N 113.044 -1.889 . . . . 0.3 111.744 -173.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 21.2 mt-10 -115.07 114.96 26.05 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.297 -0.952 . . . . 1.53 109.055 175.311 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -136.4 158.32 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 N-CA-C 107.104 -1.443 . . . . 0.27 107.104 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.04 157.74 18.24 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.83 -1.077 . . . . 0.77 109.548 -178.873 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 22.6 t -64.99 107.06 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 123.088 1.423 . . . . 0.78 108.554 173.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 10.12 16.34 Favored Glycine 0 C--N 1.267 -3.284 0 CA-C-N 111.882 -2.417 . . . . 0.48 113.041 175.052 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 -123.14 3.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 119.703 -1.237 . . . . 0.44 110.198 175.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.9 p -152.43 164.24 37.93 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 112.989 -1.605 . . . . 0.82 110.817 176.451 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.5 tp -148.29 150.96 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 113.609 -1.632 . . . . 0.32 107.774 170.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.8 m -138.54 129.28 26.47 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 113.941 -1.481 . . . . 0.31 110.996 -176.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.691 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 87.7 m-85 -125.21 145.19 50.09 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.955 -1.475 . . . . 0.53 109.089 178.339 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.526 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -137.43 124.86 21.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.943 -0.762 . . . . 0.58 108.943 174.352 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.85 114.4 19.81 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.741 -1.118 . . . . 0.32 110.208 -176.252 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.501 ' HG2' HD13 ' A' ' 71' ' ' LEU . 67.7 mtp180 -104.86 128.98 53.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.504 -0.316 . . . . 2.43 110.267 -176.024 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.491 HG21 HG21 ' A' ' 39' ' ' VAL . 20.1 t -125.5 127.48 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.902 0.858 . . . . 0.26 109.964 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -63.11 108.82 1.33 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.961 -1.472 . . . . 0.4 110.939 175.461 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.68 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.62 -54.92 11.95 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.76 112.35 173.281 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 57.57 -166.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.275 0.843 . . . . 0.71 113.275 177.395 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -107.73 127.65 53.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.37 -0.832 . . . . 1.74 109.037 172.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -123.41 -178.86 4.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.088 0.947 . . . . 2.16 112.319 -168.665 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' H ' ' HB3' ' A' ' 94' ' ' LYS . 17.4 tp -88.29 -37.36 16.07 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.586 -1.643 . . . . 1.47 106.846 154.56 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.35 145.8 19.07 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.595 -1.184 . . . . 1.4 110.895 171.303 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.82 148.48 12.42 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.348 2.699 . . . . 0.88 112.27 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HA ' HG23 ' A' ' 93' ' ' THR . 6.3 Cg_endo -55.21 132.26 51.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.091 1.861 . . . . 0.53 113.572 -175.173 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.13 106.28 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.277 -1.749 . . . . 0.77 106.277 174.299 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 91' ' ' VAL . 2.1 t -115.08 114.31 46.1 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 113.703 -1.589 . . . . 0.28 108.03 179.082 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.809 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.84 128.72 45.91 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 123.066 1.413 . . . . 1.54 109.19 172.906 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 1.002 ' HB3' HD13 ' A' ' 49' ' ' LEU . 60.0 m95 -87.89 153.54 21.23 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 112.061 -2.336 . . . . 0.34 110.709 172.295 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -135.01 125.23 26.15 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.202 -2.147 . . . . 0.62 105.202 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HB3' HG12 ' A' ' 47' ' ' VAL . 27.1 tttt -104.09 99.57 9.31 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.38 -1.711 . . . . 2.17 106.38 -175.481 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.661 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -86.45 95.14 2.01 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 115.882 -3.056 . . . . 1.23 117.078 -154.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.926 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -101.69 -48.17 4.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.007 -2.59 . . . . 3.87 104.007 135.322 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.926 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 11.6 p-90 -170.41 1.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 112.676 -2.056 . . . . 2.11 111.915 175.524 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -97.35 169.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 C-N-CA 125.275 1.43 . . . . 1.29 113.171 -159.427 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.549 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 m-20 -100.95 147.45 26.15 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 112.456 -2.156 . . . . 2.73 107.527 173.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.002 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.3 mp -79.21 -29.25 42.72 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.678 -0.409 . . . . 0.44 110.639 173.383 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -57.36 -20.93 32.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 1.23 109.608 -167.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.504 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -97.59 -27.85 14.21 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 119.78 -0.768 . . . . 1.34 111.79 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.582 ' HB2' HD12 ' A' ' 57' ' ' LEU . 5.9 mmmt -95.68 -33.37 12.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.392 -0.822 . . . . 1.4 111.319 -171.196 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.828 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.8 t -40.79 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 126.02 1.728 . . . . 0.37 111.908 175.722 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.89 -103.2 0.19 Allowed Glycine 0 C--N 1.302 -1.353 0 CA-C-N 112.427 -2.17 . . . . 0.7 113.42 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.11 -54.68 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.118 0.784 . . . . 2.75 113.118 -169.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -96.05 -29.37 14.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.487 0.661 . . . . 1.33 111.189 -174.338 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.969 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.12 106.05 13.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.541 -1.651 . . . . 1.11 106.541 173.494 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -104.68 118.28 36.18 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.074 -1.454 . . . . 0.76 107.074 167.119 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.828 ' H ' HG13 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -98.96 92.83 5.7 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.211 -2.144 . . . . 0.26 105.211 172.073 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.7 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.2 m170 -91.31 162.91 14.41 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.161 -1.381 . . . . 2.03 110.21 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -136.45 122.95 20.83 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 112.348 -2.205 . . . . 0.92 110.145 176.176 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -97.0 148.54 22.87 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 111.367 -2.651 . . . . 0.47 108.559 176.518 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 37.3 t80 -127.78 99.83 5.7 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.352 1.072 . . . . 1.39 111.563 -170.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.852 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 3.2 m-20 -113.44 103.96 11.8 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.036 -1.893 . . . . 2.42 109.285 172.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -42.1 14.38 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.054 -0.521 . . . . 2.46 110.26 174.495 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.38 61.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.295 -0.866 . . . . 1.15 110.637 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.852 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 9.4 m -99.67 -16.3 18.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.8 -1.185 . . . . 1.41 107.8 175.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 68.24 31.62 5.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.362 -1.29 . . . . 3.31 110.001 172.523 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 2.6 t -129.97 122.54 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-N 115.48 -0.782 . . . . 0.43 110.175 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.68 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 46.2 m-85 -95.92 113.22 24.83 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.026 -1.472 . . . . 1.24 107.026 164.777 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 25' ' ' SER . 22.6 tp -97.47 105.02 17.1 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.106 0.955 . . . . 0.52 108.78 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.0 m-85 -86.19 111.65 20.59 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.262 -1.755 . . . . 0.33 106.262 170.471 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -116.57 129.52 56.22 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 114.348 -1.296 . . . . 1.32 110.344 -174.833 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.5 mt -92.29 135.92 33.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 113.789 -1.551 . . . . 0.96 108.635 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -120.09 97.32 5.54 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 103.915 -2.624 . . . . 1.15 103.915 165.17 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.731 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -125.48 100.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 122.982 1.372 . . . . 0.52 109.153 -175.051 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 40.7 p -97.6 165.12 12.13 Favored 'General case' 0 N--CA 1.381 -3.886 0 CA-C-N 114.004 -1.453 . . . . 0.58 107.866 178.341 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.4 84.27 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 111.404 -2.635 . . . . 2.12 112.755 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -76.66 132.69 39.53 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 111.574 -2.557 . . . . 0.4 108.383 176.084 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.611 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 1.1 pt20 -93.63 152.02 40.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.616 -0.883 . . . . 1.43 108.616 -178.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HB3' ' HG2' ' A' ' 108' ' ' GLU . 36.8 Cg_endo -63.92 -16.84 57.15 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.75 2.3 . . . . 1.33 113.403 -167.572 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -92.04 13.06 19.87 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.961 -0.563 . . . . 1.12 111.68 -176.576 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 45' ' ' LYS . 15.9 m-30 -89.09 -61.17 1.76 Allowed 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.258 -0.577 . . . . 1.24 110.52 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.3 m 36.7 63.16 0.69 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.027 -1.471 . . . . 1.22 107.027 -158.052 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.741 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -67.21 90.94 0.19 Allowed Glycine 0 CA--C 1.481 -2.055 0 CA-C-N 111.978 -2.374 . . . . 1.43 113.782 -160.166 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -84.72 82.04 1.71 Allowed Glycine 0 C--N 1.277 -2.715 0 N-CA-C 107.933 -2.067 . . . . 0.52 107.933 168.302 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 8.3 m-85 -74.71 134.33 41.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.653 -1.274 . . . . 0.63 108.088 179.283 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -126.44 138.12 53.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.92 -0.4 . . . . 3.15 109.92 -178.633 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.648 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 4.3 m -112.09 116.42 30.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.415 -0.957 . . . . 1.08 108.415 168.065 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.809 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 64.5 mt-10 -110.19 102.07 10.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.544 -1.28 . . . . 1.81 107.544 176.302 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 39' ' ' VAL . 4.7 p -99.19 135.92 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.752 0.787 . . . . 0.54 111.36 -173.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.6 t -130.07 108.89 10.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.891 -1.504 . . . . 1.18 107.862 -179.32 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.5 m -130.3 158.47 39.7 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.8 -1.095 . . . . 0.74 108.054 179.749 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.683 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 10.96 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 125.819 1.949 . . . . 0.65 114.342 -177.489 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.683 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -146.18 -3.16 0.67 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.923 -1.035 . . . . 1.05 110.193 -176.694 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.665 ' HB3' HD22 ' A' ' 6' ' ' LEU . 4.5 mmtp -95.39 129.63 42.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.612 -0.884 . . . . 1.29 108.612 -177.263 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -131.7 128.63 39.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.81 -1.087 . . . . 0.77 112.341 -178.292 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.7 160.47 43.82 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.46 -1.245 . . . . 1.6 109.95 175.077 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -140.95 145.86 36.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.624 0.25 . . . . 1.19 110.487 176.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.758 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 89.2 p -126.8 135.53 51.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.542 -0.299 . . . . 0.84 110.915 -175.645 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -122.33 128.49 51.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.378 0.609 . . . . 1.58 111.05 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.812 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -143.08 119.0 10.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.6 -0.727 . . . . 0.86 109.694 -177.143 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.503 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -104.32 129.58 52.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.423 1.106 . . . . 2.11 113.114 -170.007 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -102.75 111.98 24.55 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.526 -1.67 . . . . 0.37 109.733 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.5 m -90.62 98.38 11.74 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.977 -0.749 . . . . 0.33 108.977 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.6 p -81.9 115.02 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-O 122.967 1.365 . . . . 0.33 109.399 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.652 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.7 m170 -83.14 99.79 10.13 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.71 -2.041 . . . . 1.19 110.05 -176.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 3.0 tm-20 . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.307 -1.315 . . . . 1.67 109.101 170.115 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 4.5 t70 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 108.625 -0.88 . . . . 1.65 108.625 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 3.0 Cg_endo -46.59 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.385 3.39 . . . . 0.97 113.954 179.013 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.669 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -123.29 -65.18 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.97 -1.014 . . . . 0.5 109.124 175.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 90.05 47.74 3.79 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 108.131 -1.987 . . . . 0.39 108.131 -174.167 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.7 tp -58.12 -41.49 83.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.783 -1.709 . . . . 0.33 110.346 -167.29 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.812 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.02 85.67 6.01 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.887 0.851 . . . . 0.72 109.772 174.796 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.08 -40.02 85.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.774 -1.557 . . . . 0.63 110.078 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.486 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 57.3 ttm -153.42 134.58 14.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 2.88 110.19 176.37 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.661 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 6.8 mtm180 -91.91 139.35 24.58 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 107.905 -1.146 . . . . 3.67 107.905 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 40.2 Cg_endo -78.64 -163.85 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.981 2.454 . . . . 0.64 113.509 -175.231 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -127.26 131.29 50.58 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.745 -0.661 . . . . 1.43 111.405 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 8.4 m-20 -43.91 -98.99 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.668 1.587 . . . . 2.06 113.162 -176.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.3 145.93 4.36 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-O 121.769 0.649 . . . . 0.3 111.758 169.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.5 112.1 10.0 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.966 -0.617 . . . . 1.53 109.707 170.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.576 HG11 ' HB ' ' A' ' 22' ' ' ILE . 10.4 m -138.87 165.87 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.093 -1.077 . . . . 0.27 108.093 -172.174 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.671 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.94 157.38 15.92 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.932 -1.031 . . . . 0.77 109.288 178.074 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 106' ' ' VAL . 59.5 t -64.77 106.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 122.96 1.362 . . . . 0.78 109.583 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.7 10.68 14.14 Favored Glycine 0 C--N 1.272 -2.995 0 CA-C-N 112.105 -2.316 . . . . 0.48 113.561 171.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.35 -122.15 3.56 Favored Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 118.615 -1.755 . . . . 0.44 110.457 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 5.7 p -151.03 165.05 34.97 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 112.716 -1.742 . . . . 0.82 110.302 177.538 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.661 HG21 HD13 ' A' ' 104' ' ' LEU . 8.3 tp -147.98 150.2 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 113.665 -1.607 . . . . 0.32 106.837 172.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -138.55 132.8 31.68 Favored 'General case' 0 C--N 1.263 -3.184 0 CA-C-N 114.672 -1.149 . . . . 0.31 110.623 -174.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.786 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 18.6 m-85 -128.38 137.71 52.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.228 -1.351 . . . . 0.53 109.98 -175.645 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.422 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.79 124.3 16.85 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.985 0.898 . . . . 0.58 111.262 172.694 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.643 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -122.94 129.26 51.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.011 -1.449 . . . . 0.32 110.328 -178.321 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.486 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 54.2 mtt180 -107.31 126.39 52.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.404 -0.362 . . . . 2.43 111.688 -174.849 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.55 HG21 HG21 ' A' ' 39' ' ' VAL . 20.1 t -128.37 131.87 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.93 0.871 . . . . 0.26 110.137 -177.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.96 118.1 9.27 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.614 -1.63 . . . . 0.4 111.439 179.203 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.78 -33.66 56.04 Favored Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.579 -1.192 . . . . 0.76 110.868 168.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 59.58 -164.19 0.22 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.735 1.383 . . . . 0.71 114.735 162.515 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -113.48 118.4 34.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.01 -1.45 . . . . 1.74 107.446 170.222 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.733 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.61 166.03 33.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.436 0.532 . . . . 2.16 112.436 -165.564 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' HB2' ' HG3' ' A' ' 35' ' ' LYS . 1.8 mt -81.86 -30.36 32.08 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.576 1.179 . . . . 1.47 109.528 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -150.6 139.36 12.95 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 112.673 -2.058 . . . . 1.4 108.661 -166.81 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -47.4 141.87 13.61 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.571 2.181 . . . . 0.88 111.397 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_exo -63.0 130.16 28.22 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.297 1.331 . . . . 0.53 111.536 -175.386 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.13 104.11 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.052 -1.462 . . . . 0.77 107.052 179.114 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.1 t -107.69 113.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 113.444 -1.707 . . . . 0.28 107.387 176.236 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.785 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -98.42 119.0 36.36 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 122.95 1.357 . . . . 1.54 110.062 176.029 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.682 ' HB3' HD22 ' A' ' 49' ' ' LEU . 46.5 m95 -86.61 139.26 30.98 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 112.079 -2.328 . . . . 0.34 110.662 175.839 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 58.1 t80 -117.55 153.75 32.68 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.166 -1.42 . . . . 0.62 107.166 170.775 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.961 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 22.9 tptt -106.6 165.57 11.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.601 -0.888 . . . . 2.17 108.601 -172.176 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.984 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -25.14 168.47 0.0 OUTLIER Glycine 0 C--O 1.204 -1.76 0 O-C-N 124.348 1.03 . . . . 1.23 114.749 169.029 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 ptmt -39.86 0.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 119.763 3.245 . . . . 3.87 119.763 -140.243 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.927 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -162.6 -15.54 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.96 1.255 . . . . 2.11 113.594 -179.413 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.636 HG12 ' HE3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -94.62 166.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.812 0 CA-C-O 122.816 1.293 . . . . 1.29 110.114 -164.687 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.684 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 3.0 p-10 -113.65 154.81 26.61 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 112.489 -2.141 . . . . 2.73 108.867 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.961 ' CD1' ' HB2' ' A' ' 43' ' ' LYS . 5.3 mp -92.35 -23.73 19.14 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.163 0.431 . . . . 0.44 112.163 169.653 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 t -61.06 -21.58 63.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.883 -0.784 . . . . 1.23 108.883 -168.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.62 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 22.1 m -101.35 -41.59 6.62 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.315 1.055 . . . . 1.34 110.457 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.684 ' HD3' ' O ' ' A' ' 48' ' ' ASP . 3.7 mptp? -73.74 -75.58 0.15 Allowed 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 113.398 -1.728 . . . . 1.4 111.821 -168.201 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 25.2 t 7.66 87.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 126.189 2.181 . . . . 0.37 113.908 175.117 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -155.5 -131.54 1.45 Allowed Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.824 -1.989 . . . . 0.7 111.693 179.068 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' CD ' ' H ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -59.81 -42.35 93.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.246 0.832 . . . . 2.75 113.246 -169.84 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.9 p80 -92.98 -38.11 11.84 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.548 -0.461 . . . . 1.33 112.075 -175.226 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.87 HD11 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -121.12 105.73 10.88 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.353 -1.351 . . . . 1.11 107.353 175.526 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -99.43 113.14 25.32 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.831 -1.544 . . . . 0.76 106.831 164.656 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.983 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -93.0 94.45 8.9 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 103.538 -2.764 . . . . 0.26 103.538 168.515 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 41.4 m-70 -96.38 164.67 12.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 123.259 1.504 . . . . 2.03 111.344 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.43 120.93 17.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 110.847 -2.888 . . . . 0.92 108.498 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.28 116.06 25.47 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.41 -1.723 . . . . 0.47 109.933 172.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -121.23 106.91 11.94 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.935 -1.03 . . . . 1.39 110.843 -169.843 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -106.14 102.16 11.6 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.67 -1.15 . . . . 2.42 109.252 172.318 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.79 -30.26 70.42 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.197 -1.365 . . . . 2.46 111.352 -174.051 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.14 -12.32 60.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.763 -0.653 . . . . 1.15 110.659 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 14.7 m -101.33 -15.85 17.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.935 -1.135 . . . . 1.41 107.935 173.276 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER 68.62 31.17 4.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.565 -1.198 . . . . 3.31 109.822 179.192 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -132.91 134.3 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.661 0.743 . . . . 0.43 110.329 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 63' ' ' TYR . 3.0 m-85 -104.24 111.52 24.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.311 -1.737 . . . . 1.24 106.311 162.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 25' ' ' SER . 29.2 tp -94.41 104.98 16.95 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.668 -1.234 . . . . 0.52 107.668 175.38 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 83.0 m-85 -86.81 113.81 22.94 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 106.642 -1.614 . . . . 0.33 106.642 171.156 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.95 121.94 36.63 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 113.724 -1.58 . . . . 1.32 110.172 -173.568 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.983 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -92.11 132.97 36.19 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.758 -1.564 . . . . 0.96 108.399 179.114 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.37 98.62 7.03 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 103.603 -2.74 . . . . 1.15 103.603 167.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.7 HG13 ' HB3' ' A' ' 74' ' ' LEU . 8.5 mt -124.55 100.24 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-O 122.97 1.367 . . . . 0.52 109.282 -174.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 77.3 p -102.25 166.07 10.78 Favored 'General case' 0 N--CA 1.384 -3.736 0 CA-C-N 114.101 -1.409 . . . . 0.58 108.5 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.44 76.17 0.18 Allowed 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 111.454 -2.612 . . . . 2.12 111.318 176.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.79 108.11 9.58 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.9 -1.955 . . . . 0.4 110.694 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -54.23 143.43 44.8 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 1.43 109.948 167.612 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 23.4 Cg_endo -61.12 -8.39 9.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.105 2.536 . . . . 1.33 113.25 -179.125 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.43 12.05 30.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.33 -0.395 . . . . 1.12 110.992 178.262 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.523 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -97.56 -3.81 38.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 118.102 -0.952 . . . . 1.24 111.08 -178.296 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.1 m -18.17 93.99 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.453 1.721 . . . . 1.22 111.291 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.936 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -40.51 114.51 0.53 Allowed Glycine 0 CA--C 1.465 -3.093 0 CA-C-N 109.626 -3.443 . . . . 1.43 114.24 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.984 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -131.68 60.69 0.67 Allowed Glycine 0 N--CA 1.405 -3.411 0 CA-C-N 111.394 -2.403 . . . . 0.52 108.941 159.544 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.812 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 31.2 m-85 -77.79 108.0 10.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.863 -1.162 . . . . 0.63 107.863 178.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.503 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 16.0 tpt180 -106.21 112.49 25.54 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.258 0.552 . . . . 3.15 110.616 -175.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 38.0 m -99.7 118.23 35.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.66 -0.7 . . . . 1.08 110.241 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.785 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 76.0 mt-10 -129.18 116.56 19.39 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.711 -0.477 . . . . 1.81 109.711 175.239 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 p -95.41 139.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.517 0.675 . . . . 0.54 110.141 177.084 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.8 m -134.41 108.5 8.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.862 -1.063 . . . . 1.18 108.271 -176.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 94' ' ' LYS . 1.1 m -131.26 -176.75 4.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.412 -0.813 . . . . 0.74 109.92 -176.056 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -10.41 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 125.04 1.462 . . . . 0.65 114.688 -177.343 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.946 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.8 t70 -159.33 0.74 0.08 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.522 -1.217 . . . . 1.05 109.338 -175.771 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.684 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -100.95 145.21 28.95 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.223 1.011 . . . . 1.29 109.718 -177.769 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -134.77 136.8 42.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.653 -2.067 . . . . 0.77 110.315 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.599 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 m-20 -155.09 154.66 32.75 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.048 -0.978 . . . . 1.6 108.623 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 9.2 p -155.8 154.45 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.296 0.48 . . . . 1.19 112.296 -175.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.812 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 79.9 p -132.01 147.79 52.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.86 -0.609 . . . . 0.84 112.367 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.16 144.76 26.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.326 -0.852 . . . . 1.58 110.606 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.786 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 7.6 m-85 -137.73 103.51 5.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.558 -0.746 . . . . 0.86 110.318 172.375 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.775 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -105.67 110.55 22.9 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 118.743 -1.183 . . . . 2.11 112.363 170.414 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.936 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -98.02 106.98 19.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.146 -1.388 . . . . 0.37 109.755 -179.265 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -83.77 96.65 8.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.512 -0.551 . . . . 0.33 109.512 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 18' ' ' VAL . 3.4 p -80.65 112.45 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.875 1.321 . . . . 0.33 109.118 177.34 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.0 m170 -80.44 99.74 8.14 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.027 -1.897 . . . . 1.19 110.656 -176.907 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 32.3 tt0 . . . . . 0 C--N 1.303 -1.414 0 CA-C-N 114.452 -1.249 . . . . 1.67 110.244 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.803 ' HB3' ' HA ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.158 1.54 . . . . 1.93 115.158 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.13 170.57 12.16 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 114.858 -1.065 . . . . 1.65 111.003 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.28 69.98 2.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.916 2.411 . . . . 0.97 112.374 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.652 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -92.88 -54.61 7.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.013 -0.994 . . . . 0.5 109.323 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.23 6.24 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.798 -2.121 . . . . 0.39 107.798 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.957 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -53.34 -36.57 61.46 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 112.78 -1.71 . . . . 0.33 110.575 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.565 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -94.82 85.29 4.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.367 -0.833 . . . . 0.72 109.642 172.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.88 -49.02 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.6 -1.182 . . . . 0.63 109.719 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.0 tpt -143.74 133.73 24.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 2.88 108.912 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 20.7 ptt180 -103.86 132.84 20.65 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.107 -0.497 . . . . 3.67 111.405 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.1 Cg_endo -64.34 151.63 84.69 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.683 2.255 . . . . 0.64 111.328 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.8 mm-40 -121.13 176.54 5.54 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.042 -0.527 . . . . 1.43 110.452 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.23 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.524 1.154 . . . . 2.06 111.586 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.27 135.61 2.0 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.11 -1.405 . . . . 0.3 111.953 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 44.8 mt-10 -114.01 115.05 27.0 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.332 -0.934 . . . . 1.53 108.943 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -136.07 163.23 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 N-CA-C 107.645 -1.242 . . . . 0.27 107.645 -173.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.44 152.36 19.14 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.866 -1.061 . . . . 0.77 108.925 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.727 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -73.3 106.6 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 123.897 1.808 . . . . 0.78 109.419 172.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.59 -3.93 5.44 Favored Glycine 0 C--N 1.274 -2.873 0 CA-C-N 110.331 -3.122 . . . . 0.48 111.196 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.13 -127.5 5.94 Favored Glycine 0 N--CA 1.411 -2.988 0 C-N-CA 119.24 -1.457 . . . . 0.44 110.217 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.5 p -150.85 170.08 20.14 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.0 -1.6 . . . . 0.82 110.76 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 HD13 ' A' ' 104' ' ' LEU . 8.7 tp -147.16 149.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 113.592 -1.64 . . . . 0.32 108.065 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 m -138.87 128.51 24.71 Favored 'General case' 0 C--N 1.268 -2.973 0 CA-C-N 113.503 -1.681 . . . . 0.31 110.73 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' HB2' ' CG ' ' A' ' 74' ' ' LEU . 45.2 m-85 -125.19 152.69 44.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.182 -1.372 . . . . 0.53 108.44 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.51 125.98 18.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.214 -0.662 . . . . 0.58 109.214 175.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.11 121.03 36.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.161 -0.927 . . . . 0.32 110.367 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 56.3 mtp180 -108.02 117.08 33.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.353 -0.385 . . . . 2.43 110.021 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.564 HG21 HG21 ' A' ' 39' ' ' VAL . 23.6 t -120.87 130.53 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.286 1.041 . . . . 0.26 110.436 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.879 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -60.96 109.12 0.98 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.286 -1.779 . . . . 0.4 113.696 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.56 3.04 Favored Glycine 0 N--CA 1.462 0.401 0 CA-C-N 114.728 -1.123 . . . . 0.76 113.091 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HB2' ' CE ' ' A' ' 68' ' ' LYS . . . -50.68 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 114.669 1.359 . . . . 0.71 114.669 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -81.58 127.59 33.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.481 -1.236 . . . . 1.74 108.361 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.835 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -157.12 177.79 11.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.168 -0.469 . . . . 2.16 111.179 -172.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.83 -51.09 71.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.45 0.643 . . . . 1.47 109.287 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.47 149.41 26.29 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.785 -1.098 . . . . 1.4 108.718 171.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -43.01 143.9 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.524 2.816 . . . . 0.88 112.651 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.835 ' HD3' HD11 ' A' ' 33' ' ' LEU . 2.0 Cg_endo -48.7 133.03 26.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.715 1.61 . . . . 0.53 113.25 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.1 105.99 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 106.54 -1.652 . . . . 0.77 106.54 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.659 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.27 114.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 CA-C-N 113.655 -1.611 . . . . 0.28 107.962 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.5 127.3 49.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 123.456 1.598 . . . . 1.54 110.096 173.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.997 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -87.04 155.47 20.14 Favored 'General case' 0 C--N 1.273 -2.724 0 CA-C-N 111.178 -2.737 . . . . 0.34 112.05 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.521 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 35.5 t80 -134.26 135.94 43.25 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 104.173 -2.528 . . . . 0.62 104.173 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.929 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 50.8 tttm -98.43 171.85 7.9 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.023 -1.843 . . . . 2.17 106.023 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.984 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -15.43 -172.48 0.0 OUTLIER Glycine 0 C--O 1.178 -3.358 0 N-CA-C 119.117 2.407 . . . . 1.23 119.117 172.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -42.62 -8.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.169 2.285 . . . . 3.87 117.169 -162.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.538 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.1 p-90 -162.09 -6.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.012 1.115 . . . . 2.11 114.012 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.929 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.5 163.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.769 0 CA-C-O 123.712 1.72 . . . . 1.29 112.565 -161.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.682 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.6 p-10 -109.94 157.65 19.04 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.987 -2.824 . . . . 2.73 105.925 170.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.044 HD23 HD21 ' A' ' 57' ' ' LEU . 5.6 mp -99.34 -30.11 12.4 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.294 -0.562 . . . . 0.44 112.185 168.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.2 t -56.9 -21.63 31.21 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.038 0.535 . . . . 1.23 109.733 -164.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -99.9 -36.12 9.51 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.86 0.838 . . . . 1.34 111.503 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.682 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -87.68 -31.85 19.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.406 -1.27 . . . . 1.4 111.319 -167.112 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.751 HG13 ' H ' ' A' ' 59' ' ' LEU . 52.4 t -36.43 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.37 111.215 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.59 -93.71 0.1 OUTLIER Glycine 0 C--N 1.298 -1.536 0 CA-C-N 112.701 -2.045 . . . . 0.7 113.812 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -94.15 -44.84 7.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.578 0.584 . . . . 2.75 112.578 -168.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.585 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 19.6 p80 -95.76 -36.21 11.25 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.339 0.59 . . . . 1.33 110.731 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.044 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -115.55 106.38 13.87 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.1 -1.815 . . . . 1.11 106.1 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -100.76 115.19 29.71 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 106.75 -1.574 . . . . 0.76 106.75 166.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.751 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -100.42 92.26 5.08 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.742 -2.318 . . . . 0.26 104.742 172.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.701 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 44.0 m170 -86.09 163.82 17.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.096 -1.411 . . . . 2.03 110.916 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.17 115.74 16.76 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.847 -1.979 . . . . 0.92 109.649 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -98.11 149.3 22.65 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 112.759 -2.019 . . . . 0.47 107.839 170.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.86 99.04 3.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.48 1.133 . . . . 1.39 110.961 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.7 m-20 -110.26 107.19 16.87 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 112.904 -1.953 . . . . 2.42 108.954 176.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -45.94 61.35 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.604 -0.725 . . . . 2.46 110.333 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.34 -30.33 71.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.745 -1.116 . . . . 1.15 110.984 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 19.5 m -89.49 -19.35 25.18 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.977 -0.749 . . . . 1.41 108.977 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.879 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 2.2 ttpm? 61.92 41.05 11.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.078 -0.965 . . . . 3.31 108.399 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 21.9 t -133.27 124.92 50.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.875 -1.057 . . . . 0.43 111.139 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.3 m-30 -97.81 106.06 18.3 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.992 -1.855 . . . . 1.24 105.992 163.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 7.9 tp -95.07 105.27 17.18 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 122.622 1.201 . . . . 0.52 108.984 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.701 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.9 m-85 -85.66 114.7 22.84 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.469 -1.696 . . . . 0.33 108.289 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 30.5 mt-10 -96.48 134.54 39.53 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.461 -1.7 . . . . 1.32 108.628 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.891 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -106.75 111.36 23.85 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.564 -1.273 . . . . 0.96 107.564 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -108.7 94.24 4.95 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 103.403 -2.814 . . . . 1.15 103.403 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.603 HG12 HD23 ' A' ' 57' ' ' LEU . 57.5 mt -120.77 100.89 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.698 1.237 . . . . 0.52 109.214 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 21' ' ' SER . 60.1 p -100.58 165.9 11.18 Favored 'General case' 0 N--CA 1.391 -3.425 0 CA-C-N 114.355 -1.293 . . . . 0.58 109.364 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 50.68 73.5 0.28 Allowed 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 110.848 -2.887 . . . . 2.12 111.722 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -73.71 112.32 9.7 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 113.004 -1.907 . . . . 0.4 110.017 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.863 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 3.4 tp60 -56.38 146.62 52.44 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 1.43 110.029 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.727 ' HD3' HG21 ' A' ' 18' ' ' VAL . 19.9 Cg_endo -61.15 -13.89 30.58 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.554 2.17 . . . . 1.33 112.742 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.863 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -104.4 17.24 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.031 -0.531 . . . . 1.12 110.45 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.6 OUTLIER -95.31 -11.29 28.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.393 -0.813 . . . . 1.24 111.005 -177.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m -17.97 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 125.668 1.855 . . . . 1.22 111.74 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.984 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -56.9 120.51 20.97 Favored Glycine 0 N--CA 1.404 -3.441 0 CA-C-N 110.633 -2.985 . . . . 1.43 114.876 -167.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.691 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -115.5 72.31 0.25 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 112.359 -1.92 . . . . 0.52 108.556 152.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.72 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 56.0 m-85 -77.04 118.38 19.54 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.728 -0.842 . . . . 0.63 108.728 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 29.4 mtp180 -114.38 125.08 53.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.212 -0.662 . . . . 3.15 109.212 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 2.9 t -112.6 117.52 32.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.899 -0.778 . . . . 1.08 108.899 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 36.0 mt-10 -132.4 104.02 6.5 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.179 -0.919 . . . . 1.81 110.115 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.659 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -94.04 142.53 13.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.418 0.628 . . . . 0.54 110.267 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.7 t -134.83 108.18 7.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.914 -1.039 . . . . 1.18 108.337 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -132.35 153.18 51.0 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.958 -1.02 . . . . 0.74 108.649 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.758 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 23.2 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.691 1.87 . . . . 0.65 113.999 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.758 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 16.6 t70 -144.17 -3.78 0.84 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.829 -1.078 . . . . 1.05 109.802 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.957 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.32 135.04 33.92 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.148 -1.056 . . . . 1.29 108.148 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.504 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 31.0 t80 -132.71 131.29 41.09 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.898 -1.501 . . . . 0.77 110.503 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.78 149.98 31.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.635 -1.166 . . . . 1.6 108.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 7.4 p -152.77 154.37 35.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.243 0.544 . . . . 1.19 112.216 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 11.6 p -129.86 150.6 51.09 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.773 0.797 . . . . 0.84 112.06 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -131.31 109.42 10.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.038 -1.437 . . . . 1.58 109.38 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.841 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.8 p90 -142.72 129.71 20.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.374 0.607 . . . . 0.86 109.667 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.5 p30 -101.93 157.96 16.48 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.899 1.333 . . . . 2.11 111.954 -172.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -121.71 109.65 14.99 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.18 -1.827 . . . . 0.37 109.745 171.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 28.9 m -91.23 97.69 11.28 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.187 -0.671 . . . . 0.33 109.187 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.6 p -81.3 116.2 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 123.204 1.478 . . . . 0.33 109.292 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.546 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 94.9 m-70 -88.81 100.26 13.02 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.571 -2.104 . . . . 1.19 109.002 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' A' ' 18' ' ' VAL . 31.4 tt0 -62.02 -64.42 0.94 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.704 -1.135 . . . . 1.67 109.82 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.43 -51.84 2.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 2.78 110.031 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 C--O 1.244 0.778 0 CA-C-N 115.845 -0.616 . . . . 6.92 109.642 178.385 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.808 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.192 0.52 . . . . 1.93 112.251 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.582 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 23.8 m-20 -82.52 174.14 6.51 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-N 115.458 -0.792 . . . . 1.65 110.246 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.84 86.91 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.478 2.118 . . . . 0.97 112.349 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.724 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -116.45 -60.29 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 0.5 109.513 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.69 5.59 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 108.473 -1.851 . . . . 0.39 108.473 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.69 HD11 ' HB3' ' A' ' 37' ' ' PRO . 12.1 tp -53.67 -45.43 70.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.403 -1.899 . . . . 0.33 111.87 -168.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.692 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.82 84.78 3.95 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.562 0.696 . . . . 0.72 109.818 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.48 -40.55 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.152 -1.385 . . . . 0.63 110.686 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.5 ttm -157.57 132.1 8.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.916 -0.584 . . . . 2.88 110.18 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.556 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 13.2 ptp180 -103.67 139.25 19.93 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.046 -0.979 . . . . 3.67 109.865 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.735 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -75.19 165.28 31.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.382 1.388 . . . . 0.64 111.135 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -122.91 -177.63 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.043 -0.526 . . . . 1.43 110.343 -172.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.94 -150.48 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-O 123.076 1.417 . . . . 2.06 111.704 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.97 131.44 1.64 Allowed Glycine 0 C--N 1.291 -1.945 0 CA-C-N 112.762 -2.017 . . . . 0.3 112.063 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -110.54 110.93 21.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.422 -0.955 . . . . 1.53 108.422 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 m -130.58 141.82 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 107.598 -1.26 . . . . 0.27 107.598 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.772 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -77.52 156.88 30.69 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.871 -1.059 . . . . 0.77 109.387 -177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 79' ' ' ALA . 3.9 t -66.38 105.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 CA-C-O 122.767 1.27 . . . . 0.78 107.886 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.0 10.01 Favored Glycine 0 C--N 1.266 -3.318 0 CA-C-N 112.36 -2.2 . . . . 0.48 112.688 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.84 4.94 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 118.668 -1.729 . . . . 0.44 108.92 172.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.9 p -151.43 163.57 38.68 Favored 'General case' 0 N--CA 1.397 -3.124 0 CA-C-N 112.882 -1.659 . . . . 0.82 110.527 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.5 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.4 tp -136.67 146.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.141 -1.845 . . . . 0.32 107.106 171.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -137.91 125.07 21.57 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 113.088 -1.869 . . . . 0.31 110.743 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 75.5 m-85 -123.36 143.24 50.23 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.266 -1.334 . . . . 0.53 109.239 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -131.99 118.73 20.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.277 -0.874 . . . . 0.58 109.79 177.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -117.11 116.15 26.76 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.514 -1.221 . . . . 0.32 110.145 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.27 124.2 49.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.362 -0.211 . . . . 2.43 110.886 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 39' ' ' VAL . 12.1 t -129.56 130.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 122.093 0.949 . . . . 0.26 110.589 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.86 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -63.66 111.54 2.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.25 -1.795 . . . . 0.4 111.589 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.853 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.49 -53.04 17.69 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 114.761 -1.108 . . . . 0.76 111.976 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.701 ' CA ' ' HE3' ' A' ' 68' ' ' LYS . . . 59.96 -174.22 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.666 0.987 . . . . 0.71 113.666 169.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -111.61 128.87 56.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.69 -1.141 . . . . 1.74 108.975 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.35 -179.47 7.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.155 0.503 . . . . 2.16 111.992 -170.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.08 -44.31 80.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.82 -1.082 . . . . 1.47 108.962 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.657 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.59 148.26 23.29 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.909 -1.041 . . . . 1.4 109.547 175.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.64 142.38 13.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.231 2.62 . . . . 0.88 111.507 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.69 ' HB3' HD11 ' A' ' 6' ' ' LEU . 1.8 Cg_endo -49.11 131.9 26.89 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.897 1.731 . . . . 0.53 113.002 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.74 104.97 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 106.922 -1.51 . . . . 0.77 106.922 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 28' ' ' VAL . 2.3 t -108.33 114.08 45.63 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 112.81 -1.996 . . . . 0.28 107.306 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.628 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.91 125.37 48.58 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-O 123.266 1.508 . . . . 1.54 110.132 174.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.902 ' HB3' HD13 ' A' ' 49' ' ' LEU . 55.2 m95 -83.49 157.06 22.54 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 111.39 -2.641 . . . . 0.34 111.555 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 20.3 t80 -135.66 139.55 43.82 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 104.794 -2.299 . . . . 0.62 104.794 168.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.996 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttm -100.63 167.24 10.46 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.424 -2.435 . . . . 2.17 104.424 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.26 -165.51 0.0 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 118.982 2.353 . . . . 1.23 118.982 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.528 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 15.0 mtpt -45.23 -11.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.095 0 O-C-N 118.592 -2.71 . . . . 3.87 116.417 -168.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.412 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 22.7 p-90 -164.18 -2.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.83 1.418 . . . . 2.11 114.83 -175.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.996 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.73 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-O 122.942 1.353 . . . . 1.29 112.173 -163.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 1.5 p-10 -109.66 101.71 10.6 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 112.29 -2.232 . . . . 2.73 112.191 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.034 HD23 HD21 ' A' ' 57' ' ' LEU . 5.1 mp -54.34 -34.89 62.02 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.041 0.756 . . . . 0.44 113.041 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 m -57.28 -21.9 37.82 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.548 0.69 . . . . 1.23 109.668 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.46 ' HB2' ' CD ' ' A' ' 52' ' ' LYS . 22.7 m -98.19 -34.91 10.55 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.982 -1.008 . . . . 1.34 111.707 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.581 ' HB2' HD12 ' A' ' 57' ' ' LEU . 3.0 mmmt -90.92 -36.06 14.36 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.941 -1.027 . . . . 1.4 111.67 -168.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.66 HG13 ' H ' ' A' ' 59' ' ' LEU . 44.3 t -37.54 96.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 125.888 1.675 . . . . 0.37 111.869 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.719 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -153.41 -111.84 0.46 Allowed Glycine 0 C--N 1.298 -1.541 0 CA-C-N 111.546 -2.57 . . . . 0.7 112.742 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -95.73 -27.44 15.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.348 0.87 . . . . 2.75 113.348 -169.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -95.36 -36.45 11.37 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.574 0.702 . . . . 1.33 110.439 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.034 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.69 105.49 11.22 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.14 -1.8 . . . . 1.11 106.14 172.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.719 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -98.56 115.86 29.53 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.658 -1.608 . . . . 0.76 106.658 165.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.66 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -92.05 92.09 8.11 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 103.495 -2.78 . . . . 0.26 103.495 167.019 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.717 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -92.33 164.22 13.59 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 113.896 -1.502 . . . . 2.03 109.502 -173.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -137.26 117.98 14.04 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 111.341 -2.663 . . . . 0.92 109.998 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -101.28 142.52 32.58 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.622 -2.081 . . . . 0.47 106.895 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -137.91 98.58 3.68 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.757 1.265 . . . . 1.39 110.792 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.27 105.72 13.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 113.132 -1.849 . . . . 2.42 109.695 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.56 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -74.83 -29.83 61.18 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.845 -1.071 . . . . 2.46 110.796 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -35.27 80.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.34 -0.845 . . . . 1.15 110.93 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -98.85 -12.38 20.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.641 -0.708 . . . . 1.41 109.839 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.86 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 18.4 tttt 67.22 33.7 5.34 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.745 0.783 . . . . 3.31 109.564 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.24 128.33 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.969 -0.559 . . . . 0.43 109.685 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.853 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 22.5 m-85 -95.71 116.2 28.53 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.586 -2.005 . . . . 1.24 105.586 162.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 25' ' ' SER . 38.0 tp -94.08 104.13 16.17 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.517 -1.29 . . . . 0.52 107.517 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.9 m-85 -83.04 110.66 18.18 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.117 -1.809 . . . . 0.33 106.117 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.2 pt-20 -114.75 122.7 47.21 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.666 -1.606 . . . . 1.32 110.278 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.716 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.4 mt -91.46 131.07 37.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.201 -1.363 . . . . 0.96 108.374 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -117.85 95.47 4.94 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 103.077 -2.934 . . . . 1.15 103.077 167.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.4 mt -121.24 100.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.979 0 CA-C-O 122.902 1.334 . . . . 0.52 108.619 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.1 p -104.43 165.16 11.24 Favored 'General case' 0 N--CA 1.389 -3.519 0 CA-C-N 114.116 -1.402 . . . . 0.58 109.941 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 38.45 75.73 0.07 Allowed 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 110.563 -3.017 . . . . 2.12 111.84 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -68.74 117.77 10.87 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.789 -2.914 . . . . 0.4 111.074 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.858 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 2.2 tp60 -51.27 135.03 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.848 -0.797 . . . . 1.43 108.848 165.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.452 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 19.3 Cg_endo -60.0 -13.49 23.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.932 2.421 . . . . 1.33 112.685 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.858 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -96.6 15.48 21.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.974 -0.557 . . . . 1.12 110.797 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.1 m-30 -95.09 -10.59 30.26 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.972 -0.381 . . . . 1.24 109.972 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.6 m -46.28 98.51 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.829 0 O-C-N 124.606 1.191 . . . . 1.22 108.732 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -169.35 -130.1 1.17 Allowed Glycine 0 C--N 1.266 -3.353 0 CA-C-N 112.698 -2.046 . . . . 1.43 113.145 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.0 118.74 0.9 Allowed Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 119.962 -1.113 . . . . 0.52 112.695 -170.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.703 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.3 m-85 -85.13 134.95 34.16 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.04 -1.58 . . . . 0.63 107.577 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.472 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 63.7 mtt180 -118.99 155.07 32.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.204 0.526 . . . . 3.15 110.6 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.634 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 75.0 m -131.31 132.26 44.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.825 -1.176 . . . . 1.08 107.825 163.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.628 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 35.0 tt0 -134.95 103.33 5.54 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.723 -1.214 . . . . 1.81 107.723 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.6 p -99.6 134.91 37.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.983 0.897 . . . . 0.54 110.835 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -133.46 108.5 8.69 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.794 -1.548 . . . . 1.18 108.864 -176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.642 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -132.09 155.13 48.66 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.376 -0.972 . . . . 0.74 108.376 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.813 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 18.61 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 125.601 1.813 . . . . 0.65 114.882 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.813 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 5.0 t70 -151.81 1.23 0.36 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.748 -1.115 . . . . 1.05 109.668 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.808 ' HE3' ' HB3' ' A' ' 1' ' ' ASP . 2.2 mmtp -98.17 130.05 44.93 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.961 -1.126 . . . . 1.29 107.961 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -131.26 147.17 52.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.991 -1.004 . . . . 0.77 111.189 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -172.13 166.24 6.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.933 -0.765 . . . . 1.6 108.933 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.4 p -155.67 156.76 35.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 1.19 110.461 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.692 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 30.8 p -135.39 147.63 49.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.715 -0.675 . . . . 0.84 111.086 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -127.19 121.92 32.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 1.58 110.066 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.735 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -141.98 116.66 9.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.121 0.486 . . . . 0.86 109.796 -175.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.3 p30 -100.3 146.26 27.14 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 122.418 1.104 . . . . 2.11 111.88 -169.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -116.76 122.91 45.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.219 -1.355 . . . . 0.37 109.349 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -101.58 96.69 7.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.508 -0.923 . . . . 0.33 108.508 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 3.8 p -79.19 114.58 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-O 123.203 1.477 . . . . 0.33 109.711 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.772 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 9.3 m-70 -79.97 99.33 7.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.098 -2.319 . . . . 1.19 109.816 -175.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 18' ' ' VAL . 35.5 tt0 -68.34 -69.42 0.33 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.039 -1.437 . . . . 1.67 109.348 172.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.51 18.1 1.31 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.817 -0.629 . . . . 2.78 112.131 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.497 -0.763 . . . . 6.92 109.858 -179.742 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 121.853 0.835 . . . . 1.93 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' HB2' ' CE ' ' A' ' 94' ' ' LYS . 8.4 m-20 -92.09 168.79 12.19 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.303 -1.317 . . . . 1.65 109.624 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 84.41 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.24 1.96 . . . . 0.97 113.132 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.84 HD11 ' HE2' ' A' ' 94' ' ' LYS . 1.8 mp -110.71 -66.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.11 -0.95 . . . . 0.5 109.187 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.85 37.47 6.06 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 108.573 -1.811 . . . . 0.39 108.573 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.92 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.2 tp -38.57 -51.34 1.62 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.767 -1.716 . . . . 0.33 110.858 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.71 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -85.93 85.57 7.37 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 121.635 0.731 . . . . 0.72 110.537 175.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.92 -33.8 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.09 -1.414 . . . . 0.63 109.553 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.421 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 18.5 ttt -163.69 136.98 5.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.361 -0.836 . . . . 2.88 110.226 174.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.628 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 6.1 ptt180 -116.11 137.57 23.52 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.031 -0.531 . . . . 3.67 110.761 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -71.58 176.66 7.8 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.986 2.457 . . . . 0.64 112.585 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -126.91 177.08 6.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.647 -0.706 . . . . 1.43 110.671 -175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.5 p-10 -71.42 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.602 1.191 . . . . 2.06 111.641 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.06 137.44 2.59 Favored Glycine 0 N--CA 1.426 -2.003 0 CA-C-N 113.821 -1.536 . . . . 0.3 111.807 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.497 ' HG3' ' CD2' ' A' ' 107' ' ' HIS . 27.9 tt0 -113.33 115.14 27.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.094 -1.053 . . . . 1.53 109.497 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -139.46 163.16 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 N-CA-C 107.308 -1.367 . . . . 0.27 107.308 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -93.92 162.02 14.07 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.548 -0.751 . . . . 0.77 109.617 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 81' ' ' PRO . 3.5 t -72.74 105.64 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.458 0 N-CA-C 107.205 -1.405 . . . . 0.78 107.205 172.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.41 3.05 6.23 Favored Glycine 0 C--N 1.263 -3.506 0 CA-C-N 112.685 -2.052 . . . . 0.48 111.472 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.9 -131.92 7.48 Favored Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 118.78 -1.676 . . . . 0.44 109.094 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.747 ' HB3' HG22 ' A' ' 77' ' ' THR . 8.2 p -152.22 168.26 25.93 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 113.016 -1.592 . . . . 0.82 110.872 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.602 HG21 HD13 ' A' ' 104' ' ' LEU . 10.7 tp -147.74 149.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 CA-C-N 113.274 -1.784 . . . . 0.32 107.536 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 m -139.22 127.08 22.13 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-N 113.513 -1.676 . . . . 0.31 111.098 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' HB2' HD23 ' A' ' 74' ' ' LEU . 33.0 m-85 -122.65 148.24 45.5 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.952 -1.476 . . . . 0.53 108.392 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -135.01 122.48 21.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.575 -0.898 . . . . 0.58 108.575 175.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -126.09 126.64 44.53 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.943 -1.026 . . . . 0.32 111.086 -174.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' HB3' HG11 ' A' ' 69' ' ' VAL . 52.0 mtt180 -113.68 123.65 50.42 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.416 -0.356 . . . . 2.43 111.135 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.0 t -122.33 125.13 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.946 0.879 . . . . 0.26 109.837 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -54.91 111.11 0.76 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.505 -1.679 . . . . 0.4 111.094 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.784 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -52.87 -43.06 60.68 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.177 -1.374 . . . . 0.76 111.162 171.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.79 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 49.23 -167.06 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.252 1.204 . . . . 0.71 114.252 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -119.77 123.13 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.062 -1.426 . . . . 1.74 107.527 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.779 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -149.78 178.58 8.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.838 0.681 . . . . 2.16 112.838 -168.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.05 -57.23 4.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.989 -1.005 . . . . 1.47 109.234 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.671 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -129.58 145.54 57.36 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.468 -0.787 . . . . 1.4 109.726 171.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.4 Cg_exo -45.46 138.89 10.15 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 122.78 2.32 . . . . 0.88 110.961 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.779 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.0 Cg_exo -58.82 136.98 77.28 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.443 1.429 . . . . 0.53 111.961 -172.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.04 104.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.369 -1.715 . . . . 0.77 106.369 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -107.25 114.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 113.44 -1.709 . . . . 0.28 107.21 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.609 ' O ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.78 129.39 53.05 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 123.222 1.487 . . . . 1.54 110.078 175.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.07 ' HB3' HD13 ' A' ' 49' ' ' LEU . 87.6 m95 -90.84 141.84 28.39 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.794 -2.457 . . . . 0.34 111.268 171.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.7 t80 -125.82 125.79 43.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.785 -1.931 . . . . 0.62 105.785 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 29.6 ttpt -103.65 108.59 19.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.8 -1.555 . . . . 2.17 106.8 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.562 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -79.77 92.02 1.32 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 115.997 -3.001 . . . . 1.23 113.968 -165.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.719 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 32.9 tttt -106.58 -32.77 7.9 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 104.24 -2.504 . . . . 3.87 104.24 138.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.741 ' HD1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER 157.85 -13.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 110.921 -2.854 . . . . 2.11 111.447 -165.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.741 HG22 ' HD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -94.76 173.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 CA-C-O 122.994 1.378 . . . . 1.29 111.909 -168.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 5.4 m-20 -104.38 155.91 18.38 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.927 -2.397 . . . . 2.73 106.228 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.07 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -84.79 -32.33 23.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 118.325 0.512 . . . . 0.44 111.464 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -20.35 37.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.711 0.767 . . . . 1.23 110.244 -167.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.757 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 26.4 t -92.22 -30.42 15.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.72 -1.127 . . . . 1.34 111.132 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 3.7 mmmt -98.81 -42.08 7.35 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.631 -1.168 . . . . 1.4 112.122 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.788 HG13 ' H ' ' A' ' 59' ' ' LEU . 54.9 t -22.57 95.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.208 1.803 . . . . 0.37 112.987 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.71 -126.61 1.36 Allowed Glycine 0 C--N 1.303 -1.275 0 CA-C-N 112.138 -2.301 . . . . 0.7 113.157 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -84.91 -20.08 31.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.881 0.697 . . . . 2.75 112.881 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.7 p80 -100.72 -37.56 8.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.347 0.594 . . . . 1.33 110.427 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.952 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.89 103.7 10.21 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.03 -1.841 . . . . 1.11 106.03 172.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -95.43 115.22 27.13 Favored 'General case' 0 N--CA 1.409 -2.521 0 N-CA-C 105.809 -1.922 . . . . 0.76 105.809 167.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.809 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.6 OUTLIER -98.94 91.58 5.11 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 103.496 -2.779 . . . . 0.26 103.496 167.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 5.8 t-80 -99.75 164.65 11.95 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.21 -1.814 . . . . 2.03 108.728 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.51 126.37 27.53 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 113.191 -1.822 . . . . 0.92 111.933 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -103.24 148.04 26.3 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 110.996 -2.82 . . . . 0.47 108.24 169.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.0 101.31 3.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.976 0.893 . . . . 1.39 110.987 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.53 109.17 17.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.322 -1.308 . . . . 2.42 111.006 169.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.562 HH11 ' HD2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.64 -31.44 65.13 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.445 -0.798 . . . . 2.46 111.013 177.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -14.93 63.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.759 -0.655 . . . . 1.15 110.431 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -106.8 -20.18 13.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.808 -1.182 . . . . 1.41 107.808 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.79 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER 60.54 40.2 17.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.652 -1.158 . . . . 3.31 109.292 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 27' ' ' ARG . 13.8 t -133.39 143.06 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.242 -0.89 . . . . 0.43 109.776 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.784 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 27.9 m-85 -105.62 113.05 26.38 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.622 -1.622 . . . . 1.24 106.622 163.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 10.1 tp -94.91 105.61 17.54 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 122.261 1.029 . . . . 0.52 108.762 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.1 m-85 -87.88 115.32 25.26 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.001 -1.454 . . . . 0.33 108.275 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -98.55 132.86 43.64 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.045 -1.889 . . . . 1.32 108.353 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.84 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -103.64 115.7 30.97 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.488 -1.301 . . . . 0.96 107.488 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -113.65 95.21 5.22 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.583 -2.377 . . . . 1.15 104.583 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.622 HG12 HD23 ' A' ' 57' ' ' LEU . 63.7 mt -119.55 100.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.928 1.347 . . . . 0.52 110.36 -174.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.747 HG22 ' HB3' ' A' ' 21' ' ' SER . 82.5 p -106.45 135.78 47.36 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.435 -1.711 . . . . 0.58 108.262 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.65 101.47 0.05 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 111.714 -2.493 . . . . 2.12 110.174 -174.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -94.87 124.68 39.06 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 109.72 -3.4 . . . . 0.4 109.402 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.797 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.64 130.94 77.65 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.295 -0.631 . . . . 1.43 109.295 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.752 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.1 Cg_endo -60.74 -10.65 14.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.129 2.553 . . . . 1.33 112.855 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.797 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -113.5 15.4 19.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.046 -0.525 . . . . 1.12 111.41 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.684 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -73.5 -57.55 3.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.417 -0.957 . . . . 1.24 108.417 177.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 26.0 m 42.67 62.07 1.86 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.665 -1.606 . . . . 1.22 106.665 -158.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.683 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -56.53 86.16 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 112.084 -2.326 . . . . 1.43 114.17 -163.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -90.79 83.38 1.3 Allowed Glycine 0 C--N 1.279 -2.62 0 N-CA-C 108.862 -1.695 . . . . 0.52 108.862 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.714 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.2 m-85 -78.07 110.93 13.45 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.997 -1.101 . . . . 0.63 108.751 -176.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -99.91 109.24 21.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.419 -0.956 . . . . 3.15 108.419 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.417 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -97.84 129.58 44.8 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.075 -0.65 . . . . 1.08 109.247 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 53.8 mt-10 -132.15 119.18 20.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.856 -0.611 . . . . 1.81 109.664 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.6 p -106.42 137.31 37.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.738 0.78 . . . . 0.54 110.794 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.1 t -129.93 109.38 10.85 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.351 -1.295 . . . . 1.18 108.313 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.589 HG21 HD12 ' A' ' 33' ' ' LEU . 1.3 m -127.45 174.98 8.57 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.35 -0.841 . . . . 0.74 109.941 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 1.018 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -3.5 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.431 1.707 . . . . 0.65 115.016 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 1.018 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 17.4 t70 -163.93 5.19 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.511 -1.222 . . . . 1.05 109.63 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.92 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -101.83 143.06 32.2 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.733 0.778 . . . . 1.29 109.088 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -131.54 136.47 47.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.165 -1.834 . . . . 0.77 110.815 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 7' ' ' PHE . 4.0 m-20 -155.43 151.73 28.16 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.903 -1.044 . . . . 1.6 109.443 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.5 p -152.32 152.62 32.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.19 111.028 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.71 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 96.0 p -130.03 147.23 51.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.227 0.537 . . . . 0.84 111.941 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -126.43 113.44 16.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.406 -0.815 . . . . 1.58 110.844 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.855 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 3.8 p90 -143.99 129.99 19.52 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.852 -0.53 . . . . 0.86 111.123 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.647 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -112.45 127.21 55.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 122.192 0.996 . . . . 2.11 113.106 -173.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -97.33 107.6 20.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.848 -1.523 . . . . 0.37 109.924 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m -88.85 97.09 10.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.99 -0.745 . . . . 0.33 108.99 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.684 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.7 p -86.95 116.97 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.631 1.205 . . . . 0.33 110.222 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.497 ' CD2' ' HG3' ' A' ' 15' ' ' GLU . 95.7 m-70 -111.57 93.79 4.64 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.739 -1.573 . . . . 1.19 112.138 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.526 ' HB2' HG21 ' A' ' 18' ' ' VAL . 31.0 tt0 -61.82 107.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.937 -0.574 . . . . 1.67 109.898 164.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.26 -78.23 0.33 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.38 -0.6 . . . . 2.78 109.38 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.241 -0.885 . . . . 6.92 109.148 179.038 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.559 ' OD1' ' HG2' ' A' ' 96' ' ' LYS . 9.6 t70 . . . . . 0 CA--C 1.487 -1.458 0 CA-C-O 124.602 2.144 . . . . 1.93 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 4.5 m-20 -106.62 158.62 32.29 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 109.09 -3.686 . . . . 1.65 110.988 -166.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.95 83.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.357 2.038 . . . . 0.97 113.734 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.06 ' HB ' ' HD3' ' A' ' 96' ' ' LYS . 1.8 mp -110.78 -69.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.026 -0.988 . . . . 0.5 109.22 173.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.447 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 92.22 50.15 2.67 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 108.199 -1.96 . . . . 0.39 108.199 -173.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.603 ' N ' HG22 ' A' ' 4' ' ' ILE . 10.1 tp -53.38 -50.29 65.41 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.984 -1.608 . . . . 0.33 110.829 -167.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -86.7 84.46 7.38 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.585 -0.734 . . . . 0.72 109.507 174.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -66.03 -39.96 85.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.342 -1.299 . . . . 0.63 109.664 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 21.7 ttt -141.49 133.95 28.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.165 -0.925 . . . . 2.88 108.651 169.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.658 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 31.7 mtt180 -99.14 127.27 35.32 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.062 -0.517 . . . . 3.67 109.64 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 10.4 Cg_endo -57.79 151.28 57.24 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.735 2.29 . . . . 0.64 111.72 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.461 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 19.3 mm-40 -126.46 169.66 12.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 1.43 111.467 -169.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.8 m-20 -65.62 -147.19 0.01 OUTLIER 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.952 1.358 . . . . 2.06 111.781 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.84 133.6 2.56 Favored Glycine 0 C--N 1.297 -1.6 0 CA-C-N 113.628 -1.623 . . . . 0.3 111.678 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.81 114.86 24.53 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.308 -0.946 . . . . 1.53 108.755 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.711 HG22 HD11 ' A' ' 104' ' ' LEU . 3.0 m -136.63 165.0 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 107.755 -1.202 . . . . 0.27 107.755 -172.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.557 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -88.48 155.52 19.62 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.934 -1.03 . . . . 0.77 110.273 -176.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.664 HG22 HG22 ' A' ' 106' ' ' VAL . 60.0 t -70.41 105.69 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 122.901 1.334 . . . . 0.78 108.253 173.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.01 12.16 Favored Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.412 -2.176 . . . . 0.48 112.367 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.86 -123.05 2.99 Favored Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.113 -1.595 . . . . 0.44 109.113 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.6 p -151.99 169.55 22.06 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 112.84 -1.68 . . . . 0.82 110.553 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -145.31 147.19 18.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 113.763 -1.562 . . . . 0.32 107.256 167.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -137.96 130.26 29.1 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.851 -1.522 . . . . 0.31 110.916 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 62.9 m-85 -126.43 147.63 49.76 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.203 -1.362 . . . . 0.53 110.128 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -136.61 123.72 21.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.953 -1.021 . . . . 0.58 109.248 175.072 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.614 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -119.74 116.31 25.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.745 -1.116 . . . . 0.32 110.185 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 39.3 mtt180 -101.21 122.15 43.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.308 -0.406 . . . . 2.43 110.77 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 39' ' ' VAL . 17.2 t -123.82 128.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 122.168 0.985 . . . . 0.26 110.248 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.99 114.21 2.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.318 -1.765 . . . . 0.4 111.016 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -55.21 -32.69 57.31 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.343 -1.298 . . . . 0.76 111.187 170.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.599 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 56.1 -172.26 0.07 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.791 1.034 . . . . 0.71 113.791 168.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 t -110.0 117.06 32.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 1.74 107.061 164.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.803 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -150.98 166.59 30.22 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.891 0.7 . . . . 2.16 112.891 -162.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -64.23 -64.56 0.85 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.063 -0.971 . . . . 1.47 109.956 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.56 158.33 74.94 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.266 -1.013 . . . . 1.4 108.266 172.132 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 4.5 Cg_endo -45.79 146.8 3.6 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.246 2.631 . . . . 0.88 112.356 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.803 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -62.64 135.65 53.91 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.655 1.57 . . . . 0.53 111.248 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.79 104.56 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.614 0 N-CA-C 106.541 -1.651 . . . . 0.77 106.541 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.643 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -108.75 114.55 47.08 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-N 113.335 -1.757 . . . . 0.28 107.814 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.898 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.89 125.39 50.94 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 123.384 1.564 . . . . 1.54 110.412 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.959 ' HB3' HD13 ' A' ' 49' ' ' LEU . 82.5 m95 -88.78 157.23 18.56 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 111.664 -2.516 . . . . 0.34 112.564 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.9 t80 -136.79 136.09 38.56 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 104.948 -2.241 . . . . 0.62 104.948 166.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.709 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 21.1 tttm -112.4 162.12 15.93 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.617 -1.623 . . . . 2.17 106.617 -173.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 1.029 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -4.35 -167.78 0.0 OUTLIER Glycine 0 C--O 1.191 -2.594 0 N-CA-C 118.692 2.237 . . . . 1.23 118.692 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -44.37 -9.07 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.201 1.926 . . . . 3.87 116.201 -166.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.606 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 30.0 p-90 -167.67 -3.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.012 1.486 . . . . 2.11 115.012 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.606 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -91.13 135.4 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-O 123.496 1.617 . . . . 1.29 112.817 -163.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -104.36 99.33 9.04 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 112.048 -2.342 . . . . 2.73 111.84 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.114 HD23 HD21 ' A' ' 57' ' ' LEU . 4.4 mp -51.93 -38.49 56.6 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.223 1.194 . . . . 0.44 114.223 -169.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 t -57.5 -22.22 42.67 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.345 0.593 . . . . 1.23 109.407 -166.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 m -100.38 -28.81 12.75 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.313 -0.858 . . . . 1.34 113.052 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.536 ' HG3' HG12 ' A' ' 47' ' ' VAL . 6.0 mmmt -90.33 -39.8 12.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.085 -0.507 . . . . 1.4 111.516 -171.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.91 HG13 ' H ' ' A' ' 59' ' ' LEU . 55.1 t -32.34 95.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 126.449 1.899 . . . . 0.37 112.3 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.651 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.82 -103.29 0.21 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 111.707 -2.497 . . . . 0.7 113.898 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -95.22 -33.15 12.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.007 0.743 . . . . 2.75 113.007 -168.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 27.6 p80 -97.88 -36.29 10.22 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.653 0.739 . . . . 1.33 110.822 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.114 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.29 106.14 12.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.39 -1.707 . . . . 1.11 106.39 174.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.87 115.86 30.6 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.517 -1.66 . . . . 0.76 106.517 165.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.91 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -103.04 93.64 5.12 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.307 -2.109 . . . . 0.26 105.307 172.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 43.7 m80 -92.86 160.38 14.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-O 122.902 1.334 . . . . 2.03 109.499 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -129.29 110.79 12.24 Favored 'General case' 0 C--N 1.265 -3.102 0 CA-C-N 111.458 -2.61 . . . . 0.92 108.936 175.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.9 m -92.28 145.38 24.53 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.582 -2.099 . . . . 0.47 107.776 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.441 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.0 t80 -141.26 99.77 3.65 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.07 0.938 . . . . 1.39 111.57 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -116.46 121.73 42.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.125 -1.398 . . . . 2.42 108.811 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.441 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -85.36 -39.07 18.04 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 113.721 -1.581 . . . . 2.46 112.117 -172.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.23 60.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.604 -0.725 . . . . 1.15 111.417 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -95.58 -16.76 21.89 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.283 -1.377 . . . . 1.41 107.283 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.599 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 67.59 31.47 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.864 -1.516 . . . . 3.31 109.789 173.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.45 128.49 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.764 0.793 . . . . 0.43 110.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.558 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 45.8 m-85 -98.47 112.22 24.31 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.143 -1.799 . . . . 1.24 106.143 162.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.4 tp -98.92 106.2 18.44 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.017 0.913 . . . . 0.52 108.61 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 51.4 m-85 -84.46 115.65 22.67 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.303 -1.317 . . . . 0.33 108.001 172.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.2 123.62 47.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.055 -1.43 . . . . 1.32 109.269 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -94.74 118.9 32.49 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.144 -1.428 . . . . 0.96 107.144 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -110.71 95.76 5.76 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 103.556 -2.757 . . . . 1.15 103.556 169.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.699 HD13 ' HE2' ' A' ' 43' ' ' LYS . 13.9 mt -123.55 99.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 123.229 1.49 . . . . 0.52 108.66 -175.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.8 p -107.53 170.07 8.2 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 113.441 -1.709 . . . . 0.58 108.007 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.9 t70 65.52 33.56 8.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.722 -2.036 . . . . 2.12 110.003 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -49.94 112.05 0.61 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.994 -1.912 . . . . 0.4 111.7 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.603 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -70.85 153.7 94.65 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.198 -0.91 . . . . 1.43 109.179 173.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 40.9 Cg_endo -66.9 -3.39 9.46 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.245 1.963 . . . . 1.33 113.189 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.82 17.0 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.265 -0.425 . . . . 1.12 110.331 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.3 m-30 -99.56 0.74 42.87 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.658 -0.497 . . . . 1.24 109.658 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 14.9 m -28.97 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 125.779 1.924 . . . . 1.22 110.579 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.871 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -34.37 106.84 0.03 OUTLIER Glycine 0 N--CA 1.411 -3.015 0 CA-C-N 109.662 -3.426 . . . . 1.43 114.798 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 1.029 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -122.66 65.39 0.51 Allowed Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.33 -1.908 . . . . 0.52 108.33 159.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.709 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 79.0 m-85 -81.48 128.81 34.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.862 -1.169 . . . . 0.63 109.562 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -135.04 104.26 5.88 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.772 -0.825 . . . . 3.15 108.772 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -102.11 129.58 48.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.474 -0.491 . . . . 1.08 110.154 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.898 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 22.0 tt0 -131.64 116.37 17.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.472 -0.785 . . . . 1.81 110.007 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.643 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -106.39 140.53 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.428 0.632 . . . . 0.54 109.957 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.1 t -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.11 -0.95 . . . . 1.18 108.745 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.667 HG21 HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.09 157.46 44.15 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 118.145 -0.931 . . . . 0.74 109.341 -178.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 1.058 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 17.92 -73.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.536 1.772 . . . . 0.65 114.662 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 1.058 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.6 t0 -150.74 1.97 0.44 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.058 -0.974 . . . . 1.05 109.697 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.06 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 14.7 mtpp -103.75 146.21 28.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 122.459 1.123 . . . . 1.29 109.541 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -136.14 140.26 43.53 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.279 -2.237 . . . . 0.77 110.6 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 2.4 m-20 -156.91 149.74 23.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.044 -0.98 . . . . 1.6 109.596 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 p -152.69 149.03 27.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.13 0.49 . . . . 1.19 110.975 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.491 ' HG ' ' HZ ' ' A' ' 7' ' ' PHE . 3.9 p -127.97 149.6 50.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.6 -0.727 . . . . 0.84 112.268 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -132.65 109.55 9.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.409 -1.269 . . . . 1.58 109.23 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.788 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 4.6 p90 -141.37 129.36 21.94 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.823 0.82 . . . . 0.86 110.078 -172.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 15.9 m-80 -105.31 146.22 29.67 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.607 -1.178 . . . . 2.11 111.107 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.871 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -112.83 118.16 34.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.042 -1.435 . . . . 0.37 109.145 173.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 m -95.25 97.51 9.93 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.842 -0.743 . . . . 0.33 109.237 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.664 HG22 HG22 ' A' ' 18' ' ' VAL . 7.2 p -86.59 113.31 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 123.331 1.539 . . . . 0.33 109.397 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 82.2 m-70 -86.15 99.8 11.77 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.295 -2.229 . . . . 1.19 109.354 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 52.7 tt0 -63.45 -74.3 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.321 -0.854 . . . . 1.67 111.114 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.54 129.73 52.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.48 -0.327 . . . . 2.78 110.381 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.434 -0.793 . . . . 6.92 110.305 179.608 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.477 0.656 . . . . 1.93 110.646 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.3 m-20 -101.65 166.71 11.76 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 114.746 -1.116 . . . . 1.65 110.057 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.03 45.95 0.39 Allowed 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.296 2.664 . . . . 0.97 113.915 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -63.15 -58.68 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.643 -0.708 . . . . 0.5 110.096 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.85 53.97 3.2 Favored Glycine 0 CA--C 1.492 -1.376 0 N-CA-C 107.625 -2.19 . . . . 0.39 107.625 -173.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.82 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.2 tp -60.75 -33.62 73.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.978 -1.611 . . . . 0.33 110.201 -165.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.87 84.61 3.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.05 -0.977 . . . . 0.72 109.572 172.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.54 -50.7 64.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.545 -1.207 . . . . 0.63 109.91 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.658 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 16.5 tpt -147.84 131.18 16.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.2 -0.909 . . . . 2.88 108.66 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 34.4 ptt180 -98.65 138.15 20.7 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 116.133 -0.485 . . . . 3.67 111.436 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.774 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 28.1 Cg_endo -68.36 153.99 72.98 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.545 2.163 . . . . 0.64 111.155 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.0 mm-40 -123.17 173.17 8.06 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.119 -0.491 . . . . 1.43 110.514 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.6 p-10 -68.33 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.67 1.224 . . . . 2.06 111.537 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 155.76 138.97 2.66 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 113.736 -1.575 . . . . 0.3 111.156 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 43.0 mt-10 -117.96 116.93 27.91 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.398 -0.964 . . . . 1.53 108.398 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.08 163.73 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.326 -1.361 . . . . 0.27 107.326 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 156.02 16.5 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.962 -1.017 . . . . 0.77 109.304 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.757 HG13 ' HD3' ' A' ' 81' ' ' PRO . 47.5 t -57.93 107.45 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 122.81 1.29 . . . . 0.78 109.825 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.56 12.25 19.57 Favored Glycine 0 C--N 1.274 -2.862 0 CA-C-N 112.029 -2.351 . . . . 0.48 114.07 170.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.8 -122.46 3.46 Favored Glycine 0 CA--C 1.478 -2.256 0 C-N-CA 118.818 -1.658 . . . . 0.44 111.103 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.2 p -151.71 167.91 26.71 Favored 'General case' 0 N--CA 1.403 -2.822 0 CA-C-N 112.474 -1.863 . . . . 0.82 110.408 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 104' ' ' LEU . 10.6 tp -146.29 150.58 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 CA-C-N 112.938 -1.937 . . . . 0.32 107.919 169.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 m -137.5 126.19 23.82 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 113.048 -1.887 . . . . 0.31 110.757 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.675 ' HD2' HD12 ' A' ' 74' ' ' LEU . 37.3 m-85 -122.11 140.99 51.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.033 -1.439 . . . . 0.53 109.408 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.78 119.52 22.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.645 -0.707 . . . . 0.58 109.601 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.774 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -121.33 116.75 25.41 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.507 -1.224 . . . . 0.32 110.691 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.658 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 28.5 mtp180 -105.05 120.04 40.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.072 -0.513 . . . . 2.43 111.142 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.524 HG21 HG21 ' A' ' 39' ' ' VAL . 12.9 t -122.14 132.72 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.707 0.765 . . . . 0.26 109.303 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.87 111.24 1.81 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.71 -1.586 . . . . 0.4 110.7 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -50.89 -35.12 31.27 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 114.675 -1.148 . . . . 0.76 110.295 169.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.63 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.09 -143.98 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.38 -0.91 . . . . 0.71 113.383 166.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.542 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -119.58 154.8 33.37 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.327 -1.36 . . . . 1.74 107.327 170.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.065 HD22 ' HA ' ' A' ' 93' ' ' THR . 3.7 tp 171.0 147.53 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.475 -1.306 . . . . 2.16 107.475 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.803 ' H ' HD12 ' A' ' 33' ' ' LEU . 24.3 tp -44.91 -42.27 7.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.031 0.92 . . . . 1.47 111.169 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.772 ' HD2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.47 -179.67 0.79 Allowed Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.197 -1.365 . . . . 1.4 108.116 175.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 8.1 Cg_exo -67.9 153.69 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.533 1.489 . . . . 0.88 108.888 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.692 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 26.4 Cg_exo -60.38 137.23 73.06 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.013 1.809 . . . . 0.53 111.548 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.27 102.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 106.94 -1.504 . . . . 0.77 106.94 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.677 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -107.59 114.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 CA-C-N 112.839 -1.982 . . . . 0.28 106.947 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.706 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.01 127.95 53.09 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 123.313 1.53 . . . . 1.54 109.22 173.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.039 ' HB3' HD13 ' A' ' 49' ' ' LEU . 69.4 m95 -85.4 154.25 21.97 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 111.448 -2.615 . . . . 0.34 111.111 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.838 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 29.9 t80 -126.22 138.2 53.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.62 105.186 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 71.2 tttt -104.76 165.05 11.33 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.719 -1.956 . . . . 2.17 105.719 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.807 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -9.65 -168.79 0.0 OUTLIER Glycine 0 C--O 1.188 -2.747 0 N-CA-C 119.522 2.569 . . . . 1.23 119.522 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 84' ' ' THR . 19.5 mtpt -45.47 -1.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 O-C-N 119.463 -2.198 . . . . 3.87 116.826 -166.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.695 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 13.8 p-90 -166.03 -10.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.403 1.26 . . . . 2.11 114.403 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.695 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.2 170.06 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-O 123.482 1.611 . . . . 1.29 112.492 -162.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.694 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 7.0 p-10 -112.88 158.13 20.57 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 111.825 -2.443 . . . . 2.73 107.528 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.039 HD13 ' HB3' ' A' ' 41' ' ' TRP . 6.0 mp -98.57 -36.94 9.73 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.142 0.423 . . . . 0.44 112.142 168.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 t -57.69 -20.76 36.23 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.719 0.637 . . . . 1.23 109.661 -162.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.694 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 17.0 m -100.47 -21.24 15.42 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.619 -0.832 . . . . 1.34 112.855 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 1.9 mmmt -94.11 -67.93 0.83 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.425 -0.807 . . . . 1.4 111.132 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.833 HG13 ' H ' ' A' ' 59' ' ' LEU . 78.5 t 12.8 93.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 126.358 1.863 . . . . 0.37 113.593 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.43 -154.49 7.28 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.052 -1.431 . . . . 0.7 110.281 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.45 ' C ' HE22 ' A' ' 58' ' ' GLN . 55.5 mt-30 -63.98 -5.21 4.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.971 1.1 . . . . 2.75 113.971 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -101.83 -41.26 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.768 0.794 . . . . 1.33 110.831 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.019 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.72 104.73 7.36 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.25 -1.759 . . . . 1.11 106.25 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.887 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -95.1 113.75 25.48 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.259 -2.126 . . . . 0.76 105.259 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.833 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -101.74 91.42 4.4 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.065 -2.568 . . . . 0.26 104.065 170.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 45.7 t60 -106.37 162.69 13.47 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.365 -1.289 . . . . 2.03 109.279 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.65 125.56 38.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 112.331 -2.213 . . . . 0.92 110.966 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -98.78 147.54 24.8 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 110.996 -2.82 . . . . 0.47 107.043 169.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.585 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 6.6 t80 -144.25 101.11 3.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.058 0.932 . . . . 1.39 112.312 -168.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 7.7 t70 -117.4 127.63 54.22 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.98 -1.464 . . . . 2.42 109.321 168.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.585 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -86.75 -41.12 14.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.813 -1.54 . . . . 2.46 112.018 -174.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.69 57.93 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.988 -1.005 . . . . 1.15 111.102 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 29.6 t -91.19 -19.4 23.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.542 -1.651 . . . . 1.41 106.542 173.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 1.4 tpmt? 70.69 29.32 3.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.841 -1.527 . . . . 3.31 109.722 173.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.04 127.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.43 111.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.544 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 61.2 m-85 -96.89 113.33 24.86 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.182 -1.784 . . . . 1.24 106.182 162.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 36.0 tp -92.4 103.82 16.22 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.345 -0.983 . . . . 0.52 108.345 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.3 m-85 -85.26 112.73 21.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.386 -1.709 . . . . 0.33 106.386 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 119.92 39.03 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.098 -1.864 . . . . 1.32 109.798 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.703 HD13 HD11 ' A' ' 76' ' ' ILE . 1.6 mt -89.41 130.83 35.71 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 114.116 -1.402 . . . . 0.96 107.984 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.887 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 81.7 m-70 -120.69 95.81 4.87 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 104.114 -2.551 . . . . 1.15 104.114 168.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 74' ' ' LEU . 12.8 mt -119.77 101.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 113.937 -1.483 . . . . 0.52 108.318 -171.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 78.5 p -101.68 166.19 10.82 Favored 'General case' 0 N--CA 1.382 -3.861 0 CA-C-N 113.987 -1.461 . . . . 0.58 109.145 -175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 39.38 78.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 111.362 -2.654 . . . . 2.12 112.579 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -70.77 121.04 17.26 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 111.089 -2.778 . . . . 0.4 110.181 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.613 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -63.07 137.91 97.19 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.49 -0.777 . . . . 1.43 109.874 174.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.757 ' HD3' HG13 ' A' ' 18' ' ' VAL . 16.5 Cg_endo -57.73 -12.86 12.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.283 2.655 . . . . 1.33 113.545 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.512 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.03 21.78 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.339 . . . . 1.12 111.245 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -46.89 8.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.536 -0.466 . . . . 1.24 111.984 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 83.2 m 22.67 79.77 0.01 OUTLIER 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.902 1.334 . . . . 1.22 110.609 -165.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.807 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.1 99.39 0.5 Allowed Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 112.711 -2.041 . . . . 1.43 114.495 -159.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.727 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -86.59 69.49 3.1 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 109.208 -1.557 . . . . 0.52 109.208 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.723 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 77.8 m-85 -78.42 128.11 33.14 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.871 -1.165 . . . . 0.63 108.758 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.838 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -122.56 156.72 33.62 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.082 0.468 . . . . 3.15 110.618 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 72.6 m -130.55 115.8 17.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.197 -0.668 . . . . 1.08 109.197 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.706 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 39.2 mt-10 -125.34 105.24 8.95 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.627 -0.429 . . . . 1.81 109.908 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.8 p -103.62 144.1 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.54 111.009 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.8 t -135.2 109.09 8.11 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.894 -1.048 . . . . 1.18 108.428 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.065 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -131.58 146.78 52.38 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-O 117.55 -1.214 . . . . 0.74 109.353 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.795 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.86 -71.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 125.49 1.744 . . . . 0.65 113.56 -167.202 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.795 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -152.18 3.66 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.159 -1.382 . . . . 1.05 110.443 -172.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.82 ' HB3' HD22 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -94.23 142.73 27.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.027 -1.101 . . . . 1.29 108.027 177.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.48 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 31.3 t80 -133.64 132.84 41.23 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 113.64 -1.618 . . . . 0.77 111.79 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.6 m-20 -151.35 153.05 34.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.063 -0.972 . . . . 1.6 110.4 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 33.4 m -148.54 148.84 30.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.117 0.484 . . . . 1.19 111.737 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.821 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 28.9 t -133.4 150.76 51.79 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.804 0.812 . . . . 0.84 111.947 174.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.45 120.86 18.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.752 -1.567 . . . . 1.58 109.916 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 10.1 p90 -143.48 130.57 20.68 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.939 -0.393 . . . . 0.86 109.939 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.795 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -107.86 128.31 54.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.318 1.056 . . . . 2.11 113.359 -170.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -95.08 109.28 21.36 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.842 -1.526 . . . . 0.37 109.196 176.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.0 m -90.43 96.79 10.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.405 -0.591 . . . . 0.33 109.405 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.613 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.2 p -77.68 113.36 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 122.765 1.269 . . . . 0.33 108.626 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -84.35 97.97 9.77 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.186 -1.825 . . . . 1.19 109.664 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.2 tm-20 -72.79 124.46 25.4 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.491 -1.686 . . . . 1.67 109.339 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.58 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.746 0.654 . . . . 2.78 110.259 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.256 -0.878 . . . . 6.92 109.93 179.032 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.581 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m-20 . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.88 0.848 . . . . 1.93 110.994 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 m-20 -94.35 161.47 29.19 Favored Pre-proline 0 N--CA 1.429 -1.508 0 CA-C-N 113.79 -1.55 . . . . 1.65 109.277 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.83 91.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.38 2.054 . . . . 0.97 112.454 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.722 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -117.8 -64.94 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.335 -0.848 . . . . 0.5 109.174 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 94.11 42.88 3.93 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.208 -1.957 . . . . 0.39 108.208 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.01 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -52.64 -39.75 62.1 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 112.87 -1.665 . . . . 0.33 110.293 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.866 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.9 84.39 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.281 -0.872 . . . . 0.72 109.6 177.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.42 -49.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.343 -1.299 . . . . 0.63 109.388 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.44 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 24.1 ttt -141.6 136.68 31.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.394 -0.821 . . . . 2.88 109.317 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.732 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -110.76 137.99 20.95 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.193 -0.458 . . . . 3.67 110.987 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.67 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 4.0 Cg_endo -71.49 155.47 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.223 1.949 . . . . 0.64 110.718 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.2 mm-40 -120.25 177.25 5.09 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.687 -0.486 . . . . 1.43 109.687 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.0 p-10 -66.67 -141.59 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 122.884 1.326 . . . . 2.06 111.828 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 148.97 133.33 2.22 Favored Glycine 0 C--N 1.291 -1.938 0 CA-C-N 113.586 -1.643 . . . . 0.3 111.716 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 28.6 mt-10 -113.62 111.86 22.56 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.357 -0.979 . . . . 1.53 108.357 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.462 ' CG1' HD13 ' A' ' 22' ' ' ILE . 3.0 m -127.74 163.64 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.862 0 N-CA-C 107.252 -1.388 . . . . 0.27 107.252 -170.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.55 152.89 18.03 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.83 -1.077 . . . . 0.77 109.13 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.866 HG21 ' HB3' ' A' ' 81' ' ' PRO . 3.7 t -66.67 105.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 122.923 1.344 . . . . 0.78 108.123 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.55 5.9 Favored Glycine 0 C--N 1.263 -3.494 0 CA-C-N 111.921 -2.4 . . . . 0.48 111.678 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.83 -127.83 6.16 Favored Glycine 0 N--CA 1.409 -3.16 0 C-N-CA 118.932 -1.604 . . . . 0.44 109.188 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.9 p -152.15 174.35 13.83 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.04 -1.58 . . . . 0.82 110.075 177.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.2 tp -147.58 150.47 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-N 113.703 -1.589 . . . . 0.32 107.505 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.5 m -138.53 124.01 19.51 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 113.222 -1.808 . . . . 0.31 109.943 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.776 ' HD2' HD12 ' A' ' 74' ' ' LEU . 33.1 m-85 -119.96 146.04 46.19 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.404 -1.271 . . . . 0.53 109.015 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.36 120.42 15.59 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.141 -0.936 . . . . 0.58 110.192 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.579 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -120.18 116.22 25.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.478 -1.237 . . . . 0.32 110.613 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.5 mtt180 -103.6 121.93 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.557 -0.292 . . . . 2.43 110.548 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG21 HG21 ' A' ' 39' ' ' VAL . 23.5 t -123.34 129.42 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.032 0.92 . . . . 0.26 110.524 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.78 110.81 2.96 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.36 -1.745 . . . . 0.4 111.529 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.634 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -51.05 -39.26 40.84 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.856 -1.066 . . . . 0.76 112.633 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 58.03 -170.64 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.517 0.727 . . . . 0.71 112.406 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.2 m -73.59 -71.54 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.49 -0.93 . . . . 1.74 108.49 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.938 HD23 HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 69.2 158.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 O-C-N 123.782 0.676 . . . . 2.16 112.378 166.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.903 ' N ' HD22 ' A' ' 33' ' ' LEU . 19.2 tp -80.71 -66.24 0.91 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.906 -0.588 . . . . 1.47 110.879 168.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.766 ' O ' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -122.91 130.12 24.73 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 114.281 1.215 . . . . 1.4 114.281 172.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' N ' HD11 ' A' ' 33' ' ' LEU . 18.4 Cg_exo -34.36 131.66 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.305 3.337 . . . . 0.88 113.171 -171.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.851 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 34.0 Cg_exo -49.02 133.47 28.65 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 122.484 2.122 . . . . 0.53 112.671 -170.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.38 103.6 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.784 -1.562 . . . . 0.77 106.784 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -105.34 113.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.959 -1.928 . . . . 0.28 107.504 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HB2' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -102.04 128.7 48.37 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-O 123.331 1.539 . . . . 1.54 109.006 174.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.054 ' HB3' HD13 ' A' ' 49' ' ' LEU . 57.2 m95 -84.91 153.27 22.96 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 111.829 -2.441 . . . . 0.34 110.867 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 17.8 t80 -122.31 135.81 54.79 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.932 -2.247 . . . . 0.62 104.932 172.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.661 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 76.9 tttt -103.31 166.52 10.38 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.674 -1.602 . . . . 2.17 106.674 -175.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA2' ' CA ' ' A' ' 85' ' ' GLY . . . -8.7 -162.09 0.0 OUTLIER Glycine 0 C--O 1.196 -2.227 0 N-CA-C 118.903 2.321 . . . . 1.23 118.903 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.746 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 39.6 pttt -38.68 -20.42 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.18 1.918 . . . . 3.87 116.18 -163.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.746 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 15.2 p-90 -167.27 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 120.073 1.306 . . . . 2.11 113.395 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -92.55 170.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 123.19 1.471 . . . . 1.29 112.072 -162.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 27.8 t70 -113.35 154.1 27.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 112.345 -2.207 . . . . 2.73 106.797 175.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.054 HD13 ' HB3' ' A' ' 41' ' ' TRP . 6.1 mp -91.29 -39.92 11.79 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 119.008 -0.52 . . . . 0.44 112.057 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.6 t -59.99 -20.14 56.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.813 -0.81 . . . . 1.23 108.813 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -86.67 -28.6 23.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.983 -1.008 . . . . 1.34 111.456 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 11.4 mmmt -100.11 -62.73 1.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.446 -0.797 . . . . 1.4 111.395 -172.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 49' ' ' LEU . 48.3 t 4.48 93.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 O-C-N 125.88 1.987 . . . . 0.37 113.804 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -164.99 -123.99 0.68 Allowed Glycine 0 C--N 1.31 -0.914 0 CA-C-N 113.001 -1.909 . . . . 0.7 113.048 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.36 -38.49 78.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.763 0.425 . . . . 2.75 111.839 -170.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 6.8 t-80 -88.16 -38.64 15.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.75 0.786 . . . . 1.33 111.463 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.0 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.14 105.29 7.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.824 -1.547 . . . . 1.11 106.824 -177.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.8 114.78 27.12 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.063 -1.458 . . . . 0.76 107.063 168.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.661 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.7 92.61 5.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.011 -2.589 . . . . 0.26 104.011 169.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.733 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 8.5 t-160 -100.13 161.38 13.64 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.924 -1.489 . . . . 2.03 109.268 -173.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.02 119.83 26.25 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 111.982 -2.372 . . . . 0.92 110.839 -173.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.794 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.4 m -97.48 146.39 25.29 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 111.826 -2.443 . . . . 0.47 106.75 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.449 ' HD1' ' CD1' ' A' ' 70' ' ' TYR . 28.5 t80 -145.43 96.63 2.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.385 1.088 . . . . 1.39 111.389 -168.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 10.8 m-20 -115.67 101.11 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.235 -1.802 . . . . 2.42 109.084 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -44.78 60.93 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.24 -0.891 . . . . 2.46 111.278 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -19.52 60.68 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.112 -0.949 . . . . 1.15 111.118 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 49.4 m -92.8 -13.12 29.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.376 -1.342 . . . . 1.41 107.376 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 tpmt? 69.6 27.45 4.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.806 -1.543 . . . . 3.31 110.52 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 67' ' ' SER . 5.4 t -131.54 126.72 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.815 0.817 . . . . 0.43 110.549 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.851 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 10.6 m-85 -101.35 109.27 21.09 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.944 -1.502 . . . . 1.24 106.944 165.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.1 tp -92.5 104.49 16.8 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.113 0.959 . . . . 0.52 108.989 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -83.9 113.82 21.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.909 -1.515 . . . . 0.33 106.909 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.733 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.5 pt-20 -117.5 122.94 45.1 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.513 -1.676 . . . . 1.32 110.086 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.776 HD12 ' HD2' ' A' ' 24' ' ' PHE . 2.4 mt -94.23 133.15 38.05 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.108 -1.405 . . . . 0.96 108.935 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 5.6 m170 -115.38 96.66 5.76 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.357 -2.831 . . . . 1.15 103.357 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.675 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.5 mt -124.59 100.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.976 1.37 . . . . 0.52 108.545 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.3 p -105.46 169.3 8.54 Favored 'General case' 0 N--CA 1.394 -3.238 0 CA-C-N 114.323 -1.308 . . . . 0.58 110.102 -172.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 36.71 69.05 0.22 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 111.206 -2.725 . . . . 2.12 111.392 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -57.19 126.26 26.42 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 112.196 -2.274 . . . . 0.4 111.397 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.716 ' O ' HG11 ' A' ' 106' ' ' VAL . 3.3 tp60 -56.05 131.42 74.17 Favored Pre-proline 0 C--O 1.223 -0.34 0 CA-C-N 115.76 -0.655 . . . . 1.43 109.634 172.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.866 ' HB3' HG21 ' A' ' 18' ' ' VAL . 21.9 Cg_endo -61.32 -15.9 43.43 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.982 2.455 . . . . 1.33 113.148 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -108.25 26.63 10.2 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.807 -0.633 . . . . 1.12 110.365 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -81.34 -52.91 6.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.47 -0.492 . . . . 1.24 111.188 -178.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.4 m 21.71 75.48 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 123.427 1.584 . . . . 1.22 109.276 -159.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.659 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.95 114.96 4.56 Favored Glycine 0 N--CA 1.407 -3.254 0 CA-C-N 112.152 -2.294 . . . . 1.43 112.397 -156.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.563 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -98.74 87.81 0.82 Allowed Glycine 0 C--N 1.273 -2.957 0 N-CA-C 109.544 -1.423 . . . . 0.52 109.544 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.737 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 m-85 -85.46 139.62 31.36 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.194 -1.503 . . . . 0.63 107.629 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.704 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 49.0 mtm180 -137.24 155.73 49.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.629 0.252 . . . . 3.15 110.378 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 3.4 m -122.82 120.95 35.05 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.147 -0.686 . . . . 1.08 109.147 173.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -123.41 105.12 9.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.002 -0.74 . . . . 1.81 109.002 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.8 p -101.55 142.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.465 0.65 . . . . 0.54 111.501 -175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 t -132.13 108.11 9.07 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.346 -1.297 . . . . 1.18 108.681 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.938 HG22 HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.36 154.01 51.1 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 117.853 -1.07 . . . . 0.74 108.718 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.735 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.72 -75.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 125.895 1.997 . . . . 0.65 114.391 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.735 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t70 -151.44 3.17 0.42 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.979 -1.01 . . . . 1.05 109.31 -175.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.01 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -96.39 128.47 43.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.378 -0.971 . . . . 1.29 108.378 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -130.57 132.15 45.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.708 -1.133 . . . . 0.77 110.879 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -154.04 153.9 32.75 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.418 -1.265 . . . . 1.6 110.379 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 59.6 m -145.02 152.44 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 1.19 110.749 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.866 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 56.3 p -131.22 148.26 52.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.641 -0.709 . . . . 0.84 109.371 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.704 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 27.9 p-10 -133.84 124.36 26.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.72 0.295 . . . . 1.58 110.329 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 9.6 p90 -143.85 126.4 15.94 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.144 0.497 . . . . 0.86 110.5 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 59.6 m-20 -103.46 136.86 42.42 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.273 1.035 . . . . 2.11 111.047 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -105.64 110.52 22.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.085 -1.416 . . . . 0.37 109.157 177.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.442 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.0 m -94.61 97.22 9.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.006 -0.738 . . . . 0.33 109.006 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.3 p -81.48 119.11 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-O 122.851 1.31 . . . . 0.33 108.883 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -91.4 99.16 12.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.034 -1.894 . . . . 1.19 108.763 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 18' ' ' VAL . 44.1 tt0 -70.01 113.54 7.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.122 -1.399 . . . . 1.67 110.094 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.79 126.78 54.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.754 -0.657 . . . . 2.78 110.087 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.533 -0.746 . . . . 6.92 109.607 -179.672 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.937 0.875 . . . . 1.93 112.569 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.616 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -117.77 147.89 42.02 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.008 -0.996 . . . . 1.65 108.74 179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.417 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -40.7 96.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 125.015 3.81 . . . . 0.97 115.162 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 6' ' ' LEU . 1.4 mp -128.85 -60.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.036 -0.983 . . . . 0.5 109.225 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.12 54.96 2.46 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.635 -1.786 . . . . 0.39 108.635 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -62.97 -32.49 73.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.466 -1.367 . . . . 0.33 111.051 -165.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.12 84.96 3.36 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.746 -0.661 . . . . 0.72 109.813 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.65 -46.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.825 -1.08 . . . . 0.63 109.766 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.59 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 25.1 ttt -140.4 130.51 24.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.408 -0.814 . . . . 2.88 108.943 174.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -102.69 128.6 27.63 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.141 -0.481 . . . . 3.67 110.195 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.683 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 10.8 Cg_endo -62.16 150.98 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.291 1.994 . . . . 0.64 110.675 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.496 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.5 mm-40 -121.96 173.91 7.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.884 -0.598 . . . . 1.43 110.327 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 8.0 p-10 -70.7 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.937 1.351 . . . . 2.06 111.896 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 158.42 130.14 1.15 Allowed Glycine 0 C--N 1.294 -1.755 0 CA-C-N 113.099 -1.864 . . . . 0.3 112.689 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -112.94 107.78 16.47 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.044 -1.078 . . . . 1.53 109.071 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.24 163.52 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 N-CA-C 107.255 -1.387 . . . . 0.27 107.255 -167.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.92 156.74 16.2 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.303 -0.862 . . . . 0.77 109.638 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.662 HG22 HG22 ' A' ' 106' ' ' VAL . 18.1 t -68.51 104.53 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 CA-C-O 122.876 1.322 . . . . 0.78 108.326 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.72 4.85 7.9 Favored Glycine 0 C--N 1.27 -3.087 0 CA-C-N 112.36 -2.2 . . . . 0.48 112.837 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.67 -125.33 5.13 Favored Glycine 0 N--CA 1.415 -2.706 0 N-CA-C 109.674 -1.37 . . . . 0.44 109.674 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 14.5 p -150.36 172.59 15.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 112.847 -1.676 . . . . 0.82 110.38 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.7 tp -148.86 145.66 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 112.896 -1.957 . . . . 0.32 106.988 172.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 m -139.08 129.13 25.18 Favored 'General case' 0 C--N 1.261 -3.278 0 CA-C-N 114.003 -1.453 . . . . 0.31 110.711 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.643 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 38.7 m-85 -127.15 145.2 50.83 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.199 -1.364 . . . . 0.53 110.012 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.11 121.61 22.88 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.432 -0.804 . . . . 0.58 109.251 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.683 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -124.42 117.78 25.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.92 -1.037 . . . . 0.32 110.541 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.7 mtt180 -107.71 118.59 37.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.209 -0.45 . . . . 2.43 110.498 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.54 HG21 HG21 ' A' ' 39' ' ' VAL . 18.5 t -117.92 127.15 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 122.044 0.926 . . . . 0.26 109.695 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.1 0.65 Allowed 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.339 -1.755 . . . . 0.4 111.076 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.697 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -51.32 -50.63 39.96 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.263 -1.335 . . . . 0.76 112.025 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.736 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 48.1 -161.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.558 0.743 . . . . 0.71 112.319 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -127.33 86.07 2.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.633 -0.877 . . . . 1.74 108.633 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.852 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -110.32 -175.83 2.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.206 -0.452 . . . . 2.16 109.914 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.24 -24.51 42.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.337 0.589 . . . . 1.47 111.471 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.852 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -151.83 -179.39 1.01 Allowed Pre-proline 0 C--O 1.212 -0.905 0 CA-C-N 115.133 -0.94 . . . . 1.4 109.148 -173.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 2.9 Cg_exo -73.19 141.98 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 N-CA-C 107.965 -1.59 . . . . 0.88 107.965 165.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 93' ' ' THR . 21.8 Cg_exo -52.34 135.31 53.67 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.087 1.191 . . . . 0.53 111.592 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 35' ' ' LYS . 2.6 t -97.58 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.68 0 N-CA-C 106.586 -1.635 . . . . 0.77 106.586 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.64 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -111.23 114.56 47.44 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.084 0 CA-C-N 113.127 -1.852 . . . . 0.28 107.517 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.836 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.02 129.85 51.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 123.086 1.422 . . . . 1.54 109.816 173.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.052 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.3 m95 -87.87 154.99 20.09 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 111.689 -2.505 . . . . 0.34 111.875 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 30.8 t80 -135.1 138.06 43.42 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 104.578 -2.379 . . . . 0.62 104.578 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.794 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 60.5 tttp -103.98 166.22 10.55 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.983 -2.229 . . . . 2.17 104.983 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.02 -165.31 0.0 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 119.215 2.446 . . . . 1.23 119.215 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.612 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 7.0 mtpp -43.37 -10.44 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 O-C-N 119.489 -2.183 . . . . 3.87 116.574 -166.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.429 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 15.2 p-90 -163.21 -9.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.751 1.389 . . . . 2.11 114.751 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.62 151.5 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 CA-C-O 123.112 1.434 . . . . 1.29 112.336 -160.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.8 t70 -110.48 127.31 55.09 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 111.87 -2.423 . . . . 2.73 108.721 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.052 HD13 ' HB3' ' A' ' 41' ' ' TRP . 3.1 mp -68.23 -34.97 77.22 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.04 -0.527 . . . . 0.44 112.268 -175.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -58.76 -21.76 56.43 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.45 0.643 . . . . 1.23 109.36 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -92.72 -29.57 15.99 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.782 -1.099 . . . . 1.34 111.365 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.76 ' HB2' HD12 ' A' ' 57' ' ' LEU . 11.1 mmmt -98.05 -30.59 12.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.526 -0.761 . . . . 1.4 111.569 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 42.7 t -45.01 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 125.704 1.602 . . . . 0.37 111.264 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.92 -98.23 0.13 Allowed Glycine 0 C--N 1.298 -1.545 0 CA-C-N 112.374 -2.194 . . . . 0.7 113.749 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -91.62 -42.32 10.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.497 . . . . 2.75 112.341 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.5 p80 -95.86 -38.12 10.42 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.073 0.463 . . . . 1.33 110.897 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.935 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.82 105.82 13.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.261 -1.755 . . . . 1.11 106.261 173.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -100.16 115.96 31.06 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 106.757 -1.571 . . . . 0.76 106.757 165.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -97.02 92.27 5.99 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 104.146 -2.538 . . . . 0.26 104.146 170.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.756 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 29.3 m-70 -91.87 162.86 14.25 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 114.361 -1.291 . . . . 2.03 110.106 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.95 115.75 14.75 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.132 -2.304 . . . . 0.92 109.835 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -92.29 147.87 22.58 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.24 -1.8 . . . . 0.47 107.463 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -142.25 98.19 3.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.244 1.021 . . . . 1.39 110.799 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.608 ' OD1' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -114.46 114.6 26.03 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.37 -1.741 . . . . 2.42 111.014 174.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.734 ' HD3' ' HE2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.526 -0.761 . . . . 2.46 110.756 175.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.83 -28.88 70.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.292 -0.867 . . . . 1.15 111.304 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.608 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 15.0 m -100.66 -18.49 16.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.175 -1.046 . . . . 1.41 108.175 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.736 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 64.05 37.33 9.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.277 -1.328 . . . . 3.31 109.736 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.65 139.18 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 115.373 -0.83 . . . . 0.43 109.758 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 70.0 m-85 -102.82 109.08 20.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.383 -1.71 . . . . 1.24 106.383 162.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.3 tp -94.53 104.07 16.02 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.404 1.097 . . . . 0.52 108.806 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.6 m-85 -88.35 113.95 24.47 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.713 -1.585 . . . . 0.33 107.624 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.756 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 8.2 pt-20 -115.0 124.46 51.7 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.877 -1.51 . . . . 1.32 109.877 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.779 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -90.23 120.8 31.69 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.416 -1.72 . . . . 0.96 108.33 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -112.12 95.65 5.59 Favored 'General case' 0 C--N 1.268 -2.947 0 N-CA-C 103.976 -2.602 . . . . 1.15 103.976 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.723 ' HB ' HG23 ' A' ' 22' ' ' ILE . 64.6 mt -120.84 98.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-O 123.26 1.505 . . . . 0.52 109.54 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 21.3 p -112.29 136.31 51.9 Favored 'General case' 0 N--CA 1.393 -3.321 0 CA-C-N 113.213 -1.812 . . . . 0.58 106.96 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER 72.83 100.13 0.07 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 111.684 -2.507 . . . . 2.12 109.017 -171.165 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.98 113.24 26.66 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 110.431 -3.077 . . . . 0.4 109.538 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.676 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -54.32 140.19 55.39 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.438 -0.801 . . . . 1.43 110.252 171.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 21.6 Cg_endo -61.03 -11.59 19.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.142 2.561 . . . . 1.33 112.875 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -97.64 11.14 38.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.124 -0.489 . . . . 1.12 110.687 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.439 ' O ' HD23 ' A' ' 104' ' ' LEU . 2.6 m-30 -97.32 -8.86 28.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 119.449 -0.31 . . . . 1.24 110.636 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 20.5 m -47.95 97.71 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.116 -1.068 . . . . 1.22 108.116 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.612 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -168.53 -129.07 1.05 Allowed Glycine 0 C--N 1.263 -3.508 0 CA-C-N 113.365 -1.743 . . . . 1.43 112.563 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -152.86 119.25 0.94 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 119.95 -1.119 . . . . 0.52 112.369 -171.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.788 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -84.97 114.7 22.35 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 113.496 -1.352 . . . . 0.63 107.541 174.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 45.2 mtm180 -105.49 127.41 52.99 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.909 0.385 . . . . 3.15 110.497 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 t -111.83 123.61 50.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.433 -0.58 . . . . 1.08 109.433 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.836 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 47.5 mt-10 -133.02 115.87 15.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.649 -0.705 . . . . 1.81 110.347 -175.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -107.7 141.46 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.266 0.555 . . . . 0.54 110.977 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 t -134.68 111.52 10.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.069 -0.968 . . . . 1.18 110.215 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.463 ' CG2' HD22 ' A' ' 33' ' ' LEU . 11.1 p -117.27 -177.45 3.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.168 -0.924 . . . . 0.74 111.213 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.986 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -18.04 -48.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 125.682 1.864 . . . . 0.65 113.678 175.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.986 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -167.54 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.837 -1.529 . . . . 1.05 110.723 -173.194 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.646 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -95.76 132.71 40.69 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.079 -1.082 . . . . 1.29 108.079 -177.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -130.99 133.97 46.27 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.269 -1.332 . . . . 0.77 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -152.15 147.32 26.3 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.458 -1.247 . . . . 1.6 109.259 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.7 p -149.64 149.22 30.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.151 0.5 . . . . 1.19 111.578 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.6 p -124.57 148.14 48.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.496 -0.775 . . . . 0.84 111.739 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -128.04 112.8 15.01 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.604 -1.18 . . . . 1.58 109.106 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.767 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 12.9 p90 -141.47 128.11 20.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.41 0.624 . . . . 0.86 109.664 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 7.7 p30 -104.71 140.26 38.32 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.233 1.016 . . . . 2.11 112.59 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -109.37 114.31 27.87 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.423 -1.262 . . . . 0.37 108.329 175.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 m -97.35 96.11 8.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.959 -0.756 . . . . 0.33 108.959 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.662 HG22 HG22 ' A' ' 18' ' ' VAL . 5.1 p -80.08 113.06 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 123.193 1.473 . . . . 0.33 109.252 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 41.1 m170 -82.78 99.04 9.43 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 112.447 -2.161 . . . . 1.19 110.229 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 41.8 tt0 -86.15 -81.54 0.21 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.441 -1.254 . . . . 1.67 108.624 167.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 46.26 71.52 0.29 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.336 0.865 . . . . 2.78 113.336 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.711 -0.662 . . . . 6.92 109.713 177.139 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 m-20 . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 122.063 0.935 . . . . 1.93 110.409 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.635 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 6.2 t70 -102.98 142.97 25.66 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.093 -1.412 . . . . 1.65 108.909 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.443 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 87.3 Cg_exo -47.52 92.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 124.156 3.237 . . . . 0.97 114.959 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.5 mp -119.18 -51.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.924 -1.035 . . . . 0.5 109.264 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.09 41.14 8.2 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.548 -1.821 . . . . 0.39 108.548 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 96' ' ' LYS . 12.4 tp -51.5 -48.18 63.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.757 -1.721 . . . . 0.33 110.927 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.737 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -92.25 84.12 5.16 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.674 0.749 . . . . 0.72 109.643 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.64 -46.49 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.33 -1.305 . . . . 0.63 110.138 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.508 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 18.1 mmt -140.96 130.7 24.22 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.044 -0.526 . . . . 2.88 111.077 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.9 ptp180 -101.24 132.65 21.65 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.123 -0.944 . . . . 3.67 108.877 173.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.784 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 68.6 Cg_endo -78.9 158.01 27.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.244 1.963 . . . . 0.64 110.172 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 12.6 mm100 -118.72 -178.41 3.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 120.348 -0.541 . . . . 1.43 112.003 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.1 p-10 -69.98 -147.97 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 122.684 1.23 . . . . 2.06 111.421 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 155.41 133.38 1.7 Allowed Glycine 0 C--N 1.291 -1.952 0 CA-C-N 113.549 -1.66 . . . . 0.3 112.227 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 36.0 mt-10 -109.96 107.47 17.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.718 -1.241 . . . . 1.53 108.153 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' CG1' HD13 ' A' ' 22' ' ' ILE . 2.8 m -125.79 163.32 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.158 0 N-CA-C 106.779 -1.563 . . . . 0.27 106.779 -171.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.54 155.84 17.08 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.064 -0.971 . . . . 0.77 108.888 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 81' ' ' PRO . 2.9 t -66.64 106.7 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 122.362 1.077 . . . . 0.78 108.56 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 6.64 8.17 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.54 -2.118 . . . . 0.48 111.663 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.86 -124.71 5.19 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.52 -1.432 . . . . 0.44 109.52 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.1 p -151.64 174.62 13.25 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 112.983 -1.609 . . . . 0.82 109.852 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.8 tp -146.14 147.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.481 -1.69 . . . . 0.32 107.119 166.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 m -140.76 130.9 24.81 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.45 -1.704 . . . . 0.31 110.17 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.602 ' HB2' HD23 ' A' ' 74' ' ' LEU . 23.7 m-85 -125.56 144.47 50.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.268 -1.333 . . . . 0.53 108.855 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.12 117.9 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.15 -0.932 . . . . 0.58 110.313 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.9 116.99 22.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 113.947 -1.479 . . . . 0.32 111.428 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 79.3 mtt-85 -104.88 127.68 52.8 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.09 -0.244 . . . . 2.43 110.775 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.3 t -126.66 126.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.084 0.945 . . . . 0.26 110.223 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -58.54 112.2 1.52 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.607 -1.633 . . . . 0.4 112.596 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.81 -57.37 12.69 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-N 114.441 -1.254 . . . . 0.76 112.086 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.848 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.29 177.29 0.24 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.37 1.248 . . . . 0.71 114.37 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -103.36 22.07 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.535 -1.211 . . . . 1.74 109.842 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.957 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -52.18 171.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.617 -1.174 . . . . 2.16 112.666 175.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.31 -51.42 54.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.275 0.56 . . . . 1.47 110.12 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -150.39 157.49 36.78 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.207 -1.035 . . . . 1.4 108.207 168.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.12 143.99 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.337 2.692 . . . . 0.88 112.798 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.957 ' HD3' HD11 ' A' ' 33' ' ' LEU . 15.0 Cg_exo -50.1 143.13 25.95 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.53 113.021 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.22 104.54 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.108 -2.182 . . . . 0.77 105.108 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.609 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -113.09 114.88 48.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.995 -1.457 . . . . 0.28 107.799 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.914 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.11 131.6 51.22 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.161 -1.382 . . . . 1.54 109.418 173.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.067 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.8 m95 -91.92 149.32 21.62 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.221 -2.263 . . . . 0.34 112.099 172.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.728 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 28.0 t80 -130.59 138.33 50.08 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.671 -2.344 . . . . 0.62 104.671 170.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.904 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 83.1 tttt -98.41 174.07 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.375 -1.713 . . . . 2.17 106.375 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -18.84 -169.64 0.0 OUTLIER Glycine 0 C--O 1.179 -3.299 0 C-N-CA 125.991 1.758 . . . . 1.23 117.282 166.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 6.7 mtpp -41.34 -14.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.846 2.536 . . . . 3.87 117.846 -160.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' GLY . 26.5 p-90 -162.46 -6.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.639 1.563 . . . . 2.11 114.891 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.904 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.97 143.74 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-O 122.827 1.299 . . . . 1.29 111.791 -163.031 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -105.89 107.1 17.92 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 112.181 -2.281 . . . . 2.73 109.9 175.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.067 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.0 mp -54.65 -42.87 71.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 112.628 0.603 . . . . 0.44 112.628 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -61.48 -19.07 61.63 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.649 -0.871 . . . . 1.23 108.649 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -86.88 -27.25 23.53 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.023 -0.989 . . . . 1.34 110.956 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 12.1 mmmt -102.9 -64.32 1.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.948 . . . . 1.4 111.847 -171.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 49' ' ' LEU . 49.3 t 3.72 92.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.743 2.017 . . . . 0.37 113.802 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -157.42 -130.17 1.19 Allowed Glycine 0 CA--C 1.525 0.676 0 CA-C-N 112.803 -1.999 . . . . 0.7 112.597 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.26 -38.11 89.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.549 0.944 . . . . 2.75 113.549 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 28.2 p80 -91.21 -31.52 16.13 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.776 0.798 . . . . 1.33 111.669 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.009 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.89 105.39 7.09 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.955 -1.498 . . . . 1.11 106.955 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -97.2 114.75 26.5 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 106.364 -1.717 . . . . 0.76 106.364 166.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.63 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.64 92.54 4.68 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.259 -2.497 . . . . 0.26 104.259 170.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 88.7 m-70 -97.35 160.54 14.27 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 115.009 -0.996 . . . . 2.03 109.348 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.88 112.13 12.18 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.768 -2.015 . . . . 0.92 109.537 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 71' ' ' LEU . 1.3 m -106.51 151.1 25.42 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 112.47 -2.15 . . . . 0.47 107.156 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 17.2 p90 -144.32 115.64 8.02 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-O 122.01 0.909 . . . . 1.39 111.196 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -94.95 96.23 9.16 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.285 -1.325 . . . . 2.42 107.957 169.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -71.78 -30.5 65.63 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.699 -1.591 . . . . 2.46 111.674 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.22 73.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.487 -0.779 . . . . 1.15 110.234 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.441 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 m -89.62 -12.13 40.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.337 -0.847 . . . . 1.41 109.057 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.848 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 1.7 ttpm? 66.03 35.28 6.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.519 -1.219 . . . . 3.31 109.743 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.604 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.7 t -125.81 136.85 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.455 0.645 . . . . 0.43 110.899 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.39 123.19 43.45 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.904 -1.517 . . . . 1.24 106.904 158.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 62' ' ' SER . 18.0 tp -105.95 104.63 14.38 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.793 -1.094 . . . . 0.52 108.114 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.2 m-85 -85.71 115.59 23.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.806 -1.543 . . . . 0.33 107.663 173.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.11 121.8 45.21 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.96 -1.473 . . . . 1.32 109.503 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.832 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.104 -1.407 . . . . 0.96 108.356 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 70.8 m80 -110.01 95.05 5.34 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 104.811 -2.292 . . . . 1.15 104.811 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.74 HD13 ' HE2' ' A' ' 87' ' ' TYR . 63.9 mt -121.51 99.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 122.825 1.297 . . . . 0.52 109.353 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.4 p -104.11 168.73 8.92 Favored 'General case' 0 N--CA 1.394 -3.266 0 CA-C-N 114.359 -1.292 . . . . 0.58 110.569 -173.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 39.33 67.89 0.41 Allowed 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 110.473 -3.058 . . . . 2.12 111.461 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -58.51 116.43 3.65 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 112.445 -2.162 . . . . 0.4 110.547 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.722 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -54.94 139.4 63.09 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.31 -0.859 . . . . 1.43 109.778 171.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.741 ' HG3' HG21 ' A' ' 18' ' ' VAL . 24.0 Cg_exo -61.23 -12.49 23.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.56 2.173 . . . . 1.33 112.863 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.525 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -103.15 14.34 31.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 1.12 110.795 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -89.73 -15.28 32.86 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.762 -0.637 . . . . 1.24 111.182 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.1 m -41.07 87.97 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 124.947 1.405 . . . . 1.22 111.211 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -157.51 -137.98 2.4 Favored Glycine 0 C--N 1.28 -2.544 0 CA-C-N 113.098 -1.864 . . . . 1.43 112.835 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.11 119.22 0.91 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.974 -1.584 . . . . 0.52 113.418 -167.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.83 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.8 m-85 -82.66 114.42 21.01 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 112.952 -1.624 . . . . 0.63 108.47 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 11.0 mmm180 -103.98 104.52 14.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.455 -0.339 . . . . 3.15 110.181 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.678 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 3.8 t -94.94 123.62 38.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.14 -0.689 . . . . 1.08 109.14 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.914 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 66.1 mt-10 -136.67 107.79 6.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.135 -0.939 . . . . 1.81 110.271 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -99.78 141.6 16.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.533 0.682 . . . . 0.54 110.388 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -141.24 109.29 5.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.821 -1.081 . . . . 1.18 108.623 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.706 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -134.5 150.65 50.81 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 117.885 -1.055 . . . . 0.74 109.477 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.886 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 29.54 -73.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.673 1.858 . . . . 0.65 114.693 177.06 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.886 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 11.1 t0 -152.13 -4.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.492 -1.231 . . . . 1.05 110.056 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.761 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -92.27 125.72 37.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.765 -1.198 . . . . 1.29 107.765 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -129.56 140.92 51.09 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.109 -0.95 . . . . 0.77 110.974 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -168.46 156.92 8.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.354 -0.839 . . . . 1.6 109.769 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 m -150.32 145.23 26.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.276 0.56 . . . . 1.19 110.098 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.845 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 26.8 p -125.2 134.71 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.616 -0.72 . . . . 0.84 110.668 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.2 117.46 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.484 0.659 . . . . 1.58 110.97 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.845 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -141.0 124.83 17.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.643 -0.708 . . . . 0.86 109.658 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.599 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 78.8 m-20 -100.16 153.22 19.42 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 122.31 1.052 . . . . 2.11 111.553 -170.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -117.02 115.37 25.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.531 -1.213 . . . . 0.37 107.943 173.465 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.514 ' HA ' HG23 ' A' ' 84' ' ' THR . 7.5 m -100.64 95.9 6.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.399 -0.963 . . . . 0.33 108.399 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.722 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.61 117.18 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.254 1.502 . . . . 0.33 108.942 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.447 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 33.4 m170 -87.72 100.17 12.63 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.47 -2.15 . . . . 1.19 108.442 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 49.0 tt0 -69.44 113.84 7.12 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.852 -1.067 . . . . 1.67 110.275 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.39 103.32 14.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 2.78 109.972 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 C--O 1.249 1.076 0 N-CA-C 109.266 -0.642 . . . . 6.92 109.266 179.31 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.471 0.653 . . . . 1.93 109.977 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.646 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 7.1 m-20 -102.05 174.14 3.08 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.153 -0.93 . . . . 1.65 110.371 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 60.2 Cg_endo -73.29 36.32 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.649 2.233 . . . . 0.97 113.791 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.79 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -57.6 -60.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.091 -0.959 . . . . 0.5 109.904 170.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 88.7 45.86 4.75 Favored Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 109.248 -1.541 . . . . 0.39 109.248 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.985 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.1 tp -46.59 -43.86 17.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.288 -1.456 . . . . 0.33 110.502 -173.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.74 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.34 84.85 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.998 0.904 . . . . 0.72 110.483 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.51 -47.3 52.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.03 -1.441 . . . . 0.63 109.612 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.539 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 16.6 tpt -152.7 133.21 13.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.372 -0.831 . . . . 2.88 109.087 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.611 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -101.09 136.51 19.7 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.771 -0.649 . . . . 3.67 110.637 -177.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.761 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.6 Cg_endo -63.41 155.29 63.17 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.2 1.934 . . . . 0.64 111.057 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.406 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.8 mm-40 -119.96 174.31 6.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.124 -0.489 . . . . 1.43 110.735 -174.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.4 p-10 -68.49 -142.66 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 122.738 1.256 . . . . 2.06 111.807 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 146.55 137.4 3.02 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.317 -1.765 . . . . 0.3 111.811 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 40.9 mt-10 -109.71 116.08 31.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.337 -0.932 . . . . 1.53 108.529 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -138.29 153.78 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.727 -1.212 . . . . 0.27 107.727 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -84.14 156.4 22.13 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.687 -1.142 . . . . 0.77 109.474 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.753 HG11 ' HD3' ' A' ' 81' ' ' PRO . 9.1 t -68.9 105.63 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 123.313 1.53 . . . . 0.78 107.629 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.39 15.2 7.16 Favored Glycine 0 C--N 1.264 -3.437 0 CA-C-N 111.926 -2.397 . . . . 0.48 112.342 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.58 -123.18 4.59 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.179 -1.486 . . . . 0.44 109.477 167.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 58.6 m -154.47 173.23 16.55 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 113.087 -1.556 . . . . 0.82 108.646 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.64 HG21 HD13 ' A' ' 104' ' ' LEU . 10.3 tp -149.11 150.58 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 N-CA-C 107.127 -1.434 . . . . 0.32 107.127 167.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.431 ' N ' HG13 ' A' ' 22' ' ' ILE . 8.6 m -137.7 123.86 20.42 Favored 'General case' 0 C--N 1.262 -3.238 0 CA-C-N 113.636 -1.62 . . . . 0.31 110.336 -177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 36.7 m-85 -117.84 147.83 42.69 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.906 -1.497 . . . . 0.53 108.38 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -140.23 122.24 15.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.272 -0.876 . . . . 0.58 109.574 176.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -116.35 115.84 26.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.873 -1.058 . . . . 0.32 109.903 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -102.74 111.6 24.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.247 -0.433 . . . . 2.43 110.283 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 91' ' ' VAL . 19.0 t -115.53 126.62 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-O 121.988 0.899 . . . . 0.26 110.185 -178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 104.33 1.04 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.564 -1.653 . . . . 0.4 110.378 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.783 ' HA3' ' NZ ' ' A' ' 68' ' ' LYS . . . -51.94 -66.95 2.27 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.163 -1.38 . . . . 0.76 112.031 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.758 ' H ' ' HB3' ' A' ' 68' ' ' LYS . . . 60.34 -167.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.762 0.825 . . . . 0.71 111.96 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -106.57 144.12 33.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 1.74 109.833 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.39 -172.14 3.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.44 0.638 . . . . 2.16 112.465 -169.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.41 -44.36 17.64 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 1.47 108.895 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.592 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 1.3 pptp? -142.36 142.39 23.66 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.321 -0.854 . . . . 1.4 108.855 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.91 146.46 4.08 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.183 2.588 . . . . 0.88 112.43 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_endo -54.9 128.4 30.33 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 120.952 1.101 . . . . 0.53 111.877 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.84 103.96 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 106.774 -1.565 . . . . 0.77 106.774 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.8 t -105.83 114.51 45.4 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 113.56 -1.654 . . . . 0.28 107.436 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.59 128.87 54.91 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-O 123.221 1.486 . . . . 1.54 109.81 176.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.023 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -90.31 152.53 20.99 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 112.138 -2.301 . . . . 0.34 111.96 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 32.8 t80 -128.02 130.75 48.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.556 -2.016 . . . . 0.62 105.556 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 tttm -107.85 102.31 11.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.878 -1.156 . . . . 2.17 107.878 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -90.9 100.11 2.65 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 116.632 -2.699 . . . . 1.23 116.88 -161.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.4 pttm -102.6 -41.18 6.34 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 103.925 -2.621 . . . . 3.87 103.925 123.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.639 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.8 p-90 -171.09 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 112.667 -2.06 . . . . 2.11 112.48 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.92 173.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-O 123.28 1.514 . . . . 1.29 112.614 -163.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.613 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.1 p-10 -96.57 161.29 13.96 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.413 -2.63 . . . . 2.73 106.887 170.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.023 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -97.43 -31.36 12.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 119.02 -0.514 . . . . 0.44 112.0 167.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -56.89 -21.8 32.36 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 123.585 0.553 . . . . 1.23 109.733 -161.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.604 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -100.79 -26.43 13.78 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.384 -0.926 . . . . 1.34 112.116 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.615 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.76 -27.12 14.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.496 -1.229 . . . . 1.4 111.537 -167.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.974 HG13 ' H ' ' A' ' 59' ' ' LEU . 74.6 t -37.18 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.53 1.532 . . . . 0.37 110.953 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.05 -105.14 0.23 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 112.803 -1.999 . . . . 0.7 114.015 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -83.95 -45.01 13.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.206 0.447 . . . . 2.75 112.206 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.566 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 57.3 p-80 -91.44 -36.83 13.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.653 . . . . 1.33 111.14 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.977 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.58 106.71 12.03 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.051 -1.463 . . . . 1.11 107.051 176.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -96.98 114.41 26.02 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 106.811 -1.551 . . . . 0.76 106.811 164.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.974 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.9 92.3 4.52 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 104.687 -2.338 . . . . 0.26 104.687 170.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.64 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 17.9 m80 -100.34 163.83 12.21 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.463 1.125 . . . . 2.03 109.473 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.84 112.92 12.89 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 112.113 -2.312 . . . . 0.92 109.817 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 4.7 m -94.95 150.03 20.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.729 -2.032 . . . . 0.47 108.289 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -144.38 107.76 4.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.354 1.073 . . . . 1.39 111.323 -170.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.11 122.54 47.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.887 -1.96 . . . . 2.42 108.913 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.65 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -79.35 -29.59 42.28 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.349 -1.296 . . . . 2.46 111.66 -177.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.31 33.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.072 -0.513 . . . . 1.15 110.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 69' ' ' VAL . 25.7 m -124.48 4.15 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.75 -0.659 . . . . 1.41 111.245 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.783 ' NZ ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.81 7.8 3.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.611 0.764 . . . . 3.31 112.318 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 67' ' ' SER . 46.0 t -76.18 117.67 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 CA-C-O 122.407 1.099 . . . . 0.43 110.223 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' A' ' 37' ' ' PRO . 81.4 m-85 -90.07 100.51 13.32 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.663 -2.062 . . . . 1.24 106.312 165.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.9 tp -93.25 103.56 15.8 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.523 1.154 . . . . 0.52 108.026 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.0 m-85 -81.78 113.91 20.06 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 113.321 -1.763 . . . . 0.33 107.716 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.434 ' CG ' ' HG ' ' A' ' 71' ' ' LEU . 51.7 mt-10 -107.32 121.21 44.12 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.328 -1.76 . . . . 1.32 109.037 -175.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.724 HD21 ' CH2' ' A' ' 41' ' ' TRP . 1.4 mm? -98.45 117.02 31.94 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 112.936 -1.938 . . . . 0.96 108.079 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -110.96 95.23 5.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 105.175 -2.157 . . . . 1.15 105.175 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.644 HG12 HD23 ' A' ' 57' ' ' LEU . 54.5 mt -121.53 99.5 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 113.842 -1.526 . . . . 0.52 106.923 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 35.8 p -106.19 167.08 10.05 Favored 'General case' 0 N--CA 1.394 -3.271 0 CA-C-N 114.197 -1.365 . . . . 0.58 109.778 -171.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 40.51 59.35 2.13 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 111.544 -2.571 . . . . 2.12 111.34 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -51.0 123.35 9.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.405 -1.725 . . . . 0.4 109.509 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.564 ' HA ' HG13 ' A' ' 18' ' ' VAL . 1.7 pt20 -78.54 156.13 78.34 Favored Pre-proline 0 C--N 1.311 -1.076 0 N-CA-C 108.033 -1.099 . . . . 1.43 108.033 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.753 ' HD3' HG11 ' A' ' 18' ' ' VAL . 50.8 Cg_endo -68.75 162.72 40.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.005 1.137 . . . . 1.33 109.975 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . 70.74 14.43 7.09 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.616 0.572 . . . . 1.12 111.705 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -80.45 -54.92 5.25 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.303 -0.999 . . . . 1.24 108.303 168.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.2 m 36.6 57.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.429 -1.323 . . . . 1.22 107.429 -160.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.672 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -48.73 85.17 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.004 0 CA-C-N 111.56 -2.563 . . . . 1.43 114.788 -161.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.487 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -90.79 78.29 1.44 Allowed Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 108.957 -1.657 . . . . 0.52 108.957 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.687 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 49.0 m-85 -80.71 122.76 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.769 -1.567 . . . . 0.63 106.769 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -115.53 107.64 15.42 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.472 -0.491 . . . . 3.15 109.677 -171.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -92.06 131.37 37.39 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.766 -0.652 . . . . 1.08 109.7 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.947 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 44.4 tt0 -139.77 110.63 6.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.407 -0.815 . . . . 1.81 109.5 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 p -102.0 137.82 28.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.656 0.741 . . . . 0.54 110.534 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.7 t -132.1 108.76 9.51 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.636 -1.165 . . . . 1.18 108.732 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.523 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.2 m -123.47 167.34 14.0 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.031 -1.1 . . . . 0.74 108.031 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.938 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -4.6 -61.26 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 125.316 1.635 . . . . 0.65 114.926 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.938 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -147.76 -10.75 0.4 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.035 -0.984 . . . . 1.05 111.211 -174.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.985 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.2 tttp -94.31 134.89 36.33 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 119.133 -1.027 . . . . 1.29 108.23 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.16 135.47 46.39 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 0.77 110.846 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -155.6 147.84 23.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.141 -0.936 . . . . 1.6 109.925 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.461 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 33.2 m -141.94 150.68 41.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.535 0.207 . . . . 1.19 110.674 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.74 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 78.4 p -134.86 132.62 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.427 . . . . 0.84 111.279 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 122.56 47.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.646 -0.707 . . . . 1.58 110.676 176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.779 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 5.0 p90 -142.63 129.48 20.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 0.86 109.416 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 71.7 m-20 -108.7 135.27 50.21 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.417 1.103 . . . . 2.11 111.783 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.49 105.51 15.78 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.102 -1.408 . . . . 0.37 110.448 178.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.446 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 10.4 m -84.12 97.34 9.29 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.732 -0.84 . . . . 0.33 108.732 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 18' ' ' VAL . 7.6 p -84.94 115.53 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 123.236 1.494 . . . . 0.33 110.087 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 78.1 m-70 -88.79 100.68 13.34 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.368 -2.196 . . . . 1.19 109.394 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.616 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.7 tt0 -56.2 -52.29 64.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.208 -1.36 . . . . 1.67 110.594 174.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.22 -30.22 0.18 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.788 -0.642 . . . . 2.78 110.056 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.315 -0.857 . . . . 6.92 109.118 179.574 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.978 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.854 0.835 . . . . 1.93 110.282 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.566 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -104.97 145.49 30.83 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.029 -1.441 . . . . 1.65 108.435 -178.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -41.34 94.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 124.656 3.571 . . . . 0.97 114.809 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 6' ' ' LEU . 1.3 mp -126.25 -61.1 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.031 -0.986 . . . . 0.5 109.58 172.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 91.11 52.81 2.31 Favored Glycine 0 CA--C 1.496 -1.142 0 N-CA-C 108.685 -1.766 . . . . 0.39 108.685 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.041 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.3 tp -59.77 -40.71 89.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.225 -1.487 . . . . 0.33 110.191 -169.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.51 5.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.99 -1.005 . . . . 0.72 109.881 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.82 -47.25 33.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.419 -1.264 . . . . 0.63 109.641 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.551 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 17.2 tpt -147.48 129.96 15.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.199 -0.909 . . . . 2.88 109.398 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -106.78 132.46 20.89 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.549 -0.75 . . . . 3.67 110.398 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.682 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 17.4 Cg_endo -66.53 153.59 77.42 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.369 2.046 . . . . 0.64 111.372 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.433 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.5 mm-40 -121.14 176.93 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.228 -0.442 . . . . 1.43 110.327 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.5 p30 -68.03 -148.56 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.384 0 CA-C-O 122.776 1.275 . . . . 2.06 111.237 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 153.4 138.74 2.73 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 113.44 -1.709 . . . . 0.3 111.745 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 29.2 mt-10 -117.47 113.09 21.53 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.297 -0.951 . . . . 1.53 109.029 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 104' ' ' LEU . 2.5 m -132.82 163.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.929 -1.508 . . . . 0.27 106.929 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -94.32 157.74 15.9 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.538 -0.755 . . . . 0.77 109.836 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 106' ' ' VAL . 2.9 t -67.89 106.35 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 107.679 -1.23 . . . . 0.78 107.679 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.46 7.57 8.95 Favored Glycine 0 C--N 1.263 -3.507 0 CA-C-N 112.657 -2.065 . . . . 0.48 112.194 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.51 -125.04 5.02 Favored Glycine 0 N--CA 1.409 -3.154 0 C-N-CA 119.181 -1.485 . . . . 0.44 109.714 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.2 p -152.74 167.87 27.54 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.127 -1.537 . . . . 0.82 110.372 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 76' ' ' ILE . 10.4 tp -147.62 149.67 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-N 113.637 -1.619 . . . . 0.32 107.652 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -139.3 127.24 22.24 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 113.711 -1.586 . . . . 0.31 110.344 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 76' ' ' ILE . 42.0 m-85 -123.71 147.18 47.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.516 -1.22 . . . . 0.53 108.812 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.19 122.59 19.49 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.179 -0.919 . . . . 0.58 109.671 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.676 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -119.03 115.64 24.74 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.593 -1.185 . . . . 0.32 110.226 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -106.71 117.62 34.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.043 -0.526 . . . . 2.43 110.394 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 39' ' ' VAL . 6.3 t -122.27 128.93 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.208 1.004 . . . . 0.26 110.739 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -60.0 110.04 1.1 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.128 -1.851 . . . . 0.4 112.352 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.18 81.43 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 114.897 -1.047 . . . . 0.76 112.463 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.863 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 58.3 -179.07 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.522 1.304 . . . . 0.71 114.522 168.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -101.11 23.81 10.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.525 -1.216 . . . . 1.74 109.809 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.034 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -57.05 175.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.52 -1.218 . . . . 2.16 113.855 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.2 tp -64.73 -56.83 11.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.315 -0.857 . . . . 1.47 109.773 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.709 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.76 143.26 48.63 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.93 -1.032 . . . . 1.4 108.642 176.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.18 140.25 11.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.606 2.204 . . . . 0.88 110.638 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.034 ' HD3' HD11 ' A' ' 33' ' ' LEU . 1.6 Cg_endo -58.94 135.29 65.73 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.325 0.683 . . . . 0.53 112.121 -171.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 92' ' ' SER . 14.1 p -99.71 104.81 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-O 123.724 1.726 . . . . 0.77 107.97 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 28' ' ' VAL . 2.1 t -105.67 114.82 46.07 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 111.892 -2.413 . . . . 0.28 107.592 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.798 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.03 126.1 47.69 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 122.939 1.352 . . . . 1.54 109.051 174.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.952 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.0 m95 -84.46 152.54 23.92 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 112.308 -2.224 . . . . 0.34 112.112 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -129.31 139.61 51.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.378 -2.452 . . . . 0.62 104.378 172.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 38.3 tttt -107.13 165.03 11.66 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.399 -1.334 . . . . 2.17 107.399 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 1.032 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -7.63 -165.43 0.0 OUTLIER Glycine 0 C--O 1.197 -2.184 0 N-CA-C 118.963 2.345 . . . . 1.23 118.963 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG3' ' HB ' ' A' ' 84' ' ' THR . 10.5 mtpp -43.06 -3.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.249 1.944 . . . . 3.87 116.249 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.585 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 20.6 p-90 -172.12 -13.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.287 1.588 . . . . 2.11 115.287 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.02 169.09 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 123.297 1.522 . . . . 1.29 112.344 -160.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.51 154.7 23.3 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.1 -2.318 . . . . 2.73 107.942 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.8 mp -94.4 -32.61 13.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.936 0.717 . . . . 0.44 112.936 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -58.05 -25.58 61.38 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.301 0.572 . . . . 1.23 109.5 -164.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -104.13 -41.57 5.78 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.299 -0.864 . . . . 1.34 113.069 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 5.9 mptt -67.02 -52.39 43.07 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.011 -0.995 . . . . 1.4 111.864 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.961 HG13 ' H ' ' A' ' 59' ' ' LEU . 11.9 t -23.85 100.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 111.38 -2.645 . . . . 0.37 113.512 175.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -166.11 -129.72 1.08 Allowed Glycine 0 C--N 1.299 -1.504 0 CA-C-N 110.561 -3.018 . . . . 0.7 112.154 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -56.47 -37.01 69.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.465 0.913 . . . . 2.75 113.465 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.667 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.5 p80 -95.07 -38.88 10.42 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.267 0.469 . . . . 1.33 112.267 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.875 ' HB2' HG12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.97 107.76 8.9 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.015 -0.735 . . . . 1.11 109.015 173.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.41 116.25 28.8 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.14 -1.43 . . . . 0.76 107.14 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.961 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -90.51 93.32 9.24 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.044 -2.206 . . . . 0.26 105.044 171.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.57 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -86.02 163.03 18.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-O 122.96 1.362 . . . . 2.03 109.382 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -141.38 118.91 11.58 Favored 'General case' 0 C--N 1.259 -3.339 0 CA-C-N 111.332 -2.667 . . . . 0.92 109.585 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.7 m -103.39 148.95 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.777 -2.011 . . . . 0.47 107.99 172.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.452 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 13.2 t80 -142.33 97.29 3.1 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.439 1.114 . . . . 1.39 110.821 -176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -117.6 118.22 31.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.786 -1.552 . . . . 2.42 109.911 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -36.33 25.02 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.557 -1.656 . . . . 2.46 111.554 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.23 67.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.432 -0.803 . . . . 1.15 110.912 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -96.55 -19.42 19.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.391 -0.966 . . . . 1.41 108.391 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.837 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 11.4 ttpt 67.08 32.54 6.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.961 -1.472 . . . . 3.31 110.427 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -128.07 126.63 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.761 0.791 . . . . 0.43 110.311 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.578 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.3 m-30 -99.17 108.81 21.5 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.119 -1.808 . . . . 1.24 106.119 166.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HG ' ' HG2' ' A' ' 73' ' ' GLU . 14.3 tp -98.25 105.74 17.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.522 1.153 . . . . 0.52 109.142 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.0 m-85 -85.45 113.52 21.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 113.322 -1.763 . . . . 0.33 107.905 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 9.6 mt-10 -107.56 121.2 44.16 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.465 -1.698 . . . . 1.32 110.044 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.844 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -91.08 126.66 36.23 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.462 -1.244 . . . . 0.96 107.849 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 78.7 m80 -117.06 95.32 4.94 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 104.569 -2.382 . . . . 1.15 104.569 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.875 HG12 ' HB2' ' A' ' 57' ' ' LEU . 25.4 mt -121.85 100.47 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-O 122.74 1.257 . . . . 0.52 109.066 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.3 p -111.86 161.13 16.7 Favored 'General case' 0 N--CA 1.395 -3.224 0 CA-C-N 114.569 -1.196 . . . . 0.58 109.572 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 48.35 57.75 5.88 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 111.271 -2.695 . . . . 2.12 110.611 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -52.62 119.81 4.96 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.824 -1.989 . . . . 0.4 110.608 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.605 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -60.15 143.84 88.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.461 -0.791 . . . . 1.43 109.306 173.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.607 ' HD3' HG11 ' A' ' 18' ' ' VAL . 31.7 Cg_endo -63.54 -3.32 5.22 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.286 1.99 . . . . 1.33 112.564 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -115.17 15.73 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.566 . . . . 1.12 110.131 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.8 m-30 -94.53 -8.7 37.54 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 118.838 -0.601 . . . . 1.24 110.181 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 15.6 m -19.1 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 125.788 1.93 . . . . 1.22 111.529 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.87 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -37.12 110.83 0.1 Allowed Glycine 0 CA--C 1.473 -2.579 0 CA-C-N 110.062 -3.245 . . . . 1.43 114.584 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 1.032 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -127.45 60.08 0.67 Allowed Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 108.277 -1.929 . . . . 0.52 108.277 157.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 80.7 m-85 -80.2 126.78 31.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.07 -1.065 . . . . 0.63 108.555 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 22.4 ttm180 -130.83 121.11 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.951 -0.468 . . . . 3.15 110.274 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.54 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -98.53 120.61 39.25 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.587 -0.523 . . . . 1.08 109.587 176.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.798 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.8 mt-10 -121.56 105.44 10.45 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.189 -0.671 . . . . 1.81 109.189 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.4 p -96.07 137.17 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.356 0.598 . . . . 0.54 110.384 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.69 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.0 t -130.09 110.65 11.78 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.875 -1.057 . . . . 1.18 109.146 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.89 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -129.06 173.63 10.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.877 -0.602 . . . . 0.74 110.17 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.9 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.96 -62.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.243 1.59 . . . . 0.65 114.474 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.9 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.9 t70 -154.24 -0.57 0.2 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.384 -1.28 . . . . 1.05 109.289 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.041 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -93.36 128.25 39.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.001 -1.111 . . . . 1.29 108.001 -177.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -130.73 130.71 44.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.756 -1.111 . . . . 0.77 110.831 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.96 151.22 35.44 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.402 -1.272 . . . . 1.6 109.02 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 9.5 p -151.13 146.59 26.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.133 0.492 . . . . 1.19 111.294 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.48 146.45 50.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.479 -0.782 . . . . 0.84 111.593 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.24 119.0 22.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.69 -1.141 . . . . 1.58 109.477 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.815 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 6.7 p90 -143.1 128.73 19.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.344 0.592 . . . . 0.86 110.153 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 41.8 m-20 -102.45 135.48 44.0 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.22 1.009 . . . . 2.11 110.999 -172.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.87 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -105.46 107.34 18.27 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.046 -1.434 . . . . 0.37 108.856 174.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 9.0 m -87.94 95.08 9.98 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.163 -1.015 . . . . 0.33 108.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 18' ' ' VAL . 3.3 p -76.69 112.51 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 122.948 1.356 . . . . 0.33 107.768 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 66.4 m170 -82.03 97.66 8.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.902 -1.954 . . . . 1.19 108.623 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HA ' HG23 ' A' ' 18' ' ' VAL . 39.2 tt0 -67.77 -35.71 79.18 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.376 -1.342 . . . . 1.67 107.376 166.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.6 68.8 0.71 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.152 -1.385 . . . . 2.78 112.564 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tmm? . . . . . 0 C--O 1.248 0.985 0 N-CA-C 108.747 -0.835 . . . . 6.92 108.747 176.691 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.333 -0.988 . . . . 1.93 108.333 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.479 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 8.0 m-20 -110.08 171.26 4.53 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.883 -0.599 . . . . 1.65 111.625 -172.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -70.51 69.04 2.09 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.579 2.186 . . . . 0.97 112.534 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.054 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -88.12 -63.82 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.8 -1.091 . . . . 0.5 108.729 171.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.917 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 91.72 43.2 4.57 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.588 -1.805 . . . . 0.39 108.588 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.854 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.0 tp -52.77 -39.59 62.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.827 -1.687 . . . . 0.33 110.389 -171.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.745 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.95 83.41 5.65 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.162 -0.926 . . . . 0.72 109.816 177.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.31 -43.03 74.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.565 -1.198 . . . . 0.63 108.835 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.36 135.67 15.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.123 -0.944 . . . . 2.88 109.571 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -113.92 136.43 22.12 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.0 -0.741 . . . . 3.67 109.0 176.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -71.58 160.08 49.34 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.437 1.425 . . . . 0.64 110.646 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.38 -177.78 3.53 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.75 -0.659 . . . . 1.43 109.498 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.9 p-10 -69.67 -151.08 0.02 OUTLIER 'General case' 0 N--CA 1.405 -2.721 0 CA-C-O 123.166 1.46 . . . . 2.06 111.939 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.453 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.04 134.86 2.01 Favored Glycine 0 C--N 1.293 -1.811 0 CA-C-N 112.824 -1.989 . . . . 0.3 112.036 -174.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 32.4 mt-10 -112.49 112.35 23.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.154 -1.023 . . . . 1.53 108.48 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.0 m -130.76 163.99 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 108.005 -1.109 . . . . 0.27 108.005 -171.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -90.97 152.84 20.54 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.279 -1.328 . . . . 0.77 109.256 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.603 HG23 ' HA ' ' A' ' 108' ' ' GLU . 21.8 t -69.4 106.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 CA-C-O 122.796 1.284 . . . . 0.78 107.663 172.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.8 11.57 7.02 Favored Glycine 0 C--N 1.263 -3.52 0 CA-C-N 111.9 -2.409 . . . . 0.48 112.717 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.38 -121.84 4.96 Favored Glycine 0 CA--C 1.472 -2.614 0 C-N-CA 118.893 -1.622 . . . . 0.44 110.419 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.9 p -152.49 172.03 17.17 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 112.614 -1.793 . . . . 0.82 110.322 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.612 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.3 tp -148.37 149.61 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 113.022 -1.899 . . . . 0.32 106.185 169.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m -137.89 124.99 21.49 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 114.411 -1.268 . . . . 0.31 111.235 -173.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.94 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.9 m-85 -119.55 139.85 51.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.921 -1.49 . . . . 0.53 109.525 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.126 -0.943 . . . . 0.58 108.75 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -122.14 115.98 23.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.374 -1.284 . . . . 0.32 110.261 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HG2' HD13 ' A' ' 71' ' ' LEU . 66.1 mtp180 -111.41 122.5 48.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.649 -0.251 . . . . 2.43 110.46 -174.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 91' ' ' VAL . 15.7 t -121.18 128.11 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.012 0.91 . . . . 0.26 110.394 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.745 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.38 109.39 1.34 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.285 -1.779 . . . . 0.4 110.486 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.65 -42.19 35.68 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.106 -0.952 . . . . 0.76 111.68 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 57.41 -166.55 0.14 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.039 0.755 . . . . 0.71 113.039 172.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 p -113.23 110.72 20.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.08 -0.964 . . . . 1.74 108.648 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.064 HD13 ' H ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -148.34 158.36 44.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.145 -0.479 . . . . 2.16 110.289 -171.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.721 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.9 mt -47.13 -37.93 10.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.053 1.406 . . . . 1.47 111.501 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.777 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.99 -178.83 0.86 Allowed Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 111.933 -2.394 . . . . 1.4 107.809 -170.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.65 145.61 20.63 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.198 -1.886 . . . . 0.88 107.198 162.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.711 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 16.6 Cg_exo -58.18 129.56 33.56 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 CA-C-N 119.49 0.854 . . . . 0.53 110.606 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.23 102.3 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 122.781 1.277 . . . . 0.77 107.657 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -104.88 115.8 47.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 112.427 -2.17 . . . . 0.28 108.023 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.92 130.83 54.52 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.108 1.432 . . . . 1.54 109.757 173.432 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.039 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.7 m95 -86.59 152.47 22.58 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.103 -2.317 . . . . 0.34 112.746 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.9 t80 -131.18 136.71 48.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.239 -2.134 . . . . 0.62 105.239 170.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.756 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 80.3 tttt -102.84 166.53 10.42 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.712 -1.588 . . . . 2.17 106.712 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.737 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.72 -168.22 0.0 OUTLIER Glycine 0 C--O 1.187 -2.8 0 N-CA-C 119.549 2.58 . . . . 1.23 119.549 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.495 ' CD ' ' HB ' ' A' ' 84' ' ' THR . 16.6 mtpt -44.97 -1.31 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.549 -2.147 . . . . 3.87 116.384 -167.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.64 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.6 p-90 -167.7 -11.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.765 1.395 . . . . 2.11 114.765 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.23 168.04 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 CA-C-O 123.459 1.6 . . . . 1.29 112.816 -159.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.5 t70 -112.28 155.43 24.08 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 111.549 -2.569 . . . . 2.73 105.937 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.039 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.4 mp -94.08 -36.34 12.14 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.579 0.955 . . . . 0.44 113.579 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 t -58.72 -21.23 54.55 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.2 -0.667 . . . . 1.23 109.2 -165.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -96.13 -27.57 14.99 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.022 -0.99 . . . . 1.34 113.419 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 16.7 mmmt -100.75 -32.6 10.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.033 0.444 . . . . 1.4 111.566 -170.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.743 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 27.0 t -35.11 97.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 125.817 1.647 . . . . 0.37 111.94 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.48 -146.2 4.43 Favored Glycine 0 C--O 1.213 -1.212 0 CA-C-N 111.604 -2.544 . . . . 0.7 110.309 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.523 ' C ' HE22 ' A' ' 58' ' ' GLN . 41.7 tt0 -71.37 -2.0 14.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.943 0.872 . . . . 2.75 112.916 -170.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 21.8 p80 -114.29 -33.38 5.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.87 0.843 . . . . 1.33 111.064 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.008 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -133.3 105.18 6.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.706 -1.961 . . . . 1.11 105.706 171.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.86 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -99.28 114.49 27.35 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.073 -1.825 . . . . 0.76 106.073 171.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.726 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -97.2 92.81 6.2 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.901 -2.259 . . . . 0.26 104.901 172.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.5 m-70 -93.53 163.07 13.71 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.013 1.387 . . . . 2.03 110.378 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.02 119.15 24.85 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 111.399 -2.637 . . . . 0.92 108.88 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -102.59 138.93 38.85 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.574 -2.103 . . . . 0.47 106.538 167.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -145.64 99.13 3.24 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.991 0.9 . . . . 1.39 112.156 -166.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 5.0 t70 -119.68 120.69 37.34 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.349 -1.296 . . . . 2.42 109.866 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -81.62 -38.8 25.44 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.684 -1.598 . . . . 2.46 111.289 -176.23 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.9 -28.01 60.45 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.69 -1.141 . . . . 1.15 111.248 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 27.5 m -89.0 -13.31 39.1 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.635 -1.246 . . . . 1.41 107.635 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.745 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 72.98 25.85 2.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.597 -1.638 . . . . 3.31 110.484 171.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.59 120.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.912 0.863 . . . . 0.43 110.709 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.711 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -103.43 105.94 16.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.322 -1.733 . . . . 1.24 106.322 166.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 8.0 tp -96.7 104.38 16.37 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 0.52 108.806 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -85.01 115.14 22.66 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.105 -1.407 . . . . 0.33 107.515 174.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -102.65 126.2 49.66 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 113.727 -1.579 . . . . 1.32 109.435 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 3.7 mm? -95.74 125.48 40.34 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.877 -1.511 . . . . 0.96 107.749 172.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.86 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 30.9 m170 -120.39 95.98 4.96 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 103.85 -2.648 . . . . 1.15 103.85 172.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.615 ' CD1' HD22 ' A' ' 57' ' ' LEU . 58.5 mt -120.3 102.22 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 113.894 -1.503 . . . . 0.52 108.874 -170.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 80.6 p -114.05 141.66 47.16 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 113.219 -1.81 . . . . 0.58 109.845 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 61.21 70.71 0.59 Allowed 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 111.28 -2.691 . . . . 2.12 110.222 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -62.45 126.9 28.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.435 -2.166 . . . . 0.4 110.524 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.78 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 3.5 tp60 -55.67 139.33 68.82 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.386 -0.824 . . . . 1.43 109.378 173.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HB3' HG21 ' A' ' 18' ' ' VAL . 34.6 Cg_endo -67.74 145.04 67.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.357 1.371 . . . . 1.33 110.888 176.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.88 17.22 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.659 0.599 . . . . 1.12 110.758 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.78 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -71.01 -30.27 66.45 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.002 -0.544 . . . . 1.24 109.712 177.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 40.6 m 14.46 79.59 0.01 OUTLIER 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.566 1.791 . . . . 1.22 110.712 -168.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.797 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -64.06 94.82 0.15 Allowed Glycine 0 N--CA 1.423 -2.216 0 CA-C-N 112.35 -2.205 . . . . 1.43 113.764 -161.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.72 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -88.19 70.48 2.66 Favored Glycine 0 C--N 1.288 -2.133 0 N-CA-C 109.324 -1.51 . . . . 0.52 109.324 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.575 ' HE2' ' CD2' ' A' ' 57' ' ' LEU . 54.3 m-85 -74.58 120.77 20.59 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.676 -1.262 . . . . 0.63 108.788 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 90.3 mtt180 -120.09 110.93 17.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.788 -0.449 . . . . 3.15 109.788 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 t -94.93 122.65 37.79 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.54 -0.541 . . . . 1.08 109.54 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.525 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 24.1 mt-10 -126.77 110.83 13.53 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.081 -0.963 . . . . 1.81 109.937 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 28' ' ' VAL . 3.0 p -107.99 139.82 28.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.443 0.639 . . . . 0.54 110.655 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -133.36 110.87 10.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.758 -1.11 . . . . 1.18 110.279 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.798 HG22 HD22 ' A' ' 33' ' ' LEU . 31.9 p -120.33 -176.33 3.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.185 -0.916 . . . . 0.74 111.123 176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 1.064 ' H ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -25.92 -45.07 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 125.724 1.89 . . . . 0.65 112.367 -178.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.756 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -172.72 7.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.77 -1.559 . . . . 1.05 110.84 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.054 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 tmtm? -92.91 123.69 36.35 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 106.571 -1.64 . . . . 1.29 106.571 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.52 123.24 29.18 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.974 -1.012 . . . . 0.77 111.124 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -145.58 144.27 30.39 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.1 -1.409 . . . . 1.6 109.873 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.4 p -142.83 145.04 32.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.947 -0.569 . . . . 1.19 109.543 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.745 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 60.9 p -130.41 133.55 46.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.935 -0.575 . . . . 0.84 111.57 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -109.13 123.72 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.82 -0.627 . . . . 1.58 110.389 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.703 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.16 115.76 9.57 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.685 -0.487 . . . . 0.86 109.685 -177.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.797 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 50.4 m-20 -100.63 141.24 33.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.051 0.929 . . . . 2.11 111.191 -168.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -111.38 111.3 22.24 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.249 -1.341 . . . . 0.37 110.061 176.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m -93.6 97.73 10.68 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.956 -0.757 . . . . 0.33 108.956 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.4 p -84.77 121.34 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 123.138 1.447 . . . . 0.33 110.32 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' THR . 98.7 m-70 -106.58 102.0 11.42 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.45 -2.159 . . . . 1.19 109.722 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.7 tt0 -67.55 -78.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.054 -0.975 . . . . 1.67 111.302 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -179.59 -173.89 0.27 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.698 -0.683 . . . . 2.78 109.617 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 57.7 ttp . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.654 -0.689 . . . . 6.92 109.641 176.463 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.593 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.534 0.683 . . . . 1.93 112.801 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.76 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 14.3 t70 -139.57 148.65 56.98 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 115.137 -0.938 . . . . 1.65 109.083 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 77.3 Cg_exo -52.2 99.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.588 2.859 . . . . 0.97 114.656 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.617 HG13 ' HB1' ' A' ' 31' ' ' ALA . 1.5 mp -125.04 -60.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 0.5 110.091 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.81 49.44 3.83 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.645 -1.782 . . . . 0.39 108.645 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 96' ' ' LYS . 12.7 tp -59.89 -41.95 92.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.839 -1.681 . . . . 0.33 110.475 -168.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.731 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -90.32 84.7 6.06 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.433 -0.803 . . . . 0.72 109.65 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -71.97 -48.02 52.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.901 -1.045 . . . . 0.63 110.313 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.543 ' CG ' ' HD3' ' A' ' 27' ' ' ARG . 20.7 mmt -136.6 130.9 33.01 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.061 -0.518 . . . . 2.88 110.828 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.731 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 26.1 mtm180 -93.78 128.14 42.86 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.565 -0.902 . . . . 3.67 108.565 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 79.1 Cg_endo -77.5 148.5 26.36 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.656 1.571 . . . . 0.64 108.807 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.574 ' O ' ' HD2' ' A' ' 24' ' ' PHE . 13.7 mm100 -112.93 179.46 3.96 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 111.629 0.233 . . . . 1.43 111.629 -168.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.72 -144.48 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 123.005 1.383 . . . . 2.06 111.325 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.44 127.82 1.59 Allowed Glycine 0 C--N 1.296 -1.69 0 CA-C-N 113.279 -1.782 . . . . 0.3 111.543 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.69 113.45 25.57 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.583 -0.895 . . . . 1.53 108.583 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.54 165.09 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 107.583 -1.265 . . . . 0.27 107.583 -167.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.67 156.9 16.2 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.939 -1.028 . . . . 0.77 108.958 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 106' ' ' VAL . 20.6 t -67.71 107.73 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 CA-C-O 122.83 1.3 . . . . 0.78 108.604 175.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 78' ' ' ASP . . . 120.98 3.58 10.72 Favored Glycine 0 C--N 1.267 -3.285 0 CA-C-N 111.788 -2.46 . . . . 0.48 113.551 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -124.48 4.59 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.077 -1.535 . . . . 0.44 110.797 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.8 p -152.13 166.37 31.87 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 112.897 -1.651 . . . . 0.82 111.279 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 104' ' ' LEU . 10.6 tp -147.84 148.71 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 113.423 -1.717 . . . . 0.32 108.02 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 m -142.1 126.98 18.22 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 113.524 -1.671 . . . . 0.31 110.827 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.704 ' HD1' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -136.13 146.75 47.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.0 -1.0 . . . . 0.53 109.429 173.226 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.861 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.9 126.1 33.33 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.517 -0.765 . . . . 0.58 109.727 -177.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -116.46 116.28 27.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.645 -1.161 . . . . 0.32 110.718 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HE ' HG11 ' A' ' 69' ' ' VAL . 43.3 mtp85 -102.25 130.36 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.835 -0.346 . . . . 2.43 110.477 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 39' ' ' VAL . 11.7 t -127.93 127.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.755 0.788 . . . . 0.26 109.874 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.37 114.81 2.6 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.711 -1.586 . . . . 0.4 111.531 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.86 -37.87 58.61 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 114.49 -1.232 . . . . 0.76 110.375 168.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.708 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 58.66 -174.68 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 115.193 1.553 . . . . 0.71 115.193 164.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -103.16 113.78 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.13 -1.396 . . . . 1.74 107.912 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.747 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -151.18 165.8 32.82 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.117 -0.492 . . . . 2.16 111.807 -166.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.8 -69.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.415 -0.587 . . . . 1.47 109.415 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 151.21 41.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.029 -0.73 . . . . 1.4 109.029 170.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HA ' HD11 ' A' ' 33' ' ' LEU . 88.1 Cg_exo -49.24 152.35 5.49 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.854 2.37 . . . . 0.88 111.873 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.747 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -65.55 134.27 37.68 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.771 1.647 . . . . 0.53 111.52 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.16 104.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 106.447 -1.686 . . . . 0.77 106.447 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.633 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.44 114.74 47.78 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 113.194 -1.821 . . . . 0.28 107.135 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.927 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.23 122.24 45.52 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 123.153 1.454 . . . . 1.54 110.265 176.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.087 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.3 m95 -86.69 152.08 22.86 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 111.978 -2.374 . . . . 0.34 110.921 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 38.4 t80 -136.97 135.15 37.42 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 104.243 -2.502 . . . . 0.62 104.243 173.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 1.021 ' HB3' HG23 ' A' ' 47' ' ' VAL . 81.4 tttt -101.7 173.12 6.56 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 105.619 -1.993 . . . . 2.17 105.619 -172.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 1.018 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -8.15 -168.03 0.0 OUTLIER Glycine 0 C--O 1.192 -2.487 0 N-CA-C 119.525 2.57 . . . . 1.23 119.525 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 84' ' ' THR . 20.4 mtpp -39.22 -22.08 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 115.834 1.791 . . . . 3.87 115.834 -163.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -161.06 -6.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.937 1.088 . . . . 2.11 113.937 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.021 HG23 ' HB3' ' A' ' 43' ' ' LYS . 31.5 m -94.4 171.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.778 0 CA-C-O 124.116 1.912 . . . . 1.29 113.539 -160.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.895 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -100.57 161.24 13.74 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 110.449 -3.069 . . . . 2.73 108.756 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.087 HD13 ' HB3' ' A' ' 41' ' ' TRP . 3.7 mp -99.42 -32.32 11.21 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 116.055 -0.52 . . . . 0.44 111.612 160.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 t -58.13 -23.78 56.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.255 0.55 . . . . 1.23 109.884 -164.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.736 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 58.5 m -102.08 -27.62 12.81 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.037 0.922 . . . . 1.34 112.907 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.895 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 28.9 mttp -90.92 -27.35 18.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.658 -1.61 . . . . 1.4 112.806 -168.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.727 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 35.9 t -50.32 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 111.529 -2.578 . . . . 0.37 111.267 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.42 -99.23 0.15 Allowed Glycine 0 C--N 1.304 -1.246 0 CA-C-N 112.421 -2.172 . . . . 0.7 113.299 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -86.05 -53.2 5.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.278 0.473 . . . . 2.75 112.278 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.1 p80 -87.54 -36.19 17.72 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.394 0.616 . . . . 1.33 111.207 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.976 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.91 106.89 13.43 Favored 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 106.35 -1.722 . . . . 1.11 106.35 176.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -102.42 116.42 32.58 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.277 -1.379 . . . . 0.76 107.277 166.12 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.693 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -95.03 92.99 7.11 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.499 -2.408 . . . . 0.26 104.499 170.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 46.5 m170 -87.66 162.56 17.04 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.645 1.212 . . . . 2.03 109.968 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.93 118.91 19.47 Favored 'General case' 0 C--N 1.268 -2.963 0 CA-C-N 111.959 -2.382 . . . . 0.92 108.933 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.532 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -101.05 149.46 23.92 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.58 -2.1 . . . . 0.47 108.202 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.4 t80 -141.61 97.05 3.08 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.224 1.012 . . . . 1.39 110.762 -174.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.4 OUTLIER -113.8 101.67 9.51 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.81 -1.541 . . . . 2.42 110.393 173.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.04 -29.71 43.71 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.263 -1.335 . . . . 2.46 110.937 -176.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.6 -21.26 65.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.196 -0.911 . . . . 1.15 109.862 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 19.4 m -110.94 -11.98 14.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.18 -0.918 . . . . 1.41 109.076 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.708 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 67.1 32.48 6.18 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.323 -0.853 . . . . 3.31 109.547 175.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.636 HG11 ' HE ' ' A' ' 27' ' ' ARG . 3.3 t -127.32 135.64 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.944 0.878 . . . . 0.43 110.425 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.7 m-30 -107.44 112.82 25.8 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.244 -1.391 . . . . 1.24 107.244 165.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 25' ' ' SER . 23.9 tp -95.32 107.65 19.78 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.041 0.924 . . . . 0.52 109.537 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.2 m-85 -87.72 112.68 22.64 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.587 -1.264 . . . . 0.33 107.587 170.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.69 120.16 41.1 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.952 -1.476 . . . . 1.32 110.381 -175.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.704 ' HB2' ' HD1' ' A' ' 24' ' ' PHE . 1.6 mt -81.74 129.42 34.72 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.958 -1.127 . . . . 0.96 107.958 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -115.88 96.57 5.65 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 103.351 -2.833 . . . . 1.15 103.351 165.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.691 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -120.83 99.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 123.047 1.403 . . . . 0.52 109.922 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.5 p -106.51 146.76 30.2 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 113.445 -1.707 . . . . 0.58 108.651 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' OD1' ' HA2' ' A' ' 19' ' ' GLY . 27.2 t70 64.8 82.7 0.18 Allowed 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 111.613 -2.54 . . . . 2.12 109.926 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.27 109.92 16.24 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 111.375 -2.648 . . . . 0.4 110.688 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.899 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 3.5 tp60 -52.74 139.13 41.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.587 -0.733 . . . . 1.43 109.862 167.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.494 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 37.7 Cg_endo -63.57 -3.39 5.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.29 2.66 . . . . 1.33 112.768 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.899 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -110.97 14.74 22.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.053 -0.521 . . . . 1.12 110.894 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -90.14 -29.66 18.14 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 117.721 -1.133 . . . . 1.24 110.756 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 75.0 m 2.34 80.34 0.0 OUTLIER 'General case' 0 C--N 1.354 0.785 0 O-C-N 125.688 1.867 . . . . 1.22 111.226 -174.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 1.018 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.19 121.7 5.61 Favored Glycine 0 N--CA 1.408 -3.213 0 CA-C-N 111.458 -2.61 . . . . 1.43 114.776 -163.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.952 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -120.94 70.23 0.39 Allowed Glycine 0 C--N 1.268 -3.24 0 CA-C-N 111.366 -2.417 . . . . 0.52 107.97 159.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.781 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 54.5 m-85 -74.49 127.61 33.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.094 -1.053 . . . . 0.63 109.013 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 48.0 mtp180 -121.38 104.68 9.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.643 -0.502 . . . . 3.15 109.643 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.476 ' H ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -91.77 121.3 33.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.09 -1.078 . . . . 1.08 108.09 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.927 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 25.7 tt0 -137.48 106.67 6.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.229 -0.896 . . . . 1.81 109.228 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.633 ' HB ' HG13 ' A' ' 39' ' ' VAL . 5.7 p -103.44 141.48 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.677 0.751 . . . . 0.54 111.305 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 t -138.71 109.88 6.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.435 -1.257 . . . . 1.18 108.563 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.566 HG21 HD12 ' A' ' 33' ' ' LEU . 1.6 m -129.44 174.21 9.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.142 -1.058 . . . . 0.74 108.142 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.979 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.88 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 125.199 1.562 . . . . 0.65 114.756 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.979 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -156.98 -0.81 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.555 -1.202 . . . . 1.05 110.042 -174.412 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.72 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -96.36 131.43 42.91 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.244 -1.021 . . . . 1.29 108.244 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -132.65 145.6 51.2 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.173 -1.376 . . . . 0.77 111.516 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 10.6 t70 -176.08 164.96 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.797 -0.638 . . . . 1.6 110.037 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.703 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 6.0 p -153.62 146.47 24.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.116 0.484 . . . . 1.19 110.576 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.57 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 88.8 p -124.34 131.94 53.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.805 -0.634 . . . . 0.84 110.55 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.79 121.12 42.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.972 0.415 . . . . 1.58 110.461 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.635 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -142.83 126.31 16.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.466 0.651 . . . . 0.86 109.789 -177.237 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 19.5 m-80 -105.09 152.88 22.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.182 0.991 . . . . 2.11 111.563 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.03 104.27 9.11 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.818 -1.083 . . . . 0.37 110.475 173.033 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -85.88 96.41 9.77 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.7 -0.8 . . . . 0.33 109.251 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 18' ' ' VAL . 7.5 p -81.87 113.22 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-O 123.387 1.565 . . . . 0.33 109.221 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -94.91 100.95 12.72 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.362 -2.199 . . . . 1.19 109.872 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 18' ' ' VAL . 36.1 tt0 -75.78 -63.58 1.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.383 -0.826 . . . . 1.67 110.134 171.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.62 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.256 -0.429 . . . . 2.78 110.646 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.6 ptm . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.62 -0.705 . . . . 6.92 109.955 -177.787 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.909 0.385 . . . . 1.93 110.599 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.592 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.0 m-20 -111.78 167.52 8.99 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.109 -0.496 . . . . 1.65 112.134 -172.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.494 ' C ' HD12 ' A' ' 4' ' ' ILE . 42.4 Cg_endo -68.45 87.16 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.814 2.343 . . . . 0.97 112.269 176.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.74 HD13 ' HE2' ' A' ' 94' ' ' LYS . 1.6 mp -126.4 -58.91 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.96 -1.018 . . . . 0.5 109.444 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.63 37.08 7.08 Favored Glycine 0 CA--C 1.496 -1.135 0 N-CA-C 108.991 -1.644 . . . . 0.39 108.991 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.147 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.9 tp -46.52 -47.5 19.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.104 -1.548 . . . . 0.33 110.383 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -89.57 83.45 6.31 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.741 0.781 . . . . 0.72 109.02 175.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.2 t -68.26 -48.28 74.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.448 -1.251 . . . . 0.63 109.598 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 ttp -148.47 129.58 14.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.651 -1.159 . . . . 2.88 108.828 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -95.84 148.64 34.87 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.662 -0.699 . . . . 3.67 109.615 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.842 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 1.9 Cg_endo -79.35 162.59 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.557 2.171 . . . . 0.64 111.074 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.511 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.4 mm-40 -125.8 169.65 12.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.099 -0.501 . . . . 1.43 110.329 -171.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' A' ' 103' ' ' ASN . 7.3 p-10 -74.78 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-O 122.695 1.236 . . . . 2.06 111.922 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 159.83 137.34 2.21 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.206 -1.815 . . . . 0.3 112.175 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 31.2 mt-10 -115.76 113.85 24.0 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.054 -1.073 . . . . 1.53 108.87 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.503 HG22 HD11 ' A' ' 104' ' ' LEU . 3.1 m -134.52 163.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.715 0 N-CA-C 107.13 -1.433 . . . . 0.27 107.13 -173.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -93.13 157.21 16.4 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.541 -0.754 . . . . 0.77 110.035 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' A' ' 81' ' ' PRO . 9.0 t -62.58 106.76 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 CA-C-O 122.956 1.36 . . . . 0.78 109.488 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.34 11.42 17.88 Favored Glycine 0 C--N 1.269 -3.18 0 CA-C-N 112.08 -2.327 . . . . 0.48 113.712 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.3 -122.33 4.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 109.867 -1.293 . . . . 0.44 109.867 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.3 p -151.66 164.24 37.36 Favored 'General case' 0 N--CA 1.401 -2.89 0 CA-C-N 113.088 -1.556 . . . . 0.82 110.971 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.825 HG23 ' HB ' ' A' ' 76' ' ' ILE . 6.8 tp -148.1 142.92 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 112.801 -1.999 . . . . 0.32 107.904 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -138.64 129.39 26.41 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-N 114.237 -1.347 . . . . 0.31 111.054 -171.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 31.8 m-85 -126.98 143.03 51.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.129 -1.396 . . . . 0.53 110.369 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -130.25 123.42 30.08 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.009 -0.996 . . . . 0.58 109.438 174.35 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.842 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -120.89 118.16 29.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.13 -1.396 . . . . 0.32 110.324 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -105.28 122.41 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.225 -0.297 . . . . 2.43 111.008 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.2 t -124.89 127.39 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.849 0.833 . . . . 0.26 109.83 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -57.64 113.31 1.76 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.665 -1.607 . . . . 0.4 111.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.76 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -54.22 -42.16 72.28 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.537 -1.21 . . . . 0.76 110.651 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.744 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.32 -151.01 0.1 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 115.193 1.553 . . . . 0.71 115.193 167.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -128.34 130.54 47.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.264 -1.334 . . . . 1.74 108.717 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -156.78 179.02 9.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.298 0.571 . . . . 2.16 111.775 -173.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.41 -42.09 59.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.712 -1.131 . . . . 1.47 108.921 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -149.48 149.9 29.89 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 1.4 109.558 175.442 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 85.4 Cg_exo -46.54 140.24 12.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.86 2.373 . . . . 0.88 112.248 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HA ' HG23 ' A' ' 93' ' ' THR . 33.3 Cg_exo -53.59 137.51 66.23 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 C-N-CA 122.095 1.863 . . . . 0.53 112.377 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.86 104.4 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 106.787 -1.56 . . . . 0.77 106.787 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.549 HG22 HG23 ' A' ' 91' ' ' VAL . 2.4 t -113.09 115.22 49.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.022 0 CA-C-N 113.782 -1.554 . . . . 0.28 107.595 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.642 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -106.55 131.67 53.45 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.896 1.331 . . . . 1.54 108.978 172.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.951 ' HB3' HD13 ' A' ' 49' ' ' LEU . 50.1 m95 -90.73 157.24 17.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.394 -2.185 . . . . 0.34 110.622 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.5 t80 -139.62 124.58 18.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.431 -2.063 . . . . 0.62 105.431 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.943 ' HD2' HD23 ' A' ' 57' ' ' LEU . 60.5 tttt -104.26 112.47 25.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.3 -1.36 . . . . 2.17 108.145 -172.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 85' ' ' GLY . . . -84.81 92.31 1.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 115.572 -3.204 . . . . 1.23 114.39 -166.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.835 ' HE3' ' HE1' ' A' ' 46' ' ' TRP . 21.9 ttpt -102.85 -31.53 10.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 103.173 -2.899 . . . . 3.87 103.173 137.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.835 ' HE1' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER 158.78 -11.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 111.243 -2.708 . . . . 2.11 111.369 -167.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.932 ' HB ' ' HE2' ' A' ' 52' ' ' LYS . 0.7 OUTLIER -88.08 168.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.03 1.395 . . . . 1.29 113.53 -165.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.662 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 16.5 t70 -113.09 132.57 55.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 111.666 -2.515 . . . . 2.73 108.886 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -76.31 -30.91 57.89 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 113.714 1.005 . . . . 0.44 113.714 -174.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -61.47 -21.94 64.63 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.26 0.482 . . . . 1.23 109.894 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 t -101.09 -20.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.825 0.822 . . . . 1.34 112.215 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.932 ' HE2' ' HB ' ' A' ' 47' ' ' VAL . 45.2 mttp -96.81 -78.21 0.47 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.219 -1.355 . . . . 1.4 113.687 -164.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.963 HG13 ' H ' ' A' ' 59' ' ' LEU . 37.8 t 22.98 98.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 125.293 1.621 . . . . 0.37 114.273 161.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -145.14 -150.87 5.3 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.251 -1.34 . . . . 0.7 113.983 -173.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -62.54 -27.13 68.95 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.83 0.452 . . . . 2.75 112.149 -170.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.668 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.3 p80 -92.52 -39.08 11.57 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.668 -0.413 . . . . 1.33 111.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -130.82 106.07 8.2 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.09 -0.707 . . . . 1.11 109.09 170.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.34 116.67 29.08 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.741 -1.577 . . . . 0.76 106.741 170.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.963 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -91.87 93.67 8.94 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 105.222 -2.14 . . . . 0.26 105.222 171.191 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 42.2 m170 -94.03 162.03 14.05 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-O 122.758 1.266 . . . . 2.03 109.933 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -132.62 111.93 11.62 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 111.775 -2.466 . . . . 0.92 108.768 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.0 m -87.67 148.75 24.65 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 112.71 -2.041 . . . . 0.47 108.518 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -126.65 97.14 4.9 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.303 1.049 . . . . 1.39 110.121 -168.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -114.34 95.05 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.327 -1.761 . . . . 2.42 108.554 177.255 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.01 -27.22 28.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.173 -0.921 . . . . 2.46 110.457 -176.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.44 -17.63 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.57 -1.196 . . . . 1.15 109.847 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.704 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 24.2 m -108.79 -15.25 14.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.925 . . . . 1.41 108.774 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.744 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 64.93 35.47 8.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.097 -0.956 . . . . 3.31 109.402 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.07 136.83 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.43 109.667 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 13.9 m-85 -101.68 116.78 33.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.685 -1.598 . . . . 1.24 106.685 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 25' ' ' SER . 24.3 tp -95.55 104.54 16.45 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.441 -0.948 . . . . 0.52 108.441 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.9 m-85 -81.92 112.03 18.65 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.539 -1.652 . . . . 0.33 106.539 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -119.68 120.88 37.92 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.97 -1.468 . . . . 1.32 110.385 -173.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.923 HD12 HD11 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -88.21 125.15 34.48 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.763 -1.562 . . . . 0.96 107.584 177.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 12.8 m170 -110.75 96.01 5.91 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.148 -2.538 . . . . 1.15 104.148 170.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.923 HD11 HD12 ' A' ' 74' ' ' LEU . 27.8 mt -119.57 99.98 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 122.89 1.328 . . . . 0.52 110.279 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 31.4 p -116.05 139.97 49.74 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 114.301 -1.318 . . . . 0.58 107.77 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 77' ' ' THR . 22.0 t70 74.85 64.98 0.07 Allowed 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.309 -2.223 . . . . 2.12 108.312 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.17 9.18 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.098 -2.319 . . . . 0.4 109.259 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -62.6 151.7 83.08 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.25 -0.648 . . . . 1.43 109.25 176.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.758 ' HB3' HG21 ' A' ' 18' ' ' VAL . 72.3 Cg_endo -72.95 11.06 0.94 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.795 2.33 . . . . 1.33 113.958 -169.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.708 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.17 -3.97 11.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.595 -0.275 . . . . 1.12 110.626 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD1' ' HE2' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -80.63 0.51 33.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.182 -0.673 . . . . 1.24 109.182 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 94.9 m -52.24 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 CA-C-O 122.609 1.195 . . . . 1.22 109.657 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 44' ' ' GLY . . . -164.98 -119.42 0.48 Allowed Glycine 0 C--N 1.27 -3.093 0 CA-C-N 113.15 -1.841 . . . . 1.43 113.559 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -164.99 121.97 1.05 Allowed Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 113.501 -1.35 . . . . 0.52 111.195 -171.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -87.01 125.48 34.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.413 -0.958 . . . . 0.63 108.413 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -105.0 132.71 50.9 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.239 -0.652 . . . . 3.15 109.239 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.47 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 3.9 m -111.76 121.7 45.79 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.837 -0.801 . . . . 1.08 108.837 169.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.642 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 41.9 mt-10 -120.01 105.2 10.81 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.78 -0.646 . . . . 1.81 109.608 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.549 HG23 HG22 ' A' ' 39' ' ' VAL . 7.1 p -99.74 134.05 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.187 0.994 . . . . 0.54 110.717 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -135.58 108.03 7.37 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.591 -1.64 . . . . 1.18 108.389 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.709 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -133.22 163.23 29.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.308 -0.853 . . . . 0.74 109.09 -178.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.74 ' HE2' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 22.28 -79.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 125.52 1.762 . . . . 0.65 113.536 168.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.616 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 16.3 t70 -153.43 6.3 0.35 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.898 -1.047 . . . . 1.05 109.156 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.147 ' HB3' HD22 ' A' ' 6' ' ' LEU . 44.7 tptt -92.01 132.1 36.8 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.782 -1.562 . . . . 1.29 106.782 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -131.7 146.17 52.03 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.941 -1.027 . . . . 0.77 111.847 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.57 163.18 2.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.98 . . . . 1.6 110.104 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.4 p -152.22 138.44 18.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.981 -0.554 . . . . 1.19 110.038 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.76 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 57.9 p -107.45 147.25 30.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.631 -0.713 . . . . 0.84 110.325 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -132.98 114.91 14.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.431 0.634 . . . . 1.58 110.354 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.792 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 33.7 p90 -143.24 140.23 30.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.082 -0.508 . . . . 0.86 109.796 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.643 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.3 m-20 -96.98 155.97 16.55 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.207 1.003 . . . . 2.11 111.974 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.666 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -125.7 114.44 18.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.726 -1.213 . . . . 0.37 107.726 164.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.433 ' HA ' HG23 ' A' ' 84' ' ' THR . 4.1 m -98.83 95.86 7.48 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.654 -0.869 . . . . 0.33 108.654 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.1 p -78.39 111.74 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 123.065 1.412 . . . . 0.33 108.834 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 65.2 m170 -78.57 98.11 6.01 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.664 -2.062 . . . . 1.19 109.788 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.69 -34.76 58.18 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.542 -1.663 . . . . 1.67 108.866 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.78 31.72 16.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.258 -0.883 . . . . 2.78 111.801 175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.17 -0.678 . . . . 6.92 109.17 177.726 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.705 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 122.044 0.926 . . . . 1.93 110.739 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.601 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 19.6 t70 -74.53 157.81 85.77 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.614 -1.175 . . . . 1.65 109.846 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 18.2 Cg_endo -61.04 77.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.737 2.292 . . . . 0.97 114.066 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.703 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -99.59 -60.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.773 -1.103 . . . . 0.5 109.574 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.7 43.69 6.01 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 108.321 -1.912 . . . . 0.39 108.321 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 4' ' ' ILE . 9.8 tp -50.11 -43.83 51.87 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.652 -1.774 . . . . 0.33 111.031 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.744 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -88.52 84.73 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.646 -0.706 . . . . 0.72 110.301 176.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.46 -40.95 72.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.447 -1.251 . . . . 0.63 109.167 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.502 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 18.2 ttt -151.06 137.45 18.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.617 -1.174 . . . . 2.88 108.655 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 7.8 ptp180 -102.47 139.23 20.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.229 -0.441 . . . . 3.67 110.201 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.859 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 14.1 Cg_endo -69.73 154.1 68.28 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.741 2.294 . . . . 0.64 112.375 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 1.9 mp0 -112.93 170.75 7.98 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.099 0.778 . . . . 1.43 113.099 -168.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 1.6 m-20 -69.88 -147.35 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.701 1.239 . . . . 2.06 110.741 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.489 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 153.32 133.31 1.84 Allowed Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 113.611 -1.631 . . . . 0.3 112.242 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 23.1 mt-10 -110.68 119.01 37.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.256 -0.972 . . . . 1.53 108.527 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.77 162.06 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.21 0 N-CA-C 107.047 -1.464 . . . . 0.27 107.047 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -96.4 155.33 16.81 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.41 -0.959 . . . . 0.77 108.41 176.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.708 HG11 ' HD3' ' A' ' 81' ' ' PRO . 6.2 t -67.28 105.85 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.862 -1.162 . . . . 0.78 107.862 173.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.34 -6.74 3.97 Favored Glycine 0 C--N 1.273 -2.953 0 CA-C-N 112.926 -1.943 . . . . 0.48 113.368 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.37 -123.93 5.29 Favored Glycine 0 CA--C 1.471 -2.704 0 C-N-CA 119.089 -1.529 . . . . 0.44 110.6 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.638 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.8 p -148.98 174.45 12.26 Favored 'General case' 0 N--CA 1.396 -3.149 0 CA-C-N 112.555 -1.822 . . . . 0.82 110.2 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.682 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.1 tp -146.09 140.39 21.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 112.651 -2.068 . . . . 0.32 107.21 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.9 m -139.24 127.59 22.79 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 113.398 -1.728 . . . . 0.31 111.492 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.779 ' HB2' HD23 ' A' ' 74' ' ' LEU . 3.4 m-85 -128.19 154.71 45.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.057 -1.429 . . . . 0.53 108.877 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -134.42 122.05 21.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.461 -0.79 . . . . 0.58 109.382 173.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.859 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -113.51 116.38 29.47 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.878 -1.056 . . . . 0.32 110.184 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.1 mtt180 -105.61 115.66 30.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.469 -0.332 . . . . 2.43 110.412 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 39' ' ' VAL . 5.8 t -118.23 126.3 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.065 0.936 . . . . 0.26 110.121 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.775 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -56.36 108.97 0.53 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.147 -1.842 . . . . 0.4 112.188 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.62 80.78 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.764 -1.107 . . . . 0.76 112.423 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 61.05 -178.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.137 1.162 . . . . 0.71 114.137 168.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -105.39 29.53 6.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.292 -1.322 . . . . 1.74 109.083 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.046 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -58.57 175.71 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.645 -1.161 . . . . 2.16 113.133 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.44 -40.52 64.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.874 0.845 . . . . 1.47 109.927 -176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.93 134.88 11.14 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.442 -1.253 . . . . 1.4 108.532 176.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -43.58 141.62 3.62 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.333 2.689 . . . . 0.88 112.18 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.046 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.0 Cg_exo -52.93 136.63 60.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.813 1.675 . . . . 0.53 113.068 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.31 104.99 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.175 -1.787 . . . . 0.77 106.175 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.65 114.37 46.78 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 113.535 -1.666 . . . . 0.28 108.037 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 1.018 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.57 122.24 43.47 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-O 123.344 1.545 . . . . 1.54 110.238 174.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.034 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.8 m95 -86.91 149.01 25.11 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.871 -2.422 . . . . 0.34 112.021 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.734 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 43.7 t80 -128.89 140.09 51.84 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.096 -2.557 . . . . 0.62 104.096 172.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.798 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 58.2 tttp -106.23 166.25 10.65 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 116.627 -1.654 . . . . 2.17 106.708 -173.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -11.97 -166.17 0.0 OUTLIER Glycine 0 C--O 1.186 -2.875 0 N-CA-C 119.136 2.414 . . . . 1.23 119.136 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.914 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 13.4 ptmt -44.14 -6.34 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.495 2.406 . . . . 3.87 117.495 -161.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.914 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 2.8 p-90 -167.95 -1.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.931 1.242 . . . . 2.11 113.266 174.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.27 167.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 CA-C-O 123.659 1.695 . . . . 1.29 112.405 -159.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 3.3 p-10 -111.35 156.99 20.73 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.137 -2.756 . . . . 2.73 106.506 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -97.9 -31.27 12.28 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.509 0.559 . . . . 0.44 112.509 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -58.52 -19.67 39.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.013 0.435 . . . . 1.23 109.88 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.406 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 73.9 m -98.25 -26.74 14.43 Favored 'General case' 0 N--CA 1.415 -2.198 0 C-N-CA 119.865 -0.734 . . . . 1.34 112.432 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.3 -32.16 10.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.623 -1.172 . . . . 1.4 111.794 -167.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.82 HG13 ' H ' ' A' ' 59' ' ' LEU . 70.3 t -35.39 92.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 O-C-N 125.076 1.485 . . . . 0.37 111.532 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . -150.25 -114.79 0.7 Allowed Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 112.338 -2.21 . . . . 0.7 111.952 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -95.74 -25.4 16.09 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.364 0.876 . . . . 2.75 113.364 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.6 p80 -93.32 -37.82 11.82 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-O 121.622 0.725 . . . . 1.33 110.079 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.005 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.66 106.97 10.51 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 105.657 -1.979 . . . . 1.11 105.657 171.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -106.39 114.59 28.81 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.445 -1.687 . . . . 0.76 106.445 166.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.82 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -92.72 92.42 7.96 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 103.957 -2.608 . . . . 0.26 103.957 175.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 80.4 t60 -95.0 159.66 14.93 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 113.944 -1.48 . . . . 2.03 110.22 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.58 121.57 39.64 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.929 -2.85 . . . . 0.92 109.153 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 25.9 m -110.23 143.47 40.34 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-N 111.773 -2.467 . . . . 0.47 106.34 167.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.88 99.51 3.35 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.748 0.785 . . . . 1.39 109.275 -164.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -115.01 132.07 56.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.489 -1.232 . . . . 2.42 109.122 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.538 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 6.1 mmm180 -119.01 18.23 13.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.06 -1.427 . . . . 2.46 111.25 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.24 -31.88 4.55 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.736 -1.574 . . . . 1.15 108.488 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t -93.18 -14.75 26.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.479 -1.237 . . . . 1.41 108.8 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.775 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 15.2 tttt 68.88 31.61 4.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.85 0.833 . . . . 3.31 109.23 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 7.9 t -128.35 125.77 64.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.603 0.716 . . . . 0.43 110.453 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.447 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.4 m-30 -101.18 107.44 18.85 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.031 -1.841 . . . . 1.24 106.031 167.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.0 tp -94.92 104.21 16.1 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.706 -1.134 . . . . 0.52 108.013 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.5 m-85 -86.94 113.65 22.89 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.68 -1.6 . . . . 0.33 106.68 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.65 125.24 49.3 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.917 -1.492 . . . . 1.32 110.585 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.916 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.2 mm? -89.59 124.51 34.62 Favored 'General case' 0 CA--C 1.471 -2.064 0 CA-C-N 112.889 -1.96 . . . . 0.96 107.698 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.935 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 26.1 m170 -114.45 94.29 4.72 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 103.15 -2.908 . . . . 1.15 103.15 167.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 22' ' ' ILE . 60.4 mt -115.14 97.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 123.603 1.668 . . . . 0.52 108.983 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 29.9 p -116.31 138.75 51.07 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 112.302 -2.226 . . . . 0.58 107.076 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 77' ' ' THR . 13.5 t70 77.76 63.77 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 O-C-N 125.855 1.972 . . . . 2.12 107.351 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -76.92 94.44 3.93 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 111.605 -2.543 . . . . 0.4 107.893 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.673 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -53.71 151.32 11.55 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-N 115.127 -0.942 . . . . 1.43 108.708 176.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.708 ' HD3' HG11 ' A' ' 18' ' ' VAL . 60.0 Cg_endo -68.83 155.32 69.02 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.039 1.159 . . . . 1.33 110.032 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 45' ' ' LYS . . . 63.38 21.69 12.91 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.381 0.426 . . . . 1.12 110.728 -175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -86.6 -13.21 46.37 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.195 -1.409 . . . . 1.24 107.195 173.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 1.022 HG21 ' N ' ' A' ' 106' ' ' VAL . 4.3 p -90.11 150.26 22.12 Favored 'General case' 1 N--CA 1.363 -4.808 0 CA-C-O 126.041 2.829 . . . . 1.22 116.17 -163.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' HA3' ' CA ' ' A' ' 45' ' ' LYS . . . 159.4 -109.61 0.41 Allowed Glycine 1 C--N 1.239 -4.833 1 CA-C-N 105.381 -5.372 . . . . 1.43 112.527 -155.532 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -167.91 124.78 1.23 Allowed Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.338 -1.41 . . . . 0.52 114.172 -170.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.798 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.3 m-85 -87.95 124.54 33.81 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.227 -1.487 . . . . 0.63 108.56 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.734 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 mtp180 -105.51 105.21 15.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.538 -0.726 . . . . 3.15 109.728 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.424 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 4.3 t -89.92 125.39 35.34 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.372 -0.973 . . . . 1.08 108.372 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 1.018 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 21.7 tt0 -145.47 106.77 4.19 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.419 -0.81 . . . . 1.81 109.961 -169.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.7 p -102.66 144.36 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.362 0.601 . . . . 0.54 110.504 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.4 m -139.12 109.47 6.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.277 -0.874 . . . . 1.18 108.898 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.852 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.39 153.78 50.45 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.401 -0.809 . . . . 0.74 109.886 -177.413 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.784 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.7 -75.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 125.654 1.846 . . . . 0.65 114.572 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.784 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 12.2 t70 -149.7 -1.07 0.45 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.087 -1.415 . . . . 1.05 109.379 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.705 ' HG2' ' HB3' ' A' ' 1' ' ' ASP . 0.6 OUTLIER -104.76 140.09 38.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.111 0.958 . . . . 1.29 109.627 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -132.61 139.06 47.61 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.142 -1.844 . . . . 0.77 110.577 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 6.8 m-20 -152.85 147.88 26.53 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.25 -0.886 . . . . 1.6 109.083 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 13.4 p -151.43 153.88 35.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.504 . . . . 1.19 110.905 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.744 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 85.7 p -137.31 130.26 30.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.774 -0.648 . . . . 0.84 110.766 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.81 116.85 33.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.615 -0.721 . . . . 1.58 110.305 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.791 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 22.5 p90 -143.12 135.8 27.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.458 0.647 . . . . 0.86 109.903 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.588 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 86.9 m-20 -97.26 156.15 16.55 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.538 -1.21 . . . . 2.11 110.387 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.959 ' HG ' HG22 ' A' ' 84' ' ' THR . 1.2 tp -120.67 132.91 55.34 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 102.336 -3.209 . . . . 0.37 102.336 166.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.544 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 23.4 m -124.16 113.57 18.51 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.318 -1.353 . . . . 0.33 109.727 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.022 ' N ' HG21 ' A' ' 84' ' ' THR . 5.6 p -102.87 114.14 41.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 113.779 -1.555 . . . . 0.33 110.046 -172.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 35.5 m-70 -79.78 98.55 7.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.798 -2.455 . . . . 1.19 109.354 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.43 ' HA ' HG23 ' A' ' 18' ' ' VAL . 70.1 tt0 -82.4 -64.11 1.24 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.099 -1.864 . . . . 1.67 109.736 175.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.59 87.68 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.897 -0.592 . . . . 2.78 110.271 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.23 -0.89 . . . . 6.92 110.974 177.138 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.207 0.527 . . . . 1.93 110.251 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 4' ' ' ILE . 5.8 m-20 -90.56 168.75 13.41 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.295 -0.866 . . . . 1.65 110.514 175.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.76 42.26 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.393 2.729 . . . . 0.97 113.357 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.962 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -58.22 -51.27 73.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.74 -0.664 . . . . 0.5 110.163 172.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.591 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 86.72 40.28 7.26 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.602 -1.799 . . . . 0.39 108.602 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.137 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.8 tp -53.2 -50.07 65.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.544 -1.828 . . . . 0.33 110.252 -172.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -84.23 84.48 7.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.72 110.176 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.2 t -73.2 -42.88 58.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.43 -1.259 . . . . 0.63 109.416 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.7 ttm -152.19 135.87 16.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.225 -0.898 . . . . 2.88 108.715 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -91.1 139.76 25.77 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.862 -0.422 . . . . 3.67 109.862 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 33.6 Cg_endo -67.49 141.57 56.22 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.091 1.86 . . . . 0.64 109.164 171.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.619 ' O ' ' HD1' ' A' ' 24' ' ' PHE . 6.3 tp60 -118.2 163.83 16.08 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.932 0.715 . . . . 1.43 112.932 -168.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.1 m-20 -57.67 -139.94 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 125.674 1.589 . . . . 2.06 112.928 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 143.13 136.19 3.13 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 113.291 -1.777 . . . . 0.3 111.975 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 35.8 mt-10 -108.51 114.93 29.16 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.349 -0.926 . . . . 1.53 108.527 175.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.4 m -135.25 163.6 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.867 0 N-CA-C 107.932 -1.136 . . . . 0.27 107.932 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 154.29 17.33 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.636 -1.166 . . . . 0.77 109.193 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.69 HG11 ' HD3' ' A' ' 81' ' ' PRO . 4.0 t -65.78 107.58 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 CA-C-O 122.845 1.307 . . . . 0.78 108.9 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.3 10.38 10.74 Favored Glycine 0 C--N 1.269 -3.162 0 CA-C-N 112.107 -2.315 . . . . 0.48 112.734 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.82 -123.43 4.89 Favored Glycine 0 N--CA 1.42 -2.409 0 C-N-CA 119.331 -1.414 . . . . 0.44 110.269 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.6 p -151.35 168.44 24.8 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.079 -1.561 . . . . 0.82 110.201 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 104' ' ' LEU . 9.0 tp -147.79 149.44 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 CA-C-N 113.693 -1.594 . . . . 0.32 108.04 169.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 m -138.11 128.64 26.44 Favored 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 114.066 -1.425 . . . . 0.31 111.163 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.619 ' HD1' ' O ' ' A' ' 12' ' ' GLN . 3.4 m-85 -126.01 147.54 49.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 113.879 -1.51 . . . . 0.53 107.817 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -140.89 127.73 20.46 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.57 0.7 . . . . 0.58 109.78 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.19 115.5 23.16 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.922 -1.035 . . . . 0.32 110.383 -176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -104.31 121.11 42.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.312 -0.255 . . . . 2.43 110.312 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.606 HG21 HG21 ' A' ' 39' ' ' VAL . 15.1 t -122.31 126.03 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.129 0.966 . . . . 0.26 110.319 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -57.83 109.01 0.65 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.151 -1.84 . . . . 0.4 111.432 176.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.606 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -50.1 -58.58 8.52 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.946 -1.025 . . . . 0.76 111.418 172.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.823 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 59.8 -171.15 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.137 1.162 . . . . 0.71 114.137 168.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -109.09 130.42 55.48 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.916 -1.038 . . . . 1.74 109.846 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -160.93 -176.2 5.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.396 0.617 . . . . 2.16 112.038 -172.298 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.8 tp -70.77 -44.86 65.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.966 -1.015 . . . . 1.47 108.741 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.597 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.46 150.27 28.41 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 114.79 -1.096 . . . . 1.4 109.634 174.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.77 148.79 5.76 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.484 2.789 . . . . 0.88 112.426 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.639 ' HA ' HG23 ' A' ' 93' ' ' THR . 4.1 Cg_exo -50.11 132.51 33.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.709 1.606 . . . . 0.53 113.207 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.3 105.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.404 -1.702 . . . . 0.77 106.404 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.626 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.56 114.5 47.11 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.784 -1.553 . . . . 0.28 107.195 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.551 ' O ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.93 124.82 50.16 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 123.287 1.518 . . . . 1.54 109.16 174.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.068 ' HB3' HD13 ' A' ' 49' ' ' LEU . 79.8 m95 -83.93 151.09 25.26 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 111.646 -2.525 . . . . 0.34 111.231 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.699 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 36.9 t80 -128.61 138.75 52.36 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 104.58 -2.378 . . . . 0.62 104.58 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.816 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 31.6 tptt -104.64 165.28 11.17 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.41 -2.07 . . . . 2.17 105.41 -172.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.803 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.62 -168.95 0.0 OUTLIER Glycine 0 C--O 1.188 -2.741 0 N-CA-C 119.321 2.488 . . . . 1.23 119.321 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -44.82 -1.47 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.95 2.204 . . . . 3.87 116.95 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.8 p-90 -167.16 -11.5 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.858 1.429 . . . . 2.11 114.858 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.674 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.37 169.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 CA-C-O 123.452 1.596 . . . . 1.29 112.889 -161.257 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.482 ' OD1' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -111.05 156.19 21.67 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 111.613 -2.54 . . . . 2.73 107.511 172.196 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.068 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -96.77 -36.88 10.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 119.292 -0.385 . . . . 0.44 111.896 169.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 t -58.15 -20.49 41.16 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.31 0.576 . . . . 1.23 109.47 -165.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -98.02 -17.64 19.04 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.302 -0.863 . . . . 1.34 113.014 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 6.2 mmmt -102.87 -54.59 2.6 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.773 -0.649 . . . . 1.4 111.174 -173.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 49' ' ' LEU . 70.3 t -6.25 90.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 O-C-N 125.93 2.019 . . . . 0.37 113.139 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.633 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.87 -129.61 1.16 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 112.579 -2.101 . . . . 0.7 112.191 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -72.65 -28.71 62.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.764 0.653 . . . . 2.75 112.764 -168.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 30.0 p80 -96.06 -37.17 10.74 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.699 0.762 . . . . 1.33 111.181 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.988 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -125.62 105.22 8.85 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.313 -1.736 . . . . 1.11 106.313 175.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.45 113.93 25.55 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 106.325 -1.732 . . . . 0.76 106.325 166.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.79 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.48 92.47 5.4 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 104.47 -2.419 . . . . 0.26 104.47 171.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 33.0 m170 -87.61 159.86 18.4 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.831 1.3 . . . . 2.03 110.306 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -135.03 110.27 8.96 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 111.548 -2.569 . . . . 0.92 109.866 175.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -91.77 148.78 21.98 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 112.302 -2.226 . . . . 0.47 107.576 174.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.8 98.31 3.31 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.45 1.119 . . . . 1.39 110.843 -173.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -118.01 124.82 49.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.554 -1.657 . . . . 2.42 109.931 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -35.41 19.12 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.148 -1.842 . . . . 2.46 110.62 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.995 -1.002 . . . . 1.15 110.789 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -90.22 -18.78 25.08 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.771 -0.826 . . . . 1.41 108.771 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.823 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 7.4 ttpt 66.0 33.18 7.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.871 -1.059 . . . . 3.31 109.367 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.48 122.91 56.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.721 0.772 . . . . 0.43 109.826 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 62' ' ' SER . 2.9 m-30 -96.67 108.39 21.0 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.548 -1.649 . . . . 1.24 106.548 167.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 28.1 tp -93.42 105.9 17.91 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.966 -1.015 . . . . 0.52 109.336 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 71.0 m-85 -91.1 111.19 22.56 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.333 -1.728 . . . . 0.33 106.333 170.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -121.61 132.29 54.59 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.722 -1.126 . . . . 1.32 110.107 -174.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.68 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.3 mt -98.27 131.71 44.37 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.199 -1.819 . . . . 0.96 108.936 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -116.8 97.64 6.08 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 104.041 -2.577 . . . . 1.15 104.041 165.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.68 HG13 ' HB3' ' A' ' 74' ' ' LEU . 10.8 mt -123.0 101.56 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.395 1.093 . . . . 0.52 108.281 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.7 p -104.76 171.56 7.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 CA-C-N 114.874 -1.057 . . . . 0.58 110.105 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 39.89 67.41 0.48 Allowed 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.838 -2.892 . . . . 2.12 111.562 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.49 116.32 6.65 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.625 -2.08 . . . . 0.4 109.878 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.828 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -67.77 152.04 96.67 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.034 -0.728 . . . . 1.43 109.034 175.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.69 ' HD3' HG11 ' A' ' 18' ' ' VAL . 38.2 Cg_endo -66.16 -8.3 19.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.45 2.1 . . . . 1.33 112.605 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.828 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -105.59 15.29 27.22 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.096 -0.502 . . . . 1.12 110.278 176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.7 m-30 -97.37 -6.4 34.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 118.849 -0.596 . . . . 1.24 110.983 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 22.9 m -23.59 95.07 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 125.497 1.748 . . . . 1.22 111.393 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.803 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -55.49 115.52 5.93 Favored Glycine 0 N--CA 1.406 -3.341 0 CA-C-N 110.431 -3.077 . . . . 1.43 114.863 -169.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.681 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -119.18 68.7 0.35 Allowed Glycine 0 C--N 1.269 -3.188 0 CA-C-N 111.815 -2.192 . . . . 0.52 108.433 149.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.816 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 32.5 m-85 -73.98 115.75 13.8 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.179 -1.045 . . . . 0.63 108.179 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.699 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 37.6 mtp180 -109.09 113.39 26.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.671 -0.492 . . . . 3.15 109.671 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.1 t -101.8 110.7 22.73 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.624 0.726 . . . . 1.08 109.355 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 0.8 OUTLIER -121.1 110.91 16.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.5 -1.227 . . . . 1.81 110.07 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HB ' HG13 ' A' ' 39' ' ' VAL . 7.0 p -100.12 140.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.299 0.571 . . . . 0.54 110.27 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -135.74 108.59 7.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.409 -0.96 . . . . 1.18 108.409 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -132.2 144.85 50.94 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-O 117.374 -1.298 . . . . 0.74 108.242 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.25 -72.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 O-C-N 125.629 1.831 . . . . 0.65 113.699 -173.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.716 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 24.8 t70 -153.33 -1.18 0.23 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.681 -1.145 . . . . 1.05 110.707 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.137 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.8 tttp -88.25 126.45 35.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.447 -0.945 . . . . 1.29 108.447 176.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 91' ' ' VAL . 15.1 t80 -130.42 117.7 20.09 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 0.77 110.063 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -134.61 141.67 46.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.498 -1.683 . . . . 1.6 108.639 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 5.0 m -136.21 144.22 44.79 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.473 . . . . 1.19 110.688 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.651 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 82.1 p -130.74 118.66 21.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.732 -0.667 . . . . 0.84 110.507 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -101.41 123.57 45.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.621 -0.718 . . . . 1.58 109.516 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.67 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.9 p90 -142.88 135.56 27.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.005 0.907 . . . . 0.86 110.581 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.778 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.6 m-80 -105.19 132.38 51.48 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.068 -1.424 . . . . 2.11 111.449 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.705 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.41 106.58 17.74 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.554 -1.203 . . . . 0.37 108.651 172.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 8.1 m -89.28 96.45 10.72 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.592 -0.892 . . . . 0.33 108.592 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 18' ' ' VAL . 4.7 p -85.2 113.69 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 123.031 1.396 . . . . 0.33 109.104 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.93 99.21 11.7 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.648 -2.069 . . . . 1.19 109.666 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.1 tt0 -69.21 -46.84 66.41 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.004 -1.907 . . . . 1.67 110.16 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.03 37.13 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.541 -0.754 . . . . 2.78 111.329 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.526 -0.749 . . . . 6.92 110.325 178.925 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.808 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 7.4 p-10 . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 122.451 1.119 . . . . 1.93 111.035 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.738 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 23.1 t70 -76.59 150.84 82.43 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 113.712 -1.585 . . . . 1.65 108.31 169.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.59 58.25 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.445 2.763 . . . . 0.97 114.421 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.993 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -67.86 -52.31 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.5 109.463 168.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.36 46.0 5.39 Favored Glycine 0 CA--C 1.494 -1.232 0 N-CA-C 108.252 -1.939 . . . . 0.39 108.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.943 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.9 tp -55.04 -38.05 67.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.69 -1.755 . . . . 0.33 110.643 -169.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.743 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -96.07 85.13 3.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.209 -0.905 . . . . 0.72 109.823 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.03 -37.55 41.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.553 -1.203 . . . . 0.63 110.01 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 tpp -151.28 134.39 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.513 -0.767 . . . . 2.88 109.636 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 17.0 ptm180 -108.57 136.86 19.89 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.786 -0.643 . . . . 3.67 109.916 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 2.0 Cg_endo -76.35 138.36 19.79 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.672 2.248 . . . . 0.64 111.531 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -89.31 -177.98 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.696 -0.684 . . . . 1.43 110.527 176.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -74.61 -142.87 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.291 1.043 . . . . 2.06 110.7 178.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.77 140.02 2.86 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.355 -1.293 . . . . 0.3 112.512 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.464 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 27.4 mt-10 -116.87 119.18 34.57 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.277 -0.961 . . . . 1.53 108.52 172.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.2 m -136.43 162.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 N-CA-C 107.068 -1.456 . . . . 0.27 107.068 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.719 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -91.03 156.53 17.86 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.039 -0.982 . . . . 0.77 110.22 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 81' ' ' PRO . 11.6 t -66.47 107.12 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-O 123.023 1.392 . . . . 0.78 108.202 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.69 14.31 12.78 Favored Glycine 0 C--N 1.266 -3.327 0 CA-C-N 111.925 -2.398 . . . . 0.48 112.438 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.89 -125.24 5.32 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.366 -1.493 . . . . 0.44 109.366 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 24.4 p -152.73 165.51 35.08 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.236 -1.482 . . . . 0.82 110.685 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 104' ' ' LEU . 10.3 tp -147.72 150.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.187 -1.824 . . . . 0.32 107.252 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -138.95 125.94 21.13 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 113.442 -1.708 . . . . 0.31 110.043 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.76 150.06 44.86 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.375 -1.284 . . . . 0.53 108.446 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.667 ' HB3' HD11 ' A' ' 71' ' ' LEU . 9.9 m -142.04 131.37 23.59 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.881 -0.785 . . . . 0.58 108.881 175.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -127.42 115.54 19.08 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.205 -1.361 . . . . 0.32 109.772 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HG2' HD13 ' A' ' 71' ' ' LEU . 48.9 mtp180 -104.98 123.4 47.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.123 -0.49 . . . . 2.43 110.329 -173.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 39' ' ' VAL . 14.1 t -123.76 127.58 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.463 1.125 . . . . 0.26 110.752 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.31 113.86 2.86 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.086 -1.87 . . . . 0.4 112.931 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 1.048 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -49.78 -64.75 3.26 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 114.313 -1.312 . . . . 0.76 111.085 166.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.705 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 60.52 -175.69 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 115.196 1.554 . . . . 0.71 115.196 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -96.55 106.88 19.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.867 -1.515 . . . . 1.74 109.759 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.988 HD12 HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -151.83 171.03 18.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.975 -0.557 . . . . 2.16 110.674 -171.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.73 -49.06 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.42 0.629 . . . . 1.47 110.244 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.645 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -149.92 158.14 37.29 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.611 -0.885 . . . . 1.4 108.611 174.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.75 139.62 3.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.159 2.573 . . . . 0.88 112.296 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.8 ' HD3' HD11 ' A' ' 33' ' ' LEU . 8.9 Cg_exo -55.27 141.96 79.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.012 1.142 . . . . 0.53 112.916 -175.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.84 106.38 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.332 -1.729 . . . . 0.77 106.332 174.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 28' ' ' VAL . 2.8 t -109.22 115.22 49.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.918 0 CA-C-N 113.384 -1.735 . . . . 0.28 108.083 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.935 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.66 130.53 52.67 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 123.126 1.441 . . . . 1.54 110.029 175.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.058 ' HB3' HD13 ' A' ' 49' ' ' LEU . 90.8 m95 -94.32 145.28 24.86 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 112.158 -2.292 . . . . 0.34 111.917 173.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.5 t80 -126.88 130.86 50.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.641 -1.985 . . . . 0.62 105.641 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 35.3 ttpt -104.76 111.58 24.36 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.523 -1.288 . . . . 2.17 107.523 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.646 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -81.24 92.63 1.49 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 116.146 -2.93 . . . . 1.23 114.274 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.753 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 tttp -106.67 -53.98 2.54 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 102.765 -3.05 . . . . 3.87 102.765 134.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.753 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 9.0 p-90 -168.0 0.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 110.171 -3.195 . . . . 2.11 110.933 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG21 ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -96.87 173.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.574 1.654 . . . . 1.29 113.357 -159.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.5 t70 -110.27 145.23 37.74 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.097 -2.774 . . . . 2.73 105.775 174.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.058 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.9 mp -80.47 -38.26 30.31 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.22 -0.592 . . . . 0.44 111.705 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -62.35 -18.78 62.35 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.809 -0.812 . . . . 1.23 108.809 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.452 ' C ' ' HD2' ' A' ' 52' ' ' LYS . 33.5 m -84.48 -22.63 30.21 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 114.681 -1.145 . . . . 1.34 111.532 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 8.0 mmmt -109.16 -67.52 0.98 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.181 -0.918 . . . . 1.4 111.623 -174.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.844 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.3 t 8.02 92.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 126.696 1.998 . . . . 0.37 113.912 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.99 -135.97 2.43 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.215 -1.812 . . . . 0.7 113.291 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.69 -36.58 79.14 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.967 1.099 . . . . 2.75 113.967 -168.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.704 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -98.19 -36.52 10.02 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 119.741 -0.784 . . . . 1.33 111.393 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.837 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.39 103.68 10.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.347 -1.353 . . . . 1.11 107.347 173.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.45 115.7 29.88 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 106.448 -1.686 . . . . 0.76 106.448 166.585 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.844 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.02 93.29 5.92 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 104.782 -2.303 . . . . 0.26 104.782 172.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 2.1 m80 -94.41 162.7 13.72 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.43 -1.259 . . . . 2.03 109.533 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.0 p-10 -137.09 112.1 8.99 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 111.961 -2.381 . . . . 0.92 110.103 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -95.66 150.8 19.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 112.455 -2.157 . . . . 0.47 108.525 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CZ ' ' HG2' ' A' ' 65' ' ' ARG . 6.7 t80 -143.67 98.53 3.26 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 122.643 1.211 . . . . 1.39 110.983 -173.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' OD2' ' HB3' ' A' ' 67' ' ' SER . 0.1 OUTLIER -110.0 105.47 14.62 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 112.759 -2.019 . . . . 2.42 110.045 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HG2' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -75.65 -30.78 59.56 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 2.46 111.038 -175.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.66 -24.49 64.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.208 -0.905 . . . . 1.15 110.461 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.539 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 6.5 t -100.94 -12.48 18.9 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.018 -0.734 . . . . 1.41 109.018 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 8.7 ttpt 67.18 31.25 6.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.101 -0.954 . . . . 3.31 110.5 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 27' ' ' ARG . 5.0 t -125.23 133.54 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.954 0.883 . . . . 0.43 110.631 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 1.048 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.9 m-85 -98.8 111.56 23.9 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.518 -2.03 . . . . 1.24 105.518 162.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.2 tp -100.87 104.0 15.2 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.113 0.959 . . . . 0.52 108.539 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 58.6 m-85 -84.64 113.39 21.24 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.929 -1.508 . . . . 0.33 106.929 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 5.2 pt-20 -117.99 123.85 46.73 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.376 -1.738 . . . . 1.32 110.216 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.825 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.1 mm? -91.88 126.87 37.13 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 112.653 -2.067 . . . . 0.96 108.127 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -116.19 96.42 5.54 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 104.368 -2.456 . . . . 1.15 104.368 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 55.5 mt -122.09 100.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 123.012 1.387 . . . . 0.52 109.875 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 45.5 p -104.18 154.38 19.82 Favored 'General case' 0 N--CA 1.394 -3.227 0 CA-C-N 113.964 -1.471 . . . . 0.58 108.492 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 44.21 85.7 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.322 -2.672 . . . . 2.12 112.429 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -71.85 136.81 47.13 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 110.926 -2.852 . . . . 0.4 111.191 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.64 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -63.44 130.12 94.08 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.259 -0.645 . . . . 1.43 109.259 173.47 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.733 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.6 Cg_endo -58.71 -13.04 16.27 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.561 2.841 . . . . 1.33 114.285 -171.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -120.45 28.8 7.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.887 -0.325 . . . . 1.12 111.622 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.557 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.21 -57.27 4.0 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.252 -0.648 . . . . 1.24 109.252 172.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 7.3 m 43.86 58.56 3.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.97 -1.492 . . . . 1.22 106.97 -157.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.745 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -51.26 85.48 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.498 0 CA-C-N 112.545 -2.116 . . . . 1.43 114.705 -164.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -92.08 80.71 1.2 Allowed Glycine 0 C--N 1.282 -2.429 0 N-CA-C 108.938 -1.665 . . . . 0.52 108.938 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 13.2 m-85 -78.64 109.8 13.18 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.812 -1.194 . . . . 0.63 108.807 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -94.36 105.03 17.0 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.694 -0.854 . . . . 3.15 108.694 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.582 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 8.4 t -95.52 126.23 40.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.571 -0.851 . . . . 1.08 109.176 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.935 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 92.3 mt-10 -133.96 118.68 18.14 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.65 -0.705 . . . . 1.81 110.367 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.522 HG22 HD21 ' A' ' 6' ' ' LEU . 3.4 p -107.52 143.67 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.485 0.659 . . . . 0.54 110.133 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 m -140.44 112.59 7.75 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.171 -0.922 . . . . 1.18 110.012 -176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.988 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -130.21 174.95 9.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 118.621 -0.704 . . . . 0.74 110.048 177.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -8.61 -60.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.196 1.56 . . . . 0.65 114.732 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.916 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.0 t70 -151.11 -8.05 0.25 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.293 -1.321 . . . . 1.05 109.669 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.993 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -91.13 124.88 35.69 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.679 -1.23 . . . . 1.29 107.679 -177.128 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -131.54 133.64 45.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.293 -0.867 . . . . 0.77 111.513 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -154.24 150.53 28.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.701 -1.136 . . . . 1.6 109.99 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' SG ' ' HG2' ' A' ' 90' ' ' GLU . 72.1 m -142.5 150.33 40.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.025 -0.361 . . . . 1.19 110.025 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.743 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 47.6 p -128.62 135.63 49.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.84 111.764 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.47 138.58 33.39 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.297 -0.865 . . . . 1.58 109.394 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.925 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -150.1 128.93 12.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.725 -0.79 . . . . 0.86 111.879 151.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.74 125.85 54.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.959 0.885 . . . . 2.11 111.279 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.94 104.17 14.12 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.133 -1.394 . . . . 0.37 109.575 -178.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.464 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.0 m -84.81 96.28 9.24 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.568 -0.901 . . . . 0.33 108.568 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.64 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.6 113.95 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 123.061 1.41 . . . . 0.33 109.18 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.719 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.0 m170 -78.55 97.24 5.69 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 112.852 -1.976 . . . . 1.19 109.653 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.7 tt0 -75.84 -34.57 60.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.228 -1.351 . . . . 1.67 109.699 172.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.48 14.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 2.78 110.84 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.505 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 26.4 mmt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.681 -0.69 . . . . 6.92 110.841 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.791 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 6.9 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.468 0.652 . . . . 1.93 109.68 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -94.14 166.07 16.35 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.014 -0.994 . . . . 1.65 111.153 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.68 84.43 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.63 2.22 . . . . 0.97 111.948 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.857 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.0 -59.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.088 -0.96 . . . . 0.5 109.488 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.23 41.4 5.53 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 108.842 -1.703 . . . . 0.39 108.842 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -49.74 -38.97 35.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.738 -1.731 . . . . 0.33 111.048 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.653 ' HE2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -92.61 84.52 5.07 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.72 109.672 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.8 -48.03 35.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.851 -1.068 . . . . 0.63 109.998 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.511 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 16.5 tpt -151.19 129.03 11.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.048 -0.978 . . . . 2.88 108.842 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.653 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 16.3 ptm180 -88.2 144.32 34.09 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.733 -0.667 . . . . 3.67 110.162 -176.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 59.8 Cg_endo -65.8 145.8 81.73 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.557 2.171 . . . . 0.64 110.161 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 4.6 tp-100 -115.67 159.03 21.89 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 119.331 -0.366 . . . . 1.43 111.747 -173.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.3 m-20 -57.89 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 123.418 1.58 . . . . 2.06 113.044 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.18 137.0 2.73 Favored Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 112.963 -1.926 . . . . 0.3 111.551 -174.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.434 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.7 mt-10 -116.06 114.45 24.57 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.714 -0.847 . . . . 1.53 108.714 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 22' ' ' ILE . 4.9 m -134.2 164.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.712 -1.218 . . . . 0.27 107.712 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -95.21 156.73 16.2 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.886 -1.052 . . . . 0.77 109.534 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.579 HG13 ' HD3' ' A' ' 81' ' ' PRO . 42.4 t -62.56 107.02 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-O 122.754 1.264 . . . . 0.78 109.294 175.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.09 11.09 Favored Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.912 -2.404 . . . . 0.48 113.333 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.7 -122.58 4.84 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 119.616 -1.278 . . . . 0.44 110.009 171.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 11.9 p -150.36 165.04 34.28 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 113.087 -1.557 . . . . 0.82 110.645 175.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.724 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.8 tp -148.08 147.48 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.078 -1.874 . . . . 0.32 107.18 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m -139.5 125.97 20.36 Favored 'General case' 0 C--N 1.259 -3.354 0 CA-C-N 113.74 -1.573 . . . . 0.31 110.396 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 10.2 m-85 -123.54 146.67 47.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.618 -1.173 . . . . 0.53 109.458 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.483 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -126.51 129.93 49.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.038 -1.097 . . . . 0.58 108.038 173.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.749 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . . . -130.66 125.16 33.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.57 -1.195 . . . . 0.32 110.812 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.5 mtt180 -115.36 123.12 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.842 0.312 . . . . 2.43 111.842 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 39' ' ' VAL . 13.2 t -121.69 128.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.775 0.798 . . . . 0.26 109.593 178.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -57.63 107.38 0.44 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.881 -1.508 . . . . 0.4 110.527 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.699 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -55.79 -39.1 75.93 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.731 -1.122 . . . . 0.76 110.925 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.67 -163.93 0.03 OUTLIER 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.695 1.368 . . . . 0.71 114.695 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -111.64 123.02 49.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.443 -1.253 . . . . 1.74 108.153 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.889 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -155.1 174.65 14.89 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.673 0.249 . . . . 2.16 111.673 -172.086 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.6 tp -62.07 -47.99 82.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 1.47 109.539 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -151.15 154.59 34.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.059 -0.973 . . . . 1.4 108.963 170.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -44.14 134.37 8.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.627 2.885 . . . . 0.88 112.049 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.889 ' HD3' HD11 ' A' ' 33' ' ' LEU . 8.7 Cg_exo -42.89 142.87 1.98 Allowed 'Trans proline' 0 CA--C 1.499 -1.232 0 C-N-CA 123.849 3.033 . . . . 0.53 115.189 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.1 99.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 105.875 -1.898 . . . . 0.77 105.875 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.6 t -103.42 114.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-N 113.504 -1.68 . . . . 0.28 107.415 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.882 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.76 128.59 52.94 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.057 -1.429 . . . . 1.54 109.743 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.964 ' HB3' HD13 ' A' ' 49' ' ' LEU . 74.0 m95 -91.51 157.86 16.79 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 112.063 -2.335 . . . . 0.34 111.104 172.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.744 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.9 t80 -139.06 125.51 20.44 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.934 -2.247 . . . . 0.62 104.934 178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.703 ' HD3' HD23 ' A' ' 57' ' ' LEU . 33.8 ttpt -103.02 100.34 10.27 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.715 -1.587 . . . . 2.17 106.715 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 86' ' ' GLY . . . -90.38 97.46 2.33 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 115.993 -3.004 . . . . 1.23 117.293 -157.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 3.8 ptmt -99.14 -47.39 5.23 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.449 -2.797 . . . . 3.87 103.449 137.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.927 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 9.4 p-90 -170.38 3.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 112.468 -2.151 . . . . 2.11 111.102 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -98.82 169.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 C-N-CA 125.04 1.336 . . . . 1.29 112.981 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.643 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -105.43 154.15 20.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.455 -2.157 . . . . 2.73 107.001 175.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.964 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.4 mp -89.24 -30.46 18.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 0.44 112.605 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -57.2 -21.0 30.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.349 0.595 . . . . 1.23 109.854 -167.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.567 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 8.0 t -96.38 -22.55 17.1 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.178 -0.919 . . . . 1.34 111.992 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 1.7 mmmt -106.55 -15.19 14.85 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.778 -1.101 . . . . 1.4 111.671 -171.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.922 HG13 ' H ' ' A' ' 59' ' ' LEU . 55.7 t -59.17 89.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 114.013 -1.449 . . . . 0.37 110.213 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.49 -142.1 3.58 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 112.438 -2.165 . . . . 0.7 112.988 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -67.4 -22.63 65.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.007 0.744 . . . . 2.75 113.007 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.607 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.1 p-80 -101.21 -38.02 8.29 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 120.23 -0.588 . . . . 1.33 111.247 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.826 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.69 102.25 8.28 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.144 -1.799 . . . . 1.11 106.144 172.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -94.41 115.02 27.15 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.724 -1.584 . . . . 0.76 106.724 167.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.922 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.95 91.49 5.35 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.114 -2.55 . . . . 0.26 104.114 167.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.727 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 34.4 m170 -90.18 162.43 15.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.228 -1.351 . . . . 2.03 110.039 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -133.57 110.48 9.94 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 112.323 -2.217 . . . . 0.92 109.866 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 14.2 m -93.95 112.36 24.19 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.89 -1.959 . . . . 0.47 109.322 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.0 t80 -102.23 98.08 8.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.96 -1.018 . . . . 1.39 110.212 -176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.91 107.08 15.21 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.585 -1.643 . . . . 2.42 109.141 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.549 ' HD3' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -81.45 -32.72 32.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.382 -0.827 . . . . 2.46 110.968 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.58 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.229 -0.896 . . . . 1.15 110.527 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 m -108.66 -18.63 13.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.72 -0.844 . . . . 1.41 108.72 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.699 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 62.99 35.65 13.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 3.31 109.979 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -129.62 130.69 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.002 -0.999 . . . . 0.43 108.392 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.55 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 3.9 m-30 -101.26 106.72 17.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.599 -1.63 . . . . 1.24 106.599 171.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 22.7 tp -96.12 104.42 16.37 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.189 -1.368 . . . . 0.52 108.316 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.727 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.7 m-85 -83.53 113.47 20.83 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 113.819 -1.537 . . . . 0.33 107.533 174.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 6.6 mt-10 -106.84 119.02 38.22 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 113.113 -1.858 . . . . 1.32 108.935 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 76' ' ' ILE . 3.1 mm? -88.36 122.76 32.23 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.454 -1.313 . . . . 0.96 107.454 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 36.8 m80 -118.31 95.67 4.98 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 104.327 -2.472 . . . . 1.15 104.327 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 74' ' ' LEU . 39.4 mt -122.11 101.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 123.041 1.4 . . . . 0.52 110.2 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.2 p -110.53 134.79 52.05 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-N 113.621 -1.627 . . . . 0.58 107.692 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 77' ' ' THR . 3.5 t70 73.14 97.31 0.07 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 111.642 -2.526 . . . . 2.12 110.024 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.74 122.77 45.14 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 110.552 -3.022 . . . . 0.4 109.943 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.546 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -64.24 138.26 97.37 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.153 -0.93 . . . . 1.43 109.577 173.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.579 ' HD3' HG13 ' A' ' 18' ' ' VAL . 26.2 Cg_endo -61.44 -9.06 12.04 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.23 2.62 . . . . 1.33 112.421 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.63 17.67 22.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.835 -0.621 . . . . 1.12 111.441 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.753 ' HD1' ' HD2' ' A' ' 45' ' ' LYS . 1.4 m-30 -85.43 -55.33 4.06 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.91 -0.774 . . . . 1.24 108.91 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 88.7 m 28.51 63.84 0.11 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 123.183 1.468 . . . . 1.22 108.68 -161.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.751 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -66.55 91.61 0.17 Allowed Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 111.975 -2.375 . . . . 1.43 114.05 -159.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -83.61 83.74 1.6 Allowed Glycine 0 C--N 1.276 -2.768 0 N-CA-C 108.185 -1.966 . . . . 0.52 108.185 169.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 3.7 m-85 -74.6 113.65 12.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.685 -1.257 . . . . 0.63 108.812 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 99.8 mtt180 -87.89 109.76 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.391 -0.966 . . . . 3.15 108.391 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.419 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 1.6 t -95.97 122.67 39.04 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.601 -0.888 . . . . 1.08 108.601 175.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.882 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 38.5 tt0 -137.82 107.64 6.29 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.244 -0.889 . . . . 1.81 110.289 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.6 p -102.59 141.57 18.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.676 0.75 . . . . 0.54 110.699 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -139.86 108.33 5.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.342 -1.299 . . . . 1.18 108.561 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.743 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.47 145.33 51.1 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-O 117.936 -1.03 . . . . 0.74 108.894 -179.045 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 32.95 -74.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 126.148 2.155 . . . . 0.65 113.578 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.791 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 0.5 OUTLIER -148.16 -8.07 0.4 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.035 -0.984 . . . . 1.05 110.563 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.857 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.9 mmtm -86.05 129.53 34.81 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.432 -1.321 . . . . 1.29 107.432 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 21.3 t80 -132.33 148.39 52.43 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.85 -1.523 . . . . 0.77 111.773 -173.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 t70 -179.0 165.39 1.52 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.207 0.942 . . . . 1.6 110.33 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.3 m -145.22 151.73 38.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.267 -0.271 . . . . 1.19 110.267 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.595 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 58.5 p -132.6 130.31 40.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.041 0.448 . . . . 0.84 112.149 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -94.56 127.32 40.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.368 -0.833 . . . . 1.58 109.393 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 87' ' ' TYR . 28.4 p90 -149.38 143.75 25.96 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.119 -0.632 . . . . 0.86 109.872 165.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.9 m-80 -115.8 140.23 49.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.255 1.026 . . . . 2.11 112.471 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.82 107.99 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.336 -1.302 . . . . 0.37 108.463 172.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.434 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 3.8 m -87.81 96.38 10.44 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.253 -0.647 . . . . 0.33 109.253 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.4 p -79.41 112.78 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.25 1.5 . . . . 0.33 108.672 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 44.0 m170 -85.65 100.34 11.91 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.527 -2.124 . . . . 1.19 109.421 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.449 ' HA ' HG23 ' A' ' 18' ' ' VAL . 37.1 tt0 -68.45 98.52 0.86 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.805 -1.089 . . . . 1.67 109.836 170.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.28 120.04 40.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.402 -0.817 . . . . 2.78 110.18 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.699 -0.667 . . . . 6.92 109.951 179.614 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.73 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 7.7 p-10 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.944 0.878 . . . . 1.93 110.464 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 9.8 m-20 -84.57 167.2 28.31 Favored Pre-proline 0 N--CA 1.428 -1.574 0 CA-C-N 114.527 -1.215 . . . . 1.65 110.067 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.38 88.18 0.33 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.311 2.007 . . . . 0.97 111.889 172.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.92 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.13 -65.16 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.378 -0.828 . . . . 0.5 109.537 177.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 93.8 49.06 2.57 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 108.595 -1.802 . . . . 0.39 108.595 -174.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.8 tp -61.41 -33.39 73.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.083 -1.558 . . . . 0.33 110.22 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.653 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -91.68 84.66 5.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.931 -1.031 . . . . 0.72 110.088 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.57 -46.6 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.899 -1.046 . . . . 0.63 110.405 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.11 131.03 11.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 2.88 109.708 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.542 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 21.2 ptt180 -108.12 142.89 26.27 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.575 -0.739 . . . . 3.67 109.843 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.781 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 11.0 Cg_endo -73.4 158.09 48.64 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.538 1.492 . . . . 0.64 110.82 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -116.3 -180.0 3.83 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.363 -0.606 . . . . 1.43 109.363 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 2.0 p-10 -71.55 -148.92 0.02 OUTLIER 'General case' 0 N--CA 1.407 -2.578 0 CA-C-O 122.932 1.348 . . . . 2.06 111.635 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.69 133.82 1.69 Allowed Glycine 0 C--N 1.293 -1.819 0 CA-C-N 113.356 -1.747 . . . . 0.3 112.045 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.2 mt-10 -113.82 111.12 21.22 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.006 -1.097 . . . . 1.53 108.082 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.424 HG11 ' HB ' ' A' ' 22' ' ' ILE . 3.0 m -126.74 163.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 106.666 -1.605 . . . . 0.27 106.666 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.74 154.61 17.48 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 115.404 -0.816 . . . . 0.77 109.27 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.719 HG21 ' HG3' ' A' ' 81' ' ' PRO . 3.1 t -64.33 106.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 CA-C-O 122.719 1.247 . . . . 0.78 108.365 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.13 8.64 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.378 -2.192 . . . . 0.48 112.145 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.96 -122.28 4.82 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 108.73 -1.748 . . . . 0.44 108.73 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.2 p -151.94 171.1 18.31 Favored 'General case' 0 N--CA 1.399 -3.015 0 CA-C-N 113.344 -1.428 . . . . 0.82 109.894 172.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 104' ' ' LEU . 10.5 tp -146.34 147.53 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 113.276 -1.783 . . . . 0.32 107.316 166.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -139.03 123.96 18.8 Favored 'General case' 0 C--N 1.262 -3.214 0 CA-C-N 113.333 -1.758 . . . . 0.31 110.241 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 74' ' ' LEU . 73.1 m-85 -123.44 145.66 48.63 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.129 -1.396 . . . . 0.53 107.769 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.795 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.3 m -138.18 124.91 20.99 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.745 0.783 . . . . 0.58 109.439 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -116.7 115.73 26.2 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.285 -1.325 . . . . 0.32 110.48 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HE ' HG11 ' A' ' 69' ' ' VAL . 77.1 mtp180 -106.41 115.57 30.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.654 -0.248 . . . . 2.43 110.549 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 91' ' ' VAL . 22.0 t -118.92 126.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.958 0.885 . . . . 0.26 110.523 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.14 112.06 1.76 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.337 -1.756 . . . . 0.4 110.724 173.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.53 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -45.2 -51.53 8.91 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 114.794 -1.094 . . . . 0.76 111.269 171.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.611 ' H ' ' CG ' ' A' ' 68' ' ' LYS . . . 55.49 -155.77 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.408 0.892 . . . . 0.71 113.408 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 p -115.68 135.92 53.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.861 -0.608 . . . . 1.74 109.953 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -155.08 -174.61 5.05 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.826 0.822 . . . . 2.16 112.8 -175.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.3 tp -98.06 -45.17 6.35 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.27 -1.332 . . . . 1.47 108.128 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.554 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.39 139.05 29.02 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.723 -1.126 . . . . 1.4 108.982 172.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.11 156.57 24.09 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.956 2.437 . . . . 0.88 111.103 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 93' ' ' THR . 3.3 Cg_endo -57.1 125.15 18.04 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.544 0.829 . . . . 0.53 112.716 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 104.54 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.054 -1.462 . . . . 0.77 107.054 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.5 t -102.73 114.42 42.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.832 -1.531 . . . . 0.28 108.397 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.02 127.85 53.05 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.743 -1.571 . . . . 1.54 109.817 175.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.99 ' HB3' HD13 ' A' ' 49' ' ' LEU . 77.0 m95 -91.63 155.03 18.63 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 111.969 -2.378 . . . . 0.34 111.677 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.642 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 39.7 t80 -133.36 139.9 47.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.316 -2.476 . . . . 0.62 104.316 170.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.817 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 62.9 tttp -102.51 166.61 10.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 105.721 -1.955 . . . . 2.17 105.721 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -14.03 -167.31 0.0 OUTLIER Glycine 0 C--O 1.183 -3.088 0 N-CA-C 119.248 2.459 . . . . 1.23 119.248 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.693 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 8.4 mtpt -44.41 -8.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 O-C-N 119.125 -2.397 . . . . 3.87 116.786 -164.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.517 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 9.9 p-90 -160.8 -9.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 114.101 1.148 . . . . 2.11 114.101 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.817 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.92 164.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 CA-C-O 123.218 1.485 . . . . 1.29 112.481 -160.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.575 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 9.9 p-10 -111.1 158.54 18.75 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 111.815 -2.448 . . . . 2.73 106.508 172.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.091 HD23 HD21 ' A' ' 57' ' ' LEU . 5.7 mp -98.88 -28.74 13.32 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.476 -0.49 . . . . 0.44 111.792 167.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -57.3 -21.37 34.37 Favored 'General case' 0 C--N 1.315 -0.891 0 O-C-N 123.706 0.629 . . . . 1.23 109.864 -163.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 33.2 m -100.03 -35.38 9.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 122.033 0.921 . . . . 1.34 112.224 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.575 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -88.61 -31.29 18.66 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.159 -1.382 . . . . 1.4 111.685 -165.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.846 HG13 ' H ' ' A' ' 59' ' ' LEU . 79.2 t -35.46 94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.392 1.477 . . . . 0.37 111.753 172.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.44 -95.91 0.11 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 112.501 -2.136 . . . . 0.7 113.837 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -95.3 -45.37 7.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.944 0.72 . . . . 2.75 112.944 -172.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 31.5 p80 -88.45 -37.11 16.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.736 0.779 . . . . 1.33 110.609 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.091 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.55 106.92 12.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.428 -1.693 . . . . 1.11 106.428 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -100.81 116.13 31.98 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 106.63 -1.619 . . . . 0.76 106.63 164.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.846 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -95.19 93.8 7.53 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 104.829 -2.285 . . . . 0.26 104.829 173.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 90.3 m-70 -84.33 162.49 20.04 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.338 -1.301 . . . . 2.03 109.887 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -140.13 114.76 9.41 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 111.986 -2.37 . . . . 0.92 109.42 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 2.0 m -101.52 149.35 24.18 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.796 -2.002 . . . . 0.47 108.628 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -141.29 98.62 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.569 1.175 . . . . 1.39 111.251 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.46 101.71 9.39 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.315 -1.766 . . . . 2.42 109.319 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -73.85 -29.58 62.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.508 -0.769 . . . . 2.46 110.228 177.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.98 70.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.106 -0.952 . . . . 1.15 110.668 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -103.36 -13.81 16.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.209 -0.905 . . . . 1.41 109.455 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER 63.36 36.88 11.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.872 0.844 . . . . 3.31 109.898 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.431 HG11 ' HE ' ' A' ' 27' ' ' ARG . 3.2 t -127.41 128.1 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.673 0.749 . . . . 0.43 109.726 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.53 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.7 m-85 -98.19 113.36 25.25 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.922 -1.881 . . . . 1.24 105.922 164.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' A' ' 25' ' ' SER . 21.7 tp -99.06 106.4 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 122.217 1.008 . . . . 0.52 109.374 174.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 55.3 m-85 -84.47 113.33 21.13 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 113.726 -1.579 . . . . 0.33 107.953 168.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.9 116.84 32.37 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.67 -1.604 . . . . 1.32 110.7 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.802 ' HB3' HG13 ' A' ' 76' ' ' ILE . 18.0 mt -81.97 123.65 29.07 Favored 'General case' 0 CA--C 1.475 -1.926 0 CA-C-N 115.081 -0.963 . . . . 0.96 108.927 170.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -111.73 93.65 4.56 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 103.108 -2.923 . . . . 1.15 103.108 163.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 74' ' ' LEU . 18.1 mt -118.39 99.96 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 122.83 1.3 . . . . 0.52 109.255 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.0 p -102.85 166.51 10.43 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 114.078 -1.419 . . . . 0.58 110.439 -176.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 41.03 67.38 0.53 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 110.658 -2.974 . . . . 2.12 111.551 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -62.18 120.01 10.1 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.894 -1.957 . . . . 0.4 111.252 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.879 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 3.1 tp60 -54.91 140.21 61.22 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.349 -0.841 . . . . 1.43 109.728 169.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.719 ' HG3' HG21 ' A' ' 18' ' ' VAL . 23.2 Cg_exo -62.9 -10.25 19.58 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.692 2.261 . . . . 1.33 112.465 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.879 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -98.64 10.76 40.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.962 -0.563 . . . . 1.12 110.773 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 83' ' ' PHE . 2.8 m-30 -95.54 -10.84 28.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.722 -0.391 . . . . 1.24 110.898 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 21.8 m -46.11 101.31 0.02 OUTLIER 'General case' 0 CA--C 1.475 -1.92 0 CA-C-O 122.358 1.075 . . . . 1.22 108.802 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.693 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -172.69 -128.79 1.08 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.701 -2.045 . . . . 1.43 113.383 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.95 119.03 0.88 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.174 -1.013 . . . . 0.52 112.712 -170.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.713 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.0 m-85 -82.81 120.94 26.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.348 -1.426 . . . . 0.63 108.212 175.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.642 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 57.7 ttt180 -110.91 104.49 13.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.976 0.417 . . . . 3.15 110.193 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.879 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.7 t -92.19 129.86 38.04 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.05 -0.722 . . . . 1.08 109.05 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.691 ' HG3' ' HB3' ' A' ' 99' ' ' CYS . 30.6 tt0 -140.22 106.69 5.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.477 -0.783 . . . . 1.81 109.458 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.634 HG21 HG11 ' A' ' 28' ' ' VAL . 5.5 p -95.05 138.01 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 121.858 0.837 . . . . 0.54 110.73 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.2 t -133.29 108.88 9.01 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.146 -1.388 . . . . 1.18 107.94 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.599 ' OG1' HD21 ' A' ' 6' ' ' LEU . 2.4 m -127.27 170.06 12.86 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.888 -1.153 . . . . 0.74 107.888 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.723 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 0.82 -65.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 125.513 1.758 . . . . 0.65 114.555 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.73 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 1.2 t0 -148.82 -8.96 0.35 Allowed 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.837 -1.074 . . . . 1.05 109.967 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.92 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.2 mmtm -87.5 124.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.79 -1.189 . . . . 1.29 107.79 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -130.65 137.41 49.58 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.735 -1.12 . . . . 0.77 111.153 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -163.07 161.85 25.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.79 -1.096 . . . . 1.6 108.892 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.691 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 3.9 p -153.46 145.33 23.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.152 0.501 . . . . 1.19 111.183 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.653 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 42.5 p -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.84 111.253 -175.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.94 125.27 50.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.226 0.536 . . . . 1.58 110.868 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.879 ' HZ ' ' HB2' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -140.1 116.18 10.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.431 -0.581 . . . . 0.86 109.431 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.574 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 51.1 m-20 -95.16 151.65 19.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.292 -0.867 . . . . 2.11 110.846 -168.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -123.95 121.28 34.87 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.256 -0.884 . . . . 0.37 108.806 174.235 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -103.35 96.05 6.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.416 -0.586 . . . . 0.33 109.416 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.5 p -77.63 116.19 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 123.077 1.418 . . . . 0.33 109.05 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 64.8 m170 -87.56 102.02 14.19 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.395 -2.184 . . . . 1.19 108.275 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.609 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 33.0 tt0 -51.94 -58.59 6.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.133 -1.394 . . . . 1.67 111.277 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.8 135.24 7.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 2.78 110.571 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.704 -0.665 . . . . 6.92 109.42 178.518 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.608 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 10.6 t70 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.798 0.332 . . . . 1.93 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.801 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 2.3 m-20 -131.36 173.96 5.25 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 123.969 0.908 . . . . 1.65 109.4 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.01 77.07 4.07 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.848 1.699 . . . . 0.97 113.19 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.826 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -93.87 -62.6 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.315 -0.994 . . . . 0.5 108.315 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.7 4.64 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 109.368 -1.493 . . . . 0.39 109.368 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.737 HD22 ' HB3' ' A' ' 96' ' ' LYS . 3.7 tp -41.04 -44.37 2.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 112.897 -1.652 . . . . 0.33 111.421 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.691 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -93.0 84.43 4.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.246 -0.888 . . . . 0.72 109.793 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 27' ' ' ARG . 15.8 t -76.16 -33.06 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.018 -1.446 . . . . 0.63 109.187 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp -167.95 137.41 2.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.095 -0.957 . . . . 2.88 109.639 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 27.7 ptt180 -105.66 148.79 37.02 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.933 -0.576 . . . . 3.67 110.079 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 13.5 Cg_endo -79.48 164.52 23.73 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.646 1.564 . . . . 0.64 110.728 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -123.7 179.3 4.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.326 -0.397 . . . . 1.43 110.337 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.2 -144.59 0.01 OUTLIER 'General case' 0 N--CA 1.41 -2.433 0 CA-C-O 122.809 1.29 . . . . 2.06 110.98 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.34 132.26 1.79 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.606 -1.634 . . . . 0.3 111.726 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.0 mt-10 -110.49 114.16 27.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.981 -1.109 . . . . 1.53 108.213 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.9 m -134.48 162.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 N-CA-C 107.821 -1.177 . . . . 0.27 107.821 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 153.15 17.95 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.487 -1.233 . . . . 0.77 108.738 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.74 HG11 ' HD3' ' A' ' 81' ' ' PRO . 5.8 t -69.0 105.01 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.826 1.298 . . . . 0.78 107.956 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.22 12.54 5.22 Favored Glycine 0 C--N 1.267 -3.304 0 CA-C-N 112.445 -2.162 . . . . 0.48 112.642 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.03 -122.66 5.14 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.264 -1.446 . . . . 0.44 110.366 170.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.705 ' HB3' HG22 ' A' ' 77' ' ' THR . 8.1 p -151.51 169.41 22.14 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 113.054 -1.573 . . . . 0.82 110.329 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -148.19 149.98 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.539 -1.664 . . . . 0.32 107.285 168.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 m -140.15 131.49 26.75 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.022 -1.445 . . . . 0.31 110.947 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.547 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 50.0 m-85 -129.55 148.05 51.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.148 -1.387 . . . . 0.53 108.764 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.566 ' HB3' HD11 ' A' ' 71' ' ' LEU . 3.5 m -140.08 127.33 21.17 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.879 0.847 . . . . 0.58 109.188 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.12 117.23 24.92 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.125 -1.398 . . . . 0.32 110.718 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 75.2 mtt180 -102.07 121.78 42.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.3 -0.409 . . . . 2.43 110.505 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.1 t -126.06 128.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 122.082 0.944 . . . . 0.26 110.531 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.36 105.39 0.5 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.444 -1.707 . . . . 0.4 112.398 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.26 89.08 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 115.061 -0.972 . . . . 0.76 111.745 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.851 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 57.54 -163.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.783 1.031 . . . . 0.71 113.783 162.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -118.89 31.13 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 1.74 109.529 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.015 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -56.1 -175.76 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.639 1.348 . . . . 2.16 114.639 176.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 tp -68.98 -53.95 17.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.04 -0.982 . . . . 1.47 109.593 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.632 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.88 146.49 47.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 114.846 -1.07 . . . . 1.4 108.688 172.106 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -42.98 140.37 3.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.464 2.776 . . . . 0.88 111.934 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.7 Cg_endo -53.16 136.59 62.17 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.563 1.509 . . . . 0.53 112.761 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.01 104.31 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.638 0 N-CA-C 106.157 -1.794 . . . . 0.77 106.157 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -106.88 114.75 46.79 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 113.136 -1.847 . . . . 0.28 107.785 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.974 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.69 125.33 50.11 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.825 -1.534 . . . . 1.54 109.58 174.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.997 ' HB3' HD13 ' A' ' 49' ' ' LEU . 68.0 m95 -86.45 149.1 25.23 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.816 -2.447 . . . . 0.34 111.482 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.618 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 25.8 t80 -125.37 138.55 54.04 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 104.66 -2.348 . . . . 0.62 104.66 169.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 67.5 tttt -99.35 171.13 8.17 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.612 -1.996 . . . . 2.17 105.612 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.929 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -19.56 -173.59 0.0 OUTLIER Glycine 0 C--O 1.179 -3.308 0 C-N-CA 126.749 2.118 . . . . 1.23 117.878 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.649 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 7.8 ttpp -40.98 -9.56 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 117.577 2.436 . . . . 3.87 117.577 -157.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.649 ' HD1' ' HB3' ' A' ' 45' ' ' LYS . 4.8 p-90 -161.58 -7.05 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.287 0.949 . . . . 2.11 113.342 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -95.39 165.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-O 123.014 1.388 . . . . 1.29 112.601 -158.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.689 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 6.5 p-10 -114.05 154.3 27.95 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 112.022 -2.353 . . . . 2.73 109.284 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.054 HD23 HD21 ' A' ' 57' ' ' LEU . 5.6 mp -98.44 -32.24 11.59 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.774 -0.648 . . . . 0.44 111.637 169.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -59.47 -23.38 62.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.369 -0.604 . . . . 1.23 109.369 -166.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.689 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 6.2 m -102.95 -27.69 12.47 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.621 -0.832 . . . . 1.34 113.023 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 11.4 mptt -80.78 -84.61 0.1 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.716 -0.674 . . . . 1.4 111.584 -173.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 24.7 t 21.68 95.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 126.068 2.105 . . . . 0.37 113.966 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.93 -99.54 0.14 Allowed Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.132 -1.395 . . . . 0.7 113.264 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -83.2 -53.57 5.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.321 0.489 . . . . 2.75 112.321 -170.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.9 p80 -92.02 -33.83 14.67 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.235 -0.586 . . . . 1.33 111.432 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.054 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.39 106.24 14.35 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.112 -1.81 . . . . 1.11 106.112 174.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -101.35 116.72 33.43 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.949 -1.5 . . . . 0.76 106.949 165.283 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.88 92.96 6.08 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.216 -2.142 . . . . 0.26 105.216 170.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.942 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.8 m170 -87.99 162.1 17.03 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.673 -1.149 . . . . 2.03 109.912 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -142.13 115.71 9.09 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.214 -2.267 . . . . 0.92 109.784 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.2 m -95.82 150.33 20.53 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.393 -2.185 . . . . 0.47 109.038 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.74 100.61 5.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.517 1.151 . . . . 1.39 111.422 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.5 t70 -114.42 114.25 25.59 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.292 -1.776 . . . . 2.42 108.819 174.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' C ' ' H ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.63 -37.13 17.05 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.054 -0.975 . . . . 2.46 112.133 -177.333 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.07 68.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.43 0.633 . . . . 1.15 110.113 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -104.12 -11.86 17.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.056 -0.974 . . . . 1.41 109.898 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.833 ' HE3' ' HA ' ' A' ' 31' ' ' ALA 0.295 0.2 OUTLIER 38.84 57.8 1.82 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 124.49 2.091 . . . . 3.31 111.568 -166.528 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 t -122.91 115.31 45.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 112.373 -2.194 . . . . 0.43 109.355 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 62' ' ' SER . 34.1 m-85 -91.25 105.96 18.16 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.898 -1.519 . . . . 1.24 106.898 167.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.7 tp -86.51 104.5 16.03 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.681 -1.145 . . . . 0.52 108.522 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.653 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 80.5 m-85 -87.25 110.81 20.45 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.795 -1.557 . . . . 0.33 106.795 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.942 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -114.3 125.59 54.06 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.148 -1.387 . . . . 1.32 110.136 -176.585 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.694 HD13 HD11 ' A' ' 76' ' ' ILE . 2.6 mt -92.41 131.9 37.2 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 113.571 -1.65 . . . . 0.96 108.437 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -119.88 97.43 5.62 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 104.491 -2.411 . . . . 1.15 104.491 165.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.712 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 14.3 mt -123.47 99.85 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.624 1.202 . . . . 0.52 108.871 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' HB3' ' A' ' 21' ' ' SER . 25.0 p -99.04 166.69 11.15 Favored 'General case' 0 N--CA 1.395 -3.22 0 CA-C-O 122.891 1.329 . . . . 0.58 110.444 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 40.58 74.17 0.11 Allowed 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 110.361 -3.108 . . . . 2.12 111.468 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -64.34 115.11 4.75 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.765 -2.016 . . . . 0.4 108.701 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -67.42 159.62 76.7 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.708 -0.849 . . . . 1.43 108.708 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.74 ' HD3' HG11 ' A' ' 18' ' ' VAL . 68.5 Cg_endo -73.68 156.34 49.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 120.984 1.123 . . . . 1.33 111.394 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.4 15.5 9.56 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.747 0.655 . . . . 1.12 110.523 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.781 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -85.29 -8.28 58.59 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.791 -0.623 . . . . 1.24 109.621 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.755 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 23.2 m -10.98 84.9 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 126.042 2.089 . . . . 1.22 111.974 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.929 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.76 118.34 3.59 Favored Glycine 0 N--CA 1.406 -3.333 0 CA-C-N 110.816 -2.902 . . . . 1.43 113.478 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.53 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -116.34 63.38 0.36 Allowed Glycine 0 C--N 1.266 -3.328 0 CA-C-N 112.545 -1.827 . . . . 0.52 108.716 158.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 75.8 m-85 -73.02 106.78 5.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.204 -1.406 . . . . 0.63 107.204 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.618 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 55.3 mtt-85 -118.3 105.36 11.67 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.242 -0.583 . . . . 3.15 109.967 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.672 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -89.36 124.48 34.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.861 -0.608 . . . . 1.08 109.642 -177.06 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.974 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 36.9 tt0 -129.2 110.81 12.29 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.77 -1.104 . . . . 1.81 109.244 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.625 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.2 p -99.97 139.95 20.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.429 0.633 . . . . 0.54 110.151 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -137.02 110.05 7.71 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.788 -1.097 . . . . 1.18 108.329 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.746 HG21 HD12 ' A' ' 33' ' ' LEU . 1.1 m -129.86 167.41 18.18 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.925 -0.769 . . . . 0.74 108.925 -176.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.801 ' HZ3' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 6.75 -69.16 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.668 1.855 . . . . 0.65 114.028 172.148 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 1' ' ' ASP . 7.5 t70 -154.23 1.98 0.23 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.672 -0.695 . . . . 1.05 109.134 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.826 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -91.68 136.19 33.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 122.073 0.94 . . . . 1.29 108.812 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -132.52 134.02 44.48 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 112.683 -2.053 . . . . 0.77 111.592 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -157.0 148.07 21.89 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.813 -1.085 . . . . 1.6 110.47 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.2 149.35 34.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.836 -0.62 . . . . 1.19 109.838 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.691 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 80.4 p -141.41 136.12 31.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.959 0.409 . . . . 0.84 110.386 176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -107.53 130.09 54.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.799 -0.637 . . . . 1.58 109.395 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.78 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -141.1 112.83 7.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.649 0.737 . . . . 0.86 109.496 -177.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.769 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 61.5 m-20 -95.37 148.76 22.1 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.51 1.148 . . . . 2.11 111.359 -167.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.807 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -119.31 108.78 15.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.052 -1.431 . . . . 0.37 110.796 177.153 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.2 m -91.54 96.92 10.74 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.687 -0.856 . . . . 0.33 108.687 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 18' ' ' VAL . 8.0 p -86.88 120.76 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.096 1.427 . . . . 0.33 109.782 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -95.41 100.97 12.66 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 112.145 -2.298 . . . . 1.19 108.987 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.713 ' HA ' HG23 ' A' ' 18' ' ' VAL . 48.7 tt0 -64.5 -54.53 30.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.255 -1.339 . . . . 1.67 110.743 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.47 14.83 0.87 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.38 -0.373 . . . . 2.78 111.041 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.389 -0.815 . . . . 6.92 109.848 -179.17 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 1.012 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 3.3 p-10 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.661 0.743 . . . . 1.93 110.128 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.548 ' HB2' HD13 ' A' ' 4' ' ' ILE . 15.2 m-20 -82.58 171.18 12.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 115.434 -0.803 . . . . 1.65 110.623 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 41.77 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.076 2.517 . . . . 0.97 113.386 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.799 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -61.59 -50.01 82.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.696 0.76 . . . . 0.5 109.537 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.21 30.55 22.23 Favored Glycine 0 CA--C 1.497 -1.064 0 N-CA-C 109.176 -1.57 . . . . 0.39 109.176 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.001 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 10.6 tp -41.8 -54.41 3.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.981 -1.609 . . . . 0.33 111.426 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.752 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -84.57 83.89 7.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.54 0.686 . . . . 0.72 109.801 176.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.69 -45.37 66.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.66 -1.155 . . . . 0.63 109.767 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.742 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 22.8 mmt -136.68 132.63 35.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.688 -0.687 . . . . 2.88 110.027 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.745 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 88.0 mtt180 -90.98 121.82 67.47 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.052 -0.721 . . . . 3.67 109.052 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.68 ' HG2' ' HE1' ' A' ' 102' ' ' PHE . 18.6 Cg_endo -62.21 156.75 48.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.858 2.372 . . . . 0.64 110.856 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 4.1 tp-100 -120.0 160.07 23.49 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 119.075 -0.488 . . . . 1.43 112.185 -167.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.605 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -58.41 -144.77 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 123.053 1.406 . . . . 2.06 112.611 176.126 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 151.38 135.31 2.29 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 113.404 -1.726 . . . . 0.3 111.951 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 26.2 mt-10 -111.03 118.74 36.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.476 -0.935 . . . . 1.53 108.476 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 22' ' ' ILE . 2.3 m -139.23 162.97 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.706 -1.22 . . . . 0.27 107.706 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.768 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.19 158.11 15.75 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.142 -0.936 . . . . 0.77 109.489 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 106' ' ' VAL . 10.1 t -66.18 107.68 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 122.993 1.378 . . . . 0.78 108.365 172.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 12.2 10.71 Favored Glycine 0 C--N 1.269 -3.159 0 CA-C-N 112.097 -2.32 . . . . 0.48 112.833 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.35 -124.7 5.09 Favored Glycine 0 N--CA 1.418 -2.507 0 C-N-CA 119.314 -1.422 . . . . 0.44 110.09 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 71.2 m -154.49 171.0 20.09 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 113.271 -1.465 . . . . 0.82 109.19 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.598 HG21 HD13 ' A' ' 104' ' ' LEU . 9.9 tp -149.11 149.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.337 0 CA-C-O 122.719 1.247 . . . . 0.32 107.78 170.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -140.42 125.42 18.43 Favored 'General case' 0 C--N 1.261 -3.241 0 CA-C-N 113.669 -1.605 . . . . 0.31 110.454 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' HB2' HD23 ' A' ' 74' ' ' LEU . 22.1 m-85 -120.03 152.25 37.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.325 -1.307 . . . . 0.53 108.049 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -139.54 129.6 25.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.787 -0.82 . . . . 0.58 108.787 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -133.2 122.18 23.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.803 -1.089 . . . . 0.32 110.695 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.742 ' HD2' ' CG ' ' A' ' 9' ' ' MET . 60.4 mtt180 -107.93 122.64 47.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.665 -0.243 . . . . 2.43 111.015 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 39' ' ' VAL . 6.6 t -121.23 125.79 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.997 0.903 . . . . 0.26 110.132 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -56.35 113.14 1.45 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.594 -1.639 . . . . 0.4 112.575 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.76 -58.07 12.47 Favored Glycine 0 C--O 1.225 -0.422 0 CA-C-N 114.589 -1.187 . . . . 0.76 111.334 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.737 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.48 -174.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.303 1.223 . . . . 0.71 114.303 167.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.6 t -110.09 25.68 11.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.001 -1.0 . . . . 1.74 109.185 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.96 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -55.05 171.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.701 -1.136 . . . . 2.16 112.889 177.154 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.1 tp -50.95 -54.91 20.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.669 -0.696 . . . . 1.47 110.415 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.584 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -147.87 155.5 44.35 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 108.212 -1.033 . . . . 1.4 108.212 172.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -39.67 138.31 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.459 2.773 . . . . 0.88 112.681 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.96 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.9 Cg_exo -55.54 139.28 82.38 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.939 1.759 . . . . 0.53 112.312 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 2.2 t -98.47 104.76 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 105.904 -1.888 . . . . 0.77 105.904 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -112.26 113.57 44.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.195 -1.82 . . . . 0.28 107.445 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.591 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.73 126.71 51.04 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 123.182 1.467 . . . . 1.54 109.346 174.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.071 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.2 m95 -84.17 152.01 24.53 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.03 -2.35 . . . . 0.34 110.957 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.6 t80 -130.04 136.46 49.41 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.747 -2.316 . . . . 0.62 104.747 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.75 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttp -102.77 168.18 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.013 -2.218 . . . . 2.17 105.013 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.993 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -9.5 -172.59 0.0 OUTLIER Glycine 0 C--O 1.183 -3.074 0 N-CA-C 119.808 2.683 . . . . 1.23 119.808 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.7 mtpp -45.82 -3.86 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 116.375 1.991 . . . . 3.87 116.375 -165.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 7.5 p-90 -163.76 -6.77 0.03 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.323 1.231 . . . . 2.11 114.323 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.34 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-O 123.41 1.576 . . . . 1.29 112.499 -162.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.1 t70 -113.84 154.12 28.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 111.585 -2.552 . . . . 2.73 105.548 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.071 HD13 ' HB3' ' A' ' 41' ' ' TRP . 2.2 mp -93.75 -37.91 11.56 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 118.362 0.528 . . . . 0.44 112.095 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 t -58.94 -21.05 57.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.754 0.788 . . . . 1.23 108.88 -169.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -84.34 -32.74 24.1 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.356 -1.293 . . . . 1.34 112.811 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.751 ' HB2' HD12 ' A' ' 57' ' ' LEU . 15.4 mmmt -104.5 -25.43 12.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.245 -0.889 . . . . 1.4 111.323 -167.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 49' ' ' LEU . 43.4 t -43.12 89.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 113.365 -1.743 . . . . 0.37 111.479 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.44 -113.84 0.5 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.209 -2.269 . . . . 0.7 112.602 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.4 -30.85 18.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.195 0.497 . . . . 2.75 112.022 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.8 p80 -90.23 -37.2 14.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.672 0.749 . . . . 1.33 111.017 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.968 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.36 106.35 9.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.317 -1.734 . . . . 1.11 106.317 174.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -95.81 115.46 27.46 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.606 -1.628 . . . . 0.76 106.606 165.703 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -99.74 92.44 5.32 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 104.411 -2.441 . . . . 0.26 104.411 170.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.633 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 63.7 m170 -81.74 161.9 23.14 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.627 -1.17 . . . . 2.03 110.114 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -133.04 112.93 12.22 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 112.592 -2.094 . . . . 0.92 108.711 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -93.9 148.82 21.78 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 112.982 -1.917 . . . . 0.47 107.408 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -139.46 97.78 3.35 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.575 1.179 . . . . 1.39 110.926 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.65 120.54 39.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 112.846 -1.979 . . . . 2.42 109.338 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.57 -34.94 27.58 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.573 -1.648 . . . . 2.46 111.38 -176.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 1.15 110.35 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 69' ' ' VAL . 18.9 t -94.52 -17.55 22.29 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.423 -0.808 . . . . 1.41 108.904 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.737 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 13.7 ttpt 62.05 37.25 14.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.024 -0.989 . . . . 3.31 108.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 67' ' ' SER . 38.0 t -128.83 131.39 68.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.369 1.081 . . . . 0.43 111.053 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -94.96 105.19 17.09 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 105.888 -1.893 . . . . 1.24 105.888 162.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.3 tp -96.55 105.24 17.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.479 1.133 . . . . 0.52 108.855 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.7 m-85 -85.22 114.58 22.43 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.33 107.846 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -107.06 119.86 40.52 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.587 -1.642 . . . . 1.32 108.998 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.83 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.7 mm? -92.81 120.9 33.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.629 -1.169 . . . . 0.96 107.919 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.67 95.61 5.33 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 104.593 -2.373 . . . . 1.15 104.593 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.63 HG12 HD23 ' A' ' 57' ' ' LEU . 66.4 mt -120.63 100.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 114.491 -1.231 . . . . 0.52 109.152 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 28.9 p -104.84 159.81 15.5 Favored 'General case' 0 N--CA 1.393 -3.32 0 CA-C-N 114.526 -1.216 . . . . 0.58 109.183 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.55 74.03 0.22 Allowed 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 111.611 -2.54 . . . . 2.12 111.158 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.37 123.54 19.87 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.228 -1.805 . . . . 0.4 111.327 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.552 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -60.59 137.0 92.64 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.477 -0.783 . . . . 1.43 109.739 170.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.542 ' HB3' HG21 ' A' ' 18' ' ' VAL . 35.4 Cg_endo -65.0 -3.36 6.96 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.32 2.68 . . . . 1.33 113.197 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.552 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -111.01 13.01 22.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.171 -0.468 . . . . 1.12 111.102 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' THR . 2.3 m-30 -86.93 -37.32 17.72 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 118.502 -0.761 . . . . 1.24 111.002 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.653 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 88.8 m 12.04 73.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.497 0 O-C-N 125.195 1.559 . . . . 1.22 110.647 -168.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.824 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -36.55 124.53 0.91 Allowed Glycine 0 N--CA 1.412 -2.926 0 CA-C-N 111.979 -2.373 . . . . 1.43 115.211 -163.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.993 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -123.59 68.56 0.47 Allowed Glycine 0 C--N 1.262 -3.54 0 CA-C-N 111.648 -2.276 . . . . 0.52 108.23 158.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.736 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 74.1 m-85 -75.07 108.53 7.87 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.094 -1.053 . . . . 0.63 108.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.634 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 25.0 mtp180 -109.33 106.88 16.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.724 -0.472 . . . . 3.15 109.724 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -91.04 116.1 28.53 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.627 -0.509 . . . . 1.08 109.627 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 34.4 mt-10 -122.61 103.03 8.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.52 -0.764 . . . . 1.81 109.144 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -95.01 143.64 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.077 0.465 . . . . 0.54 109.751 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 t -140.35 108.37 5.73 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.755 -0.832 . . . . 1.18 108.755 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.746 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.83 152.23 51.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 117.798 -1.096 . . . . 0.74 108.639 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.32 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 O-C-N 125.599 1.812 . . . . 0.65 114.572 178.065 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.674 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 25.2 t70 -145.55 -11.67 0.52 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.432 -1.258 . . . . 1.05 110.009 -174.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.012 ' HG2' ' HB2' ' A' ' 1' ' ' ASP . 2.4 mttp -90.77 124.64 35.29 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.462 -0.94 . . . . 1.29 108.462 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -131.31 127.94 38.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.251 -1.34 . . . . 0.77 109.793 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 16.1 m-20 -143.12 139.5 30.43 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.098 -1.41 . . . . 1.6 108.808 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.0 p -135.08 145.3 47.8 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.168 0.508 . . . . 1.19 109.791 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.752 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 91.5 p -131.9 126.5 34.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.49 -0.777 . . . . 0.84 110.462 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.09 119.05 36.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 1.58 111.122 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.68 ' HE1' ' HG2' ' A' ' 11' ' ' PRO . 30.0 p90 -143.61 147.05 33.78 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.52 -0.548 . . . . 0.86 109.52 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.772 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 11.4 p30 -104.04 151.81 22.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.635 1.207 . . . . 2.11 112.022 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.616 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -116.06 99.35 7.19 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.472 -1.695 . . . . 0.37 108.86 167.152 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.432 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 29.8 m -81.41 96.94 7.52 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.211 -1.033 . . . . 0.33 108.211 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 18' ' ' VAL . 3.9 p -81.27 112.54 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 123.099 1.428 . . . . 0.33 108.751 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.768 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 14.1 m-70 -77.49 97.9 5.15 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.441 -2.163 . . . . 1.19 109.222 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.47 -76.21 0.4 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.821 -1.536 . . . . 1.67 110.296 173.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.69 177.44 4.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.064 -0.516 . . . . 2.78 110.684 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.42 -0.8 . . . . 6.92 109.847 177.482 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.962 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 2.1 m-20 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.246 0.546 . . . . 1.93 110.65 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.532 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 16.7 m-20 -83.22 172.97 8.21 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 115.266 -0.879 . . . . 1.65 108.651 168.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 39.2 Cg_endo -69.74 81.28 0.82 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 121.652 1.568 . . . . 0.97 113.077 176.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.997 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.9 mp -109.18 -70.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.313 -0.858 . . . . 0.5 109.82 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 89.76 51.01 2.96 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.816 -1.714 . . . . 0.39 108.816 -172.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 4' ' ' ILE . 6.0 tp -51.73 -40.26 59.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.209 -1.495 . . . . 0.33 110.312 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.778 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.6 OUTLIER -86.2 85.17 7.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.307 -0.86 . . . . 0.72 110.461 174.473 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.26 -42.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 0.63 109.207 175.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.402 ' CB ' ' HD2' ' A' ' 27' ' ' ARG . 25.3 ttt -148.68 130.2 14.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.035 -0.984 . . . . 2.88 108.35 173.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 31.4 ptt180 -105.25 129.31 24.97 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 116.007 -0.542 . . . . 3.67 111.137 -174.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.635 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.7 Cg_endo -60.98 158.18 35.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.656 2.237 . . . . 0.64 112.122 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.503 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.4 mm-40 -126.68 174.61 8.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 1.43 111.37 -171.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 3.3 p-10 -69.72 -149.63 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.66 1.219 . . . . 2.06 111.87 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 154.62 134.35 1.9 Allowed Glycine 0 C--N 1.298 -1.583 0 CA-C-N 113.703 -1.589 . . . . 0.3 112.719 -174.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.502 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 6.1 mp0 -109.75 112.62 24.78 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.577 -1.312 . . . . 1.53 107.632 175.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.01 164.92 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 108.141 -1.059 . . . . 0.27 108.141 -172.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 154.72 17.07 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.778 -1.101 . . . . 0.77 109.69 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 106' ' ' VAL . 88.4 t -69.71 104.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 122.939 1.352 . . . . 0.78 108.517 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.21 4.1 9.37 Favored Glycine 0 C--N 1.275 -2.836 0 CA-C-N 112.217 -2.265 . . . . 0.48 112.816 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -120.17 3.12 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 108.901 -1.68 . . . . 0.44 108.901 171.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.651 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.2 p -151.59 174.05 13.91 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.102 -1.549 . . . . 0.82 110.368 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.452 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.0 tp -146.64 146.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 CA-C-N 113.213 -1.812 . . . . 0.32 106.336 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.5 m -139.21 128.0 23.42 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 114.105 -1.407 . . . . 0.31 111.157 -172.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.798 ' HD2' HD12 ' A' ' 74' ' ' LEU . 34.3 m-85 -126.14 141.46 51.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.885 -1.507 . . . . 0.53 109.726 177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.91 118.81 20.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.805 0.812 . . . . 0.58 109.715 175.426 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.635 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -113.71 113.17 24.62 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.414 -1.266 . . . . 0.32 109.203 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 99.3 mtt180 -102.66 117.8 35.45 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.952 -0.388 . . . . 2.43 109.952 -176.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.9 t -115.33 125.39 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 122.348 1.07 . . . . 0.26 110.307 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.75 107.69 0.55 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.92 -1.945 . . . . 0.4 110.384 176.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.541 ' C ' ' HE3' ' A' ' 68' ' ' LYS . . . -51.53 -40.59 47.53 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.668 -1.151 . . . . 0.76 111.775 173.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 42.77 -140.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.15 1.167 . . . . 0.71 114.15 172.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -134.54 132.31 38.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.398 -0.819 . . . . 1.74 109.555 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.89 -174.31 4.87 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.142 -0.481 . . . . 2.16 111.795 -173.525 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 tp -74.87 -51.98 12.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.029 -0.987 . . . . 1.47 108.838 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.7 151.16 59.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.311 -0.858 . . . . 1.4 109.475 176.853 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.47 138.92 7.29 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.593 2.862 . . . . 0.88 112.914 -176.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 93' ' ' THR . 2.3 Cg_endo -45.68 133.13 13.45 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 123.311 2.674 . . . . 0.53 113.351 -177.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.35 105.29 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.697 -1.594 . . . . 0.77 106.697 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.773 HG13 ' HB ' ' A' ' 91' ' ' VAL . 1.9 t -105.42 114.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 113.566 -1.652 . . . . 0.28 107.344 178.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.828 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -97.58 122.41 40.62 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-O 123.248 1.499 . . . . 1.54 109.294 173.846 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.993 ' HB3' HD13 ' A' ' 49' ' ' LEU . 63.4 m95 -88.32 153.15 21.43 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 111.769 -2.469 . . . . 0.34 110.97 173.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 39.0 t80 -131.39 134.46 46.28 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 104.432 -2.432 . . . . 0.62 104.432 173.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.796 ' HZ3' ' HB ' ' A' ' 47' ' ' VAL . 1.8 ttpm? -100.76 163.3 12.38 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.969 -1.863 . . . . 2.17 105.969 -175.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -9.77 -165.02 0.0 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.938 2.335 . . . . 1.23 118.938 -177.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.66 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 5.6 mtpp -44.28 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 O-C-N 119.541 -2.152 . . . . 3.87 116.68 -166.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.631 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.4 p-90 -165.58 -9.13 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.955 1.465 . . . . 2.11 114.955 -177.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.796 ' HB ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.0 167.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 CA-C-O 123.814 1.769 . . . . 1.29 113.215 -162.754 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.676 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 2.6 p-10 -109.67 155.9 20.91 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 110.994 -2.821 . . . . 2.73 107.164 174.252 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.9 mp -99.15 -36.81 9.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.014 0.746 . . . . 0.44 113.014 168.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.7 t -57.84 -21.21 41.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.255 0.55 . . . . 1.23 109.811 -162.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.55 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 52.3 m -99.1 -21.48 16.15 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 115.476 -0.784 . . . . 1.34 112.842 -176.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.676 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 6.7 mmmt -100.34 -36.38 9.27 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.306 -0.861 . . . . 1.4 111.184 -170.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.852 HG13 ' H ' ' A' ' 59' ' ' LEU . 74.0 t -31.63 94.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 113.373 -1.74 . . . . 0.37 111.993 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -162.74 -122.85 0.63 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 111.864 -2.425 . . . . 0.7 112.197 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.77 -47.1 79.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.748 1.018 . . . . 2.75 113.748 -169.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 38.7 p-80 -92.27 -35.33 13.83 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.256 0.55 . . . . 1.33 111.415 -174.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.975 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.56 105.27 11.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.564 -1.643 . . . . 1.11 106.564 175.358 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.23 115.57 27.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 106.844 -1.539 . . . . 0.76 106.844 164.227 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.852 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -98.97 90.71 4.72 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 103.45 -2.796 . . . . 0.26 103.45 167.604 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 29.9 t-80 -103.01 160.29 14.76 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.171 -1.377 . . . . 2.03 108.972 -173.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -130.48 113.93 14.89 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 112.295 -2.229 . . . . 0.92 110.393 -176.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -90.84 143.58 26.58 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 111.737 -2.483 . . . . 0.47 107.136 171.3 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.544 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 2.0 t80 -140.84 98.88 3.48 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.082 0.944 . . . . 1.39 111.687 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -118.11 129.87 55.79 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.169 -1.378 . . . . 2.42 109.887 170.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HA ' ' HZ3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -88.93 -38.92 14.13 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.037 -1.438 . . . . 2.46 112.616 -177.414 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.73 81.56 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.658 0.599 . . . . 1.15 111.351 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.2 p -92.05 -17.38 25.11 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.28 -1.378 . . . . 1.41 107.28 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.676 ' NZ ' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 69.19 30.99 4.14 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.526 -1.67 . . . . 3.31 109.712 171.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.9 t -122.93 123.9 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 122.159 0.98 . . . . 0.43 109.991 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.544 ' CE1' ' HD1' ' A' ' 63' ' ' TYR . 3.9 m-30 -104.13 105.81 16.09 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.926 -1.488 . . . . 1.24 107.035 170.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 25' ' ' SER . 29.5 tp -90.31 106.79 18.73 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.474 -1.239 . . . . 0.52 109.525 -176.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.613 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.6 m-85 -87.77 112.04 22.0 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.342 -1.725 . . . . 0.33 106.342 169.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 6.9 pt-20 -118.1 125.16 49.73 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.621 -1.627 . . . . 1.32 110.131 -171.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.798 HD12 ' HD2' ' A' ' 24' ' ' PHE . 1.3 mt -89.98 124.99 35.21 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.485 -1.234 . . . . 0.96 108.562 174.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -112.49 96.36 5.95 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 104.081 -2.563 . . . . 1.15 104.081 166.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.1 mt -122.4 100.67 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 123.285 1.517 . . . . 0.52 108.743 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 51.1 p -112.54 157.1 21.56 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-N 113.456 -1.702 . . . . 0.58 109.29 -172.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.12 39.71 5.42 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.89 -2.414 . . . . 2.12 108.798 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -44.28 120.86 2.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 111.997 -2.365 . . . . 0.4 110.388 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 13.0 pm0 -87.59 156.66 53.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.33 -0.989 . . . . 1.43 108.33 -177.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.812 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 50.4 Cg_endo -69.27 -3.48 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 121.296 1.331 . . . . 1.33 113.139 -170.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.54 7.57 44.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.112 -0.494 . . . . 1.12 110.212 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -92.78 -20.55 20.63 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.173 -0.467 . . . . 1.24 111.002 -176.357 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 45.2 m -49.03 103.22 0.04 OUTLIER 'General case' 0 CA--C 1.473 -2.014 0 CA-C-O 122.509 1.147 . . . . 1.22 108.552 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.66 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -174.64 -130.71 1.32 Allowed Glycine 0 C--N 1.265 -3.371 0 CA-C-N 112.364 -2.198 . . . . 1.43 112.964 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.52 118.23 0.86 Allowed Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.244 -0.979 . . . . 0.52 112.157 -172.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.763 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.4 m-85 -87.12 124.34 33.15 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.078 -1.453 . . . . 0.63 107.078 175.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 44.1 mtp180 -122.42 124.43 43.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.422 0.555 . . . . 3.15 111.698 -175.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.489 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 4.0 m -97.0 131.09 44.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 1.08 109.856 176.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.828 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.0 mt-10 -132.14 103.34 6.2 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.685 -0.857 . . . . 1.81 108.685 170.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.773 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -93.17 138.24 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.561 0.696 . . . . 0.54 110.089 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.1 m -132.59 107.81 8.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.701 -1.136 . . . . 1.18 108.903 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.608 ' OG1' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -132.08 157.97 42.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 117.669 -1.158 . . . . 0.74 108.51 -179.648 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.722 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 20.13 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 125.574 1.797 . . . . 0.65 114.276 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.722 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -146.92 -3.52 0.58 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.989 -1.005 . . . . 1.05 110.001 -177.479 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.997 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 4.9 mmmt -96.29 133.65 40.38 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.88 0.848 . . . . 1.29 109.56 -175.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.69 131.27 44.74 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.497 -1.683 . . . . 0.77 110.892 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.435 ' HB3' ' CG ' ' A' ' 7' ' ' PHE . 28.8 m-20 -144.85 140.83 28.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.428 -1.26 . . . . 1.6 108.702 176.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.7 p -138.3 154.06 49.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.254 0.55 . . . . 1.19 111.118 -176.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.778 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 36.2 t -136.12 149.35 48.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.205 1.002 . . . . 0.84 111.246 177.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -134.31 109.72 9.01 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.322 -1.763 . . . . 1.58 109.466 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 29.4 p90 -140.81 132.55 27.35 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.217 -0.66 . . . . 0.86 109.217 -174.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 2.1 p-10 -102.42 153.15 20.31 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 122.39 1.091 . . . . 2.11 111.317 -171.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -121.33 120.78 36.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.427 -1.261 . . . . 0.37 108.526 172.716 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 5.9 m -100.16 96.11 7.27 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.749 -0.834 . . . . 0.33 108.749 174.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 80' ' ' GLN . 9.5 p -84.27 116.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 123.485 1.612 . . . . 0.33 109.339 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -91.39 100.29 13.1 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 112.504 -2.134 . . . . 1.19 109.976 -175.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.812 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 9.9 tt0 -73.57 -67.22 0.61 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.923 -1.035 . . . . 1.67 109.556 170.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.85 -175.03 3.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 2.78 109.504 178.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.753 -0.641 . . . . 6.92 109.738 178.545 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.748 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 1.6 m-20 . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 120.844 0.354 . . . . 1.93 110.96 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.54 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-20 -87.81 175.76 3.96 Favored Pre-proline 0 N--CA 1.438 -1.051 0 CA-C-N 116.004 -0.544 . . . . 1.65 109.822 170.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 73.5 Cg_endo -77.21 59.48 6.61 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 121.852 1.701 . . . . 0.97 112.862 177.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.925 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -75.15 -63.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.228 -0.896 . . . . 0.5 109.457 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.61 41.29 5.75 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 107.812 -2.115 . . . . 0.39 107.812 -175.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.697 HD13 HG21 ' A' ' 4' ' ' ILE . 8.4 tp -49.25 -46.37 46.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.573 -1.814 . . . . 0.33 110.643 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.675 ' HD2' ' HE ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -88.65 84.91 6.72 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.827 0.822 . . . . 0.72 109.863 171.806 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.37 -37.82 79.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.24 -1.345 . . . . 0.63 109.285 178.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 tpp -148.65 132.92 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.837 -1.074 . . . . 2.88 108.307 171.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.675 ' HE ' ' HD2' ' A' ' 7' ' ' PHE . 38.1 mtt180 -96.24 130.81 30.03 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.886 0.374 . . . . 3.67 110.873 -174.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 13.9 Cg_endo -60.22 153.26 60.38 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.093 2.528 . . . . 0.64 111.794 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.482 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.1 mm-40 -124.67 170.19 11.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.01 -0.541 . . . . 1.43 111.999 -172.058 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.498 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.1 p-10 -70.83 -145.75 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.321 0 C-N-CA 124.673 1.189 . . . . 2.06 113.076 -175.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.76 133.1 1.58 Allowed Glycine 0 C--N 1.307 -1.06 0 CA-C-N 113.708 -1.587 . . . . 0.3 114.015 -176.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 1.7 mp0 -106.47 111.36 23.9 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.689 -1.256 . . . . 1.53 109.083 175.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.534 HG11 ' HB ' ' A' ' 22' ' ' ILE . 1.9 m -137.43 163.04 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.155 -1.054 . . . . 0.27 108.155 -174.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.448 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.13 156.26 16.39 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.78 -1.1 . . . . 0.77 109.677 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.883 HG21 ' HB3' ' A' ' 81' ' ' PRO . 24.9 t -69.93 107.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-O 123.056 1.407 . . . . 0.78 109.171 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.65 -0.6 15.67 Favored Glycine 0 C--N 1.266 -3.359 0 CA-C-N 111.957 -2.383 . . . . 0.48 112.221 176.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 -126.14 3.76 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 109.101 -1.6 . . . . 0.44 109.101 172.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 9.3 p -151.68 167.9 26.7 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-N 112.985 -1.608 . . . . 0.82 111.042 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.693 HG21 HD13 ' A' ' 104' ' ' LEU . 7.8 tp -146.11 147.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 113.291 -1.777 . . . . 0.32 108.42 170.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 m -139.88 130.6 25.87 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 113.239 -1.8 . . . . 0.31 110.399 -175.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -128.58 160.49 32.23 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.921 -1.036 . . . . 0.53 108.753 169.8 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.73 129.27 22.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.968 -1.015 . . . . 0.58 108.866 178.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.659 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.61 127.59 46.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.736 -0.666 . . . . 0.32 111.138 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -108.64 121.32 44.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.06 -0.518 . . . . 2.43 110.557 -177.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 14.6 t -123.44 127.94 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.258 1.028 . . . . 0.26 110.508 -176.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.502 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.18 110.21 1.33 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.113 -1.858 . . . . 0.4 113.212 -177.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -54.36 -48.57 63.86 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 114.587 -1.188 . . . . 0.76 112.184 171.089 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.786 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 56.74 -170.23 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.734 0.814 . . . . 0.71 112.87 173.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -114.11 35.7 4.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.243 1.021 . . . . 1.74 108.459 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.0 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.18 172.97 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.015 -1.448 . . . . 2.16 113.358 177.394 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.75 -49.62 76.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.343 0.592 . . . . 1.47 110.307 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.673 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -144.8 150.09 45.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.041 -1.096 . . . . 1.4 108.041 174.057 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.91 142.14 5.49 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.416 2.744 . . . . 0.88 111.588 -177.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.0 ' HD3' HD11 ' A' ' 33' ' ' LEU . 6.4 Cg_exo -54.54 137.45 73.0 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.138 1.225 . . . . 0.53 112.836 -174.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 35' ' ' LYS . 3.6 t -99.13 104.68 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 105.708 -1.96 . . . . 0.77 105.708 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.704 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -111.54 113.57 44.61 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.596 -1.638 . . . . 0.28 107.594 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.547 ' O ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -103.95 130.99 51.62 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 123.389 1.566 . . . . 1.54 109.751 173.173 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.05 ' HB3' HD13 ' A' ' 49' ' ' LEU . 81.9 m95 -91.23 157.25 17.27 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.859 -2.428 . . . . 0.34 111.259 173.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 27.1 t80 -131.47 130.71 42.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.564 -2.013 . . . . 0.62 105.564 175.051 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 31.7 ttpt -109.05 104.83 14.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.25 -1.759 . . . . 2.17 106.25 -176.293 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.26 91.65 1.67 Allowed Glycine 0 CA--C 1.481 -2.044 0 C-N-CA 115.906 -3.045 . . . . 1.23 114.112 -164.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 1.012 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -105.04 -27.44 11.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 104.104 -2.554 . . . . 3.87 104.104 139.549 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 1.012 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 27.5 p-90 160.2 -20.19 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.078 -2.328 . . . . 2.11 111.529 -165.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG21 ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.53 169.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 123.046 1.403 . . . . 1.29 112.539 -163.658 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.3 t70 -113.11 133.89 54.8 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 111.617 -2.538 . . . . 2.73 107.04 175.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.05 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.8 mp -69.85 -35.3 74.62 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 119.169 -0.443 . . . . 0.44 111.869 -175.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 m -58.27 -20.01 39.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.543 0.687 . . . . 1.23 109.817 -167.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 m -98.4 -18.86 18.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.973 -1.012 . . . . 1.34 112.424 -176.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.42 -70.27 0.74 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.876 -0.602 . . . . 1.4 111.118 -176.935 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.844 HG13 ' H ' ' A' ' 59' ' ' LEU . 70.5 t 16.6 91.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.23 1.812 . . . . 0.37 113.965 175.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -151.4 -138.5 2.82 Favored Glycine 0 C--N 1.319 -0.397 0 CA-C-N 114.174 -1.375 . . . . 0.7 113.488 -174.168 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -64.18 -42.83 96.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.382 0.882 . . . . 2.75 113.382 -169.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.485 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 4.8 p80 -86.97 -37.97 17.06 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 119.64 -0.824 . . . . 1.33 111.702 -175.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.915 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.39 108.76 13.07 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.289 -1.004 . . . . 1.11 108.289 170.891 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -96.34 115.69 27.84 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 105.834 -1.913 . . . . 0.76 105.834 168.614 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.844 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.09 92.28 6.74 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 104.353 -2.462 . . . . 0.26 104.353 170.357 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.651 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -88.24 164.2 15.74 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 113.748 -1.569 . . . . 2.03 111.003 -178.187 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -134.29 113.38 11.89 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 111.716 -2.493 . . . . 0.92 109.937 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.8 m -99.14 149.34 23.16 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.597 -2.092 . . . . 0.47 107.891 174.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -145.58 99.38 3.28 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.097 0.951 . . . . 1.39 112.362 -171.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.88 106.43 14.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.837 -1.528 . . . . 2.42 110.374 169.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.04 -27.68 65.87 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.556 -1.202 . . . . 2.46 110.504 179.065 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.18 73.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.216 -0.902 . . . . 1.15 110.746 175.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -91.65 -18.24 24.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.6 -0.727 . . . . 1.41 109.287 175.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.786 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 10.3 ttpt 66.62 33.82 6.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.665 -1.152 . . . . 3.31 109.699 -177.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.84 133.52 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.166 0.984 . . . . 0.43 110.766 -176.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' SER . 36.7 m-85 -97.65 108.07 20.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.532 -1.655 . . . . 1.24 106.532 161.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 15.0 tp -95.18 104.7 16.59 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.508 1.147 . . . . 0.52 109.011 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.651 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.7 m-85 -86.2 114.47 23.06 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.331 -1.759 . . . . 0.33 108.606 175.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.47 127.71 46.74 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.374 -1.739 . . . . 1.32 109.007 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.864 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -99.38 116.65 32.03 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.206 -1.405 . . . . 0.96 107.206 171.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.765 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 14.5 m80 -114.63 94.41 4.76 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 104.953 -2.24 . . . . 1.15 104.953 167.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.817 HG12 ' HB2' ' A' ' 57' ' ' LEU . 47.5 mt -118.13 99.15 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 123.18 1.466 . . . . 0.52 110.055 -173.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.7 p -106.71 163.89 12.54 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.022 -1.444 . . . . 0.58 108.121 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 68.86 38.91 1.99 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.804 -1.998 . . . . 2.12 110.215 170.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.09 118.06 2.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.207 -1.815 . . . . 0.4 112.024 -178.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.623 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -57.82 140.97 80.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.818 -1.083 . . . . 1.43 109.758 172.014 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.883 ' HB3' HG21 ' A' ' 18' ' ' VAL . 36.4 Cg_endo -67.89 5.02 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.707 2.271 . . . . 1.33 113.42 -177.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.99 -3.83 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.473 -0.33 . . . . 1.12 110.324 173.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.909 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -75.66 4.45 7.75 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.798 -0.62 . . . . 1.24 109.368 -172.046 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 29.5 m -23.02 90.07 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 125.696 1.873 . . . . 1.22 111.325 177.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.833 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -39.79 110.2 0.16 Allowed Glycine 0 CA--C 1.466 -3.029 0 CA-C-N 109.703 -3.408 . . . . 1.43 113.902 -169.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.88 62.78 0.55 Allowed Glycine 0 C--N 1.262 -3.567 0 CA-C-N 111.718 -2.241 . . . . 0.52 107.895 160.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.666 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 73.9 m-85 -81.43 109.79 16.24 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.251 -1.388 . . . . 0.63 107.251 -177.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 24.4 ttm180 -109.91 110.03 20.86 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.069 -0.715 . . . . 3.15 109.069 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.57 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.3 t -91.33 125.1 35.98 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.658 -0.867 . . . . 1.08 108.658 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 38.8 tt0 -134.03 103.88 6.0 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.309 -0.86 . . . . 1.81 109.755 -172.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.704 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.7 p -100.58 143.63 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.54 110.343 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -139.87 108.84 6.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.341 -0.845 . . . . 1.18 108.812 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.805 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.96 146.85 52.15 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-O 117.775 -1.107 . . . . 0.74 109.851 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.807 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.41 -73.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.679 1.862 . . . . 0.65 114.28 -177.275 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.807 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 10.7 t70 -151.78 -2.03 0.3 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.904 -1.044 . . . . 1.05 110.28 -175.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.925 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmmt -93.45 133.84 36.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.117 0.961 . . . . 1.29 108.849 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -130.35 129.94 43.79 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.467 -1.697 . . . . 0.77 110.16 -176.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 4.4 m-20 -146.97 142.17 27.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.166 -1.379 . . . . 1.6 109.099 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 58.3 m -144.94 148.28 33.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.604 -0.726 . . . . 1.19 110.154 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.57 ' OG ' ' HB3' ' A' ' 89' ' ' CYS . 2.9 p -128.23 148.07 50.61 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.532 -0.758 . . . . 0.84 111.567 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.79 112.37 14.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.557 -1.201 . . . . 1.58 109.58 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.76 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 7.0 p90 -141.7 131.4 24.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.6 0.714 . . . . 0.86 109.568 -175.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 5.7 p30 -105.64 138.49 41.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.532 1.158 . . . . 2.11 112.976 -168.114 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.833 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.22 103.94 13.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.667 -1.606 . . . . 0.37 109.501 173.367 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.499 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 11.9 m -86.23 95.41 9.59 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.175 -1.01 . . . . 0.33 108.333 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.784 HG22 HG22 ' A' ' 18' ' ' VAL . 8.3 p -82.74 112.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.27 1.509 . . . . 0.33 108.706 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 97.5 m-70 -85.76 99.15 11.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.276 -2.238 . . . . 1.19 109.724 -173.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -77.38 -72.82 0.33 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.129 -1.396 . . . . 1.67 110.131 172.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.55 13.0 6.47 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.68 -0.691 . . . . 2.78 109.76 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.426 ' C ' ' HD1' ' A' ' 107' ' ' HIS . 52.9 ttp . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.831 -0.622 . . . . 6.92 109.498 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 9.8 p-10 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 121.911 0.863 . . . . 1.93 110.756 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.635 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 14.2 m-20 -70.86 167.29 29.61 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.75 -1.114 . . . . 1.65 110.844 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 55.8 Cg_endo -70.2 68.07 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.933 2.422 . . . . 0.97 112.56 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.974 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -91.59 -55.39 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 114.797 -1.092 . . . . 0.5 108.927 173.141 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.614 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 84.27 48.9 4.9 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.53 -2.228 . . . . 0.39 107.53 -176.492 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.999 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.0 tp -51.24 -44.9 61.83 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 112.553 -1.823 . . . . 0.33 109.241 -173.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -82.62 83.31 7.66 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.663 -1.153 . . . . 0.72 109.544 170.874 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.98 -27.61 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.756 -1.111 . . . . 0.63 108.978 176.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.8 tpt -163.51 148.8 11.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.09 -1.414 . . . . 2.88 107.246 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 4.6 ptm180 -115.36 144.08 31.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.192 -0.603 . . . . 3.67 111.059 177.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.748 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -76.44 170.46 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.132 2.554 . . . . 0.64 112.451 -178.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -131.0 166.19 21.56 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.682 -0.69 . . . . 1.43 110.977 -171.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.625 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -65.5 -141.13 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.566 1.174 . . . . 2.06 111.982 -179.308 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.19 139.8 3.17 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.125 -1.398 . . . . 0.3 111.934 -175.189 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.9 mt-10 -116.66 118.08 31.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.813 -0.693 . . . . 1.53 109.263 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -139.29 164.77 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 107.825 -1.176 . . . . 0.27 107.825 -173.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.79 157.45 17.39 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.237 -0.892 . . . . 0.77 109.753 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 106' ' ' VAL . 16.7 t -68.66 106.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 CA-C-O 122.677 1.227 . . . . 0.78 108.116 172.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.16 3.85 10.42 Favored Glycine 0 C--N 1.27 -3.11 0 CA-C-N 112.276 -2.238 . . . . 0.48 113.554 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.85 -123.83 4.32 Favored Glycine 0 N--CA 1.422 -2.252 0 C-N-CA 119.235 -1.46 . . . . 0.44 111.252 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.1 p -150.88 166.99 28.88 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 112.826 -1.687 . . . . 0.82 110.934 178.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.569 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -149.41 150.74 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.023 -1.899 . . . . 0.32 107.638 171.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.0 m -138.22 129.51 27.48 Favored 'General case' 0 C--N 1.265 -3.096 0 CA-C-N 113.721 -1.581 . . . . 0.31 110.876 -176.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.718 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.7 m-85 -128.11 155.43 44.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.278 -1.328 . . . . 0.53 109.88 176.581 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.625 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.2 m -140.93 131.81 25.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.287 -0.869 . . . . 0.58 109.287 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.769 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -129.32 115.22 17.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 0.32 110.943 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.7 ' HE ' HG11 ' A' ' 69' ' ' VAL . 18.9 mtp180 -100.6 126.32 47.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.535 -0.302 . . . . 2.43 110.851 -177.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.5 t -127.9 129.44 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 122.057 0.932 . . . . 0.26 110.687 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.79 108.27 2.07 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.344 -1.753 . . . . 0.4 111.113 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -50.88 22.84 Favored Glycine 0 C--O 1.226 -0.391 0 CA-C-N 115.287 -0.87 . . . . 0.76 111.105 172.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.889 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . . . 61.64 -100.52 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.772 1.027 . . . . 0.71 113.772 167.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 p -146.39 -109.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 1.74 110.205 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.017 HD22 ' HA ' ' A' ' 93' ' ' THR . 4.4 tp 63.74 156.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.576 -0.528 . . . . 2.16 109.576 -175.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.952 ' H ' HD12 ' A' ' 33' ' ' LEU . 21.4 tp -53.39 -27.32 23.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.129 0.966 . . . . 1.47 110.546 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.769 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.83 177.15 2.08 Favored Pre-proline 0 C--O 1.211 -0.973 0 CA-C-N 113.549 -1.66 . . . . 1.4 106.803 178.143 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.5 Cg_exo -65.24 154.37 73.88 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.495 1.464 . . . . 0.88 109.521 174.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.64 ' HG3' HG21 ' A' ' 93' ' ' THR . 67.2 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 121.569 1.513 . . . . 0.53 113.401 -175.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.649 HG22 ' HE2' ' A' ' 35' ' ' LYS . 2.0 t -100.01 103.89 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 106.489 -1.671 . . . . 0.77 106.489 175.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.8 t -106.71 115.25 47.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.013 -1.449 . . . . 0.28 107.683 176.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.07 131.5 55.01 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 122.874 1.321 . . . . 1.54 109.615 175.989 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.022 ' HB3' HD13 ' A' ' 49' ' ' LEU . 72.0 m95 -92.48 156.83 16.91 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.425 -2.171 . . . . 0.34 112.326 174.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 37.3 t80 -129.28 133.14 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.303 -2.11 . . . . 0.62 105.303 173.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.865 ' HZ3' ' HB3' ' A' ' 43' ' ' LYS . 3.6 ttpm? -109.66 107.51 17.58 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.336 -1.357 . . . . 2.17 107.336 -177.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.32 91.91 1.63 Allowed Glycine 0 CA--C 1.487 -1.688 0 C-N-CA 115.982 -3.009 . . . . 1.23 114.562 -165.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.902 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 71.2 tttt -108.86 -24.79 11.1 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.034 -2.21 . . . . 3.87 105.034 135.216 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.902 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 25.7 p-90 159.97 -20.14 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 CA-C-N 112.677 -2.056 . . . . 2.11 111.763 -164.459 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.45 ' HB ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.34 174.11 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.461 1.6 . . . . 1.29 113.331 -163.264 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.3 t70 -109.49 155.04 21.83 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 111.208 -2.724 . . . . 2.73 105.763 173.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.022 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -89.77 -38.67 13.64 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.905 0.706 . . . . 0.44 112.905 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 t -59.58 -19.76 50.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.894 0.854 . . . . 1.23 108.936 -166.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 p -87.58 -33.11 19.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.536 -1.211 . . . . 1.34 111.317 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HG3' ' HZ1' ' A' ' 43' ' ' LYS . 5.5 mmmt -93.79 -70.37 0.71 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.266 -1.333 . . . . 1.4 111.616 -175.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.827 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.4 t 11.1 92.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.566 1.946 . . . . 0.37 113.489 177.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.605 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -146.67 -118.04 1.07 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.841 -1.527 . . . . 0.7 113.357 -177.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -86.12 -32.67 21.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.082 0.771 . . . . 2.75 113.082 -167.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -93.54 -36.69 12.29 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.026 -0.669 . . . . 1.33 110.257 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.908 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.95 105.28 11.31 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.809 -1.552 . . . . 1.11 106.809 175.899 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -98.77 115.53 28.98 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 105.763 -1.94 . . . . 0.76 105.763 165.781 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.827 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -98.51 92.03 5.44 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 103.547 -2.76 . . . . 0.26 103.547 169.171 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 83.0 t60 -99.66 162.43 13.01 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 113.943 -1.48 . . . . 2.03 108.694 -173.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.47 124.25 29.79 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 112.464 -2.153 . . . . 0.92 110.949 -177.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.688 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.2 m -93.62 148.52 22.03 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 111.08 -2.782 . . . . 0.47 106.685 169.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -138.16 98.09 3.54 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.705 1.241 . . . . 1.39 111.365 -168.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 8.4 m-20 -113.98 100.32 8.32 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 112.856 -1.975 . . . . 2.42 108.743 172.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -37.41 36.27 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.644 -0.707 . . . . 2.46 110.337 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.68 -22.2 60.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.004 -0.998 . . . . 1.15 110.448 179.232 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 47.5 m -101.69 -9.84 20.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.494 -0.776 . . . . 1.41 109.592 175.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.889 ' HE3' ' HA ' ' A' ' 31' ' ' ALA . 74.5 tttt 67.18 29.84 7.55 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.114 -0.948 . . . . 3.31 110.53 173.151 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.7 HG11 ' HE ' ' A' ' 27' ' ' ARG . 2.7 t -127.98 121.95 57.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.014 0.911 . . . . 0.43 110.588 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -100.53 107.02 18.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.396 -1.705 . . . . 1.24 106.396 167.001 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.5 tp -95.15 104.73 16.62 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.3 1.048 . . . . 0.52 109.049 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.661 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.8 m-85 -85.36 113.96 22.06 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.939 -1.482 . . . . 0.33 108.277 174.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 19.4 mt-10 -106.8 124.41 49.58 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 113.3 -1.773 . . . . 1.32 108.976 -176.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.829 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -90.69 118.18 29.92 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.995 -1.113 . . . . 0.96 107.995 173.055 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -112.14 94.33 4.88 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 103.587 -2.746 . . . . 1.15 103.587 169.422 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 52.3 mt -123.54 101.07 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.22 1.486 . . . . 0.52 110.263 -175.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 74.8 p -106.02 144.88 32.12 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 113.002 -1.908 . . . . 0.58 107.917 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 70.96 77.61 0.18 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.914 -2.403 . . . . 2.12 109.766 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.563 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -78.24 110.87 13.63 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.779 -2.464 . . . . 0.4 108.24 174.371 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.613 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -69.58 165.07 44.41 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.418 -0.956 . . . . 1.43 108.418 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HG3' HG21 ' A' ' 18' ' ' VAL . 3.8 Cg_exo -72.41 152.28 54.69 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 120.819 1.013 . . . . 1.33 111.124 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.711 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . 66.98 5.26 3.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.855 -0.612 . . . . 1.12 111.358 -177.117 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -84.42 1.49 45.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.69 -0.856 . . . . 1.24 108.69 -178.773 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.842 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 49.2 m -10.02 82.14 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.981 0 O-C-N 126.292 2.245 . . . . 1.22 111.316 171.22 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.917 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -65.71 73.94 0.11 Allowed Glycine 0 CA--C 1.473 -2.576 0 CA-C-N 111.555 -2.566 . . . . 1.43 114.002 -160.084 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -84.54 74.1 2.55 Favored Glycine 0 C--N 1.276 -2.787 0 N-CA-C 108.477 -1.849 . . . . 0.52 108.477 172.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.798 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 49.2 m-85 -80.86 121.9 26.54 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.57 -1.315 . . . . 0.63 107.694 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.79 109.82 19.54 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.645 -0.502 . . . . 3.15 109.645 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.646 ' SG ' ' HE2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -91.6 108.35 19.84 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.537 -0.542 . . . . 1.08 109.537 -179.623 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.705 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 37.3 mt-10 -118.71 103.79 9.99 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.756 -0.656 . . . . 1.81 109.486 -176.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -99.24 143.01 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.308 0.575 . . . . 0.54 110.868 -177.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -133.19 109.26 9.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.017 -1.105 . . . . 1.18 108.017 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.017 ' HA ' HD22 ' A' ' 33' ' ' LEU . 1.3 m -130.28 164.21 25.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 118.331 -0.842 . . . . 0.74 109.067 -177.169 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.872 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 7.94 -71.23 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.567 1.792 . . . . 0.65 113.392 173.516 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.758 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 28.6 t70 -147.8 -1.68 0.58 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.739 -1.119 . . . . 1.05 110.136 177.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.999 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -92.84 129.25 38.82 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.478 -1.305 . . . . 1.29 107.478 -177.543 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.46 130.58 40.71 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.023 -0.989 . . . . 0.77 110.14 175.032 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -142.48 147.9 36.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.448 -1.251 . . . . 1.6 109.031 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 6.8 p -144.48 141.88 29.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.343 0.592 . . . . 1.19 111.025 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.545 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 24.2 t -118.26 148.94 41.92 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.24 -0.891 . . . . 0.84 111.093 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 112.82 11.28 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.803 -1.544 . . . . 1.58 110.053 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.798 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 40.0 p90 -142.21 140.91 32.47 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.86 108.762 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 13' ' ' ASP . 4.3 p30 -117.39 134.44 54.82 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.497 1.141 . . . . 2.11 113.555 -174.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.917 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -95.6 109.45 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.365 -1.743 . . . . 0.37 109.6 177.422 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -86.85 96.54 10.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.272 -0.64 . . . . 0.33 109.272 -178.33 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 18' ' ' VAL . 6.8 p -83.03 113.78 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.932 1.348 . . . . 0.33 109.522 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -90.98 100.5 13.35 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 112.747 -2.024 . . . . 1.19 109.549 -176.153 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 18' ' ' VAL . 44.9 tt0 -80.74 -79.96 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.024 -0.989 . . . . 1.67 110.566 172.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.83 -48.61 8.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.954 -0.566 . . . . 2.78 110.232 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.237 -0.887 . . . . 6.92 109.818 178.97 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.99 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.611 -0.514 . . . . 1.93 109.611 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.628 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.1 m-20 -122.53 173.22 4.41 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 1.65 109.871 174.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.4 81.9 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.607 2.205 . . . . 0.97 112.365 172.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.962 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -108.11 -69.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.5 109.214 174.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.632 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 94.72 45.5 3.15 Favored Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 108.301 -1.92 . . . . 0.39 108.301 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 96' ' ' LYS . 13.3 tp -53.1 -46.13 68.55 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 112.175 -2.012 . . . . 0.33 111.623 -169.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.783 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -89.4 84.3 6.43 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.073 -0.967 . . . . 0.72 109.893 -176.195 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.4 t -72.42 -48.48 47.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.662 -1.153 . . . . 0.63 110.029 -178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.767 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 88.9 mmm -132.87 134.58 44.79 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 115.263 -0.881 . . . . 2.88 109.766 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.783 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 22.1 mtt-85 -99.28 124.23 45.69 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 109.301 -0.629 . . . . 3.67 109.301 174.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.653 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 17.6 Cg_endo -60.68 145.83 98.24 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.393 2.062 . . . . 0.64 109.606 174.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.514 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 17.9 mm-40 -121.43 170.79 9.29 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 112.286 0.476 . . . . 1.43 112.286 -168.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.0 m-20 -69.18 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.911 0 CA-C-O 122.825 1.298 . . . . 2.06 110.627 -173.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 150.08 139.26 3.03 Favored Glycine 0 N--CA 1.423 -2.184 0 CA-C-N 114.094 -1.412 . . . . 0.3 111.811 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 32.8 mt-10 -117.71 109.85 17.13 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.251 -0.974 . . . . 1.53 108.888 176.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.53 163.19 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.02 -1.474 . . . . 0.27 107.02 -175.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.751 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.41 154.7 17.32 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 115.479 -0.782 . . . . 0.77 109.874 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 106' ' ' VAL . 16.5 t -63.68 107.12 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 123.193 1.473 . . . . 0.78 108.917 173.03 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.25 -10.87 5.59 Favored Glycine 0 C--N 1.268 -3.207 0 CA-C-N 111.711 -2.495 . . . . 0.48 112.503 176.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.0 -163.69 20.36 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 119.879 -1.153 . . . . 0.44 111.316 177.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 2.5 p -122.75 169.81 10.7 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-O 122.582 1.182 . . . . 0.82 111.456 -170.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.651 HG21 HD13 ' A' ' 104' ' ' LEU . 10.4 tp -145.16 151.83 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-N 112.335 -2.211 . . . . 0.32 107.229 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.7 m -139.67 127.46 21.97 Favored 'General case' 0 C--N 1.256 -3.486 0 CA-C-N 113.815 -1.539 . . . . 0.31 110.814 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.612 ' HD2' HD12 ' A' ' 74' ' ' LEU . 27.7 m-85 -123.48 142.49 50.95 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.788 -1.551 . . . . 0.53 109.51 -178.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.99 120.17 17.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.94 0.876 . . . . 0.58 110.399 173.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -117.52 114.41 23.41 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.075 -1.421 . . . . 0.32 109.805 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.767 ' HD2' ' HG3' ' A' ' 9' ' ' MET . 88.0 mtt180 -106.71 121.76 45.0 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 121.226 -0.19 . . . . 2.43 110.564 -176.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG21 HG21 ' A' ' 39' ' ' VAL . 12.1 t -119.2 125.65 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.027 0.917 . . . . 0.26 109.925 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 108.39 0.59 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.309 -1.768 . . . . 0.4 110.959 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.711 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.11 -44.3 63.19 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.817 -1.083 . . . . 0.76 111.406 172.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.704 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 54.06 -164.2 0.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.572 0.749 . . . . 0.71 112.996 177.046 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -78.47 -71.58 0.42 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.81 -0.811 . . . . 1.74 108.81 173.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.945 HD23 HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 69.58 159.75 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.675 -0.693 . . . . 2.16 112.102 168.496 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.943 ' N ' HD22 ' A' ' 33' ' ' LEU . 17.0 tp -75.6 -71.56 0.36 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.525 -0.761 . . . . 1.47 111.149 168.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.795 ' O ' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -123.31 129.55 24.87 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 113.643 0.979 . . . . 1.4 113.643 171.555 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' N ' HD11 ' A' ' 33' ' ' LEU . 17.2 Cg_exo -32.96 129.16 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 124.735 3.623 . . . . 0.88 113.234 -170.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 1.5 Cg_endo -46.9 132.67 17.54 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.493 2.129 . . . . 0.53 112.898 -171.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.66 104.64 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 106.769 -1.567 . . . . 0.77 106.769 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.25 115.02 48.51 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.997 0 CA-C-N 113.159 -1.837 . . . . 0.28 107.262 177.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.22 128.76 53.57 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 122.972 1.368 . . . . 1.54 109.294 172.52 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.043 ' HB3' HD13 ' A' ' 49' ' ' LEU . 60.0 m95 -82.92 152.44 25.53 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 112.395 -2.184 . . . . 0.34 110.786 175.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.605 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 32.3 t80 -128.03 138.88 52.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.725 -2.324 . . . . 0.62 104.725 169.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 1.054 ' HE2' ' HG ' ' A' ' 49' ' ' LEU . 13.7 ttmt -100.4 171.53 7.7 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.927 -1.138 . . . . 2.17 107.927 -173.03 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.968 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -13.44 -169.27 0.0 OUTLIER Glycine 0 C--O 1.185 -2.931 0 O-C-N 126.673 2.483 . . . . 1.23 118.3 166.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.3 mtpp -42.4 -2.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 117.556 2.428 . . . . 3.87 117.556 -166.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.657 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.6 p-90 -169.47 -17.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.901 1.445 . . . . 2.11 114.901 -177.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.788 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.95 167.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 CA-C-O 123.464 1.602 . . . . 1.29 112.44 -161.368 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.667 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 14.4 t70 -113.89 154.27 27.81 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.537 -2.574 . . . . 2.73 104.976 169.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.054 ' HG ' ' HE2' ' A' ' 43' ' ' LYS . 6.3 mp -90.39 -36.35 14.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.901 1.074 . . . . 0.44 113.901 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 t -59.05 -20.73 55.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.585 0.707 . . . . 1.23 109.432 -164.249 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -98.88 -28.42 13.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.074 -0.966 . . . . 1.34 113.531 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.861 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.25 -40.31 7.6 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.254 0.464 . . . . 1.4 112.254 -169.402 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 ' H ' ' A' ' 59' ' ' LEU . 23.0 t -18.11 97.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 125.935 1.694 . . . . 0.37 113.063 173.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -152.83 -147.9 4.73 Favored Glycine 0 C--N 1.306 -1.125 0 CA-C-N 111.575 -2.557 . . . . 0.7 112.823 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -64.13 -16.34 61.64 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.003 0.742 . . . . 2.75 113.003 -170.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.7 p80 -102.49 -36.34 8.43 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.379 0.609 . . . . 1.33 110.899 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.83 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -129.22 103.43 6.95 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.961 -1.496 . . . . 1.11 106.961 172.348 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.27 116.04 28.38 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 106.976 -1.49 . . . . 0.76 106.976 168.503 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.813 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -98.4 93.8 6.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 105.137 -2.171 . . . . 0.26 105.137 174.632 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.628 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 46.2 m-70 -84.81 159.4 20.43 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-O 122.843 1.306 . . . . 2.03 109.618 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.97 18.75 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 111.85 -2.432 . . . . 0.92 109.645 177.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -103.52 145.45 30.0 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 111.094 -2.775 . . . . 0.47 108.709 176.623 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.436 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 38.0 t80 -139.34 97.01 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.215 1.007 . . . . 1.39 110.143 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -114.06 105.22 12.95 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.278 -1.783 . . . . 2.42 108.766 176.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.611 ' HD3' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -77.21 -36.63 54.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.588 -0.733 . . . . 2.46 110.864 -178.834 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.87 61.18 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.616 -0.72 . . . . 1.15 110.796 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.0 t -102.96 -19.82 14.46 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.351 -1.352 . . . . 1.41 107.351 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.711 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.86 35.47 11.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.321 -1.309 . . . . 3.31 110.056 177.699 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 27' ' ' ARG . 10.9 t -134.19 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.201 -0.909 . . . . 0.43 109.475 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.536 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 8.0 m-85 -102.64 111.06 23.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.068 -1.456 . . . . 1.24 107.068 166.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.7 tp -95.51 106.64 18.73 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.196 0.998 . . . . 0.52 108.86 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.2 m-85 -89.26 112.18 23.17 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.168 -1.79 . . . . 0.33 106.168 169.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.628 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -120.44 125.53 48.15 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.562 -1.199 . . . . 1.32 110.093 -173.955 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.686 ' CD1' HD11 ' A' ' 76' ' ' ILE . 1.1 mt -90.95 136.43 33.08 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.774 -1.557 . . . . 0.96 108.666 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 63.3 m170 -117.69 97.99 6.14 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.164 -2.532 . . . . 1.15 104.164 166.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.785 ' CD1' HD22 ' A' ' 57' ' ' LEU . 66.1 mt -120.31 101.62 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-O 122.718 1.247 . . . . 0.52 109.643 -174.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 12.7 p -118.4 145.49 45.15 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 114.05 -1.432 . . . . 0.58 109.872 -176.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 77' ' ' THR . 1.5 m-20 73.47 70.55 0.12 Allowed 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 111.258 -2.701 . . . . 2.12 109.924 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.53 109.33 3.19 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 111.717 -2.492 . . . . 0.4 110.947 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.742 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 3.9 tp60 -60.41 142.54 90.55 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.166 -0.924 . . . . 1.43 109.286 171.249 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 18' ' ' VAL . 26.4 Cg_exo -60.27 -18.8 54.38 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.409 2.073 . . . . 1.33 112.22 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.742 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -100.1 16.25 24.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.08 -0.509 . . . . 1.12 110.728 178.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -83.66 -36.76 23.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.831 -0.604 . . . . 1.24 110.085 -178.823 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.8 m 1.41 82.38 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 0 O-C-N 125.585 1.803 . . . . 1.22 112.179 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.968 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -47.13 117.89 3.48 Favored Glycine 0 N--CA 1.408 -3.177 0 CA-C-N 111.988 -2.369 . . . . 1.43 114.353 -171.215 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.696 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -117.51 67.57 0.32 Allowed Glycine 0 C--N 1.273 -2.927 0 N-CA-C 108.001 -2.04 . . . . 0.52 108.001 155.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.639 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 63.7 m-85 -78.13 118.99 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.765 -0.828 . . . . 0.63 108.765 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.605 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 28.4 ttm180 -114.38 126.52 55.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.45 . . . . 3.15 110.878 178.131 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.617 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 91.6 m -97.35 108.52 21.26 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.092 -0.707 . . . . 1.08 109.092 173.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 33.5 tt0 -114.84 103.26 10.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.525 -0.917 . . . . 1.81 108.525 -176.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.4 p -105.0 141.9 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.655 0.741 . . . . 0.54 111.601 -173.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -134.99 108.99 8.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.338 -1.301 . . . . 1.18 109.08 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.945 HG22 HD23 ' A' ' 33' ' ' LEU . 1.4 m -120.8 168.25 11.64 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.071 -1.455 . . . . 0.74 107.071 177.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.666 ' HZ3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -10.66 -61.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.945 1.403 . . . . 0.65 114.138 -175.576 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.99 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 0.4 OUTLIER -149.22 -3.14 0.43 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.993 -1.003 . . . . 1.05 109.994 177.776 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.962 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 3.9 mmtm -89.74 116.69 28.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.055 -1.831 . . . . 1.29 106.055 -176.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -134.06 139.69 46.15 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.892 -1.049 . . . . 0.77 111.274 -173.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.468 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 4.8 t0 -167.27 170.47 11.6 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.947 -1.024 . . . . 1.6 108.858 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 17.0 p -148.81 151.06 34.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 1.19 110.28 179.139 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.735 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 54.7 p -122.31 137.2 54.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.945 -0.702 . . . . 0.84 111.335 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -110.79 123.93 51.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.449 -0.796 . . . . 1.58 109.601 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.757 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.3 p90 -145.05 131.05 19.26 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.86 110.493 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.1 p30 -106.21 139.62 40.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.502 1.144 . . . . 2.11 112.294 -175.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -107.84 105.52 15.37 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.775 -1.557 . . . . 0.37 108.778 173.015 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.3 m -87.24 96.56 10.37 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.316 -0.994 . . . . 0.33 108.316 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 18' ' ' VAL . 3.1 p -75.39 112.2 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-O 122.842 1.306 . . . . 0.33 107.989 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.2 m170 -74.43 95.95 2.81 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.688 -2.051 . . . . 1.19 108.178 -178.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.7 tm-20 -76.15 92.86 3.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.448 -1.706 . . . . 1.67 108.191 173.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.41 151.01 35.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.277 -0.874 . . . . 2.78 111.243 -174.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.315 1.009 . . . . 6.92 111.488 176.672 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.5 m-20 . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.009 -0.737 . . . . 1.93 109.009 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.553 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 6.9 t70 -115.05 148.6 40.93 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 114.671 -1.149 . . . . 1.65 108.898 -175.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' C ' HD12 ' A' ' 4' ' ' ILE . 2.0 Cg_endo -45.44 90.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.224 3.283 . . . . 0.97 115.223 -177.306 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.7 mp -125.07 -60.52 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 114.628 -1.169 . . . . 0.5 108.042 173.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.55 33.98 6.86 Favored Glycine 0 CA--C 1.492 -1.357 0 N-CA-C 108.805 -1.718 . . . . 0.39 108.805 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.04 HD22 ' HB3' ' A' ' 96' ' ' LYS . 5.5 tp -37.92 -51.39 1.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.38 -1.91 . . . . 0.33 110.635 178.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HZ ' ' HG ' ' A' ' 100' ' ' SER . 0.7 OUTLIER -79.74 84.28 5.58 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.333 -0.849 . . . . 0.72 110.157 172.243 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.27 -41.3 57.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.634 -1.166 . . . . 0.63 108.812 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 15.6 tpt -153.92 134.77 13.76 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.747 -1.115 . . . . 2.88 109.289 173.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -104.39 140.73 21.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.26 -0.882 . . . . 3.67 109.73 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 34.7 Cg_endo -73.7 156.34 48.95 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.842 1.695 . . . . 0.64 110.46 178.187 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -118.04 -179.85 3.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.225 -0.443 . . . . 1.43 110.593 -173.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 5.4 p-10 -72.61 -145.62 0.02 OUTLIER 'General case' 0 N--CA 1.41 -2.462 0 CA-C-O 122.746 1.26 . . . . 2.06 111.704 -176.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.13 133.33 1.78 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.306 -1.77 . . . . 0.3 112.525 -176.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.484 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 37.3 mt-10 -110.36 111.16 22.27 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.682 -1.259 . . . . 1.53 108.435 176.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 22' ' ' ILE . 3.0 m -133.63 163.36 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.884 -1.154 . . . . 0.27 107.884 -172.204 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.45 147.37 23.32 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.566 -1.197 . . . . 0.77 109.193 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.958 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.79 107.42 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 CA-C-O 123.786 1.755 . . . . 0.78 109.993 174.62 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.06 -1.66 6.74 Favored Glycine 0 C--N 1.273 -2.959 0 CA-C-N 110.517 -3.038 . . . . 0.48 112.168 178.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.87 -119.66 2.48 Favored Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 119.223 -1.465 . . . . 0.44 110.383 176.068 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 48.1 t -154.09 173.63 15.79 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.611 -1.794 . . . . 0.82 108.859 173.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.1 tp -149.32 147.36 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.039 0 CA-C-N 113.237 -1.801 . . . . 0.32 106.845 167.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.3 m -140.9 126.84 19.33 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.632 -1.622 . . . . 0.31 111.338 -173.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 56.7 m-85 -124.45 147.02 48.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.65 -1.613 . . . . 0.53 109.07 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.41 120.82 16.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.132 -0.94 . . . . 0.58 110.082 176.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -113.73 116.89 30.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.467 -1.242 . . . . 0.32 110.145 -178.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 97.5 mtt180 -101.8 119.82 39.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.704 -0.225 . . . . 2.43 110.879 -177.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.9 t -118.77 125.28 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 122.067 0.937 . . . . 0.26 110.419 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.05 109.21 0.91 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.126 -1.852 . . . . 0.4 110.829 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.618 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -54.74 -33.22 55.3 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.222 -0.899 . . . . 0.76 111.947 172.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 53.97 -162.42 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.494 1.294 . . . . 0.71 114.494 169.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.0 p -118.44 38.81 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.939 -1.028 . . . . 1.74 109.2 173.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.057 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -64.44 177.32 0.89 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.678 -1.146 . . . . 2.16 113.521 -179.055 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 tp -69.21 -55.08 11.65 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.61 -0.723 . . . . 1.47 109.819 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.62 152.74 71.48 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.345 -0.843 . . . . 1.4 109.182 176.527 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -43.0 135.87 5.16 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.19 2.593 . . . . 0.88 112.987 -178.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.057 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.0 Cg_endo -55.52 135.93 71.56 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 122.726 2.284 . . . . 0.53 112.383 -176.379 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.2 104.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.507 -1.664 . . . . 0.77 106.507 177.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.63 HG22 HG13 ' A' ' 91' ' ' VAL . 42.9 t -103.84 115.22 45.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.91 0 CA-C-N 112.805 -1.998 . . . . 0.28 108.558 -179.171 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 1.054 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.33 123.38 46.69 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 113.591 -1.64 . . . . 1.54 109.444 170.465 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.971 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.9 m95 -89.34 157.37 18.21 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.702 -2.499 . . . . 0.34 111.256 173.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 21.1 t80 -136.55 125.8 24.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.876 -2.268 . . . . 0.62 104.876 167.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.801 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 20.4 tttm -102.57 162.35 12.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.494 -2.039 . . . . 2.17 105.494 -175.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.95 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -4.62 -165.94 0.0 OUTLIER Glycine 0 C--O 1.199 -2.043 0 N-CA-C 118.86 2.304 . . . . 1.23 118.86 -174.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 84' ' ' THR . 10.4 mtpp -41.67 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.026 -1.867 . . . . 3.87 115.716 -165.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 38.2 p-90 -166.02 2.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 114.416 1.265 . . . . 2.11 114.416 -177.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.39 117.11 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.993 1.378 . . . . 1.29 112.254 -163.229 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -84.85 98.42 10.3 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 112.437 -2.165 . . . . 2.73 111.32 175.211 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.013 HD23 HD21 ' A' ' 57' ' ' LEU . 4.1 mp -49.64 -36.08 23.38 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.781 -0.645 . . . . 0.44 112.719 -174.365 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 t -58.68 -22.2 56.48 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.427 -0.582 . . . . 1.23 109.427 -169.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.2 m -101.51 -28.18 12.69 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 112.919 0.711 . . . . 1.34 112.919 178.202 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 7.8 mmmt -90.1 -45.84 8.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.092 -0.504 . . . . 1.4 111.288 -171.224 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.2 t -22.67 93.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 126.504 1.922 . . . . 0.37 112.737 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -168.66 -124.73 0.74 Allowed Glycine 0 C--N 1.308 -1.025 0 CA-C-N 111.844 -2.435 . . . . 0.7 113.227 -177.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -56.8 -52.72 63.95 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.16 0.8 . . . . 2.75 113.16 -169.183 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.1 p80 -88.48 -38.6 14.86 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 112.208 0.447 . . . . 1.33 112.208 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.013 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.18 109.16 13.09 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.413 -0.958 . . . . 1.11 108.413 174.628 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -94.46 115.84 28.08 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.445 -1.687 . . . . 0.76 106.445 167.768 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.699 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.32 92.68 6.85 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 104.476 -2.416 . . . . 0.26 104.476 170.393 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 2.1 m170 -101.41 166.75 10.58 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.048 -1.433 . . . . 2.03 110.454 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 125.09 22.72 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 111.98 -2.373 . . . . 0.92 110.124 -177.458 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.3 m -94.48 148.4 22.28 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 111.506 -2.588 . . . . 0.47 107.366 172.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 2.4 t80 -135.81 97.78 3.74 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.251 1.024 . . . . 1.39 110.978 -173.286 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 5.4 m-20 -113.8 105.17 12.96 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 113.115 -1.857 . . . . 2.42 108.564 173.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.679 HH11 ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -84.41 -41.38 16.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.08 -0.964 . . . . 2.46 110.45 -178.728 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.28 -22.16 62.89 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.443 -1.253 . . . . 1.15 111.028 176.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.822 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.4 t -97.7 -16.42 19.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.285 -1.376 . . . . 1.41 107.285 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.682 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 68.04 29.18 6.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.044 -1.435 . . . . 3.31 110.903 173.699 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.48 126.87 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 121.682 0.753 . . . . 0.43 109.426 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.469 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.1 m-30 -105.0 109.11 20.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.796 -1.557 . . . . 1.24 106.796 170.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.6 tp -94.74 104.73 16.64 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 122.175 0.988 . . . . 0.52 109.516 -177.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.6 m-85 -84.16 113.33 21.0 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.134 -1.432 . . . . 0.33 107.134 171.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.51 125.61 52.16 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.789 -1.551 . . . . 1.32 110.51 -172.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.652 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -92.15 132.5 36.57 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.838 -1.528 . . . . 0.96 107.509 176.28 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 73.4 m-70 -119.95 96.72 5.29 Favored 'General case' 0 C--N 1.265 -3.066 0 N-CA-C 104.532 -2.396 . . . . 1.15 104.532 167.282 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.812 HG12 ' HB2' ' A' ' 57' ' ' LEU . 14.2 mt -122.03 99.32 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 122.382 1.087 . . . . 0.52 108.856 -174.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 75.8 p -100.41 165.0 11.66 Favored 'General case' 0 N--CA 1.388 -3.556 0 CA-C-N 114.546 -1.206 . . . . 0.58 110.374 -175.131 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 34.9 75.55 0.05 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 110.317 -3.129 . . . . 2.12 112.43 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -65.5 105.84 1.28 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 110.786 -2.916 . . . . 0.4 110.022 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.774 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.98 145.46 79.89 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.951 -0.759 . . . . 1.43 108.951 174.456 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.958 ' HD3' HG21 ' A' ' 18' ' ' VAL . 30.4 Cg_endo -62.49 150.28 88.03 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.439 1.426 . . . . 1.33 111.254 -175.029 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.53 15.48 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.725 0.64 . . . . 1.12 111.02 -175.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.58 -7.34 59.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.865 -1.161 . . . . 1.24 107.865 172.057 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.0 m -13.15 90.96 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 126.066 2.104 . . . . 1.22 112.176 -177.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.95 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -49.8 112.76 1.54 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 110.946 -2.843 . . . . 1.43 114.034 -173.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.643 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -111.25 75.73 0.22 Allowed Glycine 0 C--N 1.27 -3.103 0 N-CA-C 108.295 -1.922 . . . . 0.52 108.295 154.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.801 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 52.6 m-85 -80.08 119.15 22.5 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.298 -0.951 . . . . 0.63 109.065 175.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.5 104.21 8.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.295 -1.002 . . . . 3.15 108.295 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.6 t -90.58 127.73 36.36 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.852 -0.795 . . . . 1.08 108.852 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 1.054 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 34.1 tt0 -136.7 107.48 6.62 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.526 -0.761 . . . . 1.81 109.699 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.63 HG13 HG22 ' A' ' 39' ' ' VAL . 21.6 t -98.81 141.46 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.644 -0.422 . . . . 0.54 109.899 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 m -131.95 107.75 8.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.876 -0.787 . . . . 1.18 108.876 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.763 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.9 157.05 46.07 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 118.6 -0.714 . . . . 0.74 109.082 178.021 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 24.46 -79.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 125.61 1.819 . . . . 0.65 113.793 168.781 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.63 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 t70 -142.81 -4.17 0.96 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.894 -1.048 . . . . 1.05 109.944 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.04 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -91.65 122.74 34.49 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.536 0.684 . . . . 1.29 109.348 -177.424 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -129.81 114.29 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.388 -1.278 . . . . 0.77 110.044 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -130.44 145.26 51.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.777 -1.556 . . . . 1.6 109.531 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.503 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.5 m -142.86 147.33 35.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.374 0.607 . . . . 1.19 110.959 -178.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.569 ' HG ' ' HZ ' ' A' ' 7' ' ' PHE . 1.5 p -127.6 148.41 50.36 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.398 -0.819 . . . . 0.84 111.987 178.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.94 114.92 22.78 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.739 -1.119 . . . . 1.58 109.807 173.007 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.711 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.29 119.98 12.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.434 0.635 . . . . 0.86 109.441 -176.593 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.7 p30 -103.7 155.1 18.84 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.254 1.026 . . . . 2.11 111.59 -168.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.715 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -121.81 111.72 17.48 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.26 -1.336 . . . . 0.37 109.611 175.387 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.7 m -94.13 96.8 9.86 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.127 -0.694 . . . . 0.33 109.127 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 79' ' ' ALA . 4.0 p -82.87 113.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 122.955 1.36 . . . . 0.33 109.234 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.484 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 99.7 m-70 -87.5 101.21 13.39 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 112.201 -2.272 . . . . 1.19 109.044 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HA ' HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -64.21 95.15 0.12 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.6 -1.182 . . . . 1.67 108.647 170.762 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.18 52.82 1.83 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.068 -0.969 . . . . 2.78 109.167 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 C--O 1.245 0.843 0 CA-C-N 115.49 -0.777 . . . . 6.92 110.078 179.677 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.831 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 4.6 p-10 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.119 0.485 . . . . 1.93 109.982 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -97.95 172.8 4.49 Favored Pre-proline 0 N--CA 1.444 -0.742 0 C-N-CA 123.174 0.59 . . . . 1.65 111.281 -178.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.99 84.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.317 2.011 . . . . 0.97 111.711 171.078 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.007 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -110.01 -64.87 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.16 -0.927 . . . . 0.5 109.329 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 95.6 46.55 2.71 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 108.284 -1.926 . . . . 0.39 108.284 -175.285 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.6 tp -56.72 -47.57 79.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.156 -1.522 . . . . 0.33 111.203 -166.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.498 ' HD1' ' HA ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -93.98 84.76 4.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.933 0.873 . . . . 0.72 109.665 178.367 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.48 -35.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.983 -1.462 . . . . 0.63 109.693 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -158.57 130.9 6.88 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 114.948 -1.024 . . . . 2.88 109.016 172.41 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -109.28 133.32 20.83 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 3.67 110.206 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.69 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.5 Cg_endo -63.76 157.54 51.47 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.725 2.283 . . . . 0.64 111.966 -176.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.0 mm-40 -121.26 174.17 6.87 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.858 -0.61 . . . . 1.43 110.472 -173.137 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 5.5 p-10 -68.48 -142.85 0.01 OUTLIER 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 122.942 1.354 . . . . 2.06 111.968 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.85 137.16 2.7 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 113.433 -1.712 . . . . 0.3 112.112 -175.435 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.0 mt-10 -110.49 115.81 30.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.413 -0.958 . . . . 1.53 108.413 174.171 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -134.86 155.7 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.02 0 N-CA-C 106.982 -1.488 . . . . 0.27 106.982 -173.686 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.36 157.28 18.23 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.041 -0.981 . . . . 0.77 108.908 -179.562 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.549 HG22 ' CG2' ' A' ' 106' ' ' VAL . 21.5 t -67.69 105.98 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.847 1.308 . . . . 0.78 108.117 173.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.76 11.41 6.49 Favored Glycine 0 C--N 1.265 -3.395 0 CA-C-N 112.132 -2.304 . . . . 0.48 113.055 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.14 -126.81 5.89 Favored Glycine 0 N--CA 1.416 -2.66 0 C-N-CA 119.278 -1.439 . . . . 0.44 110.529 171.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.7 p -151.21 170.46 19.41 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 112.697 -1.752 . . . . 0.82 110.613 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.8 tp -148.7 150.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-N 112.835 -1.984 . . . . 0.32 106.952 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -138.71 130.11 27.27 Favored 'General case' 0 C--N 1.258 -3.383 0 CA-C-N 114.32 -1.309 . . . . 0.31 110.639 -175.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 74' ' ' LEU . 26.9 m-85 -124.96 142.52 51.42 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.417 -1.265 . . . . 0.53 109.85 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.83 121.28 20.42 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.078 0.942 . . . . 0.58 110.43 176.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.637 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -118.83 115.94 25.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.119 -1.401 . . . . 0.32 110.459 -178.132 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -105.06 122.81 46.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.439 -0.346 . . . . 2.43 110.76 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 39' ' ' VAL . 8.4 t -125.74 127.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 122.085 0.945 . . . . 0.26 110.126 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -58.27 114.09 2.25 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.254 -1.794 . . . . 0.4 111.397 177.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.03 -29.05 61.79 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.293 -1.321 . . . . 0.76 110.757 168.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.72 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 52.86 -166.58 0.06 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.83 1.418 . . . . 0.71 114.83 165.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 t -120.9 107.77 13.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.066 -1.457 . . . . 1.74 107.066 169.769 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.801 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -143.05 176.32 9.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.061 0.763 . . . . 2.16 113.061 -165.311 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.0 tp -70.56 -71.44 0.25 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.386 -0.825 . . . . 1.47 108.824 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -116.63 148.4 41.82 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.609 -0.723 . . . . 1.4 109.302 171.318 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 85.9 Cg_exo -46.67 142.92 9.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.877 2.385 . . . . 0.88 111.809 178.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.801 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.9 Cg_exo -62.37 139.63 78.07 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 121.938 1.759 . . . . 0.53 111.924 -173.367 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.3 104.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.813 -1.551 . . . . 0.77 106.813 178.084 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 28' ' ' VAL . 2.1 t -105.98 115.1 46.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 113.323 -1.762 . . . . 0.28 107.528 176.463 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.09 127.91 55.14 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-O 122.944 1.354 . . . . 1.54 110.132 175.371 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.932 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.3 m95 -84.21 155.77 22.36 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 112.148 -2.297 . . . . 0.34 111.923 175.358 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.9 t80 -131.16 141.48 50.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 104.703 -2.332 . . . . 0.62 104.703 170.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.768 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 62.5 tttt -108.81 163.53 13.19 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.349 -1.723 . . . . 2.17 106.349 -172.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.811 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -7.81 -165.81 0.0 OUTLIER Glycine 0 C--O 1.196 -2.252 0 O-C-N 126.4 2.312 . . . . 1.23 118.845 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 84' ' ' THR . 15.6 mtpp -44.24 -3.7 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 O-C-N 119.449 -2.207 . . . . 3.87 116.271 -169.003 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.652 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.9 p-90 -171.2 -8.99 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 N-CA-C 115.295 1.591 . . . . 2.11 115.295 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HB ' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.83 159.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 123.222 1.487 . . . . 1.29 113.795 -159.277 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.742 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -112.48 106.11 14.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 111.817 -2.447 . . . . 2.73 113.084 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.932 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.6 mp -55.08 -36.32 65.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.086 0.773 . . . . 0.44 113.086 -175.753 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -59.02 -20.85 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.763 -0.829 . . . . 1.23 108.763 -169.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 12.6 m -98.79 -41.9 7.44 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.058 -0.974 . . . . 1.34 112.088 178.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.742 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 10.7 mmmt -85.09 -37.39 20.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.952 -1.022 . . . . 1.4 112.389 -166.754 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.876 HG13 ' H ' ' A' ' 59' ' ' LEU . 17.5 t -35.2 96.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 125.967 1.707 . . . . 0.37 112.542 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.63 -138.98 3.08 Favored Glycine 0 C--N 1.3 -1.457 0 CA-C-N 111.316 -2.675 . . . . 0.7 112.809 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -74.07 -8.37 55.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.973 0.731 . . . . 2.75 112.973 -167.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.717 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 29.3 p80 -111.79 -37.52 5.12 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 120.618 -0.433 . . . . 1.33 110.985 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.803 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -121.38 102.55 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.531 -1.655 . . . . 1.11 106.531 171.86 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -95.89 116.16 28.5 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.288 -1.375 . . . . 0.76 107.288 168.119 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.876 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.24 93.28 7.21 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.965 -2.235 . . . . 0.26 104.965 170.372 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.669 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 56.8 t60 -94.19 158.98 15.34 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 122.954 1.359 . . . . 2.03 109.042 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.95 112.87 10.29 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 111.753 -2.476 . . . . 0.92 110.605 -176.183 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.4 m -97.44 149.27 22.34 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 112.308 -2.224 . . . . 0.47 108.577 174.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -141.98 97.63 3.17 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.08 0.943 . . . . 1.39 110.632 -170.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 6.0 t70 -116.76 128.0 54.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.766 -1.561 . . . . 2.42 108.596 174.046 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.86 -31.38 11.53 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.858 -1.519 . . . . 2.46 111.021 -173.465 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.47 -19.88 60.22 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.385 -1.279 . . . . 1.15 110.549 174.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 50.7 m -98.53 -20.47 17.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 107.821 -1.177 . . . . 1.41 107.821 174.734 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.72 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 69.15 32.24 3.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.13 -1.395 . . . . 3.31 109.383 175.415 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.86 129.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.615 -0.72 . . . . 0.43 109.776 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.686 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 4.9 m-85 -100.25 112.33 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.495 -1.668 . . . . 1.24 106.495 164.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 27.5 tp -95.27 106.32 18.35 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 122.09 0.948 . . . . 0.52 109.075 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -86.95 112.34 21.71 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.511 -1.663 . . . . 0.33 106.511 169.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.669 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 4.0 pt-20 -121.54 122.35 39.49 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.29 -1.323 . . . . 1.32 110.557 -173.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.716 ' CD1' HD11 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -89.08 132.08 34.95 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.033 -1.44 . . . . 0.96 108.45 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 19.8 m170 -115.03 97.01 5.97 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 103.798 -2.668 . . . . 1.15 103.798 169.005 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.727 ' CD1' HD22 ' A' ' 57' ' ' LEU . 62.9 mt -121.55 101.3 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-O 122.985 1.374 . . . . 0.52 109.775 -174.336 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.7 p -112.69 143.78 43.32 Favored 'General case' 0 N--CA 1.398 -3.045 0 CA-C-N 114.126 -1.397 . . . . 0.58 109.257 -178.218 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.77 86.05 0.12 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 111.183 -2.735 . . . . 2.12 110.49 -177.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -75.91 125.17 28.59 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 112.713 -2.04 . . . . 0.4 109.52 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.879 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -61.84 134.33 94.05 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.281 -0.872 . . . . 1.43 108.978 175.687 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.48 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 19.1 Cg_endo -60.79 145.78 98.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.704 0.936 . . . . 1.33 110.37 176.249 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.18 17.2 10.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.441 0.463 . . . . 1.12 111.288 -173.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.879 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -73.1 -32.67 65.11 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.546 -0.539 . . . . 1.24 109.546 175.745 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m 13.12 78.35 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 125.379 1.675 . . . . 1.22 111.137 -168.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.811 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -65.74 99.0 0.37 Allowed Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 112.112 -2.313 . . . . 1.43 113.877 -161.144 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.67 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.13 74.04 1.87 Allowed Glycine 0 C--N 1.289 -2.078 0 N-CA-C 109.181 -1.568 . . . . 0.52 109.181 171.288 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.644 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 45.3 m-85 -81.01 120.1 24.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.071 -1.065 . . . . 0.63 108.165 176.355 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.528 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 72.7 mtt180 -127.61 115.36 18.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.935 -0.478 . . . . 3.15 111.034 -173.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.1 m -92.64 129.12 38.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.067 -0.515 . . . . 1.08 110.03 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 41.7 tt0 -126.8 113.22 16.33 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.606 -0.887 . . . . 1.81 108.606 174.476 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.0 p -105.26 135.51 43.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.853 0.835 . . . . 0.54 110.655 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -129.45 109.2 10.87 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.856 -1.52 . . . . 1.18 108.688 -176.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.624 HG22 ' HG3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -125.11 167.11 15.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 118.249 -0.882 . . . . 0.74 108.835 178.938 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.689 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -2.94 -62.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.618 1.824 . . . . 0.65 114.571 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.689 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 12.9 t0 -150.63 -7.05 0.28 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.773 -1.103 . . . . 1.05 110.239 -176.471 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.007 ' HD2' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mttp -95.35 135.63 36.72 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.14 -1.024 . . . . 1.29 108.681 -177.533 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -132.9 142.2 48.78 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.403 -1.726 . . . . 0.77 110.735 -177.259 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -164.02 163.84 23.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.317 -0.856 . . . . 1.6 108.972 173.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 p -153.31 148.67 27.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.244 0.545 . . . . 1.19 111.198 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.5 t -125.45 148.97 48.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.913 0.863 . . . . 0.84 111.71 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.24 114.28 11.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.671 -1.604 . . . . 1.58 110.092 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.69 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 18.6 p90 -142.47 131.67 23.36 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.562 -0.533 . . . . 0.86 109.562 -176.327 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 52.7 m-20 -109.04 135.24 50.52 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.154 0.978 . . . . 2.11 111.324 -171.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -102.74 110.11 21.93 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.145 -1.389 . . . . 0.37 109.434 176.811 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 13.3 m -90.85 97.87 11.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.381 0.61 . . . . 0.33 109.391 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.5 p -82.13 115.67 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.987 1.375 . . . . 0.33 109.288 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 94.6 m-70 -87.24 99.57 12.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.552 -2.113 . . . . 1.19 109.538 -177.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.542 ' HA ' HG23 ' A' ' 18' ' ' VAL . 41.3 tt0 -75.12 -59.71 2.62 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.845 -1.525 . . . . 1.67 109.803 173.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.33 17.42 0.48 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.343 -0.844 . . . . 2.78 109.46 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.172 -0.922 . . . . 6.92 109.349 -175.274 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.659 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 6.0 p-10 . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 121.036 0.446 . . . . 1.93 110.142 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.734 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-20 -94.81 166.13 15.71 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 123.16 0.584 . . . . 1.65 112.45 -175.06 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.474 ' C ' HD12 ' A' ' 4' ' ' ILE . 24.8 Cg_exo -64.01 86.55 0.15 Allowed 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.195 2.597 . . . . 0.97 112.406 173.187 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.947 HG12 ' HD3' ' A' ' 94' ' ' LYS . 1.7 mp -119.59 -56.54 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.71 -1.132 . . . . 0.5 109.573 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.001 -1.64 . . . . 0.39 109.001 -175.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.916 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.7 tp -52.27 -37.78 56.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.309 -1.446 . . . . 0.33 109.811 -176.024 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.771 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.06 84.11 5.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.04 -0.982 . . . . 0.72 109.911 176.235 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t -72.57 -43.2 63.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.264 -1.335 . . . . 0.63 109.826 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.412 ' HB3' ' HG3' ' A' ' 27' ' ' ARG . 16.0 tpt -156.95 130.25 7.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.372 -0.831 . . . . 2.88 109.56 174.199 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.2 ptp85 -102.8 136.42 19.29 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 115.185 -0.916 . . . . 3.67 109.107 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.1 Cg_endo -74.14 160.53 42.46 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.323 1.349 . . . . 0.64 110.897 176.644 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -117.13 -179.77 3.8 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.297 -0.631 . . . . 1.43 109.297 -176.365 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 4.6 m-20 -69.99 -146.73 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 122.979 1.371 . . . . 2.06 111.264 -175.168 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.65 133.53 1.65 Allowed Glycine 0 C--N 1.294 -1.799 0 CA-C-N 113.438 -1.71 . . . . 0.3 111.5 -173.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.2 116.71 30.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.393 -0.904 . . . . 1.53 108.663 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -135.77 156.4 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.643 -1.244 . . . . 0.27 107.643 -171.736 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 156.19 18.64 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.638 -1.165 . . . . 0.77 108.916 176.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 81' ' ' PRO . 13.5 t -66.89 107.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 123.151 1.453 . . . . 0.78 108.477 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.17 3.71 11.65 Favored Glycine 0 C--N 1.266 -3.323 0 CA-C-N 111.612 -2.54 . . . . 0.48 112.463 178.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.86 -127.88 5.2 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 118.988 -1.577 . . . . 0.44 110.023 176.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 18.8 p -153.06 164.9 37.16 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 113.437 -1.381 . . . . 0.82 110.718 177.145 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 104' ' ' LEU . 10.8 tp -147.05 149.67 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.401 -1.727 . . . . 0.32 107.924 171.009 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -139.81 127.33 21.58 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 113.016 -1.902 . . . . 0.31 110.385 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.633 ' HB2' HD23 ' A' ' 74' ' ' LEU . 54.5 m-85 -121.92 147.31 46.18 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.607 -1.179 . . . . 0.53 108.883 174.256 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -132.44 119.73 21.03 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.208 -0.905 . . . . 0.58 109.183 178.199 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.644 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.39 119.96 29.76 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.456 -1.247 . . . . 0.32 110.805 -173.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.514 ' HG2' HD13 ' A' ' 71' ' ' LEU . 72.0 mtp180 -114.21 127.09 55.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.266 -0.425 . . . . 2.43 110.774 -176.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 91' ' ' VAL . 22.4 t -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-O 122.005 0.907 . . . . 0.26 110.558 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.96 111.38 2.13 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.197 -1.819 . . . . 0.4 110.566 174.172 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.81 -40.07 9.02 Favored Glycine 0 C--N 1.32 -0.336 0 CA-C-N 114.543 -1.208 . . . . 0.76 111.548 170.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 50.69 -156.01 0.12 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.869 0.868 . . . . 0.71 113.282 171.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.6 m -120.01 84.33 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.216 0.532 . . . . 1.74 110.852 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.076 HD22 ' HA ' ' A' ' 93' ' ' THR . 1.8 tp -114.28 150.38 34.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.323 -0.992 . . . . 2.16 108.323 173.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 33' ' ' LEU . 21.0 tp -44.24 -37.41 3.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.948 0.88 . . . . 1.47 111.292 178.107 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.808 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.36 178.41 1.7 Allowed Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.41 -1.268 . . . . 1.4 108.121 177.193 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.0 Cg_exo -65.59 146.23 83.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.662 1.575 . . . . 0.88 109.997 173.264 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HG3' HG21 ' A' ' 93' ' ' THR . 49.4 Cg_exo -45.57 140.76 8.63 Favored 'Trans proline' 0 CA--C 1.498 -1.297 0 C-N-CA 123.211 2.607 . . . . 0.53 113.286 178.536 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 92' ' ' SER . 7.3 p -100.09 96.84 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.075 1.417 . . . . 0.77 107.664 168.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.639 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -99.26 114.47 37.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 112.703 -2.044 . . . . 0.28 106.923 170.308 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.6 127.27 53.5 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 114.027 -1.442 . . . . 1.54 109.6 177.729 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.046 ' HB3' HD13 ' A' ' 49' ' ' LEU . 89.2 m95 -89.6 147.48 23.9 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.078 -2.328 . . . . 0.34 111.792 173.149 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.655 ' HD2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 t80 -131.35 125.48 32.78 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.71 -1.589 . . . . 0.62 106.71 172.323 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 5.1 ttpm? -98.93 109.91 22.6 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.214 -1.402 . . . . 2.17 107.214 -173.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.671 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -83.3 92.49 1.66 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 116.012 -2.994 . . . . 1.23 114.797 -167.344 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.839 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -106.15 -53.52 2.62 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.61 -3.107 . . . . 3.87 102.61 132.16 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.839 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 6.5 p-90 -167.38 -1.56 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 110.459 -3.064 . . . . 2.11 111.476 178.416 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.526 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -94.67 170.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-O 123.144 1.45 . . . . 1.29 112.496 -159.7 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 7.3 t70 -106.22 150.0 26.31 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.675 -2.511 . . . . 2.73 106.07 173.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -88.17 -36.84 16.6 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.402 -0.519 . . . . 0.44 110.902 176.106 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -59.97 -19.54 52.76 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.866 0.841 . . . . 1.23 109.011 -169.585 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -86.14 -28.78 23.76 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.571 -1.195 . . . . 1.34 111.094 -176.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 43' ' ' LYS . 2.4 mmmt -104.65 -71.4 0.74 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.03 -0.986 . . . . 1.4 111.125 -172.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.93 HG13 ' H ' ' A' ' 59' ' ' LEU . 56.2 t 19.01 85.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 O-C-N 125.366 1.667 . . . . 0.37 113.181 -177.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.74 -131.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 114.659 -1.155 . . . . 0.7 113.639 -173.379 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -48.78 -53.87 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.909 1.077 . . . . 2.75 113.909 -168.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.2 p80 -91.17 -38.09 12.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.837 -0.745 . . . . 1.33 111.498 -173.142 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.886 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.0 108.81 12.78 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.809 -0.811 . . . . 1.11 108.809 175.443 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.43 115.61 27.72 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 106.343 -1.725 . . . . 0.76 106.343 168.218 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.93 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.05 92.7 6.97 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.961 -2.237 . . . . 0.26 104.961 172.099 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 36.1 m170 -81.9 163.3 22.33 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.046 -1.434 . . . . 2.03 109.994 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -139.21 114.8 9.9 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 112.328 -2.214 . . . . 0.92 109.604 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 3.2 m -92.26 148.22 22.31 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.153 -1.84 . . . . 0.47 106.516 169.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.486 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.2 t80 -144.75 98.96 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.211 1.005 . . . . 1.39 111.011 -170.206 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 67' ' ' SER . 2.5 p30 -113.69 128.23 56.34 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.697 -1.592 . . . . 2.42 110.342 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.1 mmm180 -105.95 29.03 7.03 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.705 -1.589 . . . . 2.46 109.295 172.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.04 -30.17 6.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.195 -1.82 . . . . 1.15 109.27 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 5.7 t -111.91 -8.47 14.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.89 -1.05 . . . . 1.41 108.939 178.016 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 72.48 31.68 1.72 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.547 -0.909 . . . . 3.31 108.547 173.654 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 3.3 t -127.33 133.8 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 122.506 1.146 . . . . 0.43 111.473 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' SER . 5.0 m-85 -101.96 113.39 26.57 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.26 -1.755 . . . . 1.24 106.26 162.633 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 14.7 tp -97.36 104.82 16.88 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 122.302 1.049 . . . . 0.52 109.391 177.623 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.4 m-85 -88.64 114.58 25.4 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.833 -1.53 . . . . 0.33 108.534 174.124 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 2.9 mt-10 -103.52 125.66 50.21 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 113.708 -1.587 . . . . 1.32 109.566 -176.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.876 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -94.08 122.23 36.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.862 -1.162 . . . . 0.96 107.862 171.701 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 11.4 m170 -115.79 93.83 4.43 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.967 -2.605 . . . . 1.15 103.967 169.593 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.885 HG12 ' HB2' ' A' ' 57' ' ' LEU . 38.0 mt -121.78 100.79 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 122.883 1.325 . . . . 0.52 110.026 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 72.4 p -103.02 154.61 19.07 Favored 'General case' 0 N--CA 1.391 -3.395 0 CA-C-N 114.057 -1.429 . . . . 0.58 109.051 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.89 84.26 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.115 -2.766 . . . . 2.12 112.064 178.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -72.84 132.28 43.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 110.731 -2.94 . . . . 0.4 112.252 -175.515 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.662 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -54.01 125.62 49.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.402 -0.817 . . . . 1.43 109.323 170.074 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.4 Cg_endo -59.23 -7.19 4.67 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.738 2.959 . . . . 1.33 114.03 -175.306 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.662 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.6 0.41 19.08 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.974 -0.29 . . . . 1.12 111.569 -178.435 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.639 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.48 -58.09 9.57 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.642 0.258 . . . . 1.24 110.889 -172.601 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 34.2 m 38.64 66.2 0.55 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.592 -1.633 . . . . 1.22 106.592 -155.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -62.72 84.77 0.04 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 CA-C-N 112.445 -2.162 . . . . 1.43 114.139 -161.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -86.72 82.78 1.62 Allowed Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.916 -1.673 . . . . 0.52 108.916 175.307 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 18.1 m-85 -78.75 113.99 17.3 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.779 -1.211 . . . . 0.63 107.998 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.655 ' HB2' ' HD2' ' A' ' 42' ' ' PHE . 7.4 mtp180 -104.02 105.95 16.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.267 0.556 . . . . 3.15 109.854 -176.704 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.8 t -87.71 126.96 35.28 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.568 -0.742 . . . . 1.08 109.076 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.947 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 37.6 tt0 -136.03 110.37 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.222 -0.899 . . . . 1.81 109.606 -175.572 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.639 ' HB ' HG13 ' A' ' 39' ' ' VAL . 1.7 p -106.27 142.3 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.957 0.408 . . . . 0.54 111.046 -179.036 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.557 ' O ' HG12 ' A' ' 38' ' ' VAL . 20.7 t -132.13 108.28 9.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.919 -1.141 . . . . 1.18 107.919 177.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.076 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -131.44 146.62 52.34 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 117.912 -1.042 . . . . 0.74 108.501 -178.639 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.947 ' HD3' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 32.74 -74.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.642 1.839 . . . . 0.65 112.976 -177.558 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 22.2 t70 -147.69 -7.56 0.44 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.569 -1.196 . . . . 1.05 110.429 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.916 ' HB3' HD22 ' A' ' 6' ' ' LEU . 2.7 tttp -86.38 131.65 34.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.998 -1.112 . . . . 1.29 107.998 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -133.2 120.45 21.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.485 -1.689 . . . . 0.77 110.233 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -139.69 148.27 42.11 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.502 -1.226 . . . . 1.6 109.338 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 43.8 m -140.0 149.17 42.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.371 -0.377 . . . . 1.19 110.303 -179.032 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.771 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 40.7 p -131.9 134.43 45.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 0.84 111.273 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -107.78 119.43 39.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 1.58 110.096 177.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.738 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -142.27 118.56 10.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.137 -0.69 . . . . 0.86 109.137 -179.105 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 3.7 p30 -106.43 154.6 20.58 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 123.034 1.397 . . . . 2.11 111.876 -170.792 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.644 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -116.57 106.42 13.54 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.924 -1.944 . . . . 0.37 110.456 178.517 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -87.43 95.86 10.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.334 -0.987 . . . . 0.33 108.334 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.2 p -83.37 120.23 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 122.876 1.322 . . . . 0.33 108.54 -177.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -93.81 98.31 10.99 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 112.892 -1.958 . . . . 1.19 109.322 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 18' ' ' VAL . 27.8 tt0 -75.54 -63.86 1.2 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.258 -1.337 . . . . 1.67 109.665 171.218 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.7 126.3 35.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 2.78 110.384 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.604 -0.712 . . . . 6.92 110.002 177.686 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.677 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.227 0.537 . . . . 1.93 109.8 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 8.2 m-20 -91.47 169.74 10.82 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.318 -0.856 . . . . 1.65 109.311 173.023 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.22 81.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.464 2.109 . . . . 0.97 111.596 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.644 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -102.0 -62.51 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 115.457 -0.792 . . . . 0.5 109.608 178.685 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.12 40.71 3.68 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.987 -1.645 . . . . 0.39 108.987 -176.046 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.7 tp -55.07 -33.62 62.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.42 -1.39 . . . . 0.33 110.131 -172.592 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.833 ' CZ ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -97.81 84.58 3.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.391 -1.277 . . . . 0.72 109.608 176.847 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.65 -46.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.664 -1.153 . . . . 0.63 110.374 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ttt -159.74 134.46 7.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.851 -1.068 . . . . 2.88 108.567 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.833 ' HD2' ' CZ ' ' A' ' 7' ' ' PHE . 5.5 mmp_? -125.25 145.66 51.45 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 116.173 -0.467 . . . . 3.67 111.077 -172.023 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.812 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -70.73 159.4 52.82 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.773 1.649 . . . . 0.64 110.573 179.145 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -124.79 -176.81 3.64 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.04 -0.527 . . . . 1.43 110.142 -173.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 3.7 p-10 -68.27 -152.34 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.732 0 CA-C-O 122.869 1.318 . . . . 2.06 111.211 -177.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 153.17 139.1 2.81 Favored Glycine 0 C--N 1.287 -2.171 0 CA-C-N 113.044 -1.889 . . . . 0.3 111.744 -173.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 21.2 mt-10 -115.07 114.96 26.05 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.297 -0.952 . . . . 1.53 109.055 175.311 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -136.4 158.32 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 N-CA-C 107.104 -1.443 . . . . 0.27 107.104 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.04 157.74 18.24 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.83 -1.077 . . . . 0.77 109.548 -178.873 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 22.6 t -64.99 107.06 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 123.088 1.423 . . . . 0.78 108.554 173.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 10.12 16.34 Favored Glycine 0 C--N 1.267 -3.284 0 CA-C-N 111.882 -2.417 . . . . 0.48 113.041 175.052 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 -123.14 3.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 119.703 -1.237 . . . . 0.44 110.198 175.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.9 p -152.43 164.24 37.93 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 112.989 -1.605 . . . . 0.82 110.817 176.451 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.5 tp -148.29 150.96 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 113.609 -1.632 . . . . 0.32 107.774 170.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.8 m -138.54 129.28 26.47 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 113.941 -1.481 . . . . 0.31 110.996 -176.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.691 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 87.7 m-85 -125.21 145.19 50.09 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.955 -1.475 . . . . 0.53 109.089 178.339 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.526 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -137.43 124.86 21.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.943 -0.762 . . . . 0.58 108.943 174.352 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.85 114.4 19.81 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.741 -1.118 . . . . 0.32 110.208 -176.252 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.501 ' HG2' HD13 ' A' ' 71' ' ' LEU . 67.7 mtp180 -104.86 128.98 53.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.504 -0.316 . . . . 2.43 110.267 -176.024 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG21 HG21 ' A' ' 39' ' ' VAL . 20.1 t -125.5 127.48 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.902 0.858 . . . . 0.26 109.964 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -63.11 108.82 1.33 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.961 -1.472 . . . . 0.4 110.939 175.461 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.68 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.62 -54.92 11.95 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.76 112.35 173.281 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 57.57 -166.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.275 0.843 . . . . 0.71 113.275 177.395 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -107.73 127.65 53.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.37 -0.832 . . . . 1.74 109.037 172.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -123.41 -178.86 4.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.088 0.947 . . . . 2.16 112.319 -168.665 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' H ' ' HB3' ' A' ' 94' ' ' LYS . 17.4 tp -88.29 -37.36 16.07 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.586 -1.643 . . . . 1.47 106.846 154.56 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.35 145.8 19.07 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.595 -1.184 . . . . 1.4 110.895 171.303 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.82 148.48 12.42 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.348 2.699 . . . . 0.88 112.27 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HA ' HG23 ' A' ' 93' ' ' THR . 6.3 Cg_endo -55.21 132.26 51.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.091 1.861 . . . . 0.53 113.572 -175.173 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.13 106.28 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.277 -1.749 . . . . 0.77 106.277 174.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 91' ' ' VAL . 2.1 t -115.08 114.31 46.1 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 113.703 -1.589 . . . . 0.28 108.03 179.082 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.809 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.84 128.72 45.91 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 123.066 1.413 . . . . 1.54 109.19 172.906 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 1.002 ' HB3' HD13 ' A' ' 49' ' ' LEU . 60.0 m95 -87.89 153.54 21.23 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 112.061 -2.336 . . . . 0.34 110.709 172.295 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -135.01 125.23 26.15 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.202 -2.147 . . . . 0.62 105.202 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HB3' HG12 ' A' ' 47' ' ' VAL . 27.1 tttt -104.09 99.57 9.31 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.38 -1.711 . . . . 2.17 106.38 -175.481 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.661 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -86.45 95.14 2.01 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 115.882 -3.056 . . . . 1.23 117.078 -154.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.926 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -101.69 -48.17 4.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.007 -2.59 . . . . 3.87 104.007 135.322 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.926 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 11.6 p-90 -170.41 1.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 112.676 -2.056 . . . . 2.11 111.915 175.524 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -97.35 169.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 C-N-CA 125.275 1.43 . . . . 1.29 113.171 -159.427 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.549 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 m-20 -100.95 147.45 26.15 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 112.456 -2.156 . . . . 2.73 107.527 173.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.002 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.3 mp -79.21 -29.25 42.72 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.678 -0.409 . . . . 0.44 110.639 173.383 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -57.36 -20.93 32.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 1.23 109.608 -167.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.504 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -97.59 -27.85 14.21 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 119.78 -0.768 . . . . 1.34 111.79 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.582 ' HB2' HD12 ' A' ' 57' ' ' LEU . 5.9 mmmt -95.68 -33.37 12.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.392 -0.822 . . . . 1.4 111.319 -171.196 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.828 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.8 t -40.79 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 126.02 1.728 . . . . 0.37 111.908 175.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.89 -103.2 0.19 Allowed Glycine 0 C--N 1.302 -1.353 0 CA-C-N 112.427 -2.17 . . . . 0.7 113.42 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.11 -54.68 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.118 0.784 . . . . 2.75 113.118 -169.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -96.05 -29.37 14.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.487 0.661 . . . . 1.33 111.189 -174.338 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.969 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.12 106.05 13.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.541 -1.651 . . . . 1.11 106.541 173.494 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -104.68 118.28 36.18 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.074 -1.454 . . . . 0.76 107.074 167.119 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.828 ' H ' HG13 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -98.96 92.83 5.7 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.211 -2.144 . . . . 0.26 105.211 172.073 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.7 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.2 m170 -91.31 162.91 14.41 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.161 -1.381 . . . . 2.03 110.21 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -136.45 122.95 20.83 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 112.348 -2.205 . . . . 0.92 110.145 176.176 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -97.0 148.54 22.87 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 111.367 -2.651 . . . . 0.47 108.559 176.518 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 37.3 t80 -127.78 99.83 5.7 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.352 1.072 . . . . 1.39 111.563 -170.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.852 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 3.2 m-20 -113.44 103.96 11.8 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.036 -1.893 . . . . 2.42 109.285 172.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -42.1 14.38 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.054 -0.521 . . . . 2.46 110.26 174.495 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.38 61.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.295 -0.866 . . . . 1.15 110.637 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.852 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 9.4 m -99.67 -16.3 18.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.8 -1.185 . . . . 1.41 107.8 175.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 68.24 31.62 5.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.362 -1.29 . . . . 3.31 110.001 172.523 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 2.6 t -129.97 122.54 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-N 115.48 -0.782 . . . . 0.43 110.175 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.68 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 46.2 m-85 -95.92 113.22 24.83 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.026 -1.472 . . . . 1.24 107.026 164.777 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 25' ' ' SER . 22.6 tp -97.47 105.02 17.1 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.106 0.955 . . . . 0.52 108.78 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.0 m-85 -86.19 111.65 20.59 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.262 -1.755 . . . . 0.33 106.262 170.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -116.57 129.52 56.22 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 114.348 -1.296 . . . . 1.32 110.344 -174.833 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.5 mt -92.29 135.92 33.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 113.789 -1.551 . . . . 0.96 108.635 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -120.09 97.32 5.54 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 103.915 -2.624 . . . . 1.15 103.915 165.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.731 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -125.48 100.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 122.982 1.372 . . . . 0.52 109.153 -175.051 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 40.7 p -97.6 165.12 12.13 Favored 'General case' 0 N--CA 1.381 -3.886 0 CA-C-N 114.004 -1.453 . . . . 0.58 107.866 178.341 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.4 84.27 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 111.404 -2.635 . . . . 2.12 112.755 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -76.66 132.69 39.53 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 111.574 -2.557 . . . . 0.4 108.383 176.084 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.611 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 1.1 pt20 -93.63 152.02 40.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.616 -0.883 . . . . 1.43 108.616 -178.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HB3' ' HG2' ' A' ' 108' ' ' GLU . 36.8 Cg_endo -63.92 -16.84 57.15 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.75 2.3 . . . . 1.33 113.403 -167.572 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -92.04 13.06 19.87 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.961 -0.563 . . . . 1.12 111.68 -176.576 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 45' ' ' LYS . 15.9 m-30 -89.09 -61.17 1.76 Allowed 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.258 -0.577 . . . . 1.24 110.52 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.3 m 36.7 63.16 0.69 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.027 -1.471 . . . . 1.22 107.027 -158.052 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.741 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -67.21 90.94 0.19 Allowed Glycine 0 CA--C 1.481 -2.055 0 CA-C-N 111.978 -2.374 . . . . 1.43 113.782 -160.166 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -84.72 82.04 1.71 Allowed Glycine 0 C--N 1.277 -2.715 0 N-CA-C 107.933 -2.067 . . . . 0.52 107.933 168.302 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 8.3 m-85 -74.71 134.33 41.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.653 -1.274 . . . . 0.63 108.088 179.283 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -126.44 138.12 53.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.92 -0.4 . . . . 3.15 109.92 -178.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.648 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 4.3 m -112.09 116.42 30.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.415 -0.957 . . . . 1.08 108.415 168.065 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.809 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 64.5 mt-10 -110.19 102.07 10.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.544 -1.28 . . . . 1.81 107.544 176.302 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 39' ' ' VAL . 4.7 p -99.19 135.92 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.752 0.787 . . . . 0.54 111.36 -173.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.6 t -130.07 108.89 10.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.891 -1.504 . . . . 1.18 107.862 -179.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.5 m -130.3 158.47 39.7 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.8 -1.095 . . . . 0.74 108.054 179.749 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.683 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 10.96 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 125.819 1.949 . . . . 0.65 114.342 -177.489 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.683 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -146.18 -3.16 0.67 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.923 -1.035 . . . . 1.05 110.193 -176.694 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.677 ' HE3' ' HB3' ' A' ' 1' ' ' ASP . 4.5 mmtp -95.39 129.63 42.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.612 -0.884 . . . . 1.29 108.612 -177.263 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -131.7 128.63 39.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.81 -1.087 . . . . 0.77 112.341 -178.292 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.7 160.47 43.82 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.46 -1.245 . . . . 1.6 109.95 175.077 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -140.95 145.86 36.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.624 0.25 . . . . 1.19 110.487 176.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.758 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 89.2 p -126.8 135.53 51.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.542 -0.299 . . . . 0.84 110.915 -175.645 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -122.33 128.49 51.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.378 0.609 . . . . 1.58 111.05 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.812 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -143.08 119.0 10.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.6 -0.727 . . . . 0.86 109.694 -177.143 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.503 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -104.32 129.58 52.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.423 1.106 . . . . 2.11 113.114 -170.007 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -102.75 111.98 24.55 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.526 -1.67 . . . . 0.37 109.733 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.5 m -90.62 98.38 11.74 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.977 -0.749 . . . . 0.33 108.977 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.6 p -81.9 115.02 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-O 122.967 1.365 . . . . 0.33 109.399 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.652 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.7 m170 -83.14 99.79 10.13 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.71 -2.041 . . . . 1.19 110.05 -176.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 3.0 tm-20 -78.48 -56.53 4.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.307 -1.315 . . . . 1.67 109.101 170.115 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 139.87 39.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.134 -0.939 . . . . 2.78 110.772 -178.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.664 -0.698 . . . . 6.92 109.848 178.908 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 6.6 p-10 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.98 0.895 . . . . 1.93 110.217 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 4.5 t70 -111.84 152.31 44.1 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.293 -1.321 . . . . 1.65 108.625 -178.746 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 3.0 Cg_endo -46.59 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.385 3.39 . . . . 0.97 113.954 179.013 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.669 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -123.29 -65.18 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.97 -1.014 . . . . 0.5 109.124 175.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 90.05 47.74 3.79 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 108.131 -1.987 . . . . 0.39 108.131 -174.167 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.7 tp -58.12 -41.49 83.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.783 -1.709 . . . . 0.33 110.346 -167.29 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.812 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.02 85.67 6.01 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.887 0.851 . . . . 0.72 109.772 174.796 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.08 -40.02 85.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.774 -1.557 . . . . 0.63 110.078 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.486 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 57.3 ttm -153.42 134.58 14.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 2.88 110.19 176.37 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.661 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 6.8 mtm180 -91.91 139.35 24.58 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 107.905 -1.146 . . . . 3.67 107.905 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 40.2 Cg_endo -78.64 -163.85 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.981 2.454 . . . . 0.64 113.509 -175.231 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -127.26 131.29 50.58 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.745 -0.661 . . . . 1.43 111.405 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 8.4 m-20 -43.91 -98.99 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.668 1.587 . . . . 2.06 113.162 -176.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.3 145.93 4.36 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-O 121.769 0.649 . . . . 0.3 111.758 169.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.5 112.1 10.0 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.966 -0.617 . . . . 1.53 109.707 170.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.576 HG11 ' HB ' ' A' ' 22' ' ' ILE . 10.4 m -138.87 165.87 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.093 -1.077 . . . . 0.27 108.093 -172.174 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.671 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.94 157.38 15.92 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.932 -1.031 . . . . 0.77 109.288 178.074 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 106' ' ' VAL . 59.5 t -64.77 106.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 122.96 1.362 . . . . 0.78 109.583 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.7 10.68 14.14 Favored Glycine 0 C--N 1.272 -2.995 0 CA-C-N 112.105 -2.316 . . . . 0.48 113.561 171.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.35 -122.15 3.56 Favored Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 118.615 -1.755 . . . . 0.44 110.457 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 5.7 p -151.03 165.05 34.97 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 112.716 -1.742 . . . . 0.82 110.302 177.538 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.661 HG21 HD13 ' A' ' 104' ' ' LEU . 8.3 tp -147.98 150.2 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 113.665 -1.607 . . . . 0.32 106.837 172.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -138.55 132.8 31.68 Favored 'General case' 0 C--N 1.263 -3.184 0 CA-C-N 114.672 -1.149 . . . . 0.31 110.623 -174.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.786 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 18.6 m-85 -128.38 137.71 52.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.228 -1.351 . . . . 0.53 109.98 -175.645 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.422 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.79 124.3 16.85 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.985 0.898 . . . . 0.58 111.262 172.694 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.643 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -122.94 129.26 51.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.011 -1.449 . . . . 0.32 110.328 -178.321 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.486 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 54.2 mtt180 -107.31 126.39 52.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.404 -0.362 . . . . 2.43 111.688 -174.849 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.55 HG21 HG21 ' A' ' 39' ' ' VAL . 20.1 t -128.37 131.87 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.93 0.871 . . . . 0.26 110.137 -177.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.96 118.1 9.27 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.614 -1.63 . . . . 0.4 111.439 179.203 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.78 -33.66 56.04 Favored Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.579 -1.192 . . . . 0.76 110.868 168.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 59.58 -164.19 0.22 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.735 1.383 . . . . 0.71 114.735 162.515 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -113.48 118.4 34.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.01 -1.45 . . . . 1.74 107.446 170.222 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.733 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.61 166.03 33.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.436 0.532 . . . . 2.16 112.436 -165.564 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' HB2' ' HG3' ' A' ' 35' ' ' LYS . 1.8 mt -81.86 -30.36 32.08 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.576 1.179 . . . . 1.47 109.528 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -150.6 139.36 12.95 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 112.673 -2.058 . . . . 1.4 108.661 -166.81 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -47.4 141.87 13.61 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.571 2.181 . . . . 0.88 111.397 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_exo -63.0 130.16 28.22 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.297 1.331 . . . . 0.53 111.536 -175.386 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.13 104.11 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.052 -1.462 . . . . 0.77 107.052 179.114 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.1 t -107.69 113.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 113.444 -1.707 . . . . 0.28 107.387 176.236 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.785 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -98.42 119.0 36.36 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 122.95 1.357 . . . . 1.54 110.062 176.029 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.682 ' HB3' HD22 ' A' ' 49' ' ' LEU . 46.5 m95 -86.61 139.26 30.98 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 112.079 -2.328 . . . . 0.34 110.662 175.839 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 58.1 t80 -117.55 153.75 32.68 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.166 -1.42 . . . . 0.62 107.166 170.775 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.961 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 22.9 tptt -106.6 165.57 11.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.601 -0.888 . . . . 2.17 108.601 -172.176 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.984 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -25.14 168.47 0.0 OUTLIER Glycine 0 C--O 1.204 -1.76 0 O-C-N 124.348 1.03 . . . . 1.23 114.749 169.029 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 ptmt -39.86 0.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 119.763 3.245 . . . . 3.87 119.763 -140.243 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.927 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -162.6 -15.54 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.96 1.255 . . . . 2.11 113.594 -179.413 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.636 HG12 ' HE3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -94.62 166.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.812 0 CA-C-O 122.816 1.293 . . . . 1.29 110.114 -164.687 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.684 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 3.0 p-10 -113.65 154.81 26.61 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 112.489 -2.141 . . . . 2.73 108.867 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.961 ' CD1' ' HB2' ' A' ' 43' ' ' LYS . 5.3 mp -92.35 -23.73 19.14 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.163 0.431 . . . . 0.44 112.163 169.653 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 t -61.06 -21.58 63.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.883 -0.784 . . . . 1.23 108.883 -168.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.62 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 22.1 m -101.35 -41.59 6.62 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.315 1.055 . . . . 1.34 110.457 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.684 ' HD3' ' O ' ' A' ' 48' ' ' ASP . 3.7 mptp? -73.74 -75.58 0.15 Allowed 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 113.398 -1.728 . . . . 1.4 111.821 -168.201 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 25.2 t 7.66 87.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 126.189 2.181 . . . . 0.37 113.908 175.117 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -155.5 -131.54 1.45 Allowed Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.824 -1.989 . . . . 0.7 111.693 179.068 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' CD ' ' H ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -59.81 -42.35 93.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.246 0.832 . . . . 2.75 113.246 -169.84 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.9 p80 -92.98 -38.11 11.84 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.548 -0.461 . . . . 1.33 112.075 -175.226 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.87 HD11 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -121.12 105.73 10.88 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.353 -1.351 . . . . 1.11 107.353 175.526 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -99.43 113.14 25.32 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.831 -1.544 . . . . 0.76 106.831 164.656 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.983 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -93.0 94.45 8.9 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 103.538 -2.764 . . . . 0.26 103.538 168.515 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 41.4 m-70 -96.38 164.67 12.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 123.259 1.504 . . . . 2.03 111.344 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.43 120.93 17.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 110.847 -2.888 . . . . 0.92 108.498 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.28 116.06 25.47 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.41 -1.723 . . . . 0.47 109.933 172.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -121.23 106.91 11.94 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.935 -1.03 . . . . 1.39 110.843 -169.843 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -106.14 102.16 11.6 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.67 -1.15 . . . . 2.42 109.252 172.318 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.79 -30.26 70.42 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.197 -1.365 . . . . 2.46 111.352 -174.051 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.14 -12.32 60.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.763 -0.653 . . . . 1.15 110.659 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 14.7 m -101.33 -15.85 17.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.935 -1.135 . . . . 1.41 107.935 173.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER 68.62 31.17 4.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.565 -1.198 . . . . 3.31 109.822 179.192 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -132.91 134.3 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.661 0.743 . . . . 0.43 110.329 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 63' ' ' TYR . 3.0 m-85 -104.24 111.52 24.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.311 -1.737 . . . . 1.24 106.311 162.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 25' ' ' SER . 29.2 tp -94.41 104.98 16.95 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.668 -1.234 . . . . 0.52 107.668 175.38 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 83.0 m-85 -86.81 113.81 22.94 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 106.642 -1.614 . . . . 0.33 106.642 171.156 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.95 121.94 36.63 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 113.724 -1.58 . . . . 1.32 110.172 -173.568 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.983 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -92.11 132.97 36.19 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.758 -1.564 . . . . 0.96 108.399 179.114 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.37 98.62 7.03 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 103.603 -2.74 . . . . 1.15 103.603 167.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.7 HG13 ' HB3' ' A' ' 74' ' ' LEU . 8.5 mt -124.55 100.24 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-O 122.97 1.367 . . . . 0.52 109.282 -174.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 77.3 p -102.25 166.07 10.78 Favored 'General case' 0 N--CA 1.384 -3.736 0 CA-C-N 114.101 -1.409 . . . . 0.58 108.5 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.44 76.17 0.18 Allowed 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 111.454 -2.612 . . . . 2.12 111.318 176.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.79 108.11 9.58 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.9 -1.955 . . . . 0.4 110.694 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -54.23 143.43 44.8 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 1.43 109.948 167.612 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 23.4 Cg_endo -61.12 -8.39 9.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.105 2.536 . . . . 1.33 113.25 -179.125 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.43 12.05 30.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.33 -0.395 . . . . 1.12 110.992 178.262 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.523 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -97.56 -3.81 38.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 118.102 -0.952 . . . . 1.24 111.08 -178.296 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.1 m -18.17 93.99 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.453 1.721 . . . . 1.22 111.291 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.936 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -40.51 114.51 0.53 Allowed Glycine 0 CA--C 1.465 -3.093 0 CA-C-N 109.626 -3.443 . . . . 1.43 114.24 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.984 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -131.68 60.69 0.67 Allowed Glycine 0 N--CA 1.405 -3.411 0 CA-C-N 111.394 -2.403 . . . . 0.52 108.941 159.544 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.812 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 31.2 m-85 -77.79 108.0 10.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.863 -1.162 . . . . 0.63 107.863 178.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.503 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 16.0 tpt180 -106.21 112.49 25.54 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.258 0.552 . . . . 3.15 110.616 -175.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 38.0 m -99.7 118.23 35.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.66 -0.7 . . . . 1.08 110.241 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.785 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 76.0 mt-10 -129.18 116.56 19.39 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.711 -0.477 . . . . 1.81 109.711 175.239 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 p -95.41 139.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.517 0.675 . . . . 0.54 110.141 177.084 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.8 m -134.41 108.5 8.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.862 -1.063 . . . . 1.18 108.271 -176.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 94' ' ' LYS . 1.1 m -131.26 -176.75 4.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.412 -0.813 . . . . 0.74 109.92 -176.056 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -10.41 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 125.04 1.462 . . . . 0.65 114.688 -177.343 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.946 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.8 t70 -159.33 0.74 0.08 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.522 -1.217 . . . . 1.05 109.338 -175.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.684 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -100.95 145.21 28.95 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.223 1.011 . . . . 1.29 109.718 -177.769 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -134.77 136.8 42.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.653 -2.067 . . . . 0.77 110.315 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.599 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 m-20 -155.09 154.66 32.75 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.048 -0.978 . . . . 1.6 108.623 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 9.2 p -155.8 154.45 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.296 0.48 . . . . 1.19 112.296 -175.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.812 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 79.9 p -132.01 147.79 52.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.86 -0.609 . . . . 0.84 112.367 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.16 144.76 26.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.326 -0.852 . . . . 1.58 110.606 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.786 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 7.6 m-85 -137.73 103.51 5.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.558 -0.746 . . . . 0.86 110.318 172.375 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.775 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -105.67 110.55 22.9 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 118.743 -1.183 . . . . 2.11 112.363 170.414 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.936 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -98.02 106.98 19.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.146 -1.388 . . . . 0.37 109.755 -179.265 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -83.77 96.65 8.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.512 -0.551 . . . . 0.33 109.512 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 18' ' ' VAL . 3.4 p -80.65 112.45 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.875 1.321 . . . . 0.33 109.118 177.34 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.0 m170 -80.44 99.74 8.14 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.027 -1.897 . . . . 1.19 110.656 -176.907 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 32.3 tt0 -74.34 125.33 28.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.452 -1.249 . . . . 1.67 110.244 172.843 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.19 -61.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.185 -0.461 . . . . 2.78 110.56 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.664 -0.684 . . . . 6.92 110.865 179.761 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 119.985 -0.055 . . . . 1.6499999999999999 111.003 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.28 69.98 2.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.916 2.411 . . . . 0.96999999999999997 112.374 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.652 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -92.88 -54.61 7.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.013 -0.994 . . . . 0.5 109.323 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.23 6.24 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.798 -2.121 . . . . 0.39000000000000001 107.798 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.957 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -53.34 -36.57 61.46 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 112.78 -1.71 . . . . 0.33000000000000002 110.575 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.565 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -94.82 85.29 4.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.367 -0.833 . . . . 0.71999999999999997 109.642 172.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.88 -49.02 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.6 -1.182 . . . . 0.63 109.719 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.0 tpt -143.74 133.73 24.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 2.8799999999999999 108.912 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 20.7 ptt180 -103.86 132.84 20.65 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.107 -0.497 . . . . 3.6699999999999999 111.405 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.1 Cg_endo -64.34 151.63 84.69 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.683 2.255 . . . . 0.64000000000000001 111.328 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.8 mm-40 -121.13 176.54 5.54 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.042 -0.527 . . . . 1.4299999999999999 110.452 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.23 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.524 1.154 . . . . 2.0600000000000001 111.586 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.27 135.61 2.0 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.11 -1.405 . . . . 0.29999999999999999 111.953 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 44.8 mt-10 -114.01 115.05 27.0 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.332 -0.934 . . . . 1.53 108.943 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -136.07 163.23 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 N-CA-C 107.645 -1.242 . . . . 0.27000000000000002 107.645 -173.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.44 152.36 19.14 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.866 -1.061 . . . . 0.77000000000000002 108.925 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.727 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -73.3 106.6 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 123.897 1.808 . . . . 0.78000000000000003 109.419 172.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.59 -3.93 5.44 Favored Glycine 0 C--N 1.274 -2.873 0 CA-C-N 110.331 -3.122 . . . . 0.47999999999999998 111.196 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.13 -127.5 5.94 Favored Glycine 0 N--CA 1.411 -2.988 0 C-N-CA 119.24 -1.457 . . . . 0.44 110.217 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.5 p -150.85 170.08 20.14 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.0 -1.6 . . . . 0.81999999999999995 110.76 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 HD13 ' A' ' 104' ' ' LEU . 8.7 tp -147.16 149.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 113.592 -1.64 . . . . 0.32000000000000001 108.065 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 m -138.87 128.51 24.71 Favored 'General case' 0 C--N 1.268 -2.973 0 CA-C-N 113.503 -1.681 . . . . 0.31 110.73 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' HB2' ' CG ' ' A' ' 74' ' ' LEU . 45.2 m-85 -125.19 152.69 44.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.182 -1.372 . . . . 0.53000000000000003 108.44 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.51 125.98 18.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.214 -0.662 . . . . 0.57999999999999996 109.214 175.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.11 121.03 36.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.161 -0.927 . . . . 0.32000000000000001 110.367 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 56.3 mtp180 -108.02 117.08 33.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.353 -0.385 . . . . 2.4300000000000002 110.021 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.564 HG21 HG21 ' A' ' 39' ' ' VAL . 23.6 t -120.87 130.53 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.286 1.041 . . . . 0.26000000000000001 110.436 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.879 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -60.96 109.12 0.98 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.286 -1.779 . . . . 0.40000000000000002 113.696 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.56 3.04 Favored Glycine 0 N--CA 1.462 0.401 0 CA-C-N 114.728 -1.123 . . . . 0.76000000000000001 113.091 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HB2' ' CE ' ' A' ' 68' ' ' LYS . . . -50.68 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 114.669 1.359 . . . . 0.70999999999999996 114.669 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -81.58 127.59 33.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.481 -1.236 . . . . 1.74 108.361 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.835 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -157.12 177.79 11.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.168 -0.469 . . . . 2.1600000000000001 111.179 -172.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.83 -51.09 71.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.45 0.643 . . . . 1.47 109.287 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.47 149.41 26.29 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.785 -1.098 . . . . 1.3999999999999999 108.718 171.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -43.01 143.9 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.524 2.816 . . . . 0.88 112.651 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.835 ' HD3' HD11 ' A' ' 33' ' ' LEU . 2.0 Cg_endo -48.7 133.03 26.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.715 1.61 . . . . 0.53000000000000003 113.25 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.1 105.99 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 106.54 -1.652 . . . . 0.77000000000000002 106.54 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.659 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.27 114.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 CA-C-N 113.655 -1.611 . . . . 0.28000000000000003 107.962 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.5 127.3 49.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 123.456 1.598 . . . . 1.54 110.096 173.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.997 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -87.04 155.47 20.14 Favored 'General case' 0 C--N 1.273 -2.724 0 CA-C-N 111.178 -2.737 . . . . 0.34000000000000002 112.05 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.5 t80 -134.26 135.94 43.25 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 104.173 -2.528 . . . . 0.62 104.173 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.929 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 50.8 tttm -98.43 171.85 7.9 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.023 -1.843 . . . . 2.1699999999999999 106.023 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.984 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -15.43 -172.48 0.0 OUTLIER Glycine 0 C--O 1.178 -3.358 0 N-CA-C 119.117 2.407 . . . . 1.23 119.117 172.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -42.62 -8.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.169 2.285 . . . . 3.8700000000000001 117.169 -162.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.538 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.1 p-90 -162.09 -6.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.012 1.115 . . . . 2.1099999999999999 114.012 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.929 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.5 163.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.769 0 CA-C-O 123.712 1.72 . . . . 1.29 112.565 -161.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.682 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.6 p-10 -109.94 157.65 19.04 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.987 -2.824 . . . . 2.73 105.925 170.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.044 HD23 HD21 ' A' ' 57' ' ' LEU . 5.6 mp -99.34 -30.11 12.4 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.294 -0.562 . . . . 0.44 112.185 168.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.2 t -56.9 -21.63 31.21 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.038 0.535 . . . . 1.23 109.733 -164.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -99.9 -36.12 9.51 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.86 0.838 . . . . 1.3400000000000001 111.503 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.682 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -87.68 -31.85 19.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.406 -1.27 . . . . 1.3999999999999999 111.319 -167.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.751 HG13 ' H ' ' A' ' 59' ' ' LEU . 52.4 t -36.43 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.37 111.215 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.59 -93.71 0.1 OUTLIER Glycine 0 C--N 1.298 -1.536 0 CA-C-N 112.701 -2.045 . . . . 0.69999999999999996 113.812 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -94.15 -44.84 7.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.578 0.584 . . . . 2.75 112.578 -168.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.585 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 19.6 p80 -95.76 -36.21 11.25 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.339 0.59 . . . . 1.3300000000000001 110.731 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.044 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -115.55 106.38 13.87 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.1 -1.815 . . . . 1.1100000000000001 106.1 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.76 115.19 29.71 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 106.75 -1.574 . . . . 0.76000000000000001 106.75 166.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.751 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -100.42 92.26 5.08 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.742 -2.318 . . . . 0.26000000000000001 104.742 172.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.701 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 44.0 m170 -86.09 163.82 17.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.096 -1.411 . . . . 2.0299999999999998 110.916 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.17 115.74 16.76 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.847 -1.979 . . . . 0.92000000000000004 109.649 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -98.11 149.3 22.65 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 112.759 -2.019 . . . . 0.46999999999999997 107.839 170.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.86 99.04 3.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.48 1.133 . . . . 1.3899999999999999 110.961 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.7 m-20 -110.26 107.19 16.87 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 112.904 -1.953 . . . . 2.4199999999999999 108.954 176.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -45.94 61.35 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.604 -0.725 . . . . 2.46 110.333 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.34 -30.33 71.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.745 -1.116 . . . . 1.1499999999999999 110.984 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 19.5 m -89.49 -19.35 25.18 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.977 -0.749 . . . . 1.4099999999999999 108.977 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.879 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 2.2 ttpm? 61.92 41.05 11.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.078 -0.965 . . . . 3.3100000000000001 108.399 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 21.9 t -133.27 124.92 50.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.875 -1.057 . . . . 0.42999999999999999 111.139 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.3 m-30 -97.81 106.06 18.3 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.992 -1.855 . . . . 1.24 105.992 163.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 7.9 tp -95.07 105.27 17.18 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 122.622 1.201 . . . . 0.52000000000000002 108.984 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.701 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.9 m-85 -85.66 114.7 22.84 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.469 -1.696 . . . . 0.33000000000000002 108.289 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 30.5 mt-10 -96.48 134.54 39.53 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.461 -1.7 . . . . 1.3200000000000001 108.628 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.891 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -106.75 111.36 23.85 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.564 -1.273 . . . . 0.95999999999999996 107.564 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -108.7 94.24 4.95 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 103.403 -2.814 . . . . 1.1499999999999999 103.403 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.603 HG12 HD23 ' A' ' 57' ' ' LEU . 57.5 mt -120.77 100.89 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.698 1.237 . . . . 0.52000000000000002 109.214 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 21' ' ' SER . 60.1 p -100.58 165.9 11.18 Favored 'General case' 0 N--CA 1.391 -3.425 0 CA-C-N 114.355 -1.293 . . . . 0.57999999999999996 109.364 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 50.68 73.5 0.28 Allowed 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 110.848 -2.887 . . . . 2.1200000000000001 111.722 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -73.71 112.32 9.7 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 113.004 -1.907 . . . . 0.40000000000000002 110.017 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.863 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.38 146.62 52.44 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 1.4299999999999999 110.029 171.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.727 ' HD3' HG21 ' A' ' 18' ' ' VAL . 19.9 Cg_endo -61.15 -13.89 30.58 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.554 2.17 . . . . 1.3300000000000001 112.742 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.863 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -104.4 17.24 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.031 -0.531 . . . . 1.1200000000000001 110.45 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.6 OUTLIER -95.31 -11.29 28.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.393 -0.813 . . . . 1.24 111.005 -177.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m -17.97 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 125.668 1.855 . . . . 1.22 111.74 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.984 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -56.9 120.51 20.97 Favored Glycine 0 N--CA 1.404 -3.441 0 CA-C-N 110.633 -2.985 . . . . 1.4299999999999999 114.876 -167.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.691 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -115.5 72.31 0.25 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 112.359 -1.92 . . . . 0.52000000000000002 108.556 152.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.72 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 56.0 m-85 -77.04 118.38 19.54 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.728 -0.842 . . . . 0.63 108.728 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 29.4 mtp180 -114.38 125.08 53.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.212 -0.662 . . . . 3.1499999999999999 109.212 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 2.9 t -112.6 117.52 32.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.899 -0.778 . . . . 1.0800000000000001 108.899 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 36.0 mt-10 -132.4 104.02 6.5 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.179 -0.919 . . . . 1.8100000000000001 110.115 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.659 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -94.04 142.53 13.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.418 0.628 . . . . 0.54000000000000004 110.267 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.7 t -134.83 108.18 7.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.914 -1.039 . . . . 1.1799999999999999 108.337 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -132.35 153.18 51.0 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.958 -1.02 . . . . 0.73999999999999999 108.649 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.758 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 23.2 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.691 1.87 . . . . 0.65000000000000002 113.999 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.758 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 16.6 t70 -144.17 -3.78 0.84 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.829 -1.078 . . . . 1.05 109.802 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.957 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.32 135.04 33.92 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.148 -1.056 . . . . 1.29 108.148 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.504 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 31.0 t80 -132.71 131.29 41.09 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.898 -1.501 . . . . 0.77000000000000002 110.503 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.78 149.98 31.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.635 -1.166 . . . . 1.6000000000000001 108.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 7.4 p -152.77 154.37 35.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.243 0.544 . . . . 1.1899999999999999 112.216 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 11.6 p -129.86 150.6 51.09 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.773 0.797 . . . . 0.83999999999999997 112.06 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.667 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.0 OUTLIER -131.31 109.42 10.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.038 -1.437 . . . . 1.5800000000000001 109.38 177.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.841 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.8 p90 -142.72 129.71 20.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.374 0.607 . . . . 0.85999999999999999 109.667 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.5 p30 -101.93 157.96 16.48 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.899 1.333 . . . . 2.1099999999999999 111.954 -172.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -121.71 109.65 14.99 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.18 -1.827 . . . . 0.37 109.745 171.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 28.9 m -91.23 97.69 11.28 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.187 -0.671 . . . . 0.33000000000000002 109.187 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.6 p -81.3 116.2 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 123.204 1.478 . . . . 0.33000000000000002 109.292 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.546 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 94.9 m-70 -88.81 100.26 13.02 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.571 -2.104 . . . . 1.1899999999999999 109.002 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' A' ' 18' ' ' VAL . 31.4 tt0 . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.704 -1.135 . . . . 1.6699999999999999 109.82 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.582 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 23.8 m-20 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 110.246 -0.279 . . . . 1.6499999999999999 110.246 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.84 86.91 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.478 2.118 . . . . 0.96999999999999997 112.349 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.724 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -116.45 -60.29 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 0.5 109.513 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.69 5.59 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 108.473 -1.851 . . . . 0.39000000000000001 108.473 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.69 HD11 ' HB3' ' A' ' 37' ' ' PRO . 12.1 tp -53.67 -45.43 70.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.403 -1.899 . . . . 0.33000000000000002 111.87 -168.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.692 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.82 84.78 3.95 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.562 0.696 . . . . 0.71999999999999997 109.818 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.48 -40.55 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.152 -1.385 . . . . 0.63 110.686 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.5 ttm -157.57 132.1 8.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.916 -0.584 . . . . 2.8799999999999999 110.18 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.556 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 13.2 ptp180 -103.67 139.25 19.93 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.046 -0.979 . . . . 3.6699999999999999 109.865 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.735 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -75.19 165.28 31.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.382 1.388 . . . . 0.64000000000000001 111.135 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -122.91 -177.63 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.043 -0.526 . . . . 1.4299999999999999 110.343 -172.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.94 -150.48 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-O 123.076 1.417 . . . . 2.0600000000000001 111.704 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.97 131.44 1.64 Allowed Glycine 0 C--N 1.291 -1.945 0 CA-C-N 112.762 -2.017 . . . . 0.29999999999999999 112.063 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -110.54 110.93 21.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.422 -0.955 . . . . 1.53 108.422 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 m -130.58 141.82 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 107.598 -1.26 . . . . 0.27000000000000002 107.598 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.772 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -77.52 156.88 30.69 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.871 -1.059 . . . . 0.77000000000000002 109.387 -177.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 79' ' ' ALA . 3.9 t -66.38 105.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 CA-C-O 122.767 1.27 . . . . 0.78000000000000003 107.886 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.0 10.01 Favored Glycine 0 C--N 1.266 -3.318 0 CA-C-N 112.36 -2.2 . . . . 0.47999999999999998 112.688 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.84 4.94 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 118.668 -1.729 . . . . 0.44 108.92 172.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.9 p -151.43 163.57 38.68 Favored 'General case' 0 N--CA 1.397 -3.124 0 CA-C-N 112.882 -1.659 . . . . 0.81999999999999995 110.527 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.5 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.4 tp -136.67 146.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.141 -1.845 . . . . 0.32000000000000001 107.106 171.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -137.91 125.07 21.57 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 113.088 -1.869 . . . . 0.31 110.743 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 75.5 m-85 -123.36 143.24 50.23 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.266 -1.334 . . . . 0.53000000000000003 109.239 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -131.99 118.73 20.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.277 -0.874 . . . . 0.57999999999999996 109.79 177.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -117.11 116.15 26.76 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.514 -1.221 . . . . 0.32000000000000001 110.145 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.27 124.2 49.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.362 -0.211 . . . . 2.4300000000000002 110.886 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 39' ' ' VAL . 12.1 t -129.56 130.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 122.093 0.949 . . . . 0.26000000000000001 110.589 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.86 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -63.66 111.54 2.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.25 -1.795 . . . . 0.40000000000000002 111.589 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.853 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.49 -53.04 17.69 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 114.761 -1.108 . . . . 0.76000000000000001 111.976 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.701 ' CA ' ' HE3' ' A' ' 68' ' ' LYS . . . 59.96 -174.22 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.666 0.987 . . . . 0.70999999999999996 113.666 169.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -111.61 128.87 56.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.69 -1.141 . . . . 1.74 108.975 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.35 -179.47 7.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.155 0.503 . . . . 2.1600000000000001 111.992 -170.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.08 -44.31 80.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.82 -1.082 . . . . 1.47 108.962 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.657 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.59 148.26 23.29 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.909 -1.041 . . . . 1.3999999999999999 109.547 175.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.64 142.38 13.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.231 2.62 . . . . 0.88 111.507 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.69 ' HB3' HD11 ' A' ' 6' ' ' LEU . 1.8 Cg_endo -49.11 131.9 26.89 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.897 1.731 . . . . 0.53000000000000003 113.002 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.74 104.97 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 106.922 -1.51 . . . . 0.77000000000000002 106.922 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 28' ' ' VAL . 2.3 t -108.33 114.08 45.63 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 112.81 -1.996 . . . . 0.28000000000000003 107.306 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.628 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.91 125.37 48.58 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-O 123.266 1.508 . . . . 1.54 110.132 174.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.902 ' HB3' HD13 ' A' ' 49' ' ' LEU . 55.2 m95 -83.49 157.06 22.54 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 111.39 -2.641 . . . . 0.34000000000000002 111.555 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 20.3 t80 -135.66 139.55 43.82 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 104.794 -2.299 . . . . 0.62 104.794 168.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.996 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttm -100.63 167.24 10.46 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.424 -2.435 . . . . 2.1699999999999999 104.424 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.26 -165.51 0.0 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 118.982 2.353 . . . . 1.23 118.982 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.528 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 15.0 mtpt -45.23 -11.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.095 0 O-C-N 118.592 -2.71 . . . . 3.8700000000000001 116.417 -168.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.412 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 22.7 p-90 -164.18 -2.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.83 1.418 . . . . 2.1099999999999999 114.83 -175.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.996 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.73 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-O 122.942 1.353 . . . . 1.29 112.173 -163.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 1.5 p-10 -109.66 101.71 10.6 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 112.29 -2.232 . . . . 2.73 112.191 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.034 HD23 HD21 ' A' ' 57' ' ' LEU . 5.1 mp -54.34 -34.89 62.02 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.041 0.756 . . . . 0.44 113.041 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 m -57.28 -21.9 37.82 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.548 0.69 . . . . 1.23 109.668 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.46 ' HB2' ' CD ' ' A' ' 52' ' ' LYS . 22.7 m -98.19 -34.91 10.55 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.982 -1.008 . . . . 1.3400000000000001 111.707 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.581 ' HB2' HD12 ' A' ' 57' ' ' LEU . 3.0 mmmt -90.92 -36.06 14.36 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.941 -1.027 . . . . 1.3999999999999999 111.67 -168.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.66 HG13 ' H ' ' A' ' 59' ' ' LEU . 44.3 t -37.54 96.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 125.888 1.675 . . . . 0.37 111.869 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.719 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -153.41 -111.84 0.46 Allowed Glycine 0 C--N 1.298 -1.541 0 CA-C-N 111.546 -2.57 . . . . 0.69999999999999996 112.742 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.879 HE21 ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -95.73 -27.44 15.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.348 0.87 . . . . 2.75 113.348 -169.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -95.36 -36.45 11.37 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.574 0.702 . . . . 1.3300000000000001 110.439 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.034 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.69 105.49 11.22 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.14 -1.8 . . . . 1.1100000000000001 106.14 172.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.719 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -98.56 115.86 29.53 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.658 -1.608 . . . . 0.76000000000000001 106.658 165.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.66 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -92.05 92.09 8.11 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 103.495 -2.78 . . . . 0.26000000000000001 103.495 167.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.717 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -92.33 164.22 13.59 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 113.896 -1.502 . . . . 2.0299999999999998 109.502 -173.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -137.26 117.98 14.04 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 111.341 -2.663 . . . . 0.92000000000000004 109.998 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -101.28 142.52 32.58 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.622 -2.081 . . . . 0.46999999999999997 106.895 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -137.91 98.58 3.68 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.757 1.265 . . . . 1.3899999999999999 110.792 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.27 105.72 13.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 113.132 -1.849 . . . . 2.4199999999999999 109.695 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.56 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -74.83 -29.83 61.18 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.845 -1.071 . . . . 2.46 110.796 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -35.27 80.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.34 -0.845 . . . . 1.1499999999999999 110.93 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -98.85 -12.38 20.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.641 -0.708 . . . . 1.4099999999999999 109.839 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.86 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 18.4 tttt 67.22 33.7 5.34 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.745 0.783 . . . . 3.3100000000000001 109.564 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.24 128.33 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.969 -0.559 . . . . 0.42999999999999999 109.685 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.853 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 22.5 m-85 -95.71 116.2 28.53 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.586 -2.005 . . . . 1.24 105.586 162.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 25' ' ' SER . 38.0 tp -94.08 104.13 16.17 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.517 -1.29 . . . . 0.52000000000000002 107.517 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.9 m-85 -83.04 110.66 18.18 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.117 -1.809 . . . . 0.33000000000000002 106.117 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.2 pt-20 -114.75 122.7 47.21 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.666 -1.606 . . . . 1.3200000000000001 110.278 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.716 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.4 mt -91.46 131.07 37.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.201 -1.363 . . . . 0.95999999999999996 108.374 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -117.85 95.47 4.94 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 103.077 -2.934 . . . . 1.1499999999999999 103.077 167.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.4 mt -121.24 100.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.979 0 CA-C-O 122.902 1.334 . . . . 0.52000000000000002 108.619 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.1 p -104.43 165.16 11.24 Favored 'General case' 0 N--CA 1.389 -3.519 0 CA-C-N 114.116 -1.402 . . . . 0.57999999999999996 109.941 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 38.45 75.73 0.07 Allowed 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 110.563 -3.017 . . . . 2.1200000000000001 111.84 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.542 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -68.74 117.77 10.87 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.789 -2.914 . . . . 0.40000000000000002 111.074 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.858 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -51.27 135.03 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.848 -0.797 . . . . 1.4299999999999999 108.848 165.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 19.3 Cg_endo -60.0 -13.49 23.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.932 2.421 . . . . 1.3300000000000001 112.685 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.858 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -96.6 15.48 21.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.974 -0.557 . . . . 1.1200000000000001 110.797 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.1 m-30 -95.09 -10.59 30.26 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.972 -0.381 . . . . 1.24 109.972 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.6 m -46.28 98.51 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.829 0 O-C-N 124.606 1.191 . . . . 1.22 108.732 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -169.35 -130.1 1.17 Allowed Glycine 0 C--N 1.266 -3.353 0 CA-C-N 112.698 -2.046 . . . . 1.4299999999999999 113.145 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.0 118.74 0.9 Allowed Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 119.962 -1.113 . . . . 0.52000000000000002 112.695 -170.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.703 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.3 m-85 -85.13 134.95 34.16 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.04 -1.58 . . . . 0.63 107.577 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.472 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 63.7 mtt180 -118.99 155.07 32.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.204 0.526 . . . . 3.1499999999999999 110.6 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.634 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 75.0 m -131.31 132.26 44.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.825 -1.176 . . . . 1.0800000000000001 107.825 163.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.628 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 35.0 tt0 -134.95 103.33 5.54 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.723 -1.214 . . . . 1.8100000000000001 107.723 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.6 p -99.6 134.91 37.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.983 0.897 . . . . 0.54000000000000004 110.835 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -133.46 108.5 8.69 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.794 -1.548 . . . . 1.1799999999999999 108.864 -176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.642 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -132.09 155.13 48.66 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.376 -0.972 . . . . 0.73999999999999999 108.376 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.813 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 18.61 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 125.601 1.813 . . . . 0.65000000000000002 114.882 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.813 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 5.0 t70 -151.81 1.23 0.36 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.748 -1.115 . . . . 1.05 109.668 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.724 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmtp -98.17 130.05 44.93 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.961 -1.126 . . . . 1.29 107.961 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -131.26 147.17 52.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.991 -1.004 . . . . 0.77000000000000002 111.189 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -172.13 166.24 6.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.933 -0.765 . . . . 1.6000000000000001 108.933 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.4 p -155.67 156.76 35.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 1.1899999999999999 110.461 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.692 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 30.8 p -135.39 147.63 49.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.715 -0.675 . . . . 0.83999999999999997 111.086 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.577 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -127.19 121.92 32.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 1.5800000000000001 110.066 177.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.735 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -141.98 116.66 9.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.121 0.486 . . . . 0.85999999999999999 109.796 -175.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.3 p30 -100.3 146.26 27.14 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 122.418 1.104 . . . . 2.1099999999999999 111.88 -169.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -116.76 122.91 45.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.219 -1.355 . . . . 0.37 109.349 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -101.58 96.69 7.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.508 -0.923 . . . . 0.33000000000000002 108.508 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 3.8 p -79.19 114.58 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-O 123.203 1.477 . . . . 0.33000000000000002 109.711 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.772 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 9.3 m-70 -79.97 99.33 7.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.098 -2.319 . . . . 1.1899999999999999 109.816 -175.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 18' ' ' VAL . 35.5 tt0 . . . . . 0 C--N 1.295 -1.784 0 CA-C-N 114.039 -1.437 . . . . 1.6699999999999999 109.348 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.463 ' HB2' ' CE ' ' A' ' 94' ' ' LYS . 8.4 m-20 . . . . . 0 N--CA 1.442 -0.862 0 N-CA-C 109.624 -0.51 . . . . 1.6499999999999999 109.624 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 84.41 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.24 1.96 . . . . 0.96999999999999997 113.132 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.84 HD11 ' HE2' ' A' ' 94' ' ' LYS . 1.8 mp -110.71 -66.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.11 -0.95 . . . . 0.5 109.187 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.85 37.47 6.06 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 108.573 -1.811 . . . . 0.39000000000000001 108.573 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.92 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.2 tp -38.57 -51.34 1.62 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.767 -1.716 . . . . 0.33000000000000002 110.858 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.71 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -85.93 85.57 7.37 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 121.635 0.731 . . . . 0.71999999999999997 110.537 175.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.92 -33.8 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.09 -1.414 . . . . 0.63 109.553 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.421 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 18.5 ttt -163.69 136.98 5.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.361 -0.836 . . . . 2.8799999999999999 110.226 174.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.628 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 6.1 ptt180 -116.11 137.57 23.52 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.031 -0.531 . . . . 3.6699999999999999 110.761 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -71.58 176.66 7.8 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.986 2.457 . . . . 0.64000000000000001 112.585 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -126.91 177.08 6.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.647 -0.706 . . . . 1.4299999999999999 110.671 -175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.5 p-10 -71.42 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.602 1.191 . . . . 2.0600000000000001 111.641 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.06 137.44 2.59 Favored Glycine 0 N--CA 1.426 -2.003 0 CA-C-N 113.821 -1.536 . . . . 0.29999999999999999 111.807 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.497 ' HG3' ' CD2' ' A' ' 107' ' ' HIS . 27.9 tt0 -113.33 115.14 27.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.094 -1.053 . . . . 1.53 109.497 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -139.46 163.16 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 N-CA-C 107.308 -1.367 . . . . 0.27000000000000002 107.308 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -93.92 162.02 14.07 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.548 -0.751 . . . . 0.77000000000000002 109.617 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 81' ' ' PRO . 3.5 t -72.74 105.64 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.458 0 N-CA-C 107.205 -1.405 . . . . 0.78000000000000003 107.205 172.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.41 3.05 6.23 Favored Glycine 0 C--N 1.263 -3.506 0 CA-C-N 112.685 -2.052 . . . . 0.47999999999999998 111.472 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.9 -131.92 7.48 Favored Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 118.78 -1.676 . . . . 0.44 109.094 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.747 ' HB3' HG22 ' A' ' 77' ' ' THR . 8.2 p -152.22 168.26 25.93 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 113.016 -1.592 . . . . 0.81999999999999995 110.872 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.602 HG21 HD13 ' A' ' 104' ' ' LEU . 10.7 tp -147.74 149.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 CA-C-N 113.274 -1.784 . . . . 0.32000000000000001 107.536 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 m -139.22 127.08 22.13 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-N 113.513 -1.676 . . . . 0.31 111.098 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' HB2' HD23 ' A' ' 74' ' ' LEU . 33.0 m-85 -122.65 148.24 45.5 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.952 -1.476 . . . . 0.53000000000000003 108.392 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -135.01 122.48 21.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.575 -0.898 . . . . 0.57999999999999996 108.575 175.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -126.09 126.64 44.53 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.943 -1.026 . . . . 0.32000000000000001 111.086 -174.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' HB3' HG11 ' A' ' 69' ' ' VAL . 52.0 mtt180 -113.68 123.65 50.42 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.416 -0.356 . . . . 2.4300000000000002 111.135 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.0 t -122.33 125.13 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.946 0.879 . . . . 0.26000000000000001 109.837 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -54.91 111.11 0.76 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.505 -1.679 . . . . 0.40000000000000002 111.094 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.784 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -52.87 -43.06 60.68 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.177 -1.374 . . . . 0.76000000000000001 111.162 171.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.79 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 49.23 -167.06 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.252 1.204 . . . . 0.70999999999999996 114.252 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -119.77 123.13 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.062 -1.426 . . . . 1.74 107.527 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.779 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -149.78 178.58 8.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.838 0.681 . . . . 2.1600000000000001 112.838 -168.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.05 -57.23 4.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.989 -1.005 . . . . 1.47 109.234 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.671 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -129.58 145.54 57.36 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.468 -0.787 . . . . 1.3999999999999999 109.726 171.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.4 Cg_exo -45.46 138.89 10.15 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 122.78 2.32 . . . . 0.88 110.961 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.779 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.0 Cg_exo -58.82 136.98 77.28 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.443 1.429 . . . . 0.53000000000000003 111.961 -172.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.04 104.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.369 -1.715 . . . . 0.77000000000000002 106.369 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -107.25 114.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 113.44 -1.709 . . . . 0.28000000000000003 107.21 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.609 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.78 129.39 53.05 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 123.222 1.487 . . . . 1.54 110.078 175.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.07 ' HB3' HD13 ' A' ' 49' ' ' LEU . 87.6 m95 -90.84 141.84 28.39 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.794 -2.457 . . . . 0.34000000000000002 111.268 171.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.7 t80 -125.82 125.79 43.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.785 -1.931 . . . . 0.62 105.785 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 29.6 ttpt -103.65 108.59 19.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.8 -1.555 . . . . 2.1699999999999999 106.8 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.562 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -79.77 92.02 1.32 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 115.997 -3.001 . . . . 1.23 113.968 -165.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.719 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 32.9 tttt -106.58 -32.77 7.9 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 104.24 -2.504 . . . . 3.8700000000000001 104.24 138.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.741 ' HD1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER 157.85 -13.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 110.921 -2.854 . . . . 2.1099999999999999 111.447 -165.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.741 HG22 ' HD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -94.76 173.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 CA-C-O 122.994 1.378 . . . . 1.29 111.909 -168.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 5.4 m-20 -104.38 155.91 18.38 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.927 -2.397 . . . . 2.73 106.228 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.07 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -84.79 -32.33 23.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 118.325 0.512 . . . . 0.44 111.464 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -20.35 37.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.711 0.767 . . . . 1.23 110.244 -167.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.757 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 26.4 t -92.22 -30.42 15.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.72 -1.127 . . . . 1.3400000000000001 111.132 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 3.7 mmmt -98.81 -42.08 7.35 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.631 -1.168 . . . . 1.3999999999999999 112.122 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.788 HG13 ' H ' ' A' ' 59' ' ' LEU . 54.9 t -22.57 95.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.208 1.803 . . . . 0.37 112.987 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.71 -126.61 1.36 Allowed Glycine 0 C--N 1.303 -1.275 0 CA-C-N 112.138 -2.301 . . . . 0.69999999999999996 113.157 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.91 -20.08 31.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.881 0.697 . . . . 2.75 112.881 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.7 p80 -100.72 -37.56 8.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.347 0.594 . . . . 1.3300000000000001 110.427 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.952 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.89 103.7 10.21 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.03 -1.841 . . . . 1.1100000000000001 106.03 172.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -95.43 115.22 27.13 Favored 'General case' 0 N--CA 1.409 -2.521 0 N-CA-C 105.809 -1.922 . . . . 0.76000000000000001 105.809 167.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.809 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.6 OUTLIER -98.94 91.58 5.11 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 103.496 -2.779 . . . . 0.26000000000000001 103.496 167.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 5.8 t-80 -99.75 164.65 11.95 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.21 -1.814 . . . . 2.0299999999999998 108.728 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.51 126.37 27.53 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 113.191 -1.822 . . . . 0.92000000000000004 111.933 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -103.24 148.04 26.3 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 110.996 -2.82 . . . . 0.46999999999999997 108.24 169.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.0 101.31 3.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.976 0.893 . . . . 1.3899999999999999 110.987 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.53 109.17 17.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.322 -1.308 . . . . 2.4199999999999999 111.006 169.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.562 HH11 ' HD2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.64 -31.44 65.13 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.445 -0.798 . . . . 2.46 111.013 177.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -14.93 63.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.759 -0.655 . . . . 1.1499999999999999 110.431 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -106.8 -20.18 13.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.808 -1.182 . . . . 1.4099999999999999 107.808 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.79 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER 60.54 40.2 17.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.652 -1.158 . . . . 3.3100000000000001 109.292 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 27' ' ' ARG . 13.8 t -133.39 143.06 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.242 -0.89 . . . . 0.42999999999999999 109.776 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.784 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 27.9 m-85 -105.62 113.05 26.38 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.622 -1.622 . . . . 1.24 106.622 163.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 10.1 tp -94.91 105.61 17.54 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 122.261 1.029 . . . . 0.52000000000000002 108.762 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.1 m-85 -87.88 115.32 25.26 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.001 -1.454 . . . . 0.33000000000000002 108.275 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -98.55 132.86 43.64 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.045 -1.889 . . . . 1.3200000000000001 108.353 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.84 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -103.64 115.7 30.97 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.488 -1.301 . . . . 0.95999999999999996 107.488 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -113.65 95.21 5.22 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.583 -2.377 . . . . 1.1499999999999999 104.583 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.622 HG12 HD23 ' A' ' 57' ' ' LEU . 63.7 mt -119.55 100.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.928 1.347 . . . . 0.52000000000000002 110.36 -174.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.747 HG22 ' HB3' ' A' ' 21' ' ' SER . 82.5 p -106.45 135.78 47.36 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.435 -1.711 . . . . 0.57999999999999996 108.262 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.65 101.47 0.05 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 111.714 -2.493 . . . . 2.1200000000000001 110.174 -174.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -94.87 124.68 39.06 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 109.72 -3.4 . . . . 0.40000000000000002 109.402 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.797 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.64 130.94 77.65 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.295 -0.631 . . . . 1.4299999999999999 109.295 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.752 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.1 Cg_endo -60.74 -10.65 14.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.129 2.553 . . . . 1.3300000000000001 112.855 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.797 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -113.5 15.4 19.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.046 -0.525 . . . . 1.1200000000000001 111.41 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.684 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -73.5 -57.55 3.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.417 -0.957 . . . . 1.24 108.417 177.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 26.0 m 42.67 62.07 1.86 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.665 -1.606 . . . . 1.22 106.665 -158.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.683 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -56.53 86.16 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 112.084 -2.326 . . . . 1.4299999999999999 114.17 -163.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -90.79 83.38 1.3 Allowed Glycine 0 C--N 1.279 -2.62 0 N-CA-C 108.862 -1.695 . . . . 0.52000000000000002 108.862 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.714 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.2 m-85 -78.07 110.93 13.45 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.997 -1.101 . . . . 0.63 108.751 -176.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -99.91 109.24 21.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.419 -0.956 . . . . 3.1499999999999999 108.419 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.417 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -97.84 129.58 44.8 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.075 -0.65 . . . . 1.0800000000000001 109.247 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 53.8 mt-10 -132.15 119.18 20.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.856 -0.611 . . . . 1.8100000000000001 109.664 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.6 p -106.42 137.31 37.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.738 0.78 . . . . 0.54000000000000004 110.794 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.1 t -129.93 109.38 10.85 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.351 -1.295 . . . . 1.1799999999999999 108.313 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.589 HG21 HD12 ' A' ' 33' ' ' LEU . 1.3 m -127.45 174.98 8.57 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.35 -0.841 . . . . 0.73999999999999999 109.941 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 1.018 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -3.5 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.431 1.707 . . . . 0.65000000000000002 115.016 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 1.018 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 17.4 t70 -163.93 5.19 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.511 -1.222 . . . . 1.05 109.63 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.92 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -101.83 143.06 32.2 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.733 0.778 . . . . 1.29 109.088 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -131.54 136.47 47.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.165 -1.834 . . . . 0.77000000000000002 110.815 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 7' ' ' PHE . 4.0 m-20 -155.43 151.73 28.16 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.903 -1.044 . . . . 1.6000000000000001 109.443 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.5 p -152.32 152.62 32.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.1899999999999999 111.028 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.71 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 96.0 p -130.03 147.23 51.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.227 0.537 . . . . 0.83999999999999997 111.941 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -126.43 113.44 16.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.406 -0.815 . . . . 1.5800000000000001 110.844 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.855 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 3.8 p90 -143.99 129.99 19.52 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.852 -0.53 . . . . 0.85999999999999999 111.123 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.647 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -112.45 127.21 55.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 122.192 0.996 . . . . 2.1099999999999999 113.106 -173.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -97.33 107.6 20.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.848 -1.523 . . . . 0.37 109.924 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m -88.85 97.09 10.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.99 -0.745 . . . . 0.33000000000000002 108.99 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.684 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.7 p -86.95 116.97 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.631 1.205 . . . . 0.33000000000000002 110.222 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.497 ' CD2' ' HG3' ' A' ' 15' ' ' GLU . 95.7 m-70 -111.57 93.79 4.64 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.739 -1.573 . . . . 1.1899999999999999 112.138 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.526 ' HB2' HG21 ' A' ' 18' ' ' VAL . 31.0 tt0 . . . . . 0 C--N 1.3 -1.557 0 CA-C-N 115.937 -0.574 . . . . 1.6699999999999999 109.898 164.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 4.5 m-20 . . . . . 0 N--CA 1.443 -0.816 0 CA-C-O 119.102 -0.475 . . . . 1.6499999999999999 110.988 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.95 83.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.357 2.038 . . . . 0.96999999999999997 113.734 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.06 ' HB ' ' HD3' ' A' ' 96' ' ' LYS . 1.8 mp -110.78 -69.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.026 -0.988 . . . . 0.5 109.22 173.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.447 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 92.22 50.15 2.67 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 108.199 -1.96 . . . . 0.39000000000000001 108.199 -173.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.603 ' N ' HG22 ' A' ' 4' ' ' ILE . 10.1 tp -53.38 -50.29 65.41 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.984 -1.608 . . . . 0.33000000000000002 110.829 -167.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -86.7 84.46 7.38 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.585 -0.734 . . . . 0.71999999999999997 109.507 174.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -66.03 -39.96 85.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.342 -1.299 . . . . 0.63 109.664 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 21.7 ttt -141.49 133.95 28.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.165 -0.925 . . . . 2.8799999999999999 108.651 169.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.658 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 31.7 mtt180 -99.14 127.27 35.32 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.062 -0.517 . . . . 3.6699999999999999 109.64 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 10.4 Cg_endo -57.79 151.28 57.24 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.735 2.29 . . . . 0.64000000000000001 111.72 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 19.3 mm-40 -126.46 169.66 12.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 1.4299999999999999 111.467 -169.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.8 m-20 -65.62 -147.19 0.01 OUTLIER 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.952 1.358 . . . . 2.0600000000000001 111.781 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.84 133.6 2.56 Favored Glycine 0 C--N 1.297 -1.6 0 CA-C-N 113.628 -1.623 . . . . 0.29999999999999999 111.678 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.81 114.86 24.53 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.308 -0.946 . . . . 1.53 108.755 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.711 HG22 HD11 ' A' ' 104' ' ' LEU . 3.0 m -136.63 165.0 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 107.755 -1.202 . . . . 0.27000000000000002 107.755 -172.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.557 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -88.48 155.52 19.62 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.934 -1.03 . . . . 0.77000000000000002 110.273 -176.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.664 HG22 HG22 ' A' ' 106' ' ' VAL . 60.0 t -70.41 105.69 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 122.901 1.334 . . . . 0.78000000000000003 108.253 173.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.01 12.16 Favored Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.412 -2.176 . . . . 0.47999999999999998 112.367 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.86 -123.05 2.99 Favored Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.113 -1.595 . . . . 0.44 109.113 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.6 p -151.99 169.55 22.06 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 112.84 -1.68 . . . . 0.81999999999999995 110.553 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -145.31 147.19 18.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 113.763 -1.562 . . . . 0.32000000000000001 107.256 167.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -137.96 130.26 29.1 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.851 -1.522 . . . . 0.31 110.916 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 62.9 m-85 -126.43 147.63 49.76 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.203 -1.362 . . . . 0.53000000000000003 110.128 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -136.61 123.72 21.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.953 -1.021 . . . . 0.57999999999999996 109.248 175.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.614 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -119.74 116.31 25.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.745 -1.116 . . . . 0.32000000000000001 110.185 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 39.3 mtt180 -101.21 122.15 43.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.308 -0.406 . . . . 2.4300000000000002 110.77 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 39' ' ' VAL . 17.2 t -123.82 128.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 122.168 0.985 . . . . 0.26000000000000001 110.248 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.99 114.21 2.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.318 -1.765 . . . . 0.40000000000000002 111.016 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -55.21 -32.69 57.31 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.343 -1.298 . . . . 0.76000000000000001 111.187 170.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.599 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 56.1 -172.26 0.07 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.791 1.034 . . . . 0.70999999999999996 113.791 168.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 t -110.0 117.06 32.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 1.74 107.061 164.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.803 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -150.98 166.59 30.22 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.891 0.7 . . . . 2.1600000000000001 112.891 -162.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -64.23 -64.56 0.85 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.063 -0.971 . . . . 1.47 109.956 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.56 158.33 74.94 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.266 -1.013 . . . . 1.3999999999999999 108.266 172.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 4.5 Cg_endo -45.79 146.8 3.6 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.246 2.631 . . . . 0.88 112.356 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.803 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -62.64 135.65 53.91 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.655 1.57 . . . . 0.53000000000000003 111.248 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.79 104.56 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.614 0 N-CA-C 106.541 -1.651 . . . . 0.77000000000000002 106.541 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.643 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -108.75 114.55 47.08 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-N 113.335 -1.757 . . . . 0.28000000000000003 107.814 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.898 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.89 125.39 50.94 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 123.384 1.564 . . . . 1.54 110.412 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.959 ' HB3' HD13 ' A' ' 49' ' ' LEU . 82.5 m95 -88.78 157.23 18.56 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 111.664 -2.516 . . . . 0.34000000000000002 112.564 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.9 t80 -136.79 136.09 38.56 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 104.948 -2.241 . . . . 0.62 104.948 166.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.709 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 21.1 tttm -112.4 162.12 15.93 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.617 -1.623 . . . . 2.1699999999999999 106.617 -173.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 1.029 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -4.35 -167.78 0.0 OUTLIER Glycine 0 C--O 1.191 -2.594 0 N-CA-C 118.692 2.237 . . . . 1.23 118.692 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -44.37 -9.07 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.201 1.926 . . . . 3.8700000000000001 116.201 -166.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.606 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 30.0 p-90 -167.67 -3.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.012 1.486 . . . . 2.1099999999999999 115.012 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.606 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -91.13 135.4 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-O 123.496 1.617 . . . . 1.29 112.817 -163.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -104.36 99.33 9.04 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 112.048 -2.342 . . . . 2.73 111.84 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.114 HD23 HD21 ' A' ' 57' ' ' LEU . 4.4 mp -51.93 -38.49 56.6 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.223 1.194 . . . . 0.44 114.223 -169.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 t -57.5 -22.22 42.67 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.345 0.593 . . . . 1.23 109.407 -166.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 m -100.38 -28.81 12.75 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.313 -0.858 . . . . 1.3400000000000001 113.052 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.536 ' HG3' HG12 ' A' ' 47' ' ' VAL . 6.0 mmmt -90.33 -39.8 12.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.085 -0.507 . . . . 1.3999999999999999 111.516 -171.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.91 HG13 ' H ' ' A' ' 59' ' ' LEU . 55.1 t -32.34 95.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 126.449 1.899 . . . . 0.37 112.3 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.651 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.82 -103.29 0.21 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 111.707 -2.497 . . . . 0.69999999999999996 113.898 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -95.22 -33.15 12.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.007 0.743 . . . . 2.75 113.007 -168.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 27.6 p80 -97.88 -36.29 10.22 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.653 0.739 . . . . 1.3300000000000001 110.822 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.114 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.29 106.14 12.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.39 -1.707 . . . . 1.1100000000000001 106.39 174.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.87 115.86 30.6 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.517 -1.66 . . . . 0.76000000000000001 106.517 165.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.91 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -103.04 93.64 5.12 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.307 -2.109 . . . . 0.26000000000000001 105.307 172.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 53.2 m-70 -92.86 160.38 14.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-O 122.902 1.334 . . . . 2.0299999999999998 109.499 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -129.29 110.79 12.24 Favored 'General case' 0 C--N 1.265 -3.102 0 CA-C-N 111.458 -2.61 . . . . 0.92000000000000004 108.936 175.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.9 m -92.28 145.38 24.53 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.582 -2.099 . . . . 0.46999999999999997 107.776 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.441 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.0 t80 -141.26 99.77 3.65 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.07 0.938 . . . . 1.3899999999999999 111.57 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -116.46 121.73 42.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.125 -1.398 . . . . 2.4199999999999999 108.811 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.441 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -85.36 -39.07 18.04 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 113.721 -1.581 . . . . 2.46 112.117 -172.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.23 60.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.604 -0.725 . . . . 1.1499999999999999 111.417 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -95.58 -16.76 21.89 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.283 -1.377 . . . . 1.4099999999999999 107.283 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.599 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 67.59 31.47 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.864 -1.516 . . . . 3.3100000000000001 109.789 173.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.45 128.49 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.764 0.793 . . . . 0.42999999999999999 110.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.558 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 45.8 m-85 -98.47 112.22 24.31 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.143 -1.799 . . . . 1.24 106.143 162.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.4 tp -98.92 106.2 18.44 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.017 0.913 . . . . 0.52000000000000002 108.61 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 51.4 m-85 -84.46 115.65 22.67 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.303 -1.317 . . . . 0.33000000000000002 108.001 172.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.2 123.62 47.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.055 -1.43 . . . . 1.3200000000000001 109.269 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -94.74 118.9 32.49 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.144 -1.428 . . . . 0.95999999999999996 107.144 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -110.71 95.76 5.76 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 103.556 -2.757 . . . . 1.1499999999999999 103.556 169.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.699 HD13 ' HE2' ' A' ' 43' ' ' LYS . 13.9 mt -123.55 99.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 123.229 1.49 . . . . 0.52000000000000002 108.66 -175.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.8 p -107.53 170.07 8.2 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 113.441 -1.709 . . . . 0.57999999999999996 108.007 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.9 t70 65.52 33.56 8.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.722 -2.036 . . . . 2.1200000000000001 110.003 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -49.94 112.05 0.61 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.994 -1.912 . . . . 0.40000000000000002 111.7 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.603 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -70.85 153.7 94.65 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.198 -0.91 . . . . 1.4299999999999999 109.179 173.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 40.9 Cg_endo -66.9 -3.39 9.46 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.245 1.963 . . . . 1.3300000000000001 113.189 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.603 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.82 17.0 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.265 -0.425 . . . . 1.1200000000000001 110.331 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.3 m-30 -99.56 0.74 42.87 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.658 -0.497 . . . . 1.24 109.658 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 14.9 m -28.97 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 125.779 1.924 . . . . 1.22 110.579 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.871 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -34.37 106.84 0.03 OUTLIER Glycine 0 N--CA 1.411 -3.015 0 CA-C-N 109.662 -3.426 . . . . 1.4299999999999999 114.798 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 1.029 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -122.66 65.39 0.51 Allowed Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.33 -1.908 . . . . 0.52000000000000002 108.33 159.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.709 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 79.0 m-85 -81.48 128.81 34.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.862 -1.169 . . . . 0.63 109.562 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -135.04 104.26 5.88 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.772 -0.825 . . . . 3.1499999999999999 108.772 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -102.11 129.58 48.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.474 -0.491 . . . . 1.0800000000000001 110.154 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.898 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 22.0 tt0 -131.64 116.37 17.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.472 -0.785 . . . . 1.8100000000000001 110.007 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.643 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -106.39 140.53 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.428 0.632 . . . . 0.54000000000000004 109.957 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.1 t -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.11 -0.95 . . . . 1.1799999999999999 108.745 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.667 HG21 HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.09 157.46 44.15 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 118.145 -0.931 . . . . 0.73999999999999999 109.341 -178.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 1.058 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 17.92 -73.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.536 1.772 . . . . 0.65000000000000002 114.662 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 1.058 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.6 t0 -150.74 1.97 0.44 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.058 -0.974 . . . . 1.05 109.697 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.06 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 14.7 mtpp -103.75 146.21 28.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 122.459 1.123 . . . . 1.29 109.541 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -136.14 140.26 43.53 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.279 -2.237 . . . . 0.77000000000000002 110.6 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 2.4 m-20 -156.91 149.74 23.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.044 -0.98 . . . . 1.6000000000000001 109.596 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 p -152.69 149.03 27.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.13 0.49 . . . . 1.1899999999999999 110.975 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.491 ' HG ' ' HZ ' ' A' ' 7' ' ' PHE . 3.9 p -127.97 149.6 50.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.6 -0.727 . . . . 0.83999999999999997 112.268 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.641 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.0 OUTLIER -132.65 109.55 9.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.409 -1.269 . . . . 1.5800000000000001 109.23 178.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.788 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 4.6 p90 -141.37 129.36 21.94 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.823 0.82 . . . . 0.85999999999999999 110.078 -172.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 15.9 m-80 -105.31 146.22 29.67 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.607 -1.178 . . . . 2.1099999999999999 111.107 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.871 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -112.83 118.16 34.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.042 -1.435 . . . . 0.37 109.145 173.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 m -95.25 97.51 9.93 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.842 -0.743 . . . . 0.33000000000000002 109.237 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.664 HG22 HG22 ' A' ' 18' ' ' VAL . 7.2 p -86.59 113.31 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 123.331 1.539 . . . . 0.33000000000000002 109.397 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 82.2 m-70 -86.15 99.8 11.77 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.295 -2.229 . . . . 1.1899999999999999 109.354 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 52.7 tt0 . . . . . 0 C--N 1.303 -1.449 0 CA-C-N 115.321 -0.854 . . . . 1.6699999999999999 111.114 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 110.057 -0.349 . . . . 1.6499999999999999 110.057 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.03 45.95 0.39 Allowed 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.296 2.664 . . . . 0.96999999999999997 113.915 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.631 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -63.15 -58.68 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.643 -0.708 . . . . 0.5 110.096 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.85 53.97 3.2 Favored Glycine 0 CA--C 1.492 -1.376 0 N-CA-C 107.625 -2.19 . . . . 0.39000000000000001 107.625 -173.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.82 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.2 tp -60.75 -33.62 73.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.978 -1.611 . . . . 0.33000000000000002 110.201 -165.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.821 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.87 84.61 3.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.05 -0.977 . . . . 0.71999999999999997 109.572 172.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.54 -50.7 64.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.545 -1.207 . . . . 0.63 109.91 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.658 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 16.5 tpt -147.84 131.18 16.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.2 -0.909 . . . . 2.8799999999999999 108.66 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 34.4 ptt180 -98.65 138.15 20.7 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 116.133 -0.485 . . . . 3.6699999999999999 111.436 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.774 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 28.1 Cg_endo -68.36 153.99 72.98 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.545 2.163 . . . . 0.64000000000000001 111.155 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.0 mm-40 -123.17 173.17 8.06 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.119 -0.491 . . . . 1.4299999999999999 110.514 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.6 p-10 -68.33 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.67 1.224 . . . . 2.0600000000000001 111.537 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 155.76 138.97 2.66 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 113.736 -1.575 . . . . 0.29999999999999999 111.156 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 43.0 mt-10 -117.96 116.93 27.91 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.398 -0.964 . . . . 1.53 108.398 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.08 163.73 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.326 -1.361 . . . . 0.27000000000000002 107.326 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 156.02 16.5 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.962 -1.017 . . . . 0.77000000000000002 109.304 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.757 HG13 ' HD3' ' A' ' 81' ' ' PRO . 47.5 t -57.93 107.45 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 122.81 1.29 . . . . 0.78000000000000003 109.825 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.56 12.25 19.57 Favored Glycine 0 C--N 1.274 -2.862 0 CA-C-N 112.029 -2.351 . . . . 0.47999999999999998 114.07 170.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.8 -122.46 3.46 Favored Glycine 0 CA--C 1.478 -2.256 0 C-N-CA 118.818 -1.658 . . . . 0.44 111.103 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.2 p -151.71 167.91 26.71 Favored 'General case' 0 N--CA 1.403 -2.822 0 CA-C-N 112.474 -1.863 . . . . 0.81999999999999995 110.408 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 104' ' ' LEU . 10.6 tp -146.29 150.58 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 CA-C-N 112.938 -1.937 . . . . 0.32000000000000001 107.919 169.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 m -137.5 126.19 23.82 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 113.048 -1.887 . . . . 0.31 110.757 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.675 ' HD2' HD12 ' A' ' 74' ' ' LEU . 37.3 m-85 -122.11 140.99 51.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.033 -1.439 . . . . 0.53000000000000003 109.408 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.78 119.52 22.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.645 -0.707 . . . . 0.57999999999999996 109.601 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.774 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -121.33 116.75 25.41 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.507 -1.224 . . . . 0.32000000000000001 110.691 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.658 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 28.5 mtp180 -105.05 120.04 40.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.072 -0.513 . . . . 2.4300000000000002 111.142 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.524 HG21 HG21 ' A' ' 39' ' ' VAL . 12.9 t -122.14 132.72 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.707 0.765 . . . . 0.26000000000000001 109.303 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.87 111.24 1.81 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.71 -1.586 . . . . 0.40000000000000002 110.7 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -50.89 -35.12 31.27 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 114.675 -1.148 . . . . 0.76000000000000001 110.295 169.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.63 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.09 -143.98 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.38 -0.91 . . . . 0.70999999999999996 113.383 166.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.542 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -119.58 154.8 33.37 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.327 -1.36 . . . . 1.74 107.327 170.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.065 HD22 ' HA ' ' A' ' 93' ' ' THR . 3.7 tp 171.0 147.53 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.475 -1.306 . . . . 2.1600000000000001 107.475 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.803 ' H ' HD12 ' A' ' 33' ' ' LEU . 24.3 tp -44.91 -42.27 7.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.031 0.92 . . . . 1.47 111.169 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.772 ' HD2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.47 -179.67 0.79 Allowed Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.197 -1.365 . . . . 1.3999999999999999 108.116 175.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 8.1 Cg_exo -67.9 153.69 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.533 1.489 . . . . 0.88 108.888 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.692 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 26.4 Cg_exo -60.38 137.23 73.06 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.013 1.809 . . . . 0.53000000000000003 111.548 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.27 102.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 106.94 -1.504 . . . . 0.77000000000000002 106.94 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.677 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -107.59 114.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 CA-C-N 112.839 -1.982 . . . . 0.28000000000000003 106.947 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.706 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.01 127.95 53.09 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 123.313 1.53 . . . . 1.54 109.22 173.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.039 ' HB3' HD13 ' A' ' 49' ' ' LEU . 69.4 m95 -85.4 154.25 21.97 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 111.448 -2.615 . . . . 0.34000000000000002 111.111 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.838 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 29.9 t80 -126.22 138.2 53.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.62 105.186 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 71.2 tttt -104.76 165.05 11.33 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.719 -1.956 . . . . 2.1699999999999999 105.719 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.807 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -9.65 -168.79 0.0 OUTLIER Glycine 0 C--O 1.188 -2.747 0 N-CA-C 119.522 2.569 . . . . 1.23 119.522 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 84' ' ' THR . 19.5 mtpt -45.47 -1.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 O-C-N 119.463 -2.198 . . . . 3.8700000000000001 116.826 -166.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.695 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 13.8 p-90 -166.03 -10.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.403 1.26 . . . . 2.1099999999999999 114.403 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.695 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.2 170.06 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-O 123.482 1.611 . . . . 1.29 112.492 -162.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.694 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 7.0 p-10 -112.88 158.13 20.57 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 111.825 -2.443 . . . . 2.73 107.528 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.039 HD13 ' HB3' ' A' ' 41' ' ' TRP . 6.0 mp -98.57 -36.94 9.73 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.142 0.423 . . . . 0.44 112.142 168.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 t -57.69 -20.76 36.23 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.719 0.637 . . . . 1.23 109.661 -162.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.694 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 17.0 m -100.47 -21.24 15.42 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.619 -0.832 . . . . 1.3400000000000001 112.855 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 1.9 mmmt -94.11 -67.93 0.83 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.425 -0.807 . . . . 1.3999999999999999 111.132 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.833 HG13 ' H ' ' A' ' 59' ' ' LEU . 78.5 t 12.8 93.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 126.358 1.863 . . . . 0.37 113.593 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.43 -154.49 7.28 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.052 -1.431 . . . . 0.69999999999999996 110.281 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.45 ' C ' HE22 ' A' ' 58' ' ' GLN . 55.5 mt-30 -63.98 -5.21 4.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.971 1.1 . . . . 2.75 113.971 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -101.83 -41.26 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.768 0.794 . . . . 1.3300000000000001 110.831 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.019 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.72 104.73 7.36 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.25 -1.759 . . . . 1.1100000000000001 106.25 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.887 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -95.1 113.75 25.48 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.259 -2.126 . . . . 0.76000000000000001 105.259 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.833 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -101.74 91.42 4.4 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.065 -2.568 . . . . 0.26000000000000001 104.065 170.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 45.7 t60 -106.37 162.69 13.47 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.365 -1.289 . . . . 2.0299999999999998 109.279 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.65 125.56 38.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 112.331 -2.213 . . . . 0.92000000000000004 110.966 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -98.78 147.54 24.8 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 110.996 -2.82 . . . . 0.46999999999999997 107.043 169.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.585 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 6.6 t80 -144.25 101.11 3.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.058 0.932 . . . . 1.3899999999999999 112.312 -168.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 7.7 t70 -117.4 127.63 54.22 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.98 -1.464 . . . . 2.4199999999999999 109.321 168.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.585 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -86.75 -41.12 14.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.813 -1.54 . . . . 2.46 112.018 -174.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.69 57.93 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.988 -1.005 . . . . 1.1499999999999999 111.102 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 29.6 t -91.19 -19.4 23.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.542 -1.651 . . . . 1.4099999999999999 106.542 173.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 1.4 tpmt? 70.69 29.32 3.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.841 -1.527 . . . . 3.3100000000000001 109.722 173.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.04 127.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.42999999999999999 111.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.544 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 61.2 m-85 -96.89 113.33 24.86 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.182 -1.784 . . . . 1.24 106.182 162.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 36.0 tp -92.4 103.82 16.22 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.345 -0.983 . . . . 0.52000000000000002 108.345 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.3 m-85 -85.26 112.73 21.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.386 -1.709 . . . . 0.33000000000000002 106.386 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 119.92 39.03 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.098 -1.864 . . . . 1.3200000000000001 109.798 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.703 HD13 HD11 ' A' ' 76' ' ' ILE . 1.6 mt -89.41 130.83 35.71 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 114.116 -1.402 . . . . 0.95999999999999996 107.984 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.887 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 81.7 m-70 -120.69 95.81 4.87 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 104.114 -2.551 . . . . 1.1499999999999999 104.114 168.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 74' ' ' LEU . 12.8 mt -119.77 101.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 113.937 -1.483 . . . . 0.52000000000000002 108.318 -171.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 78.5 p -101.68 166.19 10.82 Favored 'General case' 0 N--CA 1.382 -3.861 0 CA-C-N 113.987 -1.461 . . . . 0.57999999999999996 109.145 -175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 39.38 78.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 111.362 -2.654 . . . . 2.1200000000000001 112.579 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -70.77 121.04 17.26 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 111.089 -2.778 . . . . 0.40000000000000002 110.181 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.928 HE21 ' HD2' ' A' ' 81' ' ' PRO . 2.1 tp60 -63.07 137.91 97.19 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.49 -0.777 . . . . 1.4299999999999999 109.874 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.928 ' HD2' HE21 ' A' ' 80' ' ' GLN . 16.5 Cg_endo -57.73 -12.86 12.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.283 2.655 . . . . 1.3300000000000001 113.545 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.512 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.03 21.78 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.339 . . . . 1.1200000000000001 111.245 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -46.89 8.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.536 -0.466 . . . . 1.24 111.984 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 83.2 m 22.67 79.77 0.01 OUTLIER 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.902 1.334 . . . . 1.22 110.609 -165.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.807 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.1 99.39 0.5 Allowed Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 112.711 -2.041 . . . . 1.4299999999999999 114.495 -159.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.727 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -86.59 69.49 3.1 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 109.208 -1.557 . . . . 0.52000000000000002 109.208 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.723 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 77.8 m-85 -78.42 128.11 33.14 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.871 -1.165 . . . . 0.63 108.758 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.838 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -122.56 156.72 33.62 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.082 0.468 . . . . 3.1499999999999999 110.618 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 72.6 m -130.55 115.8 17.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.197 -0.668 . . . . 1.0800000000000001 109.197 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.706 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 39.2 mt-10 -125.34 105.24 8.95 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.627 -0.429 . . . . 1.8100000000000001 109.908 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.8 p -103.62 144.1 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.54000000000000004 111.009 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.8 t -135.2 109.09 8.11 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.894 -1.048 . . . . 1.1799999999999999 108.428 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.065 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -131.58 146.78 52.38 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-O 117.55 -1.214 . . . . 0.73999999999999999 109.353 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.795 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.86 -71.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 125.49 1.744 . . . . 0.65000000000000002 113.56 -167.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.795 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -152.18 3.66 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.159 -1.382 . . . . 1.05 110.443 -172.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.82 ' HB3' HD22 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -94.23 142.73 27.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.027 -1.101 . . . . 1.29 108.027 177.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.48 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 31.3 t80 -133.64 132.84 41.23 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 113.64 -1.618 . . . . 0.77000000000000002 111.79 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.6 m-20 -151.35 153.05 34.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.063 -0.972 . . . . 1.6000000000000001 110.4 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 33.4 m -148.54 148.84 30.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.117 0.484 . . . . 1.1899999999999999 111.737 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.821 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 28.9 t -133.4 150.76 51.79 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.804 0.812 . . . . 0.83999999999999997 111.947 174.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.45 120.86 18.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.752 -1.567 . . . . 1.5800000000000001 109.916 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 10.1 p90 -143.48 130.57 20.68 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.939 -0.393 . . . . 0.85999999999999999 109.939 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.795 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -107.86 128.31 54.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.318 1.056 . . . . 2.1099999999999999 113.359 -170.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -95.08 109.28 21.36 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.842 -1.526 . . . . 0.37 109.196 176.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.0 m -90.43 96.79 10.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.405 -0.591 . . . . 0.33000000000000002 109.405 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.613 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.2 p -77.68 113.36 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 122.765 1.269 . . . . 0.33000000000000002 108.626 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -84.35 97.97 9.77 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.186 -1.825 . . . . 1.1899999999999999 109.664 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.2 tm-20 . . . . . 0 C--N 1.301 -1.512 0 CA-C-N 113.491 -1.686 . . . . 1.6699999999999999 109.339 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.457 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 m-20 . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 109.277 -0.638 . . . . 1.6499999999999999 109.277 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.83 91.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.38 2.054 . . . . 0.96999999999999997 112.454 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.722 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -117.8 -64.94 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.335 -0.848 . . . . 0.5 109.174 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 94.11 42.88 3.93 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.208 -1.957 . . . . 0.39000000000000001 108.208 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.01 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -52.64 -39.75 62.1 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 112.87 -1.665 . . . . 0.33000000000000002 110.293 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.866 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.9 84.39 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.281 -0.872 . . . . 0.71999999999999997 109.6 177.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.42 -49.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.343 -1.299 . . . . 0.63 109.388 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.44 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 24.1 ttt -141.6 136.68 31.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.394 -0.821 . . . . 2.8799999999999999 109.317 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.732 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -110.76 137.99 20.95 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.193 -0.458 . . . . 3.6699999999999999 110.987 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.67 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 4.0 Cg_endo -71.49 155.47 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.223 1.949 . . . . 0.64000000000000001 110.718 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.2 mm-40 -120.25 177.25 5.09 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.687 -0.486 . . . . 1.4299999999999999 109.687 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.0 p-10 -66.67 -141.59 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 122.884 1.326 . . . . 2.0600000000000001 111.828 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 148.97 133.33 2.22 Favored Glycine 0 C--N 1.291 -1.938 0 CA-C-N 113.586 -1.643 . . . . 0.29999999999999999 111.716 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 28.6 mt-10 -113.62 111.86 22.56 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.357 -0.979 . . . . 1.53 108.357 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.462 ' CG1' HD13 ' A' ' 22' ' ' ILE . 3.0 m -127.74 163.64 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.862 0 N-CA-C 107.252 -1.388 . . . . 0.27000000000000002 107.252 -170.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.55 152.89 18.03 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.83 -1.077 . . . . 0.77000000000000002 109.13 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.866 HG21 ' HB3' ' A' ' 81' ' ' PRO . 3.7 t -66.67 105.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 122.923 1.344 . . . . 0.78000000000000003 108.123 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.55 5.9 Favored Glycine 0 C--N 1.263 -3.494 0 CA-C-N 111.921 -2.4 . . . . 0.47999999999999998 111.678 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.83 -127.83 6.16 Favored Glycine 0 N--CA 1.409 -3.16 0 C-N-CA 118.932 -1.604 . . . . 0.44 109.188 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.9 p -152.15 174.35 13.83 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.04 -1.58 . . . . 0.81999999999999995 110.075 177.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.2 tp -147.58 150.47 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-N 113.703 -1.589 . . . . 0.32000000000000001 107.505 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.5 m -138.53 124.01 19.51 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 113.222 -1.808 . . . . 0.31 109.943 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.776 ' HD2' HD12 ' A' ' 74' ' ' LEU . 33.1 m-85 -119.96 146.04 46.19 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.404 -1.271 . . . . 0.53000000000000003 109.015 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.36 120.42 15.59 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.141 -0.936 . . . . 0.57999999999999996 110.192 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.579 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -120.18 116.22 25.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.478 -1.237 . . . . 0.32000000000000001 110.613 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.5 mtt180 -103.6 121.93 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.557 -0.292 . . . . 2.4300000000000002 110.548 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG21 HG21 ' A' ' 39' ' ' VAL . 23.5 t -123.34 129.42 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.032 0.92 . . . . 0.26000000000000001 110.524 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.78 110.81 2.96 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.36 -1.745 . . . . 0.40000000000000002 111.529 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.634 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -51.05 -39.26 40.84 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.856 -1.066 . . . . 0.76000000000000001 112.633 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 58.03 -170.64 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.517 0.727 . . . . 0.70999999999999996 112.406 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.2 m -73.59 -71.54 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.49 -0.93 . . . . 1.74 108.49 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.938 HD23 HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 69.2 158.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 O-C-N 123.782 0.676 . . . . 2.1600000000000001 112.378 166.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.903 ' N ' HD22 ' A' ' 33' ' ' LEU . 19.2 tp -80.71 -66.24 0.91 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.906 -0.588 . . . . 1.47 110.879 168.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.766 ' O ' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -122.91 130.12 24.73 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 114.281 1.215 . . . . 1.3999999999999999 114.281 172.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' N ' HD11 ' A' ' 33' ' ' LEU . 18.4 Cg_exo -34.36 131.66 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.305 3.337 . . . . 0.88 113.171 -171.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.851 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 34.0 Cg_exo -49.02 133.47 28.65 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 122.484 2.122 . . . . 0.53000000000000003 112.671 -170.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.38 103.6 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.784 -1.562 . . . . 0.77000000000000002 106.784 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -105.34 113.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.959 -1.928 . . . . 0.28000000000000003 107.504 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.587 ' NZ ' ' HB2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -102.04 128.7 48.37 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-O 123.331 1.539 . . . . 1.54 109.006 174.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.054 ' HB3' HD13 ' A' ' 49' ' ' LEU . 57.2 m95 -84.91 153.27 22.96 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 111.829 -2.441 . . . . 0.34000000000000002 110.867 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 17.8 t80 -122.31 135.81 54.79 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.932 -2.247 . . . . 0.62 104.932 172.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.661 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 76.9 tttt -103.31 166.52 10.38 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.674 -1.602 . . . . 2.1699999999999999 106.674 -175.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA2' ' CA ' ' A' ' 85' ' ' GLY . . . -8.7 -162.09 0.0 OUTLIER Glycine 0 C--O 1.196 -2.227 0 N-CA-C 118.903 2.321 . . . . 1.23 118.903 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.746 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 39.6 pttt -38.68 -20.42 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.18 1.918 . . . . 3.8700000000000001 116.18 -163.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.746 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 15.2 p-90 -167.27 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 120.073 1.306 . . . . 2.1099999999999999 113.395 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -92.55 170.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 123.19 1.471 . . . . 1.29 112.072 -162.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 27.8 t70 -113.35 154.1 27.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 112.345 -2.207 . . . . 2.73 106.797 175.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.054 HD13 ' HB3' ' A' ' 41' ' ' TRP . 6.1 mp -91.29 -39.92 11.79 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 119.008 -0.52 . . . . 0.44 112.057 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.6 t -59.99 -20.14 56.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.813 -0.81 . . . . 1.23 108.813 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -86.67 -28.6 23.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.983 -1.008 . . . . 1.3400000000000001 111.456 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 11.4 mmmt -100.11 -62.73 1.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.446 -0.797 . . . . 1.3999999999999999 111.395 -172.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 49' ' ' LEU . 48.3 t 4.48 93.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 O-C-N 125.88 1.987 . . . . 0.37 113.804 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -164.99 -123.99 0.68 Allowed Glycine 0 C--N 1.31 -0.914 0 CA-C-N 113.001 -1.909 . . . . 0.69999999999999996 113.048 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.36 -38.49 78.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.763 0.425 . . . . 2.75 111.839 -170.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 6.8 t-80 -88.16 -38.64 15.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.75 0.786 . . . . 1.3300000000000001 111.463 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.0 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.14 105.29 7.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.824 -1.547 . . . . 1.1100000000000001 106.824 -177.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.8 114.78 27.12 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.063 -1.458 . . . . 0.76000000000000001 107.063 168.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.661 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.7 92.61 5.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.011 -2.589 . . . . 0.26000000000000001 104.011 169.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.733 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 8.5 t-160 -100.13 161.38 13.64 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.924 -1.489 . . . . 2.0299999999999998 109.268 -173.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.02 119.83 26.25 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 111.982 -2.372 . . . . 0.92000000000000004 110.839 -173.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.794 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.4 m -97.48 146.39 25.29 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 111.826 -2.443 . . . . 0.46999999999999997 106.75 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.449 ' HD1' ' CD1' ' A' ' 70' ' ' TYR . 28.5 t80 -145.43 96.63 2.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.385 1.088 . . . . 1.3899999999999999 111.389 -168.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 10.8 m-20 -115.67 101.11 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.235 -1.802 . . . . 2.4199999999999999 109.084 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -44.78 60.93 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.24 -0.891 . . . . 2.46 111.278 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -19.52 60.68 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.112 -0.949 . . . . 1.1499999999999999 111.118 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 49.4 m -92.8 -13.12 29.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.376 -1.342 . . . . 1.4099999999999999 107.376 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 tpmt? 69.6 27.45 4.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.806 -1.543 . . . . 3.3100000000000001 110.52 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 67' ' ' SER . 5.4 t -131.54 126.72 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.815 0.817 . . . . 0.42999999999999999 110.549 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.851 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 10.6 m-85 -101.35 109.27 21.09 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.944 -1.502 . . . . 1.24 106.944 165.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.1 tp -92.5 104.49 16.8 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.113 0.959 . . . . 0.52000000000000002 108.989 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -83.9 113.82 21.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.909 -1.515 . . . . 0.33000000000000002 106.909 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.733 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.5 pt-20 -117.5 122.94 45.1 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.513 -1.676 . . . . 1.3200000000000001 110.086 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.776 HD12 ' HD2' ' A' ' 24' ' ' PHE . 2.4 mt -94.23 133.15 38.05 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.108 -1.405 . . . . 0.95999999999999996 108.935 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 5.6 m170 -115.38 96.66 5.76 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.357 -2.831 . . . . 1.1499999999999999 103.357 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.675 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.5 mt -124.59 100.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.976 1.37 . . . . 0.52000000000000002 108.545 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.3 p -105.46 169.3 8.54 Favored 'General case' 0 N--CA 1.394 -3.238 0 CA-C-N 114.323 -1.308 . . . . 0.57999999999999996 110.102 -172.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 36.71 69.05 0.22 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 111.206 -2.725 . . . . 2.1200000000000001 111.392 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -57.19 126.26 26.42 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 112.196 -2.274 . . . . 0.40000000000000002 111.397 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.716 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -56.05 131.42 74.17 Favored Pre-proline 0 C--O 1.223 -0.34 0 CA-C-N 115.76 -0.655 . . . . 1.4299999999999999 109.634 172.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.866 ' HB3' HG21 ' A' ' 18' ' ' VAL . 21.9 Cg_endo -61.32 -15.9 43.43 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.982 2.455 . . . . 1.3300000000000001 113.148 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -108.25 26.63 10.2 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.807 -0.633 . . . . 1.1200000000000001 110.365 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -81.34 -52.91 6.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.47 -0.492 . . . . 1.24 111.188 -178.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.4 m 21.71 75.48 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 123.427 1.584 . . . . 1.22 109.276 -159.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.659 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.95 114.96 4.56 Favored Glycine 0 N--CA 1.407 -3.254 0 CA-C-N 112.152 -2.294 . . . . 1.4299999999999999 112.397 -156.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.563 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -98.74 87.81 0.82 Allowed Glycine 0 C--N 1.273 -2.957 0 N-CA-C 109.544 -1.423 . . . . 0.52000000000000002 109.544 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.737 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 m-85 -85.46 139.62 31.36 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.194 -1.503 . . . . 0.63 107.629 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.704 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 49.0 mtm180 -137.24 155.73 49.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.629 0.252 . . . . 3.1499999999999999 110.378 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 3.4 m -122.82 120.95 35.05 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.147 -0.686 . . . . 1.0800000000000001 109.147 173.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -123.41 105.12 9.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.002 -0.74 . . . . 1.8100000000000001 109.002 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.8 p -101.55 142.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.465 0.65 . . . . 0.54000000000000004 111.501 -175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 t -132.13 108.11 9.07 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.346 -1.297 . . . . 1.1799999999999999 108.681 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.938 HG22 HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.36 154.01 51.1 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 117.853 -1.07 . . . . 0.73999999999999999 108.718 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.735 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.72 -75.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 125.895 1.997 . . . . 0.65000000000000002 114.391 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.735 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t70 -151.44 3.17 0.42 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.979 -1.01 . . . . 1.05 109.31 -175.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.01 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -96.39 128.47 43.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.378 -0.971 . . . . 1.29 108.378 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -130.57 132.15 45.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.708 -1.133 . . . . 0.77000000000000002 110.879 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -154.04 153.9 32.75 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.418 -1.265 . . . . 1.6000000000000001 110.379 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 59.6 m -145.02 152.44 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 1.1899999999999999 110.749 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.866 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 56.3 p -131.22 148.26 52.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.641 -0.709 . . . . 0.83999999999999997 109.371 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.704 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -133.84 124.36 26.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.72 0.295 . . . . 1.5800000000000001 110.329 177.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 9.6 p90 -143.85 126.4 15.94 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.144 0.497 . . . . 0.85999999999999999 110.5 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 59.6 m-20 -103.46 136.86 42.42 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.273 1.035 . . . . 2.1099999999999999 111.047 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -105.64 110.52 22.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.085 -1.416 . . . . 0.37 109.157 177.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.442 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.0 m -94.61 97.22 9.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.006 -0.738 . . . . 0.33000000000000002 109.006 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.3 p -81.48 119.11 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-O 122.851 1.31 . . . . 0.33000000000000002 108.883 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -91.4 99.16 12.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.034 -1.894 . . . . 1.1899999999999999 108.763 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 18' ' ' VAL . 44.1 tt0 . . . . . 0 C--N 1.303 -1.455 0 CA-C-N 114.122 -1.399 . . . . 1.6699999999999999 110.094 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.616 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.74 -0.837 . . . . 1.6499999999999999 108.74 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.417 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -40.7 96.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 125.015 3.81 . . . . 0.96999999999999997 115.162 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 6' ' ' LEU . 1.4 mp -128.85 -60.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.036 -0.983 . . . . 0.5 109.225 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.12 54.96 2.46 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.635 -1.786 . . . . 0.39000000000000001 108.635 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -62.97 -32.49 73.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.466 -1.367 . . . . 0.33000000000000002 111.051 -165.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.12 84.96 3.36 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.746 -0.661 . . . . 0.71999999999999997 109.813 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.65 -46.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.825 -1.08 . . . . 0.63 109.766 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.59 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 25.1 ttt -140.4 130.51 24.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.408 -0.814 . . . . 2.8799999999999999 108.943 174.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -102.69 128.6 27.63 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.141 -0.481 . . . . 3.6699999999999999 110.195 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.683 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 10.8 Cg_endo -62.16 150.98 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.291 1.994 . . . . 0.64000000000000001 110.675 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.496 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.5 mm-40 -121.96 173.91 7.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.884 -0.598 . . . . 1.4299999999999999 110.327 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 8.0 p-10 -70.7 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.937 1.351 . . . . 2.0600000000000001 111.896 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 158.42 130.14 1.15 Allowed Glycine 0 C--N 1.294 -1.755 0 CA-C-N 113.099 -1.864 . . . . 0.29999999999999999 112.689 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -112.94 107.78 16.47 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.044 -1.078 . . . . 1.53 109.071 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.24 163.52 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 N-CA-C 107.255 -1.387 . . . . 0.27000000000000002 107.255 -167.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.92 156.74 16.2 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.303 -0.862 . . . . 0.77000000000000002 109.638 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.662 HG22 HG22 ' A' ' 106' ' ' VAL . 18.1 t -68.51 104.53 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 CA-C-O 122.876 1.322 . . . . 0.78000000000000003 108.326 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.72 4.85 7.9 Favored Glycine 0 C--N 1.27 -3.087 0 CA-C-N 112.36 -2.2 . . . . 0.47999999999999998 112.837 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.67 -125.33 5.13 Favored Glycine 0 N--CA 1.415 -2.706 0 N-CA-C 109.674 -1.37 . . . . 0.44 109.674 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 14.5 p -150.36 172.59 15.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 112.847 -1.676 . . . . 0.81999999999999995 110.38 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.7 tp -148.86 145.66 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 112.896 -1.957 . . . . 0.32000000000000001 106.988 172.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 m -139.08 129.13 25.18 Favored 'General case' 0 C--N 1.261 -3.278 0 CA-C-N 114.003 -1.453 . . . . 0.31 110.711 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.643 ' HB2' HD23 ' A' ' 74' ' ' LEU . 38.7 m-85 -127.15 145.2 50.83 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.199 -1.364 . . . . 0.53000000000000003 110.012 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.11 121.61 22.88 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.432 -0.804 . . . . 0.57999999999999996 109.251 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.683 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -124.42 117.78 25.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.92 -1.037 . . . . 0.32000000000000001 110.541 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.7 mtt180 -107.71 118.59 37.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.209 -0.45 . . . . 2.4300000000000002 110.498 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.54 HG21 HG21 ' A' ' 39' ' ' VAL . 18.5 t -117.92 127.15 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 122.044 0.926 . . . . 0.26000000000000001 109.695 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.1 0.65 Allowed 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.339 -1.755 . . . . 0.40000000000000002 111.076 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.697 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -51.32 -50.63 39.96 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.263 -1.335 . . . . 0.76000000000000001 112.025 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.736 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 48.1 -161.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.558 0.743 . . . . 0.70999999999999996 112.319 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -127.33 86.07 2.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.633 -0.877 . . . . 1.74 108.633 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.852 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -110.32 -175.83 2.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.206 -0.452 . . . . 2.1600000000000001 109.914 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.24 -24.51 42.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.337 0.589 . . . . 1.47 111.471 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.852 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -151.83 -179.39 1.01 Allowed Pre-proline 0 C--O 1.212 -0.905 0 CA-C-N 115.133 -0.94 . . . . 1.3999999999999999 109.148 -173.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 2.9 Cg_exo -73.19 141.98 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 N-CA-C 107.965 -1.59 . . . . 0.88 107.965 165.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 93' ' ' THR . 21.8 Cg_exo -52.34 135.31 53.67 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.087 1.191 . . . . 0.53000000000000003 111.592 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 35' ' ' LYS . 2.6 t -97.58 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.68 0 N-CA-C 106.586 -1.635 . . . . 0.77000000000000002 106.586 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.64 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -111.23 114.56 47.44 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.084 0 CA-C-N 113.127 -1.852 . . . . 0.28000000000000003 107.517 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.836 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.02 129.85 51.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 123.086 1.422 . . . . 1.54 109.816 173.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.052 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.3 m95 -87.87 154.99 20.09 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 111.689 -2.505 . . . . 0.34000000000000002 111.875 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 30.8 t80 -135.1 138.06 43.42 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 104.578 -2.379 . . . . 0.62 104.578 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.794 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 60.5 tttp -103.98 166.22 10.55 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.983 -2.229 . . . . 2.1699999999999999 104.983 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.02 -165.31 0.0 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 119.215 2.446 . . . . 1.23 119.215 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.612 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 7.0 mtpp -43.37 -10.44 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 O-C-N 119.489 -2.183 . . . . 3.8700000000000001 116.574 -166.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.429 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 15.2 p-90 -163.21 -9.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.751 1.389 . . . . 2.1099999999999999 114.751 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.62 151.5 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 CA-C-O 123.112 1.434 . . . . 1.29 112.336 -160.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.8 t70 -110.48 127.31 55.09 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 111.87 -2.423 . . . . 2.73 108.721 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.052 HD13 ' HB3' ' A' ' 41' ' ' TRP . 3.1 mp -68.23 -34.97 77.22 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.04 -0.527 . . . . 0.44 112.268 -175.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -58.76 -21.76 56.43 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.45 0.643 . . . . 1.23 109.36 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -92.72 -29.57 15.99 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.782 -1.099 . . . . 1.3400000000000001 111.365 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.76 ' HB2' HD12 ' A' ' 57' ' ' LEU . 11.1 mmmt -98.05 -30.59 12.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.526 -0.761 . . . . 1.3999999999999999 111.569 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 42.7 t -45.01 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 125.704 1.602 . . . . 0.37 111.264 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.92 -98.23 0.13 Allowed Glycine 0 C--N 1.298 -1.545 0 CA-C-N 112.374 -2.194 . . . . 0.69999999999999996 113.749 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -91.62 -42.32 10.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.497 . . . . 2.75 112.341 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.5 p80 -95.86 -38.12 10.42 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.073 0.463 . . . . 1.3300000000000001 110.897 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.935 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.82 105.82 13.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.261 -1.755 . . . . 1.1100000000000001 106.261 173.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.16 115.96 31.06 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 106.757 -1.571 . . . . 0.76000000000000001 106.757 165.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -97.02 92.27 5.99 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 104.146 -2.538 . . . . 0.26000000000000001 104.146 170.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.756 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 29.3 m-70 -91.87 162.86 14.25 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 114.361 -1.291 . . . . 2.0299999999999998 110.106 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.95 115.75 14.75 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.132 -2.304 . . . . 0.92000000000000004 109.835 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -92.29 147.87 22.58 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.24 -1.8 . . . . 0.46999999999999997 107.463 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -142.25 98.19 3.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.244 1.021 . . . . 1.3899999999999999 110.799 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.608 ' OD1' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -114.46 114.6 26.03 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.37 -1.741 . . . . 2.4199999999999999 111.014 174.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.734 ' HD3' ' HE2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.526 -0.761 . . . . 2.46 110.756 175.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.83 -28.88 70.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.292 -0.867 . . . . 1.1499999999999999 111.304 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.608 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 15.0 m -100.66 -18.49 16.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.175 -1.046 . . . . 1.4099999999999999 108.175 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.736 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 64.05 37.33 9.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.277 -1.328 . . . . 3.3100000000000001 109.736 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.65 139.18 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 115.373 -0.83 . . . . 0.42999999999999999 109.758 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 70.0 m-85 -102.82 109.08 20.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.383 -1.71 . . . . 1.24 106.383 162.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.3 tp -94.53 104.07 16.02 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.404 1.097 . . . . 0.52000000000000002 108.806 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.6 m-85 -88.35 113.95 24.47 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.713 -1.585 . . . . 0.33000000000000002 107.624 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.756 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 8.2 pt-20 -115.0 124.46 51.7 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.877 -1.51 . . . . 1.3200000000000001 109.877 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.779 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -90.23 120.8 31.69 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.416 -1.72 . . . . 0.95999999999999996 108.33 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -112.12 95.65 5.59 Favored 'General case' 0 C--N 1.268 -2.947 0 N-CA-C 103.976 -2.602 . . . . 1.1499999999999999 103.976 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.723 ' HB ' HG23 ' A' ' 22' ' ' ILE . 64.6 mt -120.84 98.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-O 123.26 1.505 . . . . 0.52000000000000002 109.54 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 21.3 p -112.29 136.31 51.9 Favored 'General case' 0 N--CA 1.393 -3.321 0 CA-C-N 113.213 -1.812 . . . . 0.57999999999999996 106.96 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER 72.83 100.13 0.07 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 111.684 -2.507 . . . . 2.1200000000000001 109.017 -171.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.98 113.24 26.66 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 110.431 -3.077 . . . . 0.40000000000000002 109.538 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.676 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -54.32 140.19 55.39 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.438 -0.801 . . . . 1.4299999999999999 110.252 171.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.566 ' HD2' HE21 ' A' ' 80' ' ' GLN . 21.6 Cg_endo -61.03 -11.59 19.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.142 2.561 . . . . 1.3300000000000001 112.875 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -97.64 11.14 38.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.124 -0.489 . . . . 1.1200000000000001 110.687 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.439 ' O ' HD23 ' A' ' 104' ' ' LEU . 2.6 m-30 -97.32 -8.86 28.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 119.449 -0.31 . . . . 1.24 110.636 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 20.5 m -47.95 97.71 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.116 -1.068 . . . . 1.22 108.116 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.612 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -168.53 -129.07 1.05 Allowed Glycine 0 C--N 1.263 -3.508 0 CA-C-N 113.365 -1.743 . . . . 1.4299999999999999 112.563 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -152.86 119.25 0.94 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 119.95 -1.119 . . . . 0.52000000000000002 112.369 -171.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.788 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -84.97 114.7 22.35 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 113.496 -1.352 . . . . 0.63 107.541 174.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 45.2 mtm180 -105.49 127.41 52.99 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.909 0.385 . . . . 3.1499999999999999 110.497 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 t -111.83 123.61 50.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.433 -0.58 . . . . 1.0800000000000001 109.433 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.836 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 47.5 mt-10 -133.02 115.87 15.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.649 -0.705 . . . . 1.8100000000000001 110.347 -175.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -107.7 141.46 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.266 0.555 . . . . 0.54000000000000004 110.977 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 t -134.68 111.52 10.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.069 -0.968 . . . . 1.1799999999999999 110.215 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.463 ' CG2' HD22 ' A' ' 33' ' ' LEU . 11.1 p -117.27 -177.45 3.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.168 -0.924 . . . . 0.73999999999999999 111.213 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.986 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -18.04 -48.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 125.682 1.864 . . . . 0.65000000000000002 113.678 175.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.986 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -167.54 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.837 -1.529 . . . . 1.05 110.723 -173.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.646 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -95.76 132.71 40.69 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.079 -1.082 . . . . 1.29 108.079 -177.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -130.99 133.97 46.27 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.269 -1.332 . . . . 0.77000000000000002 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -152.15 147.32 26.3 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.458 -1.247 . . . . 1.6000000000000001 109.259 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.7 p -149.64 149.22 30.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.151 0.5 . . . . 1.1899999999999999 111.578 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.6 p -124.57 148.14 48.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.496 -0.775 . . . . 0.83999999999999997 111.739 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.616 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -128.04 112.8 15.01 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.604 -1.18 . . . . 1.5800000000000001 109.106 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.767 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 12.9 p90 -141.47 128.11 20.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.41 0.624 . . . . 0.85999999999999999 109.664 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 7.7 p30 -104.71 140.26 38.32 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.233 1.016 . . . . 2.1099999999999999 112.59 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -109.37 114.31 27.87 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.423 -1.262 . . . . 0.37 108.329 175.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 m -97.35 96.11 8.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.959 -0.756 . . . . 0.33000000000000002 108.959 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.662 HG22 HG22 ' A' ' 18' ' ' VAL . 5.1 p -80.08 113.06 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 123.193 1.473 . . . . 0.33000000000000002 109.252 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 41.1 m170 -82.78 99.04 9.43 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 112.447 -2.161 . . . . 1.1899999999999999 110.229 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 41.8 tt0 . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 114.441 -1.254 . . . . 1.6699999999999999 108.624 167.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.635 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 6.2 t70 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.909 -0.774 . . . . 1.6499999999999999 108.909 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.443 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 87.3 Cg_exo -47.52 92.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 124.156 3.237 . . . . 0.96999999999999997 114.959 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.5 mp -119.18 -51.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.924 -1.035 . . . . 0.5 109.264 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.09 41.14 8.2 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.548 -1.821 . . . . 0.39000000000000001 108.548 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 96' ' ' LYS . 12.4 tp -51.5 -48.18 63.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.757 -1.721 . . . . 0.33000000000000002 110.927 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.737 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -92.25 84.12 5.16 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.674 0.749 . . . . 0.71999999999999997 109.643 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.64 -46.49 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.33 -1.305 . . . . 0.63 110.138 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.508 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 18.1 mmt -140.96 130.7 24.22 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.044 -0.526 . . . . 2.8799999999999999 111.077 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.9 ptp180 -101.24 132.65 21.65 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.123 -0.944 . . . . 3.6699999999999999 108.877 173.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.784 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 68.6 Cg_endo -78.9 158.01 27.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.244 1.963 . . . . 0.64000000000000001 110.172 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 12.6 mm100 -118.72 -178.41 3.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 120.348 -0.541 . . . . 1.4299999999999999 112.003 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.1 p-10 -69.98 -147.97 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 122.684 1.23 . . . . 2.0600000000000001 111.421 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 155.41 133.38 1.7 Allowed Glycine 0 C--N 1.291 -1.952 0 CA-C-N 113.549 -1.66 . . . . 0.29999999999999999 112.227 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 36.0 mt-10 -109.96 107.47 17.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.718 -1.241 . . . . 1.53 108.153 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' CG1' HD13 ' A' ' 22' ' ' ILE . 2.8 m -125.79 163.32 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.158 0 N-CA-C 106.779 -1.563 . . . . 0.27000000000000002 106.779 -171.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.54 155.84 17.08 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.064 -0.971 . . . . 0.77000000000000002 108.888 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 81' ' ' PRO . 2.9 t -66.64 106.7 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 122.362 1.077 . . . . 0.78000000000000003 108.56 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 6.64 8.17 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.54 -2.118 . . . . 0.47999999999999998 111.663 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.86 -124.71 5.19 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.52 -1.432 . . . . 0.44 109.52 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.1 p -151.64 174.62 13.25 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 112.983 -1.609 . . . . 0.81999999999999995 109.852 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.8 tp -146.14 147.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.481 -1.69 . . . . 0.32000000000000001 107.119 166.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 m -140.76 130.9 24.81 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.45 -1.704 . . . . 0.31 110.17 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.602 ' HB2' HD23 ' A' ' 74' ' ' LEU . 23.7 m-85 -125.56 144.47 50.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.268 -1.333 . . . . 0.53000000000000003 108.855 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.12 117.9 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.15 -0.932 . . . . 0.57999999999999996 110.313 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.9 116.99 22.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 113.947 -1.479 . . . . 0.32000000000000001 111.428 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 79.3 mtt-85 -104.88 127.68 52.8 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.09 -0.244 . . . . 2.4300000000000002 110.775 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.3 t -126.66 126.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.084 0.945 . . . . 0.26000000000000001 110.223 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -58.54 112.2 1.52 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.607 -1.633 . . . . 0.40000000000000002 112.596 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.81 -57.37 12.69 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-N 114.441 -1.254 . . . . 0.76000000000000001 112.086 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.848 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.29 177.29 0.24 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.37 1.248 . . . . 0.70999999999999996 114.37 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -103.36 22.07 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.535 -1.211 . . . . 1.74 109.842 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.957 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -52.18 171.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.617 -1.174 . . . . 2.1600000000000001 112.666 175.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.31 -51.42 54.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.275 0.56 . . . . 1.47 110.12 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -150.39 157.49 36.78 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.207 -1.035 . . . . 1.3999999999999999 108.207 168.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.12 143.99 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.337 2.692 . . . . 0.88 112.798 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.957 ' HD3' HD11 ' A' ' 33' ' ' LEU . 15.0 Cg_exo -50.1 143.13 25.95 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.53000000000000003 113.021 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.22 104.54 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.108 -2.182 . . . . 0.77000000000000002 105.108 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.609 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -113.09 114.88 48.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.995 -1.457 . . . . 0.28000000000000003 107.799 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.914 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.11 131.6 51.22 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.161 -1.382 . . . . 1.54 109.418 173.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.067 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.8 m95 -91.92 149.32 21.62 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.221 -2.263 . . . . 0.34000000000000002 112.099 172.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.728 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 28.0 t80 -130.59 138.33 50.08 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.671 -2.344 . . . . 0.62 104.671 170.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.904 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 83.1 tttt -98.41 174.07 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.375 -1.713 . . . . 2.1699999999999999 106.375 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -18.84 -169.64 0.0 OUTLIER Glycine 0 C--O 1.179 -3.299 0 C-N-CA 125.991 1.758 . . . . 1.23 117.282 166.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 6.7 mtpp -41.34 -14.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.846 2.536 . . . . 3.8700000000000001 117.846 -160.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' GLY . 26.5 p-90 -162.46 -6.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.639 1.563 . . . . 2.1099999999999999 114.891 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.904 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.97 143.74 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-O 122.827 1.299 . . . . 1.29 111.791 -163.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -105.89 107.1 17.92 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 112.181 -2.281 . . . . 2.73 109.9 175.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.067 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.0 mp -54.65 -42.87 71.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 112.628 0.603 . . . . 0.44 112.628 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -61.48 -19.07 61.63 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.649 -0.871 . . . . 1.23 108.649 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -86.88 -27.25 23.53 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.023 -0.989 . . . . 1.3400000000000001 110.956 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 12.1 mmmt -102.9 -64.32 1.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.948 . . . . 1.3999999999999999 111.847 -171.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 49' ' ' LEU . 49.3 t 3.72 92.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.743 2.017 . . . . 0.37 113.802 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -157.42 -130.17 1.19 Allowed Glycine 0 CA--C 1.525 0.676 0 CA-C-N 112.803 -1.999 . . . . 0.69999999999999996 112.597 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.26 -38.11 89.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.549 0.944 . . . . 2.75 113.549 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 28.2 p80 -91.21 -31.52 16.13 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.776 0.798 . . . . 1.3300000000000001 111.669 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.009 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.89 105.39 7.09 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.955 -1.498 . . . . 1.1100000000000001 106.955 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -97.2 114.75 26.5 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 106.364 -1.717 . . . . 0.76000000000000001 106.364 166.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.63 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.64 92.54 4.68 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.259 -2.497 . . . . 0.26000000000000001 104.259 170.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 88.7 m-70 -97.35 160.54 14.27 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 115.009 -0.996 . . . . 2.0299999999999998 109.348 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.88 112.13 12.18 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.768 -2.015 . . . . 0.92000000000000004 109.537 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 71' ' ' LEU . 1.3 m -106.51 151.1 25.42 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 112.47 -2.15 . . . . 0.46999999999999997 107.156 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 17.2 p90 -144.32 115.64 8.02 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-O 122.01 0.909 . . . . 1.3899999999999999 111.196 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -94.95 96.23 9.16 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.285 -1.325 . . . . 2.4199999999999999 107.957 169.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -71.78 -30.5 65.63 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.699 -1.591 . . . . 2.46 111.674 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.22 73.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.487 -0.779 . . . . 1.1499999999999999 110.234 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.441 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 m -89.62 -12.13 40.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.337 -0.847 . . . . 1.4099999999999999 109.057 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.848 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 1.7 ttpm? 66.03 35.28 6.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.519 -1.219 . . . . 3.3100000000000001 109.743 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.604 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.7 t -125.81 136.85 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.455 0.645 . . . . 0.42999999999999999 110.899 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.39 123.19 43.45 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.904 -1.517 . . . . 1.24 106.904 158.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 62' ' ' SER . 18.0 tp -105.95 104.63 14.38 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.793 -1.094 . . . . 0.52000000000000002 108.114 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.2 m-85 -85.71 115.59 23.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.806 -1.543 . . . . 0.33000000000000002 107.663 173.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.11 121.8 45.21 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.96 -1.473 . . . . 1.3200000000000001 109.503 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.832 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.104 -1.407 . . . . 0.95999999999999996 108.356 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 70.8 m80 -110.01 95.05 5.34 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 104.811 -2.292 . . . . 1.1499999999999999 104.811 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.74 HD13 ' HE2' ' A' ' 87' ' ' TYR . 63.9 mt -121.51 99.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 122.825 1.297 . . . . 0.52000000000000002 109.353 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.4 p -104.11 168.73 8.92 Favored 'General case' 0 N--CA 1.394 -3.266 0 CA-C-N 114.359 -1.292 . . . . 0.57999999999999996 110.569 -173.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 39.33 67.89 0.41 Allowed 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 110.473 -3.058 . . . . 2.1200000000000001 111.461 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.447 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -58.51 116.43 3.65 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 112.445 -2.162 . . . . 0.40000000000000002 110.547 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.819 HE21 ' HD2' ' A' ' 81' ' ' PRO . 1.3 tp60 -54.94 139.4 63.09 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.31 -0.859 . . . . 1.4299999999999999 109.778 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HD2' HE21 ' A' ' 80' ' ' GLN . 24.0 Cg_exo -61.23 -12.49 23.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.56 2.173 . . . . 1.3300000000000001 112.863 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.525 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -103.15 14.34 31.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 1.1200000000000001 110.795 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -89.73 -15.28 32.86 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.762 -0.637 . . . . 1.24 111.182 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.1 m -41.07 87.97 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 124.947 1.405 . . . . 1.22 111.211 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -157.51 -137.98 2.4 Favored Glycine 0 C--N 1.28 -2.544 0 CA-C-N 113.098 -1.864 . . . . 1.4299999999999999 112.835 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.11 119.22 0.91 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.974 -1.584 . . . . 0.52000000000000002 113.418 -167.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.83 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.8 m-85 -82.66 114.42 21.01 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 112.952 -1.624 . . . . 0.63 108.47 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 11.0 mmm180 -103.98 104.52 14.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.455 -0.339 . . . . 3.1499999999999999 110.181 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.678 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 3.8 t -94.94 123.62 38.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.14 -0.689 . . . . 1.0800000000000001 109.14 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.914 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 66.1 mt-10 -136.67 107.79 6.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.135 -0.939 . . . . 1.8100000000000001 110.271 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -99.78 141.6 16.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.533 0.682 . . . . 0.54000000000000004 110.388 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -141.24 109.29 5.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.821 -1.081 . . . . 1.1799999999999999 108.623 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.706 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -134.5 150.65 50.81 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 117.885 -1.055 . . . . 0.73999999999999999 109.477 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.886 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 29.54 -73.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.673 1.858 . . . . 0.65000000000000002 114.693 177.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.886 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 11.1 t0 -152.13 -4.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.492 -1.231 . . . . 1.05 110.056 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.761 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -92.27 125.72 37.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.765 -1.198 . . . . 1.29 107.765 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -129.56 140.92 51.09 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.109 -0.95 . . . . 0.77000000000000002 110.974 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -168.46 156.92 8.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.354 -0.839 . . . . 1.6000000000000001 109.769 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 m -150.32 145.23 26.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.276 0.56 . . . . 1.1899999999999999 110.098 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.845 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 26.8 p -125.2 134.71 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.616 -0.72 . . . . 0.83999999999999997 110.668 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.2 117.46 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.484 0.659 . . . . 1.5800000000000001 110.97 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.845 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -141.0 124.83 17.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.643 -0.708 . . . . 0.85999999999999999 109.658 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.599 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 78.8 m-20 -100.16 153.22 19.42 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 122.31 1.052 . . . . 2.1099999999999999 111.553 -170.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -117.02 115.37 25.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.531 -1.213 . . . . 0.37 107.943 173.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.514 ' HA ' HG23 ' A' ' 84' ' ' THR . 7.5 m -100.64 95.9 6.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.399 -0.963 . . . . 0.33000000000000002 108.399 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.722 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.61 117.18 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.254 1.502 . . . . 0.33000000000000002 108.942 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.447 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 33.4 m170 -87.72 100.17 12.63 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.47 -2.15 . . . . 1.1899999999999999 108.442 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 49.0 tt0 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 114.852 -1.067 . . . . 1.6699999999999999 110.275 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.646 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.435 -1.214 0 CA-C-O 119.555 -0.259 . . . . 1.6499999999999999 110.371 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 60.2 Cg_endo -73.29 36.32 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.649 2.233 . . . . 0.96999999999999997 113.791 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.79 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -57.6 -60.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.091 -0.959 . . . . 0.5 109.904 170.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 88.7 45.86 4.75 Favored Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 109.248 -1.541 . . . . 0.39000000000000001 109.248 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.985 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.1 tp -46.59 -43.86 17.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.288 -1.456 . . . . 0.33000000000000002 110.502 -173.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.74 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.34 84.85 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.998 0.904 . . . . 0.71999999999999997 110.483 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.51 -47.3 52.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.03 -1.441 . . . . 0.63 109.612 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.539 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 16.6 tpt -152.7 133.21 13.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.372 -0.831 . . . . 2.8799999999999999 109.087 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.611 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -101.09 136.51 19.7 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.771 -0.649 . . . . 3.6699999999999999 110.637 -177.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.761 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.6 Cg_endo -63.41 155.29 63.17 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.2 1.934 . . . . 0.64000000000000001 111.057 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.406 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.8 mm-40 -119.96 174.31 6.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.124 -0.489 . . . . 1.4299999999999999 110.735 -174.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.4 p-10 -68.49 -142.66 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 122.738 1.256 . . . . 2.0600000000000001 111.807 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 146.55 137.4 3.02 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.317 -1.765 . . . . 0.29999999999999999 111.811 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 40.9 mt-10 -109.71 116.08 31.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.337 -0.932 . . . . 1.53 108.529 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -138.29 153.78 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.727 -1.212 . . . . 0.27000000000000002 107.727 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -84.14 156.4 22.13 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.687 -1.142 . . . . 0.77000000000000002 109.474 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.753 HG11 ' HD3' ' A' ' 81' ' ' PRO . 9.1 t -68.9 105.63 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 123.313 1.53 . . . . 0.78000000000000003 107.629 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.39 15.2 7.16 Favored Glycine 0 C--N 1.264 -3.437 0 CA-C-N 111.926 -2.397 . . . . 0.47999999999999998 112.342 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.58 -123.18 4.59 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.179 -1.486 . . . . 0.44 109.477 167.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 58.6 m -154.47 173.23 16.55 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 113.087 -1.556 . . . . 0.81999999999999995 108.646 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.64 HG21 HD13 ' A' ' 104' ' ' LEU . 10.3 tp -149.11 150.58 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 N-CA-C 107.127 -1.434 . . . . 0.32000000000000001 107.127 167.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.431 ' N ' HG13 ' A' ' 22' ' ' ILE . 8.6 m -137.7 123.86 20.42 Favored 'General case' 0 C--N 1.262 -3.238 0 CA-C-N 113.636 -1.62 . . . . 0.31 110.336 -177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 36.7 m-85 -117.84 147.83 42.69 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.906 -1.497 . . . . 0.53000000000000003 108.38 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -140.23 122.24 15.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.272 -0.876 . . . . 0.57999999999999996 109.574 176.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -116.35 115.84 26.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.873 -1.058 . . . . 0.32000000000000001 109.903 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -102.74 111.6 24.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.247 -0.433 . . . . 2.4300000000000002 110.283 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 91' ' ' VAL . 19.0 t -115.53 126.62 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-O 121.988 0.899 . . . . 0.26000000000000001 110.185 -178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 104.33 1.04 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.564 -1.653 . . . . 0.40000000000000002 110.378 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.783 ' HA3' ' NZ ' ' A' ' 68' ' ' LYS . . . -51.94 -66.95 2.27 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.163 -1.38 . . . . 0.76000000000000001 112.031 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.758 ' H ' ' HB3' ' A' ' 68' ' ' LYS . . . 60.34 -167.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.762 0.825 . . . . 0.70999999999999996 111.96 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -106.57 144.12 33.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 1.74 109.833 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.39 -172.14 3.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.44 0.638 . . . . 2.1600000000000001 112.465 -169.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.41 -44.36 17.64 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 1.47 108.895 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.592 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 1.3 pptp? -142.36 142.39 23.66 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.321 -0.854 . . . . 1.3999999999999999 108.855 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.91 146.46 4.08 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.183 2.588 . . . . 0.88 112.43 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_endo -54.9 128.4 30.33 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 120.952 1.101 . . . . 0.53000000000000003 111.877 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.84 103.96 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 106.774 -1.565 . . . . 0.77000000000000002 106.774 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.8 t -105.83 114.51 45.4 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 113.56 -1.654 . . . . 0.28000000000000003 107.436 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.59 128.87 54.91 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-O 123.221 1.486 . . . . 1.54 109.81 176.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.023 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -90.31 152.53 20.99 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 112.138 -2.301 . . . . 0.34000000000000002 111.96 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 32.8 t80 -128.02 130.75 48.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.556 -2.016 . . . . 0.62 105.556 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 tttm -107.85 102.31 11.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.878 -1.156 . . . . 2.1699999999999999 107.878 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -90.9 100.11 2.65 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 116.632 -2.699 . . . . 1.23 116.88 -161.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.4 pttm -102.6 -41.18 6.34 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 103.925 -2.621 . . . . 3.8700000000000001 103.925 123.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.639 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.8 p-90 -171.09 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 112.667 -2.06 . . . . 2.1099999999999999 112.48 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.92 173.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-O 123.28 1.514 . . . . 1.29 112.614 -163.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.613 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.1 p-10 -96.57 161.29 13.96 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.413 -2.63 . . . . 2.73 106.887 170.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.023 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -97.43 -31.36 12.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 119.02 -0.514 . . . . 0.44 112.0 167.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -56.89 -21.8 32.36 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 123.585 0.553 . . . . 1.23 109.733 -161.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.604 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -100.79 -26.43 13.78 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.384 -0.926 . . . . 1.3400000000000001 112.116 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.615 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.76 -27.12 14.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.496 -1.229 . . . . 1.3999999999999999 111.537 -167.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.974 HG13 ' H ' ' A' ' 59' ' ' LEU . 74.6 t -37.18 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.53 1.532 . . . . 0.37 110.953 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.05 -105.14 0.23 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 112.803 -1.999 . . . . 0.69999999999999996 114.015 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -83.95 -45.01 13.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.206 0.447 . . . . 2.75 112.206 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.579 ' HE1' ' HE3' ' A' ' 43' ' ' LYS . 19.9 p80 -91.44 -36.83 13.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.653 . . . . 1.3300000000000001 111.14 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.977 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.58 106.71 12.03 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.051 -1.463 . . . . 1.1100000000000001 107.051 176.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.565 ' HB3' ' HD2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -96.98 114.41 26.02 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 106.811 -1.551 . . . . 0.76000000000000001 106.811 164.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.974 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.9 92.3 4.52 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 104.687 -2.338 . . . . 0.26000000000000001 104.687 170.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.64 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 22.9 m-70 -100.34 163.83 12.21 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.463 1.125 . . . . 2.0299999999999998 109.473 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.84 112.92 12.89 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 112.113 -2.312 . . . . 0.92000000000000004 109.817 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 4.7 m -94.95 150.03 20.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.729 -2.032 . . . . 0.46999999999999997 108.289 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -144.38 107.76 4.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.354 1.073 . . . . 1.3899999999999999 111.323 -170.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.11 122.54 47.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.887 -1.96 . . . . 2.4199999999999999 108.913 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.65 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -79.35 -29.59 42.28 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.349 -1.296 . . . . 2.46 111.66 -177.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.31 33.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.072 -0.513 . . . . 1.1499999999999999 110.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 69' ' ' VAL . 25.7 m -124.48 4.15 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.75 -0.659 . . . . 1.4099999999999999 111.245 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.783 ' NZ ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.81 7.8 3.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.611 0.764 . . . . 3.3100000000000001 112.318 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 67' ' ' SER . 46.0 t -76.18 117.67 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 CA-C-O 122.407 1.099 . . . . 0.42999999999999999 110.223 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' A' ' 37' ' ' PRO . 81.4 m-85 -90.07 100.51 13.32 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.663 -2.062 . . . . 1.24 106.312 165.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.9 tp -93.25 103.56 15.8 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.523 1.154 . . . . 0.52000000000000002 108.026 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.0 m-85 -81.78 113.91 20.06 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 113.321 -1.763 . . . . 0.33000000000000002 107.716 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.434 ' CG ' ' HG ' ' A' ' 71' ' ' LEU . 51.7 mt-10 -107.32 121.21 44.12 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.328 -1.76 . . . . 1.3200000000000001 109.037 -175.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.724 HD21 ' CH2' ' A' ' 41' ' ' TRP . 1.4 mm? -98.45 117.02 31.94 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 112.936 -1.938 . . . . 0.95999999999999996 108.079 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -110.96 95.23 5.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 105.175 -2.157 . . . . 1.1499999999999999 105.175 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.644 HG12 HD23 ' A' ' 57' ' ' LEU . 54.5 mt -121.53 99.5 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 113.842 -1.526 . . . . 0.52000000000000002 106.923 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 35.8 p -106.19 167.08 10.05 Favored 'General case' 0 N--CA 1.394 -3.271 0 CA-C-N 114.197 -1.365 . . . . 0.57999999999999996 109.778 -171.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 40.51 59.35 2.13 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 111.544 -2.571 . . . . 2.1200000000000001 111.34 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -51.0 123.35 9.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.405 -1.725 . . . . 0.40000000000000002 109.509 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.564 ' HA ' HG13 ' A' ' 18' ' ' VAL . 1.7 pt20 -78.54 156.13 78.34 Favored Pre-proline 0 C--N 1.311 -1.076 0 N-CA-C 108.033 -1.099 . . . . 1.4299999999999999 108.033 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.753 ' HD3' HG11 ' A' ' 18' ' ' VAL . 50.8 Cg_endo -68.75 162.72 40.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.005 1.137 . . . . 1.3300000000000001 109.975 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . 70.74 14.43 7.09 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.616 0.572 . . . . 1.1200000000000001 111.705 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -80.45 -54.92 5.25 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.303 -0.999 . . . . 1.24 108.303 168.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.2 m 36.6 57.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.429 -1.323 . . . . 1.22 107.429 -160.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.672 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -48.73 85.17 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.004 0 CA-C-N 111.56 -2.563 . . . . 1.4299999999999999 114.788 -161.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.487 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -90.79 78.29 1.44 Allowed Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 108.957 -1.657 . . . . 0.52000000000000002 108.957 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.687 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 49.0 m-85 -80.71 122.76 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.769 -1.567 . . . . 0.63 106.769 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -115.53 107.64 15.42 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.472 -0.491 . . . . 3.1499999999999999 109.677 -171.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -92.06 131.37 37.39 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.766 -0.652 . . . . 1.0800000000000001 109.7 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.947 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 44.4 tt0 -139.77 110.63 6.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.407 -0.815 . . . . 1.8100000000000001 109.5 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 p -102.0 137.82 28.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.656 0.741 . . . . 0.54000000000000004 110.534 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.7 t -132.1 108.76 9.51 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.636 -1.165 . . . . 1.1799999999999999 108.732 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.523 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.2 m -123.47 167.34 14.0 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.031 -1.1 . . . . 0.73999999999999999 108.031 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.938 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -4.6 -61.26 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 125.316 1.635 . . . . 0.65000000000000002 114.926 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.938 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -147.76 -10.75 0.4 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.035 -0.984 . . . . 1.05 111.211 -174.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.985 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.2 tttp -94.31 134.89 36.33 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 119.133 -1.027 . . . . 1.29 108.23 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.16 135.47 46.39 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 0.77000000000000002 110.846 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -155.6 147.84 23.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.141 -0.936 . . . . 1.6000000000000001 109.925 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.461 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 33.2 m -141.94 150.68 41.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.535 0.207 . . . . 1.1899999999999999 110.674 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.74 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 78.4 p -134.86 132.62 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.427 . . . . 0.83999999999999997 111.279 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 122.56 47.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.646 -0.707 . . . . 1.5800000000000001 110.676 176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.779 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 5.0 p90 -142.63 129.48 20.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 0.85999999999999999 109.416 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 71.7 m-20 -108.7 135.27 50.21 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.417 1.103 . . . . 2.1099999999999999 111.783 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.49 105.51 15.78 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.102 -1.408 . . . . 0.37 110.448 178.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.446 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 10.4 m -84.12 97.34 9.29 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.732 -0.84 . . . . 0.33000000000000002 108.732 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 18' ' ' VAL . 7.6 p -84.94 115.53 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 123.236 1.494 . . . . 0.33000000000000002 110.087 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 78.1 m-70 -88.79 100.68 13.34 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.368 -2.196 . . . . 1.1899999999999999 109.394 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.616 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.7 tt0 . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 114.208 -1.36 . . . . 1.6699999999999999 110.594 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.566 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 108.435 -0.95 . . . . 1.6499999999999999 108.435 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -41.34 94.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 124.656 3.571 . . . . 0.96999999999999997 114.809 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 6' ' ' LEU . 1.3 mp -126.25 -61.1 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.031 -0.986 . . . . 0.5 109.58 172.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 91.11 52.81 2.31 Favored Glycine 0 CA--C 1.496 -1.142 0 N-CA-C 108.685 -1.766 . . . . 0.39000000000000001 108.685 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.041 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.3 tp -59.77 -40.71 89.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.225 -1.487 . . . . 0.33000000000000002 110.191 -169.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.51 5.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.99 -1.005 . . . . 0.71999999999999997 109.881 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.82 -47.25 33.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.419 -1.264 . . . . 0.63 109.641 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.551 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 17.2 tpt -147.48 129.96 15.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.199 -0.909 . . . . 2.8799999999999999 109.398 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -106.78 132.46 20.89 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.549 -0.75 . . . . 3.6699999999999999 110.398 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.682 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 17.4 Cg_endo -66.53 153.59 77.42 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.369 2.046 . . . . 0.64000000000000001 111.372 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.433 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.5 mm-40 -121.14 176.93 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.228 -0.442 . . . . 1.4299999999999999 110.327 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.5 p30 -68.03 -148.56 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.384 0 CA-C-O 122.776 1.275 . . . . 2.0600000000000001 111.237 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.476 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 153.4 138.74 2.73 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 113.44 -1.709 . . . . 0.29999999999999999 111.745 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 29.2 mt-10 -117.47 113.09 21.53 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.297 -0.951 . . . . 1.53 109.029 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 104' ' ' LEU . 2.5 m -132.82 163.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.929 -1.508 . . . . 0.27000000000000002 106.929 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -94.32 157.74 15.9 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.538 -0.755 . . . . 0.77000000000000002 109.836 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 106' ' ' VAL . 2.9 t -67.89 106.35 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 107.679 -1.23 . . . . 0.78000000000000003 107.679 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.46 7.57 8.95 Favored Glycine 0 C--N 1.263 -3.507 0 CA-C-N 112.657 -2.065 . . . . 0.47999999999999998 112.194 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.51 -125.04 5.02 Favored Glycine 0 N--CA 1.409 -3.154 0 C-N-CA 119.181 -1.485 . . . . 0.44 109.714 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.2 p -152.74 167.87 27.54 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.127 -1.537 . . . . 0.81999999999999995 110.372 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 76' ' ' ILE . 10.4 tp -147.62 149.67 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-N 113.637 -1.619 . . . . 0.32000000000000001 107.652 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -139.3 127.24 22.24 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 113.711 -1.586 . . . . 0.31 110.344 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 76' ' ' ILE . 42.0 m-85 -123.71 147.18 47.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.516 -1.22 . . . . 0.53000000000000003 108.812 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.19 122.59 19.49 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.179 -0.919 . . . . 0.57999999999999996 109.671 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.676 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -119.03 115.64 24.74 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.593 -1.185 . . . . 0.32000000000000001 110.226 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -106.71 117.62 34.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.043 -0.526 . . . . 2.4300000000000002 110.394 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 39' ' ' VAL . 6.3 t -122.27 128.93 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.208 1.004 . . . . 0.26000000000000001 110.739 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -60.0 110.04 1.1 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.128 -1.851 . . . . 0.40000000000000002 112.352 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.18 81.43 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 114.897 -1.047 . . . . 0.76000000000000001 112.463 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.863 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 58.3 -179.07 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.522 1.304 . . . . 0.70999999999999996 114.522 168.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -101.11 23.81 10.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.525 -1.216 . . . . 1.74 109.809 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.034 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -57.05 175.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.52 -1.218 . . . . 2.1600000000000001 113.855 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.2 tp -64.73 -56.83 11.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.315 -0.857 . . . . 1.47 109.773 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.709 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.76 143.26 48.63 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.93 -1.032 . . . . 1.3999999999999999 108.642 176.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.18 140.25 11.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.606 2.204 . . . . 0.88 110.638 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.034 ' HD3' HD11 ' A' ' 33' ' ' LEU . 1.6 Cg_endo -58.94 135.29 65.73 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.325 0.683 . . . . 0.53000000000000003 112.121 -171.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 92' ' ' SER . 14.1 p -99.71 104.81 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-O 123.724 1.726 . . . . 0.77000000000000002 107.97 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 28' ' ' VAL . 2.1 t -105.67 114.82 46.07 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 111.892 -2.413 . . . . 0.28000000000000003 107.592 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.798 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.03 126.1 47.69 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 122.939 1.352 . . . . 1.54 109.051 174.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.952 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.0 m95 -84.46 152.54 23.92 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 112.308 -2.224 . . . . 0.34000000000000002 112.112 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -129.31 139.61 51.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.378 -2.452 . . . . 0.62 104.378 172.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 38.3 tttt -107.13 165.03 11.66 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.399 -1.334 . . . . 2.1699999999999999 107.399 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 1.032 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -7.63 -165.43 0.0 OUTLIER Glycine 0 C--O 1.197 -2.184 0 N-CA-C 118.963 2.345 . . . . 1.23 118.963 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG3' ' HB ' ' A' ' 84' ' ' THR . 10.5 mtpp -43.06 -3.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.249 1.944 . . . . 3.8700000000000001 116.249 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.585 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 20.6 p-90 -172.12 -13.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.287 1.588 . . . . 2.1099999999999999 115.287 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.02 169.09 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 123.297 1.522 . . . . 1.29 112.344 -160.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.51 154.7 23.3 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.1 -2.318 . . . . 2.73 107.942 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.8 mp -94.4 -32.61 13.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.936 0.717 . . . . 0.44 112.936 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -58.05 -25.58 61.38 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.301 0.572 . . . . 1.23 109.5 -164.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -104.13 -41.57 5.78 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.299 -0.864 . . . . 1.3400000000000001 113.069 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 5.9 mptt -67.02 -52.39 43.07 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.011 -0.995 . . . . 1.3999999999999999 111.864 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.961 HG13 ' H ' ' A' ' 59' ' ' LEU . 11.9 t -23.85 100.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 111.38 -2.645 . . . . 0.37 113.512 175.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -166.11 -129.72 1.08 Allowed Glycine 0 C--N 1.299 -1.504 0 CA-C-N 110.561 -3.018 . . . . 0.69999999999999996 112.154 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -56.47 -37.01 69.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.465 0.913 . . . . 2.75 113.465 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.667 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.5 p80 -95.07 -38.88 10.42 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.267 0.469 . . . . 1.3300000000000001 112.267 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.875 ' HB2' HG12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.97 107.76 8.9 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.015 -0.735 . . . . 1.1100000000000001 109.015 173.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.41 116.25 28.8 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.14 -1.43 . . . . 0.76000000000000001 107.14 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.961 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -90.51 93.32 9.24 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.044 -2.206 . . . . 0.26000000000000001 105.044 171.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.57 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -86.02 163.03 18.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-O 122.96 1.362 . . . . 2.0299999999999998 109.382 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -141.38 118.91 11.58 Favored 'General case' 0 C--N 1.259 -3.339 0 CA-C-N 111.332 -2.667 . . . . 0.92000000000000004 109.585 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.7 m -103.39 148.95 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.777 -2.011 . . . . 0.46999999999999997 107.99 172.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.452 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 13.2 t80 -142.33 97.29 3.1 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.439 1.114 . . . . 1.3899999999999999 110.821 -176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -117.6 118.22 31.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.786 -1.552 . . . . 2.4199999999999999 109.911 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -36.33 25.02 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.557 -1.656 . . . . 2.46 111.554 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.23 67.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.432 -0.803 . . . . 1.1499999999999999 110.912 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -96.55 -19.42 19.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.391 -0.966 . . . . 1.4099999999999999 108.391 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.837 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 11.4 ttpt 67.08 32.54 6.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.961 -1.472 . . . . 3.3100000000000001 110.427 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -128.07 126.63 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.761 0.791 . . . . 0.42999999999999999 110.311 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.578 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.3 m-30 -99.17 108.81 21.5 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.119 -1.808 . . . . 1.24 106.119 166.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HG ' ' HG2' ' A' ' 73' ' ' GLU . 14.3 tp -98.25 105.74 17.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.522 1.153 . . . . 0.52000000000000002 109.142 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.0 m-85 -85.45 113.52 21.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 113.322 -1.763 . . . . 0.33000000000000002 107.905 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 9.6 mt-10 -107.56 121.2 44.16 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.465 -1.698 . . . . 1.3200000000000001 110.044 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.844 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -91.08 126.66 36.23 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.462 -1.244 . . . . 0.95999999999999996 107.849 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 78.7 m80 -117.06 95.32 4.94 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 104.569 -2.382 . . . . 1.1499999999999999 104.569 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.875 HG12 ' HB2' ' A' ' 57' ' ' LEU . 25.4 mt -121.85 100.47 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-O 122.74 1.257 . . . . 0.52000000000000002 109.066 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.3 p -111.86 161.13 16.7 Favored 'General case' 0 N--CA 1.395 -3.224 0 CA-C-N 114.569 -1.196 . . . . 0.57999999999999996 109.572 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 48.35 57.75 5.88 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 111.271 -2.695 . . . . 2.1200000000000001 110.611 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -52.62 119.81 4.96 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.824 -1.989 . . . . 0.40000000000000002 110.608 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.772 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -60.15 143.84 88.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.461 -0.791 . . . . 1.4299999999999999 109.306 173.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.772 ' HD2' HE21 ' A' ' 80' ' ' GLN . 31.7 Cg_endo -63.54 -3.32 5.22 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.286 1.99 . . . . 1.3300000000000001 112.564 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -115.17 15.73 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.566 . . . . 1.1200000000000001 110.131 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.8 m-30 -94.53 -8.7 37.54 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 118.838 -0.601 . . . . 1.24 110.181 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 15.6 m -19.1 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 125.788 1.93 . . . . 1.22 111.529 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.87 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -37.12 110.83 0.1 Allowed Glycine 0 CA--C 1.473 -2.579 0 CA-C-N 110.062 -3.245 . . . . 1.4299999999999999 114.584 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 1.032 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -127.45 60.08 0.67 Allowed Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 108.277 -1.929 . . . . 0.52000000000000002 108.277 157.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 80.7 m-85 -80.2 126.78 31.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.07 -1.065 . . . . 0.63 108.555 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 22.4 ttm180 -130.83 121.11 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.951 -0.468 . . . . 3.1499999999999999 110.274 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.54 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -98.53 120.61 39.25 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.587 -0.523 . . . . 1.0800000000000001 109.587 176.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.798 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.8 mt-10 -121.56 105.44 10.45 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.189 -0.671 . . . . 1.8100000000000001 109.189 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.4 p -96.07 137.17 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.356 0.598 . . . . 0.54000000000000004 110.384 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.69 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.0 t -130.09 110.65 11.78 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.875 -1.057 . . . . 1.1799999999999999 109.146 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.89 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -129.06 173.63 10.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.877 -0.602 . . . . 0.73999999999999999 110.17 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.9 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.96 -62.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.243 1.59 . . . . 0.65000000000000002 114.474 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.9 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.9 t70 -154.24 -0.57 0.2 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.384 -1.28 . . . . 1.05 109.289 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.041 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -93.36 128.25 39.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.001 -1.111 . . . . 1.29 108.001 -177.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -130.73 130.71 44.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.756 -1.111 . . . . 0.77000000000000002 110.831 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.96 151.22 35.44 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.402 -1.272 . . . . 1.6000000000000001 109.02 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 9.5 p -151.13 146.59 26.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.133 0.492 . . . . 1.1899999999999999 111.294 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.48 146.45 50.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.479 -0.782 . . . . 0.83999999999999997 111.593 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.24 119.0 22.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.69 -1.141 . . . . 1.5800000000000001 109.477 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.815 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 6.7 p90 -143.1 128.73 19.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.344 0.592 . . . . 0.85999999999999999 110.153 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 41.8 m-20 -102.45 135.48 44.0 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.22 1.009 . . . . 2.1099999999999999 110.999 -172.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.87 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -105.46 107.34 18.27 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.046 -1.434 . . . . 0.37 108.856 174.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 9.0 m -87.94 95.08 9.98 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.163 -1.015 . . . . 0.33000000000000002 108.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 18' ' ' VAL . 3.3 p -76.69 112.51 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 122.948 1.356 . . . . 0.33000000000000002 107.768 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 66.4 m170 -82.03 97.66 8.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.902 -1.954 . . . . 1.1899999999999999 108.623 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HA ' HG23 ' A' ' 18' ' ' VAL . 39.2 tt0 . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.376 -1.342 . . . . 1.6699999999999999 107.376 166.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.479 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 8.0 m-20 . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 111.625 0.232 . . . . 1.6499999999999999 111.625 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -70.51 69.04 2.09 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.579 2.186 . . . . 0.96999999999999997 112.534 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.054 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -88.12 -63.82 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.8 -1.091 . . . . 0.5 108.729 171.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.917 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 91.72 43.2 4.57 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.588 -1.805 . . . . 0.39000000000000001 108.588 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.854 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.0 tp -52.77 -39.59 62.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.827 -1.687 . . . . 0.33000000000000002 110.389 -171.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.745 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.95 83.41 5.65 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.162 -0.926 . . . . 0.71999999999999997 109.816 177.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.31 -43.03 74.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.565 -1.198 . . . . 0.63 108.835 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.36 135.67 15.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.123 -0.944 . . . . 2.8799999999999999 109.571 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -113.92 136.43 22.12 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.0 -0.741 . . . . 3.6699999999999999 109.0 176.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -71.58 160.08 49.34 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.437 1.425 . . . . 0.64000000000000001 110.646 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.38 -177.78 3.53 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.75 -0.659 . . . . 1.4299999999999999 109.498 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.9 p-10 -69.67 -151.08 0.02 OUTLIER 'General case' 0 N--CA 1.405 -2.721 0 CA-C-O 123.166 1.46 . . . . 2.0600000000000001 111.939 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.453 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.04 134.86 2.01 Favored Glycine 0 C--N 1.293 -1.811 0 CA-C-N 112.824 -1.989 . . . . 0.29999999999999999 112.036 -174.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 32.4 mt-10 -112.49 112.35 23.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.154 -1.023 . . . . 1.53 108.48 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.0 m -130.76 163.99 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 108.005 -1.109 . . . . 0.27000000000000002 108.005 -171.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -90.97 152.84 20.54 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.279 -1.328 . . . . 0.77000000000000002 109.256 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.603 HG23 ' HA ' ' A' ' 108' ' ' GLU . 21.8 t -69.4 106.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 CA-C-O 122.796 1.284 . . . . 0.78000000000000003 107.663 172.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.8 11.57 7.02 Favored Glycine 0 C--N 1.263 -3.52 0 CA-C-N 111.9 -2.409 . . . . 0.47999999999999998 112.717 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.38 -121.84 4.96 Favored Glycine 0 CA--C 1.472 -2.614 0 C-N-CA 118.893 -1.622 . . . . 0.44 110.419 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.9 p -152.49 172.03 17.17 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 112.614 -1.793 . . . . 0.81999999999999995 110.322 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.612 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.3 tp -148.37 149.61 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 113.022 -1.899 . . . . 0.32000000000000001 106.185 169.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m -137.89 124.99 21.49 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 114.411 -1.268 . . . . 0.31 111.235 -173.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.94 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.9 m-85 -119.55 139.85 51.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.921 -1.49 . . . . 0.53000000000000003 109.525 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.126 -0.943 . . . . 0.57999999999999996 108.75 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -122.14 115.98 23.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.374 -1.284 . . . . 0.32000000000000001 110.261 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HG2' HD13 ' A' ' 71' ' ' LEU . 66.1 mtp180 -111.41 122.5 48.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.649 -0.251 . . . . 2.4300000000000002 110.46 -174.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 91' ' ' VAL . 15.7 t -121.18 128.11 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.012 0.91 . . . . 0.26000000000000001 110.394 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.745 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.38 109.39 1.34 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.285 -1.779 . . . . 0.40000000000000002 110.486 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.65 -42.19 35.68 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.106 -0.952 . . . . 0.76000000000000001 111.68 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 57.41 -166.55 0.14 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.039 0.755 . . . . 0.70999999999999996 113.039 172.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 p -113.23 110.72 20.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.08 -0.964 . . . . 1.74 108.648 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.064 HD13 ' H ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -148.34 158.36 44.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.145 -0.479 . . . . 2.1600000000000001 110.289 -171.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.721 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.9 mt -47.13 -37.93 10.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.053 1.406 . . . . 1.47 111.501 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.777 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.99 -178.83 0.86 Allowed Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 111.933 -2.394 . . . . 1.3999999999999999 107.809 -170.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.65 145.61 20.63 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.198 -1.886 . . . . 0.88 107.198 162.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.711 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 16.6 Cg_exo -58.18 129.56 33.56 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 CA-C-N 119.49 0.854 . . . . 0.53000000000000003 110.606 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.23 102.3 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 122.781 1.277 . . . . 0.77000000000000002 107.657 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -104.88 115.8 47.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 112.427 -2.17 . . . . 0.28000000000000003 108.023 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.92 130.83 54.52 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.108 1.432 . . . . 1.54 109.757 173.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.039 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.7 m95 -86.59 152.47 22.58 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.103 -2.317 . . . . 0.34000000000000002 112.746 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.9 t80 -131.18 136.71 48.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.239 -2.134 . . . . 0.62 105.239 170.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.756 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 80.3 tttt -102.84 166.53 10.42 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.712 -1.588 . . . . 2.1699999999999999 106.712 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.737 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.72 -168.22 0.0 OUTLIER Glycine 0 C--O 1.187 -2.8 0 N-CA-C 119.549 2.58 . . . . 1.23 119.549 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.495 ' CD ' ' HB ' ' A' ' 84' ' ' THR . 16.6 mtpt -44.97 -1.31 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.549 -2.147 . . . . 3.8700000000000001 116.384 -167.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.64 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.6 p-90 -167.7 -11.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.765 1.395 . . . . 2.1099999999999999 114.765 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.23 168.04 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 CA-C-O 123.459 1.6 . . . . 1.29 112.816 -159.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.5 t70 -112.28 155.43 24.08 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 111.549 -2.569 . . . . 2.73 105.937 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.039 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.4 mp -94.08 -36.34 12.14 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.579 0.955 . . . . 0.44 113.579 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 t -58.72 -21.23 54.55 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.2 -0.667 . . . . 1.23 109.2 -165.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -96.13 -27.57 14.99 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.022 -0.99 . . . . 1.3400000000000001 113.419 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 16.7 mmmt -100.75 -32.6 10.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.033 0.444 . . . . 1.3999999999999999 111.566 -170.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.743 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 27.0 t -35.11 97.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 125.817 1.647 . . . . 0.37 111.94 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.48 -146.2 4.43 Favored Glycine 0 C--O 1.213 -1.212 0 CA-C-N 111.604 -2.544 . . . . 0.69999999999999996 110.309 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.523 ' C ' HE22 ' A' ' 58' ' ' GLN . 41.7 tt0 -71.37 -2.0 14.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.943 0.872 . . . . 2.75 112.916 -170.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 21.8 p80 -114.29 -33.38 5.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.87 0.843 . . . . 1.3300000000000001 111.064 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.008 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -133.3 105.18 6.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.706 -1.961 . . . . 1.1100000000000001 105.706 171.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.86 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -99.28 114.49 27.35 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.073 -1.825 . . . . 0.76000000000000001 106.073 171.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.726 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -97.2 92.81 6.2 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.901 -2.259 . . . . 0.26000000000000001 104.901 172.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.5 m-70 -93.53 163.07 13.71 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.013 1.387 . . . . 2.0299999999999998 110.378 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.02 119.15 24.85 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 111.399 -2.637 . . . . 0.92000000000000004 108.88 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -102.59 138.93 38.85 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.574 -2.103 . . . . 0.46999999999999997 106.538 167.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -145.64 99.13 3.24 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.991 0.9 . . . . 1.3899999999999999 112.156 -166.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 5.0 t70 -119.68 120.69 37.34 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.349 -1.296 . . . . 2.4199999999999999 109.866 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -81.62 -38.8 25.44 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.684 -1.598 . . . . 2.46 111.289 -176.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.9 -28.01 60.45 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.69 -1.141 . . . . 1.1499999999999999 111.248 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 27.5 m -89.0 -13.31 39.1 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.635 -1.246 . . . . 1.4099999999999999 107.635 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.745 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 72.98 25.85 2.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.597 -1.638 . . . . 3.3100000000000001 110.484 171.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.59 120.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.912 0.863 . . . . 0.42999999999999999 110.709 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.711 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -103.43 105.94 16.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.322 -1.733 . . . . 1.24 106.322 166.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 8.0 tp -96.7 104.38 16.37 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 0.52000000000000002 108.806 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -85.01 115.14 22.66 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.105 -1.407 . . . . 0.33000000000000002 107.515 174.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -102.65 126.2 49.66 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 113.727 -1.579 . . . . 1.3200000000000001 109.435 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 3.7 mm? -95.74 125.48 40.34 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.877 -1.511 . . . . 0.95999999999999996 107.749 172.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.86 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 30.9 m170 -120.39 95.98 4.96 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 103.85 -2.648 . . . . 1.1499999999999999 103.85 172.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.615 ' CD1' HD22 ' A' ' 57' ' ' LEU . 58.5 mt -120.3 102.22 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 113.894 -1.503 . . . . 0.52000000000000002 108.874 -170.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 80.6 p -114.05 141.66 47.16 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 113.219 -1.81 . . . . 0.57999999999999996 109.845 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 61.21 70.71 0.59 Allowed 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 111.28 -2.691 . . . . 2.1200000000000001 110.222 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -62.45 126.9 28.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.435 -2.166 . . . . 0.40000000000000002 110.524 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.78 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -55.67 139.33 68.82 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.386 -0.824 . . . . 1.4299999999999999 109.378 173.154 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HB3' HG21 ' A' ' 18' ' ' VAL . 34.6 Cg_endo -67.74 145.04 67.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.357 1.371 . . . . 1.3300000000000001 110.888 176.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.88 17.22 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.659 0.599 . . . . 1.1200000000000001 110.758 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.78 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -71.01 -30.27 66.45 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.002 -0.544 . . . . 1.24 109.712 177.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 40.6 m 14.46 79.59 0.01 OUTLIER 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.566 1.791 . . . . 1.22 110.712 -168.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.797 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -64.06 94.82 0.15 Allowed Glycine 0 N--CA 1.423 -2.216 0 CA-C-N 112.35 -2.205 . . . . 1.4299999999999999 113.764 -161.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.72 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -88.19 70.48 2.66 Favored Glycine 0 C--N 1.288 -2.133 0 N-CA-C 109.324 -1.51 . . . . 0.52000000000000002 109.324 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.575 ' HE2' ' CD2' ' A' ' 57' ' ' LEU . 54.3 m-85 -74.58 120.77 20.59 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.676 -1.262 . . . . 0.63 108.788 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 90.3 mtt180 -120.09 110.93 17.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.788 -0.449 . . . . 3.1499999999999999 109.788 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 t -94.93 122.65 37.79 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.54 -0.541 . . . . 1.0800000000000001 109.54 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.525 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 24.1 mt-10 -126.77 110.83 13.53 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.081 -0.963 . . . . 1.8100000000000001 109.937 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 28' ' ' VAL . 3.0 p -107.99 139.82 28.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.443 0.639 . . . . 0.54000000000000004 110.655 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -133.36 110.87 10.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.758 -1.11 . . . . 1.1799999999999999 110.279 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.798 HG22 HD22 ' A' ' 33' ' ' LEU . 31.9 p -120.33 -176.33 3.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.185 -0.916 . . . . 0.73999999999999999 111.123 176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 1.064 ' H ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -25.92 -45.07 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 125.724 1.89 . . . . 0.65000000000000002 112.367 -178.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.756 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -172.72 7.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.77 -1.559 . . . . 1.05 110.84 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.054 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 tmtm? -92.91 123.69 36.35 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 106.571 -1.64 . . . . 1.29 106.571 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.52 123.24 29.18 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.974 -1.012 . . . . 0.77000000000000002 111.124 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -145.58 144.27 30.39 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.1 -1.409 . . . . 1.6000000000000001 109.873 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.4 p -142.83 145.04 32.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.947 -0.569 . . . . 1.1899999999999999 109.543 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.745 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 60.9 p -130.41 133.55 46.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.935 -0.575 . . . . 0.83999999999999997 111.57 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.647 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -109.13 123.72 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.82 -0.627 . . . . 1.5800000000000001 110.389 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.703 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.16 115.76 9.57 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.685 -0.487 . . . . 0.85999999999999999 109.685 -177.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.797 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 50.4 m-20 -100.63 141.24 33.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.051 0.929 . . . . 2.1099999999999999 111.191 -168.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -111.38 111.3 22.24 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.249 -1.341 . . . . 0.37 110.061 176.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m -93.6 97.73 10.68 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.956 -0.757 . . . . 0.33000000000000002 108.956 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.4 p -84.77 121.34 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 123.138 1.447 . . . . 0.33000000000000002 110.32 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' THR . 98.7 m-70 -106.58 102.0 11.42 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.45 -2.159 . . . . 1.1899999999999999 109.722 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.7 tt0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-N 115.054 -0.975 . . . . 1.6699999999999999 111.302 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.76 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 14.3 t70 . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.083 -0.71 . . . . 1.6499999999999999 109.083 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 77.3 Cg_exo -52.2 99.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.588 2.859 . . . . 0.96999999999999997 114.656 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.617 HG13 ' HB1' ' A' ' 31' ' ' ALA . 1.5 mp -125.04 -60.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 0.5 110.091 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.81 49.44 3.83 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.645 -1.782 . . . . 0.39000000000000001 108.645 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 96' ' ' LYS . 12.7 tp -59.89 -41.95 92.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.839 -1.681 . . . . 0.33000000000000002 110.475 -168.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.731 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -90.32 84.7 6.06 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.433 -0.803 . . . . 0.71999999999999997 109.65 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -71.97 -48.02 52.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.901 -1.045 . . . . 0.63 110.313 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.543 ' CG ' ' HD3' ' A' ' 27' ' ' ARG . 20.7 mmt -136.6 130.9 33.01 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.061 -0.518 . . . . 2.8799999999999999 110.828 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.731 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 26.1 mtm180 -93.78 128.14 42.86 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.565 -0.902 . . . . 3.6699999999999999 108.565 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 79.1 Cg_endo -77.5 148.5 26.36 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.656 1.571 . . . . 0.64000000000000001 108.807 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.574 ' O ' ' HD2' ' A' ' 24' ' ' PHE . 17.3 mm-40 -112.93 179.46 3.96 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 111.629 0.233 . . . . 1.4299999999999999 111.629 -168.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.72 -144.48 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 123.005 1.383 . . . . 2.0600000000000001 111.325 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.44 127.82 1.59 Allowed Glycine 0 C--N 1.296 -1.69 0 CA-C-N 113.279 -1.782 . . . . 0.29999999999999999 111.543 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.69 113.45 25.57 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.583 -0.895 . . . . 1.53 108.583 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.54 165.09 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 107.583 -1.265 . . . . 0.27000000000000002 107.583 -167.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.67 156.9 16.2 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.939 -1.028 . . . . 0.77000000000000002 108.958 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 106' ' ' VAL . 20.6 t -67.71 107.73 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 CA-C-O 122.83 1.3 . . . . 0.78000000000000003 108.604 175.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 78' ' ' ASP . . . 120.98 3.58 10.72 Favored Glycine 0 C--N 1.267 -3.285 0 CA-C-N 111.788 -2.46 . . . . 0.47999999999999998 113.551 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -124.48 4.59 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.077 -1.535 . . . . 0.44 110.797 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.8 p -152.13 166.37 31.87 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 112.897 -1.651 . . . . 0.81999999999999995 111.279 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 104' ' ' LEU . 10.6 tp -147.84 148.71 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 113.423 -1.717 . . . . 0.32000000000000001 108.02 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 m -142.1 126.98 18.22 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 113.524 -1.671 . . . . 0.31 110.827 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.704 ' HD1' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -136.13 146.75 47.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.0 -1.0 . . . . 0.53000000000000003 109.429 173.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.861 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.9 126.1 33.33 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.517 -0.765 . . . . 0.57999999999999996 109.727 -177.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -116.46 116.28 27.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.645 -1.161 . . . . 0.32000000000000001 110.718 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HE ' HG11 ' A' ' 69' ' ' VAL . 43.3 mtp85 -102.25 130.36 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.835 -0.346 . . . . 2.4300000000000002 110.477 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 39' ' ' VAL . 11.7 t -127.93 127.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.755 0.788 . . . . 0.26000000000000001 109.874 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.37 114.81 2.6 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.711 -1.586 . . . . 0.40000000000000002 111.531 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.86 -37.87 58.61 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 114.49 -1.232 . . . . 0.76000000000000001 110.375 168.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.708 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 58.66 -174.68 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 115.193 1.553 . . . . 0.70999999999999996 115.193 164.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -103.16 113.78 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.13 -1.396 . . . . 1.74 107.912 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.747 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -151.18 165.8 32.82 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.117 -0.492 . . . . 2.1600000000000001 111.807 -166.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.8 -69.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.415 -0.587 . . . . 1.47 109.415 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 151.21 41.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.029 -0.73 . . . . 1.3999999999999999 109.029 170.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HA ' HD11 ' A' ' 33' ' ' LEU . 88.1 Cg_exo -49.24 152.35 5.49 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.854 2.37 . . . . 0.88 111.873 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.747 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -65.55 134.27 37.68 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.771 1.647 . . . . 0.53000000000000003 111.52 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.16 104.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 106.447 -1.686 . . . . 0.77000000000000002 106.447 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.633 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.44 114.74 47.78 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 113.194 -1.821 . . . . 0.28000000000000003 107.135 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.927 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.23 122.24 45.52 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 123.153 1.454 . . . . 1.54 110.265 176.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.087 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.3 m95 -86.69 152.08 22.86 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 111.978 -2.374 . . . . 0.34000000000000002 110.921 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 38.4 t80 -136.97 135.15 37.42 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 104.243 -2.502 . . . . 0.62 104.243 173.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 1.021 ' HB3' HG23 ' A' ' 47' ' ' VAL . 81.4 tttt -101.7 173.12 6.56 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 105.619 -1.993 . . . . 2.1699999999999999 105.619 -172.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 1.018 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -8.15 -168.03 0.0 OUTLIER Glycine 0 C--O 1.192 -2.487 0 N-CA-C 119.525 2.57 . . . . 1.23 119.525 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 84' ' ' THR . 20.4 mtpp -39.22 -22.08 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 115.834 1.791 . . . . 3.8700000000000001 115.834 -163.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -161.06 -6.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.937 1.088 . . . . 2.1099999999999999 113.937 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.021 HG23 ' HB3' ' A' ' 43' ' ' LYS . 31.5 m -94.4 171.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.778 0 CA-C-O 124.116 1.912 . . . . 1.29 113.539 -160.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.895 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -100.57 161.24 13.74 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 110.449 -3.069 . . . . 2.73 108.756 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.087 HD13 ' HB3' ' A' ' 41' ' ' TRP . 3.7 mp -99.42 -32.32 11.21 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 116.055 -0.52 . . . . 0.44 111.612 160.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 t -58.13 -23.78 56.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.255 0.55 . . . . 1.23 109.884 -164.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.736 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 58.5 m -102.08 -27.62 12.81 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.037 0.922 . . . . 1.3400000000000001 112.907 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.895 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 28.9 mttp -90.92 -27.35 18.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.658 -1.61 . . . . 1.3999999999999999 112.806 -168.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.727 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 35.9 t -50.32 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 111.529 -2.578 . . . . 0.37 111.267 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.42 -99.23 0.15 Allowed Glycine 0 C--N 1.304 -1.246 0 CA-C-N 112.421 -2.172 . . . . 0.69999999999999996 113.299 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -86.05 -53.2 5.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.278 0.473 . . . . 2.75 112.278 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.1 p80 -87.54 -36.19 17.72 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.394 0.616 . . . . 1.3300000000000001 111.207 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.976 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.91 106.89 13.43 Favored 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 106.35 -1.722 . . . . 1.1100000000000001 106.35 176.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -102.42 116.42 32.58 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.277 -1.379 . . . . 0.76000000000000001 107.277 166.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.693 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -95.03 92.99 7.11 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.499 -2.408 . . . . 0.26000000000000001 104.499 170.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 46.5 m170 -87.66 162.56 17.04 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.645 1.212 . . . . 2.0299999999999998 109.968 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.93 118.91 19.47 Favored 'General case' 0 C--N 1.268 -2.963 0 CA-C-N 111.959 -2.382 . . . . 0.92000000000000004 108.933 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.532 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -101.05 149.46 23.92 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.58 -2.1 . . . . 0.46999999999999997 108.202 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.4 t80 -141.61 97.05 3.08 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.224 1.012 . . . . 1.3899999999999999 110.762 -174.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.4 OUTLIER -113.8 101.67 9.51 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.81 -1.541 . . . . 2.4199999999999999 110.393 173.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.04 -29.71 43.71 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.263 -1.335 . . . . 2.46 110.937 -176.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.6 -21.26 65.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.196 -0.911 . . . . 1.1499999999999999 109.862 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 19.4 m -110.94 -11.98 14.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.18 -0.918 . . . . 1.4099999999999999 109.076 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.708 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 67.1 32.48 6.18 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.323 -0.853 . . . . 3.3100000000000001 109.547 175.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.636 HG11 ' HE ' ' A' ' 27' ' ' ARG . 3.3 t -127.32 135.64 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.944 0.878 . . . . 0.42999999999999999 110.425 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.7 m-30 -107.44 112.82 25.8 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.244 -1.391 . . . . 1.24 107.244 165.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 25' ' ' SER . 23.9 tp -95.32 107.65 19.78 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.041 0.924 . . . . 0.52000000000000002 109.537 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.2 m-85 -87.72 112.68 22.64 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.587 -1.264 . . . . 0.33000000000000002 107.587 170.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.69 120.16 41.1 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.952 -1.476 . . . . 1.3200000000000001 110.381 -175.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.704 ' HB2' ' HD1' ' A' ' 24' ' ' PHE . 1.6 mt -81.74 129.42 34.72 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.958 -1.127 . . . . 0.95999999999999996 107.958 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -115.88 96.57 5.65 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 103.351 -2.833 . . . . 1.1499999999999999 103.351 165.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.691 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -120.83 99.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 123.047 1.403 . . . . 0.52000000000000002 109.922 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.5 p -106.51 146.76 30.2 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 113.445 -1.707 . . . . 0.57999999999999996 108.651 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' OD1' ' HA2' ' A' ' 19' ' ' GLY . 27.2 t70 64.8 82.7 0.18 Allowed 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 111.613 -2.54 . . . . 2.1200000000000001 109.926 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.27 109.92 16.24 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 111.375 -2.648 . . . . 0.40000000000000002 110.688 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.899 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -52.74 139.13 41.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.587 -0.733 . . . . 1.4299999999999999 109.862 167.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.6 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 37.7 Cg_endo -63.57 -3.39 5.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.29 2.66 . . . . 1.3300000000000001 112.768 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.899 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -110.97 14.74 22.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.053 -0.521 . . . . 1.1200000000000001 110.894 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -90.14 -29.66 18.14 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 117.721 -1.133 . . . . 1.24 110.756 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 75.0 m 2.34 80.34 0.0 OUTLIER 'General case' 0 C--N 1.354 0.785 0 O-C-N 125.688 1.867 . . . . 1.22 111.226 -174.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 1.018 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.19 121.7 5.61 Favored Glycine 0 N--CA 1.408 -3.213 0 CA-C-N 111.458 -2.61 . . . . 1.4299999999999999 114.776 -163.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.952 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -120.94 70.23 0.39 Allowed Glycine 0 C--N 1.268 -3.24 0 CA-C-N 111.366 -2.417 . . . . 0.52000000000000002 107.97 159.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.781 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 54.5 m-85 -74.49 127.61 33.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.094 -1.053 . . . . 0.63 109.013 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 48.0 mtp180 -121.38 104.68 9.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.643 -0.502 . . . . 3.1499999999999999 109.643 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.476 ' H ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -91.77 121.3 33.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.09 -1.078 . . . . 1.0800000000000001 108.09 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.927 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 25.7 tt0 -137.48 106.67 6.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.229 -0.896 . . . . 1.8100000000000001 109.228 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.633 ' HB ' HG13 ' A' ' 39' ' ' VAL . 5.7 p -103.44 141.48 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.677 0.751 . . . . 0.54000000000000004 111.305 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 t -138.71 109.88 6.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.435 -1.257 . . . . 1.1799999999999999 108.563 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.566 HG21 HD12 ' A' ' 33' ' ' LEU . 1.6 m -129.44 174.21 9.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.142 -1.058 . . . . 0.73999999999999999 108.142 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.979 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.88 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 125.199 1.562 . . . . 0.65000000000000002 114.756 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.979 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -156.98 -0.81 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.555 -1.202 . . . . 1.05 110.042 -174.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.72 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -96.36 131.43 42.91 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.244 -1.021 . . . . 1.29 108.244 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -132.65 145.6 51.2 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.173 -1.376 . . . . 0.77000000000000002 111.516 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 10.6 t70 -176.08 164.96 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.797 -0.638 . . . . 1.6000000000000001 110.037 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.703 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 6.0 p -153.62 146.47 24.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.116 0.484 . . . . 1.1899999999999999 110.576 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.57 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 88.8 p -124.34 131.94 53.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.805 -0.634 . . . . 0.83999999999999997 110.55 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.79 121.12 42.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.972 0.415 . . . . 1.5800000000000001 110.461 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.635 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -142.83 126.31 16.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.466 0.651 . . . . 0.85999999999999999 109.789 -177.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 19.5 m-80 -105.09 152.88 22.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.182 0.991 . . . . 2.1099999999999999 111.563 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.03 104.27 9.11 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.818 -1.083 . . . . 0.37 110.475 173.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -85.88 96.41 9.77 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.7 -0.8 . . . . 0.33000000000000002 109.251 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 18' ' ' VAL . 7.5 p -81.87 113.22 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-O 123.387 1.565 . . . . 0.33000000000000002 109.221 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -94.91 100.95 12.72 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.362 -2.199 . . . . 1.1899999999999999 109.872 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 18' ' ' VAL . 36.1 tt0 . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 115.383 -0.826 . . . . 1.6699999999999999 110.134 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.592 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.0 m-20 . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 112.134 0.42 . . . . 1.6499999999999999 112.134 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.494 ' C ' HD12 ' A' ' 4' ' ' ILE . 42.4 Cg_endo -68.45 87.16 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.814 2.343 . . . . 0.96999999999999997 112.269 176.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.74 HD13 ' HE2' ' A' ' 94' ' ' LYS . 1.6 mp -126.4 -58.91 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.96 -1.018 . . . . 0.5 109.444 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.63 37.08 7.08 Favored Glycine 0 CA--C 1.496 -1.135 0 N-CA-C 108.991 -1.644 . . . . 0.39000000000000001 108.991 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.147 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.9 tp -46.52 -47.5 19.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.104 -1.548 . . . . 0.33000000000000002 110.383 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -89.57 83.45 6.31 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.741 0.781 . . . . 0.71999999999999997 109.02 175.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.2 t -68.26 -48.28 74.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.448 -1.251 . . . . 0.63 109.598 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 ttp -148.47 129.58 14.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.651 -1.159 . . . . 2.8799999999999999 108.828 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -95.84 148.64 34.87 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.662 -0.699 . . . . 3.6699999999999999 109.615 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.842 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 1.9 Cg_endo -79.35 162.59 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.557 2.171 . . . . 0.64000000000000001 111.074 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.511 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.4 mm-40 -125.8 169.65 12.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.099 -0.501 . . . . 1.4299999999999999 110.329 -171.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' A' ' 103' ' ' ASN . 7.3 p-10 -74.78 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-O 122.695 1.236 . . . . 2.0600000000000001 111.922 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 159.83 137.34 2.21 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.206 -1.815 . . . . 0.29999999999999999 112.175 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 31.2 mt-10 -115.76 113.85 24.0 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.054 -1.073 . . . . 1.53 108.87 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.503 HG22 HD11 ' A' ' 104' ' ' LEU . 3.1 m -134.52 163.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.715 0 N-CA-C 107.13 -1.433 . . . . 0.27000000000000002 107.13 -173.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -93.13 157.21 16.4 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.541 -0.754 . . . . 0.77000000000000002 110.035 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' A' ' 81' ' ' PRO . 9.0 t -62.58 106.76 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 CA-C-O 122.956 1.36 . . . . 0.78000000000000003 109.488 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.34 11.42 17.88 Favored Glycine 0 C--N 1.269 -3.18 0 CA-C-N 112.08 -2.327 . . . . 0.47999999999999998 113.712 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.3 -122.33 4.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 109.867 -1.293 . . . . 0.44 109.867 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.3 p -151.66 164.24 37.36 Favored 'General case' 0 N--CA 1.401 -2.89 0 CA-C-N 113.088 -1.556 . . . . 0.81999999999999995 110.971 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.825 HG23 ' HB ' ' A' ' 76' ' ' ILE . 6.8 tp -148.1 142.92 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 112.801 -1.999 . . . . 0.32000000000000001 107.904 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -138.64 129.39 26.41 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-N 114.237 -1.347 . . . . 0.31 111.054 -171.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 31.8 m-85 -126.98 143.03 51.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.129 -1.396 . . . . 0.53000000000000003 110.369 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -130.25 123.42 30.08 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.009 -0.996 . . . . 0.57999999999999996 109.438 174.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.842 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -120.89 118.16 29.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.13 -1.396 . . . . 0.32000000000000001 110.324 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -105.28 122.41 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.225 -0.297 . . . . 2.4300000000000002 111.008 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.2 t -124.89 127.39 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.849 0.833 . . . . 0.26000000000000001 109.83 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -57.64 113.31 1.76 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.665 -1.607 . . . . 0.40000000000000002 111.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.76 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -54.22 -42.16 72.28 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.537 -1.21 . . . . 0.76000000000000001 110.651 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.744 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.32 -151.01 0.1 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 115.193 1.553 . . . . 0.70999999999999996 115.193 167.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -128.34 130.54 47.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.264 -1.334 . . . . 1.74 108.717 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -156.78 179.02 9.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.298 0.571 . . . . 2.1600000000000001 111.775 -173.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.41 -42.09 59.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.712 -1.131 . . . . 1.47 108.921 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -149.48 149.9 29.89 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 1.3999999999999999 109.558 175.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 85.4 Cg_exo -46.54 140.24 12.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.86 2.373 . . . . 0.88 112.248 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HA ' HG23 ' A' ' 93' ' ' THR . 33.3 Cg_exo -53.59 137.51 66.23 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 C-N-CA 122.095 1.863 . . . . 0.53000000000000003 112.377 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.86 104.4 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 106.787 -1.56 . . . . 0.77000000000000002 106.787 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.549 HG22 HG23 ' A' ' 91' ' ' VAL . 2.4 t -113.09 115.22 49.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.022 0 CA-C-N 113.782 -1.554 . . . . 0.28000000000000003 107.595 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.642 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -106.55 131.67 53.45 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.896 1.331 . . . . 1.54 108.978 172.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.951 ' HB3' HD13 ' A' ' 49' ' ' LEU . 50.1 m95 -90.73 157.24 17.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.394 -2.185 . . . . 0.34000000000000002 110.622 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.5 t80 -139.62 124.58 18.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.431 -2.063 . . . . 0.62 105.431 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.943 ' HD2' HD23 ' A' ' 57' ' ' LEU . 60.5 tttt -104.26 112.47 25.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.3 -1.36 . . . . 2.1699999999999999 108.145 -172.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 85' ' ' GLY . . . -84.81 92.31 1.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 115.572 -3.204 . . . . 1.23 114.39 -166.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.835 ' HE3' ' HE1' ' A' ' 46' ' ' TRP . 21.9 ttpt -102.85 -31.53 10.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 103.173 -2.899 . . . . 3.8700000000000001 103.173 137.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.835 ' HE1' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER 158.78 -11.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 111.243 -2.708 . . . . 2.1099999999999999 111.369 -167.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.932 ' HB ' ' HE2' ' A' ' 52' ' ' LYS . 0.7 OUTLIER -88.08 168.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.03 1.395 . . . . 1.29 113.53 -165.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.662 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 16.5 t70 -113.09 132.57 55.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 111.666 -2.515 . . . . 2.73 108.886 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -76.31 -30.91 57.89 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 113.714 1.005 . . . . 0.44 113.714 -174.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -61.47 -21.94 64.63 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.26 0.482 . . . . 1.23 109.894 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 t -101.09 -20.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.825 0.822 . . . . 1.3400000000000001 112.215 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.932 ' HE2' ' HB ' ' A' ' 47' ' ' VAL . 45.2 mttp -96.81 -78.21 0.47 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.219 -1.355 . . . . 1.3999999999999999 113.687 -164.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.963 HG13 ' H ' ' A' ' 59' ' ' LEU . 37.8 t 22.98 98.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 125.293 1.621 . . . . 0.37 114.273 161.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -145.14 -150.87 5.3 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.251 -1.34 . . . . 0.69999999999999996 113.983 -173.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -62.54 -27.13 68.95 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.83 0.452 . . . . 2.75 112.149 -170.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.668 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.3 p80 -92.52 -39.08 11.57 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.668 -0.413 . . . . 1.3300000000000001 111.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -130.82 106.07 8.2 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.09 -0.707 . . . . 1.1100000000000001 109.09 170.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.34 116.67 29.08 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.741 -1.577 . . . . 0.76000000000000001 106.741 170.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.963 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -91.87 93.67 8.94 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 105.222 -2.14 . . . . 0.26000000000000001 105.222 171.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 42.2 m170 -94.03 162.03 14.05 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-O 122.758 1.266 . . . . 2.0299999999999998 109.933 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -132.62 111.93 11.62 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 111.775 -2.466 . . . . 0.92000000000000004 108.768 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.0 m -87.67 148.75 24.65 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 112.71 -2.041 . . . . 0.46999999999999997 108.518 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -126.65 97.14 4.9 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.303 1.049 . . . . 1.3899999999999999 110.121 -168.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -114.34 95.05 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.327 -1.761 . . . . 2.4199999999999999 108.554 177.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.01 -27.22 28.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.173 -0.921 . . . . 2.46 110.457 -176.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.44 -17.63 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.57 -1.196 . . . . 1.1499999999999999 109.847 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.704 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 24.2 m -108.79 -15.25 14.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.925 . . . . 1.4099999999999999 108.774 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.744 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 64.93 35.47 8.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.097 -0.956 . . . . 3.3100000000000001 109.402 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.07 136.83 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.42999999999999999 109.667 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 13.9 m-85 -101.68 116.78 33.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.685 -1.598 . . . . 1.24 106.685 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 25' ' ' SER . 24.3 tp -95.55 104.54 16.45 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.441 -0.948 . . . . 0.52000000000000002 108.441 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.9 m-85 -81.92 112.03 18.65 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.539 -1.652 . . . . 0.33000000000000002 106.539 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -119.68 120.88 37.92 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.97 -1.468 . . . . 1.3200000000000001 110.385 -173.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.923 HD12 HD11 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -88.21 125.15 34.48 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.763 -1.562 . . . . 0.95999999999999996 107.584 177.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 12.8 m170 -110.75 96.01 5.91 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.148 -2.538 . . . . 1.1499999999999999 104.148 170.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.923 HD11 HD12 ' A' ' 74' ' ' LEU . 27.8 mt -119.57 99.98 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 122.89 1.328 . . . . 0.52000000000000002 110.279 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 31.4 p -116.05 139.97 49.74 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 114.301 -1.318 . . . . 0.57999999999999996 107.77 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 77' ' ' THR . 22.0 t70 74.85 64.98 0.07 Allowed 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.309 -2.223 . . . . 2.1200000000000001 108.312 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.17 9.18 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.098 -2.319 . . . . 0.40000000000000002 109.259 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -62.6 151.7 83.08 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.25 -0.648 . . . . 1.4299999999999999 109.25 176.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.758 ' HB3' HG21 ' A' ' 18' ' ' VAL . 72.3 Cg_endo -72.95 11.06 0.94 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.795 2.33 . . . . 1.3300000000000001 113.958 -169.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.708 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.17 -3.97 11.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.595 -0.275 . . . . 1.1200000000000001 110.626 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD1' ' HE2' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -80.63 0.51 33.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.182 -0.673 . . . . 1.24 109.182 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 94.9 m -52.24 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 CA-C-O 122.609 1.195 . . . . 1.22 109.657 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 44' ' ' GLY . . . -164.98 -119.42 0.48 Allowed Glycine 0 C--N 1.27 -3.093 0 CA-C-N 113.15 -1.841 . . . . 1.4299999999999999 113.559 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -164.99 121.97 1.05 Allowed Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 113.501 -1.35 . . . . 0.52000000000000002 111.195 -171.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -87.01 125.48 34.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.413 -0.958 . . . . 0.63 108.413 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -105.0 132.71 50.9 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.239 -0.652 . . . . 3.1499999999999999 109.239 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.47 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 3.9 m -111.76 121.7 45.79 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.837 -0.801 . . . . 1.0800000000000001 108.837 169.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.642 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 41.9 mt-10 -120.01 105.2 10.81 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.78 -0.646 . . . . 1.8100000000000001 109.608 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.549 HG23 HG22 ' A' ' 39' ' ' VAL . 7.1 p -99.74 134.05 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.187 0.994 . . . . 0.54000000000000004 110.717 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -135.58 108.03 7.37 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.591 -1.64 . . . . 1.1799999999999999 108.389 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.709 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -133.22 163.23 29.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.308 -0.853 . . . . 0.73999999999999999 109.09 -178.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.74 ' HE2' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 22.28 -79.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 125.52 1.762 . . . . 0.65000000000000002 113.536 168.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.616 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 16.3 t70 -153.43 6.3 0.35 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.898 -1.047 . . . . 1.05 109.156 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.147 ' HB3' HD22 ' A' ' 6' ' ' LEU . 44.7 tptt -92.01 132.1 36.8 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.782 -1.562 . . . . 1.29 106.782 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -131.7 146.17 52.03 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.941 -1.027 . . . . 0.77000000000000002 111.847 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.57 163.18 2.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.98 . . . . 1.6000000000000001 110.104 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.4 p -152.22 138.44 18.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.981 -0.554 . . . . 1.1899999999999999 110.038 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.76 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 57.9 p -107.45 147.25 30.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.631 -0.713 . . . . 0.83999999999999997 110.325 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.559 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -132.98 114.91 14.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.431 0.634 . . . . 1.5800000000000001 110.354 176.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.792 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 33.7 p90 -143.24 140.23 30.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.082 -0.508 . . . . 0.85999999999999999 109.796 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.643 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.3 m-20 -96.98 155.97 16.55 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.207 1.003 . . . . 2.1099999999999999 111.974 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.666 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -125.7 114.44 18.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.726 -1.213 . . . . 0.37 107.726 164.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.433 ' HA ' HG23 ' A' ' 84' ' ' THR . 4.1 m -98.83 95.86 7.48 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.654 -0.869 . . . . 0.33000000000000002 108.654 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.1 p -78.39 111.74 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 123.065 1.412 . . . . 0.33000000000000002 108.834 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 65.2 m170 -78.57 98.11 6.01 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.664 -2.062 . . . . 1.1899999999999999 109.788 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 113.542 -1.663 . . . . 1.6699999999999999 108.866 171.341 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.601 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 19.6 t70 . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 109.846 -0.427 . . . . 1.6499999999999999 109.846 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 18.2 Cg_endo -61.04 77.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.737 2.292 . . . . 0.96999999999999997 114.066 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.703 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -99.59 -60.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.773 -1.103 . . . . 0.5 109.574 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.7 43.69 6.01 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 108.321 -1.912 . . . . 0.39000000000000001 108.321 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 4' ' ' ILE . 9.8 tp -50.11 -43.83 51.87 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.652 -1.774 . . . . 0.33000000000000002 111.031 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.744 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -88.52 84.73 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.646 -0.706 . . . . 0.71999999999999997 110.301 176.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.46 -40.95 72.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.447 -1.251 . . . . 0.63 109.167 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.502 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 18.2 ttt -151.06 137.45 18.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.617 -1.174 . . . . 2.8799999999999999 108.655 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 7.8 ptp180 -102.47 139.23 20.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.229 -0.441 . . . . 3.6699999999999999 110.201 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.859 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 14.1 Cg_endo -69.73 154.1 68.28 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.741 2.294 . . . . 0.64000000000000001 112.375 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -112.93 170.75 7.98 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.099 0.778 . . . . 1.4299999999999999 113.099 -168.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 1.6 m-20 -69.88 -147.35 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.701 1.239 . . . . 2.0600000000000001 110.741 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.489 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 153.32 133.31 1.84 Allowed Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 113.611 -1.631 . . . . 0.29999999999999999 112.242 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 23.1 mt-10 -110.68 119.01 37.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.256 -0.972 . . . . 1.53 108.527 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.77 162.06 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.21 0 N-CA-C 107.047 -1.464 . . . . 0.27000000000000002 107.047 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -96.4 155.33 16.81 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.41 -0.959 . . . . 0.77000000000000002 108.41 176.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.708 HG11 ' HD3' ' A' ' 81' ' ' PRO . 6.2 t -67.28 105.85 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.862 -1.162 . . . . 0.78000000000000003 107.862 173.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.34 -6.74 3.97 Favored Glycine 0 C--N 1.273 -2.953 0 CA-C-N 112.926 -1.943 . . . . 0.47999999999999998 113.368 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.37 -123.93 5.29 Favored Glycine 0 CA--C 1.471 -2.704 0 C-N-CA 119.089 -1.529 . . . . 0.44 110.6 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.638 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.8 p -148.98 174.45 12.26 Favored 'General case' 0 N--CA 1.396 -3.149 0 CA-C-N 112.555 -1.822 . . . . 0.81999999999999995 110.2 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.682 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.1 tp -146.09 140.39 21.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 112.651 -2.068 . . . . 0.32000000000000001 107.21 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.9 m -139.24 127.59 22.79 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 113.398 -1.728 . . . . 0.31 111.492 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.779 ' HB2' HD23 ' A' ' 74' ' ' LEU . 3.4 m-85 -128.19 154.71 45.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.057 -1.429 . . . . 0.53000000000000003 108.877 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -134.42 122.05 21.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.461 -0.79 . . . . 0.57999999999999996 109.382 173.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.859 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -113.51 116.38 29.47 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.878 -1.056 . . . . 0.32000000000000001 110.184 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.1 mtt180 -105.61 115.66 30.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.469 -0.332 . . . . 2.4300000000000002 110.412 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 39' ' ' VAL . 5.8 t -118.23 126.3 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.065 0.936 . . . . 0.26000000000000001 110.121 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.775 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -56.36 108.97 0.53 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.147 -1.842 . . . . 0.40000000000000002 112.188 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.62 80.78 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.764 -1.107 . . . . 0.76000000000000001 112.423 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 61.05 -178.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.137 1.162 . . . . 0.70999999999999996 114.137 168.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -105.39 29.53 6.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.292 -1.322 . . . . 1.74 109.083 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.046 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -58.57 175.71 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.645 -1.161 . . . . 2.1600000000000001 113.133 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.44 -40.52 64.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.874 0.845 . . . . 1.47 109.927 -176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.93 134.88 11.14 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.442 -1.253 . . . . 1.3999999999999999 108.532 176.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -43.58 141.62 3.62 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.333 2.689 . . . . 0.88 112.18 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.046 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.0 Cg_exo -52.93 136.63 60.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.813 1.675 . . . . 0.53000000000000003 113.068 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.31 104.99 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.175 -1.787 . . . . 0.77000000000000002 106.175 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.65 114.37 46.78 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 113.535 -1.666 . . . . 0.28000000000000003 108.037 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 1.018 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.57 122.24 43.47 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-O 123.344 1.545 . . . . 1.54 110.238 174.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.034 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.8 m95 -86.91 149.01 25.11 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.871 -2.422 . . . . 0.34000000000000002 112.021 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.734 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 43.7 t80 -128.89 140.09 51.84 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.096 -2.557 . . . . 0.62 104.096 172.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.798 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 58.2 tttp -106.23 166.25 10.65 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 116.627 -1.654 . . . . 2.1699999999999999 106.708 -173.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -11.97 -166.17 0.0 OUTLIER Glycine 0 C--O 1.186 -2.875 0 N-CA-C 119.136 2.414 . . . . 1.23 119.136 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.914 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 13.4 ptmt -44.14 -6.34 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.495 2.406 . . . . 3.8700000000000001 117.495 -161.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.914 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 2.8 p-90 -167.95 -1.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.931 1.242 . . . . 2.1099999999999999 113.266 174.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.27 167.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 CA-C-O 123.659 1.695 . . . . 1.29 112.405 -159.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 3.3 p-10 -111.35 156.99 20.73 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.137 -2.756 . . . . 2.73 106.506 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -97.9 -31.27 12.28 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.509 0.559 . . . . 0.44 112.509 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -58.52 -19.67 39.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.013 0.435 . . . . 1.23 109.88 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.406 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 73.9 m -98.25 -26.74 14.43 Favored 'General case' 0 N--CA 1.415 -2.198 0 C-N-CA 119.865 -0.734 . . . . 1.3400000000000001 112.432 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.3 -32.16 10.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.623 -1.172 . . . . 1.3999999999999999 111.794 -167.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.82 HG13 ' H ' ' A' ' 59' ' ' LEU . 70.3 t -35.39 92.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 O-C-N 125.076 1.485 . . . . 0.37 111.532 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . -150.25 -114.79 0.7 Allowed Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 112.338 -2.21 . . . . 0.69999999999999996 111.952 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -95.74 -25.4 16.09 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.364 0.876 . . . . 2.75 113.364 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.6 p80 -93.32 -37.82 11.82 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-O 121.622 0.725 . . . . 1.3300000000000001 110.079 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.005 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.66 106.97 10.51 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 105.657 -1.979 . . . . 1.1100000000000001 105.657 171.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -106.39 114.59 28.81 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.445 -1.687 . . . . 0.76000000000000001 106.445 166.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.82 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -92.72 92.42 7.96 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 103.957 -2.608 . . . . 0.26000000000000001 103.957 175.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 80.4 t60 -95.0 159.66 14.93 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 113.944 -1.48 . . . . 2.0299999999999998 110.22 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.58 121.57 39.64 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.929 -2.85 . . . . 0.92000000000000004 109.153 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 25.9 m -110.23 143.47 40.34 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-N 111.773 -2.467 . . . . 0.46999999999999997 106.34 167.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.88 99.51 3.35 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.748 0.785 . . . . 1.3899999999999999 109.275 -164.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -115.01 132.07 56.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.489 -1.232 . . . . 2.4199999999999999 109.122 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.538 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 6.1 mmm180 -119.01 18.23 13.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.06 -1.427 . . . . 2.46 111.25 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.24 -31.88 4.55 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.736 -1.574 . . . . 1.1499999999999999 108.488 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t -93.18 -14.75 26.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.479 -1.237 . . . . 1.4099999999999999 108.8 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.775 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 15.2 tttt 68.88 31.61 4.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.85 0.833 . . . . 3.3100000000000001 109.23 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 7.9 t -128.35 125.77 64.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.603 0.716 . . . . 0.42999999999999999 110.453 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.447 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.4 m-30 -101.18 107.44 18.85 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.031 -1.841 . . . . 1.24 106.031 167.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.0 tp -94.92 104.21 16.1 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.706 -1.134 . . . . 0.52000000000000002 108.013 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.5 m-85 -86.94 113.65 22.89 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.68 -1.6 . . . . 0.33000000000000002 106.68 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.65 125.24 49.3 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.917 -1.492 . . . . 1.3200000000000001 110.585 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.916 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.2 mm? -89.59 124.51 34.62 Favored 'General case' 0 CA--C 1.471 -2.064 0 CA-C-N 112.889 -1.96 . . . . 0.95999999999999996 107.698 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.935 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 26.1 m170 -114.45 94.29 4.72 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 103.15 -2.908 . . . . 1.1499999999999999 103.15 167.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 22' ' ' ILE . 60.4 mt -115.14 97.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 123.603 1.668 . . . . 0.52000000000000002 108.983 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 29.9 p -116.31 138.75 51.07 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 112.302 -2.226 . . . . 0.57999999999999996 107.076 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 77' ' ' THR . 13.5 t70 77.76 63.77 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 O-C-N 125.855 1.972 . . . . 2.1200000000000001 107.351 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -76.92 94.44 3.93 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 111.605 -2.543 . . . . 0.40000000000000002 107.893 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.673 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -53.71 151.32 11.55 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-N 115.127 -0.942 . . . . 1.4299999999999999 108.708 176.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.708 ' HD3' HG11 ' A' ' 18' ' ' VAL . 60.0 Cg_endo -68.83 155.32 69.02 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.039 1.159 . . . . 1.3300000000000001 110.032 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 45' ' ' LYS . . . 63.38 21.69 12.91 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.381 0.426 . . . . 1.1200000000000001 110.728 -175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -86.6 -13.21 46.37 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.195 -1.409 . . . . 1.24 107.195 173.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 1.022 HG21 ' N ' ' A' ' 106' ' ' VAL . 4.3 p -90.11 150.26 22.12 Favored 'General case' 1 N--CA 1.363 -4.808 0 CA-C-O 126.041 2.829 . . . . 1.22 116.17 -163.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.417 ' HA3' ' CA ' ' A' ' 45' ' ' LYS . . . 159.4 -109.61 0.41 Allowed Glycine 1 C--N 1.239 -4.833 1 CA-C-N 105.381 -5.372 . . . . 1.4299999999999999 112.527 -155.532 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -167.91 124.78 1.23 Allowed Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.338 -1.41 . . . . 0.52000000000000002 114.172 -170.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.798 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.3 m-85 -87.95 124.54 33.81 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.227 -1.487 . . . . 0.63 108.56 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.734 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 mtp180 -105.51 105.21 15.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.538 -0.726 . . . . 3.1499999999999999 109.728 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.424 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 4.3 t -89.92 125.39 35.34 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.372 -0.973 . . . . 1.0800000000000001 108.372 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 1.018 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 21.7 tt0 -145.47 106.77 4.19 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.419 -0.81 . . . . 1.8100000000000001 109.961 -169.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.7 p -102.66 144.36 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.362 0.601 . . . . 0.54000000000000004 110.504 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.4 m -139.12 109.47 6.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.277 -0.874 . . . . 1.1799999999999999 108.898 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.852 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.39 153.78 50.45 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.401 -0.809 . . . . 0.73999999999999999 109.886 -177.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.784 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.7 -75.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 125.654 1.846 . . . . 0.65000000000000002 114.572 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.784 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 12.2 t70 -149.7 -1.07 0.45 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.087 -1.415 . . . . 1.05 109.379 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.703 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -104.76 140.09 38.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.111 0.958 . . . . 1.29 109.627 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -132.61 139.06 47.61 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.142 -1.844 . . . . 0.77000000000000002 110.577 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 6.8 m-20 -152.85 147.88 26.53 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.25 -0.886 . . . . 1.6000000000000001 109.083 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 13.4 p -151.43 153.88 35.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.504 . . . . 1.1899999999999999 110.905 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.744 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 85.7 p -137.31 130.26 30.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.774 -0.648 . . . . 0.83999999999999997 110.766 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.81 116.85 33.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.615 -0.721 . . . . 1.5800000000000001 110.305 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.791 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 22.5 p90 -143.12 135.8 27.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.458 0.647 . . . . 0.85999999999999999 109.903 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.588 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 86.9 m-20 -97.26 156.15 16.55 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.538 -1.21 . . . . 2.1099999999999999 110.387 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.959 ' HG ' HG22 ' A' ' 84' ' ' THR . 1.2 tp -120.67 132.91 55.34 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 102.336 -3.209 . . . . 0.37 102.336 166.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.544 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 23.4 m -124.16 113.57 18.51 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.318 -1.353 . . . . 0.33000000000000002 109.727 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.022 ' N ' HG21 ' A' ' 84' ' ' THR . 5.6 p -102.87 114.14 41.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 113.779 -1.555 . . . . 0.33000000000000002 110.046 -172.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 35.5 m-70 -79.78 98.55 7.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.798 -2.455 . . . . 1.1899999999999999 109.354 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.43 ' HA ' HG23 ' A' ' 18' ' ' VAL . 70.1 tt0 . . . . . 0 C--N 1.295 -1.762 0 CA-C-N 113.099 -1.864 . . . . 1.6699999999999999 109.736 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 4' ' ' ILE . 5.8 m-20 . . . . . 0 N--CA 1.433 -1.285 0 N-CA-C 110.514 -0.18 . . . . 1.6499999999999999 110.514 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.76 42.26 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.393 2.729 . . . . 0.96999999999999997 113.357 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.962 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -58.22 -51.27 73.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.74 -0.664 . . . . 0.5 110.163 172.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.591 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 86.72 40.28 7.26 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.602 -1.799 . . . . 0.39000000000000001 108.602 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.137 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.8 tp -53.2 -50.07 65.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.544 -1.828 . . . . 0.33000000000000002 110.252 -172.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -84.23 84.48 7.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.71999999999999997 110.176 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.2 t -73.2 -42.88 58.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.43 -1.259 . . . . 0.63 109.416 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.7 ttm -152.19 135.87 16.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.225 -0.898 . . . . 2.8799999999999999 108.715 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -91.1 139.76 25.77 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.862 -0.422 . . . . 3.6699999999999999 109.862 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 33.6 Cg_endo -67.49 141.57 56.22 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.091 1.86 . . . . 0.64000000000000001 109.164 171.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.619 ' O ' ' HD1' ' A' ' 24' ' ' PHE . 6.3 tp60 -118.2 163.83 16.08 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.932 0.715 . . . . 1.4299999999999999 112.932 -168.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.1 m-20 -57.67 -139.94 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 125.674 1.589 . . . . 2.0600000000000001 112.928 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 143.13 136.19 3.13 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 113.291 -1.777 . . . . 0.29999999999999999 111.975 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 35.8 mt-10 -108.51 114.93 29.16 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.349 -0.926 . . . . 1.53 108.527 175.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.4 m -135.25 163.6 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.867 0 N-CA-C 107.932 -1.136 . . . . 0.27000000000000002 107.932 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 154.29 17.33 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.636 -1.166 . . . . 0.77000000000000002 109.193 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.69 HG11 ' HD3' ' A' ' 81' ' ' PRO . 4.0 t -65.78 107.58 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 CA-C-O 122.845 1.307 . . . . 0.78000000000000003 108.9 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.3 10.38 10.74 Favored Glycine 0 C--N 1.269 -3.162 0 CA-C-N 112.107 -2.315 . . . . 0.47999999999999998 112.734 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.82 -123.43 4.89 Favored Glycine 0 N--CA 1.42 -2.409 0 C-N-CA 119.331 -1.414 . . . . 0.44 110.269 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.6 p -151.35 168.44 24.8 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.079 -1.561 . . . . 0.81999999999999995 110.201 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 104' ' ' LEU . 9.0 tp -147.79 149.44 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 CA-C-N 113.693 -1.594 . . . . 0.32000000000000001 108.04 169.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 m -138.11 128.64 26.44 Favored 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 114.066 -1.425 . . . . 0.31 111.163 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.619 ' HD1' ' O ' ' A' ' 12' ' ' GLN . 3.4 m-85 -126.01 147.54 49.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 113.879 -1.51 . . . . 0.53000000000000003 107.817 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -140.89 127.73 20.46 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.57 0.7 . . . . 0.57999999999999996 109.78 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.19 115.5 23.16 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.922 -1.035 . . . . 0.32000000000000001 110.383 -176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -104.31 121.11 42.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.312 -0.255 . . . . 2.4300000000000002 110.312 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.606 HG21 HG21 ' A' ' 39' ' ' VAL . 15.1 t -122.31 126.03 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.129 0.966 . . . . 0.26000000000000001 110.319 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -57.83 109.01 0.65 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.151 -1.84 . . . . 0.40000000000000002 111.432 176.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.606 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -50.1 -58.58 8.52 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.946 -1.025 . . . . 0.76000000000000001 111.418 172.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.823 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 59.8 -171.15 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.137 1.162 . . . . 0.70999999999999996 114.137 168.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -109.09 130.42 55.48 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.916 -1.038 . . . . 1.74 109.846 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -160.93 -176.2 5.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.396 0.617 . . . . 2.1600000000000001 112.038 -172.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.8 tp -70.77 -44.86 65.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.966 -1.015 . . . . 1.47 108.741 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.597 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.46 150.27 28.41 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 114.79 -1.096 . . . . 1.3999999999999999 109.634 174.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.77 148.79 5.76 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.484 2.789 . . . . 0.88 112.426 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.639 ' HA ' HG23 ' A' ' 93' ' ' THR . 4.1 Cg_exo -50.11 132.51 33.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.709 1.606 . . . . 0.53000000000000003 113.207 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.3 105.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.404 -1.702 . . . . 0.77000000000000002 106.404 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.626 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.56 114.5 47.11 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.784 -1.553 . . . . 0.28000000000000003 107.195 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.93 124.82 50.16 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 123.287 1.518 . . . . 1.54 109.16 174.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.068 ' HB3' HD13 ' A' ' 49' ' ' LEU . 79.8 m95 -83.93 151.09 25.26 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 111.646 -2.525 . . . . 0.34000000000000002 111.231 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.699 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 36.9 t80 -128.61 138.75 52.36 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 104.58 -2.378 . . . . 0.62 104.58 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.816 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 31.6 tptt -104.64 165.28 11.17 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.41 -2.07 . . . . 2.1699999999999999 105.41 -172.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.803 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.62 -168.95 0.0 OUTLIER Glycine 0 C--O 1.188 -2.741 0 N-CA-C 119.321 2.488 . . . . 1.23 119.321 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -44.82 -1.47 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.95 2.204 . . . . 3.8700000000000001 116.95 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.8 p-90 -167.16 -11.5 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.858 1.429 . . . . 2.1099999999999999 114.858 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.674 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.37 169.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 CA-C-O 123.452 1.596 . . . . 1.29 112.889 -161.257 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.482 ' OD1' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -111.05 156.19 21.67 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 111.613 -2.54 . . . . 2.73 107.511 172.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.068 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -96.77 -36.88 10.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 119.292 -0.385 . . . . 0.44 111.896 169.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 t -58.15 -20.49 41.16 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.31 0.576 . . . . 1.23 109.47 -165.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -98.02 -17.64 19.04 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.302 -0.863 . . . . 1.3400000000000001 113.014 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 6.2 mmmt -102.87 -54.59 2.6 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.773 -0.649 . . . . 1.3999999999999999 111.174 -173.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 49' ' ' LEU . 70.3 t -6.25 90.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 O-C-N 125.93 2.019 . . . . 0.37 113.139 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.633 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.87 -129.61 1.16 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 112.579 -2.101 . . . . 0.69999999999999996 112.191 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -72.65 -28.71 62.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.764 0.653 . . . . 2.75 112.764 -168.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 30.0 p80 -96.06 -37.17 10.74 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.699 0.762 . . . . 1.3300000000000001 111.181 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.988 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -125.62 105.22 8.85 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.313 -1.736 . . . . 1.1100000000000001 106.313 175.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.45 113.93 25.55 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 106.325 -1.732 . . . . 0.76000000000000001 106.325 166.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.79 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.48 92.47 5.4 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 104.47 -2.419 . . . . 0.26000000000000001 104.47 171.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 33.0 m170 -87.61 159.86 18.4 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.831 1.3 . . . . 2.0299999999999998 110.306 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -135.03 110.27 8.96 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 111.548 -2.569 . . . . 0.92000000000000004 109.866 175.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -91.77 148.78 21.98 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 112.302 -2.226 . . . . 0.46999999999999997 107.576 174.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.8 98.31 3.31 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.45 1.119 . . . . 1.3899999999999999 110.843 -173.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -118.01 124.82 49.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.554 -1.657 . . . . 2.4199999999999999 109.931 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -35.41 19.12 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.148 -1.842 . . . . 2.46 110.62 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.995 -1.002 . . . . 1.1499999999999999 110.789 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -90.22 -18.78 25.08 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.771 -0.826 . . . . 1.4099999999999999 108.771 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.823 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 7.4 ttpt 66.0 33.18 7.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.871 -1.059 . . . . 3.3100000000000001 109.367 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.48 122.91 56.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.721 0.772 . . . . 0.42999999999999999 109.826 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 62' ' ' SER . 2.9 m-30 -96.67 108.39 21.0 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.548 -1.649 . . . . 1.24 106.548 167.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 28.1 tp -93.42 105.9 17.91 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.966 -1.015 . . . . 0.52000000000000002 109.336 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 71.0 m-85 -91.1 111.19 22.56 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.333 -1.728 . . . . 0.33000000000000002 106.333 170.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -121.61 132.29 54.59 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.722 -1.126 . . . . 1.3200000000000001 110.107 -174.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.68 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.3 mt -98.27 131.71 44.37 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.199 -1.819 . . . . 0.95999999999999996 108.936 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -116.8 97.64 6.08 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 104.041 -2.577 . . . . 1.1499999999999999 104.041 165.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.68 HG13 ' HB3' ' A' ' 74' ' ' LEU . 10.8 mt -123.0 101.56 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.395 1.093 . . . . 0.52000000000000002 108.281 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.7 p -104.76 171.56 7.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 CA-C-N 114.874 -1.057 . . . . 0.57999999999999996 110.105 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 39.89 67.41 0.48 Allowed 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.838 -2.892 . . . . 2.1200000000000001 111.562 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.49 116.32 6.65 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.625 -2.08 . . . . 0.40000000000000002 109.878 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.828 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -67.77 152.04 96.67 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.034 -0.728 . . . . 1.4299999999999999 109.034 175.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.69 ' HD3' HG11 ' A' ' 18' ' ' VAL . 38.2 Cg_endo -66.16 -8.3 19.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.45 2.1 . . . . 1.3300000000000001 112.605 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.828 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -105.59 15.29 27.22 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.096 -0.502 . . . . 1.1200000000000001 110.278 176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.7 m-30 -97.37 -6.4 34.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 118.849 -0.596 . . . . 1.24 110.983 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 22.9 m -23.59 95.07 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 125.497 1.748 . . . . 1.22 111.393 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.803 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -55.49 115.52 5.93 Favored Glycine 0 N--CA 1.406 -3.341 0 CA-C-N 110.431 -3.077 . . . . 1.4299999999999999 114.863 -169.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.681 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -119.18 68.7 0.35 Allowed Glycine 0 C--N 1.269 -3.188 0 CA-C-N 111.815 -2.192 . . . . 0.52000000000000002 108.433 149.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.816 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 32.5 m-85 -73.98 115.75 13.8 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.179 -1.045 . . . . 0.63 108.179 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.699 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 37.6 mtp180 -109.09 113.39 26.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.671 -0.492 . . . . 3.1499999999999999 109.671 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.1 t -101.8 110.7 22.73 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.624 0.726 . . . . 1.0800000000000001 109.355 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 0.8 OUTLIER -121.1 110.91 16.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.5 -1.227 . . . . 1.8100000000000001 110.07 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HB ' HG13 ' A' ' 39' ' ' VAL . 7.0 p -100.12 140.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.299 0.571 . . . . 0.54000000000000004 110.27 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -135.74 108.59 7.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.409 -0.96 . . . . 1.1799999999999999 108.409 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -132.2 144.85 50.94 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-O 117.374 -1.298 . . . . 0.73999999999999999 108.242 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.25 -72.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 O-C-N 125.629 1.831 . . . . 0.65000000000000002 113.699 -173.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.716 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 24.8 t70 -153.33 -1.18 0.23 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.681 -1.145 . . . . 1.05 110.707 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.137 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.8 tttp -88.25 126.45 35.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.447 -0.945 . . . . 1.29 108.447 176.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 91' ' ' VAL . 15.1 t80 -130.42 117.7 20.09 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 0.77000000000000002 110.063 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -134.61 141.67 46.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.498 -1.683 . . . . 1.6000000000000001 108.639 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 5.0 m -136.21 144.22 44.79 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.473 . . . . 1.1899999999999999 110.688 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.651 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 82.1 p -130.74 118.66 21.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.732 -0.667 . . . . 0.83999999999999997 110.507 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.578 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -101.41 123.57 45.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.621 -0.718 . . . . 1.5800000000000001 109.516 176.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.67 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.9 p90 -142.88 135.56 27.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.005 0.907 . . . . 0.85999999999999999 110.581 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.778 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.6 m-80 -105.19 132.38 51.48 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.068 -1.424 . . . . 2.1099999999999999 111.449 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.705 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.41 106.58 17.74 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.554 -1.203 . . . . 0.37 108.651 172.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 8.1 m -89.28 96.45 10.72 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.592 -0.892 . . . . 0.33000000000000002 108.592 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 18' ' ' VAL . 4.7 p -85.2 113.69 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 123.031 1.396 . . . . 0.33000000000000002 109.104 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.93 99.21 11.7 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.648 -2.069 . . . . 1.1899999999999999 109.666 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.1 tt0 . . . . . 0 C--N 1.302 -1.465 0 CA-C-N 113.004 -1.907 . . . . 1.6699999999999999 110.16 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.738 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 23.1 t70 . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 108.31 -0.996 . . . . 1.6499999999999999 108.31 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.59 58.25 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.445 2.763 . . . . 0.96999999999999997 114.421 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.993 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -67.86 -52.31 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.5 109.463 168.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.36 46.0 5.39 Favored Glycine 0 CA--C 1.494 -1.232 0 N-CA-C 108.252 -1.939 . . . . 0.39000000000000001 108.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.943 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.9 tp -55.04 -38.05 67.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.69 -1.755 . . . . 0.33000000000000002 110.643 -169.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.743 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -96.07 85.13 3.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.209 -0.905 . . . . 0.71999999999999997 109.823 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.03 -37.55 41.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.553 -1.203 . . . . 0.63 110.01 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 tpp -151.28 134.39 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.513 -0.767 . . . . 2.8799999999999999 109.636 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 17.0 ptm180 -108.57 136.86 19.89 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.786 -0.643 . . . . 3.6699999999999999 109.916 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 2.0 Cg_endo -76.35 138.36 19.79 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.672 2.248 . . . . 0.64000000000000001 111.531 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.676 HE21 ' C ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -89.31 -177.98 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.696 -0.684 . . . . 1.4299999999999999 110.527 176.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -74.61 -142.87 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.291 1.043 . . . . 2.0600000000000001 110.7 178.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.77 140.02 2.86 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.355 -1.293 . . . . 0.29999999999999999 112.512 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.464 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 27.4 mt-10 -116.87 119.18 34.57 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.277 -0.961 . . . . 1.53 108.52 172.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.2 m -136.43 162.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 N-CA-C 107.068 -1.456 . . . . 0.27000000000000002 107.068 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.719 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -91.03 156.53 17.86 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.039 -0.982 . . . . 0.77000000000000002 110.22 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 81' ' ' PRO . 11.6 t -66.47 107.12 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-O 123.023 1.392 . . . . 0.78000000000000003 108.202 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.69 14.31 12.78 Favored Glycine 0 C--N 1.266 -3.327 0 CA-C-N 111.925 -2.398 . . . . 0.47999999999999998 112.438 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.89 -125.24 5.32 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.366 -1.493 . . . . 0.44 109.366 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 24.4 p -152.73 165.51 35.08 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.236 -1.482 . . . . 0.81999999999999995 110.685 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 104' ' ' LEU . 10.3 tp -147.72 150.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.187 -1.824 . . . . 0.32000000000000001 107.252 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -138.95 125.94 21.13 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 113.442 -1.708 . . . . 0.31 110.043 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.76 150.06 44.86 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.375 -1.284 . . . . 0.53000000000000003 108.446 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.667 ' HB3' HD11 ' A' ' 71' ' ' LEU . 9.9 m -142.04 131.37 23.59 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.881 -0.785 . . . . 0.57999999999999996 108.881 175.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -127.42 115.54 19.08 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.205 -1.361 . . . . 0.32000000000000001 109.772 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HG2' HD13 ' A' ' 71' ' ' LEU . 48.9 mtp180 -104.98 123.4 47.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.123 -0.49 . . . . 2.4300000000000002 110.329 -173.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 39' ' ' VAL . 14.1 t -123.76 127.58 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.463 1.125 . . . . 0.26000000000000001 110.752 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.31 113.86 2.86 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.086 -1.87 . . . . 0.40000000000000002 112.931 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 1.048 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -49.78 -64.75 3.26 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 114.313 -1.312 . . . . 0.76000000000000001 111.085 166.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.705 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 60.52 -175.69 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 115.196 1.554 . . . . 0.70999999999999996 115.196 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -96.55 106.88 19.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.867 -1.515 . . . . 1.74 109.759 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.988 HD12 HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -151.83 171.03 18.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.975 -0.557 . . . . 2.1600000000000001 110.674 -171.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.73 -49.06 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.42 0.629 . . . . 1.47 110.244 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.645 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -149.92 158.14 37.29 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.611 -0.885 . . . . 1.3999999999999999 108.611 174.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.75 139.62 3.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.159 2.573 . . . . 0.88 112.296 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.8 ' HD3' HD11 ' A' ' 33' ' ' LEU . 8.9 Cg_exo -55.27 141.96 79.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.012 1.142 . . . . 0.53000000000000003 112.916 -175.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.84 106.38 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.332 -1.729 . . . . 0.77000000000000002 106.332 174.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 28' ' ' VAL . 2.8 t -109.22 115.22 49.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.918 0 CA-C-N 113.384 -1.735 . . . . 0.28000000000000003 108.083 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.935 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.66 130.53 52.67 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 123.126 1.441 . . . . 1.54 110.029 175.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.058 ' HB3' HD13 ' A' ' 49' ' ' LEU . 90.8 m95 -94.32 145.28 24.86 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 112.158 -2.292 . . . . 0.34000000000000002 111.917 173.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.5 t80 -126.88 130.86 50.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.641 -1.985 . . . . 0.62 105.641 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 35.3 ttpt -104.76 111.58 24.36 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.523 -1.288 . . . . 2.1699999999999999 107.523 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.646 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -81.24 92.63 1.49 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 116.146 -2.93 . . . . 1.23 114.274 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.753 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 tttp -106.67 -53.98 2.54 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 102.765 -3.05 . . . . 3.8700000000000001 102.765 134.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.753 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 9.0 p-90 -168.0 0.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 110.171 -3.195 . . . . 2.1099999999999999 110.933 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG21 ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -96.87 173.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.574 1.654 . . . . 1.29 113.357 -159.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.5 t70 -110.27 145.23 37.74 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.097 -2.774 . . . . 2.73 105.775 174.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.058 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.9 mp -80.47 -38.26 30.31 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.22 -0.592 . . . . 0.44 111.705 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -62.35 -18.78 62.35 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.809 -0.812 . . . . 1.23 108.809 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.452 ' C ' ' HD2' ' A' ' 52' ' ' LYS . 33.5 m -84.48 -22.63 30.21 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 114.681 -1.145 . . . . 1.3400000000000001 111.532 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 8.0 mmmt -109.16 -67.52 0.98 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.181 -0.918 . . . . 1.3999999999999999 111.623 -174.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.844 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.3 t 8.02 92.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 126.696 1.998 . . . . 0.37 113.912 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.99 -135.97 2.43 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.215 -1.812 . . . . 0.69999999999999996 113.291 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.69 -36.58 79.14 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.967 1.099 . . . . 2.75 113.967 -168.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.704 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -98.19 -36.52 10.02 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 119.741 -0.784 . . . . 1.3300000000000001 111.393 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.837 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.39 103.68 10.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.347 -1.353 . . . . 1.1100000000000001 107.347 173.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.45 115.7 29.88 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 106.448 -1.686 . . . . 0.76000000000000001 106.448 166.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.844 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.02 93.29 5.92 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 104.782 -2.303 . . . . 0.26000000000000001 104.782 172.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 4.3 m-70 -94.41 162.7 13.72 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.43 -1.259 . . . . 2.0299999999999998 109.533 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.0 p-10 -137.09 112.1 8.99 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 111.961 -2.381 . . . . 0.92000000000000004 110.103 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -95.66 150.8 19.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 112.455 -2.157 . . . . 0.46999999999999997 108.525 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CZ ' ' HG2' ' A' ' 65' ' ' ARG . 6.7 t80 -143.67 98.53 3.26 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 122.643 1.211 . . . . 1.3899999999999999 110.983 -173.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' OD2' ' HB3' ' A' ' 67' ' ' SER . 0.1 OUTLIER -110.0 105.47 14.62 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 112.759 -2.019 . . . . 2.4199999999999999 110.045 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HG2' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -75.65 -30.78 59.56 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 2.46 111.038 -175.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.66 -24.49 64.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.208 -0.905 . . . . 1.1499999999999999 110.461 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.539 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 6.5 t -100.94 -12.48 18.9 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.018 -0.734 . . . . 1.4099999999999999 109.018 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 8.7 ttpt 67.18 31.25 6.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.101 -0.954 . . . . 3.3100000000000001 110.5 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 27' ' ' ARG . 5.0 t -125.23 133.54 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.954 0.883 . . . . 0.42999999999999999 110.631 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 1.048 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.9 m-85 -98.8 111.56 23.9 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.518 -2.03 . . . . 1.24 105.518 162.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.2 tp -100.87 104.0 15.2 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.113 0.959 . . . . 0.52000000000000002 108.539 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 58.6 m-85 -84.64 113.39 21.24 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.929 -1.508 . . . . 0.33000000000000002 106.929 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 5.2 pt-20 -117.99 123.85 46.73 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.376 -1.738 . . . . 1.3200000000000001 110.216 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.825 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.1 mm? -91.88 126.87 37.13 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 112.653 -2.067 . . . . 0.95999999999999996 108.127 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -116.19 96.42 5.54 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 104.368 -2.456 . . . . 1.1499999999999999 104.368 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 55.5 mt -122.09 100.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 123.012 1.387 . . . . 0.52000000000000002 109.875 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 45.5 p -104.18 154.38 19.82 Favored 'General case' 0 N--CA 1.394 -3.227 0 CA-C-N 113.964 -1.471 . . . . 0.57999999999999996 108.492 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 44.21 85.7 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.322 -2.672 . . . . 2.1200000000000001 112.429 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -71.85 136.81 47.13 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 110.926 -2.852 . . . . 0.40000000000000002 111.191 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.824 HE21 ' HD2' ' A' ' 81' ' ' PRO . 1.1 tp60 -63.44 130.12 94.08 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.259 -0.645 . . . . 1.4299999999999999 109.259 173.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.824 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.6 Cg_endo -58.71 -13.04 16.27 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.561 2.841 . . . . 1.3300000000000001 114.285 -171.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -120.45 28.8 7.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.887 -0.325 . . . . 1.1200000000000001 111.622 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.557 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.21 -57.27 4.0 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.252 -0.648 . . . . 1.24 109.252 172.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 7.3 m 43.86 58.56 3.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.97 -1.492 . . . . 1.22 106.97 -157.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.745 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -51.26 85.48 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.498 0 CA-C-N 112.545 -2.116 . . . . 1.4299999999999999 114.705 -164.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -92.08 80.71 1.2 Allowed Glycine 0 C--N 1.282 -2.429 0 N-CA-C 108.938 -1.665 . . . . 0.52000000000000002 108.938 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 13.2 m-85 -78.64 109.8 13.18 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.812 -1.194 . . . . 0.63 108.807 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -94.36 105.03 17.0 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.694 -0.854 . . . . 3.1499999999999999 108.694 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.582 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 8.4 t -95.52 126.23 40.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.571 -0.851 . . . . 1.0800000000000001 109.176 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.935 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 92.3 mt-10 -133.96 118.68 18.14 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.65 -0.705 . . . . 1.8100000000000001 110.367 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.522 HG22 HD21 ' A' ' 6' ' ' LEU . 3.4 p -107.52 143.67 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.485 0.659 . . . . 0.54000000000000004 110.133 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 m -140.44 112.59 7.75 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.171 -0.922 . . . . 1.1799999999999999 110.012 -176.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.988 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -130.21 174.95 9.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 118.621 -0.704 . . . . 0.73999999999999999 110.048 177.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -8.61 -60.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.196 1.56 . . . . 0.65000000000000002 114.732 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.916 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.0 t70 -151.11 -8.05 0.25 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.293 -1.321 . . . . 1.05 109.669 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.993 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -91.13 124.88 35.69 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.679 -1.23 . . . . 1.29 107.679 -177.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -131.54 133.64 45.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.293 -0.867 . . . . 0.77000000000000002 111.513 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -154.24 150.53 28.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.701 -1.136 . . . . 1.6000000000000001 109.99 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' SG ' ' HG2' ' A' ' 90' ' ' GLU . 72.1 m -142.5 150.33 40.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.025 -0.361 . . . . 1.1899999999999999 110.025 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.743 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 47.6 p -128.62 135.63 49.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.83999999999999997 111.764 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.47 138.58 33.39 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.297 -0.865 . . . . 1.5800000000000001 109.394 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.925 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -150.1 128.93 12.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.725 -0.79 . . . . 0.85999999999999999 111.879 151.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.74 125.85 54.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.959 0.885 . . . . 2.1099999999999999 111.279 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.94 104.17 14.12 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.133 -1.394 . . . . 0.37 109.575 -178.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.464 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.0 m -84.81 96.28 9.24 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.568 -0.901 . . . . 0.33000000000000002 108.568 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.64 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.6 113.95 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 123.061 1.41 . . . . 0.33000000000000002 109.18 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.719 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.0 m170 -78.55 97.24 5.69 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 112.852 -1.976 . . . . 1.1899999999999999 109.653 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.7 tt0 . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 114.228 -1.351 . . . . 1.6699999999999999 109.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 119.897 -0.096 . . . . 1.6499999999999999 111.153 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.68 84.43 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.63 2.22 . . . . 0.96999999999999997 111.948 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.857 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.0 -59.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.088 -0.96 . . . . 0.5 109.488 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.23 41.4 5.53 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 108.842 -1.703 . . . . 0.39000000000000001 108.842 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -49.74 -38.97 35.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.738 -1.731 . . . . 0.33000000000000002 111.048 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.653 ' HE2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -92.61 84.52 5.07 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.71999999999999997 109.672 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.8 -48.03 35.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.851 -1.068 . . . . 0.63 109.998 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.511 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 16.5 tpt -151.19 129.03 11.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.048 -0.978 . . . . 2.8799999999999999 108.842 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.653 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 16.3 ptm180 -88.2 144.32 34.09 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.733 -0.667 . . . . 3.6699999999999999 110.162 -176.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 59.8 Cg_endo -65.8 145.8 81.73 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.557 2.171 . . . . 0.64000000000000001 110.161 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.591 HE21 ' H ' ' A' ' 13' ' ' ASP . 12.6 tp60 -115.67 159.03 21.89 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 119.331 -0.366 . . . . 1.4299999999999999 111.747 -173.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.591 ' H ' HE21 ' A' ' 12' ' ' GLN . 1.3 m-20 -57.89 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 123.418 1.58 . . . . 2.0600000000000001 113.044 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.18 137.0 2.73 Favored Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 112.963 -1.926 . . . . 0.29999999999999999 111.551 -174.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.434 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.7 mt-10 -116.06 114.45 24.57 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.714 -0.847 . . . . 1.53 108.714 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 22' ' ' ILE . 4.9 m -134.2 164.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.712 -1.218 . . . . 0.27000000000000002 107.712 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -95.21 156.73 16.2 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.886 -1.052 . . . . 0.77000000000000002 109.534 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.579 HG13 ' HD3' ' A' ' 81' ' ' PRO . 42.4 t -62.56 107.02 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-O 122.754 1.264 . . . . 0.78000000000000003 109.294 175.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.09 11.09 Favored Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.912 -2.404 . . . . 0.47999999999999998 113.333 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.7 -122.58 4.84 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 119.616 -1.278 . . . . 0.44 110.009 171.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 11.9 p -150.36 165.04 34.28 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 113.087 -1.557 . . . . 0.81999999999999995 110.645 175.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.724 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.8 tp -148.08 147.48 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.078 -1.874 . . . . 0.32000000000000001 107.18 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m -139.5 125.97 20.36 Favored 'General case' 0 C--N 1.259 -3.354 0 CA-C-N 113.74 -1.573 . . . . 0.31 110.396 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 10.2 m-85 -123.54 146.67 47.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.618 -1.173 . . . . 0.53000000000000003 109.458 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.483 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -126.51 129.93 49.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.038 -1.097 . . . . 0.57999999999999996 108.038 173.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.749 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . . . -130.66 125.16 33.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.57 -1.195 . . . . 0.32000000000000001 110.812 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.5 mtt180 -115.36 123.12 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.842 0.312 . . . . 2.4300000000000002 111.842 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 39' ' ' VAL . 13.2 t -121.69 128.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.775 0.798 . . . . 0.26000000000000001 109.593 178.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -57.63 107.38 0.44 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.881 -1.508 . . . . 0.40000000000000002 110.527 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.699 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -55.79 -39.1 75.93 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.731 -1.122 . . . . 0.76000000000000001 110.925 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.67 -163.93 0.03 OUTLIER 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.695 1.368 . . . . 0.70999999999999996 114.695 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -111.64 123.02 49.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.443 -1.253 . . . . 1.74 108.153 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.889 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -155.1 174.65 14.89 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.673 0.249 . . . . 2.1600000000000001 111.673 -172.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.6 tp -62.07 -47.99 82.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 1.47 109.539 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -151.15 154.59 34.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.059 -0.973 . . . . 1.3999999999999999 108.963 170.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -44.14 134.37 8.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.627 2.885 . . . . 0.88 112.049 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.889 ' HD3' HD11 ' A' ' 33' ' ' LEU . 8.7 Cg_exo -42.89 142.87 1.98 Allowed 'Trans proline' 0 CA--C 1.499 -1.232 0 C-N-CA 123.849 3.033 . . . . 0.53000000000000003 115.189 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.1 99.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 105.875 -1.898 . . . . 0.77000000000000002 105.875 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.6 t -103.42 114.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-N 113.504 -1.68 . . . . 0.28000000000000003 107.415 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.882 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.76 128.59 52.94 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.057 -1.429 . . . . 1.54 109.743 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.964 ' HB3' HD13 ' A' ' 49' ' ' LEU . 74.0 m95 -91.51 157.86 16.79 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 112.063 -2.335 . . . . 0.34000000000000002 111.104 172.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.744 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.9 t80 -139.06 125.51 20.44 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.934 -2.247 . . . . 0.62 104.934 178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.703 ' HD3' HD23 ' A' ' 57' ' ' LEU . 33.8 ttpt -103.02 100.34 10.27 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.715 -1.587 . . . . 2.1699999999999999 106.715 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 86' ' ' GLY . . . -90.38 97.46 2.33 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 115.993 -3.004 . . . . 1.23 117.293 -157.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 3.8 ptmt -99.14 -47.39 5.23 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.449 -2.797 . . . . 3.8700000000000001 103.449 137.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.927 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 9.4 p-90 -170.38 3.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 112.468 -2.151 . . . . 2.1099999999999999 111.102 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -98.82 169.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 C-N-CA 125.04 1.336 . . . . 1.29 112.981 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.643 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -105.43 154.15 20.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.455 -2.157 . . . . 2.73 107.001 175.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.964 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.4 mp -89.24 -30.46 18.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 0.44 112.605 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -57.2 -21.0 30.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.349 0.595 . . . . 1.23 109.854 -167.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.567 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 8.0 t -96.38 -22.55 17.1 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.178 -0.919 . . . . 1.3400000000000001 111.992 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 1.7 mmmt -106.55 -15.19 14.85 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.778 -1.101 . . . . 1.3999999999999999 111.671 -171.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.922 HG13 ' H ' ' A' ' 59' ' ' LEU . 55.7 t -59.17 89.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 114.013 -1.449 . . . . 0.37 110.213 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.49 -142.1 3.58 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 112.438 -2.165 . . . . 0.69999999999999996 112.988 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -67.4 -22.63 65.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.007 0.744 . . . . 2.75 113.007 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.607 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.1 p-80 -101.21 -38.02 8.29 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 120.23 -0.588 . . . . 1.3300000000000001 111.247 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.826 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.69 102.25 8.28 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.144 -1.799 . . . . 1.1100000000000001 106.144 172.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -94.41 115.02 27.15 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.724 -1.584 . . . . 0.76000000000000001 106.724 167.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.922 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.95 91.49 5.35 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.114 -2.55 . . . . 0.26000000000000001 104.114 167.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.727 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 34.4 m170 -90.18 162.43 15.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.228 -1.351 . . . . 2.0299999999999998 110.039 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -133.57 110.48 9.94 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 112.323 -2.217 . . . . 0.92000000000000004 109.866 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 14.2 m -93.95 112.36 24.19 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.89 -1.959 . . . . 0.46999999999999997 109.322 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.0 t80 -102.23 98.08 8.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.96 -1.018 . . . . 1.3899999999999999 110.212 -176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.91 107.08 15.21 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.585 -1.643 . . . . 2.4199999999999999 109.141 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.549 ' HD3' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -81.45 -32.72 32.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.382 -0.827 . . . . 2.46 110.968 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.58 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.229 -0.896 . . . . 1.1499999999999999 110.527 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 m -108.66 -18.63 13.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.72 -0.844 . . . . 1.4099999999999999 108.72 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.699 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 62.99 35.65 13.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 3.3100000000000001 109.979 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -129.62 130.69 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.002 -0.999 . . . . 0.42999999999999999 108.392 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.55 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 3.9 m-30 -101.26 106.72 17.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.599 -1.63 . . . . 1.24 106.599 171.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 22.7 tp -96.12 104.42 16.37 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.189 -1.368 . . . . 0.52000000000000002 108.316 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.727 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.7 m-85 -83.53 113.47 20.83 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 113.819 -1.537 . . . . 0.33000000000000002 107.533 174.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 6.6 mt-10 -106.84 119.02 38.22 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 113.113 -1.858 . . . . 1.3200000000000001 108.935 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 76' ' ' ILE . 3.1 mm? -88.36 122.76 32.23 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.454 -1.313 . . . . 0.95999999999999996 107.454 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 36.8 m80 -118.31 95.67 4.98 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 104.327 -2.472 . . . . 1.1499999999999999 104.327 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 74' ' ' LEU . 39.4 mt -122.11 101.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 123.041 1.4 . . . . 0.52000000000000002 110.2 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.2 p -110.53 134.79 52.05 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-N 113.621 -1.627 . . . . 0.57999999999999996 107.692 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 77' ' ' THR . 3.5 t70 73.14 97.31 0.07 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 111.642 -2.526 . . . . 2.1200000000000001 110.024 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.74 122.77 45.14 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 110.552 -3.022 . . . . 0.40000000000000002 109.943 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.546 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -64.24 138.26 97.37 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.153 -0.93 . . . . 1.4299999999999999 109.577 173.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.579 ' HD3' HG13 ' A' ' 18' ' ' VAL . 26.2 Cg_endo -61.44 -9.06 12.04 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.23 2.62 . . . . 1.3300000000000001 112.421 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.63 17.67 22.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.835 -0.621 . . . . 1.1200000000000001 111.441 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.753 ' HD1' ' HD2' ' A' ' 45' ' ' LYS . 1.4 m-30 -85.43 -55.33 4.06 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.91 -0.774 . . . . 1.24 108.91 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 88.7 m 28.51 63.84 0.11 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 123.183 1.468 . . . . 1.22 108.68 -161.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.751 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -66.55 91.61 0.17 Allowed Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 111.975 -2.375 . . . . 1.4299999999999999 114.05 -159.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -83.61 83.74 1.6 Allowed Glycine 0 C--N 1.276 -2.768 0 N-CA-C 108.185 -1.966 . . . . 0.52000000000000002 108.185 169.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 3.7 m-85 -74.6 113.65 12.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.685 -1.257 . . . . 0.63 108.812 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 99.8 mtt180 -87.89 109.76 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.391 -0.966 . . . . 3.1499999999999999 108.391 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.419 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 1.6 t -95.97 122.67 39.04 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.601 -0.888 . . . . 1.0800000000000001 108.601 175.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.882 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 38.5 tt0 -137.82 107.64 6.29 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.244 -0.889 . . . . 1.8100000000000001 110.289 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.6 p -102.59 141.57 18.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.676 0.75 . . . . 0.54000000000000004 110.699 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -139.86 108.33 5.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.342 -1.299 . . . . 1.1799999999999999 108.561 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.743 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.47 145.33 51.1 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-O 117.936 -1.03 . . . . 0.73999999999999999 108.894 -179.045 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 32.95 -74.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 126.148 2.155 . . . . 0.65000000000000002 113.578 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.68 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -148.16 -8.07 0.4 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.035 -0.984 . . . . 1.05 110.563 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.857 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.9 mmtm -86.05 129.53 34.81 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.432 -1.321 . . . . 1.29 107.432 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 21.3 t80 -132.33 148.39 52.43 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.85 -1.523 . . . . 0.77000000000000002 111.773 -173.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 t70 -179.0 165.39 1.52 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.207 0.942 . . . . 1.6000000000000001 110.33 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.3 m -145.22 151.73 38.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.267 -0.271 . . . . 1.1899999999999999 110.267 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.595 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 58.5 p -132.6 130.31 40.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.041 0.448 . . . . 0.83999999999999997 112.149 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -94.56 127.32 40.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.368 -0.833 . . . . 1.5800000000000001 109.393 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 87' ' ' TYR . 28.4 p90 -149.38 143.75 25.96 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.119 -0.632 . . . . 0.85999999999999999 109.872 165.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.9 m-80 -115.8 140.23 49.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.255 1.026 . . . . 2.1099999999999999 112.471 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.82 107.99 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.336 -1.302 . . . . 0.37 108.463 172.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.434 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 3.8 m -87.81 96.38 10.44 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.253 -0.647 . . . . 0.33000000000000002 109.253 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.4 p -79.41 112.78 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.25 1.5 . . . . 0.33000000000000002 108.672 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 44.0 m170 -85.65 100.34 11.91 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.527 -2.124 . . . . 1.1899999999999999 109.421 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.449 ' HA ' HG23 ' A' ' 18' ' ' VAL . 37.1 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 114.805 -1.089 . . . . 1.6699999999999999 109.836 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 9.8 m-20 . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 110.067 -0.345 . . . . 1.6499999999999999 110.067 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.38 88.18 0.33 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.311 2.007 . . . . 0.96999999999999997 111.889 172.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.92 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.13 -65.16 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.378 -0.828 . . . . 0.5 109.537 177.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 93.8 49.06 2.57 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 108.595 -1.802 . . . . 0.39000000000000001 108.595 -174.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.8 tp -61.41 -33.39 73.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.083 -1.558 . . . . 0.33000000000000002 110.22 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.653 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -91.68 84.66 5.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.931 -1.031 . . . . 0.71999999999999997 110.088 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.57 -46.6 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.899 -1.046 . . . . 0.63 110.405 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.11 131.03 11.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 2.8799999999999999 109.708 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.542 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 21.2 ptt180 -108.12 142.89 26.27 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.575 -0.739 . . . . 3.6699999999999999 109.843 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.781 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 11.0 Cg_endo -73.4 158.09 48.64 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.538 1.492 . . . . 0.64000000000000001 110.82 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -116.3 -180.0 3.83 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.363 -0.606 . . . . 1.4299999999999999 109.363 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 2.0 p-10 -71.55 -148.92 0.02 OUTLIER 'General case' 0 N--CA 1.407 -2.578 0 CA-C-O 122.932 1.348 . . . . 2.0600000000000001 111.635 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.69 133.82 1.69 Allowed Glycine 0 C--N 1.293 -1.819 0 CA-C-N 113.356 -1.747 . . . . 0.29999999999999999 112.045 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.2 mt-10 -113.82 111.12 21.22 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.006 -1.097 . . . . 1.53 108.082 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.424 HG11 ' HB ' ' A' ' 22' ' ' ILE . 3.0 m -126.74 163.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 106.666 -1.605 . . . . 0.27000000000000002 106.666 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.74 154.61 17.48 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 115.404 -0.816 . . . . 0.77000000000000002 109.27 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.719 HG21 ' HG3' ' A' ' 81' ' ' PRO . 3.1 t -64.33 106.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 CA-C-O 122.719 1.247 . . . . 0.78000000000000003 108.365 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.13 8.64 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.378 -2.192 . . . . 0.47999999999999998 112.145 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.96 -122.28 4.82 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 108.73 -1.748 . . . . 0.44 108.73 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.2 p -151.94 171.1 18.31 Favored 'General case' 0 N--CA 1.399 -3.015 0 CA-C-N 113.344 -1.428 . . . . 0.81999999999999995 109.894 172.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 104' ' ' LEU . 10.5 tp -146.34 147.53 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 113.276 -1.783 . . . . 0.32000000000000001 107.316 166.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -139.03 123.96 18.8 Favored 'General case' 0 C--N 1.262 -3.214 0 CA-C-N 113.333 -1.758 . . . . 0.31 110.241 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 74' ' ' LEU . 73.1 m-85 -123.44 145.66 48.63 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.129 -1.396 . . . . 0.53000000000000003 107.769 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.795 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.3 m -138.18 124.91 20.99 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.745 0.783 . . . . 0.57999999999999996 109.439 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -116.7 115.73 26.2 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.285 -1.325 . . . . 0.32000000000000001 110.48 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HE ' HG11 ' A' ' 69' ' ' VAL . 77.1 mtp180 -106.41 115.57 30.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.654 -0.248 . . . . 2.4300000000000002 110.549 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 91' ' ' VAL . 22.0 t -118.92 126.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.958 0.885 . . . . 0.26000000000000001 110.523 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.14 112.06 1.76 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.337 -1.756 . . . . 0.40000000000000002 110.724 173.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.53 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -45.2 -51.53 8.91 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 114.794 -1.094 . . . . 0.76000000000000001 111.269 171.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.611 ' H ' ' CG ' ' A' ' 68' ' ' LYS . . . 55.49 -155.77 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.408 0.892 . . . . 0.70999999999999996 113.408 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 p -115.68 135.92 53.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.861 -0.608 . . . . 1.74 109.953 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -155.08 -174.61 5.05 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.826 0.822 . . . . 2.1600000000000001 112.8 -175.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.3 tp -98.06 -45.17 6.35 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.27 -1.332 . . . . 1.47 108.128 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.554 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.39 139.05 29.02 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.723 -1.126 . . . . 1.3999999999999999 108.982 172.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.11 156.57 24.09 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.956 2.437 . . . . 0.88 111.103 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 93' ' ' THR . 3.3 Cg_endo -57.1 125.15 18.04 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.544 0.829 . . . . 0.53000000000000003 112.716 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 104.54 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.054 -1.462 . . . . 0.77000000000000002 107.054 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.5 t -102.73 114.42 42.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.832 -1.531 . . . . 0.28000000000000003 108.397 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.02 127.85 53.05 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.743 -1.571 . . . . 1.54 109.817 175.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.99 ' HB3' HD13 ' A' ' 49' ' ' LEU . 77.0 m95 -91.63 155.03 18.63 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 111.969 -2.378 . . . . 0.34000000000000002 111.677 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.642 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 39.7 t80 -133.36 139.9 47.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.316 -2.476 . . . . 0.62 104.316 170.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.817 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 62.9 tttp -102.51 166.61 10.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 105.721 -1.955 . . . . 2.1699999999999999 105.721 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -14.03 -167.31 0.0 OUTLIER Glycine 0 C--O 1.183 -3.088 0 N-CA-C 119.248 2.459 . . . . 1.23 119.248 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.693 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 8.4 mtpt -44.41 -8.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 O-C-N 119.125 -2.397 . . . . 3.8700000000000001 116.786 -164.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.517 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 9.9 p-90 -160.8 -9.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 114.101 1.148 . . . . 2.1099999999999999 114.101 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.817 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.92 164.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 CA-C-O 123.218 1.485 . . . . 1.29 112.481 -160.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.575 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 9.9 p-10 -111.1 158.54 18.75 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 111.815 -2.448 . . . . 2.73 106.508 172.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.091 HD23 HD21 ' A' ' 57' ' ' LEU . 5.7 mp -98.88 -28.74 13.32 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.476 -0.49 . . . . 0.44 111.792 167.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -57.3 -21.37 34.37 Favored 'General case' 0 C--N 1.315 -0.891 0 O-C-N 123.706 0.629 . . . . 1.23 109.864 -163.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 33.2 m -100.03 -35.38 9.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 122.033 0.921 . . . . 1.3400000000000001 112.224 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.575 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -88.61 -31.29 18.66 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.159 -1.382 . . . . 1.3999999999999999 111.685 -165.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.846 HG13 ' H ' ' A' ' 59' ' ' LEU . 79.2 t -35.46 94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.392 1.477 . . . . 0.37 111.753 172.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.44 -95.91 0.11 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 112.501 -2.136 . . . . 0.69999999999999996 113.837 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -95.3 -45.37 7.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.944 0.72 . . . . 2.75 112.944 -172.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 31.5 p80 -88.45 -37.11 16.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.736 0.779 . . . . 1.3300000000000001 110.609 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.091 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.55 106.92 12.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.428 -1.693 . . . . 1.1100000000000001 106.428 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.81 116.13 31.98 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 106.63 -1.619 . . . . 0.76000000000000001 106.63 164.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.846 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -95.19 93.8 7.53 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 104.829 -2.285 . . . . 0.26000000000000001 104.829 173.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 90.3 m-70 -84.33 162.49 20.04 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.338 -1.301 . . . . 2.0299999999999998 109.887 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -140.13 114.76 9.41 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 111.986 -2.37 . . . . 0.92000000000000004 109.42 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 2.0 m -101.52 149.35 24.18 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.796 -2.002 . . . . 0.46999999999999997 108.628 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -141.29 98.62 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.569 1.175 . . . . 1.3899999999999999 111.251 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.46 101.71 9.39 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.315 -1.766 . . . . 2.4199999999999999 109.319 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -73.85 -29.58 62.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.508 -0.769 . . . . 2.46 110.228 177.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.98 70.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.106 -0.952 . . . . 1.1499999999999999 110.668 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -103.36 -13.81 16.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.209 -0.905 . . . . 1.4099999999999999 109.455 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER 63.36 36.88 11.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.872 0.844 . . . . 3.3100000000000001 109.898 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.431 HG11 ' HE ' ' A' ' 27' ' ' ARG . 3.2 t -127.41 128.1 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.673 0.749 . . . . 0.42999999999999999 109.726 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.53 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.7 m-85 -98.19 113.36 25.25 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.922 -1.881 . . . . 1.24 105.922 164.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' A' ' 25' ' ' SER . 21.7 tp -99.06 106.4 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 122.217 1.008 . . . . 0.52000000000000002 109.374 174.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 55.3 m-85 -84.47 113.33 21.13 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 113.726 -1.579 . . . . 0.33000000000000002 107.953 168.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.9 116.84 32.37 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.67 -1.604 . . . . 1.3200000000000001 110.7 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.802 ' HB3' HG13 ' A' ' 76' ' ' ILE . 18.0 mt -81.97 123.65 29.07 Favored 'General case' 0 CA--C 1.475 -1.926 0 CA-C-N 115.081 -0.963 . . . . 0.95999999999999996 108.927 170.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -111.73 93.65 4.56 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 103.108 -2.923 . . . . 1.1499999999999999 103.108 163.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 74' ' ' LEU . 18.1 mt -118.39 99.96 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 122.83 1.3 . . . . 0.52000000000000002 109.255 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.0 p -102.85 166.51 10.43 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 114.078 -1.419 . . . . 0.57999999999999996 110.439 -176.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 41.03 67.38 0.53 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 110.658 -2.974 . . . . 2.1200000000000001 111.551 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -62.18 120.01 10.1 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.894 -1.957 . . . . 0.40000000000000002 111.252 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.879 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -54.91 140.21 61.22 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.349 -0.841 . . . . 1.4299999999999999 109.728 169.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.719 ' HG3' HG21 ' A' ' 18' ' ' VAL . 23.2 Cg_exo -62.9 -10.25 19.58 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.692 2.261 . . . . 1.3300000000000001 112.465 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.879 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -98.64 10.76 40.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.962 -0.563 . . . . 1.1200000000000001 110.773 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 83' ' ' PHE . 2.8 m-30 -95.54 -10.84 28.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.722 -0.391 . . . . 1.24 110.898 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 21.8 m -46.11 101.31 0.02 OUTLIER 'General case' 0 CA--C 1.475 -1.92 0 CA-C-O 122.358 1.075 . . . . 1.22 108.802 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.693 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -172.69 -128.79 1.08 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.701 -2.045 . . . . 1.4299999999999999 113.383 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.95 119.03 0.88 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.174 -1.013 . . . . 0.52000000000000002 112.712 -170.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.713 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.0 m-85 -82.81 120.94 26.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.348 -1.426 . . . . 0.63 108.212 175.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.642 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 57.7 ttt180 -110.91 104.49 13.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.976 0.417 . . . . 3.1499999999999999 110.193 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.879 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.7 t -92.19 129.86 38.04 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.05 -0.722 . . . . 1.0800000000000001 109.05 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.691 ' HG3' ' HB3' ' A' ' 99' ' ' CYS . 30.6 tt0 -140.22 106.69 5.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.477 -0.783 . . . . 1.8100000000000001 109.458 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.634 HG21 HG11 ' A' ' 28' ' ' VAL . 5.5 p -95.05 138.01 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 121.858 0.837 . . . . 0.54000000000000004 110.73 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.2 t -133.29 108.88 9.01 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.146 -1.388 . . . . 1.1799999999999999 107.94 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.599 ' OG1' HD21 ' A' ' 6' ' ' LEU . 2.4 m -127.27 170.06 12.86 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.888 -1.153 . . . . 0.73999999999999999 107.888 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.723 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 0.82 -65.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 125.513 1.758 . . . . 0.65000000000000002 114.555 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.723 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 1.2 t0 -148.82 -8.96 0.35 Allowed 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.837 -1.074 . . . . 1.05 109.967 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.92 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.2 mmtm -87.5 124.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.79 -1.189 . . . . 1.29 107.79 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -130.65 137.41 49.58 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.735 -1.12 . . . . 0.77000000000000002 111.153 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -163.07 161.85 25.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.79 -1.096 . . . . 1.6000000000000001 108.892 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.691 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 3.9 p -153.46 145.33 23.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.152 0.501 . . . . 1.1899999999999999 111.183 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.653 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 42.5 p -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.83999999999999997 111.253 -175.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.94 125.27 50.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.226 0.536 . . . . 1.5800000000000001 110.868 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.879 ' HZ ' ' HB2' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -140.1 116.18 10.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.431 -0.581 . . . . 0.85999999999999999 109.431 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.574 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 51.1 m-20 -95.16 151.65 19.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.292 -0.867 . . . . 2.1099999999999999 110.846 -168.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -123.95 121.28 34.87 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.256 -0.884 . . . . 0.37 108.806 174.235 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -103.35 96.05 6.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.416 -0.586 . . . . 0.33000000000000002 109.416 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.5 p -77.63 116.19 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 123.077 1.418 . . . . 0.33000000000000002 109.05 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 64.8 m170 -87.56 102.02 14.19 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.395 -2.184 . . . . 1.1899999999999999 108.275 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.609 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 33.0 tt0 . . . . . 0 C--N 1.299 -1.595 0 CA-C-N 114.133 -1.394 . . . . 1.6699999999999999 111.277 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.801 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 2.3 m-20 . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 109.4 -0.593 . . . . 1.6499999999999999 109.4 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.01 77.07 4.07 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.848 1.699 . . . . 0.96999999999999997 113.19 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.826 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -93.87 -62.6 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.315 -0.994 . . . . 0.5 108.315 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.7 4.64 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 109.368 -1.493 . . . . 0.39000000000000001 109.368 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.737 HD22 ' HB3' ' A' ' 96' ' ' LYS . 3.7 tp -41.04 -44.37 2.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 112.897 -1.652 . . . . 0.33000000000000002 111.421 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.691 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -93.0 84.43 4.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.246 -0.888 . . . . 0.71999999999999997 109.793 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 27' ' ' ARG . 15.8 t -76.16 -33.06 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.018 -1.446 . . . . 0.63 109.187 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp -167.95 137.41 2.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.095 -0.957 . . . . 2.8799999999999999 109.639 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 27.7 ptt180 -105.66 148.79 37.02 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.933 -0.576 . . . . 3.6699999999999999 110.079 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 13.5 Cg_endo -79.48 164.52 23.73 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.646 1.564 . . . . 0.64000000000000001 110.728 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -123.7 179.3 4.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.326 -0.397 . . . . 1.4299999999999999 110.337 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.2 -144.59 0.01 OUTLIER 'General case' 0 N--CA 1.41 -2.433 0 CA-C-O 122.809 1.29 . . . . 2.0600000000000001 110.98 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.34 132.26 1.79 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.606 -1.634 . . . . 0.29999999999999999 111.726 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.0 mt-10 -110.49 114.16 27.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.981 -1.109 . . . . 1.53 108.213 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.9 m -134.48 162.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 N-CA-C 107.821 -1.177 . . . . 0.27000000000000002 107.821 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 153.15 17.95 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.487 -1.233 . . . . 0.77000000000000002 108.738 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.74 HG11 ' HD3' ' A' ' 81' ' ' PRO . 5.8 t -69.0 105.01 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.826 1.298 . . . . 0.78000000000000003 107.956 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.22 12.54 5.22 Favored Glycine 0 C--N 1.267 -3.304 0 CA-C-N 112.445 -2.162 . . . . 0.47999999999999998 112.642 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.03 -122.66 5.14 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.264 -1.446 . . . . 0.44 110.366 170.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.705 ' HB3' HG22 ' A' ' 77' ' ' THR . 8.1 p -151.51 169.41 22.14 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 113.054 -1.573 . . . . 0.81999999999999995 110.329 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -148.19 149.98 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.539 -1.664 . . . . 0.32000000000000001 107.285 168.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 m -140.15 131.49 26.75 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.022 -1.445 . . . . 0.31 110.947 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.547 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 50.0 m-85 -129.55 148.05 51.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.148 -1.387 . . . . 0.53000000000000003 108.764 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.566 ' HB3' HD11 ' A' ' 71' ' ' LEU . 3.5 m -140.08 127.33 21.17 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.879 0.847 . . . . 0.57999999999999996 109.188 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.12 117.23 24.92 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.125 -1.398 . . . . 0.32000000000000001 110.718 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 75.2 mtt180 -102.07 121.78 42.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.3 -0.409 . . . . 2.4300000000000002 110.505 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.1 t -126.06 128.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 122.082 0.944 . . . . 0.26000000000000001 110.531 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.36 105.39 0.5 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.444 -1.707 . . . . 0.40000000000000002 112.398 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.26 89.08 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 115.061 -0.972 . . . . 0.76000000000000001 111.745 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.851 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 57.54 -163.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.783 1.031 . . . . 0.70999999999999996 113.783 162.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -118.89 31.13 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 1.74 109.529 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.015 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -56.1 -175.76 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.639 1.348 . . . . 2.1600000000000001 114.639 176.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 tp -68.98 -53.95 17.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.04 -0.982 . . . . 1.47 109.593 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.632 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.88 146.49 47.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 114.846 -1.07 . . . . 1.3999999999999999 108.688 172.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -42.98 140.37 3.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.464 2.776 . . . . 0.88 111.934 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.7 Cg_endo -53.16 136.59 62.17 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.563 1.509 . . . . 0.53000000000000003 112.761 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.01 104.31 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.638 0 N-CA-C 106.157 -1.794 . . . . 0.77000000000000002 106.157 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -106.88 114.75 46.79 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 113.136 -1.847 . . . . 0.28000000000000003 107.785 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.974 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.69 125.33 50.11 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.825 -1.534 . . . . 1.54 109.58 174.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.997 ' HB3' HD13 ' A' ' 49' ' ' LEU . 68.0 m95 -86.45 149.1 25.23 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.816 -2.447 . . . . 0.34000000000000002 111.482 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.618 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 25.8 t80 -125.37 138.55 54.04 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 104.66 -2.348 . . . . 0.62 104.66 169.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 67.5 tttt -99.35 171.13 8.17 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.612 -1.996 . . . . 2.1699999999999999 105.612 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.929 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -19.56 -173.59 0.0 OUTLIER Glycine 0 C--O 1.179 -3.308 0 C-N-CA 126.749 2.118 . . . . 1.23 117.878 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.649 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 7.8 ttpp -40.98 -9.56 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 117.577 2.436 . . . . 3.8700000000000001 117.577 -157.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.649 ' HD1' ' HB3' ' A' ' 45' ' ' LYS . 4.8 p-90 -161.58 -7.05 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.287 0.949 . . . . 2.1099999999999999 113.342 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -95.39 165.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-O 123.014 1.388 . . . . 1.29 112.601 -158.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.689 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 6.5 p-10 -114.05 154.3 27.95 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 112.022 -2.353 . . . . 2.73 109.284 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.054 HD23 HD21 ' A' ' 57' ' ' LEU . 5.6 mp -98.44 -32.24 11.59 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.774 -0.648 . . . . 0.44 111.637 169.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -59.47 -23.38 62.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.369 -0.604 . . . . 1.23 109.369 -166.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.689 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 6.2 m -102.95 -27.69 12.47 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.621 -0.832 . . . . 1.3400000000000001 113.023 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 11.4 mptt -80.78 -84.61 0.1 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.716 -0.674 . . . . 1.3999999999999999 111.584 -173.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 24.7 t 21.68 95.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 126.068 2.105 . . . . 0.37 113.966 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.93 -99.54 0.14 Allowed Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.132 -1.395 . . . . 0.69999999999999996 113.264 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -83.2 -53.57 5.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.321 0.489 . . . . 2.75 112.321 -170.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.9 p80 -92.02 -33.83 14.67 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.235 -0.586 . . . . 1.3300000000000001 111.432 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.054 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.39 106.24 14.35 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.112 -1.81 . . . . 1.1100000000000001 106.112 174.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -101.35 116.72 33.43 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.949 -1.5 . . . . 0.76000000000000001 106.949 165.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.88 92.96 6.08 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.216 -2.142 . . . . 0.26000000000000001 105.216 170.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.942 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.8 m170 -87.99 162.1 17.03 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.673 -1.149 . . . . 2.0299999999999998 109.912 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -142.13 115.71 9.09 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.214 -2.267 . . . . 0.92000000000000004 109.784 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.2 m -95.82 150.33 20.53 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.393 -2.185 . . . . 0.46999999999999997 109.038 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.74 100.61 5.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.517 1.151 . . . . 1.3899999999999999 111.422 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.5 t70 -114.42 114.25 25.59 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.292 -1.776 . . . . 2.4199999999999999 108.819 174.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.431 ' C ' ' H ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.63 -37.13 17.05 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.054 -0.975 . . . . 2.46 112.133 -177.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.07 68.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.43 0.633 . . . . 1.1499999999999999 110.113 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -104.12 -11.86 17.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.056 -0.974 . . . . 1.4099999999999999 109.898 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.833 ' HE3' ' HA ' ' A' ' 31' ' ' ALA 0.295 0.2 OUTLIER 38.84 57.8 1.82 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 124.49 2.091 . . . . 3.3100000000000001 111.568 -166.528 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 t -122.91 115.31 45.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 112.373 -2.194 . . . . 0.42999999999999999 109.355 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 62' ' ' SER . 34.1 m-85 -91.25 105.96 18.16 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.898 -1.519 . . . . 1.24 106.898 167.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.7 tp -86.51 104.5 16.03 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.681 -1.145 . . . . 0.52000000000000002 108.522 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.653 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 80.5 m-85 -87.25 110.81 20.45 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.795 -1.557 . . . . 0.33000000000000002 106.795 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.942 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -114.3 125.59 54.06 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.148 -1.387 . . . . 1.3200000000000001 110.136 -176.585 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.694 HD13 HD11 ' A' ' 76' ' ' ILE . 2.6 mt -92.41 131.9 37.2 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 113.571 -1.65 . . . . 0.95999999999999996 108.437 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -119.88 97.43 5.62 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 104.491 -2.411 . . . . 1.1499999999999999 104.491 165.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.712 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 14.3 mt -123.47 99.85 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.624 1.202 . . . . 0.52000000000000002 108.871 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' HB3' ' A' ' 21' ' ' SER . 25.0 p -99.04 166.69 11.15 Favored 'General case' 0 N--CA 1.395 -3.22 0 CA-C-O 122.891 1.329 . . . . 0.57999999999999996 110.444 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 40.58 74.17 0.11 Allowed 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 110.361 -3.108 . . . . 2.1200000000000001 111.468 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -64.34 115.11 4.75 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.765 -2.016 . . . . 0.40000000000000002 108.701 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -67.42 159.62 76.7 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.708 -0.849 . . . . 1.4299999999999999 108.708 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.74 ' HD3' HG11 ' A' ' 18' ' ' VAL . 68.5 Cg_endo -73.68 156.34 49.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 120.984 1.123 . . . . 1.3300000000000001 111.394 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.4 15.5 9.56 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.747 0.655 . . . . 1.1200000000000001 110.523 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.781 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -85.29 -8.28 58.59 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.791 -0.623 . . . . 1.24 109.621 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.755 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 23.2 m -10.98 84.9 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 126.042 2.089 . . . . 1.22 111.974 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.929 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.76 118.34 3.59 Favored Glycine 0 N--CA 1.406 -3.333 0 CA-C-N 110.816 -2.902 . . . . 1.4299999999999999 113.478 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.53 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -116.34 63.38 0.36 Allowed Glycine 0 C--N 1.266 -3.328 0 CA-C-N 112.545 -1.827 . . . . 0.52000000000000002 108.716 158.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 75.8 m-85 -73.02 106.78 5.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.204 -1.406 . . . . 0.63 107.204 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.618 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 55.3 mtt-85 -118.3 105.36 11.67 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.242 -0.583 . . . . 3.1499999999999999 109.967 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.672 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -89.36 124.48 34.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.861 -0.608 . . . . 1.0800000000000001 109.642 -177.06 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.974 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 36.9 tt0 -129.2 110.81 12.29 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.77 -1.104 . . . . 1.8100000000000001 109.244 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.625 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.2 p -99.97 139.95 20.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.429 0.633 . . . . 0.54000000000000004 110.151 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -137.02 110.05 7.71 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.788 -1.097 . . . . 1.1799999999999999 108.329 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.746 HG21 HD12 ' A' ' 33' ' ' LEU . 1.1 m -129.86 167.41 18.18 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.925 -0.769 . . . . 0.73999999999999999 108.925 -176.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.801 ' HZ3' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 6.75 -69.16 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.668 1.855 . . . . 0.65000000000000002 114.028 172.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.411 ' H ' ' HE2' ' A' ' 94' ' ' LYS . 7.5 t70 -154.23 1.98 0.23 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.672 -0.695 . . . . 1.05 109.134 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.826 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -91.68 136.19 33.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 122.073 0.94 . . . . 1.29 108.812 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -132.52 134.02 44.48 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 112.683 -2.053 . . . . 0.77000000000000002 111.592 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -157.0 148.07 21.89 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.813 -1.085 . . . . 1.6000000000000001 110.47 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.2 149.35 34.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.836 -0.62 . . . . 1.1899999999999999 109.838 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.691 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 80.4 p -141.41 136.12 31.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.959 0.409 . . . . 0.83999999999999997 110.386 176.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.597 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -107.53 130.09 54.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.799 -0.637 . . . . 1.5800000000000001 109.395 175.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.78 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -141.1 112.83 7.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.649 0.737 . . . . 0.85999999999999999 109.496 -177.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.769 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 61.5 m-20 -95.37 148.76 22.1 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.51 1.148 . . . . 2.1099999999999999 111.359 -167.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.807 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -119.31 108.78 15.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.052 -1.431 . . . . 0.37 110.796 177.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.2 m -91.54 96.92 10.74 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.687 -0.856 . . . . 0.33000000000000002 108.687 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 18' ' ' VAL . 8.0 p -86.88 120.76 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.096 1.427 . . . . 0.33000000000000002 109.782 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -95.41 100.97 12.66 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 112.145 -2.298 . . . . 1.1899999999999999 108.987 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.713 ' HA ' HG23 ' A' ' 18' ' ' VAL . 48.7 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 114.255 -1.339 . . . . 1.6699999999999999 110.743 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.548 ' HB2' HD13 ' A' ' 4' ' ' ILE . 15.2 m-20 . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 119.645 -0.216 . . . . 1.6499999999999999 110.623 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 41.77 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.076 2.517 . . . . 0.96999999999999997 113.386 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.799 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -61.59 -50.01 82.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.696 0.76 . . . . 0.5 109.537 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.21 30.55 22.23 Favored Glycine 0 CA--C 1.497 -1.064 0 N-CA-C 109.176 -1.57 . . . . 0.39000000000000001 109.176 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.001 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 10.6 tp -41.8 -54.41 3.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.981 -1.609 . . . . 0.33000000000000002 111.426 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.752 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -84.57 83.89 7.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.54 0.686 . . . . 0.71999999999999997 109.801 176.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.69 -45.37 66.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.66 -1.155 . . . . 0.63 109.767 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.742 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 22.8 mmt -136.68 132.63 35.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.688 -0.687 . . . . 2.8799999999999999 110.027 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.745 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 88.0 mtt180 -90.98 121.82 67.47 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.052 -0.721 . . . . 3.6699999999999999 109.052 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.68 ' HG2' ' HE1' ' A' ' 102' ' ' PHE . 18.6 Cg_endo -62.21 156.75 48.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.858 2.372 . . . . 0.64000000000000001 110.856 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 11.1 tp60 -120.0 160.07 23.49 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 119.075 -0.488 . . . . 1.4299999999999999 112.185 -167.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.605 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -58.41 -144.77 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 123.053 1.406 . . . . 2.0600000000000001 112.611 176.126 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 151.38 135.31 2.29 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 113.404 -1.726 . . . . 0.29999999999999999 111.951 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 26.2 mt-10 -111.03 118.74 36.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.476 -0.935 . . . . 1.53 108.476 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 22' ' ' ILE . 2.3 m -139.23 162.97 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.706 -1.22 . . . . 0.27000000000000002 107.706 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.768 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.19 158.11 15.75 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.142 -0.936 . . . . 0.77000000000000002 109.489 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 106' ' ' VAL . 10.1 t -66.18 107.68 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 122.993 1.378 . . . . 0.78000000000000003 108.365 172.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 12.2 10.71 Favored Glycine 0 C--N 1.269 -3.159 0 CA-C-N 112.097 -2.32 . . . . 0.47999999999999998 112.833 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.35 -124.7 5.09 Favored Glycine 0 N--CA 1.418 -2.507 0 C-N-CA 119.314 -1.422 . . . . 0.44 110.09 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 71.2 m -154.49 171.0 20.09 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 113.271 -1.465 . . . . 0.81999999999999995 109.19 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.598 HG21 HD13 ' A' ' 104' ' ' LEU . 9.9 tp -149.11 149.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.337 0 CA-C-O 122.719 1.247 . . . . 0.32000000000000001 107.78 170.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -140.42 125.42 18.43 Favored 'General case' 0 C--N 1.261 -3.241 0 CA-C-N 113.669 -1.605 . . . . 0.31 110.454 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' HB2' HD23 ' A' ' 74' ' ' LEU . 22.1 m-85 -120.03 152.25 37.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.325 -1.307 . . . . 0.53000000000000003 108.049 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -139.54 129.6 25.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.787 -0.82 . . . . 0.57999999999999996 108.787 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -133.2 122.18 23.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.803 -1.089 . . . . 0.32000000000000001 110.695 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.742 ' HD2' ' CG ' ' A' ' 9' ' ' MET . 60.4 mtt180 -107.93 122.64 47.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.665 -0.243 . . . . 2.4300000000000002 111.015 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 39' ' ' VAL . 6.6 t -121.23 125.79 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.997 0.903 . . . . 0.26000000000000001 110.132 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -56.35 113.14 1.45 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.594 -1.639 . . . . 0.40000000000000002 112.575 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.76 -58.07 12.47 Favored Glycine 0 C--O 1.225 -0.422 0 CA-C-N 114.589 -1.187 . . . . 0.76000000000000001 111.334 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.737 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.48 -174.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.303 1.223 . . . . 0.70999999999999996 114.303 167.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.6 t -110.09 25.68 11.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.001 -1.0 . . . . 1.74 109.185 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.96 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -55.05 171.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.701 -1.136 . . . . 2.1600000000000001 112.889 177.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.1 tp -50.95 -54.91 20.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.669 -0.696 . . . . 1.47 110.415 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.584 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -147.87 155.5 44.35 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 108.212 -1.033 . . . . 1.3999999999999999 108.212 172.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -39.67 138.31 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.459 2.773 . . . . 0.88 112.681 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.96 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.9 Cg_exo -55.54 139.28 82.38 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.939 1.759 . . . . 0.53000000000000003 112.312 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 2.2 t -98.47 104.76 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 105.904 -1.888 . . . . 0.77000000000000002 105.904 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -112.26 113.57 44.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.195 -1.82 . . . . 0.28000000000000003 107.445 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.591 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.73 126.71 51.04 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 123.182 1.467 . . . . 1.54 109.346 174.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.071 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.2 m95 -84.17 152.01 24.53 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.03 -2.35 . . . . 0.34000000000000002 110.957 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.6 t80 -130.04 136.46 49.41 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.747 -2.316 . . . . 0.62 104.747 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.75 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttp -102.77 168.18 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.013 -2.218 . . . . 2.1699999999999999 105.013 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.993 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -9.5 -172.59 0.0 OUTLIER Glycine 0 C--O 1.183 -3.074 0 N-CA-C 119.808 2.683 . . . . 1.23 119.808 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.7 mtpp -45.82 -3.86 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 116.375 1.991 . . . . 3.8700000000000001 116.375 -165.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 7.5 p-90 -163.76 -6.77 0.03 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.323 1.231 . . . . 2.1099999999999999 114.323 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.34 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-O 123.41 1.576 . . . . 1.29 112.499 -162.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.1 t70 -113.84 154.12 28.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 111.585 -2.552 . . . . 2.73 105.548 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.071 HD13 ' HB3' ' A' ' 41' ' ' TRP . 2.2 mp -93.75 -37.91 11.56 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 118.362 0.528 . . . . 0.44 112.095 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 t -58.94 -21.05 57.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.754 0.788 . . . . 1.23 108.88 -169.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -84.34 -32.74 24.1 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.356 -1.293 . . . . 1.3400000000000001 112.811 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.751 ' HB2' HD12 ' A' ' 57' ' ' LEU . 15.4 mmmt -104.5 -25.43 12.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.245 -0.889 . . . . 1.3999999999999999 111.323 -167.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 49' ' ' LEU . 43.4 t -43.12 89.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 113.365 -1.743 . . . . 0.37 111.479 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.44 -113.84 0.5 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.209 -2.269 . . . . 0.69999999999999996 112.602 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.4 -30.85 18.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.195 0.497 . . . . 2.75 112.022 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.8 p80 -90.23 -37.2 14.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.672 0.749 . . . . 1.3300000000000001 111.017 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.968 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.36 106.35 9.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.317 -1.734 . . . . 1.1100000000000001 106.317 174.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -95.81 115.46 27.46 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.606 -1.628 . . . . 0.76000000000000001 106.606 165.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -99.74 92.44 5.32 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 104.411 -2.441 . . . . 0.26000000000000001 104.411 170.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.633 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 63.7 m170 -81.74 161.9 23.14 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.627 -1.17 . . . . 2.0299999999999998 110.114 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -133.04 112.93 12.22 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 112.592 -2.094 . . . . 0.92000000000000004 108.711 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -93.9 148.82 21.78 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 112.982 -1.917 . . . . 0.46999999999999997 107.408 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -139.46 97.78 3.35 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.575 1.179 . . . . 1.3899999999999999 110.926 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.65 120.54 39.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 112.846 -1.979 . . . . 2.4199999999999999 109.338 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.57 -34.94 27.58 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.573 -1.648 . . . . 2.46 111.38 -176.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 1.1499999999999999 110.35 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 69' ' ' VAL . 18.9 t -94.52 -17.55 22.29 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.423 -0.808 . . . . 1.4099999999999999 108.904 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.737 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 13.7 ttpt 62.05 37.25 14.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.024 -0.989 . . . . 3.3100000000000001 108.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 67' ' ' SER . 38.0 t -128.83 131.39 68.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.369 1.081 . . . . 0.42999999999999999 111.053 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -94.96 105.19 17.09 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 105.888 -1.893 . . . . 1.24 105.888 162.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.3 tp -96.55 105.24 17.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.479 1.133 . . . . 0.52000000000000002 108.855 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.7 m-85 -85.22 114.58 22.43 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.33000000000000002 107.846 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -107.06 119.86 40.52 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.587 -1.642 . . . . 1.3200000000000001 108.998 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.83 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.7 mm? -92.81 120.9 33.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.629 -1.169 . . . . 0.95999999999999996 107.919 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.67 95.61 5.33 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 104.593 -2.373 . . . . 1.1499999999999999 104.593 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.63 HG12 HD23 ' A' ' 57' ' ' LEU . 66.4 mt -120.63 100.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 114.491 -1.231 . . . . 0.52000000000000002 109.152 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 28.9 p -104.84 159.81 15.5 Favored 'General case' 0 N--CA 1.393 -3.32 0 CA-C-N 114.526 -1.216 . . . . 0.57999999999999996 109.183 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.55 74.03 0.22 Allowed 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 111.611 -2.54 . . . . 2.1200000000000001 111.158 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.37 123.54 19.87 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.228 -1.805 . . . . 0.40000000000000002 111.327 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.885 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.8 OUTLIER -60.59 137.0 92.64 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.477 -0.783 . . . . 1.4299999999999999 109.739 170.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.885 ' HD2' HE21 ' A' ' 80' ' ' GLN . 35.4 Cg_endo -65.0 -3.36 6.96 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.32 2.68 . . . . 1.3300000000000001 113.197 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.552 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -111.01 13.01 22.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.171 -0.468 . . . . 1.1200000000000001 111.102 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' THR . 2.3 m-30 -86.93 -37.32 17.72 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 118.502 -0.761 . . . . 1.24 111.002 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.653 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 88.8 m 12.04 73.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.497 0 O-C-N 125.195 1.559 . . . . 1.22 110.647 -168.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.824 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -36.55 124.53 0.91 Allowed Glycine 0 N--CA 1.412 -2.926 0 CA-C-N 111.979 -2.373 . . . . 1.4299999999999999 115.211 -163.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.993 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -123.59 68.56 0.47 Allowed Glycine 0 C--N 1.262 -3.54 0 CA-C-N 111.648 -2.276 . . . . 0.52000000000000002 108.23 158.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.736 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 74.1 m-85 -75.07 108.53 7.87 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.094 -1.053 . . . . 0.63 108.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.634 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 25.0 mtp180 -109.33 106.88 16.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.724 -0.472 . . . . 3.1499999999999999 109.724 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -91.04 116.1 28.53 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.627 -0.509 . . . . 1.0800000000000001 109.627 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 34.4 mt-10 -122.61 103.03 8.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.52 -0.764 . . . . 1.8100000000000001 109.144 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -95.01 143.64 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.077 0.465 . . . . 0.54000000000000004 109.751 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 t -140.35 108.37 5.73 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.755 -0.832 . . . . 1.1799999999999999 108.755 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.746 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.83 152.23 51.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 117.798 -1.096 . . . . 0.73999999999999999 108.639 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.32 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 O-C-N 125.599 1.812 . . . . 0.65000000000000002 114.572 178.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.674 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 25.2 t70 -145.55 -11.67 0.52 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.432 -1.258 . . . . 1.05 110.009 -174.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.001 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.4 mttp -90.77 124.64 35.29 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.462 -0.94 . . . . 1.29 108.462 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -131.31 127.94 38.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.251 -1.34 . . . . 0.77000000000000002 109.793 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 16.1 m-20 -143.12 139.5 30.43 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.098 -1.41 . . . . 1.6000000000000001 108.808 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.0 p -135.08 145.3 47.8 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.168 0.508 . . . . 1.1899999999999999 109.791 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.752 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 91.5 p -131.9 126.5 34.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.49 -0.777 . . . . 0.83999999999999997 110.462 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.09 119.05 36.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 1.5800000000000001 111.122 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.68 ' HE1' ' HG2' ' A' ' 11' ' ' PRO . 30.0 p90 -143.61 147.05 33.78 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.52 -0.548 . . . . 0.85999999999999999 109.52 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.772 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 11.4 p30 -104.04 151.81 22.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.635 1.207 . . . . 2.1099999999999999 112.022 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.616 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -116.06 99.35 7.19 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.472 -1.695 . . . . 0.37 108.86 167.152 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.432 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 29.8 m -81.41 96.94 7.52 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.211 -1.033 . . . . 0.33000000000000002 108.211 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 18' ' ' VAL . 3.9 p -81.27 112.54 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 123.099 1.428 . . . . 0.33000000000000002 108.751 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.768 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 14.1 m-70 -77.49 97.9 5.15 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.441 -2.163 . . . . 1.1899999999999999 109.222 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.3 -1.544 0 CA-C-N 113.821 -1.536 . . . . 1.6699999999999999 110.296 173.287 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.532 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 16.7 m-20 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 108.651 -0.87 . . . . 1.6499999999999999 108.651 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 39.2 Cg_endo -69.74 81.28 0.82 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 121.652 1.568 . . . . 0.96999999999999997 113.077 176.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.997 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.9 mp -109.18 -70.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.313 -0.858 . . . . 0.5 109.82 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 89.76 51.01 2.96 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.816 -1.714 . . . . 0.39000000000000001 108.816 -172.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 4' ' ' ILE . 6.0 tp -51.73 -40.26 59.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.209 -1.495 . . . . 0.33000000000000002 110.312 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.778 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.6 OUTLIER -86.2 85.17 7.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.307 -0.86 . . . . 0.71999999999999997 110.461 174.473 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.26 -42.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 0.63 109.207 175.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.402 ' CB ' ' HD2' ' A' ' 27' ' ' ARG . 25.3 ttt -148.68 130.2 14.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.035 -0.984 . . . . 2.8799999999999999 108.35 173.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 31.4 ptt180 -105.25 129.31 24.97 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 116.007 -0.542 . . . . 3.6699999999999999 111.137 -174.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.635 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.7 Cg_endo -60.98 158.18 35.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.656 2.237 . . . . 0.64000000000000001 112.122 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.503 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.4 mm-40 -126.68 174.61 8.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 1.4299999999999999 111.37 -171.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 3.3 p-10 -69.72 -149.63 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.66 1.219 . . . . 2.0600000000000001 111.87 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 154.62 134.35 1.9 Allowed Glycine 0 C--N 1.298 -1.583 0 CA-C-N 113.703 -1.589 . . . . 0.29999999999999999 112.719 -174.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.502 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 6.1 mp0 -109.75 112.62 24.78 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.577 -1.312 . . . . 1.53 107.632 175.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.01 164.92 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 108.141 -1.059 . . . . 0.27000000000000002 108.141 -172.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 154.72 17.07 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.778 -1.101 . . . . 0.77000000000000002 109.69 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 106' ' ' VAL . 88.4 t -69.71 104.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 122.939 1.352 . . . . 0.78000000000000003 108.517 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.21 4.1 9.37 Favored Glycine 0 C--N 1.275 -2.836 0 CA-C-N 112.217 -2.265 . . . . 0.47999999999999998 112.816 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -120.17 3.12 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 108.901 -1.68 . . . . 0.44 108.901 171.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.651 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.2 p -151.59 174.05 13.91 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.102 -1.549 . . . . 0.81999999999999995 110.368 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.452 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.0 tp -146.64 146.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 CA-C-N 113.213 -1.812 . . . . 0.32000000000000001 106.336 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.5 m -139.21 128.0 23.42 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 114.105 -1.407 . . . . 0.31 111.157 -172.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.798 ' HD2' HD12 ' A' ' 74' ' ' LEU . 34.3 m-85 -126.14 141.46 51.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.885 -1.507 . . . . 0.53000000000000003 109.726 177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.91 118.81 20.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.805 0.812 . . . . 0.57999999999999996 109.715 175.426 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.635 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -113.71 113.17 24.62 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.414 -1.266 . . . . 0.32000000000000001 109.203 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 99.3 mtt180 -102.66 117.8 35.45 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.952 -0.388 . . . . 2.4300000000000002 109.952 -176.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.9 t -115.33 125.39 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 122.348 1.07 . . . . 0.26000000000000001 110.307 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.75 107.69 0.55 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.92 -1.945 . . . . 0.40000000000000002 110.384 176.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.541 ' C ' ' HE3' ' A' ' 68' ' ' LYS . . . -51.53 -40.59 47.53 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.668 -1.151 . . . . 0.76000000000000001 111.775 173.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.646 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 42.77 -140.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.15 1.167 . . . . 0.70999999999999996 114.15 172.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -134.54 132.31 38.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.398 -0.819 . . . . 1.74 109.555 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.89 -174.31 4.87 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.142 -0.481 . . . . 2.1600000000000001 111.795 -173.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 tp -74.87 -51.98 12.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.029 -0.987 . . . . 1.47 108.838 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.7 151.16 59.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.311 -0.858 . . . . 1.3999999999999999 109.475 176.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.47 138.92 7.29 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.593 2.862 . . . . 0.88 112.914 -176.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 93' ' ' THR . 2.3 Cg_endo -45.68 133.13 13.45 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 123.311 2.674 . . . . 0.53000000000000003 113.351 -177.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.35 105.29 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.697 -1.594 . . . . 0.77000000000000002 106.697 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.773 HG13 ' HB ' ' A' ' 91' ' ' VAL . 1.9 t -105.42 114.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 113.566 -1.652 . . . . 0.28000000000000003 107.344 178.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.828 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -97.58 122.41 40.62 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-O 123.248 1.499 . . . . 1.54 109.294 173.846 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.993 ' HB3' HD13 ' A' ' 49' ' ' LEU . 63.4 m95 -88.32 153.15 21.43 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 111.769 -2.469 . . . . 0.34000000000000002 110.97 173.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 39.0 t80 -131.39 134.46 46.28 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 104.432 -2.432 . . . . 0.62 104.432 173.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.796 ' HZ3' ' HB ' ' A' ' 47' ' ' VAL . 1.8 ttpm? -100.76 163.3 12.38 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.969 -1.863 . . . . 2.1699999999999999 105.969 -175.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -9.77 -165.02 0.0 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.938 2.335 . . . . 1.23 118.938 -177.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.66 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 5.6 mtpp -44.28 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 O-C-N 119.541 -2.152 . . . . 3.8700000000000001 116.68 -166.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.631 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.4 p-90 -165.58 -9.13 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.955 1.465 . . . . 2.1099999999999999 114.955 -177.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.796 ' HB ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.0 167.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 CA-C-O 123.814 1.769 . . . . 1.29 113.215 -162.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.676 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 2.6 p-10 -109.67 155.9 20.91 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 110.994 -2.821 . . . . 2.73 107.164 174.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.9 mp -99.15 -36.81 9.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.014 0.746 . . . . 0.44 113.014 168.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.7 t -57.84 -21.21 41.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.255 0.55 . . . . 1.23 109.811 -162.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.55 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 52.3 m -99.1 -21.48 16.15 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 115.476 -0.784 . . . . 1.3400000000000001 112.842 -176.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.676 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 6.7 mmmt -100.34 -36.38 9.27 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.306 -0.861 . . . . 1.3999999999999999 111.184 -170.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.852 HG13 ' H ' ' A' ' 59' ' ' LEU . 74.0 t -31.63 94.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 113.373 -1.74 . . . . 0.37 111.993 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -162.74 -122.85 0.63 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 111.864 -2.425 . . . . 0.69999999999999996 112.197 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.77 -47.1 79.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.748 1.018 . . . . 2.75 113.748 -169.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.7 p80 -92.27 -35.33 13.83 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.256 0.55 . . . . 1.3300000000000001 111.415 -174.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.975 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.56 105.27 11.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.564 -1.643 . . . . 1.1100000000000001 106.564 175.358 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.23 115.57 27.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 106.844 -1.539 . . . . 0.76000000000000001 106.844 164.227 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.852 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -98.97 90.71 4.72 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 103.45 -2.796 . . . . 0.26000000000000001 103.45 167.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 29.9 t-80 -103.01 160.29 14.76 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.171 -1.377 . . . . 2.0299999999999998 108.972 -173.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -130.48 113.93 14.89 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 112.295 -2.229 . . . . 0.92000000000000004 110.393 -176.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -90.84 143.58 26.58 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 111.737 -2.483 . . . . 0.46999999999999997 107.136 171.3 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.544 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 2.0 t80 -140.84 98.88 3.48 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.082 0.944 . . . . 1.3899999999999999 111.687 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -118.11 129.87 55.79 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.169 -1.378 . . . . 2.4199999999999999 109.887 170.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HA ' ' HZ3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -88.93 -38.92 14.13 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.037 -1.438 . . . . 2.46 112.616 -177.414 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.73 81.56 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.658 0.599 . . . . 1.1499999999999999 111.351 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.2 p -92.05 -17.38 25.11 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.28 -1.378 . . . . 1.4099999999999999 107.28 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.676 ' NZ ' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 69.19 30.99 4.14 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.526 -1.67 . . . . 3.3100000000000001 109.712 171.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.9 t -122.93 123.9 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 122.159 0.98 . . . . 0.42999999999999999 109.991 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.544 ' CE1' ' HD1' ' A' ' 63' ' ' TYR . 3.9 m-30 -104.13 105.81 16.09 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.926 -1.488 . . . . 1.24 107.035 170.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 25' ' ' SER . 29.5 tp -90.31 106.79 18.73 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.474 -1.239 . . . . 0.52000000000000002 109.525 -176.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.613 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.6 m-85 -87.77 112.04 22.0 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.342 -1.725 . . . . 0.33000000000000002 106.342 169.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 6.9 pt-20 -118.1 125.16 49.73 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.621 -1.627 . . . . 1.3200000000000001 110.131 -171.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.798 HD12 ' HD2' ' A' ' 24' ' ' PHE . 1.3 mt -89.98 124.99 35.21 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.485 -1.234 . . . . 0.95999999999999996 108.562 174.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -112.49 96.36 5.95 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 104.081 -2.563 . . . . 1.1499999999999999 104.081 166.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.1 mt -122.4 100.67 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 123.285 1.517 . . . . 0.52000000000000002 108.743 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 51.1 p -112.54 157.1 21.56 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-N 113.456 -1.702 . . . . 0.57999999999999996 109.29 -172.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.12 39.71 5.42 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.89 -2.414 . . . . 2.1200000000000001 108.798 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -44.28 120.86 2.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 111.997 -2.365 . . . . 0.40000000000000002 110.388 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -87.59 156.66 53.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.33 -0.989 . . . . 1.4299999999999999 108.33 -177.867 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.812 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 50.4 Cg_endo -69.27 -3.48 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 121.296 1.331 . . . . 1.3300000000000001 113.139 -170.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.54 7.57 44.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.112 -0.494 . . . . 1.1200000000000001 110.212 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -92.78 -20.55 20.63 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.173 -0.467 . . . . 1.24 111.002 -176.357 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 45.2 m -49.03 103.22 0.04 OUTLIER 'General case' 0 CA--C 1.473 -2.014 0 CA-C-O 122.509 1.147 . . . . 1.22 108.552 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.66 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -174.64 -130.71 1.32 Allowed Glycine 0 C--N 1.265 -3.371 0 CA-C-N 112.364 -2.198 . . . . 1.4299999999999999 112.964 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.52 118.23 0.86 Allowed Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.244 -0.979 . . . . 0.52000000000000002 112.157 -172.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.763 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.4 m-85 -87.12 124.34 33.15 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.078 -1.453 . . . . 0.63 107.078 175.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 44.1 mtp180 -122.42 124.43 43.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.422 0.555 . . . . 3.1499999999999999 111.698 -175.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.489 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 4.0 m -97.0 131.09 44.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 1.0800000000000001 109.856 176.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.828 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.0 mt-10 -132.14 103.34 6.2 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.685 -0.857 . . . . 1.8100000000000001 108.685 170.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.773 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -93.17 138.24 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.561 0.696 . . . . 0.54000000000000004 110.089 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.1 m -132.59 107.81 8.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.701 -1.136 . . . . 1.1799999999999999 108.903 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.608 ' OG1' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -132.08 157.97 42.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 117.669 -1.158 . . . . 0.73999999999999999 108.51 -179.648 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.722 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 20.13 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 125.574 1.797 . . . . 0.65000000000000002 114.276 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.722 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -146.92 -3.52 0.58 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.989 -1.005 . . . . 1.05 110.001 -177.479 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.997 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 4.9 mmmt -96.29 133.65 40.38 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.88 0.848 . . . . 1.29 109.56 -175.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.69 131.27 44.74 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.497 -1.683 . . . . 0.77000000000000002 110.892 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.435 ' HB3' ' CG ' ' A' ' 7' ' ' PHE . 28.8 m-20 -144.85 140.83 28.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.428 -1.26 . . . . 1.6000000000000001 108.702 176.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.7 p -138.3 154.06 49.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.254 0.55 . . . . 1.1899999999999999 111.118 -176.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.778 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 36.2 t -136.12 149.35 48.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.205 1.002 . . . . 0.83999999999999997 111.246 177.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -134.31 109.72 9.01 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.322 -1.763 . . . . 1.5800000000000001 109.466 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 29.4 p90 -140.81 132.55 27.35 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.217 -0.66 . . . . 0.85999999999999999 109.217 -174.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 2.1 p-10 -102.42 153.15 20.31 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 122.39 1.091 . . . . 2.1099999999999999 111.317 -171.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -121.33 120.78 36.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.427 -1.261 . . . . 0.37 108.526 172.716 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 5.9 m -100.16 96.11 7.27 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.749 -0.834 . . . . 0.33000000000000002 108.749 174.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 80' ' ' GLN . 9.5 p -84.27 116.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 123.485 1.612 . . . . 0.33000000000000002 109.339 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -91.39 100.29 13.1 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 112.504 -2.134 . . . . 1.1899999999999999 109.976 -175.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.812 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 9.9 tt0 . . . . . 0 C--N 1.303 -1.428 0 CA-C-N 114.923 -1.035 . . . . 1.6699999999999999 109.556 170.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.54 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-20 . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 109.822 -0.436 . . . . 1.6499999999999999 109.822 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 73.5 Cg_endo -77.21 59.48 6.61 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 121.852 1.701 . . . . 0.96999999999999997 112.862 177.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.925 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -75.15 -63.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.228 -0.896 . . . . 0.5 109.457 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.61 41.29 5.75 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 107.812 -2.115 . . . . 0.39000000000000001 107.812 -175.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.697 HD13 HG21 ' A' ' 4' ' ' ILE . 8.4 tp -49.25 -46.37 46.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.573 -1.814 . . . . 0.33000000000000002 110.643 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.675 ' HD2' ' HE ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -88.65 84.91 6.72 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.827 0.822 . . . . 0.71999999999999997 109.863 171.806 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.37 -37.82 79.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.24 -1.345 . . . . 0.63 109.285 178.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 tpp -148.65 132.92 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.837 -1.074 . . . . 2.8799999999999999 108.307 171.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.675 ' HE ' ' HD2' ' A' ' 7' ' ' PHE . 38.1 mtt180 -96.24 130.81 30.03 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.886 0.374 . . . . 3.6699999999999999 110.873 -174.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 13.9 Cg_endo -60.22 153.26 60.38 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.093 2.528 . . . . 0.64000000000000001 111.794 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.482 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.1 mm-40 -124.67 170.19 11.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.01 -0.541 . . . . 1.4299999999999999 111.999 -172.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.498 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.1 p-10 -70.83 -145.75 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.321 0 C-N-CA 124.673 1.189 . . . . 2.0600000000000001 113.076 -175.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.76 133.1 1.58 Allowed Glycine 0 C--N 1.307 -1.06 0 CA-C-N 113.708 -1.587 . . . . 0.29999999999999999 114.015 -176.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 1.7 mp0 -106.47 111.36 23.9 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.689 -1.256 . . . . 1.53 109.083 175.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.534 HG11 ' HB ' ' A' ' 22' ' ' ILE . 1.9 m -137.43 163.04 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.155 -1.054 . . . . 0.27000000000000002 108.155 -174.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.448 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.13 156.26 16.39 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.78 -1.1 . . . . 0.77000000000000002 109.677 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.883 HG21 ' HB3' ' A' ' 81' ' ' PRO . 24.9 t -69.93 107.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-O 123.056 1.407 . . . . 0.78000000000000003 109.171 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.65 -0.6 15.67 Favored Glycine 0 C--N 1.266 -3.359 0 CA-C-N 111.957 -2.383 . . . . 0.47999999999999998 112.221 176.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 -126.14 3.76 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 109.101 -1.6 . . . . 0.44 109.101 172.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 9.3 p -151.68 167.9 26.7 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-N 112.985 -1.608 . . . . 0.81999999999999995 111.042 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.693 HG21 HD13 ' A' ' 104' ' ' LEU . 7.8 tp -146.11 147.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 113.291 -1.777 . . . . 0.32000000000000001 108.42 170.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 m -139.88 130.6 25.87 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 113.239 -1.8 . . . . 0.31 110.399 -175.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -128.58 160.49 32.23 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.921 -1.036 . . . . 0.53000000000000003 108.753 169.8 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.73 129.27 22.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.968 -1.015 . . . . 0.57999999999999996 108.866 178.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.659 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.61 127.59 46.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.736 -0.666 . . . . 0.32000000000000001 111.138 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -108.64 121.32 44.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.06 -0.518 . . . . 2.4300000000000002 110.557 -177.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 14.6 t -123.44 127.94 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.258 1.028 . . . . 0.26000000000000001 110.508 -176.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.502 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.18 110.21 1.33 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.113 -1.858 . . . . 0.40000000000000002 113.212 -177.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -54.36 -48.57 63.86 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 114.587 -1.188 . . . . 0.76000000000000001 112.184 171.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.786 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 56.74 -170.23 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.734 0.814 . . . . 0.70999999999999996 112.87 173.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -114.11 35.7 4.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.243 1.021 . . . . 1.74 108.459 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.0 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.18 172.97 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.015 -1.448 . . . . 2.1600000000000001 113.358 177.394 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.75 -49.62 76.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.343 0.592 . . . . 1.47 110.307 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.673 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -144.8 150.09 45.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.041 -1.096 . . . . 1.3999999999999999 108.041 174.057 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.91 142.14 5.49 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.416 2.744 . . . . 0.88 111.588 -177.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.0 ' HD3' HD11 ' A' ' 33' ' ' LEU . 6.4 Cg_exo -54.54 137.45 73.0 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.138 1.225 . . . . 0.53000000000000003 112.836 -174.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 35' ' ' LYS . 3.6 t -99.13 104.68 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 105.708 -1.96 . . . . 0.77000000000000002 105.708 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.704 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -111.54 113.57 44.61 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.596 -1.638 . . . . 0.28000000000000003 107.594 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -103.95 130.99 51.62 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 123.389 1.566 . . . . 1.54 109.751 173.173 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.05 ' HB3' HD13 ' A' ' 49' ' ' LEU . 81.9 m95 -91.23 157.25 17.27 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.859 -2.428 . . . . 0.34000000000000002 111.259 173.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 27.1 t80 -131.47 130.71 42.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.564 -2.013 . . . . 0.62 105.564 175.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 31.7 ttpt -109.05 104.83 14.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.25 -1.759 . . . . 2.1699999999999999 106.25 -176.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.26 91.65 1.67 Allowed Glycine 0 CA--C 1.481 -2.044 0 C-N-CA 115.906 -3.045 . . . . 1.23 114.112 -164.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 1.012 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -105.04 -27.44 11.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 104.104 -2.554 . . . . 3.8700000000000001 104.104 139.549 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 1.012 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 27.5 p-90 160.2 -20.19 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.078 -2.328 . . . . 2.1099999999999999 111.529 -165.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG21 ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.53 169.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 123.046 1.403 . . . . 1.29 112.539 -163.658 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.3 t70 -113.11 133.89 54.8 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 111.617 -2.538 . . . . 2.73 107.04 175.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.05 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.8 mp -69.85 -35.3 74.62 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 119.169 -0.443 . . . . 0.44 111.869 -175.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 m -58.27 -20.01 39.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.543 0.687 . . . . 1.23 109.817 -167.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 m -98.4 -18.86 18.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.973 -1.012 . . . . 1.3400000000000001 112.424 -176.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.42 -70.27 0.74 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.876 -0.602 . . . . 1.3999999999999999 111.118 -176.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.844 HG13 ' H ' ' A' ' 59' ' ' LEU . 70.5 t 16.6 91.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.23 1.812 . . . . 0.37 113.965 175.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -151.4 -138.5 2.82 Favored Glycine 0 C--N 1.319 -0.397 0 CA-C-N 114.174 -1.375 . . . . 0.69999999999999996 113.488 -174.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -64.18 -42.83 96.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.382 0.882 . . . . 2.75 113.382 -169.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.485 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 4.8 p80 -86.97 -37.97 17.06 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 119.64 -0.824 . . . . 1.3300000000000001 111.702 -175.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.915 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.39 108.76 13.07 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.289 -1.004 . . . . 1.1100000000000001 108.289 170.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -96.34 115.69 27.84 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 105.834 -1.913 . . . . 0.76000000000000001 105.834 168.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.844 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.09 92.28 6.74 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 104.353 -2.462 . . . . 0.26000000000000001 104.353 170.357 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.651 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 4.0 m170 -88.24 164.2 15.74 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 113.748 -1.569 . . . . 2.0299999999999998 111.003 -178.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -134.29 113.38 11.89 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 111.716 -2.493 . . . . 0.92000000000000004 109.937 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.8 m -99.14 149.34 23.16 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.597 -2.092 . . . . 0.46999999999999997 107.891 174.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -145.58 99.38 3.28 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.097 0.951 . . . . 1.3899999999999999 112.362 -171.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.88 106.43 14.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.837 -1.528 . . . . 2.4199999999999999 110.374 169.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.04 -27.68 65.87 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.556 -1.202 . . . . 2.46 110.504 179.065 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.18 73.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.216 -0.902 . . . . 1.1499999999999999 110.746 175.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -91.65 -18.24 24.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.6 -0.727 . . . . 1.4099999999999999 109.287 175.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.786 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 10.3 ttpt 66.62 33.82 6.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.665 -1.152 . . . . 3.3100000000000001 109.699 -177.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.84 133.52 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.166 0.984 . . . . 0.42999999999999999 110.766 -176.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' SER . 36.7 m-85 -97.65 108.07 20.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.532 -1.655 . . . . 1.24 106.532 161.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 15.0 tp -95.18 104.7 16.59 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.508 1.147 . . . . 0.52000000000000002 109.011 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.651 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.7 m-85 -86.2 114.47 23.06 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.331 -1.759 . . . . 0.33000000000000002 108.606 175.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.47 127.71 46.74 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.374 -1.739 . . . . 1.3200000000000001 109.007 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.864 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -99.38 116.65 32.03 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.206 -1.405 . . . . 0.95999999999999996 107.206 171.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.765 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 14.5 m80 -114.63 94.41 4.76 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 104.953 -2.24 . . . . 1.1499999999999999 104.953 167.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.817 HG12 ' HB2' ' A' ' 57' ' ' LEU . 47.5 mt -118.13 99.15 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 123.18 1.466 . . . . 0.52000000000000002 110.055 -173.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.7 p -106.71 163.89 12.54 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.022 -1.444 . . . . 0.57999999999999996 108.121 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 68.86 38.91 1.99 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.804 -1.998 . . . . 2.1200000000000001 110.215 170.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.09 118.06 2.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.207 -1.815 . . . . 0.40000000000000002 112.024 -178.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.683 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -57.82 140.97 80.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.818 -1.083 . . . . 1.4299999999999999 109.758 172.014 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.883 ' HB3' HG21 ' A' ' 18' ' ' VAL . 36.4 Cg_endo -67.89 5.02 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.707 2.271 . . . . 1.3300000000000001 113.42 -177.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.99 -3.83 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.473 -0.33 . . . . 1.1200000000000001 110.324 173.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.909 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -75.66 4.45 7.75 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.798 -0.62 . . . . 1.24 109.368 -172.046 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 29.5 m -23.02 90.07 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 125.696 1.873 . . . . 1.22 111.325 177.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.833 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -39.79 110.2 0.16 Allowed Glycine 0 CA--C 1.466 -3.029 0 CA-C-N 109.703 -3.408 . . . . 1.4299999999999999 113.902 -169.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.88 62.78 0.55 Allowed Glycine 0 C--N 1.262 -3.567 0 CA-C-N 111.718 -2.241 . . . . 0.52000000000000002 107.895 160.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.666 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 73.9 m-85 -81.43 109.79 16.24 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.251 -1.388 . . . . 0.63 107.251 -177.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 24.4 ttm180 -109.91 110.03 20.86 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.069 -0.715 . . . . 3.1499999999999999 109.069 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.57 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.3 t -91.33 125.1 35.98 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.658 -0.867 . . . . 1.0800000000000001 108.658 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 38.8 tt0 -134.03 103.88 6.0 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.309 -0.86 . . . . 1.8100000000000001 109.755 -172.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.704 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.7 p -100.58 143.63 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.54000000000000004 110.343 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -139.87 108.84 6.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.341 -0.845 . . . . 1.1799999999999999 108.812 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.805 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.96 146.85 52.15 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-O 117.775 -1.107 . . . . 0.73999999999999999 109.851 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.807 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.41 -73.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.679 1.862 . . . . 0.65000000000000002 114.28 -177.275 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.807 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 10.7 t70 -151.78 -2.03 0.3 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.904 -1.044 . . . . 1.05 110.28 -175.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.925 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmmt -93.45 133.84 36.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.117 0.961 . . . . 1.29 108.849 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -130.35 129.94 43.79 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.467 -1.697 . . . . 0.77000000000000002 110.16 -176.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 4.4 m-20 -146.97 142.17 27.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.166 -1.379 . . . . 1.6000000000000001 109.099 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 58.3 m -144.94 148.28 33.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.604 -0.726 . . . . 1.1899999999999999 110.154 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.57 ' OG ' ' HB3' ' A' ' 89' ' ' CYS . 2.9 p -128.23 148.07 50.61 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.532 -0.758 . . . . 0.83999999999999997 111.567 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.79 112.37 14.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.557 -1.201 . . . . 1.5800000000000001 109.58 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.76 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 7.0 p90 -141.7 131.4 24.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.6 0.714 . . . . 0.85999999999999999 109.568 -175.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 5.7 p30 -105.64 138.49 41.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.532 1.158 . . . . 2.1099999999999999 112.976 -168.114 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.833 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.22 103.94 13.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.667 -1.606 . . . . 0.37 109.501 173.367 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.499 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 11.9 m -86.23 95.41 9.59 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.175 -1.01 . . . . 0.33000000000000002 108.333 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.784 HG22 HG22 ' A' ' 18' ' ' VAL . 8.3 p -82.74 112.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.27 1.509 . . . . 0.33000000000000002 108.706 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 97.5 m-70 -85.76 99.15 11.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.276 -2.238 . . . . 1.1899999999999999 109.724 -173.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 114.129 -1.396 . . . . 1.6699999999999999 110.131 172.792 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.635 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 14.2 m-20 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 119.859 -0.115 . . . . 1.6499999999999999 110.844 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 55.8 Cg_endo -70.2 68.07 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.933 2.422 . . . . 0.96999999999999997 112.56 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.974 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -91.59 -55.39 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 114.797 -1.092 . . . . 0.5 108.927 173.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.614 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 84.27 48.9 4.9 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.53 -2.228 . . . . 0.39000000000000001 107.53 -176.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.999 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.0 tp -51.24 -44.9 61.83 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 112.553 -1.823 . . . . 0.33000000000000002 109.241 -173.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -82.62 83.31 7.66 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.663 -1.153 . . . . 0.71999999999999997 109.544 170.874 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.98 -27.61 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.756 -1.111 . . . . 0.63 108.978 176.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.8 tpt -163.51 148.8 11.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.09 -1.414 . . . . 2.8799999999999999 107.246 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 4.6 ptm180 -115.36 144.08 31.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.192 -0.603 . . . . 3.6699999999999999 111.059 177.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.748 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -76.44 170.46 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.132 2.554 . . . . 0.64000000000000001 112.451 -178.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -131.0 166.19 21.56 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.682 -0.69 . . . . 1.4299999999999999 110.977 -171.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.625 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -65.5 -141.13 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.566 1.174 . . . . 2.0600000000000001 111.982 -179.308 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.19 139.8 3.17 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.125 -1.398 . . . . 0.29999999999999999 111.934 -175.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.9 mt-10 -116.66 118.08 31.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.813 -0.693 . . . . 1.53 109.263 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -139.29 164.77 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 107.825 -1.176 . . . . 0.27000000000000002 107.825 -173.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.79 157.45 17.39 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.237 -0.892 . . . . 0.77000000000000002 109.753 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 106' ' ' VAL . 16.7 t -68.66 106.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 CA-C-O 122.677 1.227 . . . . 0.78000000000000003 108.116 172.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.16 3.85 10.42 Favored Glycine 0 C--N 1.27 -3.11 0 CA-C-N 112.276 -2.238 . . . . 0.47999999999999998 113.554 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.85 -123.83 4.32 Favored Glycine 0 N--CA 1.422 -2.252 0 C-N-CA 119.235 -1.46 . . . . 0.44 111.252 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.1 p -150.88 166.99 28.88 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 112.826 -1.687 . . . . 0.81999999999999995 110.934 178.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.569 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -149.41 150.74 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.023 -1.899 . . . . 0.32000000000000001 107.638 171.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.0 m -138.22 129.51 27.48 Favored 'General case' 0 C--N 1.265 -3.096 0 CA-C-N 113.721 -1.581 . . . . 0.31 110.876 -176.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.718 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.7 m-85 -128.11 155.43 44.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.278 -1.328 . . . . 0.53000000000000003 109.88 176.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.625 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.2 m -140.93 131.81 25.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.287 -0.869 . . . . 0.57999999999999996 109.287 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.769 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -129.32 115.22 17.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 0.32000000000000001 110.943 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.7 ' HE ' HG11 ' A' ' 69' ' ' VAL . 18.9 mtp180 -100.6 126.32 47.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.535 -0.302 . . . . 2.4300000000000002 110.851 -177.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.5 t -127.9 129.44 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 122.057 0.932 . . . . 0.26000000000000001 110.687 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.79 108.27 2.07 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.344 -1.753 . . . . 0.40000000000000002 111.113 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -50.88 22.84 Favored Glycine 0 C--O 1.226 -0.391 0 CA-C-N 115.287 -0.87 . . . . 0.76000000000000001 111.105 172.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.889 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . . . 61.64 -100.52 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.772 1.027 . . . . 0.70999999999999996 113.772 167.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 p -146.39 -109.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 1.74 110.205 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.017 HD22 ' HA ' ' A' ' 93' ' ' THR . 4.4 tp 63.74 156.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.576 -0.528 . . . . 2.1600000000000001 109.576 -175.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.952 ' H ' HD12 ' A' ' 33' ' ' LEU . 21.4 tp -53.39 -27.32 23.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.129 0.966 . . . . 1.47 110.546 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.769 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.83 177.15 2.08 Favored Pre-proline 0 C--O 1.211 -0.973 0 CA-C-N 113.549 -1.66 . . . . 1.3999999999999999 106.803 178.143 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.5 Cg_exo -65.24 154.37 73.88 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.495 1.464 . . . . 0.88 109.521 174.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.64 ' HG3' HG21 ' A' ' 93' ' ' THR . 67.2 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 121.569 1.513 . . . . 0.53000000000000003 113.401 -175.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.649 HG22 ' HE2' ' A' ' 35' ' ' LYS . 2.0 t -100.01 103.89 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 106.489 -1.671 . . . . 0.77000000000000002 106.489 175.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.8 t -106.71 115.25 47.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.013 -1.449 . . . . 0.28000000000000003 107.683 176.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.07 131.5 55.01 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 122.874 1.321 . . . . 1.54 109.615 175.989 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.022 ' HB3' HD13 ' A' ' 49' ' ' LEU . 72.0 m95 -92.48 156.83 16.91 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.425 -2.171 . . . . 0.34000000000000002 112.326 174.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 37.3 t80 -129.28 133.14 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.303 -2.11 . . . . 0.62 105.303 173.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.865 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 3.6 ttpm? -109.66 107.51 17.58 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.336 -1.357 . . . . 2.1699999999999999 107.336 -177.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.32 91.91 1.63 Allowed Glycine 0 CA--C 1.487 -1.688 0 C-N-CA 115.982 -3.009 . . . . 1.23 114.562 -165.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.902 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 71.2 tttt -108.86 -24.79 11.1 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.034 -2.21 . . . . 3.8700000000000001 105.034 135.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.902 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 25.7 p-90 159.97 -20.14 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 CA-C-N 112.677 -2.056 . . . . 2.1099999999999999 111.763 -164.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.45 ' HB ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.34 174.11 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.461 1.6 . . . . 1.29 113.331 -163.264 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.3 t70 -109.49 155.04 21.83 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 111.208 -2.724 . . . . 2.73 105.763 173.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.022 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -89.77 -38.67 13.64 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.905 0.706 . . . . 0.44 112.905 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 t -59.58 -19.76 50.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.894 0.854 . . . . 1.23 108.936 -166.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 p -87.58 -33.11 19.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.536 -1.211 . . . . 1.3400000000000001 111.317 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HG3' ' HZ1' ' A' ' 43' ' ' LYS . 5.5 mmmt -93.79 -70.37 0.71 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.266 -1.333 . . . . 1.3999999999999999 111.616 -175.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.827 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.4 t 11.1 92.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.566 1.946 . . . . 0.37 113.489 177.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.605 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -146.67 -118.04 1.07 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.841 -1.527 . . . . 0.69999999999999996 113.357 -177.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -86.12 -32.67 21.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.082 0.771 . . . . 2.75 113.082 -167.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -93.54 -36.69 12.29 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.026 -0.669 . . . . 1.3300000000000001 110.257 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.908 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.95 105.28 11.31 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.809 -1.552 . . . . 1.1100000000000001 106.809 175.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -98.77 115.53 28.98 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 105.763 -1.94 . . . . 0.76000000000000001 105.763 165.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.827 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -98.51 92.03 5.44 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 103.547 -2.76 . . . . 0.26000000000000001 103.547 169.171 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 83.0 t60 -99.66 162.43 13.01 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 113.943 -1.48 . . . . 2.0299999999999998 108.694 -173.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.47 124.25 29.79 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 112.464 -2.153 . . . . 0.92000000000000004 110.949 -177.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.688 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.2 m -93.62 148.52 22.03 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 111.08 -2.782 . . . . 0.46999999999999997 106.685 169.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -138.16 98.09 3.54 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.705 1.241 . . . . 1.3899999999999999 111.365 -168.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 8.4 m-20 -113.98 100.32 8.32 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 112.856 -1.975 . . . . 2.4199999999999999 108.743 172.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -37.41 36.27 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.644 -0.707 . . . . 2.46 110.337 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.68 -22.2 60.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.004 -0.998 . . . . 1.1499999999999999 110.448 179.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 47.5 m -101.69 -9.84 20.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.494 -0.776 . . . . 1.4099999999999999 109.592 175.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.889 ' HE3' ' HA ' ' A' ' 31' ' ' ALA . 74.5 tttt 67.18 29.84 7.55 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.114 -0.948 . . . . 3.3100000000000001 110.53 173.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.7 HG11 ' HE ' ' A' ' 27' ' ' ARG . 2.7 t -127.98 121.95 57.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.014 0.911 . . . . 0.42999999999999999 110.588 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -100.53 107.02 18.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.396 -1.705 . . . . 1.24 106.396 167.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.5 tp -95.15 104.73 16.62 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.3 1.048 . . . . 0.52000000000000002 109.049 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.661 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.8 m-85 -85.36 113.96 22.06 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.939 -1.482 . . . . 0.33000000000000002 108.277 174.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 19.4 mt-10 -106.8 124.41 49.58 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 113.3 -1.773 . . . . 1.3200000000000001 108.976 -176.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.829 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -90.69 118.18 29.92 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.995 -1.113 . . . . 0.95999999999999996 107.995 173.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -112.14 94.33 4.88 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 103.587 -2.746 . . . . 1.1499999999999999 103.587 169.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 52.3 mt -123.54 101.07 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.22 1.486 . . . . 0.52000000000000002 110.263 -175.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 74.8 p -106.02 144.88 32.12 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 113.002 -1.908 . . . . 0.57999999999999996 107.917 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 70.96 77.61 0.18 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.914 -2.403 . . . . 2.1200000000000001 109.766 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.563 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -78.24 110.87 13.63 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.779 -2.464 . . . . 0.40000000000000002 108.24 174.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.613 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -69.58 165.07 44.41 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.418 -0.956 . . . . 1.4299999999999999 108.418 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HG3' HG21 ' A' ' 18' ' ' VAL . 3.8 Cg_exo -72.41 152.28 54.69 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 120.819 1.013 . . . . 1.3300000000000001 111.124 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.711 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . 66.98 5.26 3.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.855 -0.612 . . . . 1.1200000000000001 111.358 -177.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -84.42 1.49 45.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.69 -0.856 . . . . 1.24 108.69 -178.773 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.842 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 49.2 m -10.02 82.14 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.981 0 O-C-N 126.292 2.245 . . . . 1.22 111.316 171.22 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.917 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -65.71 73.94 0.11 Allowed Glycine 0 CA--C 1.473 -2.576 0 CA-C-N 111.555 -2.566 . . . . 1.4299999999999999 114.002 -160.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -84.54 74.1 2.55 Favored Glycine 0 C--N 1.276 -2.787 0 N-CA-C 108.477 -1.849 . . . . 0.52000000000000002 108.477 172.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.798 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 49.2 m-85 -80.86 121.9 26.54 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.57 -1.315 . . . . 0.63 107.694 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.79 109.82 19.54 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.645 -0.502 . . . . 3.1499999999999999 109.645 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.646 ' SG ' ' HE2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -91.6 108.35 19.84 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.537 -0.542 . . . . 1.0800000000000001 109.537 -179.623 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.705 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 37.3 mt-10 -118.71 103.79 9.99 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.756 -0.656 . . . . 1.8100000000000001 109.486 -176.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -99.24 143.01 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.308 0.575 . . . . 0.54000000000000004 110.868 -177.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -133.19 109.26 9.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.017 -1.105 . . . . 1.1799999999999999 108.017 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.017 ' HA ' HD22 ' A' ' 33' ' ' LEU . 1.3 m -130.28 164.21 25.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 118.331 -0.842 . . . . 0.73999999999999999 109.067 -177.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.872 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 7.94 -71.23 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.567 1.792 . . . . 0.65000000000000002 113.392 173.516 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.758 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 28.6 t70 -147.8 -1.68 0.58 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.739 -1.119 . . . . 1.05 110.136 177.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.999 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -92.84 129.25 38.82 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.478 -1.305 . . . . 1.29 107.478 -177.543 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.46 130.58 40.71 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.023 -0.989 . . . . 0.77000000000000002 110.14 175.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -142.48 147.9 36.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.448 -1.251 . . . . 1.6000000000000001 109.031 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 6.8 p -144.48 141.88 29.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.343 0.592 . . . . 1.1899999999999999 111.025 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.545 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 24.2 t -118.26 148.94 41.92 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.24 -0.891 . . . . 0.83999999999999997 111.093 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 112.82 11.28 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.803 -1.544 . . . . 1.5800000000000001 110.053 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.798 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 40.0 p90 -142.21 140.91 32.47 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.85999999999999999 108.762 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -117.39 134.44 54.82 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.497 1.141 . . . . 2.1099999999999999 113.555 -174.355 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.917 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -95.6 109.45 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.365 -1.743 . . . . 0.37 109.6 177.422 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -86.85 96.54 10.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.272 -0.64 . . . . 0.33000000000000002 109.272 -178.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 18' ' ' VAL . 6.8 p -83.03 113.78 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.932 1.348 . . . . 0.33000000000000002 109.522 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -90.98 100.5 13.35 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 112.747 -2.024 . . . . 1.1899999999999999 109.549 -176.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 18' ' ' VAL . 44.9 tt0 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 115.024 -0.989 . . . . 1.6699999999999999 110.566 172.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.628 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 109.871 -0.418 . . . . 1.6499999999999999 109.871 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.4 81.9 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.607 2.205 . . . . 0.96999999999999997 112.365 172.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.962 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -108.11 -69.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.5 109.214 174.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.632 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 94.72 45.5 3.15 Favored Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 108.301 -1.92 . . . . 0.39000000000000001 108.301 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 96' ' ' LYS . 13.3 tp -53.1 -46.13 68.55 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 112.175 -2.012 . . . . 0.33000000000000002 111.623 -169.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.783 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -89.4 84.3 6.43 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.073 -0.967 . . . . 0.71999999999999997 109.893 -176.195 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.4 t -72.42 -48.48 47.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.662 -1.153 . . . . 0.63 110.029 -178.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.767 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 88.9 mmm -132.87 134.58 44.79 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 115.263 -0.881 . . . . 2.8799999999999999 109.766 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.783 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 22.1 mtt-85 -99.28 124.23 45.69 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 109.301 -0.629 . . . . 3.6699999999999999 109.301 174.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.653 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 17.6 Cg_endo -60.68 145.83 98.24 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.393 2.062 . . . . 0.64000000000000001 109.606 174.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.514 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 17.9 mm-40 -121.43 170.79 9.29 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 112.286 0.476 . . . . 1.4299999999999999 112.286 -168.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.0 m-20 -69.18 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.911 0 CA-C-O 122.825 1.298 . . . . 2.0600000000000001 110.627 -173.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 150.08 139.26 3.03 Favored Glycine 0 N--CA 1.423 -2.184 0 CA-C-N 114.094 -1.412 . . . . 0.29999999999999999 111.811 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 32.8 mt-10 -117.71 109.85 17.13 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.251 -0.974 . . . . 1.53 108.888 176.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.53 163.19 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.02 -1.474 . . . . 0.27000000000000002 107.02 -175.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.751 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.41 154.7 17.32 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 115.479 -0.782 . . . . 0.77000000000000002 109.874 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 106' ' ' VAL . 16.5 t -63.68 107.12 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 123.193 1.473 . . . . 0.78000000000000003 108.917 173.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.25 -10.87 5.59 Favored Glycine 0 C--N 1.268 -3.207 0 CA-C-N 111.711 -2.495 . . . . 0.47999999999999998 112.503 176.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.0 -163.69 20.36 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 119.879 -1.153 . . . . 0.44 111.316 177.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 2.5 p -122.75 169.81 10.7 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-O 122.582 1.182 . . . . 0.81999999999999995 111.456 -170.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.651 HG21 HD13 ' A' ' 104' ' ' LEU . 10.4 tp -145.16 151.83 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-N 112.335 -2.211 . . . . 0.32000000000000001 107.229 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.7 m -139.67 127.46 21.97 Favored 'General case' 0 C--N 1.256 -3.486 0 CA-C-N 113.815 -1.539 . . . . 0.31 110.814 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.612 ' HD2' HD12 ' A' ' 74' ' ' LEU . 27.7 m-85 -123.48 142.49 50.95 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.788 -1.551 . . . . 0.53000000000000003 109.51 -178.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.99 120.17 17.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.94 0.876 . . . . 0.57999999999999996 110.399 173.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -117.52 114.41 23.41 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.075 -1.421 . . . . 0.32000000000000001 109.805 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.767 ' HD2' ' HG3' ' A' ' 9' ' ' MET . 88.0 mtt180 -106.71 121.76 45.0 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 121.226 -0.19 . . . . 2.4300000000000002 110.564 -176.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG21 HG21 ' A' ' 39' ' ' VAL . 12.1 t -119.2 125.65 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.027 0.917 . . . . 0.26000000000000001 109.925 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 108.39 0.59 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.309 -1.768 . . . . 0.40000000000000002 110.959 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.711 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.11 -44.3 63.19 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.817 -1.083 . . . . 0.76000000000000001 111.406 172.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.704 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 54.06 -164.2 0.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.572 0.749 . . . . 0.70999999999999996 112.996 177.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -78.47 -71.58 0.42 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.81 -0.811 . . . . 1.74 108.81 173.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.945 HD23 HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 69.58 159.75 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.675 -0.693 . . . . 2.1600000000000001 112.102 168.496 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.943 ' N ' HD22 ' A' ' 33' ' ' LEU . 17.0 tp -75.6 -71.56 0.36 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.525 -0.761 . . . . 1.47 111.149 168.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.795 ' O ' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -123.31 129.55 24.87 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 113.643 0.979 . . . . 1.3999999999999999 113.643 171.555 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' N ' HD11 ' A' ' 33' ' ' LEU . 17.2 Cg_exo -32.96 129.16 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 124.735 3.623 . . . . 0.88 113.234 -170.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 1.5 Cg_endo -46.9 132.67 17.54 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.493 2.129 . . . . 0.53000000000000003 112.898 -171.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.66 104.64 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 106.769 -1.567 . . . . 0.77000000000000002 106.769 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.25 115.02 48.51 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.997 0 CA-C-N 113.159 -1.837 . . . . 0.28000000000000003 107.262 177.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.22 128.76 53.57 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 122.972 1.368 . . . . 1.54 109.294 172.52 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.043 ' HB3' HD13 ' A' ' 49' ' ' LEU . 60.0 m95 -82.92 152.44 25.53 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 112.395 -2.184 . . . . 0.34000000000000002 110.786 175.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.605 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 32.3 t80 -128.03 138.88 52.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.725 -2.324 . . . . 0.62 104.725 169.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 1.054 ' HE2' ' HG ' ' A' ' 49' ' ' LEU . 13.7 ttmt -100.4 171.53 7.7 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.927 -1.138 . . . . 2.1699999999999999 107.927 -173.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.968 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -13.44 -169.27 0.0 OUTLIER Glycine 0 C--O 1.185 -2.931 0 O-C-N 126.673 2.483 . . . . 1.23 118.3 166.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.3 mtpp -42.4 -2.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 117.556 2.428 . . . . 3.8700000000000001 117.556 -166.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.657 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.6 p-90 -169.47 -17.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.901 1.445 . . . . 2.1099999999999999 114.901 -177.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.788 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.95 167.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 CA-C-O 123.464 1.602 . . . . 1.29 112.44 -161.368 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.667 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 14.4 t70 -113.89 154.27 27.81 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.537 -2.574 . . . . 2.73 104.976 169.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.054 ' HG ' ' HE2' ' A' ' 43' ' ' LYS . 6.3 mp -90.39 -36.35 14.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.901 1.074 . . . . 0.44 113.901 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 t -59.05 -20.73 55.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.585 0.707 . . . . 1.23 109.432 -164.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -98.88 -28.42 13.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.074 -0.966 . . . . 1.3400000000000001 113.531 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.861 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.25 -40.31 7.6 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.254 0.464 . . . . 1.3999999999999999 112.254 -169.402 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 ' H ' ' A' ' 59' ' ' LEU . 23.0 t -18.11 97.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 125.935 1.694 . . . . 0.37 113.063 173.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -152.83 -147.9 4.73 Favored Glycine 0 C--N 1.306 -1.125 0 CA-C-N 111.575 -2.557 . . . . 0.69999999999999996 112.823 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -64.13 -16.34 61.64 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.003 0.742 . . . . 2.75 113.003 -170.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.7 p80 -102.49 -36.34 8.43 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.379 0.609 . . . . 1.3300000000000001 110.899 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.83 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -129.22 103.43 6.95 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.961 -1.496 . . . . 1.1100000000000001 106.961 172.348 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.27 116.04 28.38 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 106.976 -1.49 . . . . 0.76000000000000001 106.976 168.503 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.813 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -98.4 93.8 6.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 105.137 -2.171 . . . . 0.26000000000000001 105.137 174.632 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.628 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 46.2 m-70 -84.81 159.4 20.43 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-O 122.843 1.306 . . . . 2.0299999999999998 109.618 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.97 18.75 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 111.85 -2.432 . . . . 0.92000000000000004 109.645 177.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -103.52 145.45 30.0 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 111.094 -2.775 . . . . 0.46999999999999997 108.709 176.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.436 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 38.0 t80 -139.34 97.01 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.215 1.007 . . . . 1.3899999999999999 110.143 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -114.06 105.22 12.95 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.278 -1.783 . . . . 2.4199999999999999 108.766 176.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.611 ' HD3' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -77.21 -36.63 54.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.588 -0.733 . . . . 2.46 110.864 -178.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.87 61.18 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.616 -0.72 . . . . 1.1499999999999999 110.796 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.0 t -102.96 -19.82 14.46 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.351 -1.352 . . . . 1.4099999999999999 107.351 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.711 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.86 35.47 11.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.321 -1.309 . . . . 3.3100000000000001 110.056 177.699 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 27' ' ' ARG . 10.9 t -134.19 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.201 -0.909 . . . . 0.42999999999999999 109.475 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.536 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 8.0 m-85 -102.64 111.06 23.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.068 -1.456 . . . . 1.24 107.068 166.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.7 tp -95.51 106.64 18.73 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.196 0.998 . . . . 0.52000000000000002 108.86 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.2 m-85 -89.26 112.18 23.17 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.168 -1.79 . . . . 0.33000000000000002 106.168 169.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.628 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -120.44 125.53 48.15 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.562 -1.199 . . . . 1.3200000000000001 110.093 -173.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.686 ' CD1' HD11 ' A' ' 76' ' ' ILE . 1.1 mt -90.95 136.43 33.08 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.774 -1.557 . . . . 0.95999999999999996 108.666 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 63.3 m170 -117.69 97.99 6.14 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.164 -2.532 . . . . 1.1499999999999999 104.164 166.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.785 ' CD1' HD22 ' A' ' 57' ' ' LEU . 66.1 mt -120.31 101.62 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-O 122.718 1.247 . . . . 0.52000000000000002 109.643 -174.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 12.7 p -118.4 145.49 45.15 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 114.05 -1.432 . . . . 0.57999999999999996 109.872 -176.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 77' ' ' THR . 1.5 m-20 73.47 70.55 0.12 Allowed 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 111.258 -2.701 . . . . 2.1200000000000001 109.924 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.53 109.33 3.19 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 111.717 -2.492 . . . . 0.40000000000000002 110.947 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.742 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -60.41 142.54 90.55 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.166 -0.924 . . . . 1.4299999999999999 109.286 171.249 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 18' ' ' VAL . 26.4 Cg_exo -60.27 -18.8 54.38 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.409 2.073 . . . . 1.3300000000000001 112.22 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.742 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -100.1 16.25 24.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.08 -0.509 . . . . 1.1200000000000001 110.728 178.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -83.66 -36.76 23.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.831 -0.604 . . . . 1.24 110.085 -178.823 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.8 m 1.41 82.38 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 0 O-C-N 125.585 1.803 . . . . 1.22 112.179 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.968 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -47.13 117.89 3.48 Favored Glycine 0 N--CA 1.408 -3.177 0 CA-C-N 111.988 -2.369 . . . . 1.4299999999999999 114.353 -171.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.696 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -117.51 67.57 0.32 Allowed Glycine 0 C--N 1.273 -2.927 0 N-CA-C 108.001 -2.04 . . . . 0.52000000000000002 108.001 155.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.639 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 63.7 m-85 -78.13 118.99 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.765 -0.828 . . . . 0.63 108.765 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.605 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 28.4 ttm180 -114.38 126.52 55.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.45 . . . . 3.1499999999999999 110.878 178.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.617 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 91.6 m -97.35 108.52 21.26 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.092 -0.707 . . . . 1.0800000000000001 109.092 173.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 33.5 tt0 -114.84 103.26 10.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.525 -0.917 . . . . 1.8100000000000001 108.525 -176.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.4 p -105.0 141.9 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.655 0.741 . . . . 0.54000000000000004 111.601 -173.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -134.99 108.99 8.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.338 -1.301 . . . . 1.1799999999999999 109.08 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.945 HG22 HD23 ' A' ' 33' ' ' LEU . 1.4 m -120.8 168.25 11.64 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.071 -1.455 . . . . 0.73999999999999999 107.071 177.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.666 ' HZ3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -10.66 -61.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.945 1.403 . . . . 0.65000000000000002 114.138 -175.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.634 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -149.22 -3.14 0.43 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.993 -1.003 . . . . 1.05 109.994 177.776 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.962 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 3.9 mmtm -89.74 116.69 28.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.055 -1.831 . . . . 1.29 106.055 -176.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -134.06 139.69 46.15 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.892 -1.049 . . . . 0.77000000000000002 111.274 -173.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.468 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 4.8 t0 -167.27 170.47 11.6 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.947 -1.024 . . . . 1.6000000000000001 108.858 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 17.0 p -148.81 151.06 34.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 1.1899999999999999 110.28 179.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.735 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 54.7 p -122.31 137.2 54.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.945 -0.702 . . . . 0.83999999999999997 111.335 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -110.79 123.93 51.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.449 -0.796 . . . . 1.5800000000000001 109.601 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.757 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.3 p90 -145.05 131.05 19.26 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.85999999999999999 110.493 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.1 p30 -106.21 139.62 40.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.502 1.144 . . . . 2.1099999999999999 112.294 -175.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -107.84 105.52 15.37 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.775 -1.557 . . . . 0.37 108.778 173.015 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.3 m -87.24 96.56 10.37 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.316 -0.994 . . . . 0.33000000000000002 108.316 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 18' ' ' VAL . 3.1 p -75.39 112.2 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-O 122.842 1.306 . . . . 0.33000000000000002 107.989 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.2 m170 -74.43 95.95 2.81 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.688 -2.051 . . . . 1.1899999999999999 108.178 -178.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.7 tm-20 . . . . . 0 C--N 1.301 -1.52 0 CA-C-N 113.448 -1.706 . . . . 1.6699999999999999 108.191 173.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.553 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 6.9 t70 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 108.898 -0.778 . . . . 1.6499999999999999 108.898 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.456 ' C ' HD12 ' A' ' 4' ' ' ILE . 2.0 Cg_endo -45.44 90.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.224 3.283 . . . . 0.96999999999999997 115.223 -177.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.7 mp -125.07 -60.52 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 114.628 -1.169 . . . . 0.5 108.042 173.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.55 33.98 6.86 Favored Glycine 0 CA--C 1.492 -1.357 0 N-CA-C 108.805 -1.718 . . . . 0.39000000000000001 108.805 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.04 HD22 ' HB3' ' A' ' 96' ' ' LYS . 5.5 tp -37.92 -51.39 1.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.38 -1.91 . . . . 0.33000000000000002 110.635 178.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HZ ' ' HG ' ' A' ' 100' ' ' SER . 0.7 OUTLIER -79.74 84.28 5.58 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.333 -0.849 . . . . 0.71999999999999997 110.157 172.243 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.27 -41.3 57.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.634 -1.166 . . . . 0.63 108.812 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 15.6 tpt -153.92 134.77 13.76 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.747 -1.115 . . . . 2.8799999999999999 109.289 173.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -104.39 140.73 21.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.26 -0.882 . . . . 3.6699999999999999 109.73 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 34.7 Cg_endo -73.7 156.34 48.95 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.842 1.695 . . . . 0.64000000000000001 110.46 178.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -118.04 -179.85 3.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.225 -0.443 . . . . 1.4299999999999999 110.593 -173.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 5.4 p-10 -72.61 -145.62 0.02 OUTLIER 'General case' 0 N--CA 1.41 -2.462 0 CA-C-O 122.746 1.26 . . . . 2.0600000000000001 111.704 -176.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.13 133.33 1.78 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.306 -1.77 . . . . 0.29999999999999999 112.525 -176.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.484 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 37.3 mt-10 -110.36 111.16 22.27 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.682 -1.259 . . . . 1.53 108.435 176.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 22' ' ' ILE . 3.0 m -133.63 163.36 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.884 -1.154 . . . . 0.27000000000000002 107.884 -172.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.45 147.37 23.32 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.566 -1.197 . . . . 0.77000000000000002 109.193 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.958 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.79 107.42 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 CA-C-O 123.786 1.755 . . . . 0.78000000000000003 109.993 174.62 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.06 -1.66 6.74 Favored Glycine 0 C--N 1.273 -2.959 0 CA-C-N 110.517 -3.038 . . . . 0.47999999999999998 112.168 178.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.87 -119.66 2.48 Favored Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 119.223 -1.465 . . . . 0.44 110.383 176.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 48.1 t -154.09 173.63 15.79 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.611 -1.794 . . . . 0.81999999999999995 108.859 173.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.1 tp -149.32 147.36 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.039 0 CA-C-N 113.237 -1.801 . . . . 0.32000000000000001 106.845 167.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.3 m -140.9 126.84 19.33 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.632 -1.622 . . . . 0.31 111.338 -173.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.529 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 56.7 m-85 -124.45 147.02 48.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.65 -1.613 . . . . 0.53000000000000003 109.07 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.41 120.82 16.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.132 -0.94 . . . . 0.57999999999999996 110.082 176.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -113.73 116.89 30.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.467 -1.242 . . . . 0.32000000000000001 110.145 -178.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 97.5 mtt180 -101.8 119.82 39.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.704 -0.225 . . . . 2.4300000000000002 110.879 -177.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.9 t -118.77 125.28 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 122.067 0.937 . . . . 0.26000000000000001 110.419 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.05 109.21 0.91 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.126 -1.852 . . . . 0.40000000000000002 110.829 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.618 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -54.74 -33.22 55.3 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.222 -0.899 . . . . 0.76000000000000001 111.947 172.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 53.97 -162.42 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.494 1.294 . . . . 0.70999999999999996 114.494 169.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.0 p -118.44 38.81 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.939 -1.028 . . . . 1.74 109.2 173.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.057 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -64.44 177.32 0.89 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.678 -1.146 . . . . 2.1600000000000001 113.521 -179.055 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 tp -69.21 -55.08 11.65 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.61 -0.723 . . . . 1.47 109.819 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.62 152.74 71.48 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.345 -0.843 . . . . 1.3999999999999999 109.182 176.527 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -43.0 135.87 5.16 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.19 2.593 . . . . 0.88 112.987 -178.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.057 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.0 Cg_endo -55.52 135.93 71.56 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 122.726 2.284 . . . . 0.53000000000000003 112.383 -176.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.2 104.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.507 -1.664 . . . . 0.77000000000000002 106.507 177.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.63 HG22 HG13 ' A' ' 91' ' ' VAL . 42.9 t -103.84 115.22 45.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.91 0 CA-C-N 112.805 -1.998 . . . . 0.28000000000000003 108.558 -179.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 1.054 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.33 123.38 46.69 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 113.591 -1.64 . . . . 1.54 109.444 170.465 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.971 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.9 m95 -89.34 157.37 18.21 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.702 -2.499 . . . . 0.34000000000000002 111.256 173.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 21.1 t80 -136.55 125.8 24.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.876 -2.268 . . . . 0.62 104.876 167.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.801 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 20.4 tttm -102.57 162.35 12.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.494 -2.039 . . . . 2.1699999999999999 105.494 -175.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.95 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -4.62 -165.94 0.0 OUTLIER Glycine 0 C--O 1.199 -2.043 0 N-CA-C 118.86 2.304 . . . . 1.23 118.86 -174.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 84' ' ' THR . 10.4 mtpp -41.67 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.026 -1.867 . . . . 3.8700000000000001 115.716 -165.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 38.2 p-90 -166.02 2.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 114.416 1.265 . . . . 2.1099999999999999 114.416 -177.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.39 117.11 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.993 1.378 . . . . 1.29 112.254 -163.229 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -84.85 98.42 10.3 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 112.437 -2.165 . . . . 2.73 111.32 175.211 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.013 HD23 HD21 ' A' ' 57' ' ' LEU . 4.1 mp -49.64 -36.08 23.38 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.781 -0.645 . . . . 0.44 112.719 -174.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 t -58.68 -22.2 56.48 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.427 -0.582 . . . . 1.23 109.427 -169.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.2 m -101.51 -28.18 12.69 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 112.919 0.711 . . . . 1.3400000000000001 112.919 178.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 7.8 mmmt -90.1 -45.84 8.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.092 -0.504 . . . . 1.3999999999999999 111.288 -171.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.2 t -22.67 93.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 126.504 1.922 . . . . 0.37 112.737 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -168.66 -124.73 0.74 Allowed Glycine 0 C--N 1.308 -1.025 0 CA-C-N 111.844 -2.435 . . . . 0.69999999999999996 113.227 -177.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -56.8 -52.72 63.95 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.16 0.8 . . . . 2.75 113.16 -169.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.1 p80 -88.48 -38.6 14.86 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 112.208 0.447 . . . . 1.3300000000000001 112.208 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.013 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.18 109.16 13.09 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.413 -0.958 . . . . 1.1100000000000001 108.413 174.628 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -94.46 115.84 28.08 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.445 -1.687 . . . . 0.76000000000000001 106.445 167.768 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.699 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.32 92.68 6.85 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 104.476 -2.416 . . . . 0.26000000000000001 104.476 170.393 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 2.1 m170 -101.41 166.75 10.58 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.048 -1.433 . . . . 2.0299999999999998 110.454 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 125.09 22.72 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 111.98 -2.373 . . . . 0.92000000000000004 110.124 -177.458 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.3 m -94.48 148.4 22.28 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 111.506 -2.588 . . . . 0.46999999999999997 107.366 172.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 2.4 t80 -135.81 97.78 3.74 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.251 1.024 . . . . 1.3899999999999999 110.978 -173.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 5.4 m-20 -113.8 105.17 12.96 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 113.115 -1.857 . . . . 2.4199999999999999 108.564 173.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.679 ' HG3' HH11 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -84.41 -41.38 16.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.08 -0.964 . . . . 2.46 110.45 -178.728 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.28 -22.16 62.89 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.443 -1.253 . . . . 1.1499999999999999 111.028 176.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.822 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.4 t -97.7 -16.42 19.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.285 -1.376 . . . . 1.4099999999999999 107.285 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 68.04 29.18 6.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.044 -1.435 . . . . 3.3100000000000001 110.903 173.699 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.48 126.87 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 121.682 0.753 . . . . 0.42999999999999999 109.426 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.469 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.1 m-30 -105.0 109.11 20.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.796 -1.557 . . . . 1.24 106.796 170.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.6 tp -94.74 104.73 16.64 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 122.175 0.988 . . . . 0.52000000000000002 109.516 -177.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.6 m-85 -84.16 113.33 21.0 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.134 -1.432 . . . . 0.33000000000000002 107.134 171.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.51 125.61 52.16 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.789 -1.551 . . . . 1.3200000000000001 110.51 -172.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.652 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -92.15 132.5 36.57 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.838 -1.528 . . . . 0.95999999999999996 107.509 176.28 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 73.4 m-70 -119.95 96.72 5.29 Favored 'General case' 0 C--N 1.265 -3.066 0 N-CA-C 104.532 -2.396 . . . . 1.1499999999999999 104.532 167.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.812 HG12 ' HB2' ' A' ' 57' ' ' LEU . 14.2 mt -122.03 99.32 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 122.382 1.087 . . . . 0.52000000000000002 108.856 -174.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 75.8 p -100.41 165.0 11.66 Favored 'General case' 0 N--CA 1.388 -3.556 0 CA-C-N 114.546 -1.206 . . . . 0.57999999999999996 110.374 -175.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 34.9 75.55 0.05 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 110.317 -3.129 . . . . 2.1200000000000001 112.43 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -65.5 105.84 1.28 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 110.786 -2.916 . . . . 0.40000000000000002 110.022 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.774 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.98 145.46 79.89 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.951 -0.759 . . . . 1.4299999999999999 108.951 174.456 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.958 ' HD3' HG21 ' A' ' 18' ' ' VAL . 30.4 Cg_endo -62.49 150.28 88.03 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.439 1.426 . . . . 1.3300000000000001 111.254 -175.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.53 15.48 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.725 0.64 . . . . 1.1200000000000001 111.02 -175.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.58 -7.34 59.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.865 -1.161 . . . . 1.24 107.865 172.057 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.0 m -13.15 90.96 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 126.066 2.104 . . . . 1.22 112.176 -177.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.95 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -49.8 112.76 1.54 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 110.946 -2.843 . . . . 1.4299999999999999 114.034 -173.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.643 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -111.25 75.73 0.22 Allowed Glycine 0 C--N 1.27 -3.103 0 N-CA-C 108.295 -1.922 . . . . 0.52000000000000002 108.295 154.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.801 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 52.6 m-85 -80.08 119.15 22.5 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.298 -0.951 . . . . 0.63 109.065 175.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.5 104.21 8.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.295 -1.002 . . . . 3.1499999999999999 108.295 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.6 t -90.58 127.73 36.36 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.852 -0.795 . . . . 1.0800000000000001 108.852 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 1.054 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 34.1 tt0 -136.7 107.48 6.62 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.526 -0.761 . . . . 1.8100000000000001 109.699 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.63 HG13 HG22 ' A' ' 39' ' ' VAL . 21.6 t -98.81 141.46 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.644 -0.422 . . . . 0.54000000000000004 109.899 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 m -131.95 107.75 8.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.876 -0.787 . . . . 1.1799999999999999 108.876 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.763 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.9 157.05 46.07 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 118.6 -0.714 . . . . 0.73999999999999999 109.082 178.021 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 24.46 -79.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 125.61 1.819 . . . . 0.65000000000000002 113.793 168.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.63 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 t70 -142.81 -4.17 0.96 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.894 -1.048 . . . . 1.05 109.944 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.04 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -91.65 122.74 34.49 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.536 0.684 . . . . 1.29 109.348 -177.424 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -129.81 114.29 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.388 -1.278 . . . . 0.77000000000000002 110.044 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -130.44 145.26 51.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.777 -1.556 . . . . 1.6000000000000001 109.531 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.503 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.5 m -142.86 147.33 35.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.374 0.607 . . . . 1.1899999999999999 110.959 -178.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.569 ' HG ' ' HZ ' ' A' ' 7' ' ' PHE . 1.5 p -127.6 148.41 50.36 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.398 -0.819 . . . . 0.83999999999999997 111.987 178.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.94 114.92 22.78 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.739 -1.119 . . . . 1.5800000000000001 109.807 173.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.711 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.29 119.98 12.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.434 0.635 . . . . 0.85999999999999999 109.441 -176.593 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.7 p30 -103.7 155.1 18.84 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.254 1.026 . . . . 2.1099999999999999 111.59 -168.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.715 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -121.81 111.72 17.48 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.26 -1.336 . . . . 0.37 109.611 175.387 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.7 m -94.13 96.8 9.86 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.127 -0.694 . . . . 0.33000000000000002 109.127 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 79' ' ' ALA . 4.0 p -82.87 113.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 122.955 1.36 . . . . 0.33000000000000002 109.234 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.484 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 99.7 m-70 -87.5 101.21 13.39 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 112.201 -2.272 . . . . 1.1899999999999999 109.044 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HA ' HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-N 114.6 -1.182 . . . . 1.6699999999999999 108.647 170.762 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 119.783 -0.151 . . . . 1.6499999999999999 111.281 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.99 84.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.317 2.011 . . . . 0.96999999999999997 111.711 171.078 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.007 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -110.01 -64.87 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.16 -0.927 . . . . 0.5 109.329 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 95.6 46.55 2.71 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 108.284 -1.926 . . . . 0.39000000000000001 108.284 -175.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.6 tp -56.72 -47.57 79.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.156 -1.522 . . . . 0.33000000000000002 111.203 -166.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.498 ' HD1' ' HA ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -93.98 84.76 4.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.933 0.873 . . . . 0.71999999999999997 109.665 178.367 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.48 -35.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.983 -1.462 . . . . 0.63 109.693 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -158.57 130.9 6.88 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 114.948 -1.024 . . . . 2.8799999999999999 109.016 172.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -109.28 133.32 20.83 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 3.6699999999999999 110.206 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.69 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.5 Cg_endo -63.76 157.54 51.47 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.725 2.283 . . . . 0.64000000000000001 111.966 -176.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.453 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.0 mm-40 -121.26 174.17 6.87 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.858 -0.61 . . . . 1.4299999999999999 110.472 -173.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 5.5 p-10 -68.48 -142.85 0.01 OUTLIER 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 122.942 1.354 . . . . 2.0600000000000001 111.968 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.85 137.16 2.7 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 113.433 -1.712 . . . . 0.29999999999999999 112.112 -175.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.0 mt-10 -110.49 115.81 30.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.413 -0.958 . . . . 1.53 108.413 174.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -134.86 155.7 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.02 0 N-CA-C 106.982 -1.488 . . . . 0.27000000000000002 106.982 -173.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.36 157.28 18.23 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.041 -0.981 . . . . 0.77000000000000002 108.908 -179.562 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.549 HG22 ' CG2' ' A' ' 106' ' ' VAL . 21.5 t -67.69 105.98 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.847 1.308 . . . . 0.78000000000000003 108.117 173.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.76 11.41 6.49 Favored Glycine 0 C--N 1.265 -3.395 0 CA-C-N 112.132 -2.304 . . . . 0.47999999999999998 113.055 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.14 -126.81 5.89 Favored Glycine 0 N--CA 1.416 -2.66 0 C-N-CA 119.278 -1.439 . . . . 0.44 110.529 171.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.7 p -151.21 170.46 19.41 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 112.697 -1.752 . . . . 0.81999999999999995 110.613 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.8 tp -148.7 150.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-N 112.835 -1.984 . . . . 0.32000000000000001 106.952 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -138.71 130.11 27.27 Favored 'General case' 0 C--N 1.258 -3.383 0 CA-C-N 114.32 -1.309 . . . . 0.31 110.639 -175.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 74' ' ' LEU . 26.9 m-85 -124.96 142.52 51.42 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.417 -1.265 . . . . 0.53000000000000003 109.85 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.83 121.28 20.42 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.078 0.942 . . . . 0.57999999999999996 110.43 176.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.637 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -118.83 115.94 25.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.119 -1.401 . . . . 0.32000000000000001 110.459 -178.132 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -105.06 122.81 46.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.439 -0.346 . . . . 2.4300000000000002 110.76 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 39' ' ' VAL . 8.4 t -125.74 127.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 122.085 0.945 . . . . 0.26000000000000001 110.126 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -58.27 114.09 2.25 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.254 -1.794 . . . . 0.40000000000000002 111.397 177.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.03 -29.05 61.79 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.293 -1.321 . . . . 0.76000000000000001 110.757 168.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.72 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 52.86 -166.58 0.06 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.83 1.418 . . . . 0.70999999999999996 114.83 165.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 t -120.9 107.77 13.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.066 -1.457 . . . . 1.74 107.066 169.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.801 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -143.05 176.32 9.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.061 0.763 . . . . 2.1600000000000001 113.061 -165.311 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.0 tp -70.56 -71.44 0.25 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.386 -0.825 . . . . 1.47 108.824 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -116.63 148.4 41.82 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.609 -0.723 . . . . 1.3999999999999999 109.302 171.318 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 85.9 Cg_exo -46.67 142.92 9.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.877 2.385 . . . . 0.88 111.809 178.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.801 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.9 Cg_exo -62.37 139.63 78.07 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 121.938 1.759 . . . . 0.53000000000000003 111.924 -173.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.3 104.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.813 -1.551 . . . . 0.77000000000000002 106.813 178.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 28' ' ' VAL . 2.1 t -105.98 115.1 46.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 113.323 -1.762 . . . . 0.28000000000000003 107.528 176.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.09 127.91 55.14 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-O 122.944 1.354 . . . . 1.54 110.132 175.371 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.932 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.3 m95 -84.21 155.77 22.36 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 112.148 -2.297 . . . . 0.34000000000000002 111.923 175.358 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.9 t80 -131.16 141.48 50.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 104.703 -2.332 . . . . 0.62 104.703 170.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.768 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 62.5 tttt -108.81 163.53 13.19 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.349 -1.723 . . . . 2.1699999999999999 106.349 -172.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.811 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -7.81 -165.81 0.0 OUTLIER Glycine 0 C--O 1.196 -2.252 0 O-C-N 126.4 2.312 . . . . 1.23 118.845 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 84' ' ' THR . 15.6 mtpp -44.24 -3.7 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 O-C-N 119.449 -2.207 . . . . 3.8700000000000001 116.271 -169.003 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.652 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.9 p-90 -171.2 -8.99 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 N-CA-C 115.295 1.591 . . . . 2.1099999999999999 115.295 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HB ' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.83 159.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 123.222 1.487 . . . . 1.29 113.795 -159.277 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.742 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -112.48 106.11 14.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 111.817 -2.447 . . . . 2.73 113.084 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.932 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.6 mp -55.08 -36.32 65.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.086 0.773 . . . . 0.44 113.086 -175.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -59.02 -20.85 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.763 -0.829 . . . . 1.23 108.763 -169.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 12.6 m -98.79 -41.9 7.44 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.058 -0.974 . . . . 1.3400000000000001 112.088 178.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.742 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 10.7 mmmt -85.09 -37.39 20.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.952 -1.022 . . . . 1.3999999999999999 112.389 -166.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.876 HG13 ' H ' ' A' ' 59' ' ' LEU . 17.5 t -35.2 96.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 125.967 1.707 . . . . 0.37 112.542 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.63 -138.98 3.08 Favored Glycine 0 C--N 1.3 -1.457 0 CA-C-N 111.316 -2.675 . . . . 0.69999999999999996 112.809 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -74.07 -8.37 55.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.973 0.731 . . . . 2.75 112.973 -167.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.717 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 29.3 p80 -111.79 -37.52 5.12 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 120.618 -0.433 . . . . 1.3300000000000001 110.985 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.803 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -121.38 102.55 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.531 -1.655 . . . . 1.1100000000000001 106.531 171.86 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -95.89 116.16 28.5 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.288 -1.375 . . . . 0.76000000000000001 107.288 168.119 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.876 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.24 93.28 7.21 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.965 -2.235 . . . . 0.26000000000000001 104.965 170.372 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.669 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 56.8 t60 -94.19 158.98 15.34 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 122.954 1.359 . . . . 2.0299999999999998 109.042 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.95 112.87 10.29 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 111.753 -2.476 . . . . 0.92000000000000004 110.605 -176.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.4 m -97.44 149.27 22.34 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 112.308 -2.224 . . . . 0.46999999999999997 108.577 174.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -141.98 97.63 3.17 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.08 0.943 . . . . 1.3899999999999999 110.632 -170.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 6.0 t70 -116.76 128.0 54.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.766 -1.561 . . . . 2.4199999999999999 108.596 174.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.86 -31.38 11.53 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.858 -1.519 . . . . 2.46 111.021 -173.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.47 -19.88 60.22 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.385 -1.279 . . . . 1.1499999999999999 110.549 174.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 50.7 m -98.53 -20.47 17.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 107.821 -1.177 . . . . 1.4099999999999999 107.821 174.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.72 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 69.15 32.24 3.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.13 -1.395 . . . . 3.3100000000000001 109.383 175.415 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.86 129.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.615 -0.72 . . . . 0.42999999999999999 109.776 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.686 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 4.9 m-85 -100.25 112.33 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.495 -1.668 . . . . 1.24 106.495 164.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 27.5 tp -95.27 106.32 18.35 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 122.09 0.948 . . . . 0.52000000000000002 109.075 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -86.95 112.34 21.71 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.511 -1.663 . . . . 0.33000000000000002 106.511 169.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.669 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 4.0 pt-20 -121.54 122.35 39.49 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.29 -1.323 . . . . 1.3200000000000001 110.557 -173.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.716 ' CD1' HD11 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -89.08 132.08 34.95 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.033 -1.44 . . . . 0.95999999999999996 108.45 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 19.8 m170 -115.03 97.01 5.97 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 103.798 -2.668 . . . . 1.1499999999999999 103.798 169.005 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.727 ' CD1' HD22 ' A' ' 57' ' ' LEU . 62.9 mt -121.55 101.3 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-O 122.985 1.374 . . . . 0.52000000000000002 109.775 -174.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.7 p -112.69 143.78 43.32 Favored 'General case' 0 N--CA 1.398 -3.045 0 CA-C-N 114.126 -1.397 . . . . 0.57999999999999996 109.257 -178.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.77 86.05 0.12 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 111.183 -2.735 . . . . 2.1200000000000001 110.49 -177.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.479 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -75.91 125.17 28.59 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 112.713 -2.04 . . . . 0.40000000000000002 109.52 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.879 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 1.2 tp60 -61.84 134.33 94.05 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.281 -0.872 . . . . 1.4299999999999999 108.978 175.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.685 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.1 Cg_endo -60.79 145.78 98.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.704 0.936 . . . . 1.3300000000000001 110.37 176.249 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.18 17.2 10.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.441 0.463 . . . . 1.1200000000000001 111.288 -173.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.879 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -73.1 -32.67 65.11 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.546 -0.539 . . . . 1.24 109.546 175.745 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m 13.12 78.35 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 125.379 1.675 . . . . 1.22 111.137 -168.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.811 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -65.74 99.0 0.37 Allowed Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 112.112 -2.313 . . . . 1.4299999999999999 113.877 -161.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.67 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.13 74.04 1.87 Allowed Glycine 0 C--N 1.289 -2.078 0 N-CA-C 109.181 -1.568 . . . . 0.52000000000000002 109.181 171.288 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.644 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 45.3 m-85 -81.01 120.1 24.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.071 -1.065 . . . . 0.63 108.165 176.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.528 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 72.7 mtt180 -127.61 115.36 18.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.935 -0.478 . . . . 3.1499999999999999 111.034 -173.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.1 m -92.64 129.12 38.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.067 -0.515 . . . . 1.0800000000000001 110.03 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 41.7 tt0 -126.8 113.22 16.33 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.606 -0.887 . . . . 1.8100000000000001 108.606 174.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.0 p -105.26 135.51 43.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.853 0.835 . . . . 0.54000000000000004 110.655 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -129.45 109.2 10.87 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.856 -1.52 . . . . 1.1799999999999999 108.688 -176.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.624 HG22 ' HG3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -125.11 167.11 15.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 118.249 -0.882 . . . . 0.73999999999999999 108.835 178.938 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.689 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -2.94 -62.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.618 1.824 . . . . 0.65000000000000002 114.571 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.689 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 12.9 t0 -150.63 -7.05 0.28 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.773 -1.103 . . . . 1.05 110.239 -176.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.007 ' HD2' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mttp -95.35 135.63 36.72 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.14 -1.024 . . . . 1.29 108.681 -177.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -132.9 142.2 48.78 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.403 -1.726 . . . . 0.77000000000000002 110.735 -177.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -164.02 163.84 23.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.317 -0.856 . . . . 1.6000000000000001 108.972 173.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 p -153.31 148.67 27.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.244 0.545 . . . . 1.1899999999999999 111.198 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.5 t -125.45 148.97 48.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.913 0.863 . . . . 0.83999999999999997 111.71 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.24 114.28 11.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.671 -1.604 . . . . 1.5800000000000001 110.092 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.69 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 18.6 p90 -142.47 131.67 23.36 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.562 -0.533 . . . . 0.85999999999999999 109.562 -176.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 52.7 m-20 -109.04 135.24 50.52 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.154 0.978 . . . . 2.1099999999999999 111.324 -171.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -102.74 110.11 21.93 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.145 -1.389 . . . . 0.37 109.434 176.811 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 13.3 m -90.85 97.87 11.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.381 0.61 . . . . 0.33000000000000002 109.391 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.5 p -82.13 115.67 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.987 1.375 . . . . 0.33000000000000002 109.288 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 94.6 m-70 -87.24 99.57 12.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.552 -2.113 . . . . 1.1899999999999999 109.538 -177.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.542 ' HA ' HG23 ' A' ' 18' ' ' VAL . 41.3 tt0 . . . . . 0 C--N 1.301 -1.541 0 CA-C-N 113.845 -1.525 . . . . 1.6699999999999999 109.803 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.734 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-20 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.45 0.537 . . . . 1.6499999999999999 112.45 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.474 ' C ' HD12 ' A' ' 4' ' ' ILE . 24.8 Cg_exo -64.01 86.55 0.15 Allowed 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.195 2.597 . . . . 0.96999999999999997 112.406 173.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.947 HG12 ' HD3' ' A' ' 94' ' ' LYS . 1.7 mp -119.59 -56.54 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.71 -1.132 . . . . 0.5 109.573 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.001 -1.64 . . . . 0.39000000000000001 109.001 -175.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.916 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.7 tp -52.27 -37.78 56.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.309 -1.446 . . . . 0.33000000000000002 109.811 -176.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.771 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.06 84.11 5.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.04 -0.982 . . . . 0.71999999999999997 109.911 176.235 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t -72.57 -43.2 63.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.264 -1.335 . . . . 0.63 109.826 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.412 ' HB3' ' HG3' ' A' ' 27' ' ' ARG . 16.0 tpt -156.95 130.25 7.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.372 -0.831 . . . . 2.8799999999999999 109.56 174.199 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.2 ptp85 -102.8 136.42 19.29 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 115.185 -0.916 . . . . 3.6699999999999999 109.107 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.1 Cg_endo -74.14 160.53 42.46 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.323 1.349 . . . . 0.64000000000000001 110.897 176.644 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -117.13 -179.77 3.8 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.297 -0.631 . . . . 1.4299999999999999 109.297 -176.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 4.6 m-20 -69.99 -146.73 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 122.979 1.371 . . . . 2.0600000000000001 111.264 -175.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.65 133.53 1.65 Allowed Glycine 0 C--N 1.294 -1.799 0 CA-C-N 113.438 -1.71 . . . . 0.29999999999999999 111.5 -173.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.2 116.71 30.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.393 -0.904 . . . . 1.53 108.663 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -135.77 156.4 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.643 -1.244 . . . . 0.27000000000000002 107.643 -171.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 156.19 18.64 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.638 -1.165 . . . . 0.77000000000000002 108.916 176.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 81' ' ' PRO . 13.5 t -66.89 107.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 123.151 1.453 . . . . 0.78000000000000003 108.477 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.17 3.71 11.65 Favored Glycine 0 C--N 1.266 -3.323 0 CA-C-N 111.612 -2.54 . . . . 0.47999999999999998 112.463 178.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.86 -127.88 5.2 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 118.988 -1.577 . . . . 0.44 110.023 176.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 18.8 p -153.06 164.9 37.16 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 113.437 -1.381 . . . . 0.81999999999999995 110.718 177.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 104' ' ' LEU . 10.8 tp -147.05 149.67 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.401 -1.727 . . . . 0.32000000000000001 107.924 171.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -139.81 127.33 21.58 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 113.016 -1.902 . . . . 0.31 110.385 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.633 ' HB2' HD23 ' A' ' 74' ' ' LEU . 54.5 m-85 -121.92 147.31 46.18 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.607 -1.179 . . . . 0.53000000000000003 108.883 174.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -132.44 119.73 21.03 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.208 -0.905 . . . . 0.57999999999999996 109.183 178.199 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.644 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.39 119.96 29.76 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.456 -1.247 . . . . 0.32000000000000001 110.805 -173.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.514 ' HG2' HD13 ' A' ' 71' ' ' LEU . 72.0 mtp180 -114.21 127.09 55.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.266 -0.425 . . . . 2.4300000000000002 110.774 -176.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 91' ' ' VAL . 22.4 t -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-O 122.005 0.907 . . . . 0.26000000000000001 110.558 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.96 111.38 2.13 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.197 -1.819 . . . . 0.40000000000000002 110.566 174.172 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.81 -40.07 9.02 Favored Glycine 0 C--N 1.32 -0.336 0 CA-C-N 114.543 -1.208 . . . . 0.76000000000000001 111.548 170.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 50.69 -156.01 0.12 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.869 0.868 . . . . 0.70999999999999996 113.282 171.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.6 m -120.01 84.33 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.216 0.532 . . . . 1.74 110.852 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.076 HD22 ' HA ' ' A' ' 93' ' ' THR . 1.8 tp -114.28 150.38 34.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.323 -0.992 . . . . 2.1600000000000001 108.323 173.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 33' ' ' LEU . 21.0 tp -44.24 -37.41 3.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.948 0.88 . . . . 1.47 111.292 178.107 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.808 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.36 178.41 1.7 Allowed Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.41 -1.268 . . . . 1.3999999999999999 108.121 177.193 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.0 Cg_exo -65.59 146.23 83.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.662 1.575 . . . . 0.88 109.997 173.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HG3' HG21 ' A' ' 93' ' ' THR . 49.4 Cg_exo -45.57 140.76 8.63 Favored 'Trans proline' 0 CA--C 1.498 -1.297 0 C-N-CA 123.211 2.607 . . . . 0.53000000000000003 113.286 178.536 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 92' ' ' SER . 7.3 p -100.09 96.84 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.075 1.417 . . . . 0.77000000000000002 107.664 168.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.639 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -99.26 114.47 37.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 112.703 -2.044 . . . . 0.28000000000000003 106.923 170.308 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.6 127.27 53.5 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 114.027 -1.442 . . . . 1.54 109.6 177.729 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.046 ' HB3' HD13 ' A' ' 49' ' ' LEU . 89.2 m95 -89.6 147.48 23.9 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.078 -2.328 . . . . 0.34000000000000002 111.792 173.149 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.655 ' HD2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 t80 -131.35 125.48 32.78 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.71 -1.589 . . . . 0.62 106.71 172.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 5.1 ttpm? -98.93 109.91 22.6 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.214 -1.402 . . . . 2.1699999999999999 107.214 -173.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.671 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -83.3 92.49 1.66 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 116.012 -2.994 . . . . 1.23 114.797 -167.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.839 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -106.15 -53.52 2.62 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.61 -3.107 . . . . 3.8700000000000001 102.61 132.16 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.839 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 6.5 p-90 -167.38 -1.56 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 110.459 -3.064 . . . . 2.1099999999999999 111.476 178.416 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.526 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -94.67 170.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-O 123.144 1.45 . . . . 1.29 112.496 -159.7 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 7.3 t70 -106.22 150.0 26.31 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.675 -2.511 . . . . 2.73 106.07 173.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -88.17 -36.84 16.6 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.402 -0.519 . . . . 0.44 110.902 176.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -59.97 -19.54 52.76 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.866 0.841 . . . . 1.23 109.011 -169.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -86.14 -28.78 23.76 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.571 -1.195 . . . . 1.3400000000000001 111.094 -176.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 43' ' ' LYS . 2.4 mmmt -104.65 -71.4 0.74 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.03 -0.986 . . . . 1.3999999999999999 111.125 -172.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.93 HG13 ' H ' ' A' ' 59' ' ' LEU . 56.2 t 19.01 85.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 O-C-N 125.366 1.667 . . . . 0.37 113.181 -177.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.74 -131.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 114.659 -1.155 . . . . 0.69999999999999996 113.639 -173.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -48.78 -53.87 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.909 1.077 . . . . 2.75 113.909 -168.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.2 p80 -91.17 -38.09 12.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.837 -0.745 . . . . 1.3300000000000001 111.498 -173.142 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.886 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.0 108.81 12.78 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.809 -0.811 . . . . 1.1100000000000001 108.809 175.443 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.43 115.61 27.72 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 106.343 -1.725 . . . . 0.76000000000000001 106.343 168.218 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.93 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.05 92.7 6.97 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.961 -2.237 . . . . 0.26000000000000001 104.961 172.099 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 36.1 m170 -81.9 163.3 22.33 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.046 -1.434 . . . . 2.0299999999999998 109.994 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -139.21 114.8 9.9 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 112.328 -2.214 . . . . 0.92000000000000004 109.604 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 3.2 m -92.26 148.22 22.31 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.153 -1.84 . . . . 0.46999999999999997 106.516 169.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.486 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.2 t80 -144.75 98.96 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.211 1.005 . . . . 1.3899999999999999 111.011 -170.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 67' ' ' SER . 2.5 p30 -113.69 128.23 56.34 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.697 -1.592 . . . . 2.4199999999999999 110.342 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.1 mmm180 -105.95 29.03 7.03 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.705 -1.589 . . . . 2.46 109.295 172.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.04 -30.17 6.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.195 -1.82 . . . . 1.1499999999999999 109.27 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 5.7 t -111.91 -8.47 14.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.89 -1.05 . . . . 1.4099999999999999 108.939 178.016 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 72.48 31.68 1.72 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.547 -0.909 . . . . 3.3100000000000001 108.547 173.654 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 3.3 t -127.33 133.8 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 122.506 1.146 . . . . 0.42999999999999999 111.473 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' SER . 5.0 m-85 -101.96 113.39 26.57 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.26 -1.755 . . . . 1.24 106.26 162.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 14.7 tp -97.36 104.82 16.88 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 122.302 1.049 . . . . 0.52000000000000002 109.391 177.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.4 m-85 -88.64 114.58 25.4 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.833 -1.53 . . . . 0.33000000000000002 108.534 174.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 2.9 mt-10 -103.52 125.66 50.21 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 113.708 -1.587 . . . . 1.3200000000000001 109.566 -176.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.876 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -94.08 122.23 36.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.862 -1.162 . . . . 0.95999999999999996 107.862 171.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 11.4 m170 -115.79 93.83 4.43 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.967 -2.605 . . . . 1.1499999999999999 103.967 169.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.885 HG12 ' HB2' ' A' ' 57' ' ' LEU . 38.0 mt -121.78 100.79 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 122.883 1.325 . . . . 0.52000000000000002 110.026 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 72.4 p -103.02 154.61 19.07 Favored 'General case' 0 N--CA 1.391 -3.395 0 CA-C-N 114.057 -1.429 . . . . 0.57999999999999996 109.051 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.89 84.26 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.115 -2.766 . . . . 2.1200000000000001 112.064 178.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -72.84 132.28 43.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 110.731 -2.94 . . . . 0.40000000000000002 112.252 -175.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.752 HE21 ' HD2' ' A' ' 81' ' ' PRO . 3.2 tp60 -54.01 125.62 49.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.402 -0.817 . . . . 1.4299999999999999 109.323 170.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.4 Cg_endo -59.23 -7.19 4.67 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.738 2.959 . . . . 1.3300000000000001 114.03 -175.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.662 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.6 0.41 19.08 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.974 -0.29 . . . . 1.1200000000000001 111.569 -178.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.639 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.48 -58.09 9.57 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.642 0.258 . . . . 1.24 110.889 -172.601 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 34.2 m 38.64 66.2 0.55 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.592 -1.633 . . . . 1.22 106.592 -155.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -62.72 84.77 0.04 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 CA-C-N 112.445 -2.162 . . . . 1.4299999999999999 114.139 -161.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -86.72 82.78 1.62 Allowed Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.916 -1.673 . . . . 0.52000000000000002 108.916 175.307 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 18.1 m-85 -78.75 113.99 17.3 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.779 -1.211 . . . . 0.63 107.998 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.655 ' HB2' ' HD2' ' A' ' 42' ' ' PHE . 7.4 mtp180 -104.02 105.95 16.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.267 0.556 . . . . 3.1499999999999999 109.854 -176.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.8 t -87.71 126.96 35.28 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.568 -0.742 . . . . 1.0800000000000001 109.076 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.947 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 37.6 tt0 -136.03 110.37 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.222 -0.899 . . . . 1.8100000000000001 109.606 -175.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.639 ' HB ' HG13 ' A' ' 39' ' ' VAL . 1.7 p -106.27 142.3 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.957 0.408 . . . . 0.54000000000000004 111.046 -179.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.557 ' O ' HG12 ' A' ' 38' ' ' VAL . 20.7 t -132.13 108.28 9.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.919 -1.141 . . . . 1.1799999999999999 107.919 177.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.076 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -131.44 146.62 52.34 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 117.912 -1.042 . . . . 0.73999999999999999 108.501 -178.639 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.947 ' HD3' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 32.74 -74.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.642 1.839 . . . . 0.65000000000000002 112.976 -177.558 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 22.2 t70 -147.69 -7.56 0.44 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.569 -1.196 . . . . 1.05 110.429 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.916 ' HB3' HD22 ' A' ' 6' ' ' LEU . 2.7 tttp -86.38 131.65 34.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.998 -1.112 . . . . 1.29 107.998 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -133.2 120.45 21.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.485 -1.689 . . . . 0.77000000000000002 110.233 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -139.69 148.27 42.11 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.502 -1.226 . . . . 1.6000000000000001 109.338 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 43.8 m -140.0 149.17 42.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.371 -0.377 . . . . 1.1899999999999999 110.303 -179.032 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.771 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 40.7 p -131.9 134.43 45.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 0.83999999999999997 111.273 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.632 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -107.78 119.43 39.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 1.5800000000000001 110.096 177.356 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.738 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -142.27 118.56 10.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.137 -0.69 . . . . 0.85999999999999999 109.137 -179.105 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 3.7 p30 -106.43 154.6 20.58 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 123.034 1.397 . . . . 2.1099999999999999 111.876 -170.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.644 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -116.57 106.42 13.54 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.924 -1.944 . . . . 0.37 110.456 178.517 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -87.43 95.86 10.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.334 -0.987 . . . . 0.33000000000000002 108.334 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.2 p -83.37 120.23 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 122.876 1.322 . . . . 0.33000000000000002 108.54 -177.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -93.81 98.31 10.99 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 112.892 -1.958 . . . . 1.1899999999999999 109.322 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 18' ' ' VAL . 27.8 tt0 . . . . . 0 C--N 1.302 -1.48 0 CA-C-N 114.258 -1.337 . . . . 1.6699999999999999 109.665 171.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 8.2 m-20 . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 109.311 -0.626 . . . . 1.6499999999999999 109.311 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.22 81.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.464 2.109 . . . . 0.96999999999999997 111.596 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.644 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -102.0 -62.51 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 115.457 -0.792 . . . . 0.5 109.608 178.685 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.12 40.71 3.68 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.987 -1.645 . . . . 0.39000000000000001 108.987 -176.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.7 tp -55.07 -33.62 62.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.42 -1.39 . . . . 0.33000000000000002 110.131 -172.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.833 ' CZ ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -97.81 84.58 3.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.391 -1.277 . . . . 0.71999999999999997 109.608 176.847 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.65 -46.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.664 -1.153 . . . . 0.63 110.374 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ttt -159.74 134.46 7.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.851 -1.068 . . . . 2.8799999999999999 108.567 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.833 ' HD2' ' CZ ' ' A' ' 7' ' ' PHE . 5.5 mmp_? -125.25 145.66 51.45 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 116.173 -0.467 . . . . 3.6699999999999999 111.077 -172.023 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.812 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -70.73 159.4 52.82 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.773 1.649 . . . . 0.64000000000000001 110.573 179.145 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -124.79 -176.81 3.64 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.04 -0.527 . . . . 1.4299999999999999 110.142 -173.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 3.7 p-10 -68.27 -152.34 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.732 0 CA-C-O 122.869 1.318 . . . . 2.0600000000000001 111.211 -177.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 153.17 139.1 2.81 Favored Glycine 0 C--N 1.287 -2.171 0 CA-C-N 113.044 -1.889 . . . . 0.29999999999999999 111.744 -173.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 21.2 mt-10 -115.07 114.96 26.05 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.297 -0.952 . . . . 1.53 109.055 175.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -136.4 158.32 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 N-CA-C 107.104 -1.443 . . . . 0.27000000000000002 107.104 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.04 157.74 18.24 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.83 -1.077 . . . . 0.77000000000000002 109.548 -178.873 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 22.6 t -64.99 107.06 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 123.088 1.423 . . . . 0.78000000000000003 108.554 173.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 10.12 16.34 Favored Glycine 0 C--N 1.267 -3.284 0 CA-C-N 111.882 -2.417 . . . . 0.47999999999999998 113.041 175.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 -123.14 3.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 119.703 -1.237 . . . . 0.44 110.198 175.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.9 p -152.43 164.24 37.93 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 112.989 -1.605 . . . . 0.81999999999999995 110.817 176.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.5 tp -148.29 150.96 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 113.609 -1.632 . . . . 0.32000000000000001 107.774 170.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.8 m -138.54 129.28 26.47 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 113.941 -1.481 . . . . 0.31 110.996 -176.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.691 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 87.7 m-85 -125.21 145.19 50.09 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.955 -1.475 . . . . 0.53000000000000003 109.089 178.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.526 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -137.43 124.86 21.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.943 -0.762 . . . . 0.57999999999999996 108.943 174.352 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.85 114.4 19.81 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.741 -1.118 . . . . 0.32000000000000001 110.208 -176.252 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.501 ' HG2' HD13 ' A' ' 71' ' ' LEU . 67.7 mtp180 -104.86 128.98 53.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.504 -0.316 . . . . 2.4300000000000002 110.267 -176.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.491 HG21 HG21 ' A' ' 39' ' ' VAL . 20.1 t -125.5 127.48 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.902 0.858 . . . . 0.26000000000000001 109.964 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -63.11 108.82 1.33 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.961 -1.472 . . . . 0.40000000000000002 110.939 175.461 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.68 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.62 -54.92 11.95 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.76000000000000001 112.35 173.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 57.57 -166.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.275 0.843 . . . . 0.70999999999999996 113.275 177.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -107.73 127.65 53.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.37 -0.832 . . . . 1.74 109.037 172.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -123.41 -178.86 4.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.088 0.947 . . . . 2.1600000000000001 112.319 -168.665 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' H ' ' HB3' ' A' ' 94' ' ' LYS . 17.4 tp -88.29 -37.36 16.07 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.586 -1.643 . . . . 1.47 106.846 154.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.35 145.8 19.07 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.595 -1.184 . . . . 1.3999999999999999 110.895 171.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.82 148.48 12.42 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.348 2.699 . . . . 0.88 112.27 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HA ' HG23 ' A' ' 93' ' ' THR . 6.3 Cg_endo -55.21 132.26 51.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.091 1.861 . . . . 0.53000000000000003 113.572 -175.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.13 106.28 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.277 -1.749 . . . . 0.77000000000000002 106.277 174.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 91' ' ' VAL . 2.1 t -115.08 114.31 46.1 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 113.703 -1.589 . . . . 0.28000000000000003 108.03 179.082 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.809 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.84 128.72 45.91 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 123.066 1.413 . . . . 1.54 109.19 172.906 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 1.002 ' HB3' HD13 ' A' ' 49' ' ' LEU . 60.0 m95 -87.89 153.54 21.23 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 112.061 -2.336 . . . . 0.34000000000000002 110.709 172.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -135.01 125.23 26.15 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.202 -2.147 . . . . 0.62 105.202 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HB3' HG12 ' A' ' 47' ' ' VAL . 27.1 tttt -104.09 99.57 9.31 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.38 -1.711 . . . . 2.1699999999999999 106.38 -175.481 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.661 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -86.45 95.14 2.01 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 115.882 -3.056 . . . . 1.23 117.078 -154.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.926 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -101.69 -48.17 4.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.007 -2.59 . . . . 3.8700000000000001 104.007 135.322 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.926 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 11.6 p-90 -170.41 1.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 112.676 -2.056 . . . . 2.1099999999999999 111.915 175.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -97.35 169.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 C-N-CA 125.275 1.43 . . . . 1.29 113.171 -159.427 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.549 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 m-20 -100.95 147.45 26.15 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 112.456 -2.156 . . . . 2.73 107.527 173.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.002 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.3 mp -79.21 -29.25 42.72 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.678 -0.409 . . . . 0.44 110.639 173.383 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -57.36 -20.93 32.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 1.23 109.608 -167.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.504 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -97.59 -27.85 14.21 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 119.78 -0.768 . . . . 1.3400000000000001 111.79 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.582 ' HB2' HD12 ' A' ' 57' ' ' LEU . 5.9 mmmt -95.68 -33.37 12.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.392 -0.822 . . . . 1.3999999999999999 111.319 -171.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.828 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.8 t -40.79 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 126.02 1.728 . . . . 0.37 111.908 175.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.89 -103.2 0.19 Allowed Glycine 0 C--N 1.302 -1.353 0 CA-C-N 112.427 -2.17 . . . . 0.69999999999999996 113.42 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.11 -54.68 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.118 0.784 . . . . 2.75 113.118 -169.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -96.05 -29.37 14.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.487 0.661 . . . . 1.3300000000000001 111.189 -174.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.969 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.12 106.05 13.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.541 -1.651 . . . . 1.1100000000000001 106.541 173.494 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -104.68 118.28 36.18 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.074 -1.454 . . . . 0.76000000000000001 107.074 167.119 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.828 ' H ' HG13 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -98.96 92.83 5.7 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.211 -2.144 . . . . 0.26000000000000001 105.211 172.073 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.7 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.2 m170 -91.31 162.91 14.41 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.161 -1.381 . . . . 2.0299999999999998 110.21 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -136.45 122.95 20.83 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 112.348 -2.205 . . . . 0.92000000000000004 110.145 176.176 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -97.0 148.54 22.87 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 111.367 -2.651 . . . . 0.46999999999999997 108.559 176.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 37.3 t80 -127.78 99.83 5.7 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.352 1.072 . . . . 1.3899999999999999 111.563 -170.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.852 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 3.2 m-20 -113.44 103.96 11.8 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.036 -1.893 . . . . 2.4199999999999999 109.285 172.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -42.1 14.38 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.054 -0.521 . . . . 2.46 110.26 174.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.38 61.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.295 -0.866 . . . . 1.1499999999999999 110.637 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.852 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 9.4 m -99.67 -16.3 18.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.8 -1.185 . . . . 1.4099999999999999 107.8 175.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 68.24 31.62 5.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.362 -1.29 . . . . 3.3100000000000001 110.001 172.523 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 2.6 t -129.97 122.54 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-N 115.48 -0.782 . . . . 0.42999999999999999 110.175 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.68 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 46.2 m-85 -95.92 113.22 24.83 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.026 -1.472 . . . . 1.24 107.026 164.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 25' ' ' SER . 22.6 tp -97.47 105.02 17.1 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.106 0.955 . . . . 0.52000000000000002 108.78 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.0 m-85 -86.19 111.65 20.59 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.262 -1.755 . . . . 0.33000000000000002 106.262 170.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -116.57 129.52 56.22 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 114.348 -1.296 . . . . 1.3200000000000001 110.344 -174.833 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.5 mt -92.29 135.92 33.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 113.789 -1.551 . . . . 0.95999999999999996 108.635 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -120.09 97.32 5.54 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 103.915 -2.624 . . . . 1.1499999999999999 103.915 165.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.731 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -125.48 100.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 122.982 1.372 . . . . 0.52000000000000002 109.153 -175.051 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 40.7 p -97.6 165.12 12.13 Favored 'General case' 0 N--CA 1.381 -3.886 0 CA-C-N 114.004 -1.453 . . . . 0.57999999999999996 107.866 178.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.4 84.27 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 111.404 -2.635 . . . . 2.1200000000000001 112.755 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -76.66 132.69 39.53 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 111.574 -2.557 . . . . 0.40000000000000002 108.383 176.084 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.611 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 1.1 pt20 -93.63 152.02 40.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.616 -0.883 . . . . 1.4299999999999999 108.616 -178.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HB3' ' HG2' ' A' ' 108' ' ' GLU . 36.8 Cg_endo -63.92 -16.84 57.15 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.75 2.3 . . . . 1.3300000000000001 113.403 -167.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -92.04 13.06 19.87 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.961 -0.563 . . . . 1.1200000000000001 111.68 -176.576 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 45' ' ' LYS . 15.9 m-30 -89.09 -61.17 1.76 Allowed 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.258 -0.577 . . . . 1.24 110.52 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.3 m 36.7 63.16 0.69 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.027 -1.471 . . . . 1.22 107.027 -158.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.741 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -67.21 90.94 0.19 Allowed Glycine 0 CA--C 1.481 -2.055 0 CA-C-N 111.978 -2.374 . . . . 1.4299999999999999 113.782 -160.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -84.72 82.04 1.71 Allowed Glycine 0 C--N 1.277 -2.715 0 N-CA-C 107.933 -2.067 . . . . 0.52000000000000002 107.933 168.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 8.3 m-85 -74.71 134.33 41.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.653 -1.274 . . . . 0.63 108.088 179.283 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -126.44 138.12 53.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.92 -0.4 . . . . 3.1499999999999999 109.92 -178.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.648 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 4.3 m -112.09 116.42 30.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.415 -0.957 . . . . 1.0800000000000001 108.415 168.065 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.809 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 64.5 mt-10 -110.19 102.07 10.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.544 -1.28 . . . . 1.8100000000000001 107.544 176.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 39' ' ' VAL . 4.7 p -99.19 135.92 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.752 0.787 . . . . 0.54000000000000004 111.36 -173.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.6 t -130.07 108.89 10.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.891 -1.504 . . . . 1.1799999999999999 107.862 -179.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.5 m -130.3 158.47 39.7 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.8 -1.095 . . . . 0.73999999999999999 108.054 179.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.683 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 10.96 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 125.819 1.949 . . . . 0.65000000000000002 114.342 -177.489 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.683 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -146.18 -3.16 0.67 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.923 -1.035 . . . . 1.05 110.193 -176.694 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.665 ' HB3' HD22 ' A' ' 6' ' ' LEU . 4.5 mmtp -95.39 129.63 42.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.612 -0.884 . . . . 1.29 108.612 -177.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -131.7 128.63 39.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.81 -1.087 . . . . 0.77000000000000002 112.341 -178.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.7 160.47 43.82 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.46 -1.245 . . . . 1.6000000000000001 109.95 175.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -140.95 145.86 36.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.624 0.25 . . . . 1.1899999999999999 110.487 176.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.758 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 89.2 p -126.8 135.53 51.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.542 -0.299 . . . . 0.83999999999999997 110.915 -175.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.479 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -122.33 128.49 51.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.378 0.609 . . . . 1.5800000000000001 111.05 179.773 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.812 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -143.08 119.0 10.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.6 -0.727 . . . . 0.85999999999999999 109.694 -177.143 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.503 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -104.32 129.58 52.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.423 1.106 . . . . 2.1099999999999999 113.114 -170.007 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -102.75 111.98 24.55 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.526 -1.67 . . . . 0.37 109.733 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.5 m -90.62 98.38 11.74 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.977 -0.749 . . . . 0.33000000000000002 108.977 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.6 p -81.9 115.02 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-O 122.967 1.365 . . . . 0.33000000000000002 109.399 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.652 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.7 m170 -83.14 99.79 10.13 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.71 -2.041 . . . . 1.1899999999999999 110.05 -176.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 3.0 tm-20 . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.307 -1.315 . . . . 1.6699999999999999 109.101 170.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 4.5 t70 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 108.625 -0.88 . . . . 1.6499999999999999 108.625 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 3.0 Cg_endo -46.59 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.385 3.39 . . . . 0.96999999999999997 113.954 179.013 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.669 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -123.29 -65.18 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.97 -1.014 . . . . 0.5 109.124 175.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 90.05 47.74 3.79 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 108.131 -1.987 . . . . 0.39000000000000001 108.131 -174.167 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.7 tp -58.12 -41.49 83.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.783 -1.709 . . . . 0.33000000000000002 110.346 -167.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.812 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.02 85.67 6.01 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.887 0.851 . . . . 0.71999999999999997 109.772 174.796 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.08 -40.02 85.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.774 -1.557 . . . . 0.63 110.078 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.486 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 57.3 ttm -153.42 134.58 14.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 2.8799999999999999 110.19 176.37 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.661 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 6.8 mtm180 -91.91 139.35 24.58 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 107.905 -1.146 . . . . 3.6699999999999999 107.905 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 40.2 Cg_endo -78.64 -163.85 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.981 2.454 . . . . 0.64000000000000001 113.509 -175.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -127.26 131.29 50.58 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.745 -0.661 . . . . 1.4299999999999999 111.405 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 8.4 m-20 -43.91 -98.99 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.668 1.587 . . . . 2.0600000000000001 113.162 -176.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.3 145.93 4.36 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-O 121.769 0.649 . . . . 0.29999999999999999 111.758 169.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.5 112.1 10.0 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.966 -0.617 . . . . 1.53 109.707 170.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.576 HG11 ' HB ' ' A' ' 22' ' ' ILE . 10.4 m -138.87 165.87 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.093 -1.077 . . . . 0.27000000000000002 108.093 -172.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.671 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.94 157.38 15.92 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.932 -1.031 . . . . 0.77000000000000002 109.288 178.074 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 106' ' ' VAL . 59.5 t -64.77 106.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 122.96 1.362 . . . . 0.78000000000000003 109.583 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.7 10.68 14.14 Favored Glycine 0 C--N 1.272 -2.995 0 CA-C-N 112.105 -2.316 . . . . 0.47999999999999998 113.561 171.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.35 -122.15 3.56 Favored Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 118.615 -1.755 . . . . 0.44 110.457 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 5.7 p -151.03 165.05 34.97 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 112.716 -1.742 . . . . 0.81999999999999995 110.302 177.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.661 HG21 HD13 ' A' ' 104' ' ' LEU . 8.3 tp -147.98 150.2 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 113.665 -1.607 . . . . 0.32000000000000001 106.837 172.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -138.55 132.8 31.68 Favored 'General case' 0 C--N 1.263 -3.184 0 CA-C-N 114.672 -1.149 . . . . 0.31 110.623 -174.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.786 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 18.6 m-85 -128.38 137.71 52.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.228 -1.351 . . . . 0.53000000000000003 109.98 -175.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.422 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.79 124.3 16.85 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.985 0.898 . . . . 0.57999999999999996 111.262 172.694 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.643 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -122.94 129.26 51.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.011 -1.449 . . . . 0.32000000000000001 110.328 -178.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.486 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 54.2 mtt180 -107.31 126.39 52.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.404 -0.362 . . . . 2.4300000000000002 111.688 -174.849 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.55 HG21 HG21 ' A' ' 39' ' ' VAL . 20.1 t -128.37 131.87 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.93 0.871 . . . . 0.26000000000000001 110.137 -177.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.96 118.1 9.27 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.614 -1.63 . . . . 0.40000000000000002 111.439 179.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.78 -33.66 56.04 Favored Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.579 -1.192 . . . . 0.76000000000000001 110.868 168.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 59.58 -164.19 0.22 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.735 1.383 . . . . 0.70999999999999996 114.735 162.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -113.48 118.4 34.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.01 -1.45 . . . . 1.74 107.446 170.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.733 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.61 166.03 33.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.436 0.532 . . . . 2.1600000000000001 112.436 -165.564 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' HB2' ' HG3' ' A' ' 35' ' ' LYS . 1.8 mt -81.86 -30.36 32.08 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.576 1.179 . . . . 1.47 109.528 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -150.6 139.36 12.95 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 112.673 -2.058 . . . . 1.3999999999999999 108.661 -166.81 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -47.4 141.87 13.61 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.571 2.181 . . . . 0.88 111.397 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_exo -63.0 130.16 28.22 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.297 1.331 . . . . 0.53000000000000003 111.536 -175.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.13 104.11 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.052 -1.462 . . . . 0.77000000000000002 107.052 179.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.1 t -107.69 113.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 113.444 -1.707 . . . . 0.28000000000000003 107.387 176.236 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.785 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -98.42 119.0 36.36 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 122.95 1.357 . . . . 1.54 110.062 176.029 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.682 ' HB3' HD22 ' A' ' 49' ' ' LEU . 46.5 m95 -86.61 139.26 30.98 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 112.079 -2.328 . . . . 0.34000000000000002 110.662 175.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 58.1 t80 -117.55 153.75 32.68 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.166 -1.42 . . . . 0.62 107.166 170.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.961 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 22.9 tptt -106.6 165.57 11.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.601 -0.888 . . . . 2.1699999999999999 108.601 -172.176 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.984 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -25.14 168.47 0.0 OUTLIER Glycine 0 C--O 1.204 -1.76 0 O-C-N 124.348 1.03 . . . . 1.23 114.749 169.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 ptmt -39.86 0.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 119.763 3.245 . . . . 3.8700000000000001 119.763 -140.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.927 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -162.6 -15.54 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.96 1.255 . . . . 2.1099999999999999 113.594 -179.413 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.636 HG12 ' HE3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -94.62 166.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.812 0 CA-C-O 122.816 1.293 . . . . 1.29 110.114 -164.687 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.684 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 3.0 p-10 -113.65 154.81 26.61 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 112.489 -2.141 . . . . 2.73 108.867 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.961 ' CD1' ' HB2' ' A' ' 43' ' ' LYS . 5.3 mp -92.35 -23.73 19.14 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.163 0.431 . . . . 0.44 112.163 169.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 t -61.06 -21.58 63.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.883 -0.784 . . . . 1.23 108.883 -168.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.62 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 22.1 m -101.35 -41.59 6.62 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.315 1.055 . . . . 1.3400000000000001 110.457 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.684 ' HD3' ' O ' ' A' ' 48' ' ' ASP . 3.7 mptp? -73.74 -75.58 0.15 Allowed 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 113.398 -1.728 . . . . 1.3999999999999999 111.821 -168.201 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 25.2 t 7.66 87.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 126.189 2.181 . . . . 0.37 113.908 175.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -155.5 -131.54 1.45 Allowed Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.824 -1.989 . . . . 0.69999999999999996 111.693 179.068 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -59.81 -42.35 93.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.246 0.832 . . . . 2.75 113.246 -169.84 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.9 p80 -92.98 -38.11 11.84 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.548 -0.461 . . . . 1.3300000000000001 112.075 -175.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.87 HD11 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -121.12 105.73 10.88 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.353 -1.351 . . . . 1.1100000000000001 107.353 175.526 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -99.43 113.14 25.32 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.831 -1.544 . . . . 0.76000000000000001 106.831 164.656 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.983 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -93.0 94.45 8.9 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 103.538 -2.764 . . . . 0.26000000000000001 103.538 168.515 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 41.4 m-70 -96.38 164.67 12.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 123.259 1.504 . . . . 2.0299999999999998 111.344 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.43 120.93 17.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 110.847 -2.888 . . . . 0.92000000000000004 108.498 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.28 116.06 25.47 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.41 -1.723 . . . . 0.46999999999999997 109.933 172.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -121.23 106.91 11.94 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.935 -1.03 . . . . 1.3899999999999999 110.843 -169.843 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -106.14 102.16 11.6 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.67 -1.15 . . . . 2.4199999999999999 109.252 172.318 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.79 -30.26 70.42 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.197 -1.365 . . . . 2.46 111.352 -174.051 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.14 -12.32 60.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.763 -0.653 . . . . 1.1499999999999999 110.659 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 14.7 m -101.33 -15.85 17.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.935 -1.135 . . . . 1.4099999999999999 107.935 173.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER 68.62 31.17 4.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.565 -1.198 . . . . 3.3100000000000001 109.822 179.192 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -132.91 134.3 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.661 0.743 . . . . 0.42999999999999999 110.329 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 63' ' ' TYR . 3.0 m-85 -104.24 111.52 24.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.311 -1.737 . . . . 1.24 106.311 162.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 25' ' ' SER . 29.2 tp -94.41 104.98 16.95 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.668 -1.234 . . . . 0.52000000000000002 107.668 175.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 83.0 m-85 -86.81 113.81 22.94 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 106.642 -1.614 . . . . 0.33000000000000002 106.642 171.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.95 121.94 36.63 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 113.724 -1.58 . . . . 1.3200000000000001 110.172 -173.568 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.983 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -92.11 132.97 36.19 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.758 -1.564 . . . . 0.95999999999999996 108.399 179.114 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.37 98.62 7.03 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 103.603 -2.74 . . . . 1.1499999999999999 103.603 167.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.7 HG13 ' HB3' ' A' ' 74' ' ' LEU . 8.5 mt -124.55 100.24 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-O 122.97 1.367 . . . . 0.52000000000000002 109.282 -174.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 77.3 p -102.25 166.07 10.78 Favored 'General case' 0 N--CA 1.384 -3.736 0 CA-C-N 114.101 -1.409 . . . . 0.57999999999999996 108.5 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.44 76.17 0.18 Allowed 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 111.454 -2.612 . . . . 2.1200000000000001 111.318 176.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.79 108.11 9.58 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.9 -1.955 . . . . 0.40000000000000002 110.694 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -54.23 143.43 44.8 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 1.4299999999999999 109.948 167.612 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 23.4 Cg_endo -61.12 -8.39 9.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.105 2.536 . . . . 1.3300000000000001 113.25 -179.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.43 12.05 30.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.33 -0.395 . . . . 1.1200000000000001 110.992 178.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.523 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -97.56 -3.81 38.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 118.102 -0.952 . . . . 1.24 111.08 -178.296 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.1 m -18.17 93.99 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.453 1.721 . . . . 1.22 111.291 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.936 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -40.51 114.51 0.53 Allowed Glycine 0 CA--C 1.465 -3.093 0 CA-C-N 109.626 -3.443 . . . . 1.4299999999999999 114.24 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.984 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -131.68 60.69 0.67 Allowed Glycine 0 N--CA 1.405 -3.411 0 CA-C-N 111.394 -2.403 . . . . 0.52000000000000002 108.941 159.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.812 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 31.2 m-85 -77.79 108.0 10.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.863 -1.162 . . . . 0.63 107.863 178.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.503 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 16.0 tpt180 -106.21 112.49 25.54 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.258 0.552 . . . . 3.1499999999999999 110.616 -175.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 38.0 m -99.7 118.23 35.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.66 -0.7 . . . . 1.0800000000000001 110.241 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.785 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 76.0 mt-10 -129.18 116.56 19.39 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.711 -0.477 . . . . 1.8100000000000001 109.711 175.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 p -95.41 139.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.517 0.675 . . . . 0.54000000000000004 110.141 177.084 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.8 m -134.41 108.5 8.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.862 -1.063 . . . . 1.1799999999999999 108.271 -176.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 94' ' ' LYS . 1.1 m -131.26 -176.75 4.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.412 -0.813 . . . . 0.73999999999999999 109.92 -176.056 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -10.41 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 125.04 1.462 . . . . 0.65000000000000002 114.688 -177.343 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.946 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.8 t70 -159.33 0.74 0.08 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.522 -1.217 . . . . 1.05 109.338 -175.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.684 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -100.95 145.21 28.95 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.223 1.011 . . . . 1.29 109.718 -177.769 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -134.77 136.8 42.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.653 -2.067 . . . . 0.77000000000000002 110.315 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.599 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 m-20 -155.09 154.66 32.75 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.048 -0.978 . . . . 1.6000000000000001 108.623 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 9.2 p -155.8 154.45 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.296 0.48 . . . . 1.1899999999999999 112.296 -175.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.812 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 79.9 p -132.01 147.79 52.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.86 -0.609 . . . . 0.83999999999999997 112.367 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.16 144.76 26.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.326 -0.852 . . . . 1.5800000000000001 110.606 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.786 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 7.6 m-85 -137.73 103.51 5.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.558 -0.746 . . . . 0.85999999999999999 110.318 172.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.775 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -105.67 110.55 22.9 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 118.743 -1.183 . . . . 2.1099999999999999 112.363 170.414 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.936 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -98.02 106.98 19.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.146 -1.388 . . . . 0.37 109.755 -179.265 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -83.77 96.65 8.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.512 -0.551 . . . . 0.33000000000000002 109.512 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 18' ' ' VAL . 3.4 p -80.65 112.45 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.875 1.321 . . . . 0.33000000000000002 109.118 177.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.0 m170 -80.44 99.74 8.14 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.027 -1.897 . . . . 1.1899999999999999 110.656 -176.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 32.3 tt0 . . . . . 0 C--N 1.303 -1.414 0 CA-C-N 114.452 -1.249 . . . . 1.6699999999999999 110.244 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.803 ' HB3' ' HA ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.158 1.54 . . . . 1.9299999999999999 115.158 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.13 170.57 12.16 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 114.858 -1.065 . . . . 1.6499999999999999 111.003 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.28 69.98 2.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.916 2.411 . . . . 0.96999999999999997 112.374 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.652 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -92.88 -54.61 7.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.013 -0.994 . . . . 0.5 109.323 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.23 6.24 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 107.798 -2.121 . . . . 0.39000000000000001 107.798 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.957 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -53.34 -36.57 61.46 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 112.78 -1.71 . . . . 0.33000000000000002 110.575 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.565 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -94.82 85.29 4.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.367 -0.833 . . . . 0.71999999999999997 109.642 172.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.88 -49.02 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.6 -1.182 . . . . 0.63 109.719 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.0 tpt -143.74 133.73 24.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 2.8799999999999999 108.912 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 20.7 ptt180 -103.86 132.84 20.65 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.107 -0.497 . . . . 3.6699999999999999 111.405 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.61 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.1 Cg_endo -64.34 151.63 84.69 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.683 2.255 . . . . 0.64000000000000001 111.328 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.8 mm-40 -121.13 176.54 5.54 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.042 -0.527 . . . . 1.4299999999999999 110.452 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.23 -146.22 0.01 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.524 1.154 . . . . 2.0600000000000001 111.586 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.27 135.61 2.0 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 114.11 -1.405 . . . . 0.29999999999999999 111.953 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 44.8 mt-10 -114.01 115.05 27.0 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.332 -0.934 . . . . 1.53 108.943 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -136.07 163.23 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 N-CA-C 107.645 -1.242 . . . . 0.27000000000000002 107.645 -173.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.44 152.36 19.14 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.866 -1.061 . . . . 0.77000000000000002 108.925 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.727 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -73.3 106.6 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.524 0 CA-C-O 123.897 1.808 . . . . 0.78000000000000003 109.419 172.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.59 -3.93 5.44 Favored Glycine 0 C--N 1.274 -2.873 0 CA-C-N 110.331 -3.122 . . . . 0.47999999999999998 111.196 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.13 -127.5 5.94 Favored Glycine 0 N--CA 1.411 -2.988 0 C-N-CA 119.24 -1.457 . . . . 0.44 110.217 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.5 p -150.85 170.08 20.14 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.0 -1.6 . . . . 0.81999999999999995 110.76 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.61 HG21 HD13 ' A' ' 104' ' ' LEU . 8.7 tp -147.16 149.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 113.592 -1.64 . . . . 0.32000000000000001 108.065 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 m -138.87 128.51 24.71 Favored 'General case' 0 C--N 1.268 -2.973 0 CA-C-N 113.503 -1.681 . . . . 0.31 110.73 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' HB2' ' CG ' ' A' ' 74' ' ' LEU . 45.2 m-85 -125.19 152.69 44.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.182 -1.372 . . . . 0.53000000000000003 108.44 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.51 125.98 18.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.214 -0.662 . . . . 0.57999999999999996 109.214 175.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.11 121.03 36.97 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.161 -0.927 . . . . 0.32000000000000001 110.367 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 56.3 mtp180 -108.02 117.08 33.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.353 -0.385 . . . . 2.4300000000000002 110.021 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.564 HG21 HG21 ' A' ' 39' ' ' VAL . 23.6 t -120.87 130.53 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.286 1.041 . . . . 0.26000000000000001 110.436 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.879 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -60.96 109.12 0.98 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 113.286 -1.779 . . . . 0.40000000000000002 113.696 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.56 3.04 Favored Glycine 0 N--CA 1.462 0.401 0 CA-C-N 114.728 -1.123 . . . . 0.76000000000000001 113.091 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HB2' ' CE ' ' A' ' 68' ' ' LYS . . . -50.68 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 114.669 1.359 . . . . 0.70999999999999996 114.669 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -81.58 127.59 33.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.481 -1.236 . . . . 1.74 108.361 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.835 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -157.12 177.79 11.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.168 -0.469 . . . . 2.1600000000000001 111.179 -172.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.83 -51.09 71.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.45 0.643 . . . . 1.47 109.287 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.47 149.41 26.29 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.785 -1.098 . . . . 1.3999999999999999 108.718 171.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -43.01 143.9 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.524 2.816 . . . . 0.88 112.651 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.835 ' HD3' HD11 ' A' ' 33' ' ' LEU . 2.0 Cg_endo -48.7 133.03 26.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.715 1.61 . . . . 0.53000000000000003 113.25 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.1 105.99 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 106.54 -1.652 . . . . 0.77000000000000002 106.54 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.659 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.27 114.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 CA-C-N 113.655 -1.611 . . . . 0.28000000000000003 107.962 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.5 127.3 49.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 123.456 1.598 . . . . 1.54 110.096 173.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.997 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -87.04 155.47 20.14 Favored 'General case' 0 C--N 1.273 -2.724 0 CA-C-N 111.178 -2.737 . . . . 0.34000000000000002 112.05 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.5 t80 -134.26 135.94 43.25 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 104.173 -2.528 . . . . 0.62 104.173 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.929 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 50.8 tttm -98.43 171.85 7.9 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.023 -1.843 . . . . 2.1699999999999999 106.023 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.984 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -15.43 -172.48 0.0 OUTLIER Glycine 0 C--O 1.178 -3.358 0 N-CA-C 119.117 2.407 . . . . 1.23 119.117 172.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -42.62 -8.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.169 2.285 . . . . 3.8700000000000001 117.169 -162.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.538 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.1 p-90 -162.09 -6.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.012 1.115 . . . . 2.1099999999999999 114.012 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.929 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.5 163.71 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.769 0 CA-C-O 123.712 1.72 . . . . 1.29 112.565 -161.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.682 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.6 p-10 -109.94 157.65 19.04 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.987 -2.824 . . . . 2.73 105.925 170.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.044 HD23 HD21 ' A' ' 57' ' ' LEU . 5.6 mp -99.34 -30.11 12.4 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.294 -0.562 . . . . 0.44 112.185 168.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.2 t -56.9 -21.63 31.21 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.038 0.535 . . . . 1.23 109.733 -164.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -99.9 -36.12 9.51 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.86 0.838 . . . . 1.3400000000000001 111.503 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.682 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -87.68 -31.85 19.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.406 -1.27 . . . . 1.3999999999999999 111.319 -167.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.751 HG13 ' H ' ' A' ' 59' ' ' LEU . 52.4 t -36.43 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.37 111.215 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.59 -93.71 0.1 OUTLIER Glycine 0 C--N 1.298 -1.536 0 CA-C-N 112.701 -2.045 . . . . 0.69999999999999996 113.812 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -94.15 -44.84 7.81 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.578 0.584 . . . . 2.75 112.578 -168.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.585 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 19.6 p80 -95.76 -36.21 11.25 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.339 0.59 . . . . 1.3300000000000001 110.731 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.044 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -115.55 106.38 13.87 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.1 -1.815 . . . . 1.1100000000000001 106.1 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.76 115.19 29.71 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 106.75 -1.574 . . . . 0.76000000000000001 106.75 166.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.751 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -100.42 92.26 5.08 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.742 -2.318 . . . . 0.26000000000000001 104.742 172.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.701 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 44.0 m170 -86.09 163.82 17.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.096 -1.411 . . . . 2.0299999999999998 110.916 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -131.17 115.74 16.76 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.847 -1.979 . . . . 0.92000000000000004 109.649 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -98.11 149.3 22.65 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 112.759 -2.019 . . . . 0.46999999999999997 107.839 170.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.86 99.04 3.68 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 122.48 1.133 . . . . 1.3899999999999999 110.961 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 7.7 m-20 -110.26 107.19 16.87 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 112.904 -1.953 . . . . 2.4199999999999999 108.954 176.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -45.94 61.35 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.604 -0.725 . . . . 2.46 110.333 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.34 -30.33 71.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.745 -1.116 . . . . 1.1499999999999999 110.984 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 19.5 m -89.49 -19.35 25.18 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.977 -0.749 . . . . 1.4099999999999999 108.977 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.879 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 2.2 ttpm? 61.92 41.05 11.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.078 -0.965 . . . . 3.3100000000000001 108.399 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 21.9 t -133.27 124.92 50.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.875 -1.057 . . . . 0.42999999999999999 111.139 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.3 m-30 -97.81 106.06 18.3 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.992 -1.855 . . . . 1.24 105.992 163.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 7.9 tp -95.07 105.27 17.18 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 122.622 1.201 . . . . 0.52000000000000002 108.984 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.701 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.9 m-85 -85.66 114.7 22.84 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 113.469 -1.696 . . . . 0.33000000000000002 108.289 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 30.5 mt-10 -96.48 134.54 39.53 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.461 -1.7 . . . . 1.3200000000000001 108.628 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.891 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -106.75 111.36 23.85 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.564 -1.273 . . . . 0.95999999999999996 107.564 172.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -108.7 94.24 4.95 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 103.403 -2.814 . . . . 1.1499999999999999 103.403 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.603 HG12 HD23 ' A' ' 57' ' ' LEU . 57.5 mt -120.77 100.89 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.698 1.237 . . . . 0.52000000000000002 109.214 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 21' ' ' SER . 60.1 p -100.58 165.9 11.18 Favored 'General case' 0 N--CA 1.391 -3.425 0 CA-C-N 114.355 -1.293 . . . . 0.57999999999999996 109.364 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 50.68 73.5 0.28 Allowed 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 110.848 -2.887 . . . . 2.1200000000000001 111.722 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -73.71 112.32 9.7 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 113.004 -1.907 . . . . 0.40000000000000002 110.017 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.863 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.38 146.62 52.44 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 1.4299999999999999 110.029 171.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.727 ' HD3' HG21 ' A' ' 18' ' ' VAL . 19.9 Cg_endo -61.15 -13.89 30.58 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.554 2.17 . . . . 1.3300000000000001 112.742 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.863 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -104.4 17.24 24.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.031 -0.531 . . . . 1.1200000000000001 110.45 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.6 OUTLIER -95.31 -11.29 28.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.393 -0.813 . . . . 1.24 111.005 -177.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m -17.97 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 125.668 1.855 . . . . 1.22 111.74 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.984 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -56.9 120.51 20.97 Favored Glycine 0 N--CA 1.404 -3.441 0 CA-C-N 110.633 -2.985 . . . . 1.4299999999999999 114.876 -167.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.691 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -115.5 72.31 0.25 Allowed Glycine 0 C--N 1.273 -2.933 0 CA-C-N 112.359 -1.92 . . . . 0.52000000000000002 108.556 152.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.72 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 56.0 m-85 -77.04 118.38 19.54 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.728 -0.842 . . . . 0.63 108.728 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 29.4 mtp180 -114.38 125.08 53.44 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.212 -0.662 . . . . 3.1499999999999999 109.212 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 2.9 t -112.6 117.52 32.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.899 -0.778 . . . . 1.0800000000000001 108.899 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 36.0 mt-10 -132.4 104.02 6.5 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.179 -0.919 . . . . 1.8100000000000001 110.115 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.659 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -94.04 142.53 13.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.418 0.628 . . . . 0.54000000000000004 110.267 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.7 t -134.83 108.18 7.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.914 -1.039 . . . . 1.1799999999999999 108.337 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -132.35 153.18 51.0 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-O 117.958 -1.02 . . . . 0.73999999999999999 108.649 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.758 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 23.2 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.691 1.87 . . . . 0.65000000000000002 113.999 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.758 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 16.6 t70 -144.17 -3.78 0.84 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 114.829 -1.078 . . . . 1.05 109.802 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.957 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.32 135.04 33.92 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.148 -1.056 . . . . 1.29 108.148 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.504 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 31.0 t80 -132.71 131.29 41.09 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.898 -1.501 . . . . 0.77000000000000002 110.503 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.78 149.98 31.34 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.635 -1.166 . . . . 1.6000000000000001 108.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 7.4 p -152.77 154.37 35.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.243 0.544 . . . . 1.1899999999999999 112.216 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 11.6 p -129.86 150.6 51.09 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.773 0.797 . . . . 0.83999999999999997 112.06 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.667 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.0 OUTLIER -131.31 109.42 10.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.038 -1.437 . . . . 1.5800000000000001 109.38 177.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.841 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.8 p90 -142.72 129.71 20.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.374 0.607 . . . . 0.85999999999999999 109.667 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.5 p30 -101.93 157.96 16.48 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 122.899 1.333 . . . . 2.1099999999999999 111.954 -172.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -121.71 109.65 14.99 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.18 -1.827 . . . . 0.37 109.745 171.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 28.9 m -91.23 97.69 11.28 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.187 -0.671 . . . . 0.33000000000000002 109.187 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.6 p -81.3 116.2 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 123.204 1.478 . . . . 0.33000000000000002 109.292 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.546 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 94.9 m-70 -88.81 100.26 13.02 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.571 -2.104 . . . . 1.1899999999999999 109.002 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' A' ' 18' ' ' VAL . 31.4 tt0 -62.02 -64.42 0.94 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.704 -1.135 . . . . 1.6699999999999999 109.82 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.43 -51.84 2.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.971 -0.559 . . . . 2.7799999999999998 110.031 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 C--O 1.244 0.778 0 CA-C-N 115.845 -0.616 . . . . 6.9199999999999999 109.642 178.385 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.808 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.192 0.52 . . . . 1.9299999999999999 112.251 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.582 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 23.8 m-20 -82.52 174.14 6.51 Favored Pre-proline 0 N--CA 1.436 -1.166 0 CA-C-N 115.458 -0.792 . . . . 1.6499999999999999 110.246 175.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.84 86.91 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.478 2.118 . . . . 0.96999999999999997 112.349 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.724 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -116.45 -60.29 2.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.506 -0.77 . . . . 0.5 109.513 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.69 5.59 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 108.473 -1.851 . . . . 0.39000000000000001 108.473 -176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.69 HD11 ' HB3' ' A' ' 37' ' ' PRO . 12.1 tp -53.67 -45.43 70.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.403 -1.899 . . . . 0.33000000000000002 111.87 -168.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.692 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.82 84.78 3.95 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.562 0.696 . . . . 0.71999999999999997 109.818 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.48 -40.55 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.152 -1.385 . . . . 0.63 110.686 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 60.5 ttm -157.57 132.1 8.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.916 -0.584 . . . . 2.8799999999999999 110.18 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.556 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 13.2 ptp180 -103.67 139.25 19.93 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.046 -0.979 . . . . 3.6699999999999999 109.865 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.735 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -75.19 165.28 31.37 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.382 1.388 . . . . 0.64000000000000001 111.135 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -122.91 -177.63 3.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.043 -0.526 . . . . 1.4299999999999999 110.343 -172.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.94 -150.48 0.01 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-O 123.076 1.417 . . . . 2.0600000000000001 111.704 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.97 131.44 1.64 Allowed Glycine 0 C--N 1.291 -1.945 0 CA-C-N 112.762 -2.017 . . . . 0.29999999999999999 112.063 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -110.54 110.93 21.84 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.422 -0.955 . . . . 1.53 108.422 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 m -130.58 141.82 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 107.598 -1.26 . . . . 0.27000000000000002 107.598 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.772 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -77.52 156.88 30.69 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.871 -1.059 . . . . 0.77000000000000002 109.387 -177.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 79' ' ' ALA . 3.9 t -66.38 105.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 CA-C-O 122.767 1.27 . . . . 0.78000000000000003 107.886 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.97 5.0 10.01 Favored Glycine 0 C--N 1.266 -3.318 0 CA-C-N 112.36 -2.2 . . . . 0.47999999999999998 112.688 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.84 4.94 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 118.668 -1.729 . . . . 0.44 108.92 172.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.9 p -151.43 163.57 38.68 Favored 'General case' 0 N--CA 1.397 -3.124 0 CA-C-N 112.882 -1.659 . . . . 0.81999999999999995 110.527 174.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.5 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.4 tp -136.67 146.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.141 -1.845 . . . . 0.32000000000000001 107.106 171.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -137.91 125.07 21.57 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 113.088 -1.869 . . . . 0.31 110.743 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 75.5 m-85 -123.36 143.24 50.23 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.266 -1.334 . . . . 0.53000000000000003 109.239 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -131.99 118.73 20.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.277 -0.874 . . . . 0.57999999999999996 109.79 177.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -117.11 116.15 26.76 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.514 -1.221 . . . . 0.32000000000000001 110.145 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.27 124.2 49.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.362 -0.211 . . . . 2.4300000000000002 110.886 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 39' ' ' VAL . 12.1 t -129.56 130.92 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 122.093 0.949 . . . . 0.26000000000000001 110.589 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.86 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -63.66 111.54 2.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.25 -1.795 . . . . 0.40000000000000002 111.589 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.853 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.49 -53.04 17.69 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 114.761 -1.108 . . . . 0.76000000000000001 111.976 172.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.701 ' CA ' ' HE3' ' A' ' 68' ' ' LYS . . . 59.96 -174.22 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.666 0.987 . . . . 0.70999999999999996 113.666 169.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -111.61 128.87 56.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.69 -1.141 . . . . 1.74 108.975 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -161.35 -179.47 7.42 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.155 0.503 . . . . 2.1600000000000001 111.992 -170.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -67.08 -44.31 80.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.82 -1.082 . . . . 1.47 108.962 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.657 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.59 148.26 23.29 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 114.909 -1.041 . . . . 1.3999999999999999 109.547 175.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.64 142.38 13.95 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.231 2.62 . . . . 0.88 111.507 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.69 ' HB3' HD11 ' A' ' 6' ' ' LEU . 1.8 Cg_endo -49.11 131.9 26.89 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.897 1.731 . . . . 0.53000000000000003 113.002 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.74 104.97 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 106.922 -1.51 . . . . 0.77000000000000002 106.922 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 28' ' ' VAL . 2.3 t -108.33 114.08 45.63 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 112.81 -1.996 . . . . 0.28000000000000003 107.306 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.628 ' HE2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.91 125.37 48.58 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-O 123.266 1.508 . . . . 1.54 110.132 174.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.902 ' HB3' HD13 ' A' ' 49' ' ' LEU . 55.2 m95 -83.49 157.06 22.54 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 111.39 -2.641 . . . . 0.34000000000000002 111.555 176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.472 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 20.3 t80 -135.66 139.55 43.82 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 104.794 -2.299 . . . . 0.62 104.794 168.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.996 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttm -100.63 167.24 10.46 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 104.424 -2.435 . . . . 2.1699999999999999 104.424 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.26 -165.51 0.0 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 118.982 2.353 . . . . 1.23 118.982 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.528 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 15.0 mtpt -45.23 -11.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.095 0 O-C-N 118.592 -2.71 . . . . 3.8700000000000001 116.417 -168.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.412 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 22.7 p-90 -164.18 -2.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.83 1.418 . . . . 2.1099999999999999 114.83 -175.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.996 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.73 141.34 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-O 122.942 1.353 . . . . 1.29 112.173 -163.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 1.5 p-10 -109.66 101.71 10.6 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 112.29 -2.232 . . . . 2.73 112.191 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.034 HD23 HD21 ' A' ' 57' ' ' LEU . 5.1 mp -54.34 -34.89 62.02 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.041 0.756 . . . . 0.44 113.041 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 m -57.28 -21.9 37.82 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.548 0.69 . . . . 1.23 109.668 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.46 ' HB2' ' CD ' ' A' ' 52' ' ' LYS . 22.7 m -98.19 -34.91 10.55 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.982 -1.008 . . . . 1.3400000000000001 111.707 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.581 ' HB2' HD12 ' A' ' 57' ' ' LEU . 3.0 mmmt -90.92 -36.06 14.36 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.941 -1.027 . . . . 1.3999999999999999 111.67 -168.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.66 HG13 ' H ' ' A' ' 59' ' ' LEU . 44.3 t -37.54 96.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 125.888 1.675 . . . . 0.37 111.869 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.719 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -153.41 -111.84 0.46 Allowed Glycine 0 C--N 1.298 -1.541 0 CA-C-N 111.546 -2.57 . . . . 0.69999999999999996 112.742 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.879 HE21 ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -95.73 -27.44 15.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.348 0.87 . . . . 2.75 113.348 -169.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -95.36 -36.45 11.37 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.574 0.702 . . . . 1.3300000000000001 110.439 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.034 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.69 105.49 11.22 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.14 -1.8 . . . . 1.1100000000000001 106.14 172.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.719 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -98.56 115.86 29.53 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.658 -1.608 . . . . 0.76000000000000001 106.658 165.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.66 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -92.05 92.09 8.11 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 103.495 -2.78 . . . . 0.26000000000000001 103.495 167.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.717 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -92.33 164.22 13.59 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 113.896 -1.502 . . . . 2.0299999999999998 109.502 -173.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -137.26 117.98 14.04 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 111.341 -2.663 . . . . 0.92000000000000004 109.998 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -101.28 142.52 32.58 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.622 -2.081 . . . . 0.46999999999999997 106.895 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -137.91 98.58 3.68 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.757 1.265 . . . . 1.3899999999999999 110.792 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.27 105.72 13.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 113.132 -1.849 . . . . 2.4199999999999999 109.695 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.56 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -74.83 -29.83 61.18 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.845 -1.071 . . . . 2.46 110.796 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -35.27 80.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.34 -0.845 . . . . 1.1499999999999999 110.93 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -98.85 -12.38 20.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.641 -0.708 . . . . 1.4099999999999999 109.839 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.86 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 18.4 tttt 67.22 33.7 5.34 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.745 0.783 . . . . 3.3100000000000001 109.564 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.24 128.33 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 115.969 -0.559 . . . . 0.42999999999999999 109.685 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.853 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 22.5 m-85 -95.71 116.2 28.53 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.586 -2.005 . . . . 1.24 105.586 162.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 25' ' ' SER . 38.0 tp -94.08 104.13 16.17 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.517 -1.29 . . . . 0.52000000000000002 107.517 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.9 m-85 -83.04 110.66 18.18 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 106.117 -1.809 . . . . 0.33000000000000002 106.117 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.2 pt-20 -114.75 122.7 47.21 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.666 -1.606 . . . . 1.3200000000000001 110.278 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.716 ' HB3' HG13 ' A' ' 76' ' ' ILE . 1.4 mt -91.46 131.07 37.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.201 -1.363 . . . . 0.95999999999999996 108.374 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -117.85 95.47 4.94 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 103.077 -2.934 . . . . 1.1499999999999999 103.077 167.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.4 mt -121.24 100.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.979 0 CA-C-O 122.902 1.334 . . . . 0.52000000000000002 108.619 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.1 p -104.43 165.16 11.24 Favored 'General case' 0 N--CA 1.389 -3.519 0 CA-C-N 114.116 -1.402 . . . . 0.57999999999999996 109.941 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 38.45 75.73 0.07 Allowed 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 110.563 -3.017 . . . . 2.1200000000000001 111.84 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -68.74 117.77 10.87 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.789 -2.914 . . . . 0.40000000000000002 111.074 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.858 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -51.27 135.03 31.55 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.848 -0.797 . . . . 1.4299999999999999 108.848 165.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 19.3 Cg_endo -60.0 -13.49 23.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.932 2.421 . . . . 1.3300000000000001 112.685 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.858 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -96.6 15.48 21.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.974 -0.557 . . . . 1.1200000000000001 110.797 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.1 m-30 -95.09 -10.59 30.26 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.972 -0.381 . . . . 1.24 109.972 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 53.6 m -46.28 98.51 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.829 0 O-C-N 124.606 1.191 . . . . 1.22 108.732 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -169.35 -130.1 1.17 Allowed Glycine 0 C--N 1.266 -3.353 0 CA-C-N 112.698 -2.046 . . . . 1.4299999999999999 113.145 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.0 118.74 0.9 Allowed Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 119.962 -1.113 . . . . 0.52000000000000002 112.695 -170.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.703 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.3 m-85 -85.13 134.95 34.16 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.04 -1.58 . . . . 0.63 107.577 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.472 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 63.7 mtt180 -118.99 155.07 32.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.204 0.526 . . . . 3.1499999999999999 110.6 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.634 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 75.0 m -131.31 132.26 44.39 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.825 -1.176 . . . . 1.0800000000000001 107.825 163.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.628 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 35.0 tt0 -134.95 103.33 5.54 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.723 -1.214 . . . . 1.8100000000000001 107.723 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.6 p -99.6 134.91 37.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.983 0.897 . . . . 0.54000000000000004 110.835 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -133.46 108.5 8.69 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.794 -1.548 . . . . 1.1799999999999999 108.864 -176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.642 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -132.09 155.13 48.66 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.376 -0.972 . . . . 0.73999999999999999 108.376 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.813 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 18.61 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 125.601 1.813 . . . . 0.65000000000000002 114.882 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.813 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 5.0 t70 -151.81 1.23 0.36 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.748 -1.115 . . . . 1.05 109.668 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.808 ' HE3' ' HB3' ' A' ' 1' ' ' ASP . 2.2 mmtp -98.17 130.05 44.93 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.961 -1.126 . . . . 1.29 107.961 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -131.26 147.17 52.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.991 -1.004 . . . . 0.77000000000000002 111.189 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -172.13 166.24 6.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.933 -0.765 . . . . 1.6000000000000001 108.933 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.4 p -155.67 156.76 35.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 1.1899999999999999 110.461 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.692 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 30.8 p -135.39 147.63 49.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.715 -0.675 . . . . 0.83999999999999997 111.086 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.577 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -127.19 121.92 32.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 1.5800000000000001 110.066 177.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.735 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -141.98 116.66 9.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.121 0.486 . . . . 0.85999999999999999 109.796 -175.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.3 p30 -100.3 146.26 27.14 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 122.418 1.104 . . . . 2.1099999999999999 111.88 -169.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -116.76 122.91 45.82 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.219 -1.355 . . . . 0.37 109.349 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -101.58 96.69 7.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.508 -0.923 . . . . 0.33000000000000002 108.508 173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 3.8 p -79.19 114.58 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-O 123.203 1.477 . . . . 0.33000000000000002 109.711 175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.772 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 9.3 m-70 -79.97 99.33 7.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.098 -2.319 . . . . 1.1899999999999999 109.816 -175.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 18' ' ' VAL . 35.5 tt0 -68.34 -69.42 0.33 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.039 -1.437 . . . . 1.6699999999999999 109.348 172.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.51 18.1 1.31 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.817 -0.629 . . . . 2.7799999999999998 112.131 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.497 -0.763 . . . . 6.9199999999999999 109.858 -179.742 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 121.853 0.835 . . . . 1.9299999999999999 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' HB2' ' CE ' ' A' ' 94' ' ' LYS . 8.4 m-20 -92.09 168.79 12.19 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.303 -1.317 . . . . 1.6499999999999999 109.624 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.37 84.41 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.24 1.96 . . . . 0.96999999999999997 113.132 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.84 HD11 ' HE2' ' A' ' 94' ' ' LYS . 1.8 mp -110.71 -66.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.11 -0.95 . . . . 0.5 109.187 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.85 37.47 6.06 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 108.573 -1.811 . . . . 0.39000000000000001 108.573 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.92 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.2 tp -38.57 -51.34 1.62 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 112.767 -1.716 . . . . 0.33000000000000002 110.858 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.71 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -85.93 85.57 7.37 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 121.635 0.731 . . . . 0.71999999999999997 110.537 175.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.92 -33.8 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.09 -1.414 . . . . 0.63 109.553 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.421 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 18.5 ttt -163.69 136.98 5.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.361 -0.836 . . . . 2.8799999999999999 110.226 174.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.628 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 6.1 ptt180 -116.11 137.57 23.52 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.031 -0.531 . . . . 3.6699999999999999 110.761 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 18.8 Cg_endo -71.58 176.66 7.8 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.986 2.457 . . . . 0.64000000000000001 112.585 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -126.91 177.08 6.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.647 -0.706 . . . . 1.4299999999999999 110.671 -175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.5 p-10 -71.42 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.602 1.191 . . . . 2.0600000000000001 111.641 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.06 137.44 2.59 Favored Glycine 0 N--CA 1.426 -2.003 0 CA-C-N 113.821 -1.536 . . . . 0.29999999999999999 111.807 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.497 ' HG3' ' CD2' ' A' ' 107' ' ' HIS . 27.9 tt0 -113.33 115.14 27.66 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.094 -1.053 . . . . 1.53 109.497 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -139.46 163.16 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.708 0 N-CA-C 107.308 -1.367 . . . . 0.27000000000000002 107.308 -172.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 t -93.92 162.02 14.07 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.548 -0.751 . . . . 0.77000000000000002 109.617 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 81' ' ' PRO . 3.5 t -72.74 105.64 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.458 0 N-CA-C 107.205 -1.405 . . . . 0.78000000000000003 107.205 172.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.41 3.05 6.23 Favored Glycine 0 C--N 1.263 -3.506 0 CA-C-N 112.685 -2.052 . . . . 0.47999999999999998 111.472 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.9 -131.92 7.48 Favored Glycine 0 N--CA 1.408 -3.22 0 C-N-CA 118.78 -1.676 . . . . 0.44 109.094 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.747 ' HB3' HG22 ' A' ' 77' ' ' THR . 8.2 p -152.22 168.26 25.93 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 113.016 -1.592 . . . . 0.81999999999999995 110.872 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.602 HG21 HD13 ' A' ' 104' ' ' LEU . 10.7 tp -147.74 149.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 CA-C-N 113.274 -1.784 . . . . 0.32000000000000001 107.536 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 m -139.22 127.08 22.13 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-N 113.513 -1.676 . . . . 0.31 111.098 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' HB2' HD23 ' A' ' 74' ' ' LEU . 33.0 m-85 -122.65 148.24 45.5 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.952 -1.476 . . . . 0.53000000000000003 108.392 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -135.01 122.48 21.89 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.575 -0.898 . . . . 0.57999999999999996 108.575 175.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -126.09 126.64 44.53 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.943 -1.026 . . . . 0.32000000000000001 111.086 -174.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' HB3' HG11 ' A' ' 69' ' ' VAL . 52.0 mtt180 -113.68 123.65 50.42 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.416 -0.356 . . . . 2.4300000000000002 111.135 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.0 t -122.33 125.13 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.946 0.879 . . . . 0.26000000000000001 109.837 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -54.91 111.11 0.76 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.505 -1.679 . . . . 0.40000000000000002 111.094 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.784 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -52.87 -43.06 60.68 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.177 -1.374 . . . . 0.76000000000000001 111.162 171.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.79 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 49.23 -167.06 0.03 OUTLIER 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.252 1.204 . . . . 0.70999999999999996 114.252 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -119.77 123.13 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.062 -1.426 . . . . 1.74 107.527 171.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.779 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -149.78 178.58 8.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.838 0.681 . . . . 2.1600000000000001 112.838 -168.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 tp -71.05 -57.23 4.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.989 -1.005 . . . . 1.47 109.234 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.671 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -129.58 145.54 57.36 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-N 115.468 -0.787 . . . . 1.3999999999999999 109.726 171.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.4 Cg_exo -45.46 138.89 10.15 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 122.78 2.32 . . . . 0.88 110.961 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.779 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.0 Cg_exo -58.82 136.98 77.28 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.443 1.429 . . . . 0.53000000000000003 111.961 -172.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.04 104.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 106.369 -1.715 . . . . 0.77000000000000002 106.369 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -107.25 114.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 113.44 -1.709 . . . . 0.28000000000000003 107.21 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.609 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.78 129.39 53.05 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 123.222 1.487 . . . . 1.54 110.078 175.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.07 ' HB3' HD13 ' A' ' 49' ' ' LEU . 87.6 m95 -90.84 141.84 28.39 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.794 -2.457 . . . . 0.34000000000000002 111.268 171.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.7 t80 -125.82 125.79 43.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.785 -1.931 . . . . 0.62 105.785 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 29.6 ttpt -103.65 108.59 19.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.8 -1.555 . . . . 2.1699999999999999 106.8 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.562 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -79.77 92.02 1.32 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 115.997 -3.001 . . . . 1.23 113.968 -165.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.719 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 32.9 tttt -106.58 -32.77 7.9 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 104.24 -2.504 . . . . 3.8700000000000001 104.24 138.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.741 ' HD1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER 157.85 -13.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 110.921 -2.854 . . . . 2.1099999999999999 111.447 -165.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.741 HG22 ' HD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -94.76 173.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 CA-C-O 122.994 1.378 . . . . 1.29 111.909 -168.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 5.4 m-20 -104.38 155.91 18.38 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.927 -2.397 . . . . 2.73 106.228 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.07 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -84.79 -32.33 23.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 118.325 0.512 . . . . 0.44 111.464 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -20.35 37.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.711 0.767 . . . . 1.23 110.244 -167.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.757 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 26.4 t -92.22 -30.42 15.91 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.72 -1.127 . . . . 1.3400000000000001 111.132 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 3.7 mmmt -98.81 -42.08 7.35 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.631 -1.168 . . . . 1.3999999999999999 112.122 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.788 HG13 ' H ' ' A' ' 59' ' ' LEU . 54.9 t -22.57 95.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.208 1.803 . . . . 0.37 112.987 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.71 -126.61 1.36 Allowed Glycine 0 C--N 1.303 -1.275 0 CA-C-N 112.138 -2.301 . . . . 0.69999999999999996 113.157 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.91 -20.08 31.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.881 0.697 . . . . 2.75 112.881 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.7 p80 -100.72 -37.56 8.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.347 0.594 . . . . 1.3300000000000001 110.427 176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.952 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.89 103.7 10.21 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.03 -1.841 . . . . 1.1100000000000001 106.03 172.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -95.43 115.22 27.13 Favored 'General case' 0 N--CA 1.409 -2.521 0 N-CA-C 105.809 -1.922 . . . . 0.76000000000000001 105.809 167.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.809 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.6 OUTLIER -98.94 91.58 5.11 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 103.496 -2.779 . . . . 0.26000000000000001 103.496 167.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 5.8 t-80 -99.75 164.65 11.95 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.21 -1.814 . . . . 2.0299999999999998 108.728 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.51 126.37 27.53 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 113.191 -1.822 . . . . 0.92000000000000004 111.933 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -103.24 148.04 26.3 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 110.996 -2.82 . . . . 0.46999999999999997 108.24 169.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -142.0 101.31 3.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.976 0.893 . . . . 1.3899999999999999 110.987 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.53 109.17 17.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.322 -1.308 . . . . 2.4199999999999999 111.006 169.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.562 HH11 ' HD2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.64 -31.44 65.13 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.445 -0.798 . . . . 2.46 111.013 177.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -14.93 63.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.759 -0.655 . . . . 1.1499999999999999 110.431 174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -106.8 -20.18 13.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.808 -1.182 . . . . 1.4099999999999999 107.808 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.79 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER 60.54 40.2 17.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.652 -1.158 . . . . 3.3100000000000001 109.292 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 27' ' ' ARG . 13.8 t -133.39 143.06 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 115.242 -0.89 . . . . 0.42999999999999999 109.776 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.784 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 27.9 m-85 -105.62 113.05 26.38 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.622 -1.622 . . . . 1.24 106.622 163.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 10.1 tp -94.91 105.61 17.54 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 122.261 1.029 . . . . 0.52000000000000002 108.762 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.1 m-85 -87.88 115.32 25.26 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.001 -1.454 . . . . 0.33000000000000002 108.275 174.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -98.55 132.86 43.64 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.045 -1.889 . . . . 1.3200000000000001 108.353 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.84 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -103.64 115.7 30.97 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 107.488 -1.301 . . . . 0.95999999999999996 107.488 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -113.65 95.21 5.22 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 104.583 -2.377 . . . . 1.1499999999999999 104.583 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.622 HG12 HD23 ' A' ' 57' ' ' LEU . 63.7 mt -119.55 100.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.928 1.347 . . . . 0.52000000000000002 110.36 -174.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.747 HG22 ' HB3' ' A' ' 21' ' ' SER . 82.5 p -106.45 135.78 47.36 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.435 -1.711 . . . . 0.57999999999999996 108.262 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.65 101.47 0.05 Allowed 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 111.714 -2.493 . . . . 2.1200000000000001 110.174 -174.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -94.87 124.68 39.06 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 109.72 -3.4 . . . . 0.40000000000000002 109.402 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.797 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -56.64 130.94 77.65 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.295 -0.631 . . . . 1.4299999999999999 109.295 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.752 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.1 Cg_endo -60.74 -10.65 14.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.129 2.553 . . . . 1.3300000000000001 112.855 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.797 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -113.5 15.4 19.04 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.046 -0.525 . . . . 1.1200000000000001 111.41 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.684 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -73.5 -57.55 3.92 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.417 -0.957 . . . . 1.24 108.417 177.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 26.0 m 42.67 62.07 1.86 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.665 -1.606 . . . . 1.22 106.665 -158.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.683 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -56.53 86.16 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.757 0 CA-C-N 112.084 -2.326 . . . . 1.4299999999999999 114.17 -163.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -90.79 83.38 1.3 Allowed Glycine 0 C--N 1.279 -2.62 0 N-CA-C 108.862 -1.695 . . . . 0.52000000000000002 108.862 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.714 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.2 m-85 -78.07 110.93 13.45 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.997 -1.101 . . . . 0.63 108.751 -176.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -99.91 109.24 21.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.419 -0.956 . . . . 3.1499999999999999 108.419 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.417 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -97.84 129.58 44.8 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.075 -0.65 . . . . 1.0800000000000001 109.247 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 53.8 mt-10 -132.15 119.18 20.56 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.856 -0.611 . . . . 1.8100000000000001 109.664 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.6 p -106.42 137.31 37.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.738 0.78 . . . . 0.54000000000000004 110.794 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.1 t -129.93 109.38 10.85 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.351 -1.295 . . . . 1.1799999999999999 108.313 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.589 HG21 HD12 ' A' ' 33' ' ' LEU . 1.3 m -127.45 174.98 8.57 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.35 -0.841 . . . . 0.73999999999999999 109.941 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 1.018 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -3.5 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.431 1.707 . . . . 0.65000000000000002 115.016 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 1.018 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 17.4 t70 -163.93 5.19 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.511 -1.222 . . . . 1.05 109.63 -175.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.92 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -101.83 143.06 32.2 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.733 0.778 . . . . 1.29 109.088 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -131.54 136.47 47.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.165 -1.834 . . . . 0.77000000000000002 110.815 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.501 ' CG ' ' HB2' ' A' ' 7' ' ' PHE . 4.0 m-20 -155.43 151.73 28.16 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.903 -1.044 . . . . 1.6000000000000001 109.443 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.5 p -152.32 152.62 32.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 1.1899999999999999 111.028 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.71 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 96.0 p -130.03 147.23 51.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.227 0.537 . . . . 0.83999999999999997 111.941 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -126.43 113.44 16.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.406 -0.815 . . . . 1.5800000000000001 110.844 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.855 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 3.8 p90 -143.99 129.99 19.52 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.852 -0.53 . . . . 0.85999999999999999 111.123 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.647 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -112.45 127.21 55.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 122.192 0.996 . . . . 2.1099999999999999 113.106 -173.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -97.33 107.6 20.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.848 -1.523 . . . . 0.37 109.924 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 m -88.85 97.09 10.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.99 -0.745 . . . . 0.33000000000000002 108.99 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.684 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.7 p -86.95 116.97 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 122.631 1.205 . . . . 0.33000000000000002 110.222 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.497 ' CD2' ' HG3' ' A' ' 15' ' ' GLU . 95.7 m-70 -111.57 93.79 4.64 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.739 -1.573 . . . . 1.1899999999999999 112.138 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.526 ' HB2' HG21 ' A' ' 18' ' ' VAL . 31.0 tt0 -61.82 107.27 0.81 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.937 -0.574 . . . . 1.6699999999999999 109.898 164.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.26 -78.23 0.33 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.38 -0.6 . . . . 2.7799999999999998 109.38 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.241 -0.885 . . . . 6.9199999999999999 109.148 179.038 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.559 ' OD1' ' HG2' ' A' ' 96' ' ' LYS . 9.6 t70 . . . . . 0 CA--C 1.487 -1.458 0 CA-C-O 124.602 2.144 . . . . 1.9299999999999999 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.571 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 4.5 m-20 -106.62 158.62 32.29 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 109.09 -3.686 . . . . 1.6499999999999999 110.988 -166.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.95 83.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.357 2.038 . . . . 0.96999999999999997 113.734 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.06 ' HB ' ' HD3' ' A' ' 96' ' ' LYS . 1.8 mp -110.78 -69.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.026 -0.988 . . . . 0.5 109.22 173.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.447 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 92.22 50.15 2.67 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 108.199 -1.96 . . . . 0.39000000000000001 108.199 -173.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.603 ' N ' HG22 ' A' ' 4' ' ' ILE . 10.1 tp -53.38 -50.29 65.41 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 112.984 -1.608 . . . . 0.33000000000000002 110.829 -167.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -86.7 84.46 7.38 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.585 -0.734 . . . . 0.71999999999999997 109.507 174.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -66.03 -39.96 85.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.342 -1.299 . . . . 0.63 109.664 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 21.7 ttt -141.49 133.95 28.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.165 -0.925 . . . . 2.8799999999999999 108.651 169.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.658 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 31.7 mtt180 -99.14 127.27 35.32 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.062 -0.517 . . . . 3.6699999999999999 109.64 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 10.4 Cg_endo -57.79 151.28 57.24 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.735 2.29 . . . . 0.64000000000000001 111.72 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.461 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 19.3 mm-40 -126.46 169.66 12.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 1.4299999999999999 111.467 -169.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.8 m-20 -65.62 -147.19 0.01 OUTLIER 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 122.952 1.358 . . . . 2.0600000000000001 111.781 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.84 133.6 2.56 Favored Glycine 0 C--N 1.297 -1.6 0 CA-C-N 113.628 -1.623 . . . . 0.29999999999999999 111.678 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -116.81 114.86 24.53 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.308 -0.946 . . . . 1.53 108.755 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.711 HG22 HD11 ' A' ' 104' ' ' LEU . 3.0 m -136.63 165.0 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.519 0 N-CA-C 107.755 -1.202 . . . . 0.27000000000000002 107.755 -172.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.557 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -88.48 155.52 19.62 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 114.934 -1.03 . . . . 0.77000000000000002 110.273 -176.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.664 HG22 HG22 ' A' ' 106' ' ' VAL . 60.0 t -70.41 105.69 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 122.901 1.334 . . . . 0.78000000000000003 108.253 173.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.01 12.16 Favored Glycine 0 C--N 1.272 -2.99 0 CA-C-N 112.412 -2.176 . . . . 0.47999999999999998 112.367 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.86 -123.05 2.99 Favored Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.113 -1.595 . . . . 0.44 109.113 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.6 p -151.99 169.55 22.06 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 112.84 -1.68 . . . . 0.81999999999999995 110.553 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tp -145.31 147.19 18.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 113.763 -1.562 . . . . 0.32000000000000001 107.256 167.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -137.96 130.26 29.1 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.851 -1.522 . . . . 0.31 110.916 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.7 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 62.9 m-85 -126.43 147.63 49.76 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.203 -1.362 . . . . 0.53000000000000003 110.128 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -136.61 123.72 21.64 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.953 -1.021 . . . . 0.57999999999999996 109.248 175.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.614 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -119.74 116.31 25.67 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.745 -1.116 . . . . 0.32000000000000001 110.185 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 39.3 mtt180 -101.21 122.15 43.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.308 -0.406 . . . . 2.4300000000000002 110.77 -176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG21 HG21 ' A' ' 39' ' ' VAL . 17.2 t -123.82 128.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 122.168 0.985 . . . . 0.26000000000000001 110.248 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.99 114.21 2.96 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.318 -1.765 . . . . 0.40000000000000002 111.016 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -55.21 -32.69 57.31 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.343 -1.298 . . . . 0.76000000000000001 111.187 170.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.599 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 56.1 -172.26 0.07 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.791 1.034 . . . . 0.70999999999999996 113.791 168.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 t -110.0 117.06 32.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 1.74 107.061 164.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.803 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -150.98 166.59 30.22 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.891 0.7 . . . . 2.1600000000000001 112.891 -162.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -64.23 -64.56 0.85 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.063 -0.971 . . . . 1.47 109.956 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.56 158.33 74.94 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.266 -1.013 . . . . 1.3999999999999999 108.266 172.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 4.5 Cg_endo -45.79 146.8 3.6 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.246 2.631 . . . . 0.88 112.356 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.803 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -62.64 135.65 53.91 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.655 1.57 . . . . 0.53000000000000003 111.248 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.79 104.56 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.614 0 N-CA-C 106.541 -1.651 . . . . 0.77000000000000002 106.541 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.643 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -108.75 114.55 47.08 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.115 0 CA-C-N 113.335 -1.757 . . . . 0.28000000000000003 107.814 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.898 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.89 125.39 50.94 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 123.384 1.564 . . . . 1.54 110.412 176.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.959 ' HB3' HD13 ' A' ' 49' ' ' LEU . 82.5 m95 -88.78 157.23 18.56 Favored 'General case' 0 C--N 1.271 -2.827 0 CA-C-N 111.664 -2.516 . . . . 0.34000000000000002 112.564 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.9 t80 -136.79 136.09 38.56 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 104.948 -2.241 . . . . 0.62 104.948 166.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.709 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 21.1 tttm -112.4 162.12 15.93 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.617 -1.623 . . . . 2.1699999999999999 106.617 -173.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 1.029 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -4.35 -167.78 0.0 OUTLIER Glycine 0 C--O 1.191 -2.594 0 N-CA-C 118.692 2.237 . . . . 1.23 118.692 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -44.37 -9.07 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.201 1.926 . . . . 3.8700000000000001 116.201 -166.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.606 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 30.0 p-90 -167.67 -3.3 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.012 1.486 . . . . 2.1099999999999999 115.012 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.606 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -91.13 135.4 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-O 123.496 1.617 . . . . 1.29 112.817 -163.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -104.36 99.33 9.04 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 112.048 -2.342 . . . . 2.73 111.84 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.114 HD23 HD21 ' A' ' 57' ' ' LEU . 4.4 mp -51.93 -38.49 56.6 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.223 1.194 . . . . 0.44 114.223 -169.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 t -57.5 -22.22 42.67 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.345 0.593 . . . . 1.23 109.407 -166.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 m -100.38 -28.81 12.75 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.313 -0.858 . . . . 1.3400000000000001 113.052 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.536 ' HG3' HG12 ' A' ' 47' ' ' VAL . 6.0 mmmt -90.33 -39.8 12.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.085 -0.507 . . . . 1.3999999999999999 111.516 -171.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.91 HG13 ' H ' ' A' ' 59' ' ' LEU . 55.1 t -32.34 95.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 C-N-CA 126.449 1.899 . . . . 0.37 112.3 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.651 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.82 -103.29 0.21 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 111.707 -2.497 . . . . 0.69999999999999996 113.898 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -95.22 -33.15 12.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.007 0.743 . . . . 2.75 113.007 -168.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 27.6 p80 -97.88 -36.29 10.22 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 121.653 0.739 . . . . 1.3300000000000001 110.822 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.114 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.29 106.14 12.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.39 -1.707 . . . . 1.1100000000000001 106.39 174.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.87 115.86 30.6 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.517 -1.66 . . . . 0.76000000000000001 106.517 165.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.91 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -103.04 93.64 5.12 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.307 -2.109 . . . . 0.26000000000000001 105.307 172.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 53.2 m-70 -92.86 160.38 14.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-O 122.902 1.334 . . . . 2.0299999999999998 109.499 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.543 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -129.29 110.79 12.24 Favored 'General case' 0 C--N 1.265 -3.102 0 CA-C-N 111.458 -2.61 . . . . 0.92000000000000004 108.936 175.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.9 m -92.28 145.38 24.53 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.582 -2.099 . . . . 0.46999999999999997 107.776 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.441 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.0 t80 -141.26 99.77 3.65 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.07 0.938 . . . . 1.3899999999999999 111.57 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -116.46 121.73 42.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.125 -1.398 . . . . 2.4199999999999999 108.811 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.441 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -85.36 -39.07 18.04 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 113.721 -1.581 . . . . 2.46 112.117 -172.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.19 -18.23 60.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.604 -0.725 . . . . 1.1499999999999999 111.417 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -95.58 -16.76 21.89 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.283 -1.377 . . . . 1.4099999999999999 107.283 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.599 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 67.59 31.47 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.864 -1.516 . . . . 3.3100000000000001 109.789 173.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.45 128.49 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.764 0.793 . . . . 0.42999999999999999 110.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.558 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 45.8 m-85 -98.47 112.22 24.31 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.143 -1.799 . . . . 1.24 106.143 162.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.4 tp -98.92 106.2 18.44 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.017 0.913 . . . . 0.52000000000000002 108.61 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 51.4 m-85 -84.46 115.65 22.67 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.303 -1.317 . . . . 0.33000000000000002 108.001 172.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -104.2 123.62 47.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.055 -1.43 . . . . 1.3200000000000001 109.269 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -94.74 118.9 32.49 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.144 -1.428 . . . . 0.95999999999999996 107.144 170.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -110.71 95.76 5.76 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 103.556 -2.757 . . . . 1.1499999999999999 103.556 169.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.699 HD13 ' HE2' ' A' ' 43' ' ' LYS . 13.9 mt -123.55 99.54 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 123.229 1.49 . . . . 0.52000000000000002 108.66 -175.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.8 p -107.53 170.07 8.2 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 113.441 -1.709 . . . . 0.57999999999999996 108.007 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.9 t70 65.52 33.56 8.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 112.722 -2.036 . . . . 2.1200000000000001 110.003 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -49.94 112.05 0.61 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.994 -1.912 . . . . 0.40000000000000002 111.7 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.603 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -70.85 153.7 94.65 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.198 -0.91 . . . . 1.4299999999999999 109.179 173.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 40.9 Cg_endo -66.9 -3.39 9.46 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.245 1.963 . . . . 1.3300000000000001 113.189 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.82 17.0 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.265 -0.425 . . . . 1.1200000000000001 110.331 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.3 m-30 -99.56 0.74 42.87 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.658 -0.497 . . . . 1.24 109.658 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 14.9 m -28.97 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 125.779 1.924 . . . . 1.22 110.579 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.871 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -34.37 106.84 0.03 OUTLIER Glycine 0 N--CA 1.411 -3.015 0 CA-C-N 109.662 -3.426 . . . . 1.4299999999999999 114.798 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 1.029 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -122.66 65.39 0.51 Allowed Glycine 0 N--CA 1.406 -3.343 0 N-CA-C 108.33 -1.908 . . . . 0.52000000000000002 108.33 159.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.709 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 79.0 m-85 -81.48 128.81 34.29 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.862 -1.169 . . . . 0.63 109.562 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -135.04 104.26 5.88 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.772 -0.825 . . . . 3.1499999999999999 108.772 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.4 t -102.11 129.58 48.49 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.474 -0.491 . . . . 1.0800000000000001 110.154 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.898 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 22.0 tt0 -131.64 116.37 17.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.472 -0.785 . . . . 1.8100000000000001 110.007 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.643 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -106.39 140.53 24.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.428 0.632 . . . . 0.54000000000000004 109.957 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.1 t -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.11 -0.95 . . . . 1.1799999999999999 108.745 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.667 HG21 HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -132.09 157.46 44.15 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 118.145 -0.931 . . . . 0.73999999999999999 109.341 -178.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 1.058 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 17.92 -73.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.536 1.772 . . . . 0.65000000000000002 114.662 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 1.058 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.6 t0 -150.74 1.97 0.44 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.058 -0.974 . . . . 1.05 109.697 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.06 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 14.7 mtpp -103.75 146.21 28.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 122.459 1.123 . . . . 1.29 109.541 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -136.14 140.26 43.53 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.279 -2.237 . . . . 0.77000000000000002 110.6 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 2.4 m-20 -156.91 149.74 23.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.044 -0.98 . . . . 1.6000000000000001 109.596 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 13.5 p -152.69 149.03 27.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.13 0.49 . . . . 1.1899999999999999 110.975 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.491 ' HG ' ' HZ ' ' A' ' 7' ' ' PHE . 3.9 p -127.97 149.6 50.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.6 -0.727 . . . . 0.83999999999999997 112.268 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.641 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.0 OUTLIER -132.65 109.55 9.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.409 -1.269 . . . . 1.5800000000000001 109.23 178.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.788 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 4.6 p90 -141.37 129.36 21.94 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.823 0.82 . . . . 0.85999999999999999 110.078 -172.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 15.9 m-80 -105.31 146.22 29.67 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.607 -1.178 . . . . 2.1099999999999999 111.107 -169.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.871 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -112.83 118.16 34.16 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.042 -1.435 . . . . 0.37 109.145 173.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 m -95.25 97.51 9.93 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.842 -0.743 . . . . 0.33000000000000002 109.237 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.664 HG22 HG22 ' A' ' 18' ' ' VAL . 7.2 p -86.59 113.31 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 123.331 1.539 . . . . 0.33000000000000002 109.397 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 82.2 m-70 -86.15 99.8 11.77 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 112.295 -2.229 . . . . 1.1899999999999999 109.354 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 52.7 tt0 -63.45 -74.3 0.1 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.321 -0.854 . . . . 1.6699999999999999 111.114 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.54 129.73 52.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.48 -0.327 . . . . 2.7799999999999998 110.381 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.434 -0.793 . . . . 6.9199999999999999 110.305 179.608 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.477 0.656 . . . . 1.9299999999999999 110.646 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.3 m-20 -101.65 166.71 11.76 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 114.746 -1.116 . . . . 1.6499999999999999 110.057 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.03 45.95 0.39 Allowed 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.296 2.664 . . . . 0.96999999999999997 113.915 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -63.15 -58.68 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.643 -0.708 . . . . 0.5 110.096 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.85 53.97 3.2 Favored Glycine 0 CA--C 1.492 -1.376 0 N-CA-C 107.625 -2.19 . . . . 0.39000000000000001 107.625 -173.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.82 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.2 tp -60.75 -33.62 73.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.978 -1.611 . . . . 0.33000000000000002 110.201 -165.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.87 84.61 3.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.05 -0.977 . . . . 0.71999999999999997 109.572 172.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.54 -50.7 64.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.545 -1.207 . . . . 0.63 109.91 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.658 ' HB3' ' HD3' ' A' ' 27' ' ' ARG . 16.5 tpt -147.84 131.18 16.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.2 -0.909 . . . . 2.8799999999999999 108.66 173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 34.4 ptt180 -98.65 138.15 20.7 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 116.133 -0.485 . . . . 3.6699999999999999 111.436 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.774 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 28.1 Cg_endo -68.36 153.99 72.98 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.545 2.163 . . . . 0.64000000000000001 111.155 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.0 mm-40 -123.17 173.17 8.06 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.119 -0.491 . . . . 1.4299999999999999 110.514 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.6 p-10 -68.33 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.67 1.224 . . . . 2.0600000000000001 111.537 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 155.76 138.97 2.66 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 113.736 -1.575 . . . . 0.29999999999999999 111.156 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 43.0 mt-10 -117.96 116.93 27.91 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.398 -0.964 . . . . 1.53 108.398 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.08 163.73 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.326 -1.361 . . . . 0.27000000000000002 107.326 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.36 156.02 16.5 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.962 -1.017 . . . . 0.77000000000000002 109.304 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.757 HG13 ' HD3' ' A' ' 81' ' ' PRO . 47.5 t -57.93 107.45 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 122.81 1.29 . . . . 0.78000000000000003 109.825 175.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.56 12.25 19.57 Favored Glycine 0 C--N 1.274 -2.862 0 CA-C-N 112.029 -2.351 . . . . 0.47999999999999998 114.07 170.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.8 -122.46 3.46 Favored Glycine 0 CA--C 1.478 -2.256 0 C-N-CA 118.818 -1.658 . . . . 0.44 111.103 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.2 p -151.71 167.91 26.71 Favored 'General case' 0 N--CA 1.403 -2.822 0 CA-C-N 112.474 -1.863 . . . . 0.81999999999999995 110.408 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 104' ' ' LEU . 10.6 tp -146.29 150.58 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 CA-C-N 112.938 -1.937 . . . . 0.32000000000000001 107.919 169.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 m -137.5 126.19 23.82 Favored 'General case' 0 C--N 1.263 -3.165 0 CA-C-N 113.048 -1.887 . . . . 0.31 110.757 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.675 ' HD2' HD12 ' A' ' 74' ' ' LEU . 37.3 m-85 -122.11 140.99 51.87 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.033 -1.439 . . . . 0.53000000000000003 109.408 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.78 119.52 22.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.645 -0.707 . . . . 0.57999999999999996 109.601 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.774 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -121.33 116.75 25.41 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.507 -1.224 . . . . 0.32000000000000001 110.691 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.658 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 28.5 mtp180 -105.05 120.04 40.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.072 -0.513 . . . . 2.4300000000000002 111.142 -176.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.524 HG21 HG21 ' A' ' 39' ' ' VAL . 12.9 t -122.14 132.72 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.707 0.765 . . . . 0.26000000000000001 109.303 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.87 111.24 1.81 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 113.71 -1.586 . . . . 0.40000000000000002 110.7 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -50.89 -35.12 31.27 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 114.675 -1.148 . . . . 0.76000000000000001 110.295 169.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.63 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.09 -143.98 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.38 -0.91 . . . . 0.70999999999999996 113.383 166.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.542 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -119.58 154.8 33.37 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.327 -1.36 . . . . 1.74 107.327 170.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.065 HD22 ' HA ' ' A' ' 93' ' ' THR . 3.7 tp 171.0 147.53 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.475 -1.306 . . . . 2.1600000000000001 107.475 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.803 ' H ' HD12 ' A' ' 33' ' ' LEU . 24.3 tp -44.91 -42.27 7.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.031 0.92 . . . . 1.47 111.169 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.772 ' HD2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.47 -179.67 0.79 Allowed Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.197 -1.365 . . . . 1.3999999999999999 108.116 175.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 8.1 Cg_exo -67.9 153.69 74.8 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.533 1.489 . . . . 0.88 108.888 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.692 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 26.4 Cg_exo -60.38 137.23 73.06 Favored 'Trans proline' 0 CA--C 1.503 -1.056 0 C-N-CA 122.013 1.809 . . . . 0.53000000000000003 111.548 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.27 102.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 106.94 -1.504 . . . . 0.77000000000000002 106.94 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.677 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -107.59 114.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 CA-C-N 112.839 -1.982 . . . . 0.28000000000000003 106.947 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.706 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.01 127.95 53.09 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 123.313 1.53 . . . . 1.54 109.22 173.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.039 ' HB3' HD13 ' A' ' 49' ' ' LEU . 69.4 m95 -85.4 154.25 21.97 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 111.448 -2.615 . . . . 0.34000000000000002 111.111 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.838 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 29.9 t80 -126.22 138.2 53.61 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.62 105.186 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 71.2 tttt -104.76 165.05 11.33 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.719 -1.956 . . . . 2.1699999999999999 105.719 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.807 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -9.65 -168.79 0.0 OUTLIER Glycine 0 C--O 1.188 -2.747 0 N-CA-C 119.522 2.569 . . . . 1.23 119.522 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 84' ' ' THR . 19.5 mtpt -45.47 -1.73 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 O-C-N 119.463 -2.198 . . . . 3.8700000000000001 116.826 -166.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.695 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 13.8 p-90 -166.03 -10.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.403 1.26 . . . . 2.1099999999999999 114.403 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.695 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.2 170.06 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-O 123.482 1.611 . . . . 1.29 112.492 -162.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.694 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 7.0 p-10 -112.88 158.13 20.57 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 111.825 -2.443 . . . . 2.73 107.528 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.039 HD13 ' HB3' ' A' ' 41' ' ' TRP . 6.0 mp -98.57 -36.94 9.73 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.142 0.423 . . . . 0.44 112.142 168.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 t -57.69 -20.76 36.23 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.719 0.637 . . . . 1.23 109.661 -162.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.694 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 17.0 m -100.47 -21.24 15.42 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.619 -0.832 . . . . 1.3400000000000001 112.855 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 1.9 mmmt -94.11 -67.93 0.83 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.425 -0.807 . . . . 1.3999999999999999 111.132 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.833 HG13 ' H ' ' A' ' 59' ' ' LEU . 78.5 t 12.8 93.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 126.358 1.863 . . . . 0.37 113.593 174.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.43 -154.49 7.28 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.052 -1.431 . . . . 0.69999999999999996 110.281 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.45 ' C ' HE22 ' A' ' 58' ' ' GLN . 55.5 mt-30 -63.98 -5.21 4.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.971 1.1 . . . . 2.75 113.971 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -101.83 -41.26 6.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.768 0.794 . . . . 1.3300000000000001 110.831 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.019 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.72 104.73 7.36 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.25 -1.759 . . . . 1.1100000000000001 106.25 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.887 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -95.1 113.75 25.48 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.259 -2.126 . . . . 0.76000000000000001 105.259 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.833 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -101.74 91.42 4.4 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.065 -2.568 . . . . 0.26000000000000001 104.065 170.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 45.7 t60 -106.37 162.69 13.47 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.365 -1.289 . . . . 2.0299999999999998 109.279 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.65 125.56 38.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 112.331 -2.213 . . . . 0.92000000000000004 110.966 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -98.78 147.54 24.8 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 110.996 -2.82 . . . . 0.46999999999999997 107.043 169.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.585 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 6.6 t80 -144.25 101.11 3.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.058 0.932 . . . . 1.3899999999999999 112.312 -168.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 7.7 t70 -117.4 127.63 54.22 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.98 -1.464 . . . . 2.4199999999999999 109.321 168.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.585 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -86.75 -41.12 14.38 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.813 -1.54 . . . . 2.46 112.018 -174.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.69 57.93 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.988 -1.005 . . . . 1.1499999999999999 111.102 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 29.6 t -91.19 -19.4 23.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.542 -1.651 . . . . 1.4099999999999999 106.542 173.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.63 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 1.4 tpmt? 70.69 29.32 3.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.841 -1.527 . . . . 3.3100000000000001 109.722 173.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -132.04 127.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 121.83 0.824 . . . . 0.42999999999999999 111.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.544 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 61.2 m-85 -96.89 113.33 24.86 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.182 -1.784 . . . . 1.24 106.182 162.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 36.0 tp -92.4 103.82 16.22 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 108.345 -0.983 . . . . 0.52000000000000002 108.345 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.3 m-85 -85.26 112.73 21.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.386 -1.709 . . . . 0.33000000000000002 106.386 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 119.92 39.03 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.098 -1.864 . . . . 1.3200000000000001 109.798 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.703 HD13 HD11 ' A' ' 76' ' ' ILE . 1.6 mt -89.41 130.83 35.71 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 114.116 -1.402 . . . . 0.95999999999999996 107.984 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.887 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 81.7 m-70 -120.69 95.81 4.87 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 104.114 -2.551 . . . . 1.1499999999999999 104.114 168.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 74' ' ' LEU . 12.8 mt -119.77 101.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 113.937 -1.483 . . . . 0.52000000000000002 108.318 -171.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 78.5 p -101.68 166.19 10.82 Favored 'General case' 0 N--CA 1.382 -3.861 0 CA-C-N 113.987 -1.461 . . . . 0.57999999999999996 109.145 -175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 39.38 78.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 111.362 -2.654 . . . . 2.1200000000000001 112.579 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -70.77 121.04 17.26 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 111.089 -2.778 . . . . 0.40000000000000002 110.181 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.928 HE21 ' HD2' ' A' ' 81' ' ' PRO . 2.1 tp60 -63.07 137.91 97.19 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.49 -0.777 . . . . 1.4299999999999999 109.874 174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.928 ' HD2' HE21 ' A' ' 80' ' ' GLN . 16.5 Cg_endo -57.73 -12.86 12.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.283 2.655 . . . . 1.3300000000000001 113.545 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.512 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.03 21.78 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.453 -0.339 . . . . 1.1200000000000001 111.245 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -46.89 8.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.536 -0.466 . . . . 1.24 111.984 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 83.2 m 22.67 79.77 0.01 OUTLIER 'General case' 0 C--N 1.344 0.368 0 CA-C-O 122.902 1.334 . . . . 1.22 110.609 -165.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.807 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.1 99.39 0.5 Allowed Glycine 0 N--CA 1.42 -2.425 0 CA-C-N 112.711 -2.041 . . . . 1.4299999999999999 114.495 -159.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.727 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -86.59 69.49 3.1 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 109.208 -1.557 . . . . 0.52000000000000002 109.208 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.723 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 77.8 m-85 -78.42 128.11 33.14 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.871 -1.165 . . . . 0.63 108.758 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.838 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -122.56 156.72 33.62 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.082 0.468 . . . . 3.1499999999999999 110.618 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 72.6 m -130.55 115.8 17.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.197 -0.668 . . . . 1.0800000000000001 109.197 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.706 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 39.2 mt-10 -125.34 105.24 8.95 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.627 -0.429 . . . . 1.8100000000000001 109.908 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.8 p -103.62 144.1 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.54000000000000004 111.009 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.8 t -135.2 109.09 8.11 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.894 -1.048 . . . . 1.1799999999999999 108.428 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.065 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -131.58 146.78 52.38 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-O 117.55 -1.214 . . . . 0.73999999999999999 109.353 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.795 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.86 -71.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 125.49 1.744 . . . . 0.65000000000000002 113.56 -167.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.795 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -152.18 3.66 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.159 -1.382 . . . . 1.05 110.443 -172.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.82 ' HB3' HD22 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -94.23 142.73 27.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 108.027 -1.101 . . . . 1.29 108.027 177.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.48 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 31.3 t80 -133.64 132.84 41.23 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 113.64 -1.618 . . . . 0.77000000000000002 111.79 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.6 m-20 -151.35 153.05 34.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.063 -0.972 . . . . 1.6000000000000001 110.4 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 33.4 m -148.54 148.84 30.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.117 0.484 . . . . 1.1899999999999999 111.737 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.821 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 28.9 t -133.4 150.76 51.79 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.804 0.812 . . . . 0.83999999999999997 111.947 174.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.45 120.86 18.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.752 -1.567 . . . . 1.5800000000000001 109.916 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 10.1 p90 -143.48 130.57 20.68 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.939 -0.393 . . . . 0.85999999999999999 109.939 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.795 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER -107.86 128.31 54.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.318 1.056 . . . . 2.1099999999999999 113.359 -170.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -95.08 109.28 21.36 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.842 -1.526 . . . . 0.37 109.196 176.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.0 m -90.43 96.79 10.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.405 -0.591 . . . . 0.33000000000000002 109.405 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.613 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.2 p -77.68 113.36 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 122.765 1.269 . . . . 0.33000000000000002 108.626 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -84.35 97.97 9.77 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.186 -1.825 . . . . 1.1899999999999999 109.664 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.2 tm-20 -72.79 124.46 25.4 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.491 -1.686 . . . . 1.6699999999999999 109.339 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.58 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.746 0.654 . . . . 2.7799999999999998 110.259 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.0 mmm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.256 -0.878 . . . . 6.9199999999999999 109.93 179.032 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.581 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 3.7 m-20 . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.88 0.848 . . . . 1.9299999999999999 110.994 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 64.4 m-20 -94.35 161.47 29.19 Favored Pre-proline 0 N--CA 1.429 -1.508 0 CA-C-N 113.79 -1.55 . . . . 1.6499999999999999 109.277 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.83 91.29 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.38 2.054 . . . . 0.96999999999999997 112.454 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.722 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -117.8 -64.94 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 115.335 -0.848 . . . . 0.5 109.174 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 94.11 42.88 3.93 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 108.208 -1.957 . . . . 0.39000000000000001 108.208 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.01 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -52.64 -39.75 62.1 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 112.87 -1.665 . . . . 0.33000000000000002 110.293 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.866 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -95.9 84.39 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.281 -0.872 . . . . 0.71999999999999997 109.6 177.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.42 -49.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.343 -1.299 . . . . 0.63 109.388 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.44 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 24.1 ttt -141.6 136.68 31.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.394 -0.821 . . . . 2.8799999999999999 109.317 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.732 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -110.76 137.99 20.95 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.193 -0.458 . . . . 3.6699999999999999 110.987 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.67 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 4.0 Cg_endo -71.49 155.47 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.223 1.949 . . . . 0.64000000000000001 110.718 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.2 mm-40 -120.25 177.25 5.09 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.687 -0.486 . . . . 1.4299999999999999 109.687 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 6.0 p-10 -66.67 -141.59 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 122.884 1.326 . . . . 2.0600000000000001 111.828 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 148.97 133.33 2.22 Favored Glycine 0 C--N 1.291 -1.938 0 CA-C-N 113.586 -1.643 . . . . 0.29999999999999999 111.716 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 28.6 mt-10 -113.62 111.86 22.56 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.357 -0.979 . . . . 1.53 108.357 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.462 ' CG1' HD13 ' A' ' 22' ' ' ILE . 3.0 m -127.74 163.64 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.862 0 N-CA-C 107.252 -1.388 . . . . 0.27000000000000002 107.252 -170.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.55 152.89 18.03 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.83 -1.077 . . . . 0.77000000000000002 109.13 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.866 HG21 ' HB3' ' A' ' 81' ' ' PRO . 3.7 t -66.67 105.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 CA-C-O 122.923 1.344 . . . . 0.78000000000000003 108.123 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.55 5.9 Favored Glycine 0 C--N 1.263 -3.494 0 CA-C-N 111.921 -2.4 . . . . 0.47999999999999998 111.678 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.83 -127.83 6.16 Favored Glycine 0 N--CA 1.409 -3.16 0 C-N-CA 118.932 -1.604 . . . . 0.44 109.188 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.9 p -152.15 174.35 13.83 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 113.04 -1.58 . . . . 0.81999999999999995 110.075 177.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.2 tp -147.58 150.47 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-N 113.703 -1.589 . . . . 0.32000000000000001 107.505 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.5 m -138.53 124.01 19.51 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 113.222 -1.808 . . . . 0.31 109.943 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.776 ' HD2' HD12 ' A' ' 74' ' ' LEU . 33.1 m-85 -119.96 146.04 46.19 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.404 -1.271 . . . . 0.53000000000000003 109.015 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.36 120.42 15.59 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.141 -0.936 . . . . 0.57999999999999996 110.192 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.579 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -120.18 116.22 25.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.478 -1.237 . . . . 0.32000000000000001 110.613 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.5 mtt180 -103.6 121.93 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.557 -0.292 . . . . 2.4300000000000002 110.548 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG21 HG21 ' A' ' 39' ' ' VAL . 23.5 t -123.34 129.42 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.032 0.92 . . . . 0.26000000000000001 110.524 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.78 110.81 2.96 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.36 -1.745 . . . . 0.40000000000000002 111.529 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.634 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -51.05 -39.26 40.84 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.856 -1.066 . . . . 0.76000000000000001 112.633 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 58.03 -170.64 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.517 0.727 . . . . 0.70999999999999996 112.406 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.2 m -73.59 -71.54 0.31 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.49 -0.93 . . . . 1.74 108.49 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.938 HD23 HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 69.2 158.09 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 O-C-N 123.782 0.676 . . . . 2.1600000000000001 112.378 166.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.903 ' N ' HD22 ' A' ' 33' ' ' LEU . 19.2 tp -80.71 -66.24 0.91 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.906 -0.588 . . . . 1.47 110.879 168.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.766 ' O ' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -122.91 130.12 24.73 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 114.281 1.215 . . . . 1.3999999999999999 114.281 172.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' N ' HD11 ' A' ' 33' ' ' LEU . 18.4 Cg_exo -34.36 131.66 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.305 3.337 . . . . 0.88 113.171 -171.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.851 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 34.0 Cg_exo -49.02 133.47 28.65 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 122.484 2.122 . . . . 0.53000000000000003 112.671 -170.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.38 103.6 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.784 -1.562 . . . . 0.77000000000000002 106.784 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -105.34 113.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.959 -1.928 . . . . 0.28000000000000003 107.504 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.587 ' NZ ' ' HB2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -102.04 128.7 48.37 Favored 'General case' 0 N--CA 1.406 -2.66 0 CA-C-O 123.331 1.539 . . . . 1.54 109.006 174.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.054 ' HB3' HD13 ' A' ' 49' ' ' LEU . 57.2 m95 -84.91 153.27 22.96 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 111.829 -2.441 . . . . 0.34000000000000002 110.867 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 17.8 t80 -122.31 135.81 54.79 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 104.932 -2.247 . . . . 0.62 104.932 172.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.661 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 76.9 tttt -103.31 166.52 10.38 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 106.674 -1.602 . . . . 2.1699999999999999 106.674 -175.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA2' ' CA ' ' A' ' 85' ' ' GLY . . . -8.7 -162.09 0.0 OUTLIER Glycine 0 C--O 1.196 -2.227 0 N-CA-C 118.903 2.321 . . . . 1.23 118.903 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.746 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 39.6 pttt -38.68 -20.42 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.18 1.918 . . . . 3.8700000000000001 116.18 -163.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.746 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 15.2 p-90 -167.27 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 120.073 1.306 . . . . 2.1099999999999999 113.395 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -92.55 170.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 123.19 1.471 . . . . 1.29 112.072 -162.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 27.8 t70 -113.35 154.1 27.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 112.345 -2.207 . . . . 2.73 106.797 175.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.054 HD13 ' HB3' ' A' ' 41' ' ' TRP . 6.1 mp -91.29 -39.92 11.79 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 119.008 -0.52 . . . . 0.44 112.057 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.6 t -59.99 -20.14 56.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.813 -0.81 . . . . 1.23 108.813 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -86.67 -28.6 23.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.983 -1.008 . . . . 1.3400000000000001 111.456 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 11.4 mmmt -100.11 -62.73 1.2 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.446 -0.797 . . . . 1.3999999999999999 111.395 -172.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 49' ' ' LEU . 48.3 t 4.48 93.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 O-C-N 125.88 1.987 . . . . 0.37 113.804 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -164.99 -123.99 0.68 Allowed Glycine 0 C--N 1.31 -0.914 0 CA-C-N 113.001 -1.909 . . . . 0.69999999999999996 113.048 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -69.36 -38.49 78.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.763 0.425 . . . . 2.75 111.839 -170.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 6.8 t-80 -88.16 -38.64 15.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.75 0.786 . . . . 1.3300000000000001 111.463 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.0 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -130.14 105.29 7.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.824 -1.547 . . . . 1.1100000000000001 106.824 -177.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.8 114.78 27.12 Favored 'General case' 0 N--CA 1.409 -2.48 0 N-CA-C 107.063 -1.458 . . . . 0.76000000000000001 107.063 168.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.661 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.7 92.61 5.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.011 -2.589 . . . . 0.26000000000000001 104.011 169.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.733 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 8.5 t-160 -100.13 161.38 13.64 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.924 -1.489 . . . . 2.0299999999999998 109.268 -173.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -128.02 119.83 26.25 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 111.982 -2.372 . . . . 0.92000000000000004 110.839 -173.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.794 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.4 m -97.48 146.39 25.29 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 111.826 -2.443 . . . . 0.46999999999999997 106.75 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.449 ' HD1' ' CD1' ' A' ' 70' ' ' TYR . 28.5 t80 -145.43 96.63 2.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.385 1.088 . . . . 1.3899999999999999 111.389 -168.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 10.8 m-20 -115.67 101.11 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 113.235 -1.802 . . . . 2.4199999999999999 109.084 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -44.78 60.93 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.24 -0.891 . . . . 2.46 111.278 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -19.52 60.68 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.112 -0.949 . . . . 1.1499999999999999 111.118 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 49.4 m -92.8 -13.12 29.59 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.376 -1.342 . . . . 1.4099999999999999 107.376 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 1.1 tpmt? 69.6 27.45 4.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.806 -1.543 . . . . 3.3100000000000001 110.52 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 67' ' ' SER . 5.4 t -131.54 126.72 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.815 0.817 . . . . 0.42999999999999999 110.549 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.851 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 10.6 m-85 -101.35 109.27 21.09 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.944 -1.502 . . . . 1.24 106.944 165.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.1 tp -92.5 104.49 16.8 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.113 0.959 . . . . 0.52000000000000002 108.989 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -83.9 113.82 21.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.909 -1.515 . . . . 0.33000000000000002 106.909 171.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.733 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 3.5 pt-20 -117.5 122.94 45.1 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 113.513 -1.676 . . . . 1.3200000000000001 110.086 -172.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.776 HD12 ' HD2' ' A' ' 24' ' ' PHE . 2.4 mt -94.23 133.15 38.05 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.108 -1.405 . . . . 0.95999999999999996 108.935 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 5.6 m170 -115.38 96.66 5.76 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.357 -2.831 . . . . 1.1499999999999999 103.357 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.675 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.5 mt -124.59 100.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.976 1.37 . . . . 0.52000000000000002 108.545 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.3 p -105.46 169.3 8.54 Favored 'General case' 0 N--CA 1.394 -3.238 0 CA-C-N 114.323 -1.308 . . . . 0.57999999999999996 110.102 -172.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 36.71 69.05 0.22 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 111.206 -2.725 . . . . 2.1200000000000001 111.392 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -57.19 126.26 26.42 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 112.196 -2.274 . . . . 0.40000000000000002 111.397 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.716 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -56.05 131.42 74.17 Favored Pre-proline 0 C--O 1.223 -0.34 0 CA-C-N 115.76 -0.655 . . . . 1.4299999999999999 109.634 172.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.866 ' HB3' HG21 ' A' ' 18' ' ' VAL . 21.9 Cg_endo -61.32 -15.9 43.43 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.982 2.455 . . . . 1.3300000000000001 113.148 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -108.25 26.63 10.2 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.807 -0.633 . . . . 1.1200000000000001 110.365 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -81.34 -52.91 6.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.47 -0.492 . . . . 1.24 111.188 -178.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.4 m 21.71 75.48 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 123.427 1.584 . . . . 1.22 109.276 -159.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.659 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.95 114.96 4.56 Favored Glycine 0 N--CA 1.407 -3.254 0 CA-C-N 112.152 -2.294 . . . . 1.4299999999999999 112.397 -156.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.563 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -98.74 87.81 0.82 Allowed Glycine 0 C--N 1.273 -2.957 0 N-CA-C 109.544 -1.423 . . . . 0.52000000000000002 109.544 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.737 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 9.7 m-85 -85.46 139.62 31.36 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.194 -1.503 . . . . 0.63 107.629 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.704 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 49.0 mtm180 -137.24 155.73 49.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.629 0.252 . . . . 3.1499999999999999 110.378 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 3.4 m -122.82 120.95 35.05 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.147 -0.686 . . . . 1.0800000000000001 109.147 173.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -123.41 105.12 9.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.002 -0.74 . . . . 1.8100000000000001 109.002 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.8 p -101.55 142.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.465 0.65 . . . . 0.54000000000000004 111.501 -175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.6 t -132.13 108.11 9.07 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.346 -1.297 . . . . 1.1799999999999999 108.681 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.938 HG22 HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.36 154.01 51.1 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 117.853 -1.07 . . . . 0.73999999999999999 108.718 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.735 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 21.72 -75.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 125.895 1.997 . . . . 0.65000000000000002 114.391 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.735 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t70 -151.44 3.17 0.42 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.979 -1.01 . . . . 1.05 109.31 -175.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.01 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -96.39 128.47 43.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.378 -0.971 . . . . 1.29 108.378 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -130.57 132.15 45.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.708 -1.133 . . . . 0.77000000000000002 110.879 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -154.04 153.9 32.75 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.418 -1.265 . . . . 1.6000000000000001 110.379 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 59.6 m -145.02 152.44 40.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.91 0.386 . . . . 1.1899999999999999 110.749 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.866 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 56.3 p -131.22 148.26 52.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.641 -0.709 . . . . 0.83999999999999997 109.371 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.704 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -133.84 124.36 26.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.72 0.295 . . . . 1.5800000000000001 110.329 177.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 9.6 p90 -143.85 126.4 15.94 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.144 0.497 . . . . 0.85999999999999999 110.5 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 59.6 m-20 -103.46 136.86 42.42 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 122.273 1.035 . . . . 2.1099999999999999 111.047 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -105.64 110.52 22.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.085 -1.416 . . . . 0.37 109.157 177.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.442 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.0 m -94.61 97.22 9.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.006 -0.738 . . . . 0.33000000000000002 109.006 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.3 p -81.48 119.11 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-O 122.851 1.31 . . . . 0.33000000000000002 108.883 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -91.4 99.16 12.17 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 113.034 -1.894 . . . . 1.1899999999999999 108.763 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 18' ' ' VAL . 44.1 tt0 -70.01 113.54 7.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.122 -1.399 . . . . 1.6699999999999999 110.094 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.79 126.78 54.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.754 -0.657 . . . . 2.7799999999999998 110.087 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.533 -0.746 . . . . 6.9199999999999999 109.607 -179.672 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.937 0.875 . . . . 1.9299999999999999 112.569 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.616 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -117.77 147.89 42.02 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.008 -0.996 . . . . 1.6499999999999999 108.74 179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.417 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.9 Cg_endo -40.7 96.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 125.015 3.81 . . . . 0.96999999999999997 115.162 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 6' ' ' LEU . 1.4 mp -128.85 -60.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.036 -0.983 . . . . 0.5 109.225 172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.12 54.96 2.46 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.635 -1.786 . . . . 0.39000000000000001 108.635 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.3 tp -62.97 -32.49 73.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.466 -1.367 . . . . 0.33000000000000002 111.051 -165.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.12 84.96 3.36 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.746 -0.661 . . . . 0.71999999999999997 109.813 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.65 -46.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.825 -1.08 . . . . 0.63 109.766 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.59 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 25.1 ttt -140.4 130.51 24.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.408 -0.814 . . . . 2.8799999999999999 108.943 174.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -102.69 128.6 27.63 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 116.141 -0.481 . . . . 3.6699999999999999 110.195 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.683 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 10.8 Cg_endo -62.16 150.98 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.291 1.994 . . . . 0.64000000000000001 110.675 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.496 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.5 mm-40 -121.96 173.91 7.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.884 -0.598 . . . . 1.4299999999999999 110.327 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 8.0 p-10 -70.7 -147.8 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.937 1.351 . . . . 2.0600000000000001 111.896 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 158.42 130.14 1.15 Allowed Glycine 0 C--N 1.294 -1.755 0 CA-C-N 113.099 -1.864 . . . . 0.29999999999999999 112.689 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -112.94 107.78 16.47 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.044 -1.078 . . . . 1.53 109.071 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.24 163.52 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 N-CA-C 107.255 -1.387 . . . . 0.27000000000000002 107.255 -167.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.92 156.74 16.2 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 115.303 -0.862 . . . . 0.77000000000000002 109.638 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.662 HG22 HG22 ' A' ' 106' ' ' VAL . 18.1 t -68.51 104.53 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 CA-C-O 122.876 1.322 . . . . 0.78000000000000003 108.326 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.72 4.85 7.9 Favored Glycine 0 C--N 1.27 -3.087 0 CA-C-N 112.36 -2.2 . . . . 0.47999999999999998 112.837 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.67 -125.33 5.13 Favored Glycine 0 N--CA 1.415 -2.706 0 N-CA-C 109.674 -1.37 . . . . 0.44 109.674 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 14.5 p -150.36 172.59 15.16 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 112.847 -1.676 . . . . 0.81999999999999995 110.38 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.7 tp -148.86 145.66 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 112.896 -1.957 . . . . 0.32000000000000001 106.988 172.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 m -139.08 129.13 25.18 Favored 'General case' 0 C--N 1.261 -3.278 0 CA-C-N 114.003 -1.453 . . . . 0.31 110.711 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.643 ' HB2' HD23 ' A' ' 74' ' ' LEU . 38.7 m-85 -127.15 145.2 50.83 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.199 -1.364 . . . . 0.53000000000000003 110.012 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.11 121.61 22.88 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.432 -0.804 . . . . 0.57999999999999996 109.251 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.683 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -124.42 117.78 25.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.92 -1.037 . . . . 0.32000000000000001 110.541 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.7 mtt180 -107.71 118.59 37.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.209 -0.45 . . . . 2.4300000000000002 110.498 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.54 HG21 HG21 ' A' ' 39' ' ' VAL . 18.5 t -117.92 127.15 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 122.044 0.926 . . . . 0.26000000000000001 109.695 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.1 0.65 Allowed 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.339 -1.755 . . . . 0.40000000000000002 111.076 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.697 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -51.32 -50.63 39.96 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.263 -1.335 . . . . 0.76000000000000001 112.025 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.736 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 48.1 -161.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.558 0.743 . . . . 0.70999999999999996 112.319 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -127.33 86.07 2.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.633 -0.877 . . . . 1.74 108.633 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.852 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -110.32 -175.83 2.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.206 -0.452 . . . . 2.1600000000000001 109.914 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.24 -24.51 42.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.337 0.589 . . . . 1.47 111.471 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.852 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -151.83 -179.39 1.01 Allowed Pre-proline 0 C--O 1.212 -0.905 0 CA-C-N 115.133 -0.94 . . . . 1.3999999999999999 109.148 -173.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 2.9 Cg_exo -73.19 141.98 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 N-CA-C 107.965 -1.59 . . . . 0.88 107.965 165.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 93' ' ' THR . 21.8 Cg_exo -52.34 135.31 53.67 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.087 1.191 . . . . 0.53000000000000003 111.592 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 35' ' ' LYS . 2.6 t -97.58 103.58 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.68 0 N-CA-C 106.586 -1.635 . . . . 0.77000000000000002 106.586 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.64 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -111.23 114.56 47.44 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.084 0 CA-C-N 113.127 -1.852 . . . . 0.28000000000000003 107.517 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.836 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.02 129.85 51.66 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-O 123.086 1.422 . . . . 1.54 109.816 173.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.052 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.3 m95 -87.87 154.99 20.09 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 111.689 -2.505 . . . . 0.34000000000000002 111.875 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 30.8 t80 -135.1 138.06 43.42 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 104.578 -2.379 . . . . 0.62 104.578 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.794 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 60.5 tttp -103.98 166.22 10.55 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.983 -2.229 . . . . 2.1699999999999999 104.983 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -12.02 -165.31 0.0 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 119.215 2.446 . . . . 1.23 119.215 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.612 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 7.0 mtpp -43.37 -10.44 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 O-C-N 119.489 -2.183 . . . . 3.8700000000000001 116.574 -166.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.429 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 15.2 p-90 -163.21 -9.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.751 1.389 . . . . 2.1099999999999999 114.751 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.62 151.5 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 CA-C-O 123.112 1.434 . . . . 1.29 112.336 -160.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.658 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.8 t70 -110.48 127.31 55.09 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 111.87 -2.423 . . . . 2.73 108.721 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.052 HD13 ' HB3' ' A' ' 41' ' ' TRP . 3.1 mp -68.23 -34.97 77.22 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.04 -0.527 . . . . 0.44 112.268 -175.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -58.76 -21.76 56.43 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.45 0.643 . . . . 1.23 109.36 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -92.72 -29.57 15.99 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.782 -1.099 . . . . 1.3400000000000001 111.365 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.76 ' HB2' HD12 ' A' ' 57' ' ' LEU . 11.1 mmmt -98.05 -30.59 12.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.526 -0.761 . . . . 1.3999999999999999 111.569 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 42.7 t -45.01 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 125.704 1.602 . . . . 0.37 111.264 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.92 -98.23 0.13 Allowed Glycine 0 C--N 1.298 -1.545 0 CA-C-N 112.374 -2.194 . . . . 0.69999999999999996 113.749 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -91.62 -42.32 10.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.497 . . . . 2.75 112.341 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.5 p80 -95.86 -38.12 10.42 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.073 0.463 . . . . 1.3300000000000001 110.897 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.935 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.82 105.82 13.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.261 -1.755 . . . . 1.1100000000000001 106.261 173.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.16 115.96 31.06 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 106.757 -1.571 . . . . 0.76000000000000001 106.757 165.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -97.02 92.27 5.99 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 104.146 -2.538 . . . . 0.26000000000000001 104.146 170.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.756 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 29.3 m-70 -91.87 162.86 14.25 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 114.361 -1.291 . . . . 2.0299999999999998 110.106 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.95 115.75 14.75 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 112.132 -2.304 . . . . 0.92000000000000004 109.835 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -92.29 147.87 22.58 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.24 -1.8 . . . . 0.46999999999999997 107.463 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -142.25 98.19 3.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.244 1.021 . . . . 1.3899999999999999 110.799 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.608 ' OD1' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -114.46 114.6 26.03 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.37 -1.741 . . . . 2.4199999999999999 111.014 174.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.734 ' HD3' ' HE2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.67 -33.16 66.36 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.526 -0.761 . . . . 2.46 110.756 175.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.83 -28.88 70.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.292 -0.867 . . . . 1.1499999999999999 111.304 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.608 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 15.0 m -100.66 -18.49 16.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.175 -1.046 . . . . 1.4099999999999999 108.175 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.736 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER 64.05 37.33 9.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.277 -1.328 . . . . 3.3100000000000001 109.736 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.65 139.18 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 115.373 -0.83 . . . . 0.42999999999999999 109.758 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 70.0 m-85 -102.82 109.08 20.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.383 -1.71 . . . . 1.24 106.383 162.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.3 tp -94.53 104.07 16.02 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.404 1.097 . . . . 0.52000000000000002 108.806 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.6 m-85 -88.35 113.95 24.47 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 113.713 -1.585 . . . . 0.33000000000000002 107.624 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.756 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 8.2 pt-20 -115.0 124.46 51.7 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 113.877 -1.51 . . . . 1.3200000000000001 109.877 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.779 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -90.23 120.8 31.69 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.416 -1.72 . . . . 0.95999999999999996 108.33 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -112.12 95.65 5.59 Favored 'General case' 0 C--N 1.268 -2.947 0 N-CA-C 103.976 -2.602 . . . . 1.1499999999999999 103.976 168.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.723 ' HB ' HG23 ' A' ' 22' ' ' ILE . 64.6 mt -120.84 98.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-O 123.26 1.505 . . . . 0.52000000000000002 109.54 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 21.3 p -112.29 136.31 51.9 Favored 'General case' 0 N--CA 1.393 -3.321 0 CA-C-N 113.213 -1.812 . . . . 0.57999999999999996 106.96 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER 72.83 100.13 0.07 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 111.684 -2.507 . . . . 2.1200000000000001 109.017 -171.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.98 113.24 26.66 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 110.431 -3.077 . . . . 0.40000000000000002 109.538 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.676 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -54.32 140.19 55.39 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.438 -0.801 . . . . 1.4299999999999999 110.252 171.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.566 ' HD2' HE21 ' A' ' 80' ' ' GLN . 21.6 Cg_endo -61.03 -11.59 19.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.142 2.561 . . . . 1.3300000000000001 112.875 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -97.64 11.14 38.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.124 -0.489 . . . . 1.1200000000000001 110.687 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.439 ' O ' HD23 ' A' ' 104' ' ' LEU . 2.6 m-30 -97.32 -8.86 28.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 119.449 -0.31 . . . . 1.24 110.636 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 20.5 m -47.95 97.71 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 108.116 -1.068 . . . . 1.22 108.116 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.612 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -168.53 -129.07 1.05 Allowed Glycine 0 C--N 1.263 -3.508 0 CA-C-N 113.365 -1.743 . . . . 1.4299999999999999 112.563 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -152.86 119.25 0.94 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 119.95 -1.119 . . . . 0.52000000000000002 112.369 -171.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.788 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -84.97 114.7 22.35 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 113.496 -1.352 . . . . 0.63 107.541 174.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 45.2 mtm180 -105.49 127.41 52.99 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.909 0.385 . . . . 3.1499999999999999 110.497 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.4 t -111.83 123.61 50.62 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.433 -0.58 . . . . 1.0800000000000001 109.433 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.836 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 47.5 mt-10 -133.02 115.87 15.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.649 -0.705 . . . . 1.8100000000000001 110.347 -175.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -107.7 141.46 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.266 0.555 . . . . 0.54000000000000004 110.977 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 t -134.68 111.52 10.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.069 -0.968 . . . . 1.1799999999999999 110.215 -176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.463 ' CG2' HD22 ' A' ' 33' ' ' LEU . 11.1 p -117.27 -177.45 3.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.168 -0.924 . . . . 0.73999999999999999 111.213 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.986 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -18.04 -48.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 O-C-N 125.682 1.864 . . . . 0.65000000000000002 113.678 175.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.986 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -167.54 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.837 -1.529 . . . . 1.05 110.723 -173.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.646 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -95.76 132.71 40.69 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.079 -1.082 . . . . 1.29 108.079 -177.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -130.99 133.97 46.27 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.269 -1.332 . . . . 0.77000000000000002 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -152.15 147.32 26.3 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.458 -1.247 . . . . 1.6000000000000001 109.259 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.7 p -149.64 149.22 30.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.151 0.5 . . . . 1.1899999999999999 111.578 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.6 p -124.57 148.14 48.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.496 -0.775 . . . . 0.83999999999999997 111.739 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.616 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -128.04 112.8 15.01 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.604 -1.18 . . . . 1.5800000000000001 109.106 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.767 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 12.9 p90 -141.47 128.11 20.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.41 0.624 . . . . 0.85999999999999999 109.664 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 7.7 p30 -104.71 140.26 38.32 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.233 1.016 . . . . 2.1099999999999999 112.59 -167.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -109.37 114.31 27.87 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.423 -1.262 . . . . 0.37 108.329 175.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 m -97.35 96.11 8.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.959 -0.756 . . . . 0.33000000000000002 108.959 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.662 HG22 HG22 ' A' ' 18' ' ' VAL . 5.1 p -80.08 113.06 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 123.193 1.473 . . . . 0.33000000000000002 109.252 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 41.1 m170 -82.78 99.04 9.43 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 112.447 -2.161 . . . . 1.1899999999999999 110.229 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 41.8 tt0 -86.15 -81.54 0.21 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.441 -1.254 . . . . 1.6699999999999999 108.624 167.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 46.26 71.52 0.29 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.336 0.865 . . . . 2.7799999999999998 113.336 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.711 -0.662 . . . . 6.9199999999999999 109.713 177.139 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 m-20 . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 122.063 0.935 . . . . 1.9299999999999999 110.409 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.635 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 6.2 t70 -102.98 142.97 25.66 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.093 -1.412 . . . . 1.6499999999999999 108.909 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.443 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 87.3 Cg_exo -47.52 92.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 124.156 3.237 . . . . 0.96999999999999997 114.959 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.5 mp -119.18 -51.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.924 -1.035 . . . . 0.5 109.264 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.09 41.14 8.2 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.548 -1.821 . . . . 0.39000000000000001 108.548 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 96' ' ' LYS . 12.4 tp -51.5 -48.18 63.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.757 -1.721 . . . . 0.33000000000000002 110.927 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.737 ' HE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -92.25 84.12 5.16 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.674 0.749 . . . . 0.71999999999999997 109.643 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.64 -46.49 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.33 -1.305 . . . . 0.63 110.138 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.508 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 18.1 mmt -140.96 130.7 24.22 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 116.044 -0.526 . . . . 2.8799999999999999 111.077 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.9 ptp180 -101.24 132.65 21.65 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.123 -0.944 . . . . 3.6699999999999999 108.877 173.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.784 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 68.6 Cg_endo -78.9 158.01 27.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.244 1.963 . . . . 0.64000000000000001 110.172 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 102' ' ' PHE . 12.6 mm100 -118.72 -178.41 3.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 120.348 -0.541 . . . . 1.4299999999999999 112.003 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.1 p-10 -69.98 -147.97 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 122.684 1.23 . . . . 2.0600000000000001 111.421 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 155.41 133.38 1.7 Allowed Glycine 0 C--N 1.291 -1.952 0 CA-C-N 113.549 -1.66 . . . . 0.29999999999999999 112.227 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 36.0 mt-10 -109.96 107.47 17.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.718 -1.241 . . . . 1.53 108.153 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' CG1' HD13 ' A' ' 22' ' ' ILE . 2.8 m -125.79 163.32 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.158 0 N-CA-C 106.779 -1.563 . . . . 0.27000000000000002 106.779 -171.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.54 155.84 17.08 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.064 -0.971 . . . . 0.77000000000000002 108.888 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 81' ' ' PRO . 2.9 t -66.64 106.7 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 122.362 1.077 . . . . 0.78000000000000003 108.56 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.17 6.64 8.17 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.54 -2.118 . . . . 0.47999999999999998 111.663 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.86 -124.71 5.19 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.52 -1.432 . . . . 0.44 109.52 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.1 p -151.64 174.62 13.25 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 112.983 -1.609 . . . . 0.81999999999999995 109.852 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.8 tp -146.14 147.41 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.32 0 CA-C-N 113.481 -1.69 . . . . 0.32000000000000001 107.119 166.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 m -140.76 130.9 24.81 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.45 -1.704 . . . . 0.31 110.17 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.602 ' HB2' HD23 ' A' ' 74' ' ' LEU . 23.7 m-85 -125.56 144.47 50.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.268 -1.333 . . . . 0.53000000000000003 108.855 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.12 117.9 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.15 -0.932 . . . . 0.57999999999999996 110.313 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.9 116.99 22.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 113.947 -1.479 . . . . 0.32000000000000001 111.428 -172.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 79.3 mtt-85 -104.88 127.68 52.8 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.09 -0.244 . . . . 2.4300000000000002 110.775 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.3 t -126.66 126.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.084 0.945 . . . . 0.26000000000000001 110.223 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -58.54 112.2 1.52 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.607 -1.633 . . . . 0.40000000000000002 112.596 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.81 -57.37 12.69 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-N 114.441 -1.254 . . . . 0.76000000000000001 112.086 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.848 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.29 177.29 0.24 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.37 1.248 . . . . 0.70999999999999996 114.37 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -103.36 22.07 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.535 -1.211 . . . . 1.74 109.842 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.957 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -52.18 171.22 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.617 -1.174 . . . . 2.1600000000000001 112.666 175.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.31 -51.42 54.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.275 0.56 . . . . 1.47 110.12 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -150.39 157.49 36.78 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.207 -1.035 . . . . 1.3999999999999999 108.207 168.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.12 143.99 1.17 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.337 2.692 . . . . 0.88 112.798 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.957 ' HD3' HD11 ' A' ' 33' ' ' LEU . 15.0 Cg_exo -50.1 143.13 25.95 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.53000000000000003 113.021 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.22 104.54 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.108 -2.182 . . . . 0.77000000000000002 105.108 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.609 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.4 t -113.09 114.88 48.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.995 -1.457 . . . . 0.28000000000000003 107.799 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.914 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.11 131.6 51.22 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.161 -1.382 . . . . 1.54 109.418 173.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.067 ' HB3' HD13 ' A' ' 49' ' ' LEU . 83.8 m95 -91.92 149.32 21.62 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.221 -2.263 . . . . 0.34000000000000002 112.099 172.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.728 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 28.0 t80 -130.59 138.33 50.08 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.671 -2.344 . . . . 0.62 104.671 170.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.904 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 83.1 tttt -98.41 174.07 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.375 -1.713 . . . . 2.1699999999999999 106.375 -174.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -18.84 -169.64 0.0 OUTLIER Glycine 0 C--O 1.179 -3.299 0 C-N-CA 125.991 1.758 . . . . 1.23 117.282 166.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 6.7 mtpp -41.34 -14.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 117.846 2.536 . . . . 3.8700000000000001 117.846 -160.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' GLY . 26.5 p-90 -162.46 -6.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.639 1.563 . . . . 2.1099999999999999 114.891 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.904 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.97 143.74 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.29 0 CA-C-O 122.827 1.299 . . . . 1.29 111.791 -163.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -105.89 107.1 17.92 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 112.181 -2.281 . . . . 2.73 109.9 175.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.067 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.0 mp -54.65 -42.87 71.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 112.628 0.603 . . . . 0.44 112.628 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -61.48 -19.07 61.63 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.649 -0.871 . . . . 1.23 108.649 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -86.88 -27.25 23.53 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.023 -0.989 . . . . 1.3400000000000001 110.956 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 12.1 mmmt -102.9 -64.32 1.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.948 . . . . 1.3999999999999999 111.847 -171.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 49' ' ' LEU . 49.3 t 3.72 92.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.743 2.017 . . . . 0.37 113.802 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -157.42 -130.17 1.19 Allowed Glycine 0 CA--C 1.525 0.676 0 CA-C-N 112.803 -1.999 . . . . 0.69999999999999996 112.597 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.26 -38.11 89.86 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.549 0.944 . . . . 2.75 113.549 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 28.2 p80 -91.21 -31.52 16.13 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.776 0.798 . . . . 1.3300000000000001 111.669 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.009 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.89 105.39 7.09 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.955 -1.498 . . . . 1.1100000000000001 106.955 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -97.2 114.75 26.5 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 106.364 -1.717 . . . . 0.76000000000000001 106.364 166.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.63 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.64 92.54 4.68 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.259 -2.497 . . . . 0.26000000000000001 104.259 170.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 88.7 m-70 -97.35 160.54 14.27 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 115.009 -0.996 . . . . 2.0299999999999998 109.348 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.88 112.13 12.18 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 112.768 -2.015 . . . . 0.92000000000000004 109.537 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 71' ' ' LEU . 1.3 m -106.51 151.1 25.42 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 112.47 -2.15 . . . . 0.46999999999999997 107.156 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 17.2 p90 -144.32 115.64 8.02 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-O 122.01 0.909 . . . . 1.3899999999999999 111.196 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -94.95 96.23 9.16 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 114.285 -1.325 . . . . 2.4199999999999999 107.957 169.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -71.78 -30.5 65.63 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.699 -1.591 . . . . 2.46 111.674 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.22 73.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.487 -0.779 . . . . 1.1499999999999999 110.234 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.441 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 4.0 m -89.62 -12.13 40.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.337 -0.847 . . . . 1.4099999999999999 109.057 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.848 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 1.7 ttpm? 66.03 35.28 6.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.519 -1.219 . . . . 3.3100000000000001 109.743 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.604 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.7 t -125.81 136.85 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.455 0.645 . . . . 0.42999999999999999 110.899 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -99.39 123.19 43.45 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.904 -1.517 . . . . 1.24 106.904 158.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 62' ' ' SER . 18.0 tp -105.95 104.63 14.38 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 114.793 -1.094 . . . . 0.52000000000000002 108.114 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.2 m-85 -85.71 115.59 23.47 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 113.806 -1.543 . . . . 0.33000000000000002 107.663 173.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.11 121.8 45.21 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.96 -1.473 . . . . 1.3200000000000001 109.503 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.832 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.104 -1.407 . . . . 0.95999999999999996 108.356 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 70.8 m80 -110.01 95.05 5.34 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 104.811 -2.292 . . . . 1.1499999999999999 104.811 167.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.74 HD13 ' HE2' ' A' ' 87' ' ' TYR . 63.9 mt -121.51 99.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 122.825 1.297 . . . . 0.52000000000000002 109.353 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.4 p -104.11 168.73 8.92 Favored 'General case' 0 N--CA 1.394 -3.266 0 CA-C-N 114.359 -1.292 . . . . 0.57999999999999996 110.569 -173.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 39.33 67.89 0.41 Allowed 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 110.473 -3.058 . . . . 2.1200000000000001 111.461 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -58.51 116.43 3.65 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 112.445 -2.162 . . . . 0.40000000000000002 110.547 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.819 HE21 ' HD2' ' A' ' 81' ' ' PRO . 1.3 tp60 -54.94 139.4 63.09 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.31 -0.859 . . . . 1.4299999999999999 109.778 171.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HD2' HE21 ' A' ' 80' ' ' GLN . 24.0 Cg_exo -61.23 -12.49 23.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.56 2.173 . . . . 1.3300000000000001 112.863 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.525 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -103.15 14.34 31.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 1.1200000000000001 110.795 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -89.73 -15.28 32.86 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.762 -0.637 . . . . 1.24 111.182 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 78.1 m -41.07 87.97 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 O-C-N 124.947 1.405 . . . . 1.22 111.211 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -157.51 -137.98 2.4 Favored Glycine 0 C--N 1.28 -2.544 0 CA-C-N 113.098 -1.864 . . . . 1.4299999999999999 112.835 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.11 119.22 0.91 Allowed Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.974 -1.584 . . . . 0.52000000000000002 113.418 -167.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.83 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.8 m-85 -82.66 114.42 21.01 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 112.952 -1.624 . . . . 0.63 108.47 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 11.0 mmm180 -103.98 104.52 14.5 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.455 -0.339 . . . . 3.1499999999999999 110.181 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.678 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 3.8 t -94.94 123.62 38.52 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.14 -0.689 . . . . 1.0800000000000001 109.14 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.914 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 66.1 mt-10 -136.67 107.79 6.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.135 -0.939 . . . . 1.8100000000000001 110.271 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -99.78 141.6 16.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.533 0.682 . . . . 0.54000000000000004 110.388 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -141.24 109.29 5.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.821 -1.081 . . . . 1.1799999999999999 108.623 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.706 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -134.5 150.65 50.81 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-O 117.885 -1.055 . . . . 0.73999999999999999 109.477 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.886 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 29.54 -73.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.673 1.858 . . . . 0.65000000000000002 114.693 177.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.886 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 11.1 t0 -152.13 -4.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.492 -1.231 . . . . 1.05 110.056 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.761 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -92.27 125.72 37.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.765 -1.198 . . . . 1.29 107.765 179.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -129.56 140.92 51.09 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.109 -0.95 . . . . 0.77000000000000002 110.974 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -168.46 156.92 8.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.354 -0.839 . . . . 1.6000000000000001 109.769 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 50.9 m -150.32 145.23 26.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.276 0.56 . . . . 1.1899999999999999 110.098 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.845 ' HG ' ' HE1' ' A' ' 102' ' ' PHE . 26.8 p -125.2 134.71 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.616 -0.72 . . . . 0.83999999999999997 110.668 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.2 117.46 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.484 0.659 . . . . 1.5800000000000001 110.97 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.845 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -141.0 124.83 17.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.643 -0.708 . . . . 0.85999999999999999 109.658 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.599 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 78.8 m-20 -100.16 153.22 19.42 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 122.31 1.052 . . . . 2.1099999999999999 111.553 -170.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -117.02 115.37 25.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.531 -1.213 . . . . 0.37 107.943 173.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.514 ' HA ' HG23 ' A' ' 84' ' ' THR . 7.5 m -100.64 95.9 6.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.399 -0.963 . . . . 0.33000000000000002 108.399 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.722 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.61 117.18 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.254 1.502 . . . . 0.33000000000000002 108.942 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.447 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 33.4 m170 -87.72 100.17 12.63 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.47 -2.15 . . . . 1.1899999999999999 108.442 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 49.0 tt0 -69.44 113.84 7.12 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.852 -1.067 . . . . 1.6699999999999999 110.275 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.39 103.32 14.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 2.7799999999999998 109.972 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 C--O 1.249 1.076 0 N-CA-C 109.266 -0.642 . . . . 6.9199999999999999 109.266 179.31 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.471 0.653 . . . . 1.9299999999999999 109.977 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.646 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 7.1 m-20 -102.05 174.14 3.08 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.153 -0.93 . . . . 1.6499999999999999 110.371 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 60.2 Cg_endo -73.29 36.32 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.649 2.233 . . . . 0.96999999999999997 113.791 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.79 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -57.6 -60.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.091 -0.959 . . . . 0.5 109.904 170.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 88.7 45.86 4.75 Favored Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 109.248 -1.541 . . . . 0.39000000000000001 109.248 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.985 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.1 tp -46.59 -43.86 17.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 113.288 -1.456 . . . . 0.33000000000000002 110.502 -173.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.74 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.34 84.85 6.07 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.998 0.904 . . . . 0.71999999999999997 110.483 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 t -72.51 -47.3 52.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.03 -1.441 . . . . 0.63 109.612 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.539 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 16.6 tpt -152.7 133.21 13.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.372 -0.831 . . . . 2.8799999999999999 109.087 173.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.611 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -101.09 136.51 19.7 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.771 -0.649 . . . . 3.6699999999999999 110.637 -177.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.761 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.6 Cg_endo -63.41 155.29 63.17 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.2 1.934 . . . . 0.64000000000000001 111.057 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.406 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 20.8 mm-40 -119.96 174.31 6.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.124 -0.489 . . . . 1.4299999999999999 110.735 -174.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 4.4 p-10 -68.49 -142.66 0.01 OUTLIER 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 122.738 1.256 . . . . 2.0600000000000001 111.807 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 146.55 137.4 3.02 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 113.317 -1.765 . . . . 0.29999999999999999 111.811 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 40.9 mt-10 -109.71 116.08 31.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.337 -0.932 . . . . 1.53 108.529 175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -138.29 153.78 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.727 -1.212 . . . . 0.27000000000000002 107.727 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -84.14 156.4 22.13 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.687 -1.142 . . . . 0.77000000000000002 109.474 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.753 HG11 ' HD3' ' A' ' 81' ' ' PRO . 9.1 t -68.9 105.63 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 123.313 1.53 . . . . 0.78000000000000003 107.629 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.39 15.2 7.16 Favored Glycine 0 C--N 1.264 -3.437 0 CA-C-N 111.926 -2.397 . . . . 0.47999999999999998 112.342 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.58 -123.18 4.59 Favored Glycine 0 N--CA 1.417 -2.584 0 C-N-CA 119.179 -1.486 . . . . 0.44 109.477 167.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 58.6 m -154.47 173.23 16.55 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 113.087 -1.556 . . . . 0.81999999999999995 108.646 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.64 HG21 HD13 ' A' ' 104' ' ' LEU . 10.3 tp -149.11 150.58 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 N-CA-C 107.127 -1.434 . . . . 0.32000000000000001 107.127 167.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.431 ' N ' HG13 ' A' ' 22' ' ' ILE . 8.6 m -137.7 123.86 20.42 Favored 'General case' 0 C--N 1.262 -3.238 0 CA-C-N 113.636 -1.62 . . . . 0.31 110.336 -177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 36.7 m-85 -117.84 147.83 42.69 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.906 -1.497 . . . . 0.53000000000000003 108.38 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -140.23 122.24 15.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.272 -0.876 . . . . 0.57999999999999996 109.574 176.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -116.35 115.84 26.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.873 -1.058 . . . . 0.32000000000000001 109.903 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -102.74 111.6 24.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.247 -0.433 . . . . 2.4300000000000002 110.283 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.464 HG11 HG21 ' A' ' 91' ' ' VAL . 19.0 t -115.53 126.62 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-O 121.988 0.899 . . . . 0.26000000000000001 110.185 -178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 104.33 1.04 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.564 -1.653 . . . . 0.40000000000000002 110.378 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.783 ' HA3' ' NZ ' ' A' ' 68' ' ' LYS . . . -51.94 -66.95 2.27 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.163 -1.38 . . . . 0.76000000000000001 112.031 173.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.758 ' H ' ' HB3' ' A' ' 68' ' ' LYS . . . 60.34 -167.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.762 0.825 . . . . 0.70999999999999996 111.96 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -106.57 144.12 33.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 1.74 109.833 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.39 -172.14 3.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.44 0.638 . . . . 2.1600000000000001 112.465 -169.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.41 -44.36 17.64 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 1.47 108.895 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.592 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 1.3 pptp? -142.36 142.39 23.66 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.321 -0.854 . . . . 1.3999999999999999 108.855 172.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.91 146.46 4.08 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.183 2.588 . . . . 0.88 112.43 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_endo -54.9 128.4 30.33 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 120.952 1.101 . . . . 0.53000000000000003 111.877 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.84 103.96 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 106.774 -1.565 . . . . 0.77000000000000002 106.774 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.8 t -105.83 114.51 45.4 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 113.56 -1.654 . . . . 0.28000000000000003 107.436 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.59 128.87 54.91 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-O 123.221 1.486 . . . . 1.54 109.81 176.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.023 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.0 m95 -90.31 152.53 20.99 Favored 'General case' 0 C--N 1.273 -2.741 0 CA-C-N 112.138 -2.301 . . . . 0.34000000000000002 111.96 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 32.8 t80 -128.02 130.75 48.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.556 -2.016 . . . . 0.62 105.556 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 tttm -107.85 102.31 11.53 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.878 -1.156 . . . . 2.1699999999999999 107.878 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -90.9 100.11 2.65 Favored Glycine 0 N--CA 1.424 -2.137 0 C-N-CA 116.632 -2.699 . . . . 1.23 116.88 -161.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HE2' ' CZ2' ' A' ' 46' ' ' TRP . 1.4 pttm -102.6 -41.18 6.34 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 103.925 -2.621 . . . . 3.8700000000000001 103.925 123.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.639 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.8 p-90 -171.09 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 112.667 -2.06 . . . . 2.1099999999999999 112.48 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.92 173.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-O 123.28 1.514 . . . . 1.29 112.614 -163.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.613 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 7.1 p-10 -96.57 161.29 13.96 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 111.413 -2.63 . . . . 2.73 106.887 170.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.023 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -97.43 -31.36 12.4 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 119.02 -0.514 . . . . 0.44 112.0 167.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -56.89 -21.8 32.36 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 123.585 0.553 . . . . 1.23 109.733 -161.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.604 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -100.79 -26.43 13.78 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 119.384 -0.926 . . . . 1.3400000000000001 112.116 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.615 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.76 -27.12 14.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.496 -1.229 . . . . 1.3999999999999999 111.537 -167.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.974 HG13 ' H ' ' A' ' 59' ' ' LEU . 74.6 t -37.18 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.53 1.532 . . . . 0.37 110.953 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.05 -105.14 0.23 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 112.803 -1.999 . . . . 0.69999999999999996 114.015 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -83.95 -45.01 13.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.206 0.447 . . . . 2.75 112.206 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.579 ' HE1' ' HE3' ' A' ' 43' ' ' LYS . 19.9 p80 -91.44 -36.83 13.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.653 . . . . 1.3300000000000001 111.14 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.977 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.58 106.71 12.03 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.051 -1.463 . . . . 1.1100000000000001 107.051 176.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.565 ' HB3' ' HD2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -96.98 114.41 26.02 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 106.811 -1.551 . . . . 0.76000000000000001 106.811 164.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.974 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.9 92.3 4.52 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 104.687 -2.338 . . . . 0.26000000000000001 104.687 170.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.64 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 22.9 m-70 -100.34 163.83 12.21 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 122.463 1.125 . . . . 2.0299999999999998 109.473 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -131.84 112.92 12.89 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 112.113 -2.312 . . . . 0.92000000000000004 109.817 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 4.7 m -94.95 150.03 20.6 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 112.729 -2.032 . . . . 0.46999999999999997 108.289 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -144.38 107.76 4.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.354 1.073 . . . . 1.3899999999999999 111.323 -170.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.11 122.54 47.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.887 -1.96 . . . . 2.4199999999999999 108.913 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.65 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -79.35 -29.59 42.28 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.349 -1.296 . . . . 2.46 111.66 -177.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.31 33.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.072 -0.513 . . . . 1.1499999999999999 110.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 69' ' ' VAL . 25.7 m -124.48 4.15 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.75 -0.659 . . . . 1.4099999999999999 111.245 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.783 ' NZ ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.81 7.8 3.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.611 0.764 . . . . 3.3100000000000001 112.318 -178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 67' ' ' SER . 46.0 t -76.18 117.67 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 CA-C-O 122.407 1.099 . . . . 0.42999999999999999 110.223 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' A' ' 37' ' ' PRO . 81.4 m-85 -90.07 100.51 13.32 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 112.663 -2.062 . . . . 1.24 106.312 165.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.9 tp -93.25 103.56 15.8 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 122.523 1.154 . . . . 0.52000000000000002 108.026 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.0 m-85 -81.78 113.91 20.06 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 113.321 -1.763 . . . . 0.33000000000000002 107.716 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.434 ' CG ' ' HG ' ' A' ' 71' ' ' LEU . 51.7 mt-10 -107.32 121.21 44.12 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.328 -1.76 . . . . 1.3200000000000001 109.037 -175.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.724 HD21 ' CH2' ' A' ' 41' ' ' TRP . 1.4 mm? -98.45 117.02 31.94 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 112.936 -1.938 . . . . 0.95999999999999996 108.079 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -110.96 95.23 5.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 105.175 -2.157 . . . . 1.1499999999999999 105.175 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.644 HG12 HD23 ' A' ' 57' ' ' LEU . 54.5 mt -121.53 99.5 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-N 113.842 -1.526 . . . . 0.52000000000000002 106.923 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 35.8 p -106.19 167.08 10.05 Favored 'General case' 0 N--CA 1.394 -3.271 0 CA-C-N 114.197 -1.365 . . . . 0.57999999999999996 109.778 -171.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 40.51 59.35 2.13 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 111.544 -2.571 . . . . 2.1200000000000001 111.34 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -51.0 123.35 9.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.405 -1.725 . . . . 0.40000000000000002 109.509 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.564 ' HA ' HG13 ' A' ' 18' ' ' VAL . 1.7 pt20 -78.54 156.13 78.34 Favored Pre-proline 0 C--N 1.311 -1.076 0 N-CA-C 108.033 -1.099 . . . . 1.4299999999999999 108.033 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.753 ' HD3' HG11 ' A' ' 18' ' ' VAL . 50.8 Cg_endo -68.75 162.72 40.06 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.005 1.137 . . . . 1.3300000000000001 109.975 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . 70.74 14.43 7.09 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.616 0.572 . . . . 1.1200000000000001 111.705 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -80.45 -54.92 5.25 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.303 -0.999 . . . . 1.24 108.303 168.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.2 m 36.6 57.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.429 -1.323 . . . . 1.22 107.429 -160.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.672 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -48.73 85.17 0.01 OUTLIER Glycine 0 CA--C 1.482 -2.004 0 CA-C-N 111.56 -2.563 . . . . 1.4299999999999999 114.788 -161.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.487 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -90.79 78.29 1.44 Allowed Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 108.957 -1.657 . . . . 0.52000000000000002 108.957 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.687 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 49.0 m-85 -80.71 122.76 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.769 -1.567 . . . . 0.63 106.769 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -115.53 107.64 15.42 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 120.472 -0.491 . . . . 3.1499999999999999 109.677 -171.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 t -92.06 131.37 37.39 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.766 -0.652 . . . . 1.0800000000000001 109.7 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.947 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 44.4 tt0 -139.77 110.63 6.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.407 -0.815 . . . . 1.8100000000000001 109.5 -177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 p -102.0 137.82 28.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.656 0.741 . . . . 0.54000000000000004 110.534 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.7 t -132.1 108.76 9.51 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.636 -1.165 . . . . 1.1799999999999999 108.732 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.523 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.2 m -123.47 167.34 14.0 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.031 -1.1 . . . . 0.73999999999999999 108.031 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.938 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -4.6 -61.26 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 125.316 1.635 . . . . 0.65000000000000002 114.926 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.938 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -147.76 -10.75 0.4 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.035 -0.984 . . . . 1.05 111.211 -174.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.985 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.2 tttp -94.31 134.89 36.33 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 119.133 -1.027 . . . . 1.29 108.23 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.16 135.47 46.39 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 0.77000000000000002 110.846 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -155.6 147.84 23.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.141 -0.936 . . . . 1.6000000000000001 109.925 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.461 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 33.2 m -141.94 150.68 41.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.535 0.207 . . . . 1.1899999999999999 110.674 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.74 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 78.4 p -134.86 132.62 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.427 . . . . 0.83999999999999997 111.279 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 122.56 47.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.646 -0.707 . . . . 1.5800000000000001 110.676 176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.779 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 5.0 p90 -142.63 129.48 20.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.416 -0.587 . . . . 0.85999999999999999 109.416 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 71.7 m-20 -108.7 135.27 50.21 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.417 1.103 . . . . 2.1099999999999999 111.783 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.49 105.51 15.78 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.102 -1.408 . . . . 0.37 110.448 178.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.446 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 10.4 m -84.12 97.34 9.29 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.732 -0.84 . . . . 0.33000000000000002 108.732 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 18' ' ' VAL . 7.6 p -84.94 115.53 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 123.236 1.494 . . . . 0.33000000000000002 110.087 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 78.1 m-70 -88.79 100.68 13.34 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.368 -2.196 . . . . 1.1899999999999999 109.394 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.616 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.7 tt0 -56.2 -52.29 64.94 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.208 -1.36 . . . . 1.6699999999999999 110.594 174.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.22 -30.22 0.18 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.788 -0.642 . . . . 2.7799999999999998 110.056 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.315 -0.857 . . . . 6.9199999999999999 109.118 179.574 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.978 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.854 0.835 . . . . 1.9299999999999999 110.282 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.566 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -104.97 145.49 30.83 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.029 -1.441 . . . . 1.6499999999999999 108.435 -178.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -41.34 94.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 124.656 3.571 . . . . 0.96999999999999997 114.809 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 6' ' ' LEU . 1.3 mp -126.25 -61.1 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.031 -0.986 . . . . 0.5 109.58 172.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 91.11 52.81 2.31 Favored Glycine 0 CA--C 1.496 -1.142 0 N-CA-C 108.685 -1.766 . . . . 0.39000000000000001 108.685 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.041 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.3 tp -59.77 -40.71 89.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.225 -1.487 . . . . 0.33000000000000002 110.191 -169.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.51 5.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.99 -1.005 . . . . 0.71999999999999997 109.881 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.82 -47.25 33.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.419 -1.264 . . . . 0.63 109.641 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.551 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 17.2 tpt -147.48 129.96 15.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.199 -0.909 . . . . 2.8799999999999999 109.398 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -106.78 132.46 20.89 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.549 -0.75 . . . . 3.6699999999999999 110.398 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.682 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 17.4 Cg_endo -66.53 153.59 77.42 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.369 2.046 . . . . 0.64000000000000001 111.372 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.433 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 16.5 mm-40 -121.14 176.93 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.228 -0.442 . . . . 1.4299999999999999 110.327 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 1.5 p30 -68.03 -148.56 0.01 OUTLIER 'General case' 0 N--CA 1.411 -2.384 0 CA-C-O 122.776 1.275 . . . . 2.0600000000000001 111.237 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.476 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 153.4 138.74 2.73 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 113.44 -1.709 . . . . 0.29999999999999999 111.745 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 29.2 mt-10 -117.47 113.09 21.53 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.297 -0.951 . . . . 1.53 109.029 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 104' ' ' LEU . 2.5 m -132.82 163.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.576 0 N-CA-C 106.929 -1.508 . . . . 0.27000000000000002 106.929 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.5 OUTLIER -94.32 157.74 15.9 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.538 -0.755 . . . . 0.77000000000000002 109.836 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 106' ' ' VAL . 2.9 t -67.89 106.35 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 107.679 -1.23 . . . . 0.78000000000000003 107.679 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.46 7.57 8.95 Favored Glycine 0 C--N 1.263 -3.507 0 CA-C-N 112.657 -2.065 . . . . 0.47999999999999998 112.194 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.51 -125.04 5.02 Favored Glycine 0 N--CA 1.409 -3.154 0 C-N-CA 119.181 -1.485 . . . . 0.44 109.714 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 8.2 p -152.74 167.87 27.54 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.127 -1.537 . . . . 0.81999999999999995 110.372 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 76' ' ' ILE . 10.4 tp -147.62 149.67 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 CA-C-N 113.637 -1.619 . . . . 0.32000000000000001 107.652 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.2 m -139.3 127.24 22.24 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 113.711 -1.586 . . . . 0.31 110.344 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 76' ' ' ILE . 42.0 m-85 -123.71 147.18 47.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.516 -1.22 . . . . 0.53000000000000003 108.812 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.19 122.59 19.49 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.179 -0.919 . . . . 0.57999999999999996 109.671 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.676 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -119.03 115.64 24.74 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.593 -1.185 . . . . 0.32000000000000001 110.226 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 98.6 mtt180 -106.71 117.62 34.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.043 -0.526 . . . . 2.4300000000000002 110.394 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 39' ' ' VAL . 6.3 t -122.27 128.93 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.208 1.004 . . . . 0.26000000000000001 110.739 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -60.0 110.04 1.1 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.128 -1.851 . . . . 0.40000000000000002 112.352 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.18 81.43 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 114.897 -1.047 . . . . 0.76000000000000001 112.463 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.863 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 58.3 -179.07 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.522 1.304 . . . . 0.70999999999999996 114.522 168.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -101.11 23.81 10.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.525 -1.216 . . . . 1.74 109.809 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.034 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -57.05 175.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.52 -1.218 . . . . 2.1600000000000001 113.855 -179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.2 tp -64.73 -56.83 11.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.315 -0.857 . . . . 1.47 109.773 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.709 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.76 143.26 48.63 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.93 -1.032 . . . . 1.3999999999999999 108.642 176.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.18 140.25 11.1 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.606 2.204 . . . . 0.88 110.638 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.034 ' HD3' HD11 ' A' ' 33' ' ' LEU . 1.6 Cg_endo -58.94 135.29 65.73 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.325 0.683 . . . . 0.53000000000000003 112.121 -171.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 92' ' ' SER . 14.1 p -99.71 104.81 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 CA-C-O 123.724 1.726 . . . . 0.77000000000000002 107.97 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 28' ' ' VAL . 2.1 t -105.67 114.82 46.07 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 111.892 -2.413 . . . . 0.28000000000000003 107.592 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.798 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.03 126.1 47.69 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 122.939 1.352 . . . . 1.54 109.051 174.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.952 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.0 m95 -84.46 152.54 23.92 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-N 112.308 -2.224 . . . . 0.34000000000000002 112.112 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -129.31 139.61 51.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.378 -2.452 . . . . 0.62 104.378 172.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.636 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 38.3 tttt -107.13 165.03 11.66 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.399 -1.334 . . . . 2.1699999999999999 107.399 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 1.032 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -7.63 -165.43 0.0 OUTLIER Glycine 0 C--O 1.197 -2.184 0 N-CA-C 118.963 2.345 . . . . 1.23 118.963 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG3' ' HB ' ' A' ' 84' ' ' THR . 10.5 mtpp -43.06 -3.41 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 116.249 1.944 . . . . 3.8700000000000001 116.249 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.585 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 20.6 p-90 -172.12 -13.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.287 1.588 . . . . 2.1099999999999999 115.287 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.02 169.09 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 123.297 1.522 . . . . 1.29 112.344 -160.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.51 154.7 23.3 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.1 -2.318 . . . . 2.73 107.942 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.8 mp -94.4 -32.61 13.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.936 0.717 . . . . 0.44 112.936 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -58.05 -25.58 61.38 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.301 0.572 . . . . 1.23 109.5 -164.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -104.13 -41.57 5.78 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.299 -0.864 . . . . 1.3400000000000001 113.069 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 5.9 mptt -67.02 -52.39 43.07 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.011 -0.995 . . . . 1.3999999999999999 111.864 -170.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.961 HG13 ' H ' ' A' ' 59' ' ' LEU . 11.9 t -23.85 100.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 111.38 -2.645 . . . . 0.37 113.512 175.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -166.11 -129.72 1.08 Allowed Glycine 0 C--N 1.299 -1.504 0 CA-C-N 110.561 -3.018 . . . . 0.69999999999999996 112.154 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -56.47 -37.01 69.73 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.465 0.913 . . . . 2.75 113.465 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.667 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 9.5 p80 -95.07 -38.88 10.42 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.267 0.469 . . . . 1.3300000000000001 112.267 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.875 ' HB2' HG12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.97 107.76 8.9 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.015 -0.735 . . . . 1.1100000000000001 109.015 173.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.41 116.25 28.8 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 107.14 -1.43 . . . . 0.76000000000000001 107.14 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.961 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -90.51 93.32 9.24 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.044 -2.206 . . . . 0.26000000000000001 105.044 171.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.57 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 0.6 OUTLIER -86.02 163.03 18.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-O 122.96 1.362 . . . . 2.0299999999999998 109.382 178.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -141.38 118.91 11.58 Favored 'General case' 0 C--N 1.259 -3.339 0 CA-C-N 111.332 -2.667 . . . . 0.92000000000000004 109.585 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.7 m -103.39 148.95 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 112.777 -2.011 . . . . 0.46999999999999997 107.99 172.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.452 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 13.2 t80 -142.33 97.29 3.1 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.439 1.114 . . . . 1.3899999999999999 110.821 -176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -117.6 118.22 31.53 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.786 -1.552 . . . . 2.4199999999999999 109.911 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -36.33 25.02 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.557 -1.656 . . . . 2.46 111.554 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.23 67.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.432 -0.803 . . . . 1.1499999999999999 110.912 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -96.55 -19.42 19.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.391 -0.966 . . . . 1.4099999999999999 108.391 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.837 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 11.4 ttpt 67.08 32.54 6.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.961 -1.472 . . . . 3.3100000000000001 110.427 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -128.07 126.63 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.761 0.791 . . . . 0.42999999999999999 110.311 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.578 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.3 m-30 -99.17 108.81 21.5 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.119 -1.808 . . . . 1.24 106.119 166.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HG ' ' HG2' ' A' ' 73' ' ' GLU . 14.3 tp -98.25 105.74 17.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.522 1.153 . . . . 0.52000000000000002 109.142 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 98.0 m-85 -85.45 113.52 21.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 113.322 -1.763 . . . . 0.33000000000000002 107.905 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 9.6 mt-10 -107.56 121.2 44.16 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.465 -1.698 . . . . 1.3200000000000001 110.044 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.844 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -91.08 126.66 36.23 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.462 -1.244 . . . . 0.95999999999999996 107.849 176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 78.7 m80 -117.06 95.32 4.94 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 104.569 -2.382 . . . . 1.1499999999999999 104.569 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.875 HG12 ' HB2' ' A' ' 57' ' ' LEU . 25.4 mt -121.85 100.47 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-O 122.74 1.257 . . . . 0.52000000000000002 109.066 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.3 p -111.86 161.13 16.7 Favored 'General case' 0 N--CA 1.395 -3.224 0 CA-C-N 114.569 -1.196 . . . . 0.57999999999999996 109.572 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 48.35 57.75 5.88 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 111.271 -2.695 . . . . 2.1200000000000001 110.611 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -52.62 119.81 4.96 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.824 -1.989 . . . . 0.40000000000000002 110.608 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.772 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -60.15 143.84 88.0 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.461 -0.791 . . . . 1.4299999999999999 109.306 173.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.772 ' HD2' HE21 ' A' ' 80' ' ' GLN . 31.7 Cg_endo -63.54 -3.32 5.22 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.286 1.99 . . . . 1.3300000000000001 112.564 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -115.17 15.73 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.566 . . . . 1.1200000000000001 110.131 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.8 m-30 -94.53 -8.7 37.54 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 118.838 -0.601 . . . . 1.24 110.181 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 15.6 m -19.1 90.47 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 125.788 1.93 . . . . 1.22 111.529 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.87 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -37.12 110.83 0.1 Allowed Glycine 0 CA--C 1.473 -2.579 0 CA-C-N 110.062 -3.245 . . . . 1.4299999999999999 114.584 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 1.032 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -127.45 60.08 0.67 Allowed Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 108.277 -1.929 . . . . 0.52000000000000002 108.277 157.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 80.7 m-85 -80.2 126.78 31.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.07 -1.065 . . . . 0.63 108.555 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 22.4 ttm180 -130.83 121.11 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.951 -0.468 . . . . 3.1499999999999999 110.274 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.54 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -98.53 120.61 39.25 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.587 -0.523 . . . . 1.0800000000000001 109.587 176.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.798 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.8 mt-10 -121.56 105.44 10.45 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.189 -0.671 . . . . 1.8100000000000001 109.189 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.4 p -96.07 137.17 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.356 0.598 . . . . 0.54000000000000004 110.384 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.69 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.0 t -130.09 110.65 11.78 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.875 -1.057 . . . . 1.1799999999999999 109.146 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.89 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -129.06 173.63 10.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.877 -0.602 . . . . 0.73999999999999999 110.17 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.9 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.96 -62.38 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 O-C-N 125.243 1.59 . . . . 0.65000000000000002 114.474 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.9 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.9 t70 -154.24 -0.57 0.2 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.384 -1.28 . . . . 1.05 109.289 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.041 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -93.36 128.25 39.32 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.001 -1.111 . . . . 1.29 108.001 -177.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -130.73 130.71 44.13 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.756 -1.111 . . . . 0.77000000000000002 110.831 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.96 151.22 35.44 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.402 -1.272 . . . . 1.6000000000000001 109.02 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 9.5 p -151.13 146.59 26.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.133 0.492 . . . . 1.1899999999999999 111.294 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.48 146.45 50.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.479 -0.782 . . . . 0.83999999999999997 111.593 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.24 119.0 22.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.69 -1.141 . . . . 1.5800000000000001 109.477 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.815 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 6.7 p90 -143.1 128.73 19.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.344 0.592 . . . . 0.85999999999999999 110.153 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 41.8 m-20 -102.45 135.48 44.0 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.22 1.009 . . . . 2.1099999999999999 110.999 -172.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.87 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -105.46 107.34 18.27 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.046 -1.434 . . . . 0.37 108.856 174.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 9.0 m -87.94 95.08 9.98 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.163 -1.015 . . . . 0.33000000000000002 108.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 18' ' ' VAL . 3.3 p -76.69 112.51 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-O 122.948 1.356 . . . . 0.33000000000000002 107.768 177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 66.4 m170 -82.03 97.66 8.24 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.902 -1.954 . . . . 1.1899999999999999 108.623 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HA ' HG23 ' A' ' 18' ' ' VAL . 39.2 tt0 -67.77 -35.71 79.18 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.376 -1.342 . . . . 1.6699999999999999 107.376 166.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.6 68.8 0.71 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.152 -1.385 . . . . 2.7799999999999998 112.564 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 tmm? . . . . . 0 C--O 1.248 0.985 0 N-CA-C 108.747 -0.835 . . . . 6.9199999999999999 108.747 176.691 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.333 -0.988 . . . . 1.9299999999999999 108.333 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.479 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 8.0 m-20 -110.08 171.26 4.53 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.883 -0.599 . . . . 1.6499999999999999 111.625 -172.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 48.4 Cg_endo -70.51 69.04 2.09 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.579 2.186 . . . . 0.96999999999999997 112.534 174.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.054 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -88.12 -63.82 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.8 -1.091 . . . . 0.5 108.729 171.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.917 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 91.72 43.2 4.57 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 108.588 -1.805 . . . . 0.39000000000000001 108.588 -176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.854 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.0 tp -52.77 -39.59 62.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 112.827 -1.687 . . . . 0.33000000000000002 110.389 -171.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.745 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -90.95 83.41 5.65 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.162 -0.926 . . . . 0.71999999999999997 109.816 177.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.31 -43.03 74.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.565 -1.198 . . . . 0.63 108.835 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ttt -152.36 135.67 15.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.123 -0.944 . . . . 2.8799999999999999 109.571 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -113.92 136.43 22.12 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.0 -0.741 . . . . 3.6699999999999999 109.0 176.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -71.58 160.08 49.34 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.437 1.425 . . . . 0.64000000000000001 110.646 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -120.38 -177.78 3.53 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.75 -0.659 . . . . 1.4299999999999999 109.498 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.9 p-10 -69.67 -151.08 0.02 OUTLIER 'General case' 0 N--CA 1.405 -2.721 0 CA-C-O 123.166 1.46 . . . . 2.0600000000000001 111.939 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.453 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.04 134.86 2.01 Favored Glycine 0 C--N 1.293 -1.811 0 CA-C-N 112.824 -1.989 . . . . 0.29999999999999999 112.036 -174.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 32.4 mt-10 -112.49 112.35 23.83 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.154 -1.023 . . . . 1.53 108.48 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.0 m -130.76 163.99 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 108.005 -1.109 . . . . 0.27000000000000002 108.005 -171.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -90.97 152.84 20.54 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.279 -1.328 . . . . 0.77000000000000002 109.256 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.603 HG23 ' HA ' ' A' ' 108' ' ' GLU . 21.8 t -69.4 106.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 CA-C-O 122.796 1.284 . . . . 0.78000000000000003 107.663 172.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.8 11.57 7.02 Favored Glycine 0 C--N 1.263 -3.52 0 CA-C-N 111.9 -2.409 . . . . 0.47999999999999998 112.717 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.38 -121.84 4.96 Favored Glycine 0 CA--C 1.472 -2.614 0 C-N-CA 118.893 -1.622 . . . . 0.44 110.419 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.9 p -152.49 172.03 17.17 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 112.614 -1.793 . . . . 0.81999999999999995 110.322 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.612 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.3 tp -148.37 149.61 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 113.022 -1.899 . . . . 0.32000000000000001 106.185 169.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.9 m -137.89 124.99 21.49 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 114.411 -1.268 . . . . 0.31 111.235 -173.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.94 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.9 m-85 -119.55 139.85 51.48 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.921 -1.49 . . . . 0.53000000000000003 109.525 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.126 -0.943 . . . . 0.57999999999999996 108.75 174.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -122.14 115.98 23.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.374 -1.284 . . . . 0.32000000000000001 110.261 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HG2' HD13 ' A' ' 71' ' ' LEU . 66.1 mtp180 -111.41 122.5 48.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.649 -0.251 . . . . 2.4300000000000002 110.46 -174.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 91' ' ' VAL . 15.7 t -121.18 128.11 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.012 0.91 . . . . 0.26000000000000001 110.394 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.745 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.38 109.39 1.34 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.285 -1.779 . . . . 0.40000000000000002 110.486 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.65 -42.19 35.68 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-N 115.106 -0.952 . . . . 0.76000000000000001 111.68 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 57.41 -166.55 0.14 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.039 0.755 . . . . 0.70999999999999996 113.039 172.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.6 p -113.23 110.72 20.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.08 -0.964 . . . . 1.74 108.648 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.064 HD13 ' H ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -148.34 158.36 44.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.145 -0.479 . . . . 2.1600000000000001 110.289 -171.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.721 ' N ' HD12 ' A' ' 33' ' ' LEU . 4.9 mt -47.13 -37.93 10.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 123.053 1.406 . . . . 1.47 111.501 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.777 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.99 -178.83 0.86 Allowed Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 111.933 -2.394 . . . . 1.3999999999999999 107.809 -170.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.65 145.61 20.63 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.198 -1.886 . . . . 0.88 107.198 162.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.711 ' HD2' ' HE2' ' A' ' 70' ' ' TYR . 16.6 Cg_exo -58.18 129.56 33.56 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 CA-C-N 119.49 0.854 . . . . 0.53000000000000003 110.606 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.23 102.3 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 122.781 1.277 . . . . 0.77000000000000002 107.657 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -104.88 115.8 47.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 112.427 -2.17 . . . . 0.28000000000000003 108.023 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.92 130.83 54.52 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-O 123.108 1.432 . . . . 1.54 109.757 173.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.039 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.7 m95 -86.59 152.47 22.58 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.103 -2.317 . . . . 0.34000000000000002 112.746 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.9 t80 -131.18 136.71 48.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 105.239 -2.134 . . . . 0.62 105.239 170.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.756 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 80.3 tttt -102.84 166.53 10.42 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.712 -1.588 . . . . 2.1699999999999999 106.712 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.737 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.72 -168.22 0.0 OUTLIER Glycine 0 C--O 1.187 -2.8 0 N-CA-C 119.549 2.58 . . . . 1.23 119.549 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.495 ' CD ' ' HB ' ' A' ' 84' ' ' THR . 16.6 mtpt -44.97 -1.31 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 O-C-N 119.549 -2.147 . . . . 3.8700000000000001 116.384 -167.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.64 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.6 p-90 -167.7 -11.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.765 1.395 . . . . 2.1099999999999999 114.765 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.23 168.04 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 CA-C-O 123.459 1.6 . . . . 1.29 112.816 -159.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.5 t70 -112.28 155.43 24.08 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 111.549 -2.569 . . . . 2.73 105.937 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.039 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.4 mp -94.08 -36.34 12.14 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.579 0.955 . . . . 0.44 113.579 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 t -58.72 -21.23 54.55 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.2 -0.667 . . . . 1.23 109.2 -165.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -96.13 -27.57 14.99 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.022 -0.99 . . . . 1.3400000000000001 113.419 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 16.7 mmmt -100.75 -32.6 10.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.033 0.444 . . . . 1.3999999999999999 111.566 -170.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.743 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 27.0 t -35.11 97.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 125.817 1.647 . . . . 0.37 111.94 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.48 -146.2 4.43 Favored Glycine 0 C--O 1.213 -1.212 0 CA-C-N 111.604 -2.544 . . . . 0.69999999999999996 110.309 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.523 ' C ' HE22 ' A' ' 58' ' ' GLN . 41.7 tt0 -71.37 -2.0 14.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.943 0.872 . . . . 2.75 112.916 -170.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 21.8 p80 -114.29 -33.38 5.66 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.87 0.843 . . . . 1.3300000000000001 111.064 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.008 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -133.3 105.18 6.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.706 -1.961 . . . . 1.1100000000000001 105.706 171.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.86 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -99.28 114.49 27.35 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.073 -1.825 . . . . 0.76000000000000001 106.073 171.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.726 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -97.2 92.81 6.2 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 104.901 -2.259 . . . . 0.26000000000000001 104.901 172.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 1.5 m-70 -93.53 163.07 13.71 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 123.013 1.387 . . . . 2.0299999999999998 110.378 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -128.02 119.15 24.85 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 111.399 -2.637 . . . . 0.92000000000000004 108.88 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -102.59 138.93 38.85 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 112.574 -2.103 . . . . 0.46999999999999997 106.538 167.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -145.64 99.13 3.24 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.991 0.9 . . . . 1.3899999999999999 112.156 -166.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 5.0 t70 -119.68 120.69 37.34 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.349 -1.296 . . . . 2.4199999999999999 109.866 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -81.62 -38.8 25.44 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.684 -1.598 . . . . 2.46 111.289 -176.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.9 -28.01 60.45 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.69 -1.141 . . . . 1.1499999999999999 111.248 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 27.5 m -89.0 -13.31 39.1 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.635 -1.246 . . . . 1.4099999999999999 107.635 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.745 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 72.98 25.85 2.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.597 -1.638 . . . . 3.3100000000000001 110.484 171.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.59 120.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.912 0.863 . . . . 0.42999999999999999 110.709 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.711 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -103.43 105.94 16.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.322 -1.733 . . . . 1.24 106.322 166.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 8.0 tp -96.7 104.38 16.37 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 122.511 1.148 . . . . 0.52000000000000002 108.806 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -85.01 115.14 22.66 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.105 -1.407 . . . . 0.33000000000000002 107.515 174.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -102.65 126.2 49.66 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 113.727 -1.579 . . . . 1.3200000000000001 109.435 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 24' ' ' PHE . 3.7 mm? -95.74 125.48 40.34 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-N 113.877 -1.511 . . . . 0.95999999999999996 107.749 172.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.86 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 30.9 m170 -120.39 95.98 4.96 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 103.85 -2.648 . . . . 1.1499999999999999 103.85 172.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.615 ' CD1' HD22 ' A' ' 57' ' ' LEU . 58.5 mt -120.3 102.22 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 CA-C-N 113.894 -1.503 . . . . 0.52000000000000002 108.874 -170.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 80.6 p -114.05 141.66 47.16 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-N 113.219 -1.81 . . . . 0.57999999999999996 109.845 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 61.21 70.71 0.59 Allowed 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 111.28 -2.691 . . . . 2.1200000000000001 110.222 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -62.45 126.9 28.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.435 -2.166 . . . . 0.40000000000000002 110.524 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.78 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -55.67 139.33 68.82 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.386 -0.824 . . . . 1.4299999999999999 109.378 173.154 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HB3' HG21 ' A' ' 18' ' ' VAL . 34.6 Cg_endo -67.74 145.04 67.93 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.357 1.371 . . . . 1.3300000000000001 110.888 176.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.88 17.22 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.659 0.599 . . . . 1.1200000000000001 110.758 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.78 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -71.01 -30.27 66.45 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.002 -0.544 . . . . 1.24 109.712 177.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 40.6 m 14.46 79.59 0.01 OUTLIER 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.566 1.791 . . . . 1.22 110.712 -168.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.797 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -64.06 94.82 0.15 Allowed Glycine 0 N--CA 1.423 -2.216 0 CA-C-N 112.35 -2.205 . . . . 1.4299999999999999 113.764 -161.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.72 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -88.19 70.48 2.66 Favored Glycine 0 C--N 1.288 -2.133 0 N-CA-C 109.324 -1.51 . . . . 0.52000000000000002 109.324 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.575 ' HE2' ' CD2' ' A' ' 57' ' ' LEU . 54.3 m-85 -74.58 120.77 20.59 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.676 -1.262 . . . . 0.63 108.788 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 90.3 mtt180 -120.09 110.93 17.23 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.788 -0.449 . . . . 3.1499999999999999 109.788 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.6 t -94.93 122.65 37.79 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.54 -0.541 . . . . 1.0800000000000001 109.54 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.525 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 24.1 mt-10 -126.77 110.83 13.53 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.081 -0.963 . . . . 1.8100000000000001 109.937 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 28' ' ' VAL . 3.0 p -107.99 139.82 28.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.443 0.639 . . . . 0.54000000000000004 110.655 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -133.36 110.87 10.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.758 -1.11 . . . . 1.1799999999999999 110.279 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.798 HG22 HD22 ' A' ' 33' ' ' LEU . 31.9 p -120.33 -176.33 3.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.185 -0.916 . . . . 0.73999999999999999 111.123 176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 1.064 ' H ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -25.92 -45.07 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 125.724 1.89 . . . . 0.65000000000000002 112.367 -178.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.756 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -172.72 7.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.77 -1.559 . . . . 1.05 110.84 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.054 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.6 tmtm? -92.91 123.69 36.35 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 106.571 -1.64 . . . . 1.29 106.571 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -130.52 123.24 29.18 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.974 -1.012 . . . . 0.77000000000000002 111.124 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -145.58 144.27 30.39 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.1 -1.409 . . . . 1.6000000000000001 109.873 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.4 p -142.83 145.04 32.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.947 -0.569 . . . . 1.1899999999999999 109.543 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.745 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 60.9 p -130.41 133.55 46.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.935 -0.575 . . . . 0.83999999999999997 111.57 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.647 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -109.13 123.72 49.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.82 -0.627 . . . . 1.5800000000000001 110.389 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.703 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.16 115.76 9.57 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.685 -0.487 . . . . 0.85999999999999999 109.685 -177.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.797 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 50.4 m-20 -100.63 141.24 33.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.051 0.929 . . . . 2.1099999999999999 111.191 -168.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.772 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -111.38 111.3 22.24 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.249 -1.341 . . . . 0.37 110.061 176.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m -93.6 97.73 10.68 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.956 -0.757 . . . . 0.33000000000000002 108.956 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.4 p -84.77 121.34 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 123.138 1.447 . . . . 0.33000000000000002 110.32 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' THR . 98.7 m-70 -106.58 102.0 11.42 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 112.45 -2.159 . . . . 1.1899999999999999 109.722 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.7 tt0 -67.55 -78.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.054 -0.975 . . . . 1.6699999999999999 111.302 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -179.59 -173.89 0.27 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.698 -0.683 . . . . 2.7799999999999998 109.617 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 57.7 ttp . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.654 -0.689 . . . . 6.9199999999999999 109.641 176.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.593 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.534 0.683 . . . . 1.9299999999999999 112.801 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.76 ' HB3' ' NZ ' ' A' ' 94' ' ' LYS . 14.3 t70 -139.57 148.65 56.98 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 115.137 -0.938 . . . . 1.6499999999999999 109.083 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 77.3 Cg_exo -52.2 99.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.588 2.859 . . . . 0.96999999999999997 114.656 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.617 HG13 ' HB1' ' A' ' 31' ' ' ALA . 1.5 mp -125.04 -60.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 0.5 110.091 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 87.81 49.44 3.83 Favored Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 108.645 -1.782 . . . . 0.39000000000000001 108.645 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 96' ' ' LYS . 12.7 tp -59.89 -41.95 92.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.839 -1.681 . . . . 0.33000000000000002 110.475 -168.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.731 ' CD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -90.32 84.7 6.06 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.433 -0.803 . . . . 0.71999999999999997 109.65 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -71.97 -48.02 52.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.901 -1.045 . . . . 0.63 110.313 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.543 ' CG ' ' HD3' ' A' ' 27' ' ' ARG . 20.7 mmt -136.6 130.9 33.01 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.061 -0.518 . . . . 2.8799999999999999 110.828 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.731 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 26.1 mtm180 -93.78 128.14 42.86 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.565 -0.902 . . . . 3.6699999999999999 108.565 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 79.1 Cg_endo -77.5 148.5 26.36 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.656 1.571 . . . . 0.64000000000000001 108.807 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.574 ' O ' ' HD2' ' A' ' 24' ' ' PHE . 17.3 mm-40 -112.93 179.46 3.96 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 111.629 0.233 . . . . 1.4299999999999999 111.629 -168.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.72 -144.48 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 123.005 1.383 . . . . 2.0600000000000001 111.325 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.44 127.82 1.59 Allowed Glycine 0 C--N 1.296 -1.69 0 CA-C-N 113.279 -1.782 . . . . 0.29999999999999999 111.543 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.69 113.45 25.57 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.583 -0.895 . . . . 1.53 108.583 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.54 165.09 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 107.583 -1.265 . . . . 0.27000000000000002 107.583 -167.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.67 156.9 16.2 Favored 'General case' 0 C--N 1.275 -2.654 0 CA-C-N 114.939 -1.028 . . . . 0.77000000000000002 108.958 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 106' ' ' VAL . 20.6 t -67.71 107.73 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 CA-C-O 122.83 1.3 . . . . 0.78000000000000003 108.604 175.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 78' ' ' ASP . . . 120.98 3.58 10.72 Favored Glycine 0 C--N 1.267 -3.285 0 CA-C-N 111.788 -2.46 . . . . 0.47999999999999998 113.551 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.27 -124.48 4.59 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 119.077 -1.535 . . . . 0.44 110.797 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.8 p -152.13 166.37 31.87 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 112.897 -1.651 . . . . 0.81999999999999995 111.279 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 104' ' ' LEU . 10.6 tp -147.84 148.71 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 113.423 -1.717 . . . . 0.32000000000000001 108.02 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.7 m -142.1 126.98 18.22 Favored 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 113.524 -1.671 . . . . 0.31 110.827 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.704 ' HD1' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -136.13 146.75 47.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.0 -1.0 . . . . 0.53000000000000003 109.429 173.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.861 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.9 126.1 33.33 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.517 -0.765 . . . . 0.57999999999999996 109.727 -177.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -116.46 116.28 27.37 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.645 -1.161 . . . . 0.32000000000000001 110.718 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HE ' HG11 ' A' ' 69' ' ' VAL . 43.3 mtp85 -102.25 130.36 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.835 -0.346 . . . . 2.4300000000000002 110.477 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.509 HG21 HG21 ' A' ' 39' ' ' VAL . 11.7 t -127.93 127.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.755 0.788 . . . . 0.26000000000000001 109.874 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.37 114.81 2.6 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.711 -1.586 . . . . 0.40000000000000002 111.531 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.86 -37.87 58.61 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 114.49 -1.232 . . . . 0.76000000000000001 110.375 168.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.708 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 58.66 -174.68 0.09 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 115.193 1.553 . . . . 0.70999999999999996 115.193 164.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -103.16 113.78 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.13 -1.396 . . . . 1.74 107.912 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.747 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -151.18 165.8 32.82 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.117 -0.492 . . . . 2.1600000000000001 111.807 -166.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 tp -75.8 -69.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.415 -0.587 . . . . 1.47 109.415 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 151.21 41.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.029 -0.73 . . . . 1.3999999999999999 109.029 170.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HA ' HD11 ' A' ' 33' ' ' LEU . 88.1 Cg_exo -49.24 152.35 5.49 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.854 2.37 . . . . 0.88 111.873 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.747 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.6 Cg_exo -65.55 134.27 37.68 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.771 1.647 . . . . 0.53000000000000003 111.52 -174.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.16 104.06 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 106.447 -1.686 . . . . 0.77000000000000002 106.447 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.633 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.44 114.74 47.78 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 113.194 -1.821 . . . . 0.28000000000000003 107.135 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.927 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.23 122.24 45.52 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 123.153 1.454 . . . . 1.54 110.265 176.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.087 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.3 m95 -86.69 152.08 22.86 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 111.978 -2.374 . . . . 0.34000000000000002 110.921 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 38.4 t80 -136.97 135.15 37.42 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 104.243 -2.502 . . . . 0.62 104.243 173.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 1.021 ' HB3' HG23 ' A' ' 47' ' ' VAL . 81.4 tttt -101.7 173.12 6.56 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 105.619 -1.993 . . . . 2.1699999999999999 105.619 -172.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 1.018 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -8.15 -168.03 0.0 OUTLIER Glycine 0 C--O 1.192 -2.487 0 N-CA-C 119.525 2.57 . . . . 1.23 119.525 171.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 84' ' ' THR . 20.4 mtpp -39.22 -22.08 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 115.834 1.791 . . . . 3.8700000000000001 115.834 -163.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -161.06 -6.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.937 1.088 . . . . 2.1099999999999999 113.937 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.021 HG23 ' HB3' ' A' ' 43' ' ' LYS . 31.5 m -94.4 171.69 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.778 0 CA-C-O 124.116 1.912 . . . . 1.29 113.539 -160.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.895 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -100.57 161.24 13.74 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 110.449 -3.069 . . . . 2.73 108.756 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.087 HD13 ' HB3' ' A' ' 41' ' ' TRP . 3.7 mp -99.42 -32.32 11.21 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 116.055 -0.52 . . . . 0.44 111.612 160.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 t -58.13 -23.78 56.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.255 0.55 . . . . 1.23 109.884 -164.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.736 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 58.5 m -102.08 -27.62 12.81 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.037 0.922 . . . . 1.3400000000000001 112.907 -178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.895 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 28.9 mttp -90.92 -27.35 18.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.658 -1.61 . . . . 1.3999999999999999 112.806 -168.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.727 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 35.9 t -50.32 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 111.529 -2.578 . . . . 0.37 111.267 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.42 -99.23 0.15 Allowed Glycine 0 C--N 1.304 -1.246 0 CA-C-N 112.421 -2.172 . . . . 0.69999999999999996 113.299 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -86.05 -53.2 5.22 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.278 0.473 . . . . 2.75 112.278 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.1 p80 -87.54 -36.19 17.72 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 121.394 0.616 . . . . 1.3300000000000001 111.207 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.976 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -117.91 106.89 13.43 Favored 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 106.35 -1.722 . . . . 1.1100000000000001 106.35 176.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -102.42 116.42 32.58 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.277 -1.379 . . . . 0.76000000000000001 107.277 166.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.693 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.9 OUTLIER -95.03 92.99 7.11 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.499 -2.408 . . . . 0.26000000000000001 104.499 170.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.643 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 46.5 m170 -87.66 162.56 17.04 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.645 1.212 . . . . 2.0299999999999998 109.968 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.93 118.91 19.47 Favored 'General case' 0 C--N 1.268 -2.963 0 CA-C-N 111.959 -2.382 . . . . 0.92000000000000004 108.933 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.532 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -101.05 149.46 23.92 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.58 -2.1 . . . . 0.46999999999999997 108.202 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.4 t80 -141.61 97.05 3.08 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.224 1.012 . . . . 1.3899999999999999 110.762 -174.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.4 OUTLIER -113.8 101.67 9.51 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.81 -1.541 . . . . 2.4199999999999999 110.393 173.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.04 -29.71 43.71 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.263 -1.335 . . . . 2.46 110.937 -176.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.6 -21.26 65.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.196 -0.911 . . . . 1.1499999999999999 109.862 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 19.4 m -110.94 -11.98 14.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.18 -0.918 . . . . 1.4099999999999999 109.076 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.708 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 67.1 32.48 6.18 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.323 -0.853 . . . . 3.3100000000000001 109.547 175.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.636 HG11 ' HE ' ' A' ' 27' ' ' ARG . 3.3 t -127.32 135.64 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.944 0.878 . . . . 0.42999999999999999 110.425 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' SER . 3.7 m-30 -107.44 112.82 25.8 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.244 -1.391 . . . . 1.24 107.244 165.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 25' ' ' SER . 23.9 tp -95.32 107.65 19.78 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.041 0.924 . . . . 0.52000000000000002 109.537 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.2 m-85 -87.72 112.68 22.64 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.587 -1.264 . . . . 0.33000000000000002 107.587 170.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.69 120.16 41.1 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.952 -1.476 . . . . 1.3200000000000001 110.381 -175.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.704 ' HB2' ' HD1' ' A' ' 24' ' ' PHE . 1.6 mt -81.74 129.42 34.72 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.958 -1.127 . . . . 0.95999999999999996 107.958 171.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -115.88 96.57 5.65 Favored 'General case' 0 C--N 1.267 -2.997 0 N-CA-C 103.351 -2.833 . . . . 1.1499999999999999 103.351 165.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.691 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -120.83 99.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 123.047 1.403 . . . . 0.52000000000000002 109.922 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.5 p -106.51 146.76 30.2 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 113.445 -1.707 . . . . 0.57999999999999996 108.651 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' OD1' ' HA2' ' A' ' 19' ' ' GLY . 27.2 t70 64.8 82.7 0.18 Allowed 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 111.613 -2.54 . . . . 2.1200000000000001 109.926 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.27 109.92 16.24 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 111.375 -2.648 . . . . 0.40000000000000002 110.688 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.899 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -52.74 139.13 41.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.587 -0.733 . . . . 1.4299999999999999 109.862 167.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.6 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 37.7 Cg_endo -63.57 -3.39 5.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.29 2.66 . . . . 1.3300000000000001 112.768 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.899 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -110.97 14.74 22.0 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.053 -0.521 . . . . 1.1200000000000001 110.894 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -90.14 -29.66 18.14 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 117.721 -1.133 . . . . 1.24 110.756 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 75.0 m 2.34 80.34 0.0 OUTLIER 'General case' 0 C--N 1.354 0.785 0 O-C-N 125.688 1.867 . . . . 1.22 111.226 -174.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 1.018 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.19 121.7 5.61 Favored Glycine 0 N--CA 1.408 -3.213 0 CA-C-N 111.458 -2.61 . . . . 1.4299999999999999 114.776 -163.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.952 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -120.94 70.23 0.39 Allowed Glycine 0 C--N 1.268 -3.24 0 CA-C-N 111.366 -2.417 . . . . 0.52000000000000002 107.97 159.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.781 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 54.5 m-85 -74.49 127.61 33.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.094 -1.053 . . . . 0.63 109.013 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 48.0 mtp180 -121.38 104.68 9.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 109.643 -0.502 . . . . 3.1499999999999999 109.643 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.476 ' H ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -91.77 121.3 33.27 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.09 -1.078 . . . . 1.0800000000000001 108.09 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.927 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 25.7 tt0 -137.48 106.67 6.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.229 -0.896 . . . . 1.8100000000000001 109.228 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.633 ' HB ' HG13 ' A' ' 39' ' ' VAL . 5.7 p -103.44 141.48 19.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.677 0.751 . . . . 0.54000000000000004 111.305 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 t -138.71 109.88 6.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.435 -1.257 . . . . 1.1799999999999999 108.563 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.566 HG21 HD12 ' A' ' 33' ' ' LEU . 1.6 m -129.44 174.21 9.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.142 -1.058 . . . . 0.73999999999999999 108.142 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.979 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -5.88 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 125.199 1.562 . . . . 0.65000000000000002 114.756 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.979 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -156.98 -0.81 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.555 -1.202 . . . . 1.05 110.042 -174.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.72 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -96.36 131.43 42.91 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.244 -1.021 . . . . 1.29 108.244 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -132.65 145.6 51.2 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.173 -1.376 . . . . 0.77000000000000002 111.516 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 10.6 t70 -176.08 164.96 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.797 -0.638 . . . . 1.6000000000000001 110.037 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.703 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 6.0 p -153.62 146.47 24.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.116 0.484 . . . . 1.1899999999999999 110.576 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.57 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 88.8 p -124.34 131.94 53.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.805 -0.634 . . . . 0.83999999999999997 110.55 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.79 121.12 42.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.972 0.415 . . . . 1.5800000000000001 110.461 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.635 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -142.83 126.31 16.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.466 0.651 . . . . 0.85999999999999999 109.789 -177.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 19.5 m-80 -105.09 152.88 22.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.182 0.991 . . . . 2.1099999999999999 111.563 -169.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.03 104.27 9.11 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.818 -1.083 . . . . 0.37 110.475 173.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -85.88 96.41 9.77 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.7 -0.8 . . . . 0.33000000000000002 109.251 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 18' ' ' VAL . 7.5 p -81.87 113.22 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-O 123.387 1.565 . . . . 0.33000000000000002 109.221 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -94.91 100.95 12.72 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 112.362 -2.199 . . . . 1.1899999999999999 109.872 -174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 18' ' ' VAL . 36.1 tt0 -75.78 -63.58 1.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.383 -0.826 . . . . 1.6699999999999999 110.134 171.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.62 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.256 -0.429 . . . . 2.7799999999999998 110.646 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.6 ptm . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.62 -0.705 . . . . 6.9199999999999999 109.955 -177.787 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.909 0.385 . . . . 1.9299999999999999 110.599 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.592 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.0 m-20 -111.78 167.52 8.99 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 116.109 -0.496 . . . . 1.6499999999999999 112.134 -172.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.494 ' C ' HD12 ' A' ' 4' ' ' ILE . 42.4 Cg_endo -68.45 87.16 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.814 2.343 . . . . 0.96999999999999997 112.269 176.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.74 HD13 ' HE2' ' A' ' 94' ' ' LYS . 1.6 mp -126.4 -58.91 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.96 -1.018 . . . . 0.5 109.444 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.63 37.08 7.08 Favored Glycine 0 CA--C 1.496 -1.135 0 N-CA-C 108.991 -1.644 . . . . 0.39000000000000001 108.991 -176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.147 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.9 tp -46.52 -47.5 19.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 113.104 -1.548 . . . . 0.33000000000000002 110.383 -176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -89.57 83.45 6.31 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.741 0.781 . . . . 0.71999999999999997 109.02 175.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.2 t -68.26 -48.28 74.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.448 -1.251 . . . . 0.63 109.598 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 ttp -148.47 129.58 14.52 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.651 -1.159 . . . . 2.8799999999999999 108.828 172.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -95.84 148.64 34.87 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.662 -0.699 . . . . 3.6699999999999999 109.615 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.842 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 1.9 Cg_endo -79.35 162.59 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.557 2.171 . . . . 0.64000000000000001 111.074 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.511 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 18.4 mm-40 -125.8 169.65 12.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.099 -0.501 . . . . 1.4299999999999999 110.329 -171.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' A' ' 103' ' ' ASN . 7.3 p-10 -74.78 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-O 122.695 1.236 . . . . 2.0600000000000001 111.922 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 159.83 137.34 2.21 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.206 -1.815 . . . . 0.29999999999999999 112.175 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 31.2 mt-10 -115.76 113.85 24.0 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.054 -1.073 . . . . 1.53 108.87 175.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.503 HG22 HD11 ' A' ' 104' ' ' LEU . 3.1 m -134.52 163.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.715 0 N-CA-C 107.13 -1.433 . . . . 0.27000000000000002 107.13 -173.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.533 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -93.13 157.21 16.4 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.541 -0.754 . . . . 0.77000000000000002 110.035 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' A' ' 81' ' ' PRO . 9.0 t -62.58 106.76 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 CA-C-O 122.956 1.36 . . . . 0.78000000000000003 109.488 174.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.34 11.42 17.88 Favored Glycine 0 C--N 1.269 -3.18 0 CA-C-N 112.08 -2.327 . . . . 0.47999999999999998 113.712 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.3 -122.33 4.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 109.867 -1.293 . . . . 0.44 109.867 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.3 p -151.66 164.24 37.36 Favored 'General case' 0 N--CA 1.401 -2.89 0 CA-C-N 113.088 -1.556 . . . . 0.81999999999999995 110.971 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.825 HG23 ' HB ' ' A' ' 76' ' ' ILE . 6.8 tp -148.1 142.92 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 112.801 -1.999 . . . . 0.32000000000000001 107.904 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 m -138.64 129.39 26.41 Favored 'General case' 0 C--N 1.261 -3.267 0 CA-C-N 114.237 -1.347 . . . . 0.31 111.054 -171.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 31.8 m-85 -126.98 143.03 51.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.129 -1.396 . . . . 0.53000000000000003 110.369 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.536 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -130.25 123.42 30.08 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.009 -0.996 . . . . 0.57999999999999996 109.438 174.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.842 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -120.89 118.16 29.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.13 -1.396 . . . . 0.32000000000000001 110.324 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.3 mtt180 -105.28 122.41 45.88 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.225 -0.297 . . . . 2.4300000000000002 111.008 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.2 t -124.89 127.39 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.849 0.833 . . . . 0.26000000000000001 109.83 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -57.64 113.31 1.76 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.665 -1.607 . . . . 0.40000000000000002 111.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.76 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -54.22 -42.16 72.28 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.537 -1.21 . . . . 0.76000000000000001 110.651 170.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.744 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.32 -151.01 0.1 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 115.193 1.553 . . . . 0.70999999999999996 115.193 167.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -128.34 130.54 47.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.264 -1.334 . . . . 1.74 108.717 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -156.78 179.02 9.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.298 0.571 . . . . 2.1600000000000001 111.775 -173.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.3 tp -74.41 -42.09 59.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.712 -1.131 . . . . 1.47 108.921 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -149.48 149.9 29.89 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.162 -0.926 . . . . 1.3999999999999999 109.558 175.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 85.4 Cg_exo -46.54 140.24 12.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.86 2.373 . . . . 0.88 112.248 -176.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.709 ' HA ' HG23 ' A' ' 93' ' ' THR . 33.3 Cg_exo -53.59 137.51 66.23 Favored 'Trans proline' 0 CA--C 1.507 -0.861 0 C-N-CA 122.095 1.863 . . . . 0.53000000000000003 112.377 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.86 104.4 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 106.787 -1.56 . . . . 0.77000000000000002 106.787 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.549 HG22 HG23 ' A' ' 91' ' ' VAL . 2.4 t -113.09 115.22 49.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.022 0 CA-C-N 113.782 -1.554 . . . . 0.28000000000000003 107.595 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.642 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -106.55 131.67 53.45 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.896 1.331 . . . . 1.54 108.978 172.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.951 ' HB3' HD13 ' A' ' 49' ' ' LEU . 50.1 m95 -90.73 157.24 17.53 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 112.394 -2.185 . . . . 0.34000000000000002 110.622 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.5 t80 -139.62 124.58 18.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.431 -2.063 . . . . 0.62 105.431 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.943 ' HD2' HD23 ' A' ' 57' ' ' LEU . 60.5 tttt -104.26 112.47 25.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.3 -1.36 . . . . 2.1699999999999999 108.145 -172.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 85' ' ' GLY . . . -84.81 92.31 1.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 115.572 -3.204 . . . . 1.23 114.39 -166.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.835 ' HE3' ' HE1' ' A' ' 46' ' ' TRP . 21.9 ttpt -102.85 -31.53 10.24 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 103.173 -2.899 . . . . 3.8700000000000001 103.173 137.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.835 ' HE1' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER 158.78 -11.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 111.243 -2.708 . . . . 2.1099999999999999 111.369 -167.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.932 ' HB ' ' HE2' ' A' ' 52' ' ' LYS . 0.7 OUTLIER -88.08 168.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-O 123.03 1.395 . . . . 1.29 113.53 -165.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.662 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 16.5 t70 -113.09 132.57 55.38 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 111.666 -2.515 . . . . 2.73 108.886 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.951 HD13 ' HB3' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -76.31 -30.91 57.89 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 113.714 1.005 . . . . 0.44 113.714 -174.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -61.47 -21.94 64.63 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.26 0.482 . . . . 1.23 109.894 -163.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 t -101.09 -20.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.825 0.822 . . . . 1.3400000000000001 112.215 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.932 ' HE2' ' HB ' ' A' ' 47' ' ' VAL . 45.2 mttp -96.81 -78.21 0.47 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.219 -1.355 . . . . 1.3999999999999999 113.687 -164.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.963 HG13 ' H ' ' A' ' 59' ' ' LEU . 37.8 t 22.98 98.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 125.293 1.621 . . . . 0.37 114.273 161.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -145.14 -150.87 5.3 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.251 -1.34 . . . . 0.69999999999999996 113.983 -173.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -62.54 -27.13 68.95 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.83 0.452 . . . . 2.75 112.149 -170.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.668 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.3 p80 -92.52 -39.08 11.57 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.668 -0.413 . . . . 1.3300000000000001 111.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.943 HD23 ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -130.82 106.07 8.2 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.09 -0.707 . . . . 1.1100000000000001 109.09 170.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.34 116.67 29.08 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 106.741 -1.577 . . . . 0.76000000000000001 106.741 170.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.963 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -91.87 93.67 8.94 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 105.222 -2.14 . . . . 0.26000000000000001 105.222 171.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 42.2 m170 -94.03 162.03 14.05 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-O 122.758 1.266 . . . . 2.0299999999999998 109.933 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -132.62 111.93 11.62 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 111.775 -2.466 . . . . 0.92000000000000004 108.768 173.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.0 m -87.67 148.75 24.65 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 112.71 -2.041 . . . . 0.46999999999999997 108.518 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -126.65 97.14 4.9 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.303 1.049 . . . . 1.3899999999999999 110.121 -168.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -114.34 95.05 5.08 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.327 -1.761 . . . . 2.4199999999999999 108.554 177.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HD3' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.01 -27.22 28.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.173 -0.921 . . . . 2.46 110.457 -176.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.44 -17.63 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.57 -1.196 . . . . 1.1499999999999999 109.847 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.704 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 24.2 m -108.79 -15.25 14.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.166 -0.925 . . . . 1.4099999999999999 108.774 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.744 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER 64.93 35.47 8.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.097 -0.956 . . . . 3.3100000000000001 109.402 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.07 136.83 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.42999999999999999 109.667 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 13.9 m-85 -101.68 116.78 33.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.685 -1.598 . . . . 1.24 106.685 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 25' ' ' SER . 24.3 tp -95.55 104.54 16.45 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.441 -0.948 . . . . 0.52000000000000002 108.441 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 92.9 m-85 -81.92 112.03 18.65 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.539 -1.652 . . . . 0.33000000000000002 106.539 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -119.68 120.88 37.92 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.97 -1.468 . . . . 1.3200000000000001 110.385 -173.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.923 HD12 HD11 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -88.21 125.15 34.48 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.763 -1.562 . . . . 0.95999999999999996 107.584 177.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 12.8 m170 -110.75 96.01 5.91 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.148 -2.538 . . . . 1.1499999999999999 104.148 170.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.923 HD11 HD12 ' A' ' 74' ' ' LEU . 27.8 mt -119.57 99.98 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 122.89 1.328 . . . . 0.52000000000000002 110.279 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 31.4 p -116.05 139.97 49.74 Favored 'General case' 0 N--CA 1.39 -3.449 0 CA-C-N 114.301 -1.318 . . . . 0.57999999999999996 107.77 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 77' ' ' THR . 22.0 t70 74.85 64.98 0.07 Allowed 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.309 -2.223 . . . . 2.1200000000000001 108.312 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.17 9.18 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 112.098 -2.319 . . . . 0.40000000000000002 109.259 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -62.6 151.7 83.08 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.25 -0.648 . . . . 1.4299999999999999 109.25 176.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.758 ' HB3' HG21 ' A' ' 18' ' ' VAL . 72.3 Cg_endo -72.95 11.06 0.94 Allowed 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 122.795 2.33 . . . . 1.3300000000000001 113.958 -169.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.708 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.17 -3.97 11.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.595 -0.275 . . . . 1.1200000000000001 110.626 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CD1' ' HE2' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -80.63 0.51 33.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.182 -0.673 . . . . 1.24 109.182 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 94.9 m -52.24 98.85 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 CA-C-O 122.609 1.195 . . . . 1.22 109.657 172.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 44' ' ' GLY . . . -164.98 -119.42 0.48 Allowed Glycine 0 C--N 1.27 -3.093 0 CA-C-N 113.15 -1.841 . . . . 1.4299999999999999 113.559 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -164.99 121.97 1.05 Allowed Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 113.501 -1.35 . . . . 0.52000000000000002 111.195 -171.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -87.01 125.48 34.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.413 -0.958 . . . . 0.63 108.413 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 15.3 mtp180 -105.0 132.71 50.9 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.239 -0.652 . . . . 3.1499999999999999 109.239 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.47 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 3.9 m -111.76 121.7 45.79 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.837 -0.801 . . . . 1.0800000000000001 108.837 169.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.642 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 41.9 mt-10 -120.01 105.2 10.81 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.78 -0.646 . . . . 1.8100000000000001 109.608 -178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.549 HG23 HG22 ' A' ' 39' ' ' VAL . 7.1 p -99.74 134.05 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 122.187 0.994 . . . . 0.54000000000000004 110.717 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -135.58 108.03 7.37 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.591 -1.64 . . . . 1.1799999999999999 108.389 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.709 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -133.22 163.23 29.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.308 -0.853 . . . . 0.73999999999999999 109.09 -178.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.74 ' HE2' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 22.28 -79.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 125.52 1.762 . . . . 0.65000000000000002 113.536 168.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.616 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 16.3 t70 -153.43 6.3 0.35 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.898 -1.047 . . . . 1.05 109.156 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.147 ' HB3' HD22 ' A' ' 6' ' ' LEU . 44.7 tptt -92.01 132.1 36.8 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.782 -1.562 . . . . 1.29 106.782 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -131.7 146.17 52.03 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.941 -1.027 . . . . 0.77000000000000002 111.847 -176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -176.57 163.18 2.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.045 -0.98 . . . . 1.6000000000000001 110.104 171.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.4 p -152.22 138.44 18.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.981 -0.554 . . . . 1.1899999999999999 110.038 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.76 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 57.9 p -107.45 147.25 30.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.631 -0.713 . . . . 0.83999999999999997 110.325 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.559 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -132.98 114.91 14.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.431 0.634 . . . . 1.5800000000000001 110.354 176.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.792 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 33.7 p90 -143.24 140.23 30.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.082 -0.508 . . . . 0.85999999999999999 109.796 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.643 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.3 m-20 -96.98 155.97 16.55 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.207 1.003 . . . . 2.1099999999999999 111.974 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.666 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -125.7 114.44 18.66 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.726 -1.213 . . . . 0.37 107.726 164.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.433 ' HA ' HG23 ' A' ' 84' ' ' THR . 4.1 m -98.83 95.86 7.48 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.654 -0.869 . . . . 0.33000000000000002 108.654 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 80' ' ' GLN . 4.1 p -78.39 111.74 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 123.065 1.412 . . . . 0.33000000000000002 108.834 177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 65.2 m170 -78.57 98.11 6.01 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.664 -2.062 . . . . 1.1899999999999999 109.788 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.69 -34.76 58.18 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.542 -1.663 . . . . 1.6699999999999999 108.866 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.78 31.72 16.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.258 -0.883 . . . . 2.7799999999999998 111.801 175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.17 -0.678 . . . . 6.9199999999999999 109.17 177.726 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.705 ' HB3' ' HG2' ' A' ' 96' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 122.044 0.926 . . . . 1.9299999999999999 110.739 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.601 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 19.6 t70 -74.53 157.81 85.77 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.614 -1.175 . . . . 1.6499999999999999 109.846 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 18.2 Cg_endo -61.04 77.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.737 2.292 . . . . 0.96999999999999997 114.066 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.703 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -99.59 -60.69 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.773 -1.103 . . . . 0.5 109.574 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.7 43.69 6.01 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 108.321 -1.912 . . . . 0.39000000000000001 108.321 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 4' ' ' ILE . 9.8 tp -50.11 -43.83 51.87 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.652 -1.774 . . . . 0.33000000000000002 111.031 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.744 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -88.52 84.73 6.77 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.646 -0.706 . . . . 0.71999999999999997 110.301 176.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -71.46 -40.95 72.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.447 -1.251 . . . . 0.63 109.167 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.502 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 18.2 ttt -151.06 137.45 18.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.617 -1.174 . . . . 2.8799999999999999 108.655 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 7.8 ptp180 -102.47 139.23 20.03 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 116.229 -0.441 . . . . 3.6699999999999999 110.201 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.859 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 14.1 Cg_endo -69.73 154.1 68.28 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.741 2.294 . . . . 0.64000000000000001 112.375 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -112.93 170.75 7.98 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 113.099 0.778 . . . . 1.4299999999999999 113.099 -168.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 1.6 m-20 -69.88 -147.35 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.701 1.239 . . . . 2.0600000000000001 110.741 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.489 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 153.32 133.31 1.84 Allowed Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 113.611 -1.631 . . . . 0.29999999999999999 112.242 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 23.1 mt-10 -110.68 119.01 37.73 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.256 -0.972 . . . . 1.53 108.527 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.77 162.06 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.21 0 N-CA-C 107.047 -1.464 . . . . 0.27000000000000002 107.047 -170.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -96.4 155.33 16.81 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.41 -0.959 . . . . 0.77000000000000002 108.41 176.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.708 HG11 ' HD3' ' A' ' 81' ' ' PRO . 6.2 t -67.28 105.85 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 107.862 -1.162 . . . . 0.78000000000000003 107.862 173.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.34 -6.74 3.97 Favored Glycine 0 C--N 1.273 -2.953 0 CA-C-N 112.926 -1.943 . . . . 0.47999999999999998 113.368 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.37 -123.93 5.29 Favored Glycine 0 CA--C 1.471 -2.704 0 C-N-CA 119.089 -1.529 . . . . 0.44 110.6 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.638 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.8 p -148.98 174.45 12.26 Favored 'General case' 0 N--CA 1.396 -3.149 0 CA-C-N 112.555 -1.822 . . . . 0.81999999999999995 110.2 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.682 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.1 tp -146.09 140.39 21.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 112.651 -2.068 . . . . 0.32000000000000001 107.21 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.9 m -139.24 127.59 22.79 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 113.398 -1.728 . . . . 0.31 111.492 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.779 ' HB2' HD23 ' A' ' 74' ' ' LEU . 3.4 m-85 -128.19 154.71 45.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.057 -1.429 . . . . 0.53000000000000003 108.877 174.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -134.42 122.05 21.98 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.461 -0.79 . . . . 0.57999999999999996 109.382 173.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.859 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -113.51 116.38 29.47 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.878 -1.056 . . . . 0.32000000000000001 110.184 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 99.1 mtt180 -105.61 115.66 30.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.469 -0.332 . . . . 2.4300000000000002 110.412 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 39' ' ' VAL . 5.8 t -118.23 126.3 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.065 0.936 . . . . 0.26000000000000001 110.121 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.775 ' HB1' ' HE2' ' A' ' 68' ' ' LYS . . . -56.36 108.97 0.53 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.147 -1.842 . . . . 0.40000000000000002 112.188 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.62 80.78 Favored Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.764 -1.107 . . . . 0.76000000000000001 112.423 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 61.05 -178.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.137 1.162 . . . . 0.70999999999999996 114.137 168.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 m -105.39 29.53 6.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.292 -1.322 . . . . 1.74 109.083 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.046 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -58.57 175.71 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.645 -1.161 . . . . 2.1600000000000001 113.133 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.1 tp -73.44 -40.52 64.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.874 0.845 . . . . 1.47 109.927 -176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -145.93 134.88 11.14 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.442 -1.253 . . . . 1.3999999999999999 108.532 176.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -43.58 141.62 3.62 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.333 2.689 . . . . 0.88 112.18 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.046 ' HD3' HD11 ' A' ' 33' ' ' LEU . 4.0 Cg_exo -52.93 136.63 60.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.813 1.675 . . . . 0.53000000000000003 113.068 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.31 104.99 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.603 0 N-CA-C 106.175 -1.787 . . . . 0.77000000000000002 106.175 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.65 114.37 46.78 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 113.535 -1.666 . . . . 0.28000000000000003 108.037 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 1.018 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -101.57 122.24 43.47 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-O 123.344 1.545 . . . . 1.54 110.238 174.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.034 ' HB3' HD13 ' A' ' 49' ' ' LEU . 86.8 m95 -86.91 149.01 25.11 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.871 -2.422 . . . . 0.34000000000000002 112.021 174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.734 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 43.7 t80 -128.89 140.09 51.84 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.096 -2.557 . . . . 0.62 104.096 172.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.798 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 58.2 tttp -106.23 166.25 10.65 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 116.627 -1.654 . . . . 2.1699999999999999 106.708 -173.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -11.97 -166.17 0.0 OUTLIER Glycine 0 C--O 1.186 -2.875 0 N-CA-C 119.136 2.414 . . . . 1.23 119.136 177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.914 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 13.4 ptmt -44.14 -6.34 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.495 2.406 . . . . 3.8700000000000001 117.495 -161.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.914 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 2.8 p-90 -167.95 -1.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.931 1.242 . . . . 2.1099999999999999 113.266 174.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.27 167.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.744 0 CA-C-O 123.659 1.695 . . . . 1.29 112.405 -159.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 3.3 p-10 -111.35 156.99 20.73 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.137 -2.756 . . . . 2.73 106.506 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.034 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -97.9 -31.27 12.28 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 112.509 0.559 . . . . 0.44 112.509 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -58.52 -19.67 39.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.013 0.435 . . . . 1.23 109.88 -165.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.406 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 73.9 m -98.25 -26.74 14.43 Favored 'General case' 0 N--CA 1.415 -2.198 0 C-N-CA 119.865 -0.734 . . . . 1.3400000000000001 112.432 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.3 -32.16 10.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.623 -1.172 . . . . 1.3999999999999999 111.794 -167.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.82 HG13 ' H ' ' A' ' 59' ' ' LEU . 70.3 t -35.39 92.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 O-C-N 125.076 1.485 . . . . 0.37 111.532 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' LEU . . . -150.25 -114.79 0.7 Allowed Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 112.338 -2.21 . . . . 0.69999999999999996 111.952 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -95.74 -25.4 16.09 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.364 0.876 . . . . 2.75 113.364 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.6 p80 -93.32 -37.82 11.82 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-O 121.622 0.725 . . . . 1.3300000000000001 110.079 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.005 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.66 106.97 10.51 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 105.657 -1.979 . . . . 1.1100000000000001 105.657 171.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -106.39 114.59 28.81 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.445 -1.687 . . . . 0.76000000000000001 106.445 166.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.82 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -92.72 92.42 7.96 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 103.957 -2.608 . . . . 0.26000000000000001 103.957 175.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 80.4 t60 -95.0 159.66 14.93 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 113.944 -1.48 . . . . 2.0299999999999998 110.22 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.58 121.57 39.64 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 110.929 -2.85 . . . . 0.92000000000000004 109.153 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 25.9 m -110.23 143.47 40.34 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-N 111.773 -2.467 . . . . 0.46999999999999997 106.34 167.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.88 99.51 3.35 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.748 0.785 . . . . 1.3899999999999999 109.275 -164.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -115.01 132.07 56.72 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.489 -1.232 . . . . 2.4199999999999999 109.122 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.538 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 6.1 mmm180 -119.01 18.23 13.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.06 -1.427 . . . . 2.46 111.25 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.24 -31.88 4.55 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.736 -1.574 . . . . 1.1499999999999999 108.488 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t -93.18 -14.75 26.75 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.479 -1.237 . . . . 1.4099999999999999 108.8 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.775 ' HE2' ' HB1' ' A' ' 29' ' ' ALA . 15.2 tttt 68.88 31.61 4.24 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.85 0.833 . . . . 3.3100000000000001 109.23 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 7.9 t -128.35 125.77 64.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.603 0.716 . . . . 0.42999999999999999 110.453 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.447 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.4 m-30 -101.18 107.44 18.85 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.031 -1.841 . . . . 1.24 106.031 167.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.0 tp -94.92 104.21 16.1 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.706 -1.134 . . . . 0.52000000000000002 108.013 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.5 m-85 -86.94 113.65 22.89 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.68 -1.6 . . . . 0.33000000000000002 106.68 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -118.65 125.24 49.3 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 113.917 -1.492 . . . . 1.3200000000000001 110.585 -171.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.916 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.2 mm? -89.59 124.51 34.62 Favored 'General case' 0 CA--C 1.471 -2.064 0 CA-C-N 112.889 -1.96 . . . . 0.95999999999999996 107.698 -176.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.935 ' HB2' ' HG2' ' A' ' 58' ' ' GLN . 26.1 m170 -114.45 94.29 4.72 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 103.15 -2.908 . . . . 1.1499999999999999 103.15 167.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 22' ' ' ILE . 60.4 mt -115.14 97.71 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 123.603 1.668 . . . . 0.52000000000000002 108.983 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 29.9 p -116.31 138.75 51.07 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 112.302 -2.226 . . . . 0.57999999999999996 107.076 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 77' ' ' THR . 13.5 t70 77.76 63.77 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 O-C-N 125.855 1.972 . . . . 2.1200000000000001 107.351 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -76.92 94.44 3.93 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 111.605 -2.543 . . . . 0.40000000000000002 107.893 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.673 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -53.71 151.32 11.55 Favored Pre-proline 0 N--CA 1.438 -1.034 0 CA-C-N 115.127 -0.942 . . . . 1.4299999999999999 108.708 176.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.708 ' HD3' HG11 ' A' ' 18' ' ' VAL . 60.0 Cg_endo -68.83 155.32 69.02 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.039 1.159 . . . . 1.3300000000000001 110.032 -176.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 45' ' ' LYS . . . 63.38 21.69 12.91 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.381 0.426 . . . . 1.1200000000000001 110.728 -175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -86.6 -13.21 46.37 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.195 -1.409 . . . . 1.24 107.195 173.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 1.022 HG21 ' N ' ' A' ' 106' ' ' VAL . 4.3 p -90.11 150.26 22.12 Favored 'General case' 1 N--CA 1.363 -4.808 0 CA-C-O 126.041 2.829 . . . . 1.22 116.17 -163.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' HA3' ' CA ' ' A' ' 45' ' ' LYS . . . 159.4 -109.61 0.41 Allowed Glycine 1 C--N 1.239 -4.833 1 CA-C-N 105.381 -5.372 . . . . 1.4299999999999999 112.527 -155.532 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -167.91 124.78 1.23 Allowed Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.338 -1.41 . . . . 0.52000000000000002 114.172 -170.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.798 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.3 m-85 -87.95 124.54 33.81 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.227 -1.487 . . . . 0.63 108.56 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.734 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 mtp180 -105.51 105.21 15.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.538 -0.726 . . . . 3.1499999999999999 109.728 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.424 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 4.3 t -89.92 125.39 35.34 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.372 -0.973 . . . . 1.0800000000000001 108.372 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 1.018 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 21.7 tt0 -145.47 106.77 4.19 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.419 -0.81 . . . . 1.8100000000000001 109.961 -169.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.7 p -102.66 144.36 13.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.362 0.601 . . . . 0.54000000000000004 110.504 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.4 m -139.12 109.47 6.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.277 -0.874 . . . . 1.1799999999999999 108.898 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.852 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.39 153.78 50.45 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.401 -0.809 . . . . 0.73999999999999999 109.886 -177.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.784 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.7 -75.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 125.654 1.846 . . . . 0.65000000000000002 114.572 177.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.784 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 12.2 t70 -149.7 -1.07 0.45 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.087 -1.415 . . . . 1.05 109.379 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.705 ' HG2' ' HB3' ' A' ' 1' ' ' ASP . 0.6 OUTLIER -104.76 140.09 38.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.111 0.958 . . . . 1.29 109.627 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -132.61 139.06 47.61 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.142 -1.844 . . . . 0.77000000000000002 110.577 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 6' ' ' LEU . 6.8 m-20 -152.85 147.88 26.53 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.25 -0.886 . . . . 1.6000000000000001 109.083 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 13.4 p -151.43 153.88 35.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.504 . . . . 1.1899999999999999 110.905 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.744 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 85.7 p -137.31 130.26 30.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.774 -0.648 . . . . 0.83999999999999997 110.766 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.81 116.85 33.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.615 -0.721 . . . . 1.5800000000000001 110.305 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.791 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 22.5 p90 -143.12 135.8 27.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.458 0.647 . . . . 0.85999999999999999 109.903 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.588 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 86.9 m-20 -97.26 156.15 16.55 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.538 -1.21 . . . . 2.1099999999999999 110.387 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.959 ' HG ' HG22 ' A' ' 84' ' ' THR . 1.2 tp -120.67 132.91 55.34 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 102.336 -3.209 . . . . 0.37 102.336 166.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.544 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 23.4 m -124.16 113.57 18.51 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.318 -1.353 . . . . 0.33000000000000002 109.727 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.022 ' N ' HG21 ' A' ' 84' ' ' THR . 5.6 p -102.87 114.14 41.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 113.779 -1.555 . . . . 0.33000000000000002 110.046 -172.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 35.5 m-70 -79.78 98.55 7.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 111.798 -2.455 . . . . 1.1899999999999999 109.354 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.43 ' HA ' HG23 ' A' ' 18' ' ' VAL . 70.1 tt0 -82.4 -64.11 1.24 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.099 -1.864 . . . . 1.6699999999999999 109.736 175.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.59 87.68 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.897 -0.592 . . . . 2.7799999999999998 110.271 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.23 -0.89 . . . . 6.9199999999999999 110.974 177.138 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.207 0.527 . . . . 1.9299999999999999 110.251 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 4' ' ' ILE . 5.8 m-20 -90.56 168.75 13.41 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 115.295 -0.866 . . . . 1.6499999999999999 110.514 175.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.76 42.26 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.393 2.729 . . . . 0.96999999999999997 113.357 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.962 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -58.22 -51.27 73.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.74 -0.664 . . . . 0.5 110.163 172.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.591 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 86.72 40.28 7.26 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.602 -1.799 . . . . 0.39000000000000001 108.602 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.137 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 7.8 tp -53.2 -50.07 65.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.544 -1.828 . . . . 0.33000000000000002 110.252 -172.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -84.23 84.48 7.6 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.678 0.751 . . . . 0.71999999999999997 110.176 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.2 t -73.2 -42.88 58.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.43 -1.259 . . . . 0.63 109.416 177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.7 ttm -152.19 135.87 16.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.225 -0.898 . . . . 2.8799999999999999 108.715 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -91.1 139.76 25.77 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.862 -0.422 . . . . 3.6699999999999999 109.862 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 33.6 Cg_endo -67.49 141.57 56.22 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.091 1.86 . . . . 0.64000000000000001 109.164 171.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.619 ' O ' ' HD1' ' A' ' 24' ' ' PHE . 6.3 tp60 -118.2 163.83 16.08 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 112.932 0.715 . . . . 1.4299999999999999 112.932 -168.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.1 m-20 -57.67 -139.94 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 125.674 1.589 . . . . 2.0600000000000001 112.928 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 143.13 136.19 3.13 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 113.291 -1.777 . . . . 0.29999999999999999 111.975 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 35.8 mt-10 -108.51 114.93 29.16 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.349 -0.926 . . . . 1.53 108.527 175.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.4 m -135.25 163.6 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.867 0 N-CA-C 107.932 -1.136 . . . . 0.27000000000000002 107.932 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 154.29 17.33 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.636 -1.166 . . . . 0.77000000000000002 109.193 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.69 HG11 ' HD3' ' A' ' 81' ' ' PRO . 4.0 t -65.78 107.58 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 CA-C-O 122.845 1.307 . . . . 0.78000000000000003 108.9 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.3 10.38 10.74 Favored Glycine 0 C--N 1.269 -3.162 0 CA-C-N 112.107 -2.315 . . . . 0.47999999999999998 112.734 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.82 -123.43 4.89 Favored Glycine 0 N--CA 1.42 -2.409 0 C-N-CA 119.331 -1.414 . . . . 0.44 110.269 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 12.6 p -151.35 168.44 24.8 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.079 -1.561 . . . . 0.81999999999999995 110.201 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 104' ' ' LEU . 9.0 tp -147.79 149.44 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 CA-C-N 113.693 -1.594 . . . . 0.32000000000000001 108.04 169.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.3 m -138.11 128.64 26.44 Favored 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 114.066 -1.425 . . . . 0.31 111.163 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.619 ' HD1' ' O ' ' A' ' 12' ' ' GLN . 3.4 m-85 -126.01 147.54 49.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 113.879 -1.51 . . . . 0.53000000000000003 107.817 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -140.89 127.73 20.46 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.57 0.7 . . . . 0.57999999999999996 109.78 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.583 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -121.19 115.5 23.16 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.922 -1.035 . . . . 0.32000000000000001 110.383 -176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -104.31 121.11 42.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.312 -0.255 . . . . 2.4300000000000002 110.312 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.606 HG21 HG21 ' A' ' 39' ' ' VAL . 15.1 t -122.31 126.03 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.129 0.966 . . . . 0.26000000000000001 110.319 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -57.83 109.01 0.65 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.151 -1.84 . . . . 0.40000000000000002 111.432 176.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.606 ' O ' HD11 ' A' ' 33' ' ' LEU . . . -50.1 -58.58 8.52 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.946 -1.025 . . . . 0.76000000000000001 111.418 172.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.823 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 59.8 -171.15 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.137 1.162 . . . . 0.70999999999999996 114.137 168.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -109.09 130.42 55.48 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.916 -1.038 . . . . 1.74 109.846 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -160.93 -176.2 5.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.396 0.617 . . . . 2.1600000000000001 112.038 -172.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.8 tp -70.77 -44.86 65.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.966 -1.015 . . . . 1.47 108.741 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.597 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -150.46 150.27 28.41 Favored Pre-proline 0 N--CA 1.449 -0.504 0 CA-C-N 114.79 -1.096 . . . . 1.3999999999999999 109.634 174.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.77 148.79 5.76 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.484 2.789 . . . . 0.88 112.426 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.639 ' HA ' HG23 ' A' ' 93' ' ' THR . 4.1 Cg_exo -50.11 132.51 33.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.709 1.606 . . . . 0.53000000000000003 113.207 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.3 105.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.404 -1.702 . . . . 0.77000000000000002 106.404 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.626 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.0 t -109.56 114.5 47.11 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.784 -1.553 . . . . 0.28000000000000003 107.195 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -104.93 124.82 50.16 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 123.287 1.518 . . . . 1.54 109.16 174.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.068 ' HB3' HD13 ' A' ' 49' ' ' LEU . 79.8 m95 -83.93 151.09 25.26 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 111.646 -2.525 . . . . 0.34000000000000002 111.231 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.699 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 36.9 t80 -128.61 138.75 52.36 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 104.58 -2.378 . . . . 0.62 104.58 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.816 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 31.6 tptt -104.64 165.28 11.17 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.41 -2.07 . . . . 2.1699999999999999 105.41 -172.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.803 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -10.62 -168.95 0.0 OUTLIER Glycine 0 C--O 1.188 -2.741 0 N-CA-C 119.321 2.488 . . . . 1.23 119.321 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -44.82 -1.47 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.95 2.204 . . . . 3.8700000000000001 116.95 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 11.8 p-90 -167.16 -11.5 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.858 1.429 . . . . 2.1099999999999999 114.858 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.674 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -93.37 169.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 CA-C-O 123.452 1.596 . . . . 1.29 112.889 -161.257 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.482 ' OD1' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -111.05 156.19 21.67 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 111.613 -2.54 . . . . 2.73 107.511 172.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.068 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.6 mp -96.77 -36.88 10.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 119.292 -0.385 . . . . 0.44 111.896 169.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 t -58.15 -20.49 41.16 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.31 0.576 . . . . 1.23 109.47 -165.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 m -98.02 -17.64 19.04 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.302 -0.863 . . . . 1.3400000000000001 113.014 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 6.2 mmmt -102.87 -54.59 2.6 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.773 -0.649 . . . . 1.3999999999999999 111.174 -173.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 49' ' ' LEU . 70.3 t -6.25 90.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 O-C-N 125.93 2.019 . . . . 0.37 113.139 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.633 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -156.87 -129.61 1.16 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 112.579 -2.101 . . . . 0.69999999999999996 112.191 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -72.65 -28.71 62.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.764 0.653 . . . . 2.75 112.764 -168.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 30.0 p80 -96.06 -37.17 10.74 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.699 0.762 . . . . 1.3300000000000001 111.181 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.988 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -125.62 105.22 8.85 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.313 -1.736 . . . . 1.1100000000000001 106.313 175.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.45 113.93 25.55 Favored 'General case' 0 N--CA 1.405 -2.686 0 N-CA-C 106.325 -1.732 . . . . 0.76000000000000001 106.325 166.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.79 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.48 92.47 5.4 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 104.47 -2.419 . . . . 0.26000000000000001 104.47 171.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 33.0 m170 -87.61 159.86 18.4 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-O 122.831 1.3 . . . . 2.0299999999999998 110.306 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -135.03 110.27 8.96 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 111.548 -2.569 . . . . 0.92000000000000004 109.866 175.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -91.77 148.78 21.98 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 112.302 -2.226 . . . . 0.46999999999999997 107.576 174.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.8 98.31 3.31 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.45 1.119 . . . . 1.3899999999999999 110.843 -173.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -118.01 124.82 49.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.554 -1.657 . . . . 2.4199999999999999 109.931 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 -35.41 19.12 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 113.148 -1.842 . . . . 2.46 110.62 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.995 -1.002 . . . . 1.1499999999999999 110.789 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -90.22 -18.78 25.08 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.771 -0.826 . . . . 1.4099999999999999 108.771 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.823 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 7.4 ttpt 66.0 33.18 7.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.871 -1.059 . . . . 3.3100000000000001 109.367 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.48 122.91 56.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.721 0.772 . . . . 0.42999999999999999 109.826 -177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 62' ' ' SER . 2.9 m-30 -96.67 108.39 21.0 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.548 -1.649 . . . . 1.24 106.548 167.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 28.1 tp -93.42 105.9 17.91 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.966 -1.015 . . . . 0.52000000000000002 109.336 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 71.0 m-85 -91.1 111.19 22.56 Favored 'General case' 0 C--N 1.28 -2.428 0 N-CA-C 106.333 -1.728 . . . . 0.33000000000000002 106.333 170.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -121.61 132.29 54.59 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.722 -1.126 . . . . 1.3200000000000001 110.107 -174.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.68 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.3 mt -98.27 131.71 44.37 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 113.199 -1.819 . . . . 0.95999999999999996 108.936 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -116.8 97.64 6.08 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 104.041 -2.577 . . . . 1.1499999999999999 104.041 165.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.68 HG13 ' HB3' ' A' ' 74' ' ' LEU . 10.8 mt -123.0 101.56 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 122.395 1.093 . . . . 0.52000000000000002 108.281 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 69.7 p -104.76 171.56 7.26 Favored 'General case' 0 N--CA 1.393 -3.281 0 CA-C-N 114.874 -1.057 . . . . 0.57999999999999996 110.105 -175.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 39.89 67.41 0.48 Allowed 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.838 -2.892 . . . . 2.1200000000000001 111.562 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.49 116.32 6.65 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.625 -2.08 . . . . 0.40000000000000002 109.878 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.828 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -67.77 152.04 96.67 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.034 -0.728 . . . . 1.4299999999999999 109.034 175.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.69 ' HD3' HG11 ' A' ' 18' ' ' VAL . 38.2 Cg_endo -66.16 -8.3 19.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.45 2.1 . . . . 1.3300000000000001 112.605 -173.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.828 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -105.59 15.29 27.22 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.096 -0.502 . . . . 1.1200000000000001 110.278 176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 1.7 m-30 -97.37 -6.4 34.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 118.849 -0.596 . . . . 1.24 110.983 -176.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 22.9 m -23.59 95.07 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 O-C-N 125.497 1.748 . . . . 1.22 111.393 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.803 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -55.49 115.52 5.93 Favored Glycine 0 N--CA 1.406 -3.341 0 CA-C-N 110.431 -3.077 . . . . 1.4299999999999999 114.863 -169.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.681 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -119.18 68.7 0.35 Allowed Glycine 0 C--N 1.269 -3.188 0 CA-C-N 111.815 -2.192 . . . . 0.52000000000000002 108.433 149.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.816 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 32.5 m-85 -73.98 115.75 13.8 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.179 -1.045 . . . . 0.63 108.179 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.699 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 37.6 mtp180 -109.09 113.39 26.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.671 -0.492 . . . . 3.1499999999999999 109.671 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.1 t -101.8 110.7 22.73 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.624 0.726 . . . . 1.0800000000000001 109.355 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 0.8 OUTLIER -121.1 110.91 16.79 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.5 -1.227 . . . . 1.8100000000000001 110.07 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HB ' HG13 ' A' ' 39' ' ' VAL . 7.0 p -100.12 140.91 18.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.299 0.571 . . . . 0.54000000000000004 110.27 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -135.74 108.59 7.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.409 -0.96 . . . . 1.1799999999999999 108.409 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.639 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -132.2 144.85 50.94 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-O 117.374 -1.298 . . . . 0.73999999999999999 108.242 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.716 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.25 -72.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 O-C-N 125.629 1.831 . . . . 0.65000000000000002 113.699 -173.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.716 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 24.8 t70 -153.33 -1.18 0.23 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.681 -1.145 . . . . 1.05 110.707 -175.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.137 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 2.8 tttp -88.25 126.45 35.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.447 -0.945 . . . . 1.29 108.447 176.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 91' ' ' VAL . 15.1 t80 -130.42 117.7 20.09 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.083 -1.417 . . . . 0.77000000000000002 110.063 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -134.61 141.67 46.68 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.498 -1.683 . . . . 1.6000000000000001 108.639 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 5.0 m -136.21 144.22 44.79 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.473 . . . . 1.1899999999999999 110.688 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.651 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 82.1 p -130.74 118.66 21.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.732 -0.667 . . . . 0.83999999999999997 110.507 176.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.578 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -101.41 123.57 45.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.621 -0.718 . . . . 1.5800000000000001 109.516 176.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.67 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.9 p90 -142.88 135.56 27.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.005 0.907 . . . . 0.85999999999999999 110.581 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.778 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 4.6 m-80 -105.19 132.38 51.48 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.068 -1.424 . . . . 2.1099999999999999 111.449 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.705 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.41 106.58 17.74 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.554 -1.203 . . . . 0.37 108.651 172.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 8.1 m -89.28 96.45 10.72 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.592 -0.892 . . . . 0.33000000000000002 108.592 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 18' ' ' VAL . 4.7 p -85.2 113.69 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-O 123.031 1.396 . . . . 0.33000000000000002 109.104 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -86.93 99.21 11.7 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.648 -2.069 . . . . 1.1899999999999999 109.666 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 18' ' ' VAL . 40.1 tt0 -69.21 -46.84 66.41 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 113.004 -1.907 . . . . 1.6699999999999999 110.16 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.03 37.13 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.541 -0.754 . . . . 2.7799999999999998 111.329 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.526 -0.749 . . . . 6.9199999999999999 110.325 178.925 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.808 ' HB2' ' HE3' ' A' ' 96' ' ' LYS . 7.4 p-10 . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 122.451 1.119 . . . . 1.9299999999999999 111.035 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.738 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 23.1 t70 -76.59 150.84 82.43 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 113.712 -1.585 . . . . 1.6499999999999999 108.31 169.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.59 58.25 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.445 2.763 . . . . 0.96999999999999997 114.421 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.993 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -67.86 -52.31 41.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.658 0.742 . . . . 0.5 109.463 168.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.36 46.0 5.39 Favored Glycine 0 CA--C 1.494 -1.232 0 N-CA-C 108.252 -1.939 . . . . 0.39000000000000001 108.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.943 HD22 ' HB3' ' A' ' 96' ' ' LYS . 10.9 tp -55.04 -38.05 67.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 112.69 -1.755 . . . . 0.33000000000000002 110.643 -169.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.743 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -96.07 85.13 3.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.209 -0.905 . . . . 0.71999999999999997 109.823 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.03 -37.55 41.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.553 -1.203 . . . . 0.63 110.01 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 tpp -151.28 134.39 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.513 -0.767 . . . . 2.8799999999999999 109.636 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 17.0 ptm180 -108.57 136.86 19.89 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.786 -0.643 . . . . 3.6699999999999999 109.916 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.703 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 2.0 Cg_endo -76.35 138.36 19.79 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.672 2.248 . . . . 0.64000000000000001 111.531 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.676 HE21 ' C ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -89.31 -177.98 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.696 -0.684 . . . . 1.4299999999999999 110.527 176.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -74.61 -142.87 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.291 1.043 . . . . 2.0600000000000001 110.7 178.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.77 140.02 2.86 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.355 -1.293 . . . . 0.29999999999999999 112.512 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.464 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 27.4 mt-10 -116.87 119.18 34.57 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.277 -0.961 . . . . 1.53 108.52 172.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG11 ' HB ' ' A' ' 22' ' ' ILE . 2.2 m -136.43 162.0 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 N-CA-C 107.068 -1.456 . . . . 0.27000000000000002 107.068 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.719 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -91.03 156.53 17.86 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 115.039 -0.982 . . . . 0.77000000000000002 110.22 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 81' ' ' PRO . 11.6 t -66.47 107.12 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-O 123.023 1.392 . . . . 0.78000000000000003 108.202 171.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.69 14.31 12.78 Favored Glycine 0 C--N 1.266 -3.327 0 CA-C-N 111.925 -2.398 . . . . 0.47999999999999998 112.438 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.89 -125.24 5.32 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 109.366 -1.493 . . . . 0.44 109.366 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 24.4 p -152.73 165.51 35.08 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.236 -1.482 . . . . 0.81999999999999995 110.685 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 104' ' ' LEU . 10.3 tp -147.72 150.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.187 -1.824 . . . . 0.32000000000000001 107.252 169.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -138.95 125.94 21.13 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 113.442 -1.708 . . . . 0.31 110.043 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.76 150.06 44.86 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.375 -1.284 . . . . 0.53000000000000003 108.446 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.667 ' HB3' HD11 ' A' ' 71' ' ' LEU . 9.9 m -142.04 131.37 23.59 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.881 -0.785 . . . . 0.57999999999999996 108.881 175.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -127.42 115.54 19.08 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.205 -1.361 . . . . 0.32000000000000001 109.772 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HG2' HD13 ' A' ' 71' ' ' LEU . 48.9 mtp180 -104.98 123.4 47.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.123 -0.49 . . . . 2.4300000000000002 110.329 -173.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 39' ' ' VAL . 14.1 t -123.76 127.58 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 122.463 1.125 . . . . 0.26000000000000001 110.752 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.31 113.86 2.86 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.086 -1.87 . . . . 0.40000000000000002 112.931 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 1.048 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -49.78 -64.75 3.26 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 114.313 -1.312 . . . . 0.76000000000000001 111.085 166.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.705 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 60.52 -175.69 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 115.196 1.554 . . . . 0.70999999999999996 115.196 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -96.55 106.88 19.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.867 -1.515 . . . . 1.74 109.759 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.988 HD12 HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -151.83 171.03 18.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.975 -0.557 . . . . 2.1600000000000001 110.674 -171.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.73 -49.06 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.42 0.629 . . . . 1.47 110.244 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.645 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -149.92 158.14 37.29 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.611 -0.885 . . . . 1.3999999999999999 108.611 174.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.75 139.62 3.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.159 2.573 . . . . 0.88 112.296 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.8 ' HD3' HD11 ' A' ' 33' ' ' LEU . 8.9 Cg_exo -55.27 141.96 79.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.012 1.142 . . . . 0.53000000000000003 112.916 -175.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.84 106.38 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.332 -1.729 . . . . 0.77000000000000002 106.332 174.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 28' ' ' VAL . 2.8 t -109.22 115.22 49.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.918 0 CA-C-N 113.384 -1.735 . . . . 0.28000000000000003 108.083 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.935 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.66 130.53 52.67 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-O 123.126 1.441 . . . . 1.54 110.029 175.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.058 ' HB3' HD13 ' A' ' 49' ' ' LEU . 90.8 m95 -94.32 145.28 24.86 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 112.158 -2.292 . . . . 0.34000000000000002 111.917 173.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.5 t80 -126.88 130.86 50.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 105.641 -1.985 . . . . 0.62 105.641 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 87' ' ' TYR . 35.3 ttpt -104.76 111.58 24.36 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.523 -1.288 . . . . 2.1699999999999999 107.523 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.646 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -81.24 92.63 1.49 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 116.146 -2.93 . . . . 1.23 114.274 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.753 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 tttp -106.67 -53.98 2.54 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 102.765 -3.05 . . . . 3.8700000000000001 102.765 134.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.753 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 9.0 p-90 -168.0 0.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 110.171 -3.195 . . . . 2.1099999999999999 110.933 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG21 ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -96.87 173.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 123.574 1.654 . . . . 1.29 113.357 -159.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.5 t70 -110.27 145.23 37.74 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.097 -2.774 . . . . 2.73 105.775 174.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.058 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.9 mp -80.47 -38.26 30.31 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.22 -0.592 . . . . 0.44 111.705 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -62.35 -18.78 62.35 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.809 -0.812 . . . . 1.23 108.809 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.452 ' C ' ' HD2' ' A' ' 52' ' ' LYS . 33.5 m -84.48 -22.63 30.21 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 114.681 -1.145 . . . . 1.3400000000000001 111.532 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 8.0 mmmt -109.16 -67.52 0.98 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.181 -0.918 . . . . 1.3999999999999999 111.623 -174.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.844 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.3 t 8.02 92.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 126.696 1.998 . . . . 0.37 113.912 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -150.99 -135.97 2.43 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 113.215 -1.812 . . . . 0.69999999999999996 113.291 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.69 -36.58 79.14 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 113.967 1.099 . . . . 2.75 113.967 -168.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.704 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -98.19 -36.52 10.02 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 119.741 -0.784 . . . . 1.3300000000000001 111.393 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.837 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.39 103.68 10.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.347 -1.353 . . . . 1.1100000000000001 107.347 173.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -99.45 115.7 29.88 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 106.448 -1.686 . . . . 0.76000000000000001 106.448 166.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.844 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -99.02 93.29 5.92 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 104.782 -2.303 . . . . 0.26000000000000001 104.782 172.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 4.3 m-70 -94.41 162.7 13.72 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.43 -1.259 . . . . 2.0299999999999998 109.533 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 19.0 p-10 -137.09 112.1 8.99 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 111.961 -2.381 . . . . 0.92000000000000004 110.103 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -95.66 150.8 19.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 112.455 -2.157 . . . . 0.46999999999999997 108.525 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CZ ' ' HG2' ' A' ' 65' ' ' ARG . 6.7 t80 -143.67 98.53 3.26 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 122.643 1.211 . . . . 1.3899999999999999 110.983 -173.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' OD2' ' HB3' ' A' ' 67' ' ' SER . 0.1 OUTLIER -110.0 105.47 14.62 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 112.759 -2.019 . . . . 2.4199999999999999 110.045 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' HG2' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -75.65 -30.78 59.56 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 2.46 111.038 -175.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.66 -24.49 64.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.208 -0.905 . . . . 1.1499999999999999 110.461 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.539 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 6.5 t -100.94 -12.48 18.9 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.018 -0.734 . . . . 1.4099999999999999 109.018 174.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 8.7 ttpt 67.18 31.25 6.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.101 -0.954 . . . . 3.3100000000000001 110.5 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 27' ' ' ARG . 5.0 t -125.23 133.54 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.954 0.883 . . . . 0.42999999999999999 110.631 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 1.048 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.9 m-85 -98.8 111.56 23.9 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.518 -2.03 . . . . 1.24 105.518 162.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 25' ' ' SER . 9.2 tp -100.87 104.0 15.2 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.113 0.959 . . . . 0.52000000000000002 108.539 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 58.6 m-85 -84.64 113.39 21.24 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.929 -1.508 . . . . 0.33000000000000002 106.929 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 5.2 pt-20 -117.99 123.85 46.73 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.376 -1.738 . . . . 1.3200000000000001 110.216 -171.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.825 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.1 mm? -91.88 126.87 37.13 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 112.653 -2.067 . . . . 0.95999999999999996 108.127 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -116.19 96.42 5.54 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 104.368 -2.456 . . . . 1.1499999999999999 104.368 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 55.5 mt -122.09 100.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 CA-C-O 123.012 1.387 . . . . 0.52000000000000002 109.875 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 45.5 p -104.18 154.38 19.82 Favored 'General case' 0 N--CA 1.394 -3.227 0 CA-C-N 113.964 -1.471 . . . . 0.57999999999999996 108.492 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 44.21 85.7 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.322 -2.672 . . . . 2.1200000000000001 112.429 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -71.85 136.81 47.13 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 110.926 -2.852 . . . . 0.40000000000000002 111.191 -177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.824 HE21 ' HD2' ' A' ' 81' ' ' PRO . 1.1 tp60 -63.44 130.12 94.08 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.259 -0.645 . . . . 1.4299999999999999 109.259 173.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.824 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.6 Cg_endo -58.71 -13.04 16.27 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.561 2.841 . . . . 1.3300000000000001 114.285 -171.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -120.45 28.8 7.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.887 -0.325 . . . . 1.1200000000000001 111.622 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.557 ' HA ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -75.21 -57.27 4.0 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.252 -0.648 . . . . 1.24 109.252 172.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 7.3 m 43.86 58.56 3.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 106.97 -1.492 . . . . 1.22 106.97 -157.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.745 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -51.26 85.48 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.498 0 CA-C-N 112.545 -2.116 . . . . 1.4299999999999999 114.705 -164.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -92.08 80.71 1.2 Allowed Glycine 0 C--N 1.282 -2.429 0 N-CA-C 108.938 -1.665 . . . . 0.52000000000000002 108.938 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 13.2 m-85 -78.64 109.8 13.18 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.812 -1.194 . . . . 0.63 108.807 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -94.36 105.03 17.0 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.694 -0.854 . . . . 3.1499999999999999 108.694 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.582 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 8.4 t -95.52 126.23 40.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.571 -0.851 . . . . 1.0800000000000001 109.176 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.935 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 92.3 mt-10 -133.96 118.68 18.14 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.65 -0.705 . . . . 1.8100000000000001 110.367 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.522 HG22 HD21 ' A' ' 6' ' ' LEU . 3.4 p -107.52 143.67 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.485 0.659 . . . . 0.54000000000000004 110.133 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 m -140.44 112.59 7.75 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.171 -0.922 . . . . 1.1799999999999999 110.012 -176.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.988 HG21 HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -130.21 174.95 9.33 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 118.621 -0.704 . . . . 0.73999999999999999 110.048 177.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.916 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -8.61 -60.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.196 1.56 . . . . 0.65000000000000002 114.732 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.916 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 3.0 t70 -151.11 -8.05 0.25 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.293 -1.321 . . . . 1.05 109.669 -173.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.993 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -91.13 124.88 35.69 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.679 -1.23 . . . . 1.29 107.679 -177.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -131.54 133.64 45.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.293 -0.867 . . . . 0.77000000000000002 111.513 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -154.24 150.53 28.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.701 -1.136 . . . . 1.6000000000000001 109.99 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' SG ' ' HG2' ' A' ' 90' ' ' GLU . 72.1 m -142.5 150.33 40.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.025 -0.361 . . . . 1.1899999999999999 110.025 175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.743 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 47.6 p -128.62 135.63 49.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.83999999999999997 111.764 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -83.47 138.58 33.39 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.297 -0.865 . . . . 1.5800000000000001 109.394 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.925 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -150.1 128.93 12.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.725 -0.79 . . . . 0.85999999999999999 111.879 151.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.74 125.85 54.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.959 0.885 . . . . 2.1099999999999999 111.279 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.94 104.17 14.12 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.133 -1.394 . . . . 0.37 109.575 -178.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.464 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.0 m -84.81 96.28 9.24 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.568 -0.901 . . . . 0.33000000000000002 108.568 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.64 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.7 p -77.6 113.95 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-O 123.061 1.41 . . . . 0.33000000000000002 109.18 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.719 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.0 m170 -78.55 97.24 5.69 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 112.852 -1.976 . . . . 1.1899999999999999 109.653 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 18' ' ' VAL . 34.7 tt0 -75.84 -34.57 60.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.228 -1.351 . . . . 1.6699999999999999 109.699 172.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.48 14.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 2.7799999999999998 110.84 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.505 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 26.4 mmt . . . . . 0 C--O 1.25 1.12 0 CA-C-N 115.681 -0.69 . . . . 6.9199999999999999 110.841 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.791 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 6.9 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.468 0.652 . . . . 1.9299999999999999 109.68 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -94.14 166.07 16.35 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.014 -0.994 . . . . 1.6499999999999999 111.153 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.68 84.43 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.63 2.22 . . . . 0.96999999999999997 111.948 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.857 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.0 -59.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.088 -0.96 . . . . 0.5 109.488 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.23 41.4 5.53 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 108.842 -1.703 . . . . 0.39000000000000001 108.842 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.3 tp -49.74 -38.97 35.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 112.738 -1.731 . . . . 0.33000000000000002 111.048 -172.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.653 ' HE2' ' HB3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -92.61 84.52 5.07 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.71999999999999997 109.672 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.8 -48.03 35.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.851 -1.068 . . . . 0.63 109.998 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.511 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 16.5 tpt -151.19 129.03 11.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.048 -0.978 . . . . 2.8799999999999999 108.842 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.653 ' HB3' ' HE2' ' A' ' 7' ' ' PHE . 16.3 ptm180 -88.2 144.32 34.09 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.733 -0.667 . . . . 3.6699999999999999 110.162 -176.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 59.8 Cg_endo -65.8 145.8 81.73 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.557 2.171 . . . . 0.64000000000000001 110.161 175.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.591 HE21 ' H ' ' A' ' 13' ' ' ASP . 12.6 tp60 -115.67 159.03 21.89 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 119.331 -0.366 . . . . 1.4299999999999999 111.747 -173.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.591 ' H ' HE21 ' A' ' 12' ' ' GLN . 1.3 m-20 -57.89 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 123.418 1.58 . . . . 2.0600000000000001 113.044 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.18 137.0 2.73 Favored Glycine 0 N--CA 1.436 -1.342 0 CA-C-N 112.963 -1.926 . . . . 0.29999999999999999 111.551 -174.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.434 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.7 mt-10 -116.06 114.45 24.57 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.714 -0.847 . . . . 1.53 108.714 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 22' ' ' ILE . 4.9 m -134.2 164.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 N-CA-C 107.712 -1.218 . . . . 0.27000000000000002 107.712 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.3 OUTLIER -95.21 156.73 16.2 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.886 -1.052 . . . . 0.77000000000000002 109.534 -178.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.579 HG13 ' HD3' ' A' ' 81' ' ' PRO . 42.4 t -62.56 107.02 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-O 122.754 1.264 . . . . 0.78000000000000003 109.294 175.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.08 19.09 11.09 Favored Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.912 -2.404 . . . . 0.47999999999999998 113.333 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.7 -122.58 4.84 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 119.616 -1.278 . . . . 0.44 110.009 171.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 11.9 p -150.36 165.04 34.28 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 113.087 -1.557 . . . . 0.81999999999999995 110.645 175.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.724 HG23 ' HB ' ' A' ' 76' ' ' ILE . 8.8 tp -148.08 147.48 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.333 0 CA-C-N 113.078 -1.874 . . . . 0.32000000000000001 107.18 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m -139.5 125.97 20.36 Favored 'General case' 0 C--N 1.259 -3.354 0 CA-C-N 113.74 -1.573 . . . . 0.31 110.396 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 10.2 m-85 -123.54 146.67 47.93 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.618 -1.173 . . . . 0.53000000000000003 109.458 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.483 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -126.51 129.93 49.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.038 -1.097 . . . . 0.57999999999999996 108.038 173.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.749 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . . . -130.66 125.16 33.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.57 -1.195 . . . . 0.32000000000000001 110.812 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 9' ' ' MET . 88.5 mtt180 -115.36 123.12 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.842 0.312 . . . . 2.4300000000000002 111.842 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 39' ' ' VAL . 13.2 t -121.69 128.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.775 0.798 . . . . 0.26000000000000001 109.593 178.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -57.63 107.38 0.44 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.881 -1.508 . . . . 0.40000000000000002 110.527 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.699 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -55.79 -39.1 75.93 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.731 -1.122 . . . . 0.76000000000000001 110.925 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.676 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 47.67 -163.93 0.03 OUTLIER 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.695 1.368 . . . . 0.70999999999999996 114.695 171.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -111.64 123.02 49.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.443 -1.253 . . . . 1.74 108.153 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.889 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -155.1 174.65 14.89 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.673 0.249 . . . . 2.1600000000000001 111.673 -172.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.6 tp -62.07 -47.99 82.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 1.47 109.539 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -151.15 154.59 34.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.059 -0.973 . . . . 1.3999999999999999 108.963 170.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -44.14 134.37 8.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.627 2.885 . . . . 0.88 112.049 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.889 ' HD3' HD11 ' A' ' 33' ' ' LEU . 8.7 Cg_exo -42.89 142.87 1.98 Allowed 'Trans proline' 0 CA--C 1.499 -1.232 0 C-N-CA 123.849 3.033 . . . . 0.53000000000000003 115.189 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 t -99.1 99.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 105.875 -1.898 . . . . 0.77000000000000002 105.875 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.6 t -103.42 114.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-N 113.504 -1.68 . . . . 0.28000000000000003 107.415 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.882 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -104.76 128.59 52.94 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.057 -1.429 . . . . 1.54 109.743 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.964 ' HB3' HD13 ' A' ' 49' ' ' LEU . 74.0 m95 -91.51 157.86 16.79 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 112.063 -2.335 . . . . 0.34000000000000002 111.104 172.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.744 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 30.9 t80 -139.06 125.51 20.44 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.934 -2.247 . . . . 0.62 104.934 178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.703 ' HD3' HD23 ' A' ' 57' ' ' LEU . 33.8 ttpt -103.02 100.34 10.27 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.715 -1.587 . . . . 2.1699999999999999 106.715 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 86' ' ' GLY . . . -90.38 97.46 2.33 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 115.993 -3.004 . . . . 1.23 117.293 -157.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 3.8 ptmt -99.14 -47.39 5.23 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.449 -2.797 . . . . 3.8700000000000001 103.449 137.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.927 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 9.4 p-90 -170.38 3.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 112.468 -2.151 . . . . 2.1099999999999999 111.102 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -98.82 169.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 C-N-CA 125.04 1.336 . . . . 1.29 112.981 -158.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.643 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -105.43 154.15 20.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.455 -2.157 . . . . 2.73 107.001 175.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.964 HD13 ' HB3' ' A' ' 41' ' ' TRP . 1.4 mp -89.24 -30.46 18.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 112.605 0.594 . . . . 0.44 112.605 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -57.2 -21.0 30.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.349 0.595 . . . . 1.23 109.854 -167.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.567 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 8.0 t -96.38 -22.55 17.1 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.178 -0.919 . . . . 1.3400000000000001 111.992 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HD2' ' HB3' ' A' ' 51' ' ' SER . 1.7 mmmt -106.55 -15.19 14.85 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.778 -1.101 . . . . 1.3999999999999999 111.671 -171.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.922 HG13 ' H ' ' A' ' 59' ' ' LEU . 55.7 t -59.17 89.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 114.013 -1.449 . . . . 0.37 110.213 177.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.49 -142.1 3.58 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 112.438 -2.165 . . . . 0.69999999999999996 112.988 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -67.4 -22.63 65.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.007 0.744 . . . . 2.75 113.007 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.607 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.1 p-80 -101.21 -38.02 8.29 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 120.23 -0.588 . . . . 1.3300000000000001 111.247 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.826 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.69 102.25 8.28 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.144 -1.799 . . . . 1.1100000000000001 106.144 172.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -94.41 115.02 27.15 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.724 -1.584 . . . . 0.76000000000000001 106.724 167.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.922 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -97.95 91.49 5.35 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.114 -2.55 . . . . 0.26000000000000001 104.114 167.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.727 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 34.4 m170 -90.18 162.43 15.26 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.228 -1.351 . . . . 2.0299999999999998 110.039 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -133.57 110.48 9.94 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 112.323 -2.217 . . . . 0.92000000000000004 109.866 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 14.2 m -93.95 112.36 24.19 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.89 -1.959 . . . . 0.46999999999999997 109.322 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 14.0 t80 -102.23 98.08 8.28 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.96 -1.018 . . . . 1.3899999999999999 110.212 -176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.91 107.08 15.21 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.585 -1.643 . . . . 2.4199999999999999 109.141 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.549 ' HD3' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -81.45 -32.72 32.45 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.382 -0.827 . . . . 2.46 110.968 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.67 -20.58 66.35 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.229 -0.896 . . . . 1.1499999999999999 110.527 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 m -108.66 -18.63 13.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.72 -0.844 . . . . 1.4099999999999999 108.72 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.699 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 62.99 35.65 13.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 3.3100000000000001 109.979 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -129.62 130.69 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.002 -0.999 . . . . 0.42999999999999999 108.392 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.55 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 3.9 m-30 -101.26 106.72 17.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.599 -1.63 . . . . 1.24 106.599 171.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 22.7 tp -96.12 104.42 16.37 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.189 -1.368 . . . . 0.52000000000000002 108.316 -176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.727 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.7 m-85 -83.53 113.47 20.83 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 113.819 -1.537 . . . . 0.33000000000000002 107.533 174.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 6.6 mt-10 -106.84 119.02 38.22 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 113.113 -1.858 . . . . 1.3200000000000001 108.935 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 76' ' ' ILE . 3.1 mm? -88.36 122.76 32.23 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.454 -1.313 . . . . 0.95999999999999996 107.454 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 36.8 m80 -118.31 95.67 4.98 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 104.327 -2.472 . . . . 1.1499999999999999 104.327 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 74' ' ' LEU . 39.4 mt -122.11 101.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 CA-C-O 123.041 1.4 . . . . 0.52000000000000002 110.2 -172.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 62.2 p -110.53 134.79 52.05 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-N 113.621 -1.627 . . . . 0.57999999999999996 107.692 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 77' ' ' THR . 3.5 t70 73.14 97.31 0.07 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 111.642 -2.526 . . . . 2.1200000000000001 110.024 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.74 122.77 45.14 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 110.552 -3.022 . . . . 0.40000000000000002 109.943 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.546 ' O ' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -64.24 138.26 97.37 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.153 -0.93 . . . . 1.4299999999999999 109.577 173.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.579 ' HD3' HG13 ' A' ' 18' ' ' VAL . 26.2 Cg_endo -61.44 -9.06 12.04 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.23 2.62 . . . . 1.3300000000000001 112.421 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.63 17.67 22.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.835 -0.621 . . . . 1.1200000000000001 111.441 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.753 ' HD1' ' HD2' ' A' ' 45' ' ' LYS . 1.4 m-30 -85.43 -55.33 4.06 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.91 -0.774 . . . . 1.24 108.91 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 88.7 m 28.51 63.84 0.11 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 123.183 1.468 . . . . 1.22 108.68 -161.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.751 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -66.55 91.61 0.17 Allowed Glycine 0 CA--C 1.484 -1.861 0 CA-C-N 111.975 -2.375 . . . . 1.4299999999999999 114.05 -159.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -83.61 83.74 1.6 Allowed Glycine 0 C--N 1.276 -2.768 0 N-CA-C 108.185 -1.966 . . . . 0.52000000000000002 108.185 169.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 3.7 m-85 -74.6 113.65 12.1 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.685 -1.257 . . . . 0.63 108.812 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 99.8 mtt180 -87.89 109.76 20.02 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.391 -0.966 . . . . 3.1499999999999999 108.391 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.419 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 1.6 t -95.97 122.67 39.04 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.601 -0.888 . . . . 1.0800000000000001 108.601 175.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.882 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 38.5 tt0 -137.82 107.64 6.29 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.244 -0.889 . . . . 1.8100000000000001 110.289 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.6 p -102.59 141.57 18.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.676 0.75 . . . . 0.54000000000000004 110.699 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.1 m -139.86 108.33 5.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.342 -1.299 . . . . 1.1799999999999999 108.561 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.743 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.47 145.33 51.1 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-O 117.936 -1.03 . . . . 0.73999999999999999 108.894 -179.045 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.68 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 32.95 -74.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 126.148 2.155 . . . . 0.65000000000000002 113.578 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.791 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 0.5 OUTLIER -148.16 -8.07 0.4 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.035 -0.984 . . . . 1.05 110.563 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.857 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.9 mmtm -86.05 129.53 34.81 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.432 -1.321 . . . . 1.29 107.432 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 21.3 t80 -132.33 148.39 52.43 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.85 -1.523 . . . . 0.77000000000000002 111.773 -173.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 t70 -179.0 165.39 1.52 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.207 0.942 . . . . 1.6000000000000001 110.33 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.3 m -145.22 151.73 38.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.267 -0.271 . . . . 1.1899999999999999 110.267 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.595 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 58.5 p -132.6 130.31 40.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.041 0.448 . . . . 0.83999999999999997 112.149 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -94.56 127.32 40.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.368 -0.833 . . . . 1.5800000000000001 109.393 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 87' ' ' TYR . 28.4 p90 -149.38 143.75 25.96 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.119 -0.632 . . . . 0.85999999999999999 109.872 165.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 5.9 m-80 -115.8 140.23 49.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.255 1.026 . . . . 2.1099999999999999 112.471 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -103.82 107.99 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.336 -1.302 . . . . 0.37 108.463 172.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.434 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 3.8 m -87.81 96.38 10.44 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.253 -0.647 . . . . 0.33000000000000002 109.253 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.4 p -79.41 112.78 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.25 1.5 . . . . 0.33000000000000002 108.672 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 44.0 m170 -85.65 100.34 11.91 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.527 -2.124 . . . . 1.1899999999999999 109.421 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.449 ' HA ' HG23 ' A' ' 18' ' ' VAL . 37.1 tt0 -68.45 98.52 0.86 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.805 -1.089 . . . . 1.6699999999999999 109.836 170.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.28 120.04 40.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.402 -0.817 . . . . 2.7799999999999998 110.18 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.699 -0.667 . . . . 6.9199999999999999 109.951 179.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.73 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 7.7 p-10 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.944 0.878 . . . . 1.9299999999999999 110.464 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 9.8 m-20 -84.57 167.2 28.31 Favored Pre-proline 0 N--CA 1.428 -1.574 0 CA-C-N 114.527 -1.215 . . . . 1.6499999999999999 110.067 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.38 88.18 0.33 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.311 2.007 . . . . 0.96999999999999997 111.889 172.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.92 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.6 mp -109.13 -65.16 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.378 -0.828 . . . . 0.5 109.537 177.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 93.8 49.06 2.57 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 108.595 -1.802 . . . . 0.39000000000000001 108.595 -174.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.8 tp -61.41 -33.39 73.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.083 -1.558 . . . . 0.33000000000000002 110.22 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.653 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -91.68 84.66 5.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.931 -1.031 . . . . 0.71999999999999997 110.088 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.57 -46.6 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.899 -1.046 . . . . 0.63 110.405 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.11 131.03 11.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.489 -0.778 . . . . 2.8799999999999999 109.708 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.542 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 21.2 ptt180 -108.12 142.89 26.27 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.575 -0.739 . . . . 3.6699999999999999 109.843 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.781 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 11.0 Cg_endo -73.4 158.09 48.64 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.538 1.492 . . . . 0.64000000000000001 110.82 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -116.3 -180.0 3.83 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.363 -0.606 . . . . 1.4299999999999999 109.363 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 2.0 p-10 -71.55 -148.92 0.02 OUTLIER 'General case' 0 N--CA 1.407 -2.578 0 CA-C-O 122.932 1.348 . . . . 2.0600000000000001 111.635 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.69 133.82 1.69 Allowed Glycine 0 C--N 1.293 -1.819 0 CA-C-N 113.356 -1.747 . . . . 0.29999999999999999 112.045 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.2 mt-10 -113.82 111.12 21.22 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.006 -1.097 . . . . 1.53 108.082 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.424 HG11 ' HB ' ' A' ' 22' ' ' ILE . 3.0 m -126.74 163.23 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 N-CA-C 106.666 -1.605 . . . . 0.27000000000000002 106.666 -170.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.74 154.61 17.48 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 115.404 -0.816 . . . . 0.77000000000000002 109.27 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.719 HG21 ' HG3' ' A' ' 81' ' ' PRO . 3.1 t -64.33 106.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 CA-C-O 122.719 1.247 . . . . 0.78000000000000003 108.365 174.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.13 8.64 Favored Glycine 0 C--N 1.267 -3.297 0 CA-C-N 112.378 -2.192 . . . . 0.47999999999999998 112.145 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.96 -122.28 4.82 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 108.73 -1.748 . . . . 0.44 108.73 169.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 15.2 p -151.94 171.1 18.31 Favored 'General case' 0 N--CA 1.399 -3.015 0 CA-C-N 113.344 -1.428 . . . . 0.81999999999999995 109.894 172.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 104' ' ' LEU . 10.5 tp -146.34 147.53 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 113.276 -1.783 . . . . 0.32000000000000001 107.316 166.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 m -139.03 123.96 18.8 Favored 'General case' 0 C--N 1.262 -3.214 0 CA-C-N 113.333 -1.758 . . . . 0.31 110.241 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 74' ' ' LEU . 73.1 m-85 -123.44 145.66 48.63 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.129 -1.396 . . . . 0.53000000000000003 107.769 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.795 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.3 m -138.18 124.91 20.99 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.745 0.783 . . . . 0.57999999999999996 109.439 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -116.7 115.73 26.2 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.285 -1.325 . . . . 0.32000000000000001 110.48 -177.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HE ' HG11 ' A' ' 69' ' ' VAL . 77.1 mtp180 -106.41 115.57 30.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.654 -0.248 . . . . 2.4300000000000002 110.549 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 91' ' ' VAL . 22.0 t -118.92 126.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.958 0.885 . . . . 0.26000000000000001 110.523 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -60.14 112.06 1.76 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.337 -1.756 . . . . 0.40000000000000002 110.724 173.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.53 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -45.2 -51.53 8.91 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 114.794 -1.094 . . . . 0.76000000000000001 111.269 171.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.611 ' H ' ' CG ' ' A' ' 68' ' ' LYS . . . 55.49 -155.77 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.408 0.892 . . . . 0.70999999999999996 113.408 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 p -115.68 135.92 53.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.861 -0.608 . . . . 1.74 109.953 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -155.08 -174.61 5.05 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.826 0.822 . . . . 2.1600000000000001 112.8 -175.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.3 tp -98.06 -45.17 6.35 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.27 -1.332 . . . . 1.47 108.128 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.554 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.39 139.05 29.02 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.723 -1.126 . . . . 1.3999999999999999 108.982 172.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.11 156.57 24.09 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.956 2.437 . . . . 0.88 111.103 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 93' ' ' THR . 3.3 Cg_endo -57.1 125.15 18.04 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 120.544 0.829 . . . . 0.53000000000000003 112.716 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 104.54 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.054 -1.462 . . . . 0.77000000000000002 107.054 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.5 t -102.73 114.42 42.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.832 -1.531 . . . . 0.28000000000000003 108.397 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.02 127.85 53.05 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.743 -1.571 . . . . 1.54 109.817 175.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.99 ' HB3' HD13 ' A' ' 49' ' ' LEU . 77.0 m95 -91.63 155.03 18.63 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 111.969 -2.378 . . . . 0.34000000000000002 111.677 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.642 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 39.7 t80 -133.36 139.9 47.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 104.316 -2.476 . . . . 0.62 104.316 170.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.817 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 62.9 tttp -102.51 166.61 10.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 105.721 -1.955 . . . . 2.1699999999999999 105.721 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -14.03 -167.31 0.0 OUTLIER Glycine 0 C--O 1.183 -3.088 0 N-CA-C 119.248 2.459 . . . . 1.23 119.248 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.693 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 8.4 mtpt -44.41 -8.24 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 O-C-N 119.125 -2.397 . . . . 3.8700000000000001 116.786 -164.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.517 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 9.9 p-90 -160.8 -9.33 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 114.101 1.148 . . . . 2.1099999999999999 114.101 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.817 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.92 164.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 CA-C-O 123.218 1.485 . . . . 1.29 112.481 -160.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.575 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 9.9 p-10 -111.1 158.54 18.75 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 111.815 -2.448 . . . . 2.73 106.508 172.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.091 HD23 HD21 ' A' ' 57' ' ' LEU . 5.7 mp -98.88 -28.74 13.32 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.476 -0.49 . . . . 0.44 111.792 167.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.0 t -57.3 -21.37 34.37 Favored 'General case' 0 C--N 1.315 -0.891 0 O-C-N 123.706 0.629 . . . . 1.23 109.864 -163.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.516 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 33.2 m -100.03 -35.38 9.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 122.033 0.921 . . . . 1.3400000000000001 112.224 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.575 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -88.61 -31.29 18.66 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.159 -1.382 . . . . 1.3999999999999999 111.685 -165.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.846 HG13 ' H ' ' A' ' 59' ' ' LEU . 79.2 t -35.46 94.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 125.392 1.477 . . . . 0.37 111.753 172.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.44 -95.91 0.11 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 112.501 -2.136 . . . . 0.69999999999999996 113.837 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -95.3 -45.37 7.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.944 0.72 . . . . 2.75 112.944 -172.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 31.5 p80 -88.45 -37.11 16.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.736 0.779 . . . . 1.3300000000000001 110.609 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.091 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -120.55 106.92 12.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.428 -1.693 . . . . 1.1100000000000001 106.428 176.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -100.81 116.13 31.98 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 106.63 -1.619 . . . . 0.76000000000000001 106.63 164.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.846 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -95.19 93.8 7.53 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 104.829 -2.285 . . . . 0.26000000000000001 104.829 173.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 90.3 m-70 -84.33 162.49 20.04 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.338 -1.301 . . . . 2.0299999999999998 109.887 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -140.13 114.76 9.41 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 111.986 -2.37 . . . . 0.92000000000000004 109.42 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 2.0 m -101.52 149.35 24.18 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.796 -2.002 . . . . 0.46999999999999997 108.628 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -141.29 98.62 3.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.569 1.175 . . . . 1.3899999999999999 111.251 -173.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.46 101.71 9.39 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.315 -1.766 . . . . 2.4199999999999999 109.319 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -73.85 -29.58 62.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.508 -0.769 . . . . 2.46 110.228 177.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.98 70.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.106 -0.952 . . . . 1.1499999999999999 110.668 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -103.36 -13.81 16.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.209 -0.905 . . . . 1.4099999999999999 109.455 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER 63.36 36.88 11.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.872 0.844 . . . . 3.3100000000000001 109.898 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.431 HG11 ' HE ' ' A' ' 27' ' ' ARG . 3.2 t -127.41 128.1 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.673 0.749 . . . . 0.42999999999999999 109.726 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.53 ' HE1' ' HA2' ' A' ' 30' ' ' GLY . 10.7 m-85 -98.19 113.36 25.25 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.922 -1.881 . . . . 1.24 105.922 164.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' A' ' 25' ' ' SER . 21.7 tp -99.06 106.4 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 122.217 1.008 . . . . 0.52000000000000002 109.374 174.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 55.3 m-85 -84.47 113.33 21.13 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 113.726 -1.579 . . . . 0.33000000000000002 107.953 168.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.9 116.84 32.37 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.67 -1.604 . . . . 1.3200000000000001 110.7 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.802 ' HB3' HG13 ' A' ' 76' ' ' ILE . 18.0 mt -81.97 123.65 29.07 Favored 'General case' 0 CA--C 1.475 -1.926 0 CA-C-N 115.081 -0.963 . . . . 0.95999999999999996 108.927 170.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -111.73 93.65 4.56 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 103.108 -2.923 . . . . 1.1499999999999999 103.108 163.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 74' ' ' LEU . 18.1 mt -118.39 99.96 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 122.83 1.3 . . . . 0.52000000000000002 109.255 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 67.0 p -102.85 166.51 10.43 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 114.078 -1.419 . . . . 0.57999999999999996 110.439 -176.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 41.03 67.38 0.53 Allowed 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 110.658 -2.974 . . . . 2.1200000000000001 111.551 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -62.18 120.01 10.1 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 112.894 -1.957 . . . . 0.40000000000000002 111.252 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.879 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -54.91 140.21 61.22 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.349 -0.841 . . . . 1.4299999999999999 109.728 169.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.719 ' HG3' HG21 ' A' ' 18' ' ' VAL . 23.2 Cg_exo -62.9 -10.25 19.58 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.692 2.261 . . . . 1.3300000000000001 112.465 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.879 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -98.64 10.76 40.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.962 -0.563 . . . . 1.1200000000000001 110.773 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 83' ' ' PHE . 2.8 m-30 -95.54 -10.84 28.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.722 -0.391 . . . . 1.24 110.898 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 21.8 m -46.11 101.31 0.02 OUTLIER 'General case' 0 CA--C 1.475 -1.92 0 CA-C-O 122.358 1.075 . . . . 1.22 108.802 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.693 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -172.69 -128.79 1.08 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.701 -2.045 . . . . 1.4299999999999999 113.383 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -155.95 119.03 0.88 Allowed Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 120.174 -1.013 . . . . 0.52000000000000002 112.712 -170.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.713 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 2.0 m-85 -82.81 120.94 26.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.348 -1.426 . . . . 0.63 108.212 175.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.642 ' HB3' ' HB3' ' A' ' 42' ' ' PHE . 57.7 ttt180 -110.91 104.49 13.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.976 0.417 . . . . 3.1499999999999999 110.193 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.879 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.7 t -92.19 129.86 38.04 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.05 -0.722 . . . . 1.0800000000000001 109.05 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.691 ' HG3' ' HB3' ' A' ' 99' ' ' CYS . 30.6 tt0 -140.22 106.69 5.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.477 -0.783 . . . . 1.8100000000000001 109.458 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.634 HG21 HG11 ' A' ' 28' ' ' VAL . 5.5 p -95.05 138.01 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 121.858 0.837 . . . . 0.54000000000000004 110.73 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.2 t -133.29 108.88 9.01 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.146 -1.388 . . . . 1.1799999999999999 107.94 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.599 ' OG1' HD21 ' A' ' 6' ' ' LEU . 2.4 m -127.27 170.06 12.86 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.888 -1.153 . . . . 0.73999999999999999 107.888 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.723 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 0.82 -65.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 O-C-N 125.513 1.758 . . . . 0.65000000000000002 114.555 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.73 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 1.2 t0 -148.82 -8.96 0.35 Allowed 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.837 -1.074 . . . . 1.05 109.967 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.92 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 1.2 mmtm -87.5 124.23 33.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.79 -1.189 . . . . 1.29 107.79 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -130.65 137.41 49.58 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.735 -1.12 . . . . 0.77000000000000002 111.153 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -163.07 161.85 25.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.79 -1.096 . . . . 1.6000000000000001 108.892 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.691 ' HB3' ' HG3' ' A' ' 90' ' ' GLU . 3.9 p -153.46 145.33 23.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.152 0.501 . . . . 1.1899999999999999 111.183 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.653 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 42.5 p -126.52 139.13 53.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.953 -0.567 . . . . 0.83999999999999997 111.253 -175.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.94 125.27 50.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.226 0.536 . . . . 1.5800000000000001 110.868 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.879 ' HZ ' ' HB2' ' A' ' 89' ' ' CYS . 0.3 OUTLIER -140.1 116.18 10.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.431 -0.581 . . . . 0.85999999999999999 109.431 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.574 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 51.1 m-20 -95.16 151.65 19.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.292 -0.867 . . . . 2.1099999999999999 110.846 -168.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -123.95 121.28 34.87 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.256 -0.884 . . . . 0.37 108.806 174.235 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -103.35 96.05 6.5 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.416 -0.586 . . . . 0.33000000000000002 109.416 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.594 HG11 ' O ' ' A' ' 80' ' ' GLN . 3.5 p -77.63 116.19 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 123.077 1.418 . . . . 0.33000000000000002 109.05 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 64.8 m170 -87.56 102.02 14.19 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 112.395 -2.184 . . . . 1.1899999999999999 108.275 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.609 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 33.0 tt0 -51.94 -58.59 6.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.133 -1.394 . . . . 1.6699999999999999 111.277 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.8 135.24 7.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 2.7799999999999998 110.571 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.704 -0.665 . . . . 6.9199999999999999 109.42 178.518 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.608 ' OD1' ' HE3' ' A' ' 96' ' ' LYS . 10.6 t70 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.798 0.332 . . . . 1.9299999999999999 110.283 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.801 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 2.3 m-20 -131.36 173.96 5.25 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 123.969 0.908 . . . . 1.6499999999999999 109.4 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.01 77.07 4.07 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.848 1.699 . . . . 0.96999999999999997 113.19 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.826 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -93.87 -62.6 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.315 -0.994 . . . . 0.5 108.315 171.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.7 4.64 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 109.368 -1.493 . . . . 0.39000000000000001 109.368 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.737 HD22 ' HB3' ' A' ' 96' ' ' LYS . 3.7 tp -41.04 -44.37 2.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 112.897 -1.652 . . . . 0.33000000000000002 111.421 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.691 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.1 OUTLIER -93.0 84.43 4.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.246 -0.888 . . . . 0.71999999999999997 109.793 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 27' ' ' ARG . 15.8 t -76.16 -33.06 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.018 -1.446 . . . . 0.63 109.187 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.7 tpp -167.95 137.41 2.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.095 -0.957 . . . . 2.8799999999999999 109.639 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 27.7 ptt180 -105.66 148.79 37.02 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.933 -0.576 . . . . 3.6699999999999999 110.079 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 13.5 Cg_endo -79.48 164.52 23.73 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.646 1.564 . . . . 0.64000000000000001 110.728 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -123.7 179.3 4.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.326 -0.397 . . . . 1.4299999999999999 110.337 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.2 -144.59 0.01 OUTLIER 'General case' 0 N--CA 1.41 -2.433 0 CA-C-O 122.809 1.29 . . . . 2.0600000000000001 110.98 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 152.34 132.26 1.79 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.606 -1.634 . . . . 0.29999999999999999 111.726 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.0 mt-10 -110.49 114.16 27.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.981 -1.109 . . . . 1.53 108.213 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.9 m -134.48 162.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.763 0 N-CA-C 107.821 -1.177 . . . . 0.27000000000000002 107.821 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.68 153.15 17.95 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.487 -1.233 . . . . 0.77000000000000002 108.738 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.74 HG11 ' HD3' ' A' ' 81' ' ' PRO . 5.8 t -69.0 105.01 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.826 1.298 . . . . 0.78000000000000003 107.956 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.22 12.54 5.22 Favored Glycine 0 C--N 1.267 -3.304 0 CA-C-N 112.445 -2.162 . . . . 0.47999999999999998 112.642 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.03 -122.66 5.14 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.264 -1.446 . . . . 0.44 110.366 170.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.705 ' HB3' HG22 ' A' ' 77' ' ' THR . 8.1 p -151.51 169.41 22.14 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 113.054 -1.573 . . . . 0.81999999999999995 110.329 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -148.19 149.98 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.416 0 CA-C-N 113.539 -1.664 . . . . 0.32000000000000001 107.285 168.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 m -140.15 131.49 26.75 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.022 -1.445 . . . . 0.31 110.947 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.547 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 50.0 m-85 -129.55 148.05 51.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.148 -1.387 . . . . 0.53000000000000003 108.764 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.566 ' HB3' HD11 ' A' ' 71' ' ' LEU . 3.5 m -140.08 127.33 21.17 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.879 0.847 . . . . 0.57999999999999996 109.188 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.12 117.23 24.92 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.125 -1.398 . . . . 0.32000000000000001 110.718 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 75.2 mtt180 -102.07 121.78 42.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.3 -0.409 . . . . 2.4300000000000002 110.505 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.1 t -126.06 128.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 122.082 0.944 . . . . 0.26000000000000001 110.531 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -61.36 105.39 0.5 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.444 -1.707 . . . . 0.40000000000000002 112.398 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.26 89.08 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 115.061 -0.972 . . . . 0.76000000000000001 111.745 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.851 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 57.54 -163.35 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.783 1.031 . . . . 0.70999999999999996 113.783 162.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.9 t -118.89 31.13 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.504 -0.771 . . . . 1.74 109.529 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.015 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -56.1 -175.76 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.639 1.348 . . . . 2.1600000000000001 114.639 176.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 tp -68.98 -53.95 17.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.04 -0.982 . . . . 1.47 109.593 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.632 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -139.88 146.49 47.21 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 114.846 -1.07 . . . . 1.3999999999999999 108.688 172.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -42.98 140.37 3.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.464 2.776 . . . . 0.88 111.934 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.7 Cg_endo -53.16 136.59 62.17 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.563 1.509 . . . . 0.53000000000000003 112.761 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.01 104.31 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.638 0 N-CA-C 106.157 -1.794 . . . . 0.77000000000000002 106.157 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.1 t -106.88 114.75 46.79 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 113.136 -1.847 . . . . 0.28000000000000003 107.785 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.974 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.69 125.33 50.11 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 113.825 -1.534 . . . . 1.54 109.58 174.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.997 ' HB3' HD13 ' A' ' 49' ' ' LEU . 68.0 m95 -86.45 149.1 25.23 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 111.816 -2.447 . . . . 0.34000000000000002 111.482 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.618 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 25.8 t80 -125.37 138.55 54.04 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 104.66 -2.348 . . . . 0.62 104.66 169.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 67.5 tttt -99.35 171.13 8.17 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.612 -1.996 . . . . 2.1699999999999999 105.612 -173.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.929 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -19.56 -173.59 0.0 OUTLIER Glycine 0 C--O 1.179 -3.308 0 C-N-CA 126.749 2.118 . . . . 1.23 117.878 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.649 ' HB3' ' HD1' ' A' ' 46' ' ' TRP . 7.8 ttpp -40.98 -9.56 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 117.577 2.436 . . . . 3.8700000000000001 117.577 -157.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.649 ' HD1' ' HB3' ' A' ' 45' ' ' LYS . 4.8 p-90 -161.58 -7.05 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.287 0.949 . . . . 2.1099999999999999 113.342 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -95.39 165.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 CA-C-O 123.014 1.388 . . . . 1.29 112.601 -158.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.689 ' OD2' ' HB2' ' A' ' 51' ' ' SER . 6.5 p-10 -114.05 154.3 27.95 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 112.022 -2.353 . . . . 2.73 109.284 174.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.054 HD23 HD21 ' A' ' 57' ' ' LEU . 5.6 mp -98.44 -32.24 11.59 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.774 -0.648 . . . . 0.44 111.637 169.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -59.47 -23.38 62.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.369 -0.604 . . . . 1.23 109.369 -166.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.689 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 6.2 m -102.95 -27.69 12.47 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 119.621 -0.832 . . . . 1.3400000000000001 113.023 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 11.4 mptt -80.78 -84.61 0.1 Allowed 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.716 -0.674 . . . . 1.3999999999999999 111.584 -173.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 24.7 t 21.68 95.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 126.068 2.105 . . . . 0.37 113.966 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -161.93 -99.54 0.14 Allowed Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.132 -1.395 . . . . 0.69999999999999996 113.264 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -83.2 -53.57 5.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.321 0.489 . . . . 2.75 112.321 -170.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.9 p80 -92.02 -33.83 14.67 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.235 -0.586 . . . . 1.3300000000000001 111.432 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.054 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.39 106.24 14.35 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.112 -1.81 . . . . 1.1100000000000001 106.112 174.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -101.35 116.72 33.43 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.949 -1.5 . . . . 0.76000000000000001 106.949 165.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.5 OUTLIER -97.88 92.96 6.08 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.216 -2.142 . . . . 0.26000000000000001 105.216 170.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.942 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.8 m170 -87.99 162.1 17.03 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 114.673 -1.149 . . . . 2.0299999999999998 109.912 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -142.13 115.71 9.09 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.214 -2.267 . . . . 0.92000000000000004 109.784 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.2 m -95.82 150.33 20.53 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 112.393 -2.185 . . . . 0.46999999999999997 109.038 176.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.74 100.61 5.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.517 1.151 . . . . 1.3899999999999999 111.422 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.5 t70 -114.42 114.25 25.59 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.292 -1.776 . . . . 2.4199999999999999 108.819 174.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' C ' ' H ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -87.63 -37.13 17.05 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.054 -0.975 . . . . 2.46 112.133 -177.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.15 -28.07 68.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.43 0.633 . . . . 1.1499999999999999 110.113 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -104.12 -11.86 17.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.056 -0.974 . . . . 1.4099999999999999 109.898 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.833 ' HE3' ' HA ' ' A' ' 31' ' ' ALA 0.295 0.2 OUTLIER 38.84 57.8 1.82 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 124.49 2.091 . . . . 3.3100000000000001 111.568 -166.528 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 t -122.91 115.31 45.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 112.373 -2.194 . . . . 0.42999999999999999 109.355 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 62' ' ' SER . 34.1 m-85 -91.25 105.96 18.16 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.898 -1.519 . . . . 1.24 106.898 167.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 25' ' ' SER . 32.7 tp -86.51 104.5 16.03 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.681 -1.145 . . . . 0.52000000000000002 108.522 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.653 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 80.5 m-85 -87.25 110.81 20.45 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 106.795 -1.557 . . . . 0.33000000000000002 106.795 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.942 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -114.3 125.59 54.06 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.148 -1.387 . . . . 1.3200000000000001 110.136 -176.585 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.694 HD13 HD11 ' A' ' 76' ' ' ILE . 2.6 mt -92.41 131.9 37.2 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 113.571 -1.65 . . . . 0.95999999999999996 108.437 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -119.88 97.43 5.62 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 104.491 -2.411 . . . . 1.1499999999999999 104.491 165.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.712 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 14.3 mt -123.47 99.85 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-O 122.624 1.202 . . . . 0.52000000000000002 108.871 -176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' HB3' ' A' ' 21' ' ' SER . 25.0 p -99.04 166.69 11.15 Favored 'General case' 0 N--CA 1.395 -3.22 0 CA-C-O 122.891 1.329 . . . . 0.57999999999999996 110.444 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 40.58 74.17 0.11 Allowed 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 110.361 -3.108 . . . . 2.1200000000000001 111.468 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -64.34 115.11 4.75 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.765 -2.016 . . . . 0.40000000000000002 108.701 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -67.42 159.62 76.7 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.708 -0.849 . . . . 1.4299999999999999 108.708 178.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.74 ' HD3' HG11 ' A' ' 18' ' ' VAL . 68.5 Cg_endo -73.68 156.34 49.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 120.984 1.123 . . . . 1.3300000000000001 111.394 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.4 15.5 9.56 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.747 0.655 . . . . 1.1200000000000001 110.523 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.781 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -85.29 -8.28 58.59 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.791 -0.623 . . . . 1.24 109.621 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.755 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 23.2 m -10.98 84.9 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 O-C-N 126.042 2.089 . . . . 1.22 111.974 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.929 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -46.76 118.34 3.59 Favored Glycine 0 N--CA 1.406 -3.333 0 CA-C-N 110.816 -2.902 . . . . 1.4299999999999999 113.478 -167.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.53 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -116.34 63.38 0.36 Allowed Glycine 0 C--N 1.266 -3.328 0 CA-C-N 112.545 -1.827 . . . . 0.52000000000000002 108.716 158.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 75.8 m-85 -73.02 106.78 5.04 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.204 -1.406 . . . . 0.63 107.204 175.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.618 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 55.3 mtt-85 -118.3 105.36 11.67 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.242 -0.583 . . . . 3.1499999999999999 109.967 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.672 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -89.36 124.48 34.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.861 -0.608 . . . . 1.0800000000000001 109.642 -177.06 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.974 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 36.9 tt0 -129.2 110.81 12.29 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.77 -1.104 . . . . 1.8100000000000001 109.244 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.625 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.2 p -99.97 139.95 20.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.429 0.633 . . . . 0.54000000000000004 110.151 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -137.02 110.05 7.71 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.788 -1.097 . . . . 1.1799999999999999 108.329 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.746 HG21 HD12 ' A' ' 33' ' ' LEU . 1.1 m -129.86 167.41 18.18 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.925 -0.769 . . . . 0.73999999999999999 108.925 -176.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.801 ' HZ3' ' HB2' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 6.75 -69.16 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.668 1.855 . . . . 0.65000000000000002 114.028 172.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 1' ' ' ASP . 7.5 t70 -154.23 1.98 0.23 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.672 -0.695 . . . . 1.05 109.134 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.826 ' HG3' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -91.68 136.19 33.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 122.073 0.94 . . . . 1.29 108.812 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -132.52 134.02 44.48 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 112.683 -2.053 . . . . 0.77000000000000002 111.592 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -157.0 148.07 21.89 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.813 -1.085 . . . . 1.6000000000000001 110.47 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.2 149.35 34.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.836 -0.62 . . . . 1.1899999999999999 109.838 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.691 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 80.4 p -141.41 136.12 31.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.959 0.409 . . . . 0.83999999999999997 110.386 176.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.597 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -107.53 130.09 54.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.799 -0.637 . . . . 1.5800000000000001 109.395 175.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.78 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -141.1 112.83 7.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.649 0.737 . . . . 0.85999999999999999 109.496 -177.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.769 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 61.5 m-20 -95.37 148.76 22.1 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.51 1.148 . . . . 2.1099999999999999 111.359 -167.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.807 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -119.31 108.78 15.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.052 -1.431 . . . . 0.37 110.796 177.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 7.2 m -91.54 96.92 10.74 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.687 -0.856 . . . . 0.33000000000000002 108.687 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 18' ' ' VAL . 8.0 p -86.88 120.76 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 123.096 1.427 . . . . 0.33000000000000002 109.782 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -95.41 100.97 12.66 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 112.145 -2.298 . . . . 1.1899999999999999 108.987 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.713 ' HA ' HG23 ' A' ' 18' ' ' VAL . 48.7 tt0 -64.5 -54.53 30.96 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.255 -1.339 . . . . 1.6699999999999999 110.743 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.47 14.83 0.87 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.38 -0.373 . . . . 2.7799999999999998 111.041 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.389 -0.815 . . . . 6.9199999999999999 109.848 -179.17 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 1.012 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 3.3 p-10 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.661 0.743 . . . . 1.9299999999999999 110.128 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.548 ' HB2' HD13 ' A' ' 4' ' ' ILE . 15.2 m-20 -82.58 171.18 12.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 115.434 -0.803 . . . . 1.6499999999999999 110.623 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.83 41.77 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.076 2.517 . . . . 0.96999999999999997 113.386 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.799 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.6 mp -61.59 -50.01 82.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.696 0.76 . . . . 0.5 109.537 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.21 30.55 22.23 Favored Glycine 0 CA--C 1.497 -1.064 0 N-CA-C 109.176 -1.57 . . . . 0.39000000000000001 109.176 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.001 ' HB2' ' HD3' ' A' ' 96' ' ' LYS . 10.6 tp -41.8 -54.41 3.38 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 112.981 -1.609 . . . . 0.33000000000000002 111.426 -175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.752 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.0 OUTLIER -84.57 83.89 7.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.54 0.686 . . . . 0.71999999999999997 109.801 176.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.69 -45.37 66.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.66 -1.155 . . . . 0.63 109.767 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.742 ' CG ' ' HD2' ' A' ' 27' ' ' ARG . 22.8 mmt -136.68 132.63 35.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.688 -0.687 . . . . 2.8799999999999999 110.027 172.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.745 ' HG2' ' CD2' ' A' ' 7' ' ' PHE . 88.0 mtt180 -90.98 121.82 67.47 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.052 -0.721 . . . . 3.6699999999999999 109.052 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.68 ' HG2' ' HE1' ' A' ' 102' ' ' PHE . 18.6 Cg_endo -62.21 156.75 48.68 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.858 2.372 . . . . 0.64000000000000001 110.856 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 11.1 tp60 -120.0 160.07 23.49 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 119.075 -0.488 . . . . 1.4299999999999999 112.185 -167.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.605 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -58.41 -144.77 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 123.053 1.406 . . . . 2.0600000000000001 112.611 176.126 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 151.38 135.31 2.29 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 113.404 -1.726 . . . . 0.29999999999999999 111.951 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 26.2 mt-10 -111.03 118.74 36.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.476 -0.935 . . . . 1.53 108.476 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 22' ' ' ILE . 2.3 m -139.23 162.97 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.702 0 N-CA-C 107.706 -1.22 . . . . 0.27000000000000002 107.706 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.768 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.19 158.11 15.75 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.142 -0.936 . . . . 0.77000000000000002 109.489 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 106' ' ' VAL . 10.1 t -66.18 107.68 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 122.993 1.378 . . . . 0.78000000000000003 108.365 172.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.64 12.2 10.71 Favored Glycine 0 C--N 1.269 -3.159 0 CA-C-N 112.097 -2.32 . . . . 0.47999999999999998 112.833 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.35 -124.7 5.09 Favored Glycine 0 N--CA 1.418 -2.507 0 C-N-CA 119.314 -1.422 . . . . 0.44 110.09 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 71.2 m -154.49 171.0 20.09 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 113.271 -1.465 . . . . 0.81999999999999995 109.19 175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.598 HG21 HD13 ' A' ' 104' ' ' LEU . 9.9 tp -149.11 149.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.337 0 CA-C-O 122.719 1.247 . . . . 0.32000000000000001 107.78 170.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -140.42 125.42 18.43 Favored 'General case' 0 C--N 1.261 -3.241 0 CA-C-N 113.669 -1.605 . . . . 0.31 110.454 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' HB2' HD23 ' A' ' 74' ' ' LEU . 22.1 m-85 -120.03 152.25 37.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.325 -1.307 . . . . 0.53000000000000003 108.049 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -139.54 129.6 25.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.787 -0.82 . . . . 0.57999999999999996 108.787 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -133.2 122.18 23.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.803 -1.089 . . . . 0.32000000000000001 110.695 -176.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.742 ' HD2' ' CG ' ' A' ' 9' ' ' MET . 60.4 mtt180 -107.93 122.64 47.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.665 -0.243 . . . . 2.4300000000000002 111.015 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 39' ' ' VAL . 6.6 t -121.23 125.79 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 121.997 0.903 . . . . 0.26000000000000001 110.132 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -56.35 113.14 1.45 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.594 -1.639 . . . . 0.40000000000000002 112.575 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.76 -58.07 12.47 Favored Glycine 0 C--O 1.225 -0.422 0 CA-C-N 114.589 -1.187 . . . . 0.76000000000000001 111.334 170.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.737 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 67.48 -174.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.303 1.223 . . . . 0.70999999999999996 114.303 167.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.6 t -110.09 25.68 11.51 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.001 -1.0 . . . . 1.74 109.185 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.96 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -55.05 171.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.701 -1.136 . . . . 2.1600000000000001 112.889 177.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.1 tp -50.95 -54.91 20.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.669 -0.696 . . . . 1.47 110.415 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.584 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -147.87 155.5 44.35 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 108.212 -1.033 . . . . 1.3999999999999999 108.212 172.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -39.67 138.31 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.459 2.773 . . . . 0.88 112.681 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.96 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.9 Cg_exo -55.54 139.28 82.38 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.939 1.759 . . . . 0.53000000000000003 112.312 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG2' ' HE2' ' A' ' 35' ' ' LYS . 2.2 t -98.47 104.76 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 N-CA-C 105.904 -1.888 . . . . 0.77000000000000002 105.904 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.703 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.3 t -112.26 113.57 44.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.195 -1.82 . . . . 0.28000000000000003 107.445 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.591 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.73 126.71 51.04 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 123.182 1.467 . . . . 1.54 109.346 174.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.071 ' HB3' HD13 ' A' ' 49' ' ' LEU . 76.2 m95 -84.17 152.01 24.53 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 112.03 -2.35 . . . . 0.34000000000000002 110.957 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 41.6 t80 -130.04 136.46 49.41 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 104.747 -2.316 . . . . 0.62 104.747 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.75 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 59.0 tttp -102.77 168.18 9.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.013 -2.218 . . . . 2.1699999999999999 105.013 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.993 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -9.5 -172.59 0.0 OUTLIER Glycine 0 C--O 1.183 -3.074 0 N-CA-C 119.808 2.683 . . . . 1.23 119.808 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.7 mtpp -45.82 -3.86 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 116.375 1.991 . . . . 3.8700000000000001 116.375 -165.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 7.5 p-90 -163.76 -6.77 0.03 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.323 1.231 . . . . 2.1099999999999999 114.323 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -94.34 167.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-O 123.41 1.576 . . . . 1.29 112.499 -162.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.1 t70 -113.84 154.12 28.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 111.585 -2.552 . . . . 2.73 105.548 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.071 HD13 ' HB3' ' A' ' 41' ' ' TRP . 2.2 mp -93.75 -37.91 11.56 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 118.362 0.528 . . . . 0.44 112.095 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.0 t -58.94 -21.05 57.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.754 0.788 . . . . 1.23 108.88 -169.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -84.34 -32.74 24.1 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 114.356 -1.293 . . . . 1.3400000000000001 112.811 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.751 ' HB2' HD12 ' A' ' 57' ' ' LEU . 15.4 mmmt -104.5 -25.43 12.78 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.245 -0.889 . . . . 1.3999999999999999 111.323 -167.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 49' ' ' LEU . 43.4 t -43.12 89.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 113.365 -1.743 . . . . 0.37 111.479 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -154.44 -113.84 0.5 Allowed Glycine 0 C--N 1.304 -1.241 0 CA-C-N 112.209 -2.269 . . . . 0.69999999999999996 112.602 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -89.4 -30.85 18.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.195 0.497 . . . . 2.75 112.022 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 33.8 p80 -90.23 -37.2 14.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.672 0.749 . . . . 1.3300000000000001 111.017 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.968 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.36 106.35 9.43 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.317 -1.734 . . . . 1.1100000000000001 106.317 174.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -95.81 115.46 27.46 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.606 -1.628 . . . . 0.76000000000000001 106.606 165.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -99.74 92.44 5.32 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 104.411 -2.441 . . . . 0.26000000000000001 104.411 170.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.633 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 63.7 m170 -81.74 161.9 23.14 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.627 -1.17 . . . . 2.0299999999999998 110.114 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -133.04 112.93 12.22 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 112.592 -2.094 . . . . 0.92000000000000004 108.711 169.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 1.4 m -93.9 148.82 21.78 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 112.982 -1.917 . . . . 0.46999999999999997 107.408 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -139.46 97.78 3.35 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.575 1.179 . . . . 1.3899999999999999 110.926 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.65 120.54 39.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 112.846 -1.979 . . . . 2.4199999999999999 109.338 176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -82.57 -34.94 27.58 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.573 -1.648 . . . . 2.46 111.38 -176.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.583 -0.735 . . . . 1.1499999999999999 110.35 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 69' ' ' VAL . 18.9 t -94.52 -17.55 22.29 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.423 -0.808 . . . . 1.4099999999999999 108.904 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.737 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 13.7 ttpt 62.05 37.25 14.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.024 -0.989 . . . . 3.3100000000000001 108.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 67' ' ' SER . 38.0 t -128.83 131.39 68.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.369 1.081 . . . . 0.42999999999999999 111.053 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 2.2 m-30 -94.96 105.19 17.09 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 105.888 -1.893 . . . . 1.24 105.888 162.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 13.3 tp -96.55 105.24 17.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.479 1.133 . . . . 0.52000000000000002 108.855 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.7 m-85 -85.22 114.58 22.43 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.33000000000000002 107.846 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -107.06 119.86 40.52 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.587 -1.642 . . . . 1.3200000000000001 108.998 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.83 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.7 mm? -92.81 120.9 33.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.629 -1.169 . . . . 0.95999999999999996 107.919 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.67 95.61 5.33 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 104.593 -2.373 . . . . 1.1499999999999999 104.593 167.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.63 HG12 HD23 ' A' ' 57' ' ' LEU . 66.4 mt -120.63 100.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 114.491 -1.231 . . . . 0.52000000000000002 109.152 -177.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 28.9 p -104.84 159.81 15.5 Favored 'General case' 0 N--CA 1.393 -3.32 0 CA-C-N 114.526 -1.216 . . . . 0.57999999999999996 109.183 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.55 74.03 0.22 Allowed 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 111.611 -2.54 . . . . 2.1200000000000001 111.158 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -65.37 123.54 19.87 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.228 -1.805 . . . . 0.40000000000000002 111.327 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.885 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.8 OUTLIER -60.59 137.0 92.64 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.477 -0.783 . . . . 1.4299999999999999 109.739 170.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.885 ' HD2' HE21 ' A' ' 80' ' ' GLN . 35.4 Cg_endo -65.0 -3.36 6.96 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.32 2.68 . . . . 1.3300000000000001 113.197 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.552 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -111.01 13.01 22.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.171 -0.468 . . . . 1.1200000000000001 111.102 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' THR . 2.3 m-30 -86.93 -37.32 17.72 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 118.502 -0.761 . . . . 1.24 111.002 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.653 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 88.8 m 12.04 73.84 0.01 OUTLIER 'General case' 0 C--N 1.347 0.497 0 O-C-N 125.195 1.559 . . . . 1.22 110.647 -168.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.824 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -36.55 124.53 0.91 Allowed Glycine 0 N--CA 1.412 -2.926 0 CA-C-N 111.979 -2.373 . . . . 1.4299999999999999 115.211 -163.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.993 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -123.59 68.56 0.47 Allowed Glycine 0 C--N 1.262 -3.54 0 CA-C-N 111.648 -2.276 . . . . 0.52000000000000002 108.23 158.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.736 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 74.1 m-85 -75.07 108.53 7.87 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.094 -1.053 . . . . 0.63 108.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.634 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 25.0 mtp180 -109.33 106.88 16.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.724 -0.472 . . . . 3.1499999999999999 109.724 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -91.04 116.1 28.53 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.627 -0.509 . . . . 1.0800000000000001 109.627 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 34.4 mt-10 -122.61 103.03 8.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.52 -0.764 . . . . 1.8100000000000001 109.144 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.703 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.3 p -95.01 143.64 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.077 0.465 . . . . 0.54000000000000004 109.751 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 t -140.35 108.37 5.73 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.755 -0.832 . . . . 1.1799999999999999 108.755 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.746 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -133.83 152.23 51.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 117.798 -1.096 . . . . 0.73999999999999999 108.639 178.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 25.32 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 O-C-N 125.599 1.812 . . . . 0.65000000000000002 114.572 178.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.674 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 25.2 t70 -145.55 -11.67 0.52 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.432 -1.258 . . . . 1.05 110.009 -174.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.012 ' HG2' ' HB2' ' A' ' 1' ' ' ASP . 2.4 mttp -90.77 124.64 35.29 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.462 -0.94 . . . . 1.29 108.462 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -131.31 127.94 38.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.251 -1.34 . . . . 0.77000000000000002 109.793 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 16.1 m-20 -143.12 139.5 30.43 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.098 -1.41 . . . . 1.6000000000000001 108.808 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 10.0 p -135.08 145.3 47.8 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.168 0.508 . . . . 1.1899999999999999 109.791 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.752 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 91.5 p -131.9 126.5 34.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.49 -0.777 . . . . 0.83999999999999997 110.462 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.09 119.05 36.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 1.5800000000000001 111.122 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.68 ' HE1' ' HG2' ' A' ' 11' ' ' PRO . 30.0 p90 -143.61 147.05 33.78 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.52 -0.548 . . . . 0.85999999999999999 109.52 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.772 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 11.4 p30 -104.04 151.81 22.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 122.635 1.207 . . . . 2.1099999999999999 112.022 -174.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.616 ' HB3' ' HE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -116.06 99.35 7.19 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 113.472 -1.695 . . . . 0.37 108.86 167.152 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.432 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 29.8 m -81.41 96.94 7.52 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.211 -1.033 . . . . 0.33000000000000002 108.211 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 18' ' ' VAL . 3.9 p -81.27 112.54 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 123.099 1.428 . . . . 0.33000000000000002 108.751 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.768 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 14.1 m-70 -77.49 97.9 5.15 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 112.441 -2.163 . . . . 1.1899999999999999 109.222 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -88.47 -76.21 0.4 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.821 -1.536 . . . . 1.6699999999999999 110.296 173.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.69 177.44 4.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.064 -0.516 . . . . 2.7799999999999998 110.684 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.42 -0.8 . . . . 6.9199999999999999 109.847 177.482 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.962 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 2.1 m-20 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.246 0.546 . . . . 1.9299999999999999 110.65 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.532 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 16.7 m-20 -83.22 172.97 8.21 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 115.266 -0.879 . . . . 1.6499999999999999 108.651 168.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 39.2 Cg_endo -69.74 81.28 0.82 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 121.652 1.568 . . . . 0.96999999999999997 113.077 176.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.997 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.9 mp -109.18 -70.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.313 -0.858 . . . . 0.5 109.82 176.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 89.76 51.01 2.96 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.816 -1.714 . . . . 0.39000000000000001 108.816 -172.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 4' ' ' ILE . 6.0 tp -51.73 -40.26 59.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.209 -1.495 . . . . 0.33000000000000002 110.312 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.778 ' HE2' ' HB2' ' A' ' 100' ' ' SER . 0.6 OUTLIER -86.2 85.17 7.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.307 -0.86 . . . . 0.71999999999999997 110.461 174.473 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.26 -42.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.218 -1.356 . . . . 0.63 109.207 175.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.402 ' CB ' ' HD2' ' A' ' 27' ' ' ARG . 25.3 ttt -148.68 130.2 14.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.035 -0.984 . . . . 2.8799999999999999 108.35 173.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 31.4 ptt180 -105.25 129.31 24.97 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 116.007 -0.542 . . . . 3.6699999999999999 111.137 -174.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.635 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.7 Cg_endo -60.98 158.18 35.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.656 2.237 . . . . 0.64000000000000001 112.122 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.503 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.4 mm-40 -126.68 174.61 8.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 1.4299999999999999 111.37 -171.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' N ' ' HB2' ' A' ' 102' ' ' PHE . 3.3 p-10 -69.72 -149.63 0.01 OUTLIER 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.66 1.219 . . . . 2.0600000000000001 111.87 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 154.62 134.35 1.9 Allowed Glycine 0 C--N 1.298 -1.583 0 CA-C-N 113.703 -1.589 . . . . 0.29999999999999999 112.719 -174.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.502 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 6.1 mp0 -109.75 112.62 24.78 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.577 -1.312 . . . . 1.53 107.632 175.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.01 164.92 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 N-CA-C 108.141 -1.059 . . . . 0.27000000000000002 108.141 -172.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.7 154.72 17.07 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.778 -1.101 . . . . 0.77000000000000002 109.69 178.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 106' ' ' VAL . 88.4 t -69.71 104.78 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 122.939 1.352 . . . . 0.78000000000000003 108.517 174.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.21 4.1 9.37 Favored Glycine 0 C--N 1.275 -2.836 0 CA-C-N 112.217 -2.265 . . . . 0.47999999999999998 112.816 174.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -120.17 3.12 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 108.901 -1.68 . . . . 0.44 108.901 171.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.651 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.2 p -151.59 174.05 13.91 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 113.102 -1.549 . . . . 0.81999999999999995 110.368 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.452 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.0 tp -146.64 146.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.348 0 CA-C-N 113.213 -1.812 . . . . 0.32000000000000001 106.336 166.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.5 m -139.21 128.0 23.42 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 114.105 -1.407 . . . . 0.31 111.157 -172.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.798 ' HD2' HD12 ' A' ' 74' ' ' LEU . 34.3 m-85 -126.14 141.46 51.93 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.885 -1.507 . . . . 0.53000000000000003 109.726 177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -131.91 118.81 20.29 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.805 0.812 . . . . 0.57999999999999996 109.715 175.426 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.635 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -113.71 113.17 24.62 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.414 -1.266 . . . . 0.32000000000000001 109.203 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HB3' ' CG1' ' A' ' 69' ' ' VAL . 99.3 mtt180 -102.66 117.8 35.45 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.952 -0.388 . . . . 2.4300000000000002 109.952 -176.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 11.9 t -115.33 125.39 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 122.348 1.07 . . . . 0.26000000000000001 110.307 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.75 107.69 0.55 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 112.92 -1.945 . . . . 0.40000000000000002 110.384 176.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.541 ' C ' ' HE3' ' A' ' 68' ' ' LYS . . . -51.53 -40.59 47.53 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.668 -1.151 . . . . 0.76000000000000001 111.775 173.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 42.77 -140.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.15 1.167 . . . . 0.70999999999999996 114.15 172.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -134.54 132.31 38.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.398 -0.819 . . . . 1.74 109.555 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -156.89 -174.31 4.87 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.142 -0.481 . . . . 2.1600000000000001 111.795 -173.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 tp -74.87 -51.98 12.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.029 -0.987 . . . . 1.47 108.838 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -141.7 151.16 59.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.311 -0.858 . . . . 1.3999999999999999 109.475 176.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.47 138.92 7.29 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.593 2.862 . . . . 0.88 112.914 -176.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 93' ' ' THR . 2.3 Cg_endo -45.68 133.13 13.45 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 123.311 2.674 . . . . 0.53000000000000003 113.351 -177.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.35 105.29 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.697 -1.594 . . . . 0.77000000000000002 106.697 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.773 HG13 ' HB ' ' A' ' 91' ' ' VAL . 1.9 t -105.42 114.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 113.566 -1.652 . . . . 0.28000000000000003 107.344 178.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.828 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -97.58 122.41 40.62 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-O 123.248 1.499 . . . . 1.54 109.294 173.846 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.993 ' HB3' HD13 ' A' ' 49' ' ' LEU . 63.4 m95 -88.32 153.15 21.43 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 111.769 -2.469 . . . . 0.34000000000000002 110.97 173.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 39.0 t80 -131.39 134.46 46.28 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 104.432 -2.432 . . . . 0.62 104.432 173.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.796 ' HZ3' ' HB ' ' A' ' 47' ' ' VAL . 1.8 ttpm? -100.76 163.3 12.38 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.969 -1.863 . . . . 2.1699999999999999 105.969 -175.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 43' ' ' LYS . . . -9.77 -165.02 0.0 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.938 2.335 . . . . 1.23 118.938 -177.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.66 ' N ' ' HA3' ' A' ' 85' ' ' GLY . 5.6 mtpp -44.28 -6.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 O-C-N 119.541 -2.152 . . . . 3.8700000000000001 116.68 -166.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.631 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.4 p-90 -165.58 -9.13 0.02 OUTLIER 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.955 1.465 . . . . 2.1099999999999999 114.955 -177.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.796 ' HB ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.0 167.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 CA-C-O 123.814 1.769 . . . . 1.29 113.215 -162.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.676 ' OD2' ' HD3' ' A' ' 52' ' ' LYS . 2.6 p-10 -109.67 155.9 20.91 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 110.994 -2.821 . . . . 2.73 107.164 174.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.9 mp -99.15 -36.81 9.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.014 0.746 . . . . 0.44 113.014 168.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.7 t -57.84 -21.21 41.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.255 0.55 . . . . 1.23 109.811 -162.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.55 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 52.3 m -99.1 -21.48 16.15 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 115.476 -0.784 . . . . 1.3400000000000001 112.842 -176.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.676 ' HD3' ' OD2' ' A' ' 48' ' ' ASP . 6.7 mmmt -100.34 -36.38 9.27 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.306 -0.861 . . . . 1.3999999999999999 111.184 -170.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.852 HG13 ' H ' ' A' ' 59' ' ' LEU . 74.0 t -31.63 94.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 113.373 -1.74 . . . . 0.37 111.993 175.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -162.74 -122.85 0.63 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 111.864 -2.425 . . . . 0.69999999999999996 112.197 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.77 -47.1 79.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.748 1.018 . . . . 2.75 113.748 -169.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.589 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.7 p80 -92.27 -35.33 13.83 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.256 0.55 . . . . 1.3300000000000001 111.415 -174.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.975 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -119.56 105.27 11.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.564 -1.643 . . . . 1.1100000000000001 106.564 175.358 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.23 115.57 27.63 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 106.844 -1.539 . . . . 0.76000000000000001 106.844 164.227 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.852 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -98.97 90.71 4.72 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 103.45 -2.796 . . . . 0.26000000000000001 103.45 167.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.613 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 29.9 t-80 -103.01 160.29 14.76 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.171 -1.377 . . . . 2.0299999999999998 108.972 -173.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -130.48 113.93 14.89 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 112.295 -2.229 . . . . 0.92000000000000004 110.393 -176.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -90.84 143.58 26.58 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 111.737 -2.483 . . . . 0.46999999999999997 107.136 171.3 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.544 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 2.0 t80 -140.84 98.88 3.48 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.082 0.944 . . . . 1.3899999999999999 111.687 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -118.11 129.87 55.79 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.169 -1.378 . . . . 2.4199999999999999 109.887 170.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.497 ' HA ' ' HZ3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -88.93 -38.92 14.13 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.037 -1.438 . . . . 2.46 112.616 -177.414 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.73 81.56 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.658 0.599 . . . . 1.1499999999999999 111.351 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.2 p -92.05 -17.38 25.11 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.28 -1.378 . . . . 1.4099999999999999 107.28 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.676 ' NZ ' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 69.19 30.99 4.14 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.526 -1.67 . . . . 3.3100000000000001 109.712 171.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 2.9 t -122.93 123.9 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 122.159 0.98 . . . . 0.42999999999999999 109.991 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.544 ' CE1' ' HD1' ' A' ' 63' ' ' TYR . 3.9 m-30 -104.13 105.81 16.09 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.926 -1.488 . . . . 1.24 107.035 170.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 25' ' ' SER . 29.5 tp -90.31 106.79 18.73 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.474 -1.239 . . . . 0.52000000000000002 109.525 -176.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.613 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 82.6 m-85 -87.77 112.04 22.0 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.342 -1.725 . . . . 0.33000000000000002 106.342 169.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 6.9 pt-20 -118.1 125.16 49.73 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.621 -1.627 . . . . 1.3200000000000001 110.131 -171.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.798 HD12 ' HD2' ' A' ' 24' ' ' PHE . 1.3 mt -89.98 124.99 35.21 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.485 -1.234 . . . . 0.95999999999999996 108.562 174.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -112.49 96.36 5.95 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 104.081 -2.563 . . . . 1.1499999999999999 104.081 166.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG13 ' HB3' ' A' ' 74' ' ' LEU . 12.1 mt -122.4 100.67 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 123.285 1.517 . . . . 0.52000000000000002 108.743 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 51.1 p -112.54 157.1 21.56 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-N 113.456 -1.702 . . . . 0.57999999999999996 109.29 -172.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 t70 65.12 39.71 5.42 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.89 -2.414 . . . . 2.1200000000000001 108.798 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -44.28 120.86 2.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 111.997 -2.365 . . . . 0.40000000000000002 110.388 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -87.59 156.66 53.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.33 -0.989 . . . . 1.4299999999999999 108.33 -177.867 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.812 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 50.4 Cg_endo -69.27 -3.48 11.77 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 121.296 1.331 . . . . 1.3300000000000001 113.139 -170.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.54 7.57 44.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.112 -0.494 . . . . 1.1200000000000001 110.212 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -92.78 -20.55 20.63 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.173 -0.467 . . . . 1.24 111.002 -176.357 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 45.2 m -49.03 103.22 0.04 OUTLIER 'General case' 0 CA--C 1.473 -2.014 0 CA-C-O 122.509 1.147 . . . . 1.22 108.552 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.66 ' HA3' ' N ' ' A' ' 45' ' ' LYS . . . -174.64 -130.71 1.32 Allowed Glycine 0 C--N 1.265 -3.371 0 CA-C-N 112.364 -2.198 . . . . 1.4299999999999999 112.964 178.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -153.52 118.23 0.86 Allowed Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.244 -0.979 . . . . 0.52000000000000002 112.157 -172.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.763 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 1.4 m-85 -87.12 124.34 33.15 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.078 -1.453 . . . . 0.63 107.078 175.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' A' ' 101' ' ' ASN . 44.1 mtp180 -122.42 124.43 43.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.422 0.555 . . . . 3.1499999999999999 111.698 -175.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.489 ' SG ' ' HE1' ' A' ' 102' ' ' PHE . 4.0 m -97.0 131.09 44.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.012 -0.54 . . . . 1.0800000000000001 109.856 176.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.828 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 49.0 mt-10 -132.14 103.34 6.2 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.685 -0.857 . . . . 1.8100000000000001 108.685 170.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.773 ' HB ' HG13 ' A' ' 39' ' ' VAL . 4.3 p -93.17 138.24 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.561 0.696 . . . . 0.54000000000000004 110.089 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.1 m -132.59 107.81 8.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.701 -1.136 . . . . 1.1799999999999999 108.903 -176.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.608 ' OG1' HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -132.08 157.97 42.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 117.669 -1.158 . . . . 0.73999999999999999 108.51 -179.648 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.722 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 20.13 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 125.574 1.797 . . . . 0.65000000000000002 114.276 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.722 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -146.92 -3.52 0.58 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.989 -1.005 . . . . 1.05 110.001 -177.479 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.997 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 4.9 mmmt -96.29 133.65 40.38 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.88 0.848 . . . . 1.29 109.56 -175.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.69 131.27 44.74 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 113.497 -1.683 . . . . 0.77000000000000002 110.892 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.435 ' HB3' ' CG ' ' A' ' 7' ' ' PHE . 28.8 m-20 -144.85 140.83 28.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.428 -1.26 . . . . 1.6000000000000001 108.702 176.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.7 p -138.3 154.06 49.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.254 0.55 . . . . 1.1899999999999999 111.118 -176.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.778 ' HB2' ' HE2' ' A' ' 7' ' ' PHE . 36.2 t -136.12 149.35 48.64 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.205 1.002 . . . . 0.83999999999999997 111.246 177.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -134.31 109.72 9.01 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.322 -1.763 . . . . 1.5800000000000001 109.466 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 87' ' ' TYR . 29.4 p90 -140.81 132.55 27.35 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.217 -0.66 . . . . 0.85999999999999999 109.217 -174.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 2.1 p-10 -102.42 153.15 20.31 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-O 122.39 1.091 . . . . 2.1099999999999999 111.317 -171.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -121.33 120.78 36.07 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.427 -1.261 . . . . 0.37 108.526 172.716 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 5.9 m -100.16 96.11 7.27 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.749 -0.834 . . . . 0.33000000000000002 108.749 174.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.551 HG11 ' O ' ' A' ' 80' ' ' GLN . 9.5 p -84.27 116.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 123.485 1.612 . . . . 0.33000000000000002 109.339 179.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -91.39 100.29 13.1 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 112.504 -2.134 . . . . 1.1899999999999999 109.976 -175.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.812 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 9.9 tt0 -73.57 -67.22 0.61 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.923 -1.035 . . . . 1.6699999999999999 109.556 170.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.85 -175.03 3.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.288 -0.869 . . . . 2.7799999999999998 109.504 178.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.753 -0.641 . . . . 6.9199999999999999 109.738 178.545 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.748 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 1.6 m-20 . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 120.844 0.354 . . . . 1.9299999999999999 110.96 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.54 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-20 -87.81 175.76 3.96 Favored Pre-proline 0 N--CA 1.438 -1.051 0 CA-C-N 116.004 -0.544 . . . . 1.6499999999999999 109.822 170.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 73.5 Cg_endo -77.21 59.48 6.61 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 121.852 1.701 . . . . 0.96999999999999997 112.862 177.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.925 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -75.15 -63.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.228 -0.896 . . . . 0.5 109.457 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.61 41.29 5.75 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 107.812 -2.115 . . . . 0.39000000000000001 107.812 -175.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.697 HD13 HG21 ' A' ' 4' ' ' ILE . 8.4 tp -49.25 -46.37 46.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.573 -1.814 . . . . 0.33000000000000002 110.643 -171.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.675 ' HD2' ' HE ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -88.65 84.91 6.72 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.827 0.822 . . . . 0.71999999999999997 109.863 171.806 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -67.37 -37.82 79.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.24 -1.345 . . . . 0.63 109.285 178.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 tpp -148.65 132.92 17.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.837 -1.074 . . . . 2.8799999999999999 108.307 171.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.675 ' HE ' ' HD2' ' A' ' 7' ' ' PHE . 38.1 mtt180 -96.24 130.81 30.03 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.886 0.374 . . . . 3.6699999999999999 110.873 -174.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 13.9 Cg_endo -60.22 153.26 60.38 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.093 2.528 . . . . 0.64000000000000001 111.794 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.482 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.1 mm-40 -124.67 170.19 11.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.01 -0.541 . . . . 1.4299999999999999 111.999 -172.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.498 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 4.1 p-10 -70.83 -145.75 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.321 0 C-N-CA 124.673 1.189 . . . . 2.0600000000000001 113.076 -175.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.76 133.1 1.58 Allowed Glycine 0 C--N 1.307 -1.06 0 CA-C-N 113.708 -1.587 . . . . 0.29999999999999999 114.015 -176.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.499 ' HG3' ' HB ' ' A' ' 105' ' ' THR . 1.7 mp0 -106.47 111.36 23.9 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.689 -1.256 . . . . 1.53 109.083 175.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.534 HG11 ' HB ' ' A' ' 22' ' ' ILE . 1.9 m -137.43 163.04 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.619 0 N-CA-C 108.155 -1.054 . . . . 0.27000000000000002 108.155 -174.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.448 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.13 156.26 16.39 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 114.78 -1.1 . . . . 0.77000000000000002 109.677 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.883 HG21 ' HB3' ' A' ' 81' ' ' PRO . 24.9 t -69.93 107.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 CA-C-O 123.056 1.407 . . . . 0.78000000000000003 109.171 176.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.65 -0.6 15.67 Favored Glycine 0 C--N 1.266 -3.359 0 CA-C-N 111.957 -2.383 . . . . 0.47999999999999998 112.221 176.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 -126.14 3.76 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 109.101 -1.6 . . . . 0.44 109.101 172.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 9.3 p -151.68 167.9 26.7 Favored 'General case' 0 N--CA 1.398 -3.037 0 CA-C-N 112.985 -1.608 . . . . 0.81999999999999995 111.042 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.693 HG21 HD13 ' A' ' 104' ' ' LEU . 7.8 tp -146.11 147.77 17.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 113.291 -1.777 . . . . 0.32000000000000001 108.42 170.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 m -139.88 130.6 25.87 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 113.239 -1.8 . . . . 0.31 110.399 -175.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' HD2' ' HG ' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -128.58 160.49 32.23 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.921 -1.036 . . . . 0.53000000000000003 108.753 169.8 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.73 129.27 22.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.968 -1.015 . . . . 0.57999999999999996 108.866 178.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.659 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.61 127.59 46.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.736 -0.666 . . . . 0.32000000000000001 111.138 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -108.64 121.32 44.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.06 -0.518 . . . . 2.4300000000000002 110.557 -177.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 14.6 t -123.44 127.94 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.258 1.028 . . . . 0.26000000000000001 110.508 -176.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.502 ' HB1' ' CE ' ' A' ' 68' ' ' LYS . . . -61.18 110.21 1.33 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.113 -1.858 . . . . 0.40000000000000002 113.212 -177.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' HE1' ' A' ' 70' ' ' TYR . . . -54.36 -48.57 63.86 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 114.587 -1.188 . . . . 0.76000000000000001 112.184 171.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.786 ' H ' ' HG2' ' A' ' 68' ' ' LYS . . . 56.74 -170.23 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.734 0.814 . . . . 0.70999999999999996 112.87 173.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -114.11 35.7 4.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.243 1.021 . . . . 1.74 108.459 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.0 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.18 172.97 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.015 -1.448 . . . . 2.1600000000000001 113.358 177.394 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.75 -49.62 76.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.343 0.592 . . . . 1.47 110.307 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.673 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -144.8 150.09 45.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 108.041 -1.096 . . . . 1.3999999999999999 108.041 174.057 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -44.91 142.14 5.49 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.416 2.744 . . . . 0.88 111.588 -177.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.0 ' HD3' HD11 ' A' ' 33' ' ' LEU . 6.4 Cg_exo -54.54 137.45 73.0 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.138 1.225 . . . . 0.53000000000000003 112.836 -174.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 35' ' ' LYS . 3.6 t -99.13 104.68 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.632 0 N-CA-C 105.708 -1.96 . . . . 0.77000000000000002 105.708 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.704 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 t -111.54 113.57 44.61 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.596 -1.638 . . . . 0.28000000000000003 107.594 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -103.95 130.99 51.62 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 123.389 1.566 . . . . 1.54 109.751 173.173 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.05 ' HB3' HD13 ' A' ' 49' ' ' LEU . 81.9 m95 -91.23 157.25 17.27 Favored 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 111.859 -2.428 . . . . 0.34000000000000002 111.259 173.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 27.1 t80 -131.47 130.71 42.8 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.564 -2.013 . . . . 0.62 105.564 175.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 31.7 ttpt -109.05 104.83 14.11 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.25 -1.759 . . . . 2.1699999999999999 106.25 -176.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.26 91.65 1.67 Allowed Glycine 0 CA--C 1.481 -2.044 0 C-N-CA 115.906 -3.045 . . . . 1.23 114.112 -164.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 1.012 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -105.04 -27.44 11.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 104.104 -2.554 . . . . 3.8700000000000001 104.104 139.549 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 1.012 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 27.5 p-90 160.2 -20.19 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.078 -2.328 . . . . 2.1099999999999999 111.529 -165.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG21 ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -92.53 169.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 123.046 1.403 . . . . 1.29 112.539 -163.658 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 10.3 t70 -113.11 133.89 54.8 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 111.617 -2.538 . . . . 2.73 107.04 175.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.05 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.8 mp -69.85 -35.3 74.62 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 119.169 -0.443 . . . . 0.44 111.869 -175.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 m -58.27 -20.01 39.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.543 0.687 . . . . 1.23 109.817 -167.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.1 m -98.4 -18.86 18.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.973 -1.012 . . . . 1.3400000000000001 112.424 -176.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -100.42 -70.27 0.74 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.876 -0.602 . . . . 1.3999999999999999 111.118 -176.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.844 HG13 ' H ' ' A' ' 59' ' ' LEU . 70.5 t 16.6 91.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 126.23 1.812 . . . . 0.37 113.965 175.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -151.4 -138.5 2.82 Favored Glycine 0 C--N 1.319 -0.397 0 CA-C-N 114.174 -1.375 . . . . 0.69999999999999996 113.488 -174.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -64.18 -42.83 96.51 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.382 0.882 . . . . 2.75 113.382 -169.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.485 ' CE1' ' HE2' ' A' ' 83' ' ' PHE . 4.8 p80 -86.97 -37.97 17.06 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 119.64 -0.824 . . . . 1.3300000000000001 111.702 -175.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.915 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -123.39 108.76 13.07 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.289 -1.004 . . . . 1.1100000000000001 108.289 170.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -96.34 115.69 27.84 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 105.834 -1.913 . . . . 0.76000000000000001 105.834 168.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.844 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.09 92.28 6.74 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 104.353 -2.462 . . . . 0.26000000000000001 104.353 170.357 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.651 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 4.0 m170 -88.24 164.2 15.74 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 113.748 -1.569 . . . . 2.0299999999999998 111.003 -178.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -134.29 113.38 11.89 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 111.716 -2.493 . . . . 0.92000000000000004 109.937 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.8 m -99.14 149.34 23.16 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.597 -2.092 . . . . 0.46999999999999997 107.891 174.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -145.58 99.38 3.28 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.097 0.951 . . . . 1.3899999999999999 112.362 -171.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.88 106.43 14.44 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.837 -1.528 . . . . 2.4199999999999999 110.374 169.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -69.04 -27.68 65.87 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.556 -1.202 . . . . 2.46 110.504 179.065 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.18 73.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.216 -0.902 . . . . 1.1499999999999999 110.746 175.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -91.65 -18.24 24.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.6 -0.727 . . . . 1.4099999999999999 109.287 175.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.786 ' HG2' ' H ' ' A' ' 31' ' ' ALA . 10.3 ttpt 66.62 33.82 6.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.665 -1.152 . . . . 3.3100000000000001 109.699 -177.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.84 133.52 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.166 0.984 . . . . 0.42999999999999999 110.766 -176.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' SER . 36.7 m-85 -97.65 108.07 20.71 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.532 -1.655 . . . . 1.24 106.532 161.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 15.0 tp -95.18 104.7 16.59 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.508 1.147 . . . . 0.52000000000000002 109.011 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.651 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 95.7 m-85 -86.2 114.47 23.06 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.331 -1.759 . . . . 0.33000000000000002 108.606 175.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -100.47 127.71 46.74 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.374 -1.739 . . . . 1.3200000000000001 109.007 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.864 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.4 mm? -99.38 116.65 32.03 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.206 -1.405 . . . . 0.95999999999999996 107.206 171.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.765 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 14.5 m80 -114.63 94.41 4.76 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 104.953 -2.24 . . . . 1.1499999999999999 104.953 167.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.817 HG12 ' HB2' ' A' ' 57' ' ' LEU . 47.5 mt -118.13 99.15 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 123.18 1.466 . . . . 0.52000000000000002 110.055 -173.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 81.7 p -106.71 163.89 12.54 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.022 -1.444 . . . . 0.57999999999999996 108.121 -178.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.3 t70 68.86 38.91 1.99 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.804 -1.998 . . . . 2.1200000000000001 110.215 170.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.09 118.06 2.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.207 -1.815 . . . . 0.40000000000000002 112.024 -178.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.683 HE21 ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -57.82 140.97 80.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 114.818 -1.083 . . . . 1.4299999999999999 109.758 172.014 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.883 ' HB3' HG21 ' A' ' 18' ' ' VAL . 36.4 Cg_endo -67.89 5.02 1.19 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.707 2.271 . . . . 1.3300000000000001 113.42 -177.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -118.99 -3.83 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.473 -0.33 . . . . 1.1200000000000001 110.324 173.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.909 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -75.66 4.45 7.75 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.798 -0.62 . . . . 1.24 109.368 -172.046 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 29.5 m -23.02 90.07 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 125.696 1.873 . . . . 1.22 111.325 177.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.833 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -39.79 110.2 0.16 Allowed Glycine 0 CA--C 1.466 -3.029 0 CA-C-N 109.703 -3.408 . . . . 1.4299999999999999 113.902 -169.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.88 62.78 0.55 Allowed Glycine 0 C--N 1.262 -3.567 0 CA-C-N 111.718 -2.241 . . . . 0.52000000000000002 107.895 160.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.666 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 73.9 m-85 -81.43 109.79 16.24 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.251 -1.388 . . . . 0.63 107.251 -177.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 24.4 ttm180 -109.91 110.03 20.86 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.069 -0.715 . . . . 3.1499999999999999 109.069 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.57 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 5.3 t -91.33 125.1 35.98 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.658 -0.867 . . . . 1.0800000000000001 108.658 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG3' ' SG ' ' A' ' 99' ' ' CYS . 38.8 tt0 -134.03 103.88 6.0 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.309 -0.86 . . . . 1.8100000000000001 109.755 -172.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.704 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.7 p -100.58 143.63 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.232 0.539 . . . . 0.54000000000000004 110.343 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 t -139.87 108.84 6.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.341 -0.845 . . . . 1.1799999999999999 108.812 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.805 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.96 146.85 52.15 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-O 117.775 -1.107 . . . . 0.73999999999999999 109.851 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.807 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 30.41 -73.06 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.679 1.862 . . . . 0.65000000000000002 114.28 -177.275 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.807 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 10.7 t70 -151.78 -2.03 0.3 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.904 -1.044 . . . . 1.05 110.28 -175.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.925 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 2.2 mmmt -93.45 133.84 36.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.117 0.961 . . . . 1.29 108.849 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -130.35 129.94 43.79 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 113.467 -1.697 . . . . 0.77000000000000002 110.16 -176.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' A' ' 7' ' ' PHE . 4.4 m-20 -146.97 142.17 27.24 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.166 -1.379 . . . . 1.6000000000000001 109.099 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 58.3 m -144.94 148.28 33.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.604 -0.726 . . . . 1.1899999999999999 110.154 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.57 ' OG ' ' HB3' ' A' ' 89' ' ' CYS . 2.9 p -128.23 148.07 50.61 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.532 -0.758 . . . . 0.83999999999999997 111.567 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.79 112.37 14.1 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.557 -1.201 . . . . 1.5800000000000001 109.58 177.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.76 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 7.0 p90 -141.7 131.4 24.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.6 0.714 . . . . 0.85999999999999999 109.568 -175.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 5.7 p30 -105.64 138.49 41.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.532 1.158 . . . . 2.1099999999999999 112.976 -168.114 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.833 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.22 103.94 13.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.667 -1.606 . . . . 0.37 109.501 173.367 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.499 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 11.9 m -86.23 95.41 9.59 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.175 -1.01 . . . . 0.33000000000000002 108.333 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.784 HG22 HG22 ' A' ' 18' ' ' VAL . 8.3 p -82.74 112.13 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.27 1.509 . . . . 0.33000000000000002 108.706 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 97.5 m-70 -85.76 99.15 11.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.276 -2.238 . . . . 1.1899999999999999 109.724 -173.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -77.38 -72.82 0.33 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.129 -1.396 . . . . 1.6699999999999999 110.131 172.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.55 13.0 6.47 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.68 -0.691 . . . . 2.7799999999999998 109.76 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.426 ' C ' ' HD1' ' A' ' 107' ' ' HIS . 52.9 ttp . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.831 -0.622 . . . . 6.9199999999999999 109.498 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 9.8 p-10 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 121.911 0.863 . . . . 1.9299999999999999 110.756 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.635 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 14.2 m-20 -70.86 167.29 29.61 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 114.75 -1.114 . . . . 1.6499999999999999 110.844 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 2' ' ' ASP . 55.8 Cg_endo -70.2 68.07 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.933 2.422 . . . . 0.96999999999999997 112.56 177.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.974 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.7 mp -91.59 -55.39 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 114.797 -1.092 . . . . 0.5 108.927 173.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.614 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 84.27 48.9 4.9 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 107.53 -2.228 . . . . 0.39000000000000001 107.53 -176.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.999 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.0 tp -51.24 -44.9 61.83 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 112.553 -1.823 . . . . 0.33000000000000002 109.241 -173.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 100' ' ' SER . 0.3 OUTLIER -82.62 83.31 7.66 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.663 -1.153 . . . . 0.71999999999999997 109.544 170.874 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.98 -27.61 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.756 -1.111 . . . . 0.63 108.978 176.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.8 tpt -163.51 148.8 11.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.09 -1.414 . . . . 2.8799999999999999 107.246 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 4.6 ptm180 -115.36 144.08 31.63 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.192 -0.603 . . . . 3.6699999999999999 111.059 177.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.748 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -76.44 170.46 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.132 2.554 . . . . 0.64000000000000001 112.451 -178.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -131.0 166.19 21.56 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.682 -0.69 . . . . 1.4299999999999999 110.977 -171.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.625 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -65.5 -141.13 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.566 1.174 . . . . 2.0600000000000001 111.982 -179.308 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.19 139.8 3.17 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.125 -1.398 . . . . 0.29999999999999999 111.934 -175.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 37.9 mt-10 -116.66 118.08 31.6 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.813 -0.693 . . . . 1.53 109.263 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -139.29 164.77 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.672 0 N-CA-C 107.825 -1.176 . . . . 0.27000000000000002 107.825 -173.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -90.79 157.45 17.39 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.237 -0.892 . . . . 0.77000000000000002 109.753 179.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 106' ' ' VAL . 16.7 t -68.66 106.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.187 0 CA-C-O 122.677 1.227 . . . . 0.78000000000000003 108.116 172.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.16 3.85 10.42 Favored Glycine 0 C--N 1.27 -3.11 0 CA-C-N 112.276 -2.238 . . . . 0.47999999999999998 113.554 175.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.85 -123.83 4.32 Favored Glycine 0 N--CA 1.422 -2.252 0 C-N-CA 119.235 -1.46 . . . . 0.44 111.252 176.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 17.1 p -150.88 166.99 28.88 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 112.826 -1.687 . . . . 0.81999999999999995 110.934 178.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.569 HG21 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -149.41 150.74 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 CA-C-N 113.023 -1.899 . . . . 0.32000000000000001 107.638 171.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.0 m -138.22 129.51 27.48 Favored 'General case' 0 C--N 1.265 -3.096 0 CA-C-N 113.721 -1.581 . . . . 0.31 110.876 -176.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.718 ' HB2' ' HB2' ' A' ' 74' ' ' LEU . 36.7 m-85 -128.11 155.43 44.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.278 -1.328 . . . . 0.53000000000000003 109.88 176.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.625 ' HB3' HD11 ' A' ' 71' ' ' LEU . 1.2 m -140.93 131.81 25.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.287 -0.869 . . . . 0.57999999999999996 109.287 173.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.769 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -129.32 115.22 17.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.966 -1.015 . . . . 0.32000000000000001 110.943 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.7 ' HE ' HG11 ' A' ' 69' ' ' VAL . 18.9 mtp180 -100.6 126.32 47.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.535 -0.302 . . . . 2.4300000000000002 110.851 -177.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 13.5 t -127.9 129.44 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 122.057 0.932 . . . . 0.26000000000000001 110.687 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.79 108.27 2.07 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.344 -1.753 . . . . 0.40000000000000002 111.113 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -50.88 22.84 Favored Glycine 0 C--O 1.226 -0.391 0 CA-C-N 115.287 -0.87 . . . . 0.76000000000000001 111.105 172.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.889 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . . . 61.64 -100.52 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.772 1.027 . . . . 0.70999999999999996 113.772 167.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 p -146.39 -109.61 0.09 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.545 -0.752 . . . . 1.74 110.205 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.017 HD22 ' HA ' ' A' ' 93' ' ' THR . 4.4 tp 63.74 156.27 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.576 -0.528 . . . . 2.1600000000000001 109.576 -175.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.952 ' H ' HD12 ' A' ' 33' ' ' LEU . 21.4 tp -53.39 -27.32 23.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.129 0.966 . . . . 1.47 110.546 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.769 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.83 177.15 2.08 Favored Pre-proline 0 C--O 1.211 -0.973 0 CA-C-N 113.549 -1.66 . . . . 1.3999999999999999 106.803 178.143 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.5 Cg_exo -65.24 154.37 73.88 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.495 1.464 . . . . 0.88 109.521 174.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.64 ' HG3' HG21 ' A' ' 93' ' ' THR . 67.2 Cg_exo -55.11 146.8 57.15 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 121.569 1.513 . . . . 0.53000000000000003 113.401 -175.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.649 HG22 ' HE2' ' A' ' 35' ' ' LYS . 2.0 t -100.01 103.89 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 106.489 -1.671 . . . . 0.77000000000000002 106.489 175.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.8 t -106.71 115.25 47.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.013 -1.449 . . . . 0.28000000000000003 107.683 176.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -109.07 131.5 55.01 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-O 122.874 1.321 . . . . 1.54 109.615 175.989 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.022 ' HB3' HD13 ' A' ' 49' ' ' LEU . 72.0 m95 -92.48 156.83 16.91 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.425 -2.171 . . . . 0.34000000000000002 112.326 174.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 37.3 t80 -129.28 133.14 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.303 -2.11 . . . . 0.62 105.303 173.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.865 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 3.6 ttpm? -109.66 107.51 17.58 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.336 -1.357 . . . . 2.1699999999999999 107.336 -177.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.32 91.91 1.63 Allowed Glycine 0 CA--C 1.487 -1.688 0 C-N-CA 115.982 -3.009 . . . . 1.23 114.562 -165.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.902 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 71.2 tttt -108.86 -24.79 11.1 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.034 -2.21 . . . . 3.8700000000000001 105.034 135.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.902 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 25.7 p-90 159.97 -20.14 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 CA-C-N 112.677 -2.056 . . . . 2.1099999999999999 111.763 -164.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.45 ' HB ' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.34 174.11 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.461 1.6 . . . . 1.29 113.331 -163.264 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 13.3 t70 -109.49 155.04 21.83 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 111.208 -2.724 . . . . 2.73 105.763 173.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.022 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.8 mp -89.77 -38.67 13.64 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.905 0.706 . . . . 0.44 112.905 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 t -59.58 -19.76 50.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.894 0.854 . . . . 1.23 108.936 -166.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.1 p -87.58 -33.11 19.0 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.536 -1.211 . . . . 1.3400000000000001 111.317 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HG3' ' HZ1' ' A' ' 43' ' ' LYS . 5.5 mmmt -93.79 -70.37 0.71 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.266 -1.333 . . . . 1.3999999999999999 111.616 -175.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.827 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.4 t 11.1 92.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.566 1.946 . . . . 0.37 113.489 177.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.605 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -146.67 -118.04 1.07 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.841 -1.527 . . . . 0.69999999999999996 113.357 -177.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -86.12 -32.67 21.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.082 0.771 . . . . 2.75 113.082 -167.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.63 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 7.0 p80 -93.54 -36.69 12.29 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.026 -0.669 . . . . 1.3300000000000001 110.257 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.908 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -118.95 105.28 11.31 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.809 -1.552 . . . . 1.1100000000000001 106.809 175.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -98.77 115.53 28.98 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 105.763 -1.94 . . . . 0.76000000000000001 105.763 165.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.827 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -98.51 92.03 5.44 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 103.547 -2.76 . . . . 0.26000000000000001 103.547 169.171 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 83.0 t60 -99.66 162.43 13.01 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 113.943 -1.48 . . . . 2.0299999999999998 108.694 -173.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.47 124.25 29.79 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 112.464 -2.153 . . . . 0.92000000000000004 110.949 -177.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.688 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 2.2 m -93.62 148.52 22.03 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 111.08 -2.782 . . . . 0.46999999999999997 106.685 169.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -138.16 98.09 3.54 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.705 1.241 . . . . 1.3899999999999999 111.365 -168.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 8.4 m-20 -113.98 100.32 8.32 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 112.856 -1.975 . . . . 2.4199999999999999 108.743 172.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -37.41 36.27 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.644 -0.707 . . . . 2.46 110.337 178.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.68 -22.2 60.95 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.004 -0.998 . . . . 1.1499999999999999 110.448 179.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 47.5 m -101.69 -9.84 20.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.494 -0.776 . . . . 1.4099999999999999 109.592 175.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.889 ' HE3' ' HA ' ' A' ' 31' ' ' ALA . 74.5 tttt 67.18 29.84 7.55 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.114 -0.948 . . . . 3.3100000000000001 110.53 173.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.7 HG11 ' HE ' ' A' ' 27' ' ' ARG . 2.7 t -127.98 121.95 57.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.014 0.911 . . . . 0.42999999999999999 110.588 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -100.53 107.02 18.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.396 -1.705 . . . . 1.24 106.396 167.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 11.5 tp -95.15 104.73 16.62 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.3 1.048 . . . . 0.52000000000000002 109.049 -177.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.661 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.8 m-85 -85.36 113.96 22.06 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.939 -1.482 . . . . 0.33000000000000002 108.277 174.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 19.4 mt-10 -106.8 124.41 49.58 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 113.3 -1.773 . . . . 1.3200000000000001 108.976 -176.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.829 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.6 mm? -90.69 118.18 29.92 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.995 -1.113 . . . . 0.95999999999999996 107.995 173.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -112.14 94.33 4.88 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 103.587 -2.746 . . . . 1.1499999999999999 103.587 169.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 52.3 mt -123.54 101.07 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.22 1.486 . . . . 0.52000000000000002 110.263 -175.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 74.8 p -106.02 144.88 32.12 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 113.002 -1.908 . . . . 0.57999999999999996 107.917 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 70.96 77.61 0.18 Allowed 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 111.914 -2.403 . . . . 2.1200000000000001 109.766 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.563 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -78.24 110.87 13.63 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.779 -2.464 . . . . 0.40000000000000002 108.24 174.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.613 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -69.58 165.07 44.41 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.418 -0.956 . . . . 1.4299999999999999 108.418 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HG3' HG21 ' A' ' 18' ' ' VAL . 3.8 Cg_exo -72.41 152.28 54.69 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 120.819 1.013 . . . . 1.3300000000000001 111.124 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.711 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . 66.98 5.26 3.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.855 -0.612 . . . . 1.1200000000000001 111.358 -177.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.1 OUTLIER -84.42 1.49 45.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.69 -0.856 . . . . 1.24 108.69 -178.773 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.842 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 49.2 m -10.02 82.14 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.981 0 O-C-N 126.292 2.245 . . . . 1.22 111.316 171.22 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.917 ' HA3' ' HB3' ' A' ' 104' ' ' LEU . . . -65.71 73.94 0.11 Allowed Glycine 0 CA--C 1.473 -2.576 0 CA-C-N 111.555 -2.566 . . . . 1.4299999999999999 114.002 -160.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 102' ' ' PHE . . . -84.54 74.1 2.55 Favored Glycine 0 C--N 1.276 -2.787 0 N-CA-C 108.477 -1.849 . . . . 0.52000000000000002 108.477 172.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.798 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 49.2 m-85 -80.86 121.9 26.54 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.57 -1.315 . . . . 0.63 107.694 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.79 109.82 19.54 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.645 -0.502 . . . . 3.1499999999999999 109.645 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.646 ' SG ' ' HE2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -91.6 108.35 19.84 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.537 -0.542 . . . . 1.0800000000000001 109.537 -179.623 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.705 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 37.3 mt-10 -118.71 103.79 9.99 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.756 -0.656 . . . . 1.8100000000000001 109.486 -176.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.61 ' HB ' HG13 ' A' ' 39' ' ' VAL . 2.5 p -99.24 143.01 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.308 0.575 . . . . 0.54000000000000004 110.868 -177.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -133.19 109.26 9.32 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.017 -1.105 . . . . 1.1799999999999999 108.017 -175.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.017 ' HA ' HD22 ' A' ' 33' ' ' LEU . 1.3 m -130.28 164.21 25.09 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 118.331 -0.842 . . . . 0.73999999999999999 109.067 -177.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.872 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 7.94 -71.23 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.567 1.792 . . . . 0.65000000000000002 113.392 173.516 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.758 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 28.6 t70 -147.8 -1.68 0.58 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.739 -1.119 . . . . 1.05 110.136 177.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.999 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -92.84 129.25 38.82 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.478 -1.305 . . . . 1.29 107.478 -177.543 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -132.46 130.58 40.71 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.023 -0.989 . . . . 0.77000000000000002 110.14 175.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -142.48 147.9 36.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.448 -1.251 . . . . 1.6000000000000001 109.031 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 6.8 p -144.48 141.88 29.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.343 0.592 . . . . 1.1899999999999999 111.025 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.545 ' HB2' ' CE2' ' A' ' 7' ' ' PHE . 24.2 t -118.26 148.94 41.92 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.24 -0.891 . . . . 0.83999999999999997 111.093 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 112.82 11.28 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.803 -1.544 . . . . 1.5800000000000001 110.053 -179.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.798 ' CE1' ' HB2' ' A' ' 87' ' ' TYR . 40.0 p90 -142.21 140.91 32.47 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.85999999999999999 108.762 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -117.39 134.44 54.82 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.497 1.141 . . . . 2.1099999999999999 113.555 -174.355 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.917 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -95.6 109.45 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.365 -1.743 . . . . 0.37 109.6 177.422 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 4.2 m -86.85 96.54 10.24 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.272 -0.64 . . . . 0.33000000000000002 109.272 -178.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 18' ' ' VAL . 6.8 p -83.03 113.78 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 CA-C-O 122.932 1.348 . . . . 0.33000000000000002 109.522 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -90.98 100.5 13.35 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 112.747 -2.024 . . . . 1.1899999999999999 109.549 -176.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 18' ' ' VAL . 44.9 tt0 -80.74 -79.96 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.024 -0.989 . . . . 1.6699999999999999 110.566 172.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.83 -48.61 8.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.954 -0.566 . . . . 2.7799999999999998 110.232 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.237 -0.887 . . . . 6.9199999999999999 109.818 178.97 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.99 ' HA ' ' HB3' ' A' ' 95' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.611 -0.514 . . . . 1.9299999999999999 109.611 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.628 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 1.1 m-20 -122.53 173.22 4.41 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 115.649 -0.705 . . . . 1.6499999999999999 109.871 174.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.4 81.9 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.607 2.205 . . . . 0.96999999999999997 112.365 172.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.962 ' HB ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 mp -108.11 -69.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.5 109.214 174.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.632 ' H ' ' HE2' ' A' ' 96' ' ' LYS . . . 94.72 45.5 3.15 Favored Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 108.301 -1.92 . . . . 0.39000000000000001 108.301 -175.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 96' ' ' LYS . 13.3 tp -53.1 -46.13 68.55 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 112.175 -2.012 . . . . 0.33000000000000002 111.623 -169.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.783 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -89.4 84.3 6.43 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.073 -0.967 . . . . 0.71999999999999997 109.893 -176.195 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.4 t -72.42 -48.48 47.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.662 -1.153 . . . . 0.63 110.029 -178.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.767 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 88.9 mmm -132.87 134.58 44.79 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 115.263 -0.881 . . . . 2.8799999999999999 109.766 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.783 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 22.1 mtt-85 -99.28 124.23 45.69 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 109.301 -0.629 . . . . 3.6699999999999999 109.301 174.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.653 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 17.6 Cg_endo -60.68 145.83 98.24 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.393 2.062 . . . . 0.64000000000000001 109.606 174.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.514 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 17.9 mm-40 -121.43 170.79 9.29 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 112.286 0.476 . . . . 1.4299999999999999 112.286 -168.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.0 m-20 -69.18 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.911 0 CA-C-O 122.825 1.298 . . . . 2.0600000000000001 110.627 -173.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 150.08 139.26 3.03 Favored Glycine 0 N--CA 1.423 -2.184 0 CA-C-N 114.094 -1.412 . . . . 0.29999999999999999 111.811 -176.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 32.8 mt-10 -117.71 109.85 17.13 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.251 -0.974 . . . . 1.53 108.888 176.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.53 163.19 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.734 0 N-CA-C 107.02 -1.474 . . . . 0.27000000000000002 107.02 -175.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.751 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -94.41 154.7 17.32 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 115.479 -0.782 . . . . 0.77000000000000002 109.874 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 106' ' ' VAL . 16.5 t -63.68 107.12 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 123.193 1.473 . . . . 0.78000000000000003 108.917 173.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.25 -10.87 5.59 Favored Glycine 0 C--N 1.268 -3.207 0 CA-C-N 111.711 -2.495 . . . . 0.47999999999999998 112.503 176.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.0 -163.69 20.36 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 119.879 -1.153 . . . . 0.44 111.316 177.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 2.5 p -122.75 169.81 10.7 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-O 122.582 1.182 . . . . 0.81999999999999995 111.456 -170.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.651 HG21 HD13 ' A' ' 104' ' ' LEU . 10.4 tp -145.16 151.83 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-N 112.335 -2.211 . . . . 0.32000000000000001 107.229 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.7 m -139.67 127.46 21.97 Favored 'General case' 0 C--N 1.256 -3.486 0 CA-C-N 113.815 -1.539 . . . . 0.31 110.814 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.612 ' HD2' HD12 ' A' ' 74' ' ' LEU . 27.7 m-85 -123.48 142.49 50.95 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.788 -1.551 . . . . 0.53000000000000003 109.51 -178.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.99 120.17 17.77 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.94 0.876 . . . . 0.57999999999999996 110.399 173.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -117.52 114.41 23.41 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.075 -1.421 . . . . 0.32000000000000001 109.805 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.767 ' HD2' ' HG3' ' A' ' 9' ' ' MET . 88.0 mtt180 -106.71 121.76 45.0 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 121.226 -0.19 . . . . 2.4300000000000002 110.564 -176.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG21 HG21 ' A' ' 39' ' ' VAL . 12.1 t -119.2 125.65 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 122.027 0.917 . . . . 0.26000000000000001 109.925 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.1 108.39 0.59 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.309 -1.768 . . . . 0.40000000000000002 110.959 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.711 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -53.11 -44.3 63.19 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.817 -1.083 . . . . 0.76000000000000001 111.406 172.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.704 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 54.06 -164.2 0.1 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 123.572 0.749 . . . . 0.70999999999999996 112.996 177.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -78.47 -71.58 0.42 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.81 -0.811 . . . . 1.74 108.81 173.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.945 HD23 HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 69.58 159.75 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.675 -0.693 . . . . 2.1600000000000001 112.102 168.496 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.943 ' N ' HD22 ' A' ' 33' ' ' LEU . 17.0 tp -75.6 -71.56 0.36 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.525 -0.761 . . . . 1.47 111.149 168.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.795 ' O ' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -123.31 129.55 24.87 Favored Pre-proline 0 N--CA 1.474 0.761 0 N-CA-C 113.643 0.979 . . . . 1.3999999999999999 113.643 171.555 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' N ' HD11 ' A' ' 33' ' ' LEU . 17.2 Cg_exo -32.96 129.16 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 124.735 3.623 . . . . 0.88 113.234 -170.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 1.5 Cg_endo -46.9 132.67 17.54 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.493 2.129 . . . . 0.53000000000000003 112.898 -171.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.66 104.64 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 106.769 -1.567 . . . . 0.77000000000000002 106.769 177.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.2 t -109.25 115.02 48.51 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.997 0 CA-C-N 113.159 -1.837 . . . . 0.28000000000000003 107.262 177.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -105.22 128.76 53.57 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 122.972 1.368 . . . . 1.54 109.294 172.52 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.043 ' HB3' HD13 ' A' ' 49' ' ' LEU . 60.0 m95 -82.92 152.44 25.53 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 112.395 -2.184 . . . . 0.34000000000000002 110.786 175.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.605 ' HB3' ' H ' ' A' ' 88' ' ' ARG . 32.3 t80 -128.03 138.88 52.75 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.725 -2.324 . . . . 0.62 104.725 169.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 1.054 ' HE2' ' HG ' ' A' ' 49' ' ' LEU . 13.7 ttmt -100.4 171.53 7.7 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.927 -1.138 . . . . 2.1699999999999999 107.927 -173.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.968 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -13.44 -169.27 0.0 OUTLIER Glycine 0 C--O 1.185 -2.931 0 O-C-N 126.673 2.483 . . . . 1.23 118.3 166.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 84' ' ' THR . 13.3 mtpp -42.4 -2.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 117.556 2.428 . . . . 3.8700000000000001 117.556 -166.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.657 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 8.6 p-90 -169.47 -17.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.901 1.445 . . . . 2.1099999999999999 114.901 -177.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.788 ' HB ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.95 167.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 CA-C-O 123.464 1.602 . . . . 1.29 112.44 -161.368 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.667 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 14.4 t70 -113.89 154.27 27.81 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.537 -2.574 . . . . 2.73 104.976 169.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.054 ' HG ' ' HE2' ' A' ' 43' ' ' LYS . 6.3 mp -90.39 -36.35 14.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.901 1.074 . . . . 0.44 113.901 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 t -59.05 -20.73 55.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.585 0.707 . . . . 1.23 109.432 -164.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 m -98.88 -28.42 13.46 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.074 -0.966 . . . . 1.3400000000000001 113.531 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.861 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -100.25 -40.31 7.6 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.254 0.464 . . . . 1.3999999999999999 112.254 -169.402 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 ' H ' ' A' ' 59' ' ' LEU . 23.0 t -18.11 97.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 125.935 1.694 . . . . 0.37 113.063 173.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -152.83 -147.9 4.73 Favored Glycine 0 C--N 1.306 -1.125 0 CA-C-N 111.575 -2.557 . . . . 0.69999999999999996 112.823 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -64.13 -16.34 61.64 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.003 0.742 . . . . 2.75 113.003 -170.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.62 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 26.7 p80 -102.49 -36.34 8.43 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.379 0.609 . . . . 1.3300000000000001 110.899 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.83 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -129.22 103.43 6.95 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.961 -1.496 . . . . 1.1100000000000001 106.961 172.348 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -96.27 116.04 28.38 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 106.976 -1.49 . . . . 0.76000000000000001 106.976 168.503 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.813 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -98.4 93.8 6.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 105.137 -2.171 . . . . 0.26000000000000001 105.137 174.632 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.628 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 46.2 m-70 -84.81 159.4 20.43 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-O 122.843 1.306 . . . . 2.0299999999999998 109.618 179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.43 117.97 18.75 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 111.85 -2.432 . . . . 0.92000000000000004 109.645 177.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -103.52 145.45 30.0 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 111.094 -2.775 . . . . 0.46999999999999997 108.709 176.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.436 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 38.0 t80 -139.34 97.01 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 122.215 1.007 . . . . 1.3899999999999999 110.143 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -114.06 105.22 12.95 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 113.278 -1.783 . . . . 2.4199999999999999 108.766 176.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.611 ' HD3' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -77.21 -36.63 54.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.588 -0.733 . . . . 2.46 110.864 -178.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.75 -12.87 61.18 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.616 -0.72 . . . . 1.1499999999999999 110.796 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.0 t -102.96 -19.82 14.46 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.351 -1.352 . . . . 1.4099999999999999 107.351 172.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.711 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 63.86 35.47 11.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.321 -1.309 . . . . 3.3100000000000001 110.056 177.699 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 27' ' ' ARG . 10.9 t -134.19 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-N 115.201 -0.909 . . . . 0.42999999999999999 109.475 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.536 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 8.0 m-85 -102.64 111.06 23.2 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.068 -1.456 . . . . 1.24 107.068 166.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 26.7 tp -95.51 106.64 18.73 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.196 0.998 . . . . 0.52000000000000002 108.86 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.2 m-85 -89.26 112.18 23.17 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.168 -1.79 . . . . 0.33000000000000002 106.168 169.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.628 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -120.44 125.53 48.15 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.562 -1.199 . . . . 1.3200000000000001 110.093 -173.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.686 ' CD1' HD11 ' A' ' 76' ' ' ILE . 1.1 mt -90.95 136.43 33.08 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.774 -1.557 . . . . 0.95999999999999996 108.666 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 63.3 m170 -117.69 97.99 6.14 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 104.164 -2.532 . . . . 1.1499999999999999 104.164 166.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.785 ' CD1' HD22 ' A' ' 57' ' ' LEU . 66.1 mt -120.31 101.62 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-O 122.718 1.247 . . . . 0.52000000000000002 109.643 -174.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 12.7 p -118.4 145.49 45.15 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 114.05 -1.432 . . . . 0.57999999999999996 109.872 -176.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 77' ' ' THR . 1.5 m-20 73.47 70.55 0.12 Allowed 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 111.258 -2.701 . . . . 2.1200000000000001 109.924 177.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.53 109.33 3.19 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 111.717 -2.492 . . . . 0.40000000000000002 110.947 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.742 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -60.41 142.54 90.55 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.166 -0.924 . . . . 1.4299999999999999 109.286 171.249 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 18' ' ' VAL . 26.4 Cg_exo -60.27 -18.8 54.38 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.409 2.073 . . . . 1.3300000000000001 112.22 -178.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.742 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -100.1 16.25 24.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.08 -0.509 . . . . 1.1200000000000001 110.728 178.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.597 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -83.66 -36.76 23.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 118.831 -0.604 . . . . 1.24 110.085 -178.823 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.8 m 1.41 82.38 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 0 O-C-N 125.585 1.803 . . . . 1.22 112.179 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.968 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -47.13 117.89 3.48 Favored Glycine 0 N--CA 1.408 -3.177 0 CA-C-N 111.988 -2.369 . . . . 1.4299999999999999 114.353 -171.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.696 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -117.51 67.57 0.32 Allowed Glycine 0 C--N 1.273 -2.927 0 N-CA-C 108.001 -2.04 . . . . 0.52000000000000002 108.001 155.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.639 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 63.7 m-85 -78.13 118.99 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.765 -0.828 . . . . 0.63 108.765 178.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.605 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 28.4 ttm180 -114.38 126.52 55.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.046 0.45 . . . . 3.1499999999999999 110.878 178.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.617 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 91.6 m -97.35 108.52 21.26 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.092 -0.707 . . . . 1.0800000000000001 109.092 173.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.662 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 33.5 tt0 -114.84 103.26 10.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.525 -0.917 . . . . 1.8100000000000001 108.525 -176.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 39' ' ' VAL . 6.4 p -105.0 141.9 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.655 0.741 . . . . 0.54000000000000004 111.601 -173.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -134.99 108.99 8.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.338 -1.301 . . . . 1.1799999999999999 109.08 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.945 HG22 HD23 ' A' ' 33' ' ' LEU . 1.4 m -120.8 168.25 11.64 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.071 -1.455 . . . . 0.73999999999999999 107.071 177.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.666 ' HZ3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -10.66 -61.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.945 1.403 . . . . 0.65000000000000002 114.138 -175.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.99 ' HB3' ' HA ' ' A' ' 1' ' ' ASP . 0.4 OUTLIER -149.22 -3.14 0.43 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.993 -1.003 . . . . 1.05 109.994 177.776 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.962 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 3.9 mmtm -89.74 116.69 28.04 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.055 -1.831 . . . . 1.29 106.055 -176.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -134.06 139.69 46.15 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.892 -1.049 . . . . 0.77000000000000002 111.274 -173.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.468 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 4.8 t0 -167.27 170.47 11.6 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.947 -1.024 . . . . 1.6000000000000001 108.858 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 89' ' ' CYS . 17.0 p -148.81 151.06 34.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 1.1899999999999999 110.28 179.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.735 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 54.7 p -122.31 137.2 54.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.945 -0.702 . . . . 0.83999999999999997 111.335 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -110.79 123.93 51.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.449 -0.796 . . . . 1.5800000000000001 109.601 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.757 ' HZ ' ' HZ3' ' A' ' 41' ' ' TRP . 8.3 p90 -145.05 131.05 19.26 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.85999999999999999 110.493 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.1 p30 -106.21 139.62 40.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.502 1.144 . . . . 2.1099999999999999 112.294 -175.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.651 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -107.84 105.52 15.37 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.775 -1.557 . . . . 0.37 108.778 173.015 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.3 m -87.24 96.56 10.37 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.316 -0.994 . . . . 0.33000000000000002 108.316 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 18' ' ' VAL . 3.1 p -75.39 112.2 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-O 122.842 1.306 . . . . 0.33000000000000002 107.989 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.2 m170 -74.43 95.95 2.81 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 112.688 -2.051 . . . . 1.1899999999999999 108.178 -178.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 2.7 tm-20 -76.15 92.86 3.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.448 -1.706 . . . . 1.6699999999999999 108.191 173.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.41 151.01 35.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.277 -0.874 . . . . 2.7799999999999998 111.243 -174.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.315 1.009 . . . . 6.9199999999999999 111.488 176.672 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.5 m-20 . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.009 -0.737 . . . . 1.9299999999999999 109.009 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.553 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 6.9 t70 -115.05 148.6 40.93 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 114.671 -1.149 . . . . 1.6499999999999999 108.898 -175.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' C ' HD12 ' A' ' 4' ' ' ILE . 2.0 Cg_endo -45.44 90.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.224 3.283 . . . . 0.96999999999999997 115.223 -177.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 6' ' ' LEU . 1.7 mp -125.07 -60.52 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 114.628 -1.169 . . . . 0.5 108.042 173.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.55 33.98 6.86 Favored Glycine 0 CA--C 1.492 -1.357 0 N-CA-C 108.805 -1.718 . . . . 0.39000000000000001 108.805 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.04 HD22 ' HB3' ' A' ' 96' ' ' LYS . 5.5 tp -37.92 -51.39 1.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.38 -1.91 . . . . 0.33000000000000002 110.635 178.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HZ ' ' HG ' ' A' ' 100' ' ' SER . 0.7 OUTLIER -79.74 84.28 5.58 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.333 -0.849 . . . . 0.71999999999999997 110.157 172.243 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.27 -41.3 57.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.634 -1.166 . . . . 0.63 108.812 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 15.6 tpt -153.92 134.77 13.76 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.747 -1.115 . . . . 2.8799999999999999 109.289 173.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -104.39 140.73 21.35 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.26 -0.882 . . . . 3.6699999999999999 109.73 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 34.7 Cg_endo -73.7 156.34 48.95 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.842 1.695 . . . . 0.64000000000000001 110.46 178.187 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -118.04 -179.85 3.88 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.225 -0.443 . . . . 1.4299999999999999 110.593 -173.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 5.4 p-10 -72.61 -145.62 0.02 OUTLIER 'General case' 0 N--CA 1.41 -2.462 0 CA-C-O 122.746 1.26 . . . . 2.0600000000000001 111.704 -176.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 13' ' ' ASP . . . 154.13 133.33 1.78 Allowed Glycine 0 C--N 1.293 -1.823 0 CA-C-N 113.306 -1.77 . . . . 0.29999999999999999 112.525 -176.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.484 ' HB3' ' NE2' ' A' ' 107' ' ' HIS . 37.3 mt-10 -110.36 111.16 22.27 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.682 -1.259 . . . . 1.53 108.435 176.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 22' ' ' ILE . 3.0 m -133.63 163.36 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.884 -1.154 . . . . 0.27000000000000002 107.884 -172.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.45 147.37 23.32 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.566 -1.197 . . . . 0.77000000000000002 109.193 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.958 HG21 ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.79 107.42 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 CA-C-O 123.786 1.755 . . . . 0.78000000000000003 109.993 174.62 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.06 -1.66 6.74 Favored Glycine 0 C--N 1.273 -2.959 0 CA-C-N 110.517 -3.038 . . . . 0.47999999999999998 112.168 178.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.87 -119.66 2.48 Favored Glycine 0 CA--C 1.478 -2.263 0 C-N-CA 119.223 -1.465 . . . . 0.44 110.383 176.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 48.1 t -154.09 173.63 15.79 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 112.611 -1.794 . . . . 0.81999999999999995 108.859 173.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 76' ' ' ILE . 11.1 tp -149.32 147.36 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.039 0 CA-C-N 113.237 -1.801 . . . . 0.32000000000000001 106.845 167.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.3 m -140.9 126.84 19.33 Favored 'General case' 0 C--N 1.255 -3.526 0 CA-C-N 113.632 -1.622 . . . . 0.31 111.338 -173.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.529 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 56.7 m-85 -124.45 147.02 48.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.65 -1.613 . . . . 0.53000000000000003 109.07 178.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.41 120.82 16.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.132 -0.94 . . . . 0.57999999999999996 110.082 176.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -113.73 116.89 30.11 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.467 -1.242 . . . . 0.32000000000000001 110.145 -178.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 97.5 mtt180 -101.8 119.82 39.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.704 -0.225 . . . . 2.4300000000000002 110.879 -177.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 15.9 t -118.77 125.28 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 122.067 0.937 . . . . 0.26000000000000001 110.419 -179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.05 109.21 0.91 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 113.126 -1.852 . . . . 0.40000000000000002 110.829 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.618 ' HA3' ' HE2' ' A' ' 68' ' ' LYS . . . -54.74 -33.22 55.3 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.222 -0.899 . . . . 0.76000000000000001 111.947 172.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 33' ' ' LEU . . . 53.97 -162.42 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.494 1.294 . . . . 0.70999999999999996 114.494 169.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.0 p -118.44 38.81 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.939 -1.028 . . . . 1.74 109.2 173.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.057 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -64.44 177.32 0.89 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.678 -1.146 . . . . 2.1600000000000001 113.521 -179.055 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 tp -69.21 -55.08 11.65 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.61 -0.723 . . . . 1.47 109.819 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.62 152.74 71.48 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.345 -0.843 . . . . 1.3999999999999999 109.182 176.527 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -43.0 135.87 5.16 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.19 2.593 . . . . 0.88 112.987 -178.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.057 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.0 Cg_endo -55.52 135.93 71.56 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 122.726 2.284 . . . . 0.53000000000000003 112.383 -176.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.2 104.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.507 -1.664 . . . . 0.77000000000000002 106.507 177.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.63 HG22 HG13 ' A' ' 91' ' ' VAL . 42.9 t -103.84 115.22 45.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.91 0 CA-C-N 112.805 -1.998 . . . . 0.28000000000000003 108.558 -179.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 1.054 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -103.33 123.38 46.69 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 113.591 -1.64 . . . . 1.54 109.444 170.465 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.971 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.9 m95 -89.34 157.37 18.21 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 111.702 -2.499 . . . . 0.34000000000000002 111.256 173.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 21.1 t80 -136.55 125.8 24.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.876 -2.268 . . . . 0.62 104.876 167.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.801 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 20.4 tttm -102.57 162.35 12.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.494 -2.039 . . . . 2.1699999999999999 105.494 -175.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.95 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -4.62 -165.94 0.0 OUTLIER Glycine 0 C--O 1.199 -2.043 0 N-CA-C 118.86 2.304 . . . . 1.23 118.86 -174.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 84' ' ' THR . 10.4 mtpp -41.67 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.026 -1.867 . . . . 3.8700000000000001 115.716 -165.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 38.2 p-90 -166.02 2.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 114.416 1.265 . . . . 2.1099999999999999 114.416 -177.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.39 117.11 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-O 122.993 1.378 . . . . 1.29 112.254 -163.229 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -84.85 98.42 10.3 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 112.437 -2.165 . . . . 2.73 111.32 175.211 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.013 HD23 HD21 ' A' ' 57' ' ' LEU . 4.1 mp -49.64 -36.08 23.38 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.781 -0.645 . . . . 0.44 112.719 -174.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 t -58.68 -22.2 56.48 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.427 -0.582 . . . . 1.23 109.427 -169.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.2 m -101.51 -28.18 12.69 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 112.919 0.711 . . . . 1.3400000000000001 112.919 178.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 7.8 mmmt -90.1 -45.84 8.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.092 -0.504 . . . . 1.3999999999999999 111.288 -171.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.2 t -22.67 93.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 C-N-CA 126.504 1.922 . . . . 0.37 112.737 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -168.66 -124.73 0.74 Allowed Glycine 0 C--N 1.308 -1.025 0 CA-C-N 111.844 -2.435 . . . . 0.69999999999999996 113.227 -177.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -56.8 -52.72 63.95 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.16 0.8 . . . . 2.75 113.16 -169.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.574 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 25.1 p80 -88.48 -38.6 14.86 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 112.208 0.447 . . . . 1.3300000000000001 112.208 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.013 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.18 109.16 13.09 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.413 -0.958 . . . . 1.1100000000000001 108.413 174.628 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -94.46 115.84 28.08 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.445 -1.687 . . . . 0.76000000000000001 106.445 167.768 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.699 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.32 92.68 6.85 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 104.476 -2.416 . . . . 0.26000000000000001 104.476 170.393 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 2.1 m170 -101.41 166.75 10.58 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 114.048 -1.433 . . . . 2.0299999999999998 110.454 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 125.09 22.72 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 111.98 -2.373 . . . . 0.92000000000000004 110.124 -177.458 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.3 m -94.48 148.4 22.28 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 111.506 -2.588 . . . . 0.46999999999999997 107.366 172.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.597 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 2.4 t80 -135.81 97.78 3.74 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.251 1.024 . . . . 1.3899999999999999 110.978 -173.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 5.4 m-20 -113.8 105.17 12.96 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 113.115 -1.857 . . . . 2.4199999999999999 108.564 173.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.679 ' HG3' HH11 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -84.41 -41.38 16.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.08 -0.964 . . . . 2.46 110.45 -178.728 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.28 -22.16 62.89 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.443 -1.253 . . . . 1.1499999999999999 111.028 176.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.822 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 35.4 t -97.7 -16.42 19.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.285 -1.376 . . . . 1.4099999999999999 107.285 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER 68.04 29.18 6.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.044 -1.435 . . . . 3.3100000000000001 110.903 173.699 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.48 126.87 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-O 121.682 0.753 . . . . 0.42999999999999999 109.426 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.469 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 2.1 m-30 -105.0 109.11 20.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.796 -1.557 . . . . 1.24 106.796 170.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.6 tp -94.74 104.73 16.64 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 122.175 0.988 . . . . 0.52000000000000002 109.516 -177.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.6 m-85 -84.16 113.33 21.0 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.134 -1.432 . . . . 0.33000000000000002 107.134 171.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.51 125.61 52.16 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.789 -1.551 . . . . 1.3200000000000001 110.51 -172.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.652 ' HB3' HG13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -92.15 132.5 36.57 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 113.838 -1.528 . . . . 0.95999999999999996 107.509 176.28 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 73.4 m-70 -119.95 96.72 5.29 Favored 'General case' 0 C--N 1.265 -3.066 0 N-CA-C 104.532 -2.396 . . . . 1.1499999999999999 104.532 167.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.812 HG12 ' HB2' ' A' ' 57' ' ' LEU . 14.2 mt -122.03 99.32 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 122.382 1.087 . . . . 0.52000000000000002 108.856 -174.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 75.8 p -100.41 165.0 11.66 Favored 'General case' 0 N--CA 1.388 -3.556 0 CA-C-N 114.546 -1.206 . . . . 0.57999999999999996 110.374 -175.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 34.9 75.55 0.05 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 110.317 -3.129 . . . . 2.1200000000000001 112.43 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' VAL . . . -65.5 105.84 1.28 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 110.786 -2.916 . . . . 0.40000000000000002 110.022 179.367 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.774 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.98 145.46 79.89 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.951 -0.759 . . . . 1.4299999999999999 108.951 174.456 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.958 ' HD3' HG21 ' A' ' 18' ' ' VAL . 30.4 Cg_endo -62.49 150.28 88.03 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.439 1.426 . . . . 1.3300000000000001 111.254 -175.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.53 15.48 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.725 0.64 . . . . 1.1200000000000001 111.02 -175.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.774 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.58 -7.34 59.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.865 -1.161 . . . . 1.24 107.865 172.057 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 25.0 m -13.15 90.96 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 126.066 2.104 . . . . 1.22 112.176 -177.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.95 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -49.8 112.76 1.54 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 110.946 -2.843 . . . . 1.4299999999999999 114.034 -173.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.643 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -111.25 75.73 0.22 Allowed Glycine 0 C--N 1.27 -3.103 0 N-CA-C 108.295 -1.922 . . . . 0.52000000000000002 108.295 154.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.801 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 52.6 m-85 -80.08 119.15 22.5 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.298 -0.951 . . . . 0.63 109.065 175.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.5 104.21 8.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.295 -1.002 . . . . 3.1499999999999999 108.295 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.6 t -90.58 127.73 36.36 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.852 -0.795 . . . . 1.0800000000000001 108.852 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 1.054 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 34.1 tt0 -136.7 107.48 6.62 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.526 -0.761 . . . . 1.8100000000000001 109.699 -174.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.63 HG13 HG22 ' A' ' 39' ' ' VAL . 21.6 t -98.81 141.46 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.644 -0.422 . . . . 0.54000000000000004 109.899 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.3 m -131.95 107.75 8.91 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.876 -0.787 . . . . 1.1799999999999999 108.876 -179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.763 HG21 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -132.9 157.05 46.07 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 118.6 -0.714 . . . . 0.73999999999999999 109.082 178.021 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 24.46 -79.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 125.61 1.819 . . . . 0.65000000000000002 113.793 168.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.63 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 t70 -142.81 -4.17 0.96 Allowed 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.894 -1.048 . . . . 1.05 109.944 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.04 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -91.65 122.74 34.49 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.536 0.684 . . . . 1.29 109.348 -177.424 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -129.81 114.29 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.388 -1.278 . . . . 0.77000000000000002 110.044 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -130.44 145.26 51.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.777 -1.556 . . . . 1.6000000000000001 109.531 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.503 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 38.5 m -142.86 147.33 35.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.374 0.607 . . . . 1.1899999999999999 110.959 -178.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.569 ' HG ' ' HZ ' ' A' ' 7' ' ' PHE . 1.5 p -127.6 148.41 50.36 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.398 -0.819 . . . . 0.83999999999999997 111.987 178.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.94 114.92 22.78 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.739 -1.119 . . . . 1.5800000000000001 109.807 173.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.711 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -141.29 119.98 12.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.434 0.635 . . . . 0.85999999999999999 109.441 -176.593 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 6.7 p30 -103.7 155.1 18.84 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.254 1.026 . . . . 2.1099999999999999 111.59 -168.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.715 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . 0.2 OUTLIER -121.81 111.72 17.48 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.26 -1.336 . . . . 0.37 109.611 175.387 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 6.7 m -94.13 96.8 9.86 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.127 -0.694 . . . . 0.33000000000000002 109.127 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 79' ' ' ALA . 4.0 p -82.87 113.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 122.955 1.36 . . . . 0.33000000000000002 109.234 179.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.484 ' NE2' ' HB3' ' A' ' 15' ' ' GLU . 99.7 m-70 -87.5 101.21 13.39 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 112.201 -2.272 . . . . 1.1899999999999999 109.044 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HA ' HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -64.21 95.15 0.12 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.6 -1.182 . . . . 1.6699999999999999 108.647 170.762 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.18 52.82 1.83 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.068 -0.969 . . . . 2.7799999999999998 109.167 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 C--O 1.245 0.843 0 CA-C-N 115.49 -0.777 . . . . 6.9199999999999999 110.078 179.677 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.831 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 4.6 p-10 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.119 0.485 . . . . 1.9299999999999999 109.982 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -97.95 172.8 4.49 Favored Pre-proline 0 N--CA 1.444 -0.742 0 C-N-CA 123.174 0.59 . . . . 1.6499999999999999 111.281 -178.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.99 84.69 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.317 2.011 . . . . 0.96999999999999997 111.711 171.078 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.007 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 1.5 mp -110.01 -64.87 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.16 -0.927 . . . . 0.5 109.329 176.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 95.6 46.55 2.71 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 108.284 -1.926 . . . . 0.39000000000000001 108.284 -175.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 96' ' ' LYS . 11.6 tp -56.72 -47.57 79.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.156 -1.522 . . . . 0.33000000000000002 111.203 -166.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.498 ' HD1' ' HA ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -93.98 84.76 4.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.933 0.873 . . . . 0.71999999999999997 109.665 178.367 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.48 -35.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.983 -1.462 . . . . 0.63 109.693 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tpt -158.57 130.9 6.88 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 114.948 -1.024 . . . . 2.8799999999999999 109.016 172.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -109.28 133.32 20.83 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 115.889 -0.596 . . . . 3.6699999999999999 110.206 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.69 ' HG2' ' CE1' ' A' ' 102' ' ' PHE . 9.5 Cg_endo -63.76 157.54 51.47 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.725 2.283 . . . . 0.64000000000000001 111.966 -176.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' C ' ' HB2' ' A' ' 102' ' ' PHE . 23.0 mm-40 -121.26 174.17 6.87 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.858 -0.61 . . . . 1.4299999999999999 110.472 -173.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 103' ' ' ASN . 5.5 p-10 -68.48 -142.85 0.01 OUTLIER 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 122.942 1.354 . . . . 2.0600000000000001 111.968 -178.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 149.85 137.16 2.7 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 113.433 -1.712 . . . . 0.29999999999999999 112.112 -175.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 34.0 mt-10 -110.49 115.81 30.28 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.413 -0.958 . . . . 1.53 108.413 174.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 m -134.86 155.7 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.02 0 N-CA-C 106.982 -1.488 . . . . 0.27000000000000002 106.982 -173.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.36 157.28 18.23 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 115.041 -0.981 . . . . 0.77000000000000002 108.908 -179.562 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.549 HG22 ' CG2' ' A' ' 106' ' ' VAL . 21.5 t -67.69 105.98 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.847 1.308 . . . . 0.78000000000000003 108.117 173.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.76 11.41 6.49 Favored Glycine 0 C--N 1.265 -3.395 0 CA-C-N 112.132 -2.304 . . . . 0.47999999999999998 113.055 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.14 -126.81 5.89 Favored Glycine 0 N--CA 1.416 -2.66 0 C-N-CA 119.278 -1.439 . . . . 0.44 110.529 171.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 16.7 p -151.21 170.46 19.41 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 112.697 -1.752 . . . . 0.81999999999999995 110.613 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 76' ' ' ILE . 9.8 tp -148.7 150.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.539 0 CA-C-N 112.835 -1.984 . . . . 0.32000000000000001 106.952 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -138.71 130.11 27.27 Favored 'General case' 0 C--N 1.258 -3.383 0 CA-C-N 114.32 -1.309 . . . . 0.31 110.639 -175.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 74' ' ' LEU . 26.9 m-85 -124.96 142.52 51.42 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.417 -1.265 . . . . 0.53000000000000003 109.85 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.83 121.28 20.42 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.078 0.942 . . . . 0.57999999999999996 110.43 176.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.637 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -118.83 115.94 25.48 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.119 -1.401 . . . . 0.32000000000000001 110.459 -178.132 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -105.06 122.81 46.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.439 -0.346 . . . . 2.4300000000000002 110.76 -178.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 39' ' ' VAL . 8.4 t -125.74 127.18 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 122.085 0.945 . . . . 0.26000000000000001 110.126 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -58.27 114.09 2.25 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.254 -1.794 . . . . 0.40000000000000002 111.397 177.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.03 -29.05 61.79 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.293 -1.321 . . . . 0.76000000000000001 110.757 168.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.72 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 52.86 -166.58 0.06 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.83 1.418 . . . . 0.70999999999999996 114.83 165.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 t -120.9 107.77 13.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.066 -1.457 . . . . 1.74 107.066 169.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.801 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -143.05 176.32 9.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.061 0.763 . . . . 2.1600000000000001 113.061 -165.311 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.0 tp -70.56 -71.44 0.25 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.386 -0.825 . . . . 1.47 108.824 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -116.63 148.4 41.82 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.609 -0.723 . . . . 1.3999999999999999 109.302 171.318 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 85.9 Cg_exo -46.67 142.92 9.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.877 2.385 . . . . 0.88 111.809 178.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.801 ' HD3' HD11 ' A' ' 33' ' ' LEU . 27.9 Cg_exo -62.37 139.63 78.07 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 121.938 1.759 . . . . 0.53000000000000003 111.924 -173.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.3 104.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.813 -1.551 . . . . 0.77000000000000002 106.813 178.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 28' ' ' VAL . 2.1 t -105.98 115.1 46.97 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 113.323 -1.762 . . . . 0.28000000000000003 107.528 176.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -110.09 127.91 55.14 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-O 122.944 1.354 . . . . 1.54 110.132 175.371 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.932 ' HB3' HD13 ' A' ' 49' ' ' LEU . 64.3 m95 -84.21 155.77 22.36 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 112.148 -2.297 . . . . 0.34000000000000002 111.923 175.358 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 36.9 t80 -131.16 141.48 50.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 104.703 -2.332 . . . . 0.62 104.703 170.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.768 ' HD3' ' HB ' ' A' ' 47' ' ' VAL . 62.5 tttt -108.81 163.53 13.19 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.349 -1.723 . . . . 2.1699999999999999 106.349 -172.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.811 ' HA2' ' HA2' ' A' ' 85' ' ' GLY . . . -7.81 -165.81 0.0 OUTLIER Glycine 0 C--O 1.196 -2.252 0 O-C-N 126.4 2.312 . . . . 1.23 118.845 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 84' ' ' THR . 15.6 mtpp -44.24 -3.7 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 O-C-N 119.449 -2.207 . . . . 3.8700000000000001 116.271 -169.003 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.652 ' CZ3' HG13 ' A' ' 47' ' ' VAL . 17.9 p-90 -171.2 -8.99 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 N-CA-C 115.295 1.591 . . . . 2.1099999999999999 115.295 178.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HB ' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -91.83 159.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 123.222 1.487 . . . . 1.29 113.795 -159.277 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.742 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -112.48 106.11 14.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 111.817 -2.447 . . . . 2.73 113.084 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.932 HD13 ' HB3' ' A' ' 41' ' ' TRP . 4.6 mp -55.08 -36.32 65.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 113.086 0.773 . . . . 0.44 113.086 -175.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -59.02 -20.85 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.763 -0.829 . . . . 1.23 108.763 -169.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 12.6 m -98.79 -41.9 7.44 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.058 -0.974 . . . . 1.3400000000000001 112.088 178.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.742 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 10.7 mmmt -85.09 -37.39 20.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.952 -1.022 . . . . 1.3999999999999999 112.389 -166.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.876 HG13 ' H ' ' A' ' 59' ' ' LEU . 17.5 t -35.2 96.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 125.967 1.707 . . . . 0.37 112.542 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -148.63 -138.98 3.08 Favored Glycine 0 C--N 1.3 -1.457 0 CA-C-N 111.316 -2.675 . . . . 0.69999999999999996 112.809 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -74.07 -8.37 55.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.973 0.731 . . . . 2.75 112.973 -167.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.717 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 29.3 p80 -111.79 -37.52 5.12 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 120.618 -0.433 . . . . 1.3300000000000001 110.985 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.803 HD11 HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -121.38 102.55 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.531 -1.655 . . . . 1.1100000000000001 106.531 171.86 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.5 OUTLIER -95.89 116.16 28.5 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.288 -1.375 . . . . 0.76000000000000001 107.288 168.119 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.876 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -95.24 93.28 7.21 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.965 -2.235 . . . . 0.26000000000000001 104.965 170.372 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.669 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 56.8 t60 -94.19 158.98 15.34 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-O 122.954 1.359 . . . . 2.0299999999999998 109.042 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.95 112.87 10.29 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 111.753 -2.476 . . . . 0.92000000000000004 110.605 -176.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 4.4 m -97.44 149.27 22.34 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 112.308 -2.224 . . . . 0.46999999999999997 108.577 174.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -141.98 97.63 3.17 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.08 0.943 . . . . 1.3899999999999999 110.632 -170.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 6.0 t70 -116.76 128.0 54.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.766 -1.561 . . . . 2.4199999999999999 108.596 174.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.86 -31.38 11.53 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.858 -1.519 . . . . 2.46 111.021 -173.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.47 -19.88 60.22 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.385 -1.279 . . . . 1.1499999999999999 110.549 174.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 50.7 m -98.53 -20.47 17.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 107.821 -1.177 . . . . 1.4099999999999999 107.821 174.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.72 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 69.15 32.24 3.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.13 -1.395 . . . . 3.3100000000000001 109.383 175.415 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.86 129.72 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 115.615 -0.72 . . . . 0.42999999999999999 109.776 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.686 ' HE2' ' HD2' ' A' ' 37' ' ' PRO . 4.9 m-85 -100.25 112.33 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.495 -1.668 . . . . 1.24 106.495 164.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 27.5 tp -95.27 106.32 18.35 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 122.09 0.948 . . . . 0.52000000000000002 109.075 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 96.6 m-85 -86.95 112.34 21.71 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.511 -1.663 . . . . 0.33000000000000002 106.511 169.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.669 ' HG3' ' HB3' ' A' ' 60' ' ' HIS . 4.0 pt-20 -121.54 122.35 39.49 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.29 -1.323 . . . . 1.3200000000000001 110.557 -173.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.716 ' CD1' HD11 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -89.08 132.08 34.95 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.033 -1.44 . . . . 0.95999999999999996 108.45 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . 19.8 m170 -115.03 97.01 5.97 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 103.798 -2.668 . . . . 1.1499999999999999 103.798 169.005 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.727 ' CD1' HD22 ' A' ' 57' ' ' LEU . 62.9 mt -121.55 101.3 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-O 122.985 1.374 . . . . 0.52000000000000002 109.775 -174.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.7 p -112.69 143.78 43.32 Favored 'General case' 0 N--CA 1.398 -3.045 0 CA-C-N 114.126 -1.397 . . . . 0.57999999999999996 109.257 -178.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.77 86.05 0.12 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 111.183 -2.735 . . . . 2.1200000000000001 110.49 -177.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -75.91 125.17 28.59 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 112.713 -2.04 . . . . 0.40000000000000002 109.52 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.879 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 1.2 tp60 -61.84 134.33 94.05 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.281 -0.872 . . . . 1.4299999999999999 108.978 175.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.685 ' HD2' HE21 ' A' ' 80' ' ' GLN . 19.1 Cg_endo -60.79 145.78 98.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.704 0.936 . . . . 1.3300000000000001 110.37 176.249 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 66.18 17.2 10.69 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.441 0.463 . . . . 1.1200000000000001 111.288 -173.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.879 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -73.1 -32.67 65.11 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.546 -0.539 . . . . 1.24 109.546 175.745 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 57.0 m 13.12 78.35 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 125.379 1.675 . . . . 1.22 111.137 -168.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.811 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -65.74 99.0 0.37 Allowed Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 112.112 -2.313 . . . . 1.4299999999999999 113.877 -161.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.67 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -90.13 74.04 1.87 Allowed Glycine 0 C--N 1.289 -2.078 0 N-CA-C 109.181 -1.568 . . . . 0.52000000000000002 109.181 171.288 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.644 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 45.3 m-85 -81.01 120.1 24.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.071 -1.065 . . . . 0.63 108.165 176.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.528 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 72.7 mtt180 -127.61 115.36 18.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.935 -0.478 . . . . 3.1499999999999999 111.034 -173.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.1 m -92.64 129.12 38.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.067 -0.515 . . . . 1.0800000000000001 110.03 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 41.7 tt0 -126.8 113.22 16.33 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.606 -0.887 . . . . 1.8100000000000001 108.606 174.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 39' ' ' VAL . 3.0 p -105.26 135.51 43.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.853 0.835 . . . . 0.54000000000000004 110.655 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -129.45 109.2 10.87 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.856 -1.52 . . . . 1.1799999999999999 108.688 -176.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.624 HG22 ' HG3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -125.11 167.11 15.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 118.249 -0.882 . . . . 0.73999999999999999 108.835 178.938 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.689 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -2.94 -62.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 125.618 1.824 . . . . 0.65000000000000002 114.571 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.689 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 12.9 t0 -150.63 -7.05 0.28 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.773 -1.103 . . . . 1.05 110.239 -176.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.007 ' HD2' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mttp -95.35 135.63 36.72 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.14 -1.024 . . . . 1.29 108.681 -177.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -132.9 142.2 48.78 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.403 -1.726 . . . . 0.77000000000000002 110.735 -177.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -164.02 163.84 23.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.317 -0.856 . . . . 1.6000000000000001 108.972 173.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.7 p -153.31 148.67 27.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.244 0.545 . . . . 1.1899999999999999 111.198 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.5 t -125.45 148.97 48.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.913 0.863 . . . . 0.83999999999999997 111.71 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.24 114.28 11.39 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.671 -1.604 . . . . 1.5800000000000001 110.092 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.69 ' CE1' ' HG2' ' A' ' 11' ' ' PRO . 18.6 p90 -142.47 131.67 23.36 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.562 -0.533 . . . . 0.85999999999999999 109.562 -176.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 52.7 m-20 -109.04 135.24 50.52 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 122.154 0.978 . . . . 2.1099999999999999 111.324 -171.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -102.74 110.11 21.93 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.145 -1.389 . . . . 0.37 109.434 176.811 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.443 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 13.3 m -90.85 97.87 11.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.381 0.61 . . . . 0.33000000000000002 109.391 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.5 p -82.13 115.67 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.987 1.375 . . . . 0.33000000000000002 109.288 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 94.6 m-70 -87.24 99.57 12.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 112.552 -2.113 . . . . 1.1899999999999999 109.538 -177.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.542 ' HA ' HG23 ' A' ' 18' ' ' VAL . 41.3 tt0 -75.12 -59.71 2.62 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.845 -1.525 . . . . 1.6699999999999999 109.803 173.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.33 17.42 0.48 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.343 -0.844 . . . . 2.7799999999999998 109.46 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.172 -0.922 . . . . 6.9199999999999999 109.349 -175.274 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.659 ' HB2' ' HG2' ' A' ' 96' ' ' LYS . 6.0 p-10 . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 121.036 0.446 . . . . 1.9299999999999999 110.142 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.734 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-20 -94.81 166.13 15.71 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 123.16 0.584 . . . . 1.6499999999999999 112.45 -175.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.474 ' C ' HD12 ' A' ' 4' ' ' ILE . 24.8 Cg_exo -64.01 86.55 0.15 Allowed 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.195 2.597 . . . . 0.96999999999999997 112.406 173.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.947 HG12 ' HD3' ' A' ' 94' ' ' LYS . 1.7 mp -119.59 -56.54 3.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.71 -1.132 . . . . 0.5 109.573 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 109.001 -1.64 . . . . 0.39000000000000001 109.001 -175.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.916 HD22 ' HB3' ' A' ' 96' ' ' LYS . 7.7 tp -52.27 -37.78 56.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.309 -1.446 . . . . 0.33000000000000002 109.811 -176.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.771 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.06 84.11 5.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.04 -0.982 . . . . 0.71999999999999997 109.911 176.235 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t -72.57 -43.2 63.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.264 -1.335 . . . . 0.63 109.826 178.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.412 ' HB3' ' HG3' ' A' ' 27' ' ' ARG . 16.0 tpt -156.95 130.25 7.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 115.372 -0.831 . . . . 2.8799999999999999 109.56 174.199 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 11.2 ptp85 -102.8 136.42 19.29 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 115.185 -0.916 . . . . 3.6699999999999999 109.107 179.233 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.1 Cg_endo -74.14 160.53 42.46 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.323 1.349 . . . . 0.64000000000000001 110.897 176.644 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -117.13 -179.77 3.8 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.297 -0.631 . . . . 1.4299999999999999 109.297 -176.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 4.6 m-20 -69.99 -146.73 0.01 OUTLIER 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 122.979 1.371 . . . . 2.0600000000000001 111.264 -175.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 156.65 133.53 1.65 Allowed Glycine 0 C--N 1.294 -1.799 0 CA-C-N 113.438 -1.71 . . . . 0.29999999999999999 111.5 -173.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.2 116.71 30.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.393 -0.904 . . . . 1.53 108.663 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 m -135.77 156.4 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.838 0 N-CA-C 107.643 -1.244 . . . . 0.27000000000000002 107.643 -171.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 156.19 18.64 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.638 -1.165 . . . . 0.77000000000000002 108.916 176.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 81' ' ' PRO . 13.5 t -66.89 107.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 123.151 1.453 . . . . 0.78000000000000003 108.477 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.17 3.71 11.65 Favored Glycine 0 C--N 1.266 -3.323 0 CA-C-N 111.612 -2.54 . . . . 0.47999999999999998 112.463 178.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.86 -127.88 5.2 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 118.988 -1.577 . . . . 0.44 110.023 176.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 18.8 p -153.06 164.9 37.16 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 113.437 -1.381 . . . . 0.81999999999999995 110.718 177.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 104' ' ' LEU . 10.8 tp -147.05 149.67 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.401 -1.727 . . . . 0.32000000000000001 107.924 171.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -139.81 127.33 21.58 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-N 113.016 -1.902 . . . . 0.31 110.385 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.633 ' HB2' HD23 ' A' ' 74' ' ' LEU . 54.5 m-85 -121.92 147.31 46.18 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.607 -1.179 . . . . 0.53000000000000003 108.883 174.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.473 ' H ' ' HB3' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -132.44 119.73 21.03 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.208 -0.905 . . . . 0.57999999999999996 109.183 178.199 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.644 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -125.39 119.96 29.76 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.456 -1.247 . . . . 0.32000000000000001 110.805 -173.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.514 ' HG2' HD13 ' A' ' 71' ' ' LEU . 72.0 mtp180 -114.21 127.09 55.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.266 -0.425 . . . . 2.4300000000000002 110.774 -176.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 91' ' ' VAL . 22.4 t -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-O 122.005 0.907 . . . . 0.26000000000000001 110.558 -179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -62.96 111.38 2.13 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.197 -1.819 . . . . 0.40000000000000002 110.566 174.172 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.81 -40.07 9.02 Favored Glycine 0 C--N 1.32 -0.336 0 CA-C-N 114.543 -1.208 . . . . 0.76000000000000001 111.548 170.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . 50.69 -156.01 0.12 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.869 0.868 . . . . 0.70999999999999996 113.282 171.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.6 m -120.01 84.33 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.216 0.532 . . . . 1.74 110.852 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.076 HD22 ' HA ' ' A' ' 93' ' ' THR . 1.8 tp -114.28 150.38 34.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.323 -0.992 . . . . 2.1600000000000001 108.323 173.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 33' ' ' LEU . 21.0 tp -44.24 -37.41 3.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.948 0.88 . . . . 1.47 111.292 178.107 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.808 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.36 178.41 1.7 Allowed Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.41 -1.268 . . . . 1.3999999999999999 108.121 177.193 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 35' ' ' LYS . 13.0 Cg_exo -65.59 146.23 83.98 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.662 1.575 . . . . 0.88 109.997 173.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HG3' HG21 ' A' ' 93' ' ' THR . 49.4 Cg_exo -45.57 140.76 8.63 Favored 'Trans proline' 0 CA--C 1.498 -1.297 0 C-N-CA 123.211 2.607 . . . . 0.53000000000000003 113.286 178.536 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 92' ' ' SER . 7.3 p -100.09 96.84 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 123.075 1.417 . . . . 0.77000000000000002 107.664 168.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.639 HG13 ' HB ' ' A' ' 91' ' ' VAL . 2.6 t -99.26 114.47 37.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 112.703 -2.044 . . . . 0.28000000000000003 106.923 170.308 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -107.6 127.27 53.5 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 114.027 -1.442 . . . . 1.54 109.6 177.729 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.046 ' HB3' HD13 ' A' ' 49' ' ' LEU . 89.2 m95 -89.6 147.48 23.9 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 112.078 -2.328 . . . . 0.34000000000000002 111.792 173.149 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.655 ' HD2' ' HB2' ' A' ' 88' ' ' ARG . 4.0 t80 -131.35 125.48 32.78 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.71 -1.589 . . . . 0.62 106.71 172.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG3' ' CE2' ' A' ' 87' ' ' TYR . 5.1 ttpm? -98.93 109.91 22.6 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.214 -1.402 . . . . 2.1699999999999999 107.214 -173.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.671 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -83.3 92.49 1.66 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 116.012 -2.994 . . . . 1.23 114.797 -167.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.839 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -106.15 -53.52 2.62 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.61 -3.107 . . . . 3.8700000000000001 102.61 132.16 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.839 ' CD1' ' HB3' ' A' ' 45' ' ' LYS . 6.5 p-90 -167.38 -1.56 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 110.459 -3.064 . . . . 2.1099999999999999 111.476 178.416 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.526 HG13 ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -94.67 170.88 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-O 123.144 1.45 . . . . 1.29 112.496 -159.7 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 7.3 t70 -106.22 150.0 26.31 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 111.675 -2.511 . . . . 2.73 106.07 173.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.7 mp -88.17 -36.84 16.6 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.402 -0.519 . . . . 0.44 110.902 176.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t -59.97 -19.54 52.76 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.866 0.841 . . . . 1.23 109.011 -169.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -86.14 -28.78 23.76 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.571 -1.195 . . . . 1.3400000000000001 111.094 -176.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 43' ' ' LYS . 2.4 mmmt -104.65 -71.4 0.74 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.03 -0.986 . . . . 1.3999999999999999 111.125 -172.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.93 HG13 ' H ' ' A' ' 59' ' ' LEU . 56.2 t 19.01 85.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 O-C-N 125.366 1.667 . . . . 0.37 113.181 -177.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -158.74 -131.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 114.659 -1.155 . . . . 0.69999999999999996 113.639 -173.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -48.78 -53.87 17.37 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.909 1.077 . . . . 2.75 113.909 -168.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 8.2 p80 -91.17 -38.09 12.94 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.837 -0.745 . . . . 1.3300000000000001 111.498 -173.142 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.886 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -124.0 108.81 12.78 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.809 -0.811 . . . . 1.1100000000000001 108.809 175.443 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -96.43 115.61 27.72 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 106.343 -1.725 . . . . 0.76000000000000001 106.343 168.218 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.93 ' H ' HG13 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -95.05 92.7 6.97 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.961 -2.237 . . . . 0.26000000000000001 104.961 172.099 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 36.1 m170 -81.9 163.3 22.33 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.046 -1.434 . . . . 2.0299999999999998 109.994 178.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -139.21 114.8 9.9 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 112.328 -2.214 . . . . 0.92000000000000004 109.604 175.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 3.2 m -92.26 148.22 22.31 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.153 -1.84 . . . . 0.46999999999999997 106.516 169.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.486 ' CE1' ' HG2' ' A' ' 65' ' ' ARG . 9.2 t80 -144.75 98.96 3.27 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.211 1.005 . . . . 1.3899999999999999 111.011 -170.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 67' ' ' SER . 2.5 p30 -113.69 128.23 56.34 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 113.697 -1.592 . . . . 2.4199999999999999 110.342 174.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.1 mmm180 -105.95 29.03 7.03 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.705 -1.589 . . . . 2.46 109.295 172.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.04 -30.17 6.1 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.195 -1.82 . . . . 1.1499999999999999 109.27 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 5.7 t -111.91 -8.47 14.1 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.89 -1.05 . . . . 1.4099999999999999 108.939 178.016 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER 72.48 31.68 1.72 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.547 -0.909 . . . . 3.3100000000000001 108.547 173.654 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 27' ' ' ARG . 3.3 t -127.33 133.8 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 122.506 1.146 . . . . 0.42999999999999999 111.473 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' SER . 5.0 m-85 -101.96 113.39 26.57 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.26 -1.755 . . . . 1.24 106.26 162.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 14.7 tp -97.36 104.82 16.88 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 122.302 1.049 . . . . 0.52000000000000002 109.391 177.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 97.4 m-85 -88.64 114.58 25.4 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.833 -1.53 . . . . 0.33000000000000002 108.534 174.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 2.9 mt-10 -103.52 125.66 50.21 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 113.708 -1.587 . . . . 1.3200000000000001 109.566 -176.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.876 HD21 ' CH2' ' A' ' 41' ' ' TRP . 2.8 mm? -94.08 122.23 36.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.862 -1.162 . . . . 0.95999999999999996 107.862 171.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.657 ' O ' ' HA ' ' A' ' 57' ' ' LEU . 11.4 m170 -115.79 93.83 4.43 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.967 -2.605 . . . . 1.1499999999999999 103.967 169.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.885 HG12 ' HB2' ' A' ' 57' ' ' LEU . 38.0 mt -121.78 100.79 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-O 122.883 1.325 . . . . 0.52000000000000002 110.026 -175.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 72.4 p -103.02 154.61 19.07 Favored 'General case' 0 N--CA 1.391 -3.395 0 CA-C-N 114.057 -1.429 . . . . 0.57999999999999996 109.051 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.89 84.26 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.115 -2.766 . . . . 2.1200000000000001 112.064 178.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -72.84 132.28 43.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 110.731 -2.94 . . . . 0.40000000000000002 112.252 -175.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.752 HE21 ' HD2' ' A' ' 81' ' ' PRO . 3.2 tp60 -54.01 125.62 49.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.402 -0.817 . . . . 1.4299999999999999 109.323 170.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HB3' HG21 ' A' ' 18' ' ' VAL . 19.4 Cg_endo -59.23 -7.19 4.67 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.738 2.959 . . . . 1.3300000000000001 114.03 -175.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.662 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -109.6 0.41 19.08 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.974 -0.29 . . . . 1.1200000000000001 111.569 -178.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.639 ' HA ' ' HG2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -61.48 -58.09 9.57 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.642 0.258 . . . . 1.24 110.889 -172.601 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 34.2 m 38.64 66.2 0.55 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.592 -1.633 . . . . 1.22 106.592 -155.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . -62.72 84.77 0.04 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 CA-C-N 112.445 -2.162 . . . . 1.4299999999999999 114.139 -161.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 103' ' ' ASN . . . -86.72 82.78 1.62 Allowed Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.916 -1.673 . . . . 0.52000000000000002 108.916 175.307 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.595 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 18.1 m-85 -78.75 113.99 17.3 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 113.779 -1.211 . . . . 0.63 107.998 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.655 ' HB2' ' HD2' ' A' ' 42' ' ' PHE . 7.4 mtp180 -104.02 105.95 16.29 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.267 0.556 . . . . 3.1499999999999999 109.854 -176.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 102' ' ' PHE . 1.8 t -87.71 126.96 35.28 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.568 -0.742 . . . . 1.0800000000000001 109.076 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.947 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 37.6 tt0 -136.03 110.37 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.222 -0.899 . . . . 1.8100000000000001 109.606 -175.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.639 ' HB ' HG13 ' A' ' 39' ' ' VAL . 1.7 p -106.27 142.3 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.957 0.408 . . . . 0.54000000000000004 111.046 -179.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.557 ' O ' HG12 ' A' ' 38' ' ' VAL . 20.7 t -132.13 108.28 9.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.919 -1.141 . . . . 1.1799999999999999 107.919 177.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.076 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -131.44 146.62 52.34 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 117.912 -1.042 . . . . 0.73999999999999999 108.501 -178.639 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.947 ' HD3' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER 32.74 -74.82 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.642 1.839 . . . . 0.65000000000000002 112.976 -177.558 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' H ' ' HE3' ' A' ' 94' ' ' LYS . 22.2 t70 -147.69 -7.56 0.44 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.569 -1.196 . . . . 1.05 110.429 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.916 ' HB3' HD22 ' A' ' 6' ' ' LEU . 2.7 tttp -86.38 131.65 34.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.998 -1.112 . . . . 1.29 107.998 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -133.2 120.45 21.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.485 -1.689 . . . . 0.77000000000000002 110.233 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -139.69 148.27 42.11 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.502 -1.226 . . . . 1.6000000000000001 109.338 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' HG3' ' A' ' 90' ' ' GLU . 43.8 m -140.0 149.17 42.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.371 -0.377 . . . . 1.1899999999999999 110.303 -179.032 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.771 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 40.7 p -131.9 134.43 45.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 0.83999999999999997 111.273 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.632 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -107.78 119.43 39.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 1.5800000000000001 110.096 177.356 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.738 ' HE1' ' HG ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -142.27 118.56 10.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.137 -0.69 . . . . 0.85999999999999999 109.137 -179.105 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 3.7 p30 -106.43 154.6 20.58 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 123.034 1.397 . . . . 2.1099999999999999 111.876 -170.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.644 HD13 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -116.57 106.42 13.54 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 112.924 -1.944 . . . . 0.37 110.456 178.517 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -87.43 95.86 10.17 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.334 -0.987 . . . . 0.33000000000000002 108.334 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 80' ' ' GLN . 7.2 p -83.37 120.23 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 CA-C-O 122.876 1.322 . . . . 0.33000000000000002 108.54 -177.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -93.81 98.31 10.99 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 112.892 -1.958 . . . . 1.1899999999999999 109.322 -176.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 18' ' ' VAL . 27.8 tt0 -75.54 -63.86 1.2 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.258 -1.337 . . . . 1.6699999999999999 109.665 171.218 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.7 126.3 35.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 2.7799999999999998 110.384 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.604 -0.712 . . . . 6.9199999999999999 110.002 177.686 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.677 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.227 0.537 . . . . 1.9299999999999999 109.8 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . 8.2 m-20 -91.47 169.74 10.82 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.318 -0.856 . . . . 1.6499999999999999 109.311 173.023 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.22 81.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.464 2.109 . . . . 0.96999999999999997 111.596 174.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.644 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 1.7 mp -102.0 -62.51 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 115.457 -0.792 . . . . 0.5 109.608 178.685 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.12 40.71 3.68 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.987 -1.645 . . . . 0.39000000000000001 108.987 -176.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 96' ' ' LYS . 9.7 tp -55.07 -33.62 62.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.42 -1.39 . . . . 0.33000000000000002 110.131 -172.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.833 ' CZ ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -97.81 84.58 3.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.391 -1.277 . . . . 0.71999999999999997 109.608 176.847 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.65 -46.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.664 -1.153 . . . . 0.63 110.374 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ttt -159.74 134.46 7.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.851 -1.068 . . . . 2.8799999999999999 108.567 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.833 ' HD2' ' CZ ' ' A' ' 7' ' ' PHE . 5.5 mmp_? -125.25 145.66 51.45 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 116.173 -0.467 . . . . 3.6699999999999999 111.077 -172.023 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.812 ' HG2' ' CZ ' ' A' ' 102' ' ' PHE . 19.6 Cg_endo -70.73 159.4 52.82 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.773 1.649 . . . . 0.64000000000000001 110.573 179.145 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -124.79 -176.81 3.64 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.04 -0.527 . . . . 1.4299999999999999 110.142 -173.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 3.7 p-10 -68.27 -152.34 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.732 0 CA-C-O 122.869 1.318 . . . . 2.0600000000000001 111.211 -177.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 153.17 139.1 2.81 Favored Glycine 0 C--N 1.287 -2.171 0 CA-C-N 113.044 -1.889 . . . . 0.29999999999999999 111.744 -173.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.461 ' HG2' ' HB ' ' A' ' 105' ' ' THR . 21.2 mt-10 -115.07 114.96 26.05 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.297 -0.952 . . . . 1.53 109.055 175.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 m -136.4 158.32 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 N-CA-C 107.104 -1.443 . . . . 0.27000000000000002 107.104 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -89.04 157.74 18.24 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.83 -1.077 . . . . 0.77000000000000002 109.548 -178.873 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 22.6 t -64.99 107.06 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 123.088 1.423 . . . . 0.78000000000000003 108.554 173.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 10.12 16.34 Favored Glycine 0 C--N 1.267 -3.284 0 CA-C-N 111.882 -2.417 . . . . 0.47999999999999998 113.041 175.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 -123.14 3.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 119.703 -1.237 . . . . 0.44 110.198 175.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 10.9 p -152.43 164.24 37.93 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 112.989 -1.605 . . . . 0.81999999999999995 110.817 176.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 76' ' ' ILE . 10.5 tp -148.29 150.96 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 113.609 -1.632 . . . . 0.32000000000000001 107.774 170.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.8 m -138.54 129.28 26.47 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 113.941 -1.481 . . . . 0.31 110.996 -176.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.691 ' HB2' ' HG ' ' A' ' 74' ' ' LEU . 87.7 m-85 -125.21 145.19 50.09 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.955 -1.475 . . . . 0.53000000000000003 109.089 178.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.526 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -137.43 124.86 21.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.943 -0.762 . . . . 0.57999999999999996 108.943 174.352 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 41' ' ' TRP . . . -123.85 114.4 19.81 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.741 -1.118 . . . . 0.32000000000000001 110.208 -176.252 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.501 ' HG2' HD13 ' A' ' 71' ' ' LEU . 67.7 mtp180 -104.86 128.98 53.26 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.504 -0.316 . . . . 2.4300000000000002 110.267 -176.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG21 HG21 ' A' ' 39' ' ' VAL . 20.1 t -125.5 127.48 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.902 0.858 . . . . 0.26000000000000001 109.964 -177.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -63.11 108.82 1.33 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.961 -1.472 . . . . 0.40000000000000002 110.939 175.461 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.68 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -48.62 -54.92 11.95 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.76000000000000001 112.35 173.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 57.57 -166.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.275 0.843 . . . . 0.70999999999999996 113.275 177.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -107.73 127.65 53.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.37 -0.832 . . . . 1.74 109.037 172.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -123.41 -178.86 4.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.088 0.947 . . . . 2.1600000000000001 112.319 -168.665 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' H ' ' HB3' ' A' ' 94' ' ' LYS . 17.4 tp -88.29 -37.36 16.07 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.586 -1.643 . . . . 1.47 106.846 154.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.35 145.8 19.07 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.595 -1.184 . . . . 1.3999999999999999 110.895 171.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.82 148.48 12.42 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.348 2.699 . . . . 0.88 112.27 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HA ' HG23 ' A' ' 93' ' ' THR . 6.3 Cg_endo -55.21 132.26 51.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.091 1.861 . . . . 0.53000000000000003 113.572 -175.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.13 106.28 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 106.277 -1.749 . . . . 0.77000000000000002 106.277 174.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 91' ' ' VAL . 2.1 t -115.08 114.31 46.1 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 113.703 -1.589 . . . . 0.28000000000000003 108.03 179.082 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.809 ' HD2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -99.84 128.72 45.91 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 123.066 1.413 . . . . 1.54 109.19 172.906 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 1.002 ' HB3' HD13 ' A' ' 49' ' ' LEU . 60.0 m95 -87.89 153.54 21.23 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 112.061 -2.336 . . . . 0.34000000000000002 110.709 172.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 35.8 t80 -135.01 125.23 26.15 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.202 -2.147 . . . . 0.62 105.202 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HB3' HG12 ' A' ' 47' ' ' VAL . 27.1 tttt -104.09 99.57 9.31 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.38 -1.711 . . . . 2.1699999999999999 106.38 -175.481 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.661 ' O ' ' HA2' ' A' ' 85' ' ' GLY . . . -86.45 95.14 2.01 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 115.882 -3.056 . . . . 1.23 117.078 -154.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.926 ' HE2' ' HE1' ' A' ' 46' ' ' TRP . 0.8 OUTLIER -101.69 -48.17 4.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.007 -2.59 . . . . 3.8700000000000001 104.007 135.322 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.926 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 11.6 p-90 -170.41 1.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 112.676 -2.056 . . . . 2.1099999999999999 111.915 175.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -97.35 169.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.164 0 C-N-CA 125.275 1.43 . . . . 1.29 113.171 -159.427 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.549 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 m-20 -100.95 147.45 26.15 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 112.456 -2.156 . . . . 2.73 107.527 173.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.002 HD13 ' HB3' ' A' ' 41' ' ' TRP . 5.3 mp -79.21 -29.25 42.72 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 120.678 -0.409 . . . . 0.44 110.639 173.383 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -57.36 -20.93 32.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 1.23 109.608 -167.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.504 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.7 t -97.59 -27.85 14.21 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 119.78 -0.768 . . . . 1.3400000000000001 111.79 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.582 ' HB2' HD12 ' A' ' 57' ' ' LEU . 5.9 mmmt -95.68 -33.37 12.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.392 -0.822 . . . . 1.3999999999999999 111.319 -171.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.828 HG13 ' H ' ' A' ' 59' ' ' LEU . 53.8 t -40.79 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 126.02 1.728 . . . . 0.37 111.908 175.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -159.89 -103.2 0.19 Allowed Glycine 0 C--N 1.302 -1.353 0 CA-C-N 112.427 -2.17 . . . . 0.69999999999999996 113.42 177.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.11 -54.68 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.118 0.784 . . . . 2.75 113.118 -169.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 13.0 p80 -96.05 -29.37 14.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.487 0.661 . . . . 1.3300000000000001 111.189 -174.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.969 HD21 HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -114.12 106.05 13.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.541 -1.651 . . . . 1.1100000000000001 106.541 173.494 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -104.68 118.28 36.18 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 107.074 -1.454 . . . . 0.76000000000000001 107.074 167.119 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.828 ' H ' HG13 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -98.96 92.83 5.7 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.211 -2.144 . . . . 0.26000000000000001 105.211 172.073 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.7 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 33.2 m170 -91.31 162.91 14.41 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.161 -1.381 . . . . 2.0299999999999998 110.21 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' ' CD2' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -136.45 122.95 20.83 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 112.348 -2.205 . . . . 0.92000000000000004 110.145 176.176 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 1.2 m -97.0 148.54 22.87 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 111.367 -2.651 . . . . 0.46999999999999997 108.559 176.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HD1' ' CE1' ' A' ' 70' ' ' TYR . 37.3 t80 -127.78 99.83 5.7 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.352 1.072 . . . . 1.3899999999999999 111.563 -170.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.852 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 3.2 m-20 -113.44 103.96 11.8 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.036 -1.893 . . . . 2.4199999999999999 109.285 172.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -42.1 14.38 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.054 -0.521 . . . . 2.46 110.26 174.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.38 61.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.295 -0.866 . . . . 1.1499999999999999 110.637 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.852 ' HB2' ' HB3' ' A' ' 64' ' ' ASP . 9.4 m -99.67 -16.3 18.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.8 -1.185 . . . . 1.4099999999999999 107.8 175.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HE2' ' HA3' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 68.24 31.62 5.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.362 -1.29 . . . . 3.3100000000000001 110.001 172.523 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 64' ' ' ASP . 2.6 t -129.97 122.54 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 CA-C-N 115.48 -0.782 . . . . 0.42999999999999999 110.175 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.68 ' CE2' ' HA2' ' A' ' 30' ' ' GLY . 46.2 m-85 -95.92 113.22 24.83 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.026 -1.472 . . . . 1.24 107.026 164.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 25' ' ' SER . 22.6 tp -97.47 105.02 17.1 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.106 0.955 . . . . 0.52000000000000002 108.78 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 90.0 m-85 -86.19 111.65 20.59 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.262 -1.755 . . . . 0.33000000000000002 106.262 170.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HG3' ' HB2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -116.57 129.52 56.22 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 114.348 -1.296 . . . . 1.3200000000000001 110.344 -174.833 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 76' ' ' ILE . 2.5 mt -92.29 135.92 33.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 113.789 -1.551 . . . . 0.95999999999999996 108.635 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -120.09 97.32 5.54 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 103.915 -2.624 . . . . 1.1499999999999999 103.915 165.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.731 HG13 ' HB3' ' A' ' 74' ' ' LEU . 13.2 mt -125.48 100.18 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 122.982 1.372 . . . . 0.52000000000000002 109.153 -175.051 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 40.7 p -97.6 165.12 12.13 Favored 'General case' 0 N--CA 1.381 -3.886 0 CA-C-N 114.004 -1.453 . . . . 0.57999999999999996 107.866 178.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.4 84.27 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 111.404 -2.635 . . . . 2.1200000000000001 112.755 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -76.66 132.69 39.53 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 111.574 -2.557 . . . . 0.40000000000000002 108.383 176.084 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.611 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 1.1 pt20 -93.63 152.02 40.5 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.616 -0.883 . . . . 1.4299999999999999 108.616 -178.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HB3' ' HG2' ' A' ' 108' ' ' GLU . 36.8 Cg_endo -63.92 -16.84 57.15 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 C-N-CA 122.75 2.3 . . . . 1.3300000000000001 113.403 -167.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . -92.04 13.06 19.87 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.961 -0.563 . . . . 1.1200000000000001 111.68 -176.576 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 45' ' ' LYS . 15.9 m-30 -89.09 -61.17 1.76 Allowed 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.258 -0.577 . . . . 1.24 110.52 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.3 m 36.7 63.16 0.69 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.027 -1.471 . . . . 1.22 107.027 -158.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.741 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -67.21 90.94 0.19 Allowed Glycine 0 CA--C 1.481 -2.055 0 CA-C-N 111.978 -2.374 . . . . 1.4299999999999999 113.782 -160.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -84.72 82.04 1.71 Allowed Glycine 0 C--N 1.277 -2.715 0 N-CA-C 107.933 -2.067 . . . . 0.52000000000000002 107.933 168.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 8.3 m-85 -74.71 134.33 41.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 113.653 -1.274 . . . . 0.63 108.088 179.283 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -126.44 138.12 53.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.92 -0.4 . . . . 3.1499999999999999 109.92 -178.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.648 ' SG ' ' HZ ' ' A' ' 102' ' ' PHE . 4.3 m -112.09 116.42 30.47 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.415 -0.957 . . . . 1.0800000000000001 108.415 168.065 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.809 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . 64.5 mt-10 -110.19 102.07 10.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.544 -1.28 . . . . 1.8100000000000001 107.544 176.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 39' ' ' VAL . 4.7 p -99.19 135.92 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.752 0.787 . . . . 0.54000000000000004 111.36 -173.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.6 t -130.07 108.89 10.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.891 -1.504 . . . . 1.1799999999999999 107.862 -179.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.5 m -130.3 158.47 39.7 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.8 -1.095 . . . . 0.73999999999999999 108.054 179.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.683 ' HE3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER 10.96 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 125.819 1.949 . . . . 0.65000000000000002 114.342 -177.489 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.683 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -146.18 -3.16 0.67 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.923 -1.035 . . . . 1.05 110.193 -176.694 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.677 ' HE3' ' HB3' ' A' ' 1' ' ' ASP . 4.5 mmtp -95.39 129.63 42.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.612 -0.884 . . . . 1.29 108.612 -177.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -131.7 128.63 39.36 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.81 -1.087 . . . . 0.77000000000000002 112.341 -178.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.7 160.47 43.82 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.46 -1.245 . . . . 1.6000000000000001 109.95 175.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -140.95 145.86 36.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.624 0.25 . . . . 1.1899999999999999 110.487 176.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.758 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 89.2 p -126.8 135.53 51.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.542 -0.299 . . . . 0.83999999999999997 110.915 -175.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.479 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -122.33 128.49 51.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.378 0.609 . . . . 1.5800000000000001 111.05 179.773 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.812 ' CZ ' ' HG2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -143.08 119.0 10.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.6 -0.727 . . . . 0.85999999999999999 109.694 -177.143 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.503 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 0.3 OUTLIER -104.32 129.58 52.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.423 1.106 . . . . 2.1099999999999999 113.114 -170.007 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -102.75 111.98 24.55 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.526 -1.67 . . . . 0.37 109.733 179.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 15' ' ' GLU . 14.5 m -90.62 98.38 11.74 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.977 -0.749 . . . . 0.33000000000000002 108.977 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 80' ' ' GLN . 5.6 p -81.9 115.02 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-O 122.967 1.365 . . . . 0.33000000000000002 109.399 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.652 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 11.7 m170 -83.14 99.79 10.13 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.71 -2.041 . . . . 1.1899999999999999 110.05 -176.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 3.0 tm-20 -78.48 -56.53 4.37 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.307 -1.315 . . . . 1.6699999999999999 109.101 170.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.14 139.87 39.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.134 -0.939 . . . . 2.7799999999999998 110.772 -178.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.664 -0.698 . . . . 6.9199999999999999 109.848 178.908 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 6.6 p-10 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.98 0.895 . . . . 1.9299999999999999 110.217 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 94' ' ' LYS . 4.5 t70 -111.84 152.31 44.1 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.293 -1.321 . . . . 1.6499999999999999 108.625 -178.746 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HD2' ' OD1' ' A' ' 2' ' ' ASP . 3.0 Cg_endo -46.59 93.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.385 3.39 . . . . 0.96999999999999997 113.954 179.013 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.669 HG21 HD13 ' A' ' 6' ' ' LEU . 1.7 mp -123.29 -65.18 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.97 -1.014 . . . . 0.5 109.124 175.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 90.05 47.74 3.79 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 108.131 -1.987 . . . . 0.39000000000000001 108.131 -174.167 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' A' ' 96' ' ' LYS . 8.7 tp -58.12 -41.49 83.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 112.783 -1.709 . . . . 0.33000000000000002 110.346 -167.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.812 ' CE2' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -91.02 85.67 6.01 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.887 0.851 . . . . 0.71999999999999997 109.772 174.796 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -62.08 -40.02 85.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 113.774 -1.557 . . . . 0.63 110.078 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.486 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 57.3 ttm -153.42 134.58 14.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 2.8799999999999999 110.19 176.37 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.661 ' HG2' ' HD2' ' A' ' 7' ' ' PHE . 6.8 mtm180 -91.91 139.35 24.58 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 107.905 -1.146 . . . . 3.6699999999999999 107.905 174.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 40.2 Cg_endo -78.64 -163.85 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.981 2.454 . . . . 0.64000000000000001 113.509 -175.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -127.26 131.29 50.58 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.745 -0.661 . . . . 1.4299999999999999 111.405 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 8.4 m-20 -43.91 -98.99 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.668 1.587 . . . . 2.0600000000000001 113.162 -176.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . 145.3 145.93 4.36 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-O 121.769 0.649 . . . . 0.29999999999999999 111.758 169.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.5 112.1 10.0 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.966 -0.617 . . . . 1.53 109.707 170.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.576 HG11 ' HB ' ' A' ' 22' ' ' ILE . 10.4 m -138.87 165.87 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 N-CA-C 108.093 -1.077 . . . . 0.27000000000000002 108.093 -172.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.671 ' HA ' ' HB2' ' A' ' 107' ' ' HIS . 0.2 OUTLIER -95.94 157.38 15.92 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.932 -1.031 . . . . 0.77000000000000002 109.288 178.074 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 106' ' ' VAL . 59.5 t -64.77 106.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 122.96 1.362 . . . . 0.78000000000000003 109.583 176.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.7 10.68 14.14 Favored Glycine 0 C--N 1.272 -2.995 0 CA-C-N 112.105 -2.316 . . . . 0.47999999999999998 113.561 171.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.35 -122.15 3.56 Favored Glycine 0 N--CA 1.42 -2.372 0 C-N-CA 118.615 -1.755 . . . . 0.44 110.457 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 5.7 p -151.03 165.05 34.97 Favored 'General case' 0 N--CA 1.405 -2.695 0 CA-C-N 112.716 -1.742 . . . . 0.81999999999999995 110.302 177.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.661 HG21 HD13 ' A' ' 104' ' ' LEU . 8.3 tp -147.98 150.2 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 CA-C-N 113.665 -1.607 . . . . 0.32000000000000001 106.837 172.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -138.55 132.8 31.68 Favored 'General case' 0 C--N 1.263 -3.184 0 CA-C-N 114.672 -1.149 . . . . 0.31 110.623 -174.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.786 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . 18.6 m-85 -128.38 137.71 52.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.228 -1.351 . . . . 0.53000000000000003 109.98 -175.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.422 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -140.79 124.3 16.85 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.985 0.898 . . . . 0.57999999999999996 111.262 172.694 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.643 ' HB3' ' CZ2' ' A' ' 41' ' ' TRP . . . -122.94 129.26 51.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.011 -1.449 . . . . 0.32000000000000001 110.328 -178.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.486 ' HD2' ' HB3' ' A' ' 9' ' ' MET . 54.2 mtt180 -107.31 126.39 52.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.404 -0.362 . . . . 2.4300000000000002 111.688 -174.849 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.55 HG21 HG21 ' A' ' 39' ' ' VAL . 20.1 t -128.37 131.87 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 121.93 0.871 . . . . 0.26000000000000001 110.137 -177.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' LYS . . . -65.96 118.1 9.27 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.614 -1.63 . . . . 0.40000000000000002 111.439 179.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.78 -33.66 56.04 Favored Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.579 -1.192 . . . . 0.76000000000000001 110.868 168.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' H ' ' HG3' ' A' ' 68' ' ' LYS . . . 59.58 -164.19 0.22 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.735 1.383 . . . . 0.70999999999999996 114.735 162.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -113.48 118.4 34.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.01 -1.45 . . . . 1.74 107.446 170.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.733 HD11 ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.61 166.03 33.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.436 0.532 . . . . 2.1600000000000001 112.436 -165.564 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' HB2' ' HG3' ' A' ' 35' ' ' LYS . 1.8 mt -81.86 -30.36 32.08 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.576 1.179 . . . . 1.47 109.528 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -150.6 139.36 12.95 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 112.673 -2.058 . . . . 1.3999999999999999 108.661 -166.81 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -47.4 141.87 13.61 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.571 2.181 . . . . 0.88 111.397 179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HD3' HD11 ' A' ' 33' ' ' LEU . 3.1 Cg_exo -63.0 130.16 28.22 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.297 1.331 . . . . 0.53000000000000003 111.536 -175.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.13 104.11 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.052 -1.462 . . . . 0.77000000000000002 107.052 179.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 2.1 t -107.69 113.98 45.12 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 113.444 -1.707 . . . . 0.28000000000000003 107.387 176.236 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.785 ' HE2' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -98.42 119.0 36.36 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 122.95 1.357 . . . . 1.54 110.062 176.029 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.682 ' HB3' HD22 ' A' ' 49' ' ' LEU . 46.5 m95 -86.61 139.26 30.98 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 112.079 -2.328 . . . . 0.34000000000000002 110.662 175.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 58.1 t80 -117.55 153.75 32.68 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.166 -1.42 . . . . 0.62 107.166 170.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.961 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 22.9 tptt -106.6 165.57 11.19 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.601 -0.888 . . . . 2.1699999999999999 108.601 -172.176 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.984 ' HA2' ' H ' ' A' ' 86' ' ' GLY . . . -25.14 168.47 0.0 OUTLIER Glycine 0 C--O 1.204 -1.76 0 O-C-N 124.348 1.03 . . . . 1.23 114.749 169.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.927 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 10.8 ptmt -39.86 0.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 119.763 3.245 . . . . 3.8700000000000001 119.763 -140.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.927 ' CD1' ' HG3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -162.6 -15.54 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.96 1.255 . . . . 2.1099999999999999 113.594 -179.413 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.636 HG12 ' HE3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -94.62 166.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.812 0 CA-C-O 122.816 1.293 . . . . 1.29 110.114 -164.687 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.684 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 3.0 p-10 -113.65 154.81 26.61 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 112.489 -2.141 . . . . 2.73 108.867 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.961 ' CD1' ' HB2' ' A' ' 43' ' ' LYS . 5.3 mp -92.35 -23.73 19.14 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.163 0.431 . . . . 0.44 112.163 169.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 t -61.06 -21.58 63.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.883 -0.784 . . . . 1.23 108.883 -168.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.62 ' HB2' ' HD2' ' A' ' 52' ' ' LYS . 22.1 m -101.35 -41.59 6.62 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.315 1.055 . . . . 1.3400000000000001 110.457 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.684 ' HD3' ' O ' ' A' ' 48' ' ' ASP . 3.7 mptp? -73.74 -75.58 0.15 Allowed 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 113.398 -1.728 . . . . 1.3999999999999999 111.821 -168.201 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.756 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 25.2 t 7.66 87.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 126.189 2.181 . . . . 0.37 113.908 175.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' A' ' 58' ' ' GLN . . . -155.5 -131.54 1.45 Allowed Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.824 -1.989 . . . . 0.69999999999999996 111.693 179.068 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -59.81 -42.35 93.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.246 0.832 . . . . 2.75 113.246 -169.84 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 14.9 p80 -92.98 -38.11 11.84 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.548 -0.461 . . . . 1.3300000000000001 112.075 -175.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.87 HD11 ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -121.12 105.73 10.88 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.353 -1.351 . . . . 1.1100000000000001 107.353 175.526 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -99.43 113.14 25.32 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.831 -1.544 . . . . 0.76000000000000001 106.831 164.656 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.983 ' HA ' HD22 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -93.0 94.45 8.9 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 103.538 -2.764 . . . . 0.26000000000000001 103.538 168.515 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 41.4 m-70 -96.38 164.67 12.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 123.259 1.504 . . . . 2.0299999999999998 111.344 -177.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.43 120.93 17.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 110.847 -2.888 . . . . 0.92000000000000004 108.498 179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.28 116.06 25.47 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.41 -1.723 . . . . 0.46999999999999997 109.933 172.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -121.23 106.91 11.94 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 114.935 -1.03 . . . . 1.3899999999999999 110.843 -169.843 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -106.14 102.16 11.6 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.67 -1.15 . . . . 2.4199999999999999 109.252 172.318 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.79 -30.26 70.42 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.197 -1.365 . . . . 2.46 111.352 -174.051 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.14 -12.32 60.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.763 -0.653 . . . . 1.1499999999999999 110.659 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB2' ' OD2' ' A' ' 64' ' ' ASP . 14.7 m -101.33 -15.85 17.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.935 -1.135 . . . . 1.4099999999999999 107.935 173.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER 68.62 31.17 4.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.565 -1.198 . . . . 3.3100000000000001 109.822 179.192 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -132.91 134.3 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.661 0.743 . . . . 0.42999999999999999 110.329 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 63' ' ' TYR . 3.0 m-85 -104.24 111.52 24.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.311 -1.737 . . . . 1.24 106.311 162.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 25' ' ' SER . 29.2 tp -94.41 104.98 16.95 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.668 -1.234 . . . . 0.52000000000000002 107.668 175.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 60' ' ' HIS . 83.0 m-85 -86.81 113.81 22.94 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 106.642 -1.614 . . . . 0.33000000000000002 106.642 171.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.95 121.94 36.63 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 113.724 -1.58 . . . . 1.3200000000000001 110.172 -173.568 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.983 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -92.11 132.97 36.19 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.758 -1.564 . . . . 0.95999999999999996 108.399 179.114 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.37 98.62 7.03 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 103.603 -2.74 . . . . 1.1499999999999999 103.603 167.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.7 HG13 ' HB3' ' A' ' 74' ' ' LEU . 8.5 mt -124.55 100.24 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-O 122.97 1.367 . . . . 0.52000000000000002 109.282 -174.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 77.3 p -102.25 166.07 10.78 Favored 'General case' 0 N--CA 1.384 -3.736 0 CA-C-N 114.101 -1.409 . . . . 0.57999999999999996 108.5 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.44 76.17 0.18 Allowed 'General case' 0 C--N 1.272 -2.783 0 CA-C-N 111.454 -2.612 . . . . 2.1200000000000001 111.318 176.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.79 108.11 9.58 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.9 -1.955 . . . . 0.40000000000000002 110.694 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -54.23 143.43 44.8 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 1.4299999999999999 109.948 167.612 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HD3' ' CG1' ' A' ' 18' ' ' VAL . 23.4 Cg_endo -61.12 -8.39 9.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.105 2.536 . . . . 1.3300000000000001 113.25 -179.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 80' ' ' GLN . . . -106.43 12.05 30.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.33 -0.395 . . . . 1.1200000000000001 110.992 178.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.523 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -97.56 -3.81 38.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 118.102 -0.952 . . . . 1.24 111.08 -178.296 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 27.1 m -18.17 93.99 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.453 1.721 . . . . 1.22 111.291 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.936 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . -40.51 114.51 0.53 Allowed Glycine 0 CA--C 1.465 -3.093 0 CA-C-N 109.626 -3.443 . . . . 1.4299999999999999 114.24 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.984 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . -131.68 60.69 0.67 Allowed Glycine 0 N--CA 1.405 -3.411 0 CA-C-N 111.394 -2.403 . . . . 0.52000000000000002 108.941 159.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.812 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 31.2 m-85 -77.79 108.0 10.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.863 -1.162 . . . . 0.63 107.863 178.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.503 ' H ' ' HB3' ' A' ' 42' ' ' PHE . 16.0 tpt180 -106.21 112.49 25.54 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.258 0.552 . . . . 3.1499999999999999 110.616 -175.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.604 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 38.0 m -99.7 118.23 35.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.66 -0.7 . . . . 1.0800000000000001 110.241 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.785 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 76.0 mt-10 -129.18 116.56 19.39 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.711 -0.477 . . . . 1.8100000000000001 109.711 175.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 p -95.41 139.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.517 0.675 . . . . 0.54000000000000004 110.141 177.084 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.8 m -134.41 108.5 8.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.862 -1.063 . . . . 1.1799999999999999 108.271 -176.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 94' ' ' LYS . 1.1 m -131.26 -176.75 4.12 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.412 -0.813 . . . . 0.73999999999999999 109.92 -176.056 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HD3' ' H ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -10.41 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 125.04 1.462 . . . . 0.65000000000000002 114.688 -177.343 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.946 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 8.8 t70 -159.33 0.74 0.08 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.522 -1.217 . . . . 1.05 109.338 -175.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.684 ' HB3' HD22 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -100.95 145.21 28.95 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 122.223 1.011 . . . . 1.29 109.718 -177.769 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -134.77 136.8 42.87 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.653 -2.067 . . . . 0.77000000000000002 110.315 178.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.599 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 5.1 m-20 -155.09 154.66 32.75 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.048 -0.978 . . . . 1.6000000000000001 108.623 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 9.2 p -155.8 154.45 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.296 0.48 . . . . 1.1899999999999999 112.296 -175.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.812 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 79.9 p -132.01 147.79 52.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.86 -0.609 . . . . 0.83999999999999997 112.367 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.16 144.76 26.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.326 -0.852 . . . . 1.5800000000000001 110.606 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.786 ' CZ ' ' HB3' ' A' ' 24' ' ' PHE . 7.6 m-85 -137.73 103.51 5.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.558 -0.746 . . . . 0.85999999999999999 110.318 172.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.775 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -105.67 110.55 22.9 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 118.743 -1.183 . . . . 2.1099999999999999 112.363 170.414 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.936 ' H ' ' HA3' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -98.02 106.98 19.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.146 -1.388 . . . . 0.37 109.755 -179.265 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.3 m -83.77 96.65 8.81 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.512 -0.551 . . . . 0.33000000000000002 109.512 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 18' ' ' VAL . 3.4 p -80.65 112.45 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.875 1.321 . . . . 0.33000000000000002 109.118 177.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 15.0 m170 -80.44 99.74 8.14 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.027 -1.897 . . . . 1.1899999999999999 110.656 -176.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 32.3 tt0 -74.34 125.33 28.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.452 -1.249 . . . . 1.6699999999999999 110.244 172.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.19 -61.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.185 -0.461 . . . . 2.7799999999999998 110.56 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.664 -0.684 . . . . 6.9199999999999999 110.865 179.761 . . . . . . . . 0 0 . 1 stop_ save_